PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Choi, YB; Li, HL; Kassabov, SR; Jin, I; Puthanveettil, SV; Karl, KA; Lu, Y; Kim, JH; Bailey, CH; Kandel, ER				Choi, Yun-Beom; Li, Hsiu-Ling; Kassabov, Stefan R.; Jin, Iksung; Puthanveettil, Sathyanarayanan V.; Karl, Kevin A.; Lu, Yang; Kim, Joung-Hun; Bailey, Craig H.; Kandel, Eric R.			Neurexin-Neuroligin Transsynaptic Interaction Mediates Learning-Related Synaptic Remodeling and Long-Term Facilitation in Aplysia	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; ADHESION MOLECULES; ALPHA-NEUREXINS; BETA-NEUREXINS; MOTOR SYNAPSES; MEMORY STORAGE; PLASTICITY; AUTISM; GENES; INTERMEDIATE	Neurexin and neuroligin, which undergo heterophilic interactions with each other at the synapse, are mutated in some patients with autism spectrum disorder, a set of disorders characterized by deficits in social and emotional learning. We have explored the role of neurexin and neuroligin at sensory-to-motor neuron synapses of the gill-withdrawal reflex in Aplysia, which undergoes sensitization, a simple form of learned fear. We find that depleting neurexin in the presynaptic sensory neuron or neuroligin in the postsynaptic motor neuron abolishes both long-term facilitation and the associated presynaptic growth induced by repeated pulses of serotonin. Moreover, introduction into the motor neuron of the R451C mutation of neuroligin-3 linked to autism spectrum disorder blocks both intermediate-term and long-term facilitation. Our results suggest that activity-dependent regulation of the neurexin-neuroligin interaction may govern transsynaptic signaling required for the storage of long-term memory, including emotional memory that may be impaired in autism spectrum disorder.	[Choi, Yun-Beom; Li, Hsiu-Ling; Kassabov, Stefan R.; Jin, Iksung; Puthanveettil, Sathyanarayanan V.; Lu, Yang; Bailey, Craig H.; Kandel, Eric R.] Columbia Univ, New York State Psychiat Inst, Dept Neurosci, New York, NY 10032 USA; [Choi, Yun-Beom] Columbia Univ, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA; [Li, Hsiu-Ling; Karl, Kevin A.; Kandel, Eric R.] Columbia Univ, New York State Psychiat Inst, Howard Hughes Med Inst, New York, NY 10032 USA; [Bailey, Craig H.; Kandel, Eric R.] Columbia Univ, New York State Psychiat Inst, Kavli Inst Brain Sci, Coll Phys & Surg, New York, NY 10032 USA; [Kim, Joung-Hun] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 790784, Gyungbuk, South Korea	Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Pohang University of Science & Technology (POSTECH)	Kandel, ER (corresponding author), Columbia Univ, New York State Psychiat Inst, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu			Howard Hughes Medical Institute; National Institute of Health [NS053415]; Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS053415] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Professor Timothy Rose of University of Washington for help with CODEHOP PCR and Huixiang "Vivian" Zhu and Edward Konstantinov for Aplysia culture preparation. This work is supported by grants from the Howard Hughes Medical Institute (to E.R.K.), National Institute of Health grant NS053415 (to Y.-B.C.), and the Simons Foundation (to E.R.K, Y.-B.C., and C.H.B.).	BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GLANZMAN DL, 1990, SCIENCE, V249, P779; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Marinesco S, 2006, J NEUROSCI, V26, P12682, DOI 10.1523/JNEUROSCI.3309-06.2006; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mastushita-Sakai T, 2010, P NATL ACAD SCI USA, V107, P11987, DOI 10.1073/pnas.1004433107; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; SZATMARI P, 2007, PROG BRAIN RES, V169, P179; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	46	68	68	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					468	481		10.1016/j.neuron.2011.03.020	http://dx.doi.org/10.1016/j.neuron.2011.03.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555073	Green Accepted, Bronze			2022-12-24	WOS:000290926100009
J	Neumuller, RA; Richter, C; Fischer, A; Novatchkova, M; Neumuller, KG; Knoblich, JA				Neumueller, Ralph A.; Richter, Constance; Fischer, Anja; Novatchkova, Maria; Neumueller, Klaus G.; Knoblich, Juergen A.			Genome-Wide Analysis of Self-Renewal in Drosophila Neural Stem Cells by Transgenic RNAi	CELL STEM CELL			English	Article							POLYMERASE-II ELONGATION; RIBOSOMAL-PROTEIN GENES; TRANSCRIPTION FACTORS; BRAIN-TUMOR; NEUROBLAST LINEAGES; PROGENITOR CELLS; SWI/SNF COMPLEX; ALPHA-ADAPTIN; PHOSPHATASE 4; PAF1 COMPLEX	The balance between stem cell self-renewal and differentiation is precisely controlled to ensure tissue homeostasis and prevent tumorigenesis. Here we use genome-wide transgenic RNAi to identify 620 genes potentially involved in controlling this balance in Drosophila neuroblasts. We quantify all phenotypes and derive measurements for proliferation, lineage, cell size, and cell shape. We identify a set of transcriptional regulators essential for self-renewal and use hierarchical clustering and integration with interaction data to create functional networks for the control of neuroblast self-renewal and differentiation. Our data identify key roles for the chromatin remodeling Brm complex, the spliceosome, and the TRiC/CCT-complex and show that the alternatively spliced transcription factor Lola and the transcriptional elongation factors Ssrp and Barc control self-renewal in neuroblast lineages. As our data are strongly enriched for genes highly expressed in murine neural stem cells, they are likely to provide valuable insights into mammalian stem cell biology as well.	[Neumueller, Ralph A.; Richter, Constance; Fischer, Anja; Novatchkova, Maria; Neumueller, Klaus G.; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Novatchkova, Maria] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Richter, Constance/P-8714-2019; Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Richter, Constance/0000-0003-3312-0941	Austrian Academy of Sciences, Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); EU; FWF; Austrian Science Fund (FWF) [Z 153, I 552] Funding Source: researchfish	Austrian Academy of Sciences, Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); EU(European Commission); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We wish to thank B. Dickson, K. Keleman, J. Skeath, H. Richardson, G. Dietzl, S. Bhalerao, the Vienna Drosophila RNAi Center (VDRC), the Developmental Studies Hybridoma Bank (DSHB), and the Bloomington Drosophila Stock Center for constructs, antibodies, and flystocks; E. Kleiner and L. Kirschner for technical assistance and C. Juschke for help with data analysis; N. Corsini, E. Eroglu, and M. Lancaster for comments on the manuscript; M. Madalinski for peptide synthesis and affinity purification; and members of the Knoblich lab for discussions. Work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF), the EU seventh framework program EuroSyStem, and the FWF.	Adryan B, 2006, BIOINFORMATICS, V22, P1532, DOI 10.1093/bioinformatics/btl143; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Boulay JL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-71; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Copley RR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-169; Davis RJ, 2003, DEV BIOL, V259, P272, DOI 10.1016/S0012-1606(03)00201-X; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Goeke S, 2003, NAT NEUROSCI, V6, P917, DOI 10.1038/nn1105; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Helps NR, 1998, J CELL SCI, V111, P1331; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24; MARTINBERMUDO MD, 1991, DEVELOPMENT, V113, P445; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Pfreundt U, 2010, NUCLEIC ACIDS RES, V38, pD443, DOI 10.1093/nar/gkp910; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Sousa-Nunes R, 2009, GENE DEV, V23, P359, DOI 10.1101/gad.1723609; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sur I, 2009, CURR GENOMICS, V10, P594, DOI 10.2174/138920209789503932; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Zheng L, 2008, MECH DEVELOP, V125, P18, DOI 10.1016/j.mod.2007.10.007; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	65	187	191	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					580	593		10.1016/j.stem.2011.02.022	http://dx.doi.org/10.1016/j.stem.2011.02.022			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549331	Green Published, hybrid			2022-12-24	WOS:000290927600017
J	Marteyn, A; Maury, Y; Gauthier, MM; Lecuyer, C; Vernet, R; Denis, JA; Pietu, G; Peschanski, M; Martinat, C				Marteyn, Antoine; Maury, Yves; Gauthier, Morgane M.; Lecuyer, Camille; Vernet, Remi; Denis, Jerome A.; Pietu, Genevieve; Peschanski, Marc; Martinat, Cecile			Mutant Human Embryonic Stem Cells Reveal Neurite and Synapse Formation Defects in Type 1 Myotonic Dystrophy	CELL STEM CELL			English	Article							NEUROMUSCULAR-JUNCTIONS; MUSCULAR-DYSTROPHY; NERVOUS-SYSTEM; MOTOR-NEURONS; RNA; PERSONALITY; DIFFERENTIATION; ABNORMALITIES; TRANSCRIPTION; INVOLVEMENT	Myotonic dystrophy type 1 (DM1) is a multisystem disorder affecting a variety of organs, including the central nervous system. By using neuronal progeny derived from human embryonic stem cells carrying the causal DM1 mutation, we have identified an early developmental defect in genes involved in neurite formation and the establishment of neuromuscular connections. Differential gene expression profiling and quantitative RT-PCR revealed decreased expression of two members of the SLITRK family in DM1 neural cells and in DM1 brain biopsies. In addition, DM1 motoneuron/muscle cell cocultures showed alterations that are consistent with the known role of SLITRK genes in neurite outgrowth, neuritogenesis, and synaptogenesis. Rescue and knockdown experiments suggested that the functional defects can be directly attributed to SLITRK misexpression. These neuropathological mechanisms may be clinically significant for the functional changes in neuromuscular connections associated with DM1.	[Marteyn, Antoine; Gauthier, Morgane M.; Vernet, Remi; Denis, Jerome A.; Pietu, Genevieve; Peschanski, Marc; Martinat, Cecile] I STEM AFM, INSERM UEVE UMR 861, F-91030 Evry, France; [Maury, Yves; Lecuyer, Camille] I STEM AFM, CECS, F-91030 Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Martinat, C (corresponding author), Ectycell SA, F-93230 Romainville, France.	cmartinat@istem.fr	Peschanski, Marc/N-5769-2017; Martinat, Cécile S/F-6777-2010; DENIS, Jérôme Alexandre/AAG-1650-2019	Martinat, Cécile S/0000-0002-5234-1064; DENIS, Jérôme Alexandre/0000-0002-1617-4617; Marteyn, Antoine/0000-0003-2176-3595	MediCen; Genopole; AFM (Association Francaise contre les myopathie); Region Ile de France	MediCen; Genopole; AFM (Association Francaise contre les myopathie)(Association Francaise contre les Myopathies); Region Ile de France(Region Ile-de-France)	We thank Gillian Butler-Brown and Xavier Nissan for helpful discussions, Genevieve Gourdon (INSERM U781, Paris, France) for performing the CTG repeat analysis, and Karen Sermon (AZ-VUB, Brussels, Belgium) for providing DM1 and control hESCs. Part of this work was also supported by grants from MediCen (IngeCell program), Genopole, and the AFM (Association Francaise contre les myopathie). A.M. had a fellowship from the Region Ile de France. None of the authors of this manuscript have a financial interest related to this work.	ABE K, 1994, J NEUROL SCI, V127, P179, DOI 10.1016/0022-510X(94)90071-X; Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Braun S, 1996, J NEUROL SCI, V136, P17, DOI 10.1016/0022-510X(95)00315-S; Chen SY, 2009, CURR OPIN NEUROBIOL, V19, P471, DOI 10.1016/j.conb.2009.09.005; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; CROS D, 1988, ANN NEUROL, V23, P470, DOI 10.1002/ana.410230508; Damian MS, 2001, NEUROLOGY, V56, P794, DOI 10.1212/WNL.56.6.794; de Leon MB, 2008, J NEUROSCI RES, V86, P18, DOI 10.1002/jnr.21377; Delaporte C, 1998, ARCH NEUROL-CHICAGO, V55, P635, DOI 10.1001/archneur.55.5.635; Denis JA, 2011, STEM CELLS DEV, V20, P1395, DOI 10.1089/scd.2010.0331; DYKEN PR, 1973, NEUROLOGY, V23, P465, DOI 10.1212/WNL.23.5.465; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Fenno LE, 2008, CURR OPIN GENET DEV, V18, P324, DOI 10.1016/j.gde.2008.06.004; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Harper PS, 2001, MYOTONIC DYSTROPHY; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Katayama K, 2010, MOL PSYCHIATR, V15, P177, DOI 10.1038/mp.2008.97; Katayama K, 2009, PLOS ONE, V4, pA151, DOI 10.1371/journal.pone.0007786; Krishnan AV, 2006, MUSCLE NERVE, V33, P627, DOI 10.1002/mus.20516; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Llagostera E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001134; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Mateizel I, 2008, REPROD BIOMED ONLINE, V16, P741, DOI 10.1016/S1472-6483(10)60490-7; Meola G, 2003, NEUROMUSCULAR DISORD, V13, P813, DOI 10.1016/S0960-8966(03)00137-8; Modoni A, 2004, ARCH NEUROL-CHICAGO, V61, P1943, DOI 10.1001/archneur.61.12.1943; Nagao M, 2003, ACTA NEUROPATHOL, V106, P557, DOI 10.1007/s00401-003-0759-1; O'Rourke JA, 2009, J PSYCHOSOM RES, V67, P533, DOI 10.1016/j.jpsychores.2009.06.006; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PACHTER BR, 1986, GRAEF ARCH CLIN EXP, V224, P325, DOI 10.1007/BF02150024; Panaite PA, 2008, J NEUROPATH EXP NEUR, V67, P763, DOI 10.1097/NEN.0b013e318180ec64; PARK YD, 1995, J NEUROL NEUROSUR PS, V58, P512, DOI 10.1136/jnnp.58.4.512; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Saba S, 1999, J CARDIOVASC ELECTR, V10, P1214, DOI 10.1111/j.1540-8167.1999.tb00298.x; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Sistiaga A, 2010, PSYCHOL MED, V40, P487, DOI 10.1017/S0033291709990602; STRANOCK SD, 1978, NEUROPATH APPL NEURO, V4, P407, DOI 10.1111/j.1365-2990.1978.tb01352.x; TURNPENNY P, 1994, J MED GENET, V31, P300, DOI 10.1136/jmg.31.4.300; VANDERVEN PFM, 1993, HUM MOL GENET, V2, P1889; Wheeler TM, 2007, NEUROMUSCULAR DISORD, V17, P242, DOI 10.1016/j.nmd.2006.12.015; Wheeler TM, 2008, NEUROTHERAPEUTICS, V5, P592, DOI 10.1016/j.nurt.2008.08.001; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zuchner S, 2006, MOL PSYCHIATR, V11, P888, DOI 10.1038/sj.mp.4001865	51	72	74	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					434	444		10.1016/j.stem.2011.02.004	http://dx.doi.org/10.1016/j.stem.2011.02.004			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21458401	Bronze			2022-12-24	WOS:000289707100015
J	Zonta, B; Desmazieres, A; Rinaldi, A; Tait, S; Sherman, DL; Nolan, MF; Brophy, PJ				Zonta, Barbara; Desmazieres, Anne; Rinaldi, Arianna; Tait, Steven; Sherman, Diane L.; Nolan, Matthew F.; Brophy, Peter J.			A Critical Role for Neurofascin in Regulating Action Potential Initiation through Maintenance of the Axon Initial Segment	NEURON			English	Article							CEREBELLAR PURKINJE NEURONS; CELL-ADHESION MOLECULES; BETA-IV-SPECTRIN; SODIUM-CHANNEL BETA-1; ANKYRIN-G; PYRAMIDAL NEURONS; NERVOUS-SYSTEM; ION CHANNELS; NA CHANNELS; L1 FAMILY	The axon initial segment (AIS) is critical for the initiation and propagation of action potentials. Assembly of the AIS requires interactions between scaffolding molecules and voltage-gated sodium channels, but the molecular mechanisms that stabilize the AIS are poorly understood. The neuronal isoform of Neurofascin, Nfasc186, clusters voltage-gated sodium channels at nodes of Ranvier in myelinated nerves: here, we investigate its role in AIS assembly and stabilization. Inactivation of the Nfasc gene in cerebellar Purkinje cells of adult mice causes rapid loss of Nfasc186 from the AIS but not from nodes of Ranvier. This causes AIS disintegration, impairment of motor learning and the abolition of the spontaneous tonic discharge typical of Purkinje cells. Nevertheless, action potentials with a modified waveform can still be evoked and basic motor abilities remain intact. We propose that Nfasc186 optimizes communication between mature neurons by anchoring the key elements of the adult AIS complex.	[Rinaldi, Arianna; Nolan, Matthew F.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Zonta, Barbara; Desmazieres, Anne; Tait, Steven; Sherman, Diane L.; Brophy, Peter J.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Nolan, MF (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mattnolan@ed.ac.uk; peter.brophy@ed.ac.uk	Rinaldi, Arianna/F-4713-2018; RINALDI, ARIANNA/AGG-5346-2022; Nolan, Matthew/A-1356-2009	Rinaldi, Arianna/0000-0002-5167-7420; RINALDI, ARIANNA/0000-0002-5167-7420; Nolan, Matthew/0000-0003-1062-6501; Desmazieres, Anne/0000-0001-6542-4566	Medical Research Council; Wellcome Trust; Marie Curie Excellence Grant; ARSEP; EU; MRC [G0301172, G0501216] Funding Source: UKRI; Medical Research Council [G0501216, G0301172] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Marie Curie Excellence Grant(European Commission); ARSEP; EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Heather Anderson for excellent assistance. We acknowledge generous gifts of tissue from NrCAM-null mice from Dr Valerie Castellani (University of Lyon), and these mice were originally generated by Dr Fritz Rathjen (Max-Delbruck-Centre, Berlin) to whom thanks are due for tissue used in preliminary experiments. Drs. V. Bennett and M. Rasband are thanked for generous gifts of antibodies to AnkyrinG and Caspr, respectively. We gratefully acknowledge the gift of the CreERT2 cassette from Prof. P. Chambon (IGBMC/GIE-CERBM). This work was supported by the Medical Research Council, the Wellcome Trust, a Marie Curie Excellence Grant, ARSEP, and an EU Framework 7 grant to NGIDD.	Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V291, P351, DOI 10.1113/jphysiol.1979.sp012818; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kessler M, 2008, BRAIN RES, V1218, P54, DOI 10.1016/j.brainres.2008.04.063; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Luthi A, 1997, J NEUROSCI, V17, P4688; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Palmer LM, 2010, J PHYSIOL-LONDON, V588, P1709, DOI 10.1113/jphysiol.2010.188300; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Xu XR, 2005, J NEUROSCI RES, V79, P428, DOI 10.1002/jnr.20378; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	64	108	109	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					945	956		10.1016/j.neuron.2011.02.021	http://dx.doi.org/10.1016/j.neuron.2011.02.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382554	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000288736500012
J	Charlesworth, JD; Tumer, EC; Warren, TL; Brainard, MS				Charlesworth, Jonathan D.; Tumer, Evren C.; Warren, Timothy L.; Brainard, Michael S.			Learning the microstructure of successful behavior	NATURE NEUROSCIENCE			English	Article							GANGLIA-FOREBRAIN CIRCUIT; ZEBRA FINCH SONG; MOVEMENT VARIABILITY; ADULT BIRDSONG; EYE-MOVEMENTS; MOTOR; BRAIN; RESPONSES; TIME; PERTURBATION	Reinforcement signals indicating success or failure are known to alter the probability of selecting between distinct actions. However, successful performance of many motor skills, such as speech articulation, also requires learning behavioral trajectories that vary continuously over time. Here, we investigated how temporally discrete reinforcement signals shape a continuous behavioral trajectory, the fundamental frequency of adult Bengalese finch song. We provided reinforcement contingent on fundamental frequency performance only at one point in the song. Learned changes to fundamental frequency were maximal at this point, but also extended both earlier and later in the fundamental frequency trajectory. A simple principle predicted the detailed structure of learning: birds learned to produce the average of the behavioral trajectories associated with successful outcomes. This learning rule accurately predicted the structure of learning at a millisecond timescale, demonstrating that the nervous system records fine-grained details of successful behavior and uses this information to guide learning.	[Charlesworth, Jonathan D.; Tumer, Evren C.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Charlesworth, Jonathan D.; Tumer, Evren C.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Charlesworth, Jonathan D.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Charlesworth, JD (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	jcharles@phy.ucsf.edu		Brainard, Michael/0000-0002-9425-9907; Warren, Timothy/0000-0002-4429-4106	US National Institutes of Health; US National Institute on Deafness and Other Communication Disorders; Sloan-Swartz Foundation; US National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006636] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Sloan-Swartz Foundation; US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank P. Sabes, S. Sober, L. Frank, A. Doupe and S. Lisberger for discussion and comments on the manuscript and J. Wong and C. Brown for animal care. This work was supported by US National Institutes of Health R01 and P50 grants. E. C. T. was supported by a National Research Service Award postdoctoral fellowship from the US National Institute on Deafness and Other Communication Disorders and by the Sloan-Swartz Foundation. J. D. C. and T. L. W. were supported by US National Science Foundation graduate fellowships.	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Balleine BW, 2007, ANN NY ACAD SCI, V1104, P147, DOI 10.1196/annals.1390.006; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Catania A., 1984, LEARNING; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Doya Kenji, 2000, P469; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Franz M, 2002, J NEUROBIOL, V51, P129, DOI 10.1002/neu.10043; Gardner TJ, 2006, P NATL ACAD SCI USA, V103, P6094, DOI 10.1073/pnas.0601707103; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Hermes D.J., 2006, METHODS EMPIRICAL PR, P29; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; House D., 1990, TONAL PERCEPTION SPE; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Mendez JM, 2010, J NEUROPHYSIOL, V104, P984, DOI 10.1152/jn.01031.2009; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; ROSENFELD JP, 1971, PHYSIOL BEHAV, V7, P489, DOI 10.1016/0031-9384(71)90099-0; ROSENFELD JP, 1973, SCIENCE, V181, P767, DOI 10.1126/science.181.4101.767; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schoppik D, 2008, NEURON, V58, P248, DOI 10.1016/j.neuron.2008.02.015; Skinner B. F., 1953, SCI HUMAN BEHAV; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Staddon JE., 1983, ADAPTIVE BEHAV LEARN; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Thorndike E. L., 1911, ANIMAL INTELLIGENCE; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007	50	50	50	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					373	380		10.1038/nn.2748	http://dx.doi.org/10.1038/nn.2748			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278732	Green Accepted			2022-12-24	WOS:000287650100019
J	Ohata, S; Aoki, R; Kinoshita, S; Yamaguchi, M; Tsuruoka-Kinoshita, S; Tanaka, H; Wada, H; Watabe, S; Tsuboi, T; Masai, I; Okamoto, H				Ohata, Shinya; Aoki, Ryo; Kinoshita, Shigeharu; Yamaguchi, Masahiro; Tsuruoka-Kinoshita, Sachiko; Tanaka, Hideomi; Wada, Hironori; Watabe, Shugo; Tsuboi, Takashi; Masai, Ichiro; Okamoto, Hitoshi			Dual Roles of Notch in Regulation of Apically Restricted Mitosis and Apicobasal Polarity of Neuroepithelial Cells	NEURON			English	Article							DEVELOPING ZEBRAFISH HINDBRAIN; GAMMA-SECRETASE ACTIVITY; NEURAL STEM-CELLS; EPITHELIAL POLARITY; CRUMBS COMPLEX; ADHERENS JUNCTIONS; NEURONAL POLARITY; MOTOR-NEURONS; APKC-LAMBDA; MOSAIC EYES	How the mitosis of neuroepithelial stem cells is restricted to the apical ventricular area remains unclear. In zebrafish, the mosaic eyes(rw306) (moe/epb41I5(rw306)) mutation disrupts the interaction between the putative adaptor protein Moe and the apicobasal polarity regulator Crumbs (Crb), and impairs the maintenance of neuroepithelial apicobasal polarity. While Crb interacts directly with Notch and inhibits its activity, Moe reverses this inhibition. In the moe(rw306) hindbrain, Notch activity is significantly reduced, and the number of cells that proliferate basally away from the apical area is increased. Surprisingly, activation of Notch in the moe(rw306) mutant rescues not only the basally localized proliferation but also the aberrant neuroepithelial apicobasal polarity. We present evidence that the Crb.Moe complex and Notch play key roles in a positive feedback loop to maintain the apicobasal polarity and the apical-high basal-low gradient of Notch activity in neuroepithelial cells, both of which are essential for their apically restricted mitosis.	[Ohata, Shinya; Aoki, Ryo; Kinoshita, Shigeharu; Tsuruoka-Kinoshita, Sachiko; Tanaka, Hideomi; Wada, Hironori; Okamoto, Hitoshi] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan; [Aoki, Ryo; Tsuboi, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kinoshita, Shigeharu; Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; [Yamaguchi, Masahiro; Masai, Ichiro] Okinawa Inst Sci & Technol Promot, Dev Neurobiol Unit, Okinawa 9040412, Japan	RIKEN; University of Tokyo; University of Tokyo; Okinawa Institute of Science & Technology Graduate University	Okamoto, H (corresponding author), RIKEN Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hitoshi@brain.riken.jp	Okamoto, Hitoshi/P-9767-2015; Masai, Ichiro/N-3085-2019; Kinoshita, Shigeharu/AGY-8644-2022; Masai, Ichiro/N-1130-2014; TSUBOI, Takashi/AAD-7976-2019; Ohata, Shinya/S-2320-2018	Okamoto, Hitoshi/0000-0002-7512-8549; Masai, Ichiro/0000-0002-6626-6595; Masai, Ichiro/0000-0002-6626-6595; TSUBOI, Takashi/0000-0001-8290-2021; Ohata, Shinya/0000-0003-4333-4433	Ministry of Education, Culture, Sports, Science and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	The authors thank Drs. J. Aoki, M. Guo, S. Higashijima, T. Honjo, A.M. Jensen, T. M. Jessell, B. Margolis, N. Miyasaka, R. T. Moon, S. Nagata, Y. Yoshihara, and the Zebrafish International Resource Center for reagents and the transgenic zebrafish; Dr. A. B. Chitnis for the personal communication, Drs. M. Eiraku, M. Isoda, M. Itoh, M. Kengaku, A. Takashima, H. Takeda, and S. Tsuda for technical advice; Dr. A. Thomson for critical reading of the manuscript; and the other members of the Okamoto Laboratory, Brain Science Institute Research Resources Center, and the National BioResource Project of Japan for their technical assistance, fish care, and helpful discussions. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, as well as by grants for Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency.	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Cui S, 2007, MOL CELL NEUROSCI, V34, P431, DOI 10.1016/j.mcn.2006.11.016; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Guo M, 2003, HUM MOL GENET, V12, P2669, DOI 10.1093/hmg/ddg292; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Hsu YC, 2006, DEVELOPMENT, V133, P4849, DOI 10.1242/dev.02685; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jensen AM, 2001, DEVELOPMENT, V128, P95; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kimura Y, 2008, DEVELOPMENT, V135, P3001, DOI 10.1242/dev.024802; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mitsuishi Y, 2010, J BIOL CHEM, V285, P14920, DOI 10.1074/jbc.M109.038760; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Ohata S, 2009, DEVELOPMENT, V136, P1653, DOI 10.1242/dev.033290; Ohata S, 2009, BIOCHEM BIOPH RES CO, V379, P817, DOI 10.1016/j.bbrc.2008.12.149; Oinuma I, 2007, J BIOL CHEM, V282, P303, DOI 10.1074/jbc.M607979200; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okamoto H, 2010, EXP ANIM TOKYO, V59, P9, DOI 10.1538/expanim.59.9; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Pardossi-Piquard R, 2007, BIOCHEMISTRY-US, V46, P13704, DOI 10.1021/bi701347w; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Richardson ECN, 2010, DEVELOPMENT, V137, P641, DOI 10.1242/dev.041913; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Takke C, 1999, DEVELOPMENT, V126, P1811; Tanaka H, 2007, DEVELOPMENT, V134, P3259, DOI 10.1242/dev.004267; Wada H, 2005, DEVELOPMENT, V132, P2273, DOI 10.1242/dev.01810; Wada H, 2006, DEVELOPMENT, V133, P4749, DOI 10.1242/dev.02665; Wei XY, 2002, NAT GENET, V31, P150, DOI 10.1038/ng883; Westerfield M, 2007, ZEBRAFISH BOOK; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5; Zou J, 2008, J NEUROSCI, V28, P13684, DOI 10.1523/JNEUROSCI.4333-08.2008	53	71	72	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					215	230		10.1016/j.neuron.2010.12.026	http://dx.doi.org/10.1016/j.neuron.2010.12.026			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262462	Bronze			2022-12-24	WOS:000286792900007
J	Newbern, JM; Li, XY; Shoemaker, SE; Zhou, JA; Zhong, JA; Wu, YH; Bonder, D; Hollenback, S; Coppola, G; Geschwind, DH; Landreth, GE; Sniderl, WD				Newbern, Jason M.; Li, Xiaoyan; Shoemaker, Sarah E.; Zhou, Jiang; Zhong, Jian; Wu, Yaohong; Bonder, Daniel; Hollenback, Steven; Coppola, Giovanni; Geschwind, Daniel H.; Landreth, Gary E.; Sniderl, William D.			Specific Functions for ERK/MAPK Signaling during PNS Development	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; ACTIVATED PROTEIN-KINASE; SCHWANN-CELL DEVELOPMENT; SENSORY AXON GROWTH; IN-VIVO; NEURONAL SURVIVAL; REGULATED KINASE; GLIAL-CELLS; MYELINATION; DIFFERENTIATION	We have established functions of the stimulus-dependent MAPKs, ERK1/2 and ERK5, in DRG, motor neuron, and Schwann cell development. Surprisingly, many aspects of early DRG and motor neuron development were found to be ERK1/2 independent, and Erk5 deletion had no obvious effect on embryonic PNS. In contrast, Erk1/2 deletion in developing neural crest resulted in peripheral nerves that were devoid of Schwann cell progenitors, and deletion of Erk1/2 in Schwann cell precursors caused disrupted differentiation and marked hypomyelination of axons. The Schwann cell phenotypes are similar to those reported in neuregulin-1 and ErbB mutant mice, and neuregulin effects could not be elicited in glial precursors lacking Erk1/2. ERK/MAPK regulation of myelination was specific to Schwann cells, as deletion in oligodendrocyte precursors did not impair myelin formation, but reduced precursor proliferation. Our data suggest a tight linkage between developmental functions of ERK/MAPK signaling and biological actions of specific RTK-activating factors.	[Newbern, Jason M.; Li, Xiaoyan; Shoemaker, Sarah E.; Zhou, Jiang; Wu, Yaohong; Bonder, Daniel; Hollenback, Steven; Sniderl, William D.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [Landreth, Gary E.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90024 USA; [Zhong, Jian] Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dept Neurol & Neurosci, White Plains, NY 10605 USA	University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University	Sniderl, WD (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	william_snider@med.unc.edu	Messier, Claude/A-2322-2008; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Messier, Claude/0000-0002-4791-1763; Newbern, Jason/0000-0003-2865-0112	NIH [NS031768]; NSF [IBN97-23147]; NRSA [F32NS061591]; NINDS Center [P30 NS04892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061591, R01NS031768] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are extremely grateful to D. Meijer, T. Jessell, and J. Charron for providing transgenic mice; Ben Novitch, Barbara Han, and Monica Mendelsohn for the generation of the Olig2:Cre line in the laboratory of T. Jessell; T. Muller and C. Birchmeier for the generous gift of the BFABP antibody and helpful advice; E. Anton and J. Weimer for kindly providing antibodies and guidance; Dr. Louis Reichardt for kindly providing the TrkA antibody; and A. McKell and L. Goins for assistance with mouse breeding and genotyping. This work is supported by NIH grant NS031768 to W.D.S.; NSF grant IBN97-23147 to G.E.L.; and a NRSA award F32NS061591 to J.M.N. Generation of mice and imaging were supported by Cores 3 and 5, respectively, of NINDS Center Grant P30 NS04892.	Atanasoski S, 2006, J NEUROSCI, V26, P2124, DOI 10.1523/JNEUROSCI.4594-05.2006; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Baloh RH, 2009, J NEUROSCI, V29, P2312, DOI 10.1523/JNEUROSCI.2168-08.2009; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dong ZP, 1999, J NEUROSCI RES, V56, P334, DOI 10.1002/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Finegan KG, 2009, CELL DEATH DIFFER, V16, P674, DOI 10.1038/cdd.2008.193; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Kolkova K, 2000, J NEUROSCI, V20, P2238; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li YW, 2001, MOL CELL NEUROSCI, V17, P761, DOI 10.1006/mcne.2000.0967; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Murphy P, 1996, DEVELOPMENT, V122, P2847; Nekrasova T, 2005, J IMMUNOL, V175, P2374, DOI 10.4049/jimmunol.175.4.2374; Newbern J, 2008, P NATL ACAD SCI USA, V105, P17115, DOI 10.1073/pnas.0805239105; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Soundararajan P, 2010, J NEUROSCI, V30, P6595, DOI 10.1523/JNEUROSCI.4932-09.2010; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	61	159	163	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 13	2011	69	1					91	105		10.1016/j.neuron.2010.12.003	http://dx.doi.org/10.1016/j.neuron.2010.12.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220101	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000286446300010
J	Laurent, LC; Ulitsky, I; Slavin, I; Tran, H; Schork, A; Morey, R; Lynch, C; Harness, JV; Lee, S; Barrero, MJ; Ku, S; Martynova, M; Semechkin, R; Galat, V; Gottesfeld, J; Belmonte, JCI; Murry, C; Keirstead, HS; Park, HS; Schmidt, U; Laslett, AL; Muller, FJ; Nievergelt, CM; Shamir, R; Loring, JF				Laurent, Louise C.; Ulitsky, Igor; Slavin, Ileana; Tran, Ha; Schork, Andrew; Morey, Robert; Lynch, Candace; Harness, Julie V.; Lee, Sunray; Barrero, Maria J.; Ku, Sherman; Martynova, Marina; Semechkin, Ruslan; Galat, Vasiliy; Gottesfeld, Joel; Belmonte, Juan Carlos Izpisua; Murry, Chuck; Keirstead, Hans S.; Park, Hyun-Sook; Schmidt, Uli; Laslett, Andrew L.; Muller, Franz-Josef; Nievergelt, Caroline M.; Shamir, Ron; Loring, Jeanne F.			Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in Culture	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CHROMOSOMAL-ABNORMALITIES; LUNG-CANCER; EXPRESSION; IDENTIFICATION; AMPLIFICATION; HYBRIDIZATION; MICROARRAY; REGION; TUMORS	Genomic stability is critical for the clinical use of human embryonic and induced pluripotent stem cells. We performed high-resolution SNP (single-nucleotide polymorphism) analysis on 186 pluripotent and 119 nonpluripotent samples. We report a higher frequency of subchromosomal copy number variations in pluripotent samples compared to nonpluripotent samples, with variations enriched in specific genomic regions. The distribution of these variations differed between hESCs and hiPSCs, characterized by large numbers of duplications found in a few hESC samples and moderate numbers of deletions distributed across many hiPSC samples. For hiPSCs, the reprogramming process was associated with deletions of tumor-suppressor genes, whereas time in culture was associated with duplications of oncogenic genes. We also observed duplications that arose during a differentiation protocol. Our results illustrate the dynamic nature of genomic abnormalities in pluripotent stem cells and the need for frequent genomic monitoring to assure phenotypic stability and clinical safety.	[Laurent, Louise C.; Morey, Robert] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Schork, Andrew; Nievergelt, Caroline M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Laurent, Louise C.; Slavin, Ileana; Tran, Ha; Morey, Robert; Lynch, Candace; Muller, Franz-Josef; Shamir, Ron] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Laurent, Louise C.; Slavin, Ileana; Tran, Ha; Morey, Robert; Lynch, Candace; Muller, Franz-Josef; Shamir, Ron] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Ku, Sherman; Gottesfeld, Joel] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Ulitsky, Igor] Whitehead Inst, Cambridge, MA 02142 USA; [Ulitsky, Igor; Shamir, Ron] Tel Aviv Univ, Dept Comp Sci, IL-69978 Tel Aviv, Israel; [Harness, Julie V.; Keirstead, Hans S.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Lee, Sunray; Park, Hyun-Sook] Modern Cell & Tissue Technol MCTT Inc, Seoul 139240, South Korea; [Barrero, Maria J.; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Barrero, Maria J.; Belmonte, Juan Carlos Izpisua] Ctr Med Regenerat Barcelona, E-08003 Barcelona, Spain; [Martynova, Marina; Semechkin, Ruslan] Int Stem Cell Corp, Oceanside, CA 92056 USA; [Galat, Vasiliy] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Galat, Vasiliy] Northwestern Univ, Childrens Mem Res Ctr, IPS, Chicago, IL 60614 USA; [Galat, Vasiliy] Northwestern Univ, Childrens Mem Res Ctr, Human Stem Cell Core Facil, Chicago, IL 60614 USA; [Murry, Chuck] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Schmidt, Uli] Sydney IVF, Stem Cell Lab, Sydney, NSW 2000, Australia; [Laslett, Andrew L.] CSIRO, Clayton, Vic 3168, Australia; [Laslett, Andrew L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3168, Australia; [Laslett, Andrew L.] Australian Stem Cell Ctr, Clayton, Vic 3168, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Tel Aviv University; University of California System; University of California Irvine; Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; University of Washington; University of Washington Seattle; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University	Laurent, LC (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	llaurent@ucsd.edu	Martynova, Marina/AAI-7670-2021; Shamir, Ron/E-6514-2011; Laslett, Andrew L/A-9760-2011; Loring, Jeanne F/A-1620-2011; Müller, Franz-Josef/E-3336-2010; Ulitsky, Igor/HCH-7453-2022; Barrero, Maria J./Q-1785-2017	Martynova, Marina/0000-0001-6911-619X; Shamir, Ron/0000-0003-1889-9870; Laslett, Andrew L/0000-0003-4729-8193; Loring, Jeanne F/0000-0001-6226-9767; Müller, Franz-Josef/0000-0001-9478-8430; Ulitsky, Igor/0000-0003-0555-6561; Barrero, Maria J./0000-0002-5990-7040; Nievergelt, Caroline/0000-0001-5766-8923; Galat, Vasiliy/0000-0003-3612-098X; Laurent, Louise/0000-0002-2095-7534; Gottesfeld, Joel/0000-0002-4643-5777	NIH/NICHD; Hartwell Foundation; CIRM [CL1-00502, RT1-01108, TR1-01250, RN2-00931-1]; NIH [R21MH087925, R01 HL64387, P01 HL094374, R01 HL084642, P01 GM081719]; Millipore Foundation; Esther O'Keefe Foundation; Edmond J. Safra foundation in Tel Aviv University; Legacy stem cell research fund; PEW Charitable Trust; Ministry of Education, Science and Technology [SC2250]; Ministerio de Ciencia e Innovacion of Spain [RYC-2007-01510, SAF2009-08588]; MICINN Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; NHLBI [RC1HL100168]; Israel Science Foundation [802/08]; Australian Stem Cell Centre; Victoria-California Stem Cell Alliance, CIRM [TR101250]; Victoria-California Stem Cell Alliance, state government of Victoria, Australia [TR101250]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100168, P01HL094374, R01HL064387, R01HL084642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hartwell Foundation; CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millipore Foundation; Esther O'Keefe Foundation; Edmond J. Safra foundation in Tel Aviv University; Legacy stem cell research fund; PEW Charitable Trust; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Israel Science Foundation(Israel Science Foundation); Australian Stem Cell Centre; Victoria-California Stem Cell Alliance, CIRM(California Institute for Regenerative Medicine); Victoria-California Stem Cell Alliance, state government of Victoria, Australia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge all of the collaborators who contributed samples to this study, including Eirini Papapetrou (Sadelain lab), Dongbao Chen, Ralph Graichen, Jerold Chun, Martin Pera, James Shen, Scott McKercher, Timo Otonkoski, and Sheng Ding. We would like to thank Gulsah Altun for invaluable assistance. We would like to thank the NICHD Brain and Tissue Bank for Developmental Disorders, Planned Parenthood of San Diego and Riverside Counties, and Christopher Barry for generously providing tissue specimens for this study. L.C.L. was supported by an NIH/NICHD K12 Career Development Award and the Hartwell Foundation. J.F.L., I.S., H.T., CL., and F.-J.M. are supported by CIRM (CL1-00502, RT1-01108, TR1-01250, RN2-00931-1), NIH (R21MH087925), the Millipore Foundation, and the Esther O'Keefe Foundation. I.U. was supported in part by a fellowship from the Edmond J. Safra foundation in Tel Aviv University and by the Legacy stem cell research fund. I.S. was supported by the PEW Charitable Trust. H.-S.P. and S.L. were supported by a SCRC Grant (SC2250) of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology. M.J.B. was partially supported by grants RYC-2007-01510 and SAF2009-08588 from the Ministerio de Ciencia e Innovacion of Spain. Work in the laboratory of J.C.I.B. was supported by grants from MICINN Fundacion Cellex, the G. Harold and Leila Y. Mathers Charitable Foundation, and Sanofi-Aventis. C.M. was supported by NIH grants R01 HL64387, P01 HL094374, R01 HL084642, and P01 GM081719. V.G. was partially supported by NHLBI, RC1HL100168. R. Shamir was supported in part by the Israel Science Foundation (grant no. 802/08). A.L.L. was supported by grants from the Australian Stem Cell Centre and from the Victoria-California Stem Cell Alliance (TR101250) between CIRM and the state government of Victoria, Australia. H.S.K. is the chairman of the scientific advisory board of California Stem Cell, Inc. R. Semechkin and M.M. are employees and shareholders of International Stem Cell Corporation.	ATKIN NB, 1982, LANCET, V2, P1349; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Elliman SJ, 2006, J BIOL CHEM, V281, P16, DOI 10.1074/jbc.C500415200; Fox JL, 2008, NAT BIOTECHNOL, V26, P598, DOI 10.1038/nbt0608-598; Guan XY, 1996, BLOOD, V88, P1418, DOI 10.1182/blood.V88.4.1418.bloodjournal8841418; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; Iejima D, 2010, ONCOGENE, V29, P3087, DOI 10.1038/onc.2010.69; *ILL, 2008, TECHN NOT DNA COP NU; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Koynova DK, 2007, MELANOMA RES, V17, P37, DOI 10.1097/CMR.0b013e3280141617; Kresse Stine H, 2010, BMC Res Notes, V3, P223, DOI 10.1186/1756-0500-3-223; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Midorikawa Y, 2006, ONCOGENE, V25, P5581, DOI 10.1038/sj.onc.1209537; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; RODRIGUEZ E, 1993, GENE CHROMOSOME CANC, V8, P230, DOI 10.1002/gcc.2870080405; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Skotheim RI, 2002, CANCER RES, V62, P2359; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Tanner MM, 1996, CANCER RES, V56, P3441; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993	33	632	661	1	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					106	118		10.1016/j.stem.2010.12.003	http://dx.doi.org/10.1016/j.stem.2010.12.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211785	Green Accepted, Bronze			2022-12-24	WOS:000286786200015
J	Guo, T; Mandai, K; Condie, BG; Wickramasinghe, SR; Capecchi, MR; Ginty, DD				Guo, Ting; Mandai, Kenji; Condie, Brian G.; Wickramasinghe, S. Rasika; Capecchi, Mario R.; Ginty, David D.			An evolving NGF-Hoxd1 signaling pathway mediates development of divergent neural circuits in vertebrates	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; SACRAL SPINAL-CORD; EVO-DEVO; SENSORY NEURONS; AXON GUIDANCE; IN-VIVO; PROJECTIONS; RAT; NEUROTROPHINS; EXPRESSION	Species are endowed with unique sensory capabilities that are encoded by divergent neural circuits. One potential explanation for how divergent circuits have evolved is that conserved extrinsic signals are differentially interpreted by developing neurons of different species to yield unique patterns of axonal connections. Although nerve growth factor (NGF) controls survival, maturation and axonal projections of nociceptors of different vertebrates, whether the NGF signal is differentially transduced in different species to yield unique features of nociceptor circuits is unclear. We identified a species-specific signaling module induced by NGF and mediated by a rapidly evolving Hox transcription factor, Hoxd1. NGF promoted robust expression of Hoxd1 in mice, but not chickens, both in vivo and in vitro. Mice lacking Hoxd1 displayed altered nociceptor circuitry that resembles that normally found in chicks. Conversely, ectopic expression of Hoxd1 in developing chick nociceptors promoted a pattern of axonal projections reminiscent of the mouse. Thus, conserved growth factors control divergent neuronal transcriptional events that mediate interspecies differences in neural circuits and the behaviors that they control.	[Guo, Ting; Mandai, Kenji; Wickramasinghe, S. Rasika; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Condie, Brian G.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Capecchi, Mario R.] Univ Utah, Sch Med, Dept Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Johns Hopkins University; University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Mandai, Kenji/0000-0002-0115-6635	US National Institutes of Health [NS34814]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R37NS034814, R01NS034814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Sanger for green anole embryos, cDNA and assistance with staging, N. Marsh-Armstrong for frog embryos, F. Lefcort for antibodies, S. Sockanathan, B. Zhuang and C. Lee for reagents and technical assistance with chick electroporation, A. Kolodkin, M. Li, X. Dong and H. Song for helpful discussions and members of the Ginty laboratory for comments on the manuscript, discussions and assistance throughout the course of the project. This work was supported by US National Institutes of Health grant NS34814 (D.D.G.). M.R.C. and D.D.G. are investigators of the Howard Hughes Medical Institute.	Chang C, 2009, INT J DEV BIOL, V53, P813, DOI 10.1387/ijdb.072556cc; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; CHUNG K, 1993, J COMP NEUROL, V337, P63, DOI 10.1002/cne.903370104; Chuong CM, 2000, CURR OPIN GENET DEV, V10, P449, DOI 10.1016/S0959-437X(00)00111-8; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Di-Poi N, 2009, GENOME RES, V19, P602, DOI 10.1101/gr.087932.108; DODD J, 1988, SCIENCE, V242, P692, DOI 10.1126/science.3055291; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; FROHMAN MA, 1992, MECH DEVELOP, V38, P55, DOI 10.1016/0925-4773(92)90038-L; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; HEMMING FJ, 1994, CELL TISSUE RES, V277, P519, DOI 10.1007/s004410050180; HONDA CN, 1985, J NEUROPHYSIOL, V53, P1059, DOI 10.1152/jn.1985.53.4.1059; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kardong K., 2006, VERTEBRATES COMP ANA; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kim SJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-11; KOLM PJ, 1995, DEV BIOL, V167, P34, DOI 10.1006/dbio.1995.1005; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Lucas AM, 1972, AVIAN ANATOMY INTEGU, V2; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; Martinez-Garcia F, 2002, J COMP NEUROL, V447, P99, DOI 10.1002/cne.10200; MIRNICS K, 1995, J COMP NEUROL, V355, P601, DOI 10.1002/cne.903550409; NADELHAFT I, 1983, J COMP NEUROL, V216, P36, DOI 10.1002/cne.902160105; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; PROTHERO D. R., 1992, EOCENE OLIGOCENE CLI; Rice FL, 2008, SENSES COMPREHENSIVE, P1, DOI 10.1016/B978-0-12-805408-6.00340-7; Saxod R., 1978, HDB SENSORY PHYSL, VIX, P338; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; von During M., 1979, BIOL REPTILIA, P407; Wall PD, 2002, J COMP NEUROL, V449, P298, DOI 10.1002/cne.10294; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	44	40	41	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					31	U47		10.1038/nn.2710	http://dx.doi.org/10.1038/nn.2710			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151121	Green Accepted			2022-12-24	WOS:000285684900011
J	Goold, CP; Nicoll, RA				Goold, Carleton P.; Nicoll, Roger A.			Single-Cell Optogenetic Excitation Drives Homeostatic Synaptic Depression	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; INHIBITORY POSTSYNAPTIC CURRENTS; TEMPORAL-LOBE EPILEPSY; PROTEIN-KINASE CASCADE; HIPPOCAMPAL-NEURONS; CALCIUM-CHANNELS; AMPA RECEPTOR; NEURAL ACTIVITY; NMDA RECEPTORS; II INHIBITOR	Homeostatic processes have been proposed to explain the discrepancy between the dynamics of synaptic plasticity and the stability of brain function. Forms of synaptic plasticity such as long-term potentiation alter synaptic activity in a synapse- and cell-specific fashion. Although network-wide excitation triggers compensatory homeostatic changes, it is unknown whether neurons initiate homeostatic synaptic changes in response to cell-autonomous increases in excitation. Here we employ optogenetic tools to cell-autonomously excite CA1 pyramidal neurons and find that a compensatory postsynaptic depression of both AMPAR and NMDAR function results. Elevated calcium influx through L-type calcium channels leads to activation of a pathway involving CaM kinase kinase and CaM kinase 4 that induces synaptic depression of AM PAR and NMDAR responses. The synaptic depression of AMPARs but not of NMDARs requires protein synthesis and the GluA2 AMPAR subunit, indicating that downstream of CaM kinase activation divergent pathways regulate homeostatic AM PAR and NMDAR depression.	[Goold, Carleton P.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Goold, Carleton P.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Goold, Carleton P.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	nicoll@cmp.ucsf.edu			NSF; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to K. Deisseroth for ChR2 constructs, T. Soderling for CaMK constructs, and to M. Nonaka and H. Bito for CaMK4 shRNA reagents. We thank K. Bjorgan and P. Apostolides for technical assistance, and G. Davis, A. Jackson, J. Levy, W. Lu, and S. Shipman for comments on the manuscript. C.P.G. was supported by a NSF predoctoral fellowship. R.A.N. is supported by grants from the National Institute of Mental Health.	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; CAESER M, 1991, J COMP NEUROL, V307, P87, DOI 10.1002/cne.903070109; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Goold CP, 2007, NEURON, V56, P109, DOI 10.1016/j.neuron.2007.08.006; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Isokawa M, 1997, J NEUROPHYSIOL, V77, P3355, DOI 10.1152/jn.1997.77.6.3355; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Magee JC, 1996, J NEUROPHYSIOL, V76, P3460, DOI 10.1152/jn.1996.76.5.3460; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; SCHEIBEL ME, 1974, EPILEPSIA, V15, P55, DOI 10.1111/j.1528-1157.1974.tb03997.x; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Wierenga CJ, 1999, J NEUROPHYSIOL, V82, P1352, DOI 10.1152/jn.1999.82.3.1352; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	70	164	167	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					512	528		10.1016/j.neuron.2010.09.020	http://dx.doi.org/10.1016/j.neuron.2010.09.020			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040851	Green Accepted, Bronze			2022-12-24	WOS:000284255800018
J	Liu, Y; Samad, OA; Zhang, L; Duan, B; Tong, QC; Lopes, C; Ji, RR; Lowell, BB; Ma, QF				Liu, Yang; Samad, Omar Abdel; Zhang, Ling; Duan, Bo; Tong, Qingchun; Lopes, Claudia; Ji, Ru-Rong; Lowell, Bradford B.; Ma, Qiufu			VGLUT2-Dependent Glutamate Release from Nociceptors Is Required to Sense Pain and Suppress Itch	NEURON			English	Article							MECHANICALLY EVOKED DYSESTHESIAE; C-FIBER AFFERENTS; SPINAL-CORD; EXPERIMENTAL PRURITUS; CENTRAL SENSITIZATION; SCRATCHING BEHAVIOR; GENE DELETION; NEURONS; EXPRESSION; HISTAMINE	Itch can be suppressed by painful stimuli, but the underlying neural basis is unknown. We generated conditional null mice in which vesicular glutamate transporter type 2 (VGLUT2)-dependent synaptic glutamate release from mainly Nav1.8-expressing nociceptors was abolished. These mice showed deficits in pain behaviors, including mechanical pain, heat pain, capsaicin-evoked pain, inflammatory pain, and neuropathic pain. The pain deficits were accompanied by greatly enhanced itching, as suggested by (1) sensitization of both histamine-dependent and histamine-independent itch pathways and (2) development of spontaneous scratching and skin lesions. Strikingly, intradermal capsaicin injection promotes itch responses in these mutant mice, as opposed to pain responses in control litter-mates. Consequently, coinjection of capsaicin was no longer able to mask itch evoked by pruritogenic compounds. Our studies suggest that synaptic glutamate release from a group of peripheral nociceptors is required to sense pain and suppress itch. Elimination of VGLUT2 in these nociceptors creates a mouse model of chronic neurogenic itch.	[Liu, Yang; Samad, Omar Abdel; Duan, Bo; Lopes, Claudia; Ma, Qiufu] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Liu, Yang; Samad, Omar Abdel; Duan, Bo; Lopes, Claudia; Ma, Qiufu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Tong, Qingchun; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02215 USA; [Tong, Qingchun; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Zhang, Ling; Ji, Ru-Rong] Brigham & Womens Hosp, Dept Anesthesiol, Pain Res Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ma, QF (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	qiufu_ma@dfci.harvard.edu	Ji, Ru-Rong/L-7070-2017; samad, omar/K-1921-2012	Ji, Ru-Rong/0000-0002-9355-3688; Zhang, Ling/0000-0002-8308-6553; Tong, Qingchun/0000-0002-4561-2540; Liu, Yang/0000-0002-0396-3844	National Institutes of Health National Institute of Dental and Craniofacial Research [R01DE018025]; National Institute of Neurological Disorders and Stroke [R01NS047710, P01NS047572]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572, R01NS047710] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Rohini Kuner for the Nav1.8<SUP>Cre</SUP> mice, Dr. Silvia Arber for the Tau<SUP>GFP</SUP> reporter mice, and Dr. Zhou-Feng Chen for the GRPR probe. We thank Drs. Clifford Woolf, Sang-Kyou Han, Charles Stiles, and Fu-chia Yang for critical comments on the manuscript. The work is supported by the National Institutes of Health National Institute of Dental and Craniofacial Research (Grant R01DE018025) and National Institute of Neurological Disorders and Stroke (Grants R01NS047710 and P01NS047572).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Atanassoff PG, 1999, SOMATOSENS MOT RES, V16, P291; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Brohl D, 2008, DEV BIOL, V322, P381, DOI 10.1016/j.ydbio.2008.08.002; Brull SJ, 1999, SOMATOSENS MOT RES, V16, P299; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gao Yong-Jing, 2009, Open Pain J, V2, P11; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; Handwerker HO, 2010, NEUROSCI LETT, V470, P193, DOI 10.1016/j.neulet.2009.06.092; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hosogi M, 2006, PAIN, V126, P16, DOI 10.1016/j.pain.2006.06.003; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ikoma A, 2004, NEUROLOGY, V62, P212, DOI 10.1212/WNL.62.2.212; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Ishiuji Y, 2008, BRIT J DERMATOL, V158, P78, DOI 10.1111/j.1365-2133.2007.08281.x; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; LaMotte RH, 2009, J NEUROPHYSIOL, V101, P1430, DOI 10.1152/jn.91268.2008; Leo S, 2009, EUR J PAIN, V13, P1008, DOI 10.1016/j.ejpain.2008.12.001; Lewis T., 1927, HEART, V14, P139; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2008, J NEUROSCI, V28, P125, DOI 10.1523/JNEUROSCI.4472-07.2008; LYNN B, 1992, SKIN PHARMACOL, V5, P9; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Schmelz M, 1997, J NEUROSCI, V17, P8003; Schmelz M, 2010, NEUROSCI BIOBEHAV R, V34, P171, DOI 10.1016/j.neubiorev.2008.12.004; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Sikand P, 2009, PAIN, V144, P66, DOI 10.1016/j.pain.2009.03.001; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tsujii K, 2008, J PHARMACOL SCI, V108, P385, DOI 10.1254/jphs.08200SC; Ward L, 1996, PAIN, V64, P129, DOI 10.1016/0304-3959(95)00080-1; Wood GJ, 2009, J PAIN, V10, P792, DOI 10.1016/j.jpain.2009.04.002; Xu Y, 2008, J NEUROSCI, V28, P4037, DOI 10.1523/JNEUROSCI.4126-07.2008; Zou XJ, 2002, BRAIN RES, V958, P322, DOI 10.1016/S0006-8993(02)03621-1; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	63	189	195	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					543	556		10.1016/j.neuron.2010.09.008	http://dx.doi.org/10.1016/j.neuron.2010.09.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040853	Green Accepted, Bronze			2022-12-24	WOS:000284255800020
J	Peljto, M; Dasen, JS; Mazzoni, EO; Jessell, TM; Wichterle, H				Peljto, Mirza; Dasen, Jeremy S.; Mazzoni, Esteban O.; Jessell, Thomas M.; Wichterle, Hynek			Functional Diversity of ESC-Derived Motor Neuron Subtypes Revealed through Intraspinal Transplantation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DIRECTED DIFFERENTIATION; POSITIONAL IDENTITY; GENE-EXPRESSION; IDENTIFICATION; SPECIFICATION; INNERVATION; MOTONEURONS; PROJECTIONS; INHIBITOR	Cultured ESCs can form different classes of neurons, but whether these neurons can acquire specialized subtype features typical of neurons in vivo remains unclear. We show here that mouse ESCs can be directed to form highly specific motor neuron subtypes in the absence of added factors, through a differentiation program that relies on endogenous Wnts, FGFs, and Hh-mimicking the normal program of motor neuron subtype differentiation. Molecular markers that characterize motor neuron subtypes anticipate the functional properties of these neurons in vivo: ESC-derived motor neurons grafted isochronically into chick spinal cord settle in appropriate columnar domains and select axonal trajectories with a fidelity that matches that of their in vivo generated counterparts. ESC-derived motor neurons can therefore be programmed in a predictive manner to acquire molecular and functional properties that characterize one of the many dozens of specialized motor neuron subtypes that exist in vivo.	[Peljto, Mirza; Mazzoni, Esteban O.; Wichterle, Hynek] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Jessell, Thomas M.] Columbia Univ, Med Ctr, Kavli Inst Brain Sci, Dept Neurosci & Biochem & Mol Biophys, New York, NY 10032 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Dasen, Jeremy S.] NYU, Sch Med, Smilow Neurosci Program, Dept Physiol & Neurosci, New York, NY 10016 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; New York University; New York University	Wichterle, H (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA.	hw350@columbia.edu	Califano, Andrea/F-7239-2012	mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080	A.L.S. grant; NINDS [NS058502, NS055923, NS033245]; NIH [T32 HD055165]; Ruth L. Kirschstein National Research Service; Damon Runyon Cancer Research Foundation [DRG-1937-07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, P01NS055923, R37NS033245, R01NS058502] Funding Source: NIH RePORTER	A.L.S. grant; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Roger Tsien for mCherry plasmid, Stephane Nedelec for Hb9-RFP plasmid, Susan Brenner-Morton for antibodies, Ira Schieren for FACS analysis, and members of H.W. and Doetsch labs for critical discussion. This work was supported by Project A.L.S. grant (T.M.J. and H.W.), NINDS NS058502, NS055923 (H.W.), and NS033245 (T.M.J.) grants, and NIH T32 HD055165 Ruth L. Kirschstein National Research Service Award (M.P.). J.S.D. is HHMI Early Career Scientist, E.O.M. is the David and Sylvia Lieb Fellow of the Damon Runyon Cancer Research Foundation (DRG-1937-07), and T.M.J. is a HHMI investigator.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; FERNS MJ, 1995, J COMP NEUROL, V357, P272, DOI 10.1002/cne.903570207; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES CL, 1979, J MORPHOL, V162, P275, DOI 10.1002/jmor.1051620207; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Lako M, 2001, MECH DEVELOP, V103, P49, DOI 10.1016/S0925-4773(01)00331-8; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liss B, 2008, BRAIN RES REV, V58, P314, DOI 10.1016/j.brainresrev.2007.10.004; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2009, V482, P171, DOI 10.1007/978-1-59745-060-7_11; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	43	91	94	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					355	366		10.1016/j.stem.2010.07.013	http://dx.doi.org/10.1016/j.stem.2010.07.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804971	Green Accepted, Bronze			2022-12-24	WOS:000282037800012
J	Bouvier, J; Thoby-Brisson, M; Renier, N; Dubreuil, V; Ericson, J; Champagnat, J; Pierani, A; Chedotal, A; Fortin, G				Bouvier, Julien; Thoby-Brisson, Muriel; Renier, Nicolas; Dubreuil, Veronique; Ericson, Johan; Champagnat, Jean; Pierani, Alessandra; Chedotal, Alain; Fortin, Gilles			Hindbrain interneurons and axon guidance signaling critical for breathing	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; RESPIRATORY RHYTHM GENERATION; PREBOTZINGER COMPLEX; SPINAL-CORD; IN-VITRO; GENETIC IDENTIFICATION; EXPRESSING NEURONS; PACEMAKER NEURONS; MOTOR-NEURON; IDENTITY	Breathing is a bilaterally synchronous behavior that relies on a respiratory rhythm generator located in the brainstem. An essential component of this generator is the preBotzinger complex (preBotC), which paces inspirations. Little is known about the developmental origin of the interneuronal populations forming the preBotC oscillator network. We found that the homeobox gene Dbx1 controls the fate of glutamatergic interneurons required for preBotC rhythm generation in the mouse embryo. We also found that a conditional inactivation in Dbx1-derived cells of the roundabout homolog 3 (Robo3) gene, which is necessary for axonal midline crossing, resulted in left-right de-synchronization of the preBotC oscillator. Together, these findings identify Dbx1-derived interneurons as the core rhythmogenic elements of the preBotC oscillator and indicate that Robo3-dependent guidance signaling in these cells is required for bilaterally synchronous activity.	[Pierani, Alessandra] Univ Paris Diderot, CNRS, UMR 7592, Inst Jacques Monod, Paris, France; [Bouvier, Julien; Thoby-Brisson, Muriel; Champagnat, Jean; Fortin, Gilles] CNRS UPR 3294, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France; [Renier, Nicolas; Chedotal, Alain] INSERM, U968, Paris, France; [Renier, Nicolas; Chedotal, Alain] UPMC Univ Paris 06, UMR S968, Inst Vis, Paris, France; [Renier, Nicolas; Chedotal, Alain] CNRS, UMR 7210, Paris, France; [Dubreuil, Veronique] Univ Paris Diderot, CNRS, UMR 7216, Paris, France; [Ericson, Johan] Karolinska Inst, Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Pierani, A (corresponding author), Univ Paris Diderot, CNRS, UMR 7592, Inst Jacques Monod, Paris, France.	pierani.alessandra@ijm.univ-paris-diderot.fr; alain.chedotal@inserm.fr; gilles.fortin@inaf.cnrs-gif.fr	Pierani, Alessandra/O-6136-2017; Renier, Nicolas/E-1855-2018; Bouvier, Julien/C-1018-2017; Chedotal, Alain/F-2750-2017; Thoby-Brisson, Muriel/E-1167-2014	Pierani, Alessandra/0000-0002-4872-4791; Renier, Nicolas/0000-0003-2642-4402; Bouvier, Julien/0000-0002-1307-4426; Chedotal, Alain/0000-0001-7577-3794; Thoby-Brisson, Muriel/0000-0003-3214-1724; Fortin, Gilles/0000-0002-2123-8603; Dubreuil, Veronique/0000-0001-8060-3597; Ericson, Johan/0000-0002-8019-7127	Region Ile-de-France; Fondation pour la Recherche Medicale; Fondation pour la Recherche Medicale Equipe; Association Francaise contre les Myopathies [ASS-SUB06-00123]; Ville de Paris [2006 ASES 102]; Agence Nationale de la Recherche [ANR-05-NEUR-007-01, ANR-08-MNPS-030-01, ANR-07-NEUR-007-01]; Centre National de la Recherche Scientifique; Institut de la Sante et de la Recherche Medicale	Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation pour la Recherche Medicale Equipe(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ville de Paris; Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank J.-F. Brunet, C. Goridis and A. Lumsden for comments on the manuscript; M. Tessier-Lavigne for providing the Robo3 knockout; S. Karaz for providing specimens; and S. Autran and V. Mezieres for technical assistance with genotyping. J.B. is supported by Region Ile-de-France and the Fondation pour la Recherche Medicale. This work was supported by grants from Fondation pour la Recherche Medicale Equipe (A.C.), the Association Francaise contre les Myopathies (ASS-SUB06-00123, A.C.), the Ville de Paris (2006 ASES 102, A. P.) and the Agence Nationale de la Recherche (ANR-05-NEUR-007-01 BIS to A. P., ANR-08-MNPS-030-01 to A. C. and ANR-07-NEUR-007-01 to G. F.). This work benefited from the facilities and expertise of the Imagif Cell Biology Unit and the Anicampus mouse facility of the Gif-sur-Yvette campus. This work was supported by Centre National de la Recherche Scientifique and the Institut de la Sante et de la Recherche Medicale.	BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Bouvier J, 2008, EUR J NEUROSCI, V28, P510, DOI 10.1111/j.1460-9568.2008.06345.x; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnson SM, 2001, J NEUROPHYSIOL, V85, P1772, DOI 10.1152/jn.2001.85.4.1772; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Liu YY, 2003, EUR J NEUROSCI, V17, P41, DOI 10.1046/j.1460-9568.2003.02418.x; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; McKay LC, 2005, NAT NEUROSCI, V8, P1142, DOI 10.1038/nn1517; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morgado-Valle C, 2010, J NEUROSCI, V30, P3634, DOI 10.1523/JNEUROSCI.3040-09.2010; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Tan WB, 2010, J COMP NEUROL, V518, P1862, DOI 10.1002/cne.22308; Thoby-Brisson M, 2005, J NEUROSCI, V25, P4307, DOI 10.1523/JNEUROSCI.0551-05.2005; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	50	148	149	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1066	U55		10.1038/nn.2622	http://dx.doi.org/10.1038/nn.2622			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20680010	Green Submitted			2022-12-24	WOS:000281332600011
J	Liu, K; Lu, Y; Lee, JK; Samara, R; Willenberg, R; Sears-Kraxberger, I; Tedeschi, A; Park, KK; Jin, D; Cai, B; Xu, BG; Connolly, L; Steward, O; Zheng, BH; He, ZG				Liu, Kai; Lu, Yi; Lee, Jae K.; Samara, Ramsey; Willenberg, Rafer; Sears-Kraxberger, Ilse; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; Steward, Oswald; Zheng, Binhai; He, Zhigang			PTEN deletion enhances the regenerative ability of adult corticospinal neurons	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH-INHIBITORS; NOGO-DEFICIENT MICE; AXON REGENERATION; FUNCTIONAL RECOVERY; TRACT AXONS; IN-VIVO; RAT; PLASTICITY	Despite the essential role of the corticospinal tract (CST) in controlling voluntary movements, successful regeneration of large numbers of injured CST axons beyond a spinal cord lesion has never been achieved. We found that PTEN/mTOR are critical for controlling the regenerative capacity of mouse corticospinal neurons. After development, the regrowth potential of CST axons was lost and this was accompanied by a downregulation of mTOR activity in corticospinal neurons. Axonal injury further diminished neuronal mTOR activity in these neurons. Forced upregulation of mTOR activity in corticospinal neurons by conditional deletion of Pten, a negative regulator of mTOR, enhanced compensatory sprouting of uninjured CST axons and enabled successful regeneration of a cohort of injured CST axons past a spinal cord lesion. Furthermore, these regenerating CST axons possessed the ability to reform synapses in spinal segments distal to the injury. Thus, modulating neuronal intrinsic PTEN/mTOR activity represents a potential therapeutic strategy for promoting axon regeneration and functional repair after adult spinal cord injury.	[Liu, Kai; Lu, Yi; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; He, Zhigang] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Liu, Kai; Lu, Yi; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Lee, Jae K.; Samara, Ramsey; Zheng, Binhai] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Willenberg, Rafer; Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Coll Med, Reeve Irvine Res Ctr, Irvine, CA 92717 USA; [Willenberg, Rafer; Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol Neurobiol & Behav & Neurosu, Irvine, CA 92717 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine	He, ZG (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	Lu, Yi/AEV-5561-2022	Liu, Kai/0000-0001-9351-1640; Steward, Oswald/0000-0001-7069-8756	Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke; International Spinal Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070558, R01NS068128, R01NS054734] Funding Source: NIH RePORTER	Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Spinal Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Wang for providing Rosa-stop-PLAP mice and M. Greenberg, M. Tessier-Lavigne and C. Woolf for reading the manuscript. This work was supported by grants from Wings for Life (K.L. and Z.H.), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Z.H.), the Craig H. Neilson Foundation (Y.L. and K.K.P.), the National Institute of Neurological Disorders and Stroke (Z.H., B.Z. and O.S.), the International Spinal Research Trust (Z.H.) and a private contribution to the Reeve-Irvine Research Center (O.S.). R.W. is the recipient of a predoctoral fellowship from the National Institute of Neurological Disorders and Stroke.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Berger W, 1998, NEUROSCI BIOBEHAV R, V22, P579, DOI 10.1016/S0149-7634(97)00047-X; BERNSTEI.JJ, 1973, EXP NEUROL, V41, P402, DOI 10.1016/0014-4886(73)90282-3; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Fujiki M, 1996, J COMP NEUROL, V371, P469; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hasegawa H, 2008, J COMP NEUROL, V511, P543, DOI 10.1002/cne.21862; Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Lee JK, 2009, J NEUROSCI, V29, P8649, DOI 10.1523/JNEUROSCI.1864-09.2009; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Persson S, 2006, J COMP NEUROL, V497, P683, DOI 10.1002/cne.20987; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; YIN HS, 1983, J NEUROSCI, V3, P1135; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zheng BH, 2006, TRENDS NEUROSCI, V29, P640, DOI 10.1016/j.tins.2006.09.005; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	48	643	679	5	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1075	U64		10.1038/nn.2603	http://dx.doi.org/10.1038/nn.2603			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694004	Green Accepted, Green Submitted			2022-12-24	WOS:000281332600012
J	Schlosburg, JE; Blankman, JL; Long, JZ; Nomura, DK; Pan, B; Kinsey, SG; Nguyen, PT; Ramesh, D; Booker, L; Burston, JJ; Thomas, EA; Selley, DE; Sim-Selley, LJ; Liu, QS; Lichtman, AH; Cravatt, BF				Schlosburg, Joel E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Pan, Bin; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Thomas, Elizabeth A.; Selley, Dana E.; Sim-Selley, Laura J.; Liu, Qing-song; Lichtman, Aron H.; Cravatt, Benjamin F.			Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR ADAPTATION; PRECIPITATED WITHDRAWAL; BRAIN; DELTA(9)-TETRAHYDROCANNABINOL; ANANDAMIDE; TOLERANCE; ENZYMES; IDENTIFICATION; INHIBITION	Prolonged exposure to drugs of abuse, such as cannabinoids and opioids, leads to pharmacological tolerance and receptor desensitization in the nervous system. We found that a similar form of functional antagonism was produced by sustained inactivation of monoacylglycerol lipase (MAGL), the principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol. After repeated administration, the MAGL inhibitor JZL184 lost its analgesic activity and produced cross-tolerance to cannabinoid receptor (CB1) agonists in mice, effects that were phenocopied by genetic disruption of Mgll (encoding MAGL). Chronic MAGL blockade also caused physical dependence, impaired endocannabinoid-dependent synaptic plasticity and desensitized brain CB1 receptors. These data contrast with blockade of fatty acid amide hydrolase, an enzyme that degrades the other major endocannabinoid anandamide, which produced sustained analgesia without impairing CB1 receptors. Thus, individual endocannabinoids generate distinct analgesic profiles that are either sustained or transitory and associated with agonism and functional antagonism of the brain cannabinoid system, respectively.	[Schlosburg, Joel E.; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Selley, Dana E.; Sim-Selley, Laura J.; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Pan, Bin; Liu, Qing-song] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Thomas, Elizabeth A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Virginia Commonwealth University; Scripps Research Institute; Scripps Research Institute; Medical College of Wisconsin; Scripps Research Institute	Lichtman, AH (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	alichtma@vcu.edu; cravatt@scripps.edu	Pan, Bin/C-9630-2011; Pan, Bin/D-5626-2011	Pan, Bin/0000-0002-5134-2508; Long, Jonathan/0000-0003-2631-7463	US National Institutes of Health [DA017259, DA009789, DA025285, DA005274, DA015683, DA03672, DA07027, DA014277, DA023758, DA024741]; Ruth L. Kirschstein US National Institutes of Health [DA023758, DA026261, DA026279, DA028333]; American Cancer Society; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007027, F31DA026261, F30DA023758, R01DA003672, R01DA014277, P01DA009789, R01DA024741, P01DA017259, R01DA015683, F31DA028333, R01DA025285, F31DA026279, R37DA003672, P50DA005274] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Niessen and H. Hoover for assistance with proteomics studies, I. Beletskaya and R. Abdullah for technical support and the Cravatt and Lichtman laboratories for critical reading of the manuscript. This work was supported by the US National Institutes of Health (grants DA017259, DA009789, DA025285, DA005274, DA015683, DA03672, DA005274, DA07027, DA014277, DA023758 and DA024741), Ruth L. Kirschstein US National Institutes of Health Predoctoral Fellowships (DA026261 to J.L.B., DA026279 to J.E.S., DA028333 to L.B. and DA023758 to P.T.N.), the American Cancer Society (D.K.N.) and the Skaggs Institute for Chemical Biology.	ACETO MD, 1995, EUR J PHARMACOL, V282, pR1, DOI 10.1016/0014-2999(95)00447-S; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Falenski KW, 2010, NEUROPSYCHOPHARMACOL, V35, P1775, DOI 10.1038/npp.2010.44; FAN F, 1994, J PHARMACOL EXP THER, V271, P1383; Fowler CJ, 2006, FUND CLIN PHARMACOL, V20, P549, DOI 10.1111/j.1472-8206.2006.00442.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Haller J, 2009, PSYCHOPHARMACOLOGY, V204, P607, DOI 10.1007/s00213-009-1494-7; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Lanoir J, 2006, J COMP NEUROL, V495, P607, DOI 10.1002/cne.20916; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Lichtman AH, 1996, J PHARMACOL EXP THER, V276, P585; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Luk T, 2004, BRIT J PHARMACOL, V142, P495, DOI 10.1038/sj.bjp.0705792; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; PERTWEE RG, 1991, NEUROPHARMACOLOGY, V30, P237, DOI 10.1016/0028-3908(91)90150-A; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Schlosburg JE, 2009, AAPS J, V11, P342, DOI 10.1208/s12248-009-9110-7; Sim LJ, 1996, J NEUROSCI, V16, P8057; Sim-Selley LJ, 2002, J PHARMACOL EXP THER, V303, P36, DOI 10.1124/jpet.102.035618; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sun M, 2007, J PHYSIOL-LONDON, V578, P751, DOI 10.1113/jphysiol.2006.120147; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Thomas EA, 2001, J NEUROCHEM, V76, P789, DOI 10.1046/j.1471-4159.2001.00027.x; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	50	448	460	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1113	U111		10.1038/nn.2616	http://dx.doi.org/10.1038/nn.2616			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729846	Green Accepted			2022-12-24	WOS:000281332600017
J	Jazayeri, M; Shadlen, MN				Jazayeri, Mehrdad; Shadlen, Michael N.			Temporal context calibrates interval timing	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; NEURAL BASIS; TIME; REPRESENTATION; DECISION; CUES; DISCRIMINATION; INTEGRATION; PERCEPTION; JUDGMENT	We use our sense of time to identify temporal relationships between events and to anticipate actions. The degree to which we can exploit temporal contingencies depends on the variability of our measurements of time. We asked humans to reproduce time intervals drawn from different underlying distributions. As expected, production times were more variable for longer intervals. However, production times exhibited a systematic regression toward the mean. Consequently, estimates for a sample interval differed depending on the distribution from which it was drawn. A performance-optimizing Bayesian model that takes the underlying distribution of samples into account provided an accurate description of subjects' performance, variability and bias. This finding suggests that the CNS incorporates knowledge about temporal uncertainty to adapt internal timing mechanisms to the temporal statistics of the environment.	[Jazayeri, Mehrdad] Helen Hay Whitney Fdn, New York, NY USA; [Jazayeri, Mehrdad; Shadlen, Michael N.] Univ Washington, Dept Physiol & Biophys, Natl Primate Res Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Jazayeri, M (corresponding author), Helen Hay Whitney Fdn, New York, NY USA.	mjaz@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	Helen Hay Whitney Foundation; Howard Hughes Medical Institute; US National Institutes of Health [EY11378, RR000166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to G. Horwitz for sharing resources and to both G. Horwitz and V. de Lafuente for their feedback on the manuscript. This work was supported by a fellowship from Helen Hay Whitney Foundation, the Howard Hughes Medical Institute and research grants EY11378 and RR000166 from the US National Institutes of Health.	AHRENS M, 2008, ADV NEURAL INFORM PR; ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; Bernardo JM, 1994, BAYESIAN THEORY; Brannon EM, 2008, J COGNITIVE NEUROSCI, V20, P193, DOI 10.1162/jocn.2008.20016; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Cui X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000167; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GIBBON J, 1992, J EXP ANAL BEHAV, V57, P393, DOI 10.1901/jeab.1992.57-393; Gold JI, 2008, J NEUROPHYSIOL, V100, P2653, DOI 10.1152/jn.90629.2008; Graf EW, 2005, VISION RES, V45, P3050, DOI 10.1016/j.visres.2005.08.007; HELSON H, 1948, PSYCHOL REV, V55, P297, DOI 10.1037/h0056721; HOLLINGWORTH HL, 1913, ARCH PSYCHOL, V4, P44; Hudson TE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000130; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mamassian P, 2002, NEU INF PRO, P13; Mamassian P, 2008, PSYCHOL SCI, V19, P601, DOI 10.1111/j.1467-9280.2008.02129.x; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; OKANO K, 1987, EXP BRAIN RES, V66, P155; PARDUCCI A, 1965, PSYCHOL REV, V72, P407, DOI 10.1037/h0022602; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Raphan M., 2006, NEURAL INFORM PROCES, V19, P1145; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Tanaka M, 2006, NAT NEUROSCI, V9, P20, DOI 10.1038/nn1617; Tanaka M, 2007, J NEUROSCI, V27, P12109, DOI 10.1523/JNEUROSCI.1873-07.2007; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419	48	391	393	4	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1020	U152		10.1038/nn.2590	http://dx.doi.org/10.1038/nn.2590			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581842	Green Accepted			2022-12-24	WOS:000280400600022
J	Johansen, JP; Tarpley, JW; LeDoux, JE; Blair, HT				Johansen, Joshua P.; Tarpley, Jason W.; LeDoux, Joseph E.; Blair, Hugh T.			Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; LATERAL AMYGDALA; POTENTIATED STARTLE; SYNAPTIC PLASTICITY; CONDITIONED FEAR; RAT; PROJECTIONS; RESPONSES; NUCLEUS; NEURONS	A form of aversively motivated learning called fear conditioning occurs when a neutral conditioned stimulus is paired with an aversive unconditioned stimulus (UCS). UCS-evoked depolarization of amygdala neurons may instruct Hebbian plasticity that stores memories of the conditioned stimulus-unconditioned stimulus association, but the origin of UCS inputs to the amygdala is unknown. Theory and evidence suggest that instructive UCS inputs to the amygdala will be inhibited when the UCS is expected, but this has not been found during fear conditioning. We investigated neural pathways that relay information about the UCS to the amygdala by recording neurons in the amygdala and periaqueductal gray (PAG) of rats during fear conditioning. UCS-evoked responses in both amygdala and PAG were inhibited by expectation. Pharmacological inactivation of the PAG attenuated UCS-evoked responses in the amygdala and impaired acquisition of fear conditioning, indicating that PAG may be an important part of the pathway that relays instructive signals to the amygdala.	[Johansen, Joshua P.; Tarpley, Jason W.; Blair, Hugh T.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Johansen, Joshua P.; Tarpley, Jason W.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA; [LeDoux, Joseph E.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [LeDoux, Joseph E.] Nathan S Kline Inst Psychiat Res, Emot Brain Inst, Orangeburg, NY 10962 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University; Nathan Kline Institute for Psychiatric Research	Blair, HT (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA.	jtarpley@ucla.edu; blair@psych.ucla.edu	Johansen, Joshua/N-8010-2015	Johansen, Joshua/0000-0003-4240-1550; Blair, Hugh/0000-0001-8256-5109	National Science Foundation; National Alliance for Research on Schizophrenia and Depression; US National Institutes of Health [R01 MH073700-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073700] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Alliance for Research on Schizophrenia and Depression(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to S. Nicola and A. Welday for comments on an earlier version of the manuscript and M. Fanselow, D. Buonomano, R. Thompson, D. Schiller and Y. Niv for valuable discussions. This work was supported by a National Science Foundation Graduate Research Fellowship to J.P.J. and a National Alliance for Research on Schizophrenia and Depression Young Investigator Award and US National Institutes of Health grant (R01 MH073700-01) to H. T. B.	ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Blair HT, 2005, J NEUROSCI, V25, P4198, DOI 10.1523/JNEUROSCI.0674-05.2005; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Borszcz GS, 2006, PAIN, V123, P155, DOI 10.1016/j.pain.2006.02.026; Brunzell DH, 2001, BEHAV NEUROSCI, V115, P365, DOI 10.1037//0735-7044.115.2.365; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; ENNIS M, 1991, J COMP NEUROL, V306, P480, DOI 10.1002/cne.903060311; Fanselow M.S., 1991, MIDBRAIN PERIAQUEDUC; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; HELMSTETTER FJ, 1994, J NEUROSCI, V14, P7099; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; HERRERO MT, 1991, BRAIN RES, V543, P201, DOI 10.1016/0006-8993(91)90029-U; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Keay KA, 1997, J COMP NEUROL, V385, P207, DOI 10.1002/(SICI)1096-9861(19970825)385:2<207::AID-CNE3>3.0.CO;2-5; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McNally GP, 2006, LEARN MEMORY, V13, P245, DOI 10.1101/lm.196606; McNally GP, 2006, BEHAV NEUROSCI, V120, P313, DOI 10.1037/0735-7044.120.2.313; OTTERSEN OP, 1981, J COMP NEUROL, V202, P335, DOI 10.1002/cne.902020304; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rescorla R. A., 1972, CLASSICAL CONDITIONI; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Thompson RF, 1998, NEUROBIOL LEARN MEM, V70, P150, DOI 10.1006/nlme.1998.3845; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; YOUNG SL, 1992, J EXP PSYCHOL ANIM B, V18, P400, DOI 10.1037/0097-7403.18.4.400; Zhao ZW, 2004, J NEUROSCI, V24, P10326, DOI 10.1523/JNEUROSCI.2758-04.2004	50	184	184	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					979	U102		10.1038/nn.2594	http://dx.doi.org/10.1038/nn.2594			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	632DK	20601946	Green Accepted			2022-12-24	WOS:000280400600017
J	Bero, AW; Yan, P; Roh, JH; Cirrito, JR; Stewart, FR; Raichle, ME; Lee, JM; Holtzman, DM				Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Raichle, Marcus E.; Lee, Jin-Moo; Holtzman, David M.			Neuronal activity regulates the regional vulnerability to amyloid-beta deposition	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; MESSENGER-RNA; IN-VIVO; AEROBIC GLYCOLYSIS; FUNCTIONAL CONNECTIVITY; INTERSTITIAL FLUID; DEFAULT NETWORK; GAMMA-SECRETASE; HUMAN-BRAIN	Amyloid-beta (A beta) plaque deposition in specific brain regions is a pathological hallmark of Alzheimer's disease. However, the mechanism underlying the regional vulnerability to A beta deposition in Alzheimer's disease is unknown. Herein, we provide evidence that endogenous neuronal activity regulates the regional concentration of interstitial fluid (ISF) A beta, which drives local A beta aggregation. Using in vivo microdialysis, we show that ISF A beta concentrations in several brain regions of APP transgenic mice before plaque deposition were commensurate with the degree of subsequent plaque deposition and with the concentration of lactate, a marker of neuronal activity. Furthermore, unilateral vibrissal stimulation increased ISF A beta, and unilateral vibrissal deprivation decreased ISF A beta and lactate, in contralateral barrel cortex. Long-term unilateral vibrissal deprivation decreased amyloid plaque formation and growth. Our results suggest a mechanism to account for the vulnerability of specific brain regions to A beta deposition in Alzheimer's disease.	[Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Raichle, Marcus E.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bero, Adam W.; Roh, Jee Hoon; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu	JH, Roh/F-4078-2014; Lee, Jin-Moo/K-2024-2015	JH, Roh/0000-0002-3243-0529; Lee, Jin-Moo/0000-0002-3979-0906	US National Institutes of Health [AG033452, AG029524, AG568127, NS06833, NS67905, NS32636, AG13956, P30NS057105]; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS067905, P01NS006833, P01NS032636, P50NS006833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG029524, F31AG033452, R37AG013956, R01AG013956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R.H. Mach (Washington University School of Medicine, St. Louis) for generously providing methoxy-X04 and X-34. We thank K.H. Ashe (University of Minnesota) for generously providing Tg2576 mice. We thank Eli Lilly and Co. for generously providing m266 and biotinylated 3D6 anti-A beta antibodies. This work was supported by US National Institutes of Health grants AG033452 (A.W.B.), AG029524 (J.R.C.), AG568127 (J.R.C.), NS06833 (M.E.R.), NS67905 (J.-M.L.), NS32636 (J.-M.L.), AG13956 (D.M.H.), P30NS057105 (D.M.H.) and the Cure Alzheimer's Fund (D.M.H.).	BAHMANYAR S, 1987, SCIENCE, V237, P77, DOI 10.1126/science.3299701; Bigl M, 2000, NEUROSCI LETT, V292, P107, DOI 10.1016/S0304-3940(00)01452-X; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; DURHAM D, 1978, J COMP NEUROL, V178, P629, DOI 10.1002/cne.901780403; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Flicker L, 2010, J ALZHEIMERS DIS, V20, P803, DOI 10.3233/JAD-2010-091624; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; Goldstein ME, 2007, J PHARMACOL EXP THER, V323, P102, DOI 10.1124/jpet.107.125492; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 2001, AM J PATHOL, V158, P173, DOI 10.1016/S0002-9440(10)63955-7; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Lazarov O, 2002, J NEUROSCI, V22, P9785; MELZER P, 1985, BRAIN RES, V348, P229, DOI 10.1016/0006-8993(85)90441-X; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Olney JW, 1997, ARCH NEUROL-CHICAGO, V54, P1234, DOI 10.1001/archneur.1997.00550220042012; Page K, 1996, P NATL ACAD SCI USA, V93, P14020, DOI 10.1073/pnas.93.24.14020; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rojas MJ, 2006, AM J PHYSIOL-REG I, V291, pR189, DOI 10.1152/ajpregu.00409.2005; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Uehara T, 2008, PHARMACOL BIOCHEM BE, V90, P273, DOI 10.1016/j.pbb.2008.04.001; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	49	575	589	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					750	U353		10.1038/nn.2801	http://dx.doi.org/10.1038/nn.2801			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532579	Green Accepted			2022-12-24	WOS:000290958000018
J	Ionta, S; Heydrich, L; Lenggenhager, B; Mouthon, M; Fornari, E; Chapuis, D; Gassert, R; Blanke, O				Ionta, Silvio; Heydrich, Lukas; Lenggenhager, Bigna; Mouthon, Michael; Fornari, Eleonora; Chapuis, Dominique; Gassert, Roger; Blanke, Olaf			Multisensory Mechanisms in Temporo-Parietal Cortex Support Self-Location and First-Person Perspective	NEURON			English	Article							OF-BODY EXPERIENCE; VENTRAL INTRAPARIETAL AREA; HUMAN VESTIBULAR CORTEX; TEMPOROPARIETAL JUNCTION; VISUAL-PERCEPTION; PREMOTOR CORTEX; NEURAL BASIS; STIMULATION; BRAIN; CONSCIOUSNESS	Self-consciousness has mostly been approached by philosophical enquiry and not by empirical neuroscientific study, leading to an overabundance of diverging theories and an absence of data-driven theories. Using robotic technology, we achieved specific bodily conflicts and induced predictable changes in a fundamental aspect of self-consciousness by altering where healthy subjects experienced themselves to be (self-location). Functional magnetic resonance imaging revealed that temporo-parietal junction (TPJ) activity reflected experimental changes in self-location that also depended on the first-person perspective due to visuo-tactile and visuo-vestibular conflicts. Moreover, in a large lesion analysis study of neurological patients with a well-defined state of abnormal self-location, brain damage was also localized at TPJ, providing causal evidence that TPJ encodes self-location. Our findings reveal that multisensory integration at the TPJ reflects one of the most fundamental subjective feelings of humans: the feeling of being an entity localized at a position in space and perceiving the world from this position and perspective.	[Ionta, Silvio; Heydrich, Lukas; Lenggenhager, Bigna; Mouthon, Michael; Blanke, Olaf] Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland; [Chapuis, Dominique; Gassert, Roger] Ecole Polytech Fed Lausanne, Robot Syst Lab, CH-1015 Lausanne, Switzerland; [Heydrich, Lukas; Blanke, Olaf] Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva, Switzerland; [Fornari, Eleonora] CHU Vaudois, Dept Radiol, CIBM CHUV unit, CH-1011 Lausanne, Switzerland; [Fornari, Eleonora] Univ Lausanne, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Blanke, O (corresponding author), Ecole Polytech Fed Lausanne, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland.	olaf.blanke@epfl.ch	Heydrich, Lukas/D-5283-2011; Gassert, Roger/B-6351-2011; ionta, silvio/AGB-3634-2022; Gassert, Roger/I-1591-2019	Heydrich, Lukas/0000-0001-8520-1300; Gassert, Roger/0000-0002-6373-8518; ionta, silvio/0000-0003-2078-4861; Gassert, Roger/0000-0002-6373-8518; Lenggenhager, Bigna/0000-0003-0418-9931; Mouthon, Michael/0000-0002-2557-4102	Stoicescu Foundation; Swiss Science Foundation; Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation; Swiss National Science Foundation (SNSF) [323530-123718]; Swiss National Foundation [SINERGIA CRSII1-125135/1]	Stoicescu Foundation; Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss National Foundation(Swiss National Science Foundation (SNSF))	The authors thank R. Frackowiak and C. Lopez for their critical comments on an earlier version of the manuscript. This work was supported by the Stoicescu Foundation, the Swiss Science Foundation (Sinergia grant Balancing Body and Self), the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG), and the Leenaards and the Jeantet Foundations. LH is supported by the Swiss National Science Foundation (SNSF, grant 323530-123718). The authors are supported by the Swiss National Foundation (SINERGIA CRSII1-125135/1).	Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2010, BRAIN TOPOGR, V23, P321, DOI 10.1007/s10548-010-0138-x; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Brandt C, 2005, NERVENARZT, V76, P1259, DOI 10.1007/s00115-005-1904-y; Brandt T, 1999, ANN NY ACAD SCI, V871, P293, DOI 10.1111/j.1749-6632.1999.tb09193.x; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Brugger P, 2002, COGN NEUROPSYCHIATR, P179, DOI 10.1080/13546800244000076; BRUGGER P, 1994, J NEUROL NEUROSUR PS, V57, P838, DOI 10.1136/jnnp.57.7.838; Bucher SF, 1998, ANN NEUROL, V44, P120, DOI 10.1002/ana.410440118; Critchley M., 1953, PARIETAL LOBES; Damasio AR, 1999, SCI AM, V281, P112, DOI 10.1038/scientificamerican1299-112; De Ridder D, 2007, NEW ENGL J MED, V357, P1829, DOI 10.1056/NEJMoa070010; DEVINSKY O, 1989, ARCH NEUROL-CHICAGO, V46, P1080, DOI 10.1001/archneur.1989.00520460060015; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eickhoff SB, 2006, HUM BRAIN MAPP, V27, P611, DOI 10.1002/hbm.20205; Farrell MJ, 2000, NEUROPSYCHOLOGIA, V38, P585, DOI 10.1016/S0028-3932(99)00123-2; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Fasold O, 2002, NEUROIMAGE, V17, P1384, DOI 10.1006/nimg.2002.1241; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gassert R, 2008, IEEE ENG MED BIOL, V27, P15, DOI 10.1109/EMB.2007.910265; Gassert R, 2006, CONCEPT MAGN RESON B, V29B, P191, DOI 10.1002/cmr.b.20070; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; Hecaen H., 1952, MECONNAISSANCES HALL; Iriki A, 1996, NEUROREPORT, V7, P2325; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Lopez C, 2006, NEUROREPORT, V17, P797, DOI 10.1097/01.wnr.0000221843.58373.c8; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maillard L, 2004, EPILEPSIA, V45, P391, DOI 10.1111/j.0013-9580.2004.39103.x; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Moro V, 2008, NEURON, V60, P235, DOI 10.1016/j.neuron.2008.09.022; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schilder P., 1936, J NERV MENT DIS, V83, P227, DOI [10.1097/00005053-193602000-00051, DOI 10.1097/00005053-193602000-00051]; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; Schwabe L, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.017.2008; Schwabe L, 2009, HUM BRAIN MAPP, V30, P1801, DOI 10.1002/hbm.20764; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urgesi C, 2007, NAT NEUROSCI, V10, P30, DOI 10.1038/nn1815; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Vitte E, 1996, EXP BRAIN RES, V112, P523; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215	73	299	301	3	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 28	2011	70	2					363	374		10.1016/j.neuron.2011.03.009	http://dx.doi.org/10.1016/j.neuron.2011.03.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521620	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000291073700016
J	Daw, ND; Gershman, SJ; Seymour, B; Dayan, P; Dolan, RJ				Daw, Nathaniel D.; Gershman, Samuel J.; Seymour, Ben; Dayan, Peter; Dolan, Raymond J.			Model-Based Influences on Humans' Choices and Striatal Prediction Errors	NEURON			English	Article							TEMPORAL DIFFERENCE MODELS; DOPAMINE NEURONS ENCODE; RISKY DECISION-MAKING; HUMAN BRAIN; BASAL GANGLIA; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; LEARNING SIGNALS; SUBJECTIVE VALUE	The mesostriatal dopamine system is prominently implicated in model-free reinforcement learning, with fMRI BOLD signals in ventral striatum notably covarying with model-free prediction errors. However, latent learning and devaluation studies show that behavior also shows hallmarks of model-based planning, and the interaction between model-based and model-free values, prediction errors, and preferences is underexplored. We designed a multistep decision task in which model-based and model-free influences on human choice behavior could be distinguished. By showing that choices reflected both influences we could then test the purity of the ventral striatal BOLD signal as a model-free report. Contrary to expectations, the signal reflected both model-free and model-based predictions in proportions matching those that best explained choice behavior. These results challenge the notion of a separate model-free learner and suggest a more integrated computational architecture for high-level human decision-making.	[Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10012 USA; [Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10012 USA; [Gershman, Samuel J.] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Gershman, Samuel J.] Princeton Univ, Inst Neurosci, Princeton, NJ 08540 USA; [Seymour, Ben; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	New York University; New York University; Princeton University; Princeton University; University of London; University College London; University of London; University College London	Daw, ND (corresponding author), NYU, Ctr Neural Sci, New York, NY 10012 USA.	daw@cns.nyu.edu		Dayan, Peter/0000-0003-3476-1839; Dolan, Ray/0000-0001-9356-761X; Seymour, Ben/0000-0003-1724-5832	McKnight Scholar Award; NIMH [1R01MH087882-01]; CRCNS; NARSAD; Gatsby Charitable Foundation; Wellcome Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087882] Funding Source: NIH RePORTER	McKnight Scholar Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CRCNS; NARSAD(NARSAD); Gatsby Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to Yael Niv, Dylan Simon, Aaron Bornstein, Seth Madlon-Kay, Bianca Wittmann, Bernard Balleine, Jan Glascher, and John O'Doherty for helpful conversations and advice. This work was in part supported by a McKnight Scholar Award (N.D.), NIMH grant 1R01MH087882-01, part of the CRCNS program (N.D.), a NARSAD Young Investigator Award (N.D.), the Gatsby Charitable Foundation (P.D.), and a Wellcome Trust Programme Grant to R.J.D.	ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; [Anonymous], 2010, R LANG ENV STAT COMP; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Ballmaier M, 2004, PSYCHIAT RES-NEUROIM, V130, P43, DOI 10.1016/j.pscychresns.2003.10.001; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Bates D., 2010, IME4 LINEAR MIXED EF; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bertin M, 2007, NEURAL NETWORKS, V20, P668, DOI 10.1016/j.neunet.2007.04.028; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doll BB, 2009, BRAIN RES, V1299, P74, DOI 10.1016/j.brainres.2009.07.007; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FitzGerald THB, 2010, CURR BIOL, V20, P1823, DOI 10.1016/j.cub.2010.08.048; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Fu WT, 2008, PSYCHOL RES-PSYCH FO, V72, P321, DOI 10.1007/s00426-007-0113-7; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Ito M, 2009, J NEUROSCI, V29, P9861, DOI 10.1523/JNEUROSCI.6157-08.2009; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; LOEWENSTEIN G, 2004, 0414 CORN U CTR AN E; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; MacKay D. J. C., 2003, INFORM THEORY INFERE; Maia TV, 2010, LEARN BEHAV, V38, P50, DOI 10.3758/LB.38.1.50; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MOORE AW, 1993, MACH LEARN, V13, P103, DOI 10.1023/A:1022635613229; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Niv Y, 2006, TRENDS COGN SCI, V10, P375, DOI 10.1016/j.tics.2006.06.010; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Rummery GA, 1994, 166 CUEDFINFENGTR CA; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Schonberg T, 2010, NEUROIMAGE, V49, P772, DOI 10.1016/j.neuroimage.2009.08.011; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Sutton R. S., 1990, MACH LEARN P 1990; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; [No title captured]	91	868	877	11	178	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1204	1215		10.1016/j.neuron.2011.02.027	http://dx.doi.org/10.1016/j.neuron.2011.02.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435563	Green Submitted, Green Accepted, hybrid			2022-12-24	WOS:000288886900015
J	Fino, E; Yuste, R				Fino, Elodie; Yuste, Rafael			Dense Inhibitory Connectivity in Neocortex	NEURON			English	Article							PRIMARY VISUAL-CORTEX; SYNAPTIC CONNECTIONS; GABAERGIC INTERNEURONS; DISYNAPTIC INHIBITION; PYRAMIDAL NEURONS; RAT; SUBTYPES; NETWORKS; CLASSIFICATION; ORGANIZATION	The connectivity diagram of neocortical circuits is still unknown, and there are conflicting data as to whether cortical neurons are wired specifically or not. To investigate the basic structure of cortical microcircuits, we use a two-photon photostimulation technique that enables the systematic mapping of synaptic connections with single-cell resolution. We map the inhibitory connectivity between upper layers somatostatin-positive GABAergic interneurons and pyramidal cells in mouse frontal cortex. Most, and sometimes all, inhibitory neurons are locally connected to every sampled pyramidal cell. This dense inhibitory connectivity is found at both young and mature developmental ages. Inhibitory innervation of neighboring pyramidal cells is similar, regardless of whether they are connected among themselves or not. We conclude that local inhibitory connectivity is promiscuous, does not form subnetworks, and can approach the theoretical limit of a completely connected synaptic matrix.	[Fino, Elodie; Yuste, Rafael] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute	Fino, E (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA.	ef2308@columbia.edu	Fino, Elodie/M-6586-2014	Fino, Elodie/0000-0003-1453-7784	Kavli Institute for Brain Science; National Eye Institute; Marie Curie IOF Program; NATIONAL EYE INSTITUTE [R01EY011787] Funding Source: NIH RePORTER	Kavli Institute for Brain Science; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Marie Curie IOF Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank V. Nikolenko for inspiration and help, L. McGarry, Y. Shin, and J. Miller for anatomical reconstructions, M. Dar for help with mice, L. McGarry for cluster analysis and D. Rabinowitz and members of the laboratory for help and comments. Supported by the Kavli Institute for Brain Science, the National Eye Institute, and the Marie Curie IOF Program.	[Anonymous], 1998, NEURAL NETWORKS BRAI; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Braitenberg V, 1991, ANATOMY CORTEX; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Crick F., 1986, P333; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; Douglas R., 2004, SYNAPTIC ORG BRAIN, DOI [10.1093/ACPROF:OSO/9780195159561.003.0012, DOI 10.1093/ACPROF:OSO/9780195159561.003]; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fairen A., 1984, CEREB CORTEX, V1, P201; FARBER IC, 1983, SCIENCE, V222, P1025, DOI 10.1126/science.6648515; Feldmeyer D, 2000, J PHYSIOL-LONDON, V525, P31, DOI 10.1111/j.1469-7793.2000.00031.x; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Goldberg JH, 2004, J PHYSIOL-LONDON, V558, P465, DOI 10.1113/jphysiol.2004.064519; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 2002, J COMP NEUROL, V443, P1, DOI 10.1002/cne.1425; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Halabisky B, 2006, J NEUROPHYSIOL, V96, P834, DOI 10.1152/jn.01079.2005; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; ISSEROFF A, 1984, BRAIN RES, V293, P213, DOI 10.1016/0006-8993(84)91228-9; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; Lorente de No R., 1949, PHYSL NERVOUS SYSTEM, P228; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Mountcastle VB, 1982, MINDFUL BRAIN, P1; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Otsuka T, 2009, J NEUROSCI, V29, P10533, DOI 10.1523/JNEUROSCI.2219-09.2009; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Peters A., 1976, FINE STRUCTURE NERVO; Peters A, 1984, CEREBRAL CORTEX, V1; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; THOMSON AM, 1988, J NEUROPHYSIOL, V60, P1896, DOI 10.1152/jn.1988.60.6.1896; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012	66	357	359	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1188	1203		10.1016/j.neuron.2011.02.025	http://dx.doi.org/10.1016/j.neuron.2011.02.025			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435562	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000288886900014
J	Ludmer, R; Dudai, Y; Rubin, N				Ludmer, Rachel; Dudai, Yadin; Rubin, Nava			Uncovering Camouflage: Amygdala Activation Predicts Long-Term Memory of Induced Perceptual Insight	NEURON			English	Article							FALSE DISCOVERY RATE; BRAIN ACTIVITY; VISUAL-CORTEX; RECOGNITION; STIMULI; CONSOLIDATION; FACILITATION; ENHANCEMENT; HIPPOCAMPUS; EXPERIENCES	What brain mechanisms underlie learning of new knowledge from single events? We studied encoding in long-term memory of a unique type of one-shot experience, induced perceptual insight. While undergoing an fMRI brain scan, participants viewed degraded images of real-world pictures where the underlying objects were hard to recognize ("camouflage"), followed by brief exposures to the original images ("solution"), which led to induced insight ("Aha!"). A week later, the participants' memory was tested; a solution image was classified as "remembered" if detailed perceptual knowledge was elicited from the camouflage image alone. During encoding, subsequently remembered images were associated with higher activity in midlevel visual cortex and medial frontal cortex, but most pronouncedly, in the amygdala, whose activity could be used to predict which solutions will remain in long-term memory. Our findings extend the known roles of amygdala in memory to include promotion of long-term memory of the sudden reorganization of internal representations.	[Rubin, Nava] New York Univ, Ctr Neural Sci, New York, NY 10003 USA; [Ludmer, Rachel; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	New York University; Weizmann Institute of Science	Rubin, N (corresponding author), New York Univ, Ctr Neural Sci, New York, NY 10003 USA.	nava.rubin@nyu.edu	Rubin, Nava/J-5189-2012		Minerva Foundation; Israeli Science Foundation; National Institutes of Health [R01EY014030]; Weizmann Institute-NYU collaborative research fund in the neurosciences; NATIONAL EYE INSTITUTE [R01EY014030] Funding Source: NIH RePORTER	Minerva Foundation; Israeli Science Foundation(Israel Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weizmann Institute-NYU collaborative research fund in the neurosciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Merav Ahissar, Moshe Bar, Orit Furman, Efrat Furst, Kalanit Grill-Spector, Rafi Malach, Avi Mendelsohn, Morris Moscovitch, Yuval Nir, Rony Paz, Son Preminger, Robert Shapley, and Nachum Ulanovsky for helpful discussions and comments on versions of the manuscript. We also thank Eunice Yang for assistance in the fMRI scans and preprocessing of fMRI data, Edna Haran-Furman for her help in the high-resolution scans, Sharon Gilai-Dotan for help in delineating the LOC ROIs, and Justin Kung for help in delineating the hippocampus ROIs. This work was supported by the Minerva Foundation and the Israeli Science Foundation (Y.D.), the National Institutes of Health grant R01EY014030 (N.R.), and the Weizmann Institute-NYU collaborative research fund in the neurosciences (Y.D. and N.R.).	AGGLETON J, 2000, NAT REV NEUROSCI, V7, P268; [Anonymous], 1983, CANADIAN PSYCHOL; Armony JL, 1998, J NEUROSCI, V18, P2592; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Doniger GM, 2000, J COGNITIVE NEUROSCI, V12, P615, DOI 10.1162/089892900562372; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Holland PC, 2006, J NEUROSCI, V26, P3791, DOI 10.1523/JNEUROSCI.0390-06.2006; Johnstone T, 2005, NEUROIMAGE, V25, P1112, DOI 10.1016/j.neuroimage.2004.12.016; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; KAPLAN CA, 1990, COGNITIVE PSYCHOL, V22, P374, DOI 10.1016/0010-0285(90)90008-R; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Kohler W., 1925, MENTALITY APES; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Maier N. R. F., 1931, J COMP PSYCHOL, V12, P181, DOI 10.1037/h0071361; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mendola JD, 1999, J NEUROSCI, V19, P8560; Newell A., 1981, COGNITIVE SKILLS THE, P1; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Roediger H.L., 2007, SCI MEMORY CONCEPTS, DOI [10.1093/acprof:oso/9780195310443.001.0001, DOI 10.1093/ACPROF:OSO/9780195310443.001.0001]; Rubin N, 2002, PERCEPTUAL LEARNING, P235; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Seitz AR, 2009, VISION RES, V49, P2604, DOI 10.1016/j.visres.2009.08.003; Squire LR., 1999, MEMORY MIND MOL; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Sternberg R. J, 1995, NATURE INSIGHT; STEVENS JC, 1962, J EXP ANAL BEHAV, V5, P15, DOI 10.1901/jeab.1962.5-15; Subramaniam K, 2009, J COGNITIVE NEUROSCI, V21, P415, DOI 10.1162/jocn.2009.21057; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	59	82	87	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					1002	1014		10.1016/j.neuron.2011.02.013	http://dx.doi.org/10.1016/j.neuron.2011.02.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382558	Green Accepted, Bronze			2022-12-24	WOS:000288736500016
J	Lodato, S; Rouaux, C; Quast, KB; Jantrachotechatchawan, C; Studer, M; Hensch, TK; Arlotta, P				Lodato, Simona; Rouaux, Caroline; Quast, Kathleen B.; Jantrachotechatchawan, Chanati; Studer, Michele; Hensch, Takao K.; Arlotta, Paola			Excitatory Projection Neuron Subtypes Control the Distribution of Local Inhibitory Interneurons in the Cerebral Cortex	NEURON			English	Article							CORTICAL GABAERGIC INTERNEURONS; TANGENTIAL MIGRATION; IN-VIVO; IMMUNOREACTIVE NEURONS; GANGLIONIC EMINENCE; CELLULAR-PATTERNS; CORPUS-CALLOSUM; NERVOUS-SYSTEM; ADULT MICE; MOUSE	In the mammalian cerebral cortex, the developmental events governing the integration of excitatory projection neurons and inhibitory interneurons into balanced local circuitry are poorly understood. We report that different subtypes of projection neurons uniquely and differentially determine the laminar distribution of cortical interneurons. We find that in Fezf2(-/-) cortex, the exclusive absence of subcerebral projection neurons and their replacement by callosal projection neurons cause distinctly abnormal lamination of interneurons and altered GABAergic inhibition. In addition, experimental generation of either corticofugal neurons or callosal neurons below the cortex is sufficient to recruit cortical interneurons to these ectopic locations. Strikingly, the identity of the projection neurons generated, rather than strictly their birthdate, determines the specific types of interneurons recruited. These data demonstrate that in the neocortex individual populations of projection neurons cell-extrinsically control the laminar fate of interneurons and the assembly of local inhibitory circuitry.	[Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lodato, Simona; Rouaux, Caroline; Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Lodato, Simona; Rouaux, Caroline; Jantrachotechatchawan, Chanati; Arlotta, Paola] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Quast, Kathleen B.; Hensch, Takao K.] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Studer, Michele] INSERM, U636, F-06108 Nice, France; [Studer, Michele] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, F-06108 Nice, France; [Lodato, Simona; Studer, Michele] European Sch Mol Med SEMM, Naples, Italy	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	paola_arlotta@hms.harvard.edu	Rouaux, Caroline/O-1712-2017; Lodato, Simona/A-3525-2017; Studer, Michele/P-4580-2016	Rouaux, Caroline/0000-0002-5724-2903; Lodato, Simona/0000-0001-6498-2590; Studer, Michele/0000-0001-7105-2957	NIH [NS062849, 1DP1 OD 003699-01]; Harvard Stem Cell Institute; Ellison Medical Foundation; European School of Molecular Medicine; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); European School of Molecular Medicine; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Jeffrey Macklis and Bradley Molyneaux for reagents and insightful advice; Antonio Simeone, Antonio Baldini, and Tommaso Russo for serving on S.L.'s dissertation committee and for their comments; Oscar Mann for critical input during early stages of this study; Tracy Pearse-Young for sharing the APP shRNA construct and for help with electroporations in the rat; Roberto Rusconi for support with cell counting; Jeffrey Macklis, Verne Caviness, Eiman Azim, Giulio Srubek Tomassy, Feng Zhang, and Anne Goodwin for their careful reading of the manuscript and comments; Robert Hevner, Carlos Lois, John Rubenstein, Vassilis Pachnis, and Andre Goffinet for generous sharing of antibodies, cDNA clones, and expression vectors; Yuchio Yanagawa for sharing the GAD67::GFP mice; Alyssa Meleski, Amanda Merlino, and Zachary Trayes-Gibson for outstanding technical support; and Claudio Mare for schematic drawings. This work was partially supported by grants from the NIH (NS062849) and the Harvard Stem Cell Institute to P.A. and the NIH Director's Pioneer Award (1DP1 OD 003699-01) and Ellison Medical Foundation to T.K.H. S.L. was partially supported by a predoctoral fellowship from the European School of Molecular Medicine (S.E.M.M.) and C.R. was partially supported by a Milton-Safenowitz postdoctoral fellowship from the ALS Association.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Bayer S.A., 1991, NEOCORTICAL DEV; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Elias LAB, 2008, NEURON, V59, P679, DOI 10.1016/j.neuron.2008.08.017; FAIREN A, 1986, J COMP NEUROL, V251, P67, DOI 10.1002/cne.902510105; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hammond V, 2006, J NEUROSCI, V26, P1646, DOI 10.1523/JNEUROSCI.3651-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Hirata T, 2004, DEV DYNAM, V230, P546, DOI 10.1002/dvdy.20068; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Liapi A, 2008, DEV NEUROSCI-BASEL, V30, P117, DOI 10.1159/000109857; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Mitchell BD, 2005, J COMP NEUROL, V482, P17, DOI 10.1002/cne.20428; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; PEDUZZI JD, 1988, J NEUROSCI, V8, P920; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; Polleux F, 2002, DEVELOPMENT, V129, P3147; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shimizu T, 2009, DEV GROWTH DIFFER, V51, P221, DOI 10.1111/j.1440-169X.2009.01088.x; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Tanaka DH, 2010, CEREB CORTEX, V20, P2810, DOI 10.1093/cercor/bhq027; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Yabut O, 2007, BRAIN RES, V1140, P75, DOI 10.1016/j.brainres.2005.09.070; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	67	139	139	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					763	779		10.1016/j.neuron.2011.01.015	http://dx.doi.org/10.1016/j.neuron.2011.01.015			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338885	Green Accepted, Bronze			2022-12-24	WOS:000288413200017
J	O'Connell, MN; Falchier, A; McGinnis, T; Schroeder, CE; Lakatos, P				O'Connell, Monica N.; Falchier, Arnaud; McGinnis, Tammy; Schroeder, Charles E.; Lakatos, Peter			Dual Mechanism of Neuronal Ensemble Inhibition in Primary Auditory Cortex	NEURON			English	Article							SPECTROTEMPORAL RECEPTIVE-FIELDS; THALAMIC RETICULAR NUCLEUS; GABAERGIC INHIBITION; BALANCED INHIBITION; CAT; ORGANIZATION; RESPONSES; OSCILLATIONS; PLASTICITY; MONKEYS	Inhibition plays an essential role in shaping and refining the brain's representation of sensory stimulus attributes. In primary auditory cortex (A1), so-called "sideband" inhibition helps to sharpen the tuning of local neuronal responses. Several distinct types of anatomical circuitry could underlie sideband inhibition, including direct thalamocortical (TC) afferents, as well as indirect intracortical mechanisms. The goal of the present study was to characterize sideband inhibition in A1 and to determine its mechanism by analyzing laminar profiles of neuronal ensemble activity. Our results indicate that both lemniscal and nonlemniscal TC afferents play a role in inhibitory responses via feedforward inhibition and oscillatory phase reset, respectively. We propose that the dynamic modulation of excitability in A1 due to the phase reset of ongoing oscillations may alter the tuning of local neuronal ensembles and can be regarded as a flexible overlay on the more obligatory system of lemniscal feedforward type responses.	[O'Connell, Monica N.; Falchier, Arnaud; McGinnis, Tammy; Schroeder, Charles E.; Lakatos, Peter] Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; [O'Connell, Monica N.] CUNY City Coll, Program Cognit Neurosci, New York, NY 10031 USA; [Schroeder, Charles E.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Lakatos, Peter] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; City University of New York (CUNY) System; City College of New York (CUNY); Columbia University; New York University	Lakatos, P (corresponding author), Nathan S Kline Inst Psychiat Res, Cognit Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA.	plakatos@nki.rfmh.org		Lakatos, Peter/0000-0003-0221-4021; Falchier, Arnaud/0000-0003-2426-3975	NIDCD [R21 DC010415]; NIMH [MH061989, MH060358]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061989, R01MH060358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011490, R21DC010415] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support for this work was provided by NIH grant R21 DC010415 from NIDCD, and NIMH grants MH061989 and MH060358.	AITKIN LM, 1972, J NEUROPHYSIOL, V35, P365, DOI 10.1152/jn.1972.35.3.365; Atencio CA, 2010, J NEUROPHYSIOL, V103, P192, DOI 10.1152/jn.00624.2009; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Cheung SW, 2001, J NEUROPHYSIOL, V85, P1732, DOI 10.1152/jn.2001.85.4.1732; Crabtree JW, 1998, J COMP NEUROL, V390, P167; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; FERSTER D, 1988, J NEUROSCI, V8, P1172; Foeller E, 2001, JARO, V2, P279; Fritz J, 2005, HEARING RES, V206, P159, DOI 10.1016/j.heares.2005.01.015; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; HASHIKAWA T, 1991, BRAIN RES, V544, P335, DOI 10.1016/0006-8993(91)90076-8; Horikawa J, 1996, J PHYSIOL-LONDON, V497, P629, DOI 10.1113/jphysiol.1996.sp021795; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kosaki H, 1997, J COMP NEUROL, V386, P304; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lee CC, 2004, NEUROSCIENCE, V128, P871, DOI 10.1016/j.neuroscience.2004.06.062; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MIDDLEBROOKS JC, 1980, BRAIN RES, V181, P31, DOI 10.1016/0006-8993(80)91257-3; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Moeller CK, 2010, EUR J NEUROSCI, V31, P49, DOI 10.1111/j.1460-9568.2009.07039.x; MOLINARI M, 1995, J COMP NEUROL, V362, P171, DOI 10.1002/cne.903620203; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; RECANZONE GH, 1993, J NEUROSCI, V13, P87; ROGER M, 1989, J COMP NEUROL, V287, P339, DOI 10.1002/cne.902870306; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tanji K, 2010, NEUROIMAGE, V49, P150, DOI 10.1016/j.neuroimage.2009.07.029; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; Wang J, 2000, NEUROREPORT, V11, P1137, DOI 10.1097/00001756-200004070-00045; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Winer JA, 2007, HEARING RES, V229, P3, DOI 10.1016/j.heares.2007.01.017; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Young CK, 2009, PROG NEUROBIOL, V89, P61, DOI 10.1016/j.pneurobio.2009.06.002; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	65	42	43	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					805	817		10.1016/j.neuron.2011.01.012	http://dx.doi.org/10.1016/j.neuron.2011.01.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338888	Green Accepted, Bronze			2022-12-24	WOS:000288413200020
J	Keyes, WM; Pecoraro, M; Aranda, V; Vernersson-Lindahl, E; Li, WZ; Vogel, H; Guo, XC; Garcia, EL; Michurina, TV; Enikolopov, G; Muthuswamy, SK; Mills, AA				Keyes, William M.; Pecoraro, Matte; Aranda, Victoria; Vernersson-Lindahl, Emma; Li, Wangzhi; Vogel, Hannes; Guo, Xuecui; Garcia, Elvin L.; Michurina, Tatyana V.; Enikolopov, Grigori; Muthuswamy, Senthil K.; Mills, Alea A.			Delta Np630 alpha Is an Oncogene that Targets Chromatin Remodeler Lsh to Drive Skin Stem Cell Proliferation and Tumorigenesis	CELL STEM CELL			English	Article							P53 HOMOLOG; KERATINOCYTE GROWTH; HAIR FOLLICLE; SELF-RENEWAL; SNF2 FAMILY; IN-VIVO; P63; MICE; SENESCENCE; DIFFERENTIATION	The p53 homolog p63 is essential for development, yet its role in cancer is not clear. We discovered that p63 deficiency evokes the tumor-suppressive mechanism of cellular senescence, causing a striking absence of stratified epithelia such as the skin. Here we identify the predominant p63 isoform, Delta Np63 alpha, as a protein that bypasses oncogene-induced senescence to drive tumorigenesis in vivo. Interestingly, bypass of senescence promotes stem-like proliferation and maintains survival of the keratin 15-positive stem cell population. Furthermore, we identify the chromatin-remodeling protein Lsh as a new target of Delta Np63 alpha that is an essential mediator of senescence bypass. These findings indicate that Delta Np63 alpha is an oncogene that cooperates with Ras to promote tumor-initiating stem-like proliferation and suggest that Lsh-mediated chromatin-remodeling events are critical to this process.	[Keyes, William M.; Pecoraro, Matte] UPF, CRG, Barcelona 08003, Spain; [Vogel, Hannes] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Muthuswamy, Senthil K.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Keyes, William M.; Aranda, Victoria; Vernersson-Lindahl, Emma; Li, Wangzhi; Guo, Xuecui; Garcia, Elvin L.; Michurina, Tatyana V.; Enikolopov, Grigori; Muthuswamy, Senthil K.; Mills, Alea A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cold Spring Harbor Laboratory	Keyes, WM (corresponding author), UPF, CRG, Barcelona 08003, Spain.	bill.keyes@crg.es; mills@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022; Li, Wangzhi/A-1390-2015; Enikolopov, Grigori/P-5731-2019	Muthuswamy, Senthil K/0000-0001-6564-9634; Enikolopov, Grigori/0000-0001-8178-8917; Keyes, William M./0000-0002-8917-2268; Vogel, Otto Hannes/0000-0002-0960-3508	Spanish Ministry of Science and Innovation [SAF2010-18829]; ACS [RSG-06-190-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA098830] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Johannes Zuber, Michael Hemann, and Scott Lowe for assistance and advice; Yuri Lazebnik and Dominik Duelli for DMBA-treated tissues; Chris Johns and Sohail Khan for microarray analysis; and Leif Ellisen and James W. Rocco for HNSCC cell lines. W.M.K. was funded by the Spanish Ministry of Science and Innovation (Plan Nacional -SAF2010-18829). A.A.M. was funded by an ACS Research Scholar Award (RSG-06-190-01-MGO).	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Geiman TM, 2001, BBA-GEN SUBJECTS, V1526, P211, DOI 10.1016/S0304-4165(01)00129-5; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mignone JL, 2007, CELL CYCLE, V6, P2161, DOI 10.4161/cc.6.17.4593; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2002, GENESIS, V32, P138, DOI 10.1002/gene.10067; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muegge K, 2005, BIOCHEM CELL BIOL, V83, P548, DOI 10.1139/O05-119; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tonon G, 2005, COLD SH Q B, V70, P11, DOI 10.1101/sqb.2005.70.021; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	53	153	159	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					164	176		10.1016/j.stem.2010.12.009	http://dx.doi.org/10.1016/j.stem.2010.12.009			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295273	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000287633400010
J	Ku, S; Soragni, E; Campau, E; Thomas, EA; Altun, G; Laurent, LC; Loring, JF; Napierala, M; Gottesfeld, JM				Ku, Sherman; Soragni, Elisabetta; Campau, Erica; Thomas, Elizabeth A.; Altun, Gulsah; Laurent, Louise C.; Loring, Jeanne F.; Napierala, Marek; Gottesfeld, Joel M.			Friedreich's Ataxia Induced Pluripotent Stem Cells Model Intergenerational GAA.TTC Triplet Repeat Instability	CELL STEM CELL			English	Article							MISMATCH REPAIR; DEFINED FACTORS; DEFICIENT MICE; SOMATIC-CELLS; EXPANSION; GENE; DISEASE; TRANSCRIPTION; REPLICATION; FIBROBLASTS	The inherited neurodegenerative disease Friedreich's ataxia (FRDA) is caused by GAA.TTC triplet repeat hyperexpansions within the first intron of the FXN gene, encoding the mitochondrial protein frataxin. Long GAA.TTC repeats cause heterochromatin-mediated gene silencing and loss of frataxin in affected individuals. We report the derivation of induced pluripotent stem cells (iPSCs) from FRDA patient fibroblasts by transcription factor reprogramming. FXN gene repression is maintained in the iPSCs, as are the global gene expression signatures reflecting the human disease. GAA.TTC repeats uniquely in FXN in the iPSCs exhibit repeat instability similar to patient families, where they expand and/or contract with discrete changes in length between generations. The mismatch repair enzyme MSH2, implicated in repeat instability in other triplet repeat diseases, is highly expressed in pluripotent cells and occupies FXN intron 1, and shRNA silencing of MSH2 impedes repeat expansion, providing a possible molecular explanation for repeat expansion in FRDA.	[Ku, Sherman; Soragni, Elisabetta; Campau, Erica; Thomas, Elizabeth A.; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Altun, Gulsah; Laurent, Louise C.; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92035 USA; [Napierala, Marek] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joelg@scripps.edu	Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767; Gottesfeld, Joel/0000-0002-4643-5777; Laurent, Louise/0000-0002-2095-7534	National Institutes of Neurological Disorders and Stroke (NIH); Friedreich's Ataxia Research Alliance (FARA); GoFAR; Ataxia UK; Friedreich's Ataxia Society Ireland; Repligen Corporation (Waltham, MA); Families of Spinal Muscular Atrophy; NIH WRHR [R21MH087925]; Hartwell Foundation; CIRM [CL1-00502, RT1-01108, TR1-01250]; Millipore Foundation; Esther O'Keefe Foundation; National Ataxia Foundation; FARA; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055158, R01NS062856] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance (FARA); GoFAR; Ataxia UK; Friedreich's Ataxia Society Ireland; Repligen Corporation (Waltham, MA); Families of Spinal Muscular Atrophy; NIH WRHR; Hartwell Foundation; CIRM(California Institute for Regenerative Medicine); Millipore Foundation; Esther O'Keefe Foundation; National Ataxia Foundation; FARA; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Perlman (UCLA) for providing skin biopsies and I. Singec, J. Clark, and C. Desponts for valuable advice and guidance. Additionally, we thank V. Lukiyanchuk for virus expertise, K. Clingerman for veterinary assistance, and C. Lynch for microarray analysis. This work was supported by the National Institutes of Neurological Disorders and Stroke (NIH), The Friedreich's Ataxia Research Alliance (FARA), GoFAR, Ataxia UK, Friedreich's Ataxia Society Ireland, and Repligen Corporation (Waltham, MA) to J.M.G. and by a fellowship from Families of Spinal Muscular Atrophy (to S.K.). L.C.L. is supported by NIH WRHR K12 Career Development Award and the Hartwell Foundation, and G.A. and J.F.L. are supported by CIRM (CL1-00502, RT1-01108, TR1-01250), NIH (R21MH087925), the Millipore Foundation, and the Esther O'Keefe Foundation. M.N. is supported by the National Ataxia Foundation and the FARA "Kyle Bryant Translational Research Award." J.M.G. serves as a consultant to Repligen Corporation, which is involved in the development of therapeutics for FRDA, and has a competing financial interest in this work.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Coppola G, 2006, NEUROBIOL DIS, V22, P302, DOI 10.1016/j.nbd.2005.11.014; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dion V, 2009, TRENDS GENET, V25, P288, DOI 10.1016/j.tig.2009.04.007; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer RR, 1999, J BIOL CHEM, V274, P3865, DOI 10.1074/jbc.274.6.3865; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kramer PR, 1996, HUM GENET, V98, P151, DOI 10.1007/s004390050179; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pianese L, 1997, AM J HUM GENET, V60, P460; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rindler PM, 2006, NUCLEIC ACIDS RES, V34, P6352, DOI 10.1093/nar/gkl846; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399	35	167	174	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					631	637		10.1016/j.stem.2010.09.014	http://dx.doi.org/10.1016/j.stem.2010.09.014			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040903	Bronze, Green Accepted			2022-12-24	WOS:000284390500014
J	Lee, JY; Nakada, D; Yilmaz, OH; Tothova, Z; Joseph, NM; Lim, MS; Gilliland, DG; Morrison, SJ				Lee, Jae Y.; Nakada, Daisuke; Yilmaz, Omer H.; Tothova, Zuzana; Joseph, Nancy M.; Lim, Megan S.; Gilliland, D. Gary; Morrison, Sean J.			mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion	CELL STEM CELL			English	Article							OXIDATIVE STRESS; SELF-RENEWAL; INK4A LOCUS; AKT; LEUKEMIA; P53; TRANSCRIPTION; SENESCENCE; DIFFERENTIATION; SURVIVAL	Pten deficiency depletes hematopoietic stem cells (HSCs) but expands leukemia-initiating cells, and the mTOR inhibitor, rapamycin, blocks these effects. Understanding the opposite effects of mTOR activation on HSCs versus leukemia-initiating cells could improve antileukemia therapies. We found that the depletion of Pten-deficient HSCs was not caused by oxidative stress and could not be blocked by N-acetyl-cysteine. Instead, Pten deletion induced, and rapamycin attenuated, the expression of p16(Ink4a) and p53 in HSCs, and p19(Arf) and p53 in other hematopoietic cells. p53 suppressed leukemogenesis and promoted HSC depletion after Pten deletion. p16(Ink4a) also promoted HSC depletion but had a limited role suppressing leukemogenesis. p19(Arf) strongly suppressed leukemogenesis but did not deplete HSCs. Secondary mutations attenuated this tumor suppressor response in some leukemias that arose after Pten deletion. mTOR activation therefore depletes HSCs by a tumor suppressor response that is attenuated by secondary mutations in leukemogenic clones.	[Lee, Jae Y.; Nakada, Daisuke; Yilmaz, Omer H.; Joseph, Nancy M.; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lee, Jae Y.; Nakada, Daisuke; Yilmaz, Omer H.; Joseph, Nancy M.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lim, Megan S.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Tothova, Zuzana; Gilliland, D. Gary] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Nakada, Daisuke/0000-0001-6010-7094; Lim, Megan/0000-0002-0415-2867; Lee, Jae/0000-0003-2264-9620	Howard Hughes Medical Institute; University of Michigan (UM); Japan Society for the Promotion of Science; UM-Comprehensive Cancer NIH [CA46592]; Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Michigan (UM)(University of Michigan System); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); UM-Comprehensive Cancer NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Howard Hughes Medical Institute. J.Y.L. was supported by predoctoral fellowships from the University of Michigan (UM) Biology of Aging Training Grant and the Medical Scientist Training Program. D.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. Flow cytometry was partially supported by the UM-Comprehensive Cancer NIH CA46592. Thanks to David Adams and Martin White for flow cytometry. Thanks to Chris Mountford and Sara Grove for mouse colony management and to Michael Smith and Mayya Malakh for help with genotyping. J.Y.L. and D.N. performed all experiments and participated in the design and interpretation of experiments. O.H.Y. initiated the project and generated the compound mutant mice. M.S.L. analyzed mouse pathology with help from J.Y.L. Z.T. and D.G.G. participated in the conception and interpretation of experiments. S.J.M. participated in the design and interpretation of Pten experiments and wrote the paper with J.Y.L. and D.N.	Aggerholm A, 2000, EUR J HAEMATOL, V65, P109, DOI 10.1034/j.1600-0609.2000.90181.x; Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang H, 2006, LEUKEMIA RES, V30, P262, DOI 10.1016/j.leukres.2005.07.008; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	48	148	159	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					593	605		10.1016/j.stem.2010.09.015	http://dx.doi.org/10.1016/j.stem.2010.09.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040901	Green Accepted, Bronze			2022-12-24	WOS:000284390500011
J	Konopka, G; Geschwind, DH				Konopka, Genevieve; Geschwind, Daniel H.			Human Brain Evolution: Harnessing the Genomics (R)evolution to Link Genes, Cognition, and Behavior	NEURON			English	Article							VON ECONOMO NEURONS; CHIMPANZEES PAN-TROGLODYTES; ONGOING ADAPTIVE EVOLUTION; CAJAL-RETZIUS CELLS; POSITIVE SELECTION; ACCELERATED EVOLUTION; MOLECULAR EVOLUTION; NEANDERTHAL GENOME; REGULATORY NETWORK; GERMLINE MUTATIONS	The evolution of the human brain has resulted in numerous specialized features including higher cognitive processes such as language. Knowledge of whole-genome sequence and structural variation via high-throughput sequencing technology provides an unprecedented opportunity to view human evolution at high resolution. However, phenotype discovery is a critical component of these endeavors and the use of nontraditional model organisms will also be critical for piecing together a complete picture. Ultimately, the union of developmental studies of the brain with studies of unique phenotypes in a myriad of species will result in a more thorough model of the groundwork the human brain was built upon. Furthermore, these integrative approaches should provide important insights into human diseases.	[Konopka, Genevieve; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Konopka, Genevieve; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Autism Res, Los Angeles, CA 90095 USA; [Konopka, Genevieve; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Konopka, Genevieve; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu		Konopka, Genevieve/0000-0002-3363-7302	NIMH [R37MH60233-06A1, K99MH090238]; Giannini Foundation Medical Research; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233, K99MH090238] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Giannini Foundation Medical Research; NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by a grant from the NIMH (R37MH60233-06A1) to D.H.G. G.K. is supported by an A.P. Giannini Foundation Medical Research Fellowship, a NARSAD Young Investigator Award, and the NIMH (K99MH090238).	Abellan A, 2010, J COMP NEUROL, V518, P3512, DOI 10.1002/cne.22410; Abellan A, 2010, CEREB CORTEX, V20, P1788, DOI 10.1093/cercor/bhp242; Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Allman JM, 2010, BRAIN STRUCT FUNCT, V214, P495, DOI 10.1007/s00429-010-0254-0; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bochdanovits Z, 2009, BEHAV GENET, V39, P15, DOI 10.1007/s10519-008-9233-0; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonnefont J, 2011, CELL DEATH DIFFER, V18, P293, DOI 10.1038/cdd.2010.102; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Bruder CE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-251; Brunelli S, 1996, NAT GENET, V12, P94, DOI 10.1038/ng0196-94; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Butti C, 2009, J COMP NEUROL, V515, P243, DOI 10.1002/cne.22055; Byrne RW, 2010, NEURON, V65, P815, DOI 10.1016/j.neuron.2010.03.010; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cantalupo C, 2009, EUR J NEUROSCI, V30, P431, DOI 10.1111/j.1460-9568.2009.06830.x; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crespi B, 2007, P ROY SOC B-BIOL SCI, V274, P2801, DOI 10.1098/rspb.2007.0876; Crespi BJ, 2010, ANN NY ACAD SCI, V1206, P80, DOI 10.1111/j.1749-6632.2010.05707.x; Currat M, 2006, SCIENCE, V313, P172, DOI 10.1126/science.1122712; Dean B, 2009, AUST NZ J PSYCHIAT, V43, P13, DOI 10.1080/00048670802534416; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Faiella A, 1997, EUR J HUM GENET, V5, P186, DOI 10.1159/000484761; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fisher SE, 2003, ANNU REV NEUROSCI, V26, P57, DOI 10.1146/annurev.neuro.26.041002.131144; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Geschwind DH, 2001, AM J MED GENET, V101, P370; Gherman A, 2007, PLOS GENET, V3, P1223, DOI 10.1371/journal.pgen.0030119; Goodman M, 2010, P NATL ACAD SCI USA, V107, P8918, DOI 10.1073/pnas.0914626107; Goodman M, 2009, P NATL ACAD SCI USA, V106, P20824, DOI 10.1073/pnas.0911239106; Graziano C, 2007, AM J MED GENET A, V143A, P1802, DOI 10.1002/ajmg.a.31808; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hakeem AY, 2009, ANAT REC, V292, P242, DOI 10.1002/ar.20829; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hopkins WD, 2008, NEUROIMAGE, V42, P491, DOI 10.1016/j.neuroimage.2008.05.014; Irimia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005800; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Khaitovich P, 2006, CURR BIOL, V16, pR356, DOI 10.1016/j.cub.2006.03.082; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Krubitzer L, 2005, CURR OPIN NEUROBIOL, V15, P444, DOI 10.1016/j.conb.2005.07.003; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010648; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin L, 2010, HUM MOL GENET, V19, P2958, DOI 10.1093/hmg/ddq201; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; MacDonald RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-157; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Meaburn EL, 2010, EPIGENETICS-US, V5, P578, DOI 10.4161/epi.5.7.12960; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Nielsen Karsten B, 2010, BMC Res Notes, V3, P127, DOI 10.1186/1756-0500-3-127; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; OLDHAM MC, 2009, ENCY NEUROSCIENCE, P597; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pilaz LJ, 2009, P NATL ACAD SCI USA, V106, P21924, DOI 10.1073/pnas.0909894106; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Premack D, 2007, P NATL ACAD SCI USA, V104, P13861, DOI 10.1073/pnas.0706147104; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Preuss TM, 2000, BRAIN BEHAV EVOLUT, V55, P287, DOI 10.1159/000006664; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rosso L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000150; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Rushton JP, 2009, INT J NEUROSCI, V119, P691, DOI 10.1080/00207450802325843; Santos M, 2011, BRAIN RES, V1380, P206, DOI 10.1016/j.brainres.2010.08.067; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schenker NM, 2010, CEREB CORTEX, V20, P730, DOI 10.1093/cercor/bhp138; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; SHARMA A, 2009, PLOS ONE, V4, pNIL45; Shi P, 2006, TRENDS GENET, V22, P608, DOI 10.1016/j.tig.2006.09.001; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Ticho BH, 2006, OPHTHALMIC GENET, V27, P145, DOI 10.1080/13816810600976897; Timpson N, 2007, SCIENCE, V317, DOI 10.1126/science.1141705; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernier P, 2004, ANN NY ACAD SCI, V1035, P231, DOI 10.1196/annals.1332.015; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; VONECONOMO C, 1926, NEUROL PSYCHIAT, V100, P706; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wetterbom A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r78; White SA, 2006, J NEUROSCI, V26, P10376, DOI 10.1523/JNEUROSCI.3379-06.2006; Woods RP, 2006, HUM MOL GENET, V15, P2025, DOI 10.1093/hmg/ddl126; Xu AG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000843; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu FL, 2007, SCIENCE, V316, DOI 10.1126/science.1137568; Zecevic N, 2001, J NEUROSCI, V21, P5607, DOI 10.1523/JNEUROSCI.21-15-05607.2001; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007	156	29	30	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 21	2010	68	2					231	244		10.1016/j.neuron.2010.10.012	http://dx.doi.org/10.1016/j.neuron.2010.10.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	681IJ	20955931	Green Accepted, Bronze			2022-12-24	WOS:000284304300012
J	Traynor, BJ; Singleton, AB				Traynor, Bryan J.; Singleton, Andrew B.			Nature versus Nurture: Death of a Dogma, and the Road Ahead	NEURON			English	Article							GENOME-WIDE ASSOCIATION; LIFE-STYLE; MYOCARDIAL-INFARCTION; PARKINSONS-DISEASE; PRIMARY PREVENTION; ALZHEIMER-DISEASE; RISK; HEIGHT; LOCI; VARIANTS	Interaction between the genome and the environment has been widely discussed in the literature, but has the importance ascribed to understanding these interactions been overstated? In this opinion piece, we critically discuss gene-environment interactions and attempt to answer three key questions. First, is it likely that gene-environment interactions actually exist? Second, what is the realistic value of trying to unravel these interactions, both in terms of understanding disease pathogenesis and as a means of ameliorating disease? Finally, and most importantly, do the technologies and methodologies exist to facilitate an unbiased search for gene-environment interactions? Addressing these questions highlights key areas of feasibility that must be considered in this area of research.	[Traynor, Bryan J.; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Singleton, AB (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Singleton, Andrew B/C-3010-2009; Traynor, Bryan J/G-5690-2010		NIH; National Institute on Aging [Z01-AG000949-02]; NATIONAL INSTITUTE ON AGING [ZIAAG000949, ZIAAG000933, Z01AG000949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural Research Program of the NIH and the National Institute on Aging (Z01-AG000949-02).	Akesson A, 2007, ARCH INTERN MED, V167, P2122, DOI 10.1001/archinte.167.19.2122; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Carr G, 2010, ECONOMIST, V395, P50; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Corella D, 2005, CURR OPIN MOL THER, V7, P569; Crawford FC, 2007, BRAIN RES, V1185, P45, DOI 10.1016/j.brainres.2007.09.042; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Gerra G, 2005, AM J MED GENET B, V135B, P73, DOI 10.1002/ajmg.b.30173; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; HEDBACK B, 1993, EUR HEART J, V14, P831, DOI 10.1093/eurheartj/14.6.831; Ilyin SE, 2004, TRENDS BIOTECHNOL, V22, P411, DOI 10.1016/j.tibtech.2004.06.005; Khoury MJ, 2005, AM J EPIDEMIOL, V161, P799, DOI 10.1093/aje/kwi113; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Krischek B, 2006, J HUM GENET, V51, P587, DOI 10.1007/s10038-006-0407-4; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Levin BE, 2009, INT J OBESITY, V33, pS53, DOI 10.1038/ijo.2009.18; Meijer WA, 2009, AGING MENT HEALTH, V13, P521, DOI 10.1080/13607860902860821; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Psaltopoulou Theodora, 2010, Rev Diabet Stud, V7, P26, DOI 10.1900/RDS.2010.7.26; Rutter M, 2002, ARCH GEN PSYCHIAT, V59, P996, DOI 10.1001/archpsyc.59.11.996; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2010, TRENDS GENET, V26, P438, DOI 10.1016/j.tig.2010.07.004; Steckel RH, 2004, WHAT HAS HAPPENED TO THE QUALITY OF LIFE IN THE ADVANCED INDUSTRIALIZED NATIONS, P257; Thacker EL, 2008, MOVEMENT DISORD, V23, P69, DOI 10.1002/mds.21772; Traynor BJ, 2009, NEUROEPIDEMIOLOGY, V33, P276, DOI 10.1159/000235639; van der Zee J, 2009, NEUROLOGY, V73, P626, DOI 10.1212/WNL.0b013e3181b389d9; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Williamson DF, 2004, ANN INTERN MED, V140, P951, DOI 10.7326/0003-4819-140-11-200406010-00036; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; [No title captured]	44	25	25	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 21	2010	68	2					196	200		10.1016/j.neuron.2010.10.002	http://dx.doi.org/10.1016/j.neuron.2010.10.002			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	681IJ	20955927	Green Accepted, Bronze			2022-12-24	WOS:000284304300008
J	Shonkoff, JP; Levitt, P				Shonkoff, Jack P.; Levitt, Pat			Neuroscience and the Future of Early Childhood Policy: Moving from Why to What and How	NEURON			English	Editorial Material							STRESS; FRAMEWORK; BRAIN	There is a need for greater synergy between advances in neuroscience and the formulation of innovative policies to improve life outcomes for children experiencing significant adversity. Translational developmental neuroscience can inform new theories of change to catalyze more effective interventions that lead to a more productive and healthier society.	[Shonkoff, Jack P.] Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA	Harvard University; University of Southern California	Shonkoff, JP (corresponding author), Harvard Univ, Ctr Developing Child, Cambridge, MA 02138 USA.	jack_shonkoff@harvard.edu						Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hammock EAD, 2006, HUM DEV, V49, P294, DOI 10.1159/000095581; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; National Advisory Mental Health Council's Workgroup, 2008, TRANSF NEUR RES MENT; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Shonkoff JP, 2010, CHILD DEV, V81, P357, DOI 10.1111/j.1467-8624.2009.01399.x; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Taylor SE, 2010, P NATL ACAD SCI USA, V107, P8507, DOI 10.1073/pnas.1003890107	11	64	70	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 9	2010	67	5					689	691		10.1016/j.neuron.2010.08.032	http://dx.doi.org/10.1016/j.neuron.2010.08.032			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	651PF	20826301	Bronze			2022-12-24	WOS:000281938900004
J	Tan, Y; Yu, DH; Pletting, J; Davis, RL				Tan, Ying; Yu, Dinghui; Pletting, Jennifer; Davis, Ronald L.			Gilgamesh Is Required for rutabaga-Independent Olfactory Learning in Drosophila	NEURON			English	Article							CASEIN KINASE-I; CYCLIC-AMP PHOSPHODIESTERASE; CELL-ADHESION MOLECULES; MUSHROOM BODY NEURONS; SHORT-TERM-MEMORY; PROTEIN-KINASES; PREFERENTIAL EXPRESSION; SYNAPTIC PLASTICITY; ADENYLYL-CYCLASE; GENE	Cyclic AMP signaling in Drosophila mushroom body neurons, anchored by the adenylyl cyclase encoded by the rutabaga gene, is indispensable for olfactory memory formation. From a screen for new memory mutants, we identified alleles of the gilgamesh (gish) gene, which encodes a casein kinase l gamma homolog that is preferentially expressed in the mushroom body neurons. The gish-encoded kinase participates in the physiology of these neurons underlying memory formation since the mutant memory deficit was rescued with expression of a gish cDNA in these neurons only during adulthood. A cellular memory trace, detected as increased calcium influx into the alpha'/beta' neuron processes in response to the odor used for conditioning, was disrupted in gish mutants. Epistasis experiments indicated a lack of genetic interactions between gish and rutabaga. Therefore, gish participates in a rutabaga-independent pathway for memory formation and accounts for some of the residual learning that occurs in rutabaga mutants.	[Tan, Ying; Yu, Dinghui; Pletting, Jennifer; Davis, Ronald L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Davis, Ronald L.] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA	Baylor College of Medicine; Scripps Research Institute	Tan, Y (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	yingt@bcm.edu; rdavis@scripps.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIH [NS19904]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052351, R37NS019904, R01NS019904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant NS19904 to R.L.D.	BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.0.CO;2-B; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LYLES JM, 1984, J CELL BIOL, V99, P2082, DOI 10.1083/jcb.99.6.2082; MACKIE K, 1989, J NEUROSCI, V9, P1883; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MEGGIO F, 1992, BIOCHEM BIOPH RES CO, V182, P1460, DOI 10.1016/0006-291X(92)91898-Z; Micheau J, 1999, CELL MOL LIFE SCI, V55, P534, DOI 10.1007/s000180050312; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; QIU YH, 1993, GENE DEV, V7, P1447, DOI 10.1101/gad.7.7b.1447; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717; Zhang L, 2006, DEV BIOL, V299, P221, DOI 10.1016/j.ydbio.2006.07.025	42	32	32	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					810	820		10.1016/j.neuron.2010.08.020	http://dx.doi.org/10.1016/j.neuron.2010.08.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826312	Green Accepted, Bronze			2022-12-24	WOS:000281938900015
J	Shenhav, A; Greene, JD				Shenhav, Amitai; Greene, Joshua D.			Moral Judgments Recruit Domain-General Valuation Mechanisms to Integrate Representations of Probability and Magnitude	NEURON			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; PREFRONTAL CORTEX; NEURAL MECHANISMS; EMOTION; REWARD; FMRI; NEUROECONOMICS; CONSEQUENCES; NEUROBIOLOGY	Many important moral decisions, particularly at the policy level, require the evaluation of choices involving outcomes of variable magnitude and probability. Many economic decisions involve the same problem. It is not known whether and to what extent these structurally isomorphic decisions rely on common neural mechanisms. Subjects undergoing fMRI evaluated the moral acceptability of sacrificing a single life to save a larger group of variable size and probability of dying without action. Paralleling research on economic decision making, the ventromedial prefrontal cortex and ventral striatum were specifically sensitive to the "expected moral value" of actions, i.e., the expected number of lives lost/saved. Likewise, the right anterior insula was specifically sensitive to outcome probability. Other regions tracked outcome certainty and individual differences in utilitarian tendency. The present results suggest that complex life-and-death moral decisions that affect others depend on neural circuitry adapted for more basic, self-interested decision making involving material rewards.	[Shenhav, Amitai; Greene, Joshua D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Shenhav, A (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	ashenhav@wjh.harvard.edu			NSF [SES-082197 8]; Direct For Social, Behav & Economic Scie [0821978] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We are grateful to R. Bernhard, K. Hermann, D. Murray, J. Paxton, and P. Sanchez for assistance in data collection, R. Buckner and Y.C. Kao for technical guidance, and A. Bornstein, F. Krienen, and three anonymous reviewers for their thoughtful comments on the manuscript. This work was supported by an NSF Graduate Research Fellowship awarded to A.S. and NSF SES-082197 8 awarded to J.D.G.	Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Bartels DM, 2008, COGNITION, V108, P381, DOI 10.1016/j.cognition.2008.03.001; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beer JS, 2006, PSYCHOL SCI, V17, P448, DOI 10.1111/j.1467-9280.2006.01726.x; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Boettiger CA, 2007, J NEUROSCI, V27, P14383, DOI 10.1523/JNEUROSCI.2551-07.2007; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Foot P, 1978, PROBLEM ABORTION DOC; Glimcher P.W., 2009, COGNITIVE NEUROSCIEN, P1085; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene J.D., 2009, COGNITIVE NEUROSCIEN, P987; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hauser MD, 2006, SOC COGN AFFECT NEUR, V1, P214, DOI 10.1093/scan/nsl026; Hooker C.I., 2006, ORBITOFRONTAL CORTEX, P307, DOI DOI 10.1093/ACPROF:OSO/9780198565741.003.0012; Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padoa-Schioppa C, 2007, ANN NY ACAD SCI, V1121, P232, DOI 10.1196/annals.1401.011; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Petrinovich L, 1996, ETHOL SOCIOBIOL, V17, P145, DOI 10.1016/0162-3095(96)00041-6; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Qin JG, 2009, HUM BRAIN MAPP, V30, P1338, DOI 10.1002/hbm.20604; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Thomson J Jarvis, 1986, RIGHTS RESTITUTION R; THURSTONE LL, 1954, PSYCHOL REV, V61, P47, DOI 10.1037/h0060035; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Ursu S, 2008, BRAIN RES, V1227, P110, DOI 10.1016/j.brainres.2008.06.033; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Watanabe M, 2007, CEREB CORTEX, V17, pI101, DOI 10.1093/cercor/bhm067; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104	65	167	174	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					667	677		10.1016/j.neuron.2010.07.020	http://dx.doi.org/10.1016/j.neuron.2010.07.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	646JA	20797542	Bronze			2022-12-24	WOS:000281534600015
J	Dupret, D; O'Neill, J; Pleydell-Bouverie, B; Csicsvari, J				Dupret, David; O'Neill, Joseph; Pleydell-Bouverie, Barty; Csicsvari, Jozsef			The reorganization and reactivation of hippocampal maps predict spatial memory performance	NATURE NEUROSCIENCE			English	Article							NMDA-RECEPTOR BLOCKADE; PLACE CELLS; NEURONAL ENSEMBLES; CONSOLIDATION; SLEEP; PATTERNS; TRACE; RAT; TASK; IMPAIRMENT	The hippocampus is an important brain circuit for spatial memory and the spatially selective spiking of hippocampal neuronal assemblies is thought to provide a mnemonic representation of space. We found that remembering newly learnt goal locations required NMDA receptor-dependent stabilization and enhanced reactivation of goal-related hippocampal assemblies. During spatial learning, place-related firing patterns in the CA1, but not CA3, region of the rat hippocampus were reorganized to represent new goal locations. Such reorganization did not occur when goals were marked by visual cues. The stabilization and successful retrieval of these newly acquired CA1 representations of behaviorally relevant places was NMDAR dependent and necessary for subsequent memory retention performance. Goal-related assembly patterns associated with sharp wave/ripple network oscillations, during both learning and subsequent rest periods, predicted memory performance. Together, these results suggest that the reorganization and reactivation of assembly firing patterns in the hippocampus represent the formation and expression of new spatial memory traces.	[Dupret, David; O'Neill, Joseph; Pleydell-Bouverie, Barty; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, Anat Neuropharmacol Unit, MRC, Oxford OX1 3QT, England	University of Oxford	Dupret, D (corresponding author), Univ Oxford, Dept Pharmacol, Anat Neuropharmacol Unit, MRC, S Parks Rd, Oxford OX1 3QT, England.	david.dupret@pharm.ox.ac.uk; jozsef.csicsvari@pharm.ox.ac.uk		Dupret, David/0000-0002-0040-1766	Medical Research Council; Institut de France-Fondation Louis D.; International Brain Research Organization; Saint Edmund Hall College, University of Oxford; Medical Research Council [MC_U138169944, MC_U138197111] Funding Source: researchfish; MRC [MC_U138197111, MC_U138169944] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut de France-Fondation Louis D.; International Brain Research Organization; Saint Edmund Hall College, University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J.N.P. Rawlins and D. M. Bannerman for discussions about the behavioral procedures; J.R. Huxter and K. Allen for discussions about data analysis and the manuscript; P. Somogyi, M. Capogna, C. Lever, O. Paulsen and T. Bienvenu for comments on a previous version of the manuscript and N. Campo-Urriza for technical assistance. This work was supported by the Medical Research Council. D. D. was successively funded by fellowships from the Institut de France-Fondation Louis D. and the International Brain Research Organization (Research Fellowship), and currently holds a Junior Research Fellowship in Neurosciences from Saint Edmund Hall College, University of Oxford.	BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; GLICKMAN SE, 1961, PSYCHOL BULL, V58, P218, DOI 10.1037/h0044212; Hebb Donald O., 1949, ORG BEHAV; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McDonald RJ, 2005, EUR J NEUROSCI, V22, P1201, DOI 10.1111/j.1460-9568.2005.04272.x; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1989, J NEUROSCI, V9, P4101; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	384	389	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					995	U122		10.1038/nn.2599	http://dx.doi.org/10.1038/nn.2599			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639874	Green Accepted			2022-12-24	WOS:000280400600019
J	Lemus, L; Hernandez, A; Luna, R; Zainos, A; Romo, R				Lemus, Luis; Hernandez, Adrian; Luna, Rogelio; Zainos, Antonio; Romo, Ranulfo			Do Sensory Cortices Process More than One Sensory Modality during Perceptual Judgments?	NEURON			English	Article							SECONDARY SOMATOSENSORY CORTEX; VENTRAL PREMOTOR CORTEX; SUPERIOR TEMPORAL SULCUS; PRIMATE AUDITORY-CORTEX; MACAQUE MONKEY; NEURAL CODES; RESPONSE PROPERTIES; ACOUSTIC FLUTTER; DECISION-MAKING; LAMINAR PROFILE	Recent studies have reported that sensory cortices process more than one sensory modality, challenging the long-lasting concept that they process only one. However, both the identity of these multi-modal responses and whether they contribute to perceptual judgments is unclear. We recorded from single neurons in somatosensory cortices and primary auditory cortex while trained monkeys discriminated, on interleaved trials, either between two tactile flutter stimuli or between two acoustic flutter stimuli, and during discrimination sets that combined these two sensory modalities. We found neurons in these sensory cortices that responded to stimuli that are not of their principal sensory modality during these tasks. However, the identity of the stimulus could only be decoded from responses to their principal sensory modality during the stimulation periods and not during the processing steps that link sensation and decision making. These results suggest that multimodal encoding and perceptual judgments in these tasks occur outside the sensory cortices studied here.	[Lemus, Luis; Hernandez, Adrian; Luna, Rogelio; Zainos, Antonio; Romo, Ranulfo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular Neurociencias, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx	Lemus, Luis/E-6760-2019	Lemus, Luis/0000-0002-6608-3684; romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794; Luna, Rogelio/0000-0003-0711-7562	Howard Hughes Medical Institute; Direccion del Personal Academico de la Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direccion del Personal Academico de la Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	R.R.'s research was partially supported by an International Research Scholars Award from the Howard Hughes Medical Institute and grants from the Direccion del Personal Academico de la Universidad Nacional Autonoma de Mexico and the Consejo Nacional de Ciencia y Tecnologia.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURTON H, 1991, BRAIN RES, V538, P127, DOI 10.1016/0006-8993(91)90386-A; Castellan NJ, 1988, NONPARAMETRIC STAT B; Chapman CE, 2005, J NEUROPHYSIOL, V94, P4094, DOI 10.1152/jn.00303.2005; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Fu KMG, 2004, J NEUROPHYSIOL, V92, P3522, DOI 10.1152/jn.01228.2003; Fu KMG, 2003, J NEUROSCI, V23, P7510; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Green DM, 1966, SIGNAL DETECTION THE; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; HIKOSAKA K, 1993, BIOMED RES-TOKYO, V14, P41; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; Kayser C, 2009, HEARING RES, V258, P80, DOI 10.1016/j.heares.2009.02.011; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lemus L, 2007, P NATL ACAD SCI USA, V104, P17174, DOI 10.1073/pnas.0707961104; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Lemus L, 2009, P NATL ACAD SCI USA, V106, P9471, DOI 10.1073/pnas.0904066106; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Menzel RR, 2005, CEREB CORTEX, V15, P1690, DOI 10.1093/cercor/bhi045; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; Pardo-Vazquez JL, 2008, J NEUROSCI, V28, P12396, DOI 10.1523/JNEUROSCI.3396-08.2008; Press W. H., 1992, ART SCI COMPUTING; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; STEIN BE, 1972, EXP NEUROL, V36, P179, DOI 10.1016/0014-4886(72)90145-8; Stein BE., 1993, MERGING SENSES; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4; Zhou YD, 2000, P NATL ACAD SCI USA, V97, P9777, DOI 10.1073/pnas.97.17.9777; Zhou YD, 2004, BEHAV BRAIN RES, V153, P573, DOI 10.1016/j.bbr.2003.12.024	59	70	70	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					335	348		10.1016/j.neuron.2010.06.015	http://dx.doi.org/10.1016/j.neuron.2010.06.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670839	Bronze			2022-12-24	WOS:000280461500016
J	Gandhi, S; Wood, NW				Gandhi, Sonia; Wood, Nicholas W.			Genome-wide association studies: the key to unlocking neurodegeneration?	NATURE NEUROSCIENCE			English	Article							AMYLOID-BETA-PEPTIDE; FAMILIAL ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; PRECURSOR-PROTEIN; APOLIPOPROTEIN-E; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; COMPLEX TRAITS; RISK-FACTORS; GENE	The successful discovery of genes that cause rare monogenic disorders has dominated our understanding of the genetic basis of neurodegenerative disease. The emergence of robust genome-wide association methodologies promises to explain the genetic etiology of the common sporadic forms of complex diseases. In addition to revealing the genetic susceptibility of neurodegenerative disease, genome-wide association studies (GWASs) should also be an unbiased generator of molecules that are relevant in disease pathogenesis. Despite this exciting potential, GWAS results have varied in their consistency and their ability to deliver these aims. The largest challenge that faces neuroscientists is the interpretation of the results of GWASs and the translation of the genetic findings into functional mechanisms that are biologically important in disease pathogenesis and, ultimately, treatment design. We examine recent results from GWASs of Alzheimer's disease and Parkinson's disease and explore their use and limitations. We further reflect on how these results may expedite progress in understanding and influencing the molecular pathogenesis of neurodegeneration.	[Gandhi, Sonia; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London, England	University of London; University College London	Wood, NW (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, London, England.	n.wood@ion.ucl.ac.uk	Wood, Nicholas W/C-2505-2009	Wood, Nicholas W/0000-0002-9500-3348	Wellcome Trust; Medical Research Council; Parkinson's UK; MRC [MC_G1000735, MC_PC_09003, MC_G0901330] Funding Source: UKRI; Medical Research Council [MC_PC_09003, MC_G1000735, MC_G0901330] Funding Source: researchfish; Parkinson&quot;s UK [J-0804] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors acknowledge the support of the Wellcome Trust, the Medical Research Council (Neurodegeneration strategic award) and Parkinson's UK.	Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogers J, 2006, NEUROBIOL AGING, V27, P1733, DOI 10.1016/j.neurobiolaging.2005.09.043; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Simon-Sanchez J, 2008, LANCET NEUROL, V7, P1067, DOI 10.1016/S1474-4422(08)70241-2; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; TSAI MS, 1994, AM J HUM GENET, V54, P643; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Webster S, 1997, J NEUROCHEM, V69, P388; Zhou J, 2008, J NEUROCHEM, V106, P2080, DOI 10.1111/j.1471-4159.2008.05558.x	48	70	77	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					789	794		10.1038/nn.2584	http://dx.doi.org/10.1038/nn.2584			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581814				2022-12-24	WOS:000279173900007
J	Krzyzosiak, A; Szyszka-Niagolov, M; Wietrzych, M; Gobaille, S; Muramatsu, S; Krezel, W				Krzyzosiak, Agnieszka; Szyszka-Niagolov, Monika; Wietrzych, Marta; Gobaille, Serge; Muramatsu, Shin-ichi; Krezel, Wojciech			Retinoid X Receptor Gamma Control of Affective Behaviors Involves Dopaminergic Signaling in Mice	NEURON			English	Article							DIFFERENTIAL EXPRESSION; ANTIDEPRESSANT DRUGS; SYSTEM; MODELS; ACID; OMEGA-3-FATTY-ACIDS; PRAMIPEXOLE; FLUOXETINE; DEFICITS; AGONISTS	Abnormal signaling by retinoids or n-3 polyunsaturated fatty acids has been implicated in clinical depression. The converging point in activities of these two classes of molecules is transcriptional activation of retinoid X receptors (Rxr). We show here that ablation of Rxr gamma in mice leads to depressive-like behaviors including increased despair and anhedonia, which were accompanied by reduced expression of dopamine D2 receptor in the shell of nucleus accumbens (NAc) and altered serotonin signaling. While abnormal serotonin signaling is not sufficient to generate the depressive behaviors, increasing D2r expression by chronic fluoxetine (Prozac) treatment or adenoassociated virus type2 (AAV2) mediated expression of Rxr gamma or D2r in the NAc of Rxr gamma(-/-) mice normalizes depressive-like behaviors in Rxr gamma(-/-) animals. Conversely, NAc infusion of raclopride, a D2r antagonist prevents AAV2-Rxr gamma-mediated rescue of despair behaviors in Rxr gamma(-/-) mice. Combined, our data argue that control of NAc D2r expression is critical for Rxr gamma-mediated modulation of affective behaviors.	[Krzyzosiak, Agnieszka; Szyszka-Niagolov, Monika; Wietrzych, Marta; Krezel, Wojciech] IGBMC, INSERM, U596, CNRS,UMR 7104, F-67400 Illkirch Graffenstaden, France; [Krzyzosiak, Agnieszka; Szyszka-Niagolov, Monika; Wietrzych, Marta; Krezel, Wojciech] Univ Strasbourg, F-67000 Strasbourg, France; [Krzyzosiak, Agnieszka] Wroclaw Univ Technol, Fac Chem, Div Biochem, PL-50370 Wroclaw, Poland; [Gobaille, Serge] IFR37 Neurosci, Fac Med, F-67085 Strasbourg, France; [Muramatsu, Shin-ichi] Jichi Med Univ, Div Neurol, Dept Med, Shimotsuke, Tochigi 3290498, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Wroclaw University of Science & Technology; Jichi Medical University	Krezel, W (corresponding author), IGBMC, INSERM, U596, CNRS,UMR 7104, BP 10142, F-67400 Illkirch Graffenstaden, France.	krezel@igbmc.u-strasbg.fr	Krezel, Wojciech/H-9080-2017; KREZEL, Wojciech/S-8331-2019; Muramatsu, Shin-ichi/K-9420-2013; Krzyżosiak, Agnieszka/AAW-3711-2021; Krezel, Wojciech/I-7886-2016; Muramatsu, Shinichi/ABC-6093-2021	Krezel, Wojciech/0000-0003-1605-3185; Muramatsu, Shin-ichi/0000-0002-3185-7790; Krezel, Wojciech/0000-0003-1605-3185; Muramatsu, Shinichi/0000-0002-3185-7790; Krzyzosiak, Agnieszka/0000-0002-4330-3189	French Embassy in Poland; ANR; Fondation pour la Recherche Medicale; Institut National de la Sante et de la Recherche Medicate (INSERM); Centre National de la Recherche Scientifique (CNRS); Institut Clinique de la Souris (ICS); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	French Embassy in Poland; ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicate (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Clinique de la Souris (ICS); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank Chaouki Bam'Hamed and Raphael Bour for excellent animal care, Naomi Takino, Hitomi Miyauchi, Keiko Ayabe for their help with producing AAV-vectors and Mme Carmen Schleef for expert help in HPLC analysis, and Eric Nestler, Pierre Chambon, Abdel-Mouttalib Ouagazzal and Pascal Dolle for critical reading of the manuscript. A.K. was supported by a PhD fellowship of the French Embassy in Poland and ANR grant "Neuroprotect and is a member of European Doctoral College in Strasbourg, M.S.-N. by the Association pour la Recherche sur le Cancer, M.W. by a fellowship from the Fondation pour la Recherche Medicale. This work was supported by funds from the Institut National de la Sante et de la Recherche Medicate (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Institut Clinique de la Souris (ICS), and grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and from the Ministry of Health, Labour and Welfare of Japan.	Ainsworth K, 1998, PSYCHOPHARMACOLOGY, V140, P470, DOI 10.1007/s002130050791; AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Blier P, 1998, ANN NY ACAD SCI, V861, P204, DOI 10.1111/j.1749-6632.1998.tb10192.x; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; Bremmer JD, 2008, PROG NEURO-PSYCHOPH, V32, P315, DOI 10.1016/j.pnpbp.2007.07.001; Brocco M, 2006, BEHAV PHARMACOL, V17, P559, DOI 10.1097/01.fbp.0000236267.41806.5b; Carlezon WA, 2005, BIOL PSYCHIAT, V57, P343, DOI 10.1016/j.biopsych.2004.11.038; Corrigan MH, 2000, DEPRESS ANXIETY, V11, P58, DOI 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H; Dailly E, 2004, FUND CLIN PHARMACOL, V18, P601, DOI 10.1111/j.1472-8206.2004.00287.x; Dalvi A, 1999, PSYCHOPHARMACOLOGY, V147, P14, DOI 10.1007/s002130051131; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; DziedzickaWasylewska M, 1997, J NEURAL TRANSM, V104, P515, DOI 10.1007/BF01277668; Foley KF, 2006, EXPERT REV NEUROTHER, V6, P1249, DOI 10.1586/14737175.6.9.1249; Kastner P, 1997, DEVELOPMENT, V124, P313; Kontaxakis Vassilis P, 2009, Ann Gen Psychiatry, V8, P2, DOI 10.1186/1744-859X-8-2; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; Larisch R, 1997, NEUROIMAGE, V5, P251, DOI 10.1006/nimg.1997.0267; Lechin F, 2006, PROG NEURO-PSYCHOPH, V30, P565, DOI 10.1016/j.pnpbp.2005.11.025; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; Logan Alan C, 2004, Lipids Health Dis, V3, P25; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Mattes J A, 1997, Ann Clin Psychiatry, V9, P87, DOI 10.1023/A:1026253202366; MESSIER C, 1992, PHARMACOL BIOCHEM BE, V41, P177, DOI 10.1016/0091-3057(92)90079-U; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Millan MJ, 2004, PSYCHOPHARMACOLOGY, V174, P341, DOI 10.1007/s00213-003-1770-x; Moreau JL, 1997, PSYCHOPHARMACOLOGY, V134, P357, DOI 10.1007/s002130050467; Naliwaiko K, 2004, NUTR NEUROSCI, V7, P91, DOI 10.1080/10284150410001704525; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Paterna JC, 2004, J VIROL, V78, P6808, DOI 10.1128/JVI.78.13.6808-6817.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; PIJNENBURG AJJ, 1976, EUR J PHARMACOL, V35, P45, DOI 10.1016/0014-2999(76)90299-5; Rasband W., 2006, IMAGEJ; Renard CE, 2001, PSYCHOPHARMACOLOGY, V159, P42, DOI 10.1007/s002130100836; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Siuciak JA, 2004, PSYCHOPHARMACOLOGY, V175, P163, DOI 10.1007/s00213-004-1809-7; THEOHAR C, 1982, ARZNEIMITTELFORSCH, V32-2, P783; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Willner P, 2005, J AFFECT DISORDERS, V86, P37, DOI 10.1016/j.jad.2004.12.010; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x; ZHANG M, 1996, REGULATION MOTOR BEH	47	51	53	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					908	920		10.1016/j.neuron.2010.05.004	http://dx.doi.org/10.1016/j.neuron.2010.05.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620876	Bronze			2022-12-24	WOS:000279420800013
J	Chen, JL; Lin, WC; Cha, JW; So, PT; Kubota, Y; Nedivi, E				Chen, Jerry L.; Lin, Walter C.; Cha, Jae Won; So, Peter T.; Kubota, Yoshiyuki; Nedivi, Elly			Structural basis for the role of inhibition in facilitating adult brain plasticity	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; PRIMARY VISUAL-CORTEX; CRITICAL PERIOD; MONOCULAR DEPRIVATION; MOUSE MODEL; INTERNEURONS; RESPONSES; NEURONS; CONNECTIONS	Although inhibition has been implicated in mediating plasticity in the adult brain, the underlying mechanism remains unclear. Here we present a structural mechanism for the role of inhibition in experience-dependent plasticity. Using chronic in vivo two-photon microscopy in the mouse neocortex, we show that experience drives structural remodeling of superficial layer 2/3 interneurons in an input- and circuit-specific manner, with up to 16% of branch tips undergoing remodeling. Visual deprivation initially induces dendritic branch retractions, and this is accompanied by a loss of inhibitory inputs onto neighboring pyramidal cells. The resulting decrease in inhibitory tone, also achievable pharmacologically using the antidepressant fluoxetine, provides a permissive environment for further structural adaptation, including addition of new synapse-bearing branch tips. Our findings suggest that therapeutic approaches that reduce inhibition, when combined with an instructive stimulus, could facilitate restructuring of mature circuits impaired by damage or disease, improving function and perhaps enhancing cognitive abilities.	[Chen, Jerry L.; Lin, Walter C.; Nedivi, Elly] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Chen, Jerry L.; Nedivi, Elly] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lin, Walter C.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02138 USA; [Cha, Jae Won; So, Peter T.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [So, Peter T.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Kubota, Yoshiyuki] Japan Sci & Technol Agcy, Tokyo, Japan; [Kubota, Yoshiyuki] Natl Inst Physiol Sci, Div Cerebral Circuitry, Okazaki, Aichi 444, Japan; [Kubota, Yoshiyuki] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan; [Nedivi, Elly] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Massachusetts Institute of Technology (MIT)	Nedivi, E (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nedivi@mit.edu	Nedivi, Elly/ABC-9923-2021	Kubota, Yoshiyuki/0000-0002-0950-7460; Chen, Jerry/0000-0002-7409-7859; /0000-0002-1710-0767	US National Eye Institute [R01 EY017656]; Stanley Center for Psychiatric Research; MIT-Portugal; Singapore-MIT Alliance-2; Singapore-MIT Alliance for Research and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [20500300, 22120518]; NATIONAL EYE INSTITUTE [R01EY017656] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22120518] Funding Source: KAKEN	US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Stanley Center for Psychiatric Research; MIT-Portugal; Singapore-MIT Alliance-2; Singapore-MIT Alliance for Research and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Leslie, R. Schecter and J. Hoch for comments on the manuscript; M. F. Bear for helpful discussions; M. Kozberg for assistance in data analysis; J. Coleman, H. B. Yu, S. Horng and C. McCurry for assistance with optical intrinsic imaging; Y. Yamamoto (Yokohama Demonstration Laboratory, SII NanoTecnnology Inc.) for data collection assistance by Zeiss NVision40; S. Hatada and H. Kita (National Institute of Physiological Sciences) for serial electron microscopy reconstruction; and Y. Kawaguchi for valuable discussions regarding EM reconstructions. This work was sponsored by grants to E.N. from the US National Eye Institute (R01 EY017656) and from the Stanley Center for Psychiatric Research. J. L. C. was supported in part by the MIT-Portugal program. J. W. C. was supported in part by the Singapore-MIT Alliance-2 and Singapore-MIT Alliance for Research and Technology. Y. K. was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20500300, 22120518).	Antonini A, 1999, J NEUROSCI, V19, P4388; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Bullier J, 2001, PROG BRAIN RES, V134, P193; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dong HW, 2004, J COMP NEUROL, V475, P361, DOI 10.1002/cne.20164; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; HENDRY SHC, 1994, J NEUROSCI, V14, P2383; HENDRY SHC, 1990, J NEUROSCI, V10, P2438; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; HENDRY SHC, 1988, NEURON, V1, P701, DOI 10.1016/0896-6273(88)90169-9; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kubota Y, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.004.2009; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Yamashita A, 2003, J COMP NEUROL, V464, P426, DOI 10.1002/cne.10810	49	149	150	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					587	U73		10.1038/nn.2799	http://dx.doi.org/10.1038/nn.2799			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478885	Green Accepted, Green Published			2022-12-24	WOS:000289886600014
J	Ghiasvand, NM; Rudolph, DD; Mashayekhi, M; Brzezinski, JA; Goldman, D; Glaser, T				Ghiasvand, Noor M.; Rudolph, Dellaney D.; Mashayekhi, Mohammad; Brzezinski, Joseph A.; Goldman, Daniel; Glaser, Tom			Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease	NATURE NEUROSCIENCE			English	Article							GANGLION-CELL; GENE-EXPRESSION; NON-ATTACHMENT; MATH5; RETINOPATHY; COMPETENCE; RESPONSES; NETWORK; MICE; SIZE	Individuals with nonsyndromic congenital retinal nonattachment (NCRNA) are totally blind from birth. The disease afflicts similar to 1% of Kurdish people living in a group of neighboring villages in North Khorasan, Iran. We found that NCRNA is caused by a 6,523-bp deletion that spans a remote cis regulatory element 20 kb upstream from ATOH7 (Math5), a bHLH transcription factor gene that is required for retinal ganglion cell (RGC) and optic nerve development. In humans, the absence of RGCs stimulates massive neovascular growth of fetal blood vessels in the vitreous and early retinal detachment. The remote ATOH7 element appears to act as a secondary or 'shadow' transcriptional enhancer. It has minimal sequence similarity to the primary enhancer, which is close to the Atoh7 promoter, but drives transgene expression with an identical spatiotemporal pattern in the mouse retina. The human transgene also functions appropriately in zebrafish, reflecting deep evolutionary conservation. These dual enhancers may reinforce Atoh7 expression during early critical stages of eye development when retinal neurogenesis is initiated.	[Rudolph, Dellaney D.; Brzezinski, Joseph A.; Glaser, Tom] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Rudolph, Dellaney D.; Brzezinski, Joseph A.; Glaser, Tom] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ghiasvand, Noor M.] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Sch Med, Tehran, Iran; [Ghiasvand, Noor M.] Shahid Beheshti Univ Med Sci, Dept Med Genet, Sch Med, Tehran, Iran; [Ghiasvand, Noor M.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Mashayekhi, Mohammad] Emam Ali Hosp, Ophthalmol Ward, Bojnourd, N Khorasan, Iran; Univ Michigan, Mol & Behav Neurosci Inst, Dept Biochem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Grand Valley State University; North Khorasan University of Medical Sciences; University of Michigan System; University of Michigan	Glaser, T (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	tglaser@umich.edu	Brzezinski, Joseph/AAM-4699-2021	Brzezinski, Joseph/0000-0001-5854-0315	Glaucoma Foundation; University of Michigan Center for Genetics in Health and Medicine; US National Institutes of Health [EY14259, EY18132, T32 EY13934]; NATIONAL EYE INSTITUTE [T32EY013934, R01EY018132, R01EY014259] Funding Source: NIH RePORTER	Glaucoma Foundation; University of Michigan Center for Genetics in Health and Medicine(University of Michigan System); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to A. Swaroop for facilitating this collaborative project, A. Aledavood for logistical support and encouragement, H. Parmar, J. Trobe and E. Oliver for help interpreting MRI studies, L. Prasov for assistance with mouse tissue cDNAs and retinal dissections, J. Johnson for pBGn-Cherry plasmid DNA, N. Brown for Math5-GFP transgenic mice, I. Masai for ath5:GFP transgenic fish, M. Pihalja and M. Chiang for flow cytometry advice, S. Philips and T. Masud for screening candidate genes, S. Dagenais and R. Lyons for SNP genotyping analysis, S. Barolo, N. Brown, L. Prasov, C. Chou, M. Meisler and B. Link for helpful suggestions, and to T. Saunders, M. van Keuren and the University of Michigan transgenic animal, flow cytometry and DNA sequencing cores for technical support. We are profoundly grateful to NCRNA family members for their involvement and dedication to this study over many years. The research was funded by grants from the Glaucoma Foundation and the University of Michigan Center for Genetics in Health and Medicine to T. G., and from the US National Institutes of Health to T. G. (EY14259), D. G. (EY18132) and J.A.B. (T32 EY13934).	BRODRICK JD, 1972, BRIT J OPHTHALMOL, V56, P589, DOI 10.1136/bjo.56.8.589; Brodsky MC, 2010, PEDIATRIC NEURO-OPHTHALMOLOGY, SECOND EDITION, P383, DOI 10.1007/978-0-387-69069-8_8; Brown NL, 2002, MAMM GENOME, V13, P95, DOI 10.1007/s00335-001-2101-3; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; BRZEZINSKI JA, 2004, INVEST OPHTH VIS SCI, V45, P3422; BRZEZINSKI JA, 2011, DEV BIOL IN PRESS; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Ghiasvand NM, 2000, AM J MED GENET, V92, P220, DOI 10.1002/(SICI)1096-8628(20000529)92:3<220::AID-AJMG11>3.3.CO;2-P; Ghiasvand NM, 1998, AM J MED GENET, V78, P226, DOI 10.1002/(SICI)1096-8628(19980707)78:3<226::AID-AJMG3>3.3.CO;2-F; Ghiasvand NM, 2000, AM J MED GENET, V90, P165, DOI 10.1002/(SICI)1096-8628(20000117)90:2<165::AID-AJMG15>3.0.CO;2-O; Hobert O, 2010, CURR BIOL, V20, pR697, DOI 10.1016/j.cub.2010.07.035; Hoffmann EM, 2007, SURV OPHTHALMOL, V52, P32, DOI 10.1016/j.survophthal.2006.10.002; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; Hufnagel RB, 2007, MOL CELL NEUROSCI, V36, P435, DOI 10.1016/j.mcn.2007.08.006; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Hutcheson DA, 2005, DEVELOPMENT, V132, P829, DOI 10.1242/dev.01653; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee BL, 1996, AM J OPHTHALMOL, V122, P131, DOI 10.1016/S0002-9394(14)71982-8; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; PALMER EA, 1991, OPHTHALMOLOGY, V98, P1628; Perry J.R., 1975, IRAN STUD-UK, V8, P199, DOI [10.1080/00210867508701499, DOI 10.1080/00210867508701499]; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; PHILLIPS CI, 1979, J PEDIAT OPHTH STRAB, V16, P358; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; PRASOV L, 2009, INVEST OPHTH VIS SCI, V50, P1310; Prasov L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012315; Provis JM, 2001, PROG RETIN EYE RES, V20, P799, DOI 10.1016/S1350-9462(01)00012-X; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Skowronska-Krawczyk D, 2009, DEVELOPMENT, V136, P3767, DOI 10.1242/dev.033449; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WARBURG M, 1979, T OPHTHAL SOC UK, V99, P272; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Willardsen MI, 2009, DEV BIOL, V326, P471, DOI 10.1016/j.ydbio.2008.10.046; Williams RW, 1998, J NEUROSCI, V18, P138; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005	50	100	105	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					578	U63		10.1038/nn.2798	http://dx.doi.org/10.1038/nn.2798			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441919	Green Submitted, Green Accepted			2022-12-24	WOS:000289886600013
J	Zanto, TP; Rubens, MT; Thangavel, A; Gazzaley, A				Zanto, Theodore P.; Rubens, Michael T.; Thangavel, Arul; Gazzaley, Adam			Causal role of the prefrontal cortex in top-down modulation of visual processing and working memory	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; SELECTIVE ATTENTION; SPATIAL ATTENTION; FUNCTIONAL CONNECTIVITY; EXTRASTRIATE CORTEX; COGNITIVE TASK; INFORMATION; SUPPRESSION; PERFORMANCE; BRAIN	Selective attention filters information to limit what is encoded and maintained in working memory. Although the prefrontal cortex (PFC) is central to both selective attention and working memory, the underlying neural processes that link these cognitive abilities remain elusive. Using functional magnetic resonance imaging to guide repetitive transcranial magnetic stimulation with electroencephalographic recordings in humans, we perturbed PFC function at the inferior frontal junction in participants before they performed a selective-attention, delayed-recognition task. This resulted in diminished top-down modulation of activity in posterior cortex during early encoding stages, which predicted a subsequent decrement in working memory accuracy. Participants with stronger fronto-posterior functional connectivity displayed greater disruptive effects. Our data further suggests that broad alpha-band (7-14 Hz) phase coherence subserved this long-distance top-down modulation. These results suggest that top-down modulation mediated by the prefrontal cortex is a causal link between early attentional processes and subsequent memory performance.	[Zanto, Theodore P.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol & Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zanto, TP (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	theodore.zanto@ucsf.edu; adam.gazzaley@ucsf.edu			US National Institutes of Health [1F32AG030249-01A2, 5R01AG030395]; NATIONAL INSTITUTE ON AGING [F32AG030249, R01AG030395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank V. Barres and C. Gruson-Daniel for their assistance. This work was supported by US National Institutes of Health grants 1F32AG030249-01A2 (T.P.Z.) and 5R01AG030395 (A.G.).	AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Baddeley A., 2007, WORKING MEMORY THOUG; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bollinger J, 2010, J NEUROSCI, V30, P14399, DOI 10.1523/JNEUROSCI.1547-10.2010; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Desimone Robert, 1994, P75; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Fuggetta G, 2006, J NEUROPHYSIOL, V95, P3277, DOI 10.1152/jn.01273.2005; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Miller BT, 2011, J COGNITIVE NEUROSCI, V23, P1, DOI 10.1162/jocn.2010.21516; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; UNGERLEIDER LG, 1989, EXP BRAIN RES, V76, P473, DOI 10.1007/BF00248903; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012; Zanto TP, 2010, NEUROPSYCHOLOGIA, V48, P13, DOI 10.1016/j.neuropsychologia.2009.08.003; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhang WW, 2009, NAT NEUROSCI, V12, P24, DOI 10.1038/nn.2223	50	438	444	8	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					656	U156		10.1038/nn.2773	http://dx.doi.org/10.1038/nn.2773			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	754VU	21441920	Green Accepted			2022-12-24	WOS:000289886600023
J	Neveu, P; Kye, MJ; Qi, SP; Buchholz, DE; Clegg, DO; Sahin, M; Park, IH; Kim, KS; Daley, GQ; Kornblum, HI; Shraiman, BI; Kosik, KS				Neveu, Pierre; Kye, Min Jeong; Qi, Shuping; Buchholz, David E.; Clegg, Dennis O.; Sahin, Mustafa; Park, In-Hyun; Kim, Kwang-Soo; Daley, George Q.; Kornblum, Harley I.; Shraiman, Boris I.; Kosik, Kenneth S.			MicroRNA Profiling Reveals Two Distinct p53-Related Human Pluripotent Stem Cell States	CELL STEM CELL			English	Article							IPS CELLS; GENERATION; PATHWAYS; GENES; MICE	Reprogramming methodologies have provided multiple routes for achieving pluripotency. However, pluripotency is generally considered to be an almost singular state, with subtle differences described between induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). We profiled miRNA expression levels across 49 human cell lines, including ESCs, iPSCs, differentiated cells, and cancer cell lines. We found that the resulting miRNA profiles divided the iPSCs and hESCs examined into two distinct categories irrespective of the cell line origin. The miRNAs that defined these two pluripotency categories also distinguished cancer cells from differentiated cells. Transcriptome analysis suggested that several gene sets related to p53 distinguished these categories, and overexpression of the p53-targeting miRNAs miR-92 and miR-141 in iPSCs was sufficient to change their classification status. Thus, our results suggest a subdivision of pluripotent stem cell states that is independent of their origin but related to p53 network status.	[Neveu, Pierre; Kye, Min Jeong; Buchholz, David E.; Clegg, Dennis O.; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Neveu, Pierre; Shraiman, Boris I.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kye, Min Jeong; Buchholz, David E.; Clegg, Dennis O.; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Kye, Min Jeong; Buchholz, David E.; Clegg, Dennis O.; Kosik, Kenneth S.] Univ Calif Santa Barbara, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Shraiman, Boris I.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Kye, Min Jeong; Sahin, Mustafa] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Childrens Hosp Boston, Boston, MA 02115 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, Dept Psychiat, Semel Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Semel Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Park, In-Hyun; Daley, George Q.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Div Pediat Hematol Oncol,Childrens Hosp Boston, Boston, MA 02115 USA; [Park, In-Hyun; Daley, George Q.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; [Park, In-Hyun] Yale Univ, Sch Med, Dept Genet, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Kim, Kwang-Soo] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Mol Neurobiol Lab,Dept Psychiat, Belmont, MA 02478 USA; [Kim, Kwang-Soo] Harvard Univ, Sch Med, Harvard Stem Cell Inst, McLean Hosp, Belmont, MA 02478 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Yale University; Harvard University; Harvard University; McLean Hospital	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	SAHIN, MUSTAFA/I-8653-2019; Kye, Min Jeong/ABC-3439-2020; Neveu, Pierre/C-1170-2009	SAHIN, MUSTAFA/0000-0001-7044-2953; Kye, Min Jeong/0000-0002-1323-7256; Neveu, Pierre/0000-0003-4939-3418	National Science Foundation [PHY05-51164]; A.W.M. Keck Foundation	National Science Foundation(National Science Foundation (NSF)); A.W.M. Keck Foundation	We thank E. Domany, M. Elowitz, R. Neher, T. Papagiannakopoulos, and members of the K.S.K. lab for helpful discussions; J. Thomson for the gift of virus- and episome-induced iPSC lines and reagents; K. Lao for technical support and gift of reagents; D. Kwiatkowski for the gift of p53<SUP>-/-</SUP> and p53<SUP>-/-</SUP>T-sc2<SUP>-/-</SUP> MEFs; K. Abu-Elneel for sharing miRNA profiles of fetal brain (samples were kindly provided by the Harvard Brain Tissue Resource Center); S. Ratanasirintrawoot for RNA of partially reprogrammed cells; and S. Hikita and the California Institute for Regenerative Medicine-funded Laboratory for Stem Cell Biology and Engineering. P.N. and B.I.S. research is supported in part by the National Science Foundation under Grant No. PHY05-51164. M.J.K. and D.E.B. are CIRM scholars. A.W.M. Keck Foundation grant to K.S.K. supported the studies. K.S.K. owns stock in and serves on the board of Minerva Biotechnologies corporation. G.Q.D. is a member of the scientific advisory boards and holds equity in the following companies: Epizyme, iPierian, Solasia KK, and MPM Capital, LLP.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zito Tiziano, 2008, Front Neuroinform, V2, P8, DOI 10.3389/neuro.11.008.2008	52	75	80	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					671	681		10.1016/j.stem.2010.11.012	http://dx.doi.org/10.1016/j.stem.2010.11.012			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112562	Bronze			2022-12-24	WOS:000285537700009
J	Stepien, AE; Tripodi, M; Arber, S				Stepien, Anna E.; Tripodi, Marco; Arber, Silvia			Monosynaptic Rabies Virus Reveals Premotor Network Organization and Synaptic Specificity of Cholinergic Partition Cells	NEURON			English	Article							SPINAL-CORD; COMMISSURAL INTERNEURONS; HORSERADISH-PEROXIDASE; GENE-EXPRESSION; MOTOR-NEURONS; GROUP-I; MOTONEURONS; AFFERENTS; PROJECTIONS; CIRCUITS	Movement is the behavioral output of neuronal activity in the spinal cord. Motor neurons are grouped into motor neuron pools, the functional units innervating individual muscles. Here we establish an anatomical rabies virus-based connectivity assay in early postnatal mice. We employ it to study the connectivity scheme of premotor neurons, the neuronal cohorts monosynaptically connected to motor neurons, unveiling three aspects of organization. First, motor neuron pools are connected to segmentally widely distributed yet stereotypic interneuron populations, differing for pools innervating functionally distinct muscles. Second, depending on subpopulation identity, interneurons take on local or segmentally distributed positions. Third, cholinergic partition cells involved in the regulation of motor neuron excitability segregate into ipsilaterally and bilaterally projecting populations, the latter exhibiting preferential connections to functionally equivalent motor neuron pools bilaterally. Our study visualizes the widespread yet precise nature of the connectivity matrix for premotor interneurons and reveals exquisite synaptic specificity for bilaterally projecting cholinergic partition cells.	[Stepien, Anna E.; Tripodi, Marco; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland; [Stepien, Anna E.; Tripodi, Marco; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Tripodi, Marco/AGN-5956-2022	Tripodi, Marco/0000-0002-6827-6690; Arber, Silvia/0000-0002-6261-250X	Swiss National Science Foundation; EU; ERC; Kanton of Basel-Stadt; Novartis Research Foundation; EMBO	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); ERC(European Research Council (ERC)European Commission); Kanton of Basel-Stadt; Novartis Research Foundation; EMBO(European Molecular Biology Organization (EMBO))	We are very grateful to all other members of the lab, for help and fruitful discussions; to Ian Wickerham, Ed Callaway, and Klaus Conzelmann, for helpful advice, sharing information prior to publication, and supplying us with an initial set of reagents; to Laurent Gelman, Aaron Ponti, and Patrick Schwarb, for help and advice with image acquisition and analysis; to Dimosthenis Gaidatzis, for help with statistical analysis; to Ole Kiehn, for providing vGlut2<SUP>Cre</SUP> mice; and to Pico Caroni, Andreas Luethi, and Botond Roska, for helpful comments on the manuscript and discussions. A.E.S., M.T., and S.A. were supported by grants from the Swiss National Science Foundation, EU Framework 7 program, and ERC Advanced Grant program; by the Kanton of Basel-Stadt; and by the Novartis Research Foundation. M.T. was supported by an EMBO long-term fellowship.	Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x; Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bannatyne BA, 2009, J PHYSIOL-LONDON, V587, P379, DOI 10.1113/jphysiol.2008.159129; Bannatyne BA, 2003, EUR J NEUROSCI, V18, P2273, DOI 10.1046/j.1460-9568.2003.02973.x; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Burke RE, 1996, J COMP NEUROL, V372, P465; Conradi S, 1969, Acta Physiol Scand Suppl, V333, P5; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Ekstrand MI, 2008, TRENDS MOL MED, V14, P134, DOI 10.1016/j.molmed.2007.12.008; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOLSTEGE G, 1987, EXP BRAIN RES, V67, P179, DOI 10.1007/BF00269465; HOLSTEGE JC, 1987, NEUROSCIENCE, V23, P809, DOI 10.1016/0306-4522(87)90160-6; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P637, DOI 10.1113/jphysiol.1971.sp009489; JANKOWSKA E, 1986, NEUROSCI LETT, V71, P163, DOI 10.1016/0304-3940(86)90552-5; Jankowska E, 2003, J NEUROSCI, V23, P1867; Jankowska E, 2009, J PHYSIOL-LONDON, V587, P401, DOI 10.1113/jphysiol.2008.159236; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mears SC, 1997, J NEUROSCI, V17, P3128; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Nishimaru H, 2006, J NEUROSCI, V26, P5320, DOI 10.1523/JNEUROSCI.5127-05.2006; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Renshaw B, 1941, J NEUROPHYSIOL, V4, P167, DOI 10.1152/jn.1941.4.2.167; ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93; Sakmann B, 2006, PFLUG ARCH EUR J PHY, V453, P249, DOI 10.1007/s00424-006-0172-4; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; THERIAULT E, 1988, J NEUROPHYSIOL, V60, P463, DOI 10.1152/jn.1988.60.2.463; THERIAULT E, 1988, J NEUROPHYSIOL, V60, P446, DOI 10.1152/jn.1988.60.2.446; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008; Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; WINDHORST U, 1990, PROG NEUROBIOL, V35, P135, DOI 10.1016/0301-0082(90)90020-H; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	61	167	170	4	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					456	472		10.1016/j.neuron.2010.10.019	http://dx.doi.org/10.1016/j.neuron.2010.10.019			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040847	Bronze			2022-12-24	WOS:000284255800014
J	Chen, GK; Hou, ZG; Gulbranson, DR; Thomson, JA				Chen, Guokai; Hou, Zhonggang; Gulbranson, Daniel R.; Thomson, James A.			Actin-Myosin Contractility Is Responsible for the Reduced Viability of Dissociated Human Embryonic Stem Cells	CELL STEM CELL			English	Article							ROCK INHIBITOR; DISTINCT ROLES; PHOSPHORYLATION; TRANSCRIPTION; BLEBBISTATIN; CYTOKINESIS; SPECIFICITY; SUBSTRATE; MOTILITY; CULTURE	Human ESCs are the pluripotent precursor of the three embryonic germ layers. Human ESCs exhibit basal-apical polarity, junctional complexes, integrin-dependent matrix adhesion, and E-cadherin-dependent cell-cell adhesion, all characteristics shared by the epiblast epithelium of the intact mammalian embryo. After disruption of epithelial structures, programmed cell death is commonly observed. If individualized human ESCs are prevented from reattaching and forming colonies, their viability is significantly reduced. Here, we show that actin-myosin contraction is a critical effector of the cell death response to human ESC dissociation. Inhibition of myosin heavy chain ATPase, downregulation of myosin heavy chain, and downregulation of myosin light chain all increase survival and cloning efficiency of individualized human ESCs. ROCK inhibition decreases phosphorylation of myosin light chain, suggesting that inhibition of actin-myosin contraction is also the mechanism through which ROCK inhibitors increase cloning efficiency of human ESCs.	[Chen, Guokai; Hou, Zhonggang; Gulbranson, Daniel R.; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Chen, Guokai; Hou, Zhonggang; Gulbranson, Daniel R.; Thomson, James A.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Thomson, JA (corresponding author), Morgridge Inst Res, Madison, WI 53707 USA.	thomson@primate.wisc.edu	Gulbranson, Daniel/AAE-4338-2020; Gulbranson, Daniel/AAE-4807-2020		Charlotte Geyer Foundation; Morgridge Institute for Research; NIH [UO1ES017166, RR-05-19]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; Morgridge Institute for Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Charlotte Geyer Foundation, the Morgridge Institute for Research, NIH grant UO1ES017166 (to J.A.T.) and NIH contract RR-05-19 (to J.A.T.). We thank Dr. William Bement and Dr. Ivan Rayment for their discussion and suggestions. We thank Ron Stewart for his help on statistic analysis. We also thank Clay Glennon for assistance with confocal images and videos and Deborah Faupel and Krista Eastman for editorial assistance. J.A.T. is a founder, stock owner, consultant, and board member of Cellular Dynamics International (CDI). He also serves as scientific advisor to and has financial interests in Tactics II Stem Cell Ventures.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Kang JH, 2007, BIOCHIMIE, V89, P39, DOI 10.1016/j.biochi.2006.08.003; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Okeyo KO, 2009, J BIOMECH, V42, P2540, DOI 10.1016/j.jbiomech.2009.07.002; Quintin S, 2008, TRENDS GENET, V24, P221, DOI 10.1016/j.tig.2008.02.005; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; Wang PB, 2003, J BIOL CHEM, V278, P19917, DOI 10.1074/jbc.M210337200; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	42	201	213	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					240	248		10.1016/j.stem.2010.06.017	http://dx.doi.org/10.1016/j.stem.2010.06.017			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682449	Green Accepted, Bronze			2022-12-24	WOS:000281107400015
J	Pajcini, KV; Corbel, SY; Sage, J; Pomerantz, JH; Blau, HM				Pajcini, Kostandin V.; Corbel, Stephane Y.; Sage, Julien; Pomerantz, Jason H.; Blau, Helen M.			Transient Inactivation of Rb and ARF Yields Regenerative Cells from Postmitotic Mammalian Muscle	CELL STEM CELL			English	Article							RETINOBLASTOMA GENE FAMILY; LIMB REGENERATION; TUMOR SUPPRESSION; SELF-RENEWAL; STEM-CELLS; MYOGENIC DIFFERENTIATION; NEWT TRITURUS; INK4A LOCUS; CYCLE EXIT; IN-VIVO	An outstanding biological question is why tissue regeneration in mammals is limited, whereas urodele amphibians and teleost fish regenerate major structures, largely by cell cycle reentry. Upon inactivation of Rb, proliferation of postmitotic urodele skeletal muscle is induced, whereas in mammalian muscle this mechanism does not exist. We postulated that a tumor suppressor present in mammals but absent in regenerative vertebrates, the Ink4a product ARF (alternative reading frame), is a regeneration suppressor. Concomitant inactivation of Ad and Rb led to mammalian muscle cell cycle reentry, loss of differentiation properties, and upregulation of cytokinetic machinery. Single postmitotic myocytes were isolated by laser micro-dissection-catapulting, and transient suppression of Art and Rb yielded myoblast colonies that retained the ability to differentiate and fuse into myofibers upon transplantation in vivo. These results show that differentiation of mammalian cells is reversed by inactivation of Ad and Rb and support the hypothesis that Ad evolved at the expense of regeneration.	[Pajcini, Kostandin V.; Corbel, Stephane Y.; Pomerantz, Jason H.; Blau, Helen M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol,Sch Med, Stanford, CA 94305 USA; [Sage, Julien] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Sage, Julien] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pomerantz, JH (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Craniofacial & Mesenchymal Biol, Dept Surg,Div Plast & Reconstruct Surg, San Francisco, CA 94143 USA.	jason.pomerantz@ucsfmedctr.org; hblau@stanford.edu			The Developmental and Neonatal Biology Program [2T32 HD007249]; NIH [5T32 AI07328, 5T32 HD007249, F32 AR051678-01, AG009521, AG020961, HL096113]; MDA [4320]; LLS [TR6025-09]; JDRF [34-2008-623]; CIRM [RT1-01001]; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521, R01AG020961] Funding Source: NIH RePORTER	The Developmental and Neonatal Biology Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA(Muscular Dystrophy Association); LLS; JDRF(Juvenile Diabetes Research Foundation); CIRM(California Institute for Regenerative Medicine); Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge grants 2T32 HD007249 of The Developmental and Neonatal Biology Program and NIH training grants 5T32 AI07328 and 5T32 HD007249 to K.V.P.; grant F32 AR051678-01 to J.H.P.; and NIH grants AG009521, AG020961, HL096113, MDA grant 4320, LLS grant TR6025-09, JDRF grant 34-2008-623, CIRM grant RT1-01001, and the Baxter Foundation to H.M.B.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Carlson BM, 2003, DEV DYNAM, V226, P167, DOI 10.1002/dvdy.10223; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; CRESCENZI M, 1995, ANN NY ACAD SCI, V752, P9, DOI 10.1111/j.1749-6632.1995.tb17402.x; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Gardiner DM, 1996, INT J DEV BIOL, V40, P797; Gilley J, 2001, ONCOGENE, V20, P7447, DOI 10.1038/sj.onc.1204933; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; Hickson GRX, 2008, BIOCHEM SOC T, V36, P439, DOI 10.1042/BST0360439; Hjiantoniou E, 2008, DIFFERENTIATION, V76, P182, DOI 10.1111/j.1432-0436.2007.00195.x; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kazianis S, 1999, ONCOGENE, V18, P5088, DOI 10.1038/sj.onc.1202884; Kim SH, 2003, P NATL ACAD SCI USA, V100, P211, DOI 10.1073/pnas.0135557100; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; LENTZ TL, 1969, AM J ANAT, V124, P447, DOI 10.1002/aja.1001240404; Levi BP, 2008, COLD SH Q B, V73, P539, DOI 10.1101/sqb.2008.73.049; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Perez OD, 2002, CHEM BIOL, V9, P475, DOI 10.1016/S1074-5521(02)00131-X; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sacco A, 2003, ONCOGENE, V22, P4027, DOI 10.1038/sj.onc.1206353; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Schutze K, 2007, METHOD CELL BIOL, V82, P649, DOI 10.1016/S0091-679X(06)82023-6; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stich M, 2003, PATHOL RES PRACT, V199, P405, DOI 10.1078/0344-0338-00437; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; Tanaka EM, 2008, GENE DEV, V22, P700, DOI 10.1101/gad.1660508; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Velloso CP, 2001, CURR BIOL, V11, P855, DOI 10.1016/S0960-9822(01)00234-2; Velloso CP, 2000, DIFFERENTIATION, V66, P239, DOI 10.1046/j.1432-0436.2000.660410.x; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051	73	139	144	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					198	213		10.1016/j.stem.2010.05.022	http://dx.doi.org/10.1016/j.stem.2010.05.022			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682446	Bronze, Green Accepted			2022-12-24	WOS:000281107400012
J	Ding, JB; Guzman, JN; Peterson, JD; Goldberg, JA; Surmeier, DJ				Ding, Jun B.; Guzman, Jaime N.; Peterson, Jayms D.; Goldberg, Joshua A.; Surmeier, D. James			Thalamic Gating of Corticostriatal Signaling by Cholinergic Interneurons	NEURON			English	Article							LONG-TERM POTENTIATION; CM-PF COMPLEX; MUSCARINIC RECEPTORS; BASAL GANGLIA; RAT NEOSTRIATUM; PROJECTION NEURONS; STRIATAL NEURONS; DORSAL STRIATUM; CA2+ CHANNELS; MODULATION	Salient stimuli redirect attention and suppress ongoing motor activity. This attentional shift is thought to rely upon thalamic signals to the striatum to shift cortically driven action selection, but the network mechanisms underlying this interaction are unclear. Using a brain slice preparation that preserved cortico- and thalamostriatal connectivity, it was found that activation of thalamostriatal axons in a way that mimicked the response to salient stimuli induced a burst of spikes in striatal cholinergic inter-neurons that was followed by a pause lasting more than half a second. This patterned interneuron activity triggered a transient, presynaptic suppression of cortical input to both major classes of principal medium spiny neuron (MSN) that gave way to a prolonged enhancement of postsynaptic responsiveness in striatopallidal MSNs controlling motor suppression. This differential regulation of the corti-costriatal circuitry provides a neural substrate for attentional shifts and cessation of ongoing motor activity with the appearance of salient environmental stimuli.	[Ding, Jun B.; Guzman, Jaime N.; Peterson, Jayms D.; Goldberg, Joshua A.; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Ding, Jun/B-2513-2009; Goldberg, Joshua/B-3398-2009	Ding, Jun/0000-0003-0690-1312; Goldberg, Joshua/0000-0002-5740-4087	Picower Foundation;  [NS 34696]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS054850, T32NS041234, R37NS034696, R01NS034696] Funding Source: NIH RePORTER	Picower Foundation; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Dilyan Dryanovski, Qing Ruan, Karen Saporito, and Sasha Ulrich for excellent technical assistance. Supported by NS 34696 (D.J.S.) and the Picower Foundation (D.J.S.).	AKINS PT, 1990, J NEUROCHEM, V54, P266, DOI 10.1111/j.1471-4159.1990.tb13310.x; Alcantara AA, 2001, J COMP NEUROL, V434, P445, DOI 10.1002/cne.1186; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Barral J, 1999, BRAIN RES BULL, V49, P285, DOI 10.1016/S0361-9230(99)00061-1; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; BOLAM JP, 1984, NEUROSCIENCE, V12, P711, DOI 10.1016/0306-4522(84)90165-9; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 1998, J PHYSIOL-LONDON, V510, P421, DOI 10.1111/j.1469-7793.1998.421bk.x; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Deng P, 2007, J NEUROSCI, V27, P3148, DOI 10.1523/JNEUROSCI.5535-06.2007; Deschenes M, 1996, EUR J NEUROSCI, V8, P329, DOI 10.1111/j.1460-9568.1996.tb01217.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; McCool MF, 2008, NEUROBIOL LEARN MEM, V89, P114, DOI 10.1016/j.nlm.2007.06.005; MEREDITH GE, 1990, J COMP NEUROL, V296, P204, DOI 10.1002/cne.902960203; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Perez-Rosello T, 2005, J NEUROPHYSIOL, V93, P2507, DOI 10.1152/jn.00853.2004; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reynolds JNJ, 2004, J NEUROSCI, V24, P9870, DOI 10.1523/JNEUROSCI.3225-04.2004; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; WILSON CJ, 1990, J NEUROSCI, V10, P508; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	49	306	306	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					294	307		10.1016/j.neuron.2010.06.017	http://dx.doi.org/10.1016/j.neuron.2010.06.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670836	Bronze, Green Accepted			2022-12-24	WOS:000280461500013
J	Singh, KK; Ge, XC; Mao, YW; Drane, L; Meletis, K; Samuels, BA; Tsai, LH				Singh, Karun K.; Ge, Xuecai; Mao, Yingwei; Drane, Laurel; Meletis, Konstantinos; Samuels, Benjamin A.; Tsai, Li-Huei			Dixdc1 Is a Critical Regulator of DISC1 and Embryonic Cortical Development	NEURON			English	Article							INDUCIBLE EXPRESSION; SCHIZOPHRENIA; PROTEIN; GENE; PHENOTYPES; LITHIUM; BRAIN; MICE; SUSCEPTIBILITY; ASSOCIATION	The psychiatric illness risk gene Disrupted in Schizophrenia-1 (DISC1) plays an important role in brain development; however, it is unclear how DISC1 is regulated during cortical development. Here, we report that DISC1 is regulated during embryonic neural progenitor proliferation and neuronal migration through an interaction with DIX domain containing-1 (Dixdc1), the third mammalian gene discovered to contain a Disheveled-Axin (DIX) domain. We determined that Dixdc1 functionally interacts with DISC1 to regulate neural progenitor proliferation by comodulating Wnt-GSK3 beta/beta-catenin signaling. However, DISC1 and Dixdc1 do not regulate migration via this pathway. During neuronal migration, we discovered that phosphorylation of Dixdc1 by cyclin-dependent kinase 5 (Cdk5) facilitates its interaction with the DISC1-binding partner Ndel1. Furthermore, Dixdc1 phosphorylation and its interaction with DISCI 1/Ndel1 in vivo is required for neuronal migration. Together, these data reveal that Dixdc1 integrates DISCI into Wnt-GSK beta/beta-catenin-dependent and -independent signaling pathways during cortical development and further delineate how DISC1 contributes to neuropsychiatric disorders.	[Singh, Karun K.; Ge, Xuecai; Mao, Yingwei; Drane, Laurel; Meletis, Konstantinos; Samuels, Benjamin A.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Singh, Karun K.; Ge, Xuecai; Mao, Yingwei; Drane, Laurel; Meletis, Konstantinos; Samuels, Benjamin A.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Singh, Karun K.; Mao, Yingwei; Drane, Laurel; Meletis, Konstantinos; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Samuels, Benjamin A.] Columbia Univ, Dept Psychiat & Neurosci, New York, NY 10032 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Meletis, Konstantinos/ABE-6777-2020	Mao, Yingwei/0000-0001-7339-1565; Meletis, Konstantinos/0000-0001-5665-4781	Human Frontiers Science Program Longterm; NSERC; National Alliance for Research on Schizophrenia and Depression; National Institutes of Health [NS37007]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	Human Frontiers Science Program Longterm(Human Frontier Science Program); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Alliance for Research on Schizophrenia and Depression(NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Z. Xie for the S/A-beta-catenin and pNeuroD-GFP constructs. We would like to thank Takahiro Soda and Alison Mungenast for critical reading of the manuscript, and all other Tsai lab members. L.-H. T. is an investigator of the Howard Hughes Medical Institute and the director of the neurobiology program at the Stanley Center for Psychiatric Research. K.K.S. is a recipient of the Human Frontiers Science Program Longterm fellowship and an NSERC postdoctoral fellowship. Y.M. is a recipient of the National Alliance for Research on Schizophrenia and Depression Young Investigator Award. This work was partially supported by a National Institutes of Health grant (NS37007) to L.-H.T.	Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Jungerius BJ, 2008, MOL PSYCHIATR, V13, P1060, DOI 10.1038/sj.mp.4002080; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Pletnikov MV, 2007, NEUROSCI RES, V58, P234, DOI 10.1016/j.neures.2007.03.003; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shim SY, 2008, J BIOL CHEM, V283, P12232, DOI 10.1074/jbc.M710200200; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stephens L, 2005, CURR OPIN PHARMACOL, V5, P357, DOI 10.1016/j.coph.2005.03.002; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vorstman JAS, 2009, AM J MED GENET B, V150B, P430, DOI 10.1002/ajmg.b.30827; Wang XS, 2006, BIOCHEM BIOPH RES CO, V347, P22, DOI 10.1016/j.bbrc.2006.06.050; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016	48	115	122	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					33	48		10.1016/j.neuron.2010.06.002	http://dx.doi.org/10.1016/j.neuron.2010.06.002			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624590	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000280221000007
J	Hope, KJ; Cellot, S; Ting, SB; MacRae, T; Mayotte, N; Iscove, NN; Sauvageau, G				Hope, Kristin J.; Cellot, Sonia; Ting, Stephen B.; MacRae, Tara; Mayotte, Nadine; Iscove, Norman N.; Sauvageau, Guy			An RNAi Screen Identifies Msi2 and Prox1 as Having Opposite Roles in the Regulation of Hematopoietic Stem Cell Activity	CELL STEM CELL			English	Article							BINDING PROTEIN MUSASHI; SELF-RENEWAL; ASYMMETRIC SEGREGATION; PROGENITOR CELLS; DIVISION; DIFFERENTIATION; DROSOPHILA; RECEPTORS; POLARITY; FAMILY	In this study, we describe an in vivo RNA interference functional genetics approach to evaluate the role of 20 different conserved polarity factors and fate determinants in mouse hematopoietic stem cell (HSC) activity. In total, this screen revealed three enhancers and one suppressor of HSC-derived reconstitution. Pard6a, Prkcz, and Msi2 shRNA-mediated depletion significantly impaired HSC repopulation. An in vitro promotion of differentiation was observed after the silencing of these genes, consistent with their function in regulating HSC self-renewal. Conversely, Prox1 knockdown led to in vivo accumulation of primitive and differentiated cells. HSC activity was also enhanced in vitro when Prox1 levels were experimentally reduced, identifying it as a potential antagonist of self-renewal. HSC engineered to overexpress Msi2 or Prox1 showed the reverse phenotype to those transduced with corresponding shRNA vectors. Gene expression profiling studies identified a number of known HSC and cell cycle regulators as potential downstream targets to Msi2 and Prox1	[Hope, Kristin J.; Cellot, Sonia; Ting, Stephen B.; MacRae, Tara; Mayotte, Nadine; Sauvageau, Guy] Univ Montreal, IRIC, Mol Genet Stem Cells Lab, Montreal, PQ H3C 3J7, Canada; [Iscove, Norman N.] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada	Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Sauvageau, G (corresponding author), Univ Montreal, IRIC, Mol Genet Stem Cells Lab, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca		Hope, Kristin/0000-0003-1449-4948; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institute of Health Research (CIHR) [154290]; National Health Medical Research Council; Royal Australian College of Physicians; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian College of Physicians; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	We thank M. Frechette and A. Fournier for technical assistance with mouse transplantations, D. Gagne from the IRIC flow cytometry platform, R. Lambert from the IRIC genomic platform for help with quantitative RT-PCR, and J. Landry for technical assistance with microarray experiments. The authors also thank J. Krosl for discussions and critical comments about the manuscript. This work was supported by the Canadian Institute of Health Research (CIHR) Team Grant in Hematopoietic Stem Cell Self-Renewal: From Genes to Bedside (Grant number 154290). G.S. holds a Canada Research Chair on molecular genetics of stem cells; K.J.H. and S.C. are recipients of a CIHR Post-doctoral fellowship and Clinician Scientist award, respectively; S.B.T. is the recipient of National Health Medical Research Council, Royal Australian College of Physicians, and CIHR Post-doctoral fellowships. IRIC is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation (CFI), and the Fonds de Recherche en Sante du Quebec (FRSQ).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Barbouti A, 2003, CANCER RES, V63, P1202; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Brummendorf TH, 1998, J EXP MED, V188, P1117, DOI 10.1084/jem.188.6.1117; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; De Weer A, 2008, HAEMATOL-HEMATOL J, V93, P1903, DOI 10.3324/haematol.13192; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Faubert A, 2004, ONCOGENE, V23, P7247, DOI 10.1038/sj.onc.1207944; Gu Y, 2005, CELL CYCLE, V4, P201; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; INADA S, 1983, P NATL ACAD SCI-BIOL, V80, P2351, DOI 10.1073/pnas.80.8.2351; IRNAI T, 2001, MOL CELL BIOL, V21, P3888; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; POLLEN CS, 2003, DIFFERENTIATION, V71, P28; Punzel M, 2002, EXP HEMATOL, V30, P464, DOI 10.1016/S0301-472X(02)00781-6; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Zhao Y, 2000, BLOOD, V96, P3016	51	110	118	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					101	113		10.1016/j.stem.2010.06.007	http://dx.doi.org/10.1016/j.stem.2010.06.007			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621054	Bronze			2022-12-24	WOS:000280222300017
J	Wichterle, H; Przedborski, S				Wichterle, Hynek; Przedborski, Serge			What can pluripotent stem cells teach us about neurodegenerative diseases?	NATURE NEUROSCIENCE			English	Article							PARKINSONS-DISEASE; DIRECTED DIFFERENTIATION; MOTOR-NEURONS; GLIAL-CELLS; EXPRESSION; NEUROGENESIS; MECHANISMS; INDUCTION; GENES; BRAIN	Neurodegenerative diseases represent a growing public health challenge. Current medications treat symptoms, but none halt or retard neurodegeneration. The recent advent of pluripotent cell biology has opened new avenues for neurodegenerative disease research. The greatest potential for induced pluripotent cells derived from affected individuals is likely to be their utility for modeling and understanding the mechanisms underlying neurodegenerative processes, and for searching for new treatments, including cell replacement therapies. However, much work remains to be done before pluripotent cells can be used for preclinical and clinical applications. Here we discuss the challenges of generating specific neural cell subtypes from pluripotent stem cells, the use of pluripotent stem cells to model both cell-autonomous and non-cell-autonomous mechanisms of neurodegeneration, whether adult-onset neurodegeneration can be emulated in short-term cultures and the hurdles of cell replacement therapy. Progress in these four areas will substantially accelerate effective application of pluripotent stem cells.	[Wichterle, Hynek; Przedborski, Serge] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Wichterle, Hynek; Przedborski, Serge] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Wichterle, Hynek] Columbia Univ, Dept Neurosci, New York, NY USA; [Wichterle, Hynek; Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10027 USA.	sp30@columbia.edu		Wichterle, Hynek/0000-0002-7817-0080	US National Institutes of Health [AG021617, NS042269, NS062180, NS064191, NS38370, NS058502, NS055923]; US Department of Defense [W81XWH-08-1-0522, W81XWH-08-1-0465, DAMD 17-03-1]; Parkinson Disease Foundation (New York); Thomas Hartman Foundation For Parkinson's Research; A.L.S. foundation; Muscular Dystrophy Association/Wings-over-Wall Street; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923, R21NS064191, R21NS062180, R01NS058502, P50NS038370, R01NS042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Parkinson Disease Foundation (New York); Thomas Hartman Foundation For Parkinson's Research; A.L.S. foundation; Muscular Dystrophy Association/Wings-over-Wall Street(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are supported by US National Institutes of Health grants AG021617, NS042269, NS062180, NS064191, NS38370, NS058502 and NS055923; US Department of Defense grants W81XWH-08-1-0522, W81XWH-08-1-0465 and DAMD 17-03-1; the Parkinson Disease Foundation (New York); the Thomas Hartman Foundation For Parkinson's Research; the Project A.L.S. foundation; and the Muscular Dystrophy Association/Wings-over-Wall Street.	Abujarour R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-220; Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irioka T, 2005, DEV BRAIN RES, V154, P63, DOI 10.1016/j.devbrainres.2004.10.004; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Rodriguez-Gomez JA, 2007, STEM CELLS, V25, P918, DOI 10.1634/stemcells.2006-0386; Sermon KD, 2009, HUM REPROD, V24, P1556, DOI 10.1093/humrep/dep062; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	48	35	38	3	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					800	804		10.1038/nn.2577	http://dx.doi.org/10.1038/nn.2577			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581816	Green Accepted			2022-12-24	WOS:000279173900009
J	Rebola, N; Carta, M; Lanore, F; Blanchet, C; Mulle, C				Rebola, Nelson; Carta, Mario; Lanore, Frederic; Blanchet, Christophe; Mulle, Christophe			NMDA receptor-dependent metaplasticity at hippocampal mossy fiber synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; CELLS; AMPA	Hippocampal mossy fiber synapses have been reported to lack NMDA receptor (NMDAR)-dependent long-term potentiation (LTP) of AMPA excitatory postsynaptic currents (EPSCs), unlike conventional glutamatergic synapses. An explanation for this difference may reside in the relatively low number of NMDARs at these synapses. Because mossy fiber synapses display LTP selective for NMDARs, we examined whether this would affect the plasticity rules at mossy fiber-CA3 synapses in mouse hippocampal slices. We found that LTP of NMDARs serves as a metaplastic switch making mossy fiber synapses competent for generating NMDAR-dependent LTP of AMPA EPSCs.	[Rebola, Nelson; Carta, Mario; Lanore, Frederic; Blanchet, Christophe; Mulle, Christophe] Univ Bordeaux, Interdisciplinary Inst Neurosci, Bordeaux, France; [Rebola, Nelson; Carta, Mario; Lanore, Frederic; Blanchet, Christophe; Mulle, Christophe] CNRS, UMR 5297, Interdisciplinary Inst Neurosci, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Mulle, C (corresponding author), Univ Bordeaux, Interdisciplinary Inst Neurosci, Bordeaux, France.	mulle@u-bordeaux2.fr		Mulle, Christophe/0000-0003-2709-6615; Lanore, Frederic/0000-0003-4316-6855; Carta, Mario/0000-0003-1225-2742	Centre National de la Recherche Scientifique; Conseil Regional d'Aquitaine; European Commission [LSHM-CT-2005-019055]; EMBO; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Commission(European CommissionEuropean Commission Joint Research Centre); EMBO(European Molecular Biology Organization (EMBO)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank N. Grosjean, E. Normand and A. Lacquemant for mouse breeding and J. Lourenco, D. Perrais and B. Srikumar for comments. This study was supported by grants from the Centre National de la Recherche Scientifique, the Conseil Regional d'Aquitaine and the European Commission (EUSynapse Project, contract no. LSHM-CT-2005-019055). N.R. was financed by an EMBO long-term fellowship, M.C. by a Marie Curie grant and F.L. by a fellowship from the Fondation pour la Recherche Medicale.	Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Kakegawa W, 2004, EUR J NEUROSCI, V20, P101, DOI 10.1111/j.1460-9568.2004.03461.x; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	12	37	37	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					691	693		10.1038/nn.2809	http://dx.doi.org/10.1038/nn.2809			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532578	Green Submitted			2022-12-24	WOS:000290958000009
J	Piskorowski, R; Santoro, B; Siegelbaum, SA				Piskorowski, Rebecca; Santoro, Bina; Siegelbaum, Steven A.			TRIP8b Splice Forms Act in Concert to Regulate the Localization and Expression of HCN1 Channels in CA1 Pyramidal Neurons	NEURON			English	Article							I-H; DISTAL DENDRITES; TRAFFICKING; PLASTICITY; SUBUNITS; SEIZURES; PROTEIN; BRAIN; EXCITABILITY; HIPPOCAMPUS	HCN1 channel subunits, which contribute to the hyperpolarization-activated cation current (Ih), are selectively targeted to distal apical dendrites of hippocampal CA1 pyramidal neurons. Here, we addressed the importance of the brain-specific auxiliary subunit of HCN1, TRIP8b, in regulating HCN1 expression and localization. More than ten N-terminal splice variants of TRIP8b exist in brain and exert distinct effects on HCN1 trafficking when overexpressed. We found that isoform-wide disruption of the TRIP8b/HCN1 interaction caused HCN1 to be mistargeted throughout CA1 somatodendritic compartments. In contrast, HCN1 was targeted normally to CA1 distal dendrites in a TRIP8b knockout mouse that selectively lacked exons 1b and 2. Of the two remaining hippocampal TRIP8b isoforms, TRIP8b(1a-4) promoted HCN1 surface expression in dendrites, whereas TRIP8b(1a) suppressed HCN1 misexpression in axons. Thus, proper subcellular localization of HCN1 depends on its differential additive and subtractive sculpting by two isoforms of a single auxiliary subunit.	[Piskorowski, Rebecca; Santoro, Bina; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu	Piskorowski, Rebecca Ann/G-6610-2017	Piskorowski, Rebecca Ann/0000-0003-0120-2360; Santoro, Bina/0000-0002-4277-1992	NIH [NS36658, MH80745, F32NS064732]; Italian Academy for Advanced Studies in America; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS036658, R01NS036658, F32NS064732] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Academy for Advanced Studies in America; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NS36658 and MH80745 from NIH, by fellowships from NIH F32NS064732 (R.P.), the Italian Academy for Advanced Studies in America (B.S.) and a Research Grant from the Epilepsy Foundation (B.S.). We gratefully acknowledge Terunaga Nakagawa and Morgan Sheng for providing the pLLhS and Pavel Osten for providing the pFCK(0.4)GW lentiviral vectors, and Frank Muller for generously providing the rat 7C3 monoclonal HCN1 antibody. We thank Ming-Kuei Jang and Thomas Yocum for preliminary experiments, Haiying Liu for technical assistance and Vivien Chevaleyre for experimental advice.	Arnold DB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.283pe49; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Lasiecka ZM, 2009, INT REV CEL MOL BIO, V272, P303, DOI 10.1016/S1937-6448(08)01607-9; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	30	60	63	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					495	509		10.1016/j.neuron.2011.03.023	http://dx.doi.org/10.1016/j.neuron.2011.03.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555075	Bronze, Green Accepted			2022-12-24	WOS:000290926100011
J	Pastrana, E; Silva-Vargas, V; Doetsch, F				Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona			Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells	CELL STEM CELL			English	Review							ADULT MAMMALIAN BRAIN; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM/PROGENITOR CELLS; SUBVENTRICULAR ZONE; PROGENITOR CELLS; SELF-RENEWAL; OLFACTORY-BULB; IN-VITRO; SUBEPENDYMAL ZONE; EPENDYMAL CELLS	Sphere-forming assays have been widely used to retrospectively identify stem cells based on their reported capacity to evaluate self-renewal and differentiation at the single-cell level in vitro. The discovery of markers that allow the prospective isolation of stem cells and their progeny from their in vivo niche allows the functional properties of purified populations to be defined. We provide a historical perspective of the evolution of the neurosphere assay and highlight limitations in the use of sphere-forming assays in the context of neurospheres. We discuss theoretical and technical considerations of experimental design and interpretation that surround the use of this assay with any tissue.	[Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Pastrana, Erika; Silva-Vargas, Violeta; Doetsch, Fiona] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, Columbia Stem Cell Initiat,Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Doetsch, F (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	fkd2101@columbia.edu		Pastrana, Erika/0000-0003-1745-8635	Human Frontiers Scientific Program Long-Term Fellowship [T32 MH15174-29]; Spanish Ministerio de Educacion y Ciencia; NIH NINDS, NYSTEM; Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053884] Funding Source: NIH RePORTER	Human Frontiers Scientific Program Long-Term Fellowship; Spanish Ministerio de Educacion y Ciencia(Spanish Government); NIH NINDS, NYSTEM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Maldonado-Soto for the image of the pinwheel. We apologize to the many studies we could not cite due to space limitations. V.S.V. is supported by a Human Frontiers Scientific Program Long-Term Fellowship, E.P. was supported by Grant T32 MH15174-29 and by a fellowship from the Spanish Ministerio de Educacion y Ciencia, and F.D. is a Packard Foundation Fellow and Irma T. Hirschl Fellow. We receive support from NIH NINDS, NYSTEM, and the Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Barraud P, 2005, EUR J NEUROSCI, V22, P1555, DOI 10.1111/j.1460-9568.2005.04352.x; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Costa MR, 2011, DEVELOPMENT, V138, P1057, DOI 10.1242/dev.061663; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hamanoue M, 2009, J NEUROCHEM, V110, P1575, DOI 10.1111/j.1471-4159.2009.06256.x; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; HSU YC, 2001, DEV DYNAM, V238, P302; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Imura T, 2003, J NEUROSCI, V23, P2824; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kim M, 2003, J NEUROSCI, V23, P10703; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maslov AY, 2007, STEM CELLS, V25, P132, DOI 10.1634/stemcells.2006-0032; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Neumeister B, 2009, STEM CELLS, V27, P714, DOI 10.1634/stemcells.2008-0985; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Obermair FJ, 2010, STEM CELL RES, V5, P131, DOI 10.1016/j.scr.2010.05.001; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pfenninger CV, 2011, GLIA, V59, P68, DOI 10.1002/glia.21077; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Qian XM, 1998, DEVELOPMENT, V125, P3143; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Weiss S, 1996, J NEUROSCI, V16, P7599; Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	103	592	603	4	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					486	498		10.1016/j.stem.2011.04.007	http://dx.doi.org/10.1016/j.stem.2011.04.007			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549325	Green Accepted, Bronze			2022-12-24	WOS:000290927600010
J	Huang, Z; Lujan, R; Kadurin, I; Uebele, VN; Renger, JJ; Dolphin, AC; Shah, MM				Huang, Zhuo; Lujan, Rafael; Kadurin, Ivan; Uebele, Victor N.; Renger, John J.; Dolphin, Annette C.; Shah, Mala M.			Presynaptic HCN1 channels regulate Ca(V)3.2 activity and neurotransmission at select cortical synapses	NATURE NEUROSCIENCE			English	Article							ACTIVATED CATION CHANNELS; T-TYPE; I-H; DENDRITIC INTEGRATION; SYNAPTIC-TRANSMISSION; DISTAL DENDRITES; CA1; PLASTICITY; LOCALIZATION; RELEASE	The hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are subthreshold, voltage-gated ion channels that are highly expressed in hippocampal and cortical pyramidal cell dendrites, where they are important for regulating synaptic potential integration and plasticity. We found that HCN1 subunits are also localized to the active zone of mature asymmetric synaptic terminals targeting mouse entorhinal cortical layer III pyramidal neurons. HCN channels inhibited glutamate synaptic release by suppressing the activity of low-threshold voltage-gated T-type (Ca(V)3.2) Ca2+ channels. Consistent with this, electron microscopy revealed colocalization of presynaptic HCN1 and Ca(V)3.2 subunit. This represents a previously unknown mechanism by which HCN channels regulate synaptic strength and thereby neural information processing and network excitability.	[Huang, Zhuo; Shah, Mala M.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Lujan, Rafael] Univ Castilla La Mancha, Ctr Invest Discapacidades Neurol, Dept Ciencias Med, Albacete, Spain; [Kadurin, Ivan; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Uebele, Victor N.; Renger, John J.] Merck Res Labs, Dept Depress & Circadian Rhythms, Rahway, PA USA	University of London; University College London; University of London School of Pharmacy; Universidad de Castilla-La Mancha; University of London; University College London; Merck & Company	Shah, MM (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England.	mala.shah@pharmacy.ac.uk	Lujan, Rafael/G-2555-2015; Dolphin, Annette C/F-7416-2010; Kadurin, Ivan/F-7759-2012	Dolphin, Annette C/0000-0003-4626-4856; Kadurin, Ivan/0000-0002-7720-367X; Lujan Miras, Rafael/0000-0003-2001-9545; Shah, Mala/0000-0002-8323-4739	MRC [G0700369, G0801756]; Wellcome Trust [WT087363MA]; European Research Council [ERC_2010_StG_20091118]; Spanish Ministry of Science and Innovation [BFU-2009-08404/BFI]; CONSOLIDER-Ingenio [CSD2008-00005]; Junta de Comunidades de Castilla-La Mancha [PAI08-0174-6967]; Epilepsy Research UK [0803]; US National Institutes of Health [U24NS050606]; Medical Research Council [G0700369, G0801756] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Epilepsy Research UK; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. A. Brown (University College London), D. Johnston (University of Texas), M. C. Walker (University College London) and A. Constanti (University of London) for helpful discussions. We are also grateful to S. Martin (University College London) for genotyping the transgenic mice, K. Venner (University College London) for help with processing some samples for electron microscopy, D. McCarthy (University of London) for assistance with acquisition of some electron micrographs and H. Beck (University of Bonn) and K. P. Campbell (University of Iowa) for providing Ca<INF>V</INF>3.2<SUP>+/-</SUP> breeding pairs. This work was supported by an MRC New Investigator Award (G0700369, M. M. S.), a Wellcome Trust project grant (WT087363MA, M. M. S.), a European Research Council Starter Independent Grant (ERC_2010_StG_20091118, M. M. S.), the Spanish Ministry of Science and Innovation (BFU-2009-08404/BFI and CONSOLIDER-Ingenio CSD2008-00005, R. L.), the Junta de Comunidades de Castilla-La Mancha (PAI08-0174-6967, R. L.), an Epilepsy Research UK Grant (0803, A. C. D.) and an MRC Project Grant (G0801756, A. C. D.). The monoclonal antibodies HCN1 (Clone N70/28) and Ca<INF>V</INF>3.2 (Clone N55/10) were developed by and obtained from the University of California at Davis/US National Institutes of Health NeuroMab Facility, supported by US National Institutes of Health grant U24NS050606 and maintained by the University of California at Davis.	Aponte Y, 2006, J PHYSIOL-LONDON, V574, P229, DOI 10.1113/jphysiol.2005.104042; Beaumont V, 2002, NEURON, V33, P601, DOI 10.1016/S0896-6273(02)00581-0; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Boyes J, 2007, EUR J NEUROSCI, V25, P2081, DOI 10.1111/j.1460-9568.2007.05463.x; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chevaleyre V, 2002, P NATL ACAD SCI USA, V99, P9538, DOI 10.1073/pnas.142213199; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Evans DI, 2000, J NEUROPHYSIOL, V83, P2519, DOI 10.1152/jn.2000.83.5.2519; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Gill CH, 2004, BRIT J PHARMACOL, V143, P411, DOI 10.1038/sj.bjp.0705945; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Huang Z, 2009, J NEUROSCI, V29, P10979, DOI 10.1523/JNEUROSCI.1531-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Lujan R, 2006, EUR J NEUROSCI, V23, P1479, DOI 10.1111/j.1460-9568.2006.04669.x; Lujan R, 2005, EUR J NEUROSCI, V21, P2073, DOI 10.1111/j.1460-9568.2005.04043.x; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Magee JC, 1999, NAT NEUROSCI, V2, pU9; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; PAPE HC, 1994, NEUROSCIENCE, V59, P363, DOI 10.1016/0306-4522(94)90602-5; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shipe WD, 2008, J MED CHEM, V51, P3692, DOI 10.1021/jm800419w; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Talavera K, 2006, CELL CALCIUM, V40, P97, DOI 10.1016/j.ceca.2006.04.013; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Uebele VN, 2009, NEUROREPORT, V20, P257, DOI 10.1097/WNR.0b013e3283200111; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137	49	118	123	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					478	U114		10.1038/nn.2757	http://dx.doi.org/10.1038/nn.2757			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358644	Green Accepted			2022-12-24	WOS:000288849400019
J	Koon, AC; Ashley, J; Barria, R; DasGupta, S; Brain, R; Waddell, S; Alkema, MJ; Budnik, V				Koon, Alex C.; Ashley, James; Barria, Romina; DasGupta, Shamik; Brain, Ruth; Waddell, Scott; Alkema, Mark J.; Budnik, Vivian			Autoregulatory and paracrine control of synaptic and behavioral plasticity by octopaminergic signaling	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTIONS; IN-VIVO; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; K+ CHANNEL; TYRAMINE; RECEPTOR; NEURONS	Adrenergic signaling has important roles in synaptic plasticity and metaplasticity. However, the underlying mechanisms of these functions remain poorly understood. We investigated the role of octopamine, the invertebrate counterpart of adrenaline and noradrenaline, in synaptic and behavioral plasticity in Drosophila. We found that an increase in locomotor speed induced by food deprivation was accompanied by an activity- and octopamine-dependent extension of octopaminergic arbors and that the formation and maintenance of these arbors required electrical activity. Growth of octopaminergic arbors was controlled by a cAMP- and CREB-dependent positive-feedback mechanism that required Oct beta 2R octopamine autoreceptors. Notably, this autoregulation was necessary for the locomotor response. In addition, octopamine neurons regulated the expansion of excitatory glutamatergic neuromuscular arbors through Oct beta 2Rs on glutamatergic motor neurons. Our results provide a mechanism for global regulation of excitatory synapses, presumably to maintain synaptic and behavioral plasticity in a dynamic range.	[Koon, Alex C.; Ashley, James; Barria, Romina; DasGupta, Shamik; Brain, Ruth; Waddell, Scott; Alkema, Mark J.; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu		Koon, Alex/0000-0002-4274-7052; DasGupta, Shamik/0000-0001-5803-8982; Ashley, James/0000-0002-6693-1014; DasGupta, Shamik/0000-0001-5566-7548	US National Institutes of Health [R01 MH0700000, MH09883, MH081982, GM084491]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000, R01MH069883, R01MH081982, F31MH009883] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Yoshihara, S. Speese, Y. Fuentes-Medel and C. Korkut for comments on the manuscript, C. Brewer for assistance with data analysis and the UMass Amherst antibody facility for production of the TBH antibody. This work was supported by US National Institutes of Health grants R01 MH0700000 to V. B., MH09883 to S. W., MH081982 to S. W. and GM084491 to M.J.A. M.J.A. was also supported by the Bill & Melinda Gates Foundation.	Aamodt S M, 1999, Adv Neurol, V79, P133; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; BREEN CA, 1983, NATURE, V303, P716, DOI 10.1038/303716a0; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Cheung US, 1999, J NEUROBIOL, V40, P1, DOI 10.1002/(SICI)1097-4695(199907)40:1<1::AID-NEU1>3.0.CO;2-1; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; DAVENPORT AP, 1984, PHYSIOL ENTOMOL, V9, P269, DOI 10.1111/j.1365-3032.1984.tb00709.x; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Hammer M, 1998, LEARN MEMORY, V5, P146; Han KA, 1998, J NEUROSCI, V18, P3650; Hardie SL, 2007, DEV NEUROBIOL, V67, P1396, DOI 10.1002/dneu.20459; Howell KMR, 1998, J EXP BIOL, V201, P2053; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; Kuzmiski JB, 2009, NEURON, V62, P839, DOI 10.1016/j.neuron.2009.05.027; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Marques G, 2006, INT REV NEUROBIOL, V75, P267, DOI 10.1016/S0074-7742(06)75012-7; MCGUIRE SE, 2004, SCI STKE, pPL6; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; Nishikawa K, 1999, BRAIN RES, V837, P67, DOI 10.1016/S0006-8993(99)01676-5; O'Dell TJ, 2010, CELL SIGNAL, V22, P728, DOI 10.1016/j.cellsig.2009.12.004; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Steinert JR, 2006, NEURON, V50, P723, DOI 10.1016/j.neuron.2006.04.025; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Takizawa E, 2007, ZOOL SCI, V24, P504, DOI 10.2108/zsj.24.504; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	50	91	92	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					190	U275		10.1038/nn.2716	http://dx.doi.org/10.1038/nn.2716			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186359	Green Accepted, Green Published			2022-12-24	WOS:000286595400016
J	Heinze, S; Reppert, SM				Heinze, Stanley; Reppert, Steven M.			Sun Compass Integration of Skylight Cues in Migratory Monarch Butterflies	NEURON			English	Article							POLARIZATION-SENSITIVE INTERNEURONS; DORSAL RIM AREA; CENTRAL COMPLEX; LOCUST; BRAIN; NEURONS; ORIENTATION; VISION; NEUROARCHITECTURE; CRICKETS	Migrating monarch butterflies (Danaus plexippus) use a time-compensated sun compass to navigate from eastern North America to their overwintering grounds in central Mexico. Here we describe the neuronal layout of those aspects of the butterfly's central complex likely to establish part of the internal sun compass and find them highly homologous to those of the desert locust. Intracellular recordings from neurons in the monarch sun compass network reveal responses tuned to specific E-vector angles of polarized light, as well as azimuth-dependent responses to unpolarized light, independent of spectral composition. The neural responses to these two stimuli in individual neurons are mediated through different regions of the compound eye. Moreover, these dual responses are integrated to create a consistent representation of skylight cues in the sun compass throughout the day. The results advance our understanding of how ambiguous sensory signals are processed by the brain to elicit a robust behavioral response.	[Heinze, Stanley; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Heinze, Stanley/I-4440-2019	Heinze, Stanley/0000-0002-8145-3348	AFOSR [FA9550-10-1-0480]; Human Frontier Science Program [LT000379/2009-L]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Human Frontier Science Program(Human Frontier Science Program)	We kindly thank David G. Cook of the St. Marks National Wildlife Refuge (St. Marks, Florida) and Harlen E. Aschen and Altus Aschen for providing migratory butterflies; Lauren Foley, Daniel Newman, and Andrea Pereira for animal care; Keram Pfeiffer for providing Spike2 scripts for data analysis; Eugenia Chiappe and Vivek Jayaraman for assistance with equipment for stimulus delivery; Robert Gegear. for assistance with statistical analysis; the UMASS machine shop for building custom-designed equipment; Jan-Felix Evers for providing an updated version of the skeletonize tool for neuron reconstruction in Amira4.2; and members of the Reppert lab for discussions and comments on various parts of the manuscript. This work was supported by AFOSR grant FA9550-10-1-0480. S.H. was supported by a long-term fellowship from the Human Frontier Science Program (LT000379/2009-L); the funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	COEMANS MAJM, 1994, VISION RES, V34, P1461, DOI 10.1016/0042-6989(94)90148-1; Coulson K. L., 1988, POLARIZATION INTENSI; El Jundi B, 2009, J COMP NEUROL, V517, P210, DOI 10.1002/cne.22150; FROY O, 2003, MOL BIOL EVOL, V19, P748; Heinze S, 2008, J COMP NEUROL, V511, P454, DOI 10.1002/cne.21842; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2009, J NEUROSCI, V29, P11783, DOI 10.1523/JNEUROSCI.1870-09.2009; Heinze S, 2009, J NEUROSCI, V29, P4911, DOI 10.1523/JNEUROSCI.0332-09.2009; Homberg U, 2004, NATURWISSENSCHAFTEN, V91, P199, DOI 10.1007/s00114-004-0525-9; Homberg U, 2003, J COMP NEUROL, V462, P415, DOI 10.1002/cne.10771; Homberg U, 2002, ARTHROPOD STRUCT DEV, V30, P271, DOI 10.1016/S1467-8039(02)00010-5; Kelber A, 1999, NATURE, V402, P251, DOI 10.1038/46204; Kinoshita M, 2007, J EXP BIOL, V210, P1350, DOI 10.1242/jeb.02744; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Labhart T, 2001, J EXP BIOL, V204, P2423; Labhart T, 1999, J EXP BIOL, V202, P757; Labhart T, 2009, CELL TISSUE RES, V338, P391, DOI 10.1007/s00441-009-0886-7; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Pfeiffer K, 2007, CURR BIOL, V17, P960, DOI 10.1016/j.cub.2007.04.059; Pfeiffer K, 2011, J NEUROPHYSIOL, V105, P28, DOI 10.1152/jn.00480.2010; Reppert SM, 2007, COLD SPRING HARB SYM, V72, P113, DOI 10.1101/sqb.2007.72.056; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Reppert SM, 2010, TRENDS NEUROSCI, V33, P399, DOI 10.1016/j.tins.2010.04.004; ROSSEL S, 1978, J COMP PHYSIOL, V125, P1, DOI 10.1007/BF00656826; Sakura M, 2008, J NEUROPHYSIOL, V99, P667, DOI 10.1152/jn.00784.2007; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047; Stalleicken J, 2006, J COMP PHYSIOL A, V192, P321, DOI 10.1007/s00359-005-0073-6; Stalleicken J, 2005, J EXP BIOL, V208, P2399, DOI 10.1242/jeb.01613; Trager U, 2008, J COMP NEUROL, V506, P288, DOI 10.1002/cne.21512; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; Wehner R, 2001, J EXP BIOL, V204, P2589; WEHNER R, 1982, GES ZURICH, V182, P1; Wehner R, 2006, INVERTEBRATE VISION, P291; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14	38	152	159	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					345	358		10.1016/j.neuron.2010.12.025	http://dx.doi.org/10.1016/j.neuron.2010.12.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262471	Bronze			2022-12-24	WOS:000286792900016
J	Thaxton, C; Pillai, AM; Pribisko, AL; Dupree, JL; Bhat, MA				Thaxton, Courtney; Pillai, Anilkumar M.; Pribisko, Alaine L.; Dupree, Jeffrey L.; Bhat, Manzoor A.			Nodes of Ranvier Act as Barriers to Restrict Invasion of Flanking Paranodal Domains in Myelinated Axons	NEURON			English	Article							SODIUM-CHANNEL; ANKYRIN-G; GLIA INTERACTIONS; NEUROFASCIN; EXPRESSION; GENE; REQUIREMENTS; NERVE; MYELINOGENESIS; IDENTIFICATION	Accumulation of voltage-gated sodium (Na-v) channels at nodes of Ranvier is paramount for action potential propagation along myelinated fibers, yet the mechanisms governing nodal development, organization, and stabilization remain unresolved. Here, we report that genetic ablation of the neuron-specific isoform of Neurofascin (Nfas(NF186)) in vivo results in nodal disorganization, including loss of Na-v channel and ankyrin-G (AnkG) enrichment at nodes in the peripheral nervous system (PNS) and central nervous system (CNS). Interestingly, the presence of paranodal domains failed to rescue nodal organization in the PNS and the CNS. Most importantly, using ultrastructural analysis, we demonstrate that the paranodal domains invade the nodal space in Nfasc(NF186) mutant axons and occlude node formation. Our results suggest that Nfasc(NF186)-dependent assembly of the nodal complex acts as a molecular boundary to restrict the movement of flanking paranodal domains into the nodal area, thereby facilitating the stereotypic axonal domain organization and saltatory conduction along myelinated axons.	[Thaxton, Courtney; Pillai, Anilkumar M.; Pribisko, Alaine L.; Bhat, Manzoor A.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Bhat, Manzoor A.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Bhat, Manzoor A.] Univ N Carolina, Sch Med, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [Bhat, Manzoor A.] Univ N Carolina, Sch Med, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Dupree, Jeffrey L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University	Bhat, MA (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA.	manzoor_bhat@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; BHAT, MANZOOR/S-9273-2018	BHAT, MANZOOR/0000-0003-0989-1498; Thaxton, Courtney/0000-0002-6733-369X	NIH [GM063074, NS050356]; National Multiple Sclerosis Society; State of North Carolina; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); State of North Carolina; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Michael Sendtner, William Snider, Klaus Nave, and Victoria Bautch for generously sharing the Nefl-Cre, Tau<SUP>mGFP/LacZ</SUP>, Cnp-Cre, and R26R<SUP>LacZ</SUP> mice, respectively, and Matt Rasband for sharing the anti-FIGQY antibody. We thank Alan Fanning, Alex Gow, Lori Isom, and Stephen Lambert for comments on the manuscript, and Matt Rasband for helpful discussions. We also thank anonymous reviewers for their many insightful comments and suggestions, which led to a broader discussion of our in vivo findings. This work was supported by NIH grants GM063074 and NS050356, the National Multiple Sclerosis Society, and the State of North Carolina (M.A.B.).	Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Collinson JM, 1998, GLIA, V23, P11, DOI 10.1002/(SICI)1098-1136(199805)23:1<11::AID-GLIA2>3.0.CO;2-7; DAVIDSON JM, 1993, J CELL BIOCHEM, P109; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Lambert S, 1997, J NEUROSCI, V17, P7025; LECONTE L, 1994, J MOL NEUROSCI, V5, P273, DOI 10.1007/BF02736727; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Miller MJ, 2009, J NEUROSCI RES, V87, P2842, DOI 10.1002/jnr.22121; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Rasband Matthew N., 2006, V43, P129, DOI 10.1007/014; Rios JC, 2003, J NEUROSCI, V23, P7001, DOI 10.1523/JNEUROSCI.23-18-07001.2003; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Schafer DP, 2006, NEURON GLIA BIOL, V2, P69, DOI 10.1017/S1740925X06000093; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; TENNEKOON GI, 1977, J CELL BIOL, V72, P604, DOI 10.1083/jcb.72.3.604; Thaxton C, 2010, J NEUROSCI, V30, P4868, DOI 10.1523/JNEUROSCI.5951-09.2010; Thaxton C, 2009, RESULTS PROBL CELL D, V48, P1, DOI 10.1007/400_2009_3; VOLKMER H, 1992, J CELL BIOL, V118, P149, DOI 10.1083/jcb.118.1.149; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Zonta B, 2008, J CELL BIOL, V181, P1169, DOI 10.1083/jcb.200712154	39	57	58	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					244	257		10.1016/j.neuron.2010.12.016	http://dx.doi.org/10.1016/j.neuron.2010.12.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262464	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000286792900009
J	Voss, JL; Gonsalves, BD; Federmeier, KD; Tranel, D; Cohen, NJ				Voss, Joel L.; Gonsalves, Brian D.; Federmeier, Kara D.; Tranel, Daniel; Cohen, Neal J.			Hippocampal brain-network coordination during volitional exploratory behavior enhances learning	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; MEMORY; REPRESENTATION; MOVEMENT; FMRI	Exploratory behaviors during learning determine what is studied and when, helping to optimize subsequent memory performance. To elucidate the cognitive and neural determinants of exploratory behaviors, we manipulated the control that human subjects had over the position of a moving window through which they studied objects and their locations. Our behavioral, neuropsychological and neuroimaging data indicate that volitional control benefits memory performance and is linked to a brain network that is centered on the hippocampus. Increases in correlated activity between the hippocampus and other areas were associated with specific aspects of memory, which suggests that volitional control optimizes interactions among specialized neural systems through the hippocampus. Memory is therefore an active process that is intrinsically linked to behavior. Furthermore, brain structures that are typically seen as passive participants in memory encoding (for example, the hippocampus) are actually part of an active network that controls behavior dynamically as it unfolds.	[Voss, Joel L.; Gonsalves, Brian D.; Federmeier, Kara D.; Cohen, Neal J.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Tranel, Daniel] Univ Iowa, Dept Neurol, Div Cognit Neurosci, Carver Coll Med, Iowa City, IA 52242 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa	Voss, JL (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	joelvoss@illinois.edu		Voss, Joel/0000-0003-4180-9335; Federmeier, Kara/0000-0002-7815-1808; Tranel, Daniel/0000-0002-1338-1389	US National Institutes of Health (NIH) [K99-NS069788]; Beckman Institute; Kiwanis Foundation; NIH [MH062500, NS19632]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS019632, P01NS019632, K99NS069788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC003189] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute; Kiwanis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by a US National Institutes of Health (NIH) Pathway to Independence award (K99-NS069788) and a Beckman Institute Postdoctoral Fellowship Award to J.L.V., by funds from the Kiwanis Foundation to D.T.T., and by NIH grants MH062500 to N.J.C. and NS19632 to D.T.T.	Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; Bellebaum C, 2007, CEREBELLUM, V6, P184, DOI 10.1080/14734220601169707; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chua EF, 2009, J COGNITIVE NEUROSCI, V21, P1751, DOI 10.1162/jocn.2009.21123; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Eichenbaum H, 2004, CONDITIONING CONSCIO, DOI [10.1093/acprof:oso/, DOI 10.1093/ACPROF:OSO]; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gibson JJ, 1979, ECOLOGICAL APPROACH; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Harman KL, 1999, CURR BIOL, V9, P1315, DOI 10.1016/S0960-9822(00)80053-6; HELD R, 1965, SCI AM, V213, P84, DOI 10.1038/scientificamerican1165-84; HELD R, 1963, J COMP PHYSIOL PSYCH, V56, P872, DOI 10.1037/h0040546; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kennedy PJ, 2009, P NATL ACAD SCI USA, V106, P10805, DOI 10.1073/pnas.0903259106; Kesner RP, 2009, NEUROBIOL LEARN MEM, V91, P197, DOI 10.1016/j.nlm.2008.09.004; Kesner RP, 2004, NEUROBIOL LEARN MEM, V82, P199, DOI 10.1016/j.nlm.2004.05.007; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Konkel A, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.015.2008; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; MACKWORTH NH, 1967, PERCEPT PSYCHOPHYS, V2, P547, DOI 10.3758/BF03210264; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Metcalfe J, 2010, BEHAV PROCESS, V83, P213, DOI 10.1016/j.beproc.2009.12.011; Metcalfe J, 2009, CURR DIR PSYCHOL SCI, V18, P159, DOI 10.1111/j.1467-8721.2009.01628.x; National Research Council, 1999, PEOPL LEARN; Neisser U., 1976, COGNITION REALITY PR; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Piaget J, 1953, ORIGINS INTELLIGENCE; Reber PJ, 2002, HIPPOCAMPUS, V12, P363, DOI 10.1002/hipo.10018; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sakagami M, 2007, ANN NY ACAD SCI, V1104, P89, DOI 10.1196/annals.1390.010; Shimamura AP, 2009, PSYCHOL REV, V116, P1, DOI 10.1037/a0014500; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Song EY, 2005, HIPPOCAMPUS, V15, P8, DOI 10.1002/hipo.20023; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; VANHOESEN GW, 1979, SCIENCE, V205, P608, DOI 10.1126/science.109926; Voss JL, 2009, HIPPOCAMPUS, V19, P773, DOI 10.1002/hipo.20608	50	110	110	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					115	U152		10.1038/nn.2693	http://dx.doi.org/10.1038/nn.2693			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	699TE	21102449	Green Accepted			2022-12-24	WOS:000285684900022
J	Sharma, P; Cline, HT				Sharma, Pranav; Cline, Hollis T.			Visual Activity Regulates Neural Progenitor Cells in Developing Xenopus CNS through Musashi1	NEURON			English	Article							RNA-BINDING PROTEIN; DENDRITIC ARBOR DEVELOPMENT; STEM-CELLS; IN-VIVO; ADULT NEUROGENESIS; OLFACTORY-BULB; MESSENGER-RNA; NMDA RECEPTOR; MAMMALIAN CNS; NITRIC-OXIDE	Regulation of progenitor cell fate determines the numbers of neurons in the developing brain. While proliferation of neural progenitors predominates during early central nervous system (CNS) development, progenitor cell fate shifts toward differentiation as CNS circuits develop, suggesting that signals from developing circuits may regulate proliferation and differentiation. We tested whether activity regulates neurogenesis in vivo in the developing visual system of Xenopus tadpoles. Both cell proliferation and the number of musashi1-immunoreactive progenitors in the optic tectum decrease as visual system connections become stronger. Visual deprivation for 2 days increased proliferation of musashi1-immunoreactive radial glial progenitors, while visual experience increased neuronal differentiation. Morpholino-mediated knockdown and overexpression of musashi1 indicate that musashi1 is necessary and sufficient for neural progenitor proliferation in the CNS. These data demonstrate a mechanism by which increased brain activity in developing circuits decreases cell proliferation and increases neuronal differentiation through the downregulation of musashi1 in response to circuit activity.	[Sharma, Pranav; Cline, Hollis T.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Cline, HT (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cline@scripps.edu			National Institutes of Health [DP10D000458]; Dart Neuroscience, LLC; Cold Spring Harbor Laboratory Association; California Institute of Regenerative Medicine; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dart Neuroscience, LLC; Cold Spring Harbor Laboratory Association; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (DP10D000458 to H.T.C.), Dart Neuroscience, LLC (H.T.C.), and fellowships from the Cold Spring Harbor Laboratory Association and California Institute of Regenerative Medicine to P.S. We thank Drs. Imai and Okano for generously providing the cDNA for mouse Musashi1 and members of the Cline lab for insightful discussions.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Amato MA, 2005, J COMP NEUROL, V481, P331, DOI 10.1002/cne.20387; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Bestman JE, 2008, P NATL ACAD SCI USA, V105, P20494, DOI 10.1073/pnas.0806296105; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Crevel G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000833; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Facoetti A, 2006, ANTICANCER RES, V26, P1071; Gandhi R, 2008, J NEUROCHEM, V104, P155, DOI 10.1111/j.1471-4159.2007.04955.x; Glazer RI, 2008, CELL CYCLE, V7, P2635, DOI 10.4161/cc.7.17.6522; GOOD PJ, 1993, NUCLEIC ACIDS RES, V21, P999, DOI 10.1093/nar/21.4.999; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Horisawa K, 2009, FEBS LETT, V583, P2429, DOI 10.1016/j.febslet.2009.06.045; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lehmann K, 2005, EUR J NEUROSCI, V21, P3205, DOI 10.1111/j.1460-9568.2005.04156.x; Li JL, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.006.2010; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Moody SA, 1996, J COMP NEUROL, V364, P219, DOI 10.1002/(SICI)1096-9861(19960108)364:2<219::AID-CNE3>3.0.CO;2-8; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Padmanabhan V, 2004, J CLIN PATHOL, V57, P1057, DOI 10.1136/jcp.2004.016436; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; Peunova N, 2007, CELL CYCLE, V6, P3132, DOI 10.4161/cc.6.24.5146; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Pratt KG, 2009, J NEUROPHYSIOL, V102, P399, DOI 10.1152/jn.91317.2008; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; RICHTER K, 1990, New Biologist, V2, P556; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; RUTHAZER ES, 2004, IMAGING LAB MANUAL, P112; Sadikot AF, 1998, DEV BRAIN RES, V105, P35, DOI 10.1016/S0165-3806(97)00148-X; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; STRAZNICKY K, 1972, J EMBRYOL EXP MORPH, V28, P87; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Tremblay M, 2009, J NEUROSCI, V29, P14066, DOI 10.1523/JNEUROSCI.3542-09.2009; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wu GY, 1999, J NEUROSCI, V19, P4472; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	71	33	34	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 4	2010	68	3					442	455		10.1016/j.neuron.2010.09.028	http://dx.doi.org/10.1016/j.neuron.2010.09.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040846	Green Accepted, Bronze			2022-12-24	WOS:000284255800013
J	Meaney, MJ; Ferguson-Smith, AC				Meaney, Michael J.; Ferguson-Smith, Anne C.			Epigenetic regulation of the neural transcriptome: the meaning of the marks	NATURE NEUROSCIENCE			English	Article							DNA METHYLATION; HUMAN BRAIN; HISTONE H3; CHROMATIN-STRUCTURE; MECP2; CPG; HETEROCHROMATIN; PROMOTER; DISEASE; COMPLEX	The field of epigenetics provides neurobiologists with candidate mechanisms for experience-dependent changes in gene transcription. The ability to realize the potential of epigenetics in defining the causal pathways lying between environmental signals, transcriptional regulation and neural function will depend on moving beyond correlational studies focusing on individual epigenetic marks. Here we attempt to provide a conceptual framework for integrative research on nucleotide sequence, chromatin modifications, RNA signaling and their interactions in understanding experience-dependent phenotypic plasticity. Studies in genomic imprinting may serve as an existing model for such approaches.	[Meaney, Michael J.] McGill Univ, Douglas Hosp Mental Hlth Univ Inst, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Meaney, Michael J.; Ferguson-Smith, Anne C.] Singapore Inst Clin Sci, Singapore, Singapore	McGill University; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Meaney, MJ (corresponding author), McGill Univ, Douglas Hosp Mental Hlth Univ Inst, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada.	michael.meaney@mcgill.ca	Meaney, Michael/N-5931-2019; Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894	MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish; Medical Research Council [G0800784] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akbarian S, 2009, BIOL PSYCHIAT, V65, P198, DOI 10.1016/j.biopsych.2008.08.015; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Davies W, 2008, ADV EXP MED BIOL, V626, P62; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Fujita H, 2003, MOL CELL BIOL, V23, P2645, DOI 10.1128/MCB.23.8.2645-2657.2003; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; McEwen KR, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-2; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Plagge A, 2006, CYTOGENET GENOME RES, V113, P178, DOI 10.1159/000090830; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiss A, 1997, GENES CELLS, V2, P481, DOI 10.1046/j.1365-2443.1997.1390337.x; Yamazawa K, 2010, AM J MED GENET C, V154C, P329, DOI 10.1002/ajmg.c.30270; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	58	160	165	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1313	1318		10.1038/nn1110-1313	http://dx.doi.org/10.1038/nn1110-1313			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975754				2022-12-24	WOS:000283658200007
J	Carrillo, RA; Olsen, DP; Yoon, KS; Keshishian, H				Carrillo, Robert A.; Olsen, Douglas P.; Yoon, Kenneth S.; Keshishian, Haig			Presynaptic Activity and CaMKII Modulate Retrograde Semaphorin Signaling and Synaptic Refinement	NEURON			English	Article							CONTROLLING TARGET SELECTION; DEVELOPING MAMMALIAN RETINA; SENSITIVE PARALYTIC MUTANT; GROWTH CONE GUIDANCE; PROTEIN-KINASE-II; GENETIC-ANALYSIS; IN-VIVO; DROSOPHILA LARVAE; CALCIUM-CHANNELS; AXON GUIDANCE	Establishing synaptic connections often involves the activity-dependent withdrawal of off-target contacts. We describe an in vivo role for temporally patterned electrical activity, voltage-gated calcium channels, and CaMKII in modulating the response of Drosophila motoneurons to the chemorepellent Sema-2a during synaptic refinement. Mutations affecting the Sema-2a ligand, the plexin B receptor (plexB), the voltage-gated Ca(v)2.1 calcium channel (cac), or the voltage-gated Na(v)1 sodium channel (mle(naP-ts);tipE) each result in ectopic neuromuscular contacts. Sema-2a interacts genetically with both of the channel mutations. The cac phenotype is enhanced by the Sema-2a mutation and is suppressed by either plexq overexpression or patterned, low-frequency (0.01 Hz) bouts of electrical activity in the embryo. The calcium-dependent suppression of ectopic contacts also depends on the downstream activation of CaMKII. These results indicate a role for patterned electrical activity and presynaptic calcium signaling, acting through CaMKII, in modulating a retrograde signal during the refinement of synaptic connections.	[Olsen, Douglas P.; Keshishian, Haig] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Carrillo, Robert A.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Yoon, Kenneth S.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Keshishian, H (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, Box 208103, New Haven, CT 06520 USA.			Carrillo, Robert/0000-0002-2067-9861	National Institutes of Health (NIH) [5R01NS031651, 1R21NS053807]; National Science Foundation (NSF) [IBN 0641915]; Ford Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053807, R01NS031651] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Ford Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V Budnik, C Goodman, P Garrity, L Griffith, A Kolodkin, T Littleton, and R Ordway for generously providing Drosophila stocks and reagents We also thank Rebecca Delventhal for her contribution to the plexin B analysis We thank Elke Stein, Robert Wyman. and Weimin Zhong, as well as members of the Keshishian lab, for their advice and comments on the manuscript The research was supported by grants from the National Institutes of Health (NIH) (5R01NS031651 and 1R21NS053807), and from the National Science Foundation (NSF) (IBN 0641915) to H K, and by a predoctoral fellowship from the Ford Foundation to R A C	Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Artigiani S, 2003, J BIOL CHEM, V278, P10094, DOI 10.1074/jbc.M210156200; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Brooks IM, 2003, GENETICS, V164, P163; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CASH S, 1992, J NEUROSCI, V12, P2051; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; Chang TN, 1996, J NEUROSCI, V16, P5715; Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; GANETZKY B, 1986, J NEUROGENET, V3, P19, DOI 10.3109/01677068609106892; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Griffith Leslie C., 1997, Invertebrate Neuroscience, V3, P93, DOI 10.1007/BF02480364; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hanson MG, 2008, BRAIN RES REV, V57, P77, DOI 10.1016/j.brainresrev.2007.06.021; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HONG CS, 1994, J NEUROSCI, V14, P5160; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Jarecki J, 1995, J NEUROSCI, V15, P8177; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; Jin R, 1998, J NEUROSCI, V18, P8955; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawasaki F, 2002, J NEUROSCI, V22, P5856; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; PENN AA, 1994, J NEUROSCI, V14, P3805; Pereanu W, 2007, DEV NEUROBIOL, V67, P1669, DOI 10.1002/dneu.20538; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; REDFERN PA, 1970, J PHYSIOL-LONDON, V209, P701, DOI 10.1113/jphysiol.1970.sp009187; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P1, DOI 10.1016/S0074-7742(06)75001-2; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHMIDT JT, 1985, CELL MOL NEUROBIOL, V5, P5, DOI 10.1007/BF00711083; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; Wang Z, 1998, J NEUROCHEM, V71, P378; White B, 2001, CURR BIOL, V11, pR1041, DOI 10.1016/S0960-9822(01)00621-2; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zhong Y, 2004, J NEUROSCI, V24, P1439, DOI 10.1523/JNEUROSCI.0740-02.2004; ZHONG Y, 1992, J NEUROSCI, V12, P644	80	41	42	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					32	44		10.1016/j.neuron.2010.09.005	http://dx.doi.org/10.1016/j.neuron.2010.09.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920789	Bronze, Green Accepted			2022-12-24	WOS:000283704200006
J	Molyneux, G; Geyer, FC; Magnay, FA; McCarthy, A; Kendrick, H; Natrajan, R; MacKay, A; Grigoriadis, A; Tutt, A; Ashworth, A; Reis, JS; Smalley, MJ				Molyneux, Gemma; Geyer, Felipe C.; Magnay, Fiona-Ann; McCarthy, Afshan; Kendrick, Howard; Natrajan, Rachael; MacKay, Alan; Grigoriadis, Anita; Tutt, Andrew; Ashworth, Alan; Reis-Filho, Jorge S.; Smalley, Matthew J.			BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells	CELL STEM CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; MAMMARY-GLAND; GENE-EXPRESSION; MOUSE MODEL; TUMORS; SUBTYPES; FATE; P53; BETA-1-INTEGRIN; MORPHOGENESIS	Breast cancers in BRCA1 mutation carriers frequently have a distinctive basal-like phenotype. It has been suggested that this results from an origin in basal breast epithelial stem cells. Here, we demonstrate that deleting Brca1 in mouse mammary epithelial luminal progenitors produces tumors that phenocopy human BRCA1 breast cancers. They also resemble the majority of sporadic basal-like breast tumors. However, directing Brca1 deficiency to basal cells generates tumors that express molecular markers of basal breast cancers but do not histologically resemble either human BRCA1 or the majority of sporadic basal-like breast tumors. These findings support a derivation of the majority of human BRCA1-associated and sporadic basal-like tumors from luminal progenitors rather than from basal stem cells. They also demonstrate that when target cent for transformation have the potential for phenotypic plasticity, tumor phenotypes may not directly reflect histogenesis. This has important implications for cancer prevention strategies.	[Molyneux, Gemma; Geyer, Felipe C.; Magnay, Fiona-Ann; McCarthy, Afshan; Kendrick, Howard; Natrajan, Rachael; MacKay, Alan; Ashworth, Alan; Reis-Filho, Jorge S.; Smalley, Matthew J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Grigoriadis, Anita; Tutt, Andrew] Kings Hlth Partners AHSC, Guys Hosp, Breakthrough Breast Canc Res Unit, London SE1 9RT, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; King's Health Partners; University of London; King's College London	Smalley, MJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	matthew.smalley@icr.ac.uk	Smalley, Matthew J/M-7000-2015	Smalley, Matthew J/0000-0001-9540-1146; Tutt, Andrew/0000-0001-8715-2901; Grigoriadis, Anita/0000-0003-3434-201X; Natrajan, Rachael/0000-0002-9987-2946	Breakthrough Breast Cancer; NHS	Breakthrough Breast Cancer; NHS	We thank the Breakthrough Histopathology Facility for their assistance with processing tumor tissues, Fredrik Wallberg for help with flow cytometry analysis, and Britta Weigelt for providing the centroids for human breast cancer molecular subtype assignment. This work was funded by Breakthrough Breast Cancer. We acknowledge NHS funding to the NIHR Biomedical Research Centre.	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barbera M, 2009, SURG ONCOL CLIN N AM, V18, P393, DOI 10.1016/j.soc.2009.03.001; Booth BW, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1538; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McCarthy A, 2007, J PATHOL, V211, P389, DOI 10.1002/path.2124; Melchor L, 2008, CARCINOGENESIS, V29, P1475, DOI 10.1093/carcin/bgn157; Mesquita Patricia, 2006, Critical Reviews in Oncogenesis, V12, P3; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Palacios J, 2005, BREAST CANCER RES TR, V90, P5, DOI 10.1007/s10549-004-1536-0; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smart CE, 2008, BREAST CANCER RES TR, V112, P237, DOI 10.1007/s10549-007-9859-2; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5	47	492	509	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					403	417		10.1016/j.stem.2010.07.010	http://dx.doi.org/10.1016/j.stem.2010.07.010			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804975	Bronze			2022-12-24	WOS:000282037800016
J	Ecker, JL; Dumitrescu, ON; Wong, KY; Alam, NM; Chen, SK; LeGates, T; Renna, JM; Prusky, GT; Berson, DM; Hattar, S				Ecker, Jennifer L.; Dumitrescu, Olivia N.; Wong, Kwoon Y.; Alam, Nazia M.; Chen, Shih-Kuo; LeGates, Tara; Renna, Jordan M.; Prusky, Glen T.; Berson, David M.; Hattar, Samer			Melanopsin-Expressing Retinal Ganglion-Cell Photoreceptors: Cellular Diversity and Role in Pattern Vision	NEURON			English	Article							HYPOTHALAMIC SUPRACHIASMATIC NUCLEUS; SPATIAL VISION; KNOCKOUT MICE; LIGHT; MOUSE; RESPONSES; PROJECTIONS; CONE; REVEALS; SYSTEM	Using the photopigment melanopsin, intrinsically photosensitive retinal ganglion cells (ipRGCs) respond directly to light to drive circadian clock resetting and pupillary constriction. We now report that ipRGCs are more abundant and diverse than previously appreciated, project more widely within the brain, and can support spatial visual perception. A Cre-based melanopsin reporter mouse line revealed at least five subtypes of ipRGCs with distinct morphological and physiological characteristics. Collectively, these cells project beyond the known brain targets of ipRGCs to heavily innervate the superior colliculus and dorsal lateral geniculate nucleus, retinotopically organized nuclei mediating object localization and discrimination. Mice lacking classical rod-cone photoreception, and thus entirely dependent on melanopsin for light detection, were able to discriminate grating stimuli from equiluminant gray and had measurable visual acuity. Thus, nonclassical retinal photoreception occurs within diverse cell types and influences circuits and functions encompassing luminance as well as spatial information.	[Dumitrescu, Olivia N.; Wong, Kwoon Y.; Renna, Jordan M.; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Ecker, Jennifer L.; Chen, Shih-Kuo; LeGates, Tara; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Alam, Nazia M.; Prusky, Glen T.] Weill Cornell Med Coll, Burke Med Res Inst, Dept Physiol & Biophys, White Plains, NY 10605 USA; [Hattar, Samer] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Brown University; Johns Hopkins University; Cornell University; Johns Hopkins University	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	david_berson@brown.edu; shattar@jhu.edu	Hattar, Samer/W-6927-2019	Wong, Kwoon/0000-0001-9279-7827; CHEN, SHIH-KUO/0000-0002-7921-1358; LeGates, Tara/0000-0002-6005-4786	National Institutes of Health [GM076430, EY012793, K99EY018863]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; NATIONAL EYE INSTITUTE [R00EY018863, K99EY018863, R01EY012793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank several people for providing reagents used in making the targeting construct: Naren Ramanan and David Ginty for the original Cre recombinase plasmid and FAT-flanked neomycin resistance cassette, and Jason Well and Karen Beemon for the human beta-globin intron. The melanopsin antiserum was a kind gift from Ignacio Provencio. Z/AP mice were obtained from Tudor Badea in Jeremy Nathans' laboratory who also provided lots of valuable discussions, and Z/EG mice from Seth Blackshaw. We also thank Dr. Rejji Kuruvilla, Dr. Haiqing Zhao, and David McNeill for their careful reading of the manuscript and helpful suggestions and the Johns Hopkins University Mouse Tri-Lab for support. This work was supported by the National Institutes of Health grants GM076430 (S.H.), EY012793 (D.M.B.), and K99EY018863 (K.W.), the David and Lucile Packard Foundation (S.H.), and the Alfred P. Sloan Foundation (S.H.).	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyabya O, 2006, INVEST OPHTH VIS SCI, V47, P1636, DOI 10.1167/iovs.05-1459; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; KAYAMA Y, 1979, J NEUROPHYSIOL, V42, P1495, DOI 10.1152/jn.1979.42.6.1495; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2002, NATURWISSENSCHAFTEN, V89, P525, DOI 10.1007/s00114-002-0369-0; Mrosovsky N, 1997, NEUROSCI LETT, V222, P204, DOI 10.1016/S0304-3940(97)13374-2; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Prichard JR, 2002, NEUROSCIENCE, V114, P781, DOI 10.1016/S0306-4522(02)00293-2; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, VISION RES, V44, P3411, DOI 10.1016/j.visres.2004.09.001; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034	48	435	439	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					49	60		10.1016/j.neuron.2010.05.023	http://dx.doi.org/10.1016/j.neuron.2010.05.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624591	Bronze, Green Accepted			2022-12-24	WOS:000280221000008
J	Wan, QF; Zhou, ZY; Thakur, P; Vila, A; Sherry, DM; Janz, R; Heidelberger, R				Wan, Qun-Fang; Zhou, Zhen-Yu; Thakur, Pratima; Vila, Alejandro; Sherry, David M.; Janz, Roger; Heidelberger, Ruth			SV2 Acts via Presynaptic Calcium to Regulate Neurotransmitter Release	NEURON			English	Article							SYNAPTIC VESICLE PROTEIN; RETINAL BIPOLAR NEURONS; VESICULAR GLUTAMATE TRANSPORTER-1; ADRENAL CHROMAFFIN CELLS; BOTULINUM-NEUROTOXIN-A; RIBBON SYNAPSE; DIFFERENTIAL DISTRIBUTION; NEUROMUSCULAR-JUNCTION; SECRETORY VESICLES; NERVE-TERMINALS	Synaptic vesicle 2 (SV2) proteins, critical for proper nervous system function, are implicated in human epilepsy, yet little is known about their function. We demonstrate, using direct approaches, that loss of the major SV2 isoform in a central nervous system nerve terminal is associated with an elevation in both resting and evoked presynaptic Ca2+ signals. This increase is essential for the expression of the SV2B(-/-) secretory phenotype, characterized by changes in synaptic vesicle dynamics, synaptic plasticity, and synaptic strength. Short-term reproduction of the Ca2+ phenotype in wild-type nerve terminals reproduces almost all aspects of the SV2B(-/-) secretory phenotype, while rescue of the Ca2+ phenotype in SV2B(-/)- neurons relieves every facet of the SV2B(-/-) secretory phenotype. Thus, SV2 controls key aspects of synaptic functionality via its ability to regulate presynaptic Ca2+, suggesting a potential new target for therapeutic intervention in the treatment of epilepsy.	[Wan, Qun-Fang; Zhou, Zhen-Yu; Thakur, Pratima; Vila, Alejandro; Janz, Roger; Heidelberger, Ruth] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Vila, Alejandro; Janz, Roger; Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Sherry, David M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Sherry, David M.] Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Oklahoma System; University of Oklahoma Health Sciences Center	Janz, R (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA.	roger.janz@uth.tmc.edu; ruth.heidelberger@uth.tmc.edu		Heidelberger, Ruth/0000-0002-8033-2050; Zhou, Zhenyu/0000-0002-5024-5263; Janz, Roger/0000-0002-9872-0596	National Eye Institute [EY-12128, EY-16452, EY-10608]; NIH [P30 EY07751]; NATIONAL EYE INSTITUTE [R29EY012128, P30EY010608, R01EY012128, R01EY016452, P30EY007551] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute Grant EY-12128 to R.H., EY-16452 to R.J., and Core Grant EY-10608. We thank Dr. Alice Z. Chuang for her assistance with the statistical analysis and Margaret Gondo and Joe Wilkerson for technical assistance with electron microscopy. Electron microscopy at the University of Houston was supported by an NIH CORE grant to the University of Houston College of Optometry (P30 EY07751). Electron microscopy at the University of Oklahoma Health Sciences Center was performed at the Oklahoma Medical Research Foundation Imaging Core Facility. Q.-F.W., Z.-Y.Z., PT., D.M.S., R.J., and R.H. contributed to the design and interpretation of the experiments. Q.-F.W., Z.-Y.Z., and P.T. conducted the electrophysiological experiments. A.V. and P.T. performed the immunocytochemistry. D.M.S. performed the electron microscopy. R.H., Q.-F.W., and R.J. wrote the manuscript. R.H. and R.J. supervised the project. All authors have approved the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Belair EL, 2005, J PHYSIOL-LONDON, V569, P163, DOI 10.1113/jphysiol.2005.094805; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; De Smedt T, 2007, CNS DRUG REV, V13, P43, DOI 10.1111/j.1527-3458.2007.00004.x; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; DOWLING JE, 1968, PROC R SOC SER B-BIO, V170, P205, DOI 10.1098/rspb.1968.0034; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gillis Kevin D., 1995, P155; Gomis A, 1999, J NEUROSCI, V19, P6309; Heidelberger R, 2003, VISUAL NEUROSCI, V20, P37, DOI 10.1017/S095252380320105X; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Heidelberger R, 2001, REV PHYSIOL BIOCH P, V143, P1, DOI 10.1007/BFb0115592; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1998, J NEUROSCI, V18, P9269; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; KENDRICK NC, 1977, NATURE, V265, P246, DOI 10.1038/265246a0; Kline DD, 2007, J NEUROSCI, V27, P4663, DOI 10.1523/JNEUROSCI.4946-06.2007; Krizaj D, 2002, J COMP NEUROL, V451, P1, DOI 10.1002/cne.10281; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Lezzi M, 2005, J CELL SCI, V118, P5647, DOI 10.1242/jcs.02658; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Messler P, 1996, J NEUROSCI METH, V69, P137, DOI 10.1016/S0165-0270(96)00032-5; Millar AG, 2005, J NEUROSCI, V25, P3113, DOI 10.1523/JNEUROSCI.4717-04.2005; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; Moulder KL, 2006, J NEUROSCI, V26, P6618, DOI 10.1523/JNEUROSCI.5498-05.2006; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Rouze NC, 1998, J NEUROSCI, V18, P8614; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schivell AE, 2005, MOL CELL NEUROSCI, V29, P56, DOI 10.1016/j.mcn.2004.12.011; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; SCHMIDT R, 1980, NEUROSCIENCE, V5, P625, DOI 10.1016/0306-4522(80)90060-3; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Wan QF, 2008, VISUAL NEUROSCI, V25, P523, DOI 10.1017/S0952523808080711; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wang MM, 2003, J COMP NEUROL, V460, P106, DOI 10.1002/cne.10636; Wasser CR, 2009, NEUROSCIENCE, V158, P177, DOI 10.1016/j.neuroscience.2008.03.028; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wu WW, 2008, J NEUROPHYSIOL, V100, P1897, DOI 10.1152/jn.90346.2008; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Xin Q, 1998, ANAL CHEM, V70, P1677, DOI 10.1021/ac970746o; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5; Zhou ZY, 2006, J NEUROPHYSIOL, V96, P2539, DOI 10.1152/jn.00688.2006	78	79	79	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					884	895		10.1016/j.neuron.2010.05.010	http://dx.doi.org/10.1016/j.neuron.2010.05.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620874	Green Accepted, Bronze			2022-12-24	WOS:000279420800011
J	Resnik, J; Sobel, N; Paz, R				Resnik, Jennifer; Sobel, Noam; Paz, Rony			Auditory aversive learning increases discrimination thresholds	NATURE NEUROSCIENCE			English	Article							TOP-DOWN INFLUENCES; CONDITIONED FEAR; RESPONSE PROPERTIES; TASK-DIFFICULTY; CORTEX; AMYGDALA; MEMORY; STIMULUS; NEUROSCIENCE; MECHANISMS	Animal studies of discriminative fear conditioning traditionally use stimuli that are distant in physical features and thus easily distinguished perceptually. Independently, human studies have shown that training mostly improves discrimination thresholds. We found that aversive learning actually induced an increase in discrimination thresholds in humans and that subjective aversion during conditioning predicted the individual threshold change. This counterintuitive performance deterioration occurred when using odors or sounds as aversive reinforcers and was not a result of attentional distraction or decision bias. In contrast, positive reinforcement or mere exposure induced the typically reported decrease in thresholds. Our findings indicate that aversive outcomes induce wider stimulus generalization by modulating perceptual thresholds, suggesting the engagement of low-level mechanisms. We suggest that for risk- or loss-related stimuli, less specificity could be a benefit, as it invokes the same mechanisms that respond quickly and efficiently in the face of danger.	[Resnik, Jennifer; Sobel, Noam; Paz, Rony] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Paz, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rony.paz@weizmann.ac.il	Resnik, Jennifer/AAA-5644-2020	Resnik, Jennifer/0000-0002-0573-0008; Sobel, Noam/0000-0002-3232-9391	Minerva Foundation; Israel Science Foundation	Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	We thank D. Sagi for discussions. This work was supported by a Minerva Foundation and an Israel Science Foundation Grant to R.P., an Alon and Marie-Curie Fellow.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010; Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BORDI F, 1992, J NEUROSCI, V12, P2493; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dunsmoor JE, 2011, NEUROIMAGE, V55, P1878, DOI 10.1016/j.neuroimage.2011.01.041; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Fahle M, 2002, PERCEPTUAL LEARNING; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Johnson BN, 2007, J NEUROSCI METH, V160, P231, DOI 10.1016/j.jneumeth.2006.09.008; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kurt S, 2010, P NATL ACAD SCI USA, V107, P8481, DOI 10.1073/pnas.0912357107; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Livneh U, 2010, J NEUROSCI METH, V192, P90, DOI 10.1016/j.jneumeth.2010.07.027; Macmillan N. A., 2004, DETECTION THEORY USE; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McLaren IPL, 2002, ANIM LEARN BEHAV, V30, P177, DOI 10.3758/BF03192828; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; Neumann DL, 2006, BIOL PSYCHOL, V73, P175, DOI 10.1016/j.biopsycho.2006.03.004; Paz R, 2004, TRENDS NEUROSCI, V27, P496, DOI 10.1016/j.tins.2004.04.013; Pearce J. M., 2008, ANIMAL LEARNING COGN, V3rd; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Schechtman E, 2010, J NEUROSCI, V30, P10460, DOI 10.1523/JNEUROSCI.2377-10.2010; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Wesson DW, 2010, J NEUROSCI, V30, P3013, DOI 10.1523/JNEUROSCI.6003-09.2010; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Yeshurun Y, 2008, BEHAV NEUROSCI, V122, P1031, DOI 10.1037/a0012806	50	81	84	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					791	U157		10.1038/nn.2802	http://dx.doi.org/10.1038/nn.2802			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	768SH	21552275				2022-12-24	WOS:000290958000024
J	Shipman, SL; Schnell, E; Hirai, T; Chen, BS; Roche, KW; Nicoll, RA				Shipman, Seth L.; Schnell, Eric; Hirai, Takaaki; Chen, Bo-Shiun; Roche, Katherine W.; Nicoll, Roger A.			Functional dependence of neuroligin on a new non-PDZ intracellular domain	NATURE NEUROSCIENCE			English	Article							INHIBITORY SYNAPSE FORMATION; CELL-ADHESION MOLECULE; AMPA RECEPTORS; NEUREXIN; AUTISM; MUTATION; PROTEIN; EXPRESSION; PSD-95; MECHANISMS	Neuroligins, a family of postsynaptic adhesion molecules, are important in synaptogenesis through a well-characterized transsynaptic interaction with neurexin. In addition, neuroligins are thought to drive postsynaptic assembly through binding of their intracellular domain to PSD-95. However, there is little direct evidence to support the functional necessity of the neuroligin intracellular domain in postsynaptic development. We found that presence of endogenous neuroligin obscured the study of exogenous mutated neuroligin. We therefore used chained microRNAs in rat organotypic hippocampal slices to generate a reduced background of endogenous neuroligin. On this reduced background, we found that neuroligin function was critically dependent on the cytoplasmic tail. However, this function required neither the PDZ ligand nor any other previously described cytoplasmic binding domain, but rather required a previously unknown conserved region. Mutation of a single critical residue in this region inhibited neuroligin-mediated excitatory synaptic potentiation. Finally, we found a functional distinction between neuroligins 1 and 3.	[Shipman, Seth L.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Shipman, Seth L.; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Shipman, Seth L.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Schnell, Eric] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Hirai, Takaaki; Chen, Bo-Shiun; Roche, Katherine W.] NINDS, US Natl Inst Hlth, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Roche, Katherine/W-9893-2019; Chen, Bo-Shiun/H-4633-2012; Shipman, Seth/G-2562-2011	Schnell, Eric/0000-0002-5623-5015; Roche, Katherine/0000-0001-7282-6539	US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A.M. Craig, T. Sudhof and F. Varoqueaux for neuroligin constructs. We are grateful to K. Bjorgan for technical assistance and all members of the Nicoll laboratory and E. Dreyfuss for discussion of and comments on the manuscript. This work was supported by grants from the US National Institute of Mental Health.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Daoud H, 2009, BIOL PSYCHIAT, V66, P906, DOI 10.1016/j.biopsych.2009.05.008; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gutierrez RC, 2009, NEUROSCIENCE, V162, P208, DOI 10.1016/j.neuroscience.2009.04.062; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	50	76	77	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					718	U388		10.1038/nn.2825	http://dx.doi.org/10.1038/nn.2825			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532576	Green Accepted			2022-12-24	WOS:000290958000014
J	Wang, LM; Han, XQ; Mehren, J; Hiroi, M; Billeter, JC; Miyamoto, T; Amrein, H; Levine, JD; Anderson, DJ				Wang, Liming; Han, Xiaoqing; Mehren, Jennifer; Hiroi, Makoto; Billeter, Jean-Christophe; Miyamoto, Tetsuya; Amrein, Hubert; Levine, Joel D.; Anderson, David J.			Hierarchical chemosensory regulation of male-male social interactions in Drosophila	NATURE NEUROSCIENCE			English	Article							CUTICULAR HYDROCARBONS; GUSTATORY RECEPTORS; PHEROMONE RECEPTOR; MALE-AGGRESSION; MALE COURTSHIP; SEX-PHEROMONE; MUTANT MICE; BEHAVIOR; TASTE; MELANOGASTER	Pheromones regulate male social behaviors in Drosophila, but the identities and behavioral role(s) of these chemosensory signals, and how they interact, are incompletely understood. We found that (z)-7-tricosene, a male-enriched cuticular hydrocarbon that was previously shown to inhibit male-male courtship, was essential for normal levels of aggression. The mechanisms by which (z)-7-tricosene induced aggression and suppressed courtship were independent, but both required the gustatory receptor Gr32a. Sensitivity to (z)-7-tricosene was required for the aggression-promoting effect of 11-cis-vaccenyl acetate (cVA), an olfactory pheromone, but (z)-7-tricosene sensitivity was independent of cVA. (z)-7-tricosene and cVA therefore regulate aggression in a hierarchical manner. Furthermore, the increased courtship caused by depletion of male cuticular hydrocarbons was suppressed by a mutation in the olfactory receptor Or47b. Thus, male social behaviors are controlled by gustatory pheromones that promote aggression and suppress courtship, and whose influences are dominant to olfactory pheromones that enhance these behaviors.	[Wang, Liming; Han, Xiaoqing; Anderson, David J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Han, Xiaoqing; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mehren, Jennifer] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; [Hiroi, Makoto] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Billeter, Jean-Christophe; Levine, Joel D.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Miyamoto, Tetsuya; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Berkeley; University of Toronto; University Toronto Mississauga; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, LM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	lmwang@caltech.edu; wuwei@caltech.edu	Amrein, Hubert/AAG-9480-2021; Wang, Liming/C-8402-2011; Billeter, Jean-Christophe/G-5399-2012; Hiroi, Makoto/B-6834-2008; han, xiao/HDN-9782-2022	Amrein, Hubert/0000-0001-8799-7250; Hiroi, Makoto/0000-0002-0136-5891; Billeter, Jean-Christophe/0000-0001-7796-4068	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005606, R01DC009014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031389] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [R01 DA031389] Funding Source: Medline; NIDCD NIH HHS [R01 DC005606, R01 DC009014] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; DAVIS TL, 1989, SYNTHESIS-STUTTGART, P936, DOI 10.1055/s-1989-27435; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Issa FA, 2006, CURR BIOL, V16, P2217, DOI 10.1016/j.cub.2006.08.065; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WENKERT E, 1985, J ORG CHEM, V50, P719, DOI 10.1021/jo00205a042; Wolff Nancy, 2009, J Correct Health Care, V15, P58, DOI 10.1177/1078345808326622; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	50	139	141	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					757	U392		10.1038/nn.2800	http://dx.doi.org/10.1038/nn.2800			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516101	Green Accepted			2022-12-24	WOS:000290958000019
J	Esteve, P; Sandonis, A; Cardozo, M; Malapeira, J; Ibanez, C; Crespo, I; Marcos, S; Gonzalez-Garcia, S; Toribio, ML; Arribas, J; Shimono, A; Guerrero, I; Bovolenta, P				Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Malapeira, Jordi; Ibanez, Carmen; Crespo, Inmaculada; Marcos, Severine; Gonzalez-Garcia, Sara; Luisa Toribio, Maria; Arribas, Joaquin; Shimono, Akihiko; Guerrero, Isabel; Bovolenta, Paola			SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis	NATURE NEUROSCIENCE			English	Article							FRIZZLED-RELATED PROTEIN-2; AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE; MYOCARDIAL-INFARCTION; BETA-CATENIN; CELL-FATE; NOTCH; INHIBITORS; MOUSE; METALLOPROTEINASES	It is well established that retinal neurogenesis in mouse embryos requires the activation of Notch signaling, but is independent of the Wnt signaling pathway. We found that genetic inactivation of Sfrp1 and Sfrp2, two postulated Wnt antagonists, perturbs retinal neurogenesis. In retinas from Sfrp1(-/-); Sfrp2(-/-) embryos, Notch signaling was transiently upregulated because Sfrps bind ADAM10 metalloprotease and downregulate its activity, an important step in Notch activation. The proteolysis of other ADAM10 substrates, including APP, was consistently altered in Sfrp mutants, whereas pharmacological inhibition of ADAM10 partially rescued the Sfrp1(-/-); Sfrp2(-/-) retinal phenotype. Conversely, ectopic Sfrp1 expression in the Drosophila wing imaginal disc prevented the expression of Notch targets, and this was restored by the coexpression of Kuzbanian, the Drosophila ADAM10 homolog. Together, these data indicate that Sfrps inhibit the ADAM10 metalloprotease, which might have important implications in pathological events, including cancer and Alzheimer's disease.	[Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Ibanez, Carmen; Crespo, Inmaculada; Marcos, Severine; Gonzalez-Garcia, Sara; Luisa Toribio, Maria; Guerrero, Isabel; Bovolenta, Paola] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient CSIC, Madrid, Spain; [Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Crespo, Inmaculada; Marcos, Severine; Bovolenta, Paola] Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Esteve, Pilar; Sandonis, Africa; Cardozo, Marcos; Crespo, Inmaculada; Marcos, Severine; Bovolenta, Paola] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Malapeira, Jordi; Arribas, Joaquin] Vall dHebron Inst Oncol, Barcelona, Spain; [Malapeira, Jordi; Arribas, Joaquin] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain; [Malapeira, Jordi; Arribas, Joaquin] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Shimono, Akihiko] Natl Univ Singapore, Can Sci Inst Singapore, Singapore 117548, Singapore	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; ICREA; National University of Singapore	Esteve, P (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient CSIC, Madrid, Spain.	pesteve@cbm.uam.es; pbovolenta@cbm.uam.es	Arribas, Joaquin/M-4482-2014; González-García, Sara/Y-9913-2019; Crespo, Inmaculada/AAB-5451-2019; Guerrero, Isabel/K-2518-2014; Toribio, Maria L/C-2039-2017; Malapeira, Jordi/I-7956-2014	Arribas, Joaquin/0000-0002-0504-0664; González-García, Sara/0000-0002-0315-2136; Crespo, Inmaculada/0000-0003-3086-9762; Guerrero, Isabel/0000-0001-6761-1218; Toribio, Maria L/0000-0002-8637-0373; Cardozo, Marcos J/0000-0003-2246-2946; Malapeira, Jordi/0000-0003-3503-1272	Spanish MICINN [BFU2007-61774]; Fundacion Mutual Madrilena [2006-0916]; Comunidad Autonoma de Madrid [P-SAL-0190-2006]; CSIC; Spanish Ministerio de Ciencia e Innovacion [BFU2008-03320/BMC, CSD2007-00008]; Fundacion Areces; CIBERER; ICREA Funding Source: Custom	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutual Madrilena; Comunidad Autonoma de Madrid(Comunidad de Madrid); CSIC; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Areces; CIBERER; ICREA(ICREA)	We thank J.M. Ruiz for help with initial experiments and I. Dompablo for technical assistance, H. Bellen (Jan and Dan Duncan Neurological Research Institute), T. Tabata (University of Tokyo), S. Campuzano (CSIC-Universidad Autonoma de Madrid) and the Developmental Studies Hybridoma Bank for Drosophila antibodies and stocks, and A. Ludwig (RWTH Aachen University) for the G1254023X compound. This work was supported by grants from the Spanish MICINN (BFU2007-61774), Fundacion Mutual Madrilena (2006-0916), Comunidad Autonoma de Madrid (P-SAL-0190-2006), Programa Intramural Especial-CSIC and CIBERER intramural funds to P. B.; CSIC intramural funds to P. E.; grants BFU2008-03320/BMC and CSD2007-00008 from the Spanish Ministerio de Ciencia e Innovacion to I. G. and an institutional grant from Fundacion Areces given to the Centro de Biologia Molecular "Severo Ochoa" to I.G. and M.L.T.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Esteve P, 2006, CURR OPIN NEUROBIOL, V16, P13, DOI 10.1016/j.conb.2006.01.001; Fu XY, 2006, DEV BIOL, V299, P424, DOI 10.1016/j.ydbio.2006.08.015; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Langton KP, 1998, J BIOL CHEM, V273, P16778, DOI 10.1074/jbc.273.27.16778; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Misra K, 2010, DEV BIOL, V337, P74, DOI 10.1016/j.ydbio.2009.10.015; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155	50	68	69	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					562	U43		10.1038/nn.2794	http://dx.doi.org/10.1038/nn.2794			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478884				2022-12-24	WOS:000289886600011
J	Kakegawa, W; Miyoshi, Y; Hamase, K; Matsuda, S; Matsuda, K; Kohda, K; Emi, K; Motohashi, J; Konno, R; Zaitsu, K; Yuzaki, M				Kakegawa, Wataru; Miyoshi, Yurika; Hamase, Kenji; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Konno, Ryuichi; Zaitsu, Kiyoshi; Yuzaki, Michisuke			D-Serine regulates cerebellar LTD and motor coordination through the delta 2 glutamate receptor	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; D-ASPARTATE RECEPTORS; AMINO-ACID OXIDASE; SYNAPTIC PLASTICITY; IN-VIVO; MAMMALIAN BRAIN; GRANULE CELLS; RAT-BRAIN; RACEMASE; GLIA	D-Serine (D-Ser) is an endogenous co-agonist for NMDA receptors and regulates neurotransmission and synaptic plasticity in the forebrain. D-Ser is also found in the cerebellum during the early postnatal period. Although D-Ser binds to the delta 2 glutamate receptor (GluD2, Grid2) in vitro, its physiological significance has remained unclear. Here we show that D-Ser serves as an endogenous ligand for GluD2 to regulate long-term depression (LTD) at synapses between parallel fibers and Purkinje cells in the immature cerebellum. D-Ser was released mainly from Bergmann glia after the burst stimulation of parallel fibers in immature, but not mature, cerebellum. D-Ser rapidly induced endocytosis of AMPA receptors and mutually occluded LTD in wild-type, but not Grid2-null, Purkinje cells. Moreover, mice expressing mutant GluD2 in which the binding site for D-Ser was disrupted showed impaired LTD and motor dyscoordination during development. These results indicate that glial D-Ser regulates synaptic plasticity and cerebellar functions by interacting with GluD2.	[Kakegawa, Wataru; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Kakegawa, Wataru; Matsuda, Shinji; Matsuda, Keiko; Kohda, Kazuhisa; Emi, Kyoichi; Motohashi, Junko; Yuzaki, Michisuke] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Miyoshi, Yurika; Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 812, Japan; [Konno, Ryuichi] Int Univ Hlth & Welf Grad Sch, Ctr Med Sci, Ohtawara, Tochigi, Japan	Keio University; Japan Science & Technology Agency (JST); Kyushu University; International University of Health & Welfare	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan.	myuzaki@a5.keio.jp	Matsuda, Shinji/L-4727-2013; Kakegawa, Wataru/L-4900-2013; Kakegawa, Wataru/G-5569-2016; Kohda, Kazuhisa/L-4731-2013; Yuzaki, Michisuke/K-5328-2013; Matsuda, Shinji/GRR-5226-2022; Matsuda, Keiko/L-5778-2013	Yuzaki, Michisuke/0000-0002-5750-3544; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Science and Technology Agency; Keio Gijuku Academic Development Funds; Research Grants for Life Science and Medicine; Naito Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Keio Gijuku Academic Development Funds; Research Grants for Life Science and Medicine; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	We appreciate Shiseido Co., Ltd. for their technical support concerning the 2D-HPLC analysis of D-Ser. We thank M. Watanabe for the antibodies to GluD2 and 3-PGDH, S. Nakanishi for the GFP-TeNT cDNA, M. Mishina for the Grid2-null mouse, and T. Takahashi, S. Jitsuki and T. Nishikawa for comments. This work was supported by a Grant-in-Aid for the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.Y. and W. K.), Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency (M.Y.), Keio Gijuku Academic Development Funds (W. K.), the Keio University Medical Science Fund, Research Grants for Life Science and Medicine (W. K.), the Naito Foundation Subsidy for Promotion of Specific Research Projects (W. K.) and the Takeda Science Foundation (M.Y.).	Billard JM, 2008, J CELL MOL MED, V12, P1872, DOI 10.1111/j.1582-4934.2008.00315.x; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Hansen KB, 2009, J NEUROSCI, V29, P907, DOI 10.1523/JNEUROSCI.4081-08.2009; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HASHIMOTO A, 1995, NEUROSCIENCE, V66, P635, DOI 10.1016/0306-4522(94)00597-X; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hirai H, 2005, EMBO REP, V6, P90, DOI 10.1038/sj.embor.7400312; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Jurado S, 2003, J CELL SCI, V116, P3165, DOI 10.1242/jcs.00620; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Kakegawa W, 2007, J PHYSIOL-LONDON, V584, P89, DOI 10.1113/jphysiol.2007.141291; Kakegawa W, 2009, J NEUROSCI, V29, P5738, DOI 10.1523/JNEUROSCI.6013-08.2009; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lehre KP, 2002, BIOPHYS J, V83, P125, DOI 10.1016/S0006-3495(02)75154-0; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyoshi Y, 2009, J CHROMATOGR B, V877, P2506, DOI 10.1016/j.jchromb.2009.06.028; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Oliet SHR, 2009, NEUROSCIENCE, V158, P275, DOI 10.1016/j.neuroscience.2008.01.071; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Tregnago M, 1998, BRAIN RES, V793, P54, DOI 10.1016/S0006-8993(98)00161-9; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; Wang W, 1998, DEV BRAIN RES, V111, P65, DOI 10.1016/S0165-3806(98)00123-0; Williams SM, 2006, GLIA, V53, P401, DOI 10.1002/glia.20300; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Yuzaki M, 2009, NEUROSCIENCE, V162, P633, DOI 10.1016/j.neuroscience.2008.12.002; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	45	120	121	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					603	U93		10.1038/nn.2791	http://dx.doi.org/10.1038/nn.2791			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460832				2022-12-24	WOS:000289886600016
J	Goessling, W; Allen, RS; Guan, X; Jin, P; Uchida, N; Dovey, M; Harris, JM; Metzger, ME; Bonifacino, AC; Stroncek, D; Stegner, J; Armant, M; Schlaeger, T; Tisdale, JF; Zon, LI; Donahue, RE; North, TE				Goessling, Wolfram; Allen, Robyn S.; Guan, Xiao; Jin, Ping; Uchida, Naoya; Dovey, Michael; Harris, James M.; Metzger, Mark E.; Bonifacino, Aylin C.; Stroncek, David; Stegner, Joseph; Armant, Myriam; Schlaeger, Thorsten; Tisdale, John F.; Zon, Leonard I.; Donahue, Robert E.; North, Trista E.			Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models	CELL STEM CELL			English	Article							BONE-MARROW; PROGENITOR CELLS; EXPANSION; MOBILIZATION; REPOPULATION; ENGRAFTMENT; RECEPTOR; DONORS	Hematopoietic stem cells (HSCs) are used in transplantation therapy to reconstitute the hematopoietic system. Human cord blood (hCB) transplantation has emerged as an attractive alternative treatment option when traditional HSC sources are unavailable; however, the absolute number of hCB HSCE.; transplanted is significantly lower than bone marrow or mobilized peripheral blood stem cells (MPBSCs). We previously demonstrated that dimethyl-prostaglandin E2 (dmPGE2), increased HSCs in vertebrate models. Here, we describe preclinical analyses of the therapeutic potential of dmPGE2 treatment by using human and nonhuman primate HSCs. dmPGE2 significantly increased total human hematopoietic colony formation in vitro and enhanced engraftment of unfractionated and CD34(+) hCB after xenotransplantation. In nonhuman primate autologous transplantation, dmPGE2-treated CD34(+) MPBSCs showed stable multilineage engraftment over 1 year postinfusion. Together, our analyses indicated that dmPGE2 mediates conserved responses in HSCs from human and nonhuman primates and provided sufficient preclinical information to support proceeding to an FDA-approved phase 1 clinical trial.	[Goessling, Wolfram; Zon, Leonard I.; North, Trista E.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Goessling, Wolfram; Zon, Leonard I.; North, Trista E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Div Genet, Boston, MA 02115 USA; [Goessling, Wolfram] Brigham & Womens Hosp, Dana Farber Canc Inst, Gastrointestinal Canc Ctr, Div Gastroenterol, Boston, MA 02115 USA; [Allen, Robyn S.; Metzger, Mark E.; Bonifacino, Aylin C.; Donahue, Robert E.] NHLBI, Hematol Branch, NIH, Rockville, MD 20850 USA; [Guan, Xiao; Schlaeger, Thorsten; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Jin, Ping; Stroncek, David] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Uchida, Naoya; Tisdale, John F.] NIDDK, Mol & Clin Hematol Branch, NHLBI, NIH, Bethesda, MD 20892 USA; [Dovey, Michael; Harris, James M.; North, Trista E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Stegner, Joseph; Armant, Myriam] Immune Dis Inst, Ctr Human Cell Therapy, Boston, MA 02115 USA; [Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute	North, TE (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	tnorth@bidmc.harvard.edu	Guan, Xiao/D-5656-2013; North, Trista/ABG-4789-2020	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569; Harris, James/0000-0002-8995-8324; Schlaeger, Thorsten/0000-0002-1599-9908	Harvard Stern Cell Institute; NIH NIDDK; Howard Hughes Medical Institute; National Institutes of Health, NHLBI; NIDDK; Department of Transfusion Medicine at the NIH Clinical Center; FATE Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006008, ZICHL002338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080226] Funding Source: NIH RePORTER	Harvard Stern Cell Institute; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Transfusion Medicine at the NIH Clinical Center; FATE Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The HMS researchers thank J. Trowbridge, C. Walkley, G.O. Daley J. Ritz, L. Silberstein, G. Kao, J. Antin, R. Soiffer, K. Ballen, C. Cutler, and the members of the Center for Human Cell Therapy at Harvard Medical School, Dana-Farber Cancer Institute for helpful discussions and guidance on the clinical application of dmPGE2 and the FDA application process. We are grateful to the Carolinas Cord Blood Bank for providing us with discarded cord blood units. The NIH researchers thank K. Keyvanfar for cell-sorting assistance, Y. Tian for assisting with the processing of the microarray data, and the veterinary and animal care staff at 5 Research Court and Poolesville for maintaining the nonhuman primates used in this study. This research was supported by the Harvard Stern Cell Institute (VV.G., LIZ., T.E.N.), NIH NIDDK (W.G., LIZ., TEN.), Howard Hughes Medical Institute (LIZ.), the Intramural Research Program of the National Institutes of Health, NHLBI, and/or NIDDK (R.S.A., N.U., M.E.M., A.C.B., J.F.T., RED.), and the Department of Transfusion Medicine at the NIH Clinical Center (P.J., D.S.). T.E.N. and W.G. receive patent royalties and consulting fees from FATE Therapeutics; L.I.Z. is a scientific founder and stockholder of and receives patent royalties from FATE Therapeutics, which is currently testing the use of prostaglandin E2 to enhance the efficacy of hCB transplants in an independently conducted phase I clinical trial.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P838, DOI 10.1016/j.bbmt.2007.03.007; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P82, DOI 10.1016/j.bbmt.2006.08.041; Ballen KK, 2002, TRANSFUSION, V42, P1279, DOI 10.1046/j.1537-2995.2002.00191.x; Ballinger MN, 2006, J IMMUNOL, V177, P5499, DOI 10.4049/jimmunol.177.8.5499; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Broxmeyer HE, 2009, BONE MARROW TRANSPL, V44, P627, DOI 10.1038/bmt.2009.285; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dichtel-Danjoy ML, 2009, DEVELOPMENT, V136, P761, DOI 10.1242/dev.032854; Donahue Robert E, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22a01s69; Durand C, 2007, P NATL ACAD SCI USA, V104, P20838, DOI 10.1073/pnas.0706923105; Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Laver JH, 2001, BIOL BLOOD MARROW TR, V7, P45, DOI 10.1053/bbmt.2001.v7.pm11215698; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li PL, 2010, CELL STEM CELL, V6, P199, DOI 10.1016/j.stem.2010.02.007; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Rocha V, 2010, BIOL BLOOD MARROW TR, V16, pS126, DOI 10.1016/j.bbmt.2009.11.001; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trobridge GD, 2010, GENE THER, V17, P939, DOI 10.1038/gt.2010.47; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Uchida N, 2009, J VIROL, V83, P9854, DOI 10.1128/JVI.00357-09; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	32	204	230	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					445	458		10.1016/j.stem.2011.02.003	http://dx.doi.org/10.1016/j.stem.2011.02.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474107	Green Accepted, Bronze			2022-12-24	WOS:000289707100016
J	Chua, HF; Ho, SS; Jasinska, AJ; Polk, TA; Welsh, RC; Liberzon, I; Strecher, VJ				Chua, Hannah Faye; Ho, S. Shaun; Jasinska, Agnes J.; Polk, Thad A.; Welsh, Robert C.; Liberzon, Israel; Strecher, Victor J.			Self-related neural response to tailored smoking-cessation messages predicts quitting	NATURE NEUROSCIENCE			English	Article							METAANALYSIS; EDUCATION; BRAIN	Tailored health interventions can be more effective in eliciting positive behavior change than generic interventions, but the underlying neural mechanisms are not yet understood. Here, 91 smokers participated in a functional magnetic resonance imaging session and a tailored smoking-cessation program. We found that increases in activation in self-related processing regions, particularly dorsomedial prefrontal cortex, to tailored messages predicted quitting during a 4-month follow-up.	[Chua, Hannah Faye; Jasinska, Agnes J.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chua, HF (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA.	hchua@umich.edu	Welsh, Robert/ABH-3526-2021	Ho, Shao-Hsuan/0000-0003-2617-1628; Liberzon, Israel/0000-0002-4990-556X	National Institute of Drug Abuse [R21-DA024429-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024429] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Drug Abuse grant R21DA024429-01 to H.F.C. and V.J.S.	Brug J, 1999, PATIENT EDUC COUNS, V36, P145, DOI 10.1016/S0738-3991(98)00131-1; Chua HF, 2009, BIOL PSYCHIAT, V65, P165, DOI 10.1016/j.biopsych.2008.08.030; Dijkstra A, 2005, HEALTH EDUC RES, V20, P527, DOI 10.1093/her/cyh014; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Schmitz TW, 2006, NEUROIMAGE, V30, P1050, DOI 10.1016/j.neuroimage.2005.10.030; Strecher V, 2007, ANNU REV CLIN PSYCHO, V3, P53, DOI 10.1146/annurev.clinpsy.3.022806.091428; Strecher VJ, 2008, AM J PREV MED, V34, P373, DOI 10.1016/j.amepre.2007.12.024; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Velicer WF, 2004, ADDICT BEHAV, V29, P51, DOI 10.1016/S0306-4603(03)00084-4	12	126	126	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					426	427		10.1038/nn.2761	http://dx.doi.org/10.1038/nn.2761			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	741FQ	21358641	Green Accepted			2022-12-24	WOS:000288849400012
J	Wang, P; Rodriguez, RT; Wang, J; Ghodasara, A; Kim, SK				Wang, Pei; Rodriguez, Ryan T.; Wang, Jing; Ghodasara, Amar; Kim, Seung K.			Targeting SOX17 in Human Embryonic Stem Cells Creates Unique Strategies for Isolating and Analyzing Developing Endoderm	CELL STEM CELL			English	Article							BLOOD-GROUP PROTEIN; TRANSCRIPTION FACTOR; DEFINITIVE ENDODERM; VISCERAL ENDODERM; PROGENITOR CELLS; IN-VIVO; DIFFERENTIATION; EXPRESSION; MOUSE; PANCREAS	Human embryonic stem cells (hESCs) can provide insights into development of inaccessible human tissues such as embryonic endoderm. Progress in this area has been hindered by a lack of methods for isolating endodermal cells and tracing fates of their differentiated progeny. By using homologous recombination in human ESCs, we inserted an enhanced green fluorescent protein (eGFP) transgene into the SOX17 locus, a postulated marker of human endoderm. FACS purification and gene expression profiling confirmed that SOX17(+)-hESC progeny expressed endodermal markers and unveiled specific cell surface protein combinations that permitted FACS-based isolation of primitive gut tube endodermal cells produced from unmodified human ESCs and from induced pluripotent stem cells (iPSC). Differentiating SOX17(+) endodermal cells expressed markers of liver, pancreas, and intestinal epithelium in vitro and gave rise to endodermal progeny in vivo. Thus, prospective isolation, lineage tracing, and developmental studies of SOX17(+) hESC progeny have revealed fundamental aspects of human endodermal biology.	[Wang, Pei; Rodriguez, Ryan T.; Wang, Jing; Ghodasara, Amar; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu		Wang, Pei/0000-0003-2373-7315; Kim, Seung/0000-0001-6135-7810	Larry L. Hillblom Foundation (LLHF); Mead Foundation; Harry and Leona Helmsley Trust; California Institute of Regenerative Medicine; Howard Hughes Medical Institute (HHMI)	Larry L. Hillblom Foundation (LLHF); Mead Foundation; Harry and Leona Helmsley Trust; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	We thank Drs. R. Ardehali, R. Nusse, T. Blauwkamp, T. Zwaka, J. Thomson, R. Reijo Pera, N. Nguyen, N. Byers, E. Chiao, J. Baker, H. Edlund, H. Vogel, D. Wong, H. Chang, the Birth Defects Research Laboratory at the University of Washington, and members of the S.K.K. group for materials, advice, and assistance. P.W. was supported by a Larry L. Hillblom Foundation (LLHF) fellowship. The S.K.K. group was supported by the Mead Foundation, Harry and Leona Helmsley Trust, LLHF, California Institute of Regenerative Medicine, and the Howard Hughes Medical Institute (HHMI). S.K.K. is an Investigator of the HHMI. P.W. and S.K.K. conceived the project and designed the experiments; P.W., R.T.R., J.W., and A.G. performed the experiments; P.W. and R.T.R. performed the data analysis; and P.W., R.T.R., and S.K.K. wrote the manuscript.	ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; ARGRAVES WS, 1986, J BIOL CHEM, V261, P2922; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chiao E, 2008, METHOD CELL BIOL, V86, P1, DOI 10.1016/S0091-679X(08)00001-0; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davis RP, 2008, NAT PROTOC, V3, P1550, DOI 10.1038/nprot.2008.146; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Engert S, 2009, GENESIS, V47, P603, DOI 10.1002/dvg.20540; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Hou J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-92; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Matveyenko AV, 2010, AM J PHYSIOL-ENDOC M, V299, pE713, DOI 10.1152/ajpendo.00279.2010; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Russo D, 2000, BLOOD, V96, P340, DOI 10.1182/blood.V96.1.340.013k45_340_346; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Schriebil K, 2010, BIOTECHNOL J, V5, P50, DOI 10.1002/biot.200900115; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shivdasani RA, 2002, DEV BIOL, V249, P191, DOI 10.1006/dbio.2002.0765; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zeng XM, 2008, CURR OPIN MOL THER, V10, P207; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	43	90	94	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					335	346		10.1016/j.stem.2011.01.017	http://dx.doi.org/10.1016/j.stem.2011.01.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362573	Green Accepted, Bronze			2022-12-24	WOS:000288404400015
J	Lafourcade, M; Larrieu, T; Mato, S; Duffaud, A; Sepers, M; Matias, I; De Smedt-Peyrusse, V; Labrousse, VF; Bretillon, L; Matute, C; Rodriguez-Puertas, R; Laye, S; Manzoni, OJ				Lafourcade, Mathieu; Larrieu, Thomas; Mato, Susana; Duffaud, Anais; Sepers, Marja; Matias, Isabelle; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Bretillon, Lionel; Matute, Carlos; Rodriguez-Puertas, Rafael; Laye, Sophie; Manzoni, Olivier J.			Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions	NATURE NEUROSCIENCE			English	Article							POLYUNSATURATED FATTY-ACIDS; LONG-TERM DEPRESSION; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; MOOD DISORDERS; BEHAVIOR; MICE; RECEPTORS; BRAIN	The corollaries of the obesity epidemic that plagues developed societies are malnutrition and resulting biochemical imbalances. Low levels of essential n-3 polyunsaturated fatty acids (n-3 PUFAs) have been linked to neuropsychiatric diseases, but the underlying synaptic alterations are mostly unknown. We found that lifelong n-3 PUFAs dietary insufficiency specifically ablates long-term synaptic depression mediated by endocannabinoids in the prelimbic prefrontal cortex and accumbens. In n-3-deficient mice, presynaptic cannabinoid CB1 receptors (CB(1)Rs) normally responding to endocannabinoids were uncoupled from their effector G(i/o) proteins. Finally, the dietary-induced reduction of CB1R functions in mood-controlling structures was associated with impaired emotional behavior. These findings identify a plausible synaptic substrate for the behavioral alterations caused by the n-3 PUFAs deficiency that is often observed in western diets.	[Lafourcade, Mathieu; Larrieu, Thomas; Duffaud, Anais; Sepers, Marja; Matias, Isabelle; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Laye, Sophie; Manzoni, Olivier J.] INRA, CNRS, UMR 1286, UMR 5226, Bordeaux, France; [Lafourcade, Mathieu; Sepers, Marja; Matias, Isabelle; Manzoni, Olivier J.] INSERM, U862, Physiopathol Synapt Plast Grp, Neuroctr Magendie, Bordeaux, France; [Larrieu, Thomas; Duffaud, Anais; De Smedt-Peyrusse, Veronique; Labrousse, Virginie F.; Laye, Sophie] Univ Bordeaux, Bordeaux, France; [Mato, Susana; Matute, Carlos] Univ Basque Country, Dept Neurosci, Bizkaia, Spain; [Bretillon, Lionel] INRA, CGSA, UMR1324, F-21034 Dijon, France; [Rodriguez-Puertas, Rafael] Univ Basque Country, Dept Pharmacol, Bizkaia, Spain; [Manzoni, Olivier J.] INSERM, U901, F-13258 Marseille, France; [Manzoni, Olivier J.] Univ Aix Marseille 2, UMR S901, Marseille, France; [Manzoni, Olivier J.] INMED, Marseille, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Basque Country; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Laye, S (corresponding author), INRA, CNRS, UMR 1286, UMR 5226, Bordeaux, France.	sophie.laye@bordeaux.inra.fr; olivier.manzoni@inserm.fr	Laye, Sophie/AAX-2501-2020; Matute, Carlos/N-5559-2014; Rodriguez-Puertas, Rafael/A-1127-2010; Mato, Susana/AAU-3129-2020; Manzoni, Olivier/M-7899-2016; Lafourcade, Mathieu/GQZ-7267-2022	Laye, Sophie/0000-0002-3843-1012; Matute, Carlos/0000-0001-8672-711X; Rodriguez-Puertas, Rafael/0000-0003-4517-5114; Mato, Susana/0000-0002-2005-9793; Manzoni, Olivier/0000-0002-5579-6208; Sepers, Marja/0000-0002-6510-2804; Lafourcade, Mathieu/0000-0001-6117-1194; Larrieu, Thomas/0000-0003-2406-356X; Bretillon, Lionel/0000-0002-6957-100X	INSERM; Institut National de la Recherche Agronomique; Region Aquitaine; Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministry of Health [FIS 070628]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The authors thank O. Lassalle for helping with illustrations, P. Chavis and M. Darnaudery for helpful discussions, P. Birac and C. Tridon for taking care of the mice and S. Gregoire for technical help. This work was supported by INSERM (O.J.M.), Institut National de la Recherche Agronomique (S.L.), Region Aquitaine (O.J.M. and S.L.), Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED) and the Spanish Ministry of Health (FIS 070628, ISCIII, C.M.M., R.R.P. and S.M.).	Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Bourre JM, 2005, J NUTR HEALTH AGING, V9, P31; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Haller J, 2004, EUR J NEUROSCI, V19, P1906, DOI 10.1111/j.1460-9568.2004.03293.x; Hayton SJ, 2010, J NEUROSCI, V30, P11493, DOI 10.1523/JNEUROSCI.1550-10.2010; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hill MN, 2009, TRENDS PHARMACOL SCI, V30, P484, DOI 10.1016/j.tips.2009.06.006; Jacob W, 2009, GENES BRAIN BEHAV, V8, P685, DOI 10.1111/j.1601-183X.2009.00512.x; Kauer JA, 2006, NAT NEUROSCI, V9, P593, DOI 10.1038/nn0506-593; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Leweke FM, 2008, ADDICT BIOL, V13, P264, DOI 10.1111/j.1369-1600.2008.00106.x; Liperoti R, 2009, CURR PHARM DESIGN, V15, P4165, DOI 10.2174/138161209789909683; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Mackie K, 2008, MOL CELL ENDOCRINOL, V286, pS60, DOI 10.1016/j.mce.2008.01.022; Martin BR, 2004, TRENDS PHARMACOL SCI, V25, P325, DOI 10.1016/j.tips.2004.04.005; Matias I, 2008, BBA-MOL CELL BIOL L, V1781, P52, DOI 10.1016/j.bbalip.2007.11.001; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Mato S, 2008, NEUROPHARMACOLOGY, V54, P87, DOI 10.1016/j.neuropharm.2007.04.014; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Mingam R, 2008, EUR J NEUROSCI, V28, P1877, DOI 10.1111/j.1460-9568.2008.06470.x; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; PORSOLT RD, 2001, CURR PROTOC NEUROSCI, V10; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; SAMAT A, 2008, DRUG DISCOV, V3, P187; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Steiner MA, 2008, PHARMACOGENOMICS J, V8, P196, DOI 10.1038/sj.tpj.6500466; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P1165, DOI 10.1016/j.psyneuen.2008.06.004; Uriguen L, 2004, NEUROPHARMACOLOGY, V46, P966, DOI 10.1016/j.neuropharm.2004.01.003; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5	41	225	233	3	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					345	350		10.1038/nn.2736	http://dx.doi.org/10.1038/nn.2736			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278728	Green Submitted			2022-12-24	WOS:000287650100015
J	Larsen, RS; Corlew, RJ; Henson, MA; Roberts, AC; Mishina, M; Watanabe, M; Lipton, SA; Nakanishi, N; Perez-Otano, I; Weinberg, RJ; Philpot, BD				Larsen, Rylan S.; Corlew, Rebekah J.; Henson, Maile A.; Roberts, Adam C.; Mishina, Masayoshi; Watanabe, Masahiko; Lipton, Stuart A.; Nakanishi, Nobuki; Perez-Otano, Isabel; Weinberg, Richard J.; Philpot, Benjamin D.			NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity	NATURE NEUROSCIENCE			English	Article							RECEPTOR SUBUNIT NR3A; LONG-TERM DEPRESSION; PRESYNAPTIC NMDA; SOMATOSENSORY CORTEX; VISUAL-CORTEX; TONIC FACILITATION; ENTORHINAL CORTEX; GLUTAMATE RELEASE; EXPRESSION; AUTORECEPTORS	Recent evidence suggests that presynaptic-acting NMDA receptors (preNMDARs) are important for neocortical synaptic transmission and plasticity. We found that unique properties of the NR3A subunit enable preNMDARs to enhance spontaneous and evoked glutamate release and that NR3A is required for spike timing-dependent long-term depression in the juvenile mouse visual cortex. In the mature cortex, NR2B-containing preNMDARs enhanced neurotransmission in the absence of magnesium, indicating that presynaptic NMDARs may function under depolarizing conditions throughout life. Our findings indicate that NR3A relieves preNMDARs from the dual-activation requirement of ligand-binding and depolarization; the developmental removal of NR3A limits preNMDAR functionality by restoring this associative property.	[Larsen, Rylan S.; Roberts, Adam C.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Corlew, Rebekah J.; Henson, Maile A.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Roberts, Adam C.; Weinberg, Richard J.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA; [Roberts, Adam C.; Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Lipton, Stuart A.; Nakanishi, Nobuki] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA; [Perez-Otano, Isabel] Ctr Invest Med Aplicada, Dept Neurociencias, Pamplona, Spain; [Perez-Otano, Isabel] Univ Navarra, E-31080 Pamplona, Spain; [Weinberg, Richard J.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Tokyo; Hokkaido University; Sanford Burnham Prebys Medical Discovery Institute; University of Navarra; University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	bphilpot@med.unc.edu	Weinberg, Richard/AAC-1898-2020; WATANABE, Masahiko/A-4055-2012; Watanabe, Masahiko/S-3614-2019; Perez-Otano, Isabel/S-9613-2017	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Perez-Otano, Isabel/0000-0002-7222-8202; Larsen, Rylan/0000-0002-7136-1175; Roberts, Adam/0000-0001-8596-8552; Lipton, Stuart/0000-0002-3490-1259; Weinberg, Richard/0000-0001-9689-7278; Corlew, Rebekah/0000-0001-7000-8209	National Alliance for Research on Schizophrenia and Depression; Marie Curie International Program, UTE project Centro de Investigacion Medica Aplicada; Spanish Ministry of Education and Science [SAF2006-10025, CSD2008-00005]; National Research Service Award [F31 GM080162]; University of North Carolina; National Institute of Child Health and Human Development [T32 HD40127]; NARSAD; US National Institutes of Health [RO1 NS39444]; NARSAD, NEI [R01 EY018323]; National Science Foundation [0822969, P01 HD29587, R01 EY05477, R01 EY09024]; Grants-in-Aid for Scientific Research [19100005] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587, T32HD040127] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477, R01EY018323, R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM080162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH091817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039444] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); Marie Curie International Program, UTE project Centro de Investigacion Medica Aplicada; Spanish Ministry of Education and Science(Spanish Government); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NARSAD(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)NARSAD); National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Phend and S. Burette for processing electron microscopic materials and P. McCoy and T. Riday for preparing fixed tissue for this process. We also thank J. Miriyala, J. Berrios and K. Williams for mouse colony maintenance and genotyping. We thank D. J. Brasier, T. Kash, N. Calakos and D. Corlew for early critical readings of the manuscript and R. Chitwood for technical assistance. This work was supported by National Alliance for Research on Schizophrenia and Depression, the Marie Curie International Program, UTE project Centro de Investigacion Medica Aplicada, and Spanish Ministry of Education and Science grants SAF2006-10025, CSD2008-00005 (to I.P.-O.), National Research Service Award predoctoral fellowship F31 GM080162 (to R. J. C.), a University of North Carolina dissertation completion fellowship (to M. A. H.), a National Institute of Child Health and Human Development training grant (T32 HD40127) and NARSAD Fellowships (to A. C. R.), US National Institutes of Health grant RO1 NS39444 (to R. J. W.), NARSAD, NEI R01 EY018323, and National Science Foundation grant 0822969 (to B. D. P.), and P01 HD29587, R01 EY05477 and R01 EY09024 (to S.A.L.).	Banerjee A, 2009, CEREB CORTEX, V19, P2959, DOI 10.1093/cercor/bhp067; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Brasier DJ, 2008, J NEUROSCI, V28, P2199, DOI 10.1523/JNEUROSCI.3915-07.2008; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Cheetham CEJ, 2010, J NEUROSCI, V30, P12566, DOI 10.1523/JNEUROSCI.2544-10.2010; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; Costa BM, 2009, J PHARMACOL EXP THER, V331, P618, DOI 10.1124/jpet.109.156752; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Herkert M, 1998, EUR J NEUROSCI, V10, P1553, DOI 10.1046/j.1460-9568.1998.00164.x; Karavanova I, 2007, MOL CELL NEUROSCI, V34, P468, DOI 10.1016/j.mcn.2006.12.001; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; LARSEN RS, 2010, FRONT SYNAPTIC NEURO, V2, P12; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Li YH, 2009, CURR NEUROVASC RES, V6, P104, DOI 10.2174/156720209788185632; Lin H, 2010, P NATL ACAD SCI USA, V107, P16661, DOI 10.1073/pnas.1007397107; Mameli M, 2005, J NEUROSCI, V25, P2285, DOI 10.1523/JNEUROSCI.3877-04.2005; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McGuinness L, 2010, NEURON, V68, P1109, DOI 10.1016/j.neuron.2010.11.023; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; RODRIGUEZMORENO A, 2010, FRONT SYNAPTIC NEURO, V2, P12; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Smothers CT, 2003, BRAIN RES, V987, P117, DOI 10.1016/S0006-8993(03)03315-8; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006; Yao YN, 2006, J NEUROSCI, V26, P4559, DOI 10.1523/JNEUROSCI.0560-06.2006	46	107	113	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					338	344		10.1038/nn.2750	http://dx.doi.org/10.1038/nn.2750			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297630	Green Accepted			2022-12-24	WOS:000287650100014
J	Murray, AJ; Sauer, JF; Riedel, G; McClure, C; Ansel, L; Cheyne, L; Bartos, M; Wisden, W; Wulff, P				Murray, Andrew J.; Sauer, Jonas-Frederic; Riedel, Gernot; McClure, Christina; Ansel, Laura; Cheyne, Lesley; Bartos, Marlene; Wisden, William; Wulff, Peer			Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL; SCHIZOPHRENIA; INHIBITION; BEHAVIOR; NEURONS	Parvalbumin-positive GABAergic interneurons in cortical circuits are hypothesized to control cognitive function. To test this idea directly, we functionally removed parvalbumin-positive interneurons selectively from hippocampal CA1 in mice. We found that parvalbumin-positive interneurons are dispensable for spatial reference, but are essential for spatial working memory.	[Murray, Andrew J.; Sauer, Jonas-Frederic; Riedel, Gernot; McClure, Christina; Ansel, Laura; Cheyne, Lesley; Bartos, Marlene; Wisden, William; Wulff, Peer] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Aberdeen	Wulff, P (corresponding author), Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland.	w.wisden@imperial.ac.uk; p.wulff@abdn.ac.uk	Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; McClure, Christina/0000-0002-8207-450X; Ansel Bollepalli, Laura/0000-0003-2324-7228; Bollepalli, Laura/0000-0001-5902-059X; Sauer, Jonas-Frederic/0000-0002-6854-7294; Bartos, Marlene/0000-0001-9741-1946; Wulff, Peer/0000-0002-0282-7832	Northern Research Partnership; Biotechnology and Biological Sciences Research Council [BB/H001123/1]; Royal Society; University of Aberdeen; J. Ernest Tait Estate; Lichtenberg Award; Medical Research Council [G0800401, G0601498]; BBSRC [BB/H001123/1] Funding Source: UKRI; MRC [G0601498, G0800401, G0800399] Funding Source: UKRI; Medical Research Council [G0800399] Funding Source: researchfish	Northern Research Partnership; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); University of Aberdeen; J. Ernest Tait Estate; Lichtenberg Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Klugmann and T. Kuner for AAV plasmids and technical advice, E. Fuchs and H. Monyer for Pvalb-cre mice, R. Yu for tetanus toxin light chain cDNA, D. Kuhl for the Arc/Arg3.1 cDNA, T. Goetz for bringing the FLEX system to our attention, C. Black for participation in the initial cloning of AAV vectors, P. Teismann and the microscopy core facility at the University of Aberdeen for the use of microscopy equipment, and L. Strachan, A. Plano and S. Deiana for help with surgeries and behavioral testing. We were supported by the Northern Research Partnership (J.-F.S.), Biotechnology and Biological Sciences Research Council grant BB/H001123/1 (P. W.), the Royal Society (M. B. and P. W.), the University of Aberdeen (M. B., W. W. and P. W.), the J. Ernest Tait Estate (W. W.), the Lichtenberg Award (M. B.) and Medical Research Council grants G0800401 (G.R.) and G0601498 (W.W. and P.W.).	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Glickfeld LL, 2008, J NEUROSCI, V28, P1824, DOI 10.1523/JNEUROSCI.4700-07.2008; Hampson RE, 1999, J NEUROSCI, V19, P1492; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Morris BJ, 2005, CURR OPIN PHARMACOL, V5, P101, DOI 10.1016/j.coph.2004.08.008; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Zhang ZJ, 2002, SCHIZOPHR RES, V55, P1, DOI 10.1016/S0920-9964(01)00188-8	15	199	202	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					297	299		10.1038/nn.2751	http://dx.doi.org/10.1038/nn.2751			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278730	Green Accepted, Green Submitted			2022-12-24	WOS:000287650100008
J	Fu, AKY; Hung, KW; Fu, WY; Shen, C; Chen, Y; Xia, J; Lai, KO; Ip, NY				Fu, Amy K. Y.; Hung, Kwok-Wang; Fu, Wing-Yu; Shen, Chong; Chen, Yu; Xia, Jun; Lai, Kwok-On; Ip, Nancy Y.			APC(Cdh1) mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE MORPHOGENESIS; UBIQUITIN-PROTEASOME SYSTEM; ANAPHASE-PROMOTING COMPLEX; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; PROTEIN-DEGRADATION; EXPRESSION; MODULATION; TRAFFICKING	Homeostatic plasticity is crucial for maintaining neuronal output by counteracting unrestrained changes in synaptic strength. Chronic elevation of synaptic activity by bicuculline reduces the amplitude of miniature excitatory postsynaptic currents (mEPSCs), but the underlying mechanisms of this effect remain unclear. We found that activation of EphA4 resulted in a decrease in synaptic and surface GluR1 and attenuated mEPSC amplitude through a degradation pathway that requires the ubiquitin proteasome system (UPS). Elevated synaptic activity resulted in increased tyrosine phosphorylation of EphA4, which associated with the ubiquitin ligase anaphase-promoting complex (APC) and its activator Cdh1 in neurons in a ligand-dependent manner. APC(Cdh1) interacted with and targeted GluR1 for proteasomal degradation in vitro, whereas depletion of Cdh1 in neurons abolished the EphA4-dependent downregulation of GluR1. Knockdown of EphA4 or Cdh1 prevented the reduction in mEPSC amplitude in neurons that was a result of chronic elevated activity. Our results define a mechanism by which EphA4 regulates homeostatic plasticity through an APC(Cdh1)-dependent degradation pathway.	[Fu, Amy K. Y.; Hung, Kwok-Wang; Fu, Wing-Yu; Shen, Chong; Chen, Yu; Xia, Jun; Lai, Kwok-On; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Ctr Neurosci, State Key Lab Mol Neurosci & Mol, Dept Biochem, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Ctr Neurosci, State Key Lab Mol Neurosci & Mol, Dept Biochem, Hong Kong, Peoples R China.	boip@ust.hk	Lai, Kwok On/ABC-8046-2021; Lai, Kwok-On/E-5182-2011; Lai, Kwok-On/L-7468-2019; shen, chong/J-7256-2015; Xia, Jun/C-7234-2009	Lai, Kwok-On/0000-0002-4069-054X; shen, chong/0000-0002-6222-4304; Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Xia, Jun/0000-0001-9308-2188	Research Grants Council of Hong Kong SAR (HKUST) [6444/06M, 661007, 661109, 1/06C, 6/CRF/08]; Area of Excellence Scheme of the University Grants Committee [AoE/B-15/01]; Hong Kong Jockey Club; Croucher Foundation	Research Grants Council of Hong Kong SAR (HKUST)(Hong Kong Research Grants Council); Area of Excellence Scheme of the University Grants Committee; Hong Kong Jockey Club; Croucher Foundation	We thank P. Bartlett for EphA4<SUP>-/-</SUP> mice, R. Huganir for GluR1 antibodies and the GluR1 4KR mutant expression construct, R. Malinow for the GluR1-GFP construct, J. Chamberlain for the mouse muscle cDNA library, L. Shi, W. Chau, K. Kong, X.-N. Li, W. Fang, E. Cheung, B. Butt and C. Kwong for technical assistance, and members of the Ip laboratory for discussions. This study was supported in part by the Research Grants Council of Hong Kong SAR (HKUST, 6444/06M, 661007, 661109, 1/06C and 6/CRF/08), the Area of Excellence Scheme of the University Grants Committee (AoE/B-15/01) and the Hong Kong Jockey Club. N.Y. Ip and K.-O. Lai were recipients of the Croucher Foundation Senior Research Fellowship and Croucher Foundation Fellowship, respectively.	Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Helton TD, 2008, P NATL ACAD SCI USA, V105, P19492, DOI 10.1073/pnas.0802280105; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Matyskiela Mary E., 2009, Journal of Biology (London), V8, P92, DOI 10.1186/jbiol184; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	50	127	128	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					181	U263		10.1038/nn.2715	http://dx.doi.org/10.1038/nn.2715			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186356				2022-12-24	WOS:000286595400015
J	Sanchez-Alcaniz, JA; Haege, S; Mueller, W; Pla, R; Mackay, F; Schulz, S; Lopez-Bendito, G; Stumm, R; Marin, O				Antonio Sanchez-Alcaniz, Juan; Haege, Sammy; Mueller, Wiebke; Pla, Ramon; Mackay, Fabienne; Schulz, Stefan; Lopez-Bendito, Guillermina; Stumm, Ralf; Marin, Oscar			Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CAJAL-RETZIUS CELLS; CORTICAL INTERNEURONS; TANGENTIAL MIGRATION; GANGLIONIC EMINENCE; RECEPTOR CXCR4; LIGAND; SDF-1; ACTIVATION; EXPRESSION	The chemokine Cxcl12 binds Cxcr4 and Cxcr7 receptors to control cell migration in multiple biological contexts, including brain development, leukocyte trafficking, and tumorigenesis. Both receptors are expressed in the CNS, but how they cooperate during migration has not been elucidated. Here, we used the migration of cortical interneurons as a model to study this process. We found that Cxcr4 and Cxcr7 are coexpressed in migrating interneurons, and that Cxcr7 is essential for chemokine signaling. Intriguingly, this process does not exclusively involve Cxcr7, but most critically the modulation of Cxcr4 function. Thus, Cxcr7 is necessary to regulate Cxcr4 protein levels, thereby adapting chemokine responsiveness in migrating cells. This demonstrates that a chemokine receptor modulates the function of another chemokine receptor by controlling the amount of protein that is made available for signaling at the cell surface.	[Haege, Sammy; Mueller, Wiebke; Schulz, Stefan; Stumm, Ralf] Univ Jena, Dept Pharmacol & Toxicol, D-07743 Jena, Germany; [Haege, Sammy; Stumm, Ralf] Otto Von Guericke Univ, Ctr Behav Brain Sci, D-39120 Magdeburg, Germany; [Antonio Sanchez-Alcaniz, Juan; Pla, Ramon; Lopez-Bendito, Guillermina; Marin, Oscar] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Antonio Sanchez-Alcaniz, Juan; Pla, Ramon; Lopez-Bendito, Guillermina; Marin, Oscar] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain; [Mackay, Fabienne] Monash Univ, Alfred Hosp, Dept Immunol, Melbourne, Vic 3004, Australia	Friedrich Schiller University of Jena; Otto von Guericke University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Florey Institute of Neuroscience & Mental Health; Monash University	Stumm, R (corresponding author), Univ Jena, Dept Pharmacol & Toxicol, D-07743 Jena, Germany.	ralf.stumm@med.uni-jena.de; o.marin@umh.es	Ferriz, Ramon Pla/ABF-5635-2020; Schulz, Stefan/A-6928-2017; Mackay, Fabienne/B-7440-2008; Marin, Oscar/F-3856-2012; Pla, Ramon/AAA-9243-2020; Sanchez-Alcaniz, Juan A/U-2285-2018; Lopez-Bendito, Guillermina/E-4028-2014; Sanchez-Alcaniz, Juan Antonio/A-8173-2017	Schulz, Stefan/0000-0002-5997-8885; Mackay, Fabienne/0000-0002-6074-2693; Marin, Oscar/0000-0001-6264-7027; Pla, Ramon/0000-0003-4115-149X; Lopez-Bendito, Guillermina/0000-0002-8965-6836; Sanchez-Alcaniz, Juan Antonio/0000-0002-4900-5086	Spanish Ministry of Science and Innovation (MICINN) [SAF2008-00770]; CONSOLIDER [CSD2007-00023]; EURYI; Federal State Sachsen-Anhalt; European Fund For Regional Development [EFRE 2007-2013]; Deutsche Forschungsgemeinschaft (DFG) [STU295/5-1]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EURYI(European Science Foundation (ESF)); Federal State Sachsen-Anhalt; European Fund For Regional Development(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank A. Casillas, T. Gil, M. Perez, K. Schafer, A. Sorgenfrei, and H. Stadler for technical assistance; K. Campbell (Dlx5/6-Cre-IRES-Gfp) and N. Kesaris (Lhx6-Cre) for mouse strains; E. Arenas, F. Arenzana-Seisdedos, F. Guillemot, M. Penfold, M. Thelen, and V. Pachnis for plasmids and reagents; and V. Borrell for critically reading early versions of this paper. We are also thankful to members of the Mann, Rico, and Borrell labs for helpful discussions and comments. J.A.S-A. was supported by a fellowship from the FPU program of the Spanish Ministry of Science and Innovation (MICINN). This work was supported by grants from Spanish MICINN SAF2008-00770 and CONSOLIDER CSD2007-00023, and the EURYI scheme award (see www.esf.org/euryi) (to O.M), and by Federal State Sachsen-Anhalt with the European Fund For Regional Development (EFRE 2007-2013) and Deutsche Forschungsgemeinschaft (DFG) grant STU295/5-1 (to R.S).	Bagri A, 2002, DEVELOPMENT, V129, P4249; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cubedo N, 2009, MOL CELL NEUROSCI, V40, P474, DOI 10.1016/j.mcn.2009.01.003; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Kolodziej A, 2008, J NEUROSCI, V28, P4488, DOI 10.1523/JNEUROSCI.4721-07.2008; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; LUKER KE, 2010, ONCOGENE IN PRESS; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Sasado T, 2008, DEV BIOL, V320, P328, DOI 10.1016/j.ydbio.2008.05.544; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stenman J, 2003, J NEUROSCI, V23, P167; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Stumm RK, 2003, J NEUROSCI, V23, P5123; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zhu Y, 2009, DEVELOPMENT, V136, P1919, DOI 10.1242/dev.032276; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	60	220	222	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 13	2011	69	1					77	90		10.1016/j.neuron.2010.12.006	http://dx.doi.org/10.1016/j.neuron.2010.12.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220100	Bronze			2022-12-24	WOS:000286446300009
J	Baig, SM; Koschak, A; Lieb, A; Gebhart, M; Dafinger, C; Nurnberg, G; Ali, A; Ahmad, I; Sinnegger-Brauns, MJ; Brandt, N; Engel, J; Mangoni, ME; Farooq, M; Khan, HU; Nurnberg, P; Striessnig, J; Bolz, HJ				Baig, Shahid M.; Koschak, Alexandra; Lieb, Andreas; Gebhart, Mathias; Dafinger, Claudia; Nuernberg, Gudrun; Ali, Amjad; Ahmad, Ilyas; Sinnegger-Brauns, Martina J.; Brandt, Niels; Engel, Jutta; Mangoni, Matteo E.; Farooq, Muhammad; Khan, Habib U.; Nuernberg, Peter; Striessnig, Joerg; Bolz, Hanno J.			Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness	NATURE NEUROSCIENCE			English	Article							CA2+ CHANNELS; CALCIUM-CHANNELS; POTASSIUM CHANNEL; GATING CURRENT; IONIC CURRENT; GENE; CELL; MODULATION; MUTATION; JERVELL	Deafness is genetically very heterogeneous and forms part of several syndromes. So far, delayed rectifier potassium channels have been linked to human deafness associated with prolongation of the QT interval on electrocardiograms and ventricular arrhythmia in Jervell and Lange-Nielsen syndrome. Ca(v)1.3 voltage-gated L-type calcium channels (LTCCs) translate sound-induced depolarization into neurotransmitter release in auditory hair cells and control diastolic depolarization in the mouse sinoatrial node (SAN). Human deafness has not previously been linked to defects in LTCCs. We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming alpha 1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness. All deaf subjects showed pronounced SAN dysfunction at rest. The insertion of a glycine residue in a highly conserved, alternatively spliced region near the channel pore resulted in nonconducting calcium channels that had abnormal voltage-dependent gating. We describe a human channelopathy (termed SANDD syndrome, sinoatrial node dysfunction and deafness) with a cardiac and auditory phenotype that closely resembles that of Cacna1d(-/-) mice.	[Dafinger, Claudia; Bolz, Hanno J.] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Baig, Shahid M.; Ali, Amjad; Ahmad, Ilyas; Farooq, Muhammad] Natl Inst Biotechnol & Genet Engn, Human Mol Genet Lab, Hlth Biotechnol Div, Faisalabad, Pakistan; [Koschak, Alexandra; Lieb, Andreas; Gebhart, Mathias; Sinnegger-Brauns, Martina J.; Striessnig, Joerg] Univ Innsbruck, Ctr Mol Biosci, Inst Pharm, A-6020 Innsbruck, Austria; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Inst Genet, Cologne, Germany; [Brandt, Niels; Engel, Jutta] Univ Tubingen, Inst Physiol 2, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Tubingen, Tubingen Hearing Res Ctr, Tubingen, Germany; [Brandt, Niels; Engel, Jutta] Univ Saarland, Dept Biophys, D-6650 Homburg, Germany; [Mangoni, Matteo E.] Univ Montpellier 1 & 2, CNRS, Inst Genom Fonct,Dept Physiol,UMR 5203,U661, Montpellier, France; [Khan, Habib U.] Khyber Teaching Hosp, Dept Pathol, Peshawar, Pakistan; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Bolz, Hanno J.] Bioscientia, Ctr Human Genet, Ingelheim, Germany	University of Cologne; Pakistan Institute of Engineering & Applied Science; University of Innsbruck; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Saarland University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Cologne	Bolz, HJ (corresponding author), Univ Hosp Cologne, Inst Human Genet, Cologne, Germany.	joerg.striessnig@uibk.ac.at; hanno.bolz@uk-koeln.de	Tuluc, Petronel/C-2527-2011; Mangoni, Matteo E/E-6025-2015; Baig, Shahid Mahmood/I-7309-2015; BAig, Shahid Mahmood/AAS-8365-2020; Striessnig, Joerg/S-9334-2017; Ahmad, Ilyas/AAT-6577-2021; Ali, Amjad/AAG-4441-2021	Mangoni, Matteo E/0000-0002-8892-3373; Striessnig, Joerg/0000-0002-9406-7120; Ahmad, Ilyas/0000-0003-4845-9227; Ali, Amjad/0000-0002-0486-4661; Lieb, Andreas/0000-0001-9567-649X; Brauns, Martina/0000-0002-0547-2731	Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft [BO2954/1-2]; Forschung contra Blindheit: Initiative Usher-Syndrom e.V.; Austrian Science Fund [P-20670]; Agence Nationale pour la Recherche [ANR-06-PHYSIO-004-01]; Fondation de France; Marie Curie Research Training Network CavNET [MRTN-CT-2006-035367]; University of Innsbruck; Austrian Science Fund (FWF) [P 20670] Funding Source: researchfish	Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschung contra Blindheit: Initiative Usher-Syndrom e.V.; Austrian Science Fund(Austrian Science Fund (FWF)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Marie Curie Research Training Network CavNET(European Commission); University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank the families who have participated in this study, K. Beam and W. Sandtner for discussion on gating currents, M. Thoenes, K. Zimmermann, S. Blick, G. Gajic and S. Kasperek for technical assistance, B. Ali for help with ECG recordings, K. Boss for discussion of the manuscript and C. Striessnig for artwork. This work was supported by the Geers-Stiftung, Bonn; Imhoff-Stiftung, Koln; Koln Fortune, University Hospital of Cologne, Deutsche Forschungsgemeinschaft (BO2954/1-2); Forschung contra Blindheit: Initiative Usher-Syndrom e.V. (to H.J.B.); the Austrian Science Fund (P-20670); the Agence Nationale pour la Recherche (ANR-06-PHYSIO-004-01 to M.E.M.); the Fondation de France; the Marie Curie Research Training Network CavNET (MRTN-CT-2006-035367); and the University of Innsbruck (to J.S. and A.K.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Bangalore R, 1996, AM J PHYSIOL-HEART C, V270, pH1521, DOI 10.1152/ajpheart.1996.270.5.H1521; Bitner-Glindzicz M, 2000, ADV OTO-RHINO-LARYNG, V56, P45; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Busquet P, 2010, INT J NEUROPSYCHOPH, V13, P499, DOI 10.1017/S1461145709990368; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; FUKUSHIMA K, 1995, GENOME RES, V5, P305, DOI 10.1101/gr.5.3.305; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Jones LP, 1997, J PHYSIOL-LONDON, V498, P601, DOI 10.1113/jphysiol.1997.sp021886; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; McDonough SI, 2005, BIOPHYS J, V88, P211, DOI 10.1529/biophysj.104.051714; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Striessnig J, 2010, PFLUG ARCH EUR J PHY, V460, P361, DOI 10.1007/s00424-010-0800-x; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	46	184	193	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					77	U107		10.1038/nn.2694	http://dx.doi.org/10.1038/nn.2694			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131953				2022-12-24	WOS:000285684900017
J	Huang, JK; Jarjour, AA; Nait Oumesmar, B; Kerninon, C; Williams, A; Krezel, W; Kagechika, H; Bauer, J; Zhao, C; Baron-Van Evercooren, A; Chambon, P; Ffrench-Constant, C; Franklin, RJM				Huang, Jeffrey K.; Jarjour, Andrew A.; Nait Oumesmar, Brahim; Kerninon, Christophe; Williams, Anna; Krezel, Wojciech; Kagechika, Hiroyuki; Bauer, Julien; Zhao, Chao; Baron-Van Evercooren, Anne; Chambon, Pierre; Ffrench-Constant, Charles; Franklin, Robin J. M.			Retinoid X receptor gamma signaling accelerates CNS remyelination	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; THYROID-HORMONE; SPINAL-CORD; EXPRESSION; CELLS; OLIGODENDROCYTES; DIFFERENTIATION; DEMYELINATION; DISEASE	The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-gamma were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-gamma in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-gamma by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-gamma, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-gamma is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.	[Jarjour, Andrew A.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Jarjour, Andrew A.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,Multiple Sclerosis Soc, Edinburgh, Midlothian, Scotland; [Huang, Jeffrey K.; Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, MRC Ctr Stem Cell Biol & Regenerat Med, Cambridge, England; [Huang, Jeffrey K.; Zhao, Chao; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Ctr Rech, Inst Cerveau & Moelle Epiniere, INSERM, U975, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Univ Paris 06, UMR S975, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] CNRS, UMR 7225, Paris 13, France; [Nait Oumesmar, Brahim; Kerninon, Christophe; Baron-Van Evercooren, Anne] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris 13, France; [Krezel, Wojciech; Chambon, Pierre] Inst Genet Biol Mol & Cellulaire, Dept Cell Biol & Dev, Illkirch Graffenstaden, France; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo, Japan; [Bauer, Julien] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Edinburgh; University of Edinburgh; University of Cambridge; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Tokyo Medical & Dental University (TMDU); University of Cambridge	Ffrench-Constant, C (corresponding author), Univ Edinburgh, Ctr Translat Res, Ctr Inflammat Res, Queens Med Res Inst,MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	cffc@ed.ac.uk; rjf1000@cam.ac.uk	KREZEL, Wojciech/S-8331-2019; Krezel, Wojciech/I-7886-2016; Oumesmar, Brahim Nait/E-5365-2017; Evercooren, Anne S Baron-Van/G-3632-2013; Messier, Claude/A-2322-2008; Huang, Jeffrey K./AAH-2418-2021; Krezel, Wojciech/H-9080-2017; OUMESMAR, Brahim NAIT/AAX-4135-2020; Huang, Jeffrey/J-5248-2017	Krezel, Wojciech/0000-0003-1605-3185; Oumesmar, Brahim Nait/0000-0002-1646-6281; Messier, Claude/0000-0002-4791-1763; Huang, Jeffrey K./0000-0003-0996-9451; Krezel, Wojciech/0000-0003-1605-3185; OUMESMAR, Brahim NAIT/0000-0002-1646-6281; Huang, Jeffrey/0000-0003-0996-9451; Jarjour, Andrew/0000-0002-1550-1778; Baron-Van Evercooren, Anne/0000-0002-4150-2205; Williams, Anna/0000-0002-6329-382X; Franklin, Robin/0000-0001-6522-2104; Kagechika, Hiroyuki/0000-0002-6747-1013	United Kingdom Multiple Sclerosis Society; Wellcome Trust; French Multiple Sclerosis foundation ARSEP; Biotechnology and Biological Sciences Research Council of the United Kingdom; National Multiple Sclerosis Society; AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique et des Maladies du Systeme Nerveux; Multiple Sclerosis Society of Canada; Medical Research Council [G0700711B] Funding Source: researchfish	United Kingdom Multiple Sclerosis Society; Wellcome Trust(Wellcome TrustEuropean Commission); French Multiple Sclerosis foundation ARSEP; Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique et des Maladies du Systeme Nerveux; Multiple Sclerosis Society of Canada; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Seilhean (Service d'Anatomopathologie Neurologique, G-H Pitie-Salpetriere, Paris) for classification of multiple sclerosis lesions, the French Brain Bank GIE NeuroCEB (Hopital Pitie-Salpetriere, Paris, France) and the United Kingdom Multiple Sclerosis Society Brain Bank (R. Reynolds, Imperial College, London) for multiple sclerosis tissue. All tissues were collected with the approval of the French and London Multicentre Research Ethics committees. Animal procedures were performed under a UK Home Office Project License. This work was supported by grants from the United Kingdom Multiple Sclerosis Society (R.J.M.F., C.ff.-C.), the Wellcome Trust (C.ff.-C.), the French Multiple Sclerosis foundation ARSEP (B.N.O.), the Biotechnology and Biological Sciences Research Council of the United Kingdom (C.ff.-C., J.B.), National Multiple Sclerosis Society (C.ff.-C., R.J.M.F., A.B.-V.E., B.N.O.), AP-HP Hopital Pitie-Salpetriere, Service d'Anatomopathologie Neurologique (B.N.O.) et des Maladies du Systeme Nerveux (A.B.-V.E.). A.W. holds a Wellcome Trust Intermediate Fellowship. A.A.J. holds a Fellowship from Multiple Sclerosis Society of Canada.	Almad A, 2010, J COMP NEUROL, V518, P785, DOI 10.1002/cne.22242; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Brown NS, 2000, J CLIN INVEST, V106, P73, DOI 10.1172/JCI9422; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Georgiades P, 1997, DEV DYNAM, V210, P227; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Granneman J, 1998, J NEUROSCI RES, V51, P563, DOI 10.1002/(SICI)1097-4547(19980301)51:5<563::AID-JNR3>3.0.CO;2-D; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nishimaki-Mogami T, 2008, BIOCHEM PHARMACOL, V76, P1006, DOI 10.1016/j.bcp.2008.08.005; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Pombo PMG, 1999, MOL BRAIN RES, V64, P92, DOI 10.1016/S0169-328X(98)00311-8; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; Schrage K, 2006, EUR J NEUROSCI, V23, P285, DOI 10.1111/j.1460-9568.2005.04534.x; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	40	367	394	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					45	U68		10.1038/nn.2702	http://dx.doi.org/10.1038/nn.2702			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131950	Green Accepted, Green Submitted			2022-12-24	WOS:000285684900013
J	Kikushige, Y; Shima, T; Takayanagi, S; Urata, S; Miyamoto, T; Iwasaki, H; Takenaka, K; Teshima, T; Tanaka, T; Inagaki, Y; Akashi, K				Kikushige, Yoshikane; Shima, Takahiro; Takayanagi, Shin-ichiro; Urata, Shingo; Miyamoto, Toshihiro; Iwasaki, Hiromi; Takenaka, Katsuto; Teshima, Takanori; Tanaka, Toshiyuki; Inagaki, Yoshimasa; Akashi, Koichi			TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells	CELL STEM CELL			English	Article							MONOCLONAL-ANTIBODY; INITIATING CELLS; MICE; CHAIN; PHAGOCYTOSIS; PROGENITORS; ENGRAFTMENT; ACTIVATION; AUTOIMMUNE; EXPRESSION	Acute myeloid leukemia (AML) originates from self-renewing leukemic stem cells (LSCs), an ultimate therapeutic target for AML. Here we identified T cell immunoglobulin mucin-3 (TIM-3) as a surface molecule expressed on LSCs in most types of AML except for acute promyelocytic leukemia, but not on normal hematopoietic stem cells (HSCs). TIM-3(+) but not TIM-3(-) AML cells reconstituted human AML in immunodeficient mice, suggesting that the TIM-3(+) population contains most, if not all, of functional LSCs. We established an anti-human TIM-3 mouse IgG2a antibody having complement-dependent and antibody-dependent cellular cytotoxic activities. This antibody did not harm reconstitution of normal human HSCs, but blocked engraftment of AML after xenotransplantation. Furthermore, when it is administered into mice grafted with human AML, this treatment dramatically diminished their leukemic burden and eliminated LSCs capable of reconstituting human AML in secondary recipients. These data suggest that TIM-3 is one of the promising targets to eradicate AML LSCs.	[Kikushige, Yoshikane; Shima, Takahiro; Urata, Shingo; Miyamoto, Toshihiro; Iwasaki, Hiromi; Takenaka, Katsuto; Teshima, Takanori; Akashi, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Takayanagi, Shin-ichiro; Inagaki, Yoshimasa] Kyowa Hakko Kirin Co Ltd, Innovat Drug Res Labs, Tokyo 1948538, Japan; [Tanaka, Toshiyuki] Hyogo Univ Hlth Sci, Sch Pharm, Kobe, Hyogo 6508530, Japan	Kyushu University; Kyowa Kirin Ltd	Akashi, K (corresponding author), Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan.	akashi@med.kyushu-u.ac.jp	teshima, takanori/G-1671-2012	teshima, takanori/0000-0002-0941-271X	Ministry of Education, Culture, Sports, Science and Technology in Japan; Grants-in-Aid for Scientific Research [21390295] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan. S.-i.T. and Y.I. are employees of Kyowa Hakko Kirin Co., Ltd.	Aikawa Y, 2010, NAT MED, V16, P580, DOI 10.1038/nm.2122; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Doenecke A, 1997, LEUKEMIA, V11, P1787, DOI 10.1038/sj.leu.2400781; Florian S, 2006, LEUKEMIA LYMPHOMA, V47, P207, DOI 10.1080/10428190500272507; Hauswirth AW, 2007, EUR J CLIN INVEST, V37, P73, DOI 10.1111/j.1365-2362.2007.01746.x; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; MARTELLI MP, 2010, BLOOD PRESSURE, DOI DOI 10.1182/BLOOD-2009-08-238899; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Tawara T, 2008, J IMMUNOL, V180, P2294, DOI 10.4049/jimmunol.180.4.2294; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Yalcintepe L, 2006, BLOOD, V108, P3530, DOI 10.1182/blood-2006-04-013813; Yoshimoto G, 2009, BLOOD, V114, P5034, DOI 10.1182/blood-2008-12-196055	40	288	321	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					708	717		10.1016/j.stem.2010.11.014	http://dx.doi.org/10.1016/j.stem.2010.11.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112565	Bronze			2022-12-24	WOS:000285537700012
J	Churchland, MM; Cunningham, JP; Kaufman, MT; Ryu, SI; Shenoy, KV				Churchland, Mark M.; Cunningham, John P.; Kaufman, Matthew T.; Ryu, Stephen I.; Shenoy, Krishna V.			Cortical Preparatory Activity: Representation of Movement or First Cog in a Dynamical Machine?	NEURON			English	Article							MOTOR CORTEX REFLECTS; PREMOTOR CORTEX; PRIOR INFORMATION; ARM MOVEMENTS; NEURAL VARIABILITY; NEURONAL-ACTIVITY; CELL-ACTIVITY; DIRECTION; DELAY; HAND	The motor cortices are active during both movement and movement preparation. A common assumption is that preparatory activity constitutes a subthreshold form of movement activity: a neuron active during rightward movements becomes modestly active during preparation of a rightward movement. We asked whether this pattern of activity is, in fact, observed. We found that it was not: at the level of a single neuron, preparatory tuning was weakly correlated with movement-period tuning. Yet, somewhat paradoxically, preparatory tuning could be captured by a preferred direction in an abstract "space" that described the population-level pattern of movement activity. In fact, this relationship accounted for preparatory responses better than did traditional tuning models. These results are expected if preparatory activity provides the initial state of a dynamical system whose evolution produces movement activity. Our results thus suggest that preparatory activity may not represent specific factors, and may instead play a more mechanistic role.	[Churchland, Mark M.; Cunningham, John P.; Ryu, Stephen I.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Cunningham, John P.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA 94301 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94705 USA	Stanford University; Stanford University; University of Cambridge; Palo Alto Medical Foundation Research Institute; Stanford University	Churchland, MM (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	church@stanford.edu	Kaufman, Matthew T/B-6273-2014; Kaufman, Matthew/AAK-2860-2020	Kaufman, Matthew T/0000-0002-8072-023X; Kaufman, Matthew/0000-0002-8072-023X	Helen Hay Whitney postdoctoral fellowship; National Institutes of Health (NIH); Burroughs Welcome Fund; Michael Flynn Stanford Graduate Fellowship; NIH-NINDS-CRCNS-R01; National Science Foundation (NSF); NIH NINDS [R01-NS054283]; DARPA [N66001-10-C-2010]; Stanford Center for Integrated Systems; NSF Center for Neuromorphic Systems Engineering at Caltech; Office of Naval Research; Whitaker Foundation;  [1DP1OD006409];  [NIH NINDS R01-NS054283];  [DARPA REPAIR (N66001-10-C-2010)]; Engineering and Physical Sciences Research Council [EP/H019472/1] Funding Source: researchfish; EPSRC [EP/H019472/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Helen Hay Whitney postdoctoral fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); Michael Flynn Stanford Graduate Fellowship; NIH-NINDS-CRCNS-R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Stanford Center for Integrated Systems; NSF Center for Neuromorphic Systems Engineering at Caltech(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Whitaker Foundation; ; ; ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Helen Hay Whitney postdoctoral fellowship and National Institutes of Health (NIH) postdoctoral training fellowship (M.M.C.), the Burroughs Welcome Fund Career Awards in the Biomedical Sciences (M.M.C., K.V.S.), the Michael Flynn Stanford Graduate Fellowship and NIH-NINDS-CRCNS-R01 (J.P.C.), a National Science Foundation (NSF) graduate research fellowship (M.T.K.), and the following awards to K.V.S.: NIH Director's Pioneer Award 1DP1OD006409, NIH NINDS R01-NS054283, DARPA REPAIR (N66001-10-C-2010), Stanford Center for Integrated Systems, NSF Center for Neuromorphic Systems Engineering at Caltech, Office of Naval Research, and the Whitaker Foundation. We thank M. Risch for surgical and veterinary assistance and S. Eisensee for administrative support.	Bastian A, 2003, EUR J NEUROSCI, V18, P2047, DOI 10.1046/j.1460-9568.2003.02906.x; Bastian A, 1998, NEUROREPORT, V9, P315, DOI 10.1097/00001756-199801260-00025; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2006, J NEUROPHYSIOL, V96, P2842, DOI 10.1152/jn.00857.2006; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Erlhagen W, 1999, J NEUROSCI METH, V94, P53, DOI 10.1016/S0165-0270(99)00125-9; Erlhagen W, 2002, PSYCHOL REV, V109, P545, DOI 10.1037//0033-295X.109.3.545; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; GEORGOPOULOS AP, 1989, EXP BRAIN RES, V75, P183; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghez C, 1991, Curr Opin Neurobiol, V1, P664, DOI 10.1016/S0959-4388(05)80046-7; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kalaska JF, 1998, NOVART FDN SYMP, V218, P176; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; REQUIN J, 1988, BIOL PSYCHOL, V26, P179, DOI 10.1016/0301-0511(88)90019-1; Rickert J, 2009, J NEUROSCI, V29, P13870, DOI 10.1523/JNEUROSCI.5441-08.2009; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; RIEHLE A, 1993, BEHAV BRAIN RES, V53, P35, DOI 10.1016/S0166-4328(05)80264-5; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Schaffer ES, 2006, SOC NEUR ANN M ATL G; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Scott SH, 2000, CAN J PHYSIOL PHARM, V78, P923, DOI 10.1139/y00-064; Scott SH, 1997, J NEUROPHYSIOL, V78, P2413, DOI 10.1152/jn.1997.78.5.2413; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; TURNER RS, 1991, THESIS U WASHINGTON; WEINRICH M, 1984, BRAIN, V107, P385, DOI 10.1093/brain/107.2.385; WISE SP, 1986, PROG BRAIN RES, V64, P117; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	54	239	239	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					387	400		10.1016/j.neuron.2010.09.015	http://dx.doi.org/10.1016/j.neuron.2010.09.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040842	Green Accepted, Bronze			2022-12-24	WOS:000284255800009
J	Li, F; He, ZM; Shen, JP; Huang, QA; Li, WR; Liu, XJ; He, YJ; Wolf, F; Li, CY				Li, Fang; He, Zhimin; Shen, Jingping; Huang, Qian; Li, Wenrong; Liu, Xinjian; He, Yujun; Wolf, Frank; Li, Chuan-Yuan			Apoptotic Caspases Regulate Induction of iPSCs from Human Fibroblasts	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; RETINOBLASTOMA PROTEIN; C-FLIP; MOUSE; GENERATION; RB; DEATH; MYC; P53; PATHWAY	The molecular mechanisms involved in the derivation of induced pluripotent stem cells (iPSCs) from differentiated cells are poorly understood. Here we report that caspases 3 and 8, two proteases associated with apoptotic cell death, play critical roles in induction of iPSCs from human fibroblasts. Activation of caspases 3 and 8 occurs soon after transduction of iPSC-inducing transcription factors. Oct-4, a key iPSC transcription factor, is responsible for the activation. Inhibition of caspase 3 or 8 in human fibroblast cells partially or completely (respectively) prevents the induction of iPSCs. Furthermore, retinoblastoma susceptibility (Rb) protein appears to be one of the factors that act downstream of the caspases. We propose that caspases are key facilitators of nuclear reprogramming in iPSC induction.	[Li, Fang; He, Zhimin; Shen, Jingping; Huang, Qian; Li, Wenrong; Liu, Xinjian; He, Yujun; Wolf, Frank; Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA; [Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [He, Zhimin] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Huang, Qian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Shanghai 200080, Peoples R China	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Central South University; Shanghai Jiao Tong University	Li, CY (corresponding author), Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA.	chuan.li@ucdenver.edu	Li, Chuan-Yuan/H-4148-2013		US National Cancer Institute [CA131408, CA136748]; NCI; NASA [NNX09AH19G]; National Basic Research Project of China [2010CB529900]; China National Natural Science Foundation [30325043, 30428015]; NATIONAL CANCER INSTITUTE [R01CA131408, R01CA136748] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NASA(National Aeronautics & Space Administration (NASA)); National Basic Research Project of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the various investigators who have deposited many of the plasmids used in this study at Addgene (Cambridge, MA). These include the iPSC factors deposited by Drs. Thomson (U. of Wisconsin) and Yamanaka (Kyoto University) and the dominant/negative caspase plasmids deposited by Dr. Salvesen (Burnham Institute). We also want to thank Drs. Hochedlingder and Mahereli (Harvard Medical School) for their gift of the doxycycline-inducible secondary reprogramming mouse fibroblast cells. This study was supported in part by grants CA131408 and CA136748 from the US National Cancer Institute (to C.-Y.L.), an NCI SPORE developmental grant in lung cancer research (to C.-Y.L.), and grant NNX09AH19G (to C.-Y.L.) from the NASA Space Radiation Biology Research Program. Q.H. was supported by grant 2010CB529900 from the National Basic Research Project of China and Outstanding Young Scientist grants 30325043 and 30428015 from the China National Natural Science Foundation. We thank Melissa Stauffer, PhD, of Scientific Editing Solutions, for editing the manuscript.	An B, 1996, CANCER RES, V56, P438; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dou QP, 1997, J CELL BIOCHEM, V64, P586; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVAN G, 1994, PHILOS T R SOC B, V345, P269, DOI 10.1098/rstb.1994.0105; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; Jori FP, 2007, MOL CELL NEUROSCI, V34, P299, DOI 10.1016/j.mcn.2006.11.009; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; SAVATIER P, 1994, ONCOGENE, V9, P809; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan XQ, 1997, J BIOL CHEM, V272, P9613; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	69	84	90	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					508	520		10.1016/j.stem.2010.09.003	http://dx.doi.org/10.1016/j.stem.2010.09.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887956	Green Accepted, Bronze			2022-12-24	WOS:000283270600012
J	Sierra, A; Encinas, JM; Deudero, JJP; Chancey, JH; Enikolopov, G; Overstreet-Wadiche, LS; Tsirka, SE; Maletic-Savatic, M				Sierra, Amanda; Encinas, Juan M.; Deudero, Juan J. P.; Chancey, Jessica H.; Enikolopov, Grigori; Overstreet-Wadiche, Linda S.; Tsirka, Stella E.; Maletic-Savatic, Mirjana			Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis	CELL STEM CELL			English	Article							GREEN FLUORESCENT PROTEIN; PROGRAMMED CELL-DEATH; DENTATE GYRUS; PROGENITOR CELLS; STATUS EPILEPTICUS; OLFACTORY-BULB; TERM SURVIVAL; GRANULE CELLS; NEURAL STEM; NEURONS	In the adult hippocampus, neuroprogenitor cells in the subgranular zone (SGZ) of the dentate gyrus give rise to newborn neuroblasts. However, only a small subset of these cells integrates into the hippocampal circuitry as mature neurons at the end of a 4 week period. Here, we show that the majority of the newborn cells undergo death by apoptosis in the first 1 to 4 days of their life, during the transition from amplifying neuroprogenitors to neuroblasts. These apoptotic newborn cells are rapidly cleared out through phagocytosis by unchallenged microglia present in the adult SGZ niche. Phagocytosis by the microglia is efficient and undeterred by increased age or inflammatory challenge. Our results suggest that the main critical period of newborn cell survival occurs within a few days of birth and reveal a new role for microglia in maintaining the homeostasis of the baseline neurogenic cascade.	[Sierra, Amanda; Encinas, Juan M.; Deudero, Juan J. P.; Maletic-Savatic, Mirjana] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Encinas, Juan M.; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chancey, Jessica H.; Overstreet-Wadiche, Linda S.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11733 USA	Baylor College of Medicine; Cold Spring Harbor Laboratory; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sierra, A (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	amanda.sierrasaavedra@gmail.com; maletics@bcm.edu	Enikolopov, Grigori/P-5731-2019; Sierra, Amanda/E-3305-2010; Encinas, Juan M/E-3625-2010; Encinas, Juan Manuel/N-5906-2014; Encinas, Juan Manuel/ABB-5304-2020; Tsirka, Stella/AAD-4018-2019	Enikolopov, Grigori/0000-0001-8178-8917; Sierra, Amanda/0000-0001-8415-096X; Encinas, Juan Manuel/0000-0002-0402-972X; Encinas, Juan Manuel/0000-0002-0402-972X; Chancey, Jessica/0000-0002-8807-3938; Maletic-Savatic, Mirjana/0000-0002-6548-4662; Wadiche, Linda/0000-0001-7367-5998; Pena Deudero, Juan Jose/0000-0002-0203-2247	National Institute of Neurological Disorders and Stroke [R21NS05875-1, K08NS0044276]; Child Neurology Society; U.S. Army [DAMD170110754]; NIH [P30HD024064]; Farish foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053875, R01NS042168, R01NS064025, K08NS044276] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Child Neurology Society; U.S. Army; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Farish foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank all the members of the M.M.-S. lab for discussion and Fuguo Zhou for technical assistance. We would like to thank Drs. Huda Zoghbi, Juan Botas, Thomas Zwaka, Zhou Zhang, John Swan, Katrina Gwinn, and Vicky Brandt for their critical comments. This work was supported by the National Institute of Neurological Disorders and Stroke (R21NS05875-1 and K08NS0044276); Phillip R. Dodge Young Investigator Award (Child Neurology Society); U.S. Army Medical Research Grant (DAMD170110754): NIH Intellectual and Developmental Disabilities Research Grant (P30HD024064); and the Farish foundation (M.M.-S.). J.M.E. is the recipient of a National Alliance for Research on Schizophrenia and Depression Young Investigator Award. A.S. designed and performed the experiments, analyzed the data, and wrote the paper. J.M.E., J.J.P.D., and J.H.C. performed experiments. L.S.O.-W. provided the POMC-EGFP mice and critically reviewed the paper. G.E. provided the nestin-GFP and the nestin-CFPNuc mice and critically reviewed the paper. S.E.T. provided the fms-EGFP mice and critically reviewed the paper. M.M.-S. designed and supervised all the experiments and wrote the paper.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; ALOISI F, 2005, NEUROGLIA, P285; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2002, EUR J NEUROSCI, V16, P1463, DOI 10.1046/j.1460-9568.2002.02202.x; Ekdahl CT, 2003, NEUROBIOL DIS, V14, P513, DOI 10.1016/j.nbd.2003.08.022; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekdahl CT, 2001, EUR J NEUROSCI, V14, P937, DOI 10.1046/j.0953-816x.2001.01713.x; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mallat M, 2005, CURR OPIN NEUROBIOL, V15, P101, DOI 10.1016/j.conb.2005.01.006; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Olah M, 2009, GLIA, V57, P1046, DOI 10.1002/glia.20828; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Petreanu L, 2002, J NEUROSCI, V22, P6106; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 1997, BRIT MED BULL, V53, P491; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; Yang FS, 1998, AM J PATHOL, V152, P379; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	51	969	991	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					483	495		10.1016/j.stem.2010.08.014	http://dx.doi.org/10.1016/j.stem.2010.08.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887954	Green Accepted, Bronze			2022-12-24	WOS:000283270600010
J	Andrade, A; Denome, S; Jiang, YQ; Marangoudakis, S; Lipscombe, D				Andrade, Arturo; Denome, Sylvia; Jiang, Yu-Qiu; Marangoudakis, Spiro; Lipscombe, Diane			Opioid inhibition of N-type Ca2+ channels and spinal analgesia couple to alternative splicing	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; CALCIUM-CHANNELS; NEUROPATHIC PAIN; BINDING PROTEINS; SUBSTANCE-P; T-TYPE; MODULATION; MECHANISMS; ANTINOCICEPTION; TRANSMISSION	Alternative pre-mRNA splicing occurs extensively in the nervous systems of complex organisms, including humans, considerably expanding the potential size of the proteome. Cell-specific alternative pre-mRNA splicing is thought to optimize protein function for specialized cellular tasks, but direct evidence for this is limited. Transmission of noxious thermal stimuli relies on the activity of N-type Ca(V)2.2 calcium channels in nociceptors. Using an exon-replacement strategy in mice, we show that mutually exclusive splicing patterns in the Ca(V)2.2 gene modulate N-type channel function in nociceptors, leading to a change in morphine analgesia. Exon 37a (e37a) enhances mu-opioid receptor-mediated inhibition of N-type calcium channels by promoting activity-independent inhibition. In the absence of e37a, spinal morphine analgesia is weakened in vivo but the basal response to noxious thermal stimuli is not altered. Our data suggest that highly specialized, discrete cellular responsiveness in vivo can be attributed to alternative splicing events regulated at the level of individual neurons.	[Andrade, Arturo; Denome, Sylvia; Jiang, Yu-Qiu; Marangoudakis, Spiro; Lipscombe, Diane] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	diane_lipscombe@brown.edu			US National Institutes of Health (Transgenic Facility at Brown University) [RO1NS055251, F31NS066702, P20RR015578]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055251, F31NS066702, R01NS029967] Funding Source: NIH RePORTER	US National Institutes of Health (Transgenic Facility at Brown University)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Kysik and E. Paul in the mouse transgenic facility at Brown University, R. Burwell for advice on animal behavior, T.D. Helton for help with image analyses and C.G. Phillips and S.E. Allen for helpful comments on the manuscript. This work was supported by US National Institutes of Health grants RO1NS055251 (D.L.), F31NS066702 (S.M.) and P20RR015578 (Transgenic Facility at Brown University).	Adams PJ, 2009, CHANNELS, V3, P110, DOI 10.4161/chan.3.2.7932; Altier C, 2004, TRENDS PHARMACOL SCI, V25, P465, DOI 10.1016/j.tips.2004.07.004; Altier C, 2007, J NEUROSCI, V27, P6363, DOI 10.1523/JNEUROSCI.0307-07.2007; Bao JP, 1998, J NEUROSCI, V18, P8740; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Castiglioni AJ, 2006, J PHYSIOL-LONDON, V576, P119, DOI 10.1113/jphysiol.2006.115030; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Elmslie KS, 2003, J BIOENERG BIOMEMBR, V35, P477, DOI 10.1023/B:JOBB.0000008021.55853.18; GLAUM SR, 1994, J NEUROSCI, V14, P4965; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HILLE B, 1995, LIFE SCI, V56, P989, DOI 10.1016/0024-3205(95)00038-8; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ikeda SR, 2007, NAT NEUROSCI, V10, P269, DOI 10.1038/nn0307-269; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; MALMBERG AB, 1995, PAIN, V60, P83, DOI 10.1016/0304-3959(94)00094-U; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Matthews EA, 2001, PAIN, V92, P235, DOI 10.1016/S0304-3959(01)00255-X; Mich PM, 2008, MOL PHARMACOL, V74, P904, DOI 10.1124/mol.108.045153; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; Pan JQ, 2000, J NEUROSCI, V20, P4769; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Saegusa H, 2002, NEUROSCI RES, V43, P1, DOI 10.1016/S0168-0102(02)00017-2; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; TADDESE A, 1995, SCIENCE, V270, P1366, DOI 10.1126/science.270.5240.1366; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wang YX, 2000, PAIN, V84, P151, DOI 10.1016/S0304-3959(99)00197-9; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Wilson SG, 2001, BEHAV BRAIN RES, V125, P65, DOI 10.1016/S0166-4328(01)00281-9; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhong XL, 2006, HUM MOL GENET, V15, P1497, DOI 10.1093/hmg/ddl068	50	68	70	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1249	1256		10.1038/nn.2643	http://dx.doi.org/10.1038/nn.2643			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852623	Green Accepted			2022-12-24	WOS:000282171300017
J	Muguruma, K; Nishiyama, A; Ono, Y; Miyawaki, H; Mizuhara, E; Hori, S; Kakizuka, A; Obata, K; Yanagawa, Y; Hirano, T; Sasai, Y				Muguruma, Keiko; Nishiyama, Ayaka; Ono, Yuichi; Miyawaki, Hiroyuki; Mizuhara, Eri; Hori, Seiji; Kakizuka, Akira; Obata, Kunihiko; Yanagawa, Yuchio; Hirano, Tomoo; Sasai, Yoshiki			Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE; ISTHMIC ORGANIZER; RHOMBIC-LIP; MIDBRAIN; FGF8; DIFFERENTIATION; PRECURSORS; GENES; TRANSPLANTATION; SYNAPSES	Purkinje cells are the sole output neurons of the cerebellar cortex and their dysfunction causes severe ataxia. We found that Purkinje cells could be robustly generated from mouse embryonic stem (ES) cells by recapitulating the self-inductive signaling microenvironments of the isthmic organizer. The cell-surface marker Neph3 enabled us to carry out timed prospective selection of Purkinje cell progenitors, which generated morphologically characteristic neurons with highly arborized dendrites that expressed mature Purkinje cell-specific markers such as the glutamate receptor subunit GluR delta 2. Similar to mature Purkinje cells, these neurons also showed characteristic spontaneous and repeated action potentials and their postsynaptic excitatory potentials were generated exclusively through nonNMDA glutamate receptors. Fetal transplantation of precursors isolated by fluorescence-activated cell sorting showed orthotopic integration of the grafted neurons into the Purkinje cell layer with their axons extending to the deep cerebellar nuclei and dendrites receiving climbing and parallel fibers. This selective preparation of bona fide Purkinje cells should aid future investigation of this important neuron.	[Muguruma, Keiko; Nishiyama, Ayaka; Sasai, Yoshiki] RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan; [Ono, Yuichi; Mizuhara, Eri] KAN Inst, Grp Neuronal Differentiat, Kobe, Hyogo, Japan; [Miyawaki, Hiroyuki; Hirano, Tomoo] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Hori, Seiji; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto, Japan; [Obata, Kunihiko] RIKEN, Obata Res Unit, Brain Sci Inst, Wako, Saitama, Japan; [Yanagawa, Yuchio] Gunma Univ, Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	RIKEN; Kyoto University; Kyoto University; RIKEN; Gunma University; Japan Science & Technology Agency (JST)	Sasai, Y (corresponding author), RIKEN, Organogenesis & Neurogenesis Grp, Ctr Dev Biol, Kobe, Hyogo, Japan.	yoshikisasai@cdb.riken.jp	Miyawaki, Hiroyuki/CAA-0525-2022	Muguruma, Keiko/0000-0002-3149-4408; Miyawaki, Hiroyuki/0000-0003-1556-1348	Ministry of Education, Culture, Sports, Science and Technology (Japan); Kobe Cluster Project; Leading Project; National Center of Neurology and Psychiatry	Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project; National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan)	We thank H. Enomoto and M. Eiraku for comments, T. Wataya for help in tissue preparation and members of the Sasai laboratory for discussion and advice. This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (Japan), the Kobe Cluster Project, the Leading Project (Y.S.) and the National Center of Neurology and Psychiatry (K.M.).	Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Altman J, 1997, DEV CEREBELLAR SYSTE; ANG SL, 1993, DEVELOPMENT, V118, P139; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Cendelin J, 2009, CEREBELLUM, V8, P35, DOI 10.1007/s12311-008-0061-9; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Frontali M, 2001, BRAIN RES BULL, V56, P227, DOI 10.1016/S0361-9230(01)00574-3; Garin N, 2001, NEUROSCIENCE, V105, P431, DOI 10.1016/S0306-4522(01)00127-0; HIRANO T, 1988, P NATL ACAD SCI USA, V85, P934, DOI 10.1073/pnas.85.3.934; HIRANO T, 1993, J NEUROPHYSIOL, V70, P1316, DOI 10.1152/jn.1993.70.4.1316; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Liu AM, 1999, DEVELOPMENT, V126, P4827; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Martinez S, 1999, DEVELOPMENT, V126, P1189; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Minaki Y, 2008, GENE EXPR PATTERNS, V8, P418, DOI 10.1016/j.gep.2008.04.004; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Mizuhara E, 2010, DEV BIOL, V338, P202, DOI 10.1016/j.ydbio.2009.11.032; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Raman IM, 1999, J NEUROSCI, V19, P1663; Salero E, 2007, P NATL ACAD SCI USA, V104, P2997, DOI 10.1073/pnas.0610879104; Sato T, 2001, DEVELOPMENT, V128, P2461; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; Su HL, 2006, DEV BIOL, V290, P287, DOI 10.1016/j.ydbio.2005.11.010; Tao O, 2010, J NEUROSCI RES, V88, P234, DOI 10.1002/jnr.22208; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	42	103	109	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1171	1180		10.1038/nn.2638	http://dx.doi.org/10.1038/nn.2638			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835252				2022-12-24	WOS:000282171300008
J	Freeman, SN; Burke, KA; Imoisili, MA; Cote, TR				Freeman, Scott N.; Burke, Kathryn A.; Imoisili, Menfo A.; Cote, Timothy R.			The Orphan Drug Act and the Development of Stem Cell-Based Products for Rare Diseases	CELL STEM CELL			English	Editorial Material							FDA REGULATION; THERAPIES	The Orphan Drug Act encourages the development of products for rare diseases and conditions. Many conditions that stand to benefit from stem cell-based products are rare diseases. We address the Orphan Drug Act in relation to the development of stem cell-based products.	[Freeman, Scott N.; Burke, Kathryn A.; Imoisili, Menfo A.; Cote, Timothy R.] US FDA, Off Orphan Prod Dev, Off Special Med Programs, Off Commissioner, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Cote, TR (corresponding author), US FDA, Off Orphan Prod Dev, Off Special Med Programs, Off Commissioner, Silver Spring, MD 20993 USA.	timothy.cote@fda.hhs.gov		Freeman, Scott/0000-0003-2676-3236				Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Cote T, 2010, NAT REV DRUG DISCOV, V9, P84, DOI 10.1038/nrd2546-c1; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; *US FDA, 2010, ORPH PROD DAT INT; *US FDA, 2010, INT COLL FDA EUR MED; *US FDA, 2010, BIOL INV REL APPL SY; *US FDA, 2010, ORPHANDRUG PROD DES	9	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					283	287		10.1016/j.stem.2010.08.003	http://dx.doi.org/10.1016/j.stem.2010.08.003			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804965	Bronze			2022-12-24	WOS:000282037800006
J	Fritz, JB; David, SV; Radtke-Schuller, S; Yin, PB; Shamma, SA				Fritz, Jonathan B.; David, Stephen V.; Radtke-Schuller, Susanne; Yin, Pingbo; Shamma, Shihab A.			Adaptive, behaviorally gated, persistent encoding of task-relevant auditory information in ferret frontal cortex	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL CORTEX; RECEPTIVE-FIELDS; SELECTIVE REPRESENTATION; TOP-DOWN; ATTENTION; MEMORY; PLASTICITY; PREMOTOR; NEURONS; ORGANIZATION	Top-down signals from frontal cortex are thought to be important in cognitive control of sensory processing. To explore this interaction, we compared activity in ferret frontal cortex and primary auditory cortex (A1) during auditory and visual tasks requiring discrimination between classes of reference and target stimuli. Frontal cortex responses were behaviorally gated, selectively encoded the timing and invariant behavioral meaning of target stimuli, could be rapid in onset, and sometimes persisted for hours following behavior. These results are consistent with earlier findings in A1 that attention triggered rapid, selective, persistent, task-related changes in spectrotemporal receptive fields. Simultaneously recorded local field potentials revealed behaviorally gated changes in inter-areal coherence that were selectively modulated between frontal cortex and focal regions of A1 that were responsive to target sounds. These results suggest that A1 and frontal cortex dynamically establish a functional connection during auditory behavior that shapes the flow of sensory information and maintains a persistent trace of recent task-relevant stimulus features.	[Fritz, Jonathan B.; David, Stephen V.; Yin, Pingbo; Shamma, Shihab A.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Radtke-Schuller, Susanne] Univ Munich, Bioctr, Div Neurobiol, Munich, Germany	University System of Maryland; University of Maryland College Park; University of Munich	Fritz, JB (corresponding author), Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.	ripple@umd.edu	Fritz, Jonathan/AAK-4863-2020; Shamma, Shihab A/F-9852-2012	David, Stephen/0000-0003-4135-3104; Fritz, Jonathan/0000-0002-0625-172X	US National Institutes of Health [R03DC005938, R01DC005779, F32DC008453]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008453, R01DC005779, R01DC007657, R03DC005938] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank A. Duque, J. Bizley, V. Bajo, F. Nodal and A. King for discussion and for generously sharing their unpublished neuroanatomical data on the ferret frontal cortex and its connectivity with auditory cortex, N. Mesgarani for assistance with customized MATLAB software development, M. Elhilali for discussion and for analysis of memory effects in A1, S. Gotts for discussion of LFP coherence, C. Carr for cheerfully sharing laboratory resources for neuroanatomical studies and A. Israelson, A. Rubin, K. Donaldson and D. Levitt for assistance in training the ferrets in this study. This research was funded by grants from the US National Institutes of Health (R03DC005938 to J. B. F., R01DC005779 to S. A. S. and J. B. F. and F32DC008453 to S. V. D.).	Anton-Erxleben K, 2009, CEREB CORTEX, V19, P2466, DOI 10.1093/cercor/bhp002; Baddeley A., 2007, WORKING MEMORY THOUG; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; DIPELLEGRINO G, 1993, SOMATOSENS MOT RES, V10, P245; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duque A, 2010, CEREB CORTEX, V20, P1020, DOI 10.1093/cercor/bhp164; Ehlis AC, 2009, NEUROSCIENCE, V159, P1032, DOI 10.1016/j.neuroscience.2009.01.015; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Everling S, 2006, EUR J NEUROSCI, V23, P2197, DOI 10.1111/j.1460-9568.2006.04736.x; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Frey S, 2008, PROG BRAIN RES, V169, P117, DOI 10.1016/S0079-6123(07)00007-6; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Fritz JB, 2007, J NEUROPHYSIOL, V98, P2337, DOI 10.1152/jn.00552.2007; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Funahashi S, 2006, NEUROSCIENCE, V139, P251, DOI 10.1016/j.neuroscience.2005.07.003; Fusi S, 2007, NEURON, V54, P319, DOI 10.1016/j.neuron.2007.03.017; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Jung MW, 2008, REV NEUROSCIENCE, V19, P29; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Messinger A, 2009, J NEUROSCI, V29, P5640, DOI 10.1523/JNEUROSCI.3857-08.2009; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitra P., 2007, OBSERVED BRAIN DYNAM; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rasmusson DD, 2007, NEUROSCIENCE, V149, P232, DOI 10.1016/j.neuroscience.2007.06.057; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Romanski Lizabeth M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P421, DOI 10.3758/CABN.4.4.421; Russ BE, 2007, HEARING RES, V229, P204, DOI 10.1016/j.heares.2006.10.010; Salinas E, 2009, J NEUROSCI, V29, P4369, DOI 10.1523/JNEUROSCI.0164-09.2009; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Woodman GF, 2007, CEREB CORTEX, V17, pI118, DOI 10.1093/cercor/bhm065	50	163	163	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1011	U143		10.1038/nn.2598	http://dx.doi.org/10.1038/nn.2598			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20622871	Green Accepted			2022-12-24	WOS:000280400600021
J	Frost, NA; Shroff, H; Kong, HH; Betzig, E; Blanpied, TA				Frost, Nicholas A.; Shroff, Hari; Kong, Huihui; Betzig, Eric; Blanpied, Thomas A.			Single-Molecule Discrimination of Discrete Perisynaptic and Distributed Sites of Actin Filament Assembly within Dendritic Spines	NEURON			English	Article							LONG-TERM POTENTIATION; AMPA-RECEPTORS; HIPPOCAMPAL-NEURONS; ENDOCYTIC ZONES; ARP2/3 COMPLEX; NERVOUS-SYSTEM; F-ACTIN; LOCALIZATION; ORGANIZATION; DYNAMICS	Within dendritic spines, actin is presumed to anchor receptors in the postsynaptic density and play numerous roles regulating synaptic transmission. However, the submicron dimensions of spines have hindered examination of actin dynamics within them and prevented live-cell discrimination of perisynaptic actin filaments. Using photoactivated localization microscopy, we measured movement of individual actin molecules within living spines. Velocity of single actin molecules along filaments, an index of filament polymerization rate, was highly heterogeneous within individual spines. Most strikingly, molecular velocity was elevated in discrete, well-separated foci occurring not principally at the spine tip, but in subdomains throughout the spine, including the neck. Whereas actin velocity on filaments at the synapse was substantially elevated, at the endocytic zone there was no enhanced polymerization activity. We conclude that actin subserves spatially diverse, independently regulated processes throughout spines. Perisynaptic actin forms a uniquely dynamic structure well suited for direct, active regulation of the synapse.	[Frost, Nicholas A.; Kong, Huihui; Blanpied, Thomas A.] Univ Maryland, Sch Med, Dept Physiol & Program Neurosci, Baltimore, MD 21201 USA; [Shroff, Hari; Betzig, Eric] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Shroff, Hari] Natl Inst Biomed Imaging & Bioengn, Sect High Resolut Opt Imaging, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Blanpied, TA (corresponding author), Univ Maryland, Sch Med, Dept Physiol & Program Neurosci, Baltimore, MD 21201 USA.	tblanpied@som.umaryland.edu	Shroff, Hari/E-7247-2016; Kong, Huihui/F-9024-2012	Shroff, Hari/0000-0003-3613-8215; Blanpied, Thomas/0000-0003-4957-557X; Frost, Nicholas/0000-0002-2270-643X	Summer Training in Aging Research Topics Mental Health (Start-MH) fellowship; NIGMS [T32GM008181]; NRSA [F30MH086185]; NIMH [R01MH080046]; Dana Foundation; Katherine D. and Theodore J. Carski Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH086185, R01MH080046] Funding Source: NIH RePORTER	Summer Training in Aging Research Topics Mental Health (Start-MH) fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dana Foundation; Katherine D. and Theodore J. Carski Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the following for supplying plasmids: S. McKinney (mEos2-actin), B. Imhof (GFP-actin), G. Patterson (PA-GFP), M. Rizzo (cerulean), J. Lippincott-Schwartz (tdEos-paxillin), D. Bredt (PSD-95-GFP), R.Y. Tsien (tdTomato, mCherry), G. Feng (GKAP), and M. Davidson (Dronpa). We thank also J. Kerr and H. Lu for helpful discussions, and M. Ehlers, J. Bear, and S. Thompson for comments on the manuscript. Support was provided by a Summer Training in Aging Research Topics Mental Health (Start-MH) fellowship; Training Grant NIGMS T32GM008181, and NRSA F30MH086185 (NAF) and NIMH R01MH080046; the Dana Foundation; and the Katherine D. and Theodore J. Carski Foundation (TAB). E.B. is coowner of Hestzig LLC, which has exclusively licensed PALM technology to Carl Zeiss MicroImaging, GmbH.	Allison DW, 1998, J NEUROSCI, V18, P2423; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Hering H, 2003, J NEUROSCI, V23, P11759; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim CH, 1999, J NEUROSCI, V19, P4314; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Racz B, 2008, J NEUROSCI, V28, P5654, DOI 10.1523/JNEUROSCI.0756-08.2008; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Richards DA, 2004, J PHYSIOL-LONDON, V558, P503, DOI 10.1113/jphysiol.2004.062091; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Sdrulla AD, 2007, NAT NEUROSCI, V10, P546, DOI 10.1038/nn1889; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Wang XB, 2007, J NEUROSCI, V27, P12419, DOI 10.1523/JNEUROSCI.2015-07.2007; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	67	199	200	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					86	99		10.1016/j.neuron.2010.05.026	http://dx.doi.org/10.1016/j.neuron.2010.05.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624594	Bronze, Green Accepted			2022-12-24	WOS:000280221000011
J	Bubela, T; Strotmann, A; Adams, R; Morrison, S				Bubela, Tania; Strotmann, Andreas; Adams, Rhiannon; Morrison, Shawn			Commercialization and Collaboration: Competing Policies in Publicly Funded Stem Cell Research?	CELL STEM CELL			English	Editorial Material							PATENTS	Advances in bibliometrics present new methods for analyzing emerging collaborative innovation models. These methods are illustrated by the Canadian Stem Cell Network, which fosters high-profile multidisciplinary, collaborative, international research. However, patenting negatively impacts collaboration patterns in published research. Policies directed at collaboration and commercialization may be in conflict, depending on the degree to which one activity is emphasized over the other.	[Bubela, Tania; Strotmann, Andreas] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada; [Adams, Rhiannon] Univ Alberta, Fac Law, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Morrison, Shawn] Dryas Res Ltd, Edmonton, AB T6C 2R6, Canada	University of Alberta; University of Alberta	Bubela, T (corresponding author), Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada.	tbubela@ualberta.ca	Morrison, Shawn/F-3953-2010; Strotmann, Andreas/P-5891-2017; Bubela, Tania/F-4860-2014	Strotmann, Andreas/0000-0002-0679-6498; Bubela, Tania/0000-0002-0807-2899; Morrison, Shawn/0000-0003-3674-5955	Stem Cell Network; Genome Canada	Stem Cell Network; Genome Canada(Genome Canada)	Funding for this project was provided by a Catalyst Grant from the Stem Cell Network to T.B., a Genome Canada Grant to Geoff Hicks, Manitoba Institute of Cell Biology, and Janet Rossant, Hospital for Sick Children, at which T.B. is a coinvestigator; and a SSHRC INE grant to E. Richard Gold in whose lab T.B. was a coinvestigator. These grants have provided postdoctoral fellow salary support to A.S. Dangzhi Zhao provided great assistance and expertise in all aspects of the bibliometric analyses, and Logan McLeod and Gian Jhangri provided additional assistance with regression models. Helpful comments were provided on earlier drafts of the manuscript by Timothy Caulfield, Richard Gold, David Castle, and David Hik.	ATKINSONGROSJEA.A, 2005, PUBLIC SCI PRIVATE I; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Caulfield T, 2008, REGEN MED, V3, P483, DOI 10.2217/17460751.3.4.483; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Giebel LB, 2005, NAT BIOTECHNOL, V23, P798, DOI 10.1038/nbt0705-798; Herder M, 2008, J BUS ETHICS, V77, P73, DOI 10.1007/s10551-006-9294-z; Hong W, 2009, SOCIOL QUART, V50, P145, DOI 10.1111/j.1533-8525.2008.01136.x; Huang KG, 2009, ACAD MANAGE J, V52, P1193, DOI 10.5465/AMJ.2009.47084665; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Little M, 2006, EMBO REP, V7, P1188, DOI 10.1038/sj.embor.7400861; Moed HF., 2005, CITATION ANAL RES EV; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; PLAGNOL AC, 2009, FUTURE MED, V4, P549; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Strandburg Katherine J., 2006, BERKELEY TECH LJ, V21, P1293, DOI DOI 10.2139/SSRN.926354; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; Winickoff DE, 2009, YALE J HLTH POLICY L, V9, P54	18	25	25	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					25	30		10.1016/j.stem.2010.06.010	http://dx.doi.org/10.1016/j.stem.2010.06.010			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	629TJ	20621046	Bronze			2022-12-24	WOS:000280222300009
J	Liber, D; Domaschenz, R; Holmqvist, PH; Mazzarella, L; Georgiou, A; Leleu, M; Fisher, AG; Labosky, PA; Dillon, N				Liber, Daniel; Domaschenz, Renae; Holmqvist, Per-Henrik; Mazzarella, Luca; Georgiou, Andrew; Leleu, Marion; Fisher, Amanda G.; Labosky, Patricia A.; Dillon, Niall			Epigenetic Priming of a Pre-B Cell-Specific Enhancer through Binding of Sox2 and Foxd3 at the ESC Stage	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TISSUE-SPECIFIC ENHANCERS; TRANSCRIPTION FACTORS; CHROMATIN-STRUCTURE; SELF-RENEWAL; PLURIPOTENT; MOUSE; GENES; DIFFERENTIATION; SIGNATURES	Modifications to the core histones are thought to contribute to ESC pluripotency by priming tissue-specific promoters and enhancers for later activation. However, it is unclear how these marks are targeted in ESCs and maintained during differentiation. Here, we show that the ESC factor Sox2 targets H3K4 methylation to monovalent and bivalent domains. In ESCs, Sox2 contributes to the formation of a monovalent mark at an enhancer in the pro/pre-B cell-specific lambda 5-VpreB1 locus. Binding of Foxd3 suppresses intergenic transcription of the enhancer and surrounding sequences. In pro-B cells, enhancer activity is dependent on the Sox and Fox binding sites, and the enhancer is bound by Sox4, which is required for efficient expression of lambda 5. Our results lead us to propose a factor relay model whereby ESC factors establish active epigenetic marks at tissue specific elements before being replaced by cell type-specific factors as cells differentiate.	[Liber, Daniel; Domaschenz, Renae; Holmqvist, Per-Henrik; Georgiou, Andrew; Leleu, Marion; Dillon, Niall] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London W12 0NN, England; [Mazzarella, Luca; Fisher, Amanda G.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Labosky, Patricia A.] Vanderbilt Univ, Sch Med, Ctr Stem Cell Biol, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Imperial College London; Imperial College London; Vanderbilt University	Dillon, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	niall.dillon@csc.mrc.ac.uk	mazzarella, luca/AAC-2391-2019; Holmqvist, Per-Henrik/A-2804-2016	mazzarella, luca/0000-0002-4043-3279; Holmqvist, Per-Henrik/0000-0001-8074-2749; Labosky, Patricia/0000-0001-5880-2194; Domaschenz, Renae/0000-0002-8128-138X	Medical Research Council UK; Leukaemia and Lymphoma Research; EU [HPRN-CT 00504228]; NIH [HD36720]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036720] Funding Source: NIH RePORTER; Medical Research Council [MC_U120036884, MC_U120027516] Funding Source: researchfish; MRC [MC_U120036884, MC_U120027516] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Constanz Bonifer for advice on in vivo footprinting, Rudolf Grosschedl for the E47 forced dimer construct, Pierangela Sabbattini for helpful discussions and comments on the manuscript, and Svetlana Nikic for helpful discussions. This research was funded by the Medical Research Council UK and by Leukaemia and Lymphoma Research. D.L. was funded by an EU Marie Curie Research Training Fellowship (HPRN-CT 00504228). P.A.L.'s research is funded by NIH Grant HD36720.	ALT FW, 1992, ANN NY ACAD SCI, V651, P277; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Efroni S, 2009, CELL CYCLE, V8, P43, DOI 10.4161/cc.8.1.7216; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minaee S, 2005, MOL IMMUNOL, V42, P1283, DOI 10.1016/j.molimm.2005.01.003; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Steiner AB, 2006, DEVELOPMENT, V133, P4827, DOI 10.1242/dev.02663; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tagoh H, 2006, METH MOL B, V325, P285; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	41	65	65	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					114	126		10.1016/j.stem.2010.05.020	http://dx.doi.org/10.1016/j.stem.2010.05.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621055	Bronze			2022-12-24	WOS:000280222300018
J	Benchenane, K; Peyrache, A; Khamassi, M; Tierney, PL; Gioanni, Y; Battaglia, FP; Wiener, SI				Benchenane, Karim; Peyrache, Adrien; Khamassi, Mehdi; Tierney, Patrick L.; Gioanni, Yves; Battaglia, Francesco P.; Wiener, Sidney I.			Coherent Theta Oscillations and Reorganization of Spike Timing in the Hippocampal-Prefrontal Network upon Learning	NEURON			English	Article							CORTICAL-NEURONS; SPATIAL MEMORY; IN-VIVO; DOPAMINERGIC MODULATION; CELL ASSEMBLIES; CORTEX; RAT; INTERNEURONS; SYNCHRONIZATION; NEOCORTEX	To study the interplay between hippocampus and medial prefrontal cortex (Pfc) and its importance for learning and memory consolidation, we measured the coherence in theta oscillations between these two structures in rats learning new rules on a Y maze. Coherence peaked at the choice point, most strongly after task rule acquisition. Simultaneously, Pfc pyramidal neurons reorganized their phase, concentrating at hippocampal theta trough, and synchronous cell assemblies emerged. This synchronous state may result from increased inhibition exerted by interneurons on pyramidal cells, as measured by cross-correlation, and could be modulated by dopamine: we found similar hippocampal-Pfc theta coherence increases and neuronal phase shifts following local administration of dopamine in Pfc of anesthetized rats. Pfc cell assemblies emerging during high coherence were preferentially replayed during subsequent sleep, concurrent with hippocampal sharp waves. Thus, hippocampal/prefrontal coherence could lead to synchronization of reward predicting activity in prefrontal networks, tagging it for subsequent memory consolidation.	[Benchenane, Karim; Peyrache, Adrien; Khamassi, Mehdi; Battaglia, Francesco P.; Wiener, Sidney I.] CNRS, Lab Physiol Percept & Act, Coll France, F-75231 Paris 05, France; [Khamassi, Mehdi] Univ Paris 06, CNRS FRE 2507, Inst Syst Intelligents & Robot, F-75252 Paris, France; [Tierney, Patrick L.; Gioanni, Yves] INSERM, U667, Coll France, F-75231 Paris 05, France; [Tierney, Patrick L.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Battaglia, Francesco P.] Univ Amsterdam, SILS Ctr Neurosci, NL-1098 XH Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Massachusetts Institute of Technology (MIT); University of Amsterdam	Benchenane, K (corresponding author), Univ Paris 06, ENMVI Team, CNRS, UMR 7102, 12 Rue Cuvier, F-75005 Paris, France.	karim.benchenane@snv.jussieu.fr; f.p.battaglia@uva.nl	Khamassi, Mehdi/B-2425-2012; Battaglia, Francesco F.P./F-2543-2011; Tierney, Patrick/E-5860-2010; benchenane, karim/D-8023-2015	Khamassi, Mehdi/0000-0002-2515-1046; Battaglia, Francesco F.P./0000-0003-3715-8875; benchenane, karim/0000-0001-7118-0748; Wiener, Sidney/0000-0002-5819-1319; Peyrache, Adrien/0000-0001-9708-309X	Fondation Fyssen; Fondation pour la Recherche Medicale; EC [FP6-IST 027819, FP6-IST-027140, FP6-IST-027017]	Fondation Fyssen; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EC(European CommissionEuropean Commission Joint Research Centre)	We thank Prof. J.-M. Deniau, Drs. A.-M. Thierry and M.B. Zugaro for interesting discussions, S. Doutremer for histology, Prof. D. Hopkins and N. Quenech'du for the anatomical reconstructions, V. Douchamps for help with the experiments, and Prof. A. Berthoz for support throughout the project. This work was supported by Fondation Fyssen (F.P.B.), Fondation pour la Recherche Medicale (A.P.), and EC contracts FP6-IST 027819 (ICEA), FP6-IST-027140 (BAGS), and FP6-IST-027017 (NeuroProbes).	Baeg EH, 2007, J NEUROSCI, V27, P909, DOI 10.1523/JNEUROSCI.4759-06.2007; Bandyopadhyay S, 2007, J NEUROPHYSIOL, V97, P4120, DOI 10.1152/jn.00898.2006; Birrell JM, 2000, J NEUROSCI, V20, P4320; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chapman CA, 1999, J NEUROPHYSIOL, V81, P1296, DOI 10.1152/jn.1999.81.3.1296; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; Delatour B, 2000, BEHAV BRAIN RES, V109, P113, DOI 10.1016/S0166-4328(99)00168-0; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fisher NI, 1995, STAT ANAL CIRCULAR D; Floresco SB, 1997, J NEUROSCI, V17, P1880; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hebb Donald O., 1949, ORG BEHAV; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shastri L, 2002, TRENDS COGN SCI, V6, P162, DOI 10.1016/S1364-6613(02)01868-5; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Thierry AM, 2000, HIPPOCAMPUS, V10, P411, DOI 10.1002/1098-1063(2000)10:4<411::AID-HIPO7>3.0.CO;2-A; Tierney PL, 2008, CEREB CORTEX, V18, P2251, DOI 10.1093/cercor/bhm252; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; van der Meulen JAJ, 2007, CEREB CORTEX, V17, P1444, DOI 10.1093/cercor/bhl057; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	64	553	565	2	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					921	936		10.1016/j.neuron.2010.05.013	http://dx.doi.org/10.1016/j.neuron.2010.05.013			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620877	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000279420800014
J	Mayer, C; Boehm, U				Mayer, Christian; Boehm, Ulrich			Female reproductive maturation in the absence of kisspeptin/GPR54 signaling	NATURE NEUROSCIENCE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HORMONE-SECRETION; DIPHTHERIA-TOXIN; ARCUATE NUCLEUS; NEUROBIOLOGICAL MECHANISMS; KISS-1 PEPTIDE; PREOPTIC AREA; NEURONS; PUBERTY; GPR54	Puberty onset is initiated in the brain by activation of gonadotropin-releasing hormone (GnRH) neurosecretion. Different permissive signals must be integrated for the initiation of reproductive maturation; however, the neural circuits controlling timely awakening of the reproductive axis are not understood. The identification of the neuropeptide kisspeptin as a potent activator of GnRH neuronal activity suggests that kisspeptin-releasing neurons might coordinate puberty onset. To test this hypothesis, we generated mice that specifically lack kisspeptin cells. Puberty onset in females was unaffected by kisspeptin neuron ablation. Furthermore, the animals were fertile, albeit with smaller ovaries. Consistent with this, female mice lacking neurons that express the kisspeptin receptor GPR54 were also fertile. Acute ablation of kisspeptin neurons in adult mice inhibited fertility, suggesting that there is compensation for the loss of kisspeptin neurons early in development. Our data indicate that the initiation and completion of reproductive maturation can occur in the absence of kisspeptin/GPR54 signaling.	[Mayer, Christian; Boehm, Ulrich] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany	University of Hamburg	Boehm, U (corresponding author), Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, D-2000 Hamburg, Germany.	ulrich.boehm@zmnh.uni-hamburg.de		Mayer, Christian/0000-0003-3152-5574	Deutsche Forschungsgemeinschaft [BO1743/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are indebted to O. Pongs for continuous support. A. Marquardt and D. Drexler provided expert technical assistance. We thank R. Kuhn for providing the IGD3.2 embryonic stem cells and A. Waisman for providing the R26-iDTR mice, I. Hermans-Borgmeyer for help with embryonic stem cell work and blastocyst injections, A. Derin and U. Wolters for animal caretaking, B. Mann for performing the hormone assays and M. Roberson and K. Duncan for helpful discussions. This project was supported by Deutsche Forschungsgemeinschaft grant BO1743/2 to U.B.	Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Chan YM, 2009, J NEUROENDOCRINOL, V21, P1015, DOI 10.1111/j.1365-2826.2009.01926.x; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Clarkson J, 2010, MOL CELL ENDOCRINOL, V324, P45, DOI 10.1016/j.mce.2010.01.026; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; GIBSON MJ, 1984, SCIENCE, V225, P949, DOI 10.1126/science.6382608; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x; Harris GC, 2003, ENDOCRINOLOGY, V144, P163, DOI 10.1210/en.2002-220767; Herbison AE, 2008, ENDOCRINOLOGY, V149, P597, DOI 10.1210/en.2007-1139; Herbison AE, 2010, ENDOCRINOLOGY, V151, P312, DOI 10.1210/en.2009-0552; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsui H, 2004, BIOCHEM BIOPH RES CO, V320, P383, DOI 10.1016/j.bbrc.2004.05.185; Mayer C, 2010, P NATL ACAD SCI USA, V107, P22693, DOI 10.1073/pnas.1012406108; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Navarro VM, 2005, ENDOCRINOLOGY, V146, P1689, DOI 10.1210/en.2004-1353; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tena-Sempere M, 2010, ENDOCRIN DEV, V17, P52, DOI 10.1159/000262528; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; Wen SP, 2011, ENDOCRINOLOGY, V152, P1515, DOI 10.1210/en.2010-1208	46	150	155	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					704	U297		10.1038/nn.2818	http://dx.doi.org/10.1038/nn.2818			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516099				2022-12-24	WOS:000290958000012
J	Abell, AN; Jordan, NV; Huang, WC; Prat, A; Midland, AA; Johnson, NL; Granger, DA; Mieczkowski, PA; Perou, CM; Gomez, SM; Li, LP; Johnson, GL				Abell, Amy N.; Jordan, Nicole Vincent; Huang, Weichun; Prat, Aleix; Midland, Alicia A.; Johnson, Nancy L.; Granger, Deborah A.; Mieczkowski, Piotr A.; Perou, Charles M.; Gomez, Shawn M.; Li, Leping; Johnson, Gary L.			MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells	CELL STEM CELL			English	Article							BREAST-CANCER; MOUSE EMBRYO; SELF-RENEWAL; MECHANISMS; DISEASE; KINASE; LINES	Epithelial stem cells self-renew while maintaining multipotency, but the dependence of stem cell properties on maintenance of the epithelial phenotype is unclear. We previously showed that trophoblast stem (TS) cells lacking the protein kinase MAP3K4 maintain properties of both sternness and epithelial-mesenchymal transition (EMT). Here, we show that MAP3K4 controls the activity of the histone acetyltransferase CBP, and that acetylation of histones H2A and H2B by CBP is required to maintain the epithelial phenotype. Combined loss of MAP3K4/CBP activity represses expression of epithelial genes and causes IS cells to undergo EMT while maintaining their self-renewal and multipotency properties. The expression profile of MAP3K4-deficient TS cells defines an H2B acetylation-regulated gene signature that closely overlaps with that of human breast cancer cells. Taken together, our data define an epigenetic switch that maintains the epithelial phenotype in TS cells and reveals previously unrecognized genes potentially contributing to breast cancer.	[Abell, Amy N.; Jordan, Nicole Vincent; Johnson, Nancy L.; Granger, Deborah A.; Johnson, Gary L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Abell, Amy N.; Jordan, Nicole Vincent; Prat, Aleix; Johnson, Nancy L.; Granger, Deborah A.; Mieczkowski, Piotr A.; Perou, Charles M.; Johnson, Gary L.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Prat, Aleix; Mieczkowski, Piotr A.; Perou, Charles M.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Mieczkowski, Piotr A.] Univ N Carolina, Sch Med, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Midland, Alicia A.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Midland, Alicia A.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Huang, Weichun; Li, Leping] Natl Inst Environm Hlth Sci RTP, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Abell, AN (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	amy_abell@med.unc.edu; gary_johnson@med.unc.edu	Li, Leping/F-6497-2019; Perou, Charles M/H-9934-2014; Prat, Aleix/P-8561-2014	Li, Leping/0000-0003-4208-0259; Perou, Charles M/0000-0001-9827-2247; Prat, Aleix/0000-0003-2377-540X; Gomez, Shawn/0000-0002-8251-4552; Mieczkowski, Piotr/0000-0003-2418-0096	NIH [GM30324, DK37871, GM007040]; University Cancer Research Fund; NIH, NIEHS [ES-101765]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101765, P30ES010126, Z01ES101765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030324, T32GM007040, R01GM030324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.L.J. is supported by NIH grants GM30324 and DK37871 and the University Cancer Research Fund for support of the deep Sequencing Genomics Facility. N.V.J. is supported by NIH training grant GM007040. W.H. and L.L. are supported by the Intramural Research Program of NIH, NIEHS (ES-101765). The authors thank N. Sciaky for managing databases, K. Kluckman and the UNC Animal Models Core for production of chimeras, B. Clarke for graphical work, Z. Wang for ChIP-seq discussions, and T.-P. Yao (Duke University) for CBP/p300 constructs and helpful discussions. We thank T. Magnuson, B. Snider, B. Richardson, and J. Zawistowski for careful reading of the manuscript.	Abell AN, 2009, MOL CELL BIOL, V29, P2748, DOI 10.1128/MCB.01391-08; Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	19	86	87	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					525	537		10.1016/j.stem.2011.03.008	http://dx.doi.org/10.1016/j.stem.2011.03.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549327	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000290927600013
J	Polymenidou, M; Lagier-Tourenne, C; Hutt, KR; Huelga, SC; Moran, J; Liang, TY; Ling, SC; Sun, E; Wancewicz, E; Mazur, C; Kordasiewicz, H; Sedaghat, Y; Donohue, JP; Shiue, L; Bennett, CF; Yeo, GW; Cleveland, DW				Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Hutt, Kasey R.; Huelga, Stephanie C.; Moran, Jacqueline; Liang, Tiffany Y.; Ling, Shuo-Chien; Sun, Eveline; Wancewicz, Edward; Mazur, Curt; Kordasiewicz, Holly; Sedaghat, Yalda; Donohue, John Paul; Shiue, Lily; Bennett, C. Frank; Yeo, Gene W.; Cleveland, Don W.			Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; BINDING-PROTEIN; TARDBP MUTATIONS; GENE; EXPRESSION; REGULATOR; TAU; ASSOCIATION	We used cross-linking and immunoprecipitation coupled with high-throughput sequencing to identify binding sites in 6,304 genes as the brain RNA targets for TDP-43, an RNA binding protein that, when mutated, causes amyotrophic lateral sclerosis. Massively parallel sequencing and splicing-sensitive junction arrays revealed that levels of 601 mRNAs were changed (including Fus (Tls), progranulin and other transcripts encoding neurodegenerative disease-associated proteins) and 965 altered splicing events were detected (including in sortilin, the receptor for progranulin) following depletion of TDP-43 from mouse adult brain with antisense oligonucleotides. RNAs whose levels were most depleted by reduction in TDP-43 were derived from genes with very long introns and that encode proteins involved in synaptic activity. Lastly, we found that TDP-43 autoregulates its synthesis, in part by directly binding and enhancing splicing of an intron in the 3' untranslated region of its own transcript, thereby triggering nonsense-mediated RNA degradation.	[Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Moran, Jacqueline; Ling, Shuo-Chien; Sun, Eveline; Kordasiewicz, Holly; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Hutt, Kasey R.; Huelga, Stephanie C.; Moran, Jacqueline; Liang, Tiffany Y.; Ling, Shuo-Chien; Sun, Eveline; Kordasiewicz, Holly; Yeo, Gene W.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Wancewicz, Edward; Mazur, Curt; Sedaghat, Yalda; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Donohue, John Paul; Shiue, Lily] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, RNA Ctr, Santa Cruz, CA 95064 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Isis Pharmaceuticals Inc; University of California System; University of California Santa Cruz	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	geneyeo@ucsd.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; lagier-Tourenne, Clotilde/ABE-6303-2020; Polymenidou, Magdalini/D-2254-2014; Yeo, Gene/AAE-7676-2019	lagier-Tourenne, Clotilde/0000-0002-3058-8322; Yeo, Gene/0000-0002-0799-6037; Cleveland, Don/0000-0002-1934-3682; LING, Shuo-Chien/0000-0002-0300-8812; Liang, Tiffany/0000-0002-1986-5966	Human Frontier Science Program; Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; National Science Foundation; US National Institutes of Health [R37 NS27036, HG004659, GM084317]; University of California, San Diego; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank members of B. Ren's laboratory, especially Z. Ye, S. Kuan and L. Edsall for technical help with the Illumina sequencing and U. Wagner for helpful discussions, K. Clutario and J. Boubaker for technical help, as well as all of the members of the Yeo and Cleveland laboratories, M. Ares Jr for generous support, and the neuro-team of ISIS Pharmaceuticals for critical comments and suggestions on this project. M. P. is the recipient of a Human Frontier Science Program Long Term Fellowship. C. L.-T. is the recipient of the Milton-Safenowitz post-doctoral fellowship from the Amyotrophic Lateral Sclerosis Association. D. W. C. receives salary support from the Ludwig Institute for Cancer Research. S. C. H. is funded by a National Science Foundation Graduate Research Fellowship. This work was supported by grants from the US National Institutes of Health (R37 NS27036 and an American Recovery and Reinvestment Act Challenge grant) to D. W. C and partially by grants from the US National Institutes of Health (HG004659 and GM084317) and the Stem Cell Program at the University of California, San Diego to G.W.Y.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Birve A, 2010, HUM MOL GENET, V19, P4201, DOI 10.1093/hmg/ddq338; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dreumont N, 2010, NUCLEIC ACIDS RES, V38, P1353, DOI 10.1093/nar/gkp1086; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Le Hir H, 2000, GENE DEV, V14, P1098; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Valdmanis PN, 2009, ANN HUM GENET, V73, P652, DOI 10.1111/j.1469-1809.2009.00546.x; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	50	804	817	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					459	U92		10.1038/nn.2779	http://dx.doi.org/10.1038/nn.2779			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358643	Green Accepted			2022-12-24	WOS:000288849400017
J	Huynh, MA; Ikeuchi, Y; Netherton, S; de la Torre-Ubieta, L; Kanadia, R; Stegmuller, J; Cepko, C; Bonni, S; Bonni, A				Huynh, Mai Anh; Ikeuchi, Yoshiho; Netherton, Stuart; de la Torre-Ubieta, Luis; Kanadia, Rahul; Stegmueller, Judith; Cepko, Constance; Bonni, Shirin; Bonni, Azad			An Isoform-Specific SnoN1-FOXO1 Repressor Complex Controls Neuronal Morphogenesis and Positioning in the Mammalian Brain	NEURON			English	Article							TRANSCRIPTION FACTOR FKHR; AXONAL MORPHOGENESIS; POSTMITOTIC NEURONS; RADIAL MIGRATION; DOUBLECORTIN; PATHWAY; SNON; PROTEIN; MALFORMATIONS; TRANSLOCATION	Control of neuronal positioning is fundamental to normal brain development. However, the cell-intrinsic mechanisms that govern neuronal positioning remain to be elucidated. Here, we report that the spliced protein products of the transcriptional regulator SnoN, SnoN1 and SnoN2, harbor opposing functions in the coordinate regulation of neuronal branching and positioning. Knockdown of SnoN2 stimulates axon branching in primary neurons and impairs migration of granule neurons in the rat cerebellar cortex in vivo. By contrast, SnoN1 knockdown suppresses SnoN2 knockdown-induced neuronal branching and strikingly triggers excessive migration of granule neurons in the cerebellar cortex. We also find that SnoN1 forms a complex with the transcription factor FOXO1 that represses the X-linked lissencephaly gene encoding doublecortin (DCX). Accordingly, repression of DCX mediates the ability of SnoN1 to regulate branching in primary neurons and granule neuron migration in vivo. These data define an isoform-specific SnoN1-FOXO1 transcriptional complex that orchestrates neuronal branching and positioning in the brain with important implications for the study of developmental disorders of cognition and epilepsy.	[Huynh, Mai Anh; Ikeuchi, Yoshiho; de la Torre-Ubieta, Luis; Stegmueller, Judith; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Huynh, Mai Anh; Bonni, Azad] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Huynh, Mai Anh] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [de la Torre-Ubieta, Luis; Bonni, Azad] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Netherton, Stuart; Bonni, Shirin] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Kanadia, Rahul; Cepko, Constance] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kanadia, Rahul; Cepko, Constance] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Calgary; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Ikeuchi, Yoshiho/N-1057-2019; ikeuchi, yoshiho/C-1713-2014	ikeuchi, yoshiho/0000-0002-2829-3840; de la Torre-Ubieta, Luis/0000-0001-8059-6243	NIH [NS041021, NS047188]; Canadian Institutes of Health Research; Alberta Cancer Board (ACB); ACG; Albert J. Ryan Foundation; Human Frontier Science Program Long-Term Fellowship; National Science Foundation; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077226, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021, R01NS047188, R01NS051255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Board (ACB); ACG; Albert J. Ryan Foundation; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank John Blenis and Randy King for helpful discussions, John Parnavelas for the DCX plasmids, Dan Bernard for the Smad2 RNAi plasmid, Akiyoshi Fukamizu for the Flag-FOXO1 plasmid, and members of the Bonni laboratory for helpful discussions and critical reading of the manuscript. This work was supported by NIH grants NS041021 and NS047188 (A.B.), the Canadian Institutes of Health Research and the Alberta Cancer Board (ACB) operating grants (S.B.), an ACG Postdoctoral Fellowship (S.N.), an NIH Training Grant GM077226 (M.A.H.), the Albert J. Ryan Foundation (M.A.H. and L.T.-U.), the Human Frontier Science Program Long-Term Fellowship (Y.I), the National Science Foundation (L.T.-U.), and the Deutsche Forschungsgemeinschaft (J.S.). C.C. is an investigator of the Howard Hughes Medical Institute.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altman J, 1997, DEV CEREBELLAR SYSTE; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gleeson JG, 2001, MENT RETARD DEV D R, V7, P167, DOI 10.1002/mrdd.1024; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Karl C, 2005, J NEUROCHEM, V92, P264, DOI 10.1111/j.1471-4159.2004.02879.x; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Komuro H, 1998, J NEUROSCI, V18, P1478; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; McManus MF, 2005, J CHILD NEUROL, V20, P280, DOI 10.1177/08830738050200040301; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Pelzer T, 1996, DEV DYNAM, V205, P114; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schwartzkroin PA, 2000, MENT RETARD DEV D R, V6, P268, DOI 10.1002/1098-2779(2000)6:4<268::AID-MRDD6>3.0.CO;2-B; Sisodiya SM, 2004, LANCET NEUROL, V3, P29, DOI 10.1016/S1474-4422(03)00620-3; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337	44	27	27	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 10	2011	69	5					930	944		10.1016/j.neuron.2011.02.008	http://dx.doi.org/10.1016/j.neuron.2011.02.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382553	Green Accepted, Bronze			2022-12-24	WOS:000288736500011
J	Lee, KJ; Lee, YK; Rozeboom, A; Lee, JY; Udagawa, N; Hoe, HS; Pak, DTS				Lee, Kea Joo; Lee, Yeunkum; Rozeboom, Aaron; Lee, Ji-Yun; Udagawa, Noriko; Hoe, Hyang-Sook; Pak, Daniel T. S.			Requirement for Plk2 in Orchestrated Ras and Rap Signaling, Homeostatic Structural Plasticity, and Memory	NEURON			English	Article							GTPASE-ACTIVATING PROTEIN; AMPA RECEPTOR TRAFFICKING; INTEGRIN-BINDING PROTEIN; POLO-LIKE KINASE; SYNAPTIC PLASTICITY; NMDA RECEPTOR; NEURONAL PLASTICITY; SYNGAP; POLO-LIKE-KINASE-2; PATHWAY	Ras and Rap small GTPases are important for synaptic plasticity and memory. However, their roles in homeostatic plasticity are unknown. Here, we report that polo-like kinase 2 (Plk2), a homeostatic suppressor of overexcitation, governs the activity of Ras and Rap via coordination of their regulatory proteins. Plk2 directs elimination of Ras activator RasGRF1 and Rap inhibitor SPAR via phosphorylation-dependent ubiquitin-proteasome degradation. Conversely, Plk2 phosphorylation stimulates Ras inhibitor SynGAP and Rap activator PDZGEF1. These Ras/Rap regulators perform complementary functions to downregulate dendritic spines and AMPA receptors following elevated activity, and their collective regulation by Plk2 profoundly stimulates Rap and suppresses Ras. Furthermore, perturbation of Plk2 disrupts Ras and Rap signaling, prevents homeostatic shrinkage and loss of dendritic spines, and impairs proper memory formation. Our study demonstrates a critical role of Plk2 in the synchronized tuning of Ras and Rap and underscores the functional importance of this regulation in homeostatic synaptic plasticity.	[Lee, Kea Joo; Lee, Yeunkum; Rozeboom, Aaron; Lee, Ji-Yun; Udagawa, Noriko; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20057 USA; [Hoe, Hyang-Sook] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20057 USA	Georgetown University; Georgetown University	Pak, DTS (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol, 3900 Reservoir Rd NW, Washington, DC 20057 USA.	dtp6@georgetown.edu	Lee, Ji-Yun/F-8127-2013	Lee, Ji-Yun/0000-0002-4053-6577	NIH [NS048085]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Josefina Lam for technical assistance. This study was supported by NIH grant NS048085 (DTSP).	Arendt T, 2004, EUR J NEUROSCI, V19, P2953, DOI 10.1111/j.0953-816X.2004.03409.x; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Buchsbaum R, 1996, MOL CELL BIOL, V16, P4888; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Evers DM, 2010, NAT NEUROSCI, V13, P1199, DOI 10.1038/nn.2624; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Heumann R, 2000, J CELL BIOL, V151, P1537, DOI 10.1083/jcb.151.7.1537; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Ma S, 2003, MOL CANCER RES, V1, P376; Manabe T, 2000, J NEUROSCI, V20, P2504; Martone ME, 1996, J NEUROSCI, V16, P7437; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Ryu J, 2008, J NEUROSCI, V28, P8178, DOI 10.1523/JNEUROSCI.1944-08.2008; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Ye XJ, 2010, NEURON, V68, P340, DOI 10.1016/j.neuron.2010.09.013; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	45	71	78	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					957	973		10.1016/j.neuron.2011.02.004	http://dx.doi.org/10.1016/j.neuron.2011.02.004			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382555	Bronze, Green Accepted			2022-12-24	WOS:000288736500013
J	Diester, I; Kaufman, MT; Mogri, M; Pashaie, R; Goo, W; Yizhar, O; Ramakrishnan, C; Deisseroth, K; Shenoy, KV				Diester, Ilka; Kaufman, Matthew T.; Mogri, Murtaza; Pashaie, Ramin; Goo, Werapong; Yizhar, Ofer; Ramakrishnan, Charu; Deisseroth, Karl; Shenoy, Krishna V.			An optogenetic toolbox designed for primates	NATURE NEUROSCIENCE			English	Article							SENSORY-MOTOR CORTEX; IN-VIVO CONTROL; OPTICAL CONTROL; MILLISECOND-TIMESCALE; ADENOASSOCIATED VIRUS; CORTICAL-NEURONS; NEURAL CIRCUITRY; NONHUMAN PRIMATE; GENE-THERAPY; MONKEY	Optogenetics is a technique for controlling subpopulations of neurons in the intact brain using light. This technique has the potential to enhance basic systems neuroscience research and to inform the mechanisms and treatment of brain injury and disease. Before launching large-scale primate studies, the method needs to be further characterized and adapted for use in the primate brain. We assessed the safety and efficiency of two viral vector systems (lentivirus and adeno-associated virus), two human promoters (human synapsin (hSyn) and human thymocyte-1 (hThy-1)) and three excitatory and inhibitory mammalian codon-optimized opsins (channelrhodopsin-2, enhanced Natronomonas pharaonis halorhodopsin and the step-function opsin), which we characterized electrophysiologically, histologically and behaviorally in rhesus monkeys (Macaca mulatta). We also introduced a new device for measuring in vivo fluorescence over time, allowing minimally invasive assessment of construct expression in the intact brain. We present a set of optogenetic tools designed for optogenetic experiments in the non-human primate brain.	[Diester, Ilka; Mogri, Murtaza; Pashaie, Ramin; Goo, Werapong; Yizhar, Ofer; Ramakrishnan, Charu; Deisseroth, Karl; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kaufman, Matthew T.; Deisseroth, Karl; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu; shenoy@stanford.edu	Kaufman, Matthew T/B-6273-2014; YIZHAR, OFER/AAV-8497-2021; Kaufman, Matthew/AAK-2860-2020; Diester, Ilka/D-4473-2011; Core, Vector/CAF-4832-2022	Kaufman, Matthew T/0000-0002-8072-023X; Kaufman, Matthew/0000-0002-8072-023X; Yizhar, Ofer/0000-0003-4228-1448; Ramakrishnan, Charu/0000-0002-3474-6332	Human Frontier Science Program; German Academic Exchange Service Award; National Science Foundation; Bio-X; Stanford Graduate Fellowship; Stanford University; William M. Keck Foundation; Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine; McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Institute of Mental Health; National Institute on Drug Abuse; US National Institutes of Health [1DP1OD006409]; Burroughs Wellcome Fund; US National Institutes of Health-National Institute of Neurological Disorders and Stroke [CRCNS R01-NS054283]; Defense Advanced Research Projects Agency [N66001-10-C-2010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); German Academic Exchange Service Award(Deutscher Akademischer Austausch Dienst (DAAD)); National Science Foundation(National Science Foundation (NSF)); Bio-X; Stanford Graduate Fellowship(Stanford University); Stanford University(Stanford University); William M. Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Vessal and A. Lilak for technical assistance during perfusions, M. Churchland for technical support during surgeries and technical discussions, S. Ryu for surgical assistance, M. Risch for veterinary care, D. Haven for technical support, S. Eisensee for administrative assistance, I. Witten for advice and members of the Deisseroth and Shenoy laboratories for discussions. I. D. is supported by a Human Frontier Science Program fellowship and a German Academic Exchange Service Award, M. T. K. by a National Science Foundation graduate fellowship, M.M. by Bio-X and a Stanford Graduate Fellowship and R. P. by a Stanford University Dean's Postdoctoral Fellowship Award. W. G. is supported by a Stanford Graduate Fellowship. O.Y. is supported by a Human Frontier Science Program fellowship. K. D. is supported by the William M. Keck Foundation, the Snyder Foundation, the Albert Yu and Mary Bechmann Foundation, the Wallace Coulter Foundation, the California Institute for Regenerative Medicine, the McKnight Foundation, the Esther A. and Joseph Klingenstein Fund, the National Science Foundation, the National Institute of Mental Health, the National Institute on Drug Abuse and a US National Institutes of Health Director's Pioneer Award. K. V. S. is supported by a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, US National Institutes of Health-National Institute of Neurological Disorders and Stroke grant CRCNS R01-NS054283 and a US National Institutes of Health Director's Pioneer Award (1DP1OD006409). K. D. and K. V. S. are supported by Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery (N66001-10-C-2010).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bogen IL, 2009, NEUROCHEM INT, V55, P13, DOI 10.1016/j.neuint.2009.02.006; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; CALVIN WH, 1976, J NEUROPHYSIOL, V39, P420, DOI 10.1152/jn.1976.39.2.420; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen CH, 2007, J CELL BIOCHEM, V101, P566, DOI 10.1002/jcb.21217; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Colle MA, 2010, HUM MOL GENET, V19, P147, DOI 10.1093/hmg/ddp475; Diester I, 2008, J NEUROSCI, V28, P7737, DOI 10.1523/JNEUROSCI.1347-08.2008; Disbrow E, 2003, J COMP NEUROL, V462, P382, DOI 10.1002/cne.10731; Dodiya HB, 2010, MOL THER, V18, P579, DOI 10.1038/mt.2009.216; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; GILJA V, IEEE T BIOM IN PRESS; Gordon T, 2009, NEUROSURGERY, V65, pA132, DOI 10.1227/01.NEU.0000335650.09473.D3; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; HIKOSAKA O, 1983, BRAIN RES, V272, P368, DOI 10.1016/0006-8993(83)90586-3; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; HOUSER CR, 1983, J NEUROCYTOL, V12, P617, DOI 10.1007/BF01181527; JONES EG, 1994, J NEUROSCI, V14, P611; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; Kim S, 2007, IEEE T NEUR SYS REH, V15, P493, DOI 10.1109/TNSRE.2007.908429; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	49	318	345	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					387	397		10.1038/nn.2749	http://dx.doi.org/10.1038/nn.2749			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278729	Green Accepted			2022-12-24	WOS:000287650100021
J	Kamp, TJ				Kamp, Timothy J.			An Electrifying iPSC Disease Model: Long QT Syndrome Type 2 and Heart Cells in a Dish	CELL STEM CELL			English	Editorial Material								In a recent Nature paper, Itzhaki et al. (2011) generate induced pluripotent stem cells (iPSCs) from patients with a potentially fatal inherited arrhythmia, long QT syndrome type 2. Cardiomyocytes differentiated from the patient-derived iPSCs exhibit the hallmark cardiac electrical signatures of the disease, which can be reversed by pharmacological intervention.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Clin Sci Ctr H6 370, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Kamp, TJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Clin Sci Ctr H6 370, MC 3248,600 Highland Ave, Madison, WI 53792 USA.	tjk@medicine.wisc.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876	NHLBI NIH HHS [U01 HL099773, R01 HL084615] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084615, U01HL099773] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	7	11	11	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					130	131		10.1016/j.stem.2011.01.010	http://dx.doi.org/10.1016/j.stem.2011.01.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295269	Bronze			2022-12-24	WOS:000287633400006
J	Koh, KP; Yabuuchi, A; Rao, S; Huang, Y; Cunniff, K; Nardone, J; Laiho, A; Tahiliani, M; Sommer, CA; Mostoslavsky, G; Lahesmaa, R; Orkin, SH; Rodig, SJ; Daley, GQ; Rao, A				Koh, Kian Peng; Yabuuchi, Akiko; Rao, Sridhar; Huang, Yun; Cunniff, Kerrianne; Nardone, Julie; Laiho, Asta; Tahiliani, Mamta; Sommer, Cesar A.; Mostoslavsky, Gustavo; Lahesmaa, Riitta; Orkin, Stuart H.; Rodig, Scott J.; Daley, George Q.; Rao, Anjana			Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							DNA METHYLATION; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; MYELOID CANCERS; GENOMIC DNA; 5-METHYLCYTOSINE; PLURIPOTENCY; CONVERSION; PROTEINS; ROLES	TET family enzymes convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. Here, we show that Tet1 and Tet2 are Oct4-regulated enzymes that together sustain 5hmC in mouse embryonic stem cells (ESCs) and are induced concomitantly with 5hmC during reprogramming of fibroblasts to induced pluripotent stem cells. ESCs depleted of Tet1 by RNAi show diminished expression of the Nodal antagonist Lefty1 and display hyperactive Nodal signaling and skewed differentiation into the endoderm-mesoderm lineage in embryoid bodies in vitro. In Fgf4- and heparin-supplemented culture conditions, Tet1-depleted ESCs activate the trophoblast stem cell lineage determinant Elf5 and can colonize the placenta in midgestation embryo chimeras. Consistent with these findings, Tet1-depleted ESCs form aggressive hemorrhagic teratomas with increased endoderm, reduced neuroectoderm, and ectopic appearance of trophoblastic giant cells. Thus, 5hmC is an epigenetic modification associated with the pluripotent state, and Tet1 functions to regulate the lineage differentiation potential of ESCs.	[Koh, Kian Peng; Huang, Yun; Tahiliani, Mamta; Lahesmaa, Riitta; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yabuuchi, Akiko; Rao, Sridhar; Cunniff, Kerrianne; Orkin, Stuart H.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Yabuuchi, Akiko; Rao, Sridhar; Cunniff, Kerrianne; Orkin, Stuart H.; Daley, George Q.] Harvard Stem Cell Inst, Dana Faber Canc Inst, Boston, MA 02115 USA; [Nardone, Julie] Cell Signaling Technol, Bioinformat, Danvers, MA 01923 USA; [Laiho, Asta; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Laiho, Asta; Lahesmaa, Riitta] Abo Akad Univ, FI-20520 Turku, Finland; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, Boston, MA 02118 USA; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02118 USA; [Orkin, Stuart H.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Rodig, Scott J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Daley, George Q.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Koh, Kian Peng; Huang, Yun; Tahiliani, Mamta; Lahesmaa, Riitta; Rao, Anjana] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Turku; Abo Akademi University; Boston University; Boston University; Howard Hughes Medical Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	arao@idi.harvard.edu	Sommer, Cesar A/H-9187-2013; Koh, Kian Peng/S-6279-2016; Rodig, Scott/Y-3889-2019; Sommer, Cesar A/H-7062-2012	Koh, Kian Peng/0000-0003-2523-5175; Mostoslavsky, Gustavo/0000-0002-0784-2169; Huang, Yun/0000-0001-5950-9168	NIH [AI44432, CA42471, RC1-DA028422, RO1-DK70055, RO1-DK59279, UO1-HL100001]; ARRA [RC2-HL102815]; Roche Foundation for Anemia Research; Alex's Lemonade Stand; Harvard Stem Cell Institute; American Heart Association; Academy of Finland; Sigrid Juselius Foundation; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; Johnson Johnson; Verastem; Epizyme; iPierian; Solasia KK; MPM Capital, L.L.P.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA042471, R01CA042471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA; Roche Foundation for Anemia Research; Alex's Lemonade Stand; Harvard Stem Cell Institute; American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Verastem; Epizyme; iPierian; Solasia KK; MPM Capital, L.L.P.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Gadue and G. Keller for CD4-Foxa2/GFP-Bry ESCs, C. Unitt and staff at the Specialized Rodent Histopathology Services, Brigham and Women's Hospital for mouse histology and GFP staining, P. Junni at the Finnish Microarray and Sequencing Centre, Turku Centre for Biotechnology for sample processing and array hybridization, and K. E. Waraska at the Biopolymers facility, Harvard Medical School, for low-density array-based q-PCR. This work was funded by NIH grants AI44432, CA42471, and RC1-DA028422 (to A.R.); RO1-DK70055, RO1-DK59279, UO1-HL100001, and special funds from the ARRA stimulus package RC2-HL102815 (to GOD); the Roche Foundation for Anemia Research, Alex's Lemonade Stand, and the Harvard Stem Cell Institute (to GOD); an American Heart Association postdoctoral fellowship (to K.P.K); and grants from The Academy of Finland and The Sigrid Juselius Foundation (to R.L.). G.Q.D. is an affiliate member of the Broad Institute, a recipient of Clinical Scientist Awards in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. G.Q.D. is a member of the scientific advisory boards and holds stock in or receives consulting fees from the following companies: Johnson & Johnson, Verastem, Epizyme, iPierian, Solasia KK, and MPM Capital, L.L.P..	Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	48	561	606	0	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					200	213		10.1016/j.stem.2011.01.008	http://dx.doi.org/10.1016/j.stem.2011.01.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295276	Bronze, Green Accepted			2022-12-24	WOS:000287633400013
J	Koche, RP; Smith, ZD; Adli, M; Gu, HC; Ku, MC; Gnirke, A; Bernstein, BE; Meissner, A				Koche, Richard P.; Smith, Zachary D.; Adli, Mazhar; Gu, Hongcang; Ku, Manching; Gnirke, Andreas; Bernstein, Bradley E.; Meissner, Alexander			Reprogramming Factor Expression Initiates Widespread Targeted Chromatin Remodeling	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DIFFERENTIATED CELLS; PLURIPOTENT; GENOME; MAPS; TRANSCRIPTION; CIRCUITRY; ENHANCERS; GENES	Despite rapid progress in characterizing transcription factor-driven reprogramming of somatic cells to an induced pluripotent stem cell (iPSC) state, many mechanistic questions still remain. To gain insight into the earliest events in the reprogramming process, we systematically analyzed the transcriptional and epigenetic changes that occur during early factor induction after discrete numbers of divisions. We observed rapid, genome-wide changes in the euchromatic histone modification, H3K4me2, at more than a thousand loci including large subsets of pluripotency-related or developmentally regulated gene promoters and enhancers. In contrast, patterns of the repressive H3K27me3 modification remained largely unchanged except for focused depletion specifically at positions where H3K4 methylation is gained. These chromatin regulatory events precede transcriptional changes within the corresponding loci. Our data provide evidence for an early, organized, and population-wide epigenetic response to ectopic reprogramming factors that clarify the temporal order through which somatic identity is reset during reprogramming.	[Koche, Richard P.; Smith, Zachary D.; Adli, Mazhar; Gu, Hongcang; Ku, Manching; Gnirke, Andreas; Bernstein, Bradley E.; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Koche, Richard P.; Adli, Mazhar; Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Koche, Richard P.; Adli, Mazhar; Ku, Manching; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Koche, Richard P.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Smith, Zachary D.; Bernstein, Bradley E.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bernstein, Bradley E.] Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Howard Hughes Medical Institute	Meissner, A (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu		Gu, Hongcang/0000-0002-1439-7606; Koche, Richard/0000-0002-6820-5083	MLSC; Pew Charitable Trusts; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER	MLSC; Pew Charitable Trusts; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank Tarjei Mikkelsen for critical reading of the manuscript. We would like to apologize to authors whose primary work we didn't cite because of space restrictions. B.E.B. is an early career scientist of the HHMI. A.M. is a New Investigator of the Massachusetts Life Science Center (MLSC) and Pew Scholar. This work was funded by the MLSC and Pew Charitable Trusts.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	23	283	290	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					96	105		10.1016/j.stem.2010.12.001	http://dx.doi.org/10.1016/j.stem.2010.12.001			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211784	Green Accepted, Bronze			2022-12-24	WOS:000286786200014
J	Zhang, JQ; Lian, QZ; Zhu, GL; Zhou, F; Sui, L; Tan, C; Mutalif, RA; Navasankari, R; Zhang, YL; Tse, HF; Stewart, CL; Colman, A				Zhang, Jinqiu; Lian, Qizhou; Zhu, Guili; Zhou, Fan; Sui, Lin; Tan, Cindy; Mutalif, Rafidah Abdul; Navasankari, Raju; Zhang, Yuelin; Tse, Hung-Fat; Stewart, Colin L.; Colman, Alan			A Human iPSC Model of Hutchinson Gilford Progeria Reveals Vascular Smooth Muscle and Mesenchymal Stem Cell Defects	CELL STEM CELL			English	Article							ELECTRICAL-STIMULATION; LAMINOPATHIES; FIBROBLASTS; EXPRESSION; PHENOTYPES; MOUSE; PROLIFERATION; MISREGULATION; ARCHITECTURE; RESPONSES	The segmental premature aging disease Hutchinson-Gilford Progeria syndrome (HGPS) is caused by a truncated and farnesylated form of Lamin A called progerin. HGPS affects mesenchymal lineages, including the skeletal system, dermis, and vascular smooth muscle (VSMC). To understand the underlying molecular pathology of HGPS, we derived induced pluripotent stem cells (iPSCs) from HGPS dermal fibroblasts. The iPSCs mere differentiated into neural progenitors, endothelial cells, fibroblasts, VSMCs, and mesenchymal stem cells (MSCs). Progerin levels were highest in MSCs, VSMCs, and fibroblasts, in that order, with these lineages displaying increased DNA damage, nuclear abnormalities, and HGPS-VSMC accumulating numerous calponin-staining inclusion bodies. Both HGPS-MSC and -VSMC viability was compromised by stress and hypoxia in vitro and in vivo (MSC). Because MSCs reside in low oxygen niches in vivo, we propose that, in HGPS, this causes additional depletion of the MSC pool responsible for replacing differentiated cells lost to progerin toxicity.	[Zhang, Jinqiu; Zhu, Guili; Zhou, Fan; Sui, Lin; Tan, Cindy; Mutalif, Rafidah Abdul; Navasankari, Raju; Stewart, Colin L.; Colman, Alan] A STAR Inst Med Biol, Singapore 138648, Singapore; [Lian, Qizhou; Zhang, Yuelin; Tse, Hung-Fat] Univ Hong Kong, Div Cardiol, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Lian, Qizhou] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Pokfulam, Hong Kong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Hong Kong; University of Hong Kong	Stewart, CL (corresponding author), A STAR Inst Med Biol, Singapore 138648, Singapore.	colin.stewart@imb.a-star.edu.sg; alan.colman@imb.a-star.edu.sg	Tse, Hung-Fat/C-4426-2009; Zhang, Yuelin/C-4569-2009; Lian, Qizhou/Y-1613-2019	Tse, Hung-Fat/0000-0002-9578-7808; Lian, Qizhou/0000-0001-8189-7160	Singapore Biomedical Research Council; Singapore Agency for Science, Technology and Research (A*STAR); Hong Kong Research Grant Council [HKU 8/CRF/09]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Hong Kong Research Grant Council(Hong Kong Research Grants Council)	We thank the Singapore Biomedical Research Council and the Singapore Agency for Science, Technology and Research (A*STAR) for funding this work. The animal work was supported by Hong Kong Research Grant Council (HKU 8/CRF/09). We also thank M. Costa for helpful advice.	Ackerman J, 2002, PEDIATR PATHOL MOL M, V21, P1, DOI 10.1080/15227950252774110; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Horwitz EM, 2009, ISR MED ASSOC J, V11, P209; Huang SR, 2005, HUM GENET, V118, P444, DOI 10.1007/s00439-005-0051-7; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Leskela HV, 2006, BONE, V39, P1026, DOI 10.1016/j.bone.2006.05.003; Li QA, 2011, J SURG RES, V166, P162, DOI 10.1016/j.jss.2009.08.031; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Mounkes LC, 2004, CURR OPIN CELL BIOL, V16, P322, DOI 10.1016/j.ceb.2004.03.009; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Stehbens WE, 2001, CARDIOVASC PATHOL, V10, P133, DOI 10.1016/S1054-8807(01)00069-2; Takahashi K, 2003, ADV BIOPHYS, V37, P91, DOI 10.1016/S0065-227X(03)80004-7; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Weil BR, 2009, SURGERY, V146, P190, DOI 10.1016/j.surg.2009.03.031; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868	50	345	353	2	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					31	45		10.1016/j.stem.2010.12.002	http://dx.doi.org/10.1016/j.stem.2010.12.002			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21185252	Bronze			2022-12-24	WOS:000286786200009
J	Gabriel, JP; Ausborn, J; Ampatzis, K; Mahmood, R; Eklof-Ljunggren, E; El Manira, A				Gabriel, Jens Peter; Ausborn, Jessica; Ampatzis, Konstantinos; Mahmood, Riyadh; Eklof-Ljunggren, Emma; El Manira, Abdeljabbar			Principles governing recruitment of motoneurons during swimming in zebrafish	NATURE NEUROSCIENCE			English	Article							TELEOST BRACHYDANIO-RERIO; MOTOR-NEURON DIVERSITY; MUSCLE-FIBER TYPES; SPINAL-CORD; SIZE PRINCIPLE; POSTHATCHING DEVELOPMENT; LARVAL ZEBRAFISH; NKX6 PROTEINS; CELL-SIZE; SPECIFICATION	Locomotor movements are coordinated by a network of neurons that produces sequential muscle activation. Different motoneurons need to be recruited in an orderly manner to generate movement with appropriate speed and force. However, the mechanisms governing recruitment order have not been fully clarified. Using an in vitro juvenile/adult zebrafish brainstem-spinal cord preparation, we found that motoneurons were organized into four pools with specific topographic locations and were incrementally recruited to produce swimming at different frequencies. The threshold of recruitment was not dictated by the input resistance of motoneurons, but was instead set by a combination of specific biophysical properties and the strength of the synaptic currents. Our results provide insights into the cellular and synaptic computations governing recruitment of motoneurons during locomotion.	[Gabriel, Jens Peter; Ausborn, Jessica; Ampatzis, Konstantinos; Mahmood, Riyadh; Eklof-Ljunggren, Emma; El Manira, Abdeljabbar] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	El Manira, A (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	abdel.elmanira@ki.se	Ausborn, Jessica/J-7418-2012	Ausborn, Jessica/0000-0003-4500-5131; El Manira, Abdel/0000-0001-5920-9384; Ampatzis, Konstantinos/0000-0001-7998-6463	Swedish Research Council; European Commission; Soderberg Foundation; Karolinska Institutet; German Science Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Soderberg Foundation; Karolinska Institutet(Karolinska Institutet); German Science Foundation(German Research Foundation (DFG))	We thank K. Dougherty, R. Hill, S. Grillner and D. McLean for comments and critical discussion of this manuscript. This work was funded by a grant from the Swedish Research Council, European Commission (FP7, Spinal Cord Repair), Soderberg Foundation and Karolinska Institutet. J.P.G. and J.A. received postdoctoral fellowships from the German Science Foundation.	Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Binder MD, 2002, ADV EXP MED BIOL, V508, P207; BONE Q, 1978, FISH B-NOAA, V76, P691; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Cope TC, 1995, NEWS PHYSIOL SCI, V10, P280, DOI 10.1152/physiologyonline.1995.10.6.280; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; El Manira A, 2010, PHYSIOLOGY, V25, P230, DOI 10.1152/physiol.00007.2010; El Manira A, 2008, NAT NEUROSCI, V11, P1367, DOI 10.1038/nn1208-1367; ENOKA RM, 1984, TRENDS NEUROSCI, V7, P226, DOI 10.1016/S0166-2236(84)80210-6; Fetcho JR, 2010, ANN NY ACAD SCI, V1198, P94, DOI 10.1111/j.1749-6632.2010.05539.x; Gabriel JP, 2008, J NEUROPHYSIOL, V99, P37, DOI 10.1152/jn.00785.2007; Gabriel JP, 2009, J NEUROSCI, V29, P10387, DOI 10.1523/JNEUROSCI.1978-09.2009; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V357, P453, DOI 10.1113/jphysiol.1984.sp015511; Heckman CJ, 2008, J PHYSIOL-LONDON, V586, P1225, DOI 10.1113/jphysiol.2007.145078; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; HECKMAN CJ, 1988, J NEUROPHYSIOL, V60, P1946, DOI 10.1152/jn.1988.60.6.1946; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Henneman E, 2010, HDB PHYSL NERVOUS 1, DOI 10.1002/cphy.cp010211; Hutchinson SA, 2007, DEVELOPMENT, V134, P1671, DOI 10.1242/dev.02826; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; JOHNSTON IA, 1983, MAR BEHAV PHYSIOL, V9, P83, DOI 10.1080/10236248309378586; KERNELL D, 1981, BRAIN RES, V204, P311, DOI 10.1016/0006-8993(81)90591-6; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; McLean DL, 2000, BRAIN RES BULL, V53, P595, DOI 10.1016/S0361-9230(00)00393-2; Mendell LM, 2005, J NEUROPHYSIOL, V93, P3024, DOI 10.1152/classicessays.00025.2005; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; Nanou E, 2008, P NATL ACAD SCI USA, V105, P20941, DOI 10.1073/pnas.0806403106; Sillar KT, 1998, ANN NY ACAD SCI, V860, P318, DOI 10.1111/j.1749-6632.1998.tb09059.x; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VANRAAMSDONK W, 1982, ANAT EMBRYOL, V164, P51; VANRAAMSDONK W, 1978, ANAT EMBRYOL, V153, P137; VANRAAMSDONK W, 1983, ANAT EMBRYOL, V167, P125; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	45	74	75	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					93	U125		10.1038/nn.2704	http://dx.doi.org/10.1038/nn.2704			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21113162				2022-12-24	WOS:000285684900019
J	Lu, BX; Zhang, Q; Wang, HK; Wang, Y; Nakayama, M; Ren, DJ				Lu, Boxun; Zhang, Qi; Wang, Haikun; Wang, Yan; Nakayama, Manabu; Ren, Dejian			Extracellular Calcium Controls Background Current and Neuronal Excitability via an UNC79-UNC80-NALCN Cation Channel Complex	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SENSING RECEPTOR; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; MOLECULAR RELATIONSHIPS; TRANSMEMBRANE PROTEIN; DIVALENT-CATIONS; NERVE-TERMINALS; SUBSTANCE-P; IN-VIVO	In contrast to its extensively studied intracellular roles, the molecular mechanisms by which extracellular Ca2+ regulates the basal excitability of neurons are unclear. One mechanism is believed to be through Ca2+'s interaction with the negative charges on the cell membrane (the charge screening effect). Here we show that, in cultured hippocampal neurons, lowering [Ca2+](e) activates a NALCN channel-dependent Ne-leak current (IL-Na). The coupling between [Ca2+](e) and NALCN requires a Ca2+-sensing G protein-coupled receptor, an activation of G-proteins, an UNC80 protein that bridges NALCN to a large novel protein UNC79 in the same complex, and the last amino acid of NALCN's intracellular tail. In neurons from nalcn and unc79 knockout mice, IL-Na is insensitive to changes in [Ca2+](e), and reducing [Ca2+](e) fails to elicit the excitatory effects seen in the wild-type. Therefore, extracellular Ca2+ influences neuronal excitability through the UNC79-UNC80-NALCN complex in a G protein-dependent fashion.	[Lu, Boxun; Zhang, Qi; Wang, Haikun; Wang, Yan; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Nakayama, Manabu] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba 2920818, Japan	University of Pennsylvania; Kazusa DNA Research Institute	Ren, DJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu		wang, hai kun/0000-0002-4714-4672	American Heart Association; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074257, R01NS055293] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Bruce Bean, Kevin Foskett, Igor Medina, Betsy Navarro, and Haoxing Xu for critically reading earlier versions of the manuscript and suggestions, Lixia Yue for cDNA clones, and members of the Ren lab for help in experiments and discussion. This work was supported by grants from the American Heart Association and the National Institutes of Health.	ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; ARMSTRONG CM, 1991, P NATL ACAD SCI USA, V88, P6528, DOI 10.1073/pnas.88.15.6528; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; BROWN EM, 1995, NEW ENGL J MED, V333, P234, DOI 10.1056/NEJM199507273330407; Burgo A, 2003, J PHYSIOL-LONDON, V549, P537, DOI 10.1113/jphysiol.2003.041871; Chinopoulos C, 2007, NEUROCHEM INT, V50, P148, DOI 10.1016/j.neuint.2006.07.013; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Farkas RH, 1996, J NEUROPHYSIOL, V76, P1968, DOI 10.1152/jn.1996.76.3.1968; Feng ZY, 2003, J NEUROPHYSIOL, V90, P2253, DOI 10.1152/jn.00241.2003; Formenti A, 2001, J PHYSIOL-LONDON, V535, P33, DOI 10.1111/j.1469-7793.2001.00033.x; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gama L, 2001, J BIOL CHEM, V276, P39053, DOI 10.1074/jbc.M105662200; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; HABLITZ JJ, 1986, BIOPHYS J, V50, P753, DOI 10.1016/S0006-3495(86)83515-9; Heinemann U, 1986, Adv Neurol, V44, P641; HEINEMANN U, 1980, EXP BRAIN RES, V40, P247; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; KACZMAREK LK, 1975, EPILEPSIA, V16, P91, DOI 10.1111/j.1528-1157.1975.tb04725.x; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; KRNJEVIC K, 1982, CAN J PHYSIOL PHARM, V60, P1658, DOI 10.1139/y82-244; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Liu HT, 1999, P NATL ACAD SCI USA, V96, P5286, DOI 10.1073/pnas.96.9.5286; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; MacDonald JF, 2006, TRENDS NEUROSCI, V29, P75, DOI 10.1016/j.tins.2005.12.001; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; MORRIS ME, 1993, AM J PHYSIOL, V264, pR761, DOI 10.1152/ajpregu.1993.264.4.R761; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nakayama M, 2006, FASEB J, V20, P1718, DOI 10.1096/fj.06-5952fje; Nicholls J., 2001, NEURON BRAIN; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pidasheva S, 2004, HUM MUTAT, V24, P107, DOI 10.1002/humu.20067; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Ptak K, 2009, J NEUROSCI, V29, P3720, DOI 10.1523/JNEUROSCI.5271-08.2009; PUMAIN R, 1985, EXP NEUROL, V89, P250, DOI 10.1016/0014-4886(85)90280-8; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; Snutch TP, 2007, NEURON, V54, P505, DOI 10.1016/j.neuron.2007.05.005; Stanley EF, 2000, J NEUROPHYSIOL, V83, P477, DOI 10.1152/jn.2000.83.1.477; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wang HK, 2009, BIOL REPROD, V81, P539, DOI 10.1095/biolreprod.109.077107; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Wise A, 1999, NEUROPHARMACOLOGY, V38, P1647, DOI 10.1016/S0028-3908(99)00119-7; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	65	120	125	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					488	499		10.1016/j.neuron.2010.09.014	http://dx.doi.org/10.1016/j.neuron.2010.09.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040849	Green Accepted, Bronze			2022-12-24	WOS:000284255800016
J	Li, JX; Gu, XS; Ma, YH; Calicchio, ML; Kong, D; Teng, YD; Yu, LL; Crain, AM; Vartanian, TK; Pasqualini, R; Arap, W; Libermann, TA; Snyder, EY; Sidman, RL				Li, Jianxue; Gu, Xuesong; Ma, Yinghua; Calicchio, Monica L.; Kong, Dong; Teng, Yang D.; Yu, Lili; Crain, Andrew M.; Vartanian, Timothy K.; Pasqualini, Renata; Arap, Wadih; Libermann, Towia A.; Snyder, Evan Y.; Sidman, Richard L.			Nna1 Mediates Purkinje Cell Dendritic Development via Lysyl Oxidase Propeptide and NF-kappa B Signaling	NEURON			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; TUMOR-SUPPRESSOR ACTIVITY; MATRIX-FORMING ENZYME; MUTANT MICE; LENTIVIRAL VECTORS; RAT-BRAIN; GROWTH; CANCER; DEGENERATION; TRANSDUCTION	The molecular pathways controlling cerebellar Purkinje cell dendrite formation and maturation are poorly understood. The Purkinje cell degeneration (pcd) mutant mouse is characterized by mutations in Nna1, a gene discovered in an axonal regenerative context, but whose actual function in development and disease is unknown. We found abnormal development of Purkinje cell dendrites in postnatal pcd(Sid) mice and linked this deficit to a deletion mutation in exon 7 of Nna1. With single cell gene profiling and virus-based gene transfer, we analyzed a molecular pathway downstream to Nna1 underlying abnormal Purkinje cell dendritogenesis in pcd(Sid) mice. We discovered that mutant Nna1 dramatically increases intranuclear localization of lysyl oxidase propeptide, which interferes with NF-kappa B RelA signaling and microtubule-associated protein regulation of microtubule stability, leading to underdevelopment of Purkinje cell dendrites. These findings provide insight into Nna1's role in neuronal development and why its absence renders Purkinje cells more vulnerable.	[Li, Jianxue; Sidman, Richard L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Gu, Xuesong; Kong, Dong; Libermann, Towia A.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Calicchio, Monica L.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Teng, Yang D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Teng, Yang D.] Harvard Univ, Sch Med, Vet Affairs Boston Healthcare Syst, Div SCI Res, Boston, MA 02115 USA; [Ma, Yinghua; Vartanian, Timothy K.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA; [Yu, Lili] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Crain, Andrew M.; Snyder, Evan Y.] Sanford Burnham Med Res Inst, Ctr Neurosci & Aging Res, La Jolla, CA 92037 USA; [Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Cornell University; Boston University; Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; UTMD Anderson Cancer Center	Li, JX (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	jli7@bidmc.harvard.edu		Libermann, Towia/0000-0002-4006-8179	NIH [R33 CA103056]; Nancy Lurie Marks Family Foundation; William Randolph Hearst Fund; NATIONAL CANCER INSTITUTE [R33CA103056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Lurie Marks Family Foundation; William Randolph Hearst Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kangni Zheng for assistance with cDNA sequencing, Marie G. Joseph with Affymetrix microarray, Veronica J. Peschansky with Neurolucida software, Scott B. Berger with lentiviral particle concentration, and Quanli Yang with statistic analysis. We also thank Professor Philip Leder and Janet Borden of the Harvard Medical School Department of Genetics for sharing the ataxic mice. This work was supported in part by NIH R33 CA103056 and the Nancy Lurie Marks Family Foundation (R L.S), and the William Randolph Hearst Fund (J.L.).	Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Buchinger B, 2008, CANCER LETT, V265, P45, DOI 10.1016/j.canlet.2008.02.008; Chauhan N, 1997, NEUROCHEM RES, V22, P713, DOI 10.1023/A:1027306227402; Dusart I, 2006, CEREBELLUM, V5, P163, DOI 10.1080/14734220600699373; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Ford GD, 2008, BIOCHEM BIOPH RES CO, V377, P556, DOI 10.1016/j.bbrc.2008.10.033; Gilad GM, 2005, NEUROSCI LETT, V376, P210, DOI 10.1016/j.neulet.2004.11.054; Gilad GM, 2001, NEUROSCI LETT, V310, P45, DOI 10.1016/S0304-3940(01)02089-4; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Hirai H, 2008, CEREBELLUM, V7, P273, DOI 10.1007/s12311-008-0012-5; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002; Kyuhou S, 2006, NEUROSCI LETT, V396, P91, DOI 10.1016/j.neulet.2005.11.023; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Li JX, 2006, J NEUROSCI, V26, P7839, DOI 10.1523/JNEUROSCI.1624-06.2006; Li JX, 2006, P NATL ACAD SCI USA, V103, P7847, DOI 10.1073/pnas.0602440103; Li PA, 2004, MOL BRAIN RES, V120, P115, DOI 10.1016/j.molbrainres.2003.10.013; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2009, HISTOL HISTOPATHOL, V24, P651, DOI 10.14670/HH-24.651; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; MULLEN RJ, 1977, NATURE, V270, P245, DOI 10.1038/270245a0; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rossi F, 2006, CEREBELLUM, V5, P75, DOI 10.1080/14734220600788903; Royuela M, 2008, HISTOL HISTOPATHOL, V23, P1279, DOI 10.14670/HH-23.1279; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; SAWADA Y, CEREBELLUM IN PRESS, DOI DOI 10.1007/S12311-010-0161-1; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Sirzen-Zelenskaya A, 2006, EUR J NEUROSCI, V24, P2978, DOI 10.1111/j.1460-9568.2006.05196.x; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; Szauter KM, 2005, PATHOL BIOL, V53, P448, DOI 10.1016/j.patbio.2004.12.033; Tabata T, 2000, J NEUROSCI METH, V104, P45, DOI 10.1016/S0165-0270(00)00323-X; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Torashima T, 2006, EUR J NEUROSCI, V24, P371, DOI 10.1111/j.1460-9568.2006.04927.x; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776	45	54	56	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 7	2010	68	1					45	60		10.1016/j.neuron.2010.08.013	http://dx.doi.org/10.1016/j.neuron.2010.08.013			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920790	Bronze, Green Accepted			2022-12-24	WOS:000283704200007
J	Kim, SH; Ryan, TA				Kim, Sung Hyun; Ryan, Timothy A.			CDK5 Serves as a Major Control Point in Neurotransmitter Release	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; SYNAPTIC VESICLE ENDOCYTOSIS; HIPPOCAMPAL SYNAPSES; POOL MOBILIZATION; CALCIUM-CHANNELS; PROTEIN-KINASE; CNS SYNAPSES; PHOSPHORYLATION; EXOCYTOSIS; CALCINEURIN	CDK5 is an important kinase in nervous system function, controlling neural development and postsynaptic signal integration. Here we show that CDK5 plays a major role in controlling neurotransmitter release. Inhibition of CDK5 activity, by either acute or genetic means, leads to profound potentiation of presynaptic function, including unmasking of previously "silent" synapses. Removal of CDK5 activity additionally unlocks access to the resting synaptic vesicle pool, which normally remains recalcitrant to exocytosis and recycling even following prolonged action potential stimuli. Presynaptic CDK5 levels are additionally severely depleted by chronic neuronal silencing, a treatment that is functionally similar to CDK5 knockdown with regard to presynaptic potentiation. Thus CDK5 appears to be an integral element in presynaptic homeostatic scaling, and the resting vesicle pool appears to provide a potent functional presynaptic homeostatic control parameter. These studies thus pinpoint CDK5 as a major control point for modulation of neurotransmitter release in mammalian neurons.	[Kim, Sung Hyun; Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Ryan, TA (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.	taryan@med.cornell.edu	Kim, Sung Hyun/AAI-8554-2020; Ryan, Timothy/AAO-8286-2020	Kim, Sung Hyun/0000-0002-3166-9941; Ryan, Timothy/0000-0003-2533-9548	NIH [NS036942, MH085783]; Galenea Corp (Cambridge, MA); Galena Corp; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942, R37NS036942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Galenea Corp (Cambridge, MA); Galena Corp; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Jeremy Dittman and members of the Ryan lab for valuable discussions. We thank Ricky Kwan for excellent technical assistance. vG-pH was a gift from Rob Edwards and Susan Voglamaier (UCSF). This work was supported in part by NIH grants to T.A.R. (NS036942 and MH085783) and a sponsored research agreement with Galenea Corp (Cambridge, MA). T.A.R. is a consultant with Galena Corp, which provided some financial support for the work reported here.	Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Cheng K, 2002, J BIOL CHEM, V277, P31988, DOI 10.1074/jbc.M201161200; Chergui K, 2004, P NATL ACAD SCI USA, V101, P2191, DOI 10.1073/pnas.0308652100; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dhavan R, 2002, J NEUROSCI, V22, P7879; Fernandez-Alfonso T, 2006, TRENDS CELL BIOL, V16, P413, DOI 10.1016/j.tcb.2006.06.007; Fernandez-Alfonso T, 2008, BRAIN CELL BIOL, V36, P87, DOI 10.1007/s11068-008-9030-y; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Humbert S, 2000, NEUROREPORT, V11, P2213, DOI 10.1097/00001756-200007140-00030; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; Kumashiro S, 2005, NEUROSCI RES, V51, P435, DOI 10.1016/j.neures.2004.12.018; Kwon YT, 2000, RES PRO CEL, V30, P241; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Ryan TA, 1999, J NEUROSCI, V19, P1317; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Sananbenesi F, 2007, NAT NEUROSCI, V10, P1012, DOI 10.1038/nn1943; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Taniguchi M, 2007, J BIOL CHEM, V282, P7869, DOI 10.1074/jbc.M609457200; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wei FY, 2007, MINI-REV MED CHEM, V7, P1070, DOI 10.2174/138955707782110114; Yan Z, 2002, J PHYSIOL-LONDON, V540, P761; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	49	194	199	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 9	2010	67	5					797	809		10.1016/j.neuron.2010.08.003	http://dx.doi.org/10.1016/j.neuron.2010.08.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826311	Green Accepted, Bronze			2022-12-24	WOS:000281938900014
J	LaPlant, Q; Vialou, V; Covington, HE; Dumitriu, D; Feng, JA; Warren, BL; Maze, I; Dietz, DM; Watts, EL; Iniguez, SD; Koo, JW; Mouzon, E; Renthal, W; Hollis, F; Wang, H; Noonan, MA; Ren, YH; Eisch, AJ; Bolanos, CA; Kabbaj, M; Xiao, GH; Neve, RL; Hurd, YL; Oosting, RS; Fan, GP; Morrison, JH; Nestler, EJ				LaPlant, Quincey; Vialou, Vincent; Covington, Herbert E., III; Dumitriu, Dani; Feng, Jian; Warren, Brandon L.; Maze, Ian; Dietz, David M.; Watts, Emily L.; Iniguez, Sergio D.; Koo, Ja Wook; Mouzon, Ezekiell; Renthal, William; Hollis, Fiona; Wang, Hui; Noonan, Michele A.; Ren, Yanhua; Eisch, Amelia J.; Bolanos, Carlos A.; Kabbaj, Mohamed; Xiao, Guanghua; Neve, Rachael L.; Hurd, Yasmin L.; Oosting, Ronald S.; Fan, Gouping; Morrison, John H.; Nestler, Eric J.			Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED PLASTICITY; DENDRITIC SPINES; DNA METHYLATION; CHROMATIN REGULATION; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; IN-VIVO; NEURONS; INCREASES; REWARD	Despite abundant expression of DNA methyltransferases (Dnmts) in brain, the regulation and behavioral role of DNA methylation remain poorly understood. We found that Dnmt3a expression was regulated in mouse nucleus accumbens (NAc) by chronic cocaine use and chronic social defeat stress. Moreover, NAc-specific manipulations that block DNA methylation potentiated cocaine reward and exerted antidepressant-like effects, whereas NAc-specific Dnmt3a overexpression attenuated cocaine reward and was pro-depressant. On a cellular level, we found that chronic cocaine use selectively increased thin dendritic spines on NAc neurons and that DNA methylation was both necessary and sufficient to mediate these effects. These data establish the importance of Dnmt3a in the NAc in regulating cellular and behavioral plasticity to emotional stimuli.	[LaPlant, Quincey; Vialou, Vincent; Covington, Herbert E., III; Dumitriu, Dani; Feng, Jian; Warren, Brandon L.; Maze, Ian; Dietz, David M.; Watts, Emily L.; Iniguez, Sergio D.; Koo, Ja Wook; Mouzon, Ezekiell; Ren, Yanhua; Hurd, Yasmin L.; Oosting, Ronald S.; Morrison, John H.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [LaPlant, Quincey; Renthal, William; Noonan, Michele A.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Warren, Brandon L.; Iniguez, Sergio D.; Bolanos, Carlos A.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Hollis, Fiona; Wang, Hui; Kabbaj, Mohamed] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Oosting, Ronald S.] Univ Utrecht, Dept Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Fan, Gouping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Utrecht University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Morrison, John/F-9229-2012; vialou, vincent/F-2968-2013; Maze, Ian/P-8077-2018; Kabbaj, Mohamed/M-9240-2016; Dietz, David/AAW-4574-2021; feng, jian/G-9313-2011; Iniguez, Sergio D/J-2410-2015; Dietz, David/J-9458-2015; Yan, Shuo/B-8381-2009	vialou, vincent/0000-0002-8212-751X; Dietz, David/0000-0002-6927-9236; Iniguez, Sergio D/0000-0001-5748-4219; Dietz, David/0000-0002-6927-9236; Hollis, Fiona/0000-0001-6559-5736; Renthal, William/0000-0003-0206-2101; Eisch, Amelia/0000-0001-6476-5385; Dumitriu, Dani/0000-0002-7873-5192; Maze, Ian/0000-0003-1490-7781	National Institute on Drug Abuse; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA027592, P01DA008227, R01DA014133, R21DA027592] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Jaenisch for the generous gift of the Dnmt3a plasmid and W. G. Janssen for animal perfusions. We also thank A.J. Robison for helpful discussions and comments on the manuscript. This work was supported by grants from the National Institute on Drug Abuse and National Institute of Mental Health.	Azdad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006908; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; CHRISTOFFELL D, SOC NEUR AB IN PRESS; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Grimm JW, 2003, J NEUROSCI, V23, P742; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Schroeder FA, 2008, NEUROPSYCHOPHARMACOL, V33, P2981, DOI 10.1038/npp.2008.15; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	50	442	456	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1137	U141		10.1038/nn.2619	http://dx.doi.org/10.1038/nn.2619			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729844	Green Accepted, Green Submitted			2022-12-24	WOS:000281332600020
J	Opazo, P; Labrecque, S; Tigaret, CM; Frouin, A; Wiseman, PW; De Koninck, P; Choquet, D				Opazo, Patricio; Labrecque, Simon; Tigaret, Cezar M.; Frouin, Arnaud; Wiseman, Paul W.; De Koninck, Paul; Choquet, Daniel			CaMKII Triggers the Diffusional Trapping of Surface AMPARs through Phosphorylation of Stargazin	NEURON			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; PAIRED-PULSE FACILITATION; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; GLUTAMATE-RECEPTOR; NONSYNAPTIC SITES; LATERAL MOVEMENTS; DENDRITIC SPINES	The Ca2+/calmodulin-dependent protein kinase II (CaMKII) is critically required for the synaptic recruitment of AMPA-type glutamate receptors (AMPARs) during both development and plasticity. However, the underlying mechanism is unknown. Using single-particle tracking of AMPARs, we show that CaMKII activation and postsynaptic translocation induce the synaptic trapping of AMPARs diffusing in the membrane. AMPAR immobilization requires both phosphorylation of the auxiliary subunit Stargazin and its binding to PDZ domain scaffolds. It does not depend on the PDZ binding domain of GluA1 AMPAR subunit nor its phosphorylation at Ser831. Finally, CaMKII-dependent AMPAR immobilization regulates short-term plasticity. Thus, NMDA-dependent Ca2+ influx in the post-synapse triggers a CaMKII- and Stargazin-dependent decrease in AMPAR diffusional exchange at synapses that controls synaptic function.	[Labrecque, Simon; De Koninck, Paul] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ G1J 2G3, Canada; [Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ H3A 2T8, Canada; [Opazo, Patricio; Tigaret, Cezar M.; Frouin, Arnaud; Choquet, Daniel] CNRS, UMR 5091, F-33077 Bordeaux, France; [Opazo, Patricio; Tigaret, Cezar M.; Frouin, Arnaud; Choquet, Daniel] Univ Bordeaux, F-33077 Bordeaux, France	Laval University; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	De Koninck, P (corresponding author), Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ G1J 2G3, Canada.	paul.dekoninck@crulrg.ulaval.ca; dchoquet@u-bordeaux2.fr	Choquet, Daniel/K-7893-2018; Tigaret, Cezar/AAS-6577-2021; Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/E-4203-2013	Choquet, Daniel/0000-0003-4726-9763; Tigaret, Cezar/0000-0001-5848-6697; Choquet, Daniel/0000-0003-4726-9763; Opazo, Patricio/0000-0001-8210-0758	Centre National de la Recherche Scientifique; Conseil Regional d'Aquitaine; Ministere de la Recherche; Fondation pour la Recherche Medicale; Natural Science and Engineering Council of Canada, Canadian Institute for Health Research (CIHR); CIHR	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Natural Science and Engineering Council of Canada, Canadian Institute for Health Research (CIHR)(Natural Sciences and Engineering Research Council of Canada (NSERC)Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	We thank C. Breillat, D. Bouchet, B. Tessier, F. Nault, and D. Lemelin for help in molecular biology and cell cultures. We thank R. Huganir and E. Gundelfinger for generous gift of the anti-GluA1 and anti-Shank-2 antibodies, respectively, and Y. Hayashi and S.H. Lee for alpha CaMKII shRNA. We thank K.-U. Bayer for advice on CN21 peptide and for sharing a sample for preliminary tests. We thank R. Naud for help in programming single-particle tracking routine. This work was supported by grants from the Centre National de la Recherche Scientifique, the Conseil Regional d'Aquitaine, the Ministere de la Recherche, to D.C., and the Fondation pour la Recherche Medicale through a Fellowship awarded to P.O., and by grants from the Natural Science and Engineering Council of Canada, Canadian Institute for Health Research (CIHR) and Human Frontier Science Program to both P.W.W. and P.D.K. S.L. is supported by a CIHR training grant in Neurophysics. P.D.K. is supported by a CIHR career award.	Aoki C, 2001, SYNAPSE, V40, P239, DOI 10.1002/syn.1047; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHRISTIE BR, 1994, NEUROREPORT, V5, P385, DOI 10.1097/00001756-199401120-00003; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Markram H, 1996, J PHYSIOLOGY-PARIS, V90, P229, DOI 10.1016/S0928-4257(97)81429-5; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; Medina I, 1999, EUR J NEUROSCI, V11, P2422, DOI 10.1046/j.1460-9568.1999.00664.x; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SCHULZ PE, 1995, J PHYSIOLOGY-PARIS, V89, P3, DOI 10.1016/0928-4257(96)80546-8; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Stein V, 2003, J NEUROSCI, V23, P5503; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Tsui J, 2006, J BIOL CHEM, V281, P13794, DOI 10.1074/jbc.M600966200; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wang JH, 1996, LEARN MEMORY, V3, P170, DOI 10.1101/lm.3.2-3.170; Wang JH, 1997, J NEUROPHYSIOL, V78, P2707, DOI 10.1152/jn.1997.78.5.2707; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wu J, 2006, J NEUROPHYSIOL, V95, P3519, DOI 10.1152/jn.01235.2005; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Zhang YP, 2008, P NATL ACAD SCI USA, V105, P12039, DOI 10.1073/pnas.0802940105	73	271	275	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					239	252		10.1016/j.neuron.2010.06.007	http://dx.doi.org/10.1016/j.neuron.2010.06.007			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670832	Bronze			2022-12-24	WOS:000280461500009
J	Davison, AC				Davison, Anna C.			Brave Pioneers or Clinical Cowboys?	CELL STEM CELL			English	Editorial Material																			0	6	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					504	505		10.1016/j.stem.2010.05.011	http://dx.doi.org/10.1016/j.stem.2010.05.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20578343	Bronze			2022-12-24	WOS:000278840700007
J	Lee, HHC; Deeb, TZ; Walker, JA; Davies, PA; Moss, SJ				Lee, Henry H. C.; Deeb, Tarek Z.; Walker, Joshua A.; Davies, Paul A.; Moss, Stephen J.			NMDA receptor activity downregulates KCC2 resulting in depolarizing GABA(A) receptor-mediated currents	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; K-CL COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; NEURONAL-SPECIFIC ISOFORM; POSTNATAL RAT BRAINS; SPINAL-CORD-INJURY; HIPPOCAMPAL SLICE; NEUROPATHIC PAIN; GLUTAMATE; PHOSPHORYLATION	KCC2 is a neuron-specific K+-Cl- co-transporter that maintains a low intracellular Cl-concentration that is essential for hyperpolarizing inhibition mediated by GABA(A) receptors. Deficits in KCC2 activity occur in disease states associated with pathophysiological glutamate release. However, the mechanisms by which elevated glutamate alters KCC2 function are unknown. The phosphorylation of KCC2 residue Ser940 is known to regulate its surface activity. We found that NMDA receptor activity and Ca2+ influx caused the dephosphorylation of Ser940 in dissociated rat neurons, leading to a loss of KCC2 function that lasted longer than 20 min. Protein phosphatase 1 mediated the dephosphorylation events of Ser940 that coincided with a deficit in hyperpolarizing GABAergic inhibition resulting from the loss of KCC2 activity. Blocking dephosphorylation of Ser940 reduced the glutamate-induced downregulation of KCC2 and substantially improved the maintenance of hyperpolarizing GABAergic inhibition. Reducing the downregulation of KCC2 therefore has therapeutic potential in the treatment of neurological disorders.	[Lee, Henry H. C.; Deeb, Tarek Z.; Walker, Joshua A.; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Tufts University; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, Boston, MA 02111 USA.	stephen.moss@tufts.edu	Davies, Paul A/P-4595-2017	Davies, Paul A/0000-0002-3973-3143; Lee, Henry/0000-0003-4975-7330	US National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS036296, NS047478, NS048045, NS054900]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS036296, R01NS047478, R01NS036296, R01NS081986, R21NS080064, P01NS054900, R01NS048045, R01NS051195] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Haydon and L.K. Chau for critical comments on the manuscript and H. Tang and L. Silayeva for providing technical assistance. The work was supported in part by US National Institutes of Health/National Institute of Neurological Disorders and Stroke grants NS036296, NS047478, NS048045 and NS054900. H.H.C.L. is supported by a Postdoctoral Fellowship from the American Heart Association.	Banke TG, 2008, J PHYSIOL-LONDON, V586, P4925, DOI 10.1113/jphysiol.2008.157024; Banke TG, 2006, J NEUROSCI, V26, P11720, DOI 10.1523/JNEUROSCI.2887-06.2006; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cavus I, 2008, EPILEPSIA, V49, P1358, DOI 10.1111/j.1528-1167.2008.01603.x; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cramer SW, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-36; DURING MJ, 1993, LANCET, V341, P1607; Foldy C, 2010, NAT NEUROSCI, V13, P1047, DOI 10.1038/nn.2609; Galeffi F, 2004, J NEUROSCI, V24, P4478, DOI 10.1523/JNEUROSCI.0755-04.2004; Garrett MC, 2009, J CRIT CARE, V24, P335, DOI 10.1016/j.jcrc.2008.10.015; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kitamura A, 2008, NEUROSCI RES, V62, P270, DOI 10.1016/j.neures.2008.09.002; Kristensen BW, 2003, BRAIN RES, V973, P303, DOI 10.1016/S0006-8993(03)02550-2; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Lu Y, 2008, J PHYSIOL-LONDON, V586, P5701, DOI 10.1113/jphysiol.2008.152348; Nabekura J, 2002, J NEUROSCI, V22, P4412, DOI 10.1523/JNEUROSCI.22-11-04412.2002; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; Vargova L, 2001, J CEREBR BLOOD F MET, V21, P1077, DOI 10.1097/00004647-200109000-00005; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Watanabe M, 2009, J BIOL CHEM, V284, P27980, DOI 10.1074/jbc.M109.043620; Wu LA, 2009, NEUROSCI LETT, V457, P36, DOI 10.1016/j.neulet.2009.03.107	49	188	192	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					736	U390		10.1038/nn.2806	http://dx.doi.org/10.1038/nn.2806			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532577	Green Accepted			2022-12-24	WOS:000290958000016
J	Jo, J; Whitcomb, DJ; Olsen, KM; Kerrigan, TL; Lo, SC; Bru-Mercier, G; Dickinson, B; Scullion, S; Sheng, MG; Collingridge, G; Cho, K				Jo, Jihoon; Whitcomb, Daniel J.; Olsen, Kimberly Moore; Kerrigan, Talitha L.; Lo, Shih-Ching; Bru-Mercier, Gilles; Dickinson, Bryony; Scullion, Sarah; Sheng, Morgan; Collingridge, Graham; Cho, Kwangwook			A beta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3 beta	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PROTEIN-KINASE; BETA; ACTIVATION; DEPRESSION; OLIGOMERS; MEMORY	Amyloid-beta(1-42) (A beta) is thought to be a major mediator of the cognitive deficits in Alzheimer's disease. The ability of A. to inhibit hippocampal long-term potentiation provides a cellular correlate of this action, but the underlying molecular mechanism is only partially understood. We found that a signaling pathway involving caspase-3, Akt1 and glycogen synthase kinase-3b is an important mediator of this effect in rats and mice.	[Jo, Jihoon; Whitcomb, Daniel J.; Kerrigan, Talitha L.; Bru-Mercier, Gilles; Dickinson, Bryony; Scullion, Sarah; Cho, Kwangwook] Univ Bristol, Sch Clin Sci, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Olsen, Kimberly Moore; Lo, Shih-Ching; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Scullion, Sarah; Collingridge, Graham; Cho, Kwangwook] Univ Bristol, MRC Ctr Synapt Plast, Bristol, Avon, England; [Collingridge, Graham] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; Roche Holding; Genentech; University of Bristol; University of Bristol	Cho, K (corresponding author), Univ Bristol, Sch Clin Sci, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.	kei.cho@bristol.ac.uk	Kerrigan, Talitha/C-3759-2016; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020	Collingridge, Graham L/0000-0002-9572-5359; Kerrigan, Talitha/0000-0003-2158-567X; Whitcomb, Daniel/0000-0003-2703-1643; Cho, Kwangwook/0000-0001-6724-7073; Lo, Shih-Ching/0000-0002-5187-0730	UK Alzheimer's Research Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council; Royal Society; BBSRC [BB/G003963/1] Funding Source: UKRI; MRC [MC_G1000734] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003963/1] Funding Source: researchfish; Medical Research Council [MC_G1000734, G0601841B] Funding Source: researchfish	UK Alzheimer's Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Alzheimer's Research Trust (K. C.), Biotechnology and Biological Sciences Research Council (K. C.), Medical Research Council (G. L. C.) and The Royal Society (J.J.). G. L. C. is a World Class University International Scholar and D.J.W. is an UK Alzheimer's Research Trust-funded Ph.D. student.	Allen JW, 2001, J NEUROSCI RES, V65, P45, DOI 10.1002/jnr.1126; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cho JH, 2004, J BIOL CHEM, V279, P54716, DOI 10.1074/jbc.M403364200; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004	15	244	253	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					545	547		10.1038/nn.2785	http://dx.doi.org/10.1038/nn.2785			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441921				2022-12-24	WOS:000289886600007
J	Chen, Y; Wang, HB; Yoon, SO; Xu, XM; Hottiger, MO; Svaren, J; Nave, KA; Kim, HA; Olson, EN; Lu, QR				Chen, Ying; Wang, Haibo; Yoon, Sung Ok; Xu, Xiaomei; Hottiger, Michael O.; Svaren, John; Nave, Klaus A.; Kim, Haesun A.; Olson, Eric N.; Lu, Q. Richard			HDAC-mediated deacetylation of NF-kappa B is critical for Schwann cell myelination	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE; DIFFERENTIATION; REMYELINATION; TRANSCRIPTION; RECEPTOR; GENES; MICE	Schwann cell myelination is tightly regulated by timely expression of key transcriptional regulators that respond to specific environmental cues, but the molecular mechanisms underlying such a process are poorly understood. We found that the acetylation state of NF-kappa B, which is regulated by histone deacetylases (HDACs) 1 and 2, is critical for orchestrating the myelination program. Mice lacking both HDACs 1 and 2 (HDAC1/2) exhibited severe myelin deficiency with Schwann cell development arrested at the immature stage. NF-kappa B p65 became heavily acetylated in HDAC1/2 mutants, inhibiting the expression of positive regulators of myelination and inducing the expression of differentiation inhibitors. We observed that the NF-.B protein complex switched from associating with p300 to associating with HDAC1/2 as Schwann cells differentiated. NF-kappa B and HDAC1/2 acted in a coordinated fashion to regulate the transcriptionally linked chromatin state for Schwann cell myelination. Thus, our results reveal an HDAC-mediated developmental switch for controlling myelination in the peripheral nervous system.	[Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Ying; Wang, Haibo; Xu, Xiaomei; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8001 Zurich, Switzerland; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Nave, Klaus A.] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kim, Haesun A.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; University of Zurich; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Rutgers State University Newark; Rutgers State University New Brunswick	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	Nave, Klaus-Armin/C-8883-2011; Yoon, Sung Ok/C-5992-2012; Svaren, John/A-1605-2010; Hottiger, Michael O./J-7747-2013	Svaren, John/0000-0003-2963-7921; Hottiger, Michael O./0000-0002-7323-2270	US National Institutes of Health [NS072427]; National Multiple Sclerosis Society [RG3978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. Meijer for Dhh-cre mice, B. Carter and J. Chan for critical comments, and P. Casaccia for initial discussions. We thank Q. Weng and Z. Ma for technical support, O. Nakagawa and J. Chen for the p300/CBP and p65/RelA expression vectors, and R. Kageyama for the Hes5 luciferase reporter. This study was funded in part by grants from the US National Institutes of Health (NS072427) and the National Multiple Sclerosis Society (RG3978) to Q.R.L.	Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004	23	142	146	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					437	U59		10.1038/nn.2780	http://dx.doi.org/10.1038/nn.2780			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21423191	Green Accepted			2022-12-24	WOS:000288849400014
J	Rancz, EA; Franks, KM; Schwarz, MK; Pichler, B; Schaefer, AT; Margrie, TW				Rancz, Ede A.; Franks, Kevin M.; Schwarz, Martin K.; Pichler, Bruno; Schaefer, Andreas T.; Margrie, Troy W.			Transfection via whole-cell recording in vivo: bridging single-cell physiology, genetics and connectomics	NATURE NEUROSCIENCE			English	Article							ENCODED CALCIUM INDICATOR; RABIES VIRUS; NEURONAL-ACTIVITY; CORTEX; NETWORKS; MICROSTIMULATION; TECHNOLOGIES; STIMULATION; INHIBITION; EXPRESSION	Single-cell genetic manipulation is expected to substantially advance the field of systems neuroscience. However, existing gene delivery techniques do not allow researchers to electrophysiologically characterize cells and to thereby establish an experimental link between physiology and genetics for understanding neuronal function. In the mouse brain in vivo, we found that neurons remained intact after 'blind' whole-cell recording, that DNA vectors could be delivered through the patch-pipette during such recordings and that these vectors drove protein expression in recorded cells for at least 7 d. To illustrate the utility of this approach, we recorded visually evoked synaptic responses in primary visual cortical cells while delivering DNA plasmids that allowed retrograde, monosynaptic tracing of each neuron's presynaptic inputs. By providing a biophysical profile of a cell before its specific genetic perturbation, this combinatorial method captures the synaptic and anatomical receptive field of a neuron.	[Rancz, Ede A.; Franks, Kevin M.; Schaefer, Andreas T.; Margrie, Troy W.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Rancz, Ede A.; Pichler, Bruno; Margrie, Troy W.] Natl Inst Med Res, Div Neurophysiol, Mill Hill, England; [Franks, Kevin M.] Columbia Univ, Dept Neurosci, New York, NY USA; [Schwarz, Martin K.] Max Planck Inst Med Res, Dept Mol Neurobiol, Heidelberg, Germany; [Schaefer, Andreas T.] Max Planck Inst Med Res, SNWG Behav Neurophysiol, Heidelberg, Germany	University of London; University College London; MRC National Institute for Medical Research; Columbia University; Max Planck Society; Max Planck Society	Margrie, TW (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	troy.margrie@nimr.mrc.ac.uk	Rancz, Ede Attila/AAS-6867-2020	Rancz, Ede Attila/0000-0002-7951-1385; Schaefer, Andreas/0000-0002-4677-8788	The Robert Leet and Clara Guthrie Patterson Trust; National Institute on Deafness and Other Communication Disorders (NIDCD) [K99]; The Max-Planck Gesellschaft; Medical Research Council (MRC); The Alexander Von Humboldt Foundation; Medical Research Council [MC_U117597156] Funding Source: researchfish; MRC [MC_U117597156] Funding Source: UKRI	The Robert Leet and Clara Guthrie Patterson Trust; National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); The Max-Planck Gesellschaft; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Alexander Von Humboldt Foundation(Alexander von Humboldt Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	K. M. F. thanks S. Siegelbaum and R. Axel for support and encouragement and A. Mulligan for technical assistance. We also thank P. H. Seeburg for support; D. Castro, B. Matynoga and D. Drechsel for advice; K.-K. Conzelmann for rabies virus SAD-Delta G-mCherry; and P. Boross, E. Callaway, H. Wildner and F. Guillemot for discussions and reagents. E.A.R. is a Sir Henry Wellcome Postdoctoral Fellow. This work was supported by The Robert Leet and Clara Guthrie Patterson Trust and a National Institute on Deafness and Other Communication Disorders (NIDCD) K99 grant (K.M.F.), The Max-Planck Gesellschaft (A.T.S., M.K.S.), the Medical Research Council (MRC) and The Alexander Von Humboldt Foundation (T.W.M.).	Arenkiel BR, 2009, NATURE, V461, P900, DOI 10.1038/nature08536; Arenz A, 2008, SCIENCE, V321, P977, DOI 10.1126/science.1158391; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; EILERS J, 2005, IMAGING NEUROSCIENCE, P277; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; FERSTER D, 1987, J NEUROSCI, V7, P1780; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kleinfeld D, 2005, PLOS BIOL, V3, P1685, DOI 10.1371/journal.pbio.0030355; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Mebatsion T, 2001, J VIROL, V75, P11496, DOI 10.1128/JVI.75.23.11496-11502.2001; Nevian T, 2007, PFLUG ARCH EUR J PHY, V454, P675, DOI 10.1007/s00424-007-0234-2; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Waters J, 2003, J NEUROSCI, V23, P8558; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	50	95	96	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					527	U169		10.1038/nn.2765	http://dx.doi.org/10.1038/nn.2765			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336272	Green Accepted			2022-12-24	WOS:000288849400025
J	Hakeda-Suzuki, S; Berger-Muller, S; Tomasi, T; Usui, T; Horiuchi, S; Uemura, T; Suzuki, T				Hakeda-Suzuki, Satoko; Berger-Mueller, Sandra; Tomasi, Tatiana; Usui, Tadao; Horiuchi, Shin-ya; Uemura, Tadashi; Suzuki, Takashi			Golden Goal collaborates with Flamingo in conferring synaptic-layer specificity in the visual system	NATURE NEUROSCIENCE			English	Article							7-PASS TRANSMEMBRANE CADHERIN; AXON-TARGET INTERACTIONS; DROSOPHILA; PROTEIN; RECEPTOR; SELECTION; POLARITY; NEURONS; CONNECTIONS; MOLECULES	Neuronal connections are often organized in layers that contain synapses between neurons that have similar functions. In Drosophila, R7 and R8 photoreceptors, which detect different wavelengths, form synapses in distinct medulla layers. The mechanisms underlying the specificity of synaptic-layer selection remain unclear. We found that Golden Goal (Gogo) and Flamingo (Fmi), two cell-surface proteins involved in photoreceptor targeting, functionally interact in R8 photoreceptor axons. Our results indicate that Gogo promotes R8 photoreceptor axon adhesion to the temporary layer M1, whereas Gogo and Fmi collaborate to mediate axon targeting to the final layer M3. Structure-function analysis suggested that Gogo and Fmi interact with intracellular components through the Gogo cytoplasmic domain. Moreover, Fmi was also required in target cells for R8 photoreceptor axon targeting. We propose that Gogo acts as a functional partner of Fmi for R8 photoreceptor axon targeting and that the dynamic regulation of their interaction specifies synaptic-layer selection of photoreceptors.	[Hakeda-Suzuki, Satoko; Berger-Mueller, Sandra; Tomasi, Tatiana; Suzuki, Takashi] Max Planck Inst Neurobiol, Martinsried, Germany; [Usui, Tadao; Horiuchi, Shin-ya; Uemura, Tadashi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Uemura, Tadashi] Japan Sci & Technol Agcy, CREST, Kyoto, Japan	Max Planck Society; Kyoto University; Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	suzukit@neuro.mpg.de	Suzuki, Takashi/D-3651-2019; Hakeda-suzuki, Satoko/AAU-5348-2020	Suzuki, Takashi/0000-0001-9093-2562; Hakeda-suzuki, Satoko/0000-0001-8749-1479; UEMURA, Tadashi/0000-0001-7204-3606; Usui, Tadao/0000-0002-0507-1495	Max Planck Society; Deutsche Forschungsgemeinschaft	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank N. Hengrung for helping with BiFC experiments, I. Siwanowicz for helping with agarose sections and M. Braun for electron microscopy sections. We thank I. Salecker, T. Clandinin, J. Axelrod, D. Strutt, B. Dickson, K. Keleman, H. Oda, H. Bellen, J. Morante, J. Smith, Developmental Studies Hybridoma Bank (University of Iowa), Drosophila Genetic Resource Center (Kyoto), Exelixis Collection at Harvard and Bloomington Stock Center for reagents, and FlyBase for information resources. We thank R. Klein, F. Schnorrer, J. Egea for suggestions and comments, and members of the Suzuki laboratory for critical discussions. This work was supported by the Max Planck Society and an individual grant from the Deutsche Forschungsgemeinschaft (T.S.).	Astigarraga S, 2010, CURR OPIN GENET DEV, V20, P400, DOI 10.1016/j.gde.2010.04.001; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kimura H, 2006, J CELL SCI, V119, P1118, DOI 10.1242/jcs.02832; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Mast JD, 2006, SEMIN CELL DEV BIOL, V17, P42, DOI 10.1016/j.semcdb.2005.11.004; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; MCGUIRE SE, 2004, SCI STKE, pPL6; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Newsome TP, 2000, DEVELOPMENT, V127, P851; Saka Y, 2008, METHODS, V45, P192, DOI 10.1016/j.ymeth.2008.06.005; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shima Y, 2007, NAT NEUROSCI, V10, P963, DOI 10.1038/nn1933; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469	39	47	47	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					314	323		10.1038/nn.2756	http://dx.doi.org/10.1038/nn.2756			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21317905				2022-12-24	WOS:000287650100011
J	Tanimura, S; Tadokoro, Y; Inomata, K; Nguyen, TB; Nishie, W; Yamazaki, S; Nakauchi, H; Tanaka, Y; McMillan, JR; Sawamura, D; Yancey, K; Shimizu, H; Nishimura, EK				Tanimura, Shintaro; Tadokoro, Yuko; Inomata, Ken; Nguyen Thanh Binh; Nishie, Wataru; Yamazaki, Satoshi; Nakauchi, Hiromitsu; Tanaka, Yoshio; McMillan, James R.; Sawamura, Daisuke; Yancey, Kim; Shimizu, Hiroshi; Nishimura, Emi K.			Hair Follicle Stem Cells Provide a Functional Niche for Melanocyte Stem Cells	CELL STEM CELL			English	Article							BENIGN EPIDERMOLYSIS-BULLOSA; EPIDERMAL BASEMENT-MEMBRANE; PEMPHIGOID ANTIGEN; SELF-RENEWAL; SKIN; BETA; DIFFERENTIATION; MORPHOGENESIS; ACTIVATION; INTEGRIN	In most stem cell systems, the organization of the stem cell niche and the anchoring matrix required for stem cell maintenance are largely unknown. We report here that collagen XVII (COL17A1/BP180/BPAG2), a hemidesmosomal transmembrane collagen, is highly expressed in hair follicle stem cells (HFSCs) and is required for the maintenance not only of HFSCs but also of melanocyte stem cells (MSCs), which do not express Col17a1 but directly adhere to HFSCs. Mice lacking Col17a1 show premature hair graying and hair loss. Analysis of Col17a1-null mice revealed that COL17A1 is critical for the self-renewal of HFSCs through maintaining their quiescence and immaturity, potentially explaining the mechanism underlying hair loss in human COL17A1 deficiency. Moreover, forced expression of COL17A1 in basal keratinocytes, including HFSCs, in Col17a1-null mice rescues MSCs from premature differentiation and restores TGF-8 signaling, demonstrating that HFSCs function as a critical regulatory component of the MSC niche.	[Tanimura, Shintaro; Tadokoro, Yuko; Inomata, Ken; Nguyen Thanh Binh; Tanaka, Yoshio; Nishimura, Emi K.] Kanazawa Univ, Canc Res Inst, Dept Stem Cell Med, Kanazawa, Ishikawa 9200934, Japan; [Tanimura, Shintaro; Nishie, Wataru; McMillan, James R.; Shimizu, Hiroshi; Nishimura, Emi K.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan; [Inomata, Ken] KOSE Corp, Fundamental Res Labs, Itabashi Ku, Tokyo 1740051, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] ERATO, Japan Sci & Technol Agcy JST, Chiyoda Ku, Tokyo 1020075, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Sawamura, Daisuke] Hirosaki Univ, Dept Dermatol, Sch Med, Aomori 0368562, Japan; [Yancey, Kim] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Nguyen Thanh Binh; Nishimura, Emi K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan	Kanazawa University; Hokkaido University; Japan Science & Technology Agency (JST); University of Tokyo; Hirosaki University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tokyo Medical & Dental University (TMDU)	Nishimura, EK (corresponding author), Kanazawa Univ, Canc Res Inst, Dept Stem Cell Med, Kanazawa, Ishikawa 9200934, Japan.	nishscm@tmd.ac.jp	Shimizu, Hiroshi/A-5193-2012; McMillan, James R/C-6657-2009; Nishie, Wataru/A-5236-2012	Inomata, Ken/0000-0002-3556-1380	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17689033, 19390293]; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr. Makoto Taketo for Tgfbr2 knockout mice; Dr. Hideki Nakamura, Dr. Tomohiko Wakayama, and Dr. Shoichi Iseki for their technical advice concerning electron microscopic analysis; Dr. Hiroyuki Nishimura for critical reading of the manuscript; Dr. Masashi Akiyama for discussion; Dr. Atsushi Hirao and Dr. Masako Ohmura for the use of the flow cytometer; Dr. Ken Natsuga and Ms. Kaori Sakai for sample identification; and Ms. Miss Suzuki, Ms. Megumi Sato, and Ms. Yuika Osaki for technical assistance. This study was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (17689033, 19390293), the Uehara Memorial Foundation, the Kato Memorial Bioscience Foundation, and the Takeda Science Foundation to E.K.N.	Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Darling T N, 1997, Adv Dermatol, V13, P87; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; HINTNER H, 1982, ARCH DERMATOL, V118, P375, DOI 10.1001/archderm.118.6.375; HOJIRO O, 1972, J ELECTRON MICROSC, V21, P127; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Masunaga T, 1997, J INVEST DERMATOL, V109, P200, DOI 10.1111/1523-1747.ep12319337; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; McMillan JR, 2003, J DERMATOL SCI, V31, P169, DOI 10.1016/S0923-1811(03)00045-8; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Olasz EB, 2007, J INVEST DERMATOL, V127, P2807, DOI 10.1038/sj.jid.5700970; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Powell AM, 2005, CLIN EXP DERMATOL, V30, P682, DOI 10.1111/j.1365-2230.2005.01937.x; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yang LL, 2009, MOL BIOL CELL, V20, P882, DOI 10.1091/mbc.E08-07-0731; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298	50	184	195	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					177	187		10.1016/j.stem.2010.11.029	http://dx.doi.org/10.1016/j.stem.2010.11.029			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295274	Bronze			2022-12-24	WOS:000287633400011
J	Freedman, DJ; Assad, JA				Freedman, David J.; Assad, John A.			A proposed common neural mechanism for categorization and perceptual decisions	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; EYE FIELD; REPRESENTATION; NEURONS; MACAQUE; MONKEY; CONNECTIONS; ATTENTION; INTENTION	One of the most fascinating issues in neuroscience is how the brain makes decisions. Recent evidence points to the parietal cortex as an important locus for certain kinds of decisions. Because parietal neurons are also involved in movements, it has been proposed that decisions are encoded in an intentional, action-based framework based on the movements used to report decisions. An alternative or complementary view is that decisions represent more abstract information not linked to movements per se. Parallel experiments on categorization suggest that parietal neurons can indeed represent abstract categorical outcomes that are not linked to movements. This could provide a unified or complementary view of how the brain decides and categorizes.	[Freedman, David J.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Assad, John A.] Italian Inst Technol, Ctr Neurosci & Cognit Syst, Rovereto, Italy; [Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of Chicago; Istituto Italiano di Tecnologia - IIT; Harvard University; Harvard Medical School	Freedman, DJ (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	dfreedman@uchicago.edu; jassad@hms.harvard.edu						Andersen R A, 1992, Curr Opin Neurobiol, V2, P840, DOI 10.1016/0959-4388(92)90143-9; BENNUR S, J NEUROSCI IN PRESS; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Ferrera VP, 2009, NAT NEUROSCI, V12, P1458, DOI 10.1038/nn.2434; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2009, J NEUROSCI, V29, P5671, DOI 10.1523/JNEUROSCI.2878-08.2009; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Glimcher PW, 2003, BRADFORD BOOKS, P1; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; PADOASCHIOPPA C, ANN REV NEU IN PRESS; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 2008, BETTER CONSCIOUS DEC, P71, DOI 10.7551/mitpress/9780262195805.003.0004; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106	31	91	92	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					143	146		10.1038/nn.2740	http://dx.doi.org/10.1038/nn.2740			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270782				2022-12-24	WOS:000286595400009
J	Voytek, B; Davis, M; Yago, E; Barcelo, F; Vogel, EK; Knight, RT				Voytek, Bradley; Davis, Matar; Yago, Elena; Barcelo, Francisco; Vogel, Edward K.; Knight, Robert T.			Dynamic Neuroplasticity after Human Prefrontal Cortex Damage	NEURON			English	Article							WORKING-MEMORY TASK; INDIVIDUAL-DIFFERENCES; SPATIAL NEGLECT; NEURAL MEASURES; EEG DYNAMICS; RECOVERY; NETWORKS; DEFICITS; STROKE; PLASTICITY	Memory and attention deficits are common after prefrontal cortex (PFC) damage, yet people generally recover some function over time. Recovery is thought to be dependent upon undamaged brain regions, but the temporal dynamics underlying cognitive recovery are poorly understood. Here, we provide evidence that the intact PFC compensates for damage in the lesioned PFC on a trial-by-trial basis dependent on cognitive load. The extent of this rapid functional compensation is indexed by transient increases in electrophysiological measures of attention and memory in the intact PFC, detectable within a second after stimulus presentation and only when the lesioned hemisphere is challenged. These observations provide evidence supporting a dynamic and flexible model of compensatory neural plasticity.	[Voytek, Bradley; Davis, Matar; Yago, Elena; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Barcelo, Francisco] Univ Illes Balears, Inst Univ Invest Ciencies Salut, Palma de Mallorca 07122, Spain; [Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Universitat de les Illes Balears; University of Oregon	Voytek, B (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	bradley.voytek@gmail.com	Vogel, Edward K/AAW-9466-2021; Barceló, Francisco/B-3629-2011; Voytek, Bradley/K-3305-2016	Barceló, Francisco/0000-0001-6012-7116; Voytek, Bradley/0000-0003-1640-2525	American Psychological Association [5-T32-MH18882]; National Institute of Neurological Disorders and Stroke [NS21135, PO40813, NS21135-S1]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813, R01NS021135, R56NS021135, R37NS021135] Funding Source: NIH RePORTER	American Psychological Association; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Psychological Association Diversity Program in Neuroscience (5-T32-MH18882) to B.V. and the National Institute of Neurological Disorders and Stroke (NS21135 and PO40813) to R.T.K. and (NS21135-S1) to B.V. We thank L. Tseng for assistance with data collection, A.S. Kayser for technical assistance, C. Clayworth for lesion reconstruction. and D. Scabini for patient delineation.	Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; BACHYRITA P, 1990, NEUROPSYCHOLOGIA, V28, P547, DOI 10.1016/0028-3932(90)90033-K; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bastiaansen MCM, 2002, CLIN NEUROPHYSIOL, V113, P1882, DOI 10.1016/S1388-2457(02)00303-6; Blasi V, 2002, NEURON, V36, P159, DOI 10.1016/S0896-6273(02)00936-4; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Griesmayr B, 2010, NEUROBIOL LEARN MEM, V93, P208, DOI 10.1016/j.nlm.2009.09.013; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Jackson JH., 1958, SELECTED WRITINGS JH, P29; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Knight RT, 2007, SCIENCE, V316, P1578, DOI 10.1126/science.1144677; KOLB B, 1992, RECOVERY BRAIN DAMAG; Lytton W W, 1999, Prog Brain Res, V121, P203; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P215, DOI 10.1016/0028-3932(84)90064-2; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tsuchida A, 2009, J COGNITIVE NEUROSCI, V21, P2263, DOI 10.1162/jocn.2008.21172; Van Vleet TM, 2003, BEHAV BRAIN RES, V138, P165, DOI 10.1016/S0166-4328(02)00246-2; VANRIJN ACM, 1990, MED BIOL ENG COMPUT, V28, P389, DOI 10.1007/BF02441961; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; von Monakow C, 1969, MOOD STATES MIND; Voytek B, 2010, P NATL ACAD SCI USA, V107, P18167, DOI 10.1073/pnas.1007277107; Ward NS, 2007, EUR J NEUROSCI, V25, P1865, DOI 10.1111/j.1460-9568.2007.05434.x; Wundt W. M., 1902, OUTLINES PSYCHOL; Yago Elena, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P609, DOI 10.3758/CABN.4.4.609	41	87	94	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 4	2010	68	3					401	408		10.1016/j.neuron.2010.09.018	http://dx.doi.org/10.1016/j.neuron.2010.09.018			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040843	Green Accepted, Bronze			2022-12-24	WOS:000284255800010
J	Jeanneteau, F; Deinhardt, K; Miyoshi, G; Bennett, AM; Chao, MV				Jeanneteau, Freddy; Deinhardt, Katrin; Miyoshi, Goichi; Bennett, Anton M.; Chao, Moses V.			The MAP kinase phosphatase MKP-1 regulates BDNF-induced axon branching	NATURE NEUROSCIENCE			English	Article							IN-VIVO; NEUROTROPHIC FACTOR; CATALYTIC ACTIVATION; TYROSINE-PHOSPHATASE; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; ARBOR GROWTH; PROTEIN; GENE; EXPRESSION	The refinement of neural circuits during development depends on a dynamic process of branching of axons and dendrites that leads to synapse formation and connectivity. The neurotrophin brain-derived neurotrophic factor (BDNF) is essential for the outgrowth and activity-dependent remodeling of axonal arbors in vivo. However, the mechanisms that translate extracellular signals into the formation of axonal branches are incompletely understood. We found that MAP kinase phosphatase-1 (MKP-1) controls axon branching. MKP-1 expression induced by BDNF signaling caused spatiotemporal deactivation of c-jun N-terminal kinase (JNK), which reduced the phosphorylation of JNK substrates that destabilize microtubules. Indeed, neurons from mkp-1 null mice could not produce axon branches in response to BDNF. Our results identify a signaling mechanism that regulates axonal branching and provide a framework for studying the molecular mechanisms of innervation and axonal remodeling under normal and pathological conditions.	[Jeanneteau, Freddy; Deinhardt, Katrin; Chao, Moses V.] Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY USA; [Miyoshi, Goichi] New York Univ Langone Sch Med, Smilow Neurosci Program, New York, NY USA; [Bennett, Anton M.] Yale Univ Sch Med, Dept Pharmacol, New Haven, CT USA	New York University; Yale University	Jeanneteau, F (corresponding author), Skirball Inst Biomol Med, Mol Neurobiol Program, New York, NY USA.	freddy.jeanneteau@med.nyu.edu; katrin.deinhardt@med.nyu.edu	Jeanneteau, Freddy/AAC-7052-2021; Miyoshi, Goichi/H-4759-2012; Miyoshi, Goichi/O-2029-2019	Jeanneteau, freddy/0000-0002-9606-2892; Deinhardt, Katrin/0000-0002-6473-5298; Chao, Moses/0000-0002-6969-3744; Bennett, Anton/0000-0001-5187-7599	National Alliance for Research on Schizophrenia and Depression; Human Frontier Science Program Organization; US National Institutes of Health [NS21072, HD23315, R01 AR46504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); Human Frontier Science Program Organization(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Alliance for Research on Schizophrenia and Depression (F.J. and G. M.), the Human Frontier Science Program Organization (K. D.) and grants from the US National Institutes of Health to M. V. C. (NS21072 and HD23315) and A. M. B. (R01 AR46504).	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; CARRASCO D, 1993, CELL GROWTH DIFFER, V4, P849; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Danzer SC, 2002, J NEUROSCI, V22, P9754; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; Doi M, 2007, J BIOL RHYTHM, V22, P127, DOI 10.1177/0748730406298332; Dorfman K, 1996, ONCOGENE, V13, P925; Gerecke KM, 2004, MOL CELL NEUROSCI, V27, P379, DOI 10.1016/j.mcn.2004.08.001; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Huang JK, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-59; Hutchins BI, 2008, J NEUROSCI, V28, P143, DOI 10.1523/JNEUROSCI.4548-07.2008; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Langevin LM, 2007, DEV DYNAM, V236, P1273, DOI 10.1002/dvdy.21126; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martinez A, 1998, J NEUROSCI, V18, P7336; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010	50	115	118	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1373	U103		10.1038/nn.2655	http://dx.doi.org/10.1038/nn.2655			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935641	Green Accepted			2022-12-24	WOS:000283658200018
J	Padmanabhan, K; Urban, NN				Padmanabhan, Krishnan; Urban, Nathaniel N.			Intrinsic biophysical diversity decorrelates neuronal firing while increasing information content	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; PYRAMIDAL NEURONS; NEOCORTICAL NEURONS; MITRAL/TUFTED CELLS; ODOR DISCRIMINATION; LATERAL INHIBITION; ANTENNAL LOBE; SENSORY INPUT; RELIABILITY; CIRCUIT	Although examples of variation and diversity exist throughout the nervous system, their importance remains a source of debate. Even neurons of the same molecular type have notable intrinsic differences. Largely unknown, however, is the degree to which these differences impair or assist neural coding. We examined the outputs from a single type of neuron, the mitral cells of the mouse olfactory bulb, to identical stimuli and found that each cell's spiking response was dictated by its unique biophysical fingerprint. Using this intrinsic heterogeneity, diverse populations were able to code for twofold more information than their homogeneous counterparts. In addition, biophysical variability alone reduced pair-wise output spike correlations to low levels. Our results indicate that intrinsic neuronal diversity is important for neural coding and is not simply the result of biological imprecision.	[Padmanabhan, Krishnan; Urban, Nathaniel N.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Padmanabhan, Krishnan; Urban, Nathaniel N.] Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Urban, Nathaniel N.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Urban, NN (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	nurban@cmu.edu	Urban, Nathaniel/A-4974-2008	Urban, Nathaniel/0000-0002-0365-9068	National Institute on Deafness and Other Communication Disorders [R01DC0005798]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005798, R01DC011184] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We wish to thank G.M. LaRocca for assistance with the immunohistochemistry and B. Benedetti, A. Barth, J. Castro and members of the Urban laboratory for helpful comments on this manuscript. Funding was provided by the National Institute on Deafness and Other Communication Disorders (R01DC0005798).	Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Ermentrout GB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248103; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Galan RF, 2008, J NEUROPHYSIOL, V99, P277, DOI 10.1152/jn.00563.2007; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Osborne LC, 2008, J NEUROSCI, V28, P13522, DOI 10.1523/JNEUROSCI.4390-08.2008; Ramon y Cajal S, 1952, B LOS ANGEL NEURO SO, V17, P5; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008	47	198	199	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1276	1282		10.1038/nn.2630	http://dx.doi.org/10.1038/nn.2630			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20802489	Green Accepted			2022-12-24	WOS:000282171300021
J	Lu, H; Cheng, PL; Lim, BK; Khoshnevisrad, N; Poo, MM				Lu, Hui; Cheng, Pei-lin; Lim, Byung Kook; Khoshnevisrad, Nina; Poo, Mu-ming			Elevated BDNF after Cocaine Withdrawal Facilitates LTP in Medial Prefrontal Cortex by Suppressing GABA Inhibition	NEURON			English	Article							LONG-TERM POTENTIATION; VENTRAL TEGMENTAL AREA; MIDBRAIN DOPAMINE NEURONS; DRUG-SEEKING BEHAVIOR; NEUROTROPHIC FACTOR; INDUCED REINSTATEMENT; SYNAPTIC PLASTICITY; RECEPTOR PHOSPHORYLATION; GABAERGIC INHIBITION; LASTING POTENTIATION	Medial prefrontal cortex (mPFC) is known to be involved in relapse after cocaine withdrawal, but the underlying cellular mechanism remains largely unknown. Here, we report that after terminating repeated cocaine exposure in rats, a gradual increase in the expression of brain-derived neurotrophic factor (BDNF) in the mPFC facilitates activity-induced long-term potentiation (LTP) of excitatory synapses on layer V pyramidal neurons. This enhanced synaptic plasticity could be attributed to BDNF-induced suppression of GABAergic inhibition in the mPFC by reducing the surface expression of GABA(A) receptors. The BDNF effect was mediated by BDNF-TrkB-phosphatase 2A signaling pathway. Downregulating TrkB expression bilaterally in the mPFC reduced the locomotor hypersensitivity to cocaine 8 days after cocaine withdrawal. Thus, elevated BDNF expression after cocaine withdrawal sensitizes the excitatory synapses in the mPFC to undergo activity-induced persistent potentiation that may contribute to cue-induced drug craving and drug-seeking behavior.	[Lu, Hui; Cheng, Pei-lin; Lim, Byung Kook; Khoshnevisrad, Nina; Poo, Mu-ming] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Lu, Hui/K-2322-2013; Cheng, Pei-Lin/ABB-2255-2021; Core, Vector/CAF-4832-2022	Cheng, Pei-Lin/0000-0002-0090-8153; Lim, Byungkook/0000-0002-3766-5415	USNIH; NATIONAL EYE INSTITUTE [R01EY014979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	USNIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from USNIH.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Brandon NJ, 2002, PHARMACOL THERAPEUT, V94, P113, DOI 10.1016/S0163-7258(02)00175-4; Capriles N, 2003, PSYCHOPHARMACOLOGY, V168, P66, DOI 10.1007/s00213-002-1283-z; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DICHIARA G, 1995, DRUG ALCOHOL DEPEN, V38, P95, DOI 10.1016/0376-8716(95)01118-I; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Feltenstein MW, 2008, BRIT J PHARMACOL, V154, P261, DOI 10.1038/bjp.2008.51; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Grimm JW, 2003, J NEUROSCI, V23, P742; Huang CC, 2007, CEREB CORTEX, V17, P1877, DOI 10.1093/cercor/bhl096; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jenab S, 2005, MOL BRAIN RES, V142, P134, DOI 10.1016/j.molbrainres.2005.08.015; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lu H, 2009, J NEUROSCI, V29, P12664, DOI 10.1523/JNEUROSCI.1984-09.2009; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park HJ, 2010, PSYCHIAT RES, V175, P165, DOI 10.1016/j.psychres.2008.10.005; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pu L, 2006, NAT NEUROSCI, V9, P605, DOI 10.1038/nn1687; Rebec GV, 2005, J EXP ANAL BEHAV, V84, P653, DOI 10.1901/jeab.2005.105-04; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; Sun WL, 2007, BRAIN RES, V1178, P12, DOI 10.1016/j.brainres.2007.07.051; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vargas-Perez H, 2009, SCIENCE, V324, P1732, DOI 10.1126/science.1168501; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Zhang XW, 2006, BIOCHEM BIOPH RES CO, V340, P1144, DOI 10.1016/j.bbrc.2005.12.114	49	89	95	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					821	833		10.1016/j.neuron.2010.08.012	http://dx.doi.org/10.1016/j.neuron.2010.08.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826313	Green Accepted, Bronze			2022-12-24	WOS:000281938900016
J	Thompson, BL; Levitt, P				Thompson, Barbara L.; Levitt, Pat			The Clinical-Basic Interface in Defining Pathogenesis in Disorders of Neurodevelopmental Origin	NEURON			English	Article							OPPONENT-PROCESS THEORY; FRAGILE-X-SYNDROME; RETT-SYNDROME; MOUSE MODEL; ANIMAL-MODELS; GLUCOCORTICOID-RECEPTOR; ANXIETY DISORDERS; UBIQUITIN LIGASE; GATING DEFICITS; FRONTAL-CORTEX	Human cognitive and social-emotional behaviors are heterogeneous, underscoring the challenges in modeling pathogenesis in disorders of neurodevelopmental origin in which these domains are dysfunctional. In general, animal models for these disorders are built to emulate our understanding of the clinical diagnosis, with mixed results. We suggest the utility of model systems lies in the use of different strategies to perturb hierarchical circuit development, to examine the behavioral dimensions that are most impacted, and to discern the capacity for, and heterogeneity of, neuroadaptation that will then inform treatment strategies.	[Thompson, Barbara L.; Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Thompson, Barbara L.; Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Levitt, P (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	plevitt@usc.edu	Thompson, Barbara L/A-1976-2016	Thompson, Barbara/0000-0002-7294-3900	NIH [MH067842, MH080759, MH090047, DA022785, MH078028]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH090047, R56MH067842, P50MH078028, R01MH080759, R01MH067842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022785] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Wendy Stone and Elizabeth Hammock for discussions that influenced some of the ideas presented here. The authors were supported in part by research grants from the NIH (MH067842, MH080759, MH090047, DA022785, Conte Center MH078028) and the Simons Foundation.	Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47; Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; ANNEY R, 2010, HUM MOL GEN IN PRESS, DOI DOI 10.10.1093/HMG/DDQ307; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Axelrod FB, 2002, J PEDIATR-US, V141, P518, DOI 10.1067/mpd.2002.127088; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Banihashemi L, 2010, NEUROSCIENCE, V165, P265, DOI 10.1016/j.neuroscience.2009.09.081; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell DB, 2009, PEDIATRICS, V123, P1018, DOI 10.1542/peds.2008-0819; Card JP, 2005, J NEUROSCI, V25, P9102, DOI 10.1523/JNEUROSCI.2345-05.2005; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Carvill S, 2001, J INTELL DISABIL RES, V45, P467, DOI 10.1046/j.1365-2788.2001.00366.x; Casanova MF, 2008, PSYCHIAT RES, V158, P267, DOI 10.1016/j.psychres.2006.12.009; Casanova MF, 2003, NEUROSCIENTIST, V9, P496, DOI 10.1177/1073858403253552; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Cooper-Brown L, 2008, DEV DISABIL RES REV, V14, P147, DOI 10.1002/ddrr.19; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Davis E, 2008, PSYCHIAT QUART, V79, P249, DOI 10.1007/s11126-008-9081-3; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Dykens EM, 2003, DEV NEUROPSYCHOL, V23, P291, DOI 10.1207/S15326942DN231&2_13; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Errijgers V, 2008, GENET RES, V90, P341, DOI 10.1017/S0016672308009415; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fisch GS, 2007, BEHAV GENET, V37, P1, DOI 10.1007/s10519-006-9117-0; Flint J, 2008, CURR OPIN GENET DEV, V18, P235, DOI 10.1016/j.gde.2008.07.002; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hammock EAD, 2006, HUM DEV, V49, P294, DOI 10.1159/000095581; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Insel TR, 2007, BIOL PSYCHIAT, V62, P1337, DOI 10.1016/j.biopsych.2007.10.001; Insel TR, 2009, J CLIN INVEST, V119, P700, DOI 10.1172/JCI38832; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Kellendonk C, 2009, TRENDS NEUROSCI, V32, P347, DOI 10.1016/j.tins.2009.02.003; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koshibu K, 2008, NEUROPSYCHOPHARMACOL, V33, P557, DOI 10.1038/sj.npp.1301436; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lieberman JA, 2001, BIOL PSYCHIAT, V50, P884, DOI 10.1016/S0006-3223(01)01303-8; Loesch DZ, 2004, MENT RETARD DEV D R, V10, P31, DOI 10.1002/mrdd.20006; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matsuo M, 2010, BRAIN DEV-JPN, V32, P759, DOI 10.1016/j.braindev.2010.05.005; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McEwen BS, 2001, ANN NY ACAD SCI, V935, P42; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; MENDOZA SP, 1978, DEV PSYCHOBIOL, V11, P169, DOI 10.1002/dev.420110209; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Moriceau S, 2006, J NEUROSCI, V26, P6737, DOI 10.1523/JNEUROSCI.0499-06.2006; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Mulherkar SA, 2010, NEUROBIOL DIS, V40, P586, DOI 10.1016/j.nbd.2010.08.002; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rinaman L, 2000, J NEUROSCI, V20, P2731; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Sharpe NA, 1998, NEUROSCIENCE, V84, P1163, DOI 10.1016/S0306-4522(97)00583-6; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shionoya K, 2007, HORM BEHAV, V52, P391, DOI 10.1016/j.yhbeh.2007.06.004; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; STANWOOD GD, 2008, HDB DEV COGNITIVE NE, P83; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; SUCHECKI D, 1993, DEV BRAIN RES, V75, P185, DOI 10.1016/0165-3806(93)90022-3; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Thompson BL, 2010, NEURON, V65, P437, DOI 10.1016/j.neuron.2010.02.010; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Tibbo P, 2003, DEPRESS ANXIETY, V17, P65, DOI 10.1002/da.10083; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Vismara LA, 2010, ANNU REV CLIN PSYCHO, V6, P447, DOI 10.1146/annurev.clinpsy.121208.131151; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Wei Q, 2007, J NEUROSCI, V27, P8836, DOI 10.1523/JNEUROSCI.0910-07.2007; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327	123	24	25	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					702	712		10.1016/j.neuron.2010.08.037	http://dx.doi.org/10.1016/j.neuron.2010.08.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826303	Green Accepted, Bronze			2022-12-24	WOS:000281938900006
J	Takubo, K; Goda, N; Yamada, W; Iriuchishima, H; Ikeda, E; Kubota, Y; Shima, H; Johnson, RS; Hirao, A; Suematsu, M; Suda, T				Takubo, Keiyo; Goda, Nobuhito; Yamada, Wakako; Iriuchishima, Hirono; Ikeda, Eiji; Kubota, Yoshiaki; Shima, Haruko; Johnson, Randall S.; Hirao, Atsushi; Suematsu, Makoto; Suda, Toshio			Regulation of the HIF-1 alpha Level Is Essential for Hematopoietic Stem Cells	CELL STEM CELL			English	Article							BONE-MARROW; PROGENITOR CELLS; MAINTENANCE; NICHE; QUIESCENCE; EXPRESSION; HYPOXIA; RESIDE	Hematopoietic stem cells (HSCs) are sustained in a specific microenvironment known as the stem cell niche. Mammalian HSCs are kept quiescent in the endosteal niche, a hypoxic zone of the bone marrow (BM). In this study, we show that normal HSCs maintain intracellular hypoxia and stabilize hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein. In HIF-1 alpha-deficient mice, the HSCs lost their cell cycle quiescence and HSC numbers decreased during various stress settings including bone marrow transplantation, myelosuppression, or aging, in a p16(Ink4a)/p19(Arf)-dependent manner. Overstabilization of HIF-1 alpha by biallelic loss of an E3 ubiquitin ligase for HIF-1 alpha (VHL) induced cell cycle quiescence in HSCs and their progenitors but resulted in an impairment in transplantation capacity. In contrast, monoallelic loss of VHL induced cell cycle quiescence and improved BM engraftment during bone marrow transplantation. These data indicate that HSCs maintain cell cycle quiescence through the precise regulation of HIF-1 alpha levels.	[Takubo, Keiyo; Yamada, Wakako; Iriuchishima, Hirono; Kubota, Yoshiaki; Shima, Haruko; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo 1608582, Japan; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo 1608582, Japan; [Suematsu, Makoto] Suematsu Gas Biol Project, JST ERATO, Shinjuku Ku, Tokyo 1608582, Japan; [Goda, Nobuhito] Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Ikeda, Eiji] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Yamaguchi 7558505, Japan; [Johnson, Randall S.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Goda, Nobuhito; Hirao, Atsushi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Hirao, Atsushi] Kanazawa Univ, Div Mol Genet, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan	Keio University; Keio University; Waseda University; Yamaguchi University; University of California System; University of California San Diego; Japan Science & Technology Agency (JST); Kanazawa University	Takubo, K (corresponding author), Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	keiyot@gmail.com; sudato@sc.itc.keio.ac.jp	Takubo, Keiyo/AAX-5546-2020; Suematsu, Makoto/I-8135-2013; Suda, Toshio/H-6761-2013; Kubota, Yoshiaki/L-2231-2013; Goda, Nobuhito/W-2468-2019; Suematsu, Makoto/O-5762-2018; Johnson, Randall/AAM-1189-2021	Takubo, Keiyo/0000-0002-1736-7592; Suematsu, Makoto/0000-0002-7165-6336; Suda, Toshio/0000-0001-7540-1771; Suematsu, Makoto/0000-0002-7165-6336; Johnson, Randall/0000-0002-4084-6639; Goda, Nobuhito/0000-0003-0295-4257	JSPS; MEXT [17GS0419]; JST; Grants-in-Aid for Scientific Research [21390290] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura for providing Plat E packaging cells; A. Iwama for providing Bmi1 retroviral vector; K. Rajewsky for providing Mx1-Cre mice; V. Haase for providing VHL<SUP>flox/flox</SUP> mice; H. Saya and M.C. Simon for fruitful suggestions; T. Muraki, A. Kumakubo, and T. Hirose for essential support; and F. Arai, T. Naito, N. Tago, and A. Ono for FAGS operation. K.T. was a research fellow of JSPS supported by the Global COE Programs for Human Metabolomic Systems Biology and for Stem Cell Medicine and also in part by a MEXT Grant-in-Aid for Young Scientists (B) and a Grant-in-Aid for Scientific Research on Priority Areas. A.H. and M.S. were supported in part by a MEXT Grant-in-Aid for Creative Scientific Research 17GS0419. M.S. supported FACS analysis as the Leader of ERATO, JST, Suematsu Gas Biology Project. T.S. was supported by a MEXT Grant-in-Aid for Specially Promoted Research.	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hackney JA, 2004, METH MOLEC MED, V105, P439; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Levesque JP, 2007, STEM CELLS, V25, P1954, DOI 10.1634/stemcells.2006-0688; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	38	629	650	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					391	402		10.1016/j.stem.2010.06.020	http://dx.doi.org/10.1016/j.stem.2010.06.020			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804974	Bronze			2022-12-24	WOS:000282037800015
J	Chen, SX; Tari, PK; She, K; Haas, K				Chen, Simon Xuan; Tari, Parisa Karimi; She, Kevin; Haas, Kurt			Neurexin-Neuroligin Cell Adhesion Complexes Contribute to Synaptotropic Dendritogenesis via Growth Stabilization Mechanisms In Vivo	NEURON			English	Article							INHIBITORY SYNAPSE FORMATION; DENDRITIC ARBOR GROWTH; NASCENT SYNAPSES; AMPA RECEPTORS; NMDA RECEPTOR; MATURATION; BINDING; PSD-95; AUTISM; GENE	Cell adhesion molecules are well characterized for mediating synapse initiation, specification, differentiation, and maturation, yet their contribution to directing dendritic arborization during early brain circuit formation remains unclear. Using two-photon time-lapse imaging of growing neurons within intact and awake embryonic Xenopus brain, we examine roles of [beta-neurexin (NRX) and neuroligin-1 (NLG1) in dendritic arbor development. Using methods of dynamic morphometrics for comprehensive 3D quantification of rapid dendritogenesis, we find initial trans-synaptic NRX-NLG1 adhesions confer transient morphologic stabilization independent of NMDA receptor activity, whereas persistent stabilization requires NMDA receptor-dependent synapse maturation. Disrupting NRX-NLG1 function destabilizes filopodia while reducing synaptic density and AMPA receptor mEPSC frequency. Altered dynamic growth culminates in reduced dendritic arbor complexity as neurons mature over days. These results expand the synaptotropic model of dendritogenesis to incorporate cell adhesion molecule-mediated morphological stabilization necessary for directing normal dendritic arborization, providing a potential morphological substrate for developmental cognitive impairment associated with cell adhesion molecule mutations.	[Chen, Simon Xuan; Tari, Parisa Karimi; She, Kevin; Haas, Kurt] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada; [Chen, Simon Xuan; Tari, Parisa Karimi; She, Kevin; Haas, Kurt] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	Haas, K (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada.	kurt.haas@ubc.ca	Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560; Chen, Simon/0000-0002-7595-7443	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Tula Foundation; EJLB Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Tula Foundation; EJLB Foundation	This work was funded by grants from the Canadian Institutes of Health Research (K.H.), the Michael Smith Foundation for Health Research, the Tula Foundation, and the EJLB Foundation (K.H.).	Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Hewapathirane DS, 2008, EXP NEUROL, V211, P480, DOI 10.1016/j.expneurol.2008.02.012; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Liu XF, 2009, J NEUROSCI, V29, P12229, DOI 10.1523/JNEUROSCI.2842-09.2009; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Niell CM, 2006, J THEOR BIOL, V241, P39, DOI 10.1016/j.jtbi.2005.11.014; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Rajan I, 1998, J NEUROSCI, V18, P7836; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Zamir E, 2001, J CELL SCI, V114, P3583; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	52	80	82	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					967	983		10.1016/j.neuron.2010.08.016	http://dx.doi.org/10.1016/j.neuron.2010.08.016			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869594	Bronze			2022-12-24	WOS:000282801100009
J	Onishi, A; Peng, GH; Chen, SM; Blackshaw, S				Onishi, Akishi; Peng, Guang-Hua; Chen, Shiming; Blackshaw, Seth			Pias3-dependent SUMOylation controls mammalian cone photoreceptor differentiation	NATURE NEUROSCIENCE			English	Article							THYROID-HORMONE RECEPTOR; RETINOIC ACID; CHROMATIN IMMUNOPRECIPITATION; OPSIN EXPRESSION; HOMEOBOX GENE; IN-VIVO; EVOLUTION; TRANSCRIPTION; CRX; ROD	Selective expression of retinal cone opsin genes is essential for color vision, but the mechanism mediating this process is poorly understood. Both vertebrate rod and medium wavelength-sensitive (M) cone photoreceptors differentiate by repression of a short wavelength-sensitive (S) cone differentiation program. We found that Pias3 acts in mouse cone photoreceptors to activate expression of M opsin and repress expression of S opsin, with the transcription factors Tr beta 2 and Rxr gamma mediating preferential expression of Pias3 in M cones. Finally, we observed that Pias3 directly regulated M and S cone opsin expression by modulating the cone-enriched transcription factors Rxr gamma, Ror alpha and Tr beta 1. Our results indicate that Pias3-dependent SUMOylation of photoreceptor-specific transcription factors is a common mechanism that controls both rod and cone photoreceptor subtype specification, regulating distinct molecular targets in the two cell types.	[Onishi, Akishi; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Peng, Guang-Hua; Chen, Shiming] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Chen, Shiming] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Ctr High Throughput Biol, Baltimore, MD 21205 USA; [Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	sblack@jhmi.edu	Huang, Yifei/ABE-7566-2020		US National Institutes of Health [R01EY017015, RO1EY012543]; NATIONAL EYE INSTITUTE [R01EY017015, R01EY012543] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Forrest for providing antibodies to Tr beta 2 and for supplying Tr beta 2<SUP>-/-</SUP> and Tr beta 1<SUP>-/-</SUP>; Tr beta 2<SUP>-/-</SUP> mice. We also thank J. Nathans, T. Shimogori, W. Yap and members of the Blackshaw laboratory for their comments on the manuscript. This work was supported by grants from the US National Institutes of Health (R01EY017015 to S. B. and RO1EY012543 to S. C.). S. B. is a W. M. Keck Distinguished Young Investigator in Medical Science.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Barroso-Chinea P, 2007, J NEUROSCI METH, V162, P119, DOI 10.1016/j.jneumeth.2006.12.017; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Collin Shaun P, 2004, Clin Exp Optom, V87, P217; ELAKAWI Z, 1994, BIOCHEMISTRY-US, V33, P1938, DOI 10.1021/bi00173a042; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lamb TD, 2009, PHILOS T R SOC B, V364, P2911, DOI 10.1098/rstb.2009.0102; Li DS, 2002, MOL CELL BIOL, V22, P5782, DOI 10.1128/MCB.22.16.5782-5792.2002; Li HX, 2000, MECH DEVELOP, V95, P283, DOI 10.1016/S0925-4773(00)00352-X; Lin M, 2003, J BIOL CHEM, V278, P9856, DOI 10.1074/jbc.M211417200; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; MCCAFFERY P, 1993, DEV BIOL, V158, P390, DOI 10.1006/dbio.1993.1197; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peng GH, 2005, VISUAL NEUROSCI, V22, P575, DOI 10.1017/S0952523805225063; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; Pichaud F, 1999, CURR OPIN NEUROBIOL, V9, P622, DOI 10.1016/S0959-4388(99)00014-8; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213	46	36	36	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1059	U44		10.1038/nn.2618	http://dx.doi.org/10.1038/nn.2618			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729845	Green Accepted			2022-12-24	WOS:000281332600010
J	Di Giovanni, J; Boudkkazi, S; Mochida, S; Bialowas, A; Samari, N; Leveque, C; Youssouf, F; Brechet, A; Iborra, C; Maulet, Y; Moutot, N; Debanne, D; Seagar, M; El Far, O				Di Giovanni, Jerome; Boudkkazi, Sami; Mochida, Sumiko; Bialowas, Andrzej; Samari, Nada; Leveque, Christian; Youssouf, Fahamoe; Brechet, Aline; Iborra, Cecile; Maulet, Yves; Moutot, Nicole; Debanne, Dominique; Seagar, Michael; El Far, Oussama			V-ATPase Membrane Sector Associates with Synaptobrevin to Modulate Neurotransmitter Release	NEURON			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; PROTEIN-INTERACTION SITE; COMPLEX-FORMATION; BINDING DOMAIN; LIPID-BINDING; FUSION; CHANNELS; CALMODULIN; SUBUNIT; A1	Acidification of synaptic vesicles by the vacuolar proton ATPase is essential for loading with neurotransmitter. Debated findings have suggested that V-ATPase membrane domain (VO) also contributes to Ca2+-dependent transmitter release via a direct role in vesicle membrane fusion, but the underlying mechanisms remain obscure. We now report a direct interaction between VO c-subunit and the v-SNARE synaptobrevin, constituting a molecular link between the V-ATPase and SNARE-mediated fusion. Interaction domains were mapped to the membrane-proximal domain of VAMP2 and the cytosolic 3.4 loop of c-subunit. Acute perturbation of this interaction with c-subunit 3.4 loop peptides did not affect synaptic vesicle proton pump activity, but induced a substantial decrease in neurotransmitter release probability, inhibiting glutamatergic as well as cholinergic transmission in cortical slices and cultured sympathetic neurons, respectively. Thus, V-ATPase may ensure two independent functions: proton transport by a fully assembled V-ATPase and a role in SNARE-dependent exocytosis by the VO sector.	[Di Giovanni, Jerome; Boudkkazi, Sami; Bialowas, Andrzej; Samari, Nada; Leveque, Christian; Youssouf, Fahamoe; Brechet, Aline; Iborra, Cecile; Maulet, Yves; Moutot, Nicole; Debanne, Dominique; Seagar, Michael; El Far, Oussama] INSERM, U641, F-13916 Marseille, France; [Di Giovanni, Jerome; Boudkkazi, Sami; Bialowas, Andrzej; Samari, Nada; Leveque, Christian; Youssouf, Fahamoe; Brechet, Aline; Iborra, Cecile; Maulet, Yves; Moutot, Nicole; Debanne, Dominique; Seagar, Michael; El Far, Oussama] Univ Aix Marseille 2, Fac Med Secteur Nord, IFR 11, F-13916 Marseille, France; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Leveque, Christian] CAPM, IFR 11, F-13916 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Tokyo Medical University	El Far, O (corresponding author), INSERM, U641, F-13916 Marseille, France.	oussama.elfar@univmed.fr	Debanne, Dominique/O-4673-2016; leveque, christian/GVU-3567-2022; Far, Oussama El/D-4225-2017; EL FAR, Oussama/P-9915-2019; Maulet, Yves/AAC-3207-2019	Debanne, Dominique/0000-0001-8581-5695; leveque, christian/0000-0003-2583-2148; Far, Oussama El/0000-0002-7473-8345; EL FAR, Oussama/0000-0002-7473-8345; Maulet, Yves/0000-0002-3162-0435	Association Francaise contre lea myopathies (AFM); Ministere de l'enseignement superieur et de la recherche	Association Francaise contre lea myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de l'enseignement superieur et de la recherche	This work was supported by the Association Francaise contre lea myopathies (AFM), the Ministere de l'enseignement superieur et de la recherche - Action Concertee Incitative "Biologie cellulaire, moleculaire et structurale (BCMS)", and the Grants-in aid for Scientific Research B (S.M.). We thank Christian Vannier and Amy Lee for the generous gifts of cytohesin PH domain plasmid and calmodulin clones, respectively. We are grateful to Heinrich Betz and Beat Gahwiler for critical reading of the manuscript.	Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Bedet C, 2006, J BIOL CHEM, V281, P30046, DOI 10.1074/jbc.M602155200; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Boudkkazi S, 2007, NEURON, V56, P1048, DOI 10.1016/j.neuron.2007.10.037; Bretou M, 2008, J NEUROSCI, V28, P8470, DOI 10.1523/JNEUROSCI.0860-08.2008; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; de Haro L, 2004, P NATL ACAD SCI USA, V101, P1578, DOI 10.1073/pnas.0303274101; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fdez E, 2008, MOL BIOL CELL, V19, P3379, DOI 10.1091/mbc.E08-01-0010; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Goncalves PP, 2000, BRAIN RES PROTOC, V5, P102, DOI 10.1016/S1385-299X(99)00061-6; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; MOCHIDA S, 1998, CELLULAR MOL MECH TO, P15; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Morel N, 2001, J NEUROCHEM, V79, P485, DOI 10.1046/j.1471-4159.2001.00611.x; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Quetglas S, 2002, EMBO J, V21, P3970, DOI 10.1093/emboj/cdf404; Quetglas S, 2000, P NATL ACAD SCI USA, V97, P9695, DOI 10.1073/pnas.97.17.9695; Shiff G, 1996, NEUROCHEM INT, V29, P659, DOI 10.1016/S0197-0186(96)00026-5; Skinner MA, 1999, J BIOL CHEM, V274, P23119, DOI 10.1074/jbc.274.33.23119; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373	46	71	71	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					268	279		10.1016/j.neuron.2010.06.024	http://dx.doi.org/10.1016/j.neuron.2010.06.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670834	Bronze			2022-12-24	WOS:000280461500011
J	Wilburn, B; Rudnicki, DD; Zhao, J; Weitz, TM; Cheng, Y; Gu, XF; Greiner, E; Park, CS; Wang, N; Sopher, BL; La Spada, AR; Osmand, A; Margolis, RL; Sun, YE; Yang, XW				Wilburn, Brian; Rudnicki, Dobrila D.; Zhao, Jing; Weitz, Tara Murphy; Cheng, Yin; Gu, Xiaofeng; Greiner, Erin; Park, Chang Sin; Wang, Nan; Sopher, Bryce L.; La Spada, Albert R.; Osmand, Alex; Margolis, Russell L.; Sun, Yi E.; Yang, X. William			An Antisense CAG Repeat Transcript at JPH3 Locus Mediates Expanded Polyglutamine Protein Toxicity in Huntington's Disease-like 2 Mice	NEURON			English	Article							CREB-BINDING PROTEIN; HUMAN MUTANT HUNTINGTIN; MYOTONIC-DYSTROPHY; MAMMALIAN-CELLS; HD MICE; EXPANSION; EXPRESSION; RNA; HUNTINGTONS-DISEASE-LIKE-2; HUNTINGTON-DISEASE-LIKE-2	Huntington's disease-like-2 (HDL2) is a phenocopy of Huntington's disease caused by CTG/CAG repeat expansion at the Junctophilin-3 (JPH3) locus. The mechanisms underlying HDL2 pathogenesis remain unclear. Here we developed a BAC transgenic mouse model of HDL2 (BAC-HDL2) that exhibits progressive motor deficits, selective neurodegenerative pathology, and ubiquitin-positive nuclear inclusions (NIs). Molecular analyses reveal a promoter at the transgene locus driving the expression of a CAG repeat transcript (HDL2-CAG) from the strand antisense to JPH3, which encodes an expanded polyglutamine (polyQ) protein. Importantly, BAC-HDL2 mice, but not control BAG mice, accumulate polyQ-containing NIs in a pattern strikingly similar to those in the patients. Furthermore, BAC mice with genetic silencing of the expanded CUG transcript still express HDL2-CAG transcript and manifest polyQ pathogenesis. Finally, studies of HDL2 mice and patients revealed CBP sequestration into NIs and evidence for interference of CBP-mediated transcriptional activation. These results suggest overlapping polyQ-mediated pathogenic mechanisms in HD and HDL2.	[Wilburn, Brian; Weitz, Tara Murphy; Gu, Xiaofeng; Greiner, Erin; Park, Chang Sin; Wang, Nan; Yang, X. William] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci,Brain Res Inst, Ctr Neurobehav Genet,Semel Inst Neurosci & Human, Los Angeles, CA 90095 USA; [Rudnicki, Dobrila D.; Margolis, Russell L.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol,Lab Genet Neurobiol, Baltimore, MD 21287 USA; [Zhao, Jing; Cheng, Yin; Sun, Yi E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci,Brain Res Inst, Dept Pharmacol,Mental Retardat Res Ctr,Semel Inst, Los Angeles, CA 90095 USA; [Greiner, Erin] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sopher, Bryce L.; La Spada, Albert R.] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Calif San Diego, Inst Genom Med, Div Biol Sci, Dept Pediat, La Jolla, CA 92093 USA; [La Spada, Albert R.] Univ Calif San Diego, Inst Genom Med, Div Biol Sci, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [La Spada, Albert R.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Osmand, Alex] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37920 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of Tennessee System; University of Tennessee Health Science Center	Yang, XW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci,Brain Res Inst, Ctr Neurobehav Genet,Semel Inst Neurosci & Human, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu	La Spada, Albert/AAG-8809-2020	Weitz, Tara/0000-0002-4211-0449	Hereditary Disease Foundation; National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [R01NS049501, R21NS057516, R01NS064138]; University of California, Los Angeles; The McKnight Endowment Fund for Neuroscience; National Institute of Mental Health [5T32MH073526]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH073526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057516, R01NS064138, R01NS049501] Funding Source: NIH RePORTER	Hereditary Disease Foundation; National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of California, Los Angeles(University of California System); The McKnight Endowment Fund for Neuroscience; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was generously supported by independent research grants from the Hereditary Disease Foundation to X.W.Y., R.L.M., A.O., and to D.D.R. X.W.Y. is also supported by National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS; R01NS049501), the David Weil Fund to the Semel Institute at University of California, Los Angeles, and Neuroscience of Brain Disorders Award from The McKnight Endowment Fund for Neuroscience. R.L.M. and D.D.R. are supported by NIH/NINDS (R21NS057516 and R01NS064138). We would like to thank N.S. Wexler and C. Johnson for their tremendous support of this project. We also thank members of the Yang lab for discussions and reading of the manuscript. B.W. and C.S.P. were supported by predoctoral fellowships from the UCLA Center for Neurobehavioral Genetics Predoctoral Training Program funded by National Institute of Mental Health (5T32MH073526).	BROOKS E, 2004, J CELL SCI, V277, P2363; Dorsman JC, 2002, HUM MOL GENET, V11, P1487, DOI 10.1093/hmg/11.13.1487; Gambazzi L, 2010, J PHARMACOL EXP THER, V335, P13, DOI 10.1124/jpet.110.167551; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Greenstein PE, 2007, MOVEMENT DISORD, V22, P1416, DOI 10.1002/mds.21417; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Holmes SE, 2001, NAT GENET, V29, P377, DOI 10.1038/ng760; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Margolis RL, 2001, ANN NEUROL, V50, P373, DOI 10.1002/ana.1124; Margolis RL, 2004, ANN NEUROL, V56, P670, DOI 10.1002/ana.20248; Margolis Russell L, 2005, Acta Neurol Taiwan, V14, P1; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Nishi M, 2002, BIOCHEM BIOPH RES CO, V292, P318, DOI 10.1006/bbrc.2002.6649; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osmand AP, 2006, METHOD ENZYMOL, V412, P106, DOI 10.1016/S0076-6879(06)12008-X; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Rudnicki DD, 2008, J NEUROPATH EXP NEUR, V67, P366, DOI 10.1097/NEN.0b013e31816b4aee; Rudnicki DD, 2007, ANN NEUROL, V61, P272, DOI 10.1002/ana.21081; Schneider SA, 2007, NAT CLIN PRACT NEURO, V3, P517, DOI 10.1038/ncpneuro0606; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Takeshima H, 2001, Clin Calcium, V11, P758; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yu ZX, 2002, HUM MOL GENET, V11, P905, DOI 10.1093/hmg/11.8.905; Zoghbi HY, 2002, TRENDS GENET, V18, P463, DOI 10.1016/S0168-9525(02)02729-4; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	39	107	109	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					427	440		10.1016/j.neuron.2011.03.021	http://dx.doi.org/10.1016/j.neuron.2011.03.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555070	Bronze, Green Accepted			2022-12-24	WOS:000290926100006
J	Brownell, I; Guevara, E; Bai, CB; Loomis, CA; Joyner, AL				Brownell, Isaac; Guevara, Elizabeth; Bai, C. Brian; Loomis, Cynthia A.; Joyner, Alexandra L.			Nerve-Derived Sonic Hedgehog Defines a Niche for Hair Follicle Stem Cells Capable of Becoming Epidermal Stem Cells	CELL STEM CELL			English	Article							MAMMALIAN EPIDERMIS; PROGENITOR CELLS; INDIAN HEDGEHOG; BETA-CATENIN; SKIN; MORPHOGENESIS; INNERVATION; ACTIVATION; RENEWAL; CYCLE	In adult skin, stem cells in the hair follicle bulge cyclically regenerate the follicle, whereas a distinct stem cell population maintains the epidermis. The degree to which all bulge cells have equal regenerative potential is not known. We found that Sonic hedgehog (Shh) from neurons signals to a population of cells in the telogen bulge marked by the Hedgehog response gene Gli1. Gli1-expressing bulge cells function as multipotent stem cells in their native environment and repeatedly regenerate the anagen follicle. Shh-responding perineural bulge cells incorporate into healing skin wounds where, notably, they can change their lineage into epidermal stem cells. The perineural niche (including Shh) is dispensable for follicle contributions to acute wound healing and skin homeostasis, but is necessary to maintain bulge cells capable of becoming epidermal stem cells. Thus, nerves cultivate a microenvironment where Shh creates a molecularly and phenotypically distinct population of hair follicle stem cells.	[Brownell, Isaac; Guevara, Elizabeth; Joyner, Alexandra L.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Brownell, Isaac] Mem Sloan Kettering Canc Ctr, Dermatol Serv, New York, NY 10065 USA; [Bai, C. Brian; Joyner, Alexandra L.] NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; [Loomis, Cynthia A.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; New York University; New York University	Joyner, AL (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	joynera@mskcc.org	Brownell, Isaac/Q-1937-2018		NIH [R01CA128158, F32AR55435]; Tr-Institutional Stem Cell Initiative; Dermatology Foundation; Charles A. Dana Foundation; NATIONAL CANCER INSTITUTE [R01CA128158, ZIABC011393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR055435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tr-Institutional Stem Cell Initiative; Dermatology Foundation; Charles A. Dana Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Patel, R. Turnbull, D. Stephen, and J. Chan for technical assistance. We thank M. Hassimi and Y. "Jeffrey" Zhao of the MSKCC Genomics Core Laboratory for microarray data analysis, support, and training. We thank Dr. R. Boyd for the anti-MTS24 antibody, Dr. M. Wegner for the anti-Sox9 antibody, Dr. L. Reichardt for the anti-TrkA antibody, and Dr. T. Jessell for the anti-Runx1 and anti-Runx3 antibodies. This work was supported by NIH grant R01CA128158 and the Tr-Institutional Stem Cell Initiative (to A.L.J.); and by NIH grant F32AR55435, the Dermatology Foundation, and the Charles A. Dana Foundation (to I.B.).	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Botchkarev VA, 1997, J COMP NEUROL, V386, P379, DOI 10.1002/(SICI)1096-9861(19970929)386:3<379::AID-CNE4>3.0.CO;2-Z; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Maurer M, 1998, ARCH DERMATOL RES, V290, P574, DOI 10.1007/s004030050354; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Peters EMJ, 2002, J COMP NEUROL, V448, P28, DOI 10.1002/cne.10212; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Sharghi-Namini S, 2006, J NEUROSCI, V26, P6364, DOI 10.1523/JNEUROSCI.0157-06.2006; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033	53	307	312	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					552	565		10.1016/j.stem.2011.02.021	http://dx.doi.org/10.1016/j.stem.2011.02.021			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549329	Bronze, Green Accepted			2022-12-24	WOS:000290927600015
J	Ku, SP; Tolias, AS; Logothetis, NK; Goense, J				Ku, Shih-Pi; Tolias, Andreas S.; Logothetis, Nikos K.; Goense, Jozien			fMRI of the Face-Processing Network in the Ventral Temporal Lobe of Awake and Anesthetized Macaques	NEURON			English	Article							MONKEY INFEROTEMPORAL CORTEX; PARAHIPPOCAMPAL CORTEX; HIPPOCAMPAL-FORMATION; SELECTIVE RESPONSES; OBJECT RECOGNITION; PERIRHINAL CORTEX; CEREBRAL-CORTEX; SINGLE NEURONS; VISUAL AREAS; MEMORY	The primate brain features specialized areas devoted to processing of faces, which human imaging studies localized in the superior temporal sulcus (STS) and ventral temporal cortex. Studies in macaque monkeys, in contrast, revealed face selectivity predominantly in the STS. While this discrepancy could result from a true species difference, it may simply be the consequence of technical difficulties in obtaining high-quality MR images from the ventral temporal lobe. By using an optimized fMRI protocol we here report face-selective areas in ventral TE, the parahippocampal cortex, the entorhinal cortex, and the hippocampus of awake macaques, in addition to those already known in the STS. Notably, the face-selective activation of these memory-related areas was observed although the animals were passively viewing and it was preserved even under anesthesia. These results point to similarly extensive cortical networks for face processing in humans and monkeys and highlight potential homologs of the human fusiform face area.	[Ku, Shih-Pi; Logothetis, Nikos K.; Goense, Jozien] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Tolias, Andreas S.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Tolias, Andreas S.] Rice Univ, Dept Computat & Appl Math, Houston, TX 77005 USA; [Logothetis, Nikos K.] Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M13 9PT, Lancs, England	Max Planck Society; Baylor College of Medicine; Baylor College of Medicine; Rice University; University of Manchester	Goense, J (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	jozien.goense@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019		Max Planck Society	Max Planck Society(Max Planck Society)	We are grateful to Thomas Steudel for the excellent technical support and to Hellmut Merkle for designing and building the RF coils. Andreas Bartels and Christoph Kayser provided useful information on data analysis; Natasha Sigala and Kevin Whittingstall provided helpful discussions and comments on the manuscript. This work was supported by the Max Planck Society.	Alvarado MC, 2005, J NEUROSCI, V25, P1599, DOI 10.1523/JNEUROSCI.4457-04.2005; Bachevalier J, 2008, HIPPOCAMPUS, V18, P64, DOI 10.1002/hipo.20369; Baxter MG, 2009, NEURON, V61, P667, DOI 10.1016/j.neuron.2009.02.007; Bell AH, 2009, J NEUROPHYSIOL, V101, P688, DOI 10.1152/jn.90657.2008; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; De Souza WC, 2005, J NEUROPHYSIOL, V94, P1252, DOI 10.1152/jn.00949.2004; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; Falconer K., 2003, FRACTAL GEOMETRY; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gaffan D, 2002, PHILOS T R SOC B, V357, P1111, DOI 10.1098/rstb.2002.1110; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gattass R, 2005, PHILOS T R SOC B, V360, P709, DOI 10.1098/rstb.2005.1629; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Goense JBM, 2008, NEUROIMAGE, V39, P1081, DOI 10.1016/j.neuroimage.2007.09.038; Goense JBM, 2010, METHODS, V50, P178, DOI 10.1016/j.ymeth.2009.08.003; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; Graham KS, 2010, NEUROPSYCHOLOGIA, V48, P831, DOI 10.1016/j.neuropsychologia.2010.01.001; Hadj-Bouziane F, 2008, P NATL ACAD SCI USA, V105, P5591, DOI 10.1073/pnas.0800489105; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hoffman KL, 2007, CURR BIOL, V17, P766, DOI 10.1016/j.cub.2007.03.040; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; Levy DA, 2005, LEARN MEMORY, V12, P61, DOI 10.1101/lm.84405; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P306; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Nakamura K, 1996, BEHAV BRAIN RES, V77, P53, DOI 10.1016/0166-4328(95)00227-8; Op de Beeck HP, 2008, J NEUROSCI, V28, P11796, DOI 10.1523/JNEUROSCI.3799-08.2008; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Osada T, 2008, PHILOS T R SOC B, V363, P2187, DOI 10.1098/rstb.2008.2271; Parr LA, 2009, CURR BIOL, V19, P50, DOI 10.1016/j.cub.2008.11.048; Paxinos G., 2000, RHESUS MONKEY BRAIN; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Puce A, 1998, J NEUROSCI, V18, P2188; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rajimehra R, 2009, P NATL ACAD SCI USA, V106, P1995, DOI 10.1073/pnas.0807304106; RICHES IP, 1991, J NEUROSCI, V11, P1763; Rolls ET, 2005, J NEUROPHYSIOL, V94, P833, DOI 10.1152/jn.01063.2004; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; SALEEM KS, 2006, COMBINED MRI HISTOLO; Sato N, 2003, J NEUROPHYSIOL, V90, P876, DOI 10.1152/jn.01089.2002; Schmidt CF, 2005, NEUROIMAGE, V26, P852, DOI 10.1016/j.neuroimage.2005.02.043; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Zangenehpour S, 2005, CURR BIOL, V15, P993, DOI 10.1016/j.cub.2005.04.031	65	98	99	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 28	2011	70	2					352	362		10.1016/j.neuron.2011.02.048	http://dx.doi.org/10.1016/j.neuron.2011.02.048			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521619	Bronze			2022-12-24	WOS:000291073700015
J	Bednarek, E; Caroni, P				Bednarek, Ewa; Caroni, Pico			beta-Adducin Is Required for Stable Assembly of New Synapses and Improved Memory upon Environmental Enrichment	NEURON			English	Article							SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; CORTEX; NEURONS; PHOSPHORYLATION; ORGANIZATION; POTENTIATION; INHIBITION; RECEPTOR; DYNAMICS	Learning is correlated with the assembly of new synapses, but the roles of synaptogenesis processes in memory are poorly understood. Here, we show that mice lacking beta-Adducin fail to assemble new synapses upon enhanced plasticity and exhibit diminished long-term hippocampal memory upon environmental enrichment. Enrichment-enhanced the disassembly and assembly of dynamic subpopulations of synapses. Upon enrichment, stable assembly of new synapses depended on the presence of beta-Adducin, disassembly involved beta-Adducin phosphorylation through PKC, and both were required for augmented learning. In the absence of beta-Adducin, enrichment still led to an increase in spine structures, but the assembly of synapses at those spines was compromised. Virus-mediated re-expression of beta-Adducin in hippocampal granule cells of beta-Adducin(-/-) mice rescued new synapse assembly and learning upon enrichment. Our results provide evidence that synapse disassembly and the establishment of new synapses are both critically important for augmented long-term learning and memory upon environmental enrichment.	[Bednarek, Ewa; Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch						Antonova I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007690; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Baroncelli L, 2010, CELL DEATH DIFFER, V17, P1092, DOI 10.1038/cdd.2009.193; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; De Roo M, 2008, PROG BRAIN RES, V169, P199, DOI 10.1016/S0079-6123(07)00011-8; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Gruenbaum LM, 2003, J NEUROSCI, V23, P2675; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Ivanco TL, 2000, SYNAPSE, V37, P16, DOI 10.1002/(SICI)1098-2396(200007)37:1<16::AID-SYN2>3.0.CO;2-T; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kim BG, 2008, J COMP NEUROL, V508, P473, DOI 10.1002/cne.21686; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; Parsley SL, 2007, LEARN MEMORY, V14, P75, DOI 10.1101/lm.356607; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pielage J, 2011, NEURON, V69, P1114, DOI 10.1016/j.neuron.2011.02.007; Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wanisch K, 2008, NEUROBIOL LEARN MEM, V90, P485, DOI 10.1016/j.nlm.2008.02.007; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765	43	94	95	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1132	1146		10.1016/j.neuron.2011.02.034	http://dx.doi.org/10.1016/j.neuron.2011.02.034			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435558	Bronze			2022-12-24	WOS:000288886900010
J	Santello, M; Bezzi, P; Volterra, A				Santello, Mirko; Bezzi, Paola; Volterra, Andrea			TNF alpha Controls Glutamatergic Gliotransmission in the Hippocampal Dentate Gyrus	NEURON			English	Article							NECROSIS-FACTOR-ALPHA; IMAGING ANALYSIS; AMPA RECEPTOR; 2 FORMS; ASTROCYTES; EXOCYTOSIS; RELEASE; CURRENTS; ENDOCYTOSIS; PLASTICITY	Glutamatergic gliotransmission provides a stimulatory input to excitatory synapses in the hippocampal dentate gyrus. Here, we show that tumor necrosis factor-alpha (TNF alpha) critically controls this process. With constitutive TN Fa present, activation of astrocyte P2Y1 receptors induces localized [Ca2+](i) elevations followed by glutamate release and presynaptic NMDA receptor-dependent synaptic potentiation. In preparations lacking TNF alpha, astrocytes respond with identical [Ca2+](i) elevations but fail to induce neuro-modulation. We find that TNF alpha specifically controls the glutamate release step of gliotransmission. In cultured astrocytes lacking TNF alpha glutamate exocytosis is dramatically slowed down due to altered vesicle docking. Addition of low picomolar TNF alpha promptly reconstitutes both normal exocytosis in culture and gliotransmission in situ. Alternatively, gliotransmission can be re-established without adding TNF alpha, by limiting glutamate uptake, which compensates slower release. These findings demonstrate that gliotransmission and its synaptic effects are controlled not only by astrocyte [Ca2+](i) elevations but also by permissive/homeostatic factors like TNF alpha.	[Santello, Mirko; Bezzi, Paola; Volterra, Andrea] Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland	University of Lausanne	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	andrea.volterra@unil.ch	Santello, Mirko/F-9007-2014; Bezzi, Paola/AAP-2440-2020	Santello, Mirko/0000-0002-7709-4127; Volterra, Andrea/0000-0003-1069-1602	Swiss National Foundation [3100A0-100850, 3100A0-120398]; NCCR; University of Lausanne [FBM 2006]; Novartis Foundation [26077772]; University of Lausanne	Swiss National Foundation(Swiss National Science Foundation (SNSF)); NCCR(Swiss National Science Foundation (SNSF)); University of Lausanne; Novartis Foundation(Novartis); University of Lausanne	We thank R.H. Edwards and S. Voglmaier for providing VGLUT1pHluorin and VGLUT1mCherry constructs, N. Liaudet for developing the custom-made program for two-photon Ca<SUP>2+</SUP> imaging analysis, H. Stubbe, C. Cali, J. Marcheland, P. Spagnuolo, and J. Gremion for help on experiments on cultured astrocytes, and C. Duerst and M. Saxena for help with electrophysiology experiments. We also thank A. Scimemi for precious help and suggestions on STC recordings. This work was supported by grants from the Swiss National Foundation (3100A0-100850, 3100A0-120398, and NCCR Transcure) to A.V. and from the University of Lausanne, grant FBM 2006, and Novartis Foundation (26077772) to P.B. M.S. is recipient of a University of Lausanne FBM PhD fellowship.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Aizenman CD, 2008, NEURON, V58, P651, DOI 10.1016/j.neuron.2008.05.017; Araque A, 1998, J NEUROSCI, V18, P6822; Bains JS, 2007, TRENDS NEUROSCI, V30, P417, DOI 10.1016/j.tins.2007.06.007; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bowser DN, 2007, P NATL ACAD SCI USA, V104, P4212, DOI 10.1073/pnas.0607625104; Brasier DJ, 2008, J NEUROSCI, V28, P2199, DOI 10.1523/JNEUROSCI.3915-07.2008; Cali C, 2008, J NEUROIMMUNOL, V198, P82, DOI 10.1016/j.jneuroim.2008.04.015; CHUQUET J, 2010, FENS ABSTR, V5; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kirchhoff F, 2010, SCIENCE, V327, P1212, DOI 10.1126/science.1187420; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Marchaland J, 2008, J NEUROSCI, V28, P9122, DOI 10.1523/JNEUROSCI.0040-08.2008; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; STALEY KJ, 1991, SYNAPSE, V9, P219, DOI 10.1002/syn.890090308; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Tritsch NX, 2007, NEURON, V54, P497, DOI 10.1016/j.neuron.2007.05.008; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	51	247	249	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					988	1001		10.1016/j.neuron.2011.02.003	http://dx.doi.org/10.1016/j.neuron.2011.02.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382557	Bronze			2022-12-24	WOS:000288736500015
J	Calderon, DP; Fremont, R; Kraenzlin, F; Khodakhah, K				Calderon, D. Paola; Fremont, Rachel; Kraenzlin, Franca; Khodakhah, Kamran			The neural substrates of rapid-onset Dystonia-Parkinsonism	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; DENTATE STIMULATION; NEURONAL ACTIVITY; NA+/K+-ATPASE; MOTOR SYSTEM; OUABAIN; RAT; CEREBELLUM; MICE; NA,K-ATPASE	Although dystonias are a common group of movement disorders, the mechanisms by which brain dysfunction results in dystonia are not understood. Rapid-onset Dystonia-Parkinsonism (RDP) is a hereditary dystonia caused by mutations in the ATP1A3 gene. Affected individuals can be free of symptoms for years, but rapidly develop persistent dystonia and Parkinsonism-like symptoms after a stressful experience. Using a mouse model, we found that an adverse interaction between the cerebellum and basal ganglia can account for the symptoms of these individuals. The primary instigator of dystonia was the cerebellum, whose aberrant activity altered basal ganglia function, which in turn caused dystonia. This adverse interaction between the cerebellum and basal ganglia was mediated through a di-synaptic thalamic pathway that, when severed, alleviated dystonia. Our results provide a unifying hypothesis for the involvement of cerebellum and basal ganglia in the generation of dystonia and suggest therapeutic strategies for the treatment of RDP.	[Calderon, D. Paola; Fremont, Rachel; Kraenzlin, Franca; Khodakhah, Kamran] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Khodakhah, K (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	k.khodakhah@einstein.yu.edu	Calderon, Diany/D-4683-2011	Fremont, Rachel/0000-0001-5285-7899	US National Institutes of Health [NS063227, NS054251, NS058949]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050808, R01NS058949, R01NS063227, R21NS054251] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Khodakhah laboratory for invaluable discussions and comments on the manuscript, and for evaluating and scoring motor dysfunction. We also thank D. Purpura, R. Sillitoe and S. Reeber for help and advice. This work was supported by US National Institutes of Health grants NS063227 and NS054251 to K. K. Additional support was provided by an administrative supplement to US National Institutes of Health grant NS058949 (A. Brashear).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALLEN JC, 1970, ARCH BIOCHEM BIOPHYS, V141, P322, DOI 10.1016/0003-9861(70)90138-4; ANDREW J, 1983, BRAIN, V106, P981, DOI 10.1093/brain/106.4.981; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Bauer N, 2005, HYPERTENSION, V45, P1024, DOI 10.1161/01.HYP.0000165024.47728.f7; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BROWN LL, 1989, J NEUROSCI, V9, P4033; Campbell DB, 1999, EXP NEUROL, V160, P268, DOI 10.1006/exnr.1999.7171; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; DONALDSON J, 1972, CAN J BIOCHEM CELL B, V50, P888, DOI 10.1139/o72-124; Fahn S, 1987, RECENT DEV PARKINSON; FRAIOLI B, 1975, APPL NEUROPHYSIOL, V38, P81; HEIMBURGER RF, 1967, CONFIN NEUROL, V29, P101; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jinnah HA, 2006, NEUROLOGY, V67, P1740, DOI 10.1212/01.wnl.0000246112.19504.61; Jinnah HA, 2005, MOVEMENT DISORD, V20, P283, DOI 10.1002/mds.20364; Kim JH, 2007, NAT NEUROSCI, V10, P196, DOI 10.1038/nn1839; Le Ber I, 2006, NEUROLOGY, V67, P1769, DOI 10.1212/01.wnl.0000244484.60489.50; LeDoux M S, 1998, Adv Neurol, V78, P63; LEDOUX MS, 1993, EXP NEUROL, V120, P302, DOI 10.1006/exnr.1993.1064; Lepoutre AC, 2006, J NEUROL NEUROSUR PS, V77, P1229, DOI 10.1136/jnnp.2005.083998; LI CL, 1969, EXP NEUROL, V24, P298, DOI 10.1016/0014-4886(69)90023-5; LORDEN JF, 1992, EXP NEUROL, V118, P95, DOI 10.1016/0014-4886(92)90026-M; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Neychev VK, 2008, BRAIN, V131, P2499, DOI 10.1093/brain/awn168; NIEOULLON A, 1978, BRAIN RES, V148, P143, DOI 10.1016/0006-8993(78)90384-0; Pizoli CE, 2002, J NEUROSCI, V22, P7825; RATCHESON RA, 1969, EXP NEUROL, V25, P268, DOI 10.1016/0014-4886(69)90050-8; Richter A, 1998, MOVEMENT DISORD, V13, P718, DOI 10.1002/mds.870130419; Rousseaux M, 1996, REV NEUROL, V152, P732; Ruktanonchai DJ, 1998, PHYSIOL BEHAV, V63, P403, DOI 10.1016/S0031-9384(97)00457-5; RUMBACH L, 1995, MOVEMENT DISORD, V10, P522, DOI 10.1002/mds.870100424; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Stacy MA, 2006, HDB DYSTONIA; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; URAYAMA O, 1988, BIOCHEM BIOPH RES CO, V156, P796, DOI 10.1016/S0006-291X(88)80914-8; Weidemann H, 2004, J NEUROENDOCRINOL, V16, P458, DOI 10.1111/j.1365-2826.2004.01181.x; Yoon JH, 2007, ARCH NEUROL-CHICAGO, V64, P1652, DOI 10.1001/archneur.64.11.1652; Zadro I, 2008, MOVEMENT DISORD, V23, P919, DOI 10.1002/mds.21981; ZERVAS NT, 1967, CONFIN NEUROL, V29, P93; Zhang YR, 2010, CLIN EXP PHARMACOL P, V37, P613, DOI 10.1111/j.1440-1681.2010.05364.x; Zhang YR, 2010, J COMP PHYSIOL B, V180, P117, DOI 10.1007/s00360-009-0391-z	49	164	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					357	365		10.1038/nn.2753	http://dx.doi.org/10.1038/nn.2753			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297628	Green Accepted			2022-12-24	WOS:000287650100017
J	Nagel, KI; Wilson, RI				Nagel, Katherine I.; Wilson, Rachel I.			Biophysical mechanisms underlying olfactory receptor neuron dynamics	NATURE NEUROSCIENCE			English	Article							DROSOPHILA ODORANT RECEPTORS; ANTENNAL LOBE; ADAPTATION; SYSTEM; MELANOGASTER; RESPONSES; CHANNELS; INPUT; BULB; REPRESENTATIONS	The responses of olfactory receptor neurons (ORNs) to odors have complex dynamics. Using genetics and pharmacology, we found that these dynamics in Drosophila ORNs could be separated into sequential steps, corresponding to transduction and spike generation. Each of these steps contributed distinct dynamics. Transduction dynamics could be largely explained by a simple kinetic model of ligand-receptor interactions, together with an adaptive feedback mechanism that slows transduction onset. Spiking dynamics were well described by a differentiating linear filter that was stereotyped across odors and cells. Genetic knock-down of sodium channels reshaped this filter, implying that it arises from the regulated balance of intrinsic conductances in ORNs. Complex responses can be understood as a consequence of how the stereotyped spike filter interacts with odor- and receptor-specific transduction dynamics. However, in the presence of rapidly fluctuating natural stimuli, spiking simply increases the speed and sensitivity of encoding.	[Nagel, Katherine I.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wilson, Rachel I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266	Helen Hay Whitney Foundation; US National Institutes of Health [R01DC008174]; McKnight Scholar Award; Beckman Young Investigator Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; Beckman Young Investigator Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J.R. Carlson for Or33c-Gal4, Or46a-Gal4, UAS-Or47a and UAS-Or47b, B.J. Dickson for Or59c-Gal4 and Or42a-Gal4, L. Luo for pebbled-Gal, L. Stevens for UAS-DTl, J.S. Bell, J.B. Cohen, A. L. Fairhall, M. Wachowiak and G. Yellen for conversations, and A. W. Liu, M. Meister, D. Schoppik and members of the Wilson laboratory for feedback on the manuscript. This work was funded by a Helen Hay Whitney Foundation Fellowship (to K.I.N.), a grant from the US National Institutes of Health (R01DC008174), a McKnight Scholar Award and a Beckman Young Investigator Award (to R. I. W.), and a Howard Hughes Medical Institute Early Career Scientist award (to R. I. W.).	ALMAAS TJ, 1991, J COMP PHYSIOL A, V169, P249; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Daly KC, 2004, J NEUROPHYSIOL, V92, P236, DOI 10.1152/jn.01132.2003; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Deshpande M, 2000, J NEUROBIOL, V43, P282, DOI 10.1002/(SICI)1097-4695(20000605)43:3<282::AID-NEU6>3.0.CO;2-T; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Famulare M, 2010, NEURAL COMPUT, V22, P581, DOI 10.1162/neco.2009.02-09-956; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Johnston D., 1995, FDN CELLULAR NEUROPH; KAISSLING KE, 1987, ANN NY ACAD SCI, V510, P104; Kaissling KE, 1998, CHEM SENSES, V23, P99, DOI 10.1093/chemse/23.1.99; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; KANG JS, 1995, J NEUROPHYSIOL, V74, P1435, DOI 10.1152/jn.1995.74.4.1435; Kim AJ, 2011, J COMPUT NEUROSCI, V30, P143, DOI 10.1007/s10827-010-0265-0; Laurent G, 1996, J NEUROSCI, V16, P3837; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Lundstrom BN, 2008, NEURAL COMPUT, V20, P1239, DOI 10.1162/neco.2007.05-07-536; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Reisert J, 1999, J PHYSIOL-LONDON, V519, P801, DOI 10.1111/j.1469-7793.1999.0801n.x; REYES AD, 1994, J NEUROSCI, V14, P5352; RUSHTON WAH, 1972, J PHYSIOL-LONDON, V220, pP1; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Schuckel J, 2009, J NEUROPHYSIOL, V102, P214, DOI 10.1152/jn.00162.2009; Soo FS, 2008, J NEUROSCI, V28, P1331, DOI 10.1523/JNEUROSCI.4121-07.2008; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010	50	117	118	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					208	U296		10.1038/nn.2725	http://dx.doi.org/10.1038/nn.2725			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217763	Green Accepted			2022-12-24	WOS:000286595400018
J	Rolfs, M; Jonikaitis, D; Deubel, H; Cavanagh, P				Rolfs, Martin; Jonikaitis, Donatas; Deubel, Heiner; Cavanagh, Patrick			Predictive remapping of attention across eye movements	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SPATIAL ATTENTION; PSYCHOPHYSICS TOOLBOX; PARIETAL CORTEX; SELECTION; SACCADES; SYSTEM; REPRESENTATION; PERCEPTION	Many cells in retinotopic brain areas increase their activity when saccades (rapid eye movements) are about to bring stimuli into their receptive fields. Although previous work has attempted to look at the functional correlates of such predictive remapping, no study has explicitly tested for better attentional performance at the future retinal locations of attended targets. We found that, briefly before the eyes start moving, attention drawn to the targets of upcoming saccades also shifted to those retinal locations that the targets would cover once the eyes had moved, facilitating future movements. This suggests that presaccadic visual attention shifts serve to both improve presaccadic perceptual processing at the target locations and speed subsequent eye movements to their new postsaccadic locations. Predictive remapping of attention provides a sparse, efficient mechanism for keeping track of relevant parts of the scene when frequent rapid eye movements provoke retinal smear and temporal masking.	[Rolfs, Martin; Cavanagh, Patrick] Univ Paris 05, Lab Psychol Percept, Paris, France; [Rolfs, Martin] NYU, Dept Psychol, New York, NY 10003 USA; [Jonikaitis, Donatas; Deubel, Heiner] Univ Munich, Dept Psychol, Munich, Germany	UDICE-French Research Universities; Universite Paris Cite; New York University; University of Munich	Rolfs, M (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	martin.rolfs@gmail.com; patrick.cavanagh@parisdescartes.fr	Jonikaitis, Donatas/K-6782-2019; Rolfs, Martin/A-7214-2008	Rolfs, Martin/0000-0002-8214-8556; Jonikaitis, Donatas/0000-0001-9851-0903	European Commission [235625]; Deutsche Forschungsgemeinschaft [GRK 1091]; Chaire d'Excellence grant	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chaire d'Excellence grant	We thank C. Buss for help with data acquisition. This work was supported by the 7th Framework Program of the European Commission (Marie Curie International Outgoing Fellowship 235625 awarded to M. R.), by Deutsche Forschungsgemeinschaft (GRK 1091, as a fellowship to D.J.) and by a Chaire d'Excellence grant to P. C.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Berman R, 2009, VISION RES, V49, P1233, DOI 10.1016/j.visres.2008.06.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Castet E, 2002, P NATL ACAD SCI USA, V99, P15159, DOI 10.1073/pnas.232377199; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Collins T, 2009, J VISION, V9, DOI 10.1167/9.5.29; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Gersch TM, 2006, VIS COGN, V14, P104; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; Golomb JD, 2008, J NEUROSCI, V28, P10654, DOI 10.1523/JNEUROSCI.2525-08.2008; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Knapen T, 2010, J VISION, V10, DOI 10.1167/10.1.8; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Mack A., 1998, INATTENTIONAL BLINDN; Macknik S. L., 2009, COGNITIVE NEUROSCIEN; Mathot S, 2010, EXP BRAIN RES, V200, P117, DOI 10.1007/s00221-009-2055-3; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Montagnini A, 2007, J VISION, V7, DOI 10.1167/7.14.8; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Rolfs M, 2005, EXP BRAIN RES, V166, P427, DOI 10.1007/s00221-005-2382-y; Solomon JA, 2004, VISION RES, V44, P1209, DOI 10.1016/j.visres.2003.12.003; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	38	225	227	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					252	U347		10.1038/nn.2711	http://dx.doi.org/10.1038/nn.2711			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21186360				2022-12-24	WOS:000286595400024
J	Lee, CC; Middlebrooks, JC				Lee, Chen-Chung; Middlebrooks, John C.			Auditory cortex spatial sensitivity sharpens during task performance	NATURE NEUROSCIENCE			English	Article							CORTICAL MAP REORGANIZATION; LEARNING-INDUCED PLASTICITY; THALAMIC RETICULAR NUCLEUS; SOUND-LOCALIZATION; RECEPTIVE-FIELDS; DORSAL ZONE; NEURONS; REPRESENTATION; CAT; ATTENTION	Activity in the primary auditory cortex (A1) is essential for normal sound localization behavior, but previous studies of the spatial sensitivity of neurons in A1 have found broad spatial tuning. We tested the hypothesis that spatial tuning sharpens when an animal engages in an auditory task. Cats performed a task that required evaluation of the locations of sounds and one that required active listening, but in which sound location was irrelevant. Some 26-44% of the units recorded in A1 showed substantially sharpened spatial tuning during the behavioral tasks as compared with idle conditions, with the greatest sharpening occurring during the location-relevant task. Spatial sharpening occurred on a scale of tens of seconds and could be replicated multiple times in similar to 1.5-h test sessions. Sharpening resulted primarily from increased suppression of responses to sounds at least-preferred locations. That and an observed increase in latencies suggest an important role of inhibitory mechanisms.	[Lee, Chen-Chung; Middlebrooks, John C.] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92717 USA; [Lee, Chen-Chung; Middlebrooks, John C.] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA; [Lee, Chen-Chung] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Middlebrooks, JC (corresponding author), Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Irvine, CA 92717 USA.	j.midd@uci.edu			National Institute on Deafness and Other Communication Disorders [R01 DC-000420, P30 DC-05188]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005188, R01DC000420] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank I. Harrington, E. Macpherson, J. Wiler, E. Hand, G. Rising, D. Vailliencourt, C. Ellinger and Z. Onsan for technical support. We thank A. Kirby and R. Adrian for helpful comments on the manuscript. This work was supported by National Institute on Deafness and Other Communication Disorders grants R01 DC-000420, and P30 DC-05188 (to J. Schacht).	Allen K, 2009, ATTEN PERCEPT PSYCHO, V71, P164, DOI 10.3758/APP.71.1.164; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; Best V, 2008, P NATL ACAD SCI USA, V105, P13174, DOI 10.1073/pnas.0803718105; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cansino S, 1997, BRAIN RES, V764, P53, DOI 10.1016/S0006-8993(97)00321-1; Cotillon-Williams N, 2008, J NEUROPHYSIOL, V99, P1137, DOI 10.1152/jn.01159.2007; DIAMOND DM, 1989, BEHAV NEUROSCI, V103, P471, DOI 10.1037/0735-7044.103.3.471; Efron B., 1994, INTRO BOOTSTRAP; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Furukawa S, 2002, J NEUROPHYSIOL, V87, P1749, DOI 10.1152/jn.00491.2001; Ghose GM, 2004, CURR OPIN NEUROBIOL, V14, P513, DOI 10.1016/j.conb.2004.07.003; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Green DM, 1966, SIGNAL DETECTION THE; IMIG TJ, 1990, J NEUROPHYSIOL, V63, P1448, DOI 10.1152/jn.1990.63.6.1448; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Kidd G, 2005, J ACOUST SOC AM, V118, P3804, DOI 10.1121/1.2109187; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimura A, 2007, EUR J NEUROSCI, V26, P3524, DOI 10.1111/j.1460-9568.2007.05925.x; Kopco N, 2007, J ACOUST SOC AM, V121, P420, DOI 10.1121/1.2390677; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Ma XF, 2009, J NEUROSCI, V29, P4888, DOI 10.1523/JNEUROSCI.0167-09.2009; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; McDonald JJ, 1999, J EXP PSYCHOL HUMAN, V25, P1234, DOI 10.1037/0096-1523.25.5.1234; Mickey BJ, 2003, J NEUROSCI, V23, P8649; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Rasmusson DD, 2007, NEUROSCIENCE, V149, P232, DOI 10.1016/j.neuroscience.2007.06.057; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RHODES G, 1987, PERCEPT PSYCHOPHYS, V42, P1, DOI 10.3758/BF03211508; Roberts KL, 2009, J EXP PSYCHOL HUMAN, V35, P1178, DOI 10.1037/a0014249; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; SPENCE CJ, 1994, J EXP PSYCHOL HUMAN, V20, P555, DOI 10.1037/0096-1523.20.3.555; Stecker GC, 2005, J NEUROPHYSIOL, V94, P1267, DOI 10.1152/jn.00104.2005; Ter-Mikaelian M, 2007, J NEUROSCI, V27, P6091, DOI 10.1523/JNEUROSCI.4848-06.2007; Verbny YI, 2006, J NEUROPHYSIOL, V96, P3194, DOI 10.1152/jn.00484.2006; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Witte RS, 2005, COGNITIVE BRAIN RES, V23, P171, DOI 10.1016/j.cogbrainres.2004.10.018; Zhang YF, 2008, CEREB CORTEX, V18, P1521, DOI 10.1093/cercor/bhm188; ZHOU B, 1992, J ACOUST SOC AM, V92, P1169, DOI 10.1121/1.404045; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	50	122	122	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					108	U144		10.1038/nn.2713	http://dx.doi.org/10.1038/nn.2713			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151120	Green Submitted, Green Accepted			2022-12-24	WOS:000285684900021
J	Beckervordersandforth, R; Tripathi, P; Ninkovic, J; Bayam, E; Lepier, A; Stempfhuber, B; Kirchhoff, F; Hirrlinger, J; Haslinger, A; Lie, DC; Beckers, J; Yoder, B; Irmler, M; Gotz, M				Beckervordersandforth, Ruth; Tripathi, Pratibha; Ninkovic, Jovica; Bayam, Efil; Lepier, Alexandra; Stempfhuber, Barbara; Kirchhoff, Frank; Hirrlinger, Johannes; Haslinger, Anja; Lie, D. Chichung; Beckers, Johannes; Yoder, Bradley; Irmler, Martin; Goetz, Magdalena			In Vivo Fate Mapping and Expression Analysis Reveals Molecular Hallmarks of Prospectively Isolated Adult Neural Stem Cells	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE ASTROCYTES; EPENDYMAL CELLS; PRIMARY CILIA; RADIAL GLIA; GENE; MICE; DIFFERENTIATION; TRANSCRIPTOME; PROLIFERATION; SPECIFICATION	Until now, limitations in the ability to enrich adult NSCs (aNSCs) have hampered meaningful analysis of these cells at the transcriptome level. Here we show via a split-Cre technology that coincident activity of the hGFAP and promininl promoters is a hallmark of aNSCs in vivo. Sorting of cells from the adult mouse subependymal zone (SEZ) based on their expression of GFAP and promininl isolates all self-renewing, multipotent stem cells at high purity. Comparison of the transcriptome of these purified aNSCs to parenchymal nonneurogenic astrocytes and other SEZ cells reveals aNSC hallmarks, including neuronal lineage priming and the importance of cilia- and Ca-dependent signaling pathways. Inducible deletion of the ciliary protein IFT88 in aNSCs validates the role of ciliary function in aNSCs. Our work reveals candidate molecular regulators for unique features of aNSCs and facilitates future selective analysis of aNSCs in other functional contexts, such as aging and injury.	[Beckervordersandforth, Ruth; Tripathi, Pratibha; Ninkovic, Jovica; Bayam, Efil; Stempfhuber, Barbara; Goetz, Magdalena] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Haslinger, Anja; Lie, D. Chichung] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Res Grp Adult Neural Stem Cells & Neurogenesis, Inst Dev Genet, D-85764 Neuherberg, Germany; [Beckers, Johannes; Irmler, Martin] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Expt Genet, D-85764 Neuherberg, Germany; [Ninkovic, Jovica; Lepier, Alexandra; Goetz, Magdalena] Univ Munich, Fac Med, D-80633 Munich, Germany; [Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kirchhoff, Frank] DFG Res Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; [Hirrlinger, Johannes] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol & Neural Plast N05, D-04103 Leipzig, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Yoder, Bradley] Univ Birmingham, Birmingham, AL 35294 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; German Research Foundation (DFG); Leipzig University; Technical University of Munich	Gotz, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	magdalena.goetz@helmholtz-muenchen.de	Irmler, Martin/B-3317-2013; Kirchhoff, Frank/B-9335-2008; Beckers, Johannes/K-7237-2012; Hirrlinger, Johannes/F-5984-2010; Lie, Dieter Chichung/AAS-8604-2020; Lie, Dieter Chichung/S-7914-2017; Ninkovic, Jovica/AAH-5220-2019	Irmler, Martin/0000-0003-3169-479X; Kirchhoff, Frank/0000-0002-2324-2761; Beckers, Johannes/0000-0001-7874-3822; Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442; Ninkovic, Jovica/0000-0002-4381-0041; BAYAM, EFIL/0000-0001-9776-5234	DFG [SFB596, 870]; Hans and Ilse Breuer Price; BMBF; EUTRACC; HELMA; CoReNe as well as the UAB Hepato/Renal Fibrocystic Diseases Core Center [DK074038]	DFG(German Research Foundation (DFG)); Hans and Ilse Breuer Price; BMBF(Federal Ministry of Education & Research (BMBF)); EUTRACC; HELMA; CoReNe as well as the UAB Hepato/Renal Fibrocystic Diseases Core Center	We particularly would like to thank Timothy McClintock and Frank Zaucke for probes and antibodies; Jochen Graw for human DNA; and Andrea Steiner-Mezzadri, Christiane Lach, and Timucin Ozturk for excellent technical help. We are also particularly grateful to Armen Saghatelyan, Benedikt Berninger, Emily Violette, Filippo Calzolari, Pia Johansson, Troy Ghashghaei, and Yves Barde for excellent comments on the manuscript. This work is supported by the DFG including the SFB596, 870, the Hans and Ilse Breuer Price, BMBF, EUTRACC, HELMA, and CoReNe as well as the UAB Hepato/Renal Fibrocystic Diseases Core Center (UAB HRFDCC) DK074038.	Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Karmakar S, 2005, J BIOL CHEM, V280, P28623, DOI 10.1074/jbc.M414140200; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lyons PJ, 2006, PROTEINS, V63, P1069, DOI 10.1002/prot.20946; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Nolte C, 2001, GLIA, V33, P72; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Sakaguchi M, 2007, CELL MOL LIFE SCI, V64, P1254, DOI 10.1007/s00018-007-6476-5; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425	52	240	249	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					744	758		10.1016/j.stem.2010.11.017	http://dx.doi.org/10.1016/j.stem.2010.11.017			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112568	Bronze			2022-12-24	WOS:000285537700015
J	Abbas, HA; Maccio, DR; Coskun, S; Jackson, JG; Hazen, AL; Sills, TM; You, MJ; Hirschi, KK; Lozano, G				Abbas, Hussein A.; Maccio, Daniela R.; Coskun, Suleyman; Jackson, James G.; Hazen, Amy L.; Sills, Tiffany M.; You, M. James; Hirschi, Karen K.; Lozano, Guillermina			Mdm2 Is Required for Survival of Hematopoietic Stem Cells/Progenitors via Dampening of ROS-Induced p53 Activity	CELL STEM CELL			English	Article							SLAM FAMILY RECEPTORS; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CELL QUIESCENCE; DNA-DAMAGE; YOLK-SAC; IN-VIVO; B-CELL; SENESCENCE; TUMORIGENESIS	Mdm2 is an E3 ubiquitin ligase that targets p53 for degradation. p53(515C) (encoding p53R172P) is a hypomorphic allele of p53 that rescues the embryonic lethality of Mdm2(-/-) mice. Mdin2(-/-) p53(515C/515C) mice, however, die by postnatal day 13 resulting from hematopoietic failure. Hematopoietic stem cells and progenitors of Mdm2(-/-) p53(515C/515C) mice were normal in fetal livers but were depleted in postnatal bone marrows. After birth, these mice had elevated reactive oxygen species (ROS) thus activating p53R172P. In the absence of Mdm2, stable p53R172P induced ROS and cell cycle arrest, senescence, and cell death in the hematopoietic compartment. This phenotype was partially rescued with antioxidant treatment and upon culturing of hematopoietic cells in methycellulose at 3% oxygen. p16 was also stabilized because of ROS, and its loss increased cell cycling and partially rescued hematopoiesis and survival. Thus, Mdm2 is required to control ROS-induced p53 levels for sustainable hematopoiesis.	[Abbas, Hussein A.; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Abbas, Hussein A.; Maccio, Daniela R.; Jackson, James G.; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Hazen, Amy L.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA; [You, M. James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Coskun, Suleyman; Sills, Tiffany M.; Hirschi, Karen K.] Baylor Coll Med, Dept Pediat & Mol & Cellular Biol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Sills, Tiffany M.] Baylor Coll Med, Interdept Program Cell & Mol Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Lozano, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Grad Sch Biomed Sci, Houston, TX 77030 USA.	gglozano@mdanderson.org		Coskun, Suleyman/0000-0002-4830-0606; Jackson, James Griffith/0000-0002-2640-6442	NIH [CA82577]; Cancer Center; American Cancer Society; Ladies Leukemia League; Institutional Research Grant; University of Texas; NATIONAL CANCER INSTITUTE [R01CA082577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Cancer Society(American Cancer Society); Ladies Leukemia League; Institutional Research Grant; University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA82577 to G.L. and the Cancer Center Support Grant to MDACC. We gratefully acknowledge Dr. Sean M. Post and Colby Suire for thoughtful discussions during the progress of this work and comments on the manuscript, and Emmanuelle Passegue for inspiring us to pursue this study. We would also like to thank Wendy Schober for technical assistance with flow cytometric analysis. M.J.Y. is supported by American Cancer Society Institutional Research Grant, Ladies Leukemia League, Institutional Research Grant, and Physician Scientist Award of the University of Texas M.D. Anderson Cancer.	Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Donald SP, 2001, CANCER RES, V61, P1810; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lee SH, 1999, BBA-GENE STRUCT EXPR, V1446, P389, DOI 10.1016/S0167-4781(99)00112-8; Lehar SM, 1996, ONCOGENE, V12, P1181; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; McDonnell TJ, 1999, J PATHOL, V188, P322, DOI 10.1002/(SICI)1096-9896(199907)188:3<322::AID-PATH372>3.0.CO;2-F; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; O'Leary KA, 2004, MOL CELL BIOL, V24, P186, DOI 10.1128/MCB.24.1.186-191.2004; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Palis J, 1999, DEVELOPMENT, V126, P5073; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Terzian T, 2007, MOL CELL BIOL, V27, P5479, DOI 10.1128/MCB.00555-06; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Zafon C, 2007, MED HYPOTHESES, V68, P1371, DOI 10.1016/j.mehy.2006.10.043	48	106	119	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					606	617		10.1016/j.stem.2010.09.013	http://dx.doi.org/10.1016/j.stem.2010.09.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040902	Green Accepted, Bronze			2022-12-24	WOS:000284390500012
J	Juge, N; Gray, JA; Omote, H; Miyaji, T; Inoue, T; Hara, C; Uneyama, H; Edwards, RH; Nicoll, RA; Moriyama, Y				Juge, Narinobu; Gray, John A.; Omote, Hiroshi; Miyaji, Takaaki; Inoue, Tsuyoshi; Hara, Chiaki; Uneyama, Hisayuki; Edwards, Robert H.; Nicoll, Roger A.; Moriyama, Yoshinori			Metabolic Control of Vesicular Glutamate Transport and Release	NEURON			English	Article							ANION-BINDING-SITE; KETOGENIC DIET; SYNAPTIC VESICLES; PHOSPHATE TRANSPORTER; QUANTAL SIZE; ELECTROCONVULSIVE THRESHOLD; AMINE TRANSPORTER; SEIZURE ACTIVITY; KETONE-BODIES; NEURONS	Fasting has been used to control epilepsy since antiquity, but the mechanism of coupling between metabolic state and excitatory neurotransmission remains unknown. Previous work has shown that the vesicular glutamate transporters (VGLUTs) required for exocytotic release of glutamate undergo an unusual form of regulation by Cl-. Using functional reconstitution of the purified VGLUTs into proteoliposomes, we now show that Cl- acts as an allosteric activator, and the ketone bodies that increase with fasting inhibit glutamate release by competing with at the site of allosteric regulation. Consistent with these observations, acetoacetate reduced quantal size at hippocampal synapses and suppresses glutamate release and seizures evoked with 4-aminopyridine in the brain. The results indicate an unsuspected link between metabolic state and excitatory neurotransmission through anion-dependent regulation of VGLUT activity.	[Juge, Narinobu; Omote, Hiroshi; Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan; [Gray, John A.; Nicoll, Roger A.] Univ Calif San Francisco, Sch Med, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Miyaji, Takaaki; Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Adv Sci Res Ctr, Okayama 7008530, Japan; [Inoue, Tsuyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biophys Chem, Okayama 7008530, Japan; [Hara, Chiaki] Daiichi Coll Pharmaceut Sci, Dept Pharmacol, Fukuoka 8158511, Japan; [Uneyama, Hisayuki] Ajinomoto Co Inc, Inst Life Sci, Kawasaki, Kanagawa 2105893, Japan; [Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA	Okayama University; University of California System; University of California San Francisco; Okayama University; Okayama University; Ajinomoto Co Inc; University of California System; University of California San Francisco	Moriyama, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp	Gray, John Alan/Y-5730-2019; Juge, Narinobu/M-1125-2018; INOUE, Tsuyoshi/B-1604-2011; OMOTE, Hiroshi/B-1635-2011	Juge, Narinobu/0000-0002-5825-6717; Miyaji, Takaaki/0000-0002-7257-7621; Gray, John/0000-0002-7287-0748	Japan Society for the Promotion of Science for Young Scientists; NIH [5R01MH080379]; Ministry of Education, Science, Sports and Culture of Japan; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712, R25MH060482, R37MH038256, R01MH080379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs Miki Hasa and Masafumi Iharada for help in the immunohistochemical study and purification of VGLUT1 and VGLUT3 N J was supported by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists J A.G was supported by an NIH training grant This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to Y M, NIH 5R01MH080379 to RAN, NIMH, NIGMS, and NIDA to R H E	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; APPLETON DB, 1974, EPILEPSIA, V15, P211, DOI 10.1111/j.1528-1157.1974.tb04943.x; Bailey EE, 2005, EPILEPSY BEHAV, V6, P4, DOI 10.1016/j.yebeh.2004.10.006; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; BIWERSI J, 1994, ANAL BIOCHEM, V219, P139, DOI 10.1006/abio.1994.1242; Bough KJ, 2007, EPILEPSIA, V48, P43, DOI 10.1111/j.1528-1167.2007.00915.x; Bough KJ, 2007, EPILEPSY RES, V74, P232, DOI 10.1016/j.eplepsyres.2007.03.002; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Freeman J, 2006, EPILEPSY RES, V68, P145, DOI 10.1016/j.eplepsyres.2005.10.003; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Funada M, 2001, BRAIN RES, V901, P247, DOI 10.1016/S0006-8993(01)02160-6; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Juge N, 2009, J BIOL CHEM, V284, P35073, DOI 10.1074/jbc.M109.062414; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Meurs A, 2008, EPILEPSY RES, V78, P50, DOI 10.1016/j.eplepsyres.2007.10.007; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; MORIYAMA Y, 1987, BIOCHEM BIOPH RES CO, V149, P140, DOI 10.1016/0006-291X(87)91615-9; MORIYAMA Y, 1987, J BIOL CHEM, V262, P9175; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; Nakatsuka S, 2001, J BIOL CHEM, V276, P26589, DOI 10.1074/jbc.M011754200; NAKAZAWA M, 1983, BRAIN DEV-JPN, V5, P375, DOI 10.1016/S0387-7604(83)80042-4; Noh HS, 2004, MOL BRAIN RES, V129, P80, DOI 10.1016/j.molbrainres.2004.06.020; Nordli DR, 1997, EPILEPSIA, V38, P743, DOI 10.1111/j.1528-1157.1997.tb01460.x; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Pena F, 2000, NEUROSCIENCE, V101, P547, DOI 10.1016/S0306-4522(00)00400-0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Reis M, 2000, BBA-GEN SUBJECTS, V1475, P114, DOI 10.1016/S0304-4165(00)00069-6; RUSSELL JM, 1977, J MEMBRANE BIOL, V37, P137, DOI 10.1007/BF01940929; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; SCHULDINER S, 1994, J NEUROCHEM, V62, P2067; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; Thio LL, 2000, NEUROLOGY, V54, P325, DOI 10.1212/WNL.54.2.325; Vining EPG, 1999, EPILEPSY RES, V37, P181, DOI 10.1016/S0920-1211(99)00070-4; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yudkoff M, 2008, EPILEPSIA, V49, P73, DOI 10.1111/j.1528-1167.2008.01841.x; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29; Zupec-Kania BA, 2008, NUTR CLIN PRACT, V23, P589, DOI 10.1177/0884533608326138	63	256	267	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					99	112		10.1016/j.neuron.2010.09.002	http://dx.doi.org/10.1016/j.neuron.2010.09.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920794	Bronze, Green Accepted			2022-12-24	WOS:000283704200011
J	Kuzmiski, JB; Marty, V; Baimoukhametova, DV; Bains, JS				Kuzmiski, J. Brent; Marty, Vincent; Baimoukhametova, Dinara V.; Bains, Jaideep S.			Stress-induced priming of glutamate synapses unmasks associative short-term plasticity	NATURE NEUROSCIENCE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; MESSENGER-RNA LEVELS; METHYL-D-ASPARTATE; PARAVENTRICULAR NUCLEUS; RAT HYPOTHALAMUS; SYNAPTIC-TRANSMISSION; INDUCED SENSITIZATION; GENE-EXPRESSION; AMPA RECEPTORS	Exposure to a stressor sensitizes or 'primes' the hypothalamic-pituitary-adrenal axis to a subsequent novel stressor. The synaptic mechanisms underlying this priming, however, are not known. We found that exposing a rat to a single stressor primed glutamate synapses in the paraventricular nucleus of the hypothalamus and allowed them to undergo a short-term potentiation (STP) following a burst of high-frequency afferent activity. This transient potentiation requires a corticotrophin-releasing hormone-dependent depression of postsynaptic NMDA receptors (NMDARs). The long-term depression of NMDAR function after stress prevented the vesicular release of an inhibitory retrograde messenger that, in control conditions, arrests STP. Following stress, STP manifested as an increase in the release probability of glutamate that was sufficient to induce multivesicular release. Our findings indicate that the priming of synapses to express STP is a synaptic correlate to stress-induced behavioral and neuroendocrine sensitization.	[Kuzmiski, J. Brent; Marty, Vincent; Baimoukhametova, Dinara V.; Bains, Jaideep S.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Kuzmiski, J. Brent; Marty, Vincent; Baimoukhametova, Dinara V.; Bains, Jaideep S.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary	Bains, JS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	jsbains@ucalgary.ca		Kuzmiski, Brent/0000-0002-9240-4867; Bains, Jaideep/0000-0002-3634-6463	Hotchkiss Brain Institute; Canadian Institutes for Health Research	Hotchkiss Brain Institute; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank members of the Bains laboratory and Q.J. Pittman for comments and thoughtful discussion regarding the manuscript. V.M. was supported by a fellowship from the Hotchkiss Brain Institute. J.S.B. is an Alberta Heritage Foundation for Medical Research Senior Scholar. This work was funded by an operating grant from the Canadian Institutes for Health Research.	Armario A, 2008, NEUROSCI BIOBEHAV R, V32, P1121, DOI 10.1016/j.neubiorev.2008.04.003; BARTANUSZ V, 1995, NEUROSCIENCE, V66, P247, DOI 10.1016/0306-4522(95)00084-V; Blank T, 2002, J NEUROSCI, V22, P3788; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Bruijnzeel AW, 2001, BRAIN RES, V908, P187, DOI 10.1016/S0006-8993(01)02646-4; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Champagne D, 1998, J NEUROENDOCRINOL, V10, P119, DOI 10.1046/j.1365-2826.1998.00179.x; Chen Y, 2004, NEUROSCIENCE, V126, P533, DOI 10.1016/j.neuroscience.2004.03.036; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Cook CJ, 2004, PHYSIOL BEHAV, V82, P751, DOI 10.1016/j.physbeh.2004.06.013; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Givalois L, 2000, MOL BRAIN RES, V75, P166, DOI 10.1016/S0169-328X(99)00290-9; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; Justice NJ, 2008, J COMP NEUROL, V511, P479, DOI 10.1002/cne.21848; Keller C, 2002, DRUG METAB DISPOS, V30, P173, DOI 10.1124/dmd.30.2.173; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; LEE S, 1994, MOL BRAIN RES, V24, P192, DOI 10.1016/0169-328X(94)90132-5; Li Y, 2008, J NEUROSCI, V28, P2814, DOI 10.1523/JNEUROSCI.5447-07.2008; LIPOSITS Z, 1985, HISTOCHEMISTRY, V83, P5, DOI 10.1007/BF00495294; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; MAKARA GB, 1975, NEUROENDOCRINOLOGY, V18, P213, DOI 10.1159/000122400; Mansi JA, 1996, ENDOCRINOLOGY, V137, P4619, DOI 10.1210/en.137.11.4619; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; O'Connor KA, 2004, NEUROENDOCRINOLOGY, V80, P252, DOI 10.1159/000082876; ONO N, 1985, P NATL ACAD SCI USA, V82, P3528, DOI 10.1073/pnas.82.10.3528; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARKES D, 1993, MOL ENDOCRINOL, V7, P1357, DOI 10.1210/me.7.10.1357; PECHNICK RN, 1989, EUR J PHARMACOL, V164, P257, DOI 10.1016/0014-2999(89)90466-4; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; PRETEL S, 1990, J COMP NEUROL, V294, P192, DOI 10.1002/cne.902940204; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Risbrough VB, 2006, HORM BEHAV, V50, P550, DOI 10.1016/j.yhbeh.2006.06.019; Sheng H, 2008, ENDOCRINOLOGY, V149, P1389, DOI 10.1210/en.2007-1378; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Wong YN, 2000, NEUROENDOCRINOLOGY, V71, P354, DOI 10.1159/000054556; Zhou Y, 1998, EUR J PHARMACOL, V352, P65, DOI 10.1016/S0014-2999(98)00332-X; Ziegler DR, 2000, ENDOCRINOLOGY, V141, P4801, DOI 10.1210/en.141.12.4801; Zorrilla EP, 2010, DRUG DISCOV TODAY, V15, P371, DOI 10.1016/j.drudis.2010.02.011	49	51	51	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1257	1264		10.1038/nn.2629	http://dx.doi.org/10.1038/nn.2629			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818385				2022-12-24	WOS:000282171300018
J	Deng, JV; Rodriguiz, RM; Hutchinson, AN; Kim, IH; Wetsel, WC; West, AE				Deng, Jie V.; Rodriguiz, Ramona M.; Hutchinson, Ashley N.; Kim, Il-Hwan; Wetsel, William C.; West, Anne E.			MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants	NATURE NEUROSCIENCE			English	Article							MOUSE MODEL; RETT-SYNDROME; DOPAMINERGIC MODULATION; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; SPINY NEURONS; MUTANT MICE; DELTA-FOSB; COCAINE; EXPRESSION	MeCP2 is a methyl DNA-binding transcriptional regulator that contributes to the development and function of CNS synapses; however, the requirement for MeCP2 in stimulus-regulated behavioral plasticity is not fully understood. Here we show that acute viral manipulation of MeCP2 expression in the nucleus accumbens (NAc) bidirectionally modulates amphetamine (AMPH)-induced conditioned place preference. Mecp2 hypomorphic mutant mice have more NAc GABAergic synapses and show deficient AMPH-induced structural plasticity of NAc dendritic spines. Furthermore, these mice show deficient plasticity of striatal immediate early gene inducibility after repeated AMPH administration. Notably, psychostimulants induce phosphorylation of MeCP2 at Ser421, a site that regulates MeCP2's function as a repressor. Phosphorylation is selectively induced in GABAergic interneurons of the NAc, and its extent strongly predicts the degree of behavioral sensitization. These data reveal new roles for MeCP2 both in mesolimbocortical circuit development and in the regulation of psychostimulant-induced behaviors.	[Deng, Jie V.; Hutchinson, Ashley N.; Wetsel, William C.; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Kim, Il-Hwan; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	West, AE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	west@neuro.duke.edu			National Institute of Drug Abuse [R01-DA022202, F32-DA025447]; March of Dimes Foundation [1-FY07-482]; Duke University; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA025447, R01DA022202] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); March of Dimes Foundation(March of Dimes); Duke University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are deeply grateful to M. E. Greenberg (Harvard Medical School), Z. Zhou and S. Cohen for sharing unpublished data and reagents. We thank N. Calakos (Duke University Medical Center) and F. Polleux (University of North Carolina, Chapel Hill) for providing transgenic mice; K. Vaishnav, J. Zhou, L. Du, M. Fukui, M. Cools, N. Negbenebor, P. Pattabiraman, W.-H. Qian, R. Chereau and M. Presby for technical assistance; and D. Fitzpatrick, G. Feng, J.O. McNamara, A. Brunet and M. Caron for critical reading of the manuscript. Support for this work was provided by National Institute of Drug Abuse grants R01-DA022202 (A.E.W.) and F32-DA025447 (J.V.D.); grant 1-FY07-482 from the March of Dimes Foundation (A.E.W.); along with the Duke University postdoctoral training program in Fundamental and Translational Neuroscience and the predoctoral Pharmacological Sciences Training Program.	Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gruber AJ, 2009, J NEUROPHYSIOL, V101, P1876, DOI 10.1152/jn.91002.2008; Guzman JN, 2003, J NEUROSCI, V23, P8931; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Robinson TE, 1997, J NEUROSCI, V17, P8491; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tzschentke TM, 2003, MOL PSYCHIATR, V8, P373, DOI 10.1038/sj.mp.4001269; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226; Zhang DS, 2002, J NEUROCHEM, V82, P1453, DOI 10.1046/j.1471-4159.2002.01089.x; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006; Zhang ZW, 2010, J NEUROPHYSIOL, V103, P2470, DOI 10.1152/jn.00601.2009; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	48	145	154	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1128	U132		10.1038/nn.2614	http://dx.doi.org/10.1038/nn.2614			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711186	Green Accepted			2022-12-24	WOS:000281332600019
J	Mishchenko, Y; Hu, T; Spacek, J; Mendenhall, J; Harris, KM; Chklovskii, DB				Mishchenko, Yuriy; Hu, Tao; Spacek, Josef; Mendenhall, John; Harris, Kristen M.; Chklovskii, Dmitri B.			Ultrastructural Analysis of Hippocampal Neuropil from the Connectomics Perspective	NEURON			English	Article							FALSE DISCOVERY RATE; 3-DIMENSIONAL STRUCTURE; CIRCUIT RECONSTRUCTION; WIRING OPTIMIZATION; ELECTRON-MICROSCOPY; DENDRITIC SPINES; PYRAMIDAL CELLS; AREA 17; SYNAPSES; CA1	Complete reconstructions of vertebrate neuronal circuits on the synaptic level require new approaches. Here, serial section transmission electron microscopy was automated to densely reconstruct four volumes, totaling 670 mu m(3), from the rat hippocampus as proving grounds to determine when axo-dendritic proximities predict synapses. First, in contrast with Peters' rule, the density of axons within reach of dendritic spines did not predict synaptic density along dendrites because the fraction of axons making synapses was variable. Second, an axo-dendritic touch did not predict a synapse; nevertheless, the density of synapses along a hippocampal dendrite appeared to be a universal fraction, 0.2, of the density of touches. Finally, the largest touch between an axonal bouton and spine indicated the site of actual synapses with about 80% precision but would miss about half of all synapses. Thus, it will be difficult to predict synaptic connectivity using data sets missing ultrastructural details that distinguish between axo-dendritic touches and bona fide synapses.	[Mendenhall, John; Harris, Kristen M.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78705 USA; [Mishchenko, Yuriy; Hu, Tao; Chklovskii, Dmitri B.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Spacek, Josef] Charles Univ Hosp, Fingerland Dept Pathol, Hradec Kralove 50005, Czech Republic	University of Texas System; University of Texas Austin; Howard Hughes Medical Institute; Charles University Prague	Harris, KM (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78705 USA.	kharris@mail.clm.utexas.edu; mitya@janelia.hhmi.org	Hu, Tao/E-4337-2010	Harris, Kristen/0000-0002-1943-4744	Swartz Foundation;  [NS21184];  [EB002170]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021184, R23NS021184, R01NS074644, R37NS021184] Funding Source: NIH RePORTER	Swartz Foundation; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Armen Stepanyants, Torn Bartol, Chandra Bajaj, Terry Sejnowski, Karel Svoboda, Jeff Magee, and Winfried Denk for helpful discussions and comments on the manuscript, to the anonymous reviewers for constructive comments, and to Stephen Clow for assistance with proofreading. K.M.H. was supported by NS21184 and EB002170; D.B.C. was partially supported by the Swartz Foundation.	Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; da Costa NM, 2009, J NEUROSCI, V29, P13919, DOI 10.1523/JNEUROSCI.2785-09.2009; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fiala JC, 2003, J COMP NEUROL, V465, P90, DOI 10.1002/cne.10825; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; FIALA JC, 2002, MICROSC ANAL, V52, P5; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1986, NEUROSCIENCE, V19, P857, DOI 10.1016/0306-4522(86)90304-0; Harris Kristen M., 2008, P1, DOI 10.1007/978-0-387-77232-5_1; Haykin S. O., 2008, NEURAL NETWORKS LEAR; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; JURRUS E, 2008, P IEEE INT S BIOM IM, P1609; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; NICOL D, 1982, J COMP NEUROL, V207, P45, DOI 10.1002/cne.902070105; PETERS A, 1976, J NEUROCYTOL, V5, P63, DOI 10.1007/BF01176183; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; SORRA KE, 1993, J NEUROSCI, V13, P3736; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; White EL, 2002, J NEUROCYTOL, V31, P195, DOI 10.1023/A:1024109606722; WHITE EL, 1981, J COMP NEUROL, V195, P265, DOI 10.1002/cne.901950207; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; [No title captured]	60	185	187	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					1009	1020		10.1016/j.neuron.2010.08.014	http://dx.doi.org/10.1016/j.neuron.2010.08.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869597	Green Accepted, Bronze			2022-12-24	WOS:000282801100012
J	Barker, RA; Kuan, WL				Barker, Roger A.; Kuan, Wei-Li			Graft-Induced Dyskinesias in Parkinson's Disease: What Is It All About?	CELL STEM CELL			English	Editorial Material							DOPAMINE; PATHOLOGY; STRIATUM; NEURONS		[Barker, Roger A.; Kuan, Wei-Li] Univ Cambridge, Brain Repair Ctr, Cambridge CB2 0PY, England; [Barker, Roger A.; Kuan, Wei-Li] Univ Cambridge, Dept Neurol, Cambridge CB2 0PY, England	University of Cambridge; University of Cambridge	Barker, RA (corresponding author), Univ Cambridge, Brain Repair Ctr, Cambridge CB2 0PY, England.	rab46@cam.ac.uk	Kuan, Wei-Li/ABD-7860-2020	Kuan, Wei-Li/0000-0002-0273-1320; Barker, Roger Alistair/0000-0001-8843-7730				Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Carlsson T, 2006, NEUROBIOL DIS, V21, P657, DOI 10.1016/j.nbd.2005.09.008; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Goy RL, 2007, EXPERT OPIN BIOL TH, V7, P1487, DOI 10.1517/14712598.7.10.1487; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Ma YL, 2002, ANN NEUROL, V52, P628, DOI 10.1002/ana.10359; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034	10	23	23	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					148	149		10.1016/j.stem.2010.07.003	http://dx.doi.org/10.1016/j.stem.2010.07.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682443	Bronze			2022-12-24	WOS:000281107400007
J	Kaun, KR; Azanchi, R; Maung, Z; Hirsh, J; Heberlein, U				Kaun, Karla R.; Azanchi, Reza; Maung, Zaw; Hirsh, Jay; Heberlein, Ulrike			A Drosophila model for alcohol reward	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CONDITIONED PLACE PREFERENCE; MUSHROOM BODY; ETHANOL SENSITIVITY; NEURAL MECHANISMS; DOPAMINE; NOTCH; EXPRESSION; NEURONS; PROTEIN	The rewarding properties of drugs contribute to the development of abuse and addiction. We developed a new assay for investigating the motivational properties of ethanol in the genetically tractable model Drosophila melanogaster. Flies learned to associate cues with ethanol intoxication and, although transiently aversive, the experience led to a long-lasting attraction for the ethanol-paired cue, implying that intoxication is rewarding. Temporally blocking transmission in dopaminergic neurons revealed that flies require activation of these neurons to express, but not develop, conditioned preference for ethanol-associated cues. Moreover, flies acquired, consolidated and retrieved these rewarding memories using distinct sets of neurons in the mushroom body. Finally, mutations in scabrous, encoding a fibrinogen-related peptide that regulates Notch signaling, disrupted the formation of memories for ethanol reward. Our results thus establish that Drosophila can be useful for understanding the molecular, genetic and neural mechanisms underling the rewarding properties of ethanol.	[Kaun, Karla R.; Azanchi, Reza; Maung, Zaw; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of California System; University of California San Francisco; University of Virginia	Kaun, KR (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	karla.kaun@ucsf.edu; ulrike.heberlein@ucsf.edu		Kaun, Karla/0000-0002-8756-9528	Heart and Stroke Foundation of Canada; US National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Waddell, J. Levine, M. Sokolowski, A. Barron and members of the Heberlein laboratory for reagents, input and advice, and S. Birman (Developmental Biology Institute of Marseilles-Luminy), F. Wolf (Gallo Institute), S. Sweeney (University of York), K. Kaiser (Glasgow University), N. Baker (Albert Einstein College of Medicine) and the Bloomington Stock Center for flies. Funding was provided by a Heart and Stroke Foundation of Canada Research Fellowship to K. R. K. and the US National Institutes of Health to U.H.	Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; Berger KH, 2008, ALCOHOL CLIN EXP RES, V32, P895, DOI 10.1111/j.1530-0277.2008.00659.x; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Deadwyler SA, 2010, ANN NY ACAD SCI, V1187, P140, DOI 10.1111/j.1749-6632.2009.05155.x; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Dhonnchadha BAN, 2008, BEHAV BRAIN RES, V195, P39, DOI 10.1016/j.bbr.2008.06.026; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gremel CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1443, DOI 10.1038/npp.2008.179; Hardie SL, 2006, J NEUROSCI METH, V153, P243, DOI 10.1016/j.jneumeth.2005.11.001; HU XX, 1995, GENETICS, V141, P607; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; King I, 2011, J NEUROSCI, V31, P1139, DOI 10.1523/JNEUROSCI.4416-10.2011; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; LaFerriere H, 2008, GENETICS, V178, P1895, DOI 10.1534/genetics.107.084582; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Nehring LC, 2005, J BIOL CHEM, V280, P20349, DOI 10.1074/jbc.M500273200; Pautassi RM, 2008, PHARMACOL BIOCHEM BE, V88, P393, DOI 10.1016/j.pbb.2007.09.012; Phillips TJ, 1996, INT REV NEUROBIOL, V39, P243, DOI 10.1016/S0074-7742(08)60669-8; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; Rodan AR, 2010, INT REV NEUROBIOL, V91, P25, DOI 10.1016/S0074-7742(10)91002-7; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Walker BM, 2007, BEHAV NEUROSCI, V121, P401, DOI 10.1037/0735-7044.121.2.401; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	45	151	154	0	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					612	U103		10.1038/nn.2805	http://dx.doi.org/10.1038/nn.2805			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499254	Green Accepted			2022-12-24	WOS:000289886600017
J	Riazanski, V; Deriy, LV; Shevchenko, PD; Le, B; Gomez, EA; Nelson, DJ				Riazanski, Vladimir; Deriy, Ludmila V.; Shevchenko, Pavel D.; Le, Brandy; Gomez, Erwin A.; Nelson, Deborah J.			Presynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLES; FUNCTIONAL RECONSTITUTION; ENERGY-DEPENDENCE; TRANSPORT; SYNAPSES; CHANNELS; RELEASE; CYCLE; LEADS	The absence of the chloride channel CLC-3 in Clcn3(-/-) mice results in hippocampal degeneration with a distinct temporal-spatial sequence that resembles neuronal loss in temporal lobe epilepsy. We examined how the loss of CLC-3 might affect GABAergic synaptic transmission in the hippocampus. An electrophysiological study of synaptic function in hippocampal slices taken from Clcn3(-/-) mice before the onset of neurodegeneration revealed a substantial decrease in the amplitude and frequency of miniature inhibitory postsynaptic currents compared with those in wild-type slices. We found that CLC-3 colocalized with the vesicular GABA transporter VGAT in the CA1 region of the hippocampus. Acidification of inhibitory synaptic vesicles induced by Cl- showed a marked dependence on CLC-3 expression. The decrease in inhibitory transmission in Clcn3(-/-) mice suggests that the neurotransmitter loading of synaptic vesicles was reduced, which we attribute to defective vesicular acidification. Our observations extend the role of Cl- in inhibitory transmission from that of a postsynaptic permeant species to a presynaptic regulatory element.	[Riazanski, Vladimir; Deriy, Ludmila V.; Shevchenko, Pavel D.; Le, Brandy; Gomez, Erwin A.; Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	nelson@uchicago.edu			NIH [R01 GM36823, R01 DK 080364]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Fox, S. Takamori, R. Edwards, L. Farmer and R. Sarac for conversations, V. Bindokas and P. Toth for technical help with microscopy, Y. Chen for help with immuno-electron microscopy, and F. Lamb (Univ. Iowa) for the Clcn3<SUP>-/-</SUP> strain. The study was supported by NIH R01 GM36823 and NIH R01 DK 080364 to D.J.N.	Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Cuddapah VA, 2010, J BIOL CHEM, V285, P11188, DOI 10.1074/jbc.M109.097675; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Deriy LV, 2009, CELL METAB, V10, P316, DOI 10.1016/j.cmet.2009.08.012; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Habela CW, 2008, J NEUROSCI, V28, P9205, DOI 10.1523/JNEUROSCI.1897-08.2008; Hell J. W, 1994, CELL BIOL LAB HDB, P567; HELL JW, 1990, J BIOL CHEM, V265, P2111; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Juge N, 2009, J BIOL CHEM, V284, P35073, DOI 10.1074/jbc.M109.062414; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Takamori S, 2000, J NEUROSCI, V20, P4904; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	28	50	52	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					487	U124		10.1038/nn.2775	http://dx.doi.org/10.1038/nn.2775			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378974	Green Accepted			2022-12-24	WOS:000288849400020
J	Nardo, D; Santangelo, V; Macaluso, E				Nardo, Davide; Santangelo, Valerio; Macaluso, Emiliano			Stimulus-Driven Orienting of Visuo-Spatial Attention in Complex Dynamic Environments	NEURON			English	Article							FRONTAL EYE FIELD; VISUAL-ATTENTION; CORTICAL ACTIVITY; PARIETAL CORTEX; REPRESENTATION; MOVEMENTS; SEARCH; SPACE; AREAS; PERCEPTION	In everyday life attention operates within complex and dynamic environments, while laboratory paradigms typically employ simple and stereotyped stimuli. This fMRI study investigated stimulus-driven spatial attention using a virtual-environment video. We explored the influence of bottom-up signals by computing saliency maps of the environment and by introducing attention-grabbing events in the video. We parameterized the efficacy of these signals for the orienting of spatial attention by measuring eye movements and used these parameters to analyze the imaging data. The efficacy of bottom-up signals modulated ongoing activity in dorsal fronto-parietal regions and transient activation of the ventral attention system. Our results demonstrate that the combination of computational, behavioral, and imaging techniques enables studying cognitive functions in ecologically valid contexts. We highlight the central role of the efficacy of stimulus-driven signals in both dorsal and ventral attention systems, with a dissociation of the efficacy of background salience versus distinctive events in the two systems.	[Nardo, Davide; Santangelo, Valerio; Macaluso, Emiliano] Santa Lucia Fdn, Neuroimaging Lab, I-00179 Rome, Italy; [Santangelo, Valerio] Univ Perugia, Dept Human & Educ Sci, I-06123 Perugia, Italy	IRCCS Santa Lucia; University of Perugia	Nardo, D (corresponding author), Santa Lucia Fdn, Neuroimaging Lab, I-00179 Rome, Italy.	davidenardo@gmail.com	Santangelo, Valerio/K-7556-2016; Macaluso, Emiliano/H-3139-2017; Macaluso, Emiliano/AAE-9185-2019; Nardo, Davide/G-7345-2015	Santangelo, Valerio/0000-0001-9665-8701; Macaluso, Emiliano/0000-0002-1919-5288; Macaluso, Emiliano/0000-0002-1919-5288; Nardo, Davide/0000-0002-8158-5738	European Union [242809]	European Union(European Commission)	The Neuroimaging Laboratory, Santa Lucia Foundation, is supported by The Italian Ministry of Health. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement n. 242809.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Carmi R, 2006, VISION RES, V46, P4333, DOI 10.1016/j.visres.2006.08.019; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Elazary L, 2008, J VISION, V8, DOI 10.1167/8.3.3; Fairhall SL, 2009, CEREB CORTEX, V19, P2946, DOI 10.1093/cercor/bhp064; Fink GR, 1997, BRAIN, V120, P2013, DOI 10.1093/brain/120.11.2013; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Kimmig H, 2001, EXP BRAIN RES, V141, P184, DOI 10.1007/s002210100844; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Konen CS, 2008, J NEUROSCI, V28, P8361, DOI 10.1523/JNEUROSCI.1930-08.2008; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; Natale E, 2010, NEUROPSYCHOLOGIA, V48, P1160, DOI 10.1016/j.neuropsychologia.2009.11.012; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Petit L, 1997, J NEUROPHYSIOL, V77, P3386, DOI 10.1152/jn.1997.77.6.3386; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Shikata E, 2003, EUR J NEUROSCI, V17, P1105, DOI 10.1046/j.1460-9568.2003.02540.x; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Thielscher A, 2008, NEUROSCIENCE, V151, P730, DOI 10.1016/j.neuroscience.2007.11.040; Thompson KG, 2005, J NEUROPHYSIOL, V93, P337, DOI 10.1152/jn.00330.2004; Tseng PH, 2009, J VISION, V9, DOI 10.1167/9.7.4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	43	66	66	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					1015	1028		10.1016/j.neuron.2011.02.020	http://dx.doi.org/10.1016/j.neuron.2011.02.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382559	Green Accepted, Bronze			2022-12-24	WOS:000288736500017
J	Pfeifer, JH; Masten, CL; Moore, WE; Oswald, TM; Mazziotta, JC; Iacoboni, M; Dapretto, M				Pfeifer, Jennifer H.; Masten, Carrie L.; Moore, William E., III; Oswald, Tasha M.; Mazziotta, John C.; Iacoboni, Marco; Dapretto, Mirella			Entering Adolescence: Resistance to Peer Influence, Risky Behavior, and Neural Changes in Emotion Reactivity	NEURON			English	Article							AUTOMATED IMAGE REGISTRATION; FACIAL EXPRESSIONS; NEUROSCIENCE PERSPECTIVE; DEPRESSIVE SYMPTOMS; AMYGDALA RESPONSE; DECISION-MAKING; DORSAL STRIATUM; SELF-REGULATION; POSITIVE AFFECT; REWARD	Adolescence is often described as a period of heightened reactivity to emotions paired with reduced regulatory capacities, a combination suggested to contribute to risk-taking and susceptibility to peer influence during puberty. However, no longitudinal research has definitively linked these behavioral changes to underlying neural development. Here, 38 neurotypical participants underwent two fMRI sessions across the transition from late childhood (10 years) to early adolescence (13 years). Responses to affective facial displays exhibited a combination of general and emotion-specific changes in ventral striatum (VS), ventromedial PFC, amygdala, and temporal pole. Furthermore, VS activity increases correlated with decreases in susceptibility to peer influence and risky behavior. VS and amygdala responses were also significantly more negatively coupled in early adolescence than in late childhood while processing sad and happy versus neutral faces. Together, these results suggest that VS responses to viewing emotions may play a regulatory role that is critical to adolescent interpersonal functioning.	[Pfeifer, Jennifer H.; Moore, William E., III; Oswald, Tasha M.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Masten, Carrie L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Mazziotta, John C.; Iacoboni, Marco; Dapretto, Mirella] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Iacoboni, Marco; Dapretto, Mirella] Univ Calif Los Angeles, FPR Ctr Culture Brain & Dev, Los Angeles, CA 90095 USA	University of Oregon; University of California System; University of California Davis; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Pfeifer, JH (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	jpfeifer@uoregon.edu		Moore, Will/0000-0002-7012-7803	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [RR12169, RR13642, RR00865]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, C06RR012169, M01RR000865] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors wish to express their gratitude to Kristin McNealy, Larissa Borofsky, Nicole Vazquez, Elliot Berkman, and the University of Oregon Developmental Social Neuroscience Lab, as well as three anonymous reviewers. For generous support the authors also wish to thank the Santa Fe Institute Consortium, Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation, Tamkin Foundation, Jennifer Jones-Simon Foundation, Capital Group Companies Charitable Foundation, Robson Family, and Northstar Fund. The project described was supported by grant numbers RR12169, RR13642, and RR00865 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCR or NIH.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Baird AA, 1999, J AM ACAD CHILD PSY, V38, P195, DOI 10.1097/00004583-199902000-00019; BAIRD AA, 2010, SOC NEUROSCI, P1; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Brown B. B., 2004, ADOLESCENTS RELATION; Chaplin TM, 2009, J EARLY ADOLESCENCE, V29, P307, DOI 10.1177/0272431608320125; Cyranowski JM, 2000, ARCH GEN PSYCHIAT, V57, P21, DOI 10.1001/archpsyc.57.1.21; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dishion TJ, 2011, ANNU REV PSYCHOL, V62, P189, DOI 10.1146/annurev.psych.093008.100412; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Forbes EE, 2010, J AM ACAD CHILD PSY, V49, P162, DOI 10.1016/j.jaac.2009.11.006; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Gestsdottir S, 2007, DEV PSYCHOL, V43, P508, DOI 10.1037/0012-1649.43.2.508; Grosbras MH, 2007, J NEUROSCI, V27, P8040, DOI 10.1523/JNEUROSCI.1360-07.2007; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Guyer AE, 2008, J COGNITIVE NEUROSCI, V20, P1565, DOI 10.1162/jocn.2008.20114; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Levesque J, 2004, NEUROSCIENCE, V129, P361, DOI 10.1016/j.neuroscience.2004.07.032; Levita L, 2009, NEUROIMAGE, V44, P1178, DOI 10.1016/j.neuroimage.2008.09.039; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; McRae K, 2008, NEUROIMAGE, V41, P648, DOI 10.1016/j.neuroimage.2008.02.030; Monk CS, 2003, NEUROIMAGE, V20, P420, DOI 10.1016/S1053-8119(03)00355-0; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Schlicht EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011663; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wechsler D., 2016, WECHSLER INTELLIGENC; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7	54	174	178	2	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 10	2011	69	5					1029	1036		10.1016/j.neuron.2011.02.019	http://dx.doi.org/10.1016/j.neuron.2011.02.019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	739RU	21382560	Bronze, Green Accepted			2022-12-24	WOS:000288736500018
J	Pearl, JI; Lee, AS; Leveson-Gower, DB; Sun, N; Ghosh, Z; Lan, F; Ransohoff, J; Negrin, RS; Davis, MM; Wu, JC				Pearl, Jeremy I.; Lee, Andrew S.; Leveson-Gower, Dennis B.; Sun, Ning; Ghosh, Zhumur; Lan, Feng; Ransohoff, Julia; Negrin, Robert S.; Davis, Mark M.; Wu, Joseph C.			Short-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							REGULATORY T-CELLS; COSTIMULATION BLOCKADE; TRANSPLANTATION; EXPRESSION; GENERATION; TOLERANCE; CTLA-4; SIGNAL; ICAM-1	Embryonic stem cells (ESCs) are an attractive source for tissue regeneration and repair therapies because they can be differentiated into virtually any cell type in the adult body. However, for this approach to succeed, the transplanted ESCs must survive long enough to generate a therapeutic benefit. A major obstacle facing the engraftment of ESCs is transplant rejection by the immune system. Here we show that blocking leukocyte costimulatory molecules permits ESC engraftment. We demonstrate the success of this immunosuppressive therapy for mouse ESCs, human ESCs, mouse induced pluripotent stem cells (iPSCs), human induced pluripotent stem cells, and more differentiated ESC/(iPSCs) derivatives. Additionally, we provide evidence describing the mechanism by which inhibition of costimulatory molecules suppresses T cell activation. This report describes a short-term immunosuppressive approach capable of inducing engraftment of transplanted ESCs and iPSCs, providing a significant improvement in our mechanistic understanding of the critical role costimulatory molecules play in leukocyte activation.	[Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Leveson-Gower, Dennis B.; Negrin, Robert S.] Stanford Univ, Sch Med, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Pearl, Jeremy I.; Lee, Andrew S.; Sun, Ning; Ghosh, Zhumur; Lan, Feng; Ransohoff, Julia; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Pearl, Jeremy I.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mmdavis@stanford.edu; joewu@stanford.edu	Lee, Andrew/GVU-2817-2022; Lan, Feng/I-2023-2012; Wu, Joseph/H-1067-2013	Lan, Feng/0000-0002-9038-4014; Ghosh, Zhumur/0000-0002-4877-7551; Davis, Mark/0000-0001-6868-657X; Wu, Joseph/0000-0002-6068-8041; Sun, Ning/0000-0002-7861-3646	National Institutes of Health [AI085575, HL089027, DP2OD004437]; Howard Hughes Medical Institute; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089027, R33HL089027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036142] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Marcel Daadi for assistance with stereotactic transplantation of murine neural progenitor cells. This work was supported by National Institutes of Health Grants AI085575, HL089027, and DP2OD004437 (J.C.W.), and by a Howard Hughes Medical Institute research training fellowship (J.I.P., A.S.L.). M.M.D. is supported by grants from the Howard Hughes Medical Institute, the Ellison Medical Foundation, and the National Institutes of Health.	Abdullah Z, 2007, J IMMUNOL, V178, P3390, DOI 10.4049/jimmunol.178.6.3390; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Byrne JA, 2008, HUM MOL GENET, V17, pR37, DOI 10.1093/hmg/ddn053; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chidgey AP, 2008, NATURE, V453, P330, DOI 10.1038/nature07041; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Grinnemo KH, 2008, STEM CELLS, V26, P1850, DOI 10.1634/stemcells.2008.0111; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; Kim JB, 2009, NAT PROTOC, V4, P1464, DOI 10.1038/nprot.2009.173; Kurtz J, 2009, BLOOD, V113, P3475, DOI 10.1182/blood-2008-01-133736; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P143, DOI 10.1146/annurev.iy.01.040183.001043; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; LENSCHOW DJ, 1992, SCIENCE, V257, P789, DOI 10.1126/science.1323143; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Li ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008443; Lomax GP, 2007, PLOS MED, V4, P803, DOI 10.1371/journal.pmed.0040114; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Niu G, 2008, DRUGS R&D, V9, P351, DOI 10.2165/0126839-200809060-00002; Pan YS, 2003, TRANSPLANTATION, V76, P216, DOI 10.1097/01.TP.0000069602.30162.A1; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; Toriumi H, 2009, NEUROL RES, V31, P220, DOI 10.1179/016164108X339378; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zuckerman LA, 1998, J IMMUNOL, V160, P3259	34	138	140	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					309	317		10.1016/j.stem.2011.01.012	http://dx.doi.org/10.1016/j.stem.2011.01.012			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362570	Green Accepted, Bronze			2022-12-24	WOS:000288404400012
J	Deng, LB; Kaeser, PS; Xu, W; Sudhof, TC				Deng, Lunbin; Kaeser, Pascal S.; Xu, Wei; Suedhof, Thomas C.			RIM Proteins Activate Vesicle Priming by Reversing Autoinhibitory Homodimerization of Munc13	NEURON			English	Article							READILY RELEASABLE POOL; NEUROTRANSMITTER RELEASE; BINDING-PROTEINS; TERM PLASTICITY; CA2+ CHANNELS; RAB3 EFFECTOR; RIM1-ALPHA; DOMAIN; FAMILY; UNC-13	At a synapse, the presynaptic active zone mediates synaptic vesicle exocytosis. RIM proteins are active zone scaffolding molecules that among others mediate vesicle priming and directly or indirectly interact with most other essential presynaptic proteins. In particular, the Zn2+ finger domain of RIMs binds to the C(2)A domain of the priming factor Munc13, which forms a homodimer in the absence of RIM but a heterodimer with it. Here, we show that RIMs mediate vesicle priming not by coupling Munc13 to other active zone proteins as thought but by directly activating Munc13. Specifically, we found that the isolated Zn2+ finger domain of RIMs autonomously promoted vesicle priming by binding to Munc13, thereby relieving Munc13 homodimerization. Strikingly, constitutively monomeric mutants of Munc13 rescued priming in RIM-deficient synapses, whereas wild-type Munc13 did not. Both mutant and wild-type Munc13, however, rescued priming in Munc13-deficient synapses. Thus, homodimerization of Munc13 inhibits its priming function, and RIMs activate priming by disrupting Munc13 homodimerization.	[Deng, Lunbin; Kaeser, Pascal S.; Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Lorry Lokey Bldg,265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu			National Institites of Health [NINDS 33564, DA029044]; Swiss National Science Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029044] Funding Source: NIH RePORTER	National Institites of Health; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Ly for technical assistance, Dr. Nils Brose for the gift of Munc13-antibodies and Munc13-2 KO mice, Dr. Z. Pang for the ubMunc13-2<SUP>Delta C2A</SUP> construct, and members of the Sudhof lab for comments. This work was supported by grants from the National Institites of Health (NINDS 33564 to T.C.S., DA029044 to P.S.K.), and by a Swiss National Science Foundation Postdoctoral Fellowship (to P.S.K.).	ANDREWSZWILLING YS, 2006, NATURE, V281, P457; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chevaleyre V, 2007, NEURON, V54, P801, DOI 10.1016/j.neuron.2007.05.020; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kaeser PS, 2009, NEURON, V64, P227, DOI 10.1016/j.neuron.2009.09.019; Kaeser PS, 2008, J NEUROSCI, V28, P13435, DOI 10.1523/JNEUROSCI.3235-08.2008; Katz B., 1969, RELEASE NEURAL TRANS; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lu JA, 2006, DYNAM CONT DIS SER B, V13; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Mittelstaedt T, 2010, BIOL CHEM, V391, P599, DOI 10.1515/BC.2010.064; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Weimer RM, 2006, J NEUROSCI, V26, P8040, DOI 10.1523/JNEUROSCI.2350-06.2006; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	52	174	179	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					317	331		10.1016/j.neuron.2011.01.005	http://dx.doi.org/10.1016/j.neuron.2011.01.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262469	Bronze, Green Accepted			2022-12-24	WOS:000286792900014
J	Barrero, MJ; Boue, S; Belmonte, JCI				Barrero, Maria J.; Boue, Stephanie; Izpisua Belmonte, Juan Carlos			Epigenetic Mechanisms that Regulate Cell Identity	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; CHROMATIN SIGNATURES; INTERACTION NETWORK; GENE-REGULATION; PLURIPOTENT; METHYLATION; POLYCOMB; COMPLEX; CANCER	Individual cell fate decisions can vary according to changes in gene expression in response to environmental, developmental, or metabolic cues. This plasticity is tightly regulated during embryonic development and mediated by the exquisitely coordinated activation and repression of groups of genes. Genes that become repressed are immersed in a condensed chromatin environment that renders them refractory to stimulation. This mechanism is responsible for both the loss of cell plasticity during differentiation and the preservation of cell identity. Understanding the molecular events involved in the establishment and maintenance of these restrictive domains will benefit the design of strategies for cellular reprogramming, differentiation, and cancer treatment.	[Barrero, Maria J.; Boue, Stephanie; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	belmonte@salk.edu	Barrero, Maria J./Q-1785-2017	Barrero, Maria J./0000-0002-5990-7040; Boue, Stephanie/0000-0003-0680-4168	Ministerio de Ciencia e Innovacion of Spain [RYC-2007-01510, SAF2009-08588]; G. Harold and Leila Y. Mathers Charitable G. Harold and Leila Y. Mathers Charitable and Cellex Foundation; Cellex Foundation; Sanofi-Aventis; MICINN	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); G. Harold and Leila Y. Mathers Charitable G. Harold and Leila Y. Mathers Charitable and Cellex Foundation(Foundation CELLEX); Cellex Foundation(Foundation CELLEX); Sanofi-Aventis(Sanofi-Aventis); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	We apologize for those authors whose work could not be cited because of space limitation. We would like to thank all the members of the J.C.I.B. lab at The Salk Institute for Biological Studies and the CMRB for their insightful comments and input. This work was partially supported by grants RYC-2007-01510 and SAF2009-08588 from the Ministerio de Ciencia e Innovacion of Spain to M.J.B. and grants from the G. Harold and Leila Y. Mathers Charitable and Cellex Foundations, Sanofi-Aventis, and MICINN to J.C.I.B.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012664; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li L, 2003, CANCER RES, V63, P2733; Liu JH, 2008, MOL REPROD DEV, V75, P598, DOI 10.1002/mrd.20803; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Ron-Bigger S, 2010, STEM CELLS, V28, P1349, DOI 10.1002/stem.468; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	51	76	79	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					565	570		10.1016/j.stem.2010.10.009	http://dx.doi.org/10.1016/j.stem.2010.10.009			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040898	Bronze			2022-12-24	WOS:000284390500008
J	Patel, KN; Dong, XZ				Patel, Kush N.; Dong, Xinzhong			An Itch To Be Scratched	NEURON			English	Review							SPINOTHALAMIC TRACT NEURONS; DORSAL-HORN NEURONS; PROTEASE-ACTIVATED RECEPTORS; SUBSTANCE-P RECEPTOR; LAMINA-I NEURONS; CAPSAICIN RECEPTOR; POTENTIAL ROLE; PAR-2 AGONIST; SPINAL-CORD; HUMAN-SKIN	The description of itch (formally known as pruritus) as an "unpleasant sensation that elicits the desire or reflex to scratch" (lkoma et al., 2006) is immediately familiar. Research in the field of pruritoception has added to our understanding of this area of sensory neurobiology as it pertains to both normal and pathological conditions. In particular, much progress has been made on the mechanisms and circuits of itch, which we review here.	[Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Dong, Xinzhong] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Howard Hughes Medical Institute	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA.	xdong2@jhmi.edu			NEI NIH HHS [T32 EY017203] Funding Source: Medline; NIGMS NIH HHS [R01 GM087369, R01 GM087369-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS054791, R01 NS054791-05] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama T, 2009, J NEUROPHYSIOL, V102, P2176, DOI 10.1152/jn.00463.2009; Akiyama T, 2009, J NEUROSCI, V29, P6691, DOI 10.1523/JNEUROSCI.6103-08.2009; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bell JK, 2004, BRIT J PHARMACOL, V142, P374, DOI 10.1038/sj.bjp.0705754; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Craig AD, 2002, J NEUROPHYSIOL, V87, P1902, DOI 10.1152/jn.00578.2001; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Davidson S, 2007, ACTA DERM-VENEREOL, V87, P475; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; HANDWERKER HO, 1991, J NEUROPHYSIOL, V66, P307, DOI 10.1152/jn.1991.66.1.307; HANDWERKER HO, 1992, APS J, V1, P135; Harvima IT, 2008, ARCH DERMATOL RES, V300, P461, DOI 10.1007/s00403-008-0874-x; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jinks SL, 2002, J NEUROPHYSIOL, V87, P1280, DOI 10.1152/jn.00431.2001; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Johanek LM, 2007, J NEUROSCI, V27, P7490, DOI 10.1523/JNEUROSCI.1249-07.2007; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Lewis T., 1927, HEART, V14, P139; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; OCHOA J, 1989, J PHYSIOL-LONDON, V415, P583, DOI 10.1113/jphysiol.1989.sp017737; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Simone DA, 2004, J NEUROPHYSIOL, V91, P213, DOI 10.1152/jn.00527.2003; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Szarvas S, 2003, J CLIN ANESTH, V15, P234, DOI 10.1016/S0952-8180(02)00501-9; TUCKETT RP, 1982, J INVEST DERMATOL, V79, P368, DOI 10.1111/1523-1747.ep12529734; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Ui H, 2006, EUR J PHARMACOL, V530, P172, DOI 10.1016/j.ejphar.2005.11.021; von Frey M., 1922, ARCH NEERLAND PHYSL, V7, P142; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245; Yosipovitch G, 2008, DERMATOL THER, V21, P32, DOI 10.1111/j.1529-8019.2008.00167.x	52	51	53	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					334	339		10.1016/j.neuron.2010.10.018	http://dx.doi.org/10.1016/j.neuron.2010.10.018			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040839	Bronze, Green Accepted			2022-12-24	WOS:000284255800006
J	Cai, QA; Lu, L; Tian, JH; Zhu, YB; Qiao, HF; Sheng, ZH				Cai, Qian; Lu, Li; Tian, Jin-Hua; Zhu, Yi-Bing; Qiao, Haifa; Sheng, Zu-Hang			Snapin-Regulated Late Endosomal Transport Is Critical for Efficient Autophagy-Lysosomal Function in Neurons	NEURON			English	Article							RETROGRADE TRANSPORT; NERVOUS-SYSTEM; CELLS; PROTEIN; DYNEIN; DEGENERATION; ORGANELLES; FUSION; MICE; NEURODEGENERATION	Neuron maintenance and survival require late endocytic transport from distal processes to the soma where lysosomes are predominantly localized. Here, we report a role for Snapin in attaching dynein to late endosomes through its intermediate chain (DIC). snapin(-/-) neurons exhibit aberrant accumulation of immature lysosomes, clustering and impaired retrograde transport of late endosomes along processes, reduced lysosomal proteolysis due to impaired delivery of internalized proteins and hydrolase precursors from late endosomes to lysosomes, and impaired clearance of autolysosomes, combined with reduced neuron viability and neurodegeneration. The phenotypes are rescued by expressing the snapin transgene, but not the DIC-binding-defective Snapin-L99K mutant. Snapin overexpression in wild-type neurons enhances late endocytic transport and lysosomal function, whereas expressing the mutant defective in Snapin-DIC coupling shows a dominant-negative effect. Altogether, our study highlights new mechanistic insights into "how Snapin-DIC coordinates retrograde transport and late endosomal-lysosomal trafficking critical for autophagy-lysosomal function, and thus neuronal homeostasis.	[Cai, Qian; Lu, Li; Tian, Jin-Hua; Zhu, Yi-Bing; Qiao, Haifa; Sheng, Zu-Hang] Natl Inst Neurol Disorders & Stroke, Synapt Funct Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Cai, QA (corresponding author), Natl Inst Neurol Disorders & Stroke, Synapt Funct Sect, Porter Neurosci Res Ctr, NIH, Room 2B-215,35 Convent Dr, Bethesda, MD 20892 USA.	caiq@ninds.nih.gov; shengz@ninds.nih.gov			NINDS, NIH; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002946] Funding Source: NIH RePORTER	NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Youle, H Arnheiter, and members of the Sheng lab for helpful discussions, D. Glazer-Schoenberg, M Davis, and J Tokita for editing; B Zhou for mouse maintenance and genotyping; X Zhuang, B. Firestein, P.D. Stahl, W Li, and N Raben for reagents; and NINDS Facility for Electron Microscopy, DNA Sequencing, and Protein Sequencing. L.L. and Y.-B.Z. are graduate students of the NIH-Shanghai Jiao-Tong University Joint Ph D. Program. This work was supported by the Intramural Research Program of NINDS, NIH (Z-H S.) and the NIH Pathway to Independence Award K99 (Q.C.). The authors declare no competing financial interests	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bright NA, 1997, J CELL SCI, V110, P2027; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Chen M, 2005, MOL BIOL CELL, V16, P5103, DOI 10.1091/mbc.E05-02-0165; Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lu L, 2009, BIOSCIENCE REP, V29, P261, DOI 10.1042/BSR20090043; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Overly CC, 1996, J NEUROSCI, V16, P6056; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; SWANSON JA, 1992, J CELL SCI, V103, P201; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	42	159	162	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 7	2010	68	1					73	86		10.1016/j.neuron.2010.09.022	http://dx.doi.org/10.1016/j.neuron.2010.09.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920792	Green Accepted, Bronze			2022-12-24	WOS:000283704200009
J	Jung, H; Lacombe, J; Mazzoni, EO; Liem, KF; Grinstein, J; Mahony, S; Mukhopadhyay, D; Gifford, DK; Young, RA; Anderson, KV; Wichterle, H; Dasen, JS				Jung, Heekyung; Lacombe, Julie; Mazzoni, Esteban O.; Liem, Karel F., Jr.; Grinstein, Jonathan; Mahony, Shaun; Mukhopadhyay, Debnath; Gifford, David K.; Young, Richard A.; Anderson, Kathryn V.; Wichterle, Hynek; Dasen, Jeremy S.			Global Control of Motor Neuron Topography Mediated by the Repressive Actions of a Single Hox Gene	NEURON			English	Article							SPINAL-CORD; SUBTYPE IDENTITY; POOL IDENTITY; TRANSCRIPTIONAL CODES; HOMEOBOX GENES; NEONATAL-RAT; EXPRESSION; SPECIFICATION; MOUSE; ORGANIZATION	In the developing spinal cord, regional and combinatorial activities of Hox transcription factors are critical in controlling motor neuron fates along the rostrocaudal axis, exemplified by the precise pattern of limb innervation by more than fifty Hox-dependent motor pools. The mechanisms by which motor neuron diversity is constrained to limb levels are, however, not well understood. We show that a single Hox gene, Hoxc9, has an essential role in organizing the motor system through global repressive activities. Hoxc9 is required for the generation of thoracic motor columns, and in its absence, neurons acquire the fates of limb-innervating populations. Unexpectedly, multiple Hox genes are derepressed in Hoxc9 mutants, leading to motor pool disorganization and alterations in the connections by thoracic and forelimb-level subtypes. Genome-wide analysis of Hoxc9 binding suggests that this mode of repression is mediated by direct interactions with Hox regulatory elements, independent of chromatin marks typically associated with repressed Hox genes.	[Jung, Heekyung; Lacombe, Julie; Grinstein, Jonathan; Dasen, Jeremy S.] NYU, Sch Med, Howard Hughes Med Inst, Smilow Neurosci Program,Dept Physiol & Neurosci, New York, NY 10016 USA; [Mazzoni, Esteban O.; Wichterle, Hynek] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Mazzoni, Esteban O.; Wichterle, Hynek] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Mazzoni, Esteban O.; Wichterle, Hynek] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Liem, Karel F., Jr.; Anderson, Kathryn V.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Mahony, Shaun; Gifford, David K.] MIT, Dept Comp Sci & Elect Engn, Cambridge, MA 02139 USA; [Mukhopadhyay, Debnath; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; New York University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Dasen, JS (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, Smilow Neurosci Program,Dept Physiol & Neurosci, New York, NY 10016 USA.	jeremy.dasen@nyumc.org	Mahony, Shaun/C-5699-2014; Young, Richard A/F-6495-2012	Mahony, Shaun/0000-0002-2641-1807; Young, Richard A/0000-0001-8855-8647; Anderson, Kathryn/0000-0003-1657-2161; Grinstein, Jonathan/0000-0003-2911-4506; Wichterle, Hynek/0000-0002-7817-0080; mazzoni, esteban/0000-0001-8994-681X	Project ALS; NIH [R01 NS044385, P01 NS055923, R01 NS062822]; Alfred P. Sloan Foundation; Burroughs Welcome Fund; McKnight Foundation; NYStem; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062822, R01NS044385, P01NS055923] Funding Source: NIH RePORTER	Project ALS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Burroughs Welcome Fund(Burroughs Wellcome Fund); McKnight Foundation; NYStem; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Tom Jessell, Gord Fishell, and members of the lab for comments on the manuscript. Mario Capecchi and Deneen Wellik provided Hox mutant lines, Tom Jessell provided Olig2::Cre mice, and Silvia Arber provided Pea3 antibodies. We thank NYU transgenic facility for mouse husbandry, and Brian Dynlacht for help with the in vivo ChIP assays. E.O.M. is the David and Sylvia Lieb Fellow of the Damon Runyon Cancer Research Foundation, DRG-1937-07. K.L. and K.A. are supported by grants from Project ALS and NIH R01 NS044385. S.M., D.M., D.K.G., R.A.Y., and H.W. are supported by NIH P01 NS055923. J.D. is supported by grants from the Alfred P. Sloan Foundation, Burroughs Welcome Fund, McKnight Foundation, NIH R01 NS062822, NYStem and Project ALS. J.D. is an HHMI Early Career Scientist.	Alvares LE, 2003, DEV CELL, V5, P379, DOI 10.1016/S1534-5807(03)00263-6; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Ballion B, 2001, EUR J NEUROSCI, V14, P1727, DOI 10.1046/j.0953-816x.2001.01794.x; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Blackburn J, 2009, GENESIS, V47, P680, DOI 10.1002/dvg.20547; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Burke AC, 1996, DEV BIOL, V178, P192, DOI 10.1006/dbio.1996.0210; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Deschamps J, 1999, INT J DEV BIOL, V43, P635; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Ensini M, 1998, DEVELOPMENT, V125, P969; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shah V, 2004, DEV DYNAM, V231, P43, DOI 10.1002/dvdy.20103; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SMITH CL, 1983, J COMP NEUROL, V220, P16, DOI 10.1002/cne.902200104; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tarchini B, 2005, GENE DEV, V19, P2862, DOI 10.1101/gad.351105; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Vermot J, 2005, DEVELOPMENT, V132, P1611, DOI 10.1242/dev.01718; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225	51	100	101	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 9	2010	67	5					781	796		10.1016/j.neuron.2010.08.008	http://dx.doi.org/10.1016/j.neuron.2010.08.008			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826310	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000281938900013
J	Im, HI; Hollander, JA; Bali, P; Kenny, PJ				Im, Heh-In; Hollander, Jonathan A.; Bali, Purva; Kenny, Paul J.			MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; RETT-SYNDROME; NEUROTROPHIC FACTOR; BRAIN; INCREASES; NEURONS; SEEKING; REWARD	The X-linked transcriptional repressor methyl CpG binding protein 2 (MeCP2), known for its role in the neurodevelopmental disorder Rett syndrome, is emerging as an important regulator of neuroplasticity in postmitotic neurons. Cocaine addiction is commonly viewed as a disorder of neuroplasticity, but the potential involvement of MeCP2 has not been explored. Here we identify a key role for MeCP2 in the dorsal striatum in the escalating cocaine intake seen in rats with extended access to the drug, a process that mimics the increasingly uncontrolled cocaine use seen in addicted humans. MeCP2 regulates cocaine intake through homeostatic interactions with microRNA-212 (miR-212) to control the effects of cocaine on striatal brain-derived neurotrophic factor (BDNF) levels. These data suggest that homeostatic interactions between MeCP2 and miR-212 in dorsal striatum may be important in regulating vulnerability to cocaine addiction.	[Im, Heh-In; Hollander, Jonathan A.; Bali, Purva; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA	Scripps Research Institute; State University System of Florida; University of Florida	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA.	pjkenny@scripps.edu			US National Institute on Drug Abuse [DA025983]; Ruth L. Kirschstein National Research Service; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024932, R01DA025983] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Xu from Georgetown University for the BDNF 3'-UTR reporter construct. This work was supported by a grant from the US National Institute on Drug Abuse to P.J.K. (DA025983); Ruth L. Kirschstein National Research Service Awards to H.-I. I. and J.A.H.; and a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award to H.-I. I. This is manuscript number 20438 from The Scripps Research Institute.	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; CHAO HT, 2008, SOC NEUR M WASH DC, P310; Choi KH, 2006, NEUROSCIENCE, V137, P373, DOI 10.1016/j.neuroscience.2005.10.049; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dunn HG, 2001, BRAIN DEV-JPN, V23, pS99, DOI 10.1016/S0387-7604(01)00354-0; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Grimm JW, 2003, J NEUROSCI, V23, P742; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Horger BA, 1999, J NEUROSCI, V19, P4110; Huang YH, 2008, J BIOL CHEM, V283, P2751, DOI 10.1074/jbc.M706578200; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jin J, 2008, INT J DEV NEUROSCI, V26, P457, DOI 10.1016/j.ijdevneu.2008.02.009; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Larimore JL, 2009, NEUROBIOL DIS, V34, P199, DOI 10.1016/j.nbd.2008.12.011; Logrip ML, 2008, FASEB J, V22, P2393, DOI 10.1096/fj.07-099135; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Oo TF, 2009, MOL CELL NEUROSCI, V41, P440, DOI 10.1016/j.mcn.2009.04.009; Pelka GJ, 2005, GENOMICS, V85, P441, DOI 10.1016/j.ygeno.2004.12.002; Piazza PV, 2000, J NEUROSCI, V20, P4226; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Schoenbaum G, 2007, NAT NEUROSCI, V10, P935, DOI 10.1038/nn0807-935; Temudo T, 2008, MOVEMENT DISORD, V23, P1384, DOI 10.1002/mds.22115; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104	50	322	346	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1120	U121		10.1038/nn.2615	http://dx.doi.org/10.1038/nn.2615			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711185	Green Accepted			2022-12-24	WOS:000281332600018
J	Rex, CS; Gavin, CF; Rubio, MD; Kramar, EA; Chen, LY; Jia, YS; Huganir, RL; Muzyczka, N; Gall, CM; Miller, CA; Lynch, G; Rumbaugh, G				Rex, Christopher S.; Gavin, Cristin F.; Rubio, Maria D.; Kramar, Eniko A.; Chen, Lulu Y.; Jia, Yousheng; Huganir, Richard L.; Muzyczka, Nicholas; Gall, Christine M.; Miller, Courtney A.; Lynch, Gary; Rumbaugh, Gavin			Myosin IIb Regulates Actin Dynamics during Synaptic Plasticity and Memory Formation	NEURON			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; AMPA RECEPTORS; PHOSPHORYLATION; POLYMERIZATION; CONSOLIDATION; BLEBBISTATIN; MORPHOLOGY; EXPRESSION; INHIBITOR	Reorganization of the actin cytoskeleton is essential for synaptic plasticity and memory formation. Presently, the mechanisms that trigger actin dynamics during these brain processes are poorly understood. In this study, we show that myosin II motor activity is downstream of LTP induction and is necessary for the emergence of specialized actin structures that stabilize an early phase of LTP. We also demonstrate that myosin II activity contributes importantly to an actin-dependent process that underlies memory consolidation. Pharmacological treatments that promote actin polymerization reversed the effects of a myosin II inhibitor on LTP and memory. We conclude that myosin II motors regulate plasticity by imparting mechanical forces onto the spine actin cytoskeleton in response to synaptic stimulation. These cytoskeletal forces trigger the emergence of actin structures that stabilize synaptic plasticity. Our studies provide a mechanical framework for understanding cytoskeletal dynamics associated with synaptic plasticity and memory formation.	[Gavin, Cristin F.; Rubio, Maria D.; Miller, Courtney A.; Rumbaugh, Gavin] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Gavin, Cristin F.; Rubio, Maria D.; Miller, Courtney A.; Rumbaugh, Gavin] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA; [Rex, Christopher S.; Kramar, Eniko A.; Jia, Yousheng; Lynch, Gary] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Gall, Christine M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Chen, Lulu Y.; Gall, Christine M.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Muzyczka, Nicholas] Univ Florida, Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; State University System of Florida; University of Florida; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Rumbaugh, G (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.	grumbaug@scripps.edu	Miller, Courtney A/E-8651-2010; Chen, Lulu/GXF-3271-2022; Rex, Christopher/F-2112-2010	Miller, Courtney A/0000-0001-8628-4902; Gavin, Cristin/0000-0001-7113-5015	UAB; McKnight Brain Institute; Alabama Health Sciences Foundation; National Institute of Neurological Disorders (NINDS) [NS064079, N505182, NS45260, 045540]; National Institute of Mental Health [MH083396]; National Institute on Aging [AG00096]; Kauffman Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH083396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064079, P01NS045260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024761] Funding Source: NIH RePORTER	UAB; McKnight Brain Institute; Alabama Health Sciences Foundation; National Institute of Neurological Disorders (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kauffman Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Dr. J. David Sweatt for his many helpful discussions and critical evaluation of the manuscript. We would also like to thank Huashi Li, Ryley Parrish, and Anupam Sharma for their support and technical assistance. This work was supported by UAB start-up funds, The McKnight Brain Institute, The Alabama Health Sciences Foundation and National Institute of Neurological Disorders (NINDS) grant NS064079 (G.R), NINDS grants N505182 (G.L.), and NS45260 (G.L. and C.M.G.). L.Y.C. was supported by National Institute of Mental Health grant MH083396. C.S.R. was supported by National Institute on Aging grant AG00096, NINDS grant 045540, and the Kauffman Foundation. N.M. is an inventor of patents related to rAAV technology and owns equity in a gene therapy company that is commercializing AAV for gene therapy applications.	Allison DW, 1998, J NEUROSCI, V18, P2423; Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Chen LY, 2010, P NATL ACAD SCI USA, V107, P7030, DOI 10.1073/pnas.0912973107; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Cheng XT, 2000, NEUROSCI RES, V36, P167, DOI 10.1016/S0168-0102(99)00123-6; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Even-Faitelson L, 2005, CELL SIGNAL, V17, P1137, DOI 10.1016/j.cellsig.2004.12.015; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Hirano Katsuya, 2004, Journal of Smooth Muscle Research, V40, P219, DOI 10.1540/jsmr.40.219; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kelly MT, 2007, NEUROPHARMACOLOGY, V52, P41, DOI 10.1016/j.neuropharm.2006.07.002; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lin CY, 2005, J NEUROCHEM, V94, P531, DOI 10.1111/j.1471-4159.2005.03203.x; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miyazaki T, 2000, NEUROSCI RES, V37, P299, DOI 10.1016/S0168-0102(00)00130-9; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quinn JJ, 2008, LEARN MEMORY, V15, P368, DOI 10.1101/lm.813608; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; ROMAN F, 1987, BRAIN RES, V418, P221, DOI 10.1016/0006-8993(87)90089-8; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Smart FM, 2003, P NATL ACAD SCI USA, V100, P14403, DOI 10.1073/pnas.2436349100; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zeng Q, 2000, J CELL SCI, V113, P471; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	60	155	160	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					603	617		10.1016/j.neuron.2010.07.016	http://dx.doi.org/10.1016/j.neuron.2010.07.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797537	Green Accepted, Bronze			2022-12-24	WOS:000281534600010
J	Ohgushi, M; Matsumura, M; Eiraku, M; Murakami, K; Aramaki, T; Nishiyama, A; Muguruma, K; Nakano, T; Suga, H; Ueno, M; Ishizaki, T; Suemori, H; Narumiya, S; Niwa, H; Sasai, Y				Ohgushi, Masatoshi; Matsumura, Michiru; Eiraku, Mototsugu; Murakami, Kazuhiro; Aramaki, Toshihiro; Nishiyama, Ayaka; Muguruma, Keiko; Nakano, Tokushige; Suga, Hidetaka; Ueno, Mono; Ishizaki, Toshimasa; Suemori, Hirofumi; Narumiya, Shuh; Niwa, Hitoshi; Sasai, Yoshiki			Molecular Pathway and Cell State Responsible for Dissociation-Induced Apoptosis in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							PROTEIN FAMILY; ROCK INHIBITOR; RHO GTPASES; ACTIVATION; MOUSE; RAC; MEMBRANE; ABR; SURVIVAL; PROBES	Human embryonic stem cells (hESCs), unlike mouse ones (mESCs), are vulnerable to apoptosis upon dissociation. Here, we show that the apoptosis, which is of a nonanoikis type, is caused by ROCK-dependent hyperactivation of actomyosin and efficiently suppressed by the myosin inhibitor Blebbistatin. The actomyosin hyperactivation is triggered by the loss of E-cadherin-dependent intercellular contact and also observed in dissociated mouse epiblast-derived pluripotent cells but not in mESCs. We reveal that Abr, a unique Rho-GEF family factor containing a functional Rac-GAP domain, is an indispensable upstream regulator of the apoptosis and ROCK/myosin hyperactivation. Rho activation coupled with Rac inhibition is induced in hESCs upon dissociation, but not in Abr-depleted hESCs or mESCs. Furthermore, artificial Rho or ROCK activation with Rac inhibition restores the vulnerability of Abr-depleted hESCs to dissociation-induced apoptosis. Thus, the Abr-dependent "Rho-high/Rac-low" state plays a decisive role in initiating the dissociation-induced actomyosin hyperactivation and apoptosis in hESCs.	[Ohgushi, Masatoshi; Matsumura, Michiru; Eiraku, Mototsugu; Aramaki, Toshihiro; Nishiyama, Ayaka; Muguruma, Keiko; Nakano, Tokushige; Suga, Hidetaka; Ueno, Mono; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Ohgushi, Masatoshi; Matsumura, Michiru; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Div Human Stem Cell Technol, Kobe, Hyogo 6500047, Japan; [Murakami, Kazuhiro; Niwa, Hitoshi] RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Kobe, Hyogo 6500047, Japan; [Ishizaki, Toshimasa; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068315, Japan; [Suemori, Hirofumi] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068315, Japan	RIKEN; RIKEN; RIKEN; Kyoto University; Kyoto University	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	SUGA, HIDETAKA/I-7452-2014; Murakami, Kazuhiro/AAC-4569-2019	Muguruma, Keiko/0000-0002-3149-4408; Eiraku, Mototsugu/0000-0002-9433-9085; Suga, Hidetaka/0000-0003-1924-7639; Murakami, Kazuhiro/0000-0003-1759-9542	MEXT; Kobe Cluster Project; Leading Project for Realization of Regenerative Medicine	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project for Realization of Regenerative Medicine	We are grateful to Drs. M. Matsuda and E. Kiyokawa for the Rho and Rac FRET probes and stimulating discussion, to Drs. G. Sheng, H. Enomoto, and N. Takata for invaluable comments, to Drs. M. Takeichi, M. Wenxiang, and T. Nishimura for advice on cell-adhesion and Abr analyses, to Dr. P. Tesar for mEpiSCs, to Drs. M. Miura and E. Kuranaga for FRET probes of Capases, to Dr. Y. Gotoh for caAkt, and to members of the Sasai lab for discussion and advice. This work was supported by grants-in-aid from MEXT, the Kobe Cluster Project, and the Leading Project for Realization of Regenerative Medicine (Y.S.).	Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; HEISTERKAMP N, 1993, J BIOL CHEM, V268, P16903; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JOHNSON KE, 1976, J CELL SCI, V22, P575; Kameda T, 2005, STEM CELLS, V23, P1535, DOI 10.1634/stemcells.2005-0054; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	305	317	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					225	239		10.1016/j.stem.2010.06.018	http://dx.doi.org/10.1016/j.stem.2010.06.018			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682448	Bronze			2022-12-24	WOS:000281107400014
J	Li, RH; Liang, JL; Ni, S; Zhou, T; Qing, XB; Li, HP; He, WZ; Chen, JK; Li, F; Zhuang, QA; Qin, BM; Xu, JY; Li, W; Yang, JY; Gan, Y; Qin, DJ; Feng, SP; Song, H; Yang, DS; Zhang, BL; Zeng, LW; Lai, LX; Esteban, MA; Pei, DQ				Li, Ronghui; Liang, Jialiang; Ni, Su; Zhou, Ting; Qing, Xiaobing; Li, Huapeng; He, Wenzhi; Chen, Jiekai; Li, Feng; Zhuang, Qiang; Qin, Baoming; Xu, Jianyong; Li, Wen; Yang, Jiayin; Gan, Yi; Qin, Dajiang; Feng, Shipeng; Song, Hong; Yang, Dongshan; Zhang, Biliang; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel Angel; Pei, Duanqing			A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR SNAIL; PLURIPOTENT STEM-CELLS; HUMAN EMBRYONIC STEM; GROWTH-FACTOR-BETA; E-CADHERIN; SELF-RENEWAL; MIR-200 FAMILY; GROUND-STATE; IN-VIVO; GENERATION	Epithelial-to-mesenchymal transition (EMT) is a developmental process important for cell fate determination. Fibroblasts, a product of EMT, can be reset into induced pluripotent stem cells (iPSCs) via exogenous transcription factors but the underlying mechanism is unclear. Here we show that the generation of iPSCs from mouse fibroblasts requires a mesenchymal-to-epithelial transition (MET) orchestrated by suppressing pro-EMT signals from the culture medium and activating an epithelial program inside the cells. At the transcriptional level, Sox2/Oct4 suppress the EMT mediator Snail, c-Myc downregulates TGF-beta 1 and TGF-beta receptor 2, and Klf4 induces epithelial genes including E-cadherin. Blocking MET impairs the reprogramming of fibroblasts whereas preventing EMT in epithelial cells cultured with serum can produce iPSCs without Klf4 and c-Myc. Our work not only establishes MET as a key cellular mechanism toward induced pluripotency, but also demonstrates iPSC generation as a cooperative process between the defined factors and the extracellular milieu.	[Li, Ronghui; Liang, Jialiang; Ni, Su; Zhou, Ting; Qing, Xiaobing; Li, Huapeng; He, Wenzhi; Chen, Jiekai; Li, Feng; Zhuang, Qiang; Qin, Baoming; Xu, Jianyong; Li, Wen; Yang, Jiayin; Gan, Yi; Qin, Dajiang; Feng, Shipeng; Song, Hong; Yang, Dongshan; Zhang, Biliang; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510530, Guangdong, Peoples R China; [Li, Ronghui; Liang, Jialiang; Ni, Su; Zhou, Ting; Qing, Xiaobing; Li, Huapeng; He, Wenzhi; Chen, Jiekai; Li, Feng; Zhuang, Qiang; Qin, Baoming; Xu, Jianyong; Li, Wen; Yang, Jiayin; Gan, Yi; Qin, Dajiang; Feng, Shipeng; Song, Hong; Yang, Dongshan; Zhang, Biliang; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences	Esteban, MA (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org; pei_duanqing@gibh.ac.cn	Lai, Liangxue/H-4545-2011; Qing, Xiaobing/ABF-5539-2020; Li, Ronghui/AAB-4545-2019; NI, Su/AAH-8267-2020; Yang, Dongshan/N-3333-2014; Qin, Baoming/G-1553-2015	Li, Ronghui/0000-0001-6329-5895; Yang, Dongshan/0000-0003-2449-8651; Qin, Baoming/0000-0001-7652-161X; Feng, Shipeng/0000-0002-3365-9990; Ni, Su/0000-0003-2883-574X; Chen, Jiekai/0000-0001-5168-7074	Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX2-YW-R-221, KSCX2-YW-R-244]; National Natural Science Foundation of China [30725012, 230725012, 90813033, 30630039]; Ministry of Science and Technology [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800, 2010DFB30430]; National High Technology Research and Development Program of China [2006AA02A103, 2007G-P034, 2007Z3-C7031]; Bureau of Science and Technology of Guangzhou Municipality [2008A1-E4011]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Bureau of Science and Technology of Guangzhou Municipality	This work is supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-48, KSCX2-YW-R-221), Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams, Chinese Academy of Sciences (KSCX2-YW-R-48, KSCX2-YW-R-244), National Natural Science Foundation of China (30725012, 230725012, 90813033, 30630039), Ministry of Science and Technology 973 program (2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800), Ministry of Science and Technology International Technology Cooperation Program (2010DFB30430), National High Technology Research and Development Program of China (2006AA02A103, 2007G-P034, 2007Z3-C7031), and Bureau of Science and Technology of Guangzhou Municipality (2008A1-E4011).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Amicone L, 2002, ONCOGENE, V21, P1335, DOI 10.1038/sj.onc.1205199; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Factor VM, 1997, CANCER RES, V57, P2089; Furuse M, 2009, BBA-BIOMEMBRANES, V1788, P813, DOI 10.1016/j.bbamem.2008.07.017; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Houghton FD, 2005, REPRODUCTION, V129, P129, DOI 10.1530/rep.1.00277; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Li L, 2010, STEM CELLS, V28, P247, DOI 10.1002/stem.289; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Murray SA, 2006, CELL CYCLE, V5, P2566, DOI 10.4161/cc.5.22.3502; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; PARK SM, 2002, GENE DEV, V22, P894; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	55	862	907	2	215	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					51	63		10.1016/j.stem.2010.04.014	http://dx.doi.org/10.1016/j.stem.2010.04.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621050	Bronze			2022-12-24	WOS:000280222300013
J	Sendtner, M				Sendtner, Michael			Therapy development in spinal muscular atrophy	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURON GENE; MOUSE MODEL; SMN EXPRESSION; EXTENDS SURVIVAL; VALPROIC ACID; RNA; DELIVERY; PRODUCT; PROTEIN; RESCUE	Proximal spinal muscular atrophy (SMA) is the predominant form of motor neuron disease in children and young adults. In contrast to other neurodegenerative disorders, SMA is a genetically homozygous autosomal recessive disease that is caused by deficiency of the survival motor neuron (SMN) protein. This homogeneity should in principle facilitate therapy development. Previous therapy approaches have focused on upregulation of SMN expression from a second SMN (SMN2) gene that gives rise to low amounts of functional SMN protein. Drug development to target disease-specific mechanisms at cellular and physiological levels is in its early stages, as the pathophysiological processes that underlie the main disease symptoms are still not fully understood. Mouse models have helped to make conceptual progress in the disease mechanism, but their suitability in the search for therapeutic agents remains to be validated-an issue that is ubiquitous to the translational therapeutic research of other neurodegenerative diseases. Human induced pluripotent stem cell technology for generation of large numbers of human motor neurons could help to fill this gap and advance the power of drug screening. In parallel, advances in oligonucleotide technologies for engineering SMN2 pre-mRNA splicing are approaching their first clinical trials, whose success depends on improved technologies for drug delivery to motor neurons. If this obstacle can be overcome, this could boost therapy development, not only for SMA but also for other neurodegenerative disorders.	Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany	University of Wurzburg	Sendtner, M (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany.	sendtner_m@klinik.uni-wuerzburg.de	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974	SMA Foundation; Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Industrie; Deutsche Forschungsgemeinschaft [SFB 581, B1]	SMA Foundation; Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Industrie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	I thank R. Blum and R. Gotz for critical reading and many helpful comments. Work in my laboratory on spinal muscular atrophy was supported by the SMA Foundation, the Hermann und Lilly Schilling Stiftung im Stifterverband der Deutschen Industrie and the Deutsche Forschungsgemeinschaft, grant SFB 581, B1.	Aartsma-Rus A, 2010, EUR J HUM GENET, V18, P146, DOI 10.1038/ejhg.2009.160; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Garbes L, 2009, HUM MOL GENET, V18, P3645, DOI 10.1093/hmg/ddp313; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; Jedrzejowska M, 2008, EUR J HUM GENET, V16, P930, DOI 10.1038/ejhg.2008.41; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Khoo B, 2009, CURR OPIN MOL THER, V11, P108; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meyer K, 2009, HUM MOL GENET, V18, P546, DOI 10.1093/hmg/ddn382; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Pan WH, 2006, J CELL BIOCHEM, V98, P14, DOI 10.1002/jcb.20790; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Rak K, 2009, NEUROBIOL DIS, V36, P477, DOI 10.1016/j.nbd.2009.08.014; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Simpson CL, 2006, BBA-MOL BASIS DIS, V1762, P973, DOI 10.1016/j.bbadis.2006.08.001; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2008, MOL THER, V16, P1018, DOI 10.1038/mt.2008.73; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; Valdmanis PN, 2009, CURR NEUROL NEUROSCI, V9, P198, DOI 10.1007/s11910-009-0030-9; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Zaiss AK, 2008, GENE THER, V15, P808, DOI 10.1038/gt.2008.54	48	24	24	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					795	799		10.1038/nn.2565	http://dx.doi.org/10.1038/nn.2565			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581815				2022-12-24	WOS:000279173900008
J	Vriens, J; Owsianik, G; Hofmann, T; Philipp, SE; Stab, J; Chen, XD; Benoit, M; Xue, FQ; Janssens, A; Kerselaers, S; Oberwinkler, J; Vennekens, R; Gudermann, T; Nilius, B; Voets, T				Vriens, Joris; Owsianik, Grzegorz; Hofmann, Thomas; Philipp, Stephan E.; Stab, Julia; Chen, Xiaodi; Benoit, Melissa; Xue, Fenqin; Janssens, Annelies; Kerselaers, Sara; Oberwinkler, Johannes; Vennekens, Rudi; Gudermann, Thomas; Nilius, Bernd; Voets, Thomas			TRPM3 Is a Nociceptor Channel Involved in the Detection of Noxious Heat	NEURON			English	Article							CAPSAICIN-RECEPTOR; CATION CHANNEL; PREGNENOLONE SULFATE; MICE LACKING; ION-CHANNEL; VANILLOID RECEPTOR-1; EVOKED ACTIVATION; COLD; TRPV4; TEMPERATURE	Transient receptor potential melastatin-3 (TRPM3) is a broadly expressed Ca(2+)-permeable nonselective cation channel. Previous work has demonstrated robust activation of TRPM3 by the neuroactive steroid pregnenolone sulfate (PS), but its in vivo gating mechanisms and functions remained poorly understood. Here, we provide evidence that TRPM3 functions as a chemo- and thermosensor in the somatosensory system. TRPM3 is molecularly and functionally expressed in a large subset of small-diameter sensory neurons from dorsal root and trigeminal ganglia, and mediates the aversive and nocifensive behavioral responses to PS. Moreover, we demonstrate that TRPM3 is steeply activated by heating and underlies heat sensitivity in a subset of sensory neurons. TRPM3-deficient mice exhibited clear deficits in their avoidance responses to noxious heat and in the development of inflammatory heat hyperalgesia. These experiments reveal an unanticipated role for TRPM3 as a thermosensitive nociceptor channel implicated in the detection of noxious heat.	[Vriens, Joris; Owsianik, Grzegorz; Benoit, Melissa; Xue, Fenqin; Janssens, Annelies; Kerselaers, Sara; Vennekens, Rudi; Nilius, Bernd; Voets, Thomas] Katholieke Univ Leuven, Lab Ion Channel Res & TRP Res Platform Leuven TRP, B-3000 Louvain, Belgium; [Hofmann, Thomas; Chen, Xiaodi] Univ Marburg, Inst Pharmakol & Toxikol, D-35032 Marburg, Germany; [Philipp, Stephan E.; Stab, Julia; Oberwinkler, Johannes] Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Gudermann, Thomas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany	KU Leuven; Philipps University Marburg; Saarland University; University of Munich	Vriens, J (corresponding author), Katholieke Univ Leuven, Lab Ion Channel Res & TRP Res Platform Leuven TRP, B-3000 Louvain, Belgium.	joris.vriens@med.kuleuven.be	Vennekens, Rudi/AAQ-1664-2020; Philipp, Stephan/AAR-7519-2020; Chen, Xiaodi/C-9969-2013; Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012; Vriens, Joris/G-9966-2018	Vennekens, Rudi/0000-0002-2564-5150; Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Vriens, Joris/0000-0002-2502-0409; Oberwinkler, Johannes/0000-0002-8541-3626; Chen, Xiaodi/0000-0002-1860-2814; Janssens, Annelies/0000-0002-6735-8248; Philipp, Stephan/0000-0003-1959-9167	Belgian Federal Government [IUAP P6/28]; Research Foundation-Flanders (F.W.O.) [G.0565.07, G.0761.10, KAN1.5.206.09, G.0686.09]; Research Council of the KU Leuven [GOA 2009/07, START1/09/046, EF/95/010, PFV/10/06]; HOMFOR; Deutsche Forschungsgemeinschaft (DFG); Forschungskommission der Universitat des Saarlandes; Emmy Noether Program	Belgian Federal Government; Research Foundation-Flanders (F.W.O.)(FWO); Research Council of the KU Leuven(KU Leuven); HOMFOR; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Forschungskommission der Universitat des Saarlandes; Emmy Noether Program(German Research Foundation (DFG))	We thank all the members of our laboratories for support and helpful comments. This work was supported by grants from the Belgian Federal Government (IUAP P6/28), from the Research Foundation-Flanders (F.W.O.) (G.0565.07, G.0761.10, KAN1.5.206.09 and G.0686.09), from the Research Council of the KU Leuven (GOA 2009/07, START1/09/046, EF/95/010, PFV/10/06), from HOMFOR, and from the Deutsche Forschungsgemeinschaft (DFG), from the Forschungskommission der Universitat des Saarlandes (J.O.), from the Emmy Noether Program (J.O. and T.H.), and by a donation of the Friedrich Baur Foundation to T.G. We also thank the Wellcome Trust for subventioning the Lexicon TRPM3 null mutant mice. J.V. is a postdoctoral fellow of the F.W.O.	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chen SC, 2004, BRAIN RES, V1027, P196, DOI 10.1016/j.brainres.2004.08.053; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Fischbach T, 2007, J NEUROPHYSIOL, V98, P929, DOI 10.1152/jn.01096.2006; Gavva NR, 2007, J PHARMACOL EXP THER, V323, P128, DOI 10.1124/jpet.107.125674; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Grimm C, 2005, MOL PHARMACOL, V67, P798, DOI 10.1124/mol.104.006734; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Guler AD, 2002, J NEUROSCI, V22, P6408; Havlikova H, 2002, J CLIN ENDOCR METAB, V87, P2225, DOI 10.1210/jc.87.5.2225; Hill M, 2001, J STEROID BIOCHEM, V78, P51, DOI 10.1016/S0960-0760(01)00073-5; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Nilius B, 2007, NATURE, V448, P147, DOI 10.1038/448147a; Nilius B, 2008, NAT CELL BIOL, V10, P1383, DOI 10.1038/ncb1208-1383; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Oberwinkler J., 2007, V179, P253; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Reubish DS, 2009, BIOTECHNIQUES, V47, pIII, DOI 10.2144/000113198; Schumacher M, 2008, NEUROCHEM INT, V52, P522, DOI 10.1016/j.neuint.2007.08.022; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Staaf S, 2010, GENE EXPR PATTERNS, V10, P65, DOI 10.1016/j.gep.2009.10.003; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ueda H, 2001, J PHARMACOL EXP THER, V298, P703; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	62	334	342	3	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					482	494		10.1016/j.neuron.2011.02.051	http://dx.doi.org/10.1016/j.neuron.2011.02.051			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555074	Bronze			2022-12-24	WOS:000290926100010
J	Lehtinen, MK; Zappaterra, MW; Chen, X; Yang, YJ; Hill, AD; Lun, ML; Maynard, T; Gonzalez, D; Kim, S; Ye, P; D'Ercole, AJ; Wong, ET; LaMantia, AS; Walsh, CA				Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Maynard, Thomas; Gonzalez, Dilenny; Kim, Seonhee; Ye, Ping; D'Ercole, A. Joseph; Wong, Eric T.; LaMantia, Anthony S.; Walsh, Christopher A.			The Cerebrospinal Fluid Provides a Proliferative Niche for Neural Progenitor Cells	NEURON			English	Article							GROWTH-FACTOR-I; EMBRYONIC CEREBRAL-CORTEX; LIPID PHOSPHATASE PTEN; STEM-CELLS; RETINOIC ACID; IGF-I; VENTRICULAR ZONE; GENE-EXPRESSION; NERVOUS-SYSTEM; VASCULAR NICHE	Cortical development depends on the active integration of cell-autonomous and extrinsic cues, but the coordination of these processes is poorly understood. Here, we show that the apical complex protein Pals1 and Pten have opposing roles in localizing the Igf1R to the apical, ventricular domain of cerebral cortical progenitor cells. We found that the cerebrospinal fluid (CSF), which contacts this apical domain, has an age-dependent effect on proliferation, much of which is attributable to Igf2, but that CSF contains other signaling activities as well. CSF samples from patients with glioblastoma multiforme show elevated Igf2 and stimulate stem cell proliferation in an Igf2-dependent manner. Together, our findings demonstrate that the apical complex couples intrinsic and extrinsic signaling, enabling progenitors to sense and respond appropriately to diffusible CSF-borne signals distributed widely throughout the brain. The temporal control of CSF composition may have critical relevance to normal development and neuropathological conditions.	[Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Gonzalez, Dilenny; Walsh, Christopher A.] Childrens Hosp Boston, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Gonzalez, Dilenny; Walsh, Christopher A.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Lehtinen, Maria K.; Zappaterra, Mauro W.; Chen, Xi; Yang, Yawei J.; Hill, Anthony D.; Lun, Melody; Gonzalez, Dilenny; Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zappaterra, Mauro W.; Yang, Yawei J.; Walsh, Christopher A.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Chen, Xi; Yang, Yawei J.] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Maynard, Thomas; LaMantia, Anthony S.] George Washington Univ, Sch Med, Dept Physiol & Pharmacol, George Washington Inst Neurosci, Washington, DC 20037 USA; [Lun, Melody; Wong, Eric T.] Beth Israel Deaconess Med Ctr, Brain Tumor Ctr & Neuro Oncol Unit, Boston, MA 02215 USA; [Lun, Melody; Wong, Eric T.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Ye, Ping; D'Ercole, A. Joseph] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Kim, Seonhee] Univ Texas Hlth Sci Ctr Houston, Pediat Res Ctr, Dept Pediat, Houston, TX 77030 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; George Washington University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston	Walsh, CA (corresponding author), Childrens Hosp Boston, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Maynard, Thomas/I-9039-2012	Maynard, Thomas/0000-0001-6976-3936; HILL, ANTHONY/0000-0003-2179-6493; Gonzalez, Dilenny/0000-0003-0661-5930; Walsh, Christopher/0000-0002-0156-2238	Sigrid Juselius Fellowship; Ellison/AFAR Postdoctoral Fellowship; NINDS [K99NS072192, R01 NSO48868, 3 RO1 NS032457]; Stuart H.Q. & Victoria Quan Fellowship; NIH [HD029178]; Child Neurology Foundation; A Reason To Ride research fund; NICHD [R01 HD008299]; UNC-CH; Manton Center for Orphan Disease Research; Intellectual and Developmental Disabilities Research Centers (CHB DDRC) [P30 HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042182, P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD029178, R01HD008299, R01HD029178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048868, R37NS035129, P30NS045892, R01NS032457, K99NS072192] Funding Source: NIH RePORTER	Sigrid Juselius Fellowship(Sigrid Juselius Foundation); Ellison/AFAR Postdoctoral Fellowship; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stuart H.Q. & Victoria Quan Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Neurology Foundation; A Reason To Ride research fund; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UNC-CH; Manton Center for Orphan Disease Research; Intellectual and Developmental Disabilities Research Centers (CHB DDRC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Bonni, S. Gygi, R. Segal, and members of the Walsh laboratory for helpful discussions; H. Steen for assistance with mass spectrometry; D. Rubin and J. Sheng for pMSCVhyg-Igf2; U. Berger, J. Buchanan, M. Ericsson, Y. Lin, A. Peters, C. Kourkoulis, and S. White for technical assistance. This work was supported by a Sigrid Juselius Fellowship, an Ellison/AFAR Postdoctoral Fellowship, and Award Number K99NS072192 from the NINDS (M.K.L); a Stuart H.Q. & Victoria Quan Fellowship (M.W.Z.), a NIH MSTP grant (M.W.Z. and Y.J.Y.); the Child Neurology Foundation (X.C.); A Reason To Ride research fund (M.L. and E.T.W.), a NINDS grant (R01 NSO48868) (A.J.D. and P.Y.), a NICHD grant (R01 HD008299) (A.J.D.), a NIH grant (HD029178), and an UNC-CH Reynolds Faculty Fellowship (A.S.L.); a NINDS grant (3 RO1 NS032457), the Manton Center for Orphan Disease Research, and the Intellectual and Developmental Disabilities Research Centers (CHB DDRC, P30 HD18655)(C.A.W.). C.A.W. is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the NIH.	[Anonymous], [No title captured]; AYERLELIEVRE C, 1991, DEVELOPMENT, V111, P105; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; BINOUX M, 1986, J CLIN ENDOCR METAB, V63, P1151, DOI 10.1210/jcem-63-5-1151; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; DZIEGIELEWSKA KM, 1981, DEV BIOL, V83, P193, DOI 10.1016/S0012-1606(81)80024-3; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gorski JA, 2002, J NEUROSCI, V22, P6309; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Grove EA, 1998, DEVELOPMENT, V125, P2315; Haskell GT, 2005, J NEUROSCI, V25, P7636, DOI 10.1523/JNEUROSCI.0485-05.2005; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; JOHANSSON PA, 2010, PLOS BIOL, V6, pE254, DOI DOI 10.1371/J0URNAL.PBI0.0060254; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Kim S, 2010, NEURON, V66, P69, DOI 10.1016/j.neuron.2010.03.019; LAMANTIA AS, 1993, NEURON, V10, P1035, DOI 10.1016/0896-6273(93)90052-S; Levine AJ, 2006, CELL CYCLE, V5, P1069, DOI 10.4161/cc.5.10.2771; Liu W, 2009, J NEUROSCI RES, V87, P2821, DOI 10.1002/jnr.22129; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin C, 2006, DEV BIOL, V297, P402, DOI 10.1016/j.ydbio.2006.05.010; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parada C, 2005, J PROTEOME RES, V4, P2420, DOI 10.1021/pr050213t; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Soroceanu L, 2007, P NATL ACAD SCI USA, V104, P3466, DOI 10.1073/pnas.0611271104; STYLIANOPOULOU F, 1988, DEVELOPMENT, V103, P497; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; WEBER MM, 1992, ENDOCRINOLOGY, V131, P2147, DOI 10.1210/en.131.5.2147; Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Ye P, 2010, GLIA, V58, P1031, DOI 10.1002/glia.20984; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007	64	408	419	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					893	905		10.1016/j.neuron.2011.01.023	http://dx.doi.org/10.1016/j.neuron.2011.01.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382550	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000288736500008
J	Jitsuki, S; Takemoto, K; Kawasaki, T; Tada, H; Takahashi, A; Becamel, C; Sano, A; Yuzaki, M; Zukin, RS; Ziff, EB; Kessels, HW; Takahashi, T				Jitsuki, Susumu; Takemoto, Kiwamu; Kawasaki, Taisuke; Tada, Hirobumi; Takahashi, Aoi; Becamel, Carine; Sano, Akane; Yuzaki, Michisuke; Zukin, R. Suzanne; Ziff, Edward B.; Kessels, Helmut W.; Takahashi, Takuya			Serotonin Mediates Cross-Modal Reorganization of Cortical Circuits	NEURON			English	Article							AMPA RECEPTOR TRAFFICKING; FACILITATES SYNAPTIC PLASTICITY; EXTRACELLULAR-REGULATED KINASE; PRIMARY VISUAL-CORTEX; RAT BARREL CORTEX; EXCITATORY SYNAPSES; PC12 CELLS; IN-VIVO; ACTIVATION; EXPERIENCE	Loss of one type of sensory input can cause improved functionality of other sensory systems. Whereas this form of plasticity, cross-modal plasticity, is well established, the molecular and cellular mechanisms underlying it are still unclear. Here, we show that visual deprivation (VD) increases extracellular serotonin in the juvenile rat barrel cortex. This increase in serotonin levels facilitates synaptic strengthening at layer 4 to layer 2/3 synapses within the barrel cortex. Upon VD, whisker experience leads to trafficking of the AMPA-type glutamate receptors (AMPARs) into these synapses through the activation of ERK and increased phosphorylation of AMPAR subunit GluR1 at the juvenile age when natural whisker experience no longer induces synaptic GluR1 delivery. VD thereby leads to sharpening of the functional whisker-barrel map at layer 2/3. Thus, sensory deprivation of one modality leads to serotonin release in remaining modalities, facilitates GluR1-dependent synaptic strengthening, and refines cortical organization.	[Jitsuki, Susumu; Takemoto, Kiwamu; Kawasaki, Taisuke; Tada, Hirobumi; Takahashi, Aoi; Sano, Akane; Takahashi, Takuya] Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 2360004, Japan; [Takemoto, Kiwamu; Takahashi, Takuya] PRESTO, JST, Saitama 3320012, Japan; [Becamel, Carine] Inst Genom Fonct, Dept Neurobiol, F-34094 Montpellier, France; [Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Zukin, R. Suzanne; Takahashi, Takuya] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Ziff, Edward B.] NYU, New York, NY 10016 USA; [Kessels, Helmut W.] Univ Calif San Diego, La Jolla, CA 92093 USA	Yokohama City University; Japan Science & Technology Agency (JST); Universite de Montpellier; Keio University; Yeshiva University; Albert Einstein College of Medicine; New York University; University of California System; University of California San Diego	Takahashi, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 2360004, Japan.	takahast@yokohama-cu.ac.jp	Tada, Hirobumi/ABB-7665-2020; Yuzaki, Michisuke/K-5328-2013; Takemoto, Kiwamu/HGD-3429-2022; Takemoto, Kiwamu/AAE-9926-2019	Yuzaki, Michisuke/0000-0002-5750-3544; Kessels, Helmut/0000-0002-1122-745X; Takemoto, Kiwamu/0000-0002-3301-3268; Ziff, Edward/0000-0001-7389-8649	JST,CREST; Special Coordination Funds for Promoting Science and Technology; Ishidsu Shun Memorial Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020752] Funding Source: NIH RePORTER	JST,CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ishidsu Shun Memorial Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by JST,CREST (T.T.), Special Coordination Funds for Promoting Science and Technology (T.T.), "Development of biomarker candidates for social behavior" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports,Science and Technology of Japan (TT), and Ishidsu Shun Memorial Scholarship (S.J.). We thank Dr. Philippe Mann (Institute de genomique fonctionnelle) for supporting the short hairpin constructs and characterization in his laboratory. We thank Yoshiko Kanno and Yoshinori Kamiya for technical assistance. We thank Dr. Hiroyuki Miyoshi and Atsushi Miyawaki (RIKEN) for providing Lenti-virus vector. We thank Kenkichi Takase Himeji Dokkyo) for discussion. We also thank Yasunori Hayashi (RIKEN) and Jose Esteban (CSIC) for critically reading the manuscript.	Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; BENNETTCLARKE CA, 1995, BRAIN RES, V702, P255, DOI 10.1016/0006-8993(95)00867-5; BENNETTCLARKE CA, 1994, J NEUROSCI, V14, P7594; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen A, 2003, NEUROSCIENCE, V119, P53, DOI 10.1016/S0306-4522(03)00076-9; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Dye MWG, 2007, NEUROPSYCHOLOGIA, V45, P1801, DOI 10.1016/j.neuropsychologia.2006.12.019; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Inaba M, 2009, NEUROSCI RES, V64, P191, DOI 10.1016/j.neures.2009.02.014; Johnson-Farley NN, 2005, J NEUROCHEM, V92, P72, DOI 10.1111/j.1471-4159.2004.02832.x; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim HS, 2006, BRAIN RES, V1103, P49, DOI 10.1016/j.brainres.2006.05.046; Kojic L, 1997, DEV BRAIN RES, V101, P299, DOI 10.1016/S0165-3806(97)00083-7; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Macaluso E, 2001, NEUROPSYCHOLOGIA, V39, P1304, DOI 10.1016/S0028-3932(01)00119-1; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; Normann C, 2005, BRAIN RES, V1037, P187, DOI 10.1016/j.brainres.2005.01.001; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; RAUSCHECKER JP, 1992, P NATL ACAD SCI USA, V89, P5063, DOI 10.1073/pnas.89.11.5063; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Turlejski K, 1997, NEUROREPORT, V8, P1823, DOI 10.1097/00001756-199705260-00007; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	46	94	96	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 24	2011	69	4					780	792		10.1016/j.neuron.2011.01.016	http://dx.doi.org/10.1016/j.neuron.2011.01.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338886	Bronze, Green Accepted			2022-12-24	WOS:000288413200018
J	Giessel, AJ; Sabatini, BL				Giessel, Andrew J.; Sabatini, Bernardo L.			M1 Muscarinic Receptors Boost Synaptic Potentials and Calcium Influx in Dendritic Spines by Inhibiting Postsynaptic SK Channels	NEURON			English	Article							CA2+-ACTIVATED K+ CHANNELS; CA1 PYRAMIDAL NEURONS; ACTIVATED POTASSIUM CHANNELS; LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; RAT HIPPOCAMPUS; CHOLINERGIC SYSTEMS; PLASTICITY; MEMORY; ACETYLCHOLINE	Acetylcholine release and activation of muscarinic cholinergic receptors (mAChRs) enhance synaptic plasticity in vitro and cognition and memory in vivo. Within the hippocampus, mAChRs promote NMDA-type glutamate receptor-dependent forms of long-term potentiation. Here, we use calcium (Ca) imaging combined with two-photon laser glutamate uncaging at apical spines of CA1 pyramidal neurons to examine postsynaptic mechanisms of muscarinic modulation of glutamatergic transmission. Uncaging-evoked excitatory postsynaptic potentials and Ca transients are increased by muscarinic stimulation; however, this is not due to direct modulation of glutamate receptors. Instead, nnAChRs modulate a negative feedback loop in spines that normally suppresses synaptic signals. mAChR activation reduces the Ca sensitivity of small conductance Ca-activated potassium (SK) channels that are found in the spine, resulting in increased synaptic potentials and Ca transients. These effects are mediated by M1-type muscarinic receptors and occur in a casein kinase-2-dependent manner. Thus, muscarinic modulation regulates synaptic transmission by tuning the activity of nonglutamatergic postsynaptic ion channels.	[Giessel, Andrew J.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu		Giessel, Andrew/0000-0002-0334-2984	National Institute of Neurological Disorders and Stroke [NS046579]; NIH [F31 NS065647]; Quan predoctoral fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579, F31NS065647] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Quan predoctoral fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini lab for helpful comments and critical reading of the manuscript. We also thank Bruce Bean and Wade Regehr for helpful discussions. This work was supported by grants (to B.L.S.) from the National Institute of Neurological Disorders and Stroke (NS046579) and (to A.J.G.) NIH (F31 NS065647) and Quan predoctoral fellowships.	Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Borroni AM, 2000, J NEUROSCI, V20, P9272; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; DAWSON GR, 1993, BEHAV BRAIN RES, V57, P143, DOI 10.1016/0166-4328(93)90130-I; DEUTSCH JA, 1971, SCIENCE, V174, P788, DOI 10.1126/science.174.4011.788; DRACHMAN DA, 1977, NEUROLOGY, V27, P783, DOI 10.1212/WNL.27.8.783; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; DUTAR P, 1988, J NEUROSCI, V8, P4214; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KITAJIMA I, 1992, JPN J PHARMACOL, V58, P175, DOI 10.1254/jjp.58.175; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; MADISON DV, 1987, J NEUROSCI, V7, P733; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, pU9; Maingret F, 2008, NEURON, V59, P439, DOI 10.1016/j.neuron.2008.05.026; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKRAM H, 1990, NEUROSCI LETT, V113, P62, DOI 10.1016/0304-3940(90)90495-U; MARKRAM H, 1990, J PHYSIOL-LONDON, V427, P381, DOI 10.1113/jphysiol.1990.sp018177; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Ramanathan S, 2008, J NEUROPHYSIOL, V99, P442, DOI 10.1152/jn.00998.2007; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Rouse ST, 2000, NEUROSCI LETT, V284, P182, DOI 10.1016/S0304-3940(00)01011-9; Rouse ST, 1999, LIFE SCI, V64, P501, DOI 10.1016/S0024-3205(98)00594-3; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SAH P, 1995, NEURON, V15, P435, DOI 10.1016/0896-6273(95)90047-0; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Stackman RW, 2002, J NEUROSCI, V22, P10163; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Tai C, 2006, J NEUROSCI, V26, P6249, DOI 10.1523/JNEUROSCI.1009-06.2006; Taverna S, 2005, J NEUROSCI, V25, P9162, DOI 10.1523/JNEUROSCI.2454-05.2005; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	59	126	127	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					936	947		10.1016/j.neuron.2010.09.004	http://dx.doi.org/10.1016/j.neuron.2010.09.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145006	Green Accepted, Bronze			2022-12-24	WOS:000285664900014
J	Silies, M; Klambt, C				Silies, Marion; Klaembt, Christian			APC/C-Fzr/Cdh1-dependent regulation of cell adhesion controls glial migration in the Drosophila PNS	NATURE NEUROSCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; FASCICLIN-II; PERIPHERAL GLIA; NEURONAL MIGRATION; DIFFERENT ISOFORMS; POLYSIALIC ACID; MITOTIC CYCLINS; NERVOUS-SYSTEM; EMBRYONIC CNS; MOLECULE	Interactions between neurons and glia are a key feature during the assembly of the nervous system. During development, glial cells often follow extending axons, implying that axonal outgrowth and glial migration are precisely coordinated. We found that the anaphase-promoting complex/cyclosome (APC/C) co-activator fizzy-related/Cdh1 (Fzr/Cdh1) is involved in the non-autonomous control of peripheral glial migration in postmitotic Drosophila neurons. APC/C-Fzr/Cdh1 is a cell-cycle regulator that targets proteins that are required for G1 arrest for ubiquitination and subsequent degradation. We found that Fzr/Cdh1 function is mediated by the immunoglobulin superfamily cell adhesion molecule Fasciclin2 (Fas2). In motor neurons Fzr/Cdh1 is crucial for the establishment of a graded axonal distribution of Fas2. Axonal Fas2 interacts homophilically with a glial isoform of Fas2. Glial migration is initiated along axonal segments that have low levels of Fas2 but stalls in axonal domains with high levels of Fas2 on their surfaces. This represents a simple mechanism by which a subcellular gradient of adhesiveness can coordinate glial migration with axonal growth.	[Silies, Marion; Klaembt, Christian] Univ Munster, Inst Neurobiol, Munster, Germany	University of Munster	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, Munster, Germany.	klaembt@uni-muenster.de			Klambt lab; Boehringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft	Klambt lab; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C. Lehner, J. Raff, B. Altenhein, T. Orr-Weaver, G. Tear, K. Basler, M. Landgraf and A. Nose for flies and antibodies; T. Hummel, E. Raz, A. Puschel and T. R. Clandinin for comments on the manuscript; G. Edenfeld, K. Krukkert, N. Otto, A. Weinbrecht and H. Neuert for help with initial experiments; J. Lipp for help with statistical analysis; and members of the Klambt lab for support and discussions. This work was supported by a PhD fellowship of the Boehringer Ingelheim Fonds to M. S. and grants of the Deutsche Forschungsgemeinschaft to C.K.	Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Edenfeld G, 2007, DEV BIOL, V301, P27, DOI 10.1016/j.ydbio.2006.11.013; Edenfeld G, 2006, NEURON, V52, P969, DOI 10.1016/j.neuron.2006.10.029; Franzdottir SR, 2009, NATURE, V460, P758, DOI 10.1038/nature08167; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Higgins MR, 2002, DEV BIOL, V244, P134, DOI 10.1006/dbio.2002.0583; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mao YL, 2009, DEVELOPMENT, V136, P473, DOI 10.1242/dev.026054; Mathew D, 2003, J NEUROSCI, V23, P10710; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Prag S, 2002, J CELL SCI, V115, P283; Reber A, 2006, DEVELOPMENT, V133, P3201, DOI 10.1242/dev.02488; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2003, DEVELOPMENT, V130, P1825, DOI 10.1242/dev.00413; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; von Hilchen CM, 2008, MECH DEVELOP, V125, P337, DOI 10.1016/j.mod.2007.10.010; von Hilchen CM, 2010, DEVELOPMENT, V137, P1251, DOI 10.1242/dev.042853; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wright JW, 2001, DEV BIOL, V234, P24, DOI 10.1006/dbio.2001.0247; Wright JW, 2000, DEV BIOL, V225, P59, DOI 10.1006/dbio.2000.9777; Yang Y, 2009, SCIENCE, V326, P575, DOI 10.1126/science.1177087	50	47	47	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1357	U25		10.1038/nn.2656	http://dx.doi.org/10.1038/nn.2656			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890296				2022-12-24	WOS:000283658200016
J	Bhaskar, K; Konerth, M; Kokiko-Cochran, ON; Cardona, A; Ransohoff, RM; Lamb, BT				Bhaskar, Kiran; Konerth, Megan; Kokiko-Cochran, Olga N.; Cardona, Astrid; Ransohoff, Richard M.; Lamb, Bruce T.			Regulation of Tau Pathology by the Microglial Fractalkine Receptor	NEURON			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; ALZHEIMERS-DISEASE; INFLAMMATORY RESPONSE; TRANSGENIC MODEL; MAP KINASE; PROTEIN; PHOSPHORYLATION; NEURONS; HYPERPHOSPHORYLATION; LIPOPOLYSACCHARIDE	Aggregates of the hyperphosphorylated micro-tubule-associated protein tau (MAPT) are an invariant neuropathological feature of tauopathies. Here, we show that microglial neuroinflammation promotes MAPT phosphorylation and aggregation. First, lipopolysaccharide-induced microglial activation promotes hyperphosphorylation of endogendus mouse MAPT in nontransgenic mice that is further enhanced in mice lacking the microglial-specific fractalkine receptor (CX3CR1) and is dependent upon functional toll-like receptor 4 and interleukin-1 (IL-1) receptors. Second, humanized MAPT transgenic mice lacking CX3CR1 exhibited enhanced MAPT phosphorylation and aggregation as well as behavioral impairments that correlated with increased levels of active p38 MAPK. Third, in vitro experiments demonstrate that microglial activation elevates the level of active p38 MAPK and enhances MAPT hyperphosphorylation within neurons that can be blocked by administration of an interleukih-1 receptor antagonist and a specific p38 MAPK inhibitor. Taken together, our results suggest that CX3CR1 and IL-1/p38 MAPK may serve as novel therapeutic targets for human tauopathies.	[Bhaskar, Kiran; Konerth, Megan; Kokiko-Cochran, Olga N.; Cardona, Astrid; Ransohoff, Richard M.; Lamb, Bruce T.] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Lamb, Bruce T.] Case Western Reserve Univ, Sch Med, Dept Genet & Neurosci, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Lamb, BT (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30 9500 Euclid Ave, Cleveland, OH 44195 USA.	lambb@ccf.org	Cardona, Astrid E/K-4749-2013; Bhaskar, Kiran/AAF-2755-2020	Cardona, Astrid E/0000-0002-5093-8078; 	Society for Progressive Supranuclear Palsy; Alzheimer's Association; American Health Assistance Foundation; NIH [AG023012]; Dana Foundation; National Multiple Sclerosis Society; NATIONAL INSTITUTE ON AGING [R01AG023012] Funding Source: NIH RePORTER	Society for Progressive Supranuclear Palsy; Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Guixiang Xu, Nicole Maphis, and Angeliki Maria Nikolakopoulou for their assistance in cell culture experiments, Dr Sanjay Pimplikar for providing antibodies, critical discussions, and valuable suggestions in manuscript preparation We thank Drs Robert Fairchild and Bruce Trapp for providing Il1r<SUP>-/-</SUP> and Ilr4<SUP>-/-</SUP> mice, respectively, and Dr Xiaoxia Li for providing IL-1 RA (Kineret) This work is supported by CurePSP (Society for Progressive Supranuclear Palsy) to K B, an Alzheimer's Association, American Health Assistance Foundation and NIH (AG023012) grant to B T L, Dana Foundation to R M R, National Multiple Sclerosis Society Career Transition Award to A C	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; Gerhard A, 2006, MOVEMENT DISORD, V21, P89, DOI 10.1002/mds.20668; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hartzler AW, 2002, NEUROBIOL AGING, V23, P855, DOI 10.1016/S0197-4580(02)00029-5; Hauss-Wegrzyniak B, 1998, BRAIN RES, V794, P211, DOI 10.1016/S0006-8993(98)00227-3; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ishizawa K, 2001, J NEUROPATH EXP NEUR, V60, P647, DOI 10.1093/jnen/60.6.647; Jimenez-Andrade JM, 2006, NEUROSCI LETT, V405, P62, DOI 10.1016/j.neulet.2006.06.043; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kelleher I, 2007, J NEUROCHEM, V103, P2256, DOI 10.1111/j.1471-4159.2007.04930.x; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEE S, 2010, AM J PATHOL IN PRESS; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li YK, 2003, J NEUROSCI, V23, P1605; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Masocha W, 2009, J NEUROIMMUNOL, V214, P78, DOI 10.1016/j.jneuroim.2009.06.022; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Noble W, 2009, FASEB J, V23, P739, DOI 10.1096/fj.08-113795; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Saez TE, 2004, IN VIVO, V18, P275; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Sheng JG, 2001, NEUROCHEM INT, V39, P341, DOI 10.1016/S0197-0186(01)00041-9; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Sun AY, 2003, EXP NEUROL, V183, P394, DOI 10.1016/S0014-4886(03)00180-8; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Varvel NH, 2009, J CLIN INVEST, V119, P3692, DOI 10.1172/JCI39716; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	49	392	412	4	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					19	31		10.1016/j.neuron.2010.08.023	http://dx.doi.org/10.1016/j.neuron.2010.08.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920788	Green Accepted, Bronze			2022-12-24	WOS:000283704200005
J	Evers, DM; Matta, JA; Hoe, HS; Zarkowsky, D; Lee, SH; Isaac, JT; Pak, DTS				Evers, Danielle M.; Matta, Jose A.; Hoe, Hyang-Sook; Zarkowsky, Devin; Lee, Sang Hyoung; Isaac, John T.; Pak, Daniel T. S.			Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; ETHYLMALEIMIDE-SENSITIVE FACTOR; DOMAIN-CONTAINING PROTEINS; LONG-TERM POTENTIATION; POLO-LIKE KINASE; HIPPOCAMPAL-NEURONS; SYNAPTIC-TRANSMISSION; SURFACE EXPRESSION; SUBUNIT COMPOSITION; BINDING PROTEIN	Trafficking of AMPA receptors (AMPARs) is important for many forms of synaptic plasticity. However, the link between activity and resulting synaptic alterations is not fully understood. We identified a direct interaction between N-ethylmaleimide-sensitive fusion protein (NSF), an ATPase involved in membrane fusion events and stabilization of surface AMPARs, and Polo-like kinase-2 (Plk2), an activity-inducible kinase that homeostatically decreases excitatory synapse number and strength. Plk2 disrupted the interaction of NSF with the GluA2 subunit of AMPARs, promoting extensive loss of surface GluA2 in rat hippocampal neurons, greater association of GluA2 with adaptor proteins PICK1 and GRIP1, and decreased synaptic AMPAR current. Plk2 engagement of NSF, but not Plk2 kinase activity, was required for this mechanism and occurred through a motif in the Plk2 protein that was independent of the canonical polo box interaction sites. These data reveal that heightened synaptic activity, acting through Plk2, leads to homeostatic decreases in surface AMPAR expression via the direct dissociation of NSF from GluA2.	[Evers, Danielle M.; Matta, Jose A.; Zarkowsky, Devin; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA; [Matta, Jose A.; Isaac, John T.] NIGMS, NIH, Bethesda, MD USA; [Hoe, Hyang-Sook] Georgetown Univ, Dept Neurosci, Washington, DC 20007 USA; [Lee, Sang Hyoung] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Georgetown University; Medical College of Wisconsin	Pak, DTS (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA.	dtp6@georgetown.edu	Lee, Sang/R-7518-2019	Lee, Sang H./0000-0001-5467-0331	US National Institutes of Health; National Institute of Neurological Disorders and Stroke (Biacore Molecular Interactions Shared Resource of Lombardi Comprehensive Cancer Center) [NS048085, F31NS061467, P30CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, F31NS061467, R01NS048085] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (Biacore Molecular Interactions Shared Resource of Lombardi Comprehensive Cancer Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Bilello for technical assistance. This work was supported by US National Institutes of Health and National Institute of Neurological Disorders and Stroke grants NS048085 (D.T.S.P.), F31NS061467 (D.M.E.) and P30CA051008 (Biacore Molecular Interactions Shared Resource of Lombardi Comprehensive Cancer Center).	Ang XL, 2008, J BIOL CHEM, V283, P29424, DOI 10.1074/jbc.M802475200; Beretta F, 2005, MOL CELL NEUROSCI, V28, P650, DOI 10.1016/j.mcn.2004.11.008; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Narisawa-Saito M, 2002, J BIOL CHEM, V277, P40901, DOI 10.1074/jbc.M202158200; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; States BA, 2008, MOL CELL NEUROSCI, V38, P189, DOI 10.1016/j.mcn.2008.02.003; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	50	51	54	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1199	1207		10.1038/nn.2624	http://dx.doi.org/10.1038/nn.2624			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20802490	Green Accepted			2022-12-24	WOS:000282171300011
J	Runyan, CA; Schummers, J; Van Wart, A; Kuhlman, SJ; Wilson, NR; Huang, ZJ; Sur, M				Runyan, Caroline A.; Schummers, James; Van Wart, Audra; Kuhlman, Sandra J.; Wilson, Nathan R.; Huang, Z. Josh; Sur, Mriganka			Response Features of Parvalbumin-Expressing Interneurons Suggest Precise Roles for Subtypes of Inhibition in Visual Cortex	NEURON			English	Article							RETINAL GANGLION-CELLS; LARGE BASKET CELLS; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; MACAQUE V1; SYNAPTIC CONNECTIONS; GABAERGIC NEURONS; CORTICAL NETWORKS; AUDITORY-CORTEX; STRIATE CORTEX	Inhibitory interneurons in the cerebral cortex include a vast array of subtypes, varying in their molecular signatures, electrophysiological properties, and connectivity patterns. This diversity suggests that individual inhibitory classes have unique roles in cortical circuits; however, their characterization to date has been limited to broad classifications including many subtypes. We used the Cre/LoxP system, specifically labeling parvalbumin(PV)-expressing interneurons in visual cortex of PV-Cre mice with red fluorescent protein (RFP), followed by targeted loose-patch recordings and two-photon imaging of calcium responses in vivo to characterize the visual receptive field properties of these cells. Despite their relative molecular and morphological homogeneity, we find that PV+ neurons have a diversity of feature-specific visual responses that include sharp orientation and direction-selectivity, small receptive fields, and band-pass spatial frequency tuning. These results suggest that subsets of parvalbumin interneurons are components of specific cortical networks and that perisomatic inhibition contributes to the generation of precise response properties.	[Runyan, Caroline A.; Schummers, James; Van Wart, Audra; Wilson, Nathan R.; Sur, Mriganka] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Runyan, Caroline A.; Schummers, James; Van Wart, Audra; Wilson, Nathan R.; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Kuhlman, Sandra J.; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Cold Spring Harbor Laboratory	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	msur@mit.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282; VAN WART, AUDRA/0000-0002-6719-7085; Huang, Z. Josh/0000-0003-0592-028X; Schummers, James/0000-0002-1030-824X	NIH [F31N067951, T32 MH074249, T32EY013935, F32EY018065, R01NS052784, R01EY007023, R01EY018648]; NATIONAL EYE INSTITUTE [F32EY018065, T32EY013935, R01EY018648, R01EY007023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH074249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS067951, R01NS052784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Rong Mao for assistance with mice; Marie Carlen for backcrossing PV-Cre mice into a C57BL/6 line; Yuchio Yanagawa for providing the GAD67-GFP (Delta neo) mice, Hiroki Sugihara for maintaining these mice, and Gabriel Belfort and Yingxi Lin for providing additional mice; Beau Cronin for writing data analysis software; Beata Jarosiewicz and Wasim Malik for providing technical assistance with calcium imaging data analysis and with DOG analyses; and Damon Page for guidance in the viral injection procedure. Rainev Friedrich kindly provided the algorithm for extracting spike-weighted events from calcium signals. This work was supported by NIH fellowship F31N067951 and NIH training grants T32 MH074249 and T32EY013935 (CAR.), NIH fellowship F32EY018065 (A.V.W.), a NARSAD fellowship (S.J.K.), NIH grant R01NS052784 (Z.J.H.), and NIH grants R01EY007023 and R01EY018648 (M.S.).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; BRAINARD D, 1997, FRONT NEUROSCI, V2, P155; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chow A, 1999, J NEUROSCI, V19, P9332; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; Disney AA, 2008, J COMP NEUROL, V507, P1748, DOI 10.1002/cne.21616; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DYKES RW, 1988, BRAIN RES, V441, P48, DOI 10.1016/0006-8993(88)91382-0; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1984, INVEST OPHTH VIS SCI, V25, P250; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Joshi S, 2006, J NEUROSCI METH, V156, P37, DOI 10.1016/j.jneumeth.2006.02.004; Kisvarday ZF, 2002, J NEUROCYTOL, V31, P255, DOI 10.1023/A:1024122009448; KISVARDAY ZF, 1993, EUR J NEUROSCI, V5, P1558, DOI 10.1111/j.1460-9568.1993.tb00226.x; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Lu CB, 2010, BRAIN RES, V1323, P65, DOI 10.1016/j.brainres.2010.01.090; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Palmer SE, 2007, J NEUROPHYSIOL, V98, P63, DOI 10.1152/jn.00152.2007; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; SHAPLEY R, 1985, ANNU REV NEUROSCI, V8, P547, DOI 10.1146/annurev.ne.08.030185.002555; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zaitsev AV, 2005, CEREB CORTEX, V15, P1178, DOI 10.1093/cercor/bhh218; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	67	173	174	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					847	857		10.1016/j.neuron.2010.08.006	http://dx.doi.org/10.1016/j.neuron.2010.08.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826315	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000281938900018
J	Min, SW; Cho, SH; Zhou, YG; Schroeder, S; Haroutunian, V; Seeley, WW; Huang, EJ; Shen, Y; Masliah, E; Mukherjee, C; Meyers, D; Cole, PA; Ott, M; Gan, L				Min, Sang-Won; Cho, Seo-Hyun; Zhou, Yungui; Schroeder, Sebastian; Haroutunian, Vahram; Seeley, William W.; Huang, Eric J.; Shen, Yong; Masliah, Eliezer; Mukherjee, Chandrani; Meyers, David; Cole, Philip A.; Ott, Melanie; Gan, Li			Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy	NEURON			English	Article							ALZHEIMERS-DISEASE; LYSINE ACETYLATION; MOUSE MODEL; CALORIE RESTRICTION; PHOSPHORYLATED TAU; DEACETYLASE SIRT1; UBIQUITINATION; NEURODEGENERATION; APOPTOSIS; SIRTUINS	Neurodegenerative tauopathies characterized by hyperphosphorylated tau include frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) and Alzheimer's disease (AD). Reducing tau levels improves cognitive function in mouse models of AD and FTDP-17, but the mechanisms regulating the turnover of pathogenic tau are unknown. We found that tau is acetylated and that tau acetylation prevents degradation of phosphorylated tau (p-tau). We generated two antibodies specific for acetylated tau and showed that tau acetylation is elevated in patients at early and moderate Braak stages of tauopathy. Histone acetyltransferase p300 was involved in tau acetylation and the class III protein deacetylase SIRT1 in deacetylation. Deleting SIRT1 enhanced levels of acetylated-tau and pathogenic forms of p-tau, probably by blocking proteasome-mediated degradation. Inhibiting p300 with a small molecule promoted tau deacetylation and eliminated p-tau associated with tauopathy. Modulating tau acetylation could be a new therapeutic strategy to reduce tau-mediated neurodegeneration.	[Min, Sang-Won; Cho, Seo-Hyun; Zhou, Yungui; Gan, Li] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Schroeder, Sebastian; Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Min, Sang-Won; Cho, Seo-Hyun; Seeley, William W.; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Schroeder, Sebastian; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Gan, Li] Univ Calif San Francisco, Biomed Sci & Neurosci Grad Program, San Francisco, CA 94143 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Mukherjee, Chandrani; Meyers, David; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Shen, Yong] Sun Hlth Res Inst, Haldeman Lab Mol & Cellular Neurobiol, Sun City, AZ 85351 USA; [Haroutunian, Vahram] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10468 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; Johns Hopkins University; Banner Research; Banner Health; Banner Sun Health Research Institute; Icahn School of Medicine at Mount Sinai	Gan, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Huang, Eric J./AAH-7997-2019	Huang, Eric J./0000-0002-5381-3801; Ott, Melanie/0000-0002-5697-1274	Whittier Foundation; Jr. Foundation; UCSF ADRC [AG023501-06]; NIH; FAMRI foundation; NIH/NCRR [CO6 RRO18928]; Elan Pharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG023501, R01AG030207] Funding Source: NIH RePORTER	Whittier Foundation; Jr. Foundation; UCSF ADRC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI foundation; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Elan Pharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Eric Verdin and Lennart Mucke for insightful discussions, Dr. Fred Alt from Harvard Medical School for SIRT1 null and floxed SIRT1 knockout mice, Drs. Chris Adams and Andrew Guzzetta from Stanford Mass Spectrometry Laboratory for MALDI-TOF analyses, Dr. Katerina Mancevska from New York Brain Bank at Columbia University for human brain samples, Stephen Ordway and Gary Howard for editorial review, and Kelley Nelson for administrative assistance. This work was supported in part by grants from the Whittier Foundation and the S. D Bechtel, Jr. Foundation (to L.G.), UCSF ADRC grant AG023501-06 (to W.W.S. and E.J.H), grants from NIH and FAMRI foundation (to P.A.C, D.M., and CM), a grant from NIH (to M.O), and NIH/NCRR CO6 RRO18928 (a facility grant to the J. David Gladstone Institutes). L.G. receives research funding from elan Pharmaceuticals. P.A.C. is a cofounder and consults for Acylin Inc.	Amos LA, 2004, ORG BIOMOL CHEM, V2, P2153, DOI 10.1039/b403634d; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Goodman RH, 2000, GENE DEV, V14, P1553; Greiss S, 2008, GENE DEV, V22, P2831, DOI 10.1101/gad.482608; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim Y, 2000, ANAL BIOCHEM, V280, P308, DOI 10.1006/abio.2000.4546; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Ohsawa S, 2006, FEBS LETT, V580, P5875, DOI 10.1016/j.febslet.2006.09.051; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	52	630	666	2	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					953	966		10.1016/j.neuron.2010.08.044	http://dx.doi.org/10.1016/j.neuron.2010.08.044			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869593	Bronze, Green Accepted			2022-12-24	WOS:000282801100008
J	Akam, T; Kullmann, DM				Akam, Thomas; Kullmann, Dimitri M.			Oscillations and Filtering Networks Support Flexible Routing of Information	NEURON			English	Article							GAMMA FREQUENCY OSCILLATIONS; NEURONAL SYNCHRONIZATION; SPATIAL ATTENTION; NEOCORTICAL NEURONS; PHASE RELATIONSHIP; MECHANISM; AREA; INTERNEURON; EXCITATION; MODEL	The mammalian brain exhibits profuse interregional connectivity. How information flow is rapidly and flexibly switched among connected areas remains poorly understood. Task-dependent changes in the power and interregion coherence of network oscillations suggest that such oscillations play a role in signal routing. We show that switching one of several convergent pathways from an asynchronous to an oscillatory state allows accurate selective transmission of population-coded information, which can be extracted even when other convergent pathways fire asynchronously at comparable rates. We further show that the band-pass filtering required to perform this information extraction can be implemented in a simple spiking network model with a single feed-forward interneuron layer. This constitutes a mechanism for flexible signal routing in neural circuits, which exploits sparsely synchronized network oscillations and temporal filtering by feed-forward inhibition.	[Akam, Thomas; Kullmann, Dimitri M.] UCL Inst Neurol, London WC1N 3BG, England	University of London; University College London	Akam, T (corresponding author), UCL Inst Neurol, London WC1N 3BG, England.	takam@ion.ucl.ac.uk; d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009	Kullmann, Dimitri M/0000-0001-6696-3545; Akam, Thomas/0000-0002-1810-0494	Wellcome Trust; European Research Council; MRC [G0601943, G116/147] Funding Source: UKRI; Medical Research Council [G0601943, G116/147, G0601943B] Funding Source: researchfish; Action Medical Research [1725] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research	This work was supported by the Wellcome Trust and the European Research Council. We are grateful to P. Latham for helpful discussion and comments on the manuscript.	ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Berman R, 2009, VISION RES, V49, P1233, DOI 10.1016/j.visres.2008.06.017; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2006, NEURAL COMPUT, V18, P1066, DOI 10.1162/neco.2006.18.5.1066; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Burchell TR, 1998, NEUROSCI LETT, V255, P151, DOI 10.1016/S0304-3940(98)00676-4; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chu ZG, 2003, J NEUROSCI, V23, P96; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; CRICK F, 1990, COLD SH Q B, V55, P953; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; FISHER NI, 1983, BIOMETRIKA, V70, P327, DOI 10.1093/biomet/70.2.327; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gewaltig MO, 2007, SCHOLARPEDIA, V2, P1430, DOI [DOI 10.4249/SCH0LARPEDIA.1430, 10.4249/scholarpedia.1430, DOI 10.4249/SCHOLARPEDIA.1430]; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Lee D, 2003, J NEUROSCI, V23, P6798; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Masuda N, 2009, NEURAL COMPUT, V21, P3335, DOI 10.1162/neco.2009.09-08-857; Mishra J, 2006, NEURAL NETWORKS, V19, P1329, DOI 10.1016/j.neunet.2006.08.005; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; NIEBUR E, 1993, VISION RES, V33, P2789, DOI 10.1016/0042-6989(93)90236-P; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Oren I, 2006, J NEUROSCI, V26, P9923, DOI 10.1523/JNEUROSCI.1580-06.2006; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Popescu AT, 2009, NAT NEUROSCI, V12, P801, DOI 10.1038/nn.2305; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Taylor K, 2005, CEREB CORTEX, V15, P1424, DOI 10.1093/cercor/bhi023; Tiesinga PH, 2004, J PHYSIOL-PARIS, V98, P296, DOI 10.1016/j.jphysparis.2005.09.002; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wang XJ, 1996, J NEUROSCI, V16, P6402; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zeitler M, 2008, J COMPUT NEUROSCI, V25, P89, DOI 10.1007/s10827-007-0066-2; Zylberberg A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000765	66	168	186	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					308	320		10.1016/j.neuron.2010.06.019	http://dx.doi.org/10.1016/j.neuron.2010.06.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670837	hybrid, Green Published			2022-12-24	WOS:000280461500014
J	van der Meer, MAA; Johnson, A; Schmitzer-Torbert, NC; Redish, AD				van der Meer, Matthijs A. A.; Johnson, Adam; Schmitzer-Torbert, Neil C.; Redish, A. David			Triple Dissociation of Information Processing in Dorsal Striatum, Ventral Striatum, and Hippocampus on a Learned Spatial Decision Task	NEURON			English	Article							UNIFIED FRAMEWORK; UNIT-ACTIVITY; NEURONS; REWARD; PLACE; RATS; PERFORMANCE; ENSEMBLES; NUCLEUS; REPRESENTATIONS	Decision-making studies across different domains suggest that decisions can arise from multiple, parallel systems in the brain: a flexible system utilizing action-outcome expectancies and a more rigid system based on situation-action associations. The hippocampus, ventral striatum, and dorsal striatum make unique contributions to each system, but how information processing in each of these structures supports these systems is unknown. Recent work has shown covert representations of future paths in hippocampus and of future rewards in ventral striatum. We developed analyses in order to use a comparative methodology and apply the same analyses to all three structures. Covert representations of future paths and reward were both absent from the dorsal striatum. In contrast, dorsal striatum slowly developed situation representations that selectively represented action-rich parts of the task. This triple dissociation suggests that the different roles these structures play are due to differences in information-processing mechanisms.	[van der Meer, Matthijs A. A.; Johnson, Adam; Schmitzer-Torbert, Neil C.; Redish, A. David] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Johnson, Adam] Bethel Univ, Dept Psychol, St Paul, MN 55112 USA; [Schmitzer-Torbert, Neil C.] Wabash Coll, Dept Psychol, Crawfordsville, IN 47933 USA	University of Minnesota System; University of Minnesota Twin Cities	Redish, AD (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	redish@umn.edu	van der Meer, Matthijs/E-5856-2010	van der Meer, Matthijs/0000-0002-2206-4473; Schmitzer-Torbert, Neil/0000-0001-6186-7853	NIH (Center for Cognitive Sciences, University of Minnesota) [MH068029, MH080318, T32HD007151]; IGERT [9870633]; NSF; University of Minnesota; Dissertation Fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080318, R01MH068029] Funding Source: NIH RePORTER	NIH (Center for Cognitive Sciences, University of Minnesota)(University of Minnesota SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IGERT(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System); Dissertation Fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Anoopum Gupta, Jadin Jackson, and Paul Schrater for discussion, and David Crowe and Geoffrey Schoenbaum for comments on a previous version of the manuscript. Supported by NIH grants MH068029, MH080318, T32HD007151 (Center for Cognitive Sciences, University of Minnesota), IGERT training grant 9870633, graduate student NSF fellowships, Dissertation Fellowships, and the Land Grant Professorship program at the University of Minnesota. This work has been published in abstract form (Frontiers in Systems Neuroscience, conference abstract: CoSyNe 2009); we are grateful to the conference participants for their suggestions.	Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Berke JD, 2009, J NEUROPHYSIOL, V101, P1575, DOI 10.1152/jn.91106.2008; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; HU D, 1995, P NATL ACAD SCI USA, V92, P5506, DOI 10.1073/pnas.92.12.5506; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; LAVOIE AM, 1994, BRAIN RES, V638, P157, DOI 10.1016/0006-8993(94)90645-9; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Miyazaki K, 1998, NEUROREPORT, V9, P3943, DOI 10.1097/00001756-199812010-00032; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Schacter D., 1994, MEMORY SYSTEMS; Schmitzer-Torbert N, 2004, J NEUROPHYSIOL, V91, P2259, DOI 10.1152/jn.00687.2003; Schmitzer-Torbert N, 2002, ARCH ITAL BIOL, V140, P295; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; Schneidman E, 2003, J NEUROSCI, V23, P11539; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tolman EC, 1938, PSYCHOL REV, V45, P1, DOI 10.1037/h0062733; van der Meer MAA, 2009, FRONT INTEGR NEUROSC, V3, DOI [10.3389/neuro.07.009.2009, 10.3389/neuro.07.001.2009]; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WIENER SI, 1993, J NEUROSCI, V13, P3802; Yeshenko O, 2004, BEHAV NEUROSCI, V118, P751, DOI 10.1037/0735-7044.118.4.751; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	37	156	156	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					25	32		10.1016/j.neuron.2010.06.023	http://dx.doi.org/10.1016/j.neuron.2010.06.023			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624589	Bronze, Green Accepted			2022-12-24	WOS:000280221000006
J	Zhang, XQ; Huang, CT; Chen, J; Pankratz, MT; Xi, JJ; Li, J; Yang, Y; LaVaute, TM; Li, XJ; Ayala, M; Bondarenko, GI; Du, ZW; Jin, Y; Golos, TG; Zhang, SC				Zhang, Xiaoqing; Huang, Cindy T.; Chen, Jing; Pankratz, Matthew T.; Xi, Jiajie; Li, Jin; Yang, Ying; LaVaute, Timothy M.; Li, Xue-Jun; Ayala, Melvin; Bondarenko, Gennadiy I.; Du, Zhong-Wei; Jin, Ying; Golos, Thaddeus G.; Zhang, Su-Chun			Pax6 Is a Human Neuroectoderm Cell Fate Determinant	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; NEURAL DIFFERENTIATION; DIRECTED DIFFERENTIATION; RNA INTERFERENCE; PAIRED DOMAIN; SELF-RENEWAL; EXPRESSION; MOUSE; GENES; SOX2	The transcriptional regulation of neuroectoderm (NE) specification is unknown. Here we show that Pax6 is uniformly expressed in early NE cells of human fetuses and those differentiated from human embryonic stem cells (hESCs). This is in contrast to the later expression of Pax6 in restricted mouse brain regions. Knockdown of Pax6 blocks NE specification from hESCs. Overexpression of either Pax6a or Pax6b, but not Pax6 Delta PD, triggers hESC differentiation. However, only Pax6a converts hESCs to NE. In contrast, neither loss nor gain of function of Pax6 affects mouse NE specification. Both Pax6a and Pax6b bind to pluripotent gene promoters but only Pax6a binds to NE genes during human NE specification. These findings indicate that Pax6 is a transcriptional determinant of the human NE and suggest that Pax6a and Pax6b coordinate with each other in determining the transition from pluripotency to the NE fate in human by differentially targeting pluripotent and NE genes.	[Zhang, Xiaoqing; Huang, Cindy T.; Pankratz, Matthew T.; LaVaute, Timothy M.; Li, Xue-Jun; Ayala, Melvin; Du, Zhong-Wei; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhang, Xiaoqing; Huang, Cindy T.; Pankratz, Matthew T.; LaVaute, Timothy M.; Li, Xue-Jun; Ayala, Melvin; Du, Zhong-Wei; Zhang, Su-Chun] WiCell Inst, Madison, WI 53705 USA; [Chen, Jing; Xi, Jiajie; Li, Jin] Fudan Univ, Inst Stem Cells & Regenerat Med, Shanghai Med Sch, Dept Anat & Embryol, Shanghai 200032, Peoples R China; [Yang, Ying; Jin, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Bondarenko, Gennadiy I.; Golos, Thaddeus G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Golos, Thaddeus G.] Univ Wisconsin, Sch Med & Publ Hlth, Sch Vet Med & Obstet & Gynecol, Dept Comparat Biosci, Madison, WI 53715 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anat, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	zhang@waisman.wisc.edu	Zhang, Xiaoqing/O-3424-2017	Zhang, Xiaoqing/0000-0002-7405-1893; LI, XUEJUN/0000-0003-1899-9134; Ayala, Melvin/0000-0002-8669-1046; Pankratz, Matthew/0000-0002-7397-6755	National Institutes of Neurological Diseases and Stroke [NS045926]; National Institute of Child Health and Human Development [P30 HD03352]; Ministry of Science and Technology, China [2006CB94700, 2006AA02A101]; Shanghai Municipality [06dj14001]; NIH [RR00167, RR15459, RR020141]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045926, R21NS061243] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Shanghai Municipality; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	`We thank Qilong Ying and Austin Smith for the Sox1 reporter mouse ESCs and Y. Sassai for the FoxG1 antibody. We also thank Elizabeth E. Capowski for reading our manuscript and helpful discussion. This study was supported by the National Institutes of Neurological Diseases and Stroke (NS045926 to S.-C.Z.), partly by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P30 HD03352), Ministry of Science and Technology, China (2006CB94700, 2006AA02A101), and Shanghai Municipality (06dj14001). The Wisconsin National Primate Research Center is supported by NIH grant RR00167, with support from Research Facilities Improvement Progress grant RR15459 and RR020141. The authors state that they have no competing financial interests.	Aiba K, 2006, STEM CELLS, V24, P889, DOI 10.1634/stemcells.2005-0332; AMIRTHALINGAM K, 1995, BIOCHEM BIOPH RES CO, V215, P122, DOI 10.1006/bbrc.1995.2441; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bondarenko GI, 2007, J IMMUNOL, V179, P8042, DOI 10.4049/jimmunol.179.12.8042; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Kim J, 2006, DEV BIOL, V292, P486, DOI 10.1016/j.ydbio.2005.12.041; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakata K, 1997, P NATL ACAD SCI USA, V94, P11980, DOI 10.1073/pnas.94.22.11980; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xia X, 2008, STEM CELLS, V26, P525, DOI 10.1634/stemcells.2007-0710; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19	60	299	310	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					90	100		10.1016/j.stem.2010.04.017	http://dx.doi.org/10.1016/j.stem.2010.04.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621053	Green Accepted, Bronze			2022-12-24	WOS:000280222300016
J	Billig, GM; Pal, B; Fidzinski, P; Jentsch, TJ				Billig, Gwendolyn M.; Pal, Balazs; Fidzinski, Pawel; Jentsch, Thomas J.			Ca2+-activated Cl- currents are dispensable for olfaction	NATURE NEUROSCIENCE			English	Article							ACTIVATED CHLORIDE CHANNEL; NUCLEOTIDE-GATED CHANNEL; SENSORY NEURONS; MICE DEFICIENT; TMEM16A; ACCUMULATION; CONDUCTANCE; PROTEIN; DISCRIMINATION; AMPLIFICATION	Canonical olfactory signal transduction involves the activation of cyclic AMP-activated cation channels that depolarize the cilia of receptor neurons and raise intracellular calcium. Calcium then activates Cl- currents that may be up to tenfold larger than cation currents and are believed to powerfully amplify the response. We identified Anoctamin2 (Ano2, also known as TMEM16B) as the ciliary Ca2+-activated Cl- channel of olfactory receptor neurons. Ano2 is expressed in the main olfactory epithelium (MOE) and in the vomeronasal organ (VNO), which also expresses the related Ano1 channel. Disruption of Ano2 in mice virtually abolished Ca2+-activated Cl- currents in the MOE and VNO. Ano2 disruption reduced fluid-phase electro-olfactogram responses by only similar to 40%, did not change air-phase electro-olfactograms and did not reduce performance in olfactory behavioral tasks. In contrast with the current view, cyclic nucleotide-gated cation channels do not need a boost by Cl- channels to achieve near-physiological levels of olfaction.	[Billig, Gwendolyn M.; Pal, Balazs; Fidzinski, Pawel; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Billig, Gwendolyn M.] Free Univ Berlin, Grad Program, D-1000 Berlin, Germany; [Jentsch, Thomas J.] Charite, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), Max Delbruck Ctr Mol Med MDC, Leibniz Inst Mol Pharmakol FMP, Berlin, Germany.	jentsch@fmp-berlin.de	Fidzinski, Pawel/AAM-8884-2020; Billig, Gwendolyn M/A-1297-2012	Fidzinski, Pawel/0000-0001-6373-4763; Jentsch, Thomas/0000-0002-3509-2553	Prix Louis-Jeantet de Medecine	Prix Louis-Jeantet de Medecine	We thank P. Mombaerts (Max Planck Institute for Biophysics) for providing Cnga2<SUP>-</SUP>, P2-IRES-tauLacZ and M72-IRES-tauLacZ mice, V. Hagen (FMP) for caged 8-Br-cAMP, I. Zarour and U. Heinemann (Charite) for help with ion-selective microelectrodes, S. Jabs and L. Leisle for help with flash photolysis, P. Mombaerts and B. Schroeder (MDC) for helpful discussions and N. Kronke and F. Binder for technical assistance. This work was supported, in part, by the Prix Louis-Jeantet de Medecine to T.J.J.	Boccaccio A, 2007, J NEUROPHYSIOL, V98, P153, DOI 10.1152/jn.00270.2007; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Bonigk W, 1999, J NEUROSCI, V19, P5332; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHIU D, 1988, CHEM SENSES, V13, P677; Cygnar K. D., 2010, J VIS EXP; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Kelliher KR, 2003, P NATL ACAD SCI USA, V100, P4299, DOI 10.1073/pnas.0736071100; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; Kleene SJ, 1996, J NEUROPHYSIOL, V75, P1386, DOI 10.1152/jn.1996.75.4.1386; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Nickell WT, 2006, J NEUROPHYSIOL, V95, P2003, DOI 10.1152/jn.00962.2005; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Pifferi S, 2009, J PHYSIOL-LONDON, V587, P4265, DOI 10.1113/jphysiol.2009.176131; Pinato G, 2008, CHEM SENSES, V33, P397, DOI 10.1093/chemse/bjn007; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reuter D, 1998, J NEUROSCI, V18, P6623; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Sagheddu C, 2010, J PHYSIOL-LONDON, V588, P4189, DOI 10.1113/jphysiol.2010.194407; Schneppenheim R, 2007, J THROMB HAEMOST, V5, P722, DOI 10.1111/j.1538-7836.2007.02460.x; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shimazaki R, 2006, CHEM SENSES, V31, P425, DOI 10.1093/chemse/bjj047; Slotnick B, 2005, CURR PROTOC NEUROSCI; Smith DW, 2008, PHYSIOL BEHAV, V93, P44, DOI 10.1016/j.physbeh.2007.07.011; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Vogalis F, 2005, J PHYSIOL-LONDON, V562, P785, DOI 10.1113/jphysiol.2004.079228; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	50	154	157	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					763	U370		10.1038/nn.2821	http://dx.doi.org/10.1038/nn.2821			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516098	Green Accepted			2022-12-24	WOS:000290958000020
J	Kay, L; Humphreys, L; Eickholt, BJ; Burrone, J				Kay, Louise; Humphreys, Lawrence; Eickholt, Britta J.; Burrone, Juan			Neuronal activity drives matching of pre- and postsynaptic function during synapse maturation	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; RELEASE PROBABILITY; AMPA; EXPRESSION	The structure and function of presynaptic and postsynaptic compartments varies markedly in neurons, but little is known about how they are functionally arranged with respect to each other. In rat hippocampal neurons, we found that, although they are structurally correlated from the early moments of formation, synapses only gradually become functionally matched and that this process is dependent on ongoing electrical activity.	[Kay, Louise; Humphreys, Lawrence; Eickholt, Britta J.; Burrone, Juan] Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London	Burrone, J (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England.	juan.burrone@kcl.ac.uk	Eickholt, Britta/C-5337-2009	Burrone, Juan/0000-0003-1233-668X; Eickholt, Britta/0000-0001-7873-8687	MRC; Wellcome Trust; Lister prize fellowship; MRC [G0802289, G0901307, G0901899] Funding Source: UKRI; Medical Research Council [G0802289, G0901899, G0901307] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Lister prize fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the members of the Burrone and Eickholt laboratories for help and suggestions with experiments and M. Grubb for critical reading of the manuscript. This work was supported by MRC and Wellcome Trust project grants, as well as a Lister prize fellowship to J.B. and MRC studentships to L.K. and L.H.	Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tokuoka H, 2008, P NATL ACAD SCI USA, V105, P14656, DOI 10.1073/pnas.0805705105	10	33	33	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					688	690		10.1038/nn.2826	http://dx.doi.org/10.1038/nn.2826			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532580				2022-12-24	WOS:000290958000008
J	Ganguly, K; Dimitrov, DF; Wallis, JD; Carmena, JM				Ganguly, Karunesh; Dimitrov, Dragan F.; Wallis, Jonathan D.; Carmena, Jose M.			Reversible large-scale modification of cortical networks during neuroprosthetic control	NATURE NEUROSCIENCE			English	Article							BRAIN-COMPUTER INTERFACE; MOTOR CORTEX; REACHING MOVEMENTS; ARM MOVEMENTS; PERFORMANCE; ADAPTATION; STABILITY; PATTERNS; NEURONS; SIGNALS	Brain-machine interfaces (BMIs) provide a framework for studying cortical dynamics and the neural correlates of learning. Neuroprosthetic control has been associated with tuning changes in specific neurons directly projecting to the BMI (hereafter referred to as direct neurons). However, little is known about the larger network dynamics. By monitoring ensembles of neurons that were either causally linked to BMI control or indirectly involved, we found that proficient neuroprosthetic control is associated with large-scale modifications to the cortical network in macaque monkeys. Specifically, there were changes in the preferred direction of both direct and indirect neurons. Notably, with learning, there was a relative decrease in the net modulation of indirect neural activity in comparison with direct activity. These widespread differential changes in the direct and indirect population activity were markedly stable from one day to the next and readily coexisted with the long-standing cortical network for upper limb control. Thus, the process of learning BMI control is associated with differential modification of neural populations based on their specific relation to movement control.	[Ganguly, Karunesh; Wallis, Jonathan D.; Carmena, Jose M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Ganguly, Karunesh] San Francisco VA Med Ctr, Dept Neurol & Rehabil, San Francisco, CA USA; [Ganguly, Karunesh; Carmena, Jose M.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Ganguly, Karunesh] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Dimitrov, Dragan F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Wallis, Jonathan D.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif Berkeley, Program Cognit Sci, Berkeley, CA 94720 USA; [Carmena, Jose M.] Univ Calif San Francisco, Joint Grad Grp Bioengn, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Carmena, JM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	carmena@eecs.berkeley.edu		Wallis, Joni/0000-0001-7262-7417	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development; American Heart Association/American Stroke Association; National Institute of Neurological Disorders and Stroke [NS21135]; Alfred P. Sloan Foundation; Christopher and Dana Reeve Foundation; National Science Foundation [0954243]; Defense Advanced Research Projects Agency [N66001-10-C-2008]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813, R01NS021135, R56NS021135, R37NS021135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019028] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development(US Department of Veterans Affairs); American Heart Association/American Stroke Association(American Heart Association); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Christopher and Dana Reeve Foundation; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development, and the American Heart Association/American Stroke Association (to K. G.), the National Institute of Neurological Disorders and Stroke grant number NS21135 (to J.D.W.), the Alfred P. Sloan Foundation, the Christopher and Dana Reeve Foundation, the National Science Foundation CAREER Award #0954243 and the Defense Advanced Research Projects Agency contract N66001-10-C-2008 (to J.M.C.).	Ajemian R, 2008, NEURON, V58, P414, DOI 10.1016/j.neuron.2008.02.033; Arce F, 2010, J NEUROSCI, V30, P9189, DOI 10.1523/JNEUROSCI.1603-10.2010; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Carmena JM, 2005, J NEUROSCI, V25, P10712, DOI 10.1523/JNEUROSCI.2772-05.2005; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2007, J NEUROSCI, V27, P10742, DOI 10.1523/JNEUROSCI.0959-07.2007; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Davidson AG, 2007, SCIENCE, V318, P1934, DOI 10.1126/science.1149774; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Ganguly K, 2010, J MOTOR BEHAV, V42, P355, DOI 10.1080/00222895.2010.526457; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Greenberg PA, 2004, J NEUROPHYSIOL, V92, P1042, DOI 10.1152/jn.00062.2004; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Paz R, 2004, PLOS BIOL, V2, P264, DOI 10.1371/journal.pbio.0020045; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	45	170	171	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					662	U164		10.1038/nn.2797	http://dx.doi.org/10.1038/nn.2797			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499255	Green Accepted			2022-12-24	WOS:000289886600024
J	Loh, KM; Lim, B				Loh, Kyle M.; Lim, Bing			A Precarious Balance: Pluripotency Factors as Lineage Specifiers	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GENE REGULATORY NETWORKS; SELF-RENEWAL; TRANSCRIPTION FACTORS; ES CELLS; DIFFERENTIATION; MAINTENANCE; ACTIVATION; INDUCTION; STATE	Understanding the basis of the unrestricted multilineage differentiation potential of pluripotent cells will be of developmental and translational consequence. We propose that pluripotency transcription factors are lineage specifiers that direct commitment to specific fetal lineages. Individual factors bestow the ability to differentiate into particular cell types, and concomitant expression of multiple lineage specifiers within pluripotent cells enables differentiation into every fetal lineage. Moreover, we speculate that, rather than being an intrinsically stable "ground state," pluripotency is an inherently precarious condition in which rival lineage specifiers continually compete to specify differentiation along mutually exclusive lineages.	[Loh, Kyle M.; Lim, Bing] Genome Inst Singapore, Stem Cell & Dev Biol Grp, Singapore 138672, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lim, Bing] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Loh, KM (corresponding author), Genome Inst Singapore, Stem Cell & Dev Biol Grp, Singapore 138672, Singapore.	kyle.m.loh@gmail.com; limb1@gis.a-star.edu.sg		Loh, Kyle/0000-0002-8042-0149	Davidson Institute of Talent Development; Singapore Agency for Science, Technology, and Research (A*STAR)	Davidson Institute of Talent Development; Singapore Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	We thank L.T. Ang, P.P.L. Tam, K.L. Lee, D.J.C. Heng, M.T. Fuller, S.W.S. Lim, G. Guo, and three anonymous reviewers for critical review of the manuscript and evaluation of the model disclosed therein. Moreover, we are indebted to all members of the embryonic stem cell field whose work over the past 30 years has provided the inspiration for our present proposal. K.M.L. is supported by the Davidson Institute of Talent Development and B.L. is supported by the Singapore Agency for Science, Technology, and Research (A*STAR). This manuscript is dedicated to Dale L. Woodbury for his provision of uncommon mentorship.	Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1992, DEV BIOL, V151, P339, DOI 10.1016/0012-1606(92)90174-F; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	39	175	181	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					363	369		10.1016/j.stem.2011.03.013	http://dx.doi.org/10.1016/j.stem.2011.03.013			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474100	Bronze			2022-12-24	WOS:000289707100008
J	Deguchi, Y; Donato, F; Galimberti, I; Cabuy, E; Caroni, P				Deguchi, Yuichi; Donato, Flavio; Galimberti, Ivan; Cabuy, Erik; Caroni, Pico			Temporally matched subpopulations of selectively interconnected principal neurons in the hippocampus	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; TRANSGENIC MICE; DENTATE GYRUS; GRANULE CELLS; NEUROGENESIS; DROSOPHILA; NETWORKS; CIRCUITS; ORGANIZATION; SPECIFICITY	The extent to which individual neurons are interconnected selectively within brain circuits is an unresolved problem in neuroscience. Neurons can be organized into preferentially interconnected microcircuits, but whether this reflects genetically defined subpopulations is unclear. We found that the principal neurons in the main subdivisions of the hippocampus consist of distinct subpopulations that are generated during distinct time windows and that interconnect selectively across subdivisions. In two mouse lines in which transgene expression was driven by the neuron-specific Thy1 promoter, transgene expression allowed us to visualize distinct populations of principal neurons with unique and matched patterns of gene expression, shared distinct neurogenesis and synaptogenesis time windows, and selective connectivity at dentate gyrus-CA3 and CA3-CA1 synapses. Matched subpopulation marker genes and neuronal subtype markers mapped near clusters of olfactory receptor genes. The nonoverlapping matched timings of synaptogenesis accounted for the selective connectivities of these neurons in CA3. Therefore, the hippocampus contains parallel connectivity channels assembled from distinct principal neuron subpopulations through matched schedules of synaptogenesis.	[Deguchi, Yuichi; Donato, Flavio; Galimberti, Ivan; Cabuy, Erik; Caroni, Pico] Friedrich Miescher Inst, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Basel, Switzerland.	caroni@fmi.ch		Donato, Flavio/0000-0002-0732-1654				ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Baek M, 2009, J NEUROSCI, V29, P6904, DOI 10.1523/JNEUROSCI.1585-09.2009; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dijk F, 2004, BRAIN RES, V1026, P194, DOI 10.1016/j.brainres.2004.08.034; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frotscher M, 2007, PROG BRAIN RES, V163, P133, DOI 10.1016/S0079-6123(07)63007-6; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Kamme F, 2003, J NEUROSCI, V23, P3607; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Li G, 2008, DEV NEUROSCI-BASEL, V30, P255, DOI 10.1159/000110347; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407; Pinaud R, 2008, NAT PROTOC, V3, P1370, DOI 10.1038/nprot.2008.115; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tremblay ME, 2009, J COMP NEUROL, V512, P798, DOI 10.1002/cne.21922; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	49	103	104	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					495	U135		10.1038/nn.2768	http://dx.doi.org/10.1038/nn.2768			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358645				2022-12-24	WOS:000288849400021
J	Nouvian, R; Neef, J; Bulankina, AV; Reisinger, E; Pangrsic, T; Frank, T; Sikorra, S; Brose, N; Binz, T; Moser, T				Nouvian, Regis; Neef, Jakob; Bulankina, Anna V.; Reisinger, Ellen; Pangrsic, Tina; Frank, Thomas; Sikorra, Stefan; Brose, Nils; Binz, Thomas; Moser, Tobias			Exocytosis at the hair cell ribbon synapse apparently operates without neuronal SNARE proteins	NATURE NEUROSCIENCE			English	Article							SUBSTRATE RECOGNITION; AFFERENT SYNAPSE; NEUROEXOCYTOSIS; TRANSMISSION; ENDOCYTOSIS; NEUROTOXINS; MOUSE	SNARE proteins mediate membrane fusion. Neurosecretion depends on neuronal soluble NSF attachment protein receptors ( SNAREs; SNAP-25, syntaxin-1, and synaptobrevin-1 or synaptobrevin-2) and is blocked by neurotoxin-mediated cleavage or genetic ablation. We found that exocytosis in mouse inner hair cells (IHCs) was insensitive to neurotoxins and genetic ablation of neuronal SNAREs. mRNA, but no synaptically localized protein, of neuronal SNAREs was present in IHCs. Thus, IHC exocytosis is unconventional and may operate independently of neuronal SNAREs.	[Nouvian, Regis; Neef, Jakob; Bulankina, Anna V.; Pangrsic, Tina; Frank, Thomas; Moser, Tobias] Univ Gottingen, Dept Otolaryngol, Med Ctr, InnerEarLab, Gottingen, Germany; [Nouvian, Regis; Neef, Jakob; Bulankina, Anna V.; Pangrsic, Tina; Frank, Thomas; Moser, Tobias] Univ Gottingen, Ctr Mol Physiol Brain, Med Ctr, Gottingen, Germany; [Reisinger, Ellen] Univ Gottingen, Med Ctr, Dept Otolaryngol, Mol Biol Cochlear Neurotransmiss Grp, Gottingen, Germany; [Reisinger, Ellen; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Pangrsic, Tina] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Ljubljana, Slovenia; [Sikorra, Stefan; Binz, Thomas] Hannover Med Sch, Dept Biochem, D-30623 Hannover, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Max Planck Society; University of Ljubljana; Hannover Medical School	Moser, T (corresponding author), Univ Gottingen, Dept Otolaryngol, Med Ctr, InnerEarLab, Gottingen, Germany.	tmoser@gwdg.de	Frank, Thomas/F-5273-2012; Neef, Jakob/K-2553-2012; Moser, Tobias/L-5068-2014; Nouvian, Regis/AAW-4207-2021; Nouvian, Regis/AFQ-8065-2022	Frank, Thomas/0000-0002-5113-176X; Neef, Jakob/0000-0002-4757-9385; Moser, Tobias/0000-0001-7145-0533; Nouvian, Regis/0000-0002-0901-4666; Nouvian, Regis/0000-0002-0901-4666; Reisinger, Ellen/0000-0003-3739-7569	Deutsche Forschungsgemeinschaft [800/1-1, MO896 2-1]; Max Planck Society; Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank M. C. Wilson for providing SNAP-25 knockout mice, A. Nystuen for providing lethal-wasting mice, D. Bruns and T. C. Sudhof for providing synaptobrevin-2/3 double knockout mice, J. Sorensen for discussion, and A. Leonov and C. Griesinger for DM-Nitrophen. We would like to thank R. Jahn and E. Neher for comments on the manuscript and S. Blume, N. Dankenbrink-Werder and M. Koppler for technical assistance. This work was supported by grants of the Deutsche Forschungsgemeinschaft (800/1-1 to R. N. and MO896 2-1 to T. M.), the Max Planck Society (Tandem-Project to N. B. and T. M.) and by a fellowship of the Alexander von Humboldt Foundation (T. P.).	Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nystuen AM, 2007, NEUROGENETICS, V8, P1, DOI 10.1007/s10048-006-0068-7; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sikorra S, 2008, J BIOL CHEM, V283, P21145, DOI 10.1074/jbc.M800610200; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783	15	80	81	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					411	413		10.1038/nn.2774	http://dx.doi.org/10.1038/nn.2774			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378973				2022-12-24	WOS:000288849400007
J	Doucette, W; Gire, DH; Whitesell, J; Carmean, V; Lucero, MT; Restrepo, D				Doucette, Wilder; Gire, David H.; Whitesell, Jennifer; Carmean, Vanessa; Lucero, Mary T.; Restrepo, Diego			Associative Cortex Features in the First Olfactory Brain Relay Station	NEURON			English	Article							LONG-TERM ENHANCEMENT; ODOR DISCRIMINATION; SYNCHRONIZED OSCILLATIONS; TOPOGRAPHIC ORGANIZATION; SYNAPTIC PLASTICITY; DECISION-MAKING; PIRIFORM CORTEX; BULB GLOMERULI; MITRAL CELLS; RAT	Synchronized firing of mitral cells (MCs) in the olfactory bulb (OB) has been hypothesized to help bind information together in olfactory cortex (OC). In this survey of synchronized firing by suspected MCs in awake, behaving vertebrates, we find the surprising result that synchronized firing conveys information on odor value ("Is it rewarded?") rather than odor identity ("What is the odor?"). We observed that as mice learned to discriminate between odors, synchronous firing responses to the rewarded and unrewarded odors became divergent. Furthermore, adrenergic blockage decreases the magnitude of odor divergence of synchronous trains, suggesting that MCs contribute to decision-making through adrenergic-modulated synchronized firing. Thus, in the olfactory system information on stimulus reward is found in MCs one synapse away from the sensory neuron.	[Doucette, Wilder; Gire, David H.; Restrepo, Diego] Univ Colorado, Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Doucette, Wilder; Gire, David H.; Whitesell, Jennifer; Carmean, Vanessa; Restrepo, Diego] Univ Colorado, Neurosci Program, Aurora, CO 80045 USA; [Whitesell, Jennifer; Carmean, Vanessa] Univ Colorado, Dept Physiol & Biophys, Aurora, CO 80045 USA; [Lucero, Mary T.] Univ Utah, Dept Physiol, Salt Lake City, UT 84112 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah	Restrepo, D (corresponding author), Univ Colorado, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO 80045 USA.	diego.restrepo@ucdenver.edu	Doucette, Wilder/S-2019-2016	Doucette, Wilder/0000-0003-2249-0461; Gire, David/0000-0003-4119-4270; Whitesell, Jennifer/0000-0002-2961-5207	NIH [DC00566, DC04657, DC008855, DC008066, DC002994]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004657, F30DC008066, R01DC008855, R01DC000566, R01DC002994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank Drs. Gidon Felsen, Nathan Schoppa, and Dan Tollin for discussions; Dr. Ed Hsu; Osama Abdulla; and the University of Utah Small Animal MRI Facility. This work was funded by NIH grants DC00566 (D.R.), DC04657 (D.R.), DC008855 (D.R.), DC008066 (W.D.), and DC002994 (M.L.).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Bailey CH, 2008, PROG BRAIN RES, V169, P179, DOI 10.1016/S0079-6123(07)00010-6; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bouret S, 2004, EUR J NEUROSCI, V20, P791, DOI 10.1111/j.1460-9568.2004.03526.x; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; CHANG FCT, 1984, J NEUROSCI, V4, P1850; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; DALO NL, 1990, EUR J PHARMACOL, V184, P173, DOI 10.1016/0014-2999(90)90679-Z; Doucette W, 2007, LEARN MEMORY, V14, P539, DOI 10.1101/lm.606407; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Gire DH, 2008, J NEUROPHYSIOL, V99, P2021, DOI 10.1152/jn.01324.2007; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GRAY CM, 1986, BEHAV NEUROSCI, V100, P585, DOI 10.1037/0735-7044.100.4.585; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 2006, PHYSIOL BEHAV, V88, P339, DOI 10.1016/j.physbeh.2006.04.007; Kay LM, 2010, J NEUROPHYSIOL, V104, P829, DOI 10.1152/jn.00166.2010; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kiyokage E, 2010, J NEUROSCI, V30, P1185, DOI 10.1523/JNEUROSCI.3497-09.2010; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Mandairon N, 2009, J NEUROPHYSIOL, V101, P2204, DOI 10.1152/jn.00076.2009; Martin C, 2006, EUR J NEUROSCI, V23, P1801, DOI 10.1111/j.1460-9568.2006.04711.x; Matsutani S, 2010, NEUROSCIENCE, V169, P436, DOI 10.1016/j.neuroscience.2010.05.001; Miller P, 2010, J NEUROSCI, V30, P2559, DOI 10.1523/JNEUROSCI.3047-09.2010; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Pandipati S, 2010, J NEUROPHYSIOL, V104, P665, DOI 10.1152/jn.00328.2010; Pupo A S, 2001, CNS Spectr, V6, P656; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Restrepo D, 2009, TRENDS NEUROSCI, V32, P525, DOI 10.1016/j.tins.2009.06.001; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Roberts AC, 2003, TRENDS NEUROSCI, V26, P662, DOI 10.1016/j.tins.2003.09.014; SCHOENFELD TA, 1984, J COMP NEUROL, V227, P121, DOI 10.1002/cne.902270113; SCHOENFELD TA, 1985, J COMP NEUROL, V235, P503, DOI 10.1002/cne.902350408; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, P159; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Slotnick B., 2005, CURR PROTOC NEUROSCI, V33, P8, DOI [10.1002/0471142301.ns0820s33., DOI 10.1002/0471142301.NS0820S33]; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Takahashi S, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.009.2009; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Wang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010253; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; WILSON DA, 1988, J NEUROPHYSIOL, V59, P1770, DOI 10.1152/jn.1988.59.6.1770; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950	57	109	111	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1176	1187		10.1016/j.neuron.2011.02.024	http://dx.doi.org/10.1016/j.neuron.2011.02.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435561	Green Accepted, Bronze			2022-12-24	WOS:000288886900013
J	Li, KC; Zhang, FX; Li, CL; Wang, F; Yu, MY; Zhong, YQ; Zhang, KH; Lu, YJ; Wang, QO; Ma, XL; Yao, JR; Wang, JY; Lin, LB; Han, M; Zhang, YQ; Kuner, R; Xiao, HS; Bao, L; Gao, XA; Zhang, X				Li, Kai-Cheng; Zhang, Fang-Xiong; Li, Chang-Lin; Wang, Feng; Yu, Ming-Yan; Zhong, Yan-Qing; Zhang, Kai-Hua; Lu, Ying-Jin; Wang, Qiong; Ma, Xiao-Li; Yao, Jun-Ru; Wang, Jin-Yuan; Lin, Li-Bo; Han, Mei; Zhang, Yu-Qiu; Kuner, Rohini; Xiao, Hua-Sheng; Bao, Lan; Gao, Xiang; Zhang, Xu			Follistatin-like 1 Suppresses Sensory Afferent Transmission by Activating Na+,K+-ATPase	NEURON			English	Article							DORSAL-ROOT GANGLIA; PERIPHERAL NERVOUS-SYSTEM; SYNAPTIC VESICLE; SPINAL-CORD; NA+/K+ PUMP; NEURONS; RAT; PROTEIN; EXPRESSION; ISOFORMS	Excitatory synaptic transmission is modulated by inhibitory neurotransmitters and neuromodulators. We found that the synaptic transmission of somatic sensory afferents can be rapidly regulated by a presynaptically secreted protein, follistatin-like 1 (FSTL1), which serves as a direct activator of Na+,K+-ATPase (NKA). The FSTL1 protein is highly expressed in small-diameter neurons of the dorsal root ganglion (DRG). It is transported to axon terminals via small translucent vesicles and secreted in both spontaneous and depolarization-induced manners. Biochemical assays showed that FSTL1 binds to the alpha 1 subunit of NKA and elevates NKA activity. Extracellular FSTL1 induced membrane hyperpolarization in cultured cells and inhibited afferent synaptic transmission in spinal cord slices by activating NKA. Genetic deletion of FSTL1 in small DRG neurons of mice resulted in enhanced afferent synaptic transmission and sensory hypersensitivity, which could be reduced by intrathecally applied FSTL1 protein. Thus, FSTL1-dependent activation of NKA regulates the threshold of somatic sensation.	[Zhang, Fang-Xiong; Yu, Ming-Yan; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Li, Kai-Cheng; Zhang, Fang-Xiong; Li, Chang-Lin; Wang, Feng; Zhang, Kai-Hua; Lu, Ying-Jin; Ma, Xiao-Li; Yao, Jun-Ru; Wang, Jin-Yuan; Zhang, Xu] Chinese Acad Sci, Inst Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Li, Kai-Cheng; Zhang, Fang-Xiong; Li, Chang-Lin; Wang, Feng; Zhang, Kai-Hua; Lu, Ying-Jin; Ma, Xiao-Li; Yao, Jun-Ru; Wang, Jin-Yuan; Zhang, Xu] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhong, Yan-Qing; Wang, Qiong; Bao, Lan] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zhong, Yan-Qing; Wang, Qiong; Bao, Lan] Chinese Acad Sci, Lab Mol Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Lin, Li-Bo; Xiao, Hua-Sheng] Natl Engn Ctr Biochip Shanghai, Shanghai 201203, Peoples R China; [Kuner, Rohini] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; [Han, Mei; Zhang, Yu-Qiu] Fudan Univ, Inst Neurobiol, Inst Brain Sci, Shanghai 200031, Peoples R China	Nanjing University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Ruprecht Karls University Heidelberg; Fudan University	Gao, XA (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China.	gaoxiang@nju.edu.cn; xu.zhang@ion.ac.cn	Zhang, Yu-Qiu/AAS-2516-2020; wang, jinyuan/H-9422-2018; Li, Kai/HCI-8860-2022; Kuner, Rohini/AGU-0204-2022; Zhang, Yu-Qiu/CAF-6295-2022	Wang, Feng/0000-0001-8290-2849	NNSFC [30630029, 30621062]; MOST [2011CBA00400, 2009CB522005, 2006AA020704];  [06R214160];  [2007KIP402]	NNSFC(National Natural Science Foundation of China (NSFC)); MOST; ; 	We thank Drs. M.-M. Poo, Y.-G. Chen, G.-X. Ge, L. Li, and D.-S. Li for comments, and T.-L. Xu and N. Gong for cooperation. This work was supported by NNSFC (30630029 and 30621062), MOST (2011CBA00400, 2009CB522005. and 2006AA020704), and grants 06R214160 and 2007KIP402. K.-CL. did major experiments. H.-S.X., F.-X.Z., and L.-B.L. worked with microarrays, C.-L.L. and F.W. with secretions and electrophysiology, Yan-Qing Zhong, K.-HZ., Y.-J.L, OW., J.-R.Y., and J.-Y.W. with producing proteins and antibodies and morphological and molecular analysis, M.H. and Yu-Qiu Zhang with behavioral tests. X.G., F.-X.Z., and M.-Y.Y. generated mutant mice. R.K. provided SNS-Cre mice. X.Z., L.B., and K-CL. designed the project and wrote the manuscript.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; De Groot E, 2000, INT J DEV BIOL, V44, P327; Dobretsov M, 1999, BRAIN RES, V821, P212, DOI 10.1016/S0006-8993(98)01361-4; Dobretsov M, 1999, NEUROSCIENCE, V93, P723, DOI 10.1016/S0306-4522(99)00122-0; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; ESMANN M, 1988, METHOD ENZYMOL, V156, P105; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; FINK DJ, 1995, NEUROSCI LETT, V183, P206, DOI 10.1016/0304-3940(94)11152-9; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hamada L, 2003, BRIT J PHARMACOL, V138, P1517, DOI 10.1038/sj.bjp.0705170; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hyman SE, 2005, CURR BIOL, V15, pR154, DOI 10.1016/j.cub.2005.02.037; Joester A, 2001, MATRIX BIOL, V20, P13, DOI 10.1016/S0945-053X(00)00136-0; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Krishnan AV, 2005, BRAIN, V128, P1178, DOI 10.1093/brain/awh476; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Malik-Hall M, 2003, MOL BRAIN RES, V110, P298, DOI 10.1016/S0169-328X(02)00661-7; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; MATA M, 1991, BRAIN RES, V546, P47, DOI 10.1016/0006-8993(91)91157-V; MAXWELL DJ, 1987, TRENDS NEUROSCI, V10, P117, DOI 10.1016/0166-2236(87)90056-7; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nakatsuka T, 2000, NEUROSCIENCE, V99, P549, DOI 10.1016/S0306-4522(00)00224-4; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; OCONNOR LT, 1994, J NEUROSCI, V14, P1141, DOI 10.1523/JNEUROSCI.14-03-01141.1994; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Salio C, 2005, EUR J NEUROSCI, V22, P1951, DOI 10.1111/j.1460-9568.2005.04392.x; Santos MS, 2009, NEUROSCIENCE, V158, P189, DOI 10.1016/j.neuroscience.2008.03.029; Scuri R, 2007, EUR J NEUROSCI, V25, P159, DOI 10.1111/j.1460-9568.2006.05257.x; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Sumitomo K, 2000, CANCER LETT, V155, P37, DOI 10.1016/S0304-3835(00)00407-9; Sun T, 2006, NEUROSCIENCE, V141, P1233, DOI 10.1016/j.neuroscience.2006.05.010; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Tanaka M, 2003, INT IMMUNOL, V15, P71, DOI 10.1093/intimm/dxg005; Tanaka M, 1998, INT IMMUNOL, V10, P1305, DOI 10.1093/intimm/10.9.1305; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Urch CE, 2003, BRAIN RES PROTOC, V12, P26, DOI 10.1016/S1385-299X(03)00068-0; Willis W.D., 2004, SENSORY MECH SPINAL, V207, P1067, DOI [10.1126/science.207.4435.1067.b, DOI 10.1126/SCIENCE.207.4435.1067.B]; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zhang XL, 2010, EUR J NEUROSCI, V31, P450, DOI 10.1111/j.1460-9568.2009.07060.x; ZWIJSEN A, 1994, EUR J BIOCHEM, V225, P937, DOI 10.1111/j.1432-1033.1994.0937b.x	50	71	74	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					974	987		10.1016/j.neuron.2011.01.022	http://dx.doi.org/10.1016/j.neuron.2011.01.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382556	Bronze			2022-12-24	WOS:000288736500014
J	Chen, JA; Huang, YP; Mazzoni, EO; Tan, GC; Zavadil, J; Wichterle, H				Chen, Jun-An; Huang, Yuan-Ping; Mazzoni, Esteban O.; Tan, G. Christopher; Zavadil, Jiri; Wichterle, Hynek			Mir-17-3p Controls Spinal Neural Progenitor Patterning by Regulating Olig2/Irx3 Cross-Repressive Loop	NEURON			English	Article							EMBRYONIC STEM-CELLS; MOTOR-NEURON; MICRORNAS; IDENTITY; DICER; FATE; DIFFERENTIATION; MORPHOGENESIS; SPECIFICATION; MIR-196	Neural patterning relies on transcriptional cross-repressive interactions that ensure unequivocal assignment of neural progenitor identity to proliferating cells. Progenitors of spinal motor neurons (pMN) and V2 interneurons (p2) are specified by a pair of cross-repressive transcription factors, Olig2 and Irx3. Lineage tracing revealed that many p2 progenitors transiently express the pMN marker Olig2 during spinal cord development. Here we demonstrate that the repression of Olig2 in p2 domain is controlled by mir-17-3p nnicroRNA-mediated silencing of Olig2 mRNA. Mice lacking all microRNAs or just the mir-17 similar to 92 cluster manifest a dorsal shift in pMN/p2 boundary and impairment in the production of V2 interneurons. Our findings suggest that microRNA-mediated repression of Olig2 mRNA plays a critical role during the patterning of ventral spinal progenitor domains by shifting the balance of cross-repressive interactions between Olig2 and Irx3 transcription factors.	[Chen, Jun-An; Huang, Yuan-Ping; Mazzoni, Esteban O.; Tan, G. Christopher; Wichterle, Hynek] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chen, Jun-An; Huang, Yuan-Ping; Mazzoni, Esteban O.; Tan, G. Christopher; Wichterle, Hynek] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Chen, Jun-An; Huang, Yuan-Ping; Mazzoni, Esteban O.; Tan, G. Christopher; Wichterle, Hynek] Columbia Univ, Med Ctr, Dept Neurosci, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Zavadil, Jiri] NYU, Langone Med Ctr, NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	Columbia University; Columbia University; Columbia University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Wichterle, H (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	hw350@columbia.edu	Chen, Jun-An/AAZ-2441-2021; Zavadil, Jiri/ABG-1780-2020	Chen, Jun-An/0000-0001-9870-3203; Zavadil, Jiri/0000-0003-0640-5562; Wichterle, Hynek/0000-0002-7817-0080; mazzoni, esteban/0000-0001-8994-681X	Damon Runyon Cancer Research Fund; NIH [T32HD55165, NS058502, NS055923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923, R01NS058502] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Special thanks to Andrea Ventura (Memorial Sloan-Kettering Cancer Center) for kindly providing mir-17 similar to 92<SUP>+/-</SUP> founder mice and conditional mir-17 similar to 92 floxed ES cells and for the discussion of our results. We thank Ben Novitch (UCLA) for sharing Olig2-cre mice, Tom Jessell for reagents and antibodies, and Michael Kyba (University of Minnesota) for providing inducible 2Iox-ES cells. We also thank Laskaro Zagoraiou for her help with analysis of V2 inter-neurons. We are grateful to Asa Abeliovich and Jongpil Kim for sharing reagents for the initial set of pilot studies. We would like to thank Fiona Doetsch for critical reading of the manuscript, discussion, and comments, and Rosalind Bogan for help with manuscript preparation. We would like to acknowledge The NYU Cancer Institute Genomics Facility for expert assistance with microRNA TLDA profiling. E.O.M. was in part supported by Damon Runyon Cancer Research Fund fellowship and G.C.T. was in part funded by NIH training grant (T32HD55165). This research was supported by NIH grants (NS058502 and NS055923).	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen JA, 2007, EMBO REP, V8, P287, DOI 10.1038/sj.embor.7400903; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Furusho M, 2006, DEV BIOL, V293, P348, DOI 10.1016/j.ydbio.2006.01.031; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shibasaki K, 2007, GENE EXPR PATTERNS, V7, P57, DOI 10.1016/j.modgep.2006.05.008; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Ting DT, 2004, METH MOLEC MED, V105, P23; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang J, 2007, P NATL ACAD SCI USA, V104, P20850, DOI 10.1073/pnas.0710565105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01h01s5; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	42	86	89	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					721	735		10.1016/j.neuron.2011.01.014	http://dx.doi.org/10.1016/j.neuron.2011.01.014			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338882	Bronze, Green Accepted			2022-12-24	WOS:000288413200014
J	Salimpoor, VN; Benovoy, M; Larcher, K; Dagher, A; Zatorre, RJ				Salimpoor, Valorie N.; Benovoy, Mitchel; Larcher, Kevin; Dagher, Alain; Zatorre, Robert J.			Anatomically distinct dopamine release during anticipation and experience of peak emotion to music	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; HEALTHY-MEN; REWARD; PET; REGISTRATION; VALIDATION; PREDICTION; SUBSTRATE	Music, an abstract stimulus, can arouse feelings of euphoria and craving, similar to tangible rewards that involve the striatal dopaminergic system. Using the neurochemical specificity of [C-11]raclopride positron emission tomography scanning, combined with psychophysiological measures of autonomic nervous system activity, we found endogenous dopamine release in the striatum at peak emotional arousal during music listening. To examine the time course of dopamine release, we used functional magnetic resonance imaging with the same stimuli and listeners, and found a functional dissociation: the caudate was more involved during the anticipation and the nucleus accumbens was more involved during the experience of peak emotional responses to music. These results indicate that intense pleasure in response to music can lead to dopamine release in the striatal system. Notably, the anticipation of an abstract reward can result in dopamine release in an anatomical pathway distinct from that associated with the peak pleasure itself. Our results help to explain why music is of such high value across all human societies.	[Salimpoor, Valorie N.; Larcher, Kevin; Dagher, Alain; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Salimpoor, Valorie N.; Zatorre, Robert J.] Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada; [Salimpoor, Valorie N.; Benovoy, Mitchel; Zatorre, Robert J.] Ctr Interdisciplinary Res Mus Media & Technol, Montreal, PQ, Canada; [Benovoy, Mitchel] McGill Univ, Ctr Intelligent Machines, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University	Salimpoor, VN (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	valorie.salimpoor@mail.mcgill.ca; robert.zatorre@mcgill.ca			Canadian Institutes of Health Research; Natural Science and Engineering Research Council; Jeanne Timmins Costello award; Centre for Interdisciplinary Research in Music Media and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Jeanne Timmins Costello award; Centre for Interdisciplinary Research in Music Media and Technology	We thank the staff of the Montreal Neurological Institute PET and MR Units and the staff of the Centre for Interdisciplinary Research in Music Media and Technology for help with data acquisition, M. Ferreira and M. Bouffard for their assistance with data analysis, and G. Longo for assistance with stimulus preparation. This research was supported by funding from the Canadian Institutes of Health Research to R.J.Z., a Natural Science and Engineering Research Council stipend to V.N.S., a Jeanne Timmins Costello award to V.N.S. and Centre for Interdisciplinary Research in Music Media and Technology awards to V.N.S. and M.B.	Aston JAD, 2000, NEUROIMAGE, V12, P245, DOI 10.1006/nimg.2000.0620; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; Costes N, 2009, NEUROIMAGE, V47, P1496, DOI 10.1016/j.neuroimage.2009.05.052; Dube L, 2003, COGNITION EMOTION, V17, P263, DOI 10.1080/02699930302295; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; Endres CJ, 1997, J CEREBR BLOOD F MET, V17, P932, DOI 10.1097/00004647-199709000-00002; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Grewe O, 2009, ANN NY ACAD SCI, V1169, P351, DOI 10.1111/j.1749-6632.2009.04783.x; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Huron D, 2009, MUSIC EMOTION; Huron D.B., 2006, SWEET ANTICIPATION M; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; LITTON JE, 1994, J CEREBR BLOOD F MET, V14, P358, DOI 10.1038/jcbfm.1994.45; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Slifstein M, 2010, SYNAPSE, V64, P350, DOI 10.1002/syn.20734; Sloboda JA., 2001, MUSIC EMOTION THEORY; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Valentin VV, 2009, J NEUROPHYSIOL, V102, P3384, DOI 10.1152/jn.91195.2008; Volkow ND, 1997, NATURE, V386, P827, DOI 10.1038/386827a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald D. H., 2011, NEUROBIOLOGY SENSATI; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	49	811	841	9	292	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					257	U355		10.1038/nn.2726	http://dx.doi.org/10.1038/nn.2726			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217764				2022-12-24	WOS:000286595400025
J	D'Amelio, M; Cavallucci, V; Middei, S; Marchetti, C; Pacioni, S; Ferri, A; Diamantini, A; De Zio, D; Carrara, P; Battistini, L; Moreno, S; Bacci, A; Ammassari-Teule, M; Marie, H; Cecconi, F				D'Amelio, Marcello; Cavallucci, Virve; Middei, Silvia; Marchetti, Cristina; Pacioni, Simone; Ferri, Alberto; Diamantini, Adamo; De Zio, Daniela; Carrara, Paolo; Battistini, Luca; Moreno, Sandra; Bacci, Alberto; Ammassari-Teule, Martine; Marie, Helene; Cecconi, Francesco			Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA PROTEIN; LONG-TERM DEPRESSION; DENDRITIC SPINE LOSS; A-BETA; TRANSGENIC MICE; CELL-DEATH; PRECURSOR PROTEIN; IN-VIVO; ACTIVATION	Synaptic loss is the best pathological correlate of the cognitive decline in Alzheimer's disease; however, the molecular mechanisms underlying synaptic failure are unknown. We found a non-apoptotic baseline caspase-3 activity in hippocampal dendritic spines and an enhancement of this activity at the onset of memory decline in the Tg2576-APPswe mouse model of Alzheimer's disease. In spines, caspase-3 activated calcineurin, which in turn triggered dephosphorylation and removal of the GluR1 subunit of AMPA-type receptor from postsynaptic sites. These molecular modifications led to alterations of glutamatergic synaptic transmission and plasticity and correlated with spine degeneration and a deficit in hippocampal-dependent memory. Notably, pharmacological inhibition of caspase-3 activity in Tg2576 mice rescued the observed Alzheimer-like phenotypes. Our results identify a previously unknown caspase-3-dependent mechanism that drives synaptic failure and contributes to cognitive dysfunction in Alzheimer's disease. These findings indicate that caspase-3 is a potential target for pharmacological therapy during early disease stages.	[D'Amelio, Marcello; Cavallucci, Virve; Cecconi, Francesco] Fdn Santa Lucia, IRCCS, Dulbecco Telethon Inst, Lab Mol Neuroembryol, Rome, Italy; [D'Amelio, Marcello] Univ Campus Biomed, Lab Mol Neurosci, Rome, Italy; [Middei, Silvia; Ammassari-Teule, Martine] Fdn Santa Lucia, IRCCS, CNR, Inst Neurosci, Rome, Italy; [Marchetti, Cristina; Marie, Helene] European Brain Res Inst, Lab Mol Mech Synapt Plast, Rome, Italy; [Pacioni, Simone; Bacci, Alberto] European Brain Res Inst, Lab Cellular Physiol Cort Microcircuits, Rome, Italy; [Ferri, Alberto] CNR, Inst Neurosci, Dept Psychobiol & Psychopharmacol, Rome, Italy; [Diamantini, Adamo; Battistini, Luca] Fdn Santa Lucia, IRCCS, Lab Neuroimmunol, Rome, Italy; [De Zio, Daniela; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Carrara, Paolo; Moreno, Sandra] Univ Roma Tre, Dept Biol Interdept, Lab Electron Microscopy LIME, Rome, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); IRCCS Santa Lucia; University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; University of Rome Tor Vergata; Roma Tre University	Cecconi, F (corresponding author), Fdn Santa Lucia, IRCCS, Dulbecco Telethon Inst, Lab Mol Neuroembryol, Rome, Italy.	francesco.cecconi@uniroma2.it	Battistini, luca/ABE-1882-2021; Marchetti, Cristina/G-7220-2012; Marie, Hélène/F-1404-2011; Battistini, Luca/D-6920-2014; FERRI, ALBERTO/B-7660-2015; Moreno, Sandra/D-4254-2014; Cecconi, Francesco/K-3969-2016	Marie, Hélène/0000-0003-2310-6097; Battistini, Luca/0000-0002-6488-4891; FERRI, ALBERTO/0000-0002-4097-0605; Cecconi, Francesco/0000-0002-5614-4359; moreno, sandra/0000-0002-1079-3222; Cavallucci, Virve/0000-0003-3082-6359; D'Amelio, Marcello/0000-0001-6526-1832; De Zio, Daniela/0000-0002-9454-402X; Ammassari-Teule, Martine/0000-0003-1987-5723; middei, silvia/0000-0002-0488-323X; Bacci, Alberto/0000-0002-3355-5892	Telethon Foundation; Italian Ministry of Health; Italian Ministry of University; Research and Compagnia di San Paolo	Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Research and Compagnia di San Paolo(Compagnia di San Paolo)	We thank the Animal Facility of the IRCCS Fondazione Santa Lucia/EBRI/CNR for the mouse work, Taconic for the Tg2576 mice, M. Acuna-Villa and M.W. Bennett for editorial and secretarial work, R. Nardacci, F. Fanelli and M. Nencini for research assistance and help with image processing, and A. Roberto and A. Pignataro for help with Neurolucida measurements. We are grateful to E. Perez-Paya for providing us with the apoptosome inhibitor QM56. This work was supported in part by grants from the Telethon Foundation, Ricerca Corrente and Ricerca Finalizzata from the Italian Ministry of Health, the Italian Ministry of University and Research and Compagnia di San Paolo.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bravarenko NI, 2006, EUR J NEUROSCI, V23, P129, DOI 10.1111/j.1460-9568.2005.04549.x; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; FERRER I, 1990, NEUROSCI LETT, V114, P11, DOI 10.1016/0304-3940(90)90420-E; Ferri A, 2000, J NEUROCHEM, V75, P606, DOI 10.1046/j.1471-4159.2000.0750606.x; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gylys KH, 2004, NEUROCHEM INT, V44, P125, DOI 10.1016/S0197-0186(03)00146-3; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lajtha A, 2008, HDB NEUROCHEMISTRY M; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Marin N, 2000, MECH AGEING DEV, V119, P63, DOI 10.1016/S0047-6374(00)00172-X; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Mukerjee N, 2000, ARCH BIOCHEM BIOPHYS, V379, P337, DOI 10.1006/abbi.2000.1889; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Santamaria B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006634; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	50	408	417	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					69	U97		10.1038/nn.2709	http://dx.doi.org/10.1038/nn.2709			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21151119	Green Submitted			2022-12-24	WOS:000285684900016
J	Teitelbaum, SL				Teitelbaum, Steven L.			Stem Cells and Osteoporosis Therapy	CELL STEM CELL			English	Editorial Material							PARATHYROID-HORMONE; ALENDRONATE	Skeletal remodeling requires recruitment of osteoblast precursors, in the form of MSCs, to the bone surface. In this issue of Cell Stem Cell, Wu et al. (2010) demonstrate that this event is mediated by osteoclastic mobilization of active transforming growth factor beta 1, which is inhibited by a common antiosteoporosis drug.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	teitelbs@wustl.edu		Teitelbaum, Steven/0000-0002-4054-6679				Allen MR, 2007, J BONE MINER RES, V22, P1759, DOI 10.1359/JBMR.070720; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Eisman JA, 2011, J BONE MINER RES, V26, P242, DOI 10.1002/jbmr.212; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012	9	47	55	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					553	554		10.1016/j.stem.2010.10.004	http://dx.doi.org/10.1016/j.stem.2010.10.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040895	Bronze			2022-12-24	WOS:000284390500005
J	Dombeck, DA; Harvey, CD; Tian, L; Looger, LL; Tank, DW				Dombeck, Daniel A.; Harvey, Christopher D.; Tian, Lin; Looger, Loren L.; Tank, David W.			Functional imaging of hippocampal place cells at cellular resolution during virtual navigation	NATURE NEUROSCIENCE			English	Article							FREELY MOVING ANIMALS; IN-VIVO; NEURAL ACTIVITY; PYRAMIDAL CELLS; UNIT-ACTIVITY; NEURONS; MEMORY; RATS; CA1; INTERNEURONS	Spatial navigation is often used as a behavioral task in studies of the neuronal circuits that underlie cognition, learning and memory in rodents. The combination of in vivo microscopy with genetically encoded indicators has provided an important new tool for studying neuronal circuits, but has been technically difficult to apply during navigation. Here we describe methods for imaging the activity of neurons in the CA1 region of the hippocampus with subcellular resolution in behaving mice. Neurons that expressed the genetically encoded calcium indicator GCaMP3 were imaged through a chronic hippocampal window. Head-restrained mice performed spatial behaviors in a setup combining a virtual reality system and a custom-built two-photon microscope. We optically identified populations of place cells and determined the correlation between the location of their place fields in the virtual environment and their anatomical location in the local circuit. The combination of virtual reality and high-resolution functional imaging should allow a new generation of studies to investigate neuronal circuit dynamics during behavior.	[Dombeck, Daniel A.; Harvey, Christopher D.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Dombeck, Daniel A.; Harvey, Christopher D.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Tian, Lin; Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA USA	Princeton University; Princeton University; Howard Hughes Medical Institute	Tank, DW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ddombeck@princeton.edu; dwtank@princeton.edu		Tian, Lin/0000-0001-7012-6926; Dombeck, Daniel/0000-0003-2576-5918	Princeton University; National Institutes of Health [5R01MH083686-03]; Howard Hughes Medical Institute; Helen Hay Whitney Foundation; Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686] Funding Source: NIH RePORTER	Princeton University(Princeton University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen Hay Whitney Foundation; Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Princeton University, the National Institutes of Health (grant 5R01MH083686-03), The Howard Hughes Medical Institute, The Helen Hay Whitney Foundation and The Patterson Trust. We thank F. Collman for the brain motion correction algorithm.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Ego-Stengel V, 2007, HIPPOCAMPUS, V17, P161, DOI 10.1002/hipo.20253; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nakamura NH, 2010, NEUROSCIENCE, V166, P994, DOI 10.1016/j.neuroscience.2009.12.069; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 2007, HIPPOCAMPUS BOOK, P475, DOI DOI 10.1093/ACPROF:OSO/9780195100273.003.0011; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; Reidl J, 2007, NEUROIMAGE, V34, P94, DOI 10.1016/j.neuroimage.2006.08.031; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; SCHNEE A, 2008, RATS VIRTUAL REALITY; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takahashi S, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.009.2009; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wilent WB, 2007, J NEUROPHYSIOL, V97, P4152, DOI 10.1152/jn.01200.2006; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	475	483	4	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1433	U180		10.1038/nn.2648	http://dx.doi.org/10.1038/nn.2648			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890294	Green Accepted			2022-12-24	WOS:000283658200026
J	Breakefield, XO; Sena-Esteves, M				Breakefield, Xandra O.; Sena-Esteves, Miguel			Healing Genes in the Nervous System	NEURON			English	Editorial Material							DISEASE; THERAPY; DELIVERY; BRAIN; CELLS; MICE	The evolution of gene therapy has led to the development of promising new therapeutic approaches. This NeuroView will introduce the variety of delivery vehicles currently available for gene therapy, a range of preclinical strategies for tackling major diseases of the nervous system, the clinical limitations, and ethical considerations.	[Breakefield, Xandra O.] Harvard Univ, Sch Med, Ctr Neurosci, Boston, MA 02114 USA; [Breakefield, Xandra O.] Harvard Univ, Sch Med, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02115 USA; [Breakefield, Xandra O.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp,Ctr Mol Imaging Res, Boston, MA 02115 USA; [Breakefield, Xandra O.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Sena-Esteves, Miguel] Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Gene Therapy Ctr,Dept Neurol, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Breakefield, XO (corresponding author), Harvard Univ, Sch Med, Ctr Neurosci, Boston, MA 02114 USA.	breakefield@hms.harvard.edu			NCI NIH HHS [CA069246, P01 CA069246] Funding Source: Medline; NICHD NIH HHS [R01HD060576, R01 HD060576] Funding Source: Medline; NINDS NIH HHS [P01 NS024279, NS24279, P01 NS024279-23, R01NS066310, R01 NS066310, P01 NS037409, NS037409, U01NS064096, U01 NS064096] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060576] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA069246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279, U01NS064096, P01NS037409, R01NS066310, P50NS037409] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BJORKLUND T, 2010, MOVEMENT DISORD, V161, pS161; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; Feigin A, 2007, P NATL ACAD SCI USA, V104, P19559, DOI 10.1073/pnas.0706006104; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; GRAY SJ, 2010, THERAPEUTIC IN PRESS, DOI DOI 10.4155/TDE.10.50; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Kaur B, 2009, CURR GENE THER, V9, P341, DOI 10.2174/156652309789753329; Kells AP, 2010, J NEUROSCI, V30, P9567, DOI 10.1523/JNEUROSCI.0942-10.2010; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Roy K, 2010, HUM GENE THER, V21, P915, DOI 10.1089/hum.2010.041; Ryan DA, 2010, MOL THER, V18, P1471, DOI 10.1038/mt.2010.111; Yang YH, 2010, ANN NEUROL, V67, P498, DOI 10.1002/ana.21935	13	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 21	2010	68	2					178	181		10.1016/j.neuron.2010.10.005	http://dx.doi.org/10.1016/j.neuron.2010.10.005			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	681IJ	20955923	Green Accepted, Bronze			2022-12-24	WOS:000284304300004
J	Chou, S; Chu, P; Hwang, W; Lodish, H				Chou, Song; Chu, Pat; Hwang, William; Lodish, Harvey			Expansion of Human Cord Blood Hematopoietic Stem Cells for Transplantation	CELL STEM CELL			English	Editorial Material									[Chou, Song; Lodish, Harvey] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chu, Pat; Hwang, William] Singapore Gen Hosp, Dept Hematol, Singapore 168608, Singapore; [Chu, Pat; Hwang, William] Singapore Cord Blood Bank, Singapore 229899, Singapore; [Hwang, William] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Lodish, Harvey] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Singapore General Hospital; National University of Singapore; Massachusetts Institute of Technology (MIT)	Lodish, H (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	Hwang, William/AAT-3079-2021; Hwang, William/AAX-8452-2021	Hwang, William/0000-0003-0143-6263; 	NIDDK NIH HHS [R01 DK067356] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067356] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Foeken LM, 2010, BONE MARROW TRANSPL, V45, P811, DOI 10.1038/bmt.2010.9; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hwang WYK, 2007, BIOL BLOOD MARROW TR, V13, P444, DOI 10.1016/j.bbmt.2006.11.005; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Robinson SN, 2006, BONE MARROW TRANSPL, V37, P359, DOI 10.1038/sj.bmt.1705258; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	10	40	41	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					427	428		10.1016/j.stem.2010.09.001	http://dx.doi.org/10.1016/j.stem.2010.09.001			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887947	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000283270600005
J	Navarrete, M; Araque, A				Navarrete, Marta; Araque, Alfonso			Endocannabinoids Potentiate Synaptic Transmission through Stimulation of Astrocytes	NEURON			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL CELLS; ENDOGENOUS CANNABINOIDS; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES; GLIAL-CELLS; MODULATION; PLASTICITY; NEURONS; ACTIVATION	Endocannabinoids and their receptor CB1 play key roles in brain function. Astrocytes express CB1 Rs that are activated by endocannabinoids released by neurons. However, the consequences of the endocannabinoid-mediated neuron-astrocyte signaling on synaptic transmission are unknown. We show that endocannabinoids released by hippocampal pyramidal neurons increase the probability of transmitter release at CA3-CA1 synapses. This synaptic potentiation is due to CB1R-induced Ca2+ elevations in astrocytes, which stimulate the release of glutamate that activates presynaptic metabotropic glutamate receptors. While endocannabinoids induce synaptic depression in the stimulated neuron by direct activation of presynaptic CB1 Rs, they indirectly lead to synaptic potentiation in relatively more distant neurons by activation of CB1 Rs in astrocytes. Hence, astrocyte calcium signal evoked by endogenous stimuli (neuron-released endocannabinoids) modulates synaptic transmission. Therefore, astrocytes respond to endocannabinoids that then potentiate synaptic transmission, indicating that astrocytes are actively involved in brain physiology.	[Navarrete, Marta; Araque, Alfonso] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Araque, A (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.		Navarrete, Marta/E-9266-2013	Navarrete, Marta/0000-0003-2097-4788; Araque, Alfonso/0000-0003-3840-1144	Ministerio de Genoa e Innovacion, Spain [8FU2007-064764]; European Union [HEALTH-F2-2007-202167]; Cajal Blue Brain	Ministerio de Genoa e Innovacion, Spain; European Union(European Commission); Cajal Blue Brain	We thank G Perea, W. Buno, E D Martin, and L. Maglio for helpful comments, and A Zimmer for the generous gift of the CB1R knockout mice Supported by grants from Ministerio de Genoa e Innovacion (8FU2007-064764), Spain, European Union (HEALTH-F2-2007-202167) and Cajal Blue Brain	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beierlein M, 2006, J NEUROSCI, V26, P6958, DOI 10.1523/JNEUROSCI.0613-06.2006; Cachope R, 2007, NEURON, V56, P1034, DOI 10.1016/j.neuron.2007.11.014; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DI MV, 1994, NATURE, V372, P686; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Faas GC, 2002, J NEUROSCI, V22, P6885; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Hashimotodani Y, 2007, NEUROSCIENTIST, V13, P127, DOI 10.1177/1073858406296716; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kyriakatos A, 2007, J NEUROSCI, V27, P12664, DOI 10.1523/JNEUROSCI.3174-07.2007; Lovinger David M., 2008, V184, P435; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Miura M, 2002, J NEUROSCI, V22, P8379; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porter JT, 1996, J NEUROSCI, V16, P5073; RAASTAD M, 1995, EUR J NEUROSCI, V7, P1882, DOI 10.1111/j.1460-9568.1995.tb00709.x; Rodriguez-Moreno A, 1998, NEURON, V21, P1477, DOI 10.1016/S0896-6273(00)80665-0; Sanchez-Prieto J, 2004, FEBS LETT, V576, P428, DOI 10.1016/j.febslet.2004.09.053; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Volterra A., 2002, TRIPARTITE SYNAPSE G, P164; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	53	313	317	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					113	126		10.1016/j.neuron.2010.08.043	http://dx.doi.org/10.1016/j.neuron.2010.08.043			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920795	Green Submitted, Bronze			2022-12-24	WOS:000283704200012
J	Renier, LA; Anurova, I; De Volder, AG; Carlson, S; VanMeter, J; Rauschecker, JP				Renier, Laurent A.; Anurova, Irina; De Volder, Anne G.; Carlson, Synnove; VanMeter, John; Rauschecker, Josef P.			Preserved Functional Specialization for Spatial Processing in the Middle Occipital Gyrus of the Early Blind	NEURON			English	Article							CROSS-MODAL PLASTICITY; VISUAL-CORTEX; CONGENITALLY BLIND; AUDITORY MOTION; MULTISENSORY INTEGRATION; SENSORY SUBSTITUTION; SOUND LOCALIZATION; NEURAL-NETWORKS; TACTILE ACUITY; EARLY-ONSET	The occipital cortex (OC) of early-blind humans is activated during various nonvisual perceptual and cognitive tasks, but little is known about its modular organization. Using functional MRI we tested whether processing of auditory versus tactile and spatial versus nonspatial information was dissociated in the OC of the early blind. No modality-specific OC activation was observed. However, the right middle occipital gyrus (MOG) showed a preference for spatial over nonspatial processing of both auditory and tactile stimuli. Furthermore, MOG activity was correlated with accuracy of individual sound localization performance. In sighted controls, most of extrastriate OC, including the MOG, was deactivated during auditory and tactile conditions, but the right MOG was more activated during spatial than nonspatial visual tasks. Thus, although the sensory modalities driving the neurons in the reorganized OC of blind individuals are altered, the functional specialization of extrastriate cortex is retained regardless of visual experience.	[Renier, Laurent A.; Anurova, Irina; Rauschecker, Josef P.] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Lab Integrat Neurosci & Cognit, Washington, DC 20007 USA; [Renier, Laurent A.; De Volder, Anne G.] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Anurova, Irina; Carlson, Synnove] Univ Helsinki, Inst Biomed Physiol, Neurosci Unit, FIN-00014 Helsinki, Finland; [Carlson, Synnove] Aalto Univ, Sch Sci & Technol, Low Temp Lab, Brain Res Unit, FI-00076 Aalto, Finland; [Carlson, Synnove] Univ Tampere, Sch Med, Tampere 33014, Finland; [VanMeter, John] Georgetown Univ, Med Ctr, Ctr Funct & Mol Imaging, Washington, DC 20007 USA; [Rauschecker, Josef P.] Aalto Univ, Sch Sci & Technol, Ctr Excellence Computat Complex Syst Res, Mind & Brain Lab, FI-00076 Aalto, Finland	Georgetown University; Universite Catholique Louvain; University of Helsinki; Aalto University; Tampere University; Georgetown University; Aalto University	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Lab Integrat Neurosci & Cognit, 3970 Reservoir Rd NW, Washington, DC 20007 USA.		Carlson, Synnöve/AAM-2655-2021; Carlson, Synnöve/A-6337-2013; Rauschecker, Josef P/A-4120-2013; Carlson, Synnöve/G-2210-2013; VanMeter, John W/D-2589-2018	Carlson, Synnöve/0000-0003-1462-7560; VanMeter, John W/0000-0002-7012-5197; Rauschecker, Josef P./0000-0003-4353-9084	National Institutes of Health [R01 NS052494, R01EY018923]; Cognitive Neuroscience Initiative of the National Science Foundation [BCS-0519127]; NSF [OISE-0730255]; Tinnitus Research Initiative; Academy of Finland; National Fund for Scientific Research (Belgium); Belgian American Educational Foundation; Universite Catholique de Louvain (Belgium);  [123044]; NATIONAL EYE INSTITUTE [R01EY018923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cognitive Neuroscience Initiative of the National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Tinnitus Research Initiative; Academy of Finland(Academy of Finland); National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); Belgian American Educational Foundation; Universite Catholique de Louvain (Belgium); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to the blind volunteers for their participation in our study The study was supported by grants from the National Institutes of Health (R01 NS052494 and R01EY018923), the Cognitive Neuroscience Initiative of the National Science Foundation (BCS-0519127), the NSF PIRE Program (OISE-0730255), and the Tinnitus Research Initiative to J P Rauschecker, and by grants from the Academy of Finland to S C (a National Center of Excellence grant and Neuro-Program) and to I A (grant number 123044) A G D V is a senior research associate and L Renier is a post doctoral researcher at the National Fund for Scientific Research (Belgium) L R was also supported by the Belgian American Educational Foundation and the Special Fund for Research from the Universite Catholique de Louvain (Belgium) We also wish to thank Jennifer Sasaki and Valerie Wuyts for their help in the subject recruitment and Priyanka Chablani for her editing work	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Arno P, 2001, NEUROIMAGE, V13, P632, DOI 10.1006/nimg.2000.0731; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bonino D, 2008, ARCH ITAL BIOL, V146, P133; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2003, J NEUROPHYSIOL, V90, P1965, DOI 10.1152/jn.00279.2003; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Collignon O, 2006, BRAIN RES, V1075, P175, DOI 10.1016/j.brainres.2005.12.079; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Falchier A, 2002, J NEUROSCI, V22, P5749; Fortin M, 2008, BRAIN, V131, P2995, DOI 10.1093/brain/awn250; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Goldreich D, 2003, J NEUROSCI, V23, P3439; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Hackett TA, 2009, HEARING RES, V258, P1, DOI 10.1016/j.heares.2009.10.016; Hamilton RH, 2004, NEUROREPORT, V15, P803, DOI 10.1097/00001756-200404090-00012; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HYVARINEN J, 1981, NEUROSCI LETT, V26, P239, DOI 10.1016/0304-3940(81)90139-7; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; KUJALA T, 1992, ELECTROEN CLIN NEURO, V84, P469, DOI 10.1016/0168-5597(92)90034-9; KUJALA T, 1995, EXP BRAIN RES, V104, P519; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2002, NEUROPSYCHOLOGIA, V40, P1868, DOI 10.1016/S0028-3932(02)00071-4; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Poirier C, 2005, COGNITIVE BRAIN RES, V25, P650, DOI 10.1016/j.cogbrainres.2005.08.015; Prather SC, 2004, NEUROPSYCHOLOGIA, V42, P1079, DOI 10.1016/j.neuropsychologia.2003.12.013; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2009, NEUROREPORT, V20, P543, DOI 10.1097/WNR.0b013e3283279909; RAUSCHECKER JP, 1994, EUR J NEUROSCI, V6, P149, DOI 10.1111/j.1460-9568.1994.tb00256.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; Renier LA, 2009, J NEUROSCI, V29, P10950, DOI 10.1523/JNEUROSCI.0910-09.2009; Ricciardi E, 2007, CEREB CORTEX, V17, P2933, DOI 10.1093/cercor/bhm018; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Roder B, 2003, INT J PSYCHOPHYSIOL, V50, P27, DOI 10.1016/S0167-8760(03)00122-3; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Roder B, 1996, COGNITIVE BRAIN RES, V4, P77, DOI 10.1016/0926-6410(96)00024-9; Roder B, 2001, COGNITIVE BRAIN RES, V11, P289, DOI 10.1016/S0926-6410(01)00002-7; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saenz M, 2008, J NEUROSCI, V28, P5141, DOI 10.1523/JNEUROSCI.0803-08.2008; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Stilla R, 2008, J VISION, V8, DOI 10.1167/8.10.13; Stoesz MR, 2003, INT J PSYCHOPHYSIOL, V50, P41, DOI 10.1016/S0167-8760(03)00123-5; Talairach G, 1988, COPLANAR STEREOTAXIC; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; Vanlierde A, 2003, NEUROIMAGE, V19, P698, DOI 10.1016/S1053-8119(03)00153-8; VERAART C, 1990, BRAIN RES, V510, P115, DOI 10.1016/0006-8993(90)90735-T; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weaver KE, 2007, J COGNITIVE NEUROSCI, V19, P315, DOI 10.1162/jocn.2007.19.2.315; Weeks R, 2000, J NEUROSCI, V20, P2664; Weisser V, 2005, EXP BRAIN RES, V166, P572, DOI 10.1007/s00221-005-2397-4; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	82	201	204	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					138	148		10.1016/j.neuron.2010.09.021	http://dx.doi.org/10.1016/j.neuron.2010.09.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920797	Green Accepted, Bronze			2022-12-24	WOS:000283704200014
J	Kerlin, AM; Andermann, ML; Berezovskii, VK; Reid, RC				Kerlin, Aaron M.; Andermann, Mark L.; Berezovskii, Vladimir K.; Reid, R. Clay			Broadly Tuned Response Properties of Diverse Inhibitory Neuron Subtypes in Mouse Visual Cortex	NEURON			English	Article							RECEPTIVE-FIELD PROPERTIES; GREEN FLUORESCENT PROTEIN; OCULAR DOMINANCE; IN-VIVO; FUNCTIONAL-ORGANIZATION; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; NONPYRAMIDAL NEURONS; GABAERGIC NEURONS; CORTICAL NETWORKS	Different subtypes of GABAergic neurons in sensory cortex exhibit diverse morphology, histochemical markers, and patterns of connectivity. These subtypes likely play distinct roles in cortical function, but their in vivo response properties remain unclear. We used in vivo calcium imaging, combined with immunohistochemical and genetic labels, to record visual responses in excitatory neurons and up to three distinct subtypes of GABAergic neurons (immunoreactive for parvalbumin, somatostatin, or vasoactive intestinal peptide) in layer 2/3 of mouse visual cortex. Excitatory neurons had sharp response selectivity for stimulus orientation and spatial frequency, while all GABAergic subtypes had broader selectivity. Further, bias in the responses of GABAergic neurons toward particular orientations or spatial frequencies tended to reflect net biases of the surrounding neurons. These results suggest that the sensory responses of layer 2/3 GABAergic neurons reflect the pooled activity of the surrounding population-a principle that may generalize across species and sensory modalities.	[Kerlin, Aaron M.; Andermann, Mark L.; Berezovskii, Vladimir K.; Reid, R. Clay] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Goldenson 243,220 Longwood Ave, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu	Berezovskii, Vladimir/B-9866-2013; Berezovskii, Vladimir/AAB-5253-2022	Berezovskii, Vladimir/0000-0003-4077-3940; 	NIH [R01 EY018742, P30 EY12196]; Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE [P30EY012196, R01EY018742] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Sergey Yurgenson for technical contributions and Soumya Chatterjee for assistance with cell-attached recordings. Aleksandr Vagodny, Demetris Roumis, Mark Henry, Lindsay Knox, Patrick Dempsey, and Derrick Brittain provided valuable technical assistance. We also thank Vincent Bonin, Kenichi Ohki, Lindsey Glickfeld, Prakash Kara, Mark Histed, Joshua Morgan, Jessica Cardin, Wei-Chung Allen Lee, Julie Haas, and Cindy Poo for advice, suggestions, and discussion. This work was supported by NIH grant R01 EY018742, grant P30 EY12196, and the Helen Hay Whitney Foundation (M.L.A.).	Ahmed B, 1997, J COMP NEUROL, V380, P230; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BOUSFIELD JD, 1977, BRAIN RES, V136, P154, DOI 10.1016/0006-8993(77)90140-8; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CELIO MR, 1981, NATURE, V293, P300, DOI 10.1038/293300a0; Cho W, 2010, J IND ENG CHEM, V16, P20, DOI 10.1016/j.jiec.2010.01.027; CONNOR JR, 1984, NEUROSCIENCE, V12, P1027, DOI 10.1016/0306-4522(84)90002-2; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; FELDMAN ML, 1978, J COMP NEUROL, V179, P761, DOI 10.1002/cne.901790406; Ferezou I, 2002, J NEUROSCI, V22, P7389; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; HAWKEN MJ, 1987, PROC R SOC SER B-BIO, V231, P251, DOI 10.1098/rspb.1987.0044; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARTIN KAC, 1983, EXP BRAIN RES, V50, P193; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nowak LG, 2008, CEREB CORTEX, V18, P1058, DOI 10.1093/cercor/bhm137; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; PAYNE BR, 1983, J NEUROPHYSIOL, V49, P1051, DOI 10.1152/jn.1983.49.4.1051; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Porter JT, 1999, J NEUROSCI, V19, P5228; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sagdullaev BT, 2004, DOC OPHTHALMOL, V108, P181, DOI 10.1007/s10633-004-5734-1; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; SWADLOW HA, 1988, J NEUROPHYSIOL, V59, P1162, DOI 10.1152/jn.1988.59.4.1162; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; WAHLE P, 1993, J COMP NEUROL, V329, P519, DOI 10.1002/cne.903290408; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	92	379	380	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					858	871		10.1016/j.neuron.2010.08.002	http://dx.doi.org/10.1016/j.neuron.2010.08.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826316	Green Accepted, Bronze			2022-12-24	WOS:000281938900019
J	Mohrin, M; Bourke, E; Alexander, D; Warr, MR; Barry-Holson, K; Le Beau, MM; Morrison, CG; Passegue, E				Mohrin, Mary; Bourke, Emer; Alexander, David; Warr, Matthew R.; Barry-Holson, Keegan; Le Beau, Michelle M.; Morrison, Ciaran G.; Passegue, Emmanuelle			Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; SELF-RENEWAL; DAMAGE; MECHANISMS; PROGENITOR; PROLIFERATION; PATHWAYS	Most adult stem cells, including hematopoietic stem cells (HSCs), are maintained in a quiescent or resting state in vivo. Quiescence is widely considered to be an essential protective mechanism for stem cells that minimizes endogenous stress caused by cellular respiration and DNA replication. We demonstrate that HSC quiescence can also have detrimental effects. We found that HSCs have unique cell-intrinsic mechanisms ensuring their survival in response to ionizing irradiation (IR), which include enhanced prosurvival gene expression and strong activation of p53-mediated DNA damage response. We show that quiescent and proliferating HSCs are equally radioprotected but use different types of DNA repair mechanisms. We describe how nonhomologous end joining (NHEJ)-mediated DNA repair in quiescent HSCs is associated with acquisition of genomic rearrangements, which can persist in vivo and contribute to hematopoietic abnormalities. Our results demonstrate that quiescence is a double-edged sword that renders HSCs intrinsically vulnerable to mutagenesis following DNA damage.	[Mohrin, Mary; Warr, Matthew R.; Barry-Holson, Keegan; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; [Bourke, Emer; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Alexander, David] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Le Beau, Michelle M.] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Le Beau, Michelle M.] Ctr Comprehens Canc, Chicago, IL 60637 USA	University of California System; University of California San Francisco; Ollscoil na Gaillimhe-University of Galway; University of California System; University of California Santa Cruz; University of Chicago; Robert H. Lurie Comprehensive Cancer Center	Passegue, E (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	passeguee@stemcell.ucsf.edu	Morrison, Ciaran/AAH-2034-2019; Morrison, Ciaran/B-6568-2008	Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029; Bourke, Emer/0000-0002-2218-3114; Passegue, Emmanuelle/0000-0002-3516-297X	CIRM; PHS [P01 CA40046]; Rita Allen Scholar Award; Science Foundation Ireland; NATIONAL CANCER INSTITUTE [P01CA040046] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Rita Allen Scholar Award; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. David Toczyski, Zhao-Qi Wang, and Martin Carroll for insights and suggestions, Elizabeth Davis for SKY analyses, Tara Rambaldo and Bill Hyun for management of the Flow Cytrometry core facility, Dr. Gordon Shore for anti-Bid antibody gift, Dr. William Weiss for Trp53<SUP>-/-</SUP> mice, Dr. Andrew Leavitt for mobilization reagents, and all members of the Passegue laboratory for comments and discussion. M.M. is supported by a CIRM pre-doctoral training grant. This work was supported by a PHS P01 CA40046 to M.M.L., a Science Foundation Ireland PI award to C.G.M. and a CIRM New Investigator Award and Rita Allen Scholar Award to E.P.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chambers SM, 2007, STEM CELL REV, V3, P201, DOI 10.1007/s12015-007-0027-1; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Klaude M, 1996, MUTAT RES-DNA REPAIR, V363, P89, DOI 10.1016/0921-8777(95)00063-1; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028	34	426	441	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					174	185		10.1016/j.stem.2010.06.014	http://dx.doi.org/10.1016/j.stem.2010.06.014			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20619762	Green Accepted, Bronze			2022-12-24	WOS:000281107400010
J	Higley, MJ; Sabatini, BL				Higley, Michael J.; Sabatini, Bernardo L.			Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; DENDRITIC SPINES; NMDA RECEPTOR; BASAL GANGLIA; CALCIUM PERMEABILITY; ANTIPSYCHOTIC-DRUGS; CORTICAL AFFERENTS; DORSAL STRIATUM; DISEASE MODELS; MODULATION	Striatal D2-type dopamine receptors (D2Rs) have been implicated in the pathophysiology of neuropsychiatric disorders, including Parkinson's disease and schizophrenia. Although these receptors regulate striatal synaptic plasticity, the mechanisms underlying dopaminergic modulation of glutamatergic synapses are unclear. We combined optogenetics, two-photon microscopy and glutamate uncaging to examine D2R-dependent modulation of glutamatergic synaptic transmission in mouse striatopallidal neurons. We found that D2R activation reduces corticostriatal glutamate release and attenuates both synaptic-and action potential-evoked Ca2+ influx into dendritic spines by approximately 50%. Modulation of Ca2+ signaling was mediated by a protein kinase A (PKA)-dependent regulation of Ca2+ entry through NMDA-type glutamate receptors that was inhibited by D2Rs and enhanced by activation of 2A-type adenosine receptors (A2ARs). D2Rs also produced a PKA- and A2AR-independent reduction in Ca2+ influx through R-type voltage-gated Ca2+ channels. These findings reveal that dopamine regulates spine Ca2+ by multiple pathways and that competitive modulation of PKA controls NMDAR-mediated Ca2+ signaling in the striatum.	[Higley, Michael J.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			Parkinson's Disease Foundation; National Institute of Neurological Disorders and Stroke [NS063663, NS046579]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS063663, R01NS046579] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the Sabatini laboratory and J.A. Cardin for helpful comments during the preparation of this manuscript. We thank K. Deisseroth and V. Gradinaru for assistance with the ChR2 experiments. The work was funded by grants from the Parkinson's Disease Foundation (Postdoctoral Fellowship) and the National Institute of Neurological Disorders and Stroke (NS063663) to M.J.H. and grants from the National Institute of Neurological Disorders and Stroke (NS046579) and the National Alliance for Research on Schizophrenia and Depression (Independent Investigator Award) to B. L. S.	Bamford NS, 2004, J NEUROSCI, V24, P9541, DOI 10.1523/JNEUROSCI.2891-04.2004; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; Drew MR, 2007, J NEUROSCI, V27, P7731, DOI 10.1523/JNEUROSCI.1736-07.2007; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Furukawa T, 2009, EUR J PHARMACOL, V613, P100, DOI 10.1016/j.ejphar.2009.04.036; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Higley MJ, 2008, NEURON, V59, P902, DOI 10.1016/j.neuron.2008.08.020; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; LOPEZ SH, 2000, J NEUROSCI, V20, P8987; Mahon S, 2001, CEREB CORTEX, V11, P360, DOI 10.1093/cercor/11.4.360; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Salgado H, 2005, J NEUROPHYSIOL, V94, P3771, DOI 10.1152/jn.00455.2005; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103	49	182	184	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					958	U77		10.1038/nn.2592	http://dx.doi.org/10.1038/nn.2592			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20601948	Green Accepted			2022-12-24	WOS:000280400600014
J	Janovjak, H; Szobota, S; Wyart, C; Trauner, D; Isacoff, EY				Janovjak, Harald; Szobota, Stephanie; Wyart, Claire; Trauner, Dirk; Isacoff, Ehud Y.			A light-gated, potassium-selective glutamate receptor for the optical inhibition of neuronal firing	NATURE NEUROSCIENCE			English	Article							LIGAND-BINDING DOMAIN; ION CHANNELS; CAENORHABDITIS-ELEGANS; NEURAL CIRCUITRY; REMOTE-CONTROL; K+ CHANNELS; ACTIVATION; ZEBRAFISH; TRANSPLANTATION; DROSOPHILA	Genetically targeted light-activated ion channels and pumps make it possible to determine the role of specific neurons in neuronal circuits, information processing and behavior. We developed a K+-selective ionotropic glutamate receptor that reversibly inhibits neuronal activity in response to light in dissociated neurons and brain slice and also reversibly suppresses behavior in zebrafish. The receptor is a chimera of the pore region of a K+-selective bacterial glutamate receptor and the ligand-binding domain of a light-gated mammalian kainate receptor. This hyperpolarizing light-gated channel, HyLighter, is turned on by a brief light pulse at one wavelength and turned off by a pulse at a second wavelength. The control is obtained at moderate intensity. After optical activation, the photocurrent and optical silencing of activity persists in the dark for extended periods. The low light requirement and bi-stability of HyLighter represent advantages for the dissection of neural circuitry.	[Janovjak, Harald; Szobota, Stephanie; Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Janovjak, Harald; Szobota, Stephanie; Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Wyart, Claire/AAB-4603-2020; isacoff, ehud/AAP-1459-2020; Wyart, Claire/H-3783-2016; Janovjak, Harald/O-9070-2016	Wyart, Claire/0000-0002-1668-4975; Wyart, Claire/0000-0002-1668-4975; Janovjak, Harald/0000-0002-8023-9315; Isacoff, Ehud Y./0000-0003-4775-9359	US National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function [5PN2EY018241]; Human Frontier Science Program [RPG23-2005]; National Science Foundation [FIBR 43C-1081892]; European Molecular Biology Organization; Marie-Curie fellowship; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER	US National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie-Curie fellowship(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank K. Partin, K. Kainanen, E. Gouaux and M. Hollmann for constructs, G. Sandoz, P. Koprowski and F. Tombola for discussions, D. Fortin, T. Tracey, K. Greenberg, A. Pham, M. Soden, H. Lu, E. Warp, K. McDaniel, R. Arant and Z. Fu for technical assistance, and M. Volgraf and V. Franckevicius for MAG compounds. This work was supported by the US National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241), the Human Frontier Science Program (RPG23-2005), the National Science Foundation (FIBR 43C-1081892), a fellowship of the European Molecular Biology Organization (to H.J.) and a Marie-Curie fellowship (to C. W.; the fellowship was obtained with the laboratory CNRS-UMR5020 'Neurosciences Sensorielles, Comportement Cognition').	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Borisenko V, 2005, J PHOTOCH PHOTOBIO A, V173, P21, DOI 10.1016/j.jphotochem.2004.12.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BUNCE NJ, 1987, J ORG CHEM, V52, P394, DOI 10.1021/jo00379a015; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Franks CJ, 2009, INVERTEBR NEUROSCI, V9, P43, DOI 10.1007/s10158-009-0088-8; GEREAU RW, 2008, GLUTAMATE RECEPTORS, V1; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Hoffmann J, 2006, MOL CELL NEUROSCI, V33, P335, DOI 10.1016/j.mcn.2006.08.006; Hoffmann J, 2006, MOL CELL NEUROSCI, V33, P358, DOI 10.1016/j.mcn.2006.08.004; Kotani T, 2006, METHODS, V39, P199, DOI 10.1016/j.ymeth.2005.12.006; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lee JH, 2008, J MOL BIOL, V376, P308, DOI 10.1016/j.jmb.2007.10.081; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Numano R, 2009, P NATL ACAD SCI USA, V106, P6814, DOI 10.1073/pnas.0811899106; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Schmid SM, 2009, P NATL ACAD SCI USA, V106, P10320, DOI 10.1073/pnas.0900329106; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Villmann C, 1999, EUR J NEUROSCI, V11, P1765, DOI 10.1046/j.1460-9568.1999.00594.x; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang W, 2007, EUR J NEUROSCI, V26, P2405, DOI 10.1111/j.1460-9568.2007.05862.x; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	50	99	103	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1027	U160		10.1038/nn.2589	http://dx.doi.org/10.1038/nn.2589			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581843	Green Accepted			2022-12-24	WOS:000280400600023
J	Deeg, KE; Aizenman, CD				Deeg, Katherine E.; Aizenman, Carlos D.			Sensory modality-specific homeostatic plasticity in the developing optic tectum	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; QUANTAL AMPLITUDE; EXPERIENCE; CONVERGENCE; SYNAPSES; NEURONS	We found a previously unknown form of homeostatic synaptic plasticity in multisensory neurons in the optic tectum of Xenopus laevis tadpoles. Individual tectal neurons are known to receive converging inputs from multiple sensory modalities. We observed that long-term alterations in either visual or mechanosensory activity in vivo resulted in homeostatic changes specific to each sensory modality. In contrast with typical forms of homeostatic synaptic plasticity, such as synaptic scaling, we found that this type of plasticity occurred in a pathway-specific manner that is more reminiscent of Hebbian-type plasticity.	[Deeg, Katherine E.; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Aizenman, CD (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	carlos_aizenman@brown.edu			National Science Foundation Division of Integrative Organismal Systems; National Eye Institute of the US National Institutes of Health; Whitehall Foundation; NATIONAL EYE INSTITUTE [R01EY019578] Funding Source: NIH RePORTER	National Science Foundation Division of Integrative Organismal Systems(National Science Foundation (NSF)); National Eye Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Whitehall Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank B. Connors for helpful comments on the manuscript and members of the Aizenman laboratory for their support. Funding was provided by the National Science Foundation Division of Integrative Organismal Systems, the National Eye Institute of the US National Institutes of Health and the Whitehall Foundation.	Deeg KE, 2009, J NEUROPHYSIOL, V102, P3392, DOI 10.1152/jn.00632.2009; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Hiramoto M, 2009, DEV NEUROBIOL, V69, P959, DOI 10.1002/dneu.20754; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Tyler WJ, 2007, J NEUROSCI, V27, P9427, DOI 10.1523/JNEUROSCI.0664-07.2007; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	14	30	30	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					548	550		10.1038/nn.2772	http://dx.doi.org/10.1038/nn.2772			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441922	Green Accepted			2022-12-24	WOS:000289886600008
J	Weston, MC; Nehring, RB; Wojcik, SM; Rosenmund, C				Weston, Matthew C.; Nehring, Ralf B.; Wojcik, Sonja M.; Rosenmund, Christian			Interplay between VGLUT Isoforms and Endophilin A1 Regulates Neurotransmitter Release and Short-Term Plasticity	NEURON			English	Article							VESICULAR GLUTAMATE TRANSPORTER; SYNAPTIC VESICLE ENDOCYTOSIS; QUANTAL SIZE; BAR DOMAIN; MEMBRANE CURVATURE; PHOSPHATE TRANSPORTER; MOLECULAR-CLONING; BINDING PARTNERS; RAT-BRAIN; EXPRESSION	Vesicular glutamate transporters (VGLUTs) are essential for filling synaptic vesicles with glutamate and mammals express three VGLUT isoforms (VGLUT1-3) with distinct spatiotemporal expression patterns. Here, we find that neurons expressing VGLUT1 have lower release probability and less short-term depression than neurons expressing VGLUT2 or VGLUT3. Investigation of the underlying mechanism identified endophilin A1 as a positive regulator of exocytosis whose expression levels are positively correlated with release efficiency and showed that the differences in release efficiency between VGLUT1- and VGLUT2-expressing neurons are due to VGLUT1's ability to bind endophilin A1 and inhibit endophilin-induced enhancement of release probability.	[Weston, Matthew C.; Nehring, Ralf B.; Rosenmund, Christian] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Weston, Matthew C.; Nehring, Ralf B.; Rosenmund, Christian] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wojcik, Sonja M.] Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany; [Rosenmund, Christian] Univ Med Berlin, Charite, D-10115 Berlin, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rosenmund, C (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	christian.rosenmund@charite.de	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444	Helen and Rush Record fellowship; Human Frontier Science Program; European Research Council; German Research Council Excellence Cluster Neurocure	Helen and Rush Record fellowship; Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); German Research Council Excellence Cluster Neurocure	We thank Hongmei Chen for help with mouse care and genotyping, Hui Deng and Marife Arancillo for help with cell culture and virus production, Dieter Moechars for supplying the VGLUT2 knockout mice, Etienne Herzog for supplying endophilin antibodies and cDNA, and Amy Shore for help with molecular cloning and design of Figure 8. This work was supported by a Helen and Rush Record fellowship (M.C.W.), by a Human Frontier Science Program Research Grant, by the European Research Council grant SYNVGLUT, and by the German Research Council Excellence Cluster Neurocure (C.R).	Amilhon B, 2010, J NEUROSCI, V30, P2198, DOI 10.1523/JNEUROSCI.5196-09.2010; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Bai LQ, 2001, J BIOL CHEM, V276, P36764, DOI 10.1074/jbc.M104578200; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; De Gois S, 2006, CELL MOL NEUROBIOL, V26, P679, DOI 10.1007/s10571-006-9054-8; Eastwood SL, 2005, SCHIZOPHR RES, V73, P159, DOI 10.1016/j.schres.2004.05.010; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Gras C, 2002, J NEUROSCI, V22, P5442; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Hayashi M, 2001, J BIOL CHEM, V276, P43400, DOI 10.1074/jbc.M106244200; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kashani A, 2007, NEUROBIOL AGING, V28, P568, DOI 10.1016/j.neurobiolaging.2006.02.010; Liu GS, 2003, CURR OPIN NEUROBIOL, V13, P324, DOI 10.1016/S0959-4388(03)00078-3; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Suresh S, 2010, BIOCHEMISTRY-US, V49, P5766, DOI 10.1021/bi100760e; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Voglmaier SM, 2007, CURR OPIN NEUROBIOL, V17, P374, DOI 10.1016/j.conb.2007.04.002; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yelamanchili SV, 2006, J BIOL CHEM, V281, P15671, DOI 10.1074/jbc.M600378200	54	79	79	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1147	1159		10.1016/j.neuron.2011.02.002	http://dx.doi.org/10.1016/j.neuron.2011.02.002			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435559	Bronze			2022-12-24	WOS:000288886900011
J	Westerlund, N; Zdrojewska, J; Padzik, A; Komulainen, E; Bjorkblom, B; Rannikko, E; Tararuk, T; Garcia-Frigola, C; Sandholm, J; Nguyen, L; Kallunki, T; Courtney, MJ; Coffey, ET				Westerlund, Nina; Zdrojewska, Justyna; Padzik, Artur; Komulainen, Emilia; Bjorkblom, Benny; Rannikko, Emmy; Tararuk, Tanya; Garcia-Frigola, Cristina; Sandholm, Jouko; Nguyen, Laurent; Kallunki, Tuula; Courtney, Michael J.; Coffey, Eleanor T.			Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate	NATURE NEUROSCIENCE			English	Article							N-TERMINAL KINASE-1; C-JUN; MICROTUBULE DYNAMICS; CELL-MIGRATION; PROTEIN SCG10; GROWTH CONES; IN-VITRO; JNK1; STATHMIN; BRAIN	Cell migration is the consequence of the sum of positive and negative regulatory mechanisms. Although appropriate migration of neurons is a principal feature of brain development, the negative regulatory mechanisms remain obscure. We found that JNK1 was highly active in developing cortex and that selective inhibition of JNK in the cytoplasm markedly increased both the frequency of exit from the multipolar stage and radial migration rate and ultimately led to an ill-defined cellular organization. Moreover, regulation of multipolar-stage exit and radial migration in Jnk1(-/-) (also known as Mapk8) mice, resulted from consequential changes in phosphorylation of the microtubule regulator SCG10 (also called stathmin-2). Expression of an SCG10 mutant that mimics the JNK1-phosphorylated form restored normal migration in the brains of Jnk1(-/-) mouse embryos. These findings indicate that the phosphorylation of SCG10 by JNK1 is a fundamental mechanism that governs the transition from the multipolar stage and the rate of neuronal cell movement during cortical development.	[Westerlund, Nina; Zdrojewska, Justyna; Padzik, Artur; Komulainen, Emilia; Bjorkblom, Benny; Rannikko, Emmy; Tararuk, Tanya; Sandholm, Jouko; Coffey, Eleanor T.] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland; [Westerlund, Nina; Zdrojewska, Justyna; Padzik, Artur; Komulainen, Emilia; Bjorkblom, Benny; Rannikko, Emmy; Tararuk, Tanya; Sandholm, Jouko; Coffey, Eleanor T.] Univ Turku, Turku, Finland; [Bjorkblom, Benny] Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway; [Garcia-Frigola, Cristina] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alicante, Spain; [Nguyen, Laurent] Univ Liege, Grp Interdisciplinaire Genoproteom Appl Neurosci, B-4000 Liege, Belgium; [Kallunki, Tuula] Danish Canc Soc, Copenhagen, Denmark; [Courtney, Michael J.] Univ Eastern Finland, Kuopio, Finland	Abo Akademi University; University of Turku; University of Turku; Stavanger University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Liege; Danish Cancer Society; University of Eastern Finland	Coffey, ET (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland.	ecoffey@btk.fi	Courtney, Michael J/D-6648-2016; Komulainen, Emilia/AAR-5657-2021	Courtney, Michael J/0000-0001-8693-3933; Coffey, Eleanor/0000-0002-9717-5610; Komulainen, Emilia/0000-0002-2804-1678; Garcia-Frigola, Cristina/0000-0003-2434-3879; Sandholm, Jouko/0000-0003-0638-2444; Kallunki, Tuula/0000-0002-8571-383X; Rannikko, Emmy/0000-0001-6517-275X; Nguyen, Laurent/0000-0002-8560-3008	Academy of Finland [218125, 125860, 206497, 111870, 203520, 110445]; Turku Graduate School of Biomedical Sciences; Finnish Graduate School of Neuroscience; Magnus Ehrnrooth's Foundation; FP6 STRESSPROTECT; Abo Akademi University; Danish Cancer Society; Walloon Excellence in Lifesciences and Biotechnology	Academy of Finland(Academy of Finland); Turku Graduate School of Biomedical Sciences; Finnish Graduate School of Neuroscience; Magnus Ehrnrooth's Foundation; FP6 STRESSPROTECT(European Commission); Abo Akademi University; Danish Cancer Society(Danish Cancer Society); Walloon Excellence in Lifesciences and Biotechnology	We thank T. Herdegen for mice for pilot experiments. This work was supported by grants from the Academy of Finland (218125, 125860, 206497, 111870, 203520 and 110445), Turku Graduate School of Biomedical Sciences, the Finnish Graduate School of Neuroscience, Magnus Ehrnrooth's Foundation, FP6 STRESSPROTECT and Abo Akademi University. T.K. was supported by the Danish Cancer Society. L.N. is funded by Walloon Excellence in Lifesciences and Biotechnology.	Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bjorkblom B, 2008, J BIOL CHEM, V283, P19704, DOI 10.1074/jbc.M707744200; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirai S, 2002, DEVELOPMENT, V129, P4483; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; LIM SS, 1990, J CELL BIOL, V111, P123, DOI 10.1083/jcb.111.1.123; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Rana S, 2008, EXPERT REV ANTICANC, V8, P1461, DOI 10.1586/14737140.8.9.1461; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Sluss HK, 1997, J CELL BIOCHEM, V67, P1; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Westerlund N, 2008, EXPERT OPIN THER TAR, V12, P31, DOI 10.1517/14728222.12.1.31; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	44	84	91	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					305	313		10.1038/nn.2755	http://dx.doi.org/10.1038/nn.2755			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297631	Green Submitted			2022-12-24	WOS:000287650100010
J	Marder, E; Taylor, AL				Marder, Eve; Taylor, Adam L.			Multiple models to capture the variability in biological neurons and networks	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; RHYTHMICALLY ACTIVE NEURONS; CENTRAL PATTERN GENERATOR; CIRCUIT PARAMETERS; CONDUCTANCES; EXPRESSION; SINGLE; CURRENTS; DYNAMICS; CONSTRUCTION	How tightly tuned are the synaptic and intrinsic properties that give rise to neuron and circuit function? Experimental work shows that these properties vary considerably across identified neurons in different animals. Given this variability in experimental data, this review describes some of the complications of building computational models to aid in understanding how system dynamics arise from the interaction of system components. We argue that instead of trying to build a single model that captures the generic behavior of a neuron or circuit, it is beneficial to construct a population of models that captures the behavior of the population that provided the experimental data. Studying a population of models with different underlying structure and similar behaviors provides opportunities to discover unsuspected compensatory mechanisms that contribute to neuron and network function.	[Marder, Eve; Taylor, Adam L.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Marder, Eve; Taylor, Adam L.] Brandeis Univ, Volen Ctr, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Marder, E (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	marder@brandeis.edu	Marder, Eve/A-5713-2012		US National Institutes of Health [NS17813, MH46742]; James D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, R37MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS017813, R01NS017813] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James D. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants NS17813 and MH46742, and by the James D. McDonnell Foundation.	Beer RD, 1999, J COMPUT NEUROSCI, V7, P119, DOI 10.1023/A:1008920021246; BHALLA US, 1993, J NEUROPHYSIOL, V69, P1948, DOI 10.1152/jn.1993.69.6.1948; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Desai NS, 1999, NEUROCOMPUTING, V26-7, P101, DOI 10.1016/S0925-2312(99)00004-1; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Grashow R, 2010, J NEUROSCI, V30, P9145, DOI 10.1523/JNEUROSCI.0980-10.2010; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; GUCKENHEIMER J, 1993, PHILOS T ROY SOC B, V341, P345, DOI 10.1098/rstb.1993.0121; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; HAGIWARA SUSUMU, 1958, JAPANESE JOUR PHYSIOL, V8, P234; Hobbs KH, 2008, J NEUROPHYSIOL, V99, P1871, DOI 10.1152/jn.00032.2008; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hudson AE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000838; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Jezzini SH, 2004, J NEUROPHYSIOL, V91, P958, DOI 10.1152/jn.00656.2003; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liu Z, 1998, J NEUROSCI, V18, P2309; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Maffei A, 2009, CURR OPIN NEUROBIOL, V19, P168, DOI 10.1016/j.conb.2009.05.012; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2992, DOI 10.1152/jn.00877.2007; Olypher AV, 2007, J NEUROPHYSIOL, V98, P3749, DOI 10.1152/jn.00842.2007; Olypher AV, 2010, J COMPUT NEUROSCI, V28, P361, DOI 10.1007/s10827-010-0213-z; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; Tang LS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000469; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2089, DOI 10.1152/jn.00025.2006; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316	50	255	256	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					133	138		10.1038/nn.2735	http://dx.doi.org/10.1038/nn.2735			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270780	Green Accepted			2022-12-24	WOS:000286595400007
J	Jo, J; Son, GH; Winters, BL; Kim, MJ; Whitcomb, DJ; Dickinson, BA; Lee, YB; Futai, K; Amici, M; Sheng, M; Collingridge, GL; Cho, K				Jo, Jihoon; Son, Gi Hoon; Winters, Bryony L.; Kim, Myung Jong; Whitcomb, Daniel J.; Dickinson, Bryony A.; Lee, Youn-Bok; Futai, Kensuke; Amici, Mascia; Sheng, Morgan; Collingridge, Graham L.; Cho, Kwangwook			Muscarinic receptors induce LTD of NMDAR EPSCs via a mechanism involving hippocalcin, AP2 and PSD-95	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; METHYL-D-ASPARTATE; MEDIATED SYNAPTIC-TRANSMISSION; RAT HIPPOCAMPUS; GLUTAMATE RECEPTORS; CALCIUM SENSOR; AREA CA1; POTENTIATION; PLASTICITY; PROTEIN	Although muscarinic acetylcholine receptors (mAChRs) and NMDA receptors (NMDARs) are important for synaptic plasticity, learning and memory, the manner in which they interact is poorly understood. We found that stimulation of muscarinic receptors, either by an agonist or by the synaptic release of acetylcholine, led to long-term depression (LTD) of NMDAR-mediated synaptic transmission. This form of LTD involved the release of Ca2+ from IP3-sensitive intracellular stores and was expressed via the internalization of NMDARs. Our results suggest that the molecular mechanism involves a dynamic interaction between the neuronal calcium sensor protein hippocalcin, the clathrin adaptor molecule AP2, the postsynaptic density enriched protein PSD-95 and NMDARs. We propose that hippocalcin binds to the SH3 region of PSD-95 under basal conditions, but it translocates to the plasma membrane on sensing Ca2+; in doing so, it causes PSD-95 to dissociate from NMDARs, permitting AP2 to bind and initiate their dynamin-dependent endocytosis.	[Jo, Jihoon; Son, Gi Hoon; Winters, Bryony L.; Whitcomb, Daniel J.; Dickinson, Bryony A.; Lee, Youn-Bok; Cho, Kwangwook] Univ Bristol, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Winters, Bryony L.; Amici, Mascia; Collingridge, Graham L.; Cho, Kwangwook] Univ Bristol, MRC Ctr Synapt Plast, Bristol, Avon, England; [Kim, Myung Jong; Futai, Kensuke; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	University of Bristol; University of Bristol; Massachusetts Institute of Technology (MIT); Northwell Health	Cho, K (corresponding author), Univ Bristol, Fac Med & Dent, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.	kei.cho@bristol.ac.uk	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Amici, Mascia/L-3842-2019	Collingridge, Graham L/0000-0002-9572-5359; Amici, Mascia/0000-0001-8548-4179; Sheng, Morgan/0000-0002-8703-5366; Winters, Bryony/0000-0002-4973-0771; Whitcomb, Daniel/0000-0003-2703-1643; Lee, Younbok/0000-0002-0479-9361; Cho, Kwangwook/0000-0001-6724-7073	Biotechnology and Biological Sciences Research Council; Medical Research Council; UK Alzheimer's Research Trust; Royal Society; Brain Research Centre; Korean Ministry of Education and Science and Technology; BBSRC [BB/G003963/1] Funding Source: UKRI; MRC [G0601813] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003963/1] Funding Source: researchfish; Medical Research Council [G0601813, G0601841B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Alzheimer's Research Trust; Royal Society(Royal Society of London); Brain Research Centre; Korean Ministry of Education and Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biotechnology and Biological Sciences Research Council (K.C.), the Medical Research Council (G.L.C.), UK Alzheimer's Research Trust (K.C. and D.W.), The Royal Society (J.J.) and Brain Research Centre of the 21st Century Frontier Research Programme, funded by the Korean Ministry of Education and Science and Technology (K.C. and G.L.C.).	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aramakis VB, 1999, SYNAPSE, V32, P262, DOI 10.1002/(SICI)1098-2396(19990615)32:4<262::AID-SYN3>3.3.CO;2-A; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Dickinson BA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-18; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Harney SC, 2006, J NEUROSCI, V26, P1128, DOI 10.1523/JNEUROSCI.2753-05.2006; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Hummer A, 2003, J BIOL CHEM, V278, P49386, DOI 10.1074/jbc.M306645200; Ireland DR, 2009, J NEUROPHYSIOL, V101, P1375, DOI 10.1152/jn.90643.2008; Jo J, 2006, NAT NEUROSCI, V9, P170, DOI 10.1038/nn1637; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; MARKRAM H, 1990, NEUROSCI LETT, V113, P62, DOI 10.1016/0304-3940(90)90495-U; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027	42	78	82	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1216	1224		10.1038/nn.2636	http://dx.doi.org/10.1038/nn.2636			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852624				2022-12-24	WOS:000282171300013
J	Ferron, SR; Pozo, N; Laguna, A; Aranda, S; Porlan, E; Moreno, M; Fillat, C; de la Luna, S; Sanchez, P; Arbones, ML; Farinas, I				Ferron, Sacri R.; Pozo, Natividad; Laguna, Ariadna; Aranda, Sergi; Porlan, Eva; Moreno, Mireia; Fillat, Cristina; de la Luna, Susana; Sanchez, Pilar; Arbones, Maria L.; Farinas, Isabel			Regulated Segregation of Kinase Dyrk1A during Asymmetric Neural Stem Cell Division Is Critical for EGFR-Mediated Biased Signaling	CELL STEM CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE; PROGENITOR CELLS; DOWN-SYNDROME; NEURONAL DIFFERENTIATION; FACTOR RECEPTOR; ADULT BRAIN; MOUSE-BRAIN; NEUROGENESIS; MECHANISMS	Stem cell division can result in two sibling cells exhibiting differential mitogenic and self-renewing potential. Here, we present evidence that the dual-specificity kinase Dyrk1A is part of a molecular pathway involved in the regulation of biased epidermal growth factor receptor (EGFR) signaling in the progeny of dividing neural stem cells (NSC) of the adult subependymal zone (SEZ). We show that EGFR asymmetry requires regulated sorting and that a normal Dyrk1a dosage is required to sustain EGFR in the two daughters of a symmetrically dividing progenitor. Dyrk1A is symmetrically or asymmetrically distributed during mitosis, and biochemical analyses indicate that it prevents endocytosis-mediated degradation of EGFR by a mechanism that requires phosphorylation of the EGFR signaling modulator Sprouty2. Finally, Dyrk1a heterozygous NSCs exhibit defects in self-renewal, EGF-dependent cell-fate decisions, and long-term persistence in vivo, suggesting that symmetrical divisions play a role in the maintenance of the SEZ reservoir.	[Laguna, Ariadna; Aranda, Sergi; Fillat, Cristina; de la Luna, Susana; Arbones, Maria L.] UPF, CRG, Barcelona 08003, Spain; [Laguna, Ariadna; Aranda, Sergi; Fillat, Cristina; de la Luna, Susana; Arbones, Maria L.] CIBERER, Barcelona 08003, Spain; [Ferron, Sacri R.; Pozo, Natividad; Porlan, Eva; Moreno, Mireia; Sanchez, Pilar; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain; [Ferron, Sacri R.; Pozo, Natividad; Porlan, Eva; Moreno, Mireia; Sanchez, Pilar; Farinas, Isabel] Univ Valencia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-46100 Burjassot, Spain; [de la Luna, Susana] ICREA, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Valencia; CIBERNED; University of Valencia; ICREA	Arbones, ML (corresponding author), UPF, CRG, Barcelona 08003, Spain.	mariona.arbones@crg.es; isabel.farinas@uv.es	Aranda, Sergi/X-9658-2019; porlan, Eva/AAE-6561-2022; de la Luna, Susana/E-9553-2015; Ferrón, Sacri R./I-2958-2015; Laguna, Ariadna/F-9561-2016; Arbones, Maria/D-4668-2016; Fillat, Cristina/ABH-1674-2020; Aranda, Sergi/K-1211-2015; Estelles, Mireia Moreno/H-2859-2017; Sánchez-Gómez, Pilar/K-8256-2014; Farinas, Isabel/L-7118-2014	Aranda, Sergi/0000-0003-3853-430X; porlan, Eva/0000-0003-0934-9711; de la Luna, Susana/0000-0001-7765-916X; Ferrón, Sacri R./0000-0003-0854-8575; Laguna, Ariadna/0000-0002-9732-6677; Arbones, Maria/0000-0002-6035-0235; Aranda, Sergi/0000-0003-3853-430X; Estelles, Mireia Moreno/0000-0001-8759-8794; Sánchez-Gómez, Pilar/0000-0002-0709-4973; Farinas, Isabel/0000-0003-2903-4960; Fillat, Cristina/0000-0002-0801-3338	Ministerio de Ciencia e Innovacion; Ministerio de Sanidad y Consumo [FIS04/1559]; Generalitat Valenciana; Fundacion "la Caixa"; Jerome Lejeune Foundation; EU; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacion "la Caixa"(La Caixa Foundation); Jerome Lejeune Foundation; EU(European Commission); ICREA(ICREA)	We thank M.P. Rubio, U. Brandt-Bohne, and S. Twit!) for help with constructs, viral production, and immunoblotting; M.J. Palop and E. Ramirez for help with the mouse colonies; and S. Bartlett for English editorial work. This work was supported by grants from Ministerio de Ciencia e Innovacion to IF., M.L.A., P.S., and S.L.; from Ministerio de Sanidad y Consumo (CIBERNED and Red Tercel to I.F. and CIBERER and FIS04/1559 to C.F.); Generalitat Valenciana (Programs Prometeo) and Fundacion "la Caixa" to IF.; and the Jerome Lejeune Foundation and the EU grant AnEUploidy to M.L.A. A.L. and S.A. were Fl predoctoral fellows (DuRsl, Generalitat de Catalunya).	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Cournailleau F, 2008, CURR OPIN CELL BIOL, V20, P462, DOI 10.1016/j.ceb.2008.03.007; Craig CG, 1996, J NEUROSCI, V16, P2649; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liu T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r26; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morshead CM, 2004, CURR OPIN NEUROBIOL, V14, P125, DOI 10.1016/j.conb.2004.01.008; Murakami Noriko, 2009, Biochemistry, V48, P9297, DOI 10.1021/bi9010557; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	50	52	53	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					367	379		10.1016/j.stem.2010.06.021	http://dx.doi.org/10.1016/j.stem.2010.06.021			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804972	Bronze			2022-12-24	WOS:000282037800013
J	Tritsch, NX; Rodriguez-Contreras, A; Crins, TTH; Wang, HC; Borst, JGG; Bergles, DE				Tritsch, Nicolas X.; Rodriguez-Contreras, Adrian; Crins, Tom T. H.; Wang, Han Chin; Borst, J. Gerard G.; Bergles, Dwight E.			Calcium action potentials in hair cells pattern auditory neuron activity before hearing onset	NATURE NEUROSCIENCE			English	Article							TRAPEZOID BODY; MEDIAL NUCLEUS; STIMULATION; MATURATION	We found rat central auditory neurons to fire action potentials in a precise sequence of mini-bursts before the age of hearing onset. This stereotyped pattern was initiated by hair cells in the cochlea, which trigger brief bursts of action potentials in auditory neurons each time they fire a Ca(2+) spike. By generating theta-like activity, hair cells may limit the influence of synaptic depression in developing auditory circuits and promote consolidation of synapses.	[Tritsch, Nicolas X.; Wang, Han Chin; Bergles, Dwight E.] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Rodriguez-Contreras, Adrian; Crins, Tom T. H.; Borst, J. Gerard G.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Crins, Tom T. H.] Univ Med Ctr Rotterdam, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands; [Bergles, Dwight E.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Johns Hopkins Medicine	Bergles, DE (corresponding author), Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA.	g.borst@erasmusmc.nl; dbergles@jhmi.edu	Tritsch, Nicolas/U-5266-2019; Rodriguez-Contreras, Adrian/ABC-8325-2020; Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378; Tritsch, Nicolas/0000-0003-3181-7681; Wang, Han Chin/0000-0001-8270-6645	US National Center for Research Resources [G12-RR03060]; European Union [LSHM-CT-2005-019055]; Heinsius Houbolt fund and SenterNovem (The Netherlands) [BSIK 03053]; US National Institutes of Health [DC008860, DC009464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [SC1HD068129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008860, R21DC009464] Funding Source: NIH RePORTER	US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Union(European Commission); Heinsius Houbolt fund and SenterNovem (The Netherlands)(Netherlands Government); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Center for Research Resources (G12-RR03060) to A. R.-C., the European Union (EUSynapse, LSHM-CT-2005-019055), Heinsius Houbolt fund and SenterNovem (The Netherlands, Neuro-Bsik, BSIK 03053) to J.G.G.B., and the US National Institutes of Health (DC008860 and DC009464) to D.E.B.	Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; CARLIER E, 1975, J PHYSIOL-PARIS, V70, P129; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Walsh Edward J., 1992, P161; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	15	147	147	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1050	1052		10.1038/nn.2604	http://dx.doi.org/10.1038/nn.2604			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20676105	Green Accepted			2022-12-24	WOS:000281332600007
J	Marek, KW; Kurtz, LM; Spitzer, NC				Marek, Kurt W.; Kurtz, Lisa M.; Spitzer, Nicholas C.			cJun integrates calcium activity and tlx3 expression to regulate neurotransmitter specification	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; GENE-EXPRESSION; SPINAL-CORD; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN; ELECTRICAL-ACTIVITY; CELL-DEATH; C-JUN; NEURONS; PHENOTYPE	Neuronal differentiation is accomplished through cascades of intrinsic genetic factors initiated in neuronal progenitors by external gradients of morphogens. Activity has been thought to be important only late in development, but recent evidence suggests that activity also regulates early neuronal differentiation. Activity in post-mitotic neurons before synapse formation can regulate phenotypic specification, including neurotransmitter choice, but the mechanisms are not clear. We identified a mechanism that links endogenous calcium spike activity with an intrinsic genetic pathway to specify neurotransmitter choice in neurons in the dorsal embryonic spinal cord of Xenopus tropicalis. Early activity modulated transcription of the GABAergic/glutamatergic selection gene tlx3 through a variant cAMP response element (CRE) in its promoter. The cJun transcription factor bound to this CRE site, modulated transcription and regulated neurotransmitter phenotype via its transactivation domain. Calcium signaled through cJun N-terminal phosphorylation, which integrated activity-dependent and intrinsic neurotransmitter specification. This mechanism provides a basis for early activity to regulate genetic pathways at critical decision points, switching the phenotype of developing neurons.	[Marek, Kurt W.; Kurtz, Lisa M.; Spitzer, Nicholas C.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Marek, Kurt W.; Kurtz, Lisa M.; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Neural Circuits, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [Marek, Kurt W.; Kurtz, Lisa M.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Marek, KW (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	kmarek@ucsd.edu		Spitzer, Nicholas/0000-0002-3523-1103	Damon Runyon Cancer Research Foundation; US National Institutes of Health [T32 AG00216, MH 074702]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074702, R56MH074702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015918, R01NS057690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Chung, G. Monsalve and A. de la Torre for technical assistance. We thank D. Berg, A. Ghosh and J. Gleeson for critical comments on the manuscript and I. Hsieh for technical support. This work was supported by a Damon Runyon Cancer Research Foundation Postdoctoral Fellowship to K. W. M., a US National Institutes of Health Predoctoral Fellowship (T32 AG00216) to L. M. K. and by a US National Institutes of Health grant (MH 074702) to N.C.S.	Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Borghini S, 2006, MOL CANCER RES, V4, P635, DOI 10.1158/1541-7786.MCR-05-0250; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brosenitsch TA, 2002, MOL CELL NEUROSCI, V20, P447, DOI 10.1006/mcne.2002.1135; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chang LW, 2009, J NEUROSCI, V29, P7877, DOI 10.1523/JNEUROSCI.4264-08.2009; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; DE KP, 1998, SCIENCE, V279, P227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Ghosh S, 2005, ONCOGENE, V24, P2236, DOI 10.1038/sj.onc.1208415; Gomez-Lira G, 2005, J NEUROSCI, V25, P6939, DOI 10.1523/JNEUROSCI.1674-05.2005; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Heckert LL, 1996, J BIOL CHEM, V271, P31650, DOI 10.1074/jbc.271.49.31650; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu XH, 2008, J NEUROPHYSIOL, V99, P2443, DOI 10.1152/jn.00762.2007; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Mo ZQ, 2004, DEVELOPMENT, V131, P1607, DOI 10.1242/dev.01071; Nakano T, 2005, DEV BIOL, V283, P474, DOI 10.1016/j.ydbio.2005.04.017; Ovcharenko I, 2004, GENOMICS, V84, P890, DOI 10.1016/j.ygeno.2004.07.011; Patterson KD, 1999, DEV DYNAM, V214, P34, DOI 10.1002/(SICI)1097-0177(199901)214:1<34::AID-DVDY4>3.0.CO;2-R; Peng Y, 2002, NEUROSCIENCE, V109, P657, DOI 10.1016/S0306-4522(01)00526-7; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pillai A, 2007, DEVELOPMENT, V134, P357, DOI 10.1242/dev.02717; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sugiyama C, 2007, NEUROCHEM INT, V51, P467, DOI 10.1016/j.neuint.2007.04.025; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	47	60	61	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					944	U58		10.1038/nn.2582	http://dx.doi.org/10.1038/nn.2582			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581840	Green Accepted			2022-12-24	WOS:000280400600012
J	Kusch, J; Biskup, C; Thon, S; Schulz, E; Nache, V; Zimmer, T; Schwede, F; Benndorf, K				Kusch, Jana; Biskup, Christoph; Thon, Susanne; Schulz, Eckhard; Nache, Vasilica; Zimmer, Thomas; Schwede, Frank; Benndorf, Klaus			Interdependence of Receptor Activation and Ligand Binding in HCN2 Pacemaker Channels	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; CURRENT I-H; IRREVERSIBLE-PROCESSES; RECIPROCAL RELATIONS; CAMP MODULATION; VOLTAGE SENSOR; MECHANISM; AGONIST; IDENTIFICATION; MOVEMENT	HCN pacemaker channels are tetramers mediating rhythmicity in neuronal and cardiac cells. The activity of these channels is controlled by both membrane voltage and the ligand cAMP, binding to each of the four channel subunits. The molecular mechanism underlying channel activation and the relationship between the two activation stimuli are still unknown. Using patch-clamp fluorometry and a fluorescent cAMP analog, we show that full ligand-induced activation appears already with only two ligands bound to the tetrameric channel. Kinetic analysis of channel activation and ligand binding suggests direct interaction between the voltage sensor and the cyclic nucleotide-binding domain, bypassing the pore. By exploiting the duality of activation in HCN2 channels by voltage and ligand binding, we quantify the increase of the binding affinity and overall free energy for binding upon channel activation, proving thus the principle of reciprocity between ligand binding and conformational change in a receptor protein.	[Kusch, Jana; Thon, Susanne; Nache, Vasilica; Zimmer, Thomas; Benndorf, Klaus] Univ Klinikum Jena, Inst Physiol, D-07740 Jena, Germany; [Biskup, Christoph] Univ Klinikum Jena, Biomol Photon Grp, D-07740 Jena, Germany; [Schulz, Eckhard] Fachhsch Schmalkalden, Fak Elektrotech, D-98574 Blechhammer, Schmalkalden, Germany; [Schwede, Frank] BIOLOG Life Sci Inst, D-28199 Bremen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Benndorf, K (corresponding author), Univ Klinikum Jena, Inst Physiol, D-07740 Jena, Germany.	klaus.benndorf@mti.uni-jena.de	Kusch, Jana/ABC-9738-2020	Kusch, Jana/0000-0001-7206-8133; Benndorf, Klaus/0000-0002-0707-4083	Deutsche Forschungsgemeinschaft; BIA, Bremen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BIA, Bremen	We are indebted to U.B. Kaupp for providing the cDNA and to F. Lehmann and P. Czerney (Dyomics GmbH, Jena, Germany) for providing the dyes. We also thank K. Schoknecht, S. Bernhardt, A. Kolchmeier, and B. Tietsch for excellent technical assistance. This work was supported by grants of the Deutsche Forschungsgemeinschaft to K.B. F.S. acknowledges support of BIA, Bremen. F.S. is Head of R&D of BIOLOG LSI.	Adair GS, 1925, J BIOL CHEM, V63, P529; Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; BANKS MI, 1993, J NEUROPHYSIOL, V70, P1420, DOI 10.1152/jn.1993.70.4.1420; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P71, DOI 10.1085/jgp.200709769; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chang YC, 1999, NAT NEUROSCI, V2, P219, DOI 10.1038/6313; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2006, BRIT J PHARMACOL, V147, pS17, DOI 10.1038/sj.bjp.0706502; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Edsall J. T., 1958, BIOPHYSICAL CHEM; Elinder F, 2006, J PHYSIOL-LONDON, V575, P417, DOI 10.1113/jphysiol.2006.110437; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mannikko R, 2005, J GEN PHYSIOL, V125, P305, DOI 10.1085/jgp.200409130; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Onsager L, 1931, PHYS REV, V38, P2265, DOI 10.1103/PhysRev.38.2265; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WYMAN J, 1951, J POLYM SCI, V7, P499, DOI 10.1002/pol.1951.120070506; Yifrach O, 2004, BIOPHYS J, V87, P822, DOI 10.1529/biophysj.104.040410; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	53	81	82	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					75	85		10.1016/j.neuron.2010.05.022	http://dx.doi.org/10.1016/j.neuron.2010.05.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624593	Bronze			2022-12-24	WOS:000280221000010
J	Jossin, Y; Cooper, JA				Jossin, Yves; Cooper, Jonathan A.			Reelin, Rap1 and N-cadherin orient the migration of multipolar neurons in the developing neocortex	NATURE NEUROSCIENCE			English	Article							CELL-CELL ADHESION; CEREBRAL-CORTEX; CORTICAL-NEURONS; RADIAL MIGRATION; INTERCELLULAR-JUNCTIONS; LAMINAR ORGANIZATION; SMALL GTPASES; MOUSE-BRAIN; ACTIVATION; POLARITY	Projection neurons migrate from the ventricular zone to the neocortical plate during the development of the mouse brain. Their overall movement is radial, but they become multipolar and move nonradially in the intermediate zone. Here we show that Reelin, the Rap1 GTPase and N-cadherin (NCad) are important for multipolar neurons to polarize their migration toward the cortical plate. Inhibition and rescue experiments indicated that Reelin regulates migration through Rap1 and Akt, and that the Rap1-regulated GTPases RalA, RalB, Rac1 and Cdc42 are also involved. We found that Rap1 regulated the plasma membrane localization of NCad and NCad rescued radial polarization when Rap1 was inhibited. However, inhibition of Rap1 or NCad had little effect on glia-dependent locomotion. We propose a multistep mechanism in which Reelin activates Rap1, Rap1 upregulates NCad, and NCad is needed to orient cell migration.	[Jossin, Yves; Cooper, Jonathan A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Jossin, Y (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	yves.jossin@uclouvain.be; jcooper@fhcrc.org	cagnie, barbara/D-9830-2017; Roussel, Nathalie A/A-1267-2012; Kregel, Jeroen/J-7849-2015	cagnie, barbara/0000-0003-4342-4519; Roussel, Nathalie A/0000-0002-7409-878X; Kregel, Jeroen/0000-0002-5692-1461; Jossin, Yves/0000-0001-8466-7432	Fonds National de la Recherche Scientifique, Belgium; European Commission through the Universite Catholique de Louvain; National Institutes of Health [CA41072]; NATIONAL CANCER INSTITUTE [R01CA041072, R37CA041072] Funding Source: NIH RePORTER	Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); European Commission through the Universite Catholique de Louvain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Buck for the use of her confocal microscope, W. Arthur, R. Hevner, F. Polleux, K. Sanada, L.-H. Tsai, V. Vasioukhin, A. Puschel, Y. Gotoh, P. Phelps and M. White for reagents, J. Wang and E. Jhingan for technical assistance, A. Goffinet and F. Polleux for helpful discussions, and V. Vasioukhin, S. Parkhurst, B. Edgar and S. Simo for comments on the manuscript. This work was supported by the Fonds National de la Recherche Scientifique, Belgium (Y.J.), the European Commission under the Marie Curie International Outgoing Fellowship Program through the Universite Catholique de Louvain (Y.J.) and National Institutes of Health grant CA41072 (J.A.C.).	Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; de Anda FC, 2010, J NEUROSCI, V30, P10391, DOI 10.1523/JNEUROSCI.0381-10.2010; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; GOFFINET AM, 1979, ANAT EMBRYOL, V157, P205, DOI 10.1007/BF00305160; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Jossin Y, 2003, J NEUROSCI, V23, P9953; Jossin Y, 2004, MOL NEUROBIOL, V30, P225, DOI 10.1385/MN:30:3:225; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nichols AJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-50; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Rice DS, 1998, DEVELOPMENT, V125, P3719; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Simo S, 2010, J NEUROSCI, V30, P5668, DOI 10.1523/JNEUROSCI.0035-10.2010; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Taniguchi H, 2006, DEVELOPMENT, V133, P1923, DOI 10.1242/dev.02354; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Uchida T, 2009, J NEUROSCI, V29, P10653, DOI 10.1523/JNEUROSCI.0345-09.2009; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	50	233	241	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					697	U289		10.1038/nn.2816	http://dx.doi.org/10.1038/nn.2816			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516100	Green Accepted			2022-12-24	WOS:000290958000011
J	Merlos-Suarez, A; Barriga, FM; Jung, P; Iglesias, M; Cespedes, MV; Rossell, D; Sevillano, M; Hernando-Momblona, X; da Silva-Diz, V; Munoz, P; Clevers, H; Sancho, E; Mangues, R; Batlle, E				Merlos-Suarez, Anna; Barriga, Francisco M.; Jung, Peter; Iglesias, Mar; Virtudes Cespedes, Maria; Rossell, David; Sevillano, Marta; Hernando-Momblona, Xavier; da Silva-Diz, Victoria; Munoz, Purificacion; Clevers, Hans; Sancho, Elena; Mangues, Ramon; Batlle, Eduard			The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse	CELL STEM CELL			English	Article							COLON-CANCER; EMBRYONIC STEM; BETA-CATENIN; IN-VITRO; EXPRESSION; PROGRESSION; DIFFERENTIATION; TARGET; TUMORS; DEATH	A frequent complication in colorectal cancer (CRC) is regeneration of the tumor after therapy. Here, we report that a gene signature specific for adult intestinal stem cells (ISCs) predicts disease relapse in CRC patients. ISCs are marked by high expression of the EphB2 receptor, which becomes gradually silenced as cells differentiate. Using EphB2 and the ISC marker Lgr5, we have FACS-purified and profiled mouse ISCs, crypt proliferative progenitors, and late transient amplifying cells to define a gene program specific for normal ISCs. Furthermore, we discovered that ISC-specific genes identify a stem-like cell population positioned at the bottom of tumor structures reminiscent of crypts. EphB2 sorted ISC-like tumor cells display robust tumor-initiating capacity in immunodeficient mice as well as long-term self-renewal potential. Taken together, our data suggest that the ISC program defines a cancer stem cell niche within colorectal tumors and plays a central role in CRC relapse.	[Merlos-Suarez, Anna; Barriga, Francisco M.; Jung, Peter; Sevillano, Marta; Hernando-Momblona, Xavier; Sancho, Elena; Batlle, Eduard] IRB, Oncol Program, Barcelona 08028, Spain; [Rossell, David] IRB, Biostat Unit, Barcelona 08028, Spain; [Iglesias, Mar] Univ Autonoma Barcelona, Hosp Univ Mar, Dept Pathol, Barcelona 08003, Spain; [Virtudes Cespedes, Maria; Mangues, Ramon] MICINN, CIBER BBN, Inst Biomed Res IIB St Pau, Barcelona 08025, Spain; [Virtudes Cespedes, Maria; Mangues, Ramon] MICINN, CIBER BBN, Networking Res Ctr Bioengn Biomat & Nanomed, Barcelona 08025, Spain; [da Silva-Diz, Victoria; Munoz, Purificacion] Bellvitge Biomed Res Inst IDIBELL, Catalan Canc Epigenet & Biol Program PEBC, Barcelona 08907, Spain; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Batlle, Eduard] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; ICREA	Batlle, E (corresponding author), IRB, Oncol Program, Baldiri Reixac 10, Barcelona 08028, Spain.	eduard.batlle@irbbarcelona.org	Mangues, Ramon/J-6396-2014; Hernando-Momblona, Xavier/ABH-4881-2020; Sancho, Elena/ABH-4867-2020; Rossell, David/AAM-4292-2021; Batlle, Eduard/K-8080-2014	Mangues, Ramon/0000-0003-2661-9525; Sancho, Elena/0000-0002-8182-513X; Rossell, David/0000-0002-7104-5789; Batlle, Eduard/0000-0003-2422-0326; Hernando-Momblona, Xavier/0000-0003-0755-333X; Barriga, Francisco/0000-0002-0996-7707; SEVILLANO, MARTA/0000-0001-5761-0879	H.G. Palmer (Vali d'Hebron Hospital); ERC; MICINN [PS09/00965]; NanoCoMets (CIBER-BBN); ICREA Funding Source: Custom	H.G. Palmer (Vali d'Hebron Hospital); ERC(European Research Council (ERC)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); NanoCoMets (CIBER-BBN); ICREA(ICREA)	We thank Genentech, Inc. for providing anti-EphB2 antibody Mab 2H9, Evarist Planet (IRB, Barcelona) for assistance with statistical methods, H.G. Palmer (Vali d'Hebron Hospital) for support, M. Trias (Hospital de la Santa Creu i Sant Pau) for tumor samples, A. Caton for assistance with bioinformatics, IRB Functional Genomics Facility (IRB) for technical assistance in microarray hybridization experiments, A. Rodolosse for help with ISHs, J. Comas and R. Alvarez (UB, Barcelona) for expert technical assistance with the FAGS, I. Joval for figure artwork, C. Nadal and X. Garcia (Clinic Hospital, Barcelona) for help with samples and discussions, and to all members of the Bathe Lab for support. A.M.-S. holds an AECC postdoctoral fellowship, and F.M.B. holds an IRB/La Caixa PhD fellowship. This work has been supported by grants to E.B. from ERC (FP7-EU) and MICINN (Plan Nacional I+D+i and Consolider programs) and by grants PS09/00965 (MICINN) and NanoCoMets (CIBER-BBN) to IR.M.	Anjomshoaa A, 2008, BRIT J CANCER, V99, P966, DOI 10.1038/sj.bjc.6604560; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940	29	638	662	1	117	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					511	524		10.1016/j.stem.2011.02.020	http://dx.doi.org/10.1016/j.stem.2011.02.020			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21419747	Green Published, Bronze			2022-12-24	WOS:000290927600012
J	Held, R; Ostrovsky, Y; deGelder, B; Gandhi, T; Ganesh, S; Mathur, U; Sinha, P				Held, Richard; Ostrovsky, Yuri; deGelder, Beatrice; Gandhi, Tapan; Ganesh, Suma; Mathur, Umang; Sinha, Pawan			The newly sighted fail to match seen with felt	NATURE NEUROSCIENCE			English	Article							CORTEX	Would a blind subject, on regaining sight, be able to immediately visually recognize an object previously known only by touch? We addressed this question, first formulated by Molyneux three centuries ago, by working with treatable, congenitally blind individuals. We tested their ability to visually match an object to a haptically sensed sample after sight restoration. We found a lack of immediate transfer, but such cross-modal mappings developed rapidly.	[Held, Richard; Ostrovsky, Yuri; Sinha, Pawan] MIT, Cambridge, MA 02139 USA; [deGelder, Beatrice] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Gandhi, Tapan] Indian Inst Technol, New Delhi, India; [Ganesh, Suma; Mathur, Umang] Dr Shroffs Char Eye Hosp, New Delhi, India	Massachusetts Institute of Technology (MIT); Tilburg University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Held, R (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	heldd@neco.edu; psinha@mit.edu		Gandhi, Tapan/0000-0002-3532-9389	James McDonnell Foundation; National Eye Institute [R21-EY015521]; NATIONAL EYE INSTITUTE [R21EY015521] Funding Source: NIH RePORTER	James McDonnell Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors wish to thank all members of the Project Prakash team and especially the children who participated in this study. Funding for this work was provided by the James McDonnell Foundation's Scholar Award to P. S. and the National Eye Institute (grant R21-EY015521 to P.S.).	CHESELDEN W, 1728, PHILOS T, V402, P447; Dandona R, 2003, BRIT J OPHTHALMOL, V87, P263, DOI 10.1136/bjo.87.3.263; DEGENAAR MJL, 2010, CONTINUUM COMPANION, P179; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Falchier A, 2002, J NEUROSCI, V22, P5749; Held R, 2009, OPTOMETRY VISION SCI, V86, P595, DOI 10.1097/OPX.0b013e3181a72999; LEWKOWICZ CJ, 1994, DEV INTERSENSORY PER; Locke John, 1959, ESSAY HUMAN UNDERSTA; Mandavilli A, 2006, NATURE, V441, P271, DOI 10.1038/441271a; Maurer D, 1999, CHILD DEV, V70, P1047, DOI 10.1111/1467-8624.00077; MELTZOFF AN, 1979, NATURE, V282, P403, DOI 10.1038/282403a0; MORGAN MJ, 1977, MOLYNEUXS QUESTION; Ostrovsky Y, 2009, PSYCHOL SCI, V20, P1484, DOI 10.1111/j.1467-9280.2009.02471.x; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; von Senden M., 1960, SPACE SIGHT PERCEPTI	15	108	109	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					551	553		10.1038/nn.2795	http://dx.doi.org/10.1038/nn.2795			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478887				2022-12-24	WOS:000289886600009
J	Truccolo, W; Donoghue, JA; Hochberg, LR; Eskandar, EN; Madsen, JR; Anderson, WS; Brown, EN; Halgren, E; Cash, SS				Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Eskandar, Emad N.; Madsen, Joseph R.; Anderson, William S.; Brown, Emery N.; Halgren, Eric; Cash, Sydney S.			Single-neuron dynamics in human focal epilepsy	NATURE NEUROSCIENCE			English	Article							HUMAN LIMBIC NEURONS; EPILEPTIFORM ACTIVITY; ENTORHINAL CORTEX; SPIKING ACTIVITY; FIRING PATTERNS; SEIZURES; BRAIN; TERMINATION; INITIATION; ENSEMBLE	Epileptic seizures are traditionally characterized as the ultimate expression of monolithic, hypersynchronous neuronal activity arising from unbalanced runaway excitation. Here we report the first examination of spike train patterns in large ensembles of single neurons during seizures in persons with epilepsy. Contrary to the traditional view, neuronal spiking activity during seizure initiation and spread was highly heterogeneous, not hypersynchronous, suggesting complex interactions among different neuronal groups even at the spatial scale of small cortical patches. In contrast to earlier stages, seizure termination is a nearly homogenous phenomenon followed by an almost complete cessation of spiking across recorded neuronal ensembles. Notably, even neurons outside the region of seizure onset showed significant changes in activity minutes before the seizure. These findings suggest a revision of current thinking about seizure mechanisms and point to the possibility of seizure prevention based on spiking activity in neocortical neurons.	[Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Truccolo, Wilson; Donoghue, Jacob A.; Hochberg, Leigh R.; Eskandar, Emad N.; Madsen, Joseph R.; Anderson, William S.; Brown, Emery N.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA USA; [Truccolo, Wilson] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Truccolo, Wilson; Hochberg, Leigh R.] Rehabil Res & Dev Serv, Dept Vet Affairs, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Eskandar, Emad N.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs Cellular Neurosurg & Neurosu, Boston, MA 02114 USA; [Madsen, Joseph R.] Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Madsen, Joseph R.; Anderson, William S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Div Hlth Sci & Technol, Harvard Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Halgren, Eric] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Halgren, Eric] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Halgren, Eric] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University; Brown University; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Truccolo, W (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	wilson_truccolo@brown.edu	Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273; Anderson, William/0000-0003-0958-050X	CIMIT; US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [NS062092]; NIH-NINDS [5K01NS057389]; NIH [NS018741, DP1OD003646]; NINDS [K08NS066099-01A1]; US National Eye Institute [EY017658]; US National Institute on Drug Abuse [NS063249]; US National Science Foundation [IOB 0645886]; Howard Hughes Medical Institute; Klingenstein Foundation; US Department of Veterans Affairs; Doris Duke Charitable Foundation; Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; NIH-NIDCD [R01DC009899]; NATIONAL EYE INSTITUTE [R01EY017658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS066099, R01NS018741, R01NS062092, K01NS057389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009899] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	CIMIT; US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klingenstein Foundation(Klingenstein Philanthropies); US Department of Veterans Affairs(US Department of Veterans Affairs); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank the patients who participated in this study, as well as the nursing and physician staff at each facility. We also thank A. M. Chan, C.J. Keller, A. Dykstra and J.E. Cormier for technical assistance, and J.P. Donoghue and K.J. Staley for critical reading of the manuscript. This research is funded by a CIMIT grant and US National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) NS062092 to S. S. C.; an NIH-NINDS Career Award (5K01NS057389) to W. T.; NIH NS018741 to E. H.; NINDS K08NS066099-01A1 to W. S. A.; US National Eye Institute EY017658, US National Institute on Drug Abuse NS063249, US National Science Foundation IOB 0645886, Howard Hughes Medical Institute and the Klingenstein Foundation to E.N.E.; NIH Director's Pioneer Award DP1OD003646 to E.N.B.; US Department of Veterans Affairs Career Development Transition Award, Doris Duke Charitable Foundation-Clinical Scientist Development Award, Massachusetts General Hospital-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke, and NIH-NIDCD R01DC009899 to L. R. H. The contents do not represent the views of the Department of Veterans Affairs or the United States government.	Amritkar RE, 2009, INT J BIFURCAT CHAOS, V19, P4263, DOI 10.1142/S0218127409025353; Amritkar RE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258102; BABB TL, 1987, ELECTROEN CLIN NEURO, V66, P467, DOI 10.1016/0013-4694(87)90093-9; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bikson M, 2003, J NEUROPHYSIOL, V90, P2402, DOI 10.1152/jn.00467.2003; Bower MR, 2008, J NEUROPHYSIOL, V99, P2431, DOI 10.1152/jn.01369.2007; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 1997, J NEUROSCI, V17, P2567; Buckmaster PS, 2004, COMPARATIVE MED, V54, P473; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Cymerblit-Sabba A, 2010, J NEUROSCI, V30, P1619, DOI 10.1523/JNEUROSCI.5078-09.2010; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; DELGADOESCUETA AV, 1983, EPILEPSY, P295; Engel AK, 2005, NAT REV NEUROSCI, V6, P35, DOI 10.1038/nrn1585; Engel Jr J, 1983, CLIN NEUROSCIENCES, P1349; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; HALGREN E, 1977, EPILEPSIA, V18, P89, DOI 10.1111/j.1528-1157.1977.tb05590.x; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jacobs MP, 2009, EPILEPSY BEHAV, V14, P438, DOI 10.1016/j.yebeh.2009.02.036; Jefferys JGR, 2003, EPILEPSIA, V44, P44, DOI 10.1111/j.0013-9580.2003.12004.x; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Lado FA, 2008, EPILEPSIA, V49, P1651, DOI 10.1111/j.1528-1167.2008.01669.x; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; MATSUMOTO H, 1964, EXP NEUROL, V9, P305, DOI 10.1016/0014-4886(64)90026-3; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Penfield W, 1954, EPILEPSY FUNCTIONAL; Pinto DJ, 2005, J NEUROSCI, V25, P8131, DOI 10.1523/JNEUROSCI.2278-05.2005; Santhanam G, 2007, IEEE T BIO-MED ENG, V54, P2037, DOI 10.1109/TBME.2007.895753; SAWA M, 1968, ELECTROEN CLIN NEURO, V24, P146, DOI 10.1016/0013-4694(68)90120-X; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; Schwartzkroin Philip A., 1993, P83; Staba RJ, 2002, J NEUROSCI, V22, P5694; TREIMAN DM, 2001, TREATMENT EPILEPSY P, P681; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Ulbert T, 2004, EPILEPSIA, V45, P48, DOI 10.1111/j.0013-9580.2004.04011.x; WYLER AR, 1982, ANN NEUROL, V11, P301, DOI 10.1002/ana.410110311; Yaari Y, 2002, BRAIN PATHOL, V12, P234; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	42	335	339	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					635	U130		10.1038/nn.2782	http://dx.doi.org/10.1038/nn.2782			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441925	Green Accepted, Green Published			2022-12-24	WOS:000289886600020
J	Zweifel, LS; Fadok, JP; Argilli, E; Garelick, MG; Jones, GL; Dickerson, TMK; Allen, JM; Mizumori, SJY; Bonci, A; Palmiter, RD				Zweifel, Larry S.; Fadok, Jonathan P.; Argilli, Emmanuela; Garelick, Michael G.; Jones, Graham L.; Dickerson, Tavis M. K.; Allen, James M.; Mizumori, Sheri J. Y.; Bonci, Antonello; Palmiter, Richard D.			Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ACOUSTIC STARTLE RESPONSE; PREPULSE INHIBITION; NMDA-RECEPTORS; DISCHARGE RATE; FEAR; POTENTIATION; STIMULI; MICE; AMPHETAMINE	Generalized anxiety is thought to result, in part, from impairments in contingency awareness during conditioning to cues that predict aversive or fearful outcomes. Dopamine neurons of the ventral midbrain exhibit heterogeneous responses to aversive stimuli that are thought to provide a critical modulatory signal to facilitate orientation to environmental changes and assignment of motivational value to unexpected events. Here we describe a mouse model in which activation of dopamine neurons in response to an aversive stimulus is attenuated by conditional genetic inactivation of functional NMDA receptors on dopamine neurons. We discovered that altering the magnitude of excitatory responses by dopamine neurons in response to an aversive stimulus was associated with impaired conditioning to a cue that predicts an aversive outcome. Impaired conditioning by these mice was associated with the development of a persistent, generalized anxiety-like phenotype. These data are consistent with a role for dopamine in facilitating contingency awareness that is critical for the prevention of generalized anxiety.	[Zweifel, Larry S.; Jones, Graham L.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zweifel, Larry S.; Jones, Graham L.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Zweifel, Larry S.; Fadok, Jonathan P.; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Zweifel, Larry S.; Fadok, Jonathan P.; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Fadok, Jonathan P.; Garelick, Michael G.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Argilli, Emmanuela; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Argilli, Emmanuela; Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Allen, James M.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Mizumori, Sheri J. Y.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zweifel, LS (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	larryz@uw.edu; palmiter@uw.edu	Fadok, Jonathan/AAX-2999-2020; Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Fadok, Jonathan/0000-0002-0608-5151	US National Institutes of Health [2T32 GM007270, 4 R25 GM 058501-05, 1 R01 MH58755]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R25GM058501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058755] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. D. Guler and members of the Palmiter laboratory for thoughtful discussion of this manuscript. We thank G. Froelich, V. Wall and M.J. Kim for technical support. This work was supported in part by US National Institutes of Health grants 2T32 GM007270 (to J.P.F.), 4 R25 GM 058501-05 (to T. M. K. D.) and 1 R01 MH58755 (to S.J.Y.M.).	Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; CHIODO LA, 1979, BRAIN RES, V176, P385, DOI 10.1016/0006-8993(79)90994-6; CHIODO LA, 1980, BRAIN RES, V189, P544, DOI 10.1016/0006-8993(80)90366-2; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Flood DG, 2010, PSYCHOPHARMACOLOGY, V211, P325, DOI 10.1007/s00213-010-1901-0; Grillon C, 2002, BIOL PSYCHIAT, V51, P851, DOI 10.1016/S0006-3223(01)01370-1; Grillon C, 2002, BIOL PSYCHIAT, V52, P958, DOI 10.1016/S0006-3223(02)01665-7; Grillon C, 2006, PSYCHOPHARMACOLOGY, V186, P434, DOI 10.1007/s00213-005-0124-2; Hunter AJ, 2000, HUM MOL GENET, V9, P893, DOI 10.1093/hmg/9.6.893; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Jovanovic T, 2010, PSYCHONEUROENDOCRINO, V35, P846, DOI 10.1016/j.psyneuen.2009.11.009; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; Komendantov AO, 2004, J NEUROPHYSIOL, V91, P346, DOI 10.1152/jn.00062.2003; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; MANTZ J, 1989, BRAIN RES, V476, P377, DOI 10.1016/0006-8993(89)91263-8; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; OVERTON P, 1992, SYNAPSE, V10, P131, DOI 10.1002/syn.890100208; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Ralph RJ, 1999, J NEUROSCI, V19, P4627; Richardson R, 2000, BEHAV BRAIN RES, V110, P109, DOI 10.1016/S0166-4328(99)00189-8; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Sanchez MM, 2005, BIOL PSYCHIAT, V57, P373, DOI 10.1016/j.biopsych.2004.11.032; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Swerdlow NR, 2000, J NEUROSCI, V20, P4325; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	37	166	168	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					620	U112		10.1038/nn.2808	http://dx.doi.org/10.1038/nn.2808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21499253	Green Accepted			2022-12-24	WOS:000289886600018
J	Sun, Y; Meijer, DH; Alberta, JA; Mehta, S; Kane, MF; Tien, AC; Fu, H; Petryniak, MA; Potter, GB; Liu, ZJ; Powers, JF; Runquist, IS; Rowitch, DH; Stiles, CD				Sun, Yu; Meijer, Dimphna H.; Alberta, John A.; Mehta, Shwetal; Kane, Michael F.; Tien, An-Chi; Fu, Hui; Petryniak, Magdalena A.; Potter, Gregory B.; Liu, Zijing; Powers, James F.; Runquist, I. Sophie; Rowitch, David H.; Stiles, Charles D.			Phosphorylation State of Olig2 Regulates Proliferation of Neural Progenitors	NEURON			English	Article							LOOP-HELIX FACTORS; NERVOUS-SYSTEM; MOTOR-NEURON; STEM-CELLS; OLIGODENDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; SPECIFICATION; ACETYLATION; GLIOMA; GENES	The bHLH transcription factors that regulate early development of the central nervous system can generally be classified as either antineural or proneural. Initial expression of antineural factors prevents cell cycle exit and thereby expands the pool of neural progenitors. Subsequent (and typically transient) expression of proneural factors promotes cell cycle exit, subtype specification, and differentiation. Against this backdrop, the bHLH transcription factor Olig2 in the oligodendrocyte lineage is unorthodox, showing antineural functions in multipotent CNS progenitor cells but also sustained expression and proneural functions in the formation of oligodendrocytes. We show here that the proliferative function of Olig2 is controlled by developmentally regulated phosphorylation of a conserved triple serine motif within the amino-terminal domain. In the phosphorylated state, Olig2 maintains antineural (i.e., promitotic) functions that are reflected in human glioma cells and in a genetically defined murine model of primary glioma.	[Tien, An-Chi; Petryniak, Magdalena A.; Potter, Gregory B.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Pediat, San Francisco, CA 94143 USA; [Sun, Yu; Meijer, Dimphna H.; Alberta, John A.; Mehta, Shwetal; Kane, Michael F.; Fu, Hui; Liu, Zijing; Runquist, I. Sophie; Stiles, Charles D.] Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA; [Sun, Yu; Meijer, Dimphna H.; Alberta, John A.; Mehta, Shwetal; Kane, Michael F.; Fu, Hui; Liu, Zijing; Runquist, I. Sophie; Stiles, Charles D.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Powers, James F.] Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA; [Tien, An-Chi; Petryniak, Magdalena A.; Potter, Gregory B.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Neurol Surg, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Tufts Medical Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Rowitch, DH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Pediat, 513 Parnassus Ave, San Francisco, CA 94143 USA.	rowitchd@peds.ucst.edu; charles_stiles@dfci.harvard.edu	Fu, Hui/C-2881-2011	Fu, Hui/0000-0003-0252-6009; Liu, Zijing/0000-0001-7790-0590; Potter, Gregory/0000-0002-0585-6575; Rowitch, David/0000-0002-0079-0060; Powers, James/0000-0001-8422-3938	NINDS [NS040511, NS057727]; Pediatric Low-Grade Astrocytoma Foundation;  [KO8 NS062744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040511, F32NS055631, K08NS062744, R01NS057727] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pediatric Low-Grade Astrocytoma Foundation; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge Dr. Ross Tomaino at the Taplin Biological Mass Spectrometry Facility of Harvard Medical School for helpful suggestions in the proteolytic digestions and mass spectroscopy analysis of Olig2. Excellent technical assistance was provided by Diane Goleblowski, Maria Murray, Jessica Weatherbee, and Gizelle Robinson. Finally, we are grateful to Drs. Qiufu Ma and Rosalind Segal at Dana-Farber for support and helpful suggestions. M.A.P. acknowledges KO8 NS062744 for support. This work was supported by grants from the NINDS (NS040511 and NS057727 to D.H.R. and C.D.S., respectively) and from the Pediatric Low-Grade Astrocytoma Foundation. D.H.R is a Howard Hughes Medical Institute Investigator.	ALBERTA JA, 2001, CURR PROTOC NEUROSCI, V3; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Beatus P, 1998, J NEUROSCI RES, V54, P125, DOI 10.1002/(SICI)1097-4547(19981015)54:2<125::AID-JNR1>3.3.CO;2-C; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Gong JG, 2003, CANCER RES, V63, P3340; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; KLEIHUES P, 2007, TUMOURS CENTRAL NERV; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; MEHTA S, 2011, DEVELOPMENT, V133, P363; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qian XM, 1998, DEVELOPMENT, V125, P3143; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Setoguchi T, 2004, J CELL BIOL, V166, P963, DOI 10.1083/jcb.200404104; Sun T, 2003, J NEUROSCI, V23, P9547; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	41	88	92	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					906	917		10.1016/j.neuron.2011.02.005	http://dx.doi.org/10.1016/j.neuron.2011.02.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382551	Bronze, Green Accepted			2022-12-24	WOS:000288736500009
J	Yu, PZ; Pan, GJ; Yu, JY; Thomson, JA				Yu, Pengzhi; Pan, Guangjin; Yu, Junying; Thomson, James A.			FGF2 Sustains NANOG and Switches the Outcome of BMP4-Induced Human Embryonic Stem Cell Differentiation	CELL STEM CELL			English	Article							BONE MORPHOGENETIC PROTEIN-4; HUMAN ES CELLS; MOUSE EPIBLAST; MESODERM INDUCTION; BRACHYURY T; DUSP6 MKP3; PLURIPOTENCY; EXPRESSION; CLONING; FAMILY	Here, we show that as human embryonic stem cells (ESCs) exit the pluripotent state, NANOG can play a key role in determining lineage outcome. It has previously been reported that BMPs induce differentiation of human ESCs into extraembryonic lineages. Here, we find that FGF2, acting through the MEK-ERK pathway, switches BMP4-induced human ESC differentiation outcome to mesendoderm, characterized by the uniform expression of T (brachyury) and other primitive streak markers. We also find that MEK-ERK signaling prolongs NANOG expression during BMP-induced differentiation, that forced NANOG expression results in FGF-independent BMP4 induction of mesendoderm, and that knockdown of NANOG greatly reduces T induction. Together, our results demonstrate that FGF2 signaling switches the outcome of BMP4-induced differentiation of human ESCs by maintaining NANOG levels through the MEK-ERK pathway.	[Yu, Pengzhi; Pan, Guangjin; Thomson, James A.] Morgridge Inst Res, Madison, WI 53715 USA; [Yu, Pengzhi; Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53707 USA; [Yu, Pengzhi] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA; [Yu, Junying] Cellular Dynam Int Inc, Madison, WI 53707 USA; [Thomson, James A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Barbara	Thomson, JA (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.	jthomson@morgridgeinstitute.org	Yu, Pengzhi/I-3182-2016	Yu, Pengzhi/0000-0001-7637-404X	Charlotte Geyer Foundation; NIH [PO1 GM081629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Charlotte Geyer Foundation and NIH grant PO1 GM081629. We thank Zhonggang Hou for providing the doxycycline-inducible system vector; Shulan Tian and Ron Stewart for their bioinformatics support; Gudrun A. Jonsdottir for performing sample labeling and hybridization in microarray analysis; and Justin Brumbaugh, Deborah J. Faupel, and Krista Eastman for critical reading of the manuscript.	Arkell RS, 2008, CELL SIGNAL, V20, P836, DOI 10.1016/j.cellsig.2007.12.014; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; CUNLIFFE V, 1992, NATURE, V358, P427, DOI 10.1038/358427a0; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dobrovolskaia-Zavadskaia N, 1927, CR SOC BIOL, V97, P114; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jones CM, 1996, DEVELOPMENT, V122, P1545; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; YANAGISAWA KO, 1981, DEV BIOL, V87, P242, DOI 10.1016/0012-1606(81)90147-0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	44	175	184	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					326	334		10.1016/j.stem.2011.01.001	http://dx.doi.org/10.1016/j.stem.2011.01.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362572	Bronze, Green Accepted			2022-12-24	WOS:000288404400014
J	Buecker, C; Geijsen, N				Buecker, Christa; Geijsen, Niels			Different Flavors of Pluripotency, Molecular Mechanisms, and Practical Implications	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE PLURIPOTENCY; GENE-EXPRESSION; MOUSE EPIBLAST; HOMOLOGOUS RECOMBINATION; MAINTAINS PLURIPOTENCY; SELF-RENEWAL; ES CELLS; NANOG; LINES	Pluripotent stem cells (PSCs) have been classified into two distinct states: a primitive, naive LIF-dependent state represented by murine ESCs, and a primed bFGF-dependent state observed in murine and rat epiblast stem cells (EpiSCs). The vast similarities between EpiSCs and human ESCs suggest that, despite their blastocyst origin, human ESCs exist in a primed pluripotent state. Recent findings demonstrate that the naive and primed pluripotent states are interconvertible, even in human cells, and hint that growth factor-mediated Nanog expression may be an important factor regulating the balance between them.	[Buecker, Christa; Geijsen, Niels] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Buecker, Christa; Geijsen, Niels] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Geijsen, Niels] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Geijsen, Niels] Univ Utrecht, Sch Vet Med, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Geijsen, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, CPZN 4256,185 Cambridge St, Boston, MA 02114 USA.	n.geijsen@hubrecht.eu		Buecker, Christa/0000-0003-3055-2642	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD048769] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Barrero MJ, 2010, CELL STEM CELL, V7, P565, DOI 10.1016/j.stem.2010.10.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Fischer Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012533; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Layden BT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009105; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pant D, 2009, CLONING STEM CELLS, V11, P355, DOI 10.1089/clo.2008.0078; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Solter D, 2010, CELL, V142, P676, DOI 10.1016/j.cell.2010.08.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	50	29	30	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					559	564		10.1016/j.stem.2010.10.007	http://dx.doi.org/10.1016/j.stem.2010.10.007			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040897	Bronze			2022-12-24	WOS:000284390500007
J	Wu, XW; Pang, LJ; Lei, WQ; Lu, W; Li, J; Li, ZY; Frassica, FJ; Chen, XL; Wan, M; Cao, X				Wu, Xiangwei; Pang, Lijuan; Lei, Weiqi; Lu, William; Li, Jun; Li, Zhaoyang; Frassica, Frank J.; Chen, Xueling; Wan, Mei; Cao, Xu			Inhibition of Sca-1-Positive Skeletal Stem Cell Recruitment by Alendronate Blunts the Anabolic Effects of Parathyroid Hormone on Bone Remodeling	CELL STEM CELL			English	Article							TGF-BETA; MINERAL DENSITY; MARROW; ANGIOGENESIS; OSTEOPOROSIS; RESORPTION; RECEPTOR; WOMEN; OSTEOGENESIS; PATHOGENESIS	The anabolic effects of parathyroid hormone (PTH) on bone formation are impaired by concurrent use of antiresorptive drugs. We found that the release of active transforming growth factor (TGF)-beta 1 during osteoclastic bone resorption is inhibited by alendronate. We showed that mouse Sca-1-positive (Sca-1(+)) bone marrow stromal cells are a skeletal stem cell subset, which are recruited to bone remodeling sites by active TGF-beta 1 in response to bone resorption. Alendronate inhibits the release of active TGF-beta 1 and the recruitment of Sca-1(+) skeletal stem cells for the bone formation. The observation was validated in a Tgfb1(-/-) mouse model, in which the anabolic effects of PTH on bone formation are diminished. The PTH-stimulated recruitment of injected mouse Sca-1(+) cells to the resorptive sites was inhibited by alendronate. Thus, inhibition of active TGF-beta 1 release by alendronate reduces the recruitment of Sca-1(+) skeletal stem cells and impairs the anabolic action of PTH in bone.	[Wu, Xiangwei; Pang, Lijuan; Lei, Weiqi; Li, Jun; Frassica, Frank J.; Chen, Xueling; Wan, Mei; Cao, Xu] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Wu, Xiangwei; Pang, Lijuan; Li, Jun] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China; [Wu, Xiangwei; Pang, Lijuan; Li, Jun; Chen, Xueling] Shihezi Univ, Sch Med, Shihezi 832002, Xinjiang, Peoples R China; [Lu, William; Li, Zhaoyang] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong 999777, Hong Kong, Peoples R China	Johns Hopkins University; Huazhong University of Science & Technology; Shihezi University; University of Hong Kong	Cao, X (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA.	xcao11@jhmi.edu	Sui, Yanwei/AAH-9928-2021; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022		US National Institutes of Health [DK0080898, AR 053973]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080898, R01DK057501] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Elaine P. Henze (Editorial Services Department of Orthopaedic Surgery, Johns Hopkins University) for editing the manuscript and Dr. Brendan J. Canning (Asthma and Allergy Center, Johns Hopkins University) for providing guinea pig marrow cells. This research was supported by US National Institutes of Health grants DK0080898 and AR 053973 to X. Cao.	Atfi A, 2010, NAT CELL BIOL, V12, P205, DOI 10.1038/ncb0310-205; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Bonnick Sydney L, 2006, Clin Cornerstone, V8, P28, DOI 10.1016/S1098-3597(06)80063-3; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Finkelstein JS, 2010, J CLIN ENDOCR METAB, V95, P1838, DOI 10.1210/jc.2009-1703; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Hill P A, 1998, Br J Orthod, V25, P101; Iqbal MM, 2000, SOUTH MED J, V93, P2; Kurland ES, 2000, J CLIN ENDOCR METAB, V85, P3069, DOI 10.1210/jc.85.9.3069; Kuznetsov S, 1996, CALCIFIED TISSUE INT, V59, P265, DOI 10.1007/s002239900121; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; PARFITT AM, 1982, METAB BONE DIS RELAT, V4, P1, DOI 10.1016/0221-8747(82)90002-9; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; RIGGS BL, 1991, WESTERN J MED, V154, P63; Rittmaster RS, 2000, J CLIN ENDOCR METAB, V85, P2129, DOI 10.1210/jc.85.6.2129; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Samadfam R, 2007, ENDOCRINOLOGY, V148, P2778, DOI 10.1210/en.2006-1475; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Towler DA, 2007, J CLIN INVEST, V117, P1477, DOI 10.1172/JCI32518; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Watanabe Ken, 2005, Molecular Aspects of Medicine, V26, P221, DOI 10.1016/j.mam.2005.01.006; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	42	101	106	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					571	580		10.1016/j.stem.2010.09.012	http://dx.doi.org/10.1016/j.stem.2010.09.012			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040899	Bronze, Green Accepted			2022-12-24	WOS:000284390500009
J	Hoeck, JD; Jandke, A; Blake, SM; Nye, E; Spencer-Dene, B; Brandner, S; Behrens, A				Hoeck, Joerg D.; Jandke, Anett; Blake, Sophia M.; Nye, Emma; Spencer-Dene, Bradley; Brandner, Sebastian; Behrens, Axel			Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun	NATURE NEUROSCIENCE			English	Article							RADIAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CYCLIN-E; INTERMEDIATE PROGENITORS; FATE SPECIFICATION; PROTEIN; GENE; PHOSPHORYLATION	Neural stem and progenitor cells (NSCs/NPCs) give rise to neurons, astrocytes and oligodendrocytes. However, the mechanisms underlying the decision of a stem cell to either self-renew or differentiate are incompletely understood. We demonstrate here that Fbw7 (F-box and WD repeat domain containing-7), the substrate recognition component of an SCF (complex of SKP1, CUL1 and F-box protein)-type E3 ubiquitin ligase, is a key regulator of NSC/NPC viability and differentiation. The absence of Fbw7 in the mouse brain caused severely impaired stem cell differentiation and increased progenitor cell death. Fbw7 deficiency resulted in accumulation of two SCF(Fbw7) substrates, the transcription factors active Notch1 and N-terminally phosphorylated c-Jun. Genetic and pharmacological rescue experiments identified c-Jun as a key substrate of Fbw7 in controlling progenitor cell viability, whereas inhibition of Notch signaling alleviated the block in stem cell differentiation. Thus Fbw7 controls neurogenesis by antagonizing Notch and c-Jun N-terminal kinase (JNK)/c-Jun signaling.	[Hoeck, Joerg D.; Jandke, Anett; Blake, Sophia M.; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, London, England; [Nye, Emma; Spencer-Dene, Bradley] Canc Res UK London Res Inst, Expt Pathol Lab, London, England; [Brandner, Sebastian] UCL, Inst Neurol, Dept Neurodegenerat Dis, Div Neuropathol, London, England	Cancer Research UK; Cancer Research UK; University of London; University College London	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, London, England.	axel.behrens@cancer.org.uk	Jandke, Anett/AAK-4545-2021; Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Behrens, Axel/0000-0002-1557-1143; Jandke, Anett/0000-0002-7681-7952; Hoeck, Joerg/0000-0002-2142-1555	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); MRC [85704]; Cancer Research UK; MRC [G0800020] Funding Source: UKRI; Medical Research Council [G0800020] Funding Source: researchfish	Federation of the Societies of Biochemistry and Molecular Biology (FEBS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the Animal Unit, Equipment Park, FACS Lab and the Experimental Pathology Lab at the London Research Institute for technical help and advice on histology. We are grateful to F. Radtke (Swiss Institute for Experimental Cancer Research, Lausanne, Switzerland) for floxed Notch1 mice. We thank R. Sancho for the data on Fbxw7 isoform expression in various tissues. We thank C. R. Da Costa, S. Marino and A. Martin-Villalba for critical reading of the manuscript. S. M. B. is supported by a Federation of the Societies of Biochemistry and Molecular Biology (FEBS) Long Term Fellowship. Part of this work is supported by an MRC project grant (85704) to A. B. The London Research Institute is funded by Cancer Research UK.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Besirli CG, 2005, J CELL BIOL, V170, P401, DOI 10.1083/jcb.200501138; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Fuchs SY, 2005, CANCER BIOL THER, V4, P506, DOI 10.4161/cbt.4.5.1703; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hojo M, 2000, DEVELOPMENT, V127, P2515; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Tan YM, 2008, CANCER LETT, V271, P1, DOI 10.1016/j.canlet.2008.04.036; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wang X, 2007, MOL CELL BIOL, V27, P7935, DOI 10.1128/MCB.00226-07; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018	45	132	133	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1365	U95		10.1038/nn.2644	http://dx.doi.org/10.1038/nn.2644			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935640				2022-12-24	WOS:000283658200017
J	Rouaux, C; Arlotta, P				Rouaux, Caroline; Arlotta, Paola			Fezf2 directs the differentiation of corticofugal neurons from striatal progenitors in vivo	NATURE NEUROSCIENCE			English	Article							SUBTYPE-SPECIFIC GENES; SPECIFICATION	In the developing cerebral cortex, cell-extrinsic and cell-intrinsic signals govern the establishment of neuron subtype-specific identity. Here we show that, within the niche of the striatum, the expression of a single transcription factor, Fezf2, is sufficient to generate corticofugal neurons from progenitors fated to become medium spiny neurons. This demonstrates that a specific population of cortical projection neurons can be directed to differentiate outside of the cortex by cell-autonomous signaling.	[Rouaux, Caroline; Arlotta, Paola] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02115 USA; [Rouaux, Caroline; Arlotta, Paola] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA USA; [Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Arlotta, Paola] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University	Arlotta, P (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02115 USA.	paola_arlotta@hms.harvard.edu	Rouaux, Caroline/O-1712-2017	Rouaux, Caroline/0000-0002-5724-2903	US National Institutes of Health [NS062849]; Spastic Paraplegia Foundation; Harvard Stem Cell Institute; Harvard NeuroDiscovery Center; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spastic Paraplegia Foundation; Harvard Stem Cell Institute; Harvard NeuroDiscovery Center; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Macklis (Harvard University) for reagents and advice; E. Abdel-Azim, G. Srubek-Tomassy, F. Zhang and S. Lodato for their comments; R. Hevner, (University of Washington), C. Lois (M. I. T.), K. Campbell (University of Cincinnati) and Q. Ma (Harvard Medical School) for generous sharing of antibodies, probes and expression vectors; and A. Meleski, A. Merlino and Z. Trayes-Gibson for technical support. This work was partially supported by grants to P. A. from the US National Institutes of Health (NS062849), the Spastic Paraplegia Foundation, the Harvard Stem Cell Institute and the Harvard NeuroDiscovery Center to P. A.; C. R. was partially supported by a Milton-Safenowitz postdoctoral fellowship from the ALS Association.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; FISHELL G, 1995, DEVELOPMENT, V121, pU4; Magrassi L, 1998, DEVELOPMENT, V125, P2847; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Wichterle H, 2001, DEVELOPMENT, V128, P3759	14	79	81	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1345	1347		10.1038/nn.2658	http://dx.doi.org/10.1038/nn.2658			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953195	Green Accepted			2022-12-24	WOS:000283658200012
J	Gozzi, A; Jain, A; Giovanelli, A; Bertollini, C; Crestan, V; Schwarz, AJ; Tsetsenis, T; Ragozzino, D; Gross, CT; Bifone, A				Gozzi, Alessandro; Jain, Apar; Giovanelli, Aldo; Bertollini, Cristina; Crestan, Valerio; Schwarz, Adam J.; Tsetsenis, Theodoros; Ragozzino, Davide; Gross, Cornelius T.; Bifone, Angelo			A Neural Switch for Active and Passive Fear	NEURON			English	Article							FUNCTIONAL CONNECTIVITY; AMYGDALOID COMPLEX; EXTENDED AMYGDALA; CENTRAL NUCLEUS; BINDING-SITES; RAT; VASOPRESSIN; OXYTOCIN; BRAIN; CONSOLIDATION	The central nucleus of the amygdala (CeA) serves as a major output of this structure and plays a critical role in the expression of conditioned fear. By combining cell- and tissue-specific pharmacogenetic inhibition with functional magnetic resonance imaging (fMRI), we identified circuits downstream of CeA that control fear expression in mice. Selective inhibition of a subset of neurons in CeA led to decreased conditioned freezing behavior and increased cortical arousal as visualized by fMRI. Correlation analysis of fMRI signals identified functional connectivity between CeA, cholinergic fore-brain nuclei, and activated cortical structures, and cortical arousal was blocked by cholinergic antagonists. Importantly, inhibition of these neurons switched behavioral responses to the fear stimulus from passive to active responses. Our findings identify a neural circuit in CeA that biases fear responses toward either passive or active coping strategies.	[Jain, Apar; Tsetsenis, Theodoros; Gross, Cornelius T.] EMBL, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Gozzi, Alessandro; Crestan, Valerio; Schwarz, Adam J.; Bifone, Angelo] GlaxoSmithKline Med Res Ctr, Neurosci CEDD, I-37135 Verona, Italy; [Giovanelli, Aldo; Bertollini, Cristina; Ragozzino, Davide] Univ Roma La Sapienza, Ctr Excellence BEMM, Dept Human Physiol & Pharmacol, I-00185 Rome, Italy; [Giovanelli, Aldo; Bertollini, Cristina; Ragozzino, Davide] Fdn Cenci Bolognetti, Inst Pasteur, I-00185 Rome, Italy; [Giovanelli, Aldo] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Ragozzino, Davide] Neuromed, I-86077 Pozzilli, Italy	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Sapienza University Rome; Fondazione Cenci Bolognetti; University of L'Aquila; IRCCS Neuromed	Gross, CT (corresponding author), EMBL, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	gross@embl.it	ragozzino, davide/K-6521-2016; Gozzi, Alessandro/K-6342-2016	ragozzino, davide/0000-0002-3290-7665; Gozzi, Alessandro/0000-0002-5731-4137; Tsetsenis, Theodoros/0000-0002-4642-6539	EMBL; EC	EMBL; EC(European CommissionEuropean Commission Joint Research Centre)	We thank Graham Sheridan for help with scoring behavior, Rosa Chiara Paolicelli, Viviana Triaca, and Emerald Perlas for help and advice in immunostaining experiment, Francesca Zonfrillo and Roberto Voci for mouse husbandry, and Stefania Rizzo for genotyping. This work was supported in part by funds from EMBL (C.T.G., T.T.) and the EC FP7 DEVANX Collaborative Grant (C.T.G., A.J.). A. Gozzi and A.B. are employees and shareholders of GlaxoSmithKline. A. Gozzi designed, carried out, and analyzed the fMRI experiments; A.J. designed, carried out, and analyzed the behavioral and immunohistochemical experiments and oversaw production of mice for fMRI studies; A. Giovanelli and D.R. designed, A. Giovanelli and C.B. carried out, and A. Giovanelli and D.R. analyzed the electrophysiological experiments; V.C. performed animal surgery and preparation; A.S. developed the functional connectivity frame work; T.T. oversaw production of mice for fMRI studies and performed behavioral experiments; A.B. and C.T.G. conceived the experiments with critical input from A. Gozzi and A.J. and oversaw the experimental work and analysis; C.T.G. and A. Gozzi wrote the manuscript with help from A.B.	AGGLETON JP, 1992, AMYGDALA; AMARAL D G, 1992, P1; BARATTI CM, 1979, PSYCHOPHARMACOLOGY, V64, P85, DOI 10.1007/BF00427350; Boccia MM, 2003, NEUROSCI LETT, V345, P97, DOI 10.1016/S0304-3940(03)00493-2; Cezario AF, 2008, EUR J NEUROSCI, V28, P1003, DOI 10.1111/j.1460-9568.2008.06392.x; Chen YCI, 2001, J MAGN RESON IMAGING, V14, P517, DOI 10.1002/jmri.1215; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; Dringenberg HC, 1997, EXP BRAIN RES, V116, P160, DOI 10.1007/PL00005736; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ferrari L, 2010, J NEUROSCI METH, V186, P143, DOI 10.1016/j.jneumeth.2009.11.005; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Gasbarri A, 1997, BEHAV BRAIN RES, V86, P97, DOI 10.1016/S0166-4328(96)02250-4; Gozzi A, 2007, MAGN RESON IMAGING, V25, P826, DOI 10.1016/j.mri.2007.03.003; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Jolkkonen E, 2002, NEUROSCIENCE, V111, P133, DOI 10.1016/S0306-4522(01)00578-4; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; ROOZENDAAL B, 1992, ANN NY ACAD SCI, V652, P460, DOI 10.1111/j.1749-6632.1992.tb34384.x; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schiess MC, 1999, J NEUROSCI RES, V58, P663, DOI 10.1002/(SICI)1097-4547(19991201)58:5<663::AID-JNR7>3.3.CO;2-1; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Schwarz AJ, 2007, MAGN RESON MED, V57, P704, DOI 10.1002/mrm.21179; Schwarz AJ, 2007, J NEUROSCI METH, V159, P346, DOI 10.1016/j.jneumeth.2006.07.017; Schwarz AJ, 2003, MAGN RESON IMAGING, V21, P1191, DOI 10.1016/j.mri.2003.08.020; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; TRIBOLLET E, 1988, BRAIN RES, V442, P105, DOI 10.1016/0006-8993(88)91437-0; Tsetsenis T, 2007, NAT NEUROSCI, V10, P896, DOI 10.1038/nn1919; Veinante P, 1997, J COMP NEUROL, V383, P305; Viviani D, 2008, PROG BRAIN RES, V170, P207, DOI 10.1016/S0079-6123(08)00418-4; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	39	128	131	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					656	666		10.1016/j.neuron.2010.07.008	http://dx.doi.org/10.1016/j.neuron.2010.07.008			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797541	Bronze			2022-12-24	WOS:000281534600014
J	Losonczy, A; Zemelman, BV; Vaziri, A; Magee, JC				Losonczy, Attila; Zemelman, Boris V.; Vaziri, Alipasha; Magee, Jeffrey C.			Network mechanisms of theta related neuronal activity in hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							PHASE-PRECESSION; UNIT-ACTIVITY; GABA RELEASE; PLACE CELLS; OSCILLATIONS; DYNAMICS; INFORMATION; COMPUTATION; INHIBITION; MODULATION	Although hippocampal theta oscillations represent a prime example of temporal coding in the mammalian brain, little is known about the specific biophysical mechanisms. Intracellular recordings support a particular abstract oscillatory interference model of hippocampal theta activity, the soma-dendrite interference model. To gain insight into the cellular and circuit level mechanisms of theta activity, we implemented a similar form of interference using the actual hippocampal network in mice in vitro. We found that pairing increasing levels of phasic dendritic excitation with phasic stimulation of perisomatic projecting inhibitory interneurons induced a somatic polarization and action potential timing profile that reproduced most common features. Alterations in the temporal profile of inhibition were required to fully capture all features. These data suggest that theta-related place cell activity is generated through an interaction between a phasic dendritic excitation and a phasic perisomatic shunting inhibition delivered by interneurons, a subset of which undergo activity-dependent presynaptic modulation.	[Zemelman, Boris V.; Vaziri, Alipasha; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA USA; [Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY USA	Howard Hughes Medical Institute; Columbia University	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	mageej@janelia.hhmi.org		Zemelman, Boris/0000-0003-2463-4887	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ali AB, 2010, EUR J NEUROSCI, V31, P1196, DOI 10.1111/j.1460-9568.2010.07165.x; Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bose A, 2000, J COMPUT NEUROSCI, V9, P5, DOI 10.1023/A:1008976210366; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Katona I, 1999, J NEUROSCI, V19, P4544; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Robbe D, 2009, J NEUROSCI, V29, P12597, DOI 10.1523/JNEUROSCI.2407-09.2009; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schmidt R, 2009, J NEUROSCI, V29, P13232, DOI 10.1523/JNEUROSCI.2270-09.2009; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	48	71	71	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					967	U25		10.1038/nn.2597	http://dx.doi.org/10.1038/nn.2597			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639875	Green Accepted			2022-12-24	WOS:000280400600015
J	Demarque, M; Spitzer, NC				Demarque, Michael; Spitzer, Nicholas C.			Activity-Dependent Expression of Lmx1b Regulates Specification of Serotonergic Neurons Modulating Swimming Behavior	NEURON			English	Article							POSTEMBRYONIC XENOPUS-LAEVIS; PHENOTYPE IN-VITRO; ELECTRICAL-ACTIVITY; MOLECULAR-GENETICS; SEIZURE ACTIVITY; MESSENGER-RNA; MICE LACKING; SPINAL-CORD; RECEPTORS; DIFFERENTIATION	Genetic programs, environmental factors, and electrical activity interact to drive the maturation of the brain. Although the cascade of transcription factors that leads to specification of the serotonergic phenotype has been well characterized, its interactions with electrical activity are not known. Here we show that spontaneous calcium spike activity in the hind-brain of developing Xenopus laevis larvae modulates the specification of serotonergic neurons via regulation of expression of the Lmx1b transcription factor. Activity acts downstream of Nkx2.2 but upstream of Lmx1b, leading to regulation of the serotonergic phenotype. Using global manipulation of activity and targeted alteration of Lmx1b expression, we also demonstrate that changes in the number of serotonergic neurons change larval swimming behavior. The results link activity-dependent regulation of a transcription factor to transmitter specification and altered behavior.	[Demarque, Michael; Spitzer, Nicholas C.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Demarque, Michael; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Neural Circuits, La Jolla, CA 92093 USA; [Demarque, Michael; Spitzer, Nicholas C.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Demarque, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	mdemarque@gmail.com; nspitzer@ucsd.edu		Demarque, Michael/0000-0001-5073-1651; Spitzer, Nicholas/0000-0002-3523-1103	NIH [NS15918]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015918] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Xavier Nicol, Krista Todd, and the Kristan lab for technical support; members of our laboratory for thoughtful discussion; and Davide Dulcis, Kurt Marek, and Xavier Nicol for their comments on the manuscript. This work was supported by NIH NS15918 to N.C.S.	Alenina N, 2006, STEM CELL REV, V2, P5, DOI 10.1385/SCR:2:1:5; Alexandre C, 2006, J NEUROSCI, V26, P5554, DOI 10.1523/JNEUROSCI.5156-05.2006; Antri M, 2003, EUR J NEUROSCI, V18, P1963, DOI 10.1046/j.1460-9568.2003.02916.x; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Branchereau P, 2002, J NEUROSCI, V22, P2598, DOI 10.1523/JNEUROSCI.22-07-02598.2002; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Cheng LP, 2003, J NEUROSCI, V23, P9961; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Dale N, 1997, PROG NEUROBIOL, V53, P729, DOI 10.1016/S0301-0082(97)00048-8; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; EAGLESON GW, 1990, J NEUROBIOL, V21, P427, DOI 10.1002/neu.480210305; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; GU XN, 1994, J NEUROSCI, V14, P6325; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Haldin CE, 2008, DEV BIOL, V322, P74, DOI 10.1016/j.ydbio.2008.07.012; Haldin CE, 2003, INT J DEV BIOL, V47, P253; Hansson SR, 1998, NEUROSCIENCE, V83, P1185, DOI 10.1016/S0306-4522(97)00444-2; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hewapathirane DS, 2008, EXP NEUROL, V211, P480, DOI 10.1016/j.expneurol.2008.02.012; Hunt PN, 2006, J NEUROBIOL, V66, P1239, DOI 10.1002/neu.20259; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; KAHN JA, 1982, PHILOS T R SOC B, V296, P229; Kim DS, 2007, BRAIN RES, V1154, P181, DOI 10.1016/j.brainres.2007.03.084; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lillesaar C, 2007, DEV DYNAM, V236, P1072, DOI 10.1002/dvdy.21095; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; MAREK KW, 2010, NAT NEUROSC IN PRESS; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NIITSU Y, 1995, NEUROSCI LETT, V195, P159, DOI 10.1016/0304-3940(95)11805-7; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Roubos EW, 2005, ANN NY ACAD SCI, V1040, P172, DOI 10.1196/annals.1327.022; Rudge JS, 1996, MOL CELL NEUROSCI, V7, P204, DOI 10.1006/mcne.1996.0016; Rumajogee P, 2002, J NEUROCHEM, V83, P1525, DOI 10.1046/j.1471-4159.2002.01264.x; Sasagawa S, 2002, GENESIS, V33, P81, DOI 10.1002/gene.10094; Scott MM, 2005, INT J DEV NEUROSCI, V23, P277, DOI 10.1016/j.ijdevneu.2004.05.012; Sillar KT, 2009, J EXP BIOL, V212, P2356, DOI 10.1242/jeb.029892; SILLAR KT, 1988, NATURE, V331, P262, DOI 10.1038/331262a0; Sillar KT, 1998, ANN NY ACAD SCI, V860, P318, DOI 10.1111/j.1749-6632.1998.tb09059.x; SILLAR KT, 1991, P ROY SOC B-BIOL SCI, V246, P147, DOI 10.1098/rspb.1991.0137; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; VANMIER P, 1986, INT J DEV NEUROSCI, V4, P465, DOI 10.1016/0736-5748(86)90028-6; WEDDERBURN JFS, 1994, P ROY SOC B-BIOL SCI, V257, P59, DOI 10.1098/rspb.1994.0094; Whitaker-Azmitia PM, 2001, BRAIN RES BULL, V56, P479, DOI 10.1016/S0361-9230(01)00615-3; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wilson RS, 2000, J COMP PHYSIOL B, V170, P117, DOI 10.1007/s003600050266; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhou FC, 2000, DEV BRAIN RES, V119, P33, DOI 10.1016/S0165-3806(99)00152-2	62	67	72	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					321	334		10.1016/j.neuron.2010.06.006	http://dx.doi.org/10.1016/j.neuron.2010.06.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670838	Green Accepted, Bronze			2022-12-24	WOS:000280461500015
J	Frohlich, F; McCormick, DA				Froehlich, Flavio; McCormick, David A.			Endogenous Electric Fields May Guide Neocortical Network Activity	NEURON			English	Article							SINGLE NEURON ACTIVITY; RECURRENT ACTIVITY; SLOW OSCILLATIONS; PYRAMIDAL CELLS; WORKING-MEMORY; LESS-THAN-1 HZ; IN-VIVO; SYNCHRONIZATION; HIPPOCAMPAL; POTENTIALS	Local field potentials and the underlying endogenous electric fields (EFs) are traditionally considered to be epiphenomena of structured neuronal network activity. Recently, however, externally applied EFs have been shown to modulate pharmacologically evoked network activity in rodent hippocampus. In contrast, very little is known about the role of endogenous EFs during physiological activity states in neocortex. Here, we used the neocortical slow oscillation in vitro as a model system to show that weak sinusoidal and naturalistic EFs enhance and entrain physiological neocortical network activity with an amplitude threshold within the range of in vivo endogenous field strengths. Modulation of network activity by positive and negative feedback fields based on the network activity in real-time provide direct evidence for a feedback loop between neuronal activity and endogenous EF. This significant susceptibility of active networks to EFs that only cause small changes in membrane potential in individual neurons suggests that endogenous EFs could guide neocortical network activity.	[Froehlich, Flavio; McCormick, David A.] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Frohlich, Flavio/C-9851-2009; Frohlich, Flavio/P-6429-2017	Frohlich, Flavio/0000-0002-3724-5621	National Institutes of Health; Swartz Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health. F.F. was funded by the Swartz Foundation. We thank Kristy Sundberg for her help with the in vivo experiments and her valuable input on earlier versions of this manuscript. We thank Carlos Maureira for input on an early version of this manuscript and Tatiana Engel for helpful discussions.	AMZICA F, 1995, J NEUROSCI, V15, P4658; Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Buzsaki G., 2006, RHYTHMS BRAIN; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dudek F E, 1986, Adv Neurol, V44, P593; FABER DS, 1989, PHYSIOL REV, V69, P821, DOI 10.1152/physrev.1989.69.3.821; Francis JT, 2003, J NEUROSCI, V23, P7255; Freeman WJ, 1975, MASS ACTION NERVOUS; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Fujisawa S, 2004, J PHYSIOL-LONDON, V561, P123, DOI 10.1113/jphysiol.2004.066639; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Grenier F, 2003, NEUROSCIENCE, V119, P277, DOI 10.1016/S0306-4522(03)00101-5; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hoffman KL, 2007, J NEUROSCI, V27, P11838, DOI 10.1523/JNEUROSCI.3501-07.2007; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Peters A, 1996, J COMP NEUROL, V365, P232; Peters A, 1997, CEREB CORTEX, V7, P405, DOI 10.1093/cercor/7.5.405; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rattay F, 1998, IEEE T BIO-MED ENG, V45, P766, DOI 10.1109/10.678611; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Shu YS, 2003, J NEUROSCI, V23, P10388; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SNOW RW, 1984, BRAIN RES, V323, P114, DOI 10.1016/0006-8993(84)90271-3; Spinks RL, 2008, J NEUROSCI, V28, P10961, DOI 10.1523/JNEUROSCI.1956-08.2008; Steriade M, 1996, P NATL ACAD SCI USA, V93, P2533, DOI 10.1073/pnas.93.6.2533; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Svirskis G, 1997, BIOPHYS J, V73, P3004, DOI 10.1016/S0006-3495(97)78329-2; Taylor R., 2005, ASIAN BUSINESS MANAG, V4, P5, DOI [10.1057/palgrave.abm.9200116, DOI 10.1057/PALGRAVE.ABM.9200116]; TRANCHINA D, 1986, BIOPHYS J, V50, P1139, DOI 10.1016/S0006-3495(86)83558-5; Vigmond EJ, 1997, J NEUROPHYSIOL, V78, P3107, DOI 10.1152/jn.1997.78.6.3107; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103	59	502	521	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					129	143		10.1016/j.neuron.2010.06.005	http://dx.doi.org/10.1016/j.neuron.2010.06.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624597	Green Accepted, Bronze			2022-12-24	WOS:000280221000014
J	Koehnke, J; Katsamba, PS; Ahlsen, G; Bahna, F; Vendome, J; Honig, B; Shapiro, L; Jin, XS				Koehnke, Jesko; Katsamba, Phinikoula S.; Ahlsen, Goran; Bahna, Fabiana; Vendome, Jeremie; Honig, Barry; Shapiro, Lawrence; Jin, Xiangshu			Splice Form Dependence of beta-Neurexin/Neuroligin Binding Interactions	NEURON			English	Article							CRYSTAL-STRUCTURE; ALPHA-NEUREXINS; LIGAND-BINDING; NEUROLIGIN; DOMAIN; AUTISM; COMPLEX; PROTEIN; GENES; MUTATIONS	Alternatively spliced beta-neurexins (beta-NRXs) and neuroligins (NLs) are thought to have distinct extracellular binding affinities, potentially providing a beta-NRX/NL synaptic recognition code. We utilized surface plasmon resonance to measure binding affinities between all combinations of alternatively spliced beta-NRX 1-3 and NL 1-3 ectodomains. Binding was observed for all beta-NRX/NL pairs. The presence of the NL1 B splice insertion lowers beta-NRX binding affinity by similar to 2-fold, while beta-NRX splice insertion 4 has small effects that do not synergize with NL splicing. New structures of glycosylated beta-NRXs 1 and 2 containing splice insertion 4 reveal that the insertion forms a new beta strand that replaces the beta 10 strand, leaving the NL binding site intact. This helps to explain the limited effect of splice insert 4 on NRX/NL binding affinities. These results provide new structural insights and quantitative binding information to help determine whether and how splice isoform choice plays a role in beta-NRX/NL-mediated synaptic recognition.	[Koehnke, Jesko; Katsamba, Phinikoula S.; Ahlsen, Goran; Bahna, Fabiana; Vendome, Jeremie; Honig, Barry; Shapiro, Lawrence; Jin, Xiangshu] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Katsamba, Phinikoula S.; Bahna, Fabiana; Vendome, Jeremie; Honig, Barry; Jin, Xiangshu] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Vendome, Jeremie; Honig, Barry] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Shapiro, Lawrence] Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Honig, B (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	bh6@columbia.edu; lss8@columbia.edu	Koehnke, Jesko/AAC-7363-2021; Shapiro, Lawrence/AAE-7172-2019; Koehnke, Jesko/M-4861-2017	Koehnke, Jesko/0000-0002-7153-1365; Koehnke, Jesko/0000-0002-7153-1365; Jin, Xiangshu/0000-0002-6551-8850; Katsamba, Phinikoula/0000-0003-3981-1604	National Institutes of Health [U54 CA121852]; National Science Foundation [MCB-0918535]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945, R01GM062270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grant U54 CA121852 (L.S. and B.H.) and by National Science Foundation grant MCB-0918535 (B.H.). B.H. is an investigator of the Howard Hughes Medical Institute. X-ray data were collected at the X4C beamline of the National Synchrotron Light Source, Brookhaven National Laboratory; the X4 beamlines are operated by the New York Structural Biology Center. We thank Tom Jessell and Peter Scheiffele for helpful comments on the manuscript.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; COWAN MW, 2000, SYNAPSES BALTIMORE; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Koehnke J, 2008, P NATL ACAD SCI USA, V105, P1873, DOI 10.1073/pnas.0711701105; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Shen KC, 2008, STRUCTURE, V16, P422, DOI 10.1016/j.str.2008.01.005; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Willard FS, 2006, ANAL BIOCHEM, V353, P147, DOI 10.1016/j.ab.2006.02.004	50	70	75	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					61	74		10.1016/j.neuron.2010.06.001	http://dx.doi.org/10.1016/j.neuron.2010.06.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624592	Green Accepted, Bronze			2022-12-24	WOS:000280221000009
J	Arnal, LH; Wyart, V; Giraud, AL				Arnal, Luc H.; Wyart, Valentin; Giraud, Anne-Lise			Transitions in neural oscillations reflect prediction errors generated in audiovisual speech	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; AUDITORY-CORTEX; TOP-DOWN; COMPUTATIONAL PRINCIPLES; NEURONAL OSCILLATIONS; GAMMA-OSCILLATIONS; VISUAL-CORTEX; INFORMATION; INTEGRATION; SYNCHRONIZATION	According to the predictive coding theory, top-down predictions are conveyed by backward connections and prediction errors are propagated forward across the cortical hierarchy. Using MEG in humans, we show that violating multisensory predictions causes a fundamental and qualitative change in both the frequency and spatial distribution of cortical activity. When visual speech input correctly predicted auditory speech signals, a slow delta regime (3-4 Hz) developed in higher-order speech areas. In contrast, when auditory signals invalidated predictions inferred from vision, a low-beta (14-15 Hz) / high-gamma (60-80 Hz) coupling regime appeared locally in a multisensory area (area STS). This frequency shift in oscillatory responses scaled with the degree of audio-visual congruence and was accompanied by increased gamma activity in lower sensory regions. These findings are consistent with the notion that bottom-up prediction errors are communicated in predominantly high (gamma) frequency ranges, whereas top-down predictions are mediated by slower (beta) frequencies.	[Arnal, Luc H.; Giraud, Anne-Lise] Ecole Normale Super, INSERM, U960, F-75231 Paris, France; [Wyart, Valentin] Univ Paris 06, Ctr Rech, Ctr Natl Rech Sci,Unite Mixte Rech 7225, Inst Cerveau & Moelle Epiniere,INSERM,U975, Paris, France; [Giraud, Anne-Lise] Hop La Pitie Salpetriere, Ctr Neuroimagerie Rech, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Giraud, AL (corresponding author), Ecole Normale Super, INSERM, U960, 24 Rue Lhomond, F-75231 Paris, France.	anne-lise.giraud@ens.fr	Arnal, Luc/AAE-2356-2022	Wyart, Valentin/0000-0001-6522-7837; Arnal, Luc/0000-0002-2226-6497	Centre National de la Recherche Scientifique; Fondation Fyssen	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation Fyssen	We thank the staff of the Centre de Neuroimagerie de Recherche and the Magnetoencephalography Center (Hopital de la Pitie-Salpetriere), in particular J.-D. Lemarechal, A. Ducorps and D. Schwarz, and the colleagues who commented on this work: V. van Wassenhove, B. Morillon, A. Hyafil, S. Deneve, L. Melloni, F. Griffon, A. Kleinschmidt, E. Koechlin, B. Fischer, K. Friston and C. Tallon-Baudry. This work was supported by the Centre National de la Recherche Scientifique (A.-L.G.) and the Fondation Fyssen (V.W.).	Akam T, 2010, NEURON, V67, P308, DOI 10.1016/j.neuron.2010.06.019; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; George D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000532; Ghazanfar AA, 2008, J NEUROSCI, V28, P4457, DOI 10.1523/JNEUROSCI.0541-08.2008; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kayser C, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.007.2009; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Koch SP, 2009, J NEUROSCI, V29, P13962, DOI 10.1523/JNEUROSCI.1402-09.2009; Kopell N, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00187; Kramer MA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000169; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Neisser U., 1967, COGNITIVE PSYCHOL; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Roopun AK, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.001.2008; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Stevens KN, 1967, MODELS PERCEPTION SP, P88; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008	50	211	212	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					797	U164		10.1038/nn.2810	http://dx.doi.org/10.1038/nn.2810			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21552273	Green Published			2022-12-24	WOS:000290958000025
J	Schwartz, N; Schohl, A; Ruthazer, ES				Schwartz, Neil; Schohl, Anne; Ruthazer, Edward S.			Activity-Dependent Transcription of BDNF Enhances Visual Acuity during Development	NEURON			English	Article							DEVELOPING RETINOTECTAL SYSTEM; DEVELOPING TECTAL NEURONS; LONG-TERM POTENTIATION; AXONS IN-VIVO; OPTIC TECTUM; SYNAPTIC-TRANSMISSION; NEUROTROPHIC FACTOR; RECEPTIVE-FIELDS; DENDRITE GROWTH; CRITICAL PERIOD	In the developing Xenopus tadpole, conditioning with 20 min of visual stimulation leads to increased proBDNF protein levels in the tectum measured 4 hr later. Following conditioning, the ability to induce direction selectivity in tectal neurons, as well as both retinotectal long-term potentiation and depression, thought to underlie this phenomenon, was strongly facilitated. This facilitation was blocked by knockdown of BDNF expression in tectal neurons. Animals that had been exposed to visual conditioning and subsequently received normal visual input for 7-11 hr exhibited higher spatial frequency thresholds of tectal cell responses to counterphasing gratings than non-conditioned control animals. An improvement in visual acuity was confirmed by enhanced sensitivity to counterphasing gratings in a behavioral test. These results indicate that brief sensory stimulation, by initiating nuclear transcription and de novo protein synthesis of BDNF, can facilitate the refinement of response properties in the developing visual system.	[Schwartz, Neil; Schohl, Anne; Ruthazer, Edward S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Ruthazer, ES (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	edward.ruthazer@mcgill.ca	Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014	Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151	Canadian Institutes for Health Research; EJLB Foundation; Scottish Rite Charitable Foundation; Jeanne-Timmins Costello Fellowship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); EJLB Foundation; Scottish Rite Charitable Foundation; Jeanne-Timmins Costello Fellowship	We thank Peter O'Connor for help with MATLAB, Alexendra Fletcher for help with the behavioral experiments, and Paul Patterson for the 1500 BP BONE IV promoter plasmid. We also thank Phil Barker for technical advice and reagents, and Carlos Aizenman for critically reading the manuscript. Funding provided to E.S.R. from the Canadian Institutes for Health Research and the EJLB Foundation. Funding provided to N.S. by Scottish Rite Charitable Foundation and by a Jeanne-Timmins Costello Fellowship.	Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; Carrasco MM, 2005, J NEUROPHYSIOL, V94, P1962, DOI 10.1152/jn.00166.2005; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DOBSON V, 1978, VISION RES, V18, P1469, DOI 10.1016/0042-6989(78)90001-9; Dong W, 2009, J NEUROPHYSIOL, V101, P803, DOI 10.1152/jn.90848.2008; Du JL, 2009, P NATL ACAD SCI USA, V106, P18890, DOI 10.1073/pnas.0910659106; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Good W V, 2001, Trans Am Ophthalmol Soc, V99, P253; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; GREENOUGH WT, 1987, CHILD DEV, V58, P539, DOI 10.2307/1130197; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Heimel JA, 2010, NAT NEUROSCI, V13, P642, DOI 10.1038/nn.2534; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marchionni I, 2009, J PHYSIOL-LONDON, V587, P5691, DOI 10.1113/jphysiol.2009.179945; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Maurer D, 2001, CLIN NEUROSCI RES, V1, P239, DOI 10.1016/S1566-2772(01)00010-X; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; Richards BA, 2010, NAT NEUROSCI, V13, P1098, DOI 10.1038/nn.2612; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Ruthazer ES, 2005, IMAGING NEUROSCIENCE, P191; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Sillar KT, 2009, J EXP BIOL, V212, P2356, DOI 10.1242/jeb.029892; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TSUI J, 2010, FRONT SYNAPTIC NEURO, V2, P1; Van Keuren-Jensen K, 2006, J NEUROSCI, V26, P7575, DOI 10.1523/JNEUROSCI.5083-05.2006; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; WASSERSUG RJ, 1989, AM ZOOL, V29, P65; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yang F, 2009, J CELL BIOL, V185, P727, DOI 10.1083/jcb.200811147; YOLEN NM, 1976, BRAIN BEHAV EVOLUT, V13, P451, DOI 10.1159/000123828; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	66	30	31	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					455	467		10.1016/j.neuron.2011.02.055	http://dx.doi.org/10.1016/j.neuron.2011.02.055			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555072	Bronze			2022-12-24	WOS:000290926100008
J	Anokye-Danso, F; Trivedi, CM; Juhr, D; Gupta, M; Cui, Z; Tian, Y; Zhang, YZ; Yang, WL; Gruber, PJ; Epstein, JA; Morrisey, EE				Anokye-Danso, Frederick; Trivedi, Chinmay M.; Juhr, Denise; Gupta, Mudit; Cui, Zheng; Tian, Ying; Zhang, Yuzhen; Yang, Wenli; Gruber, Peter J.; Epstein, Jonathan A.; Morrisey, Edward E.			Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; HUMAN FIBROBLASTS; DEFINED FACTORS; GENERATION; INDUCTION; PROLIFERATION; EXPRESSION; MICRORNAS; SELECTION	Transcription factor-based cellular reprogramming has opened the way to converting somatic cells to a pluripotent state, but has faced limitations resulting from the requirement for transcription factors and the relative inefficiency of the process. We show here that expression of the miR302/367 cluster rapidly and efficiently reprograms mouse and human somatic cells to an iPSC state without a requirement for exogenous transcription factors. This miRNA-based reprogramming approach is two orders of magnitude more efficient than standard Oct4/Sox2/K1f4/Myc-mediated methods. Mouse and human miR302/367 iPSCs display similar characteristics to Oct4/Sox2/K1f4/Myc-iPSCs, including pluripotency marker expression, teratoma formation, and, for mouse cells, chimera contribution and germline contribution. We found that miR367 expression is required for miR3021367-mediated reprogramming and activates Oct4 gene expression, and that suppression of Hdac2 is also required. Thus, our data show that miRNA and Hdac-mediated pathways can cooperate in a powerful way to reprogram somatic cells to pluripotency.	[Anokye-Danso, Frederick; Cui, Zheng; Tian, Ying; Zhang, Yuzhen; Yang, Wenli; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Trivedi, Chinmay M.; Gupta, Mudit; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gruber, Peter J.; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Yang, Wenli; Gruber, Peter J.; Epstein, Jonathan A.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Juhr, Denise; Gruber, Peter J.] Childrens Hosp Philadelphia, Cardiac Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	Trivedi, Chinmay M/ABA-4097-2021	Trivedi, Chinmay/0000-0002-3544-0474; Epstein, Jonathan/0000-0001-8637-4465	NIH [HL064632, HL0871325, HL100405, HL071546, HL098366]; American Heart Association Jon Holden DeHaan Myogenesis Center; Penn Institute for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064632, U01HL100405, R01HL087825, K99HL098366, R00HL098366] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Jon Holden DeHaan Myogenesis Center(American Heart Association); Penn Institute for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by funding from the NIH to E.E.M. (HL064632, HL0871325, and HL100405), J.A.E. (HL071546 and HL100405), C.M.T. (HL098366), and an American Heart Association Jon Holden DeHaan Myogenesis Center Award to E.E.M. and J.A.E. The authors thank K. Zaret for the Rosa126-laoZ MEFs and gratefully acknowledge the support of the Penn Institute for Regenerative Medicine during these studies.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Raya A, 2010, NAT PROTOC, V5, P647, DOI 10.1038/nprot.2010.9; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shu WG, 2002, DEVELOPMENT, V129, P4831; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	34	852	927	1	158	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					376	388		10.1016/j.stem.2011.03.001	http://dx.doi.org/10.1016/j.stem.2011.03.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474102	Green Accepted, Bronze			2022-12-24	WOS:000289707100010
J	Lin, JW; Shi, LY; Zhang, M; Yang, H; Qin, YR; Zhang, J; Gong, DQ; Zhang, X; Li, DS; Li, JS				Lin, Jiangwei; Shi, Linyu; Zhang, Man; Yang, Hui; Qin, Yiren; Zhang, Jun; Gong, Daoqing; Zhang, Xuan; Li, Dangsheng; Li, Jinsong			Defects in Trophoblast Cell Lineage Account for the Impaired In Vivo Development of Cloned Embryos Generated by Somatic Nuclear Transfer	CELL STEM CELL			English	Article							STEM-CELLS; ES CELLS; MOUSE BLASTOCYSTS; TETRAPLOID CELLS; MICE	The low success rate of somatic nuclear transfer (NT) is hypothesized to be mainly due to functional defects in the trophoblast cell lineage rather than the inner cell mass (ICM); this hypothesis, however, remains to be tested directly. Here we separated the ICMs from cloned blastocysts and aggregated the cloned ICM with two fertilization-derived (FD) tetraploid (4N) embryos. We found that the full-term development of cloned ICMs was dramatically improved after the trophoblast cells in the cloned blastocysts were replaced by cells from tetraploid embryos, thus providing direct evidence that defects in trophoblast cell lineage underlie the low success rate of somatic NT.	[Lin, Jiangwei; Shi, Linyu; Zhang, Man; Yang, Hui; Qin, Yiren; Zhang, Xuan; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Lin, Jiangwei; Zhang, Jun; Gong, Daoqing] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yangzhou University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Li, JS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jsli@sibs.ac.cn	Qin, Yiren/AEJ-4970-2022	Qin, Yiren/0000-0001-5137-318X; yang, hui/0000-0003-3590-722X; li, jin song/0000-0003-3456-662X	Chinese Academy of Sciences [KSCX2-YIN-R-110, KSCX2-YW-R-229, XDA01010403]; Ministry of Science and Technology [2007CB947101, 2009CB941101]; National Natural Science Foundation of China [30871430]; Shanghai Municipal Commission for Science and Technology [07DZ22919, 08DJ1400502, 09PJ1410900]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology	We thank W. Tang, D. Liang, Y. Tao and Y. Li for technical assistance. We thank Drs. N. Jing and X. Ding for critical and useful comments on the manuscript. The study was supported by grants from the Chinese Academy of Sciences (KSCX2-YIN-R-110, KSCX2-YW-R-229, XDA01010403), the Ministry of Science and Technology (2007CB947101, 2009CB941101), the National Natural Science Foundation of China (30871430), and the Shanghai Municipal Commission for Science and Technology (07DZ22919, 08DJ1400502, 09PJ1410900).	Amano T, 2002, CELL TISSUE RES, V307, P367, DOI 10.1007/s00441-002-0513-3; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Eakin GS, 2003, DEV DYNAM, V228, P751, DOI 10.1002/dvdy.10363; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jouneau A, 2006, DEVELOPMENT, V133, P1597, DOI 10.1242/dev.02317; Kato Y, 1999, DEVELOPMENT, V126, P1823; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Li JS, 2005, CURR BIOL, V15, pR756, DOI 10.1016/j.cub.2005.09.010; MacKay GE, 2005, MECH DEVELOP, V122, P1266, DOI 10.1016/j.mod.2005.09.001; Miki H, 2009, PLACENTA, V30, P543, DOI 10.1016/j.placenta.2009.03.006; NAGY A, 1990, DEVELOPMENT, V110, P815; Oda M, 2009, P NATL ACAD SCI USA, V106, P16293, DOI 10.1073/pnas.0908009106; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Rielland M, 2009, DEV BIOL, V334, P325, DOI 10.1016/j.ydbio.2009.07.022; Soares MJ, 2009, P NATL ACAD SCI USA, V106, P16014, DOI 10.1073/pnas.0908646106; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	20	34	42	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					371	375		10.1016/j.stem.2011.02.007	http://dx.doi.org/10.1016/j.stem.2011.02.007			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474101	Bronze			2022-12-24	WOS:000289707100009
J	Bell, MR; Belarde, JA; Johnson, HF; Aizenman, CD				Bell, Mark R.; Belarde, James A.; Johnson, Hannah F.; Aizenman, Carlos D.			A neuroprotective role for polyamines in a Xenopus tadpole model of epilepsy	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; RAT-BRAIN; ORNITHINE-DECARBOXYLASE; STATUS-EPILEPTICUS; NEURONAL EXCITABILITY; SYNAPTIC-TRANSMISSION; SEIZURE ACTIVITY; GENE-EXPRESSION; TRANSGENIC MICE; ION CHANNELS	Polyamines are endogenous molecules involved in cell damage following neurological insults, although it is unclear whether polyamines reduce or exacerbate this damage. We used a developmental seizure model in which we exposed Xenopus laevis tadpoles to pentylenetetrazole (PTZ), a known convulsant. We found that, after an initial PTZ exposure, seizure onset times were delayed in response to a second PTZ exposure 4 h later. This protective effect was a result of activity-dependent increases in synthesis of putrescine, the simplest polyamine. Unlike more complex polyamines that directly modulate ion channels, putrescine exerted its effect by altering the balance of excitation to inhibition. Tectal neuron recordings, 4 h after the initial seizure, revealed an elevated frequency of GABAergic spontaneous inhibitory postsynaptic currents. Our data suggest that this effect is mediated by an atypical pathway that converts putrescine into GABA, which then activates presynaptic GABA(B) receptors. Our data suggest that polyamines have a previously unknown neuroprotective role in the developing brain.	[Bell, Mark R.; Belarde, James A.; Johnson, Hannah F.; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Aizenman, CD (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	carlos_aizenman@brown.edu			American Heart Association; US National Institutes of Health; Klingenstein Fund; National Science Foundation; Brain Science Siravo Award for Epilepsy Research; Brown University	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Fund(Klingenstein Philanthropies); National Science Foundation(National Science Foundation (NSF)); Brain Science Siravo Award for Epilepsy Research; Brown University	We would like to thank B. Connors and J. Kauer with helpful discussion and suggestions to the manuscript. We also thank I. Sears, B. Clarkson and E. Stackpole for technical support and J. Lippman Bell for editorial support. This work was supported by the American Heart Association and the US National Institutes of Health. C.D.A. was also supported by the Klingenstein Fund, M.R.B. by a Graduate Research Fellowship Program award from the National Science Foundation, J.A.B. by a Brain Science Siravo Award for Epilepsy Research and H.F.J. by a Brown University Undergraduate Teaching and Research Award.	Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Camon L, 2001, J NEUROSCI RES, V66, P1101, DOI 10.1002/jnr.10024; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; de Vera N, 2002, EUR NEUROPSYCHOPHARM, V12, P397, DOI 10.1016/S0924-977X(02)00050-0; de Vera N, 2008, J NEUROSCI RES, V86, P861, DOI 10.1002/jnr.21538; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; GILAD GM, 1983, BRAIN RES, V273, P191, DOI 10.1016/0006-8993(83)91113-7; Haas KZ, 2001, HIPPOCAMPUS, V11, P615, DOI 10.1002/hipo.1076; Haas KZ, 1996, J NEUROSCI, V16, P4250; HALONEN T, 1993, EUR J NEUROSCI, V5, P1233, DOI 10.1111/j.1460-9568.1993.tb00978.x; HAYASHI Y, 1993, NEUROSCI LETT, V149, P63, DOI 10.1016/0304-3940(93)90348-O; HAYASHI Y, 1992, J NEUROCHEM, V58, P562, DOI 10.1111/j.1471-4159.1992.tb09756.x; Hewapathirane D Sesath, 2008, J Vis Exp, DOI 10.3791/705; Kaasinen SK, 2003, EXP NEUROL, V183, P645, DOI 10.1016/S0014-4886(03)00186-9; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; LASCHET J, 1992, NEUROSCIENCE, V48, P151, DOI 10.1016/0306-4522(92)90345-3; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; Liu Z, 1999, NEUROSCIENCE, V92, P1443, DOI 10.1016/S0306-4522(99)00064-0; NAJM I, 1992, DEV BRAIN RES, V69, P11, DOI 10.1016/0165-3806(92)90117-F; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NOTO T, 1986, J NEUROCHEM, V46, P1877; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PEARCE RA, 1995, J PHYSIOL-LONDON, V484, P425, DOI 10.1113/jphysiol.1995.sp020675; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1994, J NEUROPHYSIOL, V72, P2317, DOI 10.1152/jn.1994.72.5.2317; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Sankar R, 1997, DEV BRAIN RES, V98, P60, DOI 10.1016/S0165-3806(96)00165-4; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Schousboe A, 2000, NEUROCHEM RES, V25, P1241, DOI 10.1023/A:1007692012048; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; SEILER N, 1974, BIOCHEM J, V144, P29, DOI 10.1042/bj1440029; Sequerra EB, 2007, NEUROSCIENCE, V146, P489, DOI 10.1016/j.neuroscience.2007.01.062; SHIMOSATO K, 1995, BRAIN RES, V684, P243, DOI 10.1016/0006-8993(95)00468-6; Shin J, 2005, J NEUROPHYSIOL, V93, P2634, DOI 10.1152/jn.01054.2004; Shin J, 2007, J PHYSIOL-LONDON, V581, P679, DOI 10.1113/jphysiol.2007.130963; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yamasaki EN, 1999, INT J DEV NEUROSCI, V17, P201, DOI 10.1016/S0736-5748(99)00002-7; ZAWIA NH, 1990, MOL BRAIN RES, V7, P243, DOI 10.1016/0169-328X(90)90034-B; ZAWIA NH, 1993, DEV BRAIN RES, V71, P53, DOI 10.1016/0165-3806(93)90104-I	49	46	48	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					505	U144		10.1038/nn.2777	http://dx.doi.org/10.1038/nn.2777			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378970				2022-12-24	WOS:000288849400022
J	Counotte, DS; Goriounova, NA; Li, KW; Loos, M; van der Schors, RC; Schetters, D; Schoffelmeer, ANM; Smit, AB; Mansvelder, HD; Pattij, T; Spijker, S				Counotte, Danielle S.; Goriounova, Natalia A.; Li, Ka Wan; Loos, Maarten; van der Schors, Roel C.; Schetters, Dustin; Schoffelmeer, Anton N. M.; Smit, August B.; Mansvelder, Huibert D.; Pattij, Tommy; Spijker, Sabine			Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence	NATURE NEUROSCIENCE			English	Article							REACTION-TIME-TASK; TOBACCO-SMOKE; BRAIN; CORTEX	Tobacco smoking and nicotine exposure during adolescence interfere with prefrontal cortex (PFC) development and lead to cognitive impairments in later life. The molecular and cellular underpinnings of these consequences remain elusive. We found that adolescent nicotine exposure induced lasting attentional disturbances and reduced mGluR2 protein and function on presynaptic terminals of PFC glutamatergic synapses. Restoring mGluR2 activity in vivo by local infusion of a group II mGluR agonist in adult rats that received nicotine as adolescents rescued attentional disturbances.	[Counotte, Danielle S.; Goriounova, Natalia A.; Li, Ka Wan; Loos, Maarten; van der Schors, Roel C.; Smit, August B.; Mansvelder, Huibert D.; Spijker, Sabine] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [Schetters, Dustin; Schoffelmeer, Anton N. M.; Pattij, Tommy] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Spijker, S (corresponding author), Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands.	sabine.spijker@cncr.vu.nl	Spijker, Sabine/F-2300-2011; Smit, August B/E-8410-2011; Mansvelder, Huibert/N-6138-2018; Loos, Maarten/A-2768-2012; Goriounova, Natalia/ABE-6759-2020	Mansvelder, Huibert/0000-0003-1365-5340; Loos, Maarten/0000-0003-1629-2928; li, ka wan/0000-0001-6983-5055; Goriounova, Natalia/0000-0002-5917-983X; Pattij, Tommy/0000-0002-0079-7385; Spijker, Sabine/0000-0002-6814-2019	Netherlands Organization for Scientific Research; Center for Medical Systems Biology; VU University (VU European Research Council)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Medical Systems Biology; VU University (VU European Research Council)	We thank Y. van Mourik, M. Stegeman, H. Lodder, B. Lodder, C. de Kock and R. Binnekade for excellent technical assistance. Funding was received from Netherlands Organization for Scientific Research ( D.S.C., N.A.G., S.S., H.D.M., T.P., A.N.M.S. and A.B.S.), Center for Medical Systems Biology (K.W.L. and R.C.v.d.S.) and VU University (H.D.M.; Starting Independent Research Grant, VU European Research Council).	Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chassin L, 1996, HEALTH PSYCHOL, V15, P478, DOI 10.1037/0278-6133.15.6.478; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Council for Disabled Children, 2022, CHILDREN YOUNG PEOPL; Counotte DS, 2009, NEUROPSYCHOPHARMACOL, V34, P299, DOI 10.1038/npp.2008.96; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Jacobsen LK, 2005, BIOL PSYCHIAT, V57, P56, DOI 10.1016/j.biopsych.2004.10.022; Mateo Z, 2007, NEUROSCIENCE, V146, P1062, DOI 10.1016/j.neuroscience.2007.02.053; Mathers M, 2006, ADDICTION, V101, P948, DOI 10.1111/j.1360-0443.2006.01438.x; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	15	90	94	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					417	419		10.1038/nn.2770	http://dx.doi.org/10.1038/nn.2770			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336271				2022-12-24	WOS:000288849400009
J	Proia, TA; Keller, PJ; Gupta, PB; Klebba, I; Jones, AD; Sedic, M; Gilmore, H; Tung, N; Naber, SP; Schnitt, S; Lander, ES; Kuperwasser, C				Proia, Theresa A.; Keller, Patricia J.; Gupta, Piyush B.; Klebba, Ina; Jones, Ainsley D.; Sedic, Maja; Gilmore, Hannah; Tung, Nadine; Naber, Stephen P.; Schnitt, Stuart; Lander, Eric S.; Kuperwasser, Charlotte			Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BRCA1; MUTATION; DIFFERENTIATION; METASTASIS; TISSUES; RECONSTRUCTION; TRANSFORMATION; PROLIFERATION; OVARIAN	Women with inherited mutations in the BRCA1 gene have increased risk of developing breast cancer but also exhibit a predisposition for the development of aggressive basal-like breast tumors. We report here that breast epithelial cells derived from patients harboring deleterious mutations in BRCA1 (BRCA1(mut/+)) give rise to tumors with increased basal differentiation relative to cells from BRCA1(+/+) patients. Molecular analysis of disease-free breast tissues from BRCA1(mut/+) patients revealed defects in progenitor cell lineage commitment even before cancer incidence. Moreover, we discovered that the transcriptional repressor Slug is an important functional suppressor of human breast progenitor cell lineage commitment and differentiation and that it is aberrantly expressed in BRCA1(mut/+) tissues. Slug expression is necessary for increased basal-like phenotypes prior to and after neoplastic transformation. These findings demonstrate that the genetic background of patient populations, in addition to affecting incidence rates, significantly impacts progenitor cell fate commitment and, therefore, tumor phenotype.	[Proia, Theresa A.; Keller, Patricia J.; Klebba, Ina; Jones, Ainsley D.; Sedic, Maja; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Sackler Sch Biomed Res, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Proia, Theresa A.; Keller, Patricia J.; Klebba, Ina; Jones, Ainsley D.; Sedic, Maja; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Naber, Stephen P.] Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA; [Gupta, Piyush B.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Gupta, Piyush B.; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Gilmore, Hannah; Schnitt, Stuart] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Gilmore, Hannah; Tung, Nadine; Schnitt, Stuart] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Tung, Nadine] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg Oncol, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Tufts University; Tufts Medical Center; Tufts Medical Center; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Kuperwasser, C (corresponding author), Tufts Univ, Sch Med, Sackler Sch Biomed Res, Dept Anat & Cellular Biol, 136 Harrison Ave, Boston, MA 02111 USA.	charlotte.kuperwasser@tufts.edu			American Cancer Society-New England Division-Broadway on Beachside Postdoctoral Fellowship; Raymond and Beverly Sackler Foundation; Breast Cancer Research Foundation; Department of Defense [BC073866]; NIH/NCI [CA125554]; NATIONAL CANCER INSTITUTE [R01CA125554] Funding Source: NIH RePORTER	American Cancer Society-New England Division-Broadway on Beachside Postdoctoral Fellowship; Raymond and Beverly Sackler Foundation; Breast Cancer Research Foundation; Department of Defense(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gerbug Wulf, Steve Come, and Susan Troyan at Beth Israel Deaconess Medical Center for assistance with BRCA1<SUP>mut/+</SUP> tissue procurement and Kai Tao and Lisa Arendt for technical assistance. We thank Myriad Genetic Laboratories for gene-specific BRACAnalysis. We thank Annette Shepard-Barry at Tufts Medical Center in the Histology-Special Procedures Lab for histological and immunohistochemical staining. We thank Stephen Kwok for assistance with cell sorting and Supriya Gupta for assistance with gene expression experiments and data collection. We thank Josh LaBaer at Harvard Medical School for generously providing us with human cyclin D1, ras, p53, and PI3K cDNAs. This work was supported by grants from the American Cancer Society-New England Division-Broadway on Beachside Postdoctoral Fellowship (P.J.K.), the Raymond and Beverly Sackler Foundation (P.J.K., C.K.), the Breast Cancer Research Foundation (C.K., T.P.), the Department of Defense Breast Cancer Research Program (BC073866) (P.J.K., T.P., C.K.), and the NIH/NCI (CA125554, CA125554) (C.K., I.K.). C.K. is a Raymond and Beverly Sackler Foundation Scholar.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Arnes JB, 2005, CLIN CANCER RES, V11, P4003, DOI 10.1158/1078-0432.CCR-04-2064; Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Clarke CL, 2006, BRIT J CANCER, V95, P515, DOI 10.1038/sj.bjc.6603298; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Loi S, 2009, J CLIN ONCOL, V27; Miyakis S, 1998, BIOCHEM BIOPH RES CO, V251, P609, DOI 10.1006/bbrc.1998.9527; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	41	256	261	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					149	163		10.1016/j.stem.2010.12.007	http://dx.doi.org/10.1016/j.stem.2010.12.007			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295272	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000287633400009
J	Chan, CS; Glajch, KE; Gertler, TS; Guzman, JN; Mercer, JN; Lewis, AS; Goldberg, AB; Tkatch, T; Shigemoto, R; Fleming, SM; Chetkovich, DM; Osten, P; Kita, H; Surmeier, DJ				Chan, C. Savio; Glajch, Kelly E.; Gertler, Tracy S.; Guzman, Jaime N.; Mercer, Jeff N.; Lewis, Alan S.; Goldberg, Alan B.; Tkatch, Tatiana; Shigemoto, Ryuichi; Fleming, Sheila M.; Chetkovich, Dane M.; Osten, Pavel; Kita, Hitoshi; Surmeier, D. James			HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; IN-VITRO; ABSENCE EPILEPSY; DOPAMINE; PLASTICITY; OSCILLATIONS; DISORDERS; RECEPTORS; MICE; PATHOPHYSIOLOGY	Parkinson's disease is a common neurodegenerative disorder characterized by a profound motor disability that is traceable to the emergence of synchronous, rhythmic spiking in neurons of the external segment of the globus pallidus (GPe). The origins of this pathophysiology are poorly defined for the generation of pacemaking. After the induction of a parkinsonian state in mice, there was a progressive decline in autonomous GPe pacemaking, which normally serves to desynchronize activity. The loss was attributable to the downregulation of an ion channel that is essential in pacemaking, the hyperpolarization and cyclic nucleotide-gated (HCN) channel. Viral delivery of HCN2 subunits restored pacemaking and reduced burst spiking in GPe neurons. However, the motor disability induced by dopamine (DA) depletion was not reversed, suggesting that the loss of pacemaking was a consequence, rather than a cause, of key network pathophysiology, a conclusion that is consistent with the ability of L-type channel antagonists to attenuate silencing after DA depletion.	[Chan, C. Savio; Glajch, Kelly E.; Gertler, Tracy S.; Guzman, Jaime N.; Mercer, Jeff N.; Goldberg, Alan B.; Tkatch, Tatiana; Chetkovich, Dane M.; Osten, Pavel; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Lewis, Alan S.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan; [Fleming, Sheila M.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Osten, Pavel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kita, Hitoshi] Univ Tennessee, Coll Med, Dept Anat & Neurobiol, Memphis, TN USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University System of Ohio; University of Cincinnati; Cold Spring Harbor Laboratory; University of Tennessee System; University of Tennessee Health Science Center	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Shigemoto, Ryuichi/E-3628-2013; Lewis, Alan/AAV-9582-2021; Chetkovich, Dane/AAV-5457-2021	Shigemoto, Ryuichi/0000-0001-8761-9444; Lewis, Alan/0000-0002-7165-5376; Chan, C. Savio/0000-0002-3474-1718; Tkatch, Tatiana/0000-0001-6626-7435	Parkinson's Disease Foundation; American Parkinson Disease Association Research; Michael J. Fox Foundation; Hartmann Foundation; US National Institutes of Health [NS069777, MH082522, NS064757, NS05595, NS059934, NS042762, NS047085]; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH082522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065391, R01NS042762, R01NS069777, P50NS047085, F30NS064757, R01NS059934, K02NS055995] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; American Parkinson Disease Association Research; Michael J. Fox Foundation; Hartmann Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Chen, K. Saporito and S. Ulrich for technical assistance. This work was supported by grants from the Parkinson's Disease Foundation and American Parkinson Disease Association Research to C.S.C.; a grant from the Michael J. Fox Foundation to P.O.; a grant from the Hartmann Foundation to D.J.S. and US National Institutes of Health grants NS069777 to C.S.C., MH082522 to T.S.G., NS064757 to A.S.L., NS05595 and NS059934 to D.M.C., NS042762 to H.K. and NS047085 to D.J.S.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Cooper AJ, 2001, NEUROPHARMACOLOGY, V41, P62, DOI 10.1016/S0028-3908(01)00038-7; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Galati S, 2009, J PHYSIOL-LONDON, V587, P4405, DOI 10.1113/jphysiol.2009.172759; Gillies A, 2002, P ROY SOC B-BIOL SCI, V269, P545, DOI 10.1098/rspb.2001.1817; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Heimer G, 2002, J NEUROSCI, V22, P7850; Hernandez A, 2006, J NEUROPHYSIOL, V96, P2877, DOI 10.1152/jn.00664.2006; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; KITA H, 1991, BRAIN RES, V564, P296, DOI 10.1016/0006-8993(91)91466-E; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Mercer JN, 2007, J NEUROSCI, V27, P13552, DOI 10.1523/JNEUROSCI.3430-07.2007; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Rivlin-Etzion M, 2006, CURR OPIN NEUROBIOL, V16, P629, DOI 10.1016/j.conb.2006.10.002; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shin RM, 2003, J NEUROSCI, V23, P11662; Stanford IM, 2003, J NEUROPHYSIOL, V89, P1713, DOI 10.1152/jn.00864.2002; Strauss U, 2004, EUR J NEUROSCI, V19, P3048, DOI 10.1111/j.0953-816X.2004.03392.x; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Walters JR, 2007, NEUROSCIENCE, V144, P762, DOI 10.1016/j.neuroscience.2006.10.006; Walters JR, 2000, TRENDS NEUROSCI, V23, pS41, DOI 10.1016/S1471-1931(00)00024-0; Watanabe K, 2009, J NEUROPHYSIOL, V101, P665, DOI 10.1152/jn.90806.2008; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	47	126	127	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					85	U117		10.1038/nn.2692	http://dx.doi.org/10.1038/nn.2692			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21076425	Green Accepted			2022-12-24	WOS:000285684900018
J	Ferguson, SM; Eskenazi, D; Ishikawa, M; Wanat, MJ; Phillips, PEM; Dong, Y; Roth, BL; Neumaier, JF				Ferguson, Susan M.; Eskenazi, Daniel; Ishikawa, Masago; Wanat, Matthew J.; Phillips, Paul E. M.; Dong, Yan; Roth, Bryan L.; Neumaier, John F.			Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; STRIATOPALLIDAL NEURONS; ADDICTION; DOPAMINE; PLASTICITY; EXPRESSION; D1	Dorsal striatum is important for the development of drug addiction; however, a precise understanding of the roles of striatopallidal (indirect) and striatonigral (direct) pathway neurons in regulating behaviors remains elusive. Using viral-mediated expression of an engineered G protein-coupled receptor (hM(4)D), we found that activation of hM(4)D receptors with clozapine-N-oxide (CNO) potently reduced striatal neuron excitability. When hM(4)D receptors were selectively expressed in either direct or indirect pathway neurons, CNO did not change acute locomotor responses to amphetamine, but did alter behavioral plasticity associated with repeated drug treatment. Specifically, transiently disrupting striatopallidal neuronal activity facilitated behavioral sensitization, whereas decreasing excitability of striatonigral neurons impaired its persistence. These findings suggest that acute drug effects can be parsed from the behavioral adaptations associated with repeated drug exposure and highlight the utility of this approach for deconstructing neuronal pathway contributions to behavior.	[Ferguson, Susan M.; Eskenazi, Daniel; Wanat, Matthew J.; Phillips, Paul E. M.; Neumaier, John F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ishikawa, Masago; Dong, Yan] Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; [Wanat, Matthew J.; Phillips, Paul E. M.; Neumaier, John F.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Neumaier, JF (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	neumaier@uw.edu	Roth, Bryan/ABE-7032-2020; Dong, Yan/A-4154-2016; Roth, Bryan L/F-3928-2010; Phillips, Paul E. M./A-4463-2008; Ferguson, Susan/J-5427-2013; Phillips, Paul/E-7813-2013	Roth, Bryan/0000-0002-0561-6520; Dong, Yan/0000-0003-0016-9028; Phillips, Paul E. M./0000-0002-8749-7026; Ferguson, Susan/0000-0002-2840-757X; Phillips, Paul/0000-0002-8749-7026; Wanat, Matthew/0000-0003-1643-6557	US National Institutes of Health [K99 DA024762, T32 GM07266, T32 GM07108, T32 AA009455, F32 DA026273, R21 DA021793, R01 DA023206, U19MH82441]; National Institute of Mental Health; National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award; Achievement Rewards for College Scientists;  [R21 DA021273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R01DA023206, R21DA021793, F32DA026273, K99DA024762, R21DA021273] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award(NARSAD); Achievement Rewards for College Scientists; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health grants K99 DA024762 (S.M.F.), T32 GM07266 and T32 GM07108 (D.E.), T32 AA009455 and F32 DA026273 (M.J.W.), R21 DA021793 (P.E.M.P.), R01 DA023206 (Y.D.), U19MH82441 and the National Institute of Mental Health Psychoactive Drug Screening Program (B.L.R.), and R21 DA021273 (J.F.N.), an Achievement Rewards for College Scientists (D.E.), and a National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award (B.L.R.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Badiani A, 1999, BEHAV BRAIN RES, V103, P203, DOI 10.1016/S0166-4328(99)00041-8; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith Y, 1998, NEUROSCIENCE, V86, P353	14	319	322	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					22	24		10.1038/nn.2703	http://dx.doi.org/10.1038/nn.2703			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131952	Green Submitted, Green Accepted			2022-12-24	WOS:000285684900008
J	Higo, T; Hamada, K; Hisatsune, C; Nukina, N; Hashikawa, T; Hattori, M; Nakamura, T; Mikoshiba, K				Higo, Takayasu; Hamada, Kozo; Hisatsune, Chihiro; Nukina, Nobuyuki; Hashikawa, Tsutomu; Hattori, Mitsuharu; Nakamura, Takeshi; Mikoshiba, Katsuhiko			Mechanism of ER Stress-Induced Brain Damage by IP3 Receptor	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ONSET HUNTINGTON-DISEASE; TRISPHOSPHATE RECEPTORS; DEPENDENT APOPTOSIS; QUALITY-CONTROL; CHAPERONE BIP; CA2+ RELEASE; CELL-DEATH	Deranged Ca2+ signaling and an accumulation of aberrant proteins cause endoplasmic reticulum (ER) stress, which is a hallmark of cell death implicated in many neurodegenerative diseases. However, the underlying mechanisms are elusive. Here, we report that dysfunction of an ER-resident Ca2+ channel, inositol 1,4,5-trisphosphate receptor (IP3R), promotes cell death during ER stress. Heterozygous knockout of brain-dominant type1 IP3R (IP(3)R1) resulted in neuronal vulnerability to ER stress in vivo, and IP(3)R1 knockdown enhanced ER stress-induced apoptosis via mitochondria in cultured cells. The IP(3)R1 tetrameric assembly was positively regulated by the ER chaperone GRP78 in an energy-dependent manner. ER stress induced IP(3)R1 dysfunction through an impaired IP(3)R1-GRP78 interaction, which has also been observed in the brain of Huntington's disease model mice. These results suggest that IP(3)R1 senses ER stress through GRP78 to alter the Ca2+ signal to promote neuronal cell death implicated in neurodegenerative diseases.	[Higo, Takayasu; Mikoshiba, Katsuhiko] Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; [Higo, Takayasu; Hamada, Kozo; Hisatsune, Chihiro; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Lab Dev Neurobiol, Wako, Saitama 3510198, Japan; [Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Hashikawa, Tsutomu] RIKEN, Brain Sci Inst, Lab Neural Architecture, Wako, Saitama 3510198, Japan; [Hamada, Kozo; Mikoshiba, Katsuhiko] JST, ICORP SORST, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan; [Hattori, Mitsuharu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biomed Sci, Mizuho Ku, Aichi 4678603, Japan; [Nakamura, Takeshi] Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1138421, Japan	University of Tokyo; RIKEN; RIKEN; RIKEN; Japan Science & Technology Agency (JST); Nagoya City University; Juntendo University	Mikoshiba, K (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015; Hisatsune, Chihiro/C-6661-2017; Hattori, Mitsuharu/F-3859-2010; Hamada, Kozo/GXM-9371-2022; Nukina, Nobuyuki/GPP-6265-2022	Hisatsune, Chihiro/0000-0001-7811-7784; Hattori, Mitsuharu/0000-0002-0503-4969; Hamada, Kozo/0000-0002-2795-802X	Research Resource Center at the RIKEN BSI; JST; Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science and Technology, Japan	Research Resource Center at the RIKEN BSI; JST(Japan Science & Technology Agency (JST)); Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Mizutani for many biochemical experiments, including SPR analysis. We also thank T. Inoue and T. Michikawa for helpful discussion, and K. Nakamura, A. Terauchi, and A. Suzuki for excellent technical assistance. We thank for the support provided by the Research Resource Center at the RIKEN BSI for mass spectrometry, flow cytometry, and HE staining. This study was supported by a grant from the JST, Grants-in-Aid (T.H. and K.M.), the 21st Century COE Program, Center for Integrated Brain Medical Science, as well as the Ministry of Education, Culture, Sports, Science and Technology, Japan. We declare that none of the authors has a financial interest related to this work. We dedicate this report to Takeshi Nakamura, whose untimely death from cancer was a great loss for us.	Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; Blackshaw S, 2000, FASEB J, V14, P1375, DOI 10.1096/fj.14.10.1375; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Collins TJ, 2000, BIOCHEM J, V347, P593, DOI 10.1042/0264-6021:3470593; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Deyts C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008287; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Fink CC, 2000, BIOPHYS J, V79, P163, DOI 10.1016/S0006-3495(00)76281-3; Galvan DL, 1999, J BIOL CHEM, V274, P29483, DOI 10.1074/jbc.274.41.29483; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Hara K, 2008, NEUROLOGY, V71, P547, DOI 10.1212/01.wnl.0000311277.71046.a0; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; Joseph SK, 1999, BIOCHEM J, V342, P153, DOI 10.1042/0264-6021:3420153; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Khan MT, 2003, BIOCHEM J, V375, P603, DOI 10.1042/BJ20030828; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mimura N, 2007, CELL DEATH DIFFER, V14, P1475, DOI 10.1038/sj.cdd.4402151; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Nawa D, 2007, GLYCOBIOLOGY, V17, P913, DOI 10.1093/glycob/cwm067; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Sakazume S, 2009, AM J MED GENET A, V149A, P598, DOI 10.1002/ajmg.a.32707; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Seneca S, 2004, EUR J PEDIATR, V163, P717, DOI 10.1007/s00431-004-1537-3; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Thrower EC, 2001, TRENDS PHARMACOL SCI, V22, P580, DOI 10.1016/S0165-6147(00)01809-5; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Yoo SH, 2010, FASEB J, V24, P653, DOI 10.1096/fj.09-132456; Yoo SH, 2000, J BIOL CHEM, V275, P30293, DOI 10.1074/jbc.M001204200; Zhu LP, 1999, J BIOL CHEM, V274, P33267, DOI 10.1074/jbc.274.47.33267	49	109	113	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 9	2010	68	5					865	878		10.1016/j.neuron.2010.11.010	http://dx.doi.org/10.1016/j.neuron.2010.11.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145001	Bronze			2022-12-24	WOS:000285664900009
J	Bosco, DA; Morfini, G; Karabacak, NM; Song, YY; Gros-Louis, F; Pasinelli, P; Goolsby, H; Fontaine, BA; Lemay, N; McKenna-Yasek, D; Frosch, MP; Agar, JN; Julien, JP; Brady, ST; Brown, RH				Bosco, Daryl A.; Morfini, Gerardo; Karabacak, N. Murat; Song, Yuyu; Gros-Louis, Francois; Pasinelli, Piera; Goolsby, Holly; Fontaine, Benjamin A.; Lemay, Nathan; McKenna-Yasek, Diane; Frosch, Matthew P.; Agar, Jeffrey N.; Julien, Jean-Pierre; Brady, Scott T.; Brown, Robert H., Jr.			Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FAST AXONAL-TRANSPORT; HUMAN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DISEASE; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION; EXTRUDED AXOPLASM; SPINAL-CORDS; LINKED SOD1; MOUSE MODEL	Many mutations confer one or more toxic function(s) on copper/zinc superoxide dismutase 1 (SOD1) that impair motor neuron viability and cause familial amyotrophic lateral sclerosis (FALS). Using a conformation-specific antibody that detects misfolded SOD1 (C4F6), we found that oxidized wild-type SOD1 and mutant SOD1 share a conformational epitope that is not present in normal wild-type SOD1. In a subset of human sporadic ALS (SALS) cases, motor neurons in the lumbosacral spinal cord were markedly C4F6 immunoreactive, indicating that an aberrant wild-type SOD1 species was present. Recombinant, oxidized wildtype SOD1 and wild-type SOD1 immunopurified from SALS tissues inhibited kinesin-based fast axonal transport in a manner similar to that of FALS-linked mutant SOD1. Our findings suggest that wild-type SOD1 can be pathogenic in SALS and identify an SOD1-dependent pathogenic mechanism common to FALS and SALS.	[Bosco, Daryl A.; Fontaine, Benjamin A.; Lemay, Nathan; McKenna-Yasek, Diane; Brown, Robert H., Jr.] Univ Massachusetts Med Ctr, Dept Neurol, Worcester, MA USA; [Morfini, Gerardo; Song, Yuyu; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Karabacak, N. Murat; Agar, Jeffrey N.] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA; [Gros-Louis, Francois; Julien, Jean-Pierre] Univ Laval, Dept Psychiat & Neurosci, Res Ctr CHUQ, Quebec City, PQ, Canada; [Pasinelli, Piera] Thomas Jefferson Univ, Farber Inst Neurosci, Weinberg Unit ALS Res, Philadelphia, PA 19107 USA; [Goolsby, Holly; Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Morfini, Gerardo; Song, Yuyu; Brady, Scott T.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Massachusetts System; University of Massachusetts Worcester; University Massachusetts Worcester Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Brandeis University; Laval University; Jefferson University; Harvard University; Massachusetts General Hospital; Marine Biological Laboratory - Woods Hole	Bosco, DA (corresponding author), Univ Massachusetts Med Ctr, Dept Neurol, Worcester, MA USA.	daryl.bosco@umassmed.edu; robert.brown@umassmed.edu	Karabacak, N Murat/D-7227-2013; Song, Yuyu/J-8939-2019; Karabacak, Murat/AAG-2891-2019; Frosch, Matthew P/ABD-7456-2021	Karabacak, N Murat/0000-0003-2761-5593; Song, Yuyu/0000-0002-9196-1610; Karabacak, Murat/0000-0003-2761-5593; Frosch, Matthew P/0000-0002-3940-9861; Agar, Jeffery/0000-0003-2645-1873; Pasinelli, Piera/0000-0002-3385-2707	ALS Therapy Alliance-CVS Pharmacy; Marine Biological Laboratory; ALS Association; US National Institutes of Health; National Institute on Neurological Disorders and Stroke [RO1NS067206-01, U01NS05225-03, R01NS050557-05, 1RC1NS068391-01, 1RC2NS070342-01]; Canadian Institutes of Health Research; Angel Fund; ALS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, RC2NS070342, RC1NS068391, R01NS050557, R01NS065263, R01NS067206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	ALS Therapy Alliance-CVS Pharmacy; Marine Biological Laboratory; ALS Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Angel Fund; ALS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J. Landers and P. Sapp for DNA sequencing analysis of the SALS cases employed in this study, L. Hayward, A. Tiwari and R.-J. Chain for help with expression of recombinant wild-type SOD1, S. Berth, A. Leitman and M. Saparauskaite for help with axoplasm vesicle transport assays, A. Kaminska and L. Molla for help with biochemical experiments in squid axoplasm, M. Prudencio and D. Borchelt for cell lysates containing SOD1 G93 mutants, C. Vanderburg, E. Tamrazian, A. Bialik and the Diabetes and Endocrinology Research Center (University of Massachusetts Medical Center) for assistance with immunohistochemistry, K. Fitch and the Massachusetts Alzheimer Disease Research Center (P50AG005134) for assistance with human tissue samples, J. Zitzewitz for C6A/C111S-SOD1 protein, A. Weiss for assistance with mice, K. Green at the University of Massachusetts Medical Center Proteomics and Mass Spectrometry Facility for analysis of C6A/C111S-SOD1, and G. Petsko for insightful dialogue and support. We acknowledge financial support from the ALS Therapy Alliance-CVS Pharmacy (D. A. B. and G. M.), 2007/2008 Marine Biological Laboratory research fellowships (G. M.), the ALS Association (D. A. B., R. H. B. Jr, G. M. and S. T. B.), the US National Institutes of Health (D. A. B. (National Institute on Neurological Disorders and Stroke, RO1NS067206-01), R. H. B. Jr (National Institute on Neurological Disorders and Stroke, U01NS05225-03, R01NS050557-05, 1RC1NS068391-01 and 1RC2NS070342-01), S. T. B. and J.N.A.), Canadian Institutes of Health Research (J.-P.J.), the Angel Fund (R. H. B. Jr) and Project ALS (R.H.B.Jr).	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BRADY ST, 1985, CELL MOTIL CYTOSKEL, V5, P81, DOI 10.1002/cm.970050203; Bredesen DE, 1997, ANN NEUROL, V42, P135, DOI 10.1002/ana.410420202; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; DURAZO A, 2009, J BIOL CHEM, V277, P15923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Valdmanis PN, 2009, CURR NEUROL NEUROSCI, V9, P198, DOI 10.1007/s11910-009-0030-9; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	50	494	515	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1396	U133		10.1038/nn.2660	http://dx.doi.org/10.1038/nn.2660			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953194	Green Accepted, Green Submitted			2022-12-24	WOS:000283658200021
J	Fassier, C; Hutt, JA; Scholpp, S; Lumsden, A; Giros, B; Nothias, F; Schneider-Maunoury, S; Houart, C; Hazan, J				Fassier, Coralie; Hutt, James A.; Scholpp, Steffen; Lumsden, Andrew; Giros, Bruno; Nothias, Fatiha; Schneider-Maunoury, Sylvie; Houart, Corinne; Hazan, Jamile			Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway	NATURE NEUROSCIENCE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; REGULATES SYNAPTIC GROWTH; II RECEPTOR; MUTATIONS; PROTEIN; TRAFFICKING; MORPHOGENS; EXPRESSION; GUIDANCE; REQUIRES	To better understand hereditary spastic paraplegia (HSP), we characterized the function of atlastin, a protein that is frequently involved in juvenile forms of HSP, by analyzing loss- and gain-of-function phenotypes in the developing zebrafish. We found that knockdown of the gene for atlastin (atl1) caused a severe decrease in larval mobility that was preceded by abnormal architecture of spinal motor axons and was associated with a substantial upregulation of the bone morphogenetic protein (BMP) signaling pathway. Overexpression analyses confirmed that atlastin inhibits BMP signaling. In primary cultures of zebrafish spinal neurons, Atlastin partially colocalized with type I BMP receptors in late endosomes distributed along neurites, which suggests that atlastin may regulate BMP receptor trafficking. Finally, genetic or pharmacological inhibition of BMP signaling was sufficient to rescue the loss of mobility and spinal motor axon defects of atl1 morphants, emphasizing the importance of fine-tuning the balance of BMP signaling for vertebrate motor axon architecture and stability.	[Fassier, Coralie; Giros, Bruno; Nothias, Fatiha; Hazan, Jamile] CNRS, UMR 7224, Paris, France; [Fassier, Coralie; Giros, Bruno; Nothias, Fatiha; Hazan, Jamile] INSERM, U952, Paris, France; [Fassier, Coralie; Giros, Bruno; Nothias, Fatiha; Schneider-Maunoury, Sylvie; Hazan, Jamile] Univ Paris 06, Paris, France; [Hutt, James A.; Scholpp, Steffen; Lumsden, Andrew; Houart, Corinne; Hazan, Jamile] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Scholpp, Steffen] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany; [Giros, Bruno] McGill Univ, Dept Psychiat, Douglas Hosp, Montreal, PQ, Canada; [Schneider-Maunoury, Sylvie] CNRS, UMR7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; King's College London; Helmholtz Association; Karlsruhe Institute of Technology; McGill University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Hazan, J (corresponding author), CNRS, UMR 7224, Paris, France.	corinne.houart@kcl.ac.uk; jhazan@snv.jussieu.fr	Scholpp, Steffen/H-2060-2013; GIROS, Bruno/ABD-5790-2021; Houart, Corinne/B-5128-2009; Schneider-Maunoury, Sylvie/K-6795-2017; Scholpp, Steffen/E-4472-2018; Lumsden, Andrew/C-5146-2009	Scholpp, Steffen/0000-0002-4903-9657; GIROS, Bruno/0000-0001-5876-9822; Houart, Corinne/0000-0002-2062-3964; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Scholpp, Steffen/0000-0002-4903-9657; Hazan, Jamile/0000-0001-8119-0325; Nothias-Chahir, Fatiha/0000-0002-2497-2096; Fassier, Coralie/0000-0003-3015-4281	Houart laboratory; Schneider-Maunoury laboratory; Nothias laboratory; King's College Charitable Foundation; FRM; AFM; MRC; Association Strumpell-Lorrain (A-SL); MRC [G0601064] Funding Source: UKRI; Medical Research Council [G0601064, G0901899B] Funding Source: researchfish	Houart laboratory; Schneider-Maunoury laboratory; Nothias laboratory; King's College Charitable Foundation; FRM(Fondation pour la Recherche Medicale); AFM(Association Francaise contre les Myopathies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association Strumpell-Lorrain (A-SL); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Clarke, M. Salanoubat, J. Weissenbach and the Houart, Schneider-Maunoury and Nothias laboratories for discussions and support, S. Llewellyn-Jones, S. Thomas and G. Rodrigues for fish care at King's College London and IFR83/UPMC, and R. Schwartzmann and V. Georget for the IFR83 imaging platform. We thank the patients' Association Strumpell-Lorrain (A-SL) for their constant support. J. H., a CNRS research fellow, received a senior research fellowship from King's College Charitable Foundation for 2 years in C.H.'s lab. C. F. was supported by fellowships from the FRM and the AFM. This work was supported by research grants to C. H. from the MRC and from AFM and A-SL to J.H.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Andersen Soren S. L., 2001, Methods in Cell Science, V23, P205, DOI 10.1023/A:1016349232389; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Durr A, 2004, ARCH NEUROL-CHICAGO, V61, P1867, DOI 10.1001/archneur.61.12.1867; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fusco C, 2010, BRAIN DEV-JPN, V32, P592, DOI 10.1016/j.braindev.2009.08.003; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Liu Y, 2008, J BIOL CHEM, V283, P6561, DOI 10.1074/jbc.M708096200; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Matsuura I, 2008, J NEUROCHEM, V105, P1471, DOI 10.1111/j.1471-4159.2008.05251.x; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Piddini E, 2003, CURR OPIN CELL BIOL, V15, P474, DOI 10.1016/S0955-0674(03)00072-3; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Rainier S, 2006, ARCH NEUROL-CHICAGO, V63, P445, DOI 10.1001/archneur.63.3.445; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; Scarano V, 2005, J NEUROL, V252, P901, DOI 10.1007/s00415-005-0768-1; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Smith BN, 2009, CLIN GENET, V75, P485, DOI 10.1111/j.1399-0004.2009.01184.x; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006	49	87	90	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1380	U112		10.1038/nn.2662	http://dx.doi.org/10.1038/nn.2662			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935645				2022-12-24	WOS:000283658200019
J	Masri, S; Sassone-Corsi, P				Masri, Selma; Sassone-Corsi, Paolo			Plasticity and specificity of the circadian epigenome	NATURE NEUROSCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; TRANSCRIPTIONAL ACTIVATION; CHROMATIN MODIFICATION; BIOLOGICAL CLOCK; RECEPTOR; RHYTHMS; PHOSPHORYLATION; ACETYLATION; NEURONS; PATHWAY	Circadian clocks control a variety of neuronal, behavioral and physiological responses, via transcriptional regulation of an appreciable portion of the genome. We describe the complex communication network between the brain-specific central clock and the tissue-specific peripheral clocks that serve to synchronize the organism to both external and internal demands. In addition, we discuss and speculate on how epigenetic processes are involved in creating transcriptional environments that are permissive to tissue-specific gene expression programs, which work in concert with the circadian machinery. Accumulating data show that chromatin remodeling events may be critical for providing specificity and plasticity in circadian regulation, and metabolic cues may be involved in directing such epigenetic events. A detailed understanding of the communication cues between the central and peripheral clocks is crucial for a more complete understanding of the circadian system and the several levels of control that are implicated in maintaining biological timekeeping.	[Masri, Selma; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, INSERM Epigenet & Neuronal Plast U904, Sch Med, Irvine, CA 92717 USA	University of California System; University of California Irvine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, INSERM Epigenet & Neuronal Plast U904, Sch Med, Irvine, CA 92717 USA.	psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011	Masri, Selma/0000-0002-8619-8331	US National Institute of Health; INSERM (Institut National de la Sante et la Recherche Medicale), France; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM (Institut National de la Sante et la Recherche Medicale), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of our laboratory for discussions and support. Work in the laboratory is supported by the US National Institute of Health and the INSERM (Institut National de la Sante et la Recherche Medicale), France.	ABE K, 1979, NEUROENDOCRINOLOGY, V29, P119, DOI 10.1159/000122913; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kalsbeek A, 2010, J NEUROENDOCRINOL, V22, P362, DOI 10.1111/j.1365-2826.2010.01956.x; KATADA S, NAT STRUCT IN PRESS; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tousson E, 2004, J NEUROSCI, V24, P2983, DOI 10.1523/JNEUROSCI.5044-03.2004; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103	50	96	97	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1324	1329		10.1038/nn.2668	http://dx.doi.org/10.1038/nn.2668			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975756	Green Accepted			2022-12-24	WOS:000283658200009
J	Hantman, AW; Jessell, TM				Hantman, Adam W.; Jessell, Thomas M.			Clarke's column neurons as the focus of a corticospinal corollary circuit	NATURE NEUROSCIENCE			English	Article							DORSAL SPINOCEREBELLAR TRACT; SPINAL-CORD; ORIGIN; TRANSMISSION; MOVEMENT; INTERNEURONS; CEREBELLUM; AFFERENTS; PATHWAY; FIBERS	Proprioceptive sensory signals inform the CNS of the consequences of motor acts, but effective motor planning involves internal neural systems capable of anticipating actual sensory feedback. Just where and how predictive systems exert their influence remains poorly understood. We explored the possibility that spinocerebellar neurons that convey proprioceptive sensory information also integrate information from cortical command systems. Analysis of the circuitry and physiology of identified dorsal spinocerebellar tract neurons in mouse spinal cord revealed distinct populations of Clarke's column neurons that received direct excitatory and/or indirect inhibitory inputs from descending corticospinal axons. The convergence of these descending inhibitory and excitatory inputs to Clarke's column neurons established local spinal circuits with the capacity to mark or modulate incoming proprioceptive input. Together, our genetic, anatomical and physiological results indicate that Clarke's column spinocerebellar neurons nucleate local spinal corollary circuits that are relevant to motor planning and evaluation.	[Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu			Howard Hughes Medical Institute; Robert Leet and Clara Guthrie Patterson Trust; National Institute of Neurological Disorders and Stroke; Wellcome Trust; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, R37NS033245] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert Leet and Clara Guthrie Patterson Trust; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Han and K. Miao for technical assistance, J. de Nooij and G. Surmeli for help in retrograde labeling of proprioceptive afferents, J. Kirkland and M. Mendelsohn for animal care, and K. MacArthur and I. Schieren for help in preparing the manuscript. We are grateful to S. Arber, N. Asai, C. Cebrian, Z.J. Huang, J. Milbrandt, J. Sanes, G. Szabo and MMRCC-GENSAT for mouse lines, and especially to F. Costantini for permission to use unpublished Gdnf::CreERT2 mice. We thank R. Axel, M. Churchland, K. Franks, S. Grillner, J. Krakauer, C. Miall, S. Poliak, K. Ritola, D. Stettler and D. Wolpert for discussion and/or comments on the manuscript. A.W.H. was supported by the Howard Hughes Medical Institute and the Robert Leet and Clara Guthrie Patterson Trust Fellowship. T.M.J. was supported by grants from the National Institute of Neurological Disorders and Stroke, the Wellcome Trust, the G. Harold and Leila Y. Mathers Foundation, Project A.L.S. and is an investigator of the Howard Hughes Medical Institute.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; ARSHAVSKY YI, 1972, BRAIN RES, V43, P276, DOI 10.1016/0006-8993(72)90296-X; ARSHAVSKY YI, 1984, EXP BRAIN RES, V54, P426; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; D'Esposito M., 2006, MOTOR COGNITION WHAT, P1, DOI [10.1093/acprof:oso/9780198569657.001.0001, DOI 10.1093/ACPROF:OSO/978019856]; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Ebner T, 2008, CEREBELLUM, V7, P583, DOI 10.1007/s12311-008-0059-3; ECCLES JC, 1961, J PHYSIOL-LONDON, V158, P517, DOI 10.1113/jphysiol.1961.sp006783; EDGLEY SA, 1988, J PHYSIOL-LONDON, V397, P81, DOI 10.1113/jphysiol.1988.sp016989; Finger JH, 2002, J NEUROSCI, V22, P10346; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HONGO T, 1987, J COMP NEUROL, V262, P159, DOI 10.1002/cne.902620202; HONGO T, 1967, EXP BRAIN RES, V3, P135; HONGO T, 1967, EXP BRAIN RES, V3, P163; Lomeli J, 1998, NATURE, V395, P600, DOI 10.1038/26975; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; LUNDBERG A., 1964, PROGR BRAIN RES, V12, P135, DOI 10.1016/S0079-6123(08)60621-4; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; MANN MD, 1973, BRAIN BEHAV EVOLUT, V7, P34, DOI 10.1159/000124397; MATSUSHITA M, 1979, BRAIN RES, V173, P185, DOI 10.1016/0006-8993(79)90620-6; Matsushita M, 1997, J COMP NEUROL, V386, P409, DOI 10.1002/(SICI)1096-9861(19970929)386:3<409::AID-CNE6>3.0.CO;2-5; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mott F, 1888, J Anat Physiol, V22, P479; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Nosrat CA, 1996, CELL TISSUE RES, V286, P191, DOI 10.1007/s004410050688; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Prochazka A, 1997, J NEUROPHYSIOL, V77, P3237, DOI 10.1152/jn.1997.77.6.3237; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; Seki K, 2003, NAT NEUROSCI, V6, P1309, DOI 10.1038/nn1154; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; WALMSLEY B, 1991, PROG NEUROBIOL, V36, P391, DOI 10.1016/0301-0082(91)90017-U; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032	39	103	105	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1233	1239		10.1038/nn.2637	http://dx.doi.org/10.1038/nn.2637			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835249	Green Accepted			2022-12-24	WOS:000282171300015
J	Pfister, JP; Dayan, P; Lengyel, M				Pfister, Jean-Pascal; Dayan, Peter; Lengyel, Mate			Synapses with short-term plasticity are optimal estimators of presynaptic membrane potentials	NATURE NEUROSCIENCE			English	Article							NEURAL-NETWORKS; SYNAPTIC DEPRESSION; FACILITATION; NEURONS; TRANSMISSION; DYNAMICS	The trajectory of the somatic membrane potential of a cortical neuron exactly reflects the computations performed on its afferent inputs. However, the spikes of such a neuron are a very low-dimensional and discrete projection of this continually evolving signal. We explored the possibility that the neuron's efferent synapses perform the critical computational step of estimating the membrane potential trajectory from the spikes. We found that short-term changes in synaptic efficacy can be interpreted as implementing an optimal estimator of this trajectory. Short-term depression arose when presynaptic spiking was sufficiently intense as to reduce the uncertainty associated with the estimate; short-term facilitation reflected structural features of the statistics of the presynaptic neuron such as up and down states. Our analysis provides a unifying account of a powerful, but puzzling, form of plasticity.	[Pfister, Jean-Pascal; Lengyel, Mate] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England	University of Cambridge; University of London; University College London	Pfister, JP (corresponding author), Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England.	jean-pascal.pfister@eng.cam.ac.uk	Lengyel, Mate/A-6665-2013	Lengyel, Mate/0000-0001-7266-0049; Pfister, Jean-Pascal/0000-0002-1847-3389; Dayan, Peter/0000-0003-3476-1839	Wellcome Trust; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	We thank M. Hausser and R. Brown for useful references and L. Abbott, Sz. Kali and members of the Budapest Computational Neuroscience Forum for valuable discussions. This work was supported by the Wellcome Trust (J.-P.P., M.L. and P.D.) and the Gatsby Charitable Foundation (P.D.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson B.D.O., 1979, OPTIMAL FILTERING; [Anonymous], 2009, ADV NEURAL INFORM PR; Bobrowski O, 2009, NEURAL COMPUT, V21, P1277, DOI 10.1162/neco.2008.01-08-692; Carpenter G. A., 1991, PATTERN RECOGNITION; Chorev E, 2007, J NEUROSCI, V27, P5043, DOI 10.1523/JNEUROSCI.5187-06.2007; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cunningham J, 2008, ADV NEURAL INFORM PR, V20, P329; Dayan P., 2001, THEORETICAL NEUROSCI; de la Rocha J, 2002, NEUROCOMPUTING, V44, P85, DOI 10.1016/S0925-2312(02)00362-4; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Gerstner W., 2002, SPIKING NEURON MODEL; Goldman MS, 2002, J NEUROSCI, V22, P584, DOI 10.1523/JNEUROSCI.22-02-00584.2002; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HASSELMO ME, 1993, TRENDS NEUROSCI, V16, P218, DOI 10.1016/0166-2236(93)90159-J; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huys QJM, 2007, NEURAL COMPUT, V19, P404, DOI 10.1162/neco.2007.19.2.404; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Lansky P, 2008, BIOL CYBERN, V99, P253, DOI 10.1007/s00422-008-0237-x; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Loebel A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.027.2009; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Merkel M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041921; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Paninski L, 2006, J COMPUT NEUROSCI, V21, P71, DOI 10.1007/s10827-006-7200-4; PFISTER JP, 2009, FRONT SYST NEUR C CO; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shinomoto S, 1999, NEURAL COMPUT, V11, P935, DOI 10.1162/089976699300016511; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; STEIN RB, 1965, BIOPHYS J, V5, P173, DOI 10.1016/S0006-3495(65)86709-1; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	49	46	46	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1271	1275		10.1038/nn.2640	http://dx.doi.org/10.1038/nn.2640			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852625	Green Accepted			2022-12-24	WOS:000282171300020
J	Yaksi, E; Wilson, RI				Yaksi, Emre; Wilson, Rachel I.			Electrical Coupling between Olfactory Glomeruli	NEURON			English	Article							DROSOPHILA ANTENNAL LOBE; GAP-JUNCTION PROTEINS; GIANT FIBER SYSTEM; NEURAL CIRCUITS; MAMMALIAN BRAIN; GAIN-CONTROL; NEURONS; INHIBITION; MUTATIONS; REPRESENTATIONS	In the Drosophila antennal lobe, excitation can spread between glomerular processing channels. In this study, we investigated the mechanism of lateral excitation. Dual recordings from excitatory local neurons (eLNs) and projection neurons (PNs) showed that eLN-to-PN synapses transmit both hyperpolarization and depolarization, are not diminished by blocking chemical neurotransmission, and are abolished by a gap-junction mutation. This mutation eliminates odor-evoked lateral excitation in PNs and diminishes some PN odor responses. This implies that lateral excitation is mediated by electrical synapses from eLNs onto PNs. In addition, eLNs form synapses onto inhibitory LNs. Eliminating these synapses boosts some PN odor responses and reduces the disinhibitory effect of GABA receptor antagonists on PNs. Thus, eLNs have two opposing effects on PNs, driving both direct excitation and indirect inhibition. We propose that when stimuli are weak, lateral excitation promotes sensitivity, whereas when stimuli are strong, lateral excitation helps recruit inhibitory gain control.	[Yaksi, Emre; Wilson, Rachel I.] Harvard Univ, Dept Neurobiol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Dept Neurobiol, Sch Med, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012; Yaksi, Emre/A-3215-2019	Yaksi, Emre/0000-0003-3761-0235; Wilson, Rachel/0000-0001-8573-9266	Human Frontiers Science Program; National Institutes of Health [R01DC008174]; McKnight Scholar Award; Beckman Young Investigator Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; Beckman Young Investigator Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to L.C. Griffith, K. Ito, L. Luo, G. Miesenbock, M.A. Tanouye, W.D. Tracey, and R.J. Wyman for gifts of fly stocks. D. Schmucker, N. Obholzer, and N. Jurisch-Yaksi provided advice on RT-PCR experiments, and K.I. Nagel helped with the writing of the data acquisition software. We thank members of the Wilson lab for their feedback on the manuscript. This work was funded by a long-term fellowship from the Human Frontiers Science Program (to E.Y.), a grant from the National Institutes of Health (R01DC008174), a McKnight Scholar Award, and a Beckman Young Investigator Award (to R.I.W.). R.I.W. is a Howard Hughes Medical Institute Early Career Scientist.	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; BAIRD DH, 1990, GENETICS, V126, P1045; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Curtin KD, 2002, J NEUROSCI, V22, P7088; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HOMYK T, 1980, MOL GEN GENET, V177, P553; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Phelan P, 1996, J NEUROSCI, V16, P1101; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Phelan P, 2008, CURR BIOL, V18, P1955, DOI 10.1016/j.cub.2008.10.067; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Simpson JH, 2009, ADV GENET, V65, P79, DOI 10.1016/S0065-2660(09)65003-3; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Sun YA, 1996, J NEUROBIOL, V30, P340, DOI 10.1002/(SICI)1097-4695(199607)30:3<340::AID-NEU3>3.3.CO;2-B; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; THOMAS JB, 1984, J NEUROSCI, V4, P530; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Zhang Z, 1999, J NEUROBIOL, V40, P288, DOI 10.1002/(SICI)1097-4695(19990905)40:3<288::AID-NEU2>3.0.CO;2-O	50	120	122	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					1034	1047		10.1016/j.neuron.2010.08.041	http://dx.doi.org/10.1016/j.neuron.2010.08.041			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869599	Bronze, Green Accepted			2022-12-24	WOS:000282801100014
J	Kawauchi, T; Sekine, K; Shikanai, M; Chihama, K; Tomita, K; Kubo, K; Nakajima, K; Nabeshima, Y; Hoshino, M				Kawauchi, Takeshi; Sekine, Katsutoshi; Shikanai, Mima; Chihama, Kaori; Tomita, Kenji; Kubo, Ken-ichiro; Nakajima, Kazunori; Nabeshima, Yo-ichi; Hoshino, Mikio			Rab GTPases-Dependent Endocytic Pathways Regulate Neuronal Migration and Maturation through N-Cadherin Trafficking	NEURON			English	Article							INTEGRIN ENDOCYTOSIS; RECYCLING ENDOSOMES; DISTINCT FUNCTIONS; RADIAL MIGRATION; CELL-MIGRATION; ORGANIZATION; DYNAMIN; DOMAIN; EXPRESSION; PROTEINS	Although membrane trafficking pathways are involved in basic cellular functions, the evolutionally expanded number of their related family proteins suggests additional roles for membrane trafficking in higher organisms. Here, we show that several Rab-dependent trafficking pathways differentially participate in neuronal migration, an essential step for the formation of the mammalian-specific six-layered brain structure. In vivo electroporation-mediated suppression of Rab5 or dynamin to block endocytosis caused a severe neuronal migration defect in mouse cerebral cortex. Among many downstream endocytic pathways, suppression of Rab11-dependent recycling pathways exhibited a similar migration disorder, whereas inhibition of Rab7-dependent lysosomal degradation pathways affected only the final phase of neuronal migration and dendrite morphology. Inhibition of Rab5 or Rab11 perturbed the trafficking of N-cadherin, whose suppression also disturbed neuronal migration. Taken together, our findings reveal physiological roles of endocytic pathways, each of which has specific functions in distinct steps of neuronal migration and maturation during mammalian brain formation.	[Kawauchi, Takeshi; Sekine, Katsutoshi; Shikanai, Mima; Tomita, Kenji; Kubo, Ken-ichiro; Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; [Kawauchi, Takeshi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kawauchi, Takeshi; Chihama, Kaori; Nabeshima, Yo-ichi; Hoshino, Mikio] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Hoshino, Mikio] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Kodaira, Tokyo 1878502, Japan	Keio University; Japan Science & Technology Agency (JST); Kyoto University; National Center for Neurology & Psychiatry - Japan	Kawauchi, T (corresponding author), Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan.	takeshi-kawauchi@umin.ac.jp	Kawauchi, Takeshi/L-4770-2013; Kubo, Ken-ichiro/B-2520-2015; Nakajima, Kazunori/L-3396-2013	Kawauchi, Takeshi/0000-0002-8650-4474; Kubo, Ken-ichiro/0000-0003-4023-5069; Nakajima, Kazunori/0000-0003-1864-9425	Ministry of Education, Culture, Sports, and Science and Technology, Japan [21113524, 19670002, 22240041]; JST; Takeda Science Foundation; GCOE	Ministry of Education, Culture, Sports, and Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); GCOE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Baba, C. Bucci, S. Hirai, R. L. Huganir, S. Kanda, B. J. Knoll, D. Manor, M. McCaffrey, F. D. Miller, J. Miyazaki, M. Ozawa, R. E. Pagano, K. Takei, K. Tanabe, and D. L. Turner for providing plasmids, Kaori Kawauchi for a part of statistical analyses, and Ruth T. Yu and Akira Sakakibara for helpful comments. We also thank the Core Instrumentation Facility, Keio University School of Medicine for help with Leica SP5 confocal microscopy, LAS4000mini, FACS and ABI DNA sequencer. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, and Science and Technology, Japan (#21113524 to T.K., #19670002 to M.H., and #22240041 to K.N.), and by grants from the JST PRESTO program, Takeda Science Foundation and GCOE. Author contributions; T.K. conceived the study and designed and performed experiments. K.S., M.S., and K.C. performed experiments. K.T. partly performed N-cadherin knockdown. K.K. constructed a part of N-cadherin vectors. Y.N., M.H., K.N., and T.K. administrated the experimental environments. T.K. jointly wrote the paper with M.H.	Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Cameron RS, 1997, J COMP NEUROL, V387, P467; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hirai S, 2002, DEVELOPMENT, V129, P4483; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Nishimura YV, 2010, J BIOL CHEM, V285, P5878, DOI 10.1074/jbc.M109.033761; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rosales KR, 2009, MOL BIOL CELL, V20, P2831, DOI 10.1091/mbc.E08-09-0911; Rosenfeld JL, 2001, J CELL SCI, V114, P4499; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Stenmark H, 2001, GENOME BIOL, V2; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Takahashi T, 1999, J NEUROSCI, V19, P10357; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	54	221	224	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					588	602		10.1016/j.neuron.2010.07.007	http://dx.doi.org/10.1016/j.neuron.2010.07.007			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797536	Bronze			2022-12-24	WOS:000281534600009
J	Laviv, T; Riven, I; Dolev, I; Vertkin, I; Balana, B; Slesinger, PA; Slutsky, I				Laviv, Tal; Riven, Inbal; Dolev, Iftach; Vertkin, Irena; Balana, Bartosz; Slesinger, Paul A.; Slutsky, Inna			Basal GABA Regulates GABA(B)R Conformation and Release Probability at Single Hippocampal Synapses	NEURON			English	Article							PRESYNAPTIC INHIBITION; SYNAPTIC-TRANSMISSION; RECEPTOR; REARRANGEMENTS; INACTIVITY; REDUCTION; GLUTAMATE; DYNAMICS; CHANNELS	Presynaptic GABA(B) receptor (GABA(B)R) heterodimers are composed of GB(1a)/GB(2) subunits and critically influence synaptic and cognitive functions. Here, we explored local GABABR activation by integrating optical tools for monitoring receptor conformation and synaptic vesicle release at individual presynaptic boutons of hippocampal neurons. Utilizing fluorescence resonance energy transfer (FRET) spectroscopy, we detected a wide range of FRET values for CFP/YFP-tagged GB(1a)/GB(2) receptors that negatively correlated with release probabilities at single synapses. High FRET of GABA(B)Rs associated with low release probability. Notably, pharmacological manipulations that either reduced or increased basal receptor activation decreased intersynapse variability of GB(1a)/GB(2) receptor conformation. Despite variability along axons, presynaptic GABA(B)R tone was dendrite specific, having a greater impact on synapses at highly innervated proximal branches. Prolonged neuronal inactivity reduced basal receptor activation, leading to homeostatic augmentation of release probability. Our findings suggest that local variations in basal GABA concentration are a major determinant of GB(1a)/GB(2) conformational variability, which contributes to heterogeneity of neurotransmitter release at hippocampal synapses.	[Laviv, Tal; Riven, Inbal; Dolev, Iftach; Vertkin, Irena; Slutsky, Inna] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Balana, Bartosz; Slesinger, Paul A.] Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA	Tel Aviv University; Sackler Faculty of Medicine; Salk Institute	Slutsky, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	islutsky@post.tau.ac.il	Laviv, Tal/AAN-6016-2020	Slutsky, Inna/0000-0002-0700-2266	Binational Science Foundation [2007199]; Israel Science Foundation [993/08, 170/08]	Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	We thank Dr. Bernhard Bettler for critical comments on the manuscript; Dr. Nathan Dascal and Dr. Bernard Attali for discussions; Dr. Eitan Reuveny for providing TNFR<INF>2</INF><SUP>YFP</SUP>, G<INF>beta 1</INF><SUP>YFP</SUP> and G<INF>gamma 2</INF><SUP>CFP</SUP> cDNAs; Dr. Daniel Gitler for Syn<INF>1a</INF><SUP>CFP</SUP> and Hills Fogel for the help with image processing algorithms. This work was supported by Binational Science Foundation (I.S. and P.A.S., grant No. 2007199) and Israel Science Foundation (I.S., grants No. 993/08 and 170/08).	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; Matsushita S, 2010, J BIOL CHEM, V285, P10291, DOI 10.1074/jbc.M109.077990; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schikorski T, 1997, J NEUROSCI, V17, P5858; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	37	36	37	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					253	267		10.1016/j.neuron.2010.06.022	http://dx.doi.org/10.1016/j.neuron.2010.06.022			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670833	Bronze			2022-12-24	WOS:000280461500010
J	Kochlamazashvili, G; Henneberger, C; Bukalo, O; Dvoretskova, E; Senkov, O; Lievens, PMJ; Westenbroek, R; Engel, AK; Catterall, WA; Rusakov, DA; Schachner, M; Dityatev, A				Kochlamazashvili, Gaga; Henneberger, Christian; Bukalo, Olena; Dvoretskova, Elena; Senkov, Oleg; Lievens, Patricia M. -J.; Westenbroek, Ruth; Engel, Andreas K.; Catterall, William A.; Rusakov, Dmitri A.; Schachner, Melitta; Dityatev, Alexander			The Extracellular Matrix Molecule Hyaluronic Acid Regulates Hippocampal Synaptic Plasticity by Modulating Postsynaptic L-Type Ca2+ Channels	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULE; GATED CALCIUM-CHANNELS; CHONDROITIN SULFATE; FUNCTIONAL RECOVERY; DENDRITIC SPINES; DIFFERENT FORMS; NMDA RECEPTORS; MICE DEFICIENT; ACTIVATION	Although the extracellular matrix plays an important role in regulating use-dependent synaptic plasticity, the underlying molecular mechanisms are poorly understood. Here we examined the synaptic function of hyaluronic acid (HA), a major component of the extracellular matrix. Enzymatic removal of HA with hyaluronidase reduced nifedipine-sensitive whole-cell Ca2+ currents, decreased Ca2+ transients mediated by L-type voltage-dependent Ca2+ channels (L-VDCCs) in postsynaptic dendritic shafts and spines, and abolished an L-VDCC-dependent component of long-term potentiation (LTP) at the CA3-CA1 synapses in the hippocampus. Adding exogenous HA, either by bath perfusion or via local delivery near recorded synapses, completely rescued this LTP component. In a heterologous expression system, exogenous HA rapidly increased currents mediated by Ca(v)1.2, but not Ca(v)1.3, subunit-containing L-VDCCs, whereas intrahippocampal injection of hyaluronidase impaired contextual fear conditioning. Our observations unveil a previously unrecognized mechanism by which the perisynaptic extracellular matrix influences use-dependent synaptic plasticity through regulation of dendritic Ca2+ channels.	[Henneberger, Christian; Rusakov, Dmitri A.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Kochlamazashvili, Gaga; Bukalo, Olena; Schachner, Melitta; Dityatev, Alexander] Univ Med Ctr Hamburg Eppendorf, Zentrum Mol Neurobiol Hamburg, D-20251 Hamburg, Germany; [Kochlamazashvili, Gaga; Dvoretskova, Elena; Lievens, Patricia M. -J.; Dityatev, Alexander] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Senkov, Oleg; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Senkov, Oleg] Heidelberg Univ, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; [Westenbroek, Ruth; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of London; University College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; Istituto Italiano di Tecnologia - IIT; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Rusakov, DA (corresponding author), UCL, UCL Inst Neurol, London WC1N 3BG, England.	d.rusakov@ion.ucl.ac.uk; alexander.dityatev@iit.it	Henneberger, Christian/C-1557-2008; Rusakov, Dmitri/AAH-4529-2021; Dityatev, Alexander/A-4034-2008; Rusakov, Dmitri A/E-1987-2011; Engel, Andreas K/C-7781-2012; Engel, Andreas K./AAH-6384-2019	Henneberger, Christian/0000-0002-5391-7387; Rusakov, Dmitri/0000-0001-9539-9947; Dityatev, Alexander/0000-0002-0472-0553; Rusakov, Dmitri A/0000-0001-9539-9947; Engel, Andreas K/0000-0003-4899-8466; Engel, Andreas K./0000-0003-4899-8466	Deutsche Forschungsgemeinschaft [DI 702/6-1]; Italian Institute of Technology; Wellcome Trust; Medical Research Council UK; New Jersey Commission for Spinal Cord Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER; Medical Research Council [G0802216, G0900613] Funding Source: researchfish; MRC [G0900613, G0802216] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); New Jersey Commission for Spinal Cord Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Fabio Morellini and Kristin Michael for helpful suggestions, Tommaso Fellin for FVB/N-Tg(GFAPGFP)14Mes/J mice, and Joerg Striessnig for the Ca<INF>v</INF>1.3 expression vector. This work was supported by the Deutsche Forschungsgemeinschaft (DI 702/6-1 to A.D.), the Italian Institute of Technology (G.K., P.M.-J.L., and A.D.), the Wellcome Trust and Medical Research Council UK (D.A.R. and CR.), and the New Jersey Commission for Spinal Cord Research (M.S). M.S. is a consultant at the Center for Neuroscience at Shantou University Medical College, China.	Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; BARTA E, 1993, BIOCHEM J, V292, P947, DOI 10.1042/bj2920947; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brakebusch C, 2002, MOL CELL BIOL, V22, P7417, DOI 10.1128/MCB.22.21.7417-7427.2002; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3; Bukalo O, 2007, J NEUROSCI, V27, P6019, DOI 10.1523/JNEUROSCI.1022-07.2007; Calaghan SC, 2004, PROG BIOPHYS MOL BIO, V84, P29, DOI 10.1016/S0079-6107(03)00057-9; Clark NC, 2003, NEUROSCIENCE, V120, P435, DOI 10.1016/S0306-4522(03)00329-4; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; DeCostanzo AJ, 2010, J NEUROSCI, V30, P1822, DOI 10.1523/JNEUROSCI.2168-09.2010; Delling M, 2002, J NEUROSCI, V22, P7154; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Evers MR, 2002, J NEUROSCI, V22, P7177; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Handrock R, 1999, J PHYSIOL-LONDON, V521, P31, DOI 10.1111/j.1469-7793.1999.00031.x; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; JENKINS HG, 1988, J NEUROCHEM, V51, P1641, DOI 10.1111/j.1471-4159.1988.tb01135.x; KNAUS HG, 1990, J BIOL CHEM, V265, P11156; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Le Blanc C, 2004, CIRC RES, V95, P300, DOI 10.1161/01.RES.0000138017.76125.8b; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; Matthews RT, 2002, J NEUROSCI, V22, P7536; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Morellini F, 2006, EUR J NEUROSCI, V23, P1255, DOI 10.1111/j.1460-9568.2006.04657.x; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Otoom S, 2006, FUND CLIN PHARMACOL, V20, P115, DOI 10.1111/j.1472-8206.2006.00393.x; Perosa SR, 2002, EPILEPSIA, V43, P159, DOI 10.1046/j.1528-1157.43.s.5.30.x; Peters M, 2009, GENES BRAIN BEHAV, V8, P320, DOI 10.1111/j.1601-183X.2009.00474.x; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Rusakov DA, 2005, J NEUROSCI, V25, P4930, DOI 10.1523/JNEUROSCI.0338-05.2005; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Saghatelyan AK, 2003, MOL CELL NEUROSCI, V24, P271, DOI 10.1016/S1044-7431(03)00163-5; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Triggle DJ, 2006, CURR PHARM DESIGN, V12, P443, DOI 10.2174/138161206775474503; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Zhou XH, 2001, MOL CELL BIOL, V21, P5970, DOI 10.1128/MCB.21.17.5970-5978.2001	56	150	154	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					116	128		10.1016/j.neuron.2010.05.030	http://dx.doi.org/10.1016/j.neuron.2010.05.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624596	Green Accepted, Bronze			2022-12-24	WOS:000280221000013
J	Ashby, MC; Isaac, JTR				Ashby, Michael C.; Isaac, John T. R.			Maturation of a Recurrent Excitatory Neocortical Circuit by Experience-Dependent Unsilencing of Newly Formed Dendritic Spines	NEURON			English	Article							RAT BARREL CORTEX; POSTSYNAPTICALLY SILENT SYNAPSES; MOUSE SOMATOSENSORY CORTEX; CORTICAL MAP PLASTICITY; SYNAPTIC CONNECTIONS; PYRAMIDAL NEURONS; THALAMOCORTICAL SYNAPSES; SENSORY DEPRIVATION; LAYER-IV; IN-VIVO	Local recurrent excitatory circuits are ubiquitous in neocortex, yet little is known about their development or architecture. Here we introduce a quantitative technique for efficient single-cell resolution circuit mapping using 2-photon (2P) glutamate un-caging and analyze experience-dependent neonatal development of the layer 4 barrel cortex local excitatory circuit. We show that sensory experience specifically drives a 3-fold increase in connectivity at postnatal day (P) 9, producing a highly recurrent network. A profound dendritic spinogenesis occurs concurrent with the connectivity increase, but this is not experience dependent. However, in experience-deprived cortex, a much greater proportion of spines lack postsynaptic AMPA receptors (AMPARs) and synaptic connectivity via NMDA receptors (NMDARs) is the same as in normally developing cortex. Thus we describe a approach for quantitative circuit mapping and show that sensory experience sculpts an intrinsically developing template network, which is based on NMDAR-only synapses, by driving AMPARs into newly formed silent spines.	[Ashby, Michael C.; Isaac, John T. R.] Natl Inst Neurol Disorders & Stroke, NIH, Dev Synapt Plast Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Ashby, MC (corresponding author), Univ Walk, Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	m.c.ashby@bristol.ac.uk; isaac_john@lilly.com		Ashby, Michael/0000-0002-8593-8473	NINDS	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Isaac, Diamond, and McBain labs for helpful discussions during this study and to Dietmar Plenz for advice on network topology and graph theoretical analysis. We thank Dr. Ramesh Chittajallu and Dr. Sarah Caddick for contributing to the paired recording connectivity data set. This work was supported by the NINDS Intramural program.	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Cheetham CEJ, 2007, J NEUROSCI, V27, P3456, DOI 10.1523/JNEUROSCI.5143-06.2007; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; Haeusler S, 2009, J PHYSIOL-PARIS, V103, P73, DOI 10.1016/j.jphysparis.2009.05.006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2008, J NEUROPHYSIOL, V99, P1535, DOI 10.1152/jn.01127.2007; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Petersen CCH, 2003, PFLUG ARCH EUR J PHY, V447, P126, DOI 10.1007/s00424-003-1167-z; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Rigas P, 2009, J NEUROPHYSIOL, V102, P119, DOI 10.1152/jn.00126.2009; Schubert D, 2003, J NEUROSCI, V23, P2961; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White EL, 2007, BRAIN RES REV, V55, P422, DOI 10.1016/j.brainresrev.2006.12.004; White EL, 1997, SOMATOSENS MOT RES, V14, P34, DOI 10.1080/08990229771204; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	53	67	68	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 12	2011	70	3					510	521		10.1016/j.neuron.2011.02.057	http://dx.doi.org/10.1016/j.neuron.2011.02.057			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555076	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000290926100012
J	Frahm, S; Slimak, MA; Ferrarese, L; Santos-Torres, J; Antolin-Fontes, B; Auer, S; Filkin, S; Pons, S; Fontaine, JF; Tsetlin, V; Maskos, U; Ibanez-Tallon, I				Frahm, Silke; Slimak, Marta A.; Ferrarese, Leiron; Santos-Torres, Julio; Antolin-Fontes, Beatriz; Auer, Sebastian; Filkin, Sergey; Pons, Stephanie; Fontaine, Jean-Fred; Tsetlin, Victor; Maskos, Uwe; Ibanez-Tallon, Ines			Aversion to Nicotine Is Regulated by the Balanced Activity of beta 4 and alpha 5 Nicotinic Receptor Subunits in the Medial Habenula	NEURON			English	Article							VENTRAL TEGMENTAL AREA; ACETYLCHOLINE-RECEPTOR; IN-VIVO; AFRICAN-AMERICANS; UP-REGULATION; MICE LACKING; LUNG-CANCER; GENE; WITHDRAWAL; NEURONS	Nicotine dependence is linked to single nucleotide polymorphisms in the CHRNB4-CHRNA3-CHRNA5 gene cluster encoding the alpha 3 beta 4 alpha 5 nicotinic acetylcholine receptor (nAChR). Here we show that the beta 4 subunit is rate limiting for receptor activity, and that current increase by beta 4 is maximally competed by one of the most frequent variants associated with tobacco usage (D398N in alpha 5). We identify a beta 4-specific residue (S435), mapping to the intracellular vestibule of the alpha 3 beta 4 alpha 5 receptor in close proximity to alpha 5 D398N, that is essential for its ability to increase currents. Transgenic mice with targeted overexpression of Chrnb4 to endogenous sites display a strong aversion to nicotine that can be reversed by viral-mediated expression of the alpha 5 D398N variant in the medial habenula (MHb). Thus, this study both provides insights into alpha 3 beta 4 alpha 5 receptor-mediated mechanisms contributing to nicotine consumption, and identifies the MHb as a critical element in the circuitry controlling nicotine-dependent phenotypes.	[Frahm, Silke; Slimak, Marta A.; Ferrarese, Leiron; Santos-Torres, Julio; Antolin-Fontes, Beatriz; Auer, Sebastian; Ibanez-Tallon, Ines] Max Delbruck Ctr, Mol Neurobiol Grp, D-13125 Berlin, Germany; [Fontaine, Jean-Fred] Max Delbruck Ctr, Computat Biol & Data Min Grp, D-13125 Berlin, Germany; [Filkin, Sergey; Tsetlin, Victor] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Maskos, Uwe] Inst Pasteur, Dept Neurosci, Unite Neurobiol Integrat Syst Cholinerg, F-75724 Paris 15, France; [Pons, Stephanie; Maskos, Uwe] CNRS, URA2182, F-75724 Paris 15, France	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Ibanez-Tallon, I (corresponding author), Max Delbruck Ctr, Mol Neurobiol Grp, Robert Rossle Str 10, D-13125 Berlin, Germany.	ibanezi@mdc-berlin.de	Tsetlin, Victor/X-2491-2018; Fontaine, Jean-Fred/GNP-2904-2022; Filkin, Sergey/B-9991-2016	Fontaine, Jean-Fred/0000-0002-1101-4091; Filkin, Sergey/0000-0002-4710-6051; Antolin-Fontes, Beatriz/0000-0002-5724-0932; Slimak-Mastrobuoni, Marta/0000-0003-3203-2309	Helmholtz Association [31-002]; Sonderforschungsbereich [SFB 665]; Deutsche Forschungsgemeinschaft DFG [RA 424/5-1]; MCB RAS; RFBR	Helmholtz Association(Helmholtz Association); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); MCB RAS; RFBR(Russian Foundation for Basic Research (RFBR))	We thank J. Xing (Rockefeller University, New York, NY), S. Wojtke, B. Kampfrath, and J. Reiche (MDC, Germany) for technical support. We also thank J. Stitzel for mouse nAChR clones (University of Colorado, Boulder, CO); W. Kummer (University of Giessen, Germany), G. Lewin (MDC, Germany), C. Birchmeier (MDC, Germany) and M. Andrade (MDC, Germany) for helpful discussions; A. Garratt (MDC, Germany) for providing the SP antibody; and F. Rathjen (MDC, Germany) for the CD28 antibody. This work was supported by the Helmholtz Association 31-002, the Sonderforschungsbereich SFB 665, the Deutsche Forschungsgemeinschaft DFG RA 424/5-1, MCB RAS, and RFBR.	Amos CI, 2010, J NATL CANCER I, V102, P1199, DOI 10.1093/jnci/djq232; Amos CI, 2010, NAT GENET, V42, P366, DOI 10.1038/ng0510-366; Auer S, 2010, NAT METHODS, V7, P229, DOI [10.1038/NMETH.1425, 10.1038/nmeth.1425]; Bacher I, 2009, EXPERT OPIN PHARMACO, V10, P2709, DOI 10.1517/14656560903329102; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2010, TRENDS PHARMACOL SCI, V31, P46, DOI 10.1016/j.tips.2009.10.004; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Butt CM, 2005, BEHAV NEUROSCI, V119, P26, DOI 10.1037/0735-7044.119.1.26; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; De Biasi M, 2008, EXP BIOL MED, V233, P917, DOI 10.3181/0712-MR-355; DINELEYMILLER K, 1992, MOL BRAIN RES, V16, P339, DOI 10.1016/0169-328X(92)90244-6; Flora A, 2000, EUR J PHARMACOL, V393, P85, DOI 10.1016/S0014-2999(00)00040-6; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Medel YFF, 2007, J BIOL CHEM, V282, P19062, DOI 10.1074/jbc.M702354200; Gahring LC, 2010, J BIOL CHEM, V285, P26049, DOI 10.1074/jbc.M110.105346; Glatt AR, 2009, CHEM SENSES, V34, P27, DOI 10.1093/chemse/bjn049; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Kedmi M, 2004, PHYSIOL GENOMICS, V17, P221, DOI 10.1152/physiolgenomics.00202.2003; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lee Y, 2009, NEUROSCIENCE, V163, P222, DOI 10.1016/j.neuroscience.2009.05.057; Levitin F, 2008, J BIOL CHEM, V283, P16928, DOI 10.1074/jbc.M801454200; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Marks MJ, 2010, J MOL NEUROSCI, V40, P96, DOI 10.1007/s12031-009-9264-x; Maskos U, 2008, BRIT J PHARMACOL, V153, pS438, DOI 10.1038/bjp.2008.5; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MELISKA CJ, 1995, PHARMACOL BIOCHEM BE, V50, P619, DOI 10.1016/0091-3057(94)00354-8; Nashmi R, 2003, J NEUROSCI, V23, P11554; O'Dell LE, 2009, PHARMACOL BIOCHEM BE, V91, P481, DOI 10.1016/j.pbb.2008.12.011; PERRY DC, 1995, J PHARMACOL EXP THER, V275, P1030; Picciotto MR, 1998, DRUG ALCOHOL DEPEN, V51, P165, DOI 10.1016/S0376-8716(98)00074-X; Quick MW, 1999, NEUROPHARMACOLOGY, V38, P769, DOI 10.1016/S0028-3908(99)00024-6; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Rezvani K, 2010, J MOL NEUROSCI, V40, P177, DOI 10.1007/s12031-009-9272-x; Robinson SF, 1996, PSYCHOPHARMACOLOGY, V124, P332, DOI 10.1007/BF02247438; Rose JE, 2007, BIOCHEM PHARMACOL, V74, P1263, DOI 10.1016/j.bcp.2007.07.039; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Salas R, 2004, J NEUROSCI, V24, P10035, DOI 10.1523/JNEUROSCI.1939-04.2004; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Scofield MD, 2010, NEUROSCIENCE, V170, P1056, DOI 10.1016/j.neuroscience.2010.08.007; Sturzebecher AS, 2010, J PHYSIOL-LONDON, V588, P1695, DOI 10.1113/jphysiol.2010.187112; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Taraschenko OD, 2007, SYNAPSE, V61, P547, DOI 10.1002/syn.20396; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; WHITING PJ, 1988, J NEUROSCI, V8, P3395; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Xu XH, 2006, MOL CELL BIOL, V26, P5636, DOI 10.1128/MCB.00456-06; Yang KC, 2009, J PHYSIOL-LONDON, V587, P345, DOI 10.1113/jphysiol.2008.162743; Zoli M, 1998, J NEUROSCI, V18, P4461; ZOLI M, 1995, J NEUROSCI, V15, P1912, DOI 10.1523/JNEUROSCI.15-03-01912.1995	60	213	216	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 12	2011	70	3					522	535		10.1016/j.neuron.2011.04.013	http://dx.doi.org/10.1016/j.neuron.2011.04.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555077	Bronze, Green Accepted			2022-12-24	WOS:000290926100013
J	Berg, DA; Kirkham, M; Wang, H; Frisen, J; Simon, A				Berg, Daniel A.; Kirkham, Matthew; Wang, Heng; Frisen, Jonas; Simon, Andras			Dopamine Controls Neurogenesis in the Adult Salamander Midbrain in Homeostasis and during Regeneration of Dopamine Neurons	CELL STEM CELL			English	Article							SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; SUBVENTRICULAR ZONE; CELL-PROLIFERATION; TAIL REGENERATION; SPINAL-CORD; STEM-CELLS; IN-VIVO; PROGENITORS; ACTIVATION	Appropriate termination of regenerative processes is critical for producing the correct number of cells in tissues. Here we provide evidence for an end-product inhibition of dopamine neuron regeneration that is mediated by dopamine. Ablation of midbrain dopamine neurons leads to complete regeneration in salamanders. Regeneration involves extensive neurogenesis and requires activation of quiescent ependymoglia cells, which express dopamine receptors. Pharmacological compensation for dopamine loss by L-dopa inhibits ependymoglia proliferation and regeneration in a dopamine receptor-signaling-dependent manner, specifically after ablation of dopamine neurons. Systemic administration of the dopamine receptor antagonist haloperidol alone causes ependymoglia proliferation and the appearance of excessive number of neurons. Our data show that stem cell quiescence is under dopamine control and provide a model for termination once normal homeostasis is restored. The findings establish a role for dopamine in the reversible suppression of neurogenesis in the midbrain and have implications for regenerative strategies in Parkinson's disease.	[Berg, Daniel A.; Kirkham, Matthew; Wang, Heng; Frisen, Jonas; Simon, Andras] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Berg, Daniel A.; Kirkham, Matthew; Wang, Heng; Frisen, Jonas; Simon, Andras] Karolinska Inst, Ctr Dev Biol Regenerat Med DBRM, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Simon, A (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	andras.simon@ki.se	Kirkham, Matthew/I-5458-2012	Berg, Daniel/0000-0001-9595-2052; Simon, Andras/0000-0002-1018-1891; Kirkham, Matthew/0000-0003-0920-5355	Karolinska Institute, Swedish Research Council, Parkinsonfonden, Cancerfonden; AFA Forsakringar; HFSPO; Wenner-Gren Foundation	Karolinska Institute, Swedish Research Council, Parkinsonfonden, Cancerfonden(Karolinska InstitutetSwedish Research CouncilSwedish Cancer Society); AFA Forsakringar; HFSPO(Human Frontier Science Program); Wenner-Gren Foundation	We thank E. Arenas, J. Ericson, U. Lendahl, and T. Perlmann for critical reading of the manuscript. This work was supported by the Karolinska Institute, Swedish Research Council, Parkinsonfonden, Cancerfonden to A.S. and AFA Forsakringar to A.S. and J.F. M.K. was supported by a HFSPO long-term postdoctoral fellowship and H.W. was supported by a postdoctoral fellowship from the Wenner-Gren Foundation.	Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Benraiss A, 1996, DEV DYNAM, V205, P135, DOI 10.1002/(SICI)1097-0177(199602)205:2<135::AID-AJA5>3.0.CO;2-J; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Brockes J, 2005, CURR BIOL, V15, pR42, DOI 10.1016/j.cub.2004.12.049; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Carlsson T, 2007, CURR GENE THER, V7, P109, DOI 10.2174/156652307780363125; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Gonzalez A., 1994, P77; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lazzari M, 1997, J BRAIN RES, V38, P187; Lie DC, 2002, J NEUROSCI, V22, P6639; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; OBOYLE KM, 1987, J NEUROCHEM, V48, P1039, DOI 10.1111/j.1471-4159.1987.tb05623.x; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Rinner WA, 1997, NEUROSCIENCE, V79, P535, DOI 10.1016/S0306-4522(96)00687-2; Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	32	62	64	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					426	433		10.1016/j.stem.2011.02.001	http://dx.doi.org/10.1016/j.stem.2011.02.001			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474106	Bronze			2022-12-24	WOS:000289707100014
J	Mameli, M; Bellone, C; Brown, MTC; Luscher, C				Mameli, Manuel; Bellone, Camilla; Brown, Matthew T. C.; Luescher, Christian			Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DOPAMINE NEURONS; AMPA RECEPTORS; IN-VIVO; PERSISTENCE	The manner in which drug-evoked synaptic plasticity affects reward circuits remains largely elusive. We found that cocaine reduced NMDA receptor excitatory postsynaptic currents and inserted GluA2-lacking AMPA receptors in dopamine neurons of mice. Consequently, a stimulation protocol pairing glutamate release with hyperpolarizing current injections further strengthened synapses after cocaine treatment. Our data suggest that early cocaine-evoked plasticity in the ventral tegmental area inverts the rules for activity-dependent plasticity, eventually leading to addictive behavior.	[Mameli, Manuel; Bellone, Camilla; Brown, Matthew T. C.; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland; [Mameli, Manuel] UPMC, INSERM, Inst Fer Moulin, UMR S 839, Paris, France; [Luescher, Christian] Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, Geneva, Switzerland	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; bellone, camilla/0000-0002-6774-6275; Brown, Matthew/0000-0001-6983-962X; Mameli, Manuel/0000-0002-0570-6964	Swiss National Science Foundation; Systems X initiative of the Swiss Confederation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Systems X initiative of the Swiss Confederation	We thank the members of the Luscher laboratory as well as M. Frerking and A. Holtmaat for comments on the manuscript and B. Cerutti for help with the statistical analysis. This work is supported by the Swiss National Science Foundation (C.L.), the Systems X initiative of the Swiss Confederation (NeuroChoice, C.L.).	Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bowers MS, 2010, NEURON, V67, P11, DOI 10.1016/j.neuron.2010.06.004; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Kullmann DM, 1999, PHILOS T ROY SOC B, V354, P395, DOI 10.1098/rstb.1999.0392; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lane DA, 2010, NEUROSCIENCE, V169, P559, DOI 10.1016/j.neuroscience.2010.05.056; Luu P, 2008, J NEUROPHYSIOL, V100, P533, DOI 10.1152/jn.01384.2007; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wang HX, 2010, J PHYSIOL-LONDON, V588, P2823, DOI 10.1113/jphysiol.2010.187591	15	127	130	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					414	416		10.1038/nn.2763	http://dx.doi.org/10.1038/nn.2763			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21336270				2022-12-24	WOS:000288849400008
J	Pacary, E; Heng, JL; Azzarelli, R; Riou, P; Castro, D; Lebel-Potter, M; Parras, C; Bell, DM; Ridley, AJ; Parsons, M; Guillemot, F				Pacary, Emilie; Heng, Julian; Azzarelli, Roberta; Riou, Philippe; Castro, Diogo; Lebel-Potter, Melanie; Parras, Carlos; Bell, Donald M.; Ridley, Anne J.; Parsons, Maddy; Guillemot, Francois			Proneural Transcription Factors Regulate Different Steps of Cortical Neuron Migration through Rnd-Mediated Inhibition of RhoA Signaling	NEURON			English	Article							CELL-MIGRATION; IN-VIVO; RADIAL MIGRATION; FAMILY GTPASE; ROCK-I; BINDING; BHLH; NEUROGENIN; OUTGROWTH; PHOSPHORYLATION	Little is known of the intracellular machinery that controls the motility of newborn neurons. We have previously shown that this proneural protein Neurog2 promotes the migration of nascent cortical neurons by inducing the expression of the atypical Rho GTPase Rnd2. Here, we show that another proneural factor, Ascl1, promotes neuronal migration in the cortex through direct regulation of a second Rnd family member, Rnd3. Both Rnd2 and Rnd3 promote neuronal migration by inhibiting RhoA signaling, but they control distinct steps of the migratory process, multipolar to bipolar transition in the intermediate zone and locomotion in the cortical plate, respectively. Interestingly, these divergent functions directly result from the distinct subcellular distributions of the two Rnd proteins. Because Rnd proteins also regulate progenitor divisions and neurite outgrowth, we propose that proneural factors, through spatiotemporal regulation of Rnd proteins, integrate the process of neuronal migration with other events in the neurogenic program.	[Pacary, Emilie; Heng, Julian; Azzarelli, Roberta; Castro, Diogo; Lebel-Potter, Melanie; Parras, Carlos; Guillemot, Francois] MRC Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England; [Riou, Philippe; Ridley, Anne J.; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Bell, Donald M.] Natl Inst Med Res, Confocal & Image Anal Lab, London NW7 1AA, England	MRC National Institute for Medical Research; University of London; King's College London; MRC National Institute for Medical Research	Guillemot, F (corresponding author), MRC Natl Inst Med Res, Div Mol Neurobiol, Mill Hill, London NW7 1AA, England.	fguille@nimr.mrc.ac.uk	Parsons, Maddy/B-2203-2013; Guillemot, Francois/AAV-1482-2021; Castro, Diogo S/I-6217-2016; Parras, Carlos/G-6611-2017; Pacary, Emilie/N-6994-2017	Parsons, Maddy/0000-0002-2021-8379; Castro, Diogo S/0000-0001-8178-9565; Parras, Carlos/0000-0003-0248-1752; Bell, Donald/0000-0002-3788-1580; Pacary, Emilie/0000-0002-7316-4546; Heng, Julian Ik-Tsen/0000-0002-0378-7078; Azzarelli, Roberta/0000-0002-8160-7538; Ridley, Anne/0000-0001-8186-5708	Federation of European Biochemical Societies (FEBS); Medical Research Council (MAC); Australian CJ Martin Fellowship [310616]; Medical Research Council [U117570528]; Wellcome Trust [086947/Z/08/Z]; King's College London; Royal Society; BBSRC [BB/E004083/2]; BBSRC [BB/E004083/1] Funding Source: UKRI; MRC [MC_U117570528] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E004083/2, BB/E004083/1] Funding Source: researchfish; Medical Research Council [MC_U117570528] Funding Source: researchfish	Federation of European Biochemical Societies (FEBS); Medical Research Council (MAC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); King's College London(General Electric); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Sophie Wood for expert technical assistance in generating transgenic embryos, Hendrik Wildner and Molly Strom for help with cloning, and Matthew Hannah for advice on markers of subcellular compartments. We thank members of the Guillemot laboratory for suggestions and comments on the manuscript, William M. Bement, Chu-Xia Deng, Iryna M. Ethell, Mary E. Hatten, Steen Hansen, Michiyuki Matsuda, and Mathieu Vermeren for providing the constructs EGFP-UTRCH-ABD, pBS/UE-ploxPneo, pcDNA-co-filin<SUP>S3A</SUP>, pCIG2-Centrin2-Venus, pCMV-Myc-Delta p190B, FRET probes (pRai-chu1298x and pRaichu1293x), and pCA-b-EGFPm5 silencer3, respectively. E.P. was supported by a long-term Federation of European Biochemical Societies (FEBS) fellowship and a Medical Research Council (MAC) career development fellowship, J.H. by an Australian CJ Martin Fellowship (ID:310616), R.A. by an MRC studentship, D.C. by a MRC career development fellowship, P.R. in part by a Wellcome Trust V.I.P. award from King's College London, and M.P. by a Royal Society University Research Fellowship. This work was supported by a project grant from the Wellcome Trust (086947/Z/08/Z), by a Grant-in-Aid from the Medical Research Council to F.G. (U117570528), and by a project grant from the BBSRC (BB/E004083/2) to A.J.R.	Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Cau E, 1997, DEVELOPMENT, V124, P1611; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chedotal A, 2009, CURR OPIN NEUROBIOL, V19, P139, DOI 10.1016/j.conb.2009.04.005; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hirschberg A, 2010, MOL CELL BIOL, V30, P764, DOI 10.1128/MCB.01458-09; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201; Komander D, 2008, EMBO J, V27, P3175, DOI 10.1038/emboj.2008.226; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McManus MF, 2005, J CHILD NEUROL, V20, P280, DOI 10.1177/08830738050200040301; Nakamura K, 2006, NEUROSCI RES, V54, P149, DOI 10.1016/j.neures.2005.10.008; Nakamura T, 2005, METHODS, V37, P146, DOI 10.1016/j.ymeth.2005.05.021; Negishi M, 2005, NEUROSCIENTIST, V11, P187, DOI 10.1177/1073858404268768; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Nobrega-Pereira S, 2009, CEREB CORTEX, V19, pI107, DOI 10.1093/cercor/bhp044; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Sobeih MM, 2002, INT J DEV NEUROSCI, V20, P349, DOI 10.1016/S0736-5748(02)00040-0; Talens-Visconti R, 2010, J NEUROCHEM, V112, P1074, DOI 10.1111/j.1471-4159.2009.06526.x; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Tanaka H, 2002, BIOCHEM J, V365, P349, DOI 10.1042/BJ20020062; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4	67	157	157	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1069	1084		10.1016/j.neuron.2011.02.018	http://dx.doi.org/10.1016/j.neuron.2011.02.018			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435554	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000288886900006
J	Ha, NN; Byers, B; Cord, B; Shcheglovitov, A; Byrne, J; Gujar, P; Kee, K; Schule, B; Dolmetsch, RE; Langston, W; Palmer, TD; Pera, RR				Ha Nam Nguyen; Byers, Blake; Cord, Branden; Shcheglovitov, Aleksandr; Byrne, James; Gujar, Prachi; Kee, Kehkooi; Schuele, Birgitt; Dolmetsch, Ricardo E.; Langston, William; Palmer, Theo D.; Pera, Renee Reijo			LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; MIDBRAIN DOPAMINERGIC-NEURONS; LEWY-BODY-DISEASE; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; ALZHEIMERS-DISEASE; HUMAN FIBROBLASTS; KINASE-ACTIVITY; ANIMAL-MODELS	Studies of Parkinson's disease (PD) have been hindered by lack of access to affected human dopaminergic (DA) neurons. Here, we report generation of induced pluripotent stem cells that carry the p.G2019S mutation (G2019S-iPSCs) in the Leucine-Rich Repeat Kinase-2 (LRRK2) gene, the most common PD-related mutation, and their differentiation into DA neurons. The high penetrance of the LRRK2 mutation and its clinical resemblance to sporadic PD suggest that these cells could provide a valuable platform for disease analysis and drug development. We found that DA neurons derived from G2019S-iPSCs showed increased expression of key oxidative stress-response genes and alpha-synuclein protein. The mutant neurons were also more sensitive to caspase-3 activation and cell death caused by exposure to stress agents, such as hydrogen peroxide, MG-132, and 6-hydroxydopamine, than control DA neurons. This enhanced stress sensitivity is consistent with existing understanding of early PD phenotypes and represents a potential therapeutic target.	[Ha Nam Nguyen; Byers, Blake; Cord, Branden; Byrne, James; Gujar, Prachi; Kee, Kehkooi; Palmer, Theo D.; Pera, Renee Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Ha Nam Nguyen; Byers, Blake; Byrne, James; Gujar, Prachi; Kee, Kehkooi; Pera, Renee Reijo] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Byers, Blake; Palmer, Theo D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Cord, Branden] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Shcheglovitov, Aleksandr; Dolmetsch, Ricardo E.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Schuele, Birgitt; Langston, William] Parkinsons Inst & Clin Ctr, Sunnyvale, CA 94085 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Palmer, TD (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	tpalmer@stanford.edu; reneer@stanford.edu	Palmer, Theo/GSI-6635-2022	Schuele, Birgitt/0000-0002-9952-5776; KEE, KEHKOOI/0000-0001-6926-7203; Cord, Branden/0000-0002-9120-5989; Palmer, Theo/0000-0002-6266-1862	CIRM [RL1-00670-1, CL-00518-1, TG2-01159]; Blume Foundation; Kinetics Foundation; Parkinson's Alliance; Stanford Institute for Stem Cell Biology and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); Blume Foundation; Kinetics Foundation; Parkinson's Alliance; Stanford Institute for Stem Cell Biology and Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Reijo Pera Lab for their helpful suggestions and feedback and Matha Isla and Ian Irwin for HPLC analysis of dopamine release studies. This research was supported by funds from CIRM (RL1-00670-1 and CL-00518-1, RRP, TG2-01159, A.S.), the Blume Foundation (T.D.P. and B.S.), Kinetics Foundation (T.D.P.), Parkinson's Alliance (J.W.L. and B.S.), Stanford Institute for Stem Cell Biology and Regenerative Medicine (R.R.P.), and a generous donor (T.D.P. and R.R.P.).	Baba M, 1998, AM J PATHOL, V152, P879; Bayer TA, 1999, NEUROSCI LETT, V266, P213, DOI 10.1016/S0304-3940(99)00311-0; Berretta N, 2005, NEUROTOXICOLOGY, V26, P869, DOI 10.1016/j.neuro.2005.01.014; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Byrne JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007118; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Han BS, 2008, NEUROSCI LETT, V442, P190, DOI 10.1016/j.neulet.2008.06.086; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Heo HY, 2010, EXP CELL RES, V316, P649, DOI 10.1016/j.yexcr.2009.09.014; Hernandez D, 2005, NEUROSCI LETT, V389, P137, DOI 10.1016/j.neulet.2005.07.044; Ichinose H, 1999, GENE, V230, P233, DOI 10.1016/S0378-1119(99)00065-7; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Milosevic J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-25; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Paisan-Ruiz C, 2005, NEUROLOGY, V65, P696, DOI 10.1212/01.WNL.0000167552.79769.b3; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; Schule B, 2009, BBA-MOL BASIS DIS, V1792, P1043, DOI 10.1016/j.bbadis.2009.08.014; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102	44	542	565	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					267	280		10.1016/j.stem.2011.01.013	http://dx.doi.org/10.1016/j.stem.2011.01.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362567	Green Accepted, Bronze			2022-12-24	WOS:000288404400009
J	Anastassiou, CA; Perin, R; Markram, H; Koch, C				Anastassiou, Costas A.; Perin, Rodrigo; Markram, Henry; Koch, Christof			Ephaptic coupling of cortical neurons	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; APPLIED ELECTRIC-FIELDS; THETA OSCILLATIONS; IN-VIVO; SINGLE NEURONS; FREQUENCY; MODULATION; NETWORK; SYNCHRONIZATION; INFORMATION	The electrochemical processes that underlie neural function manifest themselves in ceaseless spatiotemporal field fluctuations. However, extracellular fields feed back onto the electric potential across the neuronal membrane via ephaptic coupling, independent of synapses. The extent to which such ephaptic coupling alters the functioning of neurons under physiological conditions remains unclear. To address this question, we stimulated and recorded from rat cortical pyramidal neurons in slices with a 12-electrode setup. We found that extracellular fields induced ephaptically mediated changes in the somatic membrane potential that were less than 0.5 mV under subthreshold conditions. Despite their small size, these fields could strongly entrain action potentials, particularly for slow (<8 Hz) fluctuations of the extracellular field. Finally, we simultaneously measured from up to four patched neurons located proximally to each other. Our findings indicate that endogenous brain activity can causally affect neural function through field effects under physiological conditions.	[Anastassiou, Costas A.; Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Anastassiou, Costas A.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Perin, Rodrigo; Markram, Henry] Ecole Polytech Fed Lausanne, Lab Neural Microcircuitry, CH-1015 Lausanne, Switzerland; [Koch, Christof] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	California Institute of Technology; Imperial College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Korea University	Anastassiou, CA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	costas@caltech.edu	Perin, Rodrigo/G-7691-2015	Perin, Rodrigo/0000-0001-5756-3769; Koch, Christof/0000-0001-6482-8067	Engineering Physical Sciences Research Council; Sloan-Swartz Foundation; Swiss National Science Foundation; EU Synapse; National Science Foundation; Mathers Foundation; Ministry of Education, Science and Technology [R31-10008]	Engineering Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Sloan-Swartz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU Synapse; National Science Foundation(National Science Foundation (NSF)); Mathers Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank G. Buzsaki, U. Rutishauser and E. Schomburg for comments and discussions and J. Bastiaansen for assistance. This work was funded by the Engineering Physical Sciences Research Council (C.A.A.), the Sloan-Swartz Foundation (C.A.A.), the Swiss National Science Foundation (C.A.A.), EU Synapse (R.P.), the National Science Foundation (C.K. and C.A.A.), the Mathers Foundation (C.K. and C.A.A.) and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-10008, C.K.).	Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; Arvanitaki A, 1942, J NEUROPHYSIOL, V5, P89, DOI 10.1152/jn.1942.5.2.89; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Jacobson GA, 2005, J PHYSIOL-LONDON, V564, P145, DOI 10.1113/jphysiol.2004.080903; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Koch Christof, 1999, P1; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Mann EO, 2010, NEURON, V67, P3, DOI 10.1016/j.neuron.2010.06.036; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Milstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004338; Montoro RJ, 2004, BRAIN RES REV, V47, P216, DOI 10.1016/j.brainresrev.2004.06.009; NOEBELS JL, 1978, J NEUROPHYSIOL, V41, P1267, DOI 10.1152/jn.1978.41.5.1267; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pettersen KH, 2008, BIOPHYS J, V94, P784, DOI 10.1529/biophysj.107.111179; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 2008, DENDRITES; Tabareau N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000637; TRAUB RD, 1985, NEUROSCIENCE, V14, P1033, DOI 10.1016/0306-4522(85)90274-X; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Weiss SA, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00015; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; YLINEN A, 1995, J NEUROSCI, V15, P30	50	306	311	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					217	U304		10.1038/nn.2727	http://dx.doi.org/10.1038/nn.2727			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21240273				2022-12-24	WOS:000286595400019
J	Assisi, C; Stopfer, M; Bazhenov, M				Assisi, Collins; Stopfer, Mark; Bazhenov, Maxim			Using the Structure of Inhibitory Networks to Unravel Mechanisms of Spatiotemporal Patterning	NEURON			English	Article							OSCILLATING NEURAL ASSEMBLIES; LOCUST ANTENNAL LOBE; COMPLEX NETWORKS; FEEDFORWARD INHIBITION; OLFACTORY NETWORK; NEURONAL NETWORKS; FIRING PATTERNS; MUSHROOM BODY; SYNCHRONIZATION; DYNAMICS	Neuronal networks exhibit a rich dynamical repertoire, a consequence of both the intrinsic properties of neurons and the structure of the network. It has been hypothesized that inhibitory interneurons corral principal neurons into transiently synchronous ensembles that encode sensory information and subserve behavior. How does the structure of the inhibitory network facilitate such spatiotemporal patterning? We established a relationship between an important structural property of a network, its colorings, and the dynamics it constrains. Using a model of the insect antennal lobe, we show that our description allows the explicit identification of the groups of inhibitory interneurons that switch, during odor stimulation, between activity and quiescence in a coordinated manner determined by features of the network structure. This description optimally matches the perspective of the downstream neurons looking for synchrony in ensembles of presynaptic cells and allows a low-dimensional description of seemingly complex high-dimensional network activity.	[Assisi, Collins; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Stopfer, Mark] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA	University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Assisi, C (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	collinsa@ucr.edu	Assisi, Collins/R-7467-2016	Assisi, Collins/0000-0003-0108-582X; Stopfer, Mark/0000-0001-9200-1884	US National Institute of Deafness and other Communication Disorders; US National Institute of Neurological Disorders and Stroke; US National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011422, R01DC006306] Funding Source: NIH RePORTER	US National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the US National Institute of Deafness and other Communication Disorders (C.A. and M.B.), the US National Institute of Neurological Disorders and Stroke (M.B.) and a US National Institute of Child Health and Human Development intramural award (M.S.). The authors would like to thank Professor Gilles Laurent for many stimulating discussions and insightful suggestions and Stacey Brown Daffron for providing examples of recordings from LNs made in vivo. C.A and M.B. would also like to thank Professor Terrence Sejnowski and members of the Computational Neurobiology Laboratory at the Salk Institute for Biological Studies for hospitality and a number of fruitful discussions. C.A. would like to thank Dr. Suhita Nadkarni for discussions and comments about the manuscript.	ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Ahn S, 2010, PHYSICA D, V239, P515, DOI 10.1016/j.physd.2009.12.011; APPEL K, 1977, SCI AM, V237, P108, DOI 10.1038/scientificamerican1077-108; Appel Kenneth, 1989, CONT MATH, V98; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Assisi CG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018106; Assisi C, 2007, NAT NEUROSCI, V10, P1176, DOI 10.1038/nn1947; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2010, NEURON, V67, P357, DOI 10.1016/j.neuron.2010.07.023; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Biggs N, 1986, GRAPH THEORY 1736 19; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; BOUYER JJ, 1987, NEUROSCIENCE, V22, P863, DOI 10.1016/0306-4522(87)92965-4; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; ERMENTROUT B, 1992, NEURAL NETWORKS, V5, P415, DOI 10.1016/0893-6080(92)90004-3; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Herzberg A.M., 2007, NOT AM MATH SOC, V54, P708; HODGKIN AL, 1990, B MATH BIOL, V52, P25, DOI 10.1007/BF02459568; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; Ito I, 2009, NEURON, V64, P692, DOI 10.1016/j.neuron.2009.10.004; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; KLEINFELD D, 1990, BIOPHYS J, V57, P697, DOI 10.1016/S0006-3495(90)82591-1; Kubale M., 2004, CONT MATH, V352; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; LAURENT G, 1993, J NEUROPHYSIOL, V69, P1484, DOI 10.1152/jn.1993.69.5.1484; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leitch B, 1996, J COMP NEUROL, V372, P487; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; McCormick D, 2004, SYNAPTIC ORG BRAIN; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Pecora LM, 1998, PHYS REV LETT, V80, P2109, DOI 10.1103/PhysRevLett.80.2109; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Shilnikov A, 2008, CHAOS, V18, DOI 10.1063/1.2959850; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Sloper J J, 1979, Philos Trans R Soc Lond B Biol Sci, V285, P124; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; Traub R.D., 1991, NEURONAL NETWORKS HI; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	71	27	27	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 27	2011	69	2					373	386		10.1016/j.neuron.2010.12.019	http://dx.doi.org/10.1016/j.neuron.2010.12.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262473	Bronze, Green Accepted			2022-12-24	WOS:000286792900018
J	Golde, TE; Schneider, LS; Koo, EH				Golde, Todd E.; Schneider, Lon S.; Koo, Edward H.			Anti-A beta Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift	NEURON			English	Article							MILD COGNITIVE IMPAIRMENT; RANDOMIZED CONTROLLED-TRIAL; MRC/BHF HEART PROTECTION; PLACEBO-CONTROLLED TRIAL; HIGH-RISK INDIVIDUALS; PREVENTION TRIAL; APOLIPOPROTEIN-E; TRANSGENIC MICE; BIOMARKER SIGNATURE; GINKGO-BILOBA	Most current Alzheimer's disease (AD) therapies in advanced phases of development target amyloid beta-peptide (A beta) production, aggregation, or accumulation. Translational models suggest that anti-A beta therapies may be highly effective if tested as agents to prevent or delay development of the disease or as therapies for asymptomatic patients with very early signs of AD pathology. However, anti-A beta therapeutics are currently being tested in symptomatic patients where they are likely to be much less effective or ineffective. The lack of alignment between human clinical studies and preclinical studies, together with predictions about optimal trial design based on our understanding of the initiating role of A beta aggregates in AD, has created a treatment versus prevention dilemma. In this perspective, we discuss why it is imperative to resolve this dilemma and suggest ways for moving forward in the hopes of enhancing the development of truly effective AD therapeutics.	[Golde, Todd E.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Golde, Todd E.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Southern California; University of Southern California; University of California System; University of California San Diego	Golde, TE (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, 1275 Ctr Dr,BMS J-483,POB 100159, Gainesville, FL 32610 USA.	tgolde@mbi.ufl.edu; lschneid@usc.edu; edkoo@ucsd.edu			National Institutes of Health [AG05142]; University of Southern California Alzheimer's Disease Research Center; Myriad Genetics; Lundbeck Inc.; Elan Pharmaceuticals; Sonexa Therapeutics; Kareus Therapeutics; Alzheimer's Association; AstraZeneca Pharmaceuticals; Baxter International Inc.; Johnson Johnson Inc.; Eli Lilly and Company; Myriad Pharmaceuticals Inc.; Novartis Pharmaceuticals Corporation; Pfizer Incorporated; Wyeth; Takeda Pharmaceutical Company Ltd.; Abbott Laboratories; AC Immune; GlaxoSmithKline; Ipsen Group; H. Lundbeck A/S; Merck Co Inc.; F. Hoffman-La Roche Ltd.; Sanofi-aventis LLC; Servier Laboratories; Schwabe Pharmaceuticals; Toyama Pharmaceutical Co. Ltd.; Transition Therapeutics Inc.;  [AG020206]; NATIONAL INSTITUTE ON AGING [R01AG018454, P50AG005142, P01AG020206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Alzheimer's Disease Research Center; Myriad Genetics; Lundbeck Inc.(Lundbeck Corporation); Elan Pharmaceuticals; Sonexa Therapeutics; Kareus Therapeutics; Alzheimer's Association(Alzheimer's Association); AstraZeneca Pharmaceuticals(AstraZeneca); Baxter International Inc.; Johnson Johnson Inc.(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Company(Eli Lilly); Myriad Pharmaceuticals Inc.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Incorporated; Wyeth(Wyeth); Takeda Pharmaceutical Company Ltd.(Takeda Pharmaceutical Company Ltd); Abbott Laboratories(Abbott Laboratories); AC Immune; GlaxoSmithKline(GlaxoSmithKline); Ipsen Group(Ipsen); H. Lundbeck A/S; Merck Co Inc.(Merck & Company); F. Hoffman-La Roche Ltd.; Sanofi-aventis LLC; Servier Laboratories; Schwabe Pharmaceuticals; Toyama Pharmaceutical Co. Ltd.; Transition Therapeutics Inc.; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in part, by the National Institutes of Health Grant AG05142, the University of Southern California Alzheimer's Disease Research Center (L.S.S.), and AG020206 (E.H.K., T.E.G.). E.H.K. and T.E.G. are inventors on several patents relating to AD therapeutics. E.H.K. has served as a consultant for Pfizer Inc. (including Wyeth Research) and GlaxoSmithKline. T.E.G. has received support for research form Myriad Genetics and Lundbeck Inc. T.E.G. has received consulting fees from Elan Pharmaceuticals, Lundbeck Inc., Sonexa Therapeutics, and Kareus Therapeutics. L.S.S. is an editor for the Cochrane Dementia and Cognitive Improvement Group, which oversees systematic reviews of medications for cognitive impairment and dementia; has received a grant from the Alzheimer's Association for a registry for dementia and cognitive impairment trials and grant or research support from AstraZeneca Pharmaceuticals, Baxter International Inc., Elan Pharmaceuticals, Johnson & Johnson Inc., Eli Lilly and Company, Myriad Pharmaceuticals Inc., Novartis Pharmaceuticals Corporation, Pfizer Incorporated (including Wyeth), and Takeda Pharmaceutical Company Ltd.; has served as a consultant for or received consulting fees from Abbott Laboratories, AC Immune, AstraZeneca Pharmaceuticals, Elan Pharmaceuticals, Eli Lilly and Company, GlaxoSmithKline, Ipsen Group, Johnson & Johnson Inc., H. Lundbeck A/S, Myriad Pharmaceuticals Inc., Merck & Co Inc., Novartis Pharmaceuticals Corporation, F. Hoffman-La Roche Ltd., Sanofi-aventis LLC, Servier Laboratories, Schwabe Pharmaceuticals, Toyama Pharmaceutical Co. Ltd., and Transition Therapeutics Inc.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; [Anonymous], 2010, WORLD ALZHEIMER REPO; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2006, ALZ DIS ASSOC DIS, V20, pS63, DOI 10.1097/00002093-200607001-00009; Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1602/neurorx.1.2.213; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Craig MC, 2005, LANCET NEUROL, V4, P190, DOI 10.1016/S1474-4422(05)01016-1; Cummings JL, 1998, NEUROLOGY, V51, pS1, DOI 10.1212/WNL.51.1_Suppl_1.S1; Das P, 2001, NEUROBIOL AGING, V22, P721, DOI 10.1016/S0197-4580(01)00245-7; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Ghiso J, 2006, BRAIN PATHOL, V16, P71; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Golde TE, 2005, BRAIN PATHOL, V15, P84, DOI 10.1111/j.1750-3639.2005.tb00104.x; Golde TE, 2010, EXP NEUROL, V223, P252, DOI 10.1016/j.expneurol.2009.07.035; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Grady D, 2002, AM J MED, V113, P543, DOI 10.1016/S0002-9343(02)01270-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jones RW, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt49; Katz Russell, 2004, NeuroRx, V1, P189, DOI 10.1602/neurorx.1.2.189; Kryscio RJ, 2004, STAT MED, V23, P285, DOI 10.1002/sim.1716; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; Martin BK, 2002, CONTROL CLIN TRIALS, V23, P93, DOI 10.1016/S0197-2456(01)00189-1; Meinert CL, 2009, ALZHEIMERS DEMENT, V5, P93, DOI 10.1016/j.jalz.2008.09.004; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raschetti R, 2007, PLOS MED, V4, P1818, DOI 10.1371/journal.pmed.0040338; Reiman EM, 2010, BIOMARK MED, V4, P3, DOI [10.2217/bmm.09.91, 10.2217/BMM.09.91]; Romas SN, 1999, NEUROLOGY, V53, P517, DOI 10.1212/WNL.53.3.517; Roses AD, 1997, ARCH NEUROL-CHICAGO, V54, P1226, DOI 10.1001/archneur.1997.00550220036011; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Salloway S, 2008, ALZHEIMERS DEMENT, V4, P65, DOI 10.1016/j.jalz.2007.10.001; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Schneider LS, 2009, ALZHEIMERS DEMENT, V5, P388, DOI 10.1016/j.jalz.2009.07.038; SCHNEIDER LS, 2011, ARCH NEUROL IN PRESS; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shepherd C, 2009, ACTA NEUROPATHOL, V118, P37, DOI 10.1007/s00401-009-0521-4; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663, DOI 10.1001/jama.2009.1913; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Vellas B, 2006, NEUROLOGY, V67, pS1, DOI 10.1212/WNL.67.9_suppl_3.S1; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	68	284	293	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 27	2011	69	2					203	213		10.1016/j.neuron.2011.01.002	http://dx.doi.org/10.1016/j.neuron.2011.01.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262461	Green Accepted, Bronze			2022-12-24	WOS:000286792900006
J	Takahashi, H; Arstikaitis, P; Prasad, T; Bartlett, TE; Wang, YT; Murphy, TH; Craig, AM				Takahashi, Hideto; Arstikaitis, Pamela; Prasad, Tuhina; Bartlett, Thomas E.; Wang, Yu Tian; Murphy, Timothy H.; Craig, Ann Marie			Postsynaptic TrkC and Presynaptic PTP sigma Function as a Bidirectional Excitatory Synaptic Organizing Complex	NEURON			English	Article							TYROSINE-PHOSPHATASE-SIGMA; IMMUNOGLOBULIN-LIKE DOMAIN; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIN RECEPTORS; TRANSGENIC MICE; PDZ DOMAINS; NTRK3 GENE; IN-VIVO; NEUROLIGINS; LAR	Neurotrophin receptor tyrosine kinases (Trks) have well-defined trophic roles in nervous system development through kinase activation by neurotrophins. Yet Trks have typical cell-adhesion domains and express noncatalytic isoforms, suggesting additional functions. Here we discovered noncatalytic TrkC in an unbiased hippocampal neuron-fibroblast coculture screen for proteins that trigger differentiation of neurotransmitter release sites in axons. All TrkC isoforms, but not TrkA or TrkB, function directly in excitatory glutamatergic synaptic adhesion by neurotrophin-independent high-affinity trans binding to axonal protein tyrosine phosphatase receptor PTP sigma. PTP sigma triggers and TrkC mediates clustering of postsynaptic molecules in dendrites, indicating bidirectional synaptic organizing functions. Effects of a TrkC-neutralizing antibody that blocks TrkC-PTP sigma interaction and TrkC knockdown in culture and in vivo reveal essential roles of TrkC-PTP sigma in glutamatergic synapse formation. Thus, postsynaptic TrkC trans interaction with presynaptic PTP sigma generates bidirectional adhesion and recruitment essential for excitatory synapse development and positions these signaling molecules at the center of synaptic pathways.	[Takahashi, Hideto; Arstikaitis, Pamela; Prasad, Tuhina; Bartlett, Thomas E.; Wang, Yu Tian; Murphy, Timothy H.; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Takahashi, Hideto; Arstikaitis, Pamela; Prasad, Tuhina; Murphy, Timothy H.; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Bartlett, Thomas E.; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Craig, AM (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada.	amcraig@interchange.ubc.ca	Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008; Takahashi, Hideto/T-2650-2018; Murphy, Timothy/AAW-1975-2021; Craig, Ann Marie/M-2054-2014; Murphy, Timothy H/I-4982-2014	Takahashi, Hideto/0000-0002-6473-5060; Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490	National Institutes of Health [MH070860]; CIHR [MOP-84241, MOP-12675]; Canada Research Chair; Michael Smith Foundation for Health Research; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Michael Linhoff for his cDNA expression library and screening method, Dr. Daisaku Yokomaku for advice and technical assistance, and Xiling Zhou for excellent preparation of neuron cultures. We thank Dr. Robert Holt and team at the Michael Smith Genome Sciences Centre for arraying the cDNA subpool and preparing DNA in 384 well format. P. A. would like to thank Dr. Hillel Adesnik for his help in learning the in utero electroporation technique. This work was supported by National Institutes of Health MH070860, CIHR MOP-84241, Canada Research Chair and Michael Smith Foundation for Health Research salary awards to A.M.C., CIHR MOP-12675 to T.H.M., and by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad to H.T.	Alonso P, 2008, GENES BRAIN BEHAV, V7, P778, DOI 10.1111/j.1601-183X.2008.00418.x; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Armengol L, 2002, MOL PSYCHIATR, V7, P928, DOI 10.1038/sj.mp.4001134; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dierssen M, 2006, NEUROBIOL DIS, V24, P403, DOI 10.1016/j.nbd.2006.07.015; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Esteban PF, 2006, J CELL BIOL, V173, P291, DOI 10.1083/jcb.200512013; Feng Y, 2008, AM J PSYCHIAT, V165, P610, DOI 10.1176/appi.ajp.2007.07050805; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Krasnoperov V, 2002, J BIOL CHEM, V277, P35887, DOI 10.1074/jbc.M205478200; Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; McAllister AK, 2001, CELL MOL LIFE SCI, V58, P1054, DOI 10.1007/PL00000920; Meathrel K, 2002, J NEUROSCI RES, V70, P24, DOI 10.1002/jnr.10382; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Sahun I, 2007, J NEUROSCI, V27, P2253, DOI 10.1523/JNEUROSCI.4055-06.2007; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; SIDDIQUI TJ, 2010, CURR OPIN N IN PRESS; Siu R, 2007, MOL CELL BIOL, V27, P208, DOI 10.1128/MCB.00707-06; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Urfer R, 1998, J BIOL CHEM, V273, P5829, DOI 10.1074/jbc.273.10.5829; URFER R, 1995, EMBO J, V14, P2795, DOI 10.1002/j.1460-2075.1995.tb07279.x; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279	51	148	149	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					287	303		10.1016/j.neuron.2010.12.024	http://dx.doi.org/10.1016/j.neuron.2010.12.024			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262467	Bronze, Green Accepted			2022-12-24	WOS:000286792900012
J	Li, JX; Lisberger, SG				Li, Jennifer X.; Lisberger, Stephen G.			Learned Timing of Motor Behavior in the Smooth Eye Movement Region of the Frontal Eye Fields	NEURON			English	Article							DURATION-DISCRIMINATION TASK; PURKINJE-CELLS; TEMPORAL INFORMATION; NEURONAL RESPONSES; FLOCCULAR COMPLEX; BRAIN ACTIVATION; BASAL GANGLIA; AREA MT; PURSUIT; CORTEX	Proper timing is a critical aspect of motor learning. We report a relationship between a representation of time and an expression of learned timing in neurons in the smooth eye movement region of the frontal eye fields (FEF(SEM)). During prelearning pursuit of target motion at a constant velocity, each FEF(SEM) neuron is most active at a distinct time relative to the onset of pursuit tracking. In response to an instructive change in target direction, a neuron expresses the most learning when the instruction occurs near the time of its maximal participation in prelearning pursuit. Different neurons are most active, and undergo the most learning, at distinct times during pursuit. We suggest that the representation of time in the FEF(SEM) drives learning that is temporally linked to an instructive change in target motion, and that this may be a general function of motor areas of the cortex.	[Li, Jennifer X.; Lisberger, Stephen G.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Li, Jennifer X.; Lisberger, Stephen G.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Li, Jennifer X.; Lisberger, Stephen G.] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Lisberger, Stephen G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Li, JX (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	jennifer.li@ucsf.edu			Howard Hughes Medical Institute, National Institute of Mental Health [MH077970]; National Science Foundation; National Institutes of Health [NS655982]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS065598] Funding Source: NIH RePORTER	Howard Hughes Medical Institute, National Institute of Mental Health(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research supported by the Howard Hughes Medical Institute, National Institute of Mental Health Grant MH077970, and predoctoral fellowships from the National Science Foundation and the National Institutes of Health (NS655982). We thank Karen MacLeod, Elizabeth Montgomery, Stefanie Tokiyama, Lazslo Bocskai, Darrell Floyd, Dirk Kleinhesselink, Ken McGary, and Scott Ruffner for technical assistance. Finally, we thank colleagues for helpful comments and discussions.	Arce F, 2010, J NEUROSCI, V30, P5415, DOI 10.1523/JNEUROSCI.0076-10.2010; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; BUONOMANO DV, 1994, NEURAL COMPUT, V6, P38, DOI 10.1162/neco.1994.6.1.38; Caljouw SR, 2004, EXP BRAIN RES, V155, P427, DOI 10.1007/s00221-003-1739-3; Carey MR, 2005, NAT NEUROSCI, V8, P813, DOI 10.1038/nn1470; Chiba A, 2008, EXP BRAIN RES, V186, P671, DOI 10.1007/s00221-008-1347-3; Chou IH, 2004, J NEUROSCI, V24, P4124, DOI 10.1523/JNEUROSCI.0172-04.2004; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Cui DM, 2003, J NEUROPHYSIOL, V89, P2678, DOI 10.1152/jn.00501.2002; de Hemptinne C, 2007, J NEUROSCI, V27, P4334, DOI 10.1523/JNEUROSCI.0388-07.2007; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; KRAUZLIS RJ, 1994, J NEUROPHYSIOL, V72, P2045, DOI 10.1152/jn.1994.72.4.2045; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; LEICHNETZ GR, 1989, VISUAL NEUROSCI, V3, P171, DOI 10.1017/S0952523800004478; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; LYNCH JC, 1987, EXP BRAIN RES, V68, P437; MacAvoy MG, 1991, CEREB CORTEX, V1, P95, DOI 10.1093/cercor/1.1.95; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Medina JF, 2009, J NEUROPHYSIOL, V102, P2039, DOI 10.1152/jn.00075.2009; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Ono S, 2005, J NEUROPHYSIOL, V93, P108, DOI 10.1152/jn.00588.2004; Ono S, 2006, J NEUROPHYSIOL, V96, P2819, DOI 10.1152/jn.00538.2006; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Oshio KI, 2006, EUR J NEUROSCI, V23, P2779, DOI 10.1111/j.1460-9568.2006.04781.x; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; Ramachandran R, 2005, J NEUROPHYSIOL, V93, P2028, DOI 10.1152/jn.00832.2004; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; Sakurai Y, 2004, EUR J NEUROSCI, V20, P1069, DOI 10.1111/j.1460-9568.2004.03525.x; Schoppik D, 2008, NEURON, V58, P248, DOI 10.1016/j.neuron.2008.02.015; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sherk H, 2001, PROG BRAIN RES, V134, P247; Shih LYL, 2009, NEUROREPORT, V20, P897, DOI 10.1097/WNR.0b013e3283270b6e; Smith A, 2003, NEUROIMAGE, V20, P344, DOI 10.1016/S1053-8119(03)00337-9; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Squatrito S, 1997, J NEUROSCI, V17, P3847; Stanton GB, 2005, EXP BRAIN RES, V165, P179, DOI 10.1007/s00221-005-2292-z; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; Tanaka M, 2001, NATURE, V409, P191, DOI 10.1038/35051582; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yang Y, 2010, J NEUROPHYSIOL, V104, P2850, DOI 10.1152/jn.00761.2010	59	11	11	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 13	2011	69	1					159	169		10.1016/j.neuron.2010.11.043	http://dx.doi.org/10.1016/j.neuron.2010.11.043			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220106	Bronze, Green Accepted			2022-12-24	WOS:000286446300015
J	Lukacs, RU; Memarzadeh, S; Wu, H; Witte, ON				Lukacs, Rita U.; Memarzadeh, Sanaz; Wu, Hong; Witte, Owen N.			Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation	CELL STEM CELL			English	Article							MAMMARY STEM/PROGENITOR CELLS; MURINE PROSTATE; ANDROGEN RECEPTOR; SONIC HEDGEHOG; POOR-PROGNOSIS; BETA-CATENIN; NEURAL-TUBE; BASAL-CELLS; IN-VITRO; CANCER	The Polycomb group transcriptional repressor Bmi-1 is often upregulated in prostate cancer, but its functional roles in prostate stem cell maintenance and prostate cancer are unclear. Loss- and gain-of-function analysis in a prostate sphere assay indicates that Bmi-1 expression is required for self-renewal activity and maintenance of p63(+) stem cells. Loss of Bmi-1 blocks the self-renewal activity induced by heightened beta-catenin signaling, suggesting that Bmi-1 is required for full activity of another self-renewal pathway. In vivo, Bmi-1 expression is necessary for normal prostate tubule regeneration. Altered self-renewal and proliferation through Bmi-1 modulation diminishes the susceptibility of prostate cells to transformation. In an in vivo prostate regeneration system, Bmi-1 inhibition protects prostate cells from FGF10-driven hyperplasia and slows the growth of aggressive Pten-deletion-induced prostate cancer. We conclude that Bmi-1 is a crucial regulator of self-renewal in adult prostate cells and plays important roles in prostate cancer initiation and progression.	[Lukacs, Rita U.; Witte, Owen N.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Memarzadeh, Sanaz] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Wu, Hong; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Hong; Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Witte, ON (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	owenwitte@mednet.ucla.edu			Prostate Cancer Foundation; California Institute for Regenerative Medicine [T1-00005, TG2-01169]; Ovarian Cancer Research Fund; Stewart and Lynda Resnik Prostate Cancer Foundation; Stein/Oppenheimer Clinical Transitional Seed Grant; DOD [PCO31130]; NCI [UO1 CA84128-06, RO1 CA107166]; NATIONAL CANCER INSTITUTE [R01CA107166, U01CA084128] Funding Source: NIH RePORTER	Prostate Cancer Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Ovarian Cancer Research Fund; Stewart and Lynda Resnik Prostate Cancer Foundation; Stein/Oppenheimer Clinical Transitional Seed Grant; DOD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Donghui Cheng, Mireille Riedinger, and Stephanie Wiltzius for assistance with sorting, FGF10 virus preparation, and Cre/shRNA cloning. We thank Andrew Goldstein, David Mulholland, Devon Lawson, Li Xin, Yang Zong, and Houjian Cai for helpful discussions about results and the manuscript. Funding sources: O.N.W. is an Investigator of the Howard Hughes Medical Institute and is supported by the Prostate Cancer Foundation Challenge Award for Defining Targets and Biomarkers in Prostate Cancer Stem Cells. R.U.L. is supported by the California Institute for Regenerative Medicine training grant (T1-00005 and TG2-01169). S.M. is supported by the Ovarian Cancer Research Fund, the Stewart and Lynda Resnik Prostate Cancer Foundation Grant at UCLA, and the Stein/Oppenheimer Clinical Transitional Seed Grant. H.W. is supported by the Prostate Cancer Foundation, DOD PCO31130, NCI UO1 CA84128-06, and RO1 CA107166.	Asselin-Labat ML, 2008, COLD SH Q B, V73, P469, DOI 10.1101/sqb.2008.73.020; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Carson Culley C 3rd, 2006, N C Med J, V67, P122; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Huggins C, 1941, CANCER RES, V1, P293; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Isaacs J. T., 1987, CONTROL CELL PROLIFE; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ontiveros CS, 2008, PROSTATE, V68, P1263, DOI 10.1002/pros.20770; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Shaw GL, 2007, BJU INT, V99, P1056, DOI 10.1111/j.1464-410X.2007.06770.x; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	54	214	228	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					682	693		10.1016/j.stem.2010.11.013	http://dx.doi.org/10.1016/j.stem.2010.11.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112563	Bronze, Green Accepted			2022-12-24	WOS:000285537700010
J	Warren, L; Manos, PD; Ahfeldt, T; Loh, YH; Li, H; Lau, F; Ebina, W; Mandal, PK; Smith, ZD; Meissner, A; Daley, GQ; Brack, AS; Collins, JJ; Cowan, C; Schlaeger, TM; Rossi, DJ				Warren, Luigi; Manos, Philip D.; Ahfeldt, Tim; Loh, Yuin-Han; Li, Hu; Lau, Frank; Ebina, Wataru; Mandal, Pankaj K.; Smith, Zachary D.; Meissner, Alexander; Daley, George Q.; Brack, Andrew S.; Collins, James J.; Cowan, Chad; Schlaeger, Thorsten M.; Rossi, Derrick J.			Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA	CELL STEM CELL			English	Article							TOLL-LIKE RECEPTORS; STEM-CELLS; ANTIVIRAL RESPONSES; IN-VITRO; INDUCTION; VECTOR; FIBROBLASTS; GENERATION; ANTIGEN; VIRUS	Clinical application of induced pluripotent stem cells (iPSCs) is limited by the low efficiency of iPSC derivation and the fact that most protocols modify the genome to effect cellular reprogramming. Moreover, safe and effective means of directing the fate of patient-specific iPSCs toward clinically useful cell types are lacking. Here we describe a simple, nonintegrating strategy for reprogramming cell fate based on administration of synthetic mRNA modified to overcome innate antiviral responses. We show that this approach can reprogram multiple human cell types to pluripotency with efficiencies that greatly surpass established protocols. We further show that the same technology can be used to efficiently direct the differentiation of RNA-induced pluripotent stem cells (RiPSCs) into terminally differentiated myogenic cells. This technology represents a safe, efficient strategy for somatic cell reprogramming and directing cell fate that has broad applicability for basic research, disease modeling, and regenerative medicine.	[Warren, Luigi; Ebina, Wataru; Mandal, Pankaj K.; Rossi, Derrick J.] Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Manos, Philip D.; Daley, George Q.; Schlaeger, Thorsten M.; Rossi, Derrick J.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Manos, Philip D.; Ahfeldt, Tim; Lau, Frank; Meissner, Alexander; Daley, George Q.; Cowan, Chad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Meissner, Alexander; Daley, George Q.; Brack, Andrew S.; Cowan, Chad; Rossi, Derrick J.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ahfeldt, Tim; Brack, Andrew S.; Cowan, Chad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Loh, Yuin-Han; Daley, George Q.; Schlaeger, Thorsten M.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Loh, Yuin-Han; Daley, George Q.; Schlaeger, Thorsten M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loh, Yuin-Han] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Lau, Frank; Cowan, Chad] Stowers Med Inst, Boston, MA 02114 USA; [Smith, Zachary D.; Meissner, Alexander] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Daley, George Q.; Collins, James J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Stowers Institute for Medical Research; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Rossi, DJ (corresponding author), Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, 300 Longwood Ave, Boston, MA 02115 USA.	rossi@idi.harvard.edu	Loh, Yuin-Han/E-1096-2014; Ahfeldt, Tim/E-2935-2017; mandal, pankaj/B-4885-2016	Loh, Yuin-Han/0000-0002-4715-6454; Schlaeger, Thorsten/0000-0002-1599-9908; Ahfeldt, Tim/0000-0001-6377-7376; Mandal, Pankaj/0000-0003-1993-9918	Harvard Stem Cell Institute; A*Star Institute of Medical Biology and Singapore stem cell consortium; Roberto and Allison Mignone Fund for Stem Cell Research; Howard Hughes Medical Institute; NIH [RL1DE019021]; SysCODE (Systems-based Consortium for Organ Design Engineering); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019021] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; A*Star Institute of Medical Biology and Singapore stem cell consortium; Roberto and Allison Mignone Fund for Stem Cell Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SysCODE (Systems-based Consortium for Organ Design Engineering); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors wish to thank Sun Hur, Victor Li, Laurence Daheron, Odelya Hartung, Alys Peisley, Sutheera Ratanasirintrawoot, Brad Hamilton, Chenmei Luo, Jonathan Kagan, Julie Sahalie, Alejandro De Los Angeles, and Lior Zangi for help, insight, and suggestions. D.J.R., A.M., GOD, A.S.B, C.C., and T.M.S. were supported by grants from the Harvard Stem Cell Institute. Y.-H.L. is supported by the A*Star Institute of Medical Biology and Singapore stem cell consortium. T.A. was supported by the Roberto and Allison Mignone Fund for Stem Cell Research. J.J.C. is supported by Howard Hughes Medical Institute, SysCODE (Systems-based Consortium for Organ Design & Engineering), and NIH grant # RL1DE019021. D.J.R. recently founded a company, Mod-eRNA Therapeutics, dedicated to the clinical translation of this technology. G.Q.D. is a member of the scientific advisory boards and holds equity in the following companies: Epizyme, iPierian, Solasia KK, and MPM Capital, LLP. C.C. is on the SAB of lpierian. L.W. is a consultant for Stemgent.	Audouy S, 2001, MOL MEMBR BIOL, V18, P129, DOI 10.1080/713816122; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Elango N, 2005, BIOCHEM BIOPH RES CO, V330, P958, DOI 10.1016/j.bbrc.2005.03.067; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2007, CURR OPIN DRUG DISC, V10, P523; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nallagatla SR, 2008, RNA, V14, P1201, DOI 10.1261/rna.1007408; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rabinovich PM, 2006, HUM GENE THER, V17, P1027, DOI 10.1089/hum.2006.17.1027; Rabinovich PM, 2009, HUM GENE THER, V20, P51, DOI 10.1089/hum.2008.068; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Van den Bosch GA, 2006, J IMMUNOTHER, V29, P512, DOI 10.1097/01.cji.0000210385.48327.1e; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YISRAELI JK, 1989, METHOD ENZYMOL, V180, P42; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	53	1792	2092	16	476	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					618	630		10.1016/j.stem.2010.08.012	http://dx.doi.org/10.1016/j.stem.2010.08.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	20888316	Green Accepted, Bronze			2022-12-24	WOS:000284390500013
J	Mayshar, Y; Ben-David, U; Lavon, N; Biancotti, JC; Yakir, B; Clark, AT; Plath, K; Lowry, WE; Benvenisty, N				Mayshar, Yoav; Ben-David, Uri; Lavon, Neta; Biancotti, Juan-Carlos; Yakir, Benjamin; Clark, Amander T.; Plath, Kathrin; Lowry, William E.; Benvenisty, Nissim			Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							COPY NUMBER VARIATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE-EXPRESSION; CULTURE; ANEUPLOIDY; ABNORMALITIES; LEUKEMIAS; IDENTIFY; PROGRAM; REGIONS	Because of their somatic cell origin, human induced pluripotent stem cells (HiPSCs) are assumed to carry a normal diploid genome, and adaptive chromosomal aberrations have not been fully evaluated. Here, we analyzed the chromosomal integrity of 66 HiPSC and 38 human embryonic si:em cell (HESC) samples from 18 different studies by global gene expression meta-analysis. We report identification of a substantial number of cell lines carrying full and partial chromosomal aberrations, half of which were validated at the DNA level. Several aberrations resulted from culture adaptation, and others are suspected to originate from the parent somatic cell. Our classification revealed a third type of aneuploidy already evident in early passage HiPSCs, suggesting considerable selective pressure during the reprogramming process. The analysis indicated high incidence of chromosome 12 duplications, resulting in significant enrichment for cell cycle-related genes. Such aneuploidy may limit the differentiation capacity and increase the tumorigenicity of HiPSCs.	[Mayshar, Yoav; Ben-David, Uri; Lavon, Neta; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Biancotti, Juan-Carlos] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Yakir, Benjamin] Hebrew Univ Jerusalem, Dept Stat, IL-91905 Jerusalem, Israel; [Clark, Amander T.; Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Clark, Amander T.; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Broad Stem Cell Ctr, Los Angeles, CA 90095 USA; [Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Hebrew University of Jerusalem; Cedars Sinai Medical Center; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378; Mayshar, Yoav/0000-0002-5553-2472; Plath, Kathrin/0000-0001-7796-3372	European Community [018739]; Morasha-ISF [943/09]; Legacy Heritage Fund of New York	European Community(European Commission); Morasha-ISF; Legacy Heritage Fund of New York	We would like to thank Tamar Golan-Lev for excellent technical assistance, Dr. Danny Kitzberg for critically reading this manuscript and Dr. Sagiv Shifman for stimulating discussions. N.B. is the Herbert Cohn Chair in Cancer Research. This research was partially supported by funds from the European Community (ESTOOLS. Grant number 018739) and by funds from the Morasha-ISF (Grant number 943/09). We gratefully acknowledge support for this project provided by a grant from the Legacy Heritage Fund of New York.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Crawley JJ, 2002, GENOME BIOL, V3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Furge KA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-67; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Kadaja M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000397; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lilljebjorn H, 2007, LEUKEMIA, V21, P2137, DOI 10.1038/sj.leu.2404879; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Masayesva BG, 2004, P NATL ACAD SCI USA, V101, P8715, DOI 10.1073/pnas.0400027101; McIntyre A, 2007, BRIT J CANCER, V97, P1707, DOI 10.1038/sj.bjc.6604079; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phillips JL, 2001, CANCER RES, V61, P8143; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Reuter VE, 2005, MODERN PATHOL, V18, pS51, DOI 10.1038/modpathol.3800309; Schoch C, 2005, LEUKEMIA, V19, P1224, DOI 10.1038/sj.leu.2403810; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	38	546	576	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					521	531		10.1016/j.stem.2010.07.017	http://dx.doi.org/10.1016/j.stem.2010.07.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887957	Bronze			2022-12-24	WOS:000283270600013
J	Schonewille, M; Belmeguenai, A; Koekkoek, SK; Houtman, SH; Boele, HJ; van Beugen, BJ; Gao, Z; Badura, A; Ohtsuki, G; Amerika, WE; Hosy, E; Hoebeek, FE; Elgersma, Y; Hansel, C; De Zeeuw, CI				Schonewille, M.; Belmeguenai, A.; Koekkoek, S. K.; Houtman, S. H.; Boele, H. J.; van Beugen, B. J.; Gao, Z.; Badura, A.; Ohtsuki, G.; Amerika, W. E.; Hosy, E.; Hoebeek, F. E.; Elgersma, Y.; Hansel, C.; De Zeeuw, C. I.			Purkinje Cell-Specific Knockout of the Protein Phosphatase PP2B Impairs Potentiation and Cerebellar Motor Learning	NEURON			English	Article							LONG-TERM DEPRESSION; CONDITIONED EYELID RESPONSES; BIDIRECTIONAL PLASTICITY; SYNAPTIC DEPRESSION; AMPA RECEPTOR; INHIBITION; LTD; MEMORY; CALCINEURIN; SYNAPSES	Cerebellar motor learning is required to obtain procedural skills. Studies have provided supportive evidence for a potential role of kinase-mediated long-term depression (LTD) at the parallel fiber to Purkinje cell synapse in cerebellar learning. Recently, phosphatases have been implicated in the induction of potentiation of Purkinje cell activities in vitro, but it remains to be shown whether and how phosphatase-mediated potentiation contributes to motor learning. Here, we investigated its possible role by creating and testing a Purkinje cell-specific knockout of calcium/calmodulin-activated protein-phosphatase-2B (L7-PP2B). The selective deletion of PP2B indeed abolished postsynaptic long-term potentiation in Purkinje cells and their ability to increase their excitability, whereas LTD was unaffected. The mutants showed impaired "gain-decrease" and "gain-increase" adaptation of their vestibulo-ocular reflex (VOR) as well as impaired acquisition of classical delay conditioning of their eyeblink response. Thus, our data indicate that PP2B may indeed mediate potentiation in Purkinje cells and contribute prominently to cerebellar motor learning.	[Schonewille, M.; Belmeguenai, A.; Koekkoek, S. K.; Houtman, S. H.; Boele, H. J.; van Beugen, B. J.; Gao, Z.; Badura, A.; Ohtsuki, G.; Amerika, W. E.; Hosy, E.; Hoebeek, F. E.; Elgersma, Y.; Hansel, C.; De Zeeuw, C. I.] Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; [Belmeguenai, A.] Univ Lyon 1, Lab Physiol Integrat Cellulaire & Mol, F-69622 Villeurbanne, France; [De Zeeuw, C. I.] Royal Acad Sci KNAW, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Hansel, C (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	chansel@bsd.uchicago.edu; c.dezeeuw@erasmusmc.nl	Boele, Henk-Jan/AAI-7261-2021; Ohtsuki/AAB-4570-2019; Elgersma, Ype/F-5164-2013; Boele, Henk-Jan/AAK-3836-2021; Badura, Aleksandra/ABC-5427-2020; Schonewille, Martijn/E-6170-2013	Boele, Henk-Jan/0000-0001-8449-4391; Ohtsuki/0000-0003-3004-5886; Elgersma, Ype/0000-0002-3758-1297; Badura, Aleksandra/0000-0002-0119-5108; Reitsma-Houtman, Simone Hendrika/0000-0003-4386-5728; hosy, eric/0000-0002-2479-5915	Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (Neuro-Bsik; YE); Erasmus University; NIH [NS62771]; Prinses Beatrix Fonds; SENSOPAC; CEREBNET; European Community; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062771] Funding Source: NIH RePORTER	Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); Senter (Neuro-Bsik; YE); Erasmus University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prinses Beatrix Fonds; SENSOPAC; CEREBNET; European Community(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We kindly thank J. van der Burg, E. Haasdijk, E. Galliano, R. de Avila Freire, E. Goedknegt, and M. Rutteman for their excellent technical assistance; we kindly thank S. Tonegawa for providing the PP2B-loxP mice; and we kindly thank the Dutch Organization for Medical Sciences (ZonMw; Y.E. C.I.D.Z.), Life Sciences (ALW; A. Belmeguenai, F.E.H., C.H., C.I.D.Z.), Senter (Neuro-Bsik; YE., C.I.D.Z.), Erasmus University Fellowship (MS), NIH (#NS62771; C.H.), Prinses Beatrix Fonds (C.I.D.Z.), and the SENSOPAC, CEREBNET, and C7 programs of the European Community (C.I.D.Z.) for their financial support.	AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; De Zeeuw CI, 2008, NEURON, V58, P655, DOI 10.1016/j.neuron.2008.05.019; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dean P, 2008, CEREBELLUM, V7, P567, DOI 10.1007/s12311-008-0067-3; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Gauck V, 2000, J NEUROSCI, V20, P3006; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Isope P, 2002, J NEUROSCI, V22, P9668; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Launey T, 2004, P NATL ACAD SCI USA, V101, P676, DOI 10.1073/pnas.0302914101; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Porrill J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000085; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Telgkamp P, 2002, J NEUROSCI, V22, P8447; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; van Woerden GM, 2009, NAT NEUROSCI, V12, P823, DOI 10.1038/nn.2329; Welsh JP, 2005, P NATL ACAD SCI USA, V102, P17166, DOI 10.1073/pnas.0508191102; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	37	168	168	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					618	628		10.1016/j.neuron.2010.07.009	http://dx.doi.org/10.1016/j.neuron.2010.07.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797538	Green Accepted, Bronze			2022-12-24	WOS:000281534600011
J	Nelson, SM; Cohen, AL; Power, JD; Wig, GS; Miezin, FM; Wheeler, ME; Velanova, K; Donaldson, DI; Phillips, JS; Schlaggar, BL; Petersen, SE				Nelson, Steven M.; Cohen, Alexander L.; Power, Jonathan D.; Wig, Gagan S.; Miezin, Francis M.; Wheeler, Mark E.; Velanova, Katerina; Donaldson, David I.; Phillips, Jeffrey S.; Schlaggar, Bradley L.; Petersen, Steven E.			A Parcellation Scheme for Human Left Lateral Parietal Cortex	NEURON			English	Article							ANTERIOR PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; RECOGNITION MEMORY; EPISODIC RETRIEVAL; HUMAN BRAIN; TOP-DOWN; ATTENTION; NETWORKS; RECOLLECTION; COMPONENTS	The parietal lobe has long been viewed as a collection of architectonic and functional subdivisions. Though much parietal research has focused on mechanisms of visuospatial attention and control-related processes, more recent functional neuroimaging studies of memory retrieval have reported greater activity in left lateral parietal cortex (LLPC) when items are correctly identified as previously studied ("old") versus unstudied ("new"). These studies have suggested functional divisions within LLPC that may provide distinct contributions toward recognition memory judgments. Here, we define regions within LLPC by developing a parcellation scheme that integrates data from resting-state functional connectivity MRI and functional MRI. This combined approach results in a 6-fold parcellation of LLPC based on the presence (or absence) of memory-retrieval-related activity, dissociations in the profile of task-evoked time courses, and membership in large-scale brain networks. This parcellation should serve as a roadmap for future investigations aimed at understanding LLPC function.	[Nelson, Steven M.; Cohen, Alexander L.; Power, Jonathan D.; Wig, Gagan S.; Miezin, Francis M.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Miezin, Francis M.; Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Radiol, St Louis, MO 63110 USA; [Schlaggar, Bradley L.; Petersen, Steven E.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Schlaggar, Bradley L.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Psychol, St Louis, MO 63110 USA; [Donaldson, David I.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Wheeler, Mark E.; Phillips, Jeffrey S.] Univ Pittsburgh, Dept Psychol, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA; [Wheeler, Mark E.; Velanova, Katerina; Phillips, Jeffrey S.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Velanova, Katerina] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Stirling; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nelson, SM (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63110 USA.	stevenelson@wustl.edu	Schlaggar, Bradley/AAZ-4153-2020; Petersen, Steve/ABF-1368-2020; Nelson, Steven/C-1003-2009; Donaldson, David I/A-5249-2009; Cohen, Alexander/A-6865-2009; Cohen, Alexander Li/H-6594-2019	Donaldson, David I/0000-0002-8036-3455; Cohen, Alexander/0000-0001-6557-5866; Cohen, Alexander Li/0000-0001-6557-5866; Power, Jonathan/0000-0002-6922-100X; Phillips, Jeffrey/0000-0003-0079-9441	National Institutes of Health [NS32979, NS41255, NS46424, NS62489, NS53425]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032979, F30NS062489, R01NS046424, R21NS041255, K02NS053425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kathleen McDermott, Kelly Barnes, Nico Dosenbach, Jessica Church, Alecia Vogel, Christopher Fetsch, and Maital Neta for helpful discussion; Mark McAvoy and Avi Snyder for technical support; and Randy Buckner for generously providing data. Funding for this work came from National Institutes of Health grants NS32979 (S.E.P), NS41255 (S.E.P), NS46424 (S.E.P.), NS62489 (A.L.C.), and NS53425 (B.L.S.).	Bender-deMoll S., 2006, J SOCIAL STRUCTURE, V7, P1; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Dobbins IG, 2004, J COGNITIVE NEUROSCI, V16, P908, DOI 10.1162/0898929041502751; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Donaldson DI, 2010, J COGNITIVE NEUROSCI, V22, P377, DOI 10.1162/jocn.2009.21242; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gobel SM, 2004, CURR BIOL, V14, pR517, DOI 10.1016/j.cub.2004.06.042; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Lancaster JL, 1995, HUM BRAIN MAPP, V3, P209, DOI 10.1002/hbm.460030305; McDermott KB, 2009, NEUROPSYCHOLOGIA, V47, P2290, DOI 10.1016/j.neuropsychologia.2008.12.025; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; Michelon P, 2003, NEUROIMAGE, V19, P1612, DOI 10.1016/S1053-8119(03)00111-3; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Phillips JS, 2009, NEUROIMAGE, V46, P1209, DOI 10.1016/j.neuroimage.2009.02.044; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; Reynolds JR, 2006, CEREB CORTEX, V16, P519, DOI 10.1093/cercor/bhi131; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simons JS, 2008, NEUROPSYCHOLOGIA, V46, P1185, DOI 10.1016/j.neuropsychologia.2007.07.024; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2009, CEREB CORTEX, V19, P1539, DOI 10.1093/cercor/bhn191; Talairach J., 1988, COPLANAR STEREOTAXIC; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Velanova K, 2003, J NEUROSCI, V23, P8460; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wheeler ME, 2008, J COGNITIVE NEUROSCI, V20, P2211, DOI 10.1162/jocn.2008.20155; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	67	278	279	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					156	170		10.1016/j.neuron.2010.05.025	http://dx.doi.org/10.1016/j.neuron.2010.05.025			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624599	Green Accepted, Bronze			2022-12-24	WOS:000280221000016
J	Taylor, PL; Barker, RA; Blume, KG; Cattaneo, E; Colman, A; Deng, H; Edgar, H; Fox, IJ; Gerstle, C; Goldstein, LSB; High, KA; Lyall, A; Parkman, R; Pitossi, FJ; Prentice, ED; Rooke, HM; Sipp, DA; Srivastava, A; Stayn, S; Steinberg, GK; Wagers, AJ; Weissman, IL				Taylor, Patrick L.; Barker, Roger A.; Blume, Karl G.; Cattaneo, Elena; Colman, Alan; Deng, Hongkui; Edgar, Harold; Fox, Ira J.; Gerstle, Claude; Goldstein, Lawrence S. B.; High, Katherine A.; Lyall, Andrew; Parkman, Robertson; Pitossi, Fernando J.; Prentice, Ernest D.; Rooke, Heather M.; Sipp, Douglas A.; Srivastava, Alok; Stayn, Susan; Steinberg, Gary K.; Wagers, Amy J.; Weissman, Irving L.			Patients Beware: Commercialized Stem Cell Treatments on the Web	CELL STEM CELL			English	News Item							ISSCR GUIDELINES	A report by the International Society for Stem Cell Research (ISSCR)'s Task Force on Unproven Stem Cell Treatments outlines development of resources for patients, their families, and physicians seeking information on stem cell treatments.	[Rooke, Heather M.] Int Soc Stem Cell Res, Boston, MA 02115 USA; [Taylor, Patrick L.] Childrens Hosp, Boston, MA 02115 USA; [Barker, Roger A.] Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; [Blume, Karl G.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Cattaneo, Elena] Univ Milan, I-20133 Milan, Italy; [Colman, Alan] ASTAR Singapore Stem Cell Consortium, Singapore 138648, Singapore; [Deng, Hongkui] Peking Univ, Beijing 100871, Peoples R China; [Edgar, Harold] Columbia Law Sch, New York, NY 10027 USA; [Fox, Ira J.] UPMC, Childrens Hosp Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15201 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [High, Katherine A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Lyall, Andrew] Stem Cell Network, Ottawa, ON K1H 8L6, Canada; [Parkman, Robertson] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Pitossi, Fernando J.] Fdn Inst Leloir IIBBA CONICET, RA-1405 Buenos Aires, DF, Argentina; [Prentice, Ernest D.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA; [Sipp, Douglas A.] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Srivastava, Alok] Christian Med Coll & Hosp, Vellore 632004, Tamil Nadu, India; [Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; University of Cambridge; Stanford University; University of Milan; Agency for Science Technology & Research (A*STAR); Peking University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Los Angeles; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Nebraska System; University of Nebraska Medical Center; RIKEN; Christian Medical College & Hospital (CMCH) Vellore; Harvard University; Joslin Diabetes Center, Inc.	Rooke, HM (corresponding author), Int Soc Stem Cell Res, Boston, MA 02115 USA.		Sipp, Doug/C-9218-2017; High, Katherine A./AAB-9322-2020	Sipp, Doug/0000-0002-5979-0938; Pitossi, Fernando/0000-0001-5104-9726; CATTANEO, ELENA/0000-0002-0755-4917; High, Katherine/0000-0002-0805-6223; Barker, Roger Alistair/0000-0001-8843-7730	Medical Research Council [G0300723B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		COHEN IG, 2010, IOWA L REV, V95; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; *ISSCR, 2008, GUID CLIN TRANSL STE; ISSCR, 2008, PAT HDB STEM CELL TH; *ISSCR, 2006, GUID COND HUM EMBR S; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Taylor PL, 2007, NAT BIOTECHNOL, V25, P398, DOI 10.1038/nbt0407-398; *US LIB MED, 2007, FACT SHEET MED J SEL; Weissman Irving, 2009, Cell Stem Cell, V5, P151, DOI 10.1016/j.stem.2009.07.013	10	38	39	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					43	49		10.1016/j.stem.2010.06.001	http://dx.doi.org/10.1016/j.stem.2010.06.001			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621049	Green Published, Bronze			2022-12-24	WOS:000280222300012
J	Wu, ZH; Sweeney, LB; Ayoob, JC; Chak, K; Andreone, BJ; Ohyama, T; Kerr, R; Luo, LQ; Zlatic, M; Kolodkin, AL				Wu, Zhuhao; Sweeney, Lora B.; Ayoob, Joseph C.; Chak, Kayam; Andreone, Benjamin J.; Ohyama, Tomoko; Kerr, Rex; Luo, Liqun; Zlatic, Marta; Kolodkin, Alex L.			A Combinatorial Semaphorin Code Instructs the Initial Steps of Sensory Circuit Assembly in the Drosophila CNS	NEURON			English	Article							GROWTH CONE GUIDANCE; FASCICLIN-II; GENETIC-ANALYSIS; AXON GUIDANCE; PLEXIN-B; EXPRESSION PATTERNS; LONGITUDINAL AXONS; CELL RECOGNITION; ROBO RECEPTORS; PRONEURAL GENE	Longitudinal axon fascicles within the Drosophila embryonic CNS provide connections between body segments and are required for coordinated neural signaling along the anterior-posterior axis. We show here that establishment of select CNS longitudinal tracts and formation of precise mechanosensory afferent innervation to the same CNS region are coordinately regulated by the secreted semaphorins Sema-2a and Sema-2b. Both Sema-2a and Sema-2b utilize the same neuronal receptor, plexin B (PlexB), but serve distinct guidance functions. Localized Sema-2b attraction promotes the initial assembly of a subset of CNS longitudinal projections and subsequent targeting of chordotonal sensory afferent axons to these same longitudinal connectives, whereas broader Sema-2a repulsion serves to prevent aberrant innervation. In the absence of Sema-2b or PlexB, chordotonal afferent connectivity within the CNS is severely disrupted, resulting in specific larval behavioral deficits. These results reveal that distinct semaphorin-mediated guidance functions converge at PlexB and are critical for functional neural circuit assembly.	[Wu, Zhuhao; Ayoob, Joseph C.; Chak, Kayam; Andreone, Benjamin J.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Sweeney, Lora B.; Luo, Liqun] Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Sweeney, Lora B.; Luo, Liqun] Stanford Univ, Neurosci Program, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ohyama, Tomoko; Kerr, Rex; Zlatic, Marta] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Wu, Zhuhao/I-5852-2018	Sweeney, Lora/0000-0001-9242-5601; Zlatic, Marta/0000-0002-3149-2250; Wu, Zhuhao/0000-0002-2471-0555; Luo, Liqun/0000-0001-5467-9264; Ohyama, Tomoko/0000-0003-1697-1138	NIH [R01 NS35165, R01 DC005982]; Janelia Farm HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janelia Farm HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are very grateful to K. Venken and H. Bellen for expert support with BAC transgenic techniques, B. Dickson for the Sema2b-tau Myc marker line and Sema-2b cDNA construct, C. Montell for the iav-GAL4 stock, B. McCabe for the fourth chromosome GFP marker, M. Pucak and the NINDS Multi-photon Core Facility at JHMI (MH084020) for confocal imaging, and D. McClellan for her helpful comments on the manuscript. We also thank J. Cho for mapping the UAS:PlexB<SUP>EcTM</SUP> stock, C. Nacopoulos for assistance with fly genetics, and members of the Kolodkin, Luo, and Zlatic laboratories for their helpful discussions throughout the course of this project. We are grateful to N. Swierczek for writing the MWT software, D. Hoffmann for building the behavioral rigs and D. Olbris, R. Svirskas, and E. Trautman for their help with behavior data analysis. We also thank the Bloomington Stock Center and the Drosophila Genome Research Center for fly stocks. This work was supported by NIH R01 NS35165 to A.L.K., R01 DC005982 to L.L., and by Janelia Farm HHMI funding to M.Z. and R.K.. R.K. and M.Z. are Fellows at Janelia Farm Howard Hughes Medical Institute; A.L.K. and L.L. are Investigators of the Howard Hughes Medical Institute.	Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; Bates KE, 2007, DEV BIOL, V302, P522, DOI 10.1016/j.ydbio.2006.10.015; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; Caldwell JC, 2003, P NATL ACAD SCI USA, V100, P16053, DOI 10.1073/pnas.2535546100; Carrillo RA, 2010, NEURON, V68, P32, DOI 10.1016/j.neuron.2010.09.005; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; Eberl DF, 1999, CURR OPIN NEUROBIOL, V9, P389, DOI 10.1016/S0959-4388(99)80058-0; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Farmer WT, 2008, DEVELOPMENT, V135, P3643, DOI 10.1242/dev.023325; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hiramoto M, 2006, NAT NEUROSCI, V9, P58, DOI 10.1038/nn1612; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Khare N, 2000, MECH DEVELOP, V91, P393, DOI 10.1016/S0925-4773(99)00297-X; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lopez-Bendito G, 2007, J NEUROSCI, V27, P3395, DOI 10.1523/JNEUROSCI.4605-06.2007; Mann F, 2007, PROG NEUROBIOL, V82, P57, DOI 10.1016/j.pneurobio.2007.02.011; Mastick GS, 2010, CELL ADHES MIGR, V4, P337, DOI 10.4161/cam.4.3.11219; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MERRITT DJ, 1995, J NEUROSCI, V15, P1755, DOI 10.1523/JNEUROSCI.15-03-01755.1995; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Swan LE, 2004, GENE DEV, V18, P223, DOI 10.1101/gad.287604; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wolman MA, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-6; Wolman MA, 2007, J NEUROSCI, V27, P9653, DOI 10.1523/JNEUROSCI.1741-07.2007; YAO KM, 1994, J NEUROCHEM, V63, P41; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	59	64	64	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 28	2011	70	2					281	298		10.1016/j.neuron.2011.02.050	http://dx.doi.org/10.1016/j.neuron.2011.02.050			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521614	Green Accepted, Bronze			2022-12-24	WOS:000291073700010
J	Baumann, S; Griffiths, TD; Sun, L; Petkov, CI; Thiele, A; Rees, A				Baumann, Simon; Griffiths, Timothy D.; Sun, Li; Petkov, Christopher I.; Thiele, Alexander; Rees, Adrian			Orthogonal representation of sound dimensions in the primate midbrain	NATURE NEUROSCIENCE			English	Article							INFERIOR COLLICULUS; CAT; ORGANIZATION; RESPONSES; AWAKE	Natural sounds are characterized by their spectral content and the modulation of energy over time. Using functional magnetic resonance imaging in awake macaques, we observed topographical representations of these spectral and temporal dimensions in a single structure, the inferior colliculus, the principal auditory nucleus in the midbrain. These representations are organized as a map with two approximately perpendicular axes: one representing increasing temporal rate and the other increasing spectral frequency.	[Baumann, Simon; Griffiths, Timothy D.; Sun, Li; Petkov, Christopher I.; Thiele, Alexander; Rees, Adrian] Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Baumann, S (corresponding author), Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	simon.baumann@ncl.ac.uk	Rees, Adrian/H-2200-2012; Petkov, Christopher/O-5318-2015	Rees, Adrian/0000-0003-3313-8375; Petkov, Christopher/0000-0002-4932-7907; Thiele, Alexander/0000-0003-4894-0213; Sun, Li/0000-0003-3022-9191; Griffiths, Timothy/0000-0001-8066-4381	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We wish to thank D. Hunter for his assistance in animal handling and data recording. This research was funded by the Wellcome Trust.	Baumann S, 2010, NEUROIMAGE, V50, P1099, DOI 10.1016/j.neuroimage.2009.12.103; BREGMAN AS, 1990, AUDITOY SCENE ANAL P; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; HALL JW, 1984, J ACOUST SOC AM, V76, P50, DOI 10.1121/1.391005; Heil P, 1995, AUDIT NEUROSCI, V1, P363; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Langner G, 2002, HEARING RES, V168, P110, DOI 10.1016/S0378-5955(02)00367-2; MERZENICH MM, 1974, BRAIN RES, V77, P397, DOI 10.1016/0006-8993(74)90630-1; MULLERPREUSS P, 1994, HEARING RES, V80, P197, DOI 10.1016/0378-5955(94)90111-2; ROSE JE, 1963, J NEUROPHYSIOL, V26, P294, DOI 10.1152/jn.1963.26.2.294; RYAN A, 1978, EXP BRAIN RES, V32, P389; SCHREINER CE, 1988, J NEUROPHYSIOL, V60, P1823, DOI 10.1152/jn.1988.60.6.1823; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303	15	88	89	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					423	425		10.1038/nn.2771	http://dx.doi.org/10.1038/nn.2771			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21378972	Green Accepted			2022-12-24	WOS:000288849400011
J	Volkow, ND; Baler, RD; Goldstein, RZ				Volkow, Nora D.; Baler, Ruben D.; Goldstein, Rita Z.			Addiction: Pulling at the Neural Threads of Social Behaviors	NEURON			English	Editorial Material							PREFRONTAL CORTEX; DRUG-ABUSE	Addiction coopts the brain's neuronal circuits necessary for insight, reward, motivation, and social behaviors. This functional overlap results in addicted individuals making poor choices despite awareness of the negative consequences; it explains why previously rewarding life situations and the threat of judicial punishment cannot stop drug taking and why a medical rather than a criminal approach is more effective in curtailing addiction.	[Volkow, Nora D.; Baler, Ruben D.] Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA; [Goldstein, Rita Z.] Brookhaven Natl Lab, Ctr Translat Neuroimaging, Dept Med Res, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); United States Department of Energy (DOE); Brookhaven National Laboratory	Volkow, ND (corresponding author), Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ACQUAS E, 1992, J NEUROCHEM, V58, P1620, DOI 10.1111/j.1471-4159.1992.tb10033.x; Behen ME, 2009, BRAIN IMAGING BEHAV, V3, P292, DOI 10.1007/s11682-009-9071-6; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Karelina K, 2011, PSYCHOSOM MED, V73, P67, DOI 10.1097/PSY.0b013e3182002116; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Martinez D, 2010, BIOL PSYCHIAT, V67, P275, DOI 10.1016/j.biopsych.2009.07.037; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Mumola C., 2006, BUREAU JUSTICE STAT; *ONDCP, 2004, EC COSTS DRUG AB US; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Weiss F, 2001, NEUROTOX RES, V3, P145, DOI 10.1007/BF03033235	19	143	145	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 24	2011	69	4					599	602		10.1016/j.neuron.2011.01.027	http://dx.doi.org/10.1016/j.neuron.2011.01.027			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338873	Green Accepted, Bronze			2022-12-24	WOS:000288413200005
J	Narayanan, R; Dougherty, KJ; Johnston, D				Narayanan, Rishikesh; Dougherty, Kevin J.; Johnston, Daniel			Calcium Store Depletion Induces Persistent Perisomatic Increases in the Functional Density of h Channels in Hippocampal Pyramidal Neurons	NEURON			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED CATION CHANNELS; OPERATED CA2+ ENTRY; CYCLOPIAZONIC ACID; I-H; INTRINSIC EXCITABILITY; SLEEP-DEPRIVATION; PLASTICITY; CA-2+-ATPASE; INHIBITOR	The regulation of intracellular calcium by the endoplasmic reticulum (ER) plays a critical role in neuronal function. While the consequences associated with depleting calcium from the ER have been studied in multiple systems, it is not known whether the intrinsic properties of a neuron change in response to such perturbations. In this study, we demonstrate that the depletion of calcium from the ER of hippocampal CA1 pyramidal neurons induces a persistent, perisomatic increase in the density of functional h channels resulting in a reduction in intrinsic excitability and an increase in the optimal response frequency. This form of intrinsic plasticity is dependent on the elevation of cytoplasmic calcium, inositol triphosphate receptors, store-operated calcium channels, and the protein kinase A pathway. We postulate that this form of depletion-induced intrinsic plasticity is a neuroprotective mechanism that reduces excitability after depletion of calcium stores triggered through altered network activity during pathological conditions.	[Narayanan, Rishikesh; Dougherty, Kevin J.; Johnston, Daniel] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnston, D (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	djohnston@mail.clm.utexas.edu	Narayanan, Rishikesh/C-3191-2009	Narayanan, Rishikesh/0000-0002-1362-4635	International Human Frontier Science Program Organization; National Institutes of Health [MH90665, MH48432, MH44754, NS37444]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH090665, R01MH094839, R37MH044754, R01MH048432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank members of the Center for Learning and Memory for helpful discussions and comments on the manuscript. The International Human Frontier Science Program Organization (R.N.) and the National Institutes of Health (fellowship to K.J.D.: MH90665; grants to D.J.: MH48432, MH44754, and NS37444) supported this study.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Baba A, 2003, J NEUROSCI, V23, P7737; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Carnevale NT, 2006, NEURON BOOK; CHANG F, 1991, J PHYSIOL-LONDON, V440, P367, DOI 10.1113/jphysiol.1991.sp018713; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; DEMAUREX N, 1992, J BIOL CHEM, V267, P2318; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Magee JC, 1998, J NEUROSCI, V18, P7613; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; McDermott CM, 2003, J NEUROSCI, V23, P9687; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Nicolay NH, 2007, J NEUROSCI RES, V85, P2026, DOI 10.1002/jnr.21328; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park MK, 2008, NEUROSCIENTIST, V14, P68, DOI 10.1177/1073858407305691; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Sankar R, 1998, J NEUROSCI, V18, P8382; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; UYAMA Y, 1992, BRIT J PHARMACOL, V106, P208, DOI 10.1111/j.1476-5381.1992.tb14316.x; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang RH, 2010, BRAIN RES, V1343, P135, DOI 10.1016/j.brainres.2010.05.019; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	47	63	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					921	935		10.1016/j.neuron.2010.11.033	http://dx.doi.org/10.1016/j.neuron.2010.11.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145005	Green Accepted, Bronze			2022-12-24	WOS:000285664900013
J	Burgalossi, A; Jung, SY; Meyer, G; Jockusch, WJ; Jahn, O; Taschenberger, H; O'Connor, VM; Nishiki, T; Takahashi, M; Brose, N; Rhee, JS				Burgalossi, Andrea; Jung, Sangyong; Meyer, Guido; Jockusch, Wolf J.; Jahn, Olaf; Taschenberger, Holger; O'Connor, Vincent M.; Nishiki, Tei-ichi; Takahashi, Masami; Brose, Nils; Rhee, Jeong-Seop			SNARE Protein Recycling by alpha SNAP and beta SNAP Supports Synaptic Vesicle Priming	NEURON			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; MEMBRANE-FUSION; ASYNCHRONOUS RELEASE; HIPPOCAMPAL-NEURONS; NEUROMUSCULAR-JUNCTION; SYNCHRONOUS RELEASE; SECRETORY VESICLES; SYNAPTOTAGMIN-I	Neurotransmitter release proceeds by Ca2+-triggered, SNARE-complex-dependent synaptic vesicle fusion. After fusion, the ATPase NSF and its cofactors alpha- and beta SNAP disassemble SNARE complexes, thereby recycling individual SNAREs for subsequent fusion reactions. We examined the effects of genetic perturbation of alpha- and beta SNAP expression on synaptic vesicle exocytosis, employing a new Ca2+ uncaging protocol to study synaptic vesicle trafficking, priming, and fusion in small glutamatergic synapses of hippocampal neurons. By characterizing this protocol, we show that synchronous and asynchronous transmitter release involve different Ca2+ sensors and are not caused by distinct releasable vesicle pools, and that tonic transmitter release is due to ongoing priming and fusion of new synaptic vesicles during high synaptic activity. Our analysis of alpha- and beta SNAP deletion mutant neurons shows that the two NSF cofactors support synaptic vesicle priming by determining the availability of free SNARE components, particularly during phases of high synaptic activity.	[Burgalossi, Andrea; Jung, Sangyong; Meyer, Guido; Jockusch, Wolf J.; Brose, Nils; Rhee, Jeong-Seop] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Jahn, Olaf] Max Planck Inst Expt Med, Prote Grp, D-37075 Gottingen, Germany; [Jahn, Olaf] Max Planck Inst Expt Med, DFG CMPB, D-37075 Gottingen, Germany; [O'Connor, Vincent M.] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Taschenberger, Holger] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Nishiki, Tei-ichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Kanagawa 2288555, Japan	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Okayama University; Kitasato University	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	brose@em.mpg.de; rhee@em.mpg.de	Jahn, Olaf/AAD-8212-2020; Jung, Sangyong/AAW-9166-2020	Jahn, Olaf/0000-0002-3397-8924; Taschenberger, Holger/0000-0003-3186-3231; O'Connor, Vincent/0000-0003-3185-5709	Max Planck Society; European Community [MEST-CT-2004-504193]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Community(European Commission)	We thank F. Benseler, A. Galinski, T. Hellmann, I. Thanhauser, D. Schwerdtfeger, and the staff of our Transgenic Animal Facility for invaluable support. We thank D. Fasshauer for SNAP and NSF expression plasmids, and E. Neher and H. Betz for advice and critical comments on the manuscript. This work was supported by the Max Planck Society and the European Community (Marie Curie NEUREST fellowship MEST-CT-2004-504193 to A.B.).	Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; He P, 1999, J NEUROPHYSIOL, V82, P3406, DOI 10.1152/jn.1999.82.6.3406; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kuner T, 2008, P NATL ACAD SCI USA, V105, P347, DOI 10.1073/pnas.0707197105; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Martin HGS, 2006, J CELL BIOCHEM, V99, P1203, DOI 10.1002/jcb.20998; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nishiki T, 2001, NEUROSCIENCE, V107, P363, DOI 10.1016/S0306-4522(01)00370-0; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Peter F, 1998, J CELL SCI, V111, P2625; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sakaba T, 2008, NEURON, V57, P406, DOI 10.1016/j.neuron.2007.11.029; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tolar LA, 1998, J NEUROSCI, V18, P10250; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xu JH, 2002, J NEUROSCI, V22, P53, DOI 10.1523/JNEUROSCI.22-01-00053.2002; Xu T, 2001, NAT CELL BIOL, V3, P691, DOI 10.1038/35087000; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; ZUCKER RS, 1983, J GEN PHYSIOL, V81, P355, DOI 10.1085/jgp.81.3.355	46	66	65	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					473	487		10.1016/j.neuron.2010.09.019	http://dx.doi.org/10.1016/j.neuron.2010.09.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040848	Bronze			2022-12-24	WOS:000284255800015
J	Appelbaum, L; Wang, G; Yokogawa, T; Skariah, GM; Smith, SJ; Mourrain, P; Mignot, E				Appelbaum, Lior; Wang, Gordon; Yokogawa, Tohei; Skariah, Gemini M.; Smith, Stephen J.; Mourrain, Philippe; Mignot, Emmanuel			Circadian and Homeostatic Regulation of Structural Synaptic Plasticity in Hypocretin Neurons	NEURON			English	Article							AMPA RECEPTORS; SLEEP; PENTRAXIN; NARP; OREXIN; WAKEFULNESS; EXPRESSION; ZEBRAFISH; SYNAPTOGENESIS; GENES	Neurons exhibit rhythmic activity that ultimately affects behavior such as sleep. In living zebrafish larvae, we used time-lapse two-photon imaging of the presynaptic marker synaptophysin in hypocretin/orexin (HCRT) neurons to determine the dynamics of synaptic modifications during the day and night. We observed circadian rhythmicity in synapse number in HCRT axons. This rhythm is regulated primarily by the circadian clock but is also-affected by sleep deprivation. Furthermore, NPTX2, a protein implicated in AMPA receptor clustering, modulates circadian synaptic changes. In zebrafish, nptx2b is a rhythmic gene that is mostly expressed in hypothalamic and pineal gland cells. Arrhythmic transgenic nptx2b overexpression (hcrt:NPTX2b) increases synapse number and abolishes rhythmicity in HCRT axons. Finally, hcrt:NPTX2b fish are resistant to the sleep-promoting effects of melatonin. This behavioral effect is consistent with NPTX2b-mediated increased activity of HCRT circuitry. These data provide real-time in vivo evidence of circadian and homeostatic regulation of structural synaptic plasticity.	[Appelbaum, Lior; Yokogawa, Tohei; Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94305 USA; [Wang, Gordon; Smith, Stephen J.] Stanford Univ, Beckman Ctr, Dept Mol & Cellular Physiol, Palo Alto, CA 94305 USA; [Yokogawa, Tohei] NICHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; [Mourrain, Philippe] INSERM, U784, F-75005 Paris, France; [Appelbaum, Lior; Yokogawa, Tohei; Skariah, Gemini M.; Mourrain, Philippe; Mignot, Emmanuel] Stanford Univ, Dept Psychiat & Behav Sci, Ctr Narcolepsy, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institut National de la Sante et de la Recherche Medicale (Inserm); Stanford University	Appelbaum, L (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	mourrain@stanford.edu	Mourrain, Philippe/N-4671-2017	Smith, Stephen/0000-0002-2290-8701; Wang, Gordon/0000-0002-2707-7118	McKnight Foundation; NIH [NS23724, NS062798]; Howard Hughes Medical Research Institute; Vincent Coates Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, R01NS062798, P50NS023724] Funding Source: NIH RePORTER	McKnight Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Research Institute(Howard Hughes Medical Institute); Vincent Coates Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Laura Alexandere and Wilfredo Mann for assistance in fish maintenance and experiments We thank Dr Geraldine Maro for her expertise and assistance in confocal microscopy We also thank Dr Jamie Zeitzer and Dr Oren levy for helping in statistical analysis and Dr Matthew E Carter. Dr Brian Grone, Dr Juliette Faraco, Dr Simon Warby, Dr Yoav Gothilf, and Dr Luis de Lecea for helpful comments on the manuscript This research was supported by the McKnight Foundation. the NIH (NS23724, NS062798), the Howard Hughes Medical Research Institute (E M), and the Vincent Coates Foundation (S J S)	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Appelbaum L, 2009, P NATL ACAD SCI USA, V106, P21942, DOI 10.1073/pnas.906637106; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Basheer R, 1997, J NEUROSCI, V17, P9746; Berman JR, 2009, J COMP NEUROL, V517, P695, DOI 10.1002/cne.22171; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Carvalho Lara, 2009, V546, P273, DOI 10.1007/978-1-60327-977-2_17; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Ebihara T, 2003, J NEUROSCI, V23, P2170; Faraco JH, 2006, J BIOL CHEM, V281, P29753, DOI 10.1074/jbc.M605811200; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johnson AW, 2007, J NEUROSCI, V27, P13430, DOI 10.1523/JNEUROSCI.4320-07.2007; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Koch SM, 2010, J NEUROSCI, V30, P5404, DOI 10.1523/JNEUROSCI.4893-09.2010; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Livneh Y, 2009, J NEUROSCI, V29, P86, DOI 10.1523/JNEUROSCI.4105-08.2009; LU J, 1993, J COMP PHYSIOL A, V173, P765, DOI 10.1007/BF02451907; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Munoz E, 2003, CHRONOBIOL INT, V20, P371, DOI 10.1081/CBI-120022525; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nishino S, 2006; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, BIOESSAYS, V24, P419, DOI 10.1002/bies.10091; Panula P, 2010, ACTA PHYSIOL, V198, P381, DOI 10.1111/j.1748-1716.2009.02038.x; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Pyza E, 2008, ACTA NEUROBIOL EXP, V68, P322; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Reti IM, 2008, NEUROSCIENCE, V151, P352, DOI 10.1016/j.neuroscience.2007.10.040; Reti IM, 2002, J NEUROCHEM, V82, P1561, DOI 10.1046/j.1471-4159.2002.01141.x; Reti IM, 2008, BEHAV NEUROSCI, V122, P760, DOI 10.1037/a0012514; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Stutz AM, 2007, OBESITY, V15, P607, DOI 10.1038/oby.2007.564; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Terao A, 2006, NEUROSCIENCE, V137, P593, DOI 10.1016/j.neuroscience.2005.08.059; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tsui CC, 1996, J NEUROSCI, V16, P2463; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	65	124	127	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					87	98		10.1016/j.neuron.2010.09.006	http://dx.doi.org/10.1016/j.neuron.2010.09.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920793	Green Accepted, Bronze			2022-12-24	WOS:000283704200010
J	Logothetis, NK; Augath, M; Murayama, Y; Rauch, A; Sultan, F; Goense, J; Oeltermann, A; Merkle, H				Logothetis, Nikos K.; Augath, Mark; Murayama, Yusuke; Rauch, Alexander; Sultan, Fahad; Goense, Jozien; Oeltermann, Axel; Merkle, Hellmut			The effects of electrical microstimulation on cortical signal propagation	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CAT VISUAL-CORTEX; FRONTAL EYE FIELD; STRIATE CORTEX; INTRACORTICAL MICROSTIMULATION; FUNCTIONAL MRI; RAT NEOCORTEX; MOTOR CORTEX; FMRI SIGNAL; AREA MT	Electrical stimulation has been used in animals and humans to study potential causal links between neural activity and specific cognitive functions. Recently, it has found increasing use in electrotherapy and neural prostheses. However, the manner in which electrical stimulation-elicited signals propagate in brain tissues remains unclear. We used combined electrostimulation, neurophysiology, microinjection and functional magnetic resonance imaging (fMRI) to study the cortical activity patterns elicited during stimulation of cortical afferents in monkeys. We found that stimulation of a site in the lateral geniculate nucleus (LGN) increased the fMRI signal in the regions of primary visual cortex (V1) that received input from that site, but suppressed it in the retinotopically matched regions of extrastriate cortex. Consistent with previous observations, intracranial recordings indicated that a short excitatory response occurring immediately after a stimulation pulse was followed by a long-lasting inhibition. Following microinjections of GABA antagonists in V1, LGN stimulation induced positive fMRI signals in all of the cortical areas. Taken together, our findings suggest that electrical stimulation disrupts cortico-cortical signal propagation by silencing the output of any neocortical area whose afferents are electrically stimulated.	[Logothetis, Nikos K.; Augath, Mark; Murayama, Yusuke; Rauch, Alexander; Goense, Jozien; Oeltermann, Axel] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Manchester, Lancs, England; [Sultan, Fahad] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Tubingen, Germany; [Merkle, Hellmut] NINDS, Lab Funct & Mol Imaging, US NIH, Bethesda, MD 20892 USA	Max Planck Society; University of Manchester; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019		Max Planck Society; German Research Foundation [DFG SFB-A9]; US National Institutes of Health (National Institute Neurological Disorders and Stroke)	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); US National Institutes of Health (National Institute Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Kayser, O. Eschenko and M. Munk for reading the manuscript and for useful suggestions. Many thanks also go to D. Blaurock for editing, S. Weber for fine-mechanic work and T. Steudel and P. Douay for help with the alert monkey experiments. This research was supported by the Max Planck Society, the German Research Foundation (DFG SFB-A9) and by the intramural research program of the US National Institutes of Health (National Institute Neurological Disorders and Stroke, H.M.).	Allen EA, 2007, SCIENCE, V317, P1918, DOI 10.1126/science.1146426; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; Brewer AA, 2002, J NEUROSCI, V22, P10416; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Butovas S, 2007, EUR J NEUROSCI, V25, P2161, DOI 10.1111/j.1460-9568.2007.05449.x; Butovas S, 2006, J NEUROPHYSIOL, V96, P1227, DOI 10.1152/jn.01170.2005; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; DEFELIPE J, 1986, J NEUROSCI, V6, P3749, DOI 10.1523/jneurosci.06-12-03749.1986; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Driver J, 2009, TRENDS COGN SCI, V13, P319, DOI 10.1016/j.tics.2009.04.007; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ekstrom LB, 2009, J NEUROSCI, V29, P10683, DOI 10.1523/JNEUROSCI.0673-09.2009; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRIES W, 1983, PROC R SOC SER B-BIO, V219, P53, DOI 10.1098/rspb.1983.0058; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guillery RW, 1995, J ANAT, V187, P583; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Kara P, 2002, P NATL ACAD SCI USA, V99, P16261, DOI 10.1073/pnas.242625499; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; LI C, 1963, J CELL COMPAR PHYSL, V61, P165, DOI 10.1002/jcp.1030610207; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Pezaris JS, 2007, P NATL ACAD SCI USA, V104, P7670, DOI 10.1073/pnas.0608563104; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Sultan F, 2007, MAGN RESON IMAGING, V25, P754, DOI 10.1016/j.mri.2007.03.014; Tehovnik EJ, 2005, J NEUROPHYSIOL, V93, P1, DOI 10.1152/jn.00736.2004; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034	50	226	231	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1283	1291		10.1038/nn.2631	http://dx.doi.org/10.1038/nn.2631			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818384				2022-12-24	WOS:000282171300022
J	Junek, S; Kludt, E; Wolf, F; Schild, D				Junek, Stephan; Kludt, Eugen; Wolf, Fred; Schild, Detlev			Olfactory Coding with Patterns of Response Latencies	NEURON			English	Article							RAT SOMATOSENSORY CORTEX; XENOPUS-LAEVIS TADPOLES; RECEPTOR NEURON INPUT; ODOR REPRESENTATIONS; SPIKE LATENCIES; STIMULUS LOCATION; BULB; DISCRIMINATION; TIME; CELLS	The encoding of odors by spatiotemporal patterns of mitral/tufted (M/T) cells in the vertebrate olfactory bulb has been discussed controversially. Motivated by temporal constraints from behavioral studies, we investigated the information contained in odor-evoked first-spike latencies. Using simultaneous recordings of dozens of M/T cells with a high temporal resolution and quantitative ensemble correlation techniques, we show that latency patterns, and in particular latency rank patterns, are highly odor specific and reproducible. They reliably predict the odor identity as well as the odor concentration on a single-trial basis and on short timescales in fact, more reliably than patterns of firing rates. Furthermore, we show that latency ranks exhibit a better reproducibility at the level of M/T cells than in olfactory receptor neurons. Our results suggest that the latency patterns of M/T cells contain all the information higher brain centers need to identify odors and their concentrations.	[Junek, Stephan; Kludt, Eugen; Schild, Detlev] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany; [Junek, Stephan; Schild, Detlev] Univ Gottingen, DFG Res Ctr Mol Physiol Brain CMPB, D-37073 Gottingen, Germany; [Junek, Stephan; Schild, Detlev] DFG Excellence Cluster 171, D-37073 Gottingen, Germany; [Junek, Stephan; Wolf, Fred; Schild, Detlev] Bernstein Focus Neurotechnol Gottingen, D-37073 Gottingen, Germany; [Junek, Stephan; Kludt, Eugen; Wolf, Fred; Schild, Detlev] Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany; [Wolf, Fred] Univ Gottingen, Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Wolf, Fred] Univ Gottingen, Fac Phys, D-37073 Gottingen, Germany	University of Gottingen; German Research Foundation (DFG); University of Gottingen; Max Planck Society; University of Gottingen; University of Gottingen	Junek, S (corresponding author), Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Humboldtallee 23, D-37073 Gottingen, Germany.	sjunek@gwdg.de	Wolf, Fred/D-5771-2011	Wolf, Fred/0000-0002-7068-3762	DFG Center for Molecular Physiology of the Brain; DFG [171]; Bernstein Center for Computational Neuorscience [01GQ0432, 01GQ1005B]; Bernstein Focus Neurotechnology [01GQ0811, 01GQ0810]	DFG Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Bernstein Center for Computational Neuorscience; Bernstein Focus Neurotechnology	We would like to thank R. Friedrich for providing the MATLAB code for the reconstruction of firing rates. We further thank P. Salonikidis, I. Manzini, M. Alevra, and P. Brown for reading the manuscript, and T. Nagel, J. Kowalski, H. Benseler, and W. Grabe for expert technical support. This project was funded by the DFG Center for Molecular Physiology of the Brain (D.S.), the DFG Excellence Cluster 171 (S.J., D.S.), the Bernstein Center for Computational Neuorscience (01GQ0432 and 01GQ1005B; S.J., E.K., D.S.) and the Bernstein Focus Neurotechnology (01GQ0811 and 01GQ0810; D.S., S.J., F.W.).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; BEICHELT FE, 2003, TEUBNER TASCHENBUCH; BURR DC, 1979, VISION RES, V19, P523, DOI 10.1016/0042-6989(79)90137-8; Cang JH, 2003, J NEUROSCI, V23, P4108; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; CARR CE, 1990, J NEUROSCI, V10, P3227; Czesnik D, 2003, EUR J NEUROSCI, V17, P113, DOI 10.1046/j.1460-9568.2003.02448.x; Delorme A, 2003, J COMPUT NEUROSCI, V15, P357, DOI 10.1023/A:1027420012134; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; GETCHELL TV, 1978, J PHYSIOL-LONDON, V282, P521, DOI 10.1113/jphysiol.1978.sp012479; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gomez G, 1996, J EXP BIOL, V199, P1771; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Heil P, 1997, J NEUROPHYSIOL, V77, P2642, DOI 10.1152/jn.1997.77.5.2642; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Junek S, 2009, BIOPHYS J, V96, P3801, DOI 10.1016/j.bpj.2008.12.3962; KAUER JS, 1977, J PHYSIOL-LONDON, V272, P495, DOI 10.1113/jphysiol.1977.sp012056; KENDALL M, 1990, RANK CORRELATION MET, V5, P29; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; KISELEVA EI, 1995, ZH OBSHCH BIOL, V56, P329; Kuwahara M., 1976, DIGITAL PROCESSING B, P187, DOI DOI 10.1007/978-1-4684-0769-3_13; LAING DG, 1986, PHYSIOL BEHAV, V37, P163, DOI 10.1016/0031-9384(86)90400-2; Laing DG, 2003, CHEM SENSES, V28, P57, DOI 10.1093/chemse/28.1.57; LAING DG, 1994, BRAIN RES, V651, P317, DOI 10.1016/0006-8993(94)90712-9; Lam YW, 2003, EUR J NEUROSCI, V17, P436, DOI 10.1046/j.1460-9568.2003.02457.x; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lehmkuhle MJ, 2006, J NEUROPHYSIOL, V95, P1369, DOI 10.1152/jn.01334.2004; Lin BJ, 2007, J PHYSIOL-LONDON, V582, P163, DOI 10.1113/jphysiol.2006.125963; Manzini I, 2002, J NEUROSCI METH, V121, P159, DOI 10.1016/S0165-0270(02)00248-0; Manzini I, 2008, J NEUROSCI METH, V167, P140, DOI 10.1016/j.jneumeth.2007.07.018; Manzini I, 2007, EUR J NEUROSCI, V26, P925, DOI 10.1111/j.1460-9568.2007.05731.x; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Moreaux L, 2008, FRONT NEUROSCI-SWITZ, V2, P176, DOI 10.3389/neuro.01.032.2008; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petersen RS, 2002, BIOSYSTEMS, V67, P187, DOI 10.1016/S0303-2647(02)00076-X; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Scott JW, 2006, CHEM SENSES, V31, P119, DOI 10.1093/chemse/bjj013; Slotnick B, 2007, CHEM SENSES, V32, P445, DOI 10.1093/chemse/bjm013; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Thorpe S, 1998, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, P113; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Weisstein E.W., 2002, CRC CONCISE ENCY MAT; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008; Wright GA, 2005, P ROY SOC B-BIOL SCI, V272, P2417, DOI 10.1098/rspb.2005.3252; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	57	87	88	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					872	884		10.1016/j.neuron.2010.08.005	http://dx.doi.org/10.1016/j.neuron.2010.08.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826317	Bronze			2022-12-24	WOS:000281938900020
J	Millard, SS; Lu, ZY; Zipursky, SL; Meinertzhagen, IA				Millard, S. Sean; Lu, Zhiyuan; Zipursky, S. Lawrence; Meinertzhagen, Ian A.			Drosophila Dscam Proteins Regulate Postsynaptic Specificity at Multiple-Contact Synapses	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; VISUAL-SYSTEM; NERVOUS-SYSTEM; SELF-AVOIDANCE; AXON GUIDANCE; SYNAPTIC CONNECTIONS; NETRIN RECEPTOR; REQUIRE DSCAM; MOUSE RETINA; MORPHOGENESIS	In both vertebrate and invertebrate visual systems, neurons form multiple-contact synapses at which a single presynaptic site releases neurotransmitter upon a discrete combination of different postsynaptic cells. Recognition mechanisms underlying the assembly of such synapses are not known. In Drosophila, photoreceptor terminals form tetrad synapses that incorporate an invariable pair of postsynaptic elements, one each from lamina interneuron L1 and L2, and two elements from other cells. Here, we demonstrate that Drosophila Dscam1 and Dscam2, genes encoding homophilic repulsive proteins, act redundantly to ensure the invariable combination of L1 and L2 postsynaptic elements at all tetrads. We demonstrate that this strict pairing is lost in Dscam1;Dscam2 double mutants. Thus, removing these two repulsive proteins allows elements from the same cell to incorporate into the same postsynaptic tetrad, altering the specificity of photoreceptor transmission. We propose that Dscams regulate synaptic specificity by excluding inappropriate partners at multiple-contact synapses.	[Millard, S. Sean; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Lu, Zhiyuan; Meinertzhagen, Ian A.] Dalhousie Univ, Dept Psychol, Life Sci Ctr, Halifax, NS B3H 4J1, Canada	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Dalhousie University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu; i.a.meinertzhagen@dal.ca	Millard, Sean/A-8522-2013	Millard, Sean/0000-0001-8573-4625; Meinertzhagen, Ian/0000-0002-6578-4526; Zipursky, Stephen/0000-0001-5630-7181	NIH [EY03592, DC006485]; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Jim Clemens, Kelsey Martin, Carlos Portera-Cailliau, Alvaro Sagasti, and members of the Zipursky lab for critical comments on the manuscript and Shin-ya Takemura at Janelia Farm for technical help with serial EM. We thank Dorian Gunning for generating the Dscam1 monoclonal antibody and Susan Yee for technical help with figures and text. We acknowledge the technical help of Mss. Rita Kostyleva, Jane Anne Home, and Dorota Tarnogorska (Dalhousie) and the support of NIH (EY03592, to I.A.M., and DC006485, to S.L.Z.). S.L.Z. is an investigator of the Howard Hughes Medical Institute, and I.A.M. was a Killam Fellow of the Canada Council.	Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; FROHLICH A, 1983, J NEUROSCI, V3, P2336; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; HALL DH, 1991, J NEUROSCI, V11, P1; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li HL, 2009, NEURON, V61, P527, DOI 10.1016/j.neuron.2009.01.010; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; Meinertzhagen I. A., 1993, DEV DROSOPHILA MELAN, V2; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen IA, 1996, J NEUROSCI METH, V69, P59, DOI 10.1016/S0165-0270(96)00021-0; Meinertzhagen IA, 2000, EUR J NEUROSCI, V12, P1342, DOI 10.1046/j.1460-9568.2000.00033.x; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Peters A., 1991, FINE STRUCTURE NERVO; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SHAW SR, 1986, P NATL ACAD SCI USA, V83, P7961, DOI 10.1073/pnas.83.20.7961; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Vogt AK, 2005, NEUROSCIENCE, V134, P783, DOI 10.1016/j.neuroscience.2005.04.039; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	39	58	58	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 9	2010	67	5					761	768		10.1016/j.neuron.2010.08.030	http://dx.doi.org/10.1016/j.neuron.2010.08.030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826308	Green Accepted, Bronze			2022-12-24	WOS:000281938900011
J	Marrs, WR; Blankman, JL; Horne, EA; Thomazeau, A; Lin, YH; Coy, J; Bodor, AL; Muccioli, GG; Hu, SSJ; Woodruff, G; Fung, S; Lafourcade, M; Alexander, JP; Long, JZ; Li, WW; Xu, C; Moller, T; Mackie, K; Manzoni, OJ; Cravatt, BF; Stella, N				Marrs, William R.; Blankman, Jacqueline L.; Horne, Eric A.; Thomazeau, Aurore; Lin, Yi Hsing; Coy, Jonathan; Bodor, Agnes L.; Muccioli, Giulio G.; Hu, Sherry Shu-Jung; Woodruff, Grace; Fung, Susan; Lafourcade, Mathieu; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Xu, Cong; Moeller, Thomas; Mackie, Ken; Manzoni, Olivier J.; Cravatt, Benjamin F.; Stella, Nephi			The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors	NATURE NEUROSCIENCE			English	Article							2-ARACHIDONOYLGLYCEROL HYDROLYSIS; ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; ANANDAMIDE; BLOCKADE; BRAIN; MODULATION; ACID; INHIBITOR; ENZYMES	The endocannabinoid 2-arachidonoylglycerol (2-AG) regulates neurotransmission and neuroinflammation by activating CB1 cannabinoid receptors on neurons and CB2 cannabinoid receptors on microglia. Enzymes that hydrolyze 2-AG, such as monoacylglycerol lipase, regulate the accumulation and efficacy of 2-AG at cannabinoid receptors. We found that the recently described serine hydrolase alpha-beta-hydrolase domain 6 (ABHD6) also controls the accumulation and efficacy of 2-AG at cannabinoid receptors. In cells from the BV-2 microglia cell line, ABHD6 knockdown reduced hydrolysis of 2-AG and increased the efficacy with which 2-AG can stimulate CB2-mediated cell migration. ABHD6 was expressed by neurons in primary culture and its inhibition led to activity-dependent accumulation of 2-AG. In adult mouse cortex, ABHD6 was located postsynaptically and its selective inhibition allowed the induction of CB1-dependent long-term depression by otherwise subthreshold stimulation. Our results indicate that ABHD6 is a rate-limiting step of 2-AG signaling and is therefore a bona fide member of the endocannabinoid signaling system.	[Horne, Eric A.; Lin, Yi Hsing; Coy, Jonathan; Xu, Cong; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Marrs, William R.; Fung, Susan] Univ Washington, Neurobiol & Behav Grad Program, Seattle, WA 98195 USA; [Blankman, Jacqueline L.; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Blankman, Jacqueline L.; Alexander, Jessica P.; Long, Jonathan Z.; Li, Weiwei; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Thomazeau, Aurore; Lafourcade, Mathieu; Manzoni, Olivier J.] Equipe Physiopathol Plast Synapt, INSERM, U862, Bordeaux, France; [Bodor, Agnes L.] Univ Washington, Dept Otolaryngol, Seattle, WA 98195 USA; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, CHAM7230, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium; [Hu, Sherry Shu-Jung; Mackie, Ken] Indiana Univ, Gill Ctr Biomol Sci, Dept Psychol & Brain Sci, Bloomington, IN USA; [Woodruff, Grace] Univ Washington, Neurobiol Undergraduate Program, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Stella, Nephi] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Washington; University of Washington Seattle; Universite Catholique Louvain; Indiana University System; Indiana University Bloomington; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stella, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nstella@uw.edu	Lafourcade, Mathieu/GQZ-7267-2022; LI, WEWEI/F-8657-2010; Manzoni, Olivier/M-7899-2016; Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013	Manzoni, Olivier/0000-0002-5579-6208; Mackie, Ken/0000-0001-8501-6199; Thomazeau, Aurore/0000-0002-7668-2867; Lafourcade, Mathieu/0000-0001-6117-1194; Long, Jonathan/0000-0003-2631-7463; Muccioli, Giulio/0000-0002-1600-9259	National Institute on Drug Abuse [DA14486, DA26430, DA017259, DA009789, DA025285, DA026161]; National Institute of General Medical Sciences (PHS NRSA) [2T32 GM007270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA014486, R01DA025285, R01DA026430, P01DA017259, K05DA021696] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of General Medical Sciences (PHS NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (DA14486 and DA26430 to N.S., DA017259, DA009789 and DA025285 to B. F. C. and DA026161 to J.L.B.) and from the National Institute of General Medical Sciences (PHS NRSA 2T32 GM007270 to W. R. M.).	Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; BEROD A, 1981, J HISTOCHEM CYTOCHEM, V29, P844, DOI 10.1177/29.7.6167611; Bisogno T, 2009, BBA-MOL CELL BIOL L, V1791, P53, DOI 10.1016/j.bbalip.2008.10.007; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Burston JJ, 2008, J PHARMACOL EXP THER, V327, P546, DOI 10.1124/jpet.108.141382; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Horne EA, 2008, FUTURE LIPIDOL, V3, P435, DOI 10.2217/17460875.3.4.435; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; KANO M, 2009, PHYSIOL REV, V309, P380; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; Marrs W, 2007, CHEM BIOL, V14, P1309, DOI 10.1016/j.chembiol.2007.12.004; Marrs W, 2009, AAPS J, V11, P307, DOI 10.1208/s12248-009-9109-0; Miller AM, 2009, GLIA, V57, P875, DOI 10.1002/glia.20813; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MUCCIOLI GG, 2007, ANAL BIOCHEM, V373, P220; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Saario SM, 2005, CHEM BIOL, V12, P649, DOI 10.1016/j.chembiol.2005.04.013; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STELLA N, 1995, J NEUROSCI, V15, P3307; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Straiker A, 2006, AAPS J, V8, pE272; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Yates JR, 1996, ANAL CHEM, V68, pA534, DOI 10.1021/ac962050l	42	322	330	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					951	U67		10.1038/nn.2601	http://dx.doi.org/10.1038/nn.2601			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20657592	Green Accepted			2022-12-24	WOS:000280400600013
J	Kaneko, N; Marin, O; Koike, M; Hirota, Y; Uchiyama, Y; Wu, JY; Lu, QA; Tessier-Lavigne, M; Alvarez-Buylla, A; Okano, H; Rubenstein, JLR; Sawamoto, K				Kaneko, Naoko; Marin, Oscar; Koike, Masato; Hirota, Yuki; Uchiyama, Yasuo; Wu, Jane Y.; Lu, Qiang; Tessier-Lavigne, Marc; Alvarez-Buylla, Arturo; Okano, Hideyuki; Rubenstein, John L. R.; Sawamoto, Kazunobu			New Neurons Clear the Path of Astrocytic Processes for Their Rapid Migration in the Adult Brain	NEURON			English	Article							CELL-MIGRATION; INTERNEURON MIGRATION; NEUROBLAST MIGRATION; DIRECTIONAL GUIDANCE; SUBVENTRICULAR ZONE; RADIAL GLIA; PRECURSORS; CHEMOREPULSION; NEUROGENESIS; ORGANIZATION	In the long-range neuronal migration of adult mammals, young neurons travel from the subventricular zone to the olfactory bulb, a long journey (millimeters to centimeters, depending on the species). How can these neurons migrate through the dense meshwork of neuronal and glial processes of the adult brain parenchyma? Previous studies indicate that young neurons achieve this by migrating in chains through astrocytic tunnels. Here, we report that young migrating neurons actively control the formation and maintenance of their own migration route. New neurons secrete the diffusible protein Slit1, whose receptor, Robo, is expressed on astrocytes. We show that the Slit-Robo pathway is required for morphologic and organizational changes in astrocytes that result in the formation and maintenance of the astrocytic tunnels. Through this neuron-glia interaction, the new neurons regulate the formation of the astrocytic meshwork that is needed to enable their rapid and directional migration in adult brain.	[Kaneko, Naoko; Hirota, Yuki; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Inst Mol Med, Dept Dev & Regenerat Biol, Aichi 4678601, Japan; [Marin, Oscar] CSIC, Inst Neurociencias, Alicante 03550, Spain; [Marin, Oscar] Univ Miguel Hernandez, Alicante 03550, Spain; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Lu, Qiang] Beckman Res Inst City Hope, Div Neurosci, Duarte, CA USA; [Tessier-Lavigne, Marc] Genentech Inc, San Francisco, CA 94080 USA; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjyuku Ku, Tokyo 1608582, Japan; [Rubenstein, John L. R.] Univ Calif San Francisco, Ctr Neurobiol & Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA	Nagoya City University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Juntendo University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; City of Hope; Beckman Research Institute of City of Hope; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Keio University; University of California System; University of California San Francisco	Sawamoto, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Inst Mol Med, Dept Dev & Regenerat Biol, Aichi 4678601, Japan.	sawamoto@med.nagoya-cu.ac.jp	Marin, Oscar/F-3856-2012; Kaneko, Naoko/P-2054-2019; Okano, Hideyuki/I-7584-2019; Hirota, Yuki/A-9736-2015; Koike, Masato/F-9584-2010	Marin, Oscar/0000-0001-6264-7027; Hirota, Yuki/0000-0001-9629-0038; Koike, Masato/0000-0002-3174-5684; Sawamoto, Kazunobu/0000-0003-1984-5129; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Kaneko, Naoko/0000-0003-3121-7117	Ministry of Education, Culture, Sports, Science & Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW); Japan Society for the Promotion of Science (JSPS); Human Frontier Science Program (HFSP); Toray Science Foundation; Keio University Medical Science Fund; Inoue Foundation for Science; NOVARTIS Foundation (Japan) for the Promotion of Science; Kowa Life Science Foundation; NIH [CA114197, CA107193]; James S. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA114197, R01CA107193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science & Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Toray Science Foundation(Toray Industries, Inc.); Keio University Medical Science Fund; Inoue Foundation for Science(Inoue Foundation for Science); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Kowa Life Science Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the anonymous reviewers for helpful comments on the manuscript; Dr. Fujio Murakami for providing the specific antibodies to Robo1 and Robo2; Dr. Didier Trono for providing the lentivirus packaging plasmids, psPAX2 and pMD2.G; Dr. Nathaniel Heintz and the Mutant Mouse Regional Resource Center (MMRRC) for providing the Gfap-EGFP mice; and Drs. Ichiro Miyoshi, Tatsumi Hirata, Francois Renault-Mihara and Takehiko Sunabori and Miss Rie Ueda for technical support. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Ministry of Health, Labor and Welfare (MHLW), Japan Society for the Promotion of Science (JSPS), Human Frontier Science Program (HFSP), Toray Science Foundation, Keio University Medical Science Fund, Inoue Foundation for Science, NOVARTIS Foundation (Japan) for the Promotion of Science, and Kowa Life Science Foundation. J.Y.W is supported by NIH (CA114197, CA107193) and James S. McDonnell Foundation. N.K. was an Inoue Fellow.	Andrews W, 2006, DEVELOPMENT, V133, P2243, DOI 10.1242/dev.02379; Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Anton ES, 1997, DEVELOPMENT, V124, P3501; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chazal G, 2000, J NEUROSCI, V20, P1446; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Garcia-Marques J, 2010, GLIA, V58, P218, DOI 10.1002/glia.20918; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirota Y, 2007, J NEUROSCI, V27, P12829, DOI 10.1523/JNEUROSCI.1014-07.2007; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Jankovski A, 1996, J COMP NEUROL, V371, P376; Kaneko N, 2009, NEUROSCI RES, V63, P155, DOI 10.1016/j.neures.2008.12.001; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Murase S, 2002, J NEUROSCI, V22, P3568; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Okano H, 2008, PHILOS T R SOC B, V363, P2111, DOI 10.1098/rstb.2008.2264; Petreanu L, 2002, J NEUROSCI, V22, P6106; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Shiau CE, 2008, NAT NEUROSCI, V11, P269, DOI 10.1038/nn2051; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; UCHIYAMA Y, 1984, CELL TISSUE RES, V237, P117; Wang X, 2007, J NEUROSCI RES, V85, P3567, DOI 10.1002/jnr.21440; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	45	157	166	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					213	223		10.1016/j.neuron.2010.06.018	http://dx.doi.org/10.1016/j.neuron.2010.06.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670830	Green Accepted, Bronze			2022-12-24	WOS:000280461500007
J	Miller, JP; Holcomb, J; Al-Ramahi, I; de Haro, M; Gafni, J; Zhang, NZ; Kim, E; Sanhueza, M; Torcassi, C; Kwak, S; Botas, J; Hughes, RE; Ellerby, LM				Miller, John P.; Holcomb, Jennifer; Al-Ramahi, Ismael; de Haro, Maria; Gafni, Juliette; Zhang, Ningzhe; Kim, Eugene; Sanhueza, Mario; Torcassi, Cameron; Kwak, Seung; Botas, Juan; Hughes, Robert E.; Ellerby, Lisa M.			Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease	NEURON			English	Article							N-TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; CASPASE CLEAVAGE; STRIATAL CELLS; POLYGLUTAMINE EXPANSION; REDUCES TOXICITY; POTENTIAL ROLE; MOUSE MODEL; HUMAN BRAIN; PROTEIN	Proteolytic cleavage of huntingtin (Htt) is known to be a key event in the pathogenesis of Huntington's disease (HD). Our understanding of proteolytic processing of Htt has thus far focused on the protease families-caspases and calpains. Identifying critical proteases involved in Htt proteolysis and toxicity using an unbiased approach has not been reported. To accomplish this, we designed a high-throughput western blot-based screen to examine the generation of the smallest N-terminal polyglutamine-containing Htt fragment. We screened 514 siRNAs targeting the repertoire of human protease genes. This screen identified 11 proteases that, when inhibited, reduced Htt fragment accumulation. Three of these belonged to the matrix metalloproteinase (MMP) family. One family member, MMP-10, directly cleaves Htt and prevents cell death when knocked down in striatal cells. Correspondingly, MMPs are activated in HD mouse models, and loss of function of Drosophila homologs of MMPs suppresses Htt-induced neuronal dysfunction in vivo.	[Miller, John P.; Holcomb, Jennifer; Gafni, Juliette; Zhang, Ningzhe; Torcassi, Cameron; Hughes, Robert E.; Ellerby, Lisa M.] Buck Inst Age Res, Novato, CA 94945 USA; [Al-Ramahi, Ismael; de Haro, Maria; Kim, Eugene; Sanhueza, Mario; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kwak, Seung] CHDI Fdn Inc, Princeton, NJ 08540 USA	Buck Institute for Research on Aging; Baylor College of Medicine	Hughes, RE (corresponding author), Buck Inst Age Res, Novato, CA 94945 USA.	rhughes@buckinstitute.org; lellerby@buckinstitute.org	Al-Ramahi, Ismael/B-4000-2017	Al-Ramahi, Ismael/0000-0002-1275-1114; Sanhueza, Mario/0000-0002-0125-0154; de Haro, Maria/0000-0002-8654-2526	NIH [NS040251, NS042179]; CHDI; Nathan Shock [P30AG025708]; HDF;  [AG000266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040251, R56NS042179, R01NS042179, RL1NS062413, R01NS074408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266, P30AG025708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI; Nathan Shock; HDF; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH (NS040251 to L.M.E.), (NS042179 to J.B.), CHDI (to R.E.H., L.M.E., and J.B.), T32 training grant AG000266 (J.P.M.), and Nathan Shock P30AG025708. We thank Danielle Crippen for training in immunohistochemistry and Espen Walker, University of New Mexico, for assistance in providing in situ zymography protocol. Hdh<SUP>7Q/7Q</SUP> and Hdh<SUP>111Q/111Q</SUP> cells were generously provided by Dr. Marcy MacDonald (Massachusetts General Hospital). I.A.-R. was funded by a postdoctoral fellowship from the HDF. We thank Doug Beckner for technical help on graphics.	Albin RL, 1995, ANN NEUROL, V38, P835, DOI 10.1002/ana.410380602; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Atwal RS, 2008, AUTOPHAGY, V4, P91, DOI 10.4161/auto.5201; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bertini I, 2004, J MOL BIOL, V336, P707, DOI 10.1016/j.jmb.2003.12.033; Bhide PG, 1996, J NEUROSCI, V16, P5523; Cai Z, 2006, NEUROSCIENCE, V137, P425, DOI 10.1016/j.neuroscience.2005.09.023; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; Choi WS, 2008, J THROMB HAEMOST, V6, P517, DOI 10.1111/j.1538-7836.2007.02871.x; Cuadrado E, 2009, J PROTEOME RES, V8, P3191, DOI 10.1021/pr801012x; CUDKOWICZ M, 1990, ANN NEUROL, V27, P200, DOI 10.1002/ana.410270217; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GourfinkelAn I, 1997, ANN NEUROL, V42, P712, DOI 10.1002/ana.410420507; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; HORNEBECK W, 1991, CR SOC BIOL, V185, P127; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kegel KB, 2009, BIOCHEM BIOPH RES CO, V387, P472, DOI 10.1016/j.bbrc.2009.07.039; Kegel KB, 2009, J NEUROCHEM, V110, P1585, DOI 10.1111/j.1471-4159.2009.06255.x; Kim M, 1999, J NEUROSCI, V19, P964; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Konttinen YT, 1999, ANN RHEUM DIS, V58, P691, DOI 10.1136/ard.58.11.691; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lee H, 2009, NEUROBIOL DIS, V34, P189, DOI 10.1016/j.nbd.2008.12.012; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo DC, 2002, J BIOL CHEM, V277, P25527, DOI 10.1074/jbc.M202494200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mao ZK, 2006, EUR J NEUROSCI, V23, P1701, DOI 10.1111/j.1460-9568.2006.04686.x; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Mookerjee S, 2009, J NEUROSCI, V29, P15134, DOI 10.1523/JNEUROSCI.4720-09.2009; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ronco P, 2007, SEMIN NEPHROL, V27, P352, DOI 10.1016/j.semnephrol.2007.02.006; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wei S, 2003, BIOCHEMISTRY-US, V42, P12200, DOI 10.1021/bi035358x; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Xue MZ, 2009, BRAIN, V132, P26, DOI 10.1093/brain/awn215; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	61	127	130	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					199	212		10.1016/j.neuron.2010.06.021	http://dx.doi.org/10.1016/j.neuron.2010.06.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670829	Green Accepted, Bronze			2022-12-24	WOS:000280461500006
J	Loh, YH; Hartung, O; Li, H; Guo, CG; Sahalie, JM; Manos, PD; Urbach, A; Heffner, GC; Grskovic, M; Vigneault, F; Lensch, MW; Park, IH; Agarwal, S; Church, GM; Collins, JJ; Irion, S; Daley, GQ				Loh, Yuin-Han; Hartung, Odelya; Li, Hu; Guo, Chunguang; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Grskovic, Marica; Vigneault, Francois; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Church, George M.; Collins, James J.; Irion, Stefan; Daley, George Q.			Reprogramming of T Cells from Human Peripheral Blood	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; FIBROBLASTS; EXPRESSION; INDUCTION		[Grskovic, Marica; Irion, Stefan] iPierian Inc, San Francisco, CA 94080 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Guo, Chunguang; Lensch, M. William; Collins, James J.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Guo, Chunguang] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA; [Guo, Chunguang; Vigneault, Francois; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston University; Boston University; Harvard University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Irion, S (corresponding author), iPierian Inc, San Francisco, CA 94080 USA.	stefanirion@ipierian.com; george.daley@childrens.harvard.edu	/GLR-9975-2022; Loh, Yuin-Han/E-1096-2014; Grskovic, Marica/AAJ-4080-2021	Loh, Yuin-Han/0000-0002-4715-6454; Urbach, Achia/0000-0001-9393-4504; church, george/0000-0001-6232-9969	National Institutes of Health (NIH) [RL1DE019021]; Howard Hughes Medical Institute; SysCODE (Systems-based Consortium for Organ Design Engineering); Agency of Science, Technology, and Research (A*Star); Institute of Medical Biology, Singapore; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019021] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); SysCODE (Systems-based Consortium for Organ Design Engineering); Agency of Science, Technology, and Research (A*Star)(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology, Singapore; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by grants from the National Institutes of Health (NIH) and the Howard Hughes Medical Institute to G.Q.D. J.J.C. is supported by SysCODE (Systems-based Consortium for Organ Design & Engineering), NIH grant # RL1DE019021. Y.-H.L. is supported by the overseas fellowship from Agency of Science, Technology, and Research (A*Star) and the Institute of Medical Biology, Singapore. We are grateful to Ann M. Mullally, Anupama Narla, Benjamin L. Ebert, Lars U.W. Muller, Axel Schambach, and Stelios Andreadis for technical assistances. We acknowledge Sabine Loewer for helpful discussions and critical comments on the manuscript. G.Q.D. is a member of the Scientific Advisory Board of iPierian, Inc. M.G. and S.I. are employed by iPierian, Inc., a biotechnology company using iPSCs for drug discovery.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Ikehata H, 2003, ENVIRON MOL MUTAGEN, V41, P280, DOI 10.1002/em.10153; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; MUELLER DL, 1994, J IMMUNOL, V153, P3014; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	22	214	241	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					15	19		10.1016/j.stem.2010.06.004	http://dx.doi.org/10.1016/j.stem.2010.06.004			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621044	Green Accepted, Bronze			2022-12-24	WOS:000280222300007
J	Mira, H; Andreu, Z; Suh, H; Lie, DC; Jessberger, S; Consiglio, A; San Emeterio, J; Hortiguela, R; Marques-Torrejon, MA; Nakashima, K; Colak, D; Gotz, M; Farinas, I; Gage, FH				Mira, Helena; Andreu, Zoraida; Suh, Hoonkyo; Lie, D. Chichung; Jessberger, Sebastian; Consiglio, Antonella; San Emeterio, Juana; Hortigueela, Rafael; Angeles Marques-Torrejon, Maria; Nakashima, Kinichi; Colak, Dilek; Goetz, Magdalena; Farinas, Isabel; Gage, Fred H.			Signaling through BMPR-IA Regulates Quiescence and Long-Term Activity of Neural Stem Cells in the Adult Hippocampus	CELL STEM CELL			English	Article							BONE MORPHOGENETIC PROTEIN; NERVOUS-SYSTEM; PROGENITOR CELLS; NEUROGENESIS; EXPRESSION; RECEPTOR; NOGGIN; SUBPOPULATIONS; MAINTENANCE; MECHANISMS	Neural stem cells (NSCs) in the adult hippocampus divide infrequently, and the molecules that modulate their quiescence are largely unknown. Here, we show that bone morphogenetic protein (BMP) signaling is active in hippocampal NSCs, downstream of BMPR-IA. BMPs reversibly diminish proliferation of cultured NSCs while maintaining their undifferentiated state. In vivo, acute blockade of BMP signaling in the hippocampus by intracerebral infusion of Noggin first recruits quiescent NSCs into the cycle and increases neurogenesis; subsequently, it leads to decreased stem cell division and depletion of precursors and newborn neurons. Consistently, selective ablation of Bmpr1a in hippocampal NSCs, or inactivation of BMP canonical signaling in conditional Smad4 knockout mice, transiently enhances proliferation but later leads to a reduced number of precursors, thereby limiting neuronal birth. BMPs are therefore required to balance NSC quiescence/proliferation and to prevent loss of the stem cell activity that supports continuous neurogenesis in the mature hippocampus.	[Mira, Helena; Suh, Hoonkyo; Jessberger, Sebastian; Consiglio, Antonella; Nakashima, Kinichi; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Mira, Helena; Andreu, Zoraida; San Emeterio, Juana; Hortigueela, Rafael] Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Madrid 28220, Spain; [Andreu, Zoraida; Angeles Marques-Torrejon, Maria; Farinas, Isabel] Univ Valencia, Dept Cellular Biol, Valencia 46100, Spain; [Suh, Hoonkyo] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Lie, D. Chichung] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Dev Genet, D-85764 Munich, Germany; [Jessberger, Sebastian] ETH, Dept Biol, Inst Cell Biol, CH-8092 Zurich, Switzerland; [Consiglio, Antonella] Ctr Med Regenerat Barcelona, Barcelona 08003, Spain; [Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma 6300101, Japan; [Colak, Dilek; Goetz, Magdalena] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Munich, Germany; [Andreu, Zoraida; Angeles Marques-Torrejon, Maria; Farinas, Isabel] CIBERNED, Valencia 46100, Spain	Salk Institute; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Valencia; Cleveland Clinic Foundation; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Nara Institute of Science & Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; CIBERNED	Mira, H (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	helena.mira@uv.es; gage@salk.edu	Lie, Dieter Chichung/AAS-8604-2020; Lie, Dieter Chichung/S-7914-2017; Andreu, Zoraida/AAB-3722-2019; consiglio, antonella/G-1815-2016; Marques, Maria Angeles/AAH-2720-2019; Jessberger, Sebastian/AAJ-4032-2020; consiglio, antonella/AAA-5864-2019; Farinas, Isabel/L-7118-2014	Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442; consiglio, antonella/0000-0002-3988-6254; consiglio, antonella/0000-0002-3988-6254; Jessberger, Sebastian/0000-0002-0056-8275; Mira, Helena/0000-0001-8574-9544; Farinas, Isabel/0000-0003-2903-4960; Suh, Hoonkyo/0000-0002-4227-2982; Hortiguela, Rafael/0000-0002-9621-6441	Deutsche Forschungsgemeirischaft; Spanish Ministerio de Educacion y Ciencia (MEC); Centro de Investigacion Principe Felipe; FPI/MEC; Helma; Ministerio de Sanidad y Consumo (MSC; Fondo de Investigacion Sanitaria) [PI06/0754, PI09/2254]; MEC [SAF2005-06325]; MSC; Fundacion "la Caixa"; Bavarian Network on Adult Neural Stem Cells "FORNEUROCELL";  [SFB 596]	Deutsche Forschungsgemeirischaft; Spanish Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Centro de Investigacion Principe Felipe; FPI/MEC(Spanish Government); Helma; Ministerio de Sanidad y Consumo (MSC; Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III); MEC(European Commission); MSC; Fundacion "la Caixa"(La Caixa Foundation); Bavarian Network on Adult Neural Stem Cells "FORNEUROCELL"; 	The authors thank Dr.Yuji Mishina for Bmpr1a<SUP>flox/fllox</SUP> and Bmpr1a<SUP>wt/null</SUP> mice and Dr. C.X. Deng for the Smad4<SUP>flox/flox</SUP> mice. They also thank Mary Lynn Gage for editorial support, Dr. Pilar Sanchez-Gomez for helpful discussions and suggestions, Dr. Mari Paz Rubio, Maria Jose Palop, Andre Luis Carvalho, Mireia Moreno, Yolanda Noriega, and Mario Alia for technical assistance. S.J. was supported in part by the Deutsche Forschungsgemeirischaft; H.M. was supported by the Programa Ramon y Cajal from the Spanish Ministerio de Educacion y Ciencia (MEC); Z.A. was supported by the Centro de Investigacion Principe Felipe; and M.A.M-T. is a recipient of a pre-doctoral fellowship from the FPI/MEC. M.G. was funded by Helma and SFB 596. Additional support was provided by grants from Ministerio de Sanidad y Consumo (MSC; Fondo de Investigacion Sanitaria-PI06/0754 and PI09/2254) to H.M.; from MEC (SAF2005-06325), MSC (RETIC Tercel and CIBERNED) and Fundacion "la Caixa" to IF., and from the Bavarian Network on Adult Neural Stem Cells "FORNEUROCELL" to D.C.L.	AIZAWA K, 2009, AGING IN PRESS, DOI DOI 10.1016/J.NEUROBIO-LAGING.2008.12.011; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Coskun V, 2001, INT J DEV NEUROSCI, V19, P219, DOI 10.1016/S0736-5748(00)00092-7; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Hall AK, 2004, J NEUROSCI RES, V76, P1, DOI 10.1002/jnr.20019; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	329	342	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					78	89		10.1016/j.stem.2010.04.016	http://dx.doi.org/10.1016/j.stem.2010.04.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621052	Bronze			2022-12-24	WOS:000280222300015
J	Yano, M; Hayakawa-Yano, Y; Mele, A; Darnell, RB				Yano, Masato; Hayakawa-Yano, Yoshika; Mele, Aldo; Darnell, Robert B.			Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 Signaling	NEURON			English	Article							SPLICING REGULATION; BINDING PROTEINS; CORTICAL DEVELOPMENT; VLDL RECEPTOR; GENOME-WIDE; REELIN; BRAIN; INSIGHTS; GENE; PATHWAY	Neuronal migration leads to a highly organized laminar structure in the mammalian brain, and its misregulation causes lissencephaly and behavioral and cognitive defects. Reelin signaling, which is mediated in part by a key adaptor, disabled-1 (Dab1), plays a critical but incompletely understood role in this process. We found that the neuron-specific RNA-binding protein Nova2 regulates neuronal migration in late-generated cortical and Purkinje neurons. An unbiased HITS-CLIP and exon junction array search for Nova-dependent reelin-pathway RNAs at E14.5 revealed only one candidate-an alternatively spliced isoform of Dab1 (Dab1.7bc). In utero electroporation demonstrated that Dab1.7bc was sufficient to induce neuronal migration defects in wild-type mice and exacerbate defects when Dab1 levels were reduced, whereas Dab1 overexpression mitigates defects in Nova2 null mice. Thus, Nova2 regulates an RNA switch controlling the ability of Dab1 to mediate neuronal responsiveness to reelin signaling and neuronal migration, suggesting new links between splicing regulation, brain disease, and development.	[Yano, Masato; Hayakawa-Yano, Yoshika; Mele, Aldo; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10065 USA; [Yano, Masato; Hayakawa-Yano, Yoshika; Mele, Aldo; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Darnell, RB (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10065 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Yano, Masato/L-1299-2013	Darnell, Robert B/0000-0002-5134-8088; Yano, Masato/0000-0003-0589-478X	National Institutes of Health; National Center for Research Resources at the National Institutes of Health [UL1 RR024143]; JSPS; KANAE Foundation for the promotion of medical science; Mochida Memorial Foundation for medical and pharmaceutical research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069473, R01NS034389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KANAE Foundation for the promotion of medical science; Mochida Memorial Foundation for medical and pharmaceutical research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Dr. J. Kohyama for helpful advice with in utero electroporation; Dr. J. Ule for help with ASPIRE analysis of exon junction arrays; Dr. N. Heintz for L7-L10a-GFP mice; Drs. Y. Okada and H. Okano for mRFP-pcXN2, which is mRFP1 cDNA originally from Dr. R. Tsien; Dr. S. Arber for Er81 antibody; Dr. H. J. Okano for generating the HuC expression vector construct; Drs. A. Sali and U. Pieper for peptide predictions; Drs. J. Darnell, G. Dunn, M. Frias, M. Ruggiu, and C. Zhang for thoughtful comments; J. Fak and N. Rehman for technical support; and all the members of Dr. Damell's laboratory for encouragement and kind support. This work was supported by National Institutes of Health (grants to R.B.D) and the Rockefeller University Hospital (CTSA grant UL1 RR024143) from the National Center for Research Resources at the National Institutes of Health. M.Y. was supported by a JSPS postdoctoral fellowship for research abroad, KANAE Foundation for the promotion of medical science, and Mochida Memorial Foundation for medical and pharmaceutical research. R.B.D. is a Howard Hughes Medical Institute Investigator.	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Amadio JP, 2006, CELL, V126, P1033, DOI 10.1016/j.cell.2006.09.007; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bar I, 2003, J BIOL CHEM, V278, P5802, DOI 10.1074/jbc.M207178200; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Darnell RB, 2006, COLD SPRING HARB SYM, V71, P321, DOI 10.1101/sqb.2006.71.002; DARNELL RB, 2010, REV RNA IN PRESS; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; HaginoYamagishi K, 1997, BRAIN RES, V752, P261, DOI 10.1016/S0006-8993(96)01472-2; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Katyal S, 2004, EMBO J, V23, P1878, DOI 10.1038/sj.emboj.7600185; Larouche M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001653; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 1999, J NEUROSCI, V19, P10357; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Ule J, 2007, ADV EXP MED BIOL, V623, P148, DOI 10.1007/978-0-387-77374-2_9; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254	61	124	124	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					848	858		10.1016/j.neuron.2010.05.007	http://dx.doi.org/10.1016/j.neuron.2010.05.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620871	Bronze, Green Accepted			2022-12-24	WOS:000279420800008
J	Cimadamore, F; Fishwick, K; Giusto, E; Gnedeva, K; Cattarossi, G; Miller, A; Pluchino, S; Brill, LM; Bronner-Fraser, M; Terskikh, AV				Cimadamore, Flavio; Fishwick, Katherine; Giusto, Elena; Gnedeva, Ksenia; Cattarossi, Giulio; Miller, Amber; Pluchino, Stefano; Brill, Laurence M.; Bronner-Fraser, Marianne; Terskikh, Alexey V.			Human ESC-Derived Neural Crest Model Reveals a Key Role for SOX2 in Sensory Neurogenesis	CELL STEM CELL			English	Article							ACHAETE-SCUTE HOMOLOG-1; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; LATERAL INHIBITION; NERVOUS-SYSTEM; CELL-ADHESION; STEM-CELLS; EXPRESSION; NEURONS; GENES	The transcription factor SOX2 is widely known to play a critical role in the central nervous system; however, its role in peripheral neurogenesis remains poorly understood. We recently developed an hESC-based model in which migratory cells undergo epithelial to mesenchymal transition (EMT) to acquire properties of neural crest (NC) cells. In this model, we found that migratory NC progenitors downregulate SOX2, but then start re-expressing SOX2 as they differentiate to form neurogenic dorsal root ganglion (DRG)like clusters. SOX2 downregulation was sufficient to induce EMT and resulted in massive apoptosis when neuronal differentiation was induced. In vivo, downregulation of SOX2 in chick and mouse NC cells significantly reduced the numbers of neurons within DRG. We found that SOX2 binds directly to NGN1 and MASH1 promoters and is required for their expression. Our data suggest that SOX2 plays a key role for NGN1-dependent acquisition of neuronal fates in sensory ganglia.	[Cimadamore, Flavio; Giusto, Elena; Gnedeva, Ksenia; Cattarossi, Giulio; Miller, Amber; Brill, Laurence M.; Terskikh, Alexey V.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Fishwick, Katherine; Bronner-Fraser, Marianne] CALTECH, Pasadena, CA 91125 USA; [Giusto, Elena; Pluchino, Stefano] IRCCS, Inst Expt Neurol, I-20132 Milan, Italy	Sanford Burnham Prebys Medical Discovery Institute; California Institute of Technology	Cimadamore, F (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	flavioc@burnham.org; terskikh@burnham.org	Pluchino, Stefano/AAE-9037-2019; Giusto, Elena/AAY-9554-2021; Terskikh, Alexey/U-8407-2019	Pluchino, Stefano/0000-0002-6267-9472; Giusto, Elena/0000-0003-0562-1466; Cimadamore, Flavio/0000-0002-3649-0545; Bronner, Marianne/0000-0003-4274-1862	CIRM [RS1004661]; Sanford-Burnham Medical Research Institute; NIH Blueprint; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); Sanford-Burnham Medical Research Institute; NIH Blueprint(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank C.-T. Huang and K. Liu for their help with cloning, lentiviral production, and microarray analysis. We thank Dr. S. Albini, Dr. S. Forcales, and Professor L. Puri for sharing their expertise in chromatin immunoprecipitation techniques. Sox2LoxP mice were kindly provided by Dr. Nicolis, and Wnt1-CRE mice were kindly provided by Dr. Y. Yamaguchi. We thank Dr. J. Hou for helping with IP-MS data analysis. This work has been supported by CIRM postdoctoral fellowship to F.C., CIRM grant RS1004661 to A.T., and transient research support to A.V. Terskikh from the Sanford-Burnham Medical Research Institute and an NIH Blueprint core grant (PI, S.A. Lipton).	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Cai L, 2000, DEVELOPMENT, V127, P3021; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Cau E, 2000, DEVELOPMENT, V127, P2323; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chen B, 2009, DEV BIOL, V326, P75, DOI 10.1016/j.ydbio.2008.10.039; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Cimadamore F, 2009, STEM CELLS, V27, P1772, DOI 10.1002/stem.107; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hagstrom SA, 2005, AM J MED GENET A, V138A, P95, DOI 10.1002/ajmg.a.30803; HAMBURGER V, 1988, J NEUROSCI, V8, P3535; Henderson DJ, 1997, J ANAT, V191, P507, DOI 10.1046/j.1469-7580.1997.19140507.x; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Kahane N, 1998, CELL TISSUE RES, V294, P297, DOI 10.1007/s004410051180; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kobayashi M, 2000, MECH DEVELOP, V98, P151, DOI 10.1016/S0925-4773(00)00451-2; Konishi Y, 2006, BRAIN RES, V1116, P93, DOI 10.1016/j.brainres.2006.07.103; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Linker C, 2000, DEV BIOL, V224, P215, DOI 10.1006/dbio.2000.9723; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Meulemans D, 2004, DEV CELL, V7, P291, DOI 10.1016/j.devcel.2004.08.007; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; MOULD AP, 1994, J BIOL CHEM, V269, P27224; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Paratore C, 2001, DEVELOPMENT, V128, P3949; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Thomas S, 2008, HUM MOL GENET, V17, P3411, DOI 10.1093/hmg/ddn235; Varadkar P, 2008, DEV DYNAM, V237, P1144, DOI 10.1002/dvdy.21502; Voroteliak E A, 2002, Izv Akad Nauk Ser Biol, P30; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008	61	70	76	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					538	551		10.1016/j.stem.2011.03.011	http://dx.doi.org/10.1016/j.stem.2011.03.011			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549328	Green Accepted, Bronze			2022-12-24	WOS:000290927600014
J	Pang, ZPP; Bacaj, T; Yang, XF; Zhou, P; Xu, W; Sudhof, TC				Pang, Zhiping P.; Bacaj, Taulant; Yang, Xiaofei; Zhou, Peng; Xu, Wei; Suedhof, Thomas C.			Doc2 Supports Spontaneous Synaptic Transmission by a Ca2+-Independent Mechanism	NEURON			English	Article							NEUROTRANSMITTER RELEASE; CA2+ SENSOR; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; 3-DIMENSIONAL STRUCTURE; PHOSPHOLIPID-BINDING; ASYNCHRONOUS RELEASE; VESICLE FUSION; CALCIUM SENSOR; C2A DOMAIN	Two families of Ca2+-binding proteins have been proposed as Ca2+ sensors for spontaneous release: synaptotagmins and Doc2s, with the intriguing possibility that Doc2s may represent high-affinity Ca2+ sensors that are activated by deletion of synaptotagmins, thereby accounting for the increased spontaneous release in synaptotagmin-deficient synapses. Here, we use an shRNA-dependent quadruple knockdown of all four Ca2+-binding proteins of the Doc2 family to confirm that Doc2-deficient synapses exhibit a marked decrease in the frequency of spontaneous release events. Knockdown of Doc2s in synaptotagmin-1-deficient synapses, however, failed to reduce either the increased spontaneous release or the decreased evoked release of these synapses, suggesting that Doc2s do not constitute Ca2+ sensors for asynchronous release. Moreover, rescue experiments revealed that the decrease in spontaneous release induced by the Doc2 knockdown in wildtype synapses is fully reversed by mutant Doc2B lacking Ca2+-binding sites. Thus, our data suggest that Doc2s are modulators of spontaneous synaptic transmission that act by a Ca2+-independent mechanism.	[Pang, Zhiping P.; Bacaj, Taulant; Yang, Xiaofei; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Zhou, Peng; Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu	Pang, Zhiping/AAF-5757-2020; Zhou, Peng/M-3917-2013	Pang, Zhiping/0000-0002-6183-1233	National Institute of Mental Health ([NIMH]) [1R01 MH089054, P50 MH086403]; NARSAD; National Institute of Neurological Disorders and Stroke National Research Service [1F32NS067896]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089054, P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067896] Funding Source: NIH RePORTER	National Institute of Mental Health ([NIMH])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); National Institute of Neurological Disorders and Stroke National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ira Huryeva for excellent technical support and Dr. Axel Brunger for help with circular dichroism spectra measurements. This paper was supported by a Recovery Act grant from the National Institute of Mental Health ([NIMH] 1R01 MH089054), a NIMH Conte Center Award (P50 MH086403), a NARSAD Young Investigator Award (to Z.P.P.), and a National Institute of Neurological Disorders and Stroke National Research Service Award fellowship (1F32NS067896, to T.B.).	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Higashio H, 2008, J IMMUNOL, V180, P4774, DOI 10.4049/jimmunol.180.7.4774; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Kojima T, 1996, J BIOCHEM-TOKYO, V120, P671; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; Martens S, 2010, BIOCHEM SOC T, V38, P213, DOI 10.1042/BST0380213; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Mochida S, 1998, P NATL ACAD SCI USA, V95, P11418, DOI 10.1073/pnas.95.19.11418; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Stacey WC, 2000, J NEUROPHYSIOL, V83, P1394, DOI 10.1152/jn.2000.83.3.1394; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Yang XF, 2010, NEURON, V68, P907, DOI 10.1016/j.neuron.2010.11.001	42	106	106	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 28	2011	70	2					244	251		10.1016/j.neuron.2011.03.011	http://dx.doi.org/10.1016/j.neuron.2011.03.011			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521611	Bronze, Green Accepted			2022-12-24	WOS:000291073700007
J	Glynn, MW; Elmer, BM; Garay, PA; Liu, XB; Needleman, LA; El-Sabeawy, F; McAllister, AK				Glynn, Marian W.; Elmer, Bradford M.; Garay, Paula A.; Liu, Xiao-Bo; Needleman, Leigh A.; El-Sabeawy, Faten; McAllister, A. Kimberley			MHCI negatively regulates synapse density during the establishment of cortical connections	NATURE NEUROSCIENCE			English	Article							CLASS-I MOLECULES; ACTIVITY-DEPENDENT REGULATION; RECEPTOR INTERNALIZATION; ACTIVITY BLOCKADE; GENE-EXPRESSION; HEAVY-CHAINS; CNS; PLASTICITY; ABSENCE; SURFACE	Major histocompatibility complex class I (MHCI) molecules modulate activity-dependent refinement and plasticity. We found that MHCI also negatively regulates the density and function of cortical synapses during their initial establishment both in vitro and in vivo. MHCI molecules are expressed on cortical neurons before and during synaptogenesis. In vitro, decreasing surface MHCI (sMHCI) on neurons increased glutamatergic and GABAergic synapse density, whereas overexpression decreased it. In vivo, synapse density was higher throughout development in beta 2m(-/-) mice. MHCI also negatively regulated the strength of excitatory, but not inhibitory, synapses and controlled the balance of excitation and inhibition onto cortical neurons. sMHCI levels were modulated by activity and were necessary for activity to negatively regulate glutamatergic synapse density. Finally, acute changes in sMHCI and activity altered synapse density exclusively during early postnatal development. These results identify a previously unknown function for immune proteins in the negative regulation of the initial establishment and function of cortical connections.	[Glynn, Marian W.; Elmer, Bradford M.; Garay, Paula A.; Liu, Xiao-Bo; Needleman, Leigh A.; El-Sabeawy, Faten; McAllister, A. Kimberley] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	kmcallister@ucdavis.edu		McAllister, A. Kimberley/0000-0001-9177-9889	National Institute for Environmental Health Sciences; John Merck Fund; March of Dimes; Cure Autism Now; Autism Speaks; National Institute of Neurological Disorders and Stroke [R01NS060125]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060125] Funding Source: NIH RePORTER	National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); John Merck Fund; March of Dimes(March of Dimes); Cure Autism Now; Autism Speaks; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to M. Edidin (Johns Hopkins University) for the H2-K<SUP>b</SUP>-CFP construct, J. Fritschy (University of Zurich) for antibodies to GABA receptor and J. Trimmer (University of California Davis) for the antibody to PSD-95. We also thank J. Trimmer and E. Diaz (University of California Davis) for advice and for supporting the project. This project was funded by a National Institute for Environmental Health Sciences Training grant (M. W. G.), the John Merck Fund (A. K. M.), the March of Dimes (A. K. M.), Cure Autism Now (A. K. M.), Autism Speaks (A. K. M.) and National Institute of Neurological Disorders and Stroke grant R01NS060125 (A. K. M.). We are especially grateful to the Higgins and Gassin Family Foundations for their invaluable support of basic science research and our work.	Abbas A., 2017, CELLULAR MOL IMMUNOL, P281; Bodnar A, 2003, INT IMMUNOL, V15, P331, DOI 10.1093/intimm/dxg042; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Bouwman J, 2004, NEUROSCIENCE, V126, P115, DOI 10.1016/j.neuroscience.2004.03.027; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; CHAKRABARTI A, 1992, BIOCHEMISTRY-US, V31, P7182, DOI 10.1021/bi00146a022; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; DeFelipe J, 1999, CEREB CORTEX, V9, P722, DOI 10.1093/cercor/9.7.722; DEMARIA S, 1992, CELL IMMUNOL, V142, P103, DOI 10.1016/0008-8749(92)90272-Q; Fishman D, 2004, FOLIA BIOL-PRAGUE, V50, P35; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; HOCHMAN JH, 1988, J IMMUNOL, V140, P2322; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Huupponen J, 2007, J PHYSIOL-LONDON, V581, P505, DOI 10.1113/jphysiol.2007.130062; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; MADRIGAL JA, 1991, J EXP MED, V174, P1085, DOI 10.1084/jem.174.5.1085; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; MCALLISTER AK, 2007, ANN REV NEU IN PRESS; Naranda T, 1997, P NATL ACAD SCI USA, V94, P11692, DOI 10.1073/pnas.94.21.11692; Nawa H, 2000, MOL PSYCHIATR, V5, P594, DOI 10.1038/sj.mp.4000730; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; O'Connor TP, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-18; OLSSON L, 1994, P NATL ACAD SCI USA, V91, P9086, DOI 10.1073/pnas.91.19.9086; Patel MR, 2009, SCIENCE, V323, P1500, DOI 10.1126/science.1169025; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Santos SG, 2004, J BIOL CHEM, V279, P53062, DOI 10.1074/jbc.M408794200; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; SCHNABL E, 1990, J EXP MED, V171, P1431, DOI 10.1084/jem.171.5.1431; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Spiliotis ET, 2002, MOL BIOL CELL, V13, P1566, DOI 10.1091/mbc.01-07-0322; Stagsted J, 1998, APMIS Suppl, V85, P1; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796	49	120	127	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					442	U71		10.1038/nn.2764	http://dx.doi.org/10.1038/nn.2764			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358642	Green Accepted			2022-12-24	WOS:000288849400015
J	Crochet, S; Poulet, JFA; Kremer, Y; Petersen, CCH				Crochet, Sylvain; Poulet, James F. A.; Kremer, Yves; Petersen, Carl C. H.			Synaptic Mechanisms Underlying Sparse Coding of Active Touch	NEURON			English	Article							RAT BARREL CORTEX; PRIMARY SOMATOSENSORY CORTEX; THALAMOCORTICAL FEEDFORWARD INHIBITION; SENSORY RESPONSES; BEHAVING MICE; TACTILE DISCRIMINATION; SENSORIMOTOR SYSTEM; OBJECT LOCALIZATION; NEURONAL-ACTIVITY; RECEPTIVE-FIELDS	Sensory information is actively gathered by animals, but the synaptic mechanisms driving neuronal circuit function during active sensory processing are poorly understood. Here, we investigated the synaptically driven membrane potential dynamics during active whisker sensation using whole-cell recordings from layer 2/3 pyramidal neurons in the primary somatosensory barrel cortex of behaving mice. Although whisker contact with an object evoked rapid depolarization in all neurons, these touch responses only drove action potentials in similar to 10% of the cells. Such sparse coding was ensured by cell-specific reversal potentials of the touch-evoked response that were hyperpolarized relative to action potential threshold for most neurons. Intercontact interval profoundly influenced touch-evoked postsynaptic potentials, interestingly without affecting the peak membrane potential of the touch response. Dual whole-cell recordings indicated highly correlated membrane potential dynamics during active touch. Sparse action potential firing within synchronized cortical layer 2/3 microcircuits therefore appears to robustly signal each active touch response.	[Crochet, Sylvain; Poulet, James F. A.; Kremer, Yves; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland; [Crochet, Sylvain] CNRS, Lyon Neurosci Res Ctr, Integrat Physiol Brain Arousal Syst UMR5292, INSERM,U1028, F-69500 Bron, France; [Poulet, James F. A.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-10392 Berlin, Germany; [Poulet, James F. A.] Charite, Neurocure Neurosci Res Ctr, D-10117 Berlin, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017	Petersen, Carl/0000-0003-3344-4495; Kremer, Yves/0000-0002-2319-1394; Crochet, Sylvain/0000-0002-2965-8899; Poulet, James/0000-0003-0296-5415	Swiss National Science Foundation; Human Frontiers in Science Program; SystemsX.ch; Deutsche Forschungs Gemeinschaft; Agence Nationale de la Recherche, France	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers in Science Program(Human Frontier Science Program); SystemsX.ch; Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG)); Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was funded by grants from the Swiss National Science Foundation (CCHP), Human Frontiers in Science Program (J.F.A.P. and C.C.H.P.), SystemsX.ch (C.C.H.P.), Deutsche Forschungs Gemeinschaft (J.F.A.P.), and Agence Nationale de la Recherche, France (S.C.).	AHISSAR E, 2000, NAT NEUROSCI, V406, P1263; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brecht M, 2007, CURR OPIN NEUROBIOL, V17, P408, DOI 10.1016/j.conb.2007.07.008; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gerdjikov TV, 2010, NEURON, V65, P530, DOI 10.1016/j.neuron.2010.02.007; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Vijayan S, 2010, J NEUROPHYSIOL, V103, P2074, DOI 10.1152/jn.00474.2009; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	61	169	170	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1160	1175		10.1016/j.neuron.2011.02.022	http://dx.doi.org/10.1016/j.neuron.2011.02.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435560	Bronze			2022-12-24	WOS:000288886900012
J	Yang, JF; Dominguez, B; de Winter, F; Gould, TW; Eriksson, JE; Lee, KF				Yang, Jiefei; Dominguez, Bertha; de Winter, Fred; Gould, Thomas W.; Eriksson, John E.; Lee, Kuo-Fen			Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse	NATURE NEUROSCIENCE			English	Article							FILAMENT PROTEIN NESTIN; INTERMEDIATE-FILAMENTS; JUNCTION; PHOSPHORYLATION; INNERVATION; P35; EXPRESSION; MUSCLE; MICE; CDK5	Positive and negative regulation of neurotransmitter receptor aggregation on the postsynaptic membrane is a critical event during synapse formation. Acetylcholine (ACh) and agrin are two opposing signals that regulate ACh receptor (AChR) clustering during neuromuscular junction (NMJ) development. ACh induces dispersion of AChR clusters that are not stabilized by agrin via a cyclin-dependent kinase 5 (Cdk5)-mediated mechanism, but regulation of Cdk5 activation is poorly understood. We found that the intermediate filament protein nestin physically interacts with Cdk5 and is required for ACh-induced association of p35, the co-activator of Cdk5, with the muscle membrane. Blockade of nestin-dependent signaling inhibited ACh-induced Cdk5 activation and the dispersion of AChR clusters in cultured myotubes. Similar to the effects of Cdk5 gene inactivation, knockdown of nestin in agrin-deficient mouse embryos substantially restored AChR clusters. These results suggest that nestin is required for ACh-induced, Cdk5-dependent dispersion of AChR clusters during NMJ development.	[Yang, Jiefei; Dominguez, Bertha; de Winter, Fred; Gould, Thomas W.; Lee, Kuo-Fen] Salk Inst Biol Studies, La Jolla, CA USA; [Eriksson, John E.] Abo Akad Univ, Dept Biosci, Turku, Finland	Salk Institute; Abo Akademi University	Lee, KF (corresponding author), Salk Inst Biol Studies, La Jolla, CA USA.	klee@salk.edu	De Winter, Fred/AAZ-8671-2020	De Winter, Fred/0000-0002-3042-2429	US National Institutes of Health [HD034534, NS047345, NS060833, NS044420]; Muscular Dystrophy Association [MDA4230]; Academy of Finland, the Research Institute of the Abo Akademi University Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044420, R01NS060833, R01NS047345] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Academy of Finland, the Research Institute of the Abo Akademi University Foundation(Academy of Finland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L.-H. Tsai for the Cdk5 and p35 constructs and A. Nagy for communicating his unpublished results. This study is supported by US National Institutes of Health grants HD034534, NS047345, NS060833 and NS044420 (K.-F.L.), Muscular Dystrophy Association fellowship MDA4230 (J.Y.), and Academy of Finland, the Research Institute of the Abo Akademi University Foundation (J.E.E.).	An MC, 2010, P NATL ACAD SCI USA, V107, P10702, DOI 10.1073/pnas.1004956107; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; BLOCH RJ, 1981, DEV BIOL, V81, P386, DOI 10.1016/0012-1606(81)90305-5; BLOCH RJ, 1983, J NEUROSCI, V3, P2670; Carlsson L, 1999, EXP CELL RES, V251, P213, DOI 10.1006/excr.1999.4569; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Dong XP, 2006, NEUROSIGNALS, V15, P53, DOI 10.1159/000094484; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Hamann M, 1995, J PHYSIOL-LONDON, V489, P791, DOI 10.1113/jphysiol.1995.sp021092; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Hyder CL, 2008, FEBS LETT, V582, P2140, DOI 10.1016/j.febslet.2008.04.064; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kang H, 2007, J NEUROSCI, V27, P5948, DOI 10.1523/JNEUROSCI.0621-07.2007; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Madhavan R, 2005, MOL CELL NEUROSCI, V28, P403, DOI 10.1016/j.mcn.2004.10.005; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Nazarian J, 2005, PHYSIOL GENOMICS, V21, P70, DOI 10.1152/physiolgenomics.00227.2004; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; PALLARI HM, 2006, SCI STKE, pPE53, DOI DOI 10.1126/STKE.3662006PE53; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shi L, 2010, NEURON, V65, P204, DOI 10.1016/j.neuron.2010.01.012; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Vaittinen S, 1999, AM J PATHOL, V154, P591, DOI 10.1016/S0002-9440(10)65304-7; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131	46	36	37	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					324	330		10.1038/nn.2747	http://dx.doi.org/10.1038/nn.2747			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21278733	Green Accepted			2022-12-24	WOS:000287650100012
J	Hyman, SE				Hyman, Steven E.			Cognitive Enhancement: Promises and Perils	NEURON			English	Editorial Material								The potential use of drugs to enhance cognition, emotion, and executive function has engendered controversy despite the fact that few such agents exist today. Here, I provide a context for discussions based on medical, regulatory, and ethical concerns that have been raised by the possibility that enhancers will emerge from current efforts to discover drugs for neuropsychiatric disorders.	Harvard Univ, Off Provost, Cambridge, MA 02138 USA	Harvard University	Hyman, SE (corresponding author), Harvard Univ, Off Provost, Massachusetts Hall, Cambridge, MA 02138 USA.	seh@harvard.edu						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angold A, 2000, J AM ACAD CHILD PSY, V39, P39, DOI 10.1097/00004583-200001000-00015; Beddington J, 2008, NATURE, V455, P1057, DOI 10.1038/4551057a; Caldwell JA, 2005, AVIAT SPACE ENVIR MD, V76, pC39; Foresight Mental Capital and Wellbeing Project, 2008, FOR MIGR GLOB ENV CH; Fukuyama Francis, 2002, OUR POSTHUMAN FUTURE; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Moreno J. D., 2006, MIND WARS BRAIN RES; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; The President's Council on Bioethics, 2003, THER BIOT PURS HAPP	12	43	44	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 24	2011	69	4					595	598		10.1016/j.neuron.2011.02.012	http://dx.doi.org/10.1016/j.neuron.2011.02.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338872	Bronze			2022-12-24	WOS:000288413200004
J	Graf, ABA; Kohn, A; Jazayeri, M; Movshon, JA				Graf, Arnulf B. A.; Kohn, Adam; Jazayeri, Mehrdad; Movshon, J. Anthony			Decoding the activity of neuronal populations in macaque primary visual cortex	NATURE NEUROSCIENCE			English	Article							NEURAL POPULATIONS; CODING EFFICIENCY; SINGLE NEURONS; CODES; DISCRIMINATION; INFORMATION; ORIENTATION; CELLS; VARIABILITY; COMPUTATION	Visual function depends on the accuracy of signals carried by visual cortical neurons. Combining information across neurons should improve this accuracy because single neuron activity is variable. We examined the reliability of information inferred from populations of simultaneously recorded neurons in macaque primary visual cortex. We considered a decoding framework that computes the likelihood of visual stimuli from a pattern of population activity by linearly combining neuronal responses and tested this framework for orientation estimation and discrimination. We derived a simple parametric decoder assuming neuronal independence and a more sophisticated empirical decoder that learned the structure of the measured neuronal response distributions, including their correlated variability. The empirical decoder used the structure of these response distributions to perform better than its parametric variant, indicating that their structure contains critical information for sensory decoding. These results show how neuronal responses can best be used to inform perceptual decision-making.	[Graf, Arnulf B. A.; Kohn, Adam; Jazayeri, Mehrdad; Movshon, J. Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Graf, ABA (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	graf@vis.caltech.edu			US National Institutes of Health [EY2017, EY4440]; Swartz Foundation;  [EY7158]; NATIONAL EYE INSTITUTE [R37EY004440, R01EY004440, R01EY002017] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to M. Smith and R. Kelly for their help with recording and to E. Simoncelli and M. Yanike for helpful comments on the manuscript. This research was supported by US National Institutes of Health research grants EY2017 and EY4440, training grant EY7158 and the Swartz Foundation.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; [Anonymous], 2002, LEARNING KERNELS; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; BEVERLEY KI, 1975, J PHYSIOL-LONDON, V249, P387, DOI 10.1113/jphysiol.1975.sp011021; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Carandini M, 1997, J NEUROSCI, V17, P8621; Dayan P., 2001, THEORETICAL NEUROSCI; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Jaynes E.T., 2003, PROBABILITY THEORY L; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 1996, J NEUROSCI, V16, pU5; Shamir M, 2006, NEURAL COMPUT, V18, P1951, DOI 10.1162/neco.2006.18.8.1951; Simoncelli E. P., 2009, COGNITIVE NEUROSCIEN; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Tassinari H, 2006, J NEUROSCI, V26, P10154, DOI 10.1523/JNEUROSCI.2779-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Vapnik V.N., 1995, NATURE STAT LEARNING; VOGELS R, 1990, J NEUROSCI, V10, P3543; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	166	168	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					239	U332		10.1038/nn.2733	http://dx.doi.org/10.1038/nn.2733			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217762	Green Accepted			2022-12-24	WOS:000286595400022
J	Smith-Berdan, S; Nguyen, A; Hassanein, D; Zimmer, M; Ugarte, F; Ciriza, J; Li, D; Garcia-Ojeda, ME; Hinck, L; Forsberg, EC				Smith-Berdan, Stephanie; Nguyen, Andrew; Hassanein, Deena; Zimmer, Matthew; Ugarte, Fernando; Ciriza, Jesus; Li, Dean; Garcia-Ojeda, Marcos E.; Hinck, Lindsay; Forsberg, E. Camilla			Robo4 Cooperates with Cxcr4 to Specify Hematopoietic Stem Cell Localization to Bone Marrow Niches	CELL STEM CELL			English	Article							COLONY-STIMULATING FACTOR; PROGENITOR CELLS; CHEMOKINE RECEPTOR; HEPARAN-SULFATE; MAGIC ROUNDABOUT; REPELLENT SLIT; NOD/SCID MICE; MOBILIZATION; BLOOD; ANGIOGENESIS	Specific bone marrow (BM) niches are critical for hematopoietic stem cell (HSC) function during both normal hematopoiesis and in stem cell transplantation therapy. We demonstrate that the guidance molecule Robo4 functions to specifically anchor HSCs to BM niches. Robo4-deficient HSCs displayed poor localization to BM niches and drastically reduced long-term reconstitution capability while retaining multilineage potential. Cxcr4, a critical regulator of HSC location, is upregulated in Robo4(-/-) HSCs to compensate for Robo4 loss. Robo4 deletion led to altered HSC mobilization efficiency, revealing that inhibition of both Cxcr4- and Robo4-mediated niche interactions are necessary for efficient HSC mobilization. Surprisingly, we found that WT HSCs express very low levels of Cxcr4 and respond poorly to Cxcr4 manipulation relative to other hematopoietic cells. We conclude that Robo4 cooperates with Cxcr4 to endow HSCs with competitive access to limited stem cell niches, and we propose Robo4 as a therapeutic target in HSC transplantation therapy.	[Smith-Berdan, Stephanie; Nguyen, Andrew; Hassanein, Deena; Zimmer, Matthew; Ugarte, Fernando; Hinck, Lindsay; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA; [Ciriza, Jesus; Garcia-Ojeda, Marcos E.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Li, Dean] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA	University of California System; University of California Santa Cruz; University of California System; University of California Merced; Utah System of Higher Education; University of Utah	Forsberg, EC (corresponding author), Univ Calif Santa Cruz, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA.	cforsber@ucsc.edu	Ciriza, Jesus/M-3821-2018	Ciriza, Jesus/0000-0002-8666-622X; Hinck, Lindsay/0000-0002-4009-3913	University of California Santa Cruz; California Institute for Regenerative Medicine (CIRM); UCSC; Government of Navarra, Spain; University of California; DOD; AAF; JDRF; NIH [RO1 CA-128902]; NATIONAL CANCER INSTITUTE [R01CA128902] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077671] Funding Source: NIH RePORTER	University of California Santa Cruz(University of California System); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); UCSC; Government of Navarra, Spain; University of California(University of California System); DOD(United States Department of Defense); AAF; JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Andrew Leavitt for generously providing reagents. This work was funded by University of California Santa Cruz start-up funds (E.C.F.); California Institute for Regenerative Medicine (CIRM) Stem Cell Training Program Awards (AN., FU., and J.C.); a UCSC Minority Access to Research Careers Fellowship (D.H.); a postdoctoral fellowship from the Government of Navarra, Spain (J.C.); and University of California, Merced start-up funds (M.E.G.-O.). D.L. is supported by the DOD, AAF, JDRF, and NIH. L.H. was partially funded by NIH (RO1 CA-128902). E.C.F. is the recipient of a CIRM New Faculty Award. University of Utah has licensed intellectual property surrounding the Robo4 pathway to Navigen. Both the University of Utah and D.Y.L. have equity in Navigen.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Bonig H, 2009, EXP HEMATOL, V37, P402, DOI 10.1016/j.exphem.2008.10.017; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Flomenberg N, 2005, ACTA HAEMATOL-BASEL, V114, P198, DOI 10.1159/000088410; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Forsberg EC, 2009, HAEMATOL-HEMATOL J, V94, P1477, DOI 10.3324/haematol.2009.013730; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kikuta T, 2000, EXP HEMATOL, V28, P311, DOI 10.1016/S0301-472X(99)00151-4; Lapidot T, 2001, ANN NY ACAD SCI, V938, P83, DOI 10.1111/j.1749-6632.2001.tb03577.x; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Sasaki Y, 2009, INT J HEMATOL, V90, P553, DOI 10.1007/s12185-009-0451-x; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Watt SM, 2008, VOX SANG, V94, P18, DOI 10.1111/j.1423-0410.2007.00995.x; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	44	99	103	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					72	83		10.1016/j.stem.2010.11.030	http://dx.doi.org/10.1016/j.stem.2010.11.030			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211783	Green Accepted, Bronze			2022-12-24	WOS:000286786200012
J	Boulanger, A; Clouet-Redt, C; Farge, M; Flandre, A; Guignard, T; Fernando, C; Juge, F; Dura, JM				Boulanger, Ana; Clouet-Redt, Christelle; Farge, Morgane; Flandre, Adrien; Guignard, Thomas; Fernando, Celine; Juge, Francois; Dura, Jean-Maurice			ftz-f1 and Hr39 opposing roles on EcR expression during Drosophila mushroom body neuron remodeling	NATURE NEUROSCIENCE			English	Article							NUCLEAR RECEPTORS; ECDYSONE RECEPTOR; BINDING PROTEIN; TIME-LAPSE; GENE; METAMORPHOSIS; ELEMENT; TRANSCRIPTION; DEGENERATION; REQUIREMENT	Developmental axon pruning is a general mechanism that is required for maturation of neural circuits. During Drosophila metamorphosis, the larval-specific dendrites and axons of early gamma neurons of the mushroom bodies are pruned and replaced by adult-specific processes. We found that the nuclear receptor ftz-f1 is required for this pruning, activates expression of the steroid hormone receptor EcR-B1, whose activity is essential for gamma remodeling, and represses expression of Hr39, an ftz-f1 homologous gene. If inappropriately expressed in the gamma neurons, HR39 inhibits normal pruning, probably by competing with endogenous FTZ-F1, which results in decreased EcR-B1 expression. EcR-B1 was previously identified as a target of the TGF beta signaling pathway. We found that the ftz-f1 and Hr39 pathway apparently acts independently of TGF beta signaling, suggesting that EcR-B1 is the target of two parallel molecular pathways that act during gamma neuron remodeling.	[Boulanger, Ana; Clouet-Redt, Christelle; Farge, Morgane; Flandre, Adrien; Guignard, Thomas; Dura, Jean-Maurice] Inst Human Genet, CNRS, UPR1142, Montpellier, France; [Fernando, Celine; Juge, Francois] Inst Genet Mol Montpellier, CNRS, UMR 5535, Montpellier, France; [Fernando, Celine; Juge, Francois] Univ Montpellier 2, Montpellier, France; [Fernando, Celine; Juge, Francois] Univ Montpellier I, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	Dura, JM (corresponding author), Inst Human Genet, CNRS, UPR1142, Montpellier, France.	jmdura@igh.cnrs.fr	Juge, François/P-2371-2017	Juge, Francois/0000-0001-5015-2019	CNRS; Fondation pour la Recherche Medicale; EEC; Association pour la Recherche sur le Cancer [3744]; Association Francaise contre les Myopathies [MNM1 2007]; Agence Nationale de la Recherche [ANR-07-NEURO-034-01]; Association Francaise contre les Myopathies Agence Nationale de la Recherche; Region Languedoc-Roussillon; Association pour la Recherche sur le Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EEC; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies Agence Nationale de la Recherche(French National Research Agency (ANR)); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We are particularly grateful to L. Fradkin for helpful discussions and comments on the manuscript. We thank L. Luo and T. Lee for babo, usp and several MARCM stocks; H. Ueda for the ftz-f1<SUP>ex7</SUP>FRT2A stock, the pUAST-beta ftz-f1 vector and the antibody to FTZ-F1; C. Woodard for the ftz-f1<SUP>19</SUP> stock; L. Pick for the UAS-alpha ftz-f1 stock and the GST-FTZ-F1 expression vector; C. Thummel for the antibody to ECR-B1 (ascite fluid); B. Dickson for the antibody to TRIO; M. O'Connor for the UAS-babo-act (1B3 strong) and the UAS-babo Delta I (2 transgenes 5A2-8A2) stocks and unpublished data pertaining to antibody to BABO and to babo transcripts and K. Matthews and K. Cook at the Bloomington Drosophila Stock Center. We also thank N. Lautredou at the Centre Regional d'Imagerie Cellulaire and J. Cau at the "Plateau d'Imagerie Cellulaire" for help with confocal imaging and P. Atger and C. Sarrauste de Menthiere at the "service iconographie IGH". Transgenic lines were generated by BestGene. This work was supported by the CNRS, grants from the Fondation pour la Recherche Medicale, the EEC Marie Curie 5th framework, the Association pour la Recherche sur le Cancer (n<SUP>o</SUP> 3744), the Association Francaise contre les Myopathies (MNM1 2007) and the Agence Nationale de la Recherche (ANR-07-NEURO-034-01). A.B. was supported by a postdoctoral fellowship from Fondation pour la Recherche Medicale, EEC Marie Curie 5th framework, from Association Francaise contre les Myopathies Agence Nationale de la Recherche. C.C.-R. was supported by a joint Ph.D. grant from the CNRS and Region Languedoc-Roussillon and then by a predoctoral Association pour la Recherche sur le Cancer fellowship.	Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; AYER S, 1993, NUCLEIC ACIDS RES, V21, P1619, DOI 10.1093/nar/21.7.1619; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brown HLD, 2006, DEVELOPMENT, V133, P275, DOI 10.1242/dev.02191; Crispi S, 1998, J MOL BIOL, V275, P561, DOI 10.1006/jmbi.1997.1473; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; GONZYTREBOUL G, 1995, GENE DEV, V9, P1137, DOI 10.1101/gad.9.9.1137; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; Hoopfer ED, 2008, J NEUROSCI, V28, P6092, DOI 10.1523/JNEUROSCI.0677-08.2008; Horner M., 1997, DROS INF SERV, V80, P35; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Ito K, 1997, DEVELOPMENT, V124, P761; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; Murata T, 1996, MOL CELL BIOL, V16, P6509; Nicolai M, 2003, J NEUROBIOL, V57, P291, DOI 10.1002/neu.10277; OHNO CK, 1994, MOL CELL BIOL, V14, P3166, DOI 10.1128/MCB.14.5.3166; ROBERTSON HM, 1988, GENETICS, V118, P461; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; UEDA H, 1991, NUCLEIC ACIDS RES, V19, P3689, DOI 10.1093/nar/19.13.3689; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Yamada M, 2000, DEVELOPMENT, V127, P5083; YANG MY, 1995, NEURON, V15, P45; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	41	53	55	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					37	U57		10.1038/nn.2700	http://dx.doi.org/10.1038/nn.2700			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131955				2022-12-24	WOS:000285684900012
J	Ciarleglio, CM; Axley, JC; Strauss, BR; Gamble, KL; McMahon, DG				Ciarleglio, Christopher M.; Axley, John C.; Strauss, Benjamin R.; Gamble, Karen L.; McMahon, Douglas G.			Perinatal photoperiod imprints the circadian clock	NATURE NEUROSCIENCE			English	Article							MOUSE SUPRACHIASMATIC NUCLEUS; LIGHT; PACEMAKER; RESPONSES; BEHAVIOR; PERIOD	Using real-time gene expression imaging and behavioral analysis, we found that the perinatal photoperiod has lasting effects on the circadian rhythms expressed by clock neurons as well as on mouse behavior, and sets the responsiveness of the biological clock to subsequent changes in photoperiod. These developmental gene x environment interactions tune circadian clock responses to subsequent seasonal photoperiods and may contribute to the influence of season on neurobehavioral disorders in humans.	[Ciarleglio, Christopher M.; McMahon, Douglas G.] Vanderbilt Univ, Neurosci Grad Program, Nashville, TN 37203 USA; [Ciarleglio, Christopher M.; Axley, John C.; Strauss, Benjamin R.; Gamble, Karen L.; McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University	McMahon, DG (corresponding author), Vanderbilt Univ, Neurosci Grad Program, Nashville, TN 37203 USA.	douglas.g.mcmahon@vanderbilt.edu	Gamble, Karen/A-1753-2010; Ciarleglio, Christopher M/D-8463-2013	Ciarleglio, Christopher M/0000-0002-8490-8715; Gamble, Karen/0000-0003-3813-8577; Axley, John/0000-0002-4207-7984	US National Institutes of Health [P50 MH078028, T32 MH64913, F31 MH080547]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028, T32MH065215, T32MH064913, F31MH080547] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank J.Y. Cohen for kindly providing custom software programming. This work was supported by US National Institutes of Health grants P50 MH078028 (D.G.M.), T32 MH64913 and F31 MH080547 (C.M.C.).	BARRETT RK, 1989, J COMP PHYSIOL A, V165, P41, DOI 10.1007/BF00613798; Ciarleglio CM, 2009, J NEUROSCI, V29, P1670, DOI 10.1523/JNEUROSCI.3801-08.2009; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Ishida Y, 2001, J NEUROSCI RES, V64, P612, DOI 10.1002/jnr.1114; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Pyter LM, 2006, BEHAV NEUROSCI, V120, P125, DOI 10.1037/0735-7044.120.1.125; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Wehr TA, 2001, ARCH GEN PSYCHIAT, V58, P1108, DOI 10.1001/archpsyc.58.12.1108; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978	15	108	109	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					25	27		10.1038/nn.2699	http://dx.doi.org/10.1038/nn.2699			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131951	Green Accepted			2022-12-24	WOS:000285684900009
J	Calu, DJ; Roesch, MR; Haney, RZ; Holland, PC; Schoenbaum, G				Calu, Donna J.; Roesch, Matthew R.; Haney, Richard Z.; Holland, Peter C.; Schoenbaum, Geoffrey			Neural Correlates of Variations in Event Processing during Learning in Central Nucleus of Amygdala	NEURON			English	Article							SURPRISE-INDUCED ENHANCEMENT; LESIONS DISRUPT INCREMENTS; CONDITIONED-STIMULUS; ORIENTING RESPONSE; DOPAMINE NEURONS; BASOLATERAL AMYGDALA; PREDICTIVE ACCURACY; LATERAL HABENULA; REWARD; RATS	Attention or variations in event processing help drive learning. Lesion studies have implicated the central nucleus of the amygdala (CeA) in this process, particularly when expected rewards are omitted. However, lesion studies cannot specify how information processing in CeA supports such learning. To address these questions, we recorded CeA neurons in rats performing a task in which rewards were delivered or omitted unexpectedly. We found that activity in CeA neurons increased selectively at the time of omission and declined again with learning. Increased firing correlated with CeA-inactivation sensitive measures of attention. Notably CeA neurons did not fire to the cues or in response to unexpected rewards. These results indicate that CeA contributes to learning in response to reward omission due to a specific role in signaling actual omission rather than a more general involvement in signaling expectancies, errors, or reward value.	[Calu, Donna J.; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Haney, Richard Z.; Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Schoenbaum, Geoffrey] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Roesch, Matthew R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Roesch, Matthew R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Holland, Peter C.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Program Neurosci, 20 Penn St,HSF-2 S251, Baltimore, MD 21201 USA.	schoenbg@schoenbaumlab.org		Calu, Donna/0000-0003-2377-9494	NIDA [R01-DA015718, K01DA021609]; NIMH [F31-MH080514]; NIA [R01-AG027097]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH053667, R01MH080865, F31MH080514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718, K01DA021609] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the NIDA (R01-DA015718, G.S.; K01DA021609, M.R.), NIMH (F31-MH080514, D.C.), and NIA (R01-AG027097; G.S.).	Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Bucci DJ, 2007, EUR J NEUROSCI, V26, P2669, DOI 10.1111/j.1460-9568.2007.05902.x; Bucci DJ, 1998, J NEUROSCI, V18, P8038; CHIBA AA, 1995, J NEUROSCI, V15, P7315; Groshek F, 2005, BEHAV NEUROSCI, V119, P202, DOI 10.1037/0735-7044.119.1.202; Hall, 1982, QUANTITATIVE ANAL BE, V3, P241; Han JS, 1999, BEHAV NEUROSCI, V113, P143, DOI 10.1037/0735-7044.113.1.143; HOLLAND PC, 1993, BEHAV NEUROSCI, V107, P246, DOI 10.1037/0735-7044.107.2.246; Holland PC, 2006, J NEUROSCI, V26, P3791, DOI 10.1523/JNEUROSCI.0390-06.2006; Holland PC, 2006, NEUROBIOL LEARN MEM, V85, P30, DOI 10.1016/j.nlm.2005.07.001; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; HOLLAND PC, 1993, BEHAV NEUROSCI, V107, P235, DOI 10.1037/0735-7044.107.2.235; Holland PC, 2005, J EXP PSYCHOL ANIM B, V31, P155, DOI 10.1037/0097-7403.31.2.155; Holland PC, 2001, BEHAV NEUROSCI, V115, P945, DOI 10.1037//0735-7044.115.4.945; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hong S, 2008, NEURON, V60, P720, DOI 10.1016/j.neuron.2008.09.035; KAYE H, 1984, Q J EXP PSYCHOL-B, V36, P131, DOI 10.1080/14640748408402199; Lee HJ, 2008, EUR J NEUROSCI, V27, P3043, DOI 10.1111/j.1460-9568.2008.06272.x; Lee HJ, 2006, J NEUROSCI, V26, P6077, DOI 10.1523/JNEUROSCI.1316-06.2006; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; McDannald M, 2004, EUR J NEUROSCI, V20, P240, DOI 10.1111/j.0953-816X.2004.03458.x; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paxinos G, 2009, RAT BRAIN STEREOTAXI; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; PEARCE JM, 1988, Q J EXP PSYCHOL-B, V40, P181; Pitkanen A., 2000, AMYGDALA FUNCTIONAL; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; SWAN JA, 1988, J EXP PSYCHOL ANIM B, V14, P292, DOI 10.1037/0097-7403.14.3.292; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tye KM, 2010, J NEUROSCI, V30, P116, DOI 10.1523/JNEUROSCI.4240-09.2010; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WALLACE DM, 1992, BRAIN RES BULL, V28, P447, DOI 10.1016/0361-9230(92)90046-Z; WILSON PN, 1992, Q J EXP PSYCHOL-B, V44B, P17	38	46	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					991	1001		10.1016/j.neuron.2010.11.019	http://dx.doi.org/10.1016/j.neuron.2010.11.019			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	699LM	21145010	Bronze, Green Accepted			2022-12-24	WOS:000285664900018
J	Barnabe-Heider, F; Goritz, C; Sabelstrom, H; Takebayashi, H; Pfrieger, FW; Meletis, K; Frisen, J				Barnabe-Heider, Fanie; Goritz, Christian; Sabelstrom, Hanna; Takebayashi, Hirohide; Pfrieger, Frank W.; Meletis, Konstantinos; Frisen, Jonas			Origin of New Glial Cells in Intact and Injured Adult Spinal Cord	CELL STEM CELL			English	Article							GRAY-MATTER ASTROCYTES; NEURAL STEM-CELL; REACTIVE ASTROCYTES; PROGENITOR CELLS; EPENDYMAL CELLS; GAP-JUNCTIONS; SCAR TISSUE; BETA-CELLS; BRAIN; OLIGODENDROCYTES	Several distinct cell types in the adult central nervous system have been suggested to act as stem or progenitor cells generating new cells under physiological or pathological conditions. We have assessed the origin of new cells in the adult mouse spinal cord by genetic fate mapping. Oligodendrocyte progenitors self-renew, give rise to new mature oligodendrocytes, and constitute the dominating proliferating cell population in the intact adult spinal cord. In contrast, astrocytes and ependymal cells, which are restricted to limited self-duplication in the intact spinal cord, generate the largest number of cells after spinal cord injury. Only ependymal cells generate progeny of multiple fates, and neural stem cell activity in the intact and injured adult spinal cord is confined to this cell population. We provide an integrated view of how several distinct cell types contribute in complementary ways to cell maintenance and the reaction to injury.	[Barnabe-Heider, Fanie; Goritz, Christian; Sabelstrom, Hanna; Meletis, Konstantinos; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Takebayashi, Hirohide] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto 8608556, Japan; [Pfrieger, Frank W.] Univ Strasbourg, Inst Cellular & Integrat Neurosci INCI, CNRS, UPR 3212, F-67084 Strasbourg, France	Karolinska Institutet; Kumamoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021; Pfrieger, Frank/AAX-3208-2020; Takebayashi, Hirohide/AAO-1693-2020; Meletis, Konstantinos/ABE-6777-2020	Göritz, Christian/0000-0003-0799-766X; Pfrieger, Frank/0000-0001-7085-1431; Sabelstrom, Hanna/0000-0002-1736-7234; Meletis, Konstantinos/0000-0001-5665-4781	Swedish Research Council; Swedish Cancer Society; Swedish Agency for Innovation Systems; Karolinska Institute; Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse; Canadian Institutes of Health Research (CIHR); Christopher and Dana Reeve Foundation (CDRF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Agency for Innovation Systems(Vinnova); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Christopher and Dana Reeve Foundation (CDRF)	We are indebted to the members of the J.F. lab for valuable discussions. We thank Drs. H. Okano, T. Edlund, and U. Lendahl for providing antibodies. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Swedish Agency for Innovation Systems, the Karolinska Institute, Tobias Stiftelsen, and Knut och Alice Wallenbergs Stiftelse. F.B.-H. was supported by postdoctoral fellowships from Canadian Institutes of Health Research (CIHR) and Christopher and Dana Reeve Foundation (CDRF).	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carlen M, 2006, EXP CELL RES, V312, P2851, DOI 10.1016/j.yexcr.2006.05.012; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; FRISEN J, 1993, INT J DEV NEUROSCI, V11, P461, DOI 10.1016/0736-5748(93)90020-E; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ohori Y, 2006, J NEUROSCI, V26, P11948, DOI 10.1523/JNEUROSCI.3127-06.2006; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pompolo S, 2001, BRAIN RES, V906, P143, DOI 10.1016/S0006-8993(01)02574-4; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Weiss S, 1996, J NEUROSCI, V16, P7599; Wu D, 2005, J NEUROCYTOL, V34, P459, DOI 10.1007/s11068-006-8998-4; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Xu Y, 2006, NEUROSCI LETT, V397, P174, DOI 10.1016/j.neulet.2005.12.051; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	57	410	429	4	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					470	482		10.1016/j.stem.2010.07.014	http://dx.doi.org/10.1016/j.stem.2010.07.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887953	Bronze			2022-12-24	WOS:000283270600009
J	Palacios, D; Mozzetta, C; Consalvi, S; Caretti, G; Saccone, V; Proserpio, V; Marquez, VE; Valente, S; Mai, A; Forcales, SV; Sartorelli, V; Puri, PL				Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Caretti, Giuseppina; Saccone, Valentina; Proserpio, Valentina; Marquez, Victor E.; Valente, Sergio; Mai, Antonello; Forcales, Sonia V.; Sartorelli, Vittorio; Puri, Pier Lorenzo			TNF/p38 alpha/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR ACTIVITY; POLYCOMB GROUP PROTEINS; SKELETAL-MUSCLE; GENE-EXPRESSION; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; TARGET GENES; STEM-CELL; FATE; DIFFERENTIATION	How regeneration cues are converted into the epigenetic information that controls gene expression in adult stem cells is currently unknown. We identified an inflammation-activated signaling in muscle stem (satellite) cells, by which the polycomb repressive complex 2 (PRC2) represses Pax7 expression during muscle regeneration. TNF-activated p38 alpha kinase promotes the interaction between YY1 and PRC2, via threonine 372 phosphorylation of EZH2, the enzymatic subunit of the complex, leading to the formation of repressive chromatin on Pax7 promoter. TNF-alpha antibodies stimulate satellite cell proliferation in regenerating muscles of dystrophic or normal mice. Genetic knockdown or pharmacological inhibition of the enzymatic components of the p38/PRC2 signaling-p38 alpha and EZH2-invariably promote Pax7 expression and expansion of satellite cells that retain their differentiation potential upon signaling resumption. Genetic knockdown of Pax7 impaired satellite cell proliferation in response to p38 inhibition, thereby establishing the biological link between p38/PRC2 signaling to Pax7 and satellite cell decision to proliferate or differentiate.	[Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Saccone, Valentina; Puri, Pier Lorenzo] IRCCS Fdn Santa Lucia, DTI, I-00143 Rome, Italy; [Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Saccone, Valentina; Puri, Pier Lorenzo] European Brain Res Inst, I-00143 Rome, Italy; [Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Saccone, Valentina; Puri, Pier Lorenzo] Sanford Burnham Inst Med Res, La Jolla, CA 92037 USA; [Caretti, Giuseppina; Proserpio, Valentina; Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Caretti, Giuseppina; Proserpio, Valentina] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Marquez, Victor E.] NCI, Med Chem Lab, Frederick, MD 21720 USA; [Valente, Sergio; Mai, Antonello] Univ Roma La Sapienza, Dept Chem & Drug Technol, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	IRCCS Santa Lucia; Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Milan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fondazione Cenci Bolognetti; Sapienza University Rome	Puri, PL (corresponding author), IRCCS Fdn Santa Lucia, DTI, I-00143 Rome, Italy.	plpuri@dti.telethon.it	Mozzetta, Chiara/Q-2786-2019; Marquez, Victor/AAP-3549-2021; Mozzetta, Chiara/K-9947-2018; Proserpio, Valentina/AAB-3630-2019; Forcales, Sonia/AAU-8996-2020; Forcales, Sonia-V./B-2157-2013; Palacios, Daniela/K-4698-2016; Palacios, Daniela/AAA-7608-2019; Mai, Antonello/AAC-2144-2019; Consalvi, Silvia/K-5960-2016; Valente, Sergio/K-2198-2016	Mozzetta, Chiara/0000-0002-7147-7266; Mozzetta, Chiara/0000-0002-7147-7266; Proserpio, Valentina/0000-0003-2071-4206; Forcales, Sonia/0000-0002-7111-4959; Forcales, Sonia-V./0000-0002-7111-4959; Palacios, Daniela/0000-0002-2207-2369; Palacios, Daniela/0000-0002-2207-2369; Valente, Sergio/0000-0002-2241-607X; Sartorelli, Vittorio/0000-0002-9284-3675; Puri, Pier Lorenzo/0000-0003-4964-0095; Saccone, Valentina/0000-0002-0566-6384; Mai, Antonello/0000-0001-9176-2382	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) [R01 AR053779]; European Community [241440]; Sanford Children's Health Research Center; Association Francaise contre les Myopathies (AFM) [14767]; Associazione Italiana Ricerca sul Cancro (AIRC); Parent Project Onlus; AIRC MFAG; Marie Curie Reintegration Grant; AFM; National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the NIH; Fondazione Telethon Funding Source: Custom; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052779, ZIAAR041126] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); European Community(European Commission); Sanford Children's Health Research Center; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Parent Project Onlus; AIRC MFAG(Fondazione AIRC per la ricerca sul cancro); Marie Curie Reintegration Grant(European Commission); AFM(Association Francaise contre les Myopathies); National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fondazione Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	P.L.P. is an Associate Telethon Scientist of the Dulbecco Telethon Institute (DTI) and Associate Investigator of Sanford Children's Health Research Center. This work has been supported by the following grants to P.L.P.: R01 AR053779 from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD); research funding from the European Community's Seventh Framework Programme in the project ENDOSTEM (Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue; grant agreement number 241440); Sanford Children's Health Research Center grant; Association Francaise contre les Myopathies (AFM, Pharmacological treatment of muscular dystrophy: insight into deacetylase inhibitor-mediated regeneration and synergistic cooperation with anti-inflammatoryagents" code # 14767); Associazione Italiana Ricerca sul Cancro (AIRC); and Parent Project Onlus.; G.C. is supported by AIRC MFAG and Marie Curie Reintegration Grant. C.M. is a recipient of AFM fellowship. This work was also supported in part by the Intramural Program of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the NIH to V.S.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Chow CW, 2006, CELL, V127, P887, DOI 10.1016/j.cell.2006.11.015; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gillespie MA, 2009, J CELL BIOL, V187, P991, DOI 10.1083/jcb.200907037; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Holterman CE, 2007, J CELL BIOL, V179, P911, DOI 10.1083/jcb.200709083; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lassar AB, 2009, J CELL BIOL, V187, P941, DOI 10.1083/jcb.200911123; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Mai A, 2007, CHEMMEDCHEM, V2, P987, DOI 10.1002/cmdc.200700023; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Merdes G, 2009, DEV CELL, V17, P440, DOI 10.1016/j.devcel.2009.10.001; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mozzetta C, 2009, INT J BIOCHEM CELL B, V41, P701, DOI 10.1016/j.biocel.2008.08.033; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Panning B, 2010, CELL STEM CELL, V6, P3, DOI 10.1016/j.stem.2009.12.013; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Peterson JM, 2008, INT REV IMMUNOL, V27, P375, DOI 10.1080/08830180802302389; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Radley HG, 2008, NEUROMUSCULAR DISORD, V18, P227, DOI 10.1016/j.nmd.2007.11.002; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Wong ESM, 2009, DEV CELL, V17, P142, DOI 10.1016/j.devcel.2009.05.009; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	79	292	303	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					455	469		10.1016/j.stem.2010.08.013	http://dx.doi.org/10.1016/j.stem.2010.08.013			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887952	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000283270600008
J	Chittajallu, R; Isaac, JTR				Chittajallu, Ramesh; Isaac, John T. R.			Emergence of cortical inhibition by coordinated sensory-driven plasticity at distinct synaptic loci	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; THALAMOCORTICAL FEEDFORWARD INHIBITION; EXCITATORY NEURONAL NETWORK; FAST-SPIKING INTERNEURONS; RECEPTOR SUBUNIT NR3A; SPINY STELLATE CELLS; NMDA RECEPTORS; LAYER-IV; SOMATOSENSORY CORTEX; REGIONAL EXPRESSION	Feedforward GABAergic inhibition sets the dendritic integration window, thereby controlling timing and output in cortical circuits. However, the manner in which feedforward inhibitory circuits emerge is unclear, despite this being a critical step for neocortical development and function. We found that sensory experience drove plasticity of the feedforward inhibitory circuit in mouse layer 4 somatosensory barrel cortex in the second postnatal week via two distinct mechanisms. First, sensory experience selectively strengthened thalamocortical-to-feedforward interneuron inputs via a presynaptic mechanism but did not regulate other inhibitory circuit components. Second, experience drove a postsynaptic mechanism in which a downregulation of a prominent thalamocortical NMDA excitatory postsynaptic potential in stellate cells regulated the final expression of functional feedforward inhibitory input. Thus, experience is required for specific, coordinated changes at thalamocortical synapses onto both inhibitory and excitatory neurons, producing a circuit plasticity that results in maturation of functional feedforward inhibition in layer 4.	[Chittajallu, Ramesh; Isaac, John T. R.] NINDS, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Chittajallu, R (corresponding author), NINDS, Dev Synapt Plast Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	chittajallur@ninds.nih.gov; isaacj@ninds.nih.gov	Chittajallu, Ramesh/AAX-3749-2020	Chittajallu, Ramesh/0000-0002-9794-0052	National Institute of Neurological Disorders and Stroke	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. McBain for discussions and Y. Yanagawa (Gunma University) for providing GAD67-GFP knockin mouse. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Program.	Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Binshtok AM, 2006, J NEUROSCI, V26, P708, DOI 10.1523/JNEUROSCI.4409-05.2006; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; Espinosa F, 2009, J NEUROPHYSIOL, V101, P2290, DOI 10.1152/jn.90754.2008; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Hardingham N, 2008, NEURON, V60, P861, DOI 10.1016/j.neuron.2008.10.018; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hull C, 2009, J NEUROSCI, V29, P9127, DOI 10.1523/JNEUROSCI.5971-08.2009; Kremkow J, 2010, J COMPUT NEUROSCI, V28, P579, DOI 10.1007/s10827-010-0240-9; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lee SH, 2007, J NEUROPHYSIOL, V97, P4380, DOI 10.1152/jn.01217.2006; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Oren I, 2009, J NEUROSCI, V29, P939, DOI 10.1523/JNEUROSCI.3251-08.2009; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Shoykhet M, 2005, J NEUROPHYSIOL, V94, P3987, DOI 10.1152/jn.00569.2005; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yoon BJ, 2009, P NATL ACAD SCI USA, V106, P9860, DOI 10.1073/pnas.0901305106	42	64	64	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1240	1248		10.1038/nn.2639	http://dx.doi.org/10.1038/nn.2639			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20871602	Green Accepted			2022-12-24	WOS:000282171300016
J	Liu, C; Maejima, T; Wyler, SC; Casadesus, G; Herlitze, S; Deneris, ES				Liu, Chen; Maejima, Takashi; Wyler, Steven C.; Casadesus, Gemma; Herlitze, Stefan; Deneris, Evan S.			Pet-1 is required across different stages of life to regulate serotonergic function	NATURE NEUROSCIENCE			English	Article							TRANSPORTER MESSENGER-RNA; NORMAL ANXIETY-LIKE; NEURON DEVELOPMENT; RAPHE NEURONS; BEHAVIOR; STRESS; RAT; VULNERABILITY; PROJECTIONS; ACTIVATION	Transcriptional cascades are required for the specification of serotonin (5-HT) neurons and behaviors modulated by 5-HT. Several cascade factors are expressed throughout the lifespan, which suggests that their control of behavior might not be temporally restricted to programming normal numbers of 5-HT neurons. We used new mouse conditional targeting approaches to investigate the ongoing requirements for Pet-1 (also called Fev), a cascade factor that is required for the initiation of 5-HT synthesis, but whose expression persists into adulthood. We found that Pet-1 was required after the generation of 5-HT neurons for multiple steps in 5-HT neuron maturation, including axonal innervation of the somatosensory cortex, expression of appropriate firing properties, and the expression of the Htr1a and Htr1b autoreceptors. Pet-1 was still required in adult 5-HT neurons to preserve normal anxiety-related behaviors through direct autoregulated control of serotonergic gene expression. These findings indicate that Pet-1 is required across the lifespan of the mouse and that behavioral pathogenesis can result from both developmental and adult-onset alterations in serotonergic transcription.	[Liu, Chen; Maejima, Takashi; Wyler, Steven C.; Casadesus, Gemma; Herlitze, Stefan; Deneris, Evan S.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Deneris, ES (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	esd@case.edu		Casadesus, Gemma/0000-0002-5206-5637; Liu, Chen/0000-0002-5922-0951	US National Institutes of Health [MH062723, MH078028]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH078028, R01MH062723] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Landmesser for suggestions on retrograde tracing; S. Dymecki and P. Chambon for CreER<SUP>T2</SUP> plasmids; Q. Ma for the mycPet-1 vector; J. Zhu for the Gata3<SUP>loxP/loxP</SUP> mice; K. Lobur for assistance with genotyping of mice; J. Reeves for behavioral testing in the Case Rodent Behavior Core; and L. Landmesser, S. Maricich and J. Silver for comments on the manuscript. This work was supported by grants MH062723 and MH078028 to E.S.D. (US National Institutes of Health).	Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bayliss DA, 1997, J NEUROPHYSIOL, V77, P1349, DOI 10.1152/jn.1997.77.3.1349; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; FORNAL CA, 1994, J PHARMACOL EXP THER, V270, P1345; Gardner KL, 2009, BRAIN RES, V1305, P47, DOI 10.1016/j.brainres.2009.09.065; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Krueger KC, 2008, J NEUROSCI, V28, P12748, DOI 10.1523/JNEUROSCI.4349-08.2008; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Ludwig V, 2007, J NEUROSCI METH, V162, P108, DOI 10.1016/j.jneumeth.2006.12.011; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pum ME, 2009, BEHAV NEUROSCI, V123, P449, DOI 10.1037/a0014478; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rivera HM, 2009, BRAIN RES, V1259, P51, DOI 10.1016/j.brainres.2008.12.067; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Scott MM, 2005, INT J DEV NEUROSCI, V23, P277, DOI 10.1016/j.ijdevneu.2004.05.012; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Sommer W, 2001, NEUROPSYCHOPHARMACOL, V24, P430, DOI 10.1016/S0893-133X(00)00210-4; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Vertes RP, 1999, J COMP NEUROL, V407, P555; Vitalis T, 2007, EUR J NEUROSCI, V26, P331, DOI 10.1111/j.1460-9568.2007.05661.x; Vogt MA, 2008, EXP NEUROL, V211, P25, DOI 10.1016/j.expneurol.2007.12.012; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	47	129	130	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1190	1198		10.1038/nn.2623	http://dx.doi.org/10.1038/nn.2623			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20818386	Green Accepted, Green Submitted			2022-12-24	WOS:000282171300010
J	Sanz-Clemente, A; Matta, JA; Isaac, JTR; Roche, KW				Sanz-Clemente, Antonio; Matta, Jose A.; Isaac, John T. R.; Roche, Katherine W.			Casein Kinase 2 Regulates the NR2 Subunit Composition of Synaptic NMDA Receptors	NEURON			English	Article							D-ASPARTATE RECEPTORS; DEPENDENT PROTEIN-KINASE; SURFACE EXPRESSION; RAT-BRAIN; HIPPOCAMPAL SYNAPSES; VISUAL-CORTEX; CROSS-TALK; PHOSPHORYLATION; CK2; TRAFFICKING	N-methyl-D-aspartate (NMDA) receptors (NMDARs) play a central role in development, synaptic plasticity, and neurological disease. NMDAR subunit composition defines their biophysical properties and downstream signaling. Casein kinase 2 (CK2) phosphorylates the NR2B subunit within its PDZ-binding domain; however, the consequences for NMDAR localization and function are unclear. Here we show that CK2 phosphorylation of NR2B regulates synaptic NR2B and NR2A in response to activity. We find that CK2 phosphorylates NR2B, but not NR2A, to drive NR2B-endocytosis and remove NR2B from synapses resulting in an increase in synaptic NR2A expression. During development there is an activity-dependent switch from NR2B to NR2A at cortical synapses. We observe an increase in CK2 expression and NR2B phosphorylation over this same critical period and show that the acute activity-dependent switch in NR2 subunit composition at developing hippocampal synapses requires CK2 activity. Thus, CK2 plays a central role in determining the NR2 subunit content of synaptic NMDARs.	[Sanz-Clemente, Antonio; Roche, Katherine W.] Natl Inst Neurol Disorders & Stroke, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA; [Matta, Jose A.; Isaac, John T. R.] Natl Inst Neurol Disorders & Stroke, Synapt Plast Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roche, KW (corresponding author), Natl Inst Neurol Disorders & Stroke, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Sanz-Clemente, Antonio/AAF-7124-2019; Roche, Katherine/W-9893-2019	Sanz-Clemente, Antonio/0000-0002-1256-4722; Roche, Katherine/0000-0001-7282-6539	NINDS; NIGMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank John D. Badger II for technical assistance. We also thank the NINDS sequencing facility and light imaging facility for expertise and advice. This research was supported by the NINDS Intramural Research Program (A.S-C.; K.W.R.; J.T.R.I) and the Pharmacology Research Associate (PRAT) Program, NIGMS (J.A.M).	AKSENOVA MV, 1991, FEBS LETT, V279, P55, DOI 10.1016/0014-5793(91)80249-3; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; CARMICHAEL DF, 1982, J BIOL CHEM, V257, P440; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chao CC, 2007, J NEUROSCI, V27, P6243, DOI 10.1523/JNEUROSCI.1531-07.2007; CHARRIAUTMARLANGUE C, 1991, P NATL ACAD SCI USA, V88, P10232, DOI 10.1073/pnas.88.22.10232; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Clapp P, 2010, J PHARMACOL EXP THER, V332, P720, DOI 10.1124/jpet.109.158741; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; GIRAULT JA, 1990, J NEUROCHEM, V55, P1772, DOI 10.1111/j.1471-4159.1990.tb04968.x; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; HEMMINGS BA, 1982, EUR J BIOCHEM, V127, P473; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Igaz LM, 2002, J NEUROSCI, V22, P6781; Jung EJ, 1998, BIOCHEM BIOPH RES CO, V246, P238, DOI 10.1006/bbrc.1998.8605; Kew JNC, 1998, J NEUROSCI, V18, P1935; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kimura R, 2008, J PHYSIOL-LONDON, V586, P3195, DOI 10.1113/jphysiol.2008.151894; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; LITCHFIELD DW, 1994, CELL MOL BIOL RES, V40, P373; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; MARTIN ME, 1990, INT J DEV NEUROSCI, V8, P47; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Song C, 2003, J BIOL CHEM, V278, P33364, DOI 10.1074/jbc.M304240200; Soto D, 2004, BIOCHEM BIOPH RES CO, V322, P542, DOI 10.1016/j.bbrc.2004.07.158; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Tanemoto M, 2002, NEURON, V34, P387, DOI 10.1016/S0896-6273(02)00675-X; Tovar KR, 1999, J NEUROSCI, V19, P4180; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Wenzel A, 1997, J NEUROCHEM, V68, P469; Xu J, 2003, J BIOL CHEM, V278, P26929, DOI 10.1074/jbc.M300401200; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zhao Y, 1996, BIOCHEMISTRY-US, V35, P11797, DOI 10.1021/bi960471r	68	149	150	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					984	996		10.1016/j.neuron.2010.08.011	http://dx.doi.org/10.1016/j.neuron.2010.08.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869595	Green Accepted, Bronze			2022-12-24	WOS:000282801100010
J	Satoh, AK; Xia, HA; Yan, LM; Liu, CH; Hardie, RC; Ready, DF				Satoh, Akiko K.; Xia, Hongai; Yan, Limin; Liu, Che-Hsiung; Hardie, Roger C.; Ready, Donald F.			Arrestin Translocation Is Stoichiometric to Rhodopsin Isomerization and Accelerated by Phototransduction in Drosophila Photoreceptors	NEURON			English	Article							LIGHT-DEPENDENT TRANSLOCATION; NINAC MYOSIN-III; IN-VIVO; VERTEBRATE PHOTORECEPTORS; RETINAL-DEGENERATION; ROD PHOTORECEPTORS; VISUAL ARRESTIN; CELL-SURVIVAL; S-ANTIGEN; PROTEIN	Upon illumination, visual arrestin translocates from photoreceptor cell bodies to rhodopsin and membrane-rich photosensory compartments, vertebrate outer segments or invertebrate rhabdomeres, where it quenches activated rhodopsin. Both the mechanism and function of arrestin translocation are unresolved and controversial. In dark-adapted photoreceptors of the fruitfly Drosophila, confocal immunocytochemistry shows arrestin (Arr2) associated with distributed photoreceptor endomembranes. Immunocytochemistry and live imaging of GFP-tagged Arr2 demonstrate rapid reversible translocation to stimulated rhabdomeres in stoichiometric proportion to rhodopsin photoisomerization. Translocation is very rapid in normal photoreceptors (time constant <10 s) and can also be resolved in the time course of electroretinogram recordings. Genetic elimination of key phototransduction proteins, including phospholipase C (PLC), Gq, and the light-sensitive Ca2+-permeable TRP channels, slows translocation by 10- to 100-fold. Our results indicate that Arr2 translocation in Drosophila photoreceptors is driven by diffusion, but profoundly accelerated by phototransduction and Ca2+ influx.	[Yan, Limin; Liu, Che-Hsiung; Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Satoh, Akiko K.] Nagoya Univ, Grad Sch Sci, Dept Biol Sci, Nagoya, Aichi 4668601, Japan; [Xia, Hongai; Ready, Donald F.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	University of Cambridge; Nagoya University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hardie, RC (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.	rch14@cam.ac.uk; dready@bilbo.bio.purdue.edu	Satoh, Akiko/AAH-6218-2019	Hardie, Roger/0000-0001-5531-3264; Satoh, Akiko/0000-0001-7336-6642	NIH [NEI10306]; BBSRC [BB/G006865/1]; Naito Foundation [25-040920]; Novartis Foundation [20-120]; KAKENHI [21687005, 21113510]; NSF-MEU [0217552-IBN]; NATIONAL EYE INSTITUTE [R01EY010306] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G006865/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Naito Foundation(Naito Memorial Foundation); Novartis Foundation(Novartis); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NSF-MEU; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Dr. R. Ranganathan (Rabbit anti-Arr2) and Dr. C.S. Zuker (Rabbit anti-NinaA) for reagents and fly stocks. This work was supported by NIH grant NEI10306 (DFR). BBSRC BB/G006865/1 (RCH). A.K.S. was supported by Naito Foundation (25-040920), Novartis Foundation (20-120), and KAKENHI (21687005 and 21113510). Live cell imaging was supported by NSF-MEU grant 0217552-IBN (PI, Dr. K. Robinson). We are indebted to Drs Ken Robinson and Doekele Stavenga for critical comments on earlier versions of the manuscript.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; ARIKAWA K, 1994, ZOOL SCI, V11, P391; Belusic G, 2010, J COMP PHYSIOL A, V196, P23, DOI 10.1007/s00359-009-0489-5; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chinchore Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000377; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Elias R, 2004, MOL VIS, V10, P672; Elsaesser R, 2010, P NATL ACAD SCI USA, V107, P4740, DOI 10.1073/pnas.0906386107; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hardie RC, 2003, J BIOL CHEM, V278, P18851, DOI 10.1074/jbc.M300310200; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARDIE RC, 2008, SENSES COMPREHENSIVE, V1, P77; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Hofstee CA, 1996, VISUAL NEUROSCI, V13, P897, DOI 10.1017/S0952523800009147; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; MANGINI NJ, 1994, VISUAL NEUROSCI, V11, P561, DOI 10.1017/S0952523800002467; MATSUMOTO H, 1987, P NATL ACAD SCI USA, V84, P985, DOI 10.1073/pnas.84.4.985; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; MATSUMOTOSUZUKI E, 1989, J NEUROCYTOL, V18, P87, DOI 10.1007/BF01188427; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mendez A, 2003, J NEUROSCI, V23, P3124; MINKE B, 1979, J GEN PHYSIOL, V73, P517, DOI 10.1085/jgp.73.5.517; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Orisme W, 2010, CELL SIGNAL, V22, P447, DOI 10.1016/j.cellsig.2009.10.016; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Reidel B, 2008, CELL MOTIL CYTOSKEL, V65, P785, DOI 10.1002/cm.20300; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; STAVENGA DG, 1996, PROG RETIN EYE RES, V15, P231, DOI DOI 10.1016/1350-9462(95)00011-9; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1	50	39	39	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					997	1008		10.1016/j.neuron.2010.08.024	http://dx.doi.org/10.1016/j.neuron.2010.08.024			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869596	Green Accepted, Bronze			2022-12-24	WOS:000282801100011
J	Yang, YM; Fedchyshyn, MJ; Grande, G; Aitoubah, J; Tsang, CW; Xie, H; Ackerley, CA; Trimble, WS; Wang, LY				Yang, Yi-Mei; Fedchyshyn, Michael J.; Grande, Giovanbattista; Aitoubah, Jamila; Tsang, Christopher W.; Xie, Hong; Ackerley, Cameron A.; Trimble, William S.; Wang, Lu-Yang			Septins Regulate Developmental Switching from Microdomain to Nanodomain Coupling of Ca2+ Influx to Neurotransmitter Release at a Central Synapse	NEURON			English	Article							SQUID GIANT SYNAPSE; AUDITORY BRAIN-STEM; TRANSMITTER RELEASE; RAT CALYX; MAMMALIAN SEPTINS; CALCIUM-CHANNELS; VESICLE FUSION; TRANSMISSION; ARCHITECTURE; PROTEINS	Neurotransmitter release depends critically on close spatial coupling of Ca2+ entry to synaptic vesicles at the nerve terminal; however, the molecular substrates determining their physical proximity are unknown. Using the calyx of Held synapse, where "microdomain" coupling predominates at immature stages and developmentally switches to "nanodomain" coupling, we demonstrate that deletion of the filamentous protein Septin 5 imparts immature synapses with striking morphological and functional features reminiscent of mature synapses. This includes synaptic vesicles tightly localized to active zones, resistance to the slow Ca2+ buffer EGTA and a reduced number of Ca2+ channels required to trigger single fusion events. Disrupting Septin 5 organization acutely transforms microdomain to nanodomain coupling and potentiates quantal output in immature wild-type terminals. These observations suggest that Septin 5 is a core molecular substrate that differentiates distinct release modalities at the central synapse.	[Tsang, Christopher W.; Xie, Hong; Trimble, William S.] Hosp Sick Children, Program Cell Biol, Toronto, ON M5G 1X8, Canada; [Yang, Yi-Mei; Fedchyshyn, Michael J.; Grande, Giovanbattista; Aitoubah, Jamila; Wang, Lu-Yang] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Yang, Yi-Mei; Fedchyshyn, Michael J.; Grande, Giovanbattista; Aitoubah, Jamila; Wang, Lu-Yang] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Tsang, Christopher W.; Xie, Hong; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Ackerley, Cameron A.] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Trimble, WS (corresponding author), Hosp Sick Children, Program Cell Biol, Toronto, ON M5G 1X8, Canada.	w.trimble@utoronto.ca; luyang.wang@utoronto.ca		Yang, Yi-Mei/0000-0003-1491-8106	Canadian Institutes of Health Research (CIHR) [MOP-143867, MOP-97950]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by individual operating grants (MOP-143867 and MOP-97950) from Canadian Institutes of Health Research (CIHR) (to L.-Y.W. and W.S.T., respectively). W.S.T. and L.-Y.W. are the recipients of Canada Research Chairs. We thank Drs. Milton Charlton and Harold Atwood for critically reviewing an early version of this paper and other members of the Wang and Trimble labs for technical assistance, comments and discussions.	ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gentile L, 2005, EUR J NEUROSCI, V21, P278, DOI 10.1111/j.1460-9568.2004.03841.x; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Kochubey O, 2009, J PHYSIOL-LONDON, V587, P3009, DOI 10.1113/jphysiol.2009.172387; Leao RM, 2009, BRAZ J MED BIOL RES, V42, P94, DOI 10.1590/S0100-879X2009000100014; Matveev V, 2009, J NEUROSCI, V29, P12196, DOI 10.1523/JNEUROSCI.0263-09.2009; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rollenhagen A, 2006, CELL TISSUE RES, V326, P221, DOI 10.1007/s00441-006-0288-z; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; STANLEY EF, 1991, NEURON, V7, P585, DOI 10.1016/0896-6273(91)90371-6; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Suzuki G, 2009, HUM MOL GENET, V18, P1652, DOI 10.1093/hmg/ddp086; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Tsang CW, 2008, MOL CELL BIOL, V28, P7012, DOI 10.1128/MCB.00035-08; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang LY, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-36; Wang LY, 2008, J NEUROSCI, V28, P14450, DOI 10.1523/JNEUROSCI.4245-08.2008; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Wimmer VC, 2006, J NEUROSCI, V26, P109, DOI 10.1523/JNEUROSCI.3268-05.2006; WU LG, 1994, J NEUROSCI, V14, P5613; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Yang YM, 2006, J NEUROSCI, V26, P5698, DOI 10.1523/JNEUROSCI.4889-05.2006; Yersin A, 2003, P NATL ACAD SCI USA, V100, P8736, DOI 10.1073/pnas.1533137100; YOSHIKAMI D, 1989, ANN NY ACAD SCI, V560, P230, DOI 10.1111/j.1749-6632.1989.tb24100.x; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	61	87	88	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 15	2010	67	1					100	115		10.1016/j.neuron.2010.06.003	http://dx.doi.org/10.1016/j.neuron.2010.06.003			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624595	Green Accepted, Bronze			2022-12-24	WOS:000280221000012
J	Ohshiro, T; Angelaki, DE; DeAngelis, GC				Ohshiro, Tomokazu; Angelaki, Dora E.; DeAngelis, Gregory C.			A normalization model of multisensory integration	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS NEURONS; NEURAL-NETWORK MODEL; CAT STRIATE CORTEX; VISUAL-CORTEX; UNISENSORY INTEGRATION; POPULATION ACTIVITY; HEADING PERCEPTION; RECEPTIVE-FIELDS; SIMPLE CELLS; MST NEURONS	Responses of neurons that integrate multiple sensory inputs are traditionally characterized in terms of a set of empirical principles. However, a simple computational framework that accounts for these empirical features of multisensory integration has not been established. We propose that divisive normalization, acting at the stage of multisensory integration, can account for many of the empirical principles of multisensory integration shown by single neurons, such as the principle of inverse effectiveness and the spatial principle. This model, which uses a simple functional operation (normalization) for which there is considerable experimental support, also accounts for the recent observation that the mathematical rule by which multisensory neurons combine their inputs changes with cue reliability. The normalization model, which makes a strong testable prediction regarding cross-modal suppression, may therefore provide a simple unifying computational account of the important features of multisensory integration by neurons.	[Ohshiro, Tomokazu; DeAngelis, Gregory C.] Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Angelaki, Dora E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Rochester; Washington University (WUSTL)	DeAngelis, GC (corresponding author), Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	gdeangelis@cvs.rochester.edu		DeAngelis, Gregory/0000-0002-1635-1273	US National Institutes of Health [EY016178, EY019087]; NATIONAL EYE INSTITUTE [R01EY019087, R01EY016178] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank R. Jacobs, A. Pouget, J. Drugowitsch, D. Barany, A. Anzai, T. Sanada, R. Sasaki and H. Kim for helpful discussions and comments on the manuscript. This work was supported by US National Institutes of Health R01 grants EY016178 to G.C.D. and EY019087 to D.E.A.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Alvarado JC, 2007, J NEUROPHYSIOL, V97, P3193, DOI 10.1152/jn.00018.2007; Alvarado JC, 2008, BRAIN RES, V1242, P13, DOI 10.1016/j.brainres.2008.03.074; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Britten KH, 1999, J NEUROSCI, V19, P5074; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 1997, J NEUROSCI, V17, P8621; Alvarado JC, 2009, J NEUROSCI, V29, P6580, DOI 10.1523/JNEUROSCI.0525-09.2009; Cuppini C, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00006; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Heuer HW, 2007, J NEUROPHYSIOL, V98, P1115, DOI 10.1152/jn.00083.2007; Jiang W, 2001, J NEUROPHYSIOL, V85, P506, DOI 10.1152/jn.2001.85.2.506; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Magosso E, 2008, NEURAL NETWORKS, V21, P817, DOI 10.1016/j.neunet.2008.06.003; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1986, BRAIN RES, V365, P350; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Morgan ML, 2008, NEURON, V59, P662, DOI 10.1016/j.neuron.2008.06.024; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Patton PE, 2003, NEURAL COMPUT, V15, P783, DOI 10.1162/08997660360581903; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Perrault TJ, 2003, J NEUROPHYSIOL, V90, P4022, DOI 10.1152/jn.00494.2003; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rowland BA, 2007, PERCEPTION, V36, P1431, DOI 10.1068/p5842; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; Ursino M, 2009, J COMPUT NEUROSCI, V26, P55, DOI 10.1007/s10827-008-0096-4; WALLACE MT, 1994, J NEUROPHYSIOL, V71, P429, DOI 10.1152/jn.1994.71.1.429	50	178	178	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					775	U281		10.1038/nn.2815	http://dx.doi.org/10.1038/nn.2815			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21552274	Green Accepted			2022-12-24	WOS:000290958000022
J	Wilson, SR; Gerhold, KA; Bifolck-Fisher, A; Liu, Q; Patel, KN; Dong, XZ; Bautista, DM				Wilson, Sarah R.; Gerhold, Kristin A.; Bifolck-Fisher, Amber; Liu, Qin; Patel, Kush N.; Dong, Xinzhong; Bautista, Diana M.			TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch	NATURE NEUROSCIENCE			English	Article							G-BETA-GAMMA; ION-CHANNEL TRPA1; SPINOTHALAMIC TRACT NEURONS; ALLERGIC RHINITIS; ACTIVATED RECEPTOR-2; SPINAL-CORD; PAIN; PRURITUS; MICE; PATHWAY	Itch, the unpleasant sensation that evokes a desire to scratch, accompanies numerous skin and nervous system disorders. In many cases, pathological itch is insensitive to antihistamine treatment. Recent studies have identified members of the Mas-related G protein-coupled receptor (Mrgpr) family that are activated by mast cell mediators and promote histamine-independent itch. MrgprA3 and MrgprC11 act as receptors for the pruritogens chloroquine and BAM8-22, respectively. However, the signaling pathways and transduction channels activated downstream of these pruritogens are largely unknown. We found that TRPA1 is the downstream target of both MrgprA3 and MrgprC11 in cultured sensory neurons and heterologous cells. TRPA1 is required for Mrgpr-mediated signaling, as sensory neurons from TRPA1-deficient mice exhibited markedly diminished responses to chloroquine and BAM8-22. Similarly, TRPA1-deficient mice displayed little to no scratching in response to these pruritogens. Our findings indicate that TRPA1 is an essential component of the signaling pathways that promote histamine-independent itch.	[Wilson, Sarah R.; Gerhold, Kristin A.; Bifolck-Fisher, Amber; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Liu, Qin; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Liu, Qin; Patel, Kush N.; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University of California System; University of California Berkeley; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu			US National Institutes of Health [DOD007123A]; Pew Scholars Program; Rita Allen Foundation; McKnight Scholars Fund; National Science Foundation; US National Institutes of Health; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007123] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Rita Allen Foundation; McKnight Scholars Fund; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Kollarik for advice on PCR, R. Brem for use of equipment, T. Morita for technical support, and R. Brem, J. Ngai, J. Sack, M. Tsunozaki, P. Aryal and M. Pellegrino for helpful discussions and critical reading of the manuscript. This study was supported by a US National Institutes of Health Innovator Award (DOD007123A), the Pew Scholars Program, the Rita Allen Foundation, and the McKnight Scholars Fund (D. M. B.), the National Science Foundation (S. R. W.), and a US National Institutes of Health grant (X.D.).	Abila B, 1994, Afr J Med Med Sci, V23, P139; AJAYI AA, 1989, EUR J CLIN PHARMACOL, V37, P539, DOI 10.1007/BF00558141; Andriantsoanirina V, 2010, SCAND J INFECT DIS, V42, P22, DOI 10.3109/00365540903289670; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bianchi E, 2009, J NEUROCHEM, V111, P171, DOI 10.1111/j.1471-4159.2009.06308.x; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2009, NAT NEUROSCI, V12, P544, DOI 10.1038/nn.2292; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Guan Y, 2010, P NATL ACAD SCI USA, V107, P15933, DOI 10.1073/pnas.1011221107; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Howarth PH, 2000, ALLERGY, V55, P7, DOI 10.1034/j.1398-9995.2000.00802.x; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lee MG, 2008, J IMMUNOL, V180, P2251, DOI 10.4049/jimmunol.180.4.2251; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Montell C, 2008, NEURON, V58, P825, DOI 10.1016/j.neuron.2008.06.006; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Nathan RA, 2009, SOUTH MED J, V102, P935, DOI 10.1097/SMJ.0b013e3181b01c68; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rousset M, 2004, J BIOL CHEM, V279, P14619, DOI 10.1074/jbc.M313284200; Rukwied R, 2000, BRIT J DERMATOL, V142, P1114, DOI 10.1046/j.1365-2133.2000.03535.x; Sardana N, 2010, ALLERGY ASTHMA PROC, V31, P5, DOI 10.2500/aap.2010.31.3308; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2008, PAIN, V139, P681, DOI 10.1016/j.pain.2008.08.002; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Yosipovitch G, 2003, AM J CLIN DERMATOL, V4, P617, DOI 10.2165/00128071-200304090-00004; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	50	394	414	3	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					595	U82		10.1038/nn.2789	http://dx.doi.org/10.1038/nn.2789			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460831	Green Accepted, Green Submitted			2022-12-24	WOS:000289886600015
J	Faas, GC; Raghavachari, S; Lisman, JE; Mody, I				Faas, Guido C.; Raghavachari, Sridhar; Lisman, John E.; Mody, Istvan			Calmodulin as a direct detector of Ca2+ signals	NATURE NEUROSCIENCE			English	Article							IQ-MOTIF PROTEINS; CALCIUM-BINDING; HIPPOCAMPAL-NEURONS; CALBINDIN-D-28K; DENDRITES; SPINES; BRAIN	Many forms of signal transduction occur when Ca2+ enters the cytoplasm of a cell. It has been generally thought that there is a fast buffer that rapidly reduces the free Ca2+ level and that it is this buffered level of Ca2+ that triggers downstream biochemical processes, notably the activation of calmodulin (CaM) and the resulting activation of CaM-dependent enzymes. Given the importance of these transduction processes, it is crucial to understand exactly how Ca2+ activates CaM. We have determined the rate at which Ca2+ binds to CaM and found that Ca2+ binds more rapidly to CaM than to other Ca2+-binding proteins. This property of CaM and its high concentration support a new view of signal transduction: CaM directly intercepts incoming Ca2+ and sets the free Ca2+ level (that is, it strongly contributes to fast Ca2+ buffering) rather than responding to the lower Ca2+ level set by other buffers. This property is crucial for making CaM an efficient transducer. Our results also suggest that other Ca2+ binding proteins have a previously undescribed role in regulating the lifetime of Ca2+ bound to CaM and thereby setting the gain of signal transduction.	[Faas, Guido C.; Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Raghavachari, Sridhar] Duke Univ, Dept Neurobiol, Durham, NC USA; [Lisman, John E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Mody, Istvan] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Duke University; Brandeis University; University of California System; University of California Los Angeles	Faas, GC (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	gfaas@ucla.edu		Faas, Guido/0000-0002-1339-7698	US National Institutes of Health (NIH) [NS027528, NS030549]; Coelho Endowment; NIH [DA027807]; National Science Foundation [NSF0642000]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027528, R37NS030549, R01NS030549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coelho Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Adelman (The Vollum Institute) for purified CaM and mutants of CaM (CaM<INF>EF12</INF> and CaM<INF>EF34</INF>), K. Baimbridge (University of Britsh Columbia) for purified calbindin and E. B. S. Faas (Syrinx Design) for help in designing the photodiode pre-amplifier. J. E. L. would like to thank W. Ross and I. Llano for conversations at the Marine Biological Laboratory Woods Hole that led to important insights into this problem. Supported by the US National Institutes of Health (NIH) grants NS027528, NS030549 and the Coelho Endowment to I. M., NIH grant DA027807 to J. E. L. and S. R., and the National Science Foundation grant NSF0642000 to S.R.	Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; BANAYSCHWARTZ M, 1992, AGE, V15, P51, DOI 10.1007/BF02435024; Berggard T, 2002, J BIOL CHEM, V277, P16662, DOI 10.1074/jbc.M200415200; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BIBER A, 1984, EXP BRAIN RES, V56, P323; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; BROWN BL, 1985, CLIN ENDOCRINOL, V23, P201, DOI 10.1111/j.1365-2265.1985.tb00216.x; Cornelisse LN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001073; Faas GC, 2005, BIOPHYS J, V88, P4421, DOI 10.1529/biophysj.104.057745; Faas GC, 2007, PLOS BIOL, V5, P2646, DOI 10.1371/journal.pbio.0050311; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Kubota Y, 2008, J NEUROPHYSIOL, V99, P264, DOI 10.1152/jn.00876.2007; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; LINSE S, 1991, J BIOL CHEM, V266, P8050; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Nagerl UV, 2000, J NEUROSCI, V20, P1831; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Otmakhov N, 1997, J NEUROSCI, V17, P5357; PORUMB T, 1994, ANAL BIOCHEM, V220, P227, DOI 10.1006/abio.1994.1332; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647	28	125	126	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					301	304		10.1038/nn.2746	http://dx.doi.org/10.1038/nn.2746			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21258328	Green Accepted			2022-12-24	WOS:000287650100009
J	Han, YY; Kaeser, PS; Sudhof, TC; Schneggenburger, R				Han, Yunyun; Kaeser, Pascal S.; Suedhof, Thomas C.; Schneggenburger, Ralf			RIM Determines Ca2+ Channel Density and Vesicle Docking at the Presynaptic Active Zone	NEURON			English	Article							PROTEINS; RELEASE; FUSION; CALYX; RAB3	At presynaptic active zones, neurotransmitter release is initiated by the opening of voltage-gated Ca2+ channels close to docked vesicles. The mechanisms that enrich Ca2+ channels at active zones are, however, largely unknown, possibly because of the limited presynaptic accessibility of most synapses. Here, we have established a Cre-lox based conditional knockout approach at a presynaptically accessible central nervous system synapse, the calyx of Held, to directly study the functions of RIM proteins. Removal of all RIM1/2 isoforms strongly reduced the presynaptic Ca2+ channel density, revealing a role of RIM proteins in Ca2+ channel targeting. Removal of RIMs also reduced the readily releasable pool, paralleled by a similar reduction of the number of docked vesicles, and the Ca2+ channel-vesicle coupling was decreased. Thus, RIM proteins co-ordinately regulate key functions for fast transmitter release, enabling a high presynaptic Ca2+ channel density and vesicle docking at the active zone.	[Han, Yunyun; Schneggenburger, Ralf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland; [Kaeser, Pascal S.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kaeser, Pascal S.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stanford University; Howard Hughes Medical Institute; Stanford University	Schneggenburger, R (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland.	ralf.schneggenburger@epfl.ch	Han, Yunyun/AAG-4427-2021; Han, Yunyun/O-2092-2013	Han, Yunyun/0000-0003-2336-167X; Han, Yunyun/0000-0003-2336-167X	Swiss National Science Foundation (SNF) [31003A_122496]; Synapsis foundation; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029044] Funding Source: NIH RePORTER	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Synapsis foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Heather Murray for expert technical assistance; Dr. Graham Knott (Center for Interdisciplinary Electron Microscopy; EPFL) for help and advice with EM; Dr. Daniel Keller for help with flat surface rendering of active zone profiles; Dr. Patrick Charnay and Dr. Hans Jorg Fehling for the gift of mouse lines; and Dr. Olexiy Kochubey, Dr. Erwin Neher, and Dr. David Perkel for comments on the manuscript. This research was supported by grants from the Swiss National Science Foundation (SNF; 31003A_122496) and the Synapsis foundation (both to R.S.).	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kochubey O, 2009, J PHYSIOL-LONDON, V587, P3009, DOI 10.1113/jphysiol.2009.172387; Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325; Satzler K, 2002, J NEUROSCI, V22, P10567; SATZLER K, NAT CELL BIOL, DOI DOI 10.1007/S00441-006-0272-7; SATZLER K, NAT CELL BIOL, DOI DOI 10.1523/JNEUROSCI.3235-08.2008; SATZLER K, NAT CELL BIOL, DOI DOI 10.1016/J.NEURON.2007.12.026; SATZLER K, NAT CELL BIOL, DOI DOI 10.1016/J.NEURON.2006.03.014; SATZLER K, NAT CELL BIOL, DOI DOI 10.1038/SJ.EMBOJ.7600753; SATZLER K, NAT CELL BIOL, DOI DOI 10.1002/EJI.200636745; SATZLER K, NAT CELL BIOL, DOI DOI 10.1007/S00424-004-1247-8; SATZLER K, NAT CELL BIOL, DOI DOI 10.1038/NN1904; SATZLER K, NAT CELL BIOL, DOI DOI 10.1146/ANNUREV.NEURO.26.041002.131412; SATZLER K, NAT CELL BIOL, DOI DOI 10.1523/JNEUROSCI.2232-09.2009; SATZLER K, NAT CELL BIOL, DOI DOI 10.1007/S00441-006-0244-Y; SATZLER K, NAT CELL BIOL, DOI DOI 10.1016/J.NEUROSCIENCE.2007.06.011; SATZLER K, NAT CELL BIOL, DOI DOI 10.1007/S00424-006-0143-9; SATZLER K, NAT CELL BIOL, DOI DOI 10.1016/J.NEULET.2008.08.026; SATZLER K, NAT CELL BIOL, DOI DOI 10.1111/J.1600-0854.2008.00759.X; SATZLER K, NAT CELL BIOL; SATZLER K, NAT CELL BIOL, DOI DOI 10.1038/SJ.EMBOJ.7601425; SATZLER K, NAT CELL BIOL, DOI DOI 10.1523/JNEUROSCI.0350-05.2005; SATZLER K, NAT CELL BIOL, DOI DOI 10.1111/J.1460-9568.2009.06811.X; SATZLER K, NAT CELL BIOL, DOI DOI 10.1016/S0361-9230(03)00050-9; SATZLER K, NAT CELL BIOL, DOI DOI 10.1016/S0888-7543(02)00024-1; SATZLER K, NAT CELL BIOL, DOI DOI 10.1523/JNEUROSCI.2104-04.2004; SATZLER K, NAT CELL BIOL, DOI DOI 10.1126/SCIENCE.1126308; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Shankar G. M., J NEUROSCI, V27, P2866, DOI [10.1523/JNEUROSCI.4970-06.2007, DOI 10.1523/JNEUROSCI.4970-06.2007]; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199	35	237	242	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					304	316		10.1016/j.neuron.2010.12.014	http://dx.doi.org/10.1016/j.neuron.2010.12.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262468	Green Accepted, Bronze			2022-12-24	WOS:000286792900013
J	Schwarzkopf, DS; Song, C; Rees, G				Schwarzkopf, D. Samuel; Song, Chen; Rees, Geraint			The surface area of human V1 predicts the subjective experience of object size	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; EBBINGHAUS ILLUSION; REPRESENTATION; CONNECTIONS	The surface area of human primary visual cortex (V1) varies substantially between individuals for unknown reasons. We found that this variability was strongly and negatively correlated with the magnitude of two common visual illusions, where two physically identical objects appear different in size as a result of their context. Because such illusions dissociate conscious perception from physical stimulation, our findings indicate that the surface area of V1 predicts variability in conscious experience.	[Schwarzkopf, D. Samuel; Song, Chen; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Schwarzkopf, D. Samuel; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, London, England.	s.schwarzkopf@fil.ion.ucl.ac.uk	Song, Chen/B-3269-2008; Schwarzkopf, D. Sam/F-5285-2012; Rees, Geraint/C-1493-2008; Song, Chen/ABC-2033-2021	Song, Chen/0000-0002-5418-5747; Schwarzkopf, D. Sam/0000-0003-3686-1622; Rees, Geraint/0000-0002-9623-7007; 	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank F. Sengpiel for comments on the manuscript. This work was supported by the Wellcome Trust.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; Bosking WH, 1997, J NEUROSCI, V17, P2112; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; de Fockert J, 2007, J EXP PSYCHOL HUMAN, V33, P738, DOI 10.1037/0096-1523.33.3.738; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; FISHER GH, 1967, NATURE, V215, P553, DOI 10.1038/215553a0; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; GILBERT CD, 1989, J NEUROSCI, V9, P2432; MASSARO DW, 1971, J EXP PSYCHOL, V89, P147, DOI 10.1037/h0031158; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376	14	188	189	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					28	30		10.1038/nn.2706	http://dx.doi.org/10.1038/nn.2706			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21131954	Green Accepted			2022-12-24	WOS:000285684900010
J	Ma, S; Tang, KH; Chan, YP; Lee, TK; Kwan, PS; Castilho, A; Ng, I; Man, K; Wong, N; To, KF; Zheng, BJ; Lai, PBS; Lo, CM; Chan, KW; Guan, XY				Ma, Stephanie; Tang, Kwan Ho; Chan, Yuen Piu; Lee, Terence K.; Kwan, Pak Shing; Castilho, Antonia; Ng, Irene; Man, Kwan; Wong, Nathalie; To, Ka-Fai; Zheng, Bo-Jian; Lai, Paul B. S.; Lo, Chung Mau; Chan, Kwok Wah; Guan, Xin-Yuan			miR-130b Promotes CD133(+) Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1	CELL STEM CELL			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; CANCER STEM-CELLS; P53-INDUCED NUCLEAR-PROTEIN-1; MICRORNA EXPRESSION; DICER; MECHANISMS; IDENTIFICATION; PROGRESSION; SURVIVAL; DISEASE	A novel paradigm in tumor biology suggests that cancer growth is driven by stem-like cells within a tumor, called tumor-initiating cells (TICs) or cancer stem cells (CSCs). Here we describe the identification and characterization of such cells from hepatocellular carcinoma (HCC) using the marker CD133. CD133 accounts for approximately 1.3%-13.6% of the cells in the bulk tumor of human primary HCC samples. When compared with their CD133- counterparts, CD133(+) cells not only possess the preferential ability to form undifferentiated tumor spheroids in vitro but also express an enhanced level of stem cell-associated genes, have a greater ability to form tumors when implanted orthotopically in immunodeficient mice, and can be serially passaged into secondary animal recipients. Xenografts resemble the original human tumor and maintain a similar percentage of tumorigenic CD133(+) cells. Quantitative PCR analysis of 41 separate HCC tissue specimens with follow-up data found that CD133(+) tumor cells were frequently detected at low quantities in HCC, and their presence was also associated with worse overall survival and higher recurrence rates. Subsequent differential microRNA expression profiling of CD133(+) and CD133(-) cells from human HCC clinical specimens and cell lines identified an overexpression of miR-130b in CD133(+) TICs. Functional studies on miR-130b lentiviral-transduced CD133(-) cells demonstrated superior resistance to chemotherapeutic agents, enhanced tumorigenicity in vivo, and a greater potential for self renewal. Conversely, antagonizing miR-130b in CD133(+) TICs yielded an opposing effect. The increased miR-130b paralleled the reduced TP53INP1, a known miR-130b target. Silencing TP53INP1 in CD133(-) cells enhanced both self renewal and tumorigenicity in vivo. Collectively, miR-130b regulates CD133(+) liver TICs, in part, via silencing TP53INP1.	[Ma, Stephanie; Tang, Kwan Ho; Chan, Yuen Piu; Lee, Terence K.; Castilho, Antonia; Ng, Irene; Chan, Kwok Wah] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Kwan, Pak Shing; Guan, Xin-Yuan] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Man, Kwan; Lo, Chung Mau] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Zheng, Bo-Jian] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Ma, Stephanie; Lee, Terence K.; Castilho, Antonia; Ng, Irene; Man, Kwan; Guan, Xin-Yuan] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Wong, Nathalie; To, Ka-Fai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Lai, Paul B. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ma, S (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	stefma@hkucc.hku.hk; kwchan@pathology.hku.hk; xyguan@hkucc.hku.hk	Lai, Paul BS/K-8556-2015; Guan, Xin-Yuan/A-3639-2009; /A-3639-2009; Ma, Stephanie Kwai Yee/C-4766-2009	Lai, Paul BS/0000-0002-9469-6728; Guan, Xin-Yuan/0000-0002-4485-6017; Tang, Kwan Ho/0000-0001-7729-5159; Ng, Irene Oi-lin/0000-0001-7532-2029; /0000-0003-1874-9805; Lee, Kin Wah/0000-0003-0682-322X; Ma, Stephanie Kwai Yee/0000-0002-2029-7943	Research Grant Council Collaborative Research Fund [HKU 1/06C, HKU 7/CRG/09, HKU5/CRF/08]; National Key Sci-Tech Special Project of Infectious Diseases [2008ZX1002-022]; University of Hong Kong Strategic Research Theme in Cancer; University of Hong Kong	Research Grant Council Collaborative Research Fund; National Key Sci-Tech Special Project of Infectious Diseases; University of Hong Kong Strategic Research Theme in Cancer; University of Hong Kong(University of Hong Kong)	The authors would like to thank Dr. Alice Carrier (INSERM; France) for her gift of the monoclonal rat anti-human TP53INP1 (E12) antibody, Drs. Man Lung Yeung and Kuan-The Jeang (NIH; USA) for their gift of the full-length 3'UTR TP53INP1 plasmid, Mr. Fai Ng (University of Hong Kong, HK) for his expert assistance with the cell-sorting facility and Professor George Tsao (Centre for Cancer Research, University of Hong Kong, HK) for his support on cancer stem cell studies. This work was generously supported by Sir Michael and Lady Kadoorie Funded Research into Cancer Genetics, Research Grant Council Collaborative Research Fund (HKU 1/06C, HKU 7/CRG/09 and HKU5/CRF/08), National Key Sci-Tech Special Project of Infectious Diseases (2008ZX1002-022), The University of Hong Kong Strategic Research Theme in Cancer, The University of Hong Kong Seed Funding Program, The University of Hong Kong Small Project Funding Program, and Donation of the Li Ka Shing Foundation of Matching Grants of The University of Hong Kong.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gommeaux J, 2007, MOL CELL BIOL, V27, P2215, DOI 10.1128/MCB.01454-06; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ito Y, 2006, ANTICANCER RES, V26, P4391; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiang PH, 2006, WORLD J GASTROENTERO, V12, P691, DOI 10.3748/wjg.v12.i5.691; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ogawa Kumiko, 2005, Medical Molecular Morphology, V38, P23, DOI 10.1007/s00795-004-0265-0; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tomasin R, 2001, J BIOL CHEM, V276, P44185, DOI 10.1074/jbc.M105647200; Tomasini R, 2002, EUR J CELL BIOL, V81, P294, DOI 10.1078/0171-9335-00248; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	44	323	342	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					694	707		10.1016/j.stem.2010.11.010	http://dx.doi.org/10.1016/j.stem.2010.11.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112564	Bronze			2022-12-24	WOS:000285537700011
J	Lomber, SG; Meredith, MA; Kral, A				Lomber, Stephen G.; Meredith, M. Alex; Kral, Andrej			Cross-modal plasticity in specific auditory cortices underlies visual compensations in the deaf	NATURE NEUROSCIENCE			English	Article							DORSAL ZONE; REVERSIBLE DEACTIVATION; COOLING DEACTIVATION; DISCRIMINATION TASK; DOUBLE DISSOCIATION; CONGENITALLY BLIND; SOUND LOCALIZATION; MOVEMENT DETECTION; PARIETAL CORTEX; WHITE CATS	When the brain is deprived of input from one sensory modality, it often compensates with supranormal performance in one or more of the intact sensory systems. In the absence of acoustic input, it has been proposed that cross-modal reorganization of deaf auditory cortex may provide the neural substrate mediating compensatory visual function. We tested this hypothesis using a battery of visual psychophysical tasks and found that congenitally deaf cats, compared with hearing cats, have superior localization in the peripheral field and lower visual movement detection thresholds. In the deaf cats, reversible deactivation of posterior auditory cortex selectively eliminated superior visual localization abilities, whereas deactivation of the dorsal auditory cortex eliminated superior visual motion detection. Our results indicate that enhanced visual performance in the deaf is caused by cross-modal reorganization of deaf auditory cortex and it is possible to localize individual visual functions in discrete portions of reorganized auditory cortex.	[Lomber, Stephen G.] Univ Western Ontario, Dept Psychol, Dept Physiol & Pharmacol, Ctr Brain & Mind, London, ON, Canada; [Meredith, M. Alex] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA USA; [Kral, Andrej] Hannover Med Sch, Inst Audioneurotechnol, Dept Expt Otol, Hannover, Germany	Western University (University of Western Ontario); Virginia Commonwealth University; Hannover Medical School	Lomber, SG (corresponding author), Univ Western Ontario, Dept Psychol, Dept Physiol & Pharmacol, Ctr Brain & Mind, London, ON, Canada.	steve.lomber@uwo.ca	Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909; Kral, Andrej/0000-0002-7762-4642; Meredith, M Alex/0000-0002-8081-6901	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Deutsche Forschungsgemeinschaft; US National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. D. Corneil, M. A. Goodale, W. A. Roberts, D. F. Sherry, B. Timney and J. Snow for helpful discussions and comments on the project and manuscript. We thank A. J. McMillan and A. Carrasco for preparing all of the figures and for help with the preparation of the manuscript. We also thank A. J. McMillan for assistance with the fabrication of the cooling loops, surgical implantations and care of the animals. J. G. Mellott graciously assisted with the histological processing of the brains. We gratefully acknowledge the support of the Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Deutsche Forschungsgemeinschaft and the US National Institutes of Health.	Auer ET, 2007, NEUROREPORT, V18, P645, DOI 10.1097/WNR.0b013e3280d943b9; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Berkley M.A., 1970, ANIMAL PSYCHOPHYSICS, P231; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; BROSS M, 1979, PERCEPT MOTOR SKILL, V48, P187, DOI 10.2466/pms.1979.48.1.187; Brozinsky CJ, 2004, COGNITIVE BRAIN RES, V21, P1, DOI 10.1016/j.cogbrainres.2004.05.002; Carrasco A, 2009, J NEUROSCI, V29, P14323, DOI 10.1523/JNEUROSCI.2905-09.2009; Collignon O, 2009, EXP BRAIN RES, V192, P343, DOI 10.1007/s00221-008-1553-z; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Finney EM, 2001, COGNITIVE BRAIN RES, V11, P171, DOI 10.1016/S0926-6410(00)00082-3; GUILLERY RW, 1981, INVEST OPHTH VIS SCI, V21, P27; HALL SE, 1991, BEHAV BRAIN RES, V44, P1, DOI 10.1016/S0166-4328(05)80233-5; He JF, 1997, J NEUROSCI, V17, P2615; Heid S, 1998, HEARING RES, V115, P101, DOI 10.1016/S0378-5955(97)00182-2; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; Kral A, 2003, EXP BRAIN RES, V153, P605, DOI 10.1007/s00221-003-1609-z; Kral A, 2002, CEREB CORTEX, V12, P797, DOI 10.1093/cercor/12.8.797; Kral A, 2006, PROG BRAIN RES, V157, P283, DOI 10.1016/S0079-6123(06)57018-9; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; LEVICK WR, 1980, VISION RES, V20, P1001, DOI 10.1016/0042-6989(80)90083-8; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lomber SG, 2001, PROG BRAIN RES, V134, P265; Lomber SG, 2001, VISUAL NEUROSCI, V18, P487, DOI 10.1017/S0952523801183148; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Malhotra S, 2008, J NEUROPHYSIOL, V99, P1628, DOI 10.1152/jn.01228.2007; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; Mellott JG, 2010, HEARING RES, V267, P119, DOI 10.1016/j.heares.2010.04.003; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MIDDLEBROOKS JC, 1983, J NEUROSCI, V3, P203; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; PALMER LA, 1978, J COMP NEUROL, V177, P237, DOI 10.1002/cne.901770205; PASTERNAK T, 1980, J COMP PHYSIOL PSYCH, V94, P943, DOI 10.1037/h0077806; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; REYNOLDS HN, 1993, AM J PSYCHOL, V106, P523, DOI 10.2307/1422967; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Stecker GC, 2005, J NEUROPHYSIOL, V94, P1267, DOI 10.1152/jn.00104.2005; STEWART DL, 1970, EXP NEUROL, V28, P525, DOI 10.1016/0014-4886(70)90190-1; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Voss P, 2008, NEUROIMAGE, V40, P746, DOI 10.1016/j.neuroimage.2007.12.020; Weeks R, 2000, J NEUROSCI, V20, P2664; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yang XF, 2006, NEUROBIOL DIS, V23, P637, DOI 10.1016/j.nbd.2006.05.006	50	309	315	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1421	U163		10.1038/nn.2653	http://dx.doi.org/10.1038/nn.2653			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935644				2022-12-24	WOS:000283658200024
J	Altimus, CM; Guler, AD; Alam, NM; Arman, AC; Prusky, GT; Sampath, AP; Hattar, S				Altimus, Cara M.; Gueler, Ali D.; Alam, Nazia M.; Arman, A. Cyrus; Prusky, Glen T.; Sampath, Alapakkam P.; Hattar, Samer			Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; SPECTRAL SENSITIVITY; VISUAL FUNCTIONS; NON-CONE; MELANOPSIN; MOUSE; RESPONSES; PHASE; MICE; RHYTHMS	In mammals, synchronization of the circadian pacemaker in the hypothalamus is achieved through direct input from the eyes conveyed by intrinsically photosensitive retinal ganglion cells (ipRGCs). Circadian photoentrainment can be maintained by rod and cone photoreceptors, but their functional contributions and their retinal circuits that impinge on ipRGCs are not well understood. Using mice that lack functional rods or in which rods are the only functional photoreceptors, we found that rods were solely responsible for photoentrainment at scotopic light intensities. Rods were also capable of driving circadian photoentrainment at photopic intensities at which they were incapable of supporting a visually guided behavior. Using mice in which cone photoreceptors were ablated, we found that rods signal through cones at high light intensities, but not at low light intensities. Thus, rods use two distinct retinal circuits to drive ipRGC function to support circadian photoentrainment across a wide range of light intensities.	[Altimus, Cara M.; Gueler, Ali D.; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Alam, Nazia M.; Prusky, Glen T.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Arman, A. Cyrus; Sampath, Alapakkam P.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Hattar, Samer] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Cornell University; University of Southern California; Johns Hopkins University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	asampath@usc.edu; shattar@jhu.edu	Hattar, Samer/W-6927-2019	Guler, Ali Deniz/0000-0001-8218-850X	Johns Hopkins University Mouse Tri-Lab; US National Institutes of Health [GM076430, EY017606]; David and Lucile Packard Foundation; Alfred P. Sloan Foundation; McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE [R01EY017606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER	Johns Hopkins University Mouse Tri-Lab; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank J. Nathans for the h. red DTA mice. We also want to thank R. Kuruvilla, H. Zhao and M. Halpern for their careful reading of the manuscript and helpful suggestions and the Johns Hopkins University Mouse Tri-Lab for its support. This work was supported by US National Institutes of Health grants GM076430 (S.H.) and EY017606 (A.P.S.), the David and Lucile Packard Foundation (S.H.), the Alfred P. Sloan Foundation (S.H.) and the McKnight Endowment Fund for Neurosciences (A.P.S.).	Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Brainard GC, 2001, J NEUROSCI, V21, P6405; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; EBIHARA S, 1980, PHYSIOL BEHAV, V24, P523, DOI 10.1016/0031-9384(80)90246-2; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; Lall GS, 2010, NEURON, V66, P417, DOI 10.1016/j.neuron.2010.04.037; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Protti DA, 2005, J NEUROPHYSIOL, V93, P3479, DOI 10.1152/jn.00839.2004; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sampath AP, 2005, NEURON, V46, P413, DOI 10.1016/j.neuron.2005.04.006; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wright HR, 2004, J PINEAL RES, V36, P140, DOI 10.1046/j.1600-079X.2003.00108.x; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	50	179	182	3	31	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1107	U102		10.1038/nn.2617	http://dx.doi.org/10.1038/nn.2617			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711184	Green Accepted, Green Submitted			2022-12-24	WOS:000281332600016
J	Smith-Hicks, C; Xiao, B; Deng, RK; Ji, YF; Zhao, X; Shepherd, JD; Posern, G; Kuhl, D; Huganir, RL; Ginty, DD; Worley, PF; Linden, DJ				Smith-Hicks, Constance; Xiao, Bo; Deng, Rongkang; Ji, Yifei; Zhao, Xia; Shepherd, Jason D.; Posern, Guido; Kuhl, Dietmar; Huganir, Richard L.; Ginty, David D.; Worley, Paul F.; Linden, David J.			SRF binding to SRE 6.9 in the Arc promoter is essential for LTD in cultured Purkinje cells	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; SERUM RESPONSE FACTOR; IMMEDIATE-EARLY GENE; PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; LATE-PHASE; ARC/ARG3.1; TRANSCRIPTION	It has been suggested that gene expression and protein synthesis are required for both long-term memory consolidation and late phases of long-term potentiation and long-term depression (LTD). The necessary genes and the specific transcription factor binding sites in their promoters remain unknown. We found that inhibition of the transcription factor SRF or its cofactor MAL blocked the late phase of LTD in mouse cultured cerebellar Purkinje cells, as did deletion of the immediate early gene Arc. Using neuronal bacterial artificial chromosome (BAC) transfection, we found that, in Arc(-/-) cells transfected with a wild-type Arc BAC, late-phase LTD was rescued. However, mutation of one SRF-binding site in the Arc promoter (SRE 6.9RF engineered to bind mutated SRE 6.9 restored late-phase LTD in Arc(-/-), S) blocked this rescue. Co-transfection of wild-type Arc and SRE 6.9 mutant BAC cells. Thus, SRF binding to SRE 6.9 in the Arc promoter is required for the late phase of cerebellar LTD.	[Smith-Hicks, Constance; Xiao, Bo; Shepherd, Jason D.; Huganir, Richard L.; Ginty, David D.; Worley, Paul F.; Linden, David J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Smith-Hicks, Constance; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Xiao, Bo; Deng, Rongkang; Ji, Yifei; Zhao, Xia] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Shepherd, Jason D.; Huganir, Richard L.; Ginty, David D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Posern, Guido] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; [Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Inst Mol & Cellular Cognit, Hamburg, Germany	Johns Hopkins University; Johns Hopkins University; Sichuan University; Howard Hughes Medical Institute; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	dlinden@jhmi.edu	Shepherd, Jason/N-8555-2018; Kuhl, Dietmar/A-4689-2009	Shepherd, Jason/0000-0001-7384-8289; Kuhl, Dietmar/0000-0002-4772-6701; Xiao, Bo/0000-0002-6161-9478	US Public Health Service (NIH) [R37 MH51106, P50 MH084020, 5K12 NS001696-07]; National Basic Research Program of China [2004CB518800]; Science Fund for Creative Research Group, China; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020, R01MH064856, R37MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001696] Funding Source: NIH RePORTER	US Public Health Service (NIH)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Basic Research Program of China(National Basic Research Program of China); Science Fund for Creative Research Group, China(Science Fund for Creative Research Groups); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. VanNess for excellent technical assistance and to members of the Linden and Worley laboratories for helpful suggestions. M. Greenberg's laboratory (Harvard University) provided the Gal4-SRF fusion construct plasmid. The authors thank B. Knoll (University of Tubingen) for sharing beta-actin constructs and for helpful suggestions. The FLAG-tagged dominant-negative MAL was a generous gift from R. Prywes (Columbia University). This work supported by grants from the US Public Health Service (NIH R37 MH51106 to D.J.L., P50 MH084020 to D.J.L., D.D.G., P.F.W. and R.L.H., and NIH 5K12 NS001696-07 to C.S.-H.), the National Basic Research Program of China (2004CB518800 to B.X. and 2004CB518800 to X.Z.) and the Science Fund for Creative Research Group, China (B.X.).	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Karachot L, 2001, J NEUROPHYSIOL, V86, P280, DOI 10.1152/jn.2001.86.1.280; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Murashima M, 1999, J NEUROSCI, V19, P7326, DOI 10.1523/JNEUROSCI.19-17-07326.1999; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014	38	49	49	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1082	U73		10.1038/nn.2611	http://dx.doi.org/10.1038/nn.2611			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694003	Green Accepted			2022-12-24	WOS:000281332600013
J	Norddahl, GL; Pronk, CJ; Wahlestedt, M; Sten, G; Nygren, JM; Ugale, A; Sigvardsson, M; Bryder, D				Norddahl, Gudmundur L.; Pronk, Cornelis J.; Wahlestedt, Martin; Sten, Gerd; Nygren, Jens M.; Ugale, Amol; Sigvardsson, Mikael; Bryder, David			Accumulating Mitochondrial DNA Mutations Drive Premature Hematopoietic Aging Phenotypes Distinct from Physiological Stem Cell Aging	CELL STEM CELL			English	Article							SERIAL TRANSPLANTATION; P-GLYCOPROTEIN; EXPRESSION; APOPTOSIS; PROLIFERATION; REPOPULATION; PATHWAYS; EFFLUX; NUMBER; REPAIR	Somatic stem cells mediate tissue maintenance for the lifetime of an organism. Despite the well-established longevity that is a prerequisite for such function, accumulating data argue for compromised stem cell function with age. Identifying the mechanisms underlying age-dependent stem cell dysfunction is therefore key to understanding the aging process. Here, using a model carrying a proofreading-defective mitochondrial DNA polymerase, we demonstrate hematopoietic defects reminiscent of premature HSC aging, including anemia, lymphopenia, and myeloid lineage skewing. However, in contrast to physiological stem cell aging, rapidly accumulating mitochondria! DNA mutations had little functional effect on the hematopoietic stem cell pool, and instead caused distinct differentiation blocks and/or disappearance of downstream progenitors. These results show that intact mitochondrial function is required for appropriate multilineage stem cell differentiation, but argue against mitochondria! DNA mutations per se being a primary driver of somatic stern cell aging.	[Norddahl, Gudmundur L.; Pronk, Cornelis J.; Wahlestedt, Martin; Sten, Gerd; Nygren, Jens M.; Ugale, Amol; Bryder, David] Lund Univ, BMC D14, Inst Expt Med Sci, Immunol Sect, S-22184 Lund, Sweden; [Sten, Gerd; Bryder, David] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22100 Lund, Sweden; [Nygren, Jens M.] Halmstad Univ, Ctr Res Welf Hlth & Sport, S-30118 Halmstad, Sweden; [Sigvardsson, Mikael] Linkoping Univ, Inst Clin & Expt Med, S-58183 Linkoping, Sweden	Lund University; Lund University; Halmstad University; Linkoping University	Bryder, D (corresponding author), Lund Univ, BMC D14, Inst Expt Med Sci, Immunol Sect, Tornavagen 10, S-22184 Lund, Sweden.	david.bryder@med.lu.se	Bryder, David/Q-6292-2019	Sigvardsson, Mikael/0000-0001-8527-7276; Bryder, David/0000-0002-8761-4237; Nygren, Jens M/0000-0002-3576-2393	Swedish Cancer Foundation; Swedish Medical Research Council; Swedish Pediatric Leukemia Foundation; Crafoord Foundation	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Pediatric Leukemia Foundation; Crafoord Foundation	We gratefully acknowledge N.-G. Larsson for making mutator mice available, T. Suda for details on ATP measurements, and the Stanford PAN facility for help with microarray experiments. The work was supported by grants to D.B. from the Swedish Cancer Foundation, the Swedish Medical Research Council, the Swedish Pediatric Leukemia Foundation, and the Crafoord Foundation. G.L.N., C.J.P. and D.B. designed studies. All authors contributed to experiments. D.B. and G.L.N. wrote the manuscript.	Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Attema JL, 2009, ONCOGENE, V28, P2238, DOI 10.1038/onc.2009.94; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARRISON DE, 1980, BLOOD, V55, P77; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Marques-Santos LF, 2003, BIOSCIENCE REP, V23, P199, DOI 10.1023/B:BIRE.0000007693.33521.18; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peachman KK, 2001, P NATL ACAD SCI USA, V98, P1717, DOI 10.1073/pnas.98.4.1717; Pronk CJ, 2008, CELL CYCLE, V7, P706, DOI 10.4161/cc.7.6.5565; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Pronk CJH, 2011, METHODS MOL BIOL, V699, P275, DOI 10.1007/978-1-61737-950-5_13; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wong Alice, 2002, Methods Mol Biol, V197, P129, DOI 10.1385/1-59259-284-8:129	39	180	185	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					499	510		10.1016/j.stem.2011.03.009	http://dx.doi.org/10.1016/j.stem.2011.03.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549326	Bronze			2022-12-24	WOS:000290927600011
J	Baseler, HA; Gouws, A; Haak, KV; Racey, C; Crossland, MD; Tufail, A; Rubin, GS; Cornelissen, FW; Morland, AB				Baseler, Heidi A.; Gouws, Andre; Haak, Koen V.; Racey, Christopher; Crossland, Michael D.; Tufail, Adnan; Rubin, Gary S.; Cornelissen, Frans W.; Morland, Antony B.			Large-scale remapping of visual cortex is absent in adult humans with macular degeneration	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELD; STRIATE CORTEX; CORTICAL MAPS; FUNCTIONAL MRI; RETINAL LESIONS; V1 NEURONS; MACAQUE V1; REORGANIZATION; MONKEY	The occipital lobe contains retinotopic representations of the visual field. The representation of the central retina in early visual areas (V1-3) is found at the occipital pole. When the central retina is lesioned in both eyes by macular degeneration, this region of visual cortex at the occipital pole is accordingly deprived of input. However, even when such lesions occur in adulthood, some visually driven activity in and around the occipital pole can be observed. It has been suggested that this activity is a result of remapping of this area so that it now responds to inputs from intact, peripheral retina. We evaluated whether or not remapping of visual cortex underlies this activity. Our functional magnetic resonance imaging results provide no evidence of remapping, questioning the contemporary view that early visual areas of the adult human brain have the capacity to reorganize extensively.	[Baseler, Heidi A.; Gouws, Andre; Racey, Christopher; Morland, Antony B.] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, Lab Expt Ophthalmol, Univ Med Ctr Groningen, Groningen, Netherlands; [Haak, Koen V.; Cornelissen, Frans W.] Univ Groningen, BCN Neuroimaging Ctr, Univ Med Ctr Groningen, Groningen, Netherlands; [Crossland, Michael D.; Tufail, Adnan; Rubin, Gary S.] UCL, Inst Ophthalmol, London, England; [Crossland, Michael D.; Tufail, Adnan] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Morland, Antony B.] Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Groningen; University of Groningen; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Hull; University of York - UK	Morland, AB (corresponding author), Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	a.morland@psychology.york.ac.uk	Baseler, Heidi/AAI-7387-2020; Haak, Koen/AAM-5500-2020; Haak, Koen V/G-6417-2018; Crossland, Michael D/B-5600-2008	Baseler, Heidi/0000-0003-0995-8453; Haak, Koen/0000-0001-9309-1906; Haak, Koen V/0000-0001-9309-1906; Crossland, Michael D/0000-0001-6833-6043; Tufail, Adnan/0000-0001-6131-7640; Morland, Antony/0000-0002-6754-5545; Gouws, Andre/0000-0003-0674-7829	Medical Research Council [G0401339]; Stichting Nederlands Oogheelkundig Onderzoek; European Union [043157, 043261]; Department of Health; MRC [G0401339] Funding Source: UKRI; Medical Research Council [G0700729B] Funding Source: researchfish; Fight for Sight [1777/78] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stichting Nederlands Oogheelkundig Onderzoek; European Union(European Commission); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	We would like to thank all of our participants. We thank Edward Silson for constructive discussion of the manuscript. We are also grateful to the Medical Research Council for funding this study (G0401339). K. V. H. and F. W. C. were supported by a grant from Stichting Nederlands Oogheelkundig Onderzoek and by European Union grants #043157 (Syntex) and #043261 (Percept). A. T., G. S. R. and M. D. C. also received financial support from the Department of Health through an award made by the National Institute for Health Research to Moorfields Eye Hospital National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health or the EU commission.	Andrews TJ, 1997, J NEUROSCI, V17, P2859; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Angelucci A, 2006, J COMP NEUROL, V498, P330, DOI 10.1002/cne.21060; Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; Crossland MD, 2008, INVEST OPHTH VIS SCI, V49, P3734, DOI 10.1167/iovs.07-1621; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hoffmann MB, 2003, J NEUROSCI, V23, P8921; Horton JC, 1997, J NEUROSCI, V17, P3684; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaas JH, 2002, PROG BRAIN RES, V138, P167, DOI 10.1016/S0079-6123(02)38077-4; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Levin N, 2010, NEURON, V65, P21, DOI 10.1016/j.neuron.2009.12.006; Lewis SM, 2005, EXP BRAIN RES, V165, P447, DOI 10.1007/s00221-005-2336-4; Liu TT, 2010, INVEST OPHTH VIS SCI, V51, P6826, DOI 10.1167/iovs.09-4926; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Masuda Y, 2010, INVEST OPHTH VIS SCI, V51, P5356, DOI 10.1167/iovs.09-4775; Morland AB, 2001, ACTA PSYCHOL, V107, P229, DOI 10.1016/S0001-6918(01)00025-7; Muckli L, 2009, P NATL ACAD SCI USA, V106, P13034, DOI 10.1073/pnas.0809688106; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1	50	128	131	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					649	U148		10.1038/nn.2793	http://dx.doi.org/10.1038/nn.2793			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441924				2022-12-24	WOS:000289886600022
J	Chatzigeorgiou, M; Schafer, WR				Chatzigeorgiou, Marios; Schafer, William R.			Lateral Facilitation between Primary Mechanosensory Neurons Controls Nose Touch Perception in C. elegans	NEURON			English	Article							TRP CHANNELS; GENE; DEG/ENAC; SENSITIVITY; EXPRESSION; MOLECULES; CIRCUIT; PROTEIN; FAMILY; ROLES	The nematode C. elegans senses head and nose touch using multiple classes of mechanoreceptor neurons that are electrically coupled through a network of gap junctions. Using in vivo neuroimaging, we have found that multidendritic nociceptors in the head respond to harsh touch throughout their receptive field but respond to gentle touch only at the tip of the nose. Whereas the harsh touch response depends solely on cell-autonomous mechanosensory channels, gentle nose touch responses require facilitation by additional nose touch mechanoreceptors, which couple electrically to the nociceptors in a hub-and-spoke gap junction network. Conversely, nociceptor activity indirectly facilitates activation of the nose touch neurons, demonstrating that information flow across the network is bidirectional. Thus, a simple gap-junction circuit acts as a coincidence detector that allows primary sensory neurons to integrate information from neighboring mechanoreceptors and generate somatosensory perception.	[Chatzigeorgiou, Marios; Schafer, William R.] MRC, Mol Biol Lab, Div Cell Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Schafer, WR (corresponding author), MRC, Mol Biol Lab, Div Cell Biol, Hills Rd, Cambridge CB2 2QH, England.	wschafer@mrc-lmb.cam.ac.uk		Schafer, William/0000-0002-6676-8034	Medical Research Council [MC_U105185857] Funding Source: Medline; MRC [MC_U105185857] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatzigeorgiou M, 2010, J NEUROPHYSIOL, V104, P3334, DOI 10.1152/jn.00330.2010; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; DRISCOLL M, 1997, C ELEGANS, V2; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Goodman MB, 2004, J NEUROSCI, V24, P9220, DOI 10.1523/JNEUROSCI.3342-04.2004; Hall DH., 2008, C ELEGANS ATLAS; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kerr Rex A, 2006, WormBook, P1; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; STARICH TA, 1993, GENETICS, V133, P527; Starich TA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-16; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu J, 2001, GENE DEV, V15, P789, DOI 10.1101/gad.857401	38	57	61	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 28	2011	70	2					299	309		10.1016/j.neuron.2011.02.046	http://dx.doi.org/10.1016/j.neuron.2011.02.046			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521615	hybrid, Green Published			2022-12-24	WOS:000291073700011
J	Jacob, C; Christen, CN; Pereira, JA; Somandin, C; Baggiolini, A; Lotscher, P; Ozcelik, M; Tricaud, N; Meijer, D; Yamaguchi, T; Matthias, P; Suter, U				Jacob, Claire; Christen, Carlos N.; Pereira, Jorge A.; Somandin, Christian; Baggiolini, Arianna; Loetscher, Pirmin; Oezcelik, Murat; Tricaud, Nicolas; Meijer, Dies; Yamaguchi, Teppei; Matthias, Patrick; Suter, Ueli			HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells	NATURE NEUROSCIENCE			English	Article							HISTONE DEACETYLASE INHIBITORS; PERIPHERAL NERVOUS-SYSTEM; BETA-CATENIN; GENE-EXPRESSION; DIFFERENTIATION; SOX10; REVEALS; MOUSE; REMYELINATION; PROGRESSION	Histone deacetylases (HDACs) are major epigenetic regulators. We show that HDAC1 and HDAC2 functions are critical for myelination of the peripheral nervous system. Using mouse genetics, we have ablated Hdac1 and Hdac2 specifically in Schwann cells, resulting in massive Schwann cell loss and virtual absence of myelin in mutant sciatic nerves. Expression of Sox10 and Krox20, the main transcriptional regulators of Schwann cell myelination, was greatly reduced. We demonstrate that in Schwann cells, HDAC1 and HDAC2 exert specific primary functions: HDAC2 activates the transcriptional program of myelination in synergy with Sox10, whereas HDAC1 controls Schwann cell survival by regulating the levels of active beta-catenin.	[Jacob, Claire; Christen, Carlos N.; Pereira, Jorge A.; Somandin, Christian; Baggiolini, Arianna; Loetscher, Pirmin; Oezcelik, Murat; Tricaud, Nicolas; Suter, Ueli] Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, Zurich, Switzerland; [Meijer, Dies] Erasmus Univ, Dept Cell Biol & Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Yamaguchi, Teppei; Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Erasmus University Rotterdam; Erasmus MC; Friedrich Miescher Institute for Biomedical Research; Novartis	Jacob, C (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Cell Biol, Zurich, Switzerland.	claire.jacob@cell.biol.ethz.ch; usuter@cell.biol.ethz.ch	Jacob, Claire/C-1485-2012; Meijer, Dies/C-7786-2012; Suter, Ueli/A-1624-2010	Jacob, Claire/0000-0001-9567-3950; Meijer, Dies/0000-0002-8461-6341; Baggiolini, Arianna/0000-0002-2476-561X; Tricaud, Nicolas/0000-0002-1620-4046	Swiss National Science Foundation (SNSF) [PMPDP3_122738/1]; Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair; Novartis Research Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Novartis Research Foundation	We thank M. Wegner (Universtat Erlangen-Nurnberg), E. Seto (Moffitt Cancer Center), S. Schreiber (Harvard University), Z. Werb and B. Welm (University of Utah), J. Crabtree (Stanford University), T. Reya (Duke University Medical Center), W. J. Pavan (US National Institutes of Health), A. McCallion and M. Prasad (Johns Hopkins University School of Medicine) and D. R. Colman (McGill University) for providing constructs and antibodies, T. Meier, W. Seufert and N. Mantei for critically reading the manuscript and the Functional Genomic Center Zurich for gene array analyses. These studies were supported by two Swiss National Science Foundation (SNSF) grants, a Marie-Heim Vogtlin subsidy (PMPDP3_122738/1) to C. Jacob, and another SNSF grant to U. Suter, and by a grant from the Swiss National Center for Competence in Research (NCCR) Neural Plasticity and Repair to U. Suter. The work in the laboratory of P. Matthias was supported by the Novartis Research Foundation.	Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Bordonaro M, 2007, EXP CELL RES, V313, P1652, DOI 10.1016/j.yexcr.2007.02.008; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Dutton JR, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-105; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Ghazvini M, 2002, EMBO J, V21, P4612, DOI 10.1093/emboj/cdf475; Ghislain J, 2006, EMBO REP, V7, P52, DOI 10.1038/sj.embor.7400573; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Jacob C, 2008, J CELL BIOL, V182, P519, DOI 10.1083/jcb.200710161; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zorick TS, 1999, DEVELOPMENT, V126, P1397; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	44	129	131	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					429	U53		10.1038/nn.2762	http://dx.doi.org/10.1038/nn.2762			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21423190				2022-12-24	WOS:000288849400013
J	Jaramillo, S; Zador, AM				Jaramillo, Santiago; Zador, Anthony M.			The auditory cortex mediates the perceptual effects of acoustic temporal expectation	NATURE NEUROSCIENCE			English	Article							ATTENTION; RESPONSES; NEURONS; TIME; DISCRIMINATION; CONTEXT; RAT	When events occur at predictable instants, anticipation improves performance. Knowledge of event timing modulates motor circuits and thereby improves response speed. By contrast, the neuronal mechanisms that underlie changes in sensory perception resulting from expectation are not well understood. We developed a behavioral procedure for rats in which we manipulated expectations about sound timing. Valid expectations improved both the speed and the accuracy of the subjects' performance, indicating not only improved motor preparedness but also enhanced perception. Single-neuron recordings in primary auditory cortex showed enhanced representation of sounds during periods of heightened expectation. Furthermore, we found that activity in auditory cortex was causally linked to the performance of the task and that changes in the neuronal representation of sounds predicted performance on a trial-by-trial basis. Our results indicate that changes in neuronal representation as early as primary sensory cortex mediate the perceptual advantage conferred by temporal expectation.	[Jaramillo, Santiago; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136	Swartz Foundation; US National Institutes of Health; Marie Robertson Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005415] Funding Source: NIH RePORTER	Swartz Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Robertson Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank G. H. Otazu, A. E. Baker, J.M. Abolafia and B.J. Burbach for assistance with preliminary studies. This research was supported by a postdoctoral fellowship from the Swartz Foundation and by grants from the Swartz Foundation, the US National Institutes of Health and the Marie Robertson Fund.	Anderson B, 2008, NEUROPSYCHOLOGIA, V46, P947, DOI 10.1016/j.neuropsychologia.2007.11.025; Asari H, 2009, J NEUROPHYSIOL, V102, P2638, DOI 10.1152/jn.00577.2009; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bialek W., 1996, SPIKES EXPLORING NEU; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Haykin S., 2001, ADAPTIVE FILTER THEO; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lange K, 2003, PSYCHOPHYSIOLOGY, V40, P806, DOI 10.1111/1469-8986.00081; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Ohl FW, 1999, LEARN MEMORY, V6, P347; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Syka J, 2002, HEARING RES, V172, P151, DOI 10.1016/S0378-5955(02)00578-6; TAI L, 2008, NATURE PRECEDINGS; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003	38	179	183	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					246	U340		10.1038/nn.2688	http://dx.doi.org/10.1038/nn.2688			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21170056	Green Accepted			2022-12-24	WOS:000286595400023
J	Weiss, LA; Dahanukar, A; Kwon, JY; Banerjee, D; Carlson, JR				Weiss, Linnea A.; Dahanukar, Anupama; Kwon, Jae Young; Banerjee, Diya; Carlson, John R.			The Molecular and Cellular Basis of Bitter Taste in Drosophila	NEURON			English	Article							GUSTATORY RECEPTOR NEURONS; OLFACTORY RECEPTORS; ODORANT RECEPTORS; CAFFEINE RESPONSE; MAMMALIAN SWEET; IN-VIVO; MELANOGASTER; GENE; EXPRESSION; INSECT	The extent of diversity among bitter-sensing neurons is a fundamental issue in the field of taste. Data are limited and conflicting as to whether bitter neurons are broadly tuned and uniform, resulting in indiscriminate avoidance of bitter stimuli, or diverse, allowing a more discerning evaluation of food sources. We provide a systematic analysis of how bitter taste is encoded by the major taste organ of the Drosophila head, the labellum. Each of 16 bitter compounds is tested physiologically against all 31 taste hairs, revealing responses that are diverse in magnitude and dynamics. Four functional classes of bitter neurons are defined. Four corresponding classes are defined through expression analysis of all 68 gustatory taste receptors. A receptor-to-neuron-to-tastant map is constructed. Misexpression of one receptor confers bitter responses as predicted by the map. These results reveal a degree of complexity that greatly expands the capacity of the system to encode bitter taste.	[Weiss, Linnea A.; Dahanukar, Anupama; Kwon, Jae Young; Banerjee, Diya; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Dahanukar, Anupama] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Kwon, Jae Young] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Yale University; University of California System; University of California Riverside; Sungkyunkwan University (SKKU)	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	Weiss, Linnea A/K-8062-2014; Weiss, Linnea A/AFV-8680-2022	, Linnea/0000-0002-7593-7821; Dahanukar, Anupama/0000-0003-0534-7700	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011697, R01DC002174, R01DC004729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health. We thank Jennifer Perry for helpful discussions and construction of GAL4 lines. We thank Drs. K. Scott, H. Amrein, and H. Keshishian for sharing reagents.	ADLER E, 2000, J NEUROSCI, V100, P5028; Bai L, 2009, J NEUROSCI, V29, P12940, DOI 10.1523/JNEUROSCI.3525-09.2009; BARGMANN CI, 2006, WORMBOOK C ELEGANS R; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cobb Matthew, 2009, SEB Experimental Biology Series, V63, P1; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Elmore T, 2003, J NEUROSCI, V23, P9906; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 2002, J NEUROSCI, V22, P7281; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; HAMMER O, 2001, VET HUM TOXICOL, V35, P234; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Keast RSJ, 2003, CHEM SENSES, V28, P301, DOI 10.1093/chemse/28.4.301; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Koul O., 2005, INSECT ANTIFEEDANTS; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Miller CJ, 2010, GENETICS, V186, P79, DOI 10.1534/genetics.110.117622; Mitri C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000147; Miyazaki T, 2010, J COMP NEUROL, V518, P4147, DOI 10.1002/cne.22433; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; NATHANS J, 1989, SCI AM, V260, P42, DOI 10.1038/scientificamerican0289-42; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Power ME, 1943, J MORPHOL, V72, P517, DOI 10.1002/jmor.1050720306; Ray A, 2008, PLOS BIOL, V6, P1069, DOI 10.1371/journal.pbio.0060125; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schoonhoven L. M., 2005, Insect-plant biology; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; TANIMURA T, 1988, GENETICS, V119, P399; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	77	253	261	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					258	272		10.1016/j.neuron.2011.01.001	http://dx.doi.org/10.1016/j.neuron.2011.01.001			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262465	Green Accepted, Bronze			2022-12-24	WOS:000286792900010
J	Orlov, T; Makin, TR; Zohary, E				Orlov, Tanya; Makin, Tamar R.; Zohary, Ehud			Topographic Representation of the Human Body in the Occipitotemporal Cortex	NEURON			English	Article							PRIMARY MOTOR CORTEX; FUNCTIONAL MRI; VISUAL-CORTEX; CORTICAL REPRESENTATIONS; EXTRASTRIATE CORTEX; OCCIPITAL CORTEX; FMRI DATA; AREA; ORGANIZATION; FACES	Large-scale topographic representations of the body have long been established in the somatosensory and motor cortices. Using functional imaging, we identified a topographically organized body part map within the occipitotemporal cortex (OTC), with distinct clusters of voxels showing clear preference for different visually presented body parts. This representation was consistent both across hemispheres and participants. Using converging methods, the preference for specific body parts was demonstrated to be robust and did not merely reflect shape differences between the categories. Finally, execution of (unseen) movements with different body parts resulted in a limited topographic representation of the limbs and trunk, which partially overlapped with the visual body part map. This motor-driven activation in the OTC could not be explained solely by visual or motor imagery of the body parts. This suggests that visual and motor-related information converge within the OTC in a body part specific manner.	[Orlov, Tanya; Makin, Tamar R.; Zohary, Ehud] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Zohary, Ehud] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; [Makin, Tamar R.] Univ Oxford, Dept Clin Neurol, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Oxford	Zohary, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	udiz@cc.huji.ac.il		Makin, Tamar/0000-0002-5816-8979	Israel Binational Science Foundation [2005227]; Royal Society	Israel Binational Science Foundation(US-Israel Binational Science Foundation); Royal Society(Royal Society of London)	We thank Rafi Malach, Eli Nelken, and Laurence Hunt for helpful discussions, Nick Holmes for comments on the manuscript, and Gadi Blumrosen for technical assistance. This research was supported by the US-Israel Binational Science Foundation (Grant no. 2005227). T.R.M. was partially funded by a Royal Society, Newton International Fellowship.	Alkadhi H, 2002, AM J NEURORADIOL, V23, P1524; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Beauchamp MS, 2007, J NEUROSCI, V27, P8261, DOI 10.1523/JNEUROSCI.0754-07.2007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bracci S, 2010, J NEUROPHYSIOL, V103, P3389, DOI 10.1152/jn.00215.2010; Chan AWY, 2010, NAT NEUROSCI, V13, P417, DOI 10.1038/nn.2502; COHEN J, 1988, APPL MULTIPLE REGRES; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Filimon F, 2009, J NEUROSCI, V29, P2961, DOI 10.1523/JNEUROSCI.3211-08.2009; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Ishizu T, 2009, NEUROSCI LETT, V465, P85, DOI 10.1016/j.neulet.2009.08.079; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; KAAS JH, 1979, SCIENCE, V204, P521, DOI 10.1126/science.107591; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kontaris I, 2009, NEUROPSYCHOLOGIA, V47, P3118, DOI 10.1016/j.neuropsychologia.2009.07.012; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Legendre P, 1998, NUMERICAL ECOLOGY, V2, P17; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; LONGFORD NT, 1993, SCIENCE, V85, P388; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, NAT NEUROSCI, V8, P125, DOI 10.1038/nn0205-125a; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Sanes JN, 2001, NEUROIMAGE, V13, P968, DOI 10.1006/nimg.2000.0733; Schwartz AB, 2007, J PHYSIOL-LONDON, V579, P581, DOI 10.1113/jphysiol.2006.126698; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Urgesi C, 2004, CURR BIOL, V14, P2130, DOI 10.1016/j.cub.2004.11.031; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012	51	156	156	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					586	600		10.1016/j.neuron.2010.09.032	http://dx.doi.org/10.1016/j.neuron.2010.09.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040856	Bronze			2022-12-24	WOS:000284255800023
J	Brief, E; Illes, J				Brief, Elena; Illes, Judy			Tangles of Neurogenetics, Neuroethics, and Culture	NEURON			English	Editorial Material							COMMUNITIES; ISSUES; OWNERSHIP	Neurogenetics promises rich insights into how the mind works. Researchers investigating the range of topics from normal brain functioning to pathological states are increasingly looking to genetics for clues on human variability and disease etiology. Is it fair to assume this interest in neurogenetics is universal? How should researchers and clinicians approach ideas of consent to research or prediction of disease when a subject or patient understands the mind with concepts or language incompatible with neurogenetics? In this paper we consider how non-Western philosophies bring complexity to ideas of individual and community consent and confidentiality in the context of neurogenetics.	[Brief, Elena; Illes, Judy] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC V6T 2B5, Canada	University of British Columbia	Brief, E (corresponding author), Univ British Columbia, Dept Med, Div Neurol, 2211 Wesbrook Mall,Koerner S124, Vancouver, BC V6T 2B5, Canada.	elanabrief@gmail.com	Kam, Grace/F-5364-2012		Canadian Institutes of Health Research [CNE 85117] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Arbour L, 2006, COMMUNITY GENET, V9, P153, DOI 10.1159/000092651; Butler R, 2010, CAN J NEUROL SCI, V37, P359, DOI 10.1017/S0317167100010258; Caldwell JY, 2005, AM INDIAN ALASKA NAT, V12, P1; Gillett G, 2007, SOC SCI MED, V65, P2093, DOI 10.1016/j.socscimed.2007.06.024; Illes J, 2007, ANN NY ACAD SCI, V1097, P278, DOI 10.1196/annals.1379.030; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Norton IM, 1996, J CONSULT CLIN PSYCH, V64, P856, DOI 10.1037/0022-006X.64.5.856; Petit C., 1998, TRYING STUDY TRIBES; Port RV, 2008, CLIN GENET, V73, P132, DOI 10.1111/j.1399-0004.2007.00943.x; RACINE E, 2010, SCI PHILOS PERSPECTI; Santos Lorrieann, 2008, Prog Community Health Partnersh, V2, P321, DOI 10.1353/cpr.0.0046; Skene L, 2002, TRENDS MOL MED, V8, P48, DOI 10.1016/S1471-4914(01)02195-5; Weijer C, 1999, NAT GENET, V23, P275, DOI 10.1038/15455; Wilson S., 2008, RES CEREMONY INDIGEN	14	7	7	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 21	2010	68	2					174	177		10.1016/j.neuron.2010.09.041	http://dx.doi.org/10.1016/j.neuron.2010.09.041			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	681IJ	20955922	Bronze			2022-12-24	WOS:000284304300003
J	Zoghbi, HY; Warren, ST				Zoghbi, Huda Y.; Warren, Stephen T.			Neurogenetics: Advancing the "Next-Generation" of Brain Research	NEURON			English	Review							DUCHENNE MUSCULAR-DYSTROPHY; 3Q29 MICRODELETION SYNDROME; SCAFFOLDING PROTEIN SHANK3; MOUSE MODEL; HUNTINGTONS-DISEASE; KNOCKOUT RATS; X-CHROMOSOME; COPY-NUMBER; GENE; DNA	There can be little doubt that genetics has transformed our understanding of mechanisms mediating brain disorders. The last two decades have brought tremendous progress in terms of accurate molecular diagnoses and knowledge of the genes and pathways that are involved in a large number of neurological and psychiatric disorders. Likewise, new methods and analytical approaches, including genome array studies and "next-generation" sequencing technologies, are bringing us deeper insights into the subtle complexities of the genetic architecture that determines our risks for these disorders. As we now seek to translate these discoveries back to clinical applications, a major challenge for the field will be in bridging the gap between genes and biology. In this Overview of Neuron's special review issue on neurogenetics, we reflect on progress made over the last two decades and highlight the challenges as well as the exciting opportunities for the future.	[Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Program Dev Biol, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Program Dev Biol, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Warren, Stephen T.] Emory Univ, Sch Med, Dept Pediat & Biochem, Atlanta, GA 30322 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Emory University; Emory University	Zoghbi, HY (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Program Dev Biol, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu	Warren, Stephen T/A-2498-2012	Zoghbi, Huda/0000-0002-0700-3349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS027699] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bouwknecht JA, 2008, BEHAV PHARMACOL, V19, P385, DOI 10.1097/FBP.0b013e32830c3658; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Clayton-Smith J, 2010, CLIN DYSMORPHOL, V19, P128, DOI 10.1097/MCD.0b013e32833a1e3c; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Duvick L, 2010, NEURON, V67, P929, DOI 10.1016/j.neuron.2010.08.022; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Ess KC, 2010, CURR OPIN NEUROL, V23, P189, DOI 10.1097/WCO.0b013e32832c4ff5; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; FRANCKE U, 1985, AM J HUM GENET, V37, P250; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Jones Nick, 2010, Nat Rev Neurol, V6, P181, DOI 10.1038/nrneurol.2010.19; Kelley DB, 2010, CURR OPIN NEUROBIOL, V20, P748, DOI 10.1016/j.conb.2010.08.007; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kratter IH, 2010, NEURON, V67, P897, DOI 10.1016/j.neuron.2010.09.012; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; LINDENBAUM RH, 1979, J MED GENET, V16, P389, DOI 10.1136/jmg.16.5.389; Lupski JR, 2009, GENOME MED, V1, DOI 10.1186/gm42; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mastrianni JA, 2010, GENET MED, V12, P187, DOI 10.1097/GIM.0b013e3181cd7374; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Phelan MC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-14; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Quintero-Rivera F, 2010, AM J MED GENET A, V152A, P2459, DOI 10.1002/ajmg.a.33573; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHULZ SB, 2010, GENES BRAIN BEH 0706, DOI DOI 10.1111/J.1601-183X.2010.00607.X; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; SPENCE JE, 1988, AM J HUM GENET, V42, P217; STOSKOPF C, 1992, HEALTH SERV RES, V26, P743; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yang DS, 2010, HUM MOL GENET, V19, P3983, DOI 10.1093/hmg/ddq313; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	81	33	33	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 21	2010	68	2					165	173		10.1016/j.neuron.2010.10.015	http://dx.doi.org/10.1016/j.neuron.2010.10.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	681IJ	20955921	Green Accepted, Bronze			2022-12-24	WOS:000284304300002
J	Gu, JP; Lee, CW; Fan, YJ; Komlos, D; Tang, X; Sun, CC; Yu, KA; Hartzell, HC; Chen, G; Bamburg, JR; Zheng, JQ				Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Komlos, Daniel; Tang, Xin; Sun, Chicheng; Yu, Kuai; Hartzell, H. Criss; Chen, Gong; Bamburg, James R.; Zheng, James Q.			ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOGENESIS; HIPPOCAMPAL SYNAPSES; RECYCLING ENDOSOMES; LIM-KINASE; F-ACTIN; COFILIN; LTP; PHOSPHORYLATION; MORPHOLOGY	Dendritic spines undergo actin-based growth and shrinkage during synaptic plasticity, in which the actin depolymerizing factor (ADF)/cofilin family of actin-associated proteins are important. Elevated ADF/cofilin activities often lead to reduced spine size and immature spine morphology but can also enhance synaptic potentiation in some cases. Thus, ADF/cofilin may have distinct effects on postsynaptic structure and function. We found that ADF/cofilin-mediated actin dynamics regulated AMPA receptor (AMPAR) trafficking during synaptic potentiation, which was distinct from actin's structural role in spine morphology. Specifically, elevated ADF/cofilin activity markedly enhanced surface addition of AMPARs after chemically induced long-term potentiation (LTP), whereas inhibition of ADF/cofilin abolished AMPAR addition. We found that chemically induced LTP elicited a temporal sequence of ADF/cofilin dephosphorylation and phosphorylation that underlies AMPAR trafficking and spine enlargement. These findings suggest that temporally regulated ADF/cofilin activities function in postsynaptic modifications of receptor number and spine size during synaptic plasticity.	[Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Yu, Kuai; Hartzell, H. Criss; Zheng, James Q.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Gu, Jiaping; Lee, Chi Wai; Fan, Yanjie; Yu, Kuai; Hartzell, H. Criss; Zheng, James Q.] Emory Univ, Sch Med, Dept Neurol, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Komlos, Daniel] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Tang, Xin; Sun, Chicheng; Chen, Gong] Penn State Univ, Dept Biol, Huck Inst Life Sci, University Pk, PA 16802 USA; [Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Emory University; Emory University; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Colorado State University	Zheng, JQ (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	james.zheng@emory.edu	Lee, Chi Wai/D-3186-2013; Lee, Chi Wai/G-5098-2013; Tang, Xin/E-8191-2016; Sun, Chicheng/C-9980-2016	Lee, Chi Wai/0000-0002-9384-2308; Sun, Chicheng/0000-0003-3837-2267; Chen JNU, Gong/0000-0002-1857-3670; Lee, Chi Wai/0000-0003-4619-3189	US National Institutes of Health [GM083889 GM084363, HD023315, NS40371, NS054858, EY014852, GM60448]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448, R01GM083889, R01GM084363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054858, R01NS040371] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the US National Institutes of Health to J.Q.Z. (GM083889 GM084363, and HD023315), J.R.B. (NS40371), G.C. (NS054858) and H.C.H. (EY014852 and GM60448).	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; AUNIS D, 1988, J EXP BIOL, V139, P253; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hoogenraad SC, 2004, BIOESSAYS, V26, P141, DOI 10.1002/bies.10402; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Kim CH, 1999, J NEUROSCI, V19, P4314; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee CW, 2009, NAT NEUROSCI, V12, P848, DOI 10.1038/nn.2322; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Onuma H, 1998, NEUROSCI RES, V30, P313, DOI 10.1016/S0168-0102(98)00012-1; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	46	234	245	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1208	1215		10.1038/nn.2634	http://dx.doi.org/10.1038/nn.2634			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835250	Green Accepted			2022-12-24	WOS:000282171300012
J	Yang, JA; van Oosten, AL; Theunissen, TW; Guo, G; Silva, JCR; Smith, A				Yang, Jian; van Oosten, Anouk L.; Theunissen, Thorold W.; Guo, Ge; Silva, Jose C. R.; Smith, Austin			Stat3 Activation Is Limiting for Reprogramming to Ground State Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; EPIBLAST; DIFFERENTIATION; DERIVATION; INHIBITION; MAINTAINS; ROLES; NANOG; LINES	The cytokine leukemia inhibitory factor (Lif) sustains self-renewal of mouse embryonic and induced pluripotent stem cells by activating Jak kinase and the transcription factor Stat3. Here we investigate whether Jak/Stat3 may also contribute to induction of pluripotency. EpiSCs derived from postimplantation embryos express low levels of Lif receptor and Stat3. We introduced into EpiSCs a Jak/Stat3 activating receptor (GY118F) responsive to granulocyte colony stimulating factor (Gcsf). On transfer to ground state culture, in which MAPK signaling and glycogen synthase kinase are inhibited, Gcsf induced transcriptional resetting and functional reprogramming. Activation of a tamoxifen-regulatable fusion, Stat3ER(T2), also converted EpiSCs into chimera-competent iPSCs. We exploited GY118F to increase Jak/Stat3 activity during somatic cell reprogramming. Incompletely reprogrammed cells derived from neural stem cells or fibroblasts responded to Gcsf with elevated frequencies of progression to ground state pluripotency. These findings indicate that Jak/Stat3 participate directly in molecular reprogramming and that activation of this pathway is a limiting component.	[Yang, Jian; van Oosten, Anouk L.; Theunissen, Thorold W.; Guo, Ge; Silva, Jose C. R.; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Yang, Jian; van Oosten, Anouk L.; Theunissen, Thorold W.; Guo, Ge; Silva, Jose C. R.; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk	Silva, Jose C R/X-5140-2019; Silva, Jose/G-1920-2014	Silva, Jose C R/0000-0001-5487-1117; Silva, Jose/0000-0001-5487-1117; Smith, Austin/0000-0002-3029-4682; Theunissen, Thorold/0000-0001-6943-7858	European Commission; Biotechnology and Biological Sciences Research Council; Medical Research Council; MRC [G0700665, G0800784] Funding Source: UKRI; Medical Research Council [G0300723B, G0800784, G0700665, G19/38, G0800784B] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Jason Wray for comments on the manuscript and preparation of Gcsf. We are grateful to Jenny Nichols for EpiSCs, Rachel Walker for flow cytometry, Peter Humphreys for imaging, Bill Mansfield for chimera production, and Samuel Jameson and staff for mouse husbandry. Recombinant proteins were provided by Marko Hyvonen. We thank Pierre Savatier for generously providing the Stat3ER<SUP>T2</SUP> construct and Toshio Kitamura for Plat-E cells. This study was supported by the European Commission projects ESTOOLs and EuroSyStem, the Biotechnology and Biological Sciences Research Council, and the Medical Research Council. T.W.T. is a Wellcome Trust PhD Fellow, J.C.R.S. is a Wellcome Trust Career Development Fellow, and A.S. is a Medical Research Council Professor. Author contributions: J.Y. performed and analyzed EpiSC reprogramming experiments, T.W.T. and A.L.v.O. carried out somatic cell reprogramming supervised by J.C.R.S., G.G. provided constructs and advice, and A.S. designed the study and wrote the paper.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva N, 2008, REVSTAT-STAT J, V6, P253; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	175	182	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					319	328		10.1016/j.stem.2010.06.022	http://dx.doi.org/10.1016/j.stem.2010.06.022			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804969	Green Published, hybrid			2022-12-24	WOS:000282037800009
J	Foldy, C; Lee, SH; Morgan, RJ; Soltesz, I				Foldy, Csaba; Lee, Sang-Hun; Morgan, Robert J.; Soltesz, Ivan			Regulation of fast-spiking basket cell synapses by the chloride channel ClC-2	NATURE NEUROSCIENCE			English	Article							POSTSYNAPTIC INHIBITION; PERISOMATIC INHIBITION; CONDUCTANCE; HIPPOCAMPUS	Parvalbumin-expressing, fast-spiking basket cells are important for the generation of synchronous, rhythmic population activities in the hippocampus. We found that GABA(A) receptor-mediated synaptic inputs from murine parvalbumin-expressing basket cells were selectively modulated by the membrane voltage-and intracellular chloride-dependent chloride channel ClC-2. Our data reveal a previously unknown cell type-specific regulation of intracellular chloride homeostasis in the perisomatic region of hippocampal pyramidal neurons.	[Foldy, Csaba; Lee, Sang-Hun; Morgan, Robert J.; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Foldy, C (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA.	foldy@stanford.edu	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966; Foldy, Csaba/0000-0001-8709-8490	US National Institutes of Health [NS38580]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038580] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Zhu for excellent technical assistance, K. Ding and D. Szabadics for camera lucida reconstructions, M. Case for genotyping, J.E. Melvin for the ClC-2 knockout mouse and L. Hilgenberg, M.A. Smith, M. Cahalan, M.V. Jones, Z. Nusser and R.L. McDonald for discussions. This work was supported by US National Institutes of Health grant NS38580 (to I.S.) and the Epilepsy Foundation through the generous support of the Eric W. Lothman Training Fellowship (to S.-H.L.).	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Foldy C, 2007, NAT NEUROSCI, V10, P1128, DOI 10.1038/nn1952; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Inglefield JR, 1997, J NEUROSCI METH, V75, P127, DOI 10.1016/S0165-0270(97)00054-X; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; SMITH RL, 1995, J NEUROSCI, V15, P4057; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325	15	65	66	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1047	1049		10.1038/nn.2609	http://dx.doi.org/10.1038/nn.2609			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20676104	Green Accepted, Green Submitted			2022-12-24	WOS:000281332600006
J	Zhang, XF; Bertaso, F; Yoo, JW; Baumgartel, K; Clancy, SM; Lee, V; Cienfuegos, C; Wilmot, C; Avis, J; Hunyh, T; Daguia, C; Schmedt, C; Noebels, J; Jegla, T				Zhang, Xiaofei; Bertaso, Federica; Yoo, Jong W.; Baumgaertel, Karsten; Clancy, Sinead M.; Lee, Van; Cienfuegos, Cynthia; Wilmot, Carly; Avis, Jacqueline; Hunyh, Truc; Daguia, Catherine; Schmedt, Christian; Noebels, Jeffrey; Jegla, Timothy			Deletion of the potassium channel Kv12.2 causes hippocampal hyperexcitability and epilepsy	NATURE NEUROSCIENCE			English	Article							K+ CHANNEL; BRAIN; BEHAVIOR; GENOME; GENES	We found the voltage-gated K(+) channel Kv12.2 to be a potent regulator of excitability in hippocampal pyramidal neurons. Genetic deletion and pharmacologic block of Kv12.2 substantially reduced the firing threshold of these neurons. Kv12.2(-/-) (also known as Kcnh3(-/-)) mice showed signs of persistent neuronal hyperexcitability including frequent interictal spiking, spontaneous seizures and increased sensitivity to the chemoconvulsant pentylenetetrazol.	[Zhang, Xiaofei; Bertaso, Federica; Baumgaertel, Karsten; Clancy, Sinead M.; Jegla, Timothy] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yoo, Jong W.; Noebels, Jeffrey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lee, Van; Cienfuegos, Cynthia; Wilmot, Carly; Avis, Jacqueline; Hunyh, Truc; Daguia, Catherine; Schmedt, Christian] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Baylor College of Medicine; Novartis	Jegla, T (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	tjj3@psu.edu	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X; Jegla, Timothy/0000-0001-8616-2390; Noebels, Jeffrey/0000-0002-2887-0839	Genomics Institute of the Novartis Research Foundation; US National Institute of Neurological Disorders and Stroke; American Heart Association; INSERM; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057000, R01NS069842] Funding Source: NIH RePORTER	Genomics Institute of the Novartis Research Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Lentivirus vectors were kindly provided by A. Maximov. The project was funded by the Genomics Institute of the Novartis Research Foundation, US National Institute of Neurological Disorders and Stroke grants awarded to T.J. and J.N., an American Heart Association fellowship supporting X.Z. and INSERM funds supporting F.B.	Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Holmes GL, 2007, NEUROLOGY, V69, pS28, DOI 10.1212/01.wnl.0000302369.24230.c6; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Miyake A, 2009, J NEUROSCI, V29, P14637, DOI 10.1523/JNEUROSCI.0901-09.2009; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; STRENG J, 1971, CAN J PSYCHOLOGY, V25, P62, DOI 10.1037/h0082368; Trudeau MC, 1999, J NEUROSCI, V19, P2906	15	46	46	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1056	1058		10.1038/nn.2610	http://dx.doi.org/10.1038/nn.2610			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20676103	Green Accepted			2022-12-24	WOS:000281332600009
J	Newman, AM; Cooper, JB				Newman, Aaron M.; Cooper, James B.			Lab-Specific Gene Expression Signatures in Pluripotent Stem Cells	CELL STEM CELL			English	Article							DIFFERENTIATION; EFFICIENCY	Pluripotent stem cells derived from both embryonic and reprogrammed somatic cells have significant potential for human regenerative medicine. Despite similarities in developmental potential, however, several groups have found fundamental differences between embryonic stem cell (ESC) and induced-pluripotent stem cell (iPSC) lines that may have important implications for iPSC-based medical therapies. Using an unsupervised clustering algorithm, we further studied the genetic homogeneity of iPSC and ESC lines by reanalyzing microarray gene expression data from seven different laboratories. Unexpectedly, this analysis revealed a strong correlation between gene expression signatures and specific laboratories in both ESC and iPSC lines. Nearly one-third of the genes with lab-specific expression signatures are also differentially expressed between ESCs and iPSCs. These data are consistent with the hypothesis that in vitro microenvironmental context differentially impacts the gene expression signatures of both iPSCs and ESCs.	[Newman, Aaron M.; Cooper, James B.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Cooper, James B.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Cooper, JB (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.	jcooper@lifesci.ucsb.edu	Newman, Aaron M/ABE-1620-2021	Newman, Aaron M/0000-0002-1857-8172	University of California at Santa Barbara	University of California at Santa Barbara	We are grateful to the University of California at Santa Barbara for a Graduate Dissertation Fellowship awarded to A.M.N. and for an anonymous private gift that supported this work.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Dolgin E, 2010, NATURE, V464, P663, DOI 10.1038/464663a; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	23	165	168	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					258	262		10.1016/j.stem.2010.06.016	http://dx.doi.org/10.1016/j.stem.2010.06.016			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682451	Bronze			2022-12-24	WOS:000281107400017
J	Kristensen, AS; Jenkins, MA; Banke, TG; Schousboe, A; Makino, Y; Johnson, RC; Huganir, R; Traynelis, SF				Kristensen, Anders S.; Jenkins, Meagan A.; Banke, Tue G.; Schousboe, Arne; Makino, Yuichi; Johnson, Richard C.; Huganir, Richard; Traynelis, Stephen F.			Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BIDIRECTIONAL SYNAPTIC PLASTICITY; LIGAND-BINDING CORE; PROTEIN-KINASE; PHOSPHORYLATION SITE; GLUTAMATE RECEPTORS; GLUR1 SUBUNIT; UNITARY CONDUCTANCE; STRUCTURAL BASIS; TRAFFICKING	The function, trafficking and synaptic signaling of AMPA receptors are tightly regulated by phosphorylation. Ca2+/calmodulin-dependent kinase II (CaMKII) phosphorylates the GluA1 AMPA receptor subunit at Ser831 to increase single-channel conductance. We show that CaMKII increases the conductance of native heteromeric AMPA receptors in mouse hippocampal neurons through phosphorylation of Ser831. In addition, co-expression of transmembrane AMPA receptor regulatory proteins (TARPs) with recombinant receptors is required for phospho-Ser831 to increase conductance of heteromeric GluA1-GluA2 receptors. Finally, phosphorylation of Ser831 increases the efficiency with which each subunit can activate, independent of agonist efficacy, thereby increasing the likelihood that more receptor subunits will be simultaneously activated during gating. This underlies the observation that phospho-Ser831 increases the frequency of openings to larger conductances rather than altering unitary conductance. Together, these findings suggest that CaMKII phosphorylation of GluA1-Ser831 decreases the activation energy for an intrasubunit conformational change that regulates the conductance of the receptor when the channel pore opens.	[Kristensen, Anders S.; Jenkins, Meagan A.; Banke, Tue G.; Traynelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Kristensen, Anders S.] Univ Copenhagen, Dept Med Chem, Copenhagen, Denmark; [Schousboe, Arne] Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Copenhagen, Denmark; [Makino, Yuichi; Johnson, Richard C.; Huganir, Richard] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Makino, Yuichi; Johnson, Richard C.; Huganir, Richard] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Emory University; University of Copenhagen; University of Copenhagen; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Traynelis, SF (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	strayne@emory.edu	Kristensen, Anders Skov/B-4414-2009	Kristensen, Anders Skov/0000-0001-8955-6790; Schousboe, Arne/0000-0001-9600-402X; Banke, Tue/0000-0001-8417-4400	US National Institutes of Health [NS068464, NS036654]; Howard Hughes Medical Institute; Alfred Benzon Foundation; Lundbeck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068464, R37NS036654, R01NS036654] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alfred Benzon Foundation; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Derkach and J. Howe for comments on the manuscript. We thank D. Colquhoun (University College London) for providing software for time course fitting and single channel dwell time and amplitude analysis (SCAN, EKDIST). GluA1 and GluA2 cDNA was provided by P. Seeburg (Max-Planck-Institut fur medizinische Forschung) and gamma 8 cDNA by R. Nicoll (University of California, San Francisco). This work was supported by the US National Institutes of Health (NS068464, NS036654; S.F.T.), the Howard Hughes Medical Institute (R.H.), the Alfred Benzon Foundation (A.S.K., T.G.B.) and the Lundbeck Foundation (A.S.).	Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2003, BIOPHYS J, V84, P1701, DOI 10.1016/S0006-3495(03)74978-9; Frandsen A, 2005, MOL PHARMACOL, V67, P703, DOI 10.1124/mol.104.002931; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Holmes WR, 2006, J NEUROPHYSIOL, V96, P1478, DOI 10.1152/jn.00248.2006; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Lamsa K, 2007, J PHYSIOL-LONDON, V584, P885, DOI 10.1113/jphysiol.2007.137380; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman J., 2006, SCI STKE, V2006, pr; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Milstein AD, 2009, P NATL ACAD SCI USA, V106, P11348, DOI 10.1073/pnas.0905570106; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Poon K, 2010, BIOPHYS J, V99, P1437, DOI 10.1016/j.bpj.2010.06.058; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	50	182	187	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					727	U327		10.1038/nn.2804	http://dx.doi.org/10.1038/nn.2804			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21516102	Green Accepted			2022-12-24	WOS:000290958000015
J	Scott, DA; Das, U; Tang, Y; Roy, S				Scott, David A.; Das, Utpal; Tang, Yong; Roy, Subhojit			Mechanistic Logic Underlying the Axonal Transport of Cytosolic Proteins	NEURON			English	Article							SLOW COMPONENT-B; SYNAPSIN-I; HIPPOCAMPAL-NEURONS; POSTTRANSLATIONAL MODIFICATION; PRESYNAPTIC TERMINALS; MOTOR-NEURONS; TUBULIN; KINESIN; COMPLEX; NEUROFILAMENTS	Proteins vital to presynaptic function are synthesized in the neuronal perikarya and delivered into synapses via two modes of axonal transport. While membrane-anchoring proteins are conveyed in fast axonal transport via motor-driven vesicles, cytosolic proteins travel in slow axonal transport via mechanisms that are poorly understood. We found that in cultured axons, populations of cytosolic proteins tagged to photoactivatable GFP (PAGFP) move with a slow motor-dependent anterograde bias distinct from both vesicular trafficking and diffusion of untagged PAGFP. The overall bias is likely generated by an intricate particle kinetics involving transient assembly and short-range vectorial spurts. In vivo biochemical studies reveal that cytosolic proteins are organized into higher order structures within axon-enriched fractions that are largely segregated from vesicles. Data-driven biophysical modeling best predicts a scenario where soluble molecules dynamically assemble into mobile supra-molecular structures. We propose a model where cytosolic proteins are transported by dynamically assembling into multiprotein complexes that are directly/indirectly conveyed by motors.	[Scott, David A.; Das, Utpal; Tang, Yong; Roy, Subhojit] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Roy, S (corresponding author), Univ Calif San Diego, Dept Neurosci, 312 MTF,9500 Gilman Dr,MC 0624, La Jolla, CA 92093 USA.	s1roy@ucsd.edu	Das, Utpal/E-4692-2013		University of California, San Diego; March of Dimes foundation; NIH [P50AG005131]; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	University of California, San Diego(University of California System); March of Dimes foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by start-up funds from University of California, San Diego and grants from the March of Dimes foundation (Basil O'Connor) and NIH (P50AG005131-project 2) to S.R. The authors thank Dr. Ge Yang (Carnegie Mellon University) for his suggestion of and initial assistance with the intensity-center analysis. We are grateful to Drs. Patterson and Lippincott Schwartz (National Institutes of Health) for the PAGFP construct. We also thank Drs. George Augustine (Duke University), Bernardo Sabatini (Harvard), Christoph Kaether (Leibniz Institute, Germany) and Leon Lagnado (Medical Research Council, Cambridge, UK) for providing the GFP:synapsin-I, PAGFP: CamKIla, APP:YFP, and synaptophysin:mRFP respectively.	AHMARI SE, 2000, J NEUROSCI, V3, P3723; BOOJ S, 1986, ACTA PHYSIOL SCAND, V128, P155, DOI 10.1111/j.1748-1716.1986.tb07962.x; Brangwynne CP, 2007, P NATL ACAD SCI USA, V104, P16128, DOI 10.1073/pnas.0703094104; Brangwynne CP, 2009, TRENDS CELL BIOL, V19, P423, DOI 10.1016/j.tcb.2009.04.004; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Dorn JF, 2008, METHOD CELL BIOL, V85, P497, DOI 10.1016/S0091-679X(08)85022-4; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Galbraith JA, 1999, P NATL ACAD SCI USA, V96, P11589, DOI 10.1073/pnas.96.20.11589; GARNER JA, 1982, J NEUROSCI, V2, P1824; GARNER JA, 1987, J NEUROCHEM, V49, P905, DOI 10.1111/j.1471-4159.1987.tb00979.x; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; LASEK RJ, 1984, J CELL BIOL, V99, pS212, DOI 10.1083/jcb.99.1.212s; Lillemeier BF, 2001, EMBO J, V20, P2508, DOI 10.1093/emboj/20.10.2508; Lund LM, 2001, BIOCHEM BIOPH RES CO, V289, P1157, DOI 10.1006/bbrc.2001.6111; Lund LM, 2002, J NEUROSCI RES, V67, P720, DOI 10.1002/jnr.10162; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; PAGGI P, 1992, MOL NEUROBIOL, V6, P239, DOI 10.1007/BF02780556; PETRUCCI TC, 1991, J NEUROSCI, V11, P2938; PFISTER KK, 1989, BIOCHEMISTRY-US, V28, P9006, DOI 10.1021/bi00449a008; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Roy S, 2000, J NEUROSCI, V20, P6849, DOI 10.1523/JNEUROSCI.20-18-06849.2000; Roy S, 2008, J NEUROSCI, V28, P5248, DOI 10.1523/JNEUROSCI.0309-08.2008; Roy S, 2007, J NEUROSCI, V27, P3131, DOI 10.1523/JNEUROSCI.4999-06.2007; Shakiryanova D, 2005, NAT NEUROSCI, V8, P173, DOI 10.1038/nn1377; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Uchida A, 2009, MOL BIOL CELL, V20, P4997, DOI 10.1091/mbc.E09-04-0304; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; WHITTAKER VP, 1993, J NEUROCYTOL, V22, P735, DOI 10.1007/BF01181319; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Yan YP, 2005, J NEUROSCI, V25, P7014, DOI 10.1523/JNEUROSCI.2001-05.2005; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	39	78	79	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 12	2011	70	3					441	454		10.1016/j.neuron.2011.03.022	http://dx.doi.org/10.1016/j.neuron.2011.03.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768HZ	21555071	Bronze, Green Accepted			2022-12-24	WOS:000290926100007
J	Buckley, PT; Lee, MT; Sul, JY; Miyashiro, KY; Bell, TJ; Fisher, SA; Kim, J; Eberwine, J				Buckley, Peter T.; Lee, Miler T.; Sul, Jai-Yoon; Miyashiro, Kevin Y.; Bell, Thomas J.; Fisher, Stephen A.; Kim, Junhyong; Eberwine, James			Cytoplasmic Intron Sequence-Retaining Transcripts Can Be Dendritically Targeted via ID Element Retrotransposons	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; X MENTAL-RETARDATION; MESSENGER-RNA; BC1 RNA; LOCALIZATION SIGNALS; HIPPOCAMPAL-NEURONS; DENDRITES; TRANSPORT; IDENTIFICATION; AMPLIFICATION	RNA precursors give rise to mRNA after splicing of intronic sequences traditionally thought to occur in the nucleus. Here, we show that intron sequences are retained in a number of dendritically-targeted mRNAs, by using microarray and Illumine sequencing of isolated dendritic mRNA as well as in situ hybridization. Many of the retained introns contain ID elements, a class of SINE retrotransposon. A portion of these SINEs confers dendritic targeting to exogenous and endogenous transcripts showing the necessity of ID-mediated mechanisms for the targeting of different transcripts to dendrites. ID elements are capable of selectively altering the distribution of endogenous proteins, providing a link between intronic SINEs and protein function. As such, the ID element represents a common dendritic targeting element found across multiple RNAs. Retention of intronic sequence is a more general phenomenon than previously thought and plays a functional role in the biology of the neuron, partly mediated by co-opted repetitive sequences.	[Buckley, Peter T.; Sul, Jai-Yoon; Miyashiro, Kevin Y.; Bell, Thomas J.; Eberwine, James] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Buckley, Peter T.; Lee, Miler T.; Fisher, Stephen A.; Kim, Junhyong; Eberwine, James] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Lee, Miler T.; Fisher, Stephen A.; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Lee, Miler T.; Kim, Junhyong; Eberwine, James] Univ Penn, Genom & Computat Biol Program, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Eberwine, J (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	eberwine@upenn.edu	Eberwine, James/B-2247-2010		Commonwealth of Pennsylvania; DOE [DE-FG02-97ER25308]; NIH [AG9900]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088849, R01MH078136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009900, R01AG009900] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD004117] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania; DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Maronski for help with cell cultures, and C. Garner for the MAP2 antibody. This work was funded in part by HRF funds from the Commonwealth of Pennsylvania (J.K.), DOE Computational Science Graduate Fellowship, DE-FG02-97ER25308 (M.T.L.), and NIH AG9900 (J.E.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Bell TJ, 2010, P NATL ACAD SCI USA, V107, P21152, DOI 10.1073/pnas.1015264107; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eom T, 2003, J NEUROSCI, V23, P10433; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kass DH, 1996, J MOL EVOL, V42, P7, DOI 10.1007/BF00163205; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Khanam T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000961; KIM JM, 1994, P NATL ACAD SCI USA, V91, P3607, DOI 10.1073/pnas.91.9.3607; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kobayashi H, 2005, EUR J NEUROSCI, V22, P2977, DOI 10.1111/j.1460-9568.2005.04508.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MILNER RJ, 1984, P NATL ACAD SCI-BIOL, V81, P713, DOI 10.1073/pnas.81.3.713; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; Miyashiro KY, 2009, TRENDS PHARMACOL SCI, V30, P203, DOI 10.1016/j.tips.2009.01.005; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Muslimov IA, 2006, J CELL BIOL, V175, P427, DOI 10.1083/jcb.200607008; Prakash N, 1997, EUR J NEUROSCI, V9, P523, DOI 10.1111/j.1460-9568.1997.tb01629.x; Smit A, 1996, REPEATMASKER OPEN 30; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395	44	99	105	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					877	884		10.1016/j.neuron.2011.02.028	http://dx.doi.org/10.1016/j.neuron.2011.02.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382548	Green Accepted, Bronze			2022-12-24	WOS:000288736500006
J	Muller, M; Pym, ECG; Tong, A; Davis, GW				Mueller, Martin; Pym, Edward C. G.; Tong, Amy; Davis, Graeme W.			Rab3-GAP Controls the Progression of Synaptic Homeostasis at a Late Stage of Vesicle Release	NEURON			English	Article							CA2+-DEPENDENT EXOCYTOSIS; RETROGRADE SIGNAL; BINDING-PROTEINS; GENETIC-ANALYSIS; MEMBRANE-FUSION; ACTIVE ZONES; DROSOPHILA; PLASTICITY; CHANNELS; CELLS	Homeostatic signaling systems stabilize neural function through the modulation of neurotransmitter receptor abundance, ion channel density, and presynaptic neurotransmitter release. Molecular mechanisms that drive these changes are being unveiled. In theory, molecular mechanisms may also exist to oppose the induction or expression of homeostatic plasticity, but these mechanisms have yet to be explored. In an ongoing electrophysiology-based genetic screen, we have tested 162 new mutations for genes involved in homeostatic signaling at the Drosophila NMJ. This screen identified a mutation in the rab3-GAP gene. We show that Rab3-GAP is necessary for the induction and expression of synaptic homeostasis. We then provide evidence that Rab3-GAP relieves an opposing influence on homeostasis that is catalyzed by Rab3 and which is independent of any change in NMJ anatomy. These data define roles for Rab3-GAP and Rab3 in synaptic homeostasis and uncover a mechanism, acting at a late stage of vesicle release, that opposes the progression of homeostatic plasticity.	[Mueller, Martin; Pym, Edward C. G.; Tong, Amy; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St,Rock Hall 4th Floor N, San Francisco, CA 94158 USA.	gdavis@biochem.ucsf.edu			Swiss National Science Foundation [PBSKP3-123456/1]; National Institute of Health [NS39313]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a fellowship of the Swiss National Science Foundation (PBSKP3-123456/1) to MM., and a National Institute of Health grant (NS39313) to G.W.D. We thank Daniel Brasier, Dion Dickman, Meg Younger, and the members of the Davis lab for comments and discussion.	Aligianis IA, 2005, NAT GENET, V37, P221, DOI 10.1038/ng1517; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Clabecq A, 2000, J BIOL CHEM, V275, P31786, DOI 10.1074/jbc.M003705200; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; FISCHER V, 1990, P NATL ACAD SCI USA, V87, P1988; FISCHER V, 1991, NATURE, V349, P79; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; LEZZI M, 1999, MOL ENDOCRINOL, V13, P202; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Lnenicka GA, 2006, J NEUROSCI, V26, P12283, DOI 10.1523/JNEUROSCI.2665-06.2006; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Oishi H, 1998, J BIOL CHEM, V273, P34580, DOI 10.1074/jbc.273.51.34580; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sakane A, 2006, P NATL ACAD SCI USA, V103, P10029, DOI 10.1073/pnas.0600304103; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	52	72	73	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					749	762		10.1016/j.neuron.2011.01.025	http://dx.doi.org/10.1016/j.neuron.2011.01.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338884	Bronze, Green Accepted			2022-12-24	WOS:000288413200016
J	Teichmann, HM; Shen, K				Teichmann, Hannah M.; Shen, Kang			UNC-6 and UNC-40 promote dendritic growth through PAR-4 in Caenorhabditis elegans neurons	NATURE NEUROSCIENCE			English	Article							COMMISSURAL AXON GUIDANCE; C-ELEGANS; CYTOPLASMIC LOCALIZATION; NERVOUS-SYSTEM; NETRIN UNC-6; DROSOPHILA; RECEPTORS; OUTGROWTH; CELLS; ASYMMETRY	Axons navigating through the developing nervous system are instructed by external attractive and repulsive cues. Emerging evidence suggests the same cues control dendrite development, but it is not understood how they differentially instruct axons and dendrites. We studied a C. elegans motor neuron whose axon and dendrite adopt different trajectories and lengths. We found that the guidance cue UNC-6 (Netrin) is required for both axon and dendrite development. Its repulsive receptor UNC-5 repelled the axon from the ventral cell body, whereas the attractive receptor UNC-40 (DCC) was dendritically enriched and promotes anteroposterior dendritic growth. Although the endogenous ventrally secreted UNC-6 instructs axon guidance, dorsal or even membrane-tethered UNC-6 could support dendrite development. Unexpectedly, the serine-threonine kinase PAR-4 (LKB1) was selectively required for the activity of the UNC-40 pathway in dendrite outgrowth. These data suggest that axon and dendrite of one neuron interpret common environmental cues with different receptors and downstream signaling pathways.	[Teichmann, Hannah M.; Shen, Kang] Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kangshen@stanford.edu			Human Frontier Science Foundation; W.M. Keck Foundation; Howard Hughes Medical Institute; Boehringer Ingelheim; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	Human Frontier Science Foundation(Human Frontier Science Program); W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the International Caenorhabditis Genetic Center and the C. Kenyon (University of California, San Francisco), E. Lundquist (University of Kansas) and C. Bargmann (Rockefeller University) laboratories for strains and K. Kemphues laboratory (Cornell University) for par-4 cDNA, as well as C. Gao and Y. Fu for technical assistance. This work was supported by the Human Frontier Science Foundation, the W.M. Keck Foundation and the Howard Hughes Medical Institute (K. S.) and a Boehringer Ingelheim graduate fellowship (H. M. T.).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Finger JH, 2002, J NEUROSCI, V22, P10346; FIRE A, 1990, NUCLEIC ACIDS RES, V18, P4269, DOI 10.1093/nar/18.14.4269; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu GF, 2007, J NEUROSCI, V27, P957, DOI 10.1523/JNEUROSCI.4616-06.2007; Margeta MA, 2009, P NATL ACAD SCI USA, V106, P1632, DOI 10.1073/pnas.0812078106; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Mello C, 1995, METHOD CELL BIOL, V48, P451; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Moore SW, 2009, SCIENCE, V325, P166, DOI 10.1126/science.1173851; MORTON DG, 1992, GENETICS, V130, P771; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wadsworth WG, 2002, TRENDS NEUROSCI, V25, P423, DOI 10.1016/S0166-2236(02)02206-3; Watts JL, 2000, DEVELOPMENT, V127, P1467; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	48	31	41	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					165	U364		10.1038/nn.2717	http://dx.doi.org/10.1038/nn.2717			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186357	Green Accepted			2022-12-24	WOS:000286595400013
J	Lechner, SG; Markworth, S; Poole, K; Smith, ES; Lapatsina, L; Frahm, S; May, M; Pischke, S; Suzuki, M; Ibanez-Tallon, I; Luft, FC; Jordan, J; Lewin, GR				Lechner, Stefan G.; Markworth, Soeren; Poole, Kate; Smith, Ewan St John; Lapatsina, Liudmilla; Frahm, Silke; May, Marcus; Pischke, Sven; Suzuki, Makoto; Ibanez-Tallon, Ines; Luft, Friedrich C.; Jordan, Jens; Lewin, Gary R.			The Molecular and Cellular Identity of Peripheral Osmoreceptors	NEURON			English	Article							CATION CHANNEL TRPV4; WATER DRINKING; OSMOSENSITIVE MECHANISMS; PRESSOR-RESPONSE; HEALTHY-SUBJECTS; MICE LACKING; RAT-LIVER; ACTIVATION; AFFERENT; VASOPRESSIN	In mammals, the osmolality of the extracellular fluid (ECF) is highly stable despite radical changes in salt/water intake and excretion. Afferent systems are required to detect hypo- or hyperosmotic shifts in the ECF to trigger homeostatic control of osmolality. In humans, a pressor reflex is triggered by simply drinking water which may be mediated by peripheral osmoreceptors. Here, we identified afferent neurons in the thoracic dorsal root ganglia (DRG) of mice that innervate hepatic blood vessels and detect physiological hypo-osmotic shifts in blood osmolality. Hepatic sensory neurons are equipped with an inward current that faithfully transduces graded changes in osmolality within the physiological range (similar to 15 mOsm). In mice lacking the osmotically activated ion channel, TRPV4, hepatic sensory neurons no longer exhibit osmosensitive inward currents and activation of peripheral osmoreceptors in vivo is abolished. We have thus identified a new population of sensory neurons that transduce ongoing changes in hepatic osmolality.	[Lechner, Stefan G.; Markworth, Soeren; Poole, Kate; Smith, Ewan St John; Lapatsina, Liudmilla; Frahm, Silke; Ibanez-Tallon, Ines; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13092 Berlin, Germany; [May, Marcus] Hannover Med Sch, Inst Clin Pharmacol, D-30625 Hannover, Germany; [Pischke, Sven; Jordan, Jens] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Suzuki, Makoto] Jichi Med Sch, Dept Pharmacol, Minami Kawachi, Tochigi 3290498, Japan; [Luft, Friedrich C.; Jordan, Jens; Lewin, Gary R.] Charite Campus Buch, ECRC, D-13125 Berlin, Germany; [Lewin, Gary R.] Charite, D-45050 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hannover Medical School; Hannover Medical School; Jichi Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Robert Rossle Str 10, D-13092 Berlin, Germany.	glewin@mdc-berlin.de	St. John Smith, Ewan/G-1776-2011; Poole, Kate/G-1830-2011; Lewin, Gary R/B-8028-2011; May, Marcus/A-1456-2017	St. John Smith, Ewan/0000-0002-2699-1979; Poole, Kate/0000-0003-0879-6093; May, Marcus/0000-0002-7513-4244; Luft, Friedrich/0000-0002-8635-1199; Lechner, Stefan/0000-0001-9402-9127; Lewin, Gary/0000-0002-2890-6352	MDC; ECRC	MDC; ECRC	This work was supported by an internal clinical cooperation grant from the MDC and ECRC to GIRL. and J.J. We would like to thank Andrew Plested, Jan Siemens, and Paul Heppenstall for critical reading of the manuscript. Additional support was obtained from the Deutsche Forschungsgemeinschaft to G.R.L. (SFB 665). We are thankful for the excellent technical assistance of Heike Thranhardt.	ADACHI A, 1976, AM J PHYSIOL, V231, P1043, DOI 10.1152/ajplegacy.1976.231.4.1043; ADACHI A, 1984, J AUTONOM NERV SYST, V10, P269, DOI 10.1016/0165-1838(84)90023-7; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; BAERTSCHI AJ, 1981, J PHYSIOL-LONDON, V315, P217, DOI 10.1113/jphysiol.1981.sp013743; Belyantseva IA, 1999, EUR J NEUROSCI, V11, P457, DOI 10.1046/j.1460-9568.1999.00458.x; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Boschmann M, 2003, J CLIN ENDOCR METAB, V88, P6015, DOI 10.1210/jc.2003-030780; Boschmann M, 2007, J CLIN ENDOCR METAB, V92, P3334, DOI 10.1210/jc.2006-1438; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Brierley SM, 2008, GASTROENTEROLOGY, V134, pA8; CAROBI C, 1985, NEUROSCI LETT, V62, P261, DOI 10.1016/0304-3940(85)90365-9; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cenac N, 2008, GASTROENTEROLOGY, V135, P937, DOI 10.1053/j.gastro.2008.05.024; CHOIKWON S, 1991, AM J PHYSIOL, V261, pE18, DOI 10.1152/ajpendo.1991.261.1.E18; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dai Y, 2002, J NEUROSCI, V22, P7737; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fields RD, 1997, J NEUROSCI, V17, P7252; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hanson SA, 2004, TRANSFUSION, V44, P924, DOI 10.1111/j.1537-2995.2004.03426.x; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Jordan J, 1999, LANCET, V353, P723, DOI 10.1016/S0140-6736(99)99015-3; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Lechner SG, 2009, J PHYSIOL-LONDON, V587, P3493, DOI 10.1113/jphysiol.2009.175059; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lipp A, 2005, NEUROLOGY, V65, P905, DOI 10.1212/01.wnl.0000176060.90959.36; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Lu CC, 2003, CIRCULATION, V108, P2660, DOI 10.1161/01.CIR.0000101966.24899.CB; MAGNI F, 1983, J AUTONOM NERV SYST, V8, P237, DOI 10.1016/0165-1838(83)90108-X; McHugh J, 2010, HYPERTENSION, V55, P1438, DOI 10.1161/HYPERTENSIONAHA.110.151860; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; NIIJIMA A, 1969, SCIENCE, V166, P1519, DOI 10.1126/science.166.3912.1519; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; OLIET SHR, 1993, AM J PHYSIOL, V265, pR1475, DOI 10.1152/ajpregu.1993.265.6.R1475; Raj SR, 2006, HYPERTENSION, V48, P329, DOI 10.1161/01.HYP.0000229906.27330.4f; Schroeder C, 2002, CIRCULATION, V106, P2806, DOI 10.1161/01.CIR.0000038921.64575.D0; Scot EM, 2000, LANCET, V356, P2013, DOI 10.1016/S0140-6736(05)72987-1; Scott EM, 2001, CLIN SCI, V100, P335, DOI 10.1042/CS20000177; Shannon JR, 2002, AM J MED, V112, P355, DOI 10.1016/S0002-9343(02)01025-2; Sharif-Naeini R, 2008, NEURON, V58, P179, DOI 10.1016/j.neuron.2008.02.013; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Stookey JD, 2008, OBESITY, V16, P2481, DOI 10.1038/oby.2008.409; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P3973, DOI 10.1210/jc.2007-0232; Tank J, 2003, HYPERTENSION, V41, P1234, DOI 10.1161/01.HYP.0000070957.08219.C9; Taylor AC, 2008, AM J PHYSIOL-REG I, V294, pR1285, DOI 10.1152/ajpregu.00003.2008; VALLET PG, 1982, BRAIN RES, V239, P271, DOI 10.1016/0006-8993(82)90850-2; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200	66	103	107	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					332	344		10.1016/j.neuron.2010.12.028	http://dx.doi.org/10.1016/j.neuron.2010.12.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262470	Bronze			2022-12-24	WOS:000286792900015
J	Bayes, A; van de Lagemaat, LN; Collins, MO; Croning, MDR; Whittle, IR; Choudhary, JS; Grant, SGN				Bayes, Alex; van de Lagemaat, Louie N.; Collins, Mark O.; Croning, Mike D. R.; Whittle, Ian R.; Choudhary, Jyoti S.; Grant, Seth G. N.			Characterization of the proteome, diseases and evolution of the human postsynaptic density	NATURE NEUROSCIENCE			English	Article							PHENOTYPE ONTOLOGY; SCHIZOPHRENIA; TOOL	We isolated the postsynaptic density from human neocortex (hPSD) and identified 1,461 proteins. hPSD mutations cause 133 neurological and psychiatric diseases and were enriched in cognitive, affective and motor phenotypes underpinned by sets of genes. Strong protein sequence conservation in mammalian lineages, particularly in hub proteins, indicates conserved function and organization in primate and rodent models. The hPSD is an important structure for nervous system disease and behavior.	[Bayes, Alex; van de Lagemaat, Louie N.; Croning, Mike D. R.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, Cambs, England; [Whittle, Ian R.] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland	Wellcome Trust Sanger Institute; University of Edinburgh	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Genes Cognit Programme, Hinxton, Cambs, England.	sg3@sanger.ac.uk	Bayés, Àlex/H-2854-2015; whittle, ian/AAX-7309-2021; Collins, Mark/AAB-7484-2021; Collins, Mark/A-3752-2012; Choudhary, Jyoti/S-1232-2017	Bayés, Àlex/0000-0002-5265-6306; Collins, Mark/0000-0002-7656-4975; Choudhary, Jyoti/0000-0003-0881-5477; Grant, Seth/0000-0001-8732-8735	EMBO; European Commission; Wellcome Trust; Scottish Higher Education Funding Council; Medical Research Council; US National Institutes of Health; Melville Trust; MRC [G0802238] Funding Source: UKRI; Medical Research Council [G0802238] Funding Source: researchfish; Chief Scientist Office [CZB/4/486] Funding Source: researchfish	EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Scottish Higher Education Funding Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melville Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank C.P. Ponting, P.J. Brophy, R.A.W. Frank, N.H. Komiyama, M.V. Kopanitsa, T.J. Ryan and members of the Genes to Cognition Programme for critical comments on the manuscript and for discussions. We thank the tissue donors, without whom this study would have been impossible. A.B. is supported by EMBO and the European Commission. L.N.v.L., M.O.C., M.D.R.C., J.S.C. and S.G.N.G. are supported by the Wellcome Trust. I.R.W. is supported by Scottish Higher Education Funding Council and by grants from the Medical Research Council, the US National Institutes of Health and the Melville Trust.	Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Harris LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003964; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Miao HX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002847; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Wang HY, 2007, PLOS BIOL, V5, P335, DOI 10.1371/journal.pbio.0050013; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004	14	323	325	1	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					19	21		10.1038/nn.2719	http://dx.doi.org/10.1038/nn.2719			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21170055	Green Accepted			2022-12-24	WOS:000285684900007
J	Lagerstrom, MC; Rogoz, K; Abrahamsen, B; Persson, E; Reinius, B; Nordenankar, K; Olund, C; Smith, C; Mendez, JA; Chen, ZF; Wood, JN; Wallen-Mackenzie, A; Kullander, K				Lagerstrom, Malin C.; Rogoz, Katarzyna; Abrahamsen, Bjarke; Persson, Emma; Reinius, Bjorn; Nordenankar, Karin; Olund, Caroline; Smith, Casey; Mendez, Jose Alfredo; Chen, Zhou-Feng; Wood, John N.; Wallen-Mackenzie, Asa; Kullander, Klas			VGLUT2-Dependent Sensory Neurons in the TRPV1 Population Regulate Pain and Itch	NEURON			English	Article							SPINAL-CORD; INTRATHECAL MORPHINE; BEHAVIORAL-RESPONSES; EXPRESSION LEVELS; NEURAL PATHWAY; NOXIOUS HEAT; GLUTAMATE; RECEPTOR; RECOMBINASE; PRURITOGENS	The natural response to itch sensation is to scratch, which relieves the itch through an unknown mechanism. Interaction between pain and itch has been frequently demonstrated, and the selectivity hypothesis of itch, based on data from electrophysiological and behavioral experiments, postulates the existence of primary pain afferents capable of repressing itch. Here, we demonstrate that deletion of vesicular glutamate transporter (VGLUT) 2 in a subpopulation of neurons partly overlapping with the vanilloid receptor (TRPV1) primary afferents resulted in a dramatic increase in itch behavior accompanied by a reduced responsiveness to thermal pain. The increased itch behavior was reduced by administration of antihistaminergic drugs and by genetic deletion of the gastrin-releasing peptide receptor, demonstrating a dependence on VGLUT2 to maintain normal levels of both histaminergic and nonhistaminergic itch. This study establishes that VGLUT2 is a major player in TRPV1 thermal nociception and also serves to regulate a normal itch response.	[Lagerstrom, Malin C.; Rogoz, Katarzyna; Persson, Emma; Reinius, Bjorn; Nordenankar, Karin; Olund, Caroline; Smith, Casey; Mendez, Jose Alfredo; Wallen-Mackenzie, Asa; Kullander, Klas] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden; [Abrahamsen, Bjarke; Wood, John N.] UCL, Mol Nocicept Grp, London WC1E 6BT, England; [Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; [Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; [Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Dev Biol, St Louis, MO 63110 USA	Uppsala University; University of London; University College London; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kullander, K (corresponding author), Uppsala Univ, Dept Neurosci, Box 593, S-75124 Uppsala, Sweden.	klas.kullander@neuro.uu.se	Abrahamsen, Bjarke/ABD-5874-2020; Mendez, J Alfredo/E-2031-2015; Wallén-Mackenzie, Åsa/B-9105-2017	Mendez, J Alfredo/0000-0002-2859-7086; Wallén-Mackenzie, Åsa/0000-0002-8713-070X; Abrahamsen, Bjarke/0000-0002-6128-8269; Reinius, Bjorn/0000-0002-7021-5248; Kullander, Klas/0000-0001-6418-5460	Swedish Medical Research Council [2003-2258, 2004-5567, 2007-3630/4479]; Swedish Brain Foundation; Foundations of Knut and Alice Wallenberg; A. Wiberg; M. Bergwall; Ahlen; Hedlund; Uppsala University; Knut and Alice Wallenberg Foundation; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Brain Foundation; Foundations of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); A. Wiberg; M. Bergwall; Ahlen; Hedlund; Uppsala University; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Wootz, J. Dahlbom, C. Ingman, and T. Jansson for technical assistance; Drs. T. Ebendal, S. Arber, and S. Dufour for providing Th-Cre, Tau<SUP>mGFP</SUP> and Ht-Pa-Cre mice. This work was supported by grants from the Swedish Medical Research Council (2003-2258, 2004-5567, and 2007-3630/4479), the Swedish Brain Foundation, and the foundations of Knut and Alice Wallenberg, A. Wiberg, M. Bergwall, Ahlen, Hedlund, and Uppsala University. K.K. is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation. The authors declare no competing financial interests.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; Atanassoff PG, 1999, SOMATOSENS MOT RES, V16, P291; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; CARSTENS E, 2009, SCI PAIN, P115; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Gezelius H, 2006, J PHYSIOL-PARIS, V100, P297, DOI 10.1016/j.jphysparis.2007.05.001; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ikoma A, 2005, PAIN, V113, P148, DOI 10.1016/j.pain.2004.10.003; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; JESSELL TM, 1978, BRAIN RES, V152, P183, DOI 10.1016/0006-8993(78)90146-4; Leo S, 2009, EUR J PAIN, V13, P1008, DOI 10.1016/j.ejpain.2008.12.001; Li JL, 2003, J COMP NEUROL, V457, P236, DOI 10.1002/cne.10556; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Loeb WF, 1999, CLIN CHEM LAB ANIMAL; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Raffaeli W, 2006, EUR J ANAESTH, V23, P605, DOI 10.1017/S026502150600038X; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Roza C, 2003, J PHYSIOL-LONDON, V550, P921, DOI 10.1113/jphysiol.2003.046110; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Schmelz M, 2001, NAT NEUROSCI, V4, P9, DOI 10.1038/82956; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Sikand P, 2009, PAIN, V144, P66, DOI 10.1016/j.pain.2009.03.001; Slappendel R, 2000, EUR J ANAESTH, V17, P616, DOI 10.1046/j.1365-2346.2000.00727.x; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; TUCKETT RP, 1982, J INVEST DERMATOL, V79, P368, DOI 10.1111/1523-1747.ep12529734; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Ward L, 1996, PAIN, V64, P129, DOI 10.1016/0304-3959(95)00080-1; Yosipovitch G, 2007, BRIT J DERMATOL, V156, P629, DOI 10.1111/j.1365-2133.2006.07711.x	46	160	166	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					529	542		10.1016/j.neuron.2010.09.016	http://dx.doi.org/10.1016/j.neuron.2010.09.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040852	Bronze, Green Accepted			2022-12-24	WOS:000284255800019
J	Hikida, T; Kimura, K; Wada, N; Funabiki, K; Nakanishi, S				Hikida, Takatoshi; Kimura, Kensuke; Wada, Norio; Funabiki, Kazuo; Nakanishi, Shigetada			Distinct Roles of Synaptic Transmission in Direct and Indirect Striatal Pathways to Reward and Aversive Behavior	NEURON			English	Article							CONDITIONED PLACE PREFERENCE; COCAINE-INDUCED LOCOMOTION; BASAL GANGLIA; DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; NEURAL MECHANISMS; GENE-EXPRESSION; D1 RECEPTOR; MICE; MODULATION	In the basal ganglia, convergent input and dopaminergic modulation of the direct striatonigral and the indirect striatopallidal pathways are critical in rewarding and aversive learning and drug addiction. To explore how the basal ganglia information is processed and integrated through these two pathways, we developed a reversible neurotransmission blocking technique, in which transmission of each pathway was selectively blocked by specific expression of transmission-blocking tetanus toxin in a doxycycline-dependent manner. The results indicated that the coordinated modulation of these two pathways was necessary for dopamine-mediated acute psychostimulant actions. This modulation, however, shifted to the predominant roles of the direct pathway in reward learning and cocaine sensitization and the indirect pathway in aversive behavior. These two pathways thus have distinct roles: the direct pathway critical for distinguishing associative rewarding stimuli from nonassociative ones and the indirect pathway for rapid memory formation to avoid aversive stimuli.	[Hikida, Takatoshi; Kimura, Kensuke; Wada, Norio; Funabiki, Kazuo; Nakanishi, Shigetada] Osaka Biosci Inst, Dept Syst Biol, Osaka 5650874, Japan; [Hikida, Takatoshi] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kimura, Kensuke] Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 6068501, Japan	Japan Science & Technology Agency (JST); Kyoto University	Nakanishi, S (corresponding author), Osaka Biosci Inst, Dept Syst Biol, 6-2-4 Furuedai, Osaka 5650874, Japan.	snakanis@obi.or.jp	Hikida, Takatoshi/J-5561-2017	Hikida, Takatoshi/0000-0002-8653-311X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17002016, 20790264]; JST; Takeda Science Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank R. Sprengel and M. Yokoi for plasmids and T. Kaneko and M. Takahashi for antibodies. This work was supported by Grants KAKENHI 17002016 (S.N.) and 20790264 (T.H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST PRESTO program (T.H.); and by grants from the Takeda Science Foundation (S.N.) and Uehara Memorial Foundation (T.H.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Baker DA, 1996, J PHARMACOL EXP THER, V279, P392; Baker DA, 1998, SYNAPSE, V30, P181, DOI 10.1002/(SICI)1098-2396(199810)30:2<181::AID-SYN8>3.0.CO;2-8; Caine SB, 2007, J NEUROSCI, V27, P13140, DOI 10.1523/JNEUROSCI.2284-07.2007; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; CUELLO AC, 1978, J COMP NEUROL, V178, P129, DOI 10.1002/cne.901780108; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; DI CG, 1988, P NATL ACAD SCI USA, V85, P5274; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goto Y, 2005, NEURON, V47, P255, DOI 10.1016/j.neuron.2005.06.017; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Han JS, 1997, J NEUROSCI, V17, P3913; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Liu ZH, 2008, NEUROPSYCHOPHARMACOL, V33, P3010, DOI 10.1038/npp.2008.4; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; MAENO H, 1982, MOL CELL BIOCHEM, V43, P65, DOI 10.1007/BF00423094; Marshall J F, 1998, Adv Pharmacol, V42, P678; Masugi M, 1999, J NEUROSCI, V19, P955; MILLER RJ, 1980, J HISTOCHEM CYTOCHEM, V28, P903, DOI 10.1177/28.8.7003009; Miner LL, 1995, NEUROREPORT, V6, P2314, DOI 10.1097/00001756-199511270-00011; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith JW, 2002, NEUROSCIENCE, V113, P755, DOI 10.1016/S0306-4522(02)00257-9; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Wada N, 2007, P NATL ACAD SCI USA, V104, P16690, DOI 10.1073/pnas.0708165104; Welter M, 2007, P NATL ACAD SCI USA, V104, P6840, DOI 10.1073/pnas.0610790104; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Xu M, 2000, BRAIN RES, V852, P198, DOI 10.1016/S0006-8993(99)02258-1; Yamamoto M, 2003, J NEUROSCI, V23, P6759	51	403	409	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					896	907		10.1016/j.neuron.2010.05.011	http://dx.doi.org/10.1016/j.neuron.2010.05.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620875	Bronze			2022-12-24	WOS:000279420800012
J	Huberfeld, G; de la Prida, LM; Pallud, J; Cohen, I; Le Van Quyen, M; Adam, C; Clemenceau, S; Baulac, M; Miles, R				Huberfeld, Gilles; de la Prida, Liset Menendez; Pallud, Johan; Cohen, Ivan; Le Van Quyen, Michel; Adam, Claude; Clemenceau, Stephane; Baulac, Michel; Miles, Richard			Glutamatergic pre-ictal discharges emerge at the transition to seizure in human epilepsy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; RAT HIPPOCAMPAL SLICE; SYSTEM IN-VITRO; EPILEPTIFORM ACTIVITY; MOUSE HIPPOCAMPUS; LIMBIC NETWORKS; DENTATE GYRUS; NEURONS; CORTEX; PROPAGATION	The mechanisms involved in the transition to an epileptic seizure remain unclear. To examine them, we used tissue slices from human subjects with mesial temporal lobe epilepsies. Ictal-like discharges were induced in the subiculum by increasing excitability along with alkalinization or low Mg2+. During the transition, distinct pre-ictal discharges emerged concurrently with interictal events. Intracranial recordings from the mesial temporal cortex of subjects with epilepsy revealed that similar discharges before seizures were restricted to seizure onset sites. In vitro, pre-ictal events spread faster and had larger amplitudes than interictal discharges and had a distinct initiation site. These events depended on glutamatergic mechanisms and were preceded by pyramidal cell firing, whereas interneuron firing preceded interictal events that depended on both glutamatergic and depolarizing GABAergic transmission. Once established, recurrence of these pre-ictal discharges triggered seizures. Thus, the subiculum supports seizure generation, and the transition to seizure involves an emergent glutamatergic population activity.	[Huberfeld, Gilles; de la Prida, Liset Menendez; Pallud, Johan; Cohen, Ivan; Clemenceau, Stephane; Baulac, Michel; Miles, Richard] Univ Paris 06, Inst Cerveau & Moelle Epiniere, Ctr Natl Rech Sci CNRS, Ctr Rech,INSERM,UMRS975,UMR7225, Paris, France; [Huberfeld, Gilles; Adam, Claude; Clemenceau, Stephane; Baulac, Michel] Ctr Hosp Univ Pitie Salpetriere, AP HP, Unite Epileptol, Paris, France; [Huberfeld, Gilles] UPMC, Dept Neurophysiol, Ctr Hosp Univ Pitie Salptriere, Paris, France; [de la Prida, Liset Menendez] CSIC, Lab Circuitos Neuronales, Inst Cajal, Madrid, Spain; [Pallud, Johan] Univ Paris 05, Serv Neurochirurg, Ctr Hosp Ste Anne, Paris, France; [Le Van Quyen, Michel] UPMC, Network Dynam & Cellular Excitabil, Ctr Rech Inst Cerveau & Moelle Epiniere, INSERM,CNRS,UMRS975,UMR7225, Paris, France; [Clemenceau, Stephane] Ctr Hosp Univ Pitie Salpetriere, AP HP, Serv Neurochirurg, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Huberfeld, G (corresponding author), Univ Paris 06, Inst Cerveau & Moelle Epiniere, Ctr Natl Rech Sci CNRS, Ctr Rech,INSERM,UMRS975,UMR7225, Paris, France.	gilles.huberfeld@upmc.fr; richard.miles@upmc.fr	de la Prida, Liset M/O-1342-2013	de la Prida, Liset M/0000-0002-0160-6472; Cohen, Ivan/0000-0001-6046-5289; Pallud, Johan/0000-0002-1652-9844; Miles, Richard/0000-0001-7303-0233	INSERM; CNRS; AP-HP; Federation pour la Recherche Medicale; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche; European Community (EPICURE) [LSH-037315]; Spain-France Joint Action [HF2006-0082]; Spanish National Research Council (Consejo Superior de Investigaciones Cientificas) [200720I023]; Spanish Ministry of Innovation and Science [BFU2006-10584-BFI, BFU2009-07989]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); AP-HP; Federation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community (EPICURE)(European Commission); Spain-France Joint Action; Spanish National Research Council (Consejo Superior de Investigaciones Cientificas); Spanish Ministry of Innovation and Science(Spanish Government)	We wish to thank M. Noulhiane for her help with imaging and statistics, M.-L. Tanguy for help with statistical analysis, E. Eugene for his technical assistance, M. Valderrama for software assistance and L. Wittner for participating in initial recordings. We gratefully acknowledge financial support from INSERM, the CNRS, the AP-HP, the Federation pour la Recherche Medicale, the Federation pour la Recherche sur le Cerveau, the Agence Nationale de la Recherche, the European Community (EPICURE, LSH-037315), Spain-France Joint Action (HF2006-0082), the Spanish National Research Council (Consejo Superior de Investigaciones Cientificas 200720I023) and the Spanish Ministry of Innovation and Science (BFU2006-10584-BFI and BFU2009-07989).	ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Avoli M, 1996, J NEUROSCI, V16, P3912; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 2009, J NEUROSCI, V29, P3660, DOI 10.1523/JNEUROSCI.5309-08.2009; Chabardes S, 2005, BRAIN, V128, P1818, DOI 10.1093/brain/awh512; Chassoux F, 2008, EPILEPSIA, V49, P51, DOI 10.1111/j.1528-1167.2007.01267.x; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; D'Antuono M, 2004, BRAIN, V127, P1626, DOI 10.1093/brain/awh181; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; de la Prida LM, 2002, NEUROREPORT, V13, P1421, DOI 10.1097/00001756-200208070-00015; Derchansky M, 2008, J PHYSIOL-LONDON, V586, P477, DOI 10.1113/jphysiol.2007.143065; Derchansky M, 2004, HIPPOCAMPUS, V14, P935, DOI 10.1002/hipo.20007; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Ebersole JS, 1996, EPILEPSIA, V37, P386, DOI 10.1111/j.1528-1157.1996.tb00577.x; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Gabriel S, 2004, J NEUROSCI, V24, P10416, DOI 10.1523/JNEUROSCI.2074-04.2004; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Gnatkovsky V, 2008, ANN NEUROL, V64, P674, DOI 10.1002/ana.21519; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Jandova K, 2006, BRAIN, V129, P3290, DOI 10.1093/brain/awl218; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; Kaila K, 1997, J NEUROSCI, V17, P7662; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Le Van Quyen M, 2007, TRENDS NEUROSCI, V30, P365, DOI 10.1016/j.tins.2007.05.006; LEHNERTZ K, 2007, EPILEPSY COMPREHENSI; McGonigal A, 2007, BRAIN, V130, P3169, DOI 10.1093/brain/awm218; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Spencer SS, 1999, EPILEPSIA, V40, P708, DOI 10.1111/j.1528-1157.1999.tb00767.x; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; Staba RJ, 2004, ANN NEUROL, V56, P108, DOI 10.1002/ana.20164; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Van Quyen ML, 2008, J NEUROSCI, V28, P6104, DOI 10.1523/JNEUROSCI.0437-08.2008; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; Wittner L, 2007, J PHYSIOL-LONDON, V584, P867, DOI 10.1113/jphysiol.2007.138131; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	50	201	202	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					627	U121		10.1038/nn.2790	http://dx.doi.org/10.1038/nn.2790			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21460834	Green Submitted			2022-12-24	WOS:000289886600019
J	Wang, XQ; Tsai, JW; LaMonica, B; Kriegstein, AR				Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget; Kriegstein, Arnold R.			A new subtype of progenitor cell in the mouse embryonic neocortex	NATURE NEUROSCIENCE			English	Article							RADIAL GLIAL-CELLS; MAMMALIAN NEUROEPITHELIAL CELLS; NEURAL STEM; CORTICAL NEUROGENESIS; ASYMMETRIC INHERITANCE; NEURONAL MIGRATION; RNA INTERFERENCE; CORTEX; DIVISION; EVOLUTION	A hallmark of mammalian brain evolution is cortical expansion, which reflects an increase in the number of cortical neurons established by the progenitor cell subtypes present and the number of their neurogenic divisions. Recent studies have revealed a new class of radial glia-like (oRG) progenitor cells in the human brain, which reside in the outer subventricular zone. Expansion of the subventricular zone and appearance of oRG cells may have been essential evolutionary steps leading from lissencephalic to gyrencephalic neocortex. Here we show that oRG-like progenitor cells are present in the mouse embryonic neocortex. They arise from asymmetric divisions of radial glia and undergo self-renewing asymmetric divisions to generate neurons. Moreover, mouse oRG cells undergo mitotic somal translocation whereby centrosome movement into the basal process during interphase precedes nuclear translocation. Our finding of oRG cells in the developing rodent brain fills a gap in our understanding of neocortical expansion.	[Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Wang, Xiaoqun; Tsai, Jin-Wu; LaMonica, Bridget; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [LaMonica, Bridget] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wang, XQ (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	wangx2@stemcell.ucsf.edu; kriegsteina@stemcell.ucsf.edu		Ostrem, Bridget/0000-0003-2107-3930; Tsai, Jin-Wu/0000-0003-0135-759X	Bernard Osher Foundation; US National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035710, R01NS021223, R01NS072630] Funding Source: NIH RePORTER	Bernard Osher Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Alvarez-Buylla, D. Lim, C. Harwell, W. P. Ge and L. Fuentealba for comments on the manuscript and members of the Kriegstein laboratory for discussions. We thank W. Walantus and Y.Y. Wang for mouse surgery and technical support and D. V. Hansen and J.H. Lui for ideas and discussion. We thank F. Gage (Salk Institute) for GFP-retrovirus reagents. This work was supported by grants from the Bernard Osher Foundation and the US National Institute of Neurological Disorders and Stroke (to A.R.K.).	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Cheung AFP, 2007, J ANAT, V211, P164, DOI 10.1111/j.1469-7580.2007.00769.x; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor S.C., 2007, NOVART FDN SYMP, V288, P73; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2007, NOVART FDN SYMP, V288, P96; Noctor Stephen C, 2007, Novartis Found Symp, V288, P59; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Walantus William, 2007, J Vis Exp, P239, DOI 10.3791/239; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435	39	332	338	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					555	U34		10.1038/nn.2807	http://dx.doi.org/10.1038/nn.2807			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21478886	Green Accepted			2022-12-24	WOS:000289886600010
J	Kusy, S; Gault, N; Ferri, F; Lewandowski, D; Barroca, V; Jaracz-Ros, A; Losson, R; Romeo, PH				Kusy, Sophie; Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Losson, Regine; Romeo, Paul-Henri			Adult Hematopoiesis is Regulated by TIF1 gamma, a Repressor of TAL1 and PU.1 Transcriptional Activity	CELL STEM CELL			English	Article							STEM-CELLS; SELF-RENEWAL; MYELOID PROGENITORS; EXPRESSION; GENE; SCL; DIFFERENTIATION; PROLIFERATION; FAMILY; ERYTHROPOIESIS	Crosstalk between transcription factors and cytokines precisely regulates tissue homeostasis. Transcriptional intermediary factor 1 gamma (TIF1 gamma) regulates vertebrate hematopoietic development, can control transcription elongation, and is a component of the TGF-beta signaling pathway. Here we show that deletion of TIF1 gamma in adult hematopoiesis is compatible with life and long-term maintenance of essential blood cell lineages. However, loss of TIF1 gamma results in deficient long-term hematopoietic stem cell (LTHSC) transplantation activity, deficient short-term HSC (ST-HSC) bone marrow retention, and priming ST-HSCs to myelomonocytic lineage. These defects are hematopoietic cell-autonomous, and priming of TIF1 gamma-deficient ST-HSCs can be partially rescued by wild-type hematopoietic cells. TIF1 gamma can form complexes with TAL1 or PU.1 two essential DNA-binding proteins in hematopoiesis occupy specific subsets of their DNA binding sites in vivo, and repress their transcriptional activity. These results suggest a regulation of adult hematopoiesis through TIF1 gamma-mediated transcriptional repression of TAL1 and PU.1 target genes.	[Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] INSERM, U967, F-92265 Fontenay Aux Roses, France; [Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] Univ Paris 07, F-92265 Fontenay Aux Roses, France; [Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Barroca, Vilma; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] Univ Paris 11, F-92265 Fontenay Aux Roses, France; [Losson, Regine] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France; [Kusy, Sophie; Gault, Nathalie; Ferri, Federica; Lewandowski, Daniel; Jaracz-Ros, Agnieszka; Romeo, Paul-Henri] CEA DSV IRCM LRTS, F-92265 Fontenay Aux Roses, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; UDICE-French Research Universities; Universite Paris Saclay	Romeo, PH (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	paul-henri.romeo@cea.fr	Lewandowski, Daniel/E-3154-2018; Romeo, Paul-Henri/L-5989-2017	Lewandowski, Daniel/0000-0001-8416-2629; Romeo, Paul-Henri/0000-0002-8294-0367; Ferri, Federica/0000-0003-4083-1362; Gault, Nathalie/0000-0001-6233-1946	Fondation contre la Leucemie; ARC [3710]; Inserm; CEA/DSV	Fondation contre la Leucemie; ARC(Australian Research Council); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA/DSV(French Atomic Energy Commission)	This work is dedicated to R. Losson, who recently passed away. We acknowledge T. Hoang, N. Goardon, and F. Pflumio for helpful discussions and initial experiment, and P. Chambon, F. Moreau-Gachelin, P. Jalinot, and Y. Pekarsky for the gift of the plasmids. We are grateful to the staff of the iRCM animal facility for excellent support during the mouse studies and to H. Benjelloun, N. Dechamps, and J. Baijer of the iRCM cytometry platform for excellent support during the FAGS and cell sorting experiments. S.K., F.F., A.J.-R., and V.B. are supperted by fellowships from ARC, DimStem Pole, CEA, and lnserm. This project was supported by grants from La Fondation contre la Leucemie, ARC (3710), Inserm, and CEA/DSV.	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Burda P, 2010, LEUKEMIA, V24, P1249, DOI 10.1038/leu.2010.104; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; de la Grange PB, 2008, STEM CELLS, V26, P1658, DOI 10.1634/stemcells.2007-0952; de la Grange PB, 2006, BLOOD, V108, P2998, DOI 10.1182/blood-2006-05-022988; Dey S, 2010, MOL CELL BIOL, V30, P2181, DOI 10.1128/MCB.01441-09; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jalili A, 2010, TRANSFUSION, V50, P2002, DOI 10.1111/j.1537-2995.2010.02664.x; Kim J, 2008, GENESIS, V46, P329, DOI 10.1002/dvg.20401; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; Yan KP, 2004, GENE, V334, P3, DOI 10.1016/j.gene.2004.02.056; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	42	34	35	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					412	425		10.1016/j.stem.2011.02.005	http://dx.doi.org/10.1016/j.stem.2011.02.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474105	Bronze			2022-12-24	WOS:000289707100013
J	Bretscher, AJ; Kodama-Namba, E; Busch, KE; Murphy, RJ; Soltesz, Z; Laurent, P; de Bono, M				Bretscher, Andrew Jonathan; Kodama-Namba, Eiji; Busch, Karl Emanuel; Murphy, Robin Joseph; Soltesz, Zoltan; Laurent, Patrick; de Bono, Mario			Temperature, Oxygen, and Salt-Sensing Neurons in C. elegans Are Carbon Dioxide Sensors that Control Avoidance Behavior	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; NERVOUS-SYSTEM; CHEMOSENSORY RECEPTORS; THERMOSENSORY NEURONS; GUANYLATE-CYCLASE; NATURAL VARIATION; DROSOPHILA; CO2; ANHYDRASE	Homeostatic control of body fluid CO2 is essential in animals but is poorly understood. C. elegans relies on diffusion for gas exchange and avoids environments with elevated CO2. We show that C. elegans temperature, O-2, and salt-sensing neurons are also CO2 sensors mediating CO2 avoidance. AFD thermosensors respond to increasing CO2 by a fall and then rise in Ca2+ and show a Ca2+ spike when CO2 decreases. BAG O-2 sensors and ASE salt sensors are both activated by CO2 and remain tonically active while high CO2 persists. CO2-evoked Ca2+ responses in AFD and BAG neurons require cGMP-gated ion channels. Atypical soluble guanylate cyclases mediating O-2 responses also contribute to BAG CO2 responses. AFD and BAG neurons together stimulate turning when CO2 rises and inhibit turning when CO2 falls. Our results show that C. elegans senses CO2 using functionally diverse sensory neurons acting homeostatically to minimize exposure to elevated CO2.	[Bretscher, Andrew Jonathan; Kodama-Namba, Eiji; Busch, Karl Emanuel; Murphy, Robin Joseph; Soltesz, Zoltan; Laurent, Patrick; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	debono@mrc-lmb.cam.ac.uk	laurent, patrick/ABD-9373-2021	laurent, patrick/0000-0001-5360-5597; de Bono, Mario/0000-0001-8347-0443; Busch, Karl Emanuel/0000-0001-7886-3226	Swiss National Science Foundation; EMBO; Medical Research Council, UK; MRC [MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Caenorhabditis Genetics Centre, the C. elegans Knockout Consortium, Piali Sengupta, Bill Schafer, Ikue Mori, and Oliver Hobert for strains; the Dana-Farber Cancer Institute and Source Bioscience for reagents; Robyn Branicky for comments on the manuscript; and all the de Bono and Schafer lab members for insight, help, and advice. K.E.B. was funded by the Swiss National Science Foundation, P.L. was funded by EMBO, and otherwise research was funded by either the Medical Research Council, UK, or private funds.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Boon EM, 2005, CURR OPIN CHEM BIOL, V9, P441, DOI 10.1016/j.cbpa.2005.08.015; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Buchanan GF, 2010, P NATL ACAD SCI USA, V107, P16354, DOI 10.1073/pnas.1004587107; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Bustami HP, 2002, COMP BIOCHEM PHYS A, V133, P595, DOI 10.1016/S1095-6433(02)00155-1; Cammer WB, 2000, EXS, V90, P475; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Coates EL, 1998, J COMP PHYSIOL A, V182, P163, DOI 10.1007/s003590050167; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; DUSENBERY DB, 1975, GENETICS, V80, P297; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Jiang C, 2005, RESP PHYSIOL NEUROBI, V145, P115, DOI 10.1016/j.resp.2004.07.005; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kerr Rex A., 2006, V351, P253; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Lahiri S, 2003, INT J BIOCHEM CELL B, V35, P1413, DOI 10.1016/S1357-2725(03)00050-5; Lehmann FO, 2005, J EXP BIOL, V208, P3645, DOI 10.1242/jeb.01788; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Ortiz CO, 2009, CURR BIOL, V19, P996, DOI 10.1016/j.cub.2009.05.043; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Richerson GB, 2005, EXP PHYSIOL, V90, P259, DOI 10.1113/expphysiol.2005.029843; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; RIDDERSTRALE Y, 1985, ACTA PHYSIOL SCAND, V124, P557, DOI 10.1111/j.1748-1716.1985.tb00048.x; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Syrjanen L, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-28; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang WG, 2002, J PHYSIOL-LONDON, V540, P951, DOI 10.1113/jphysiol.2001.013443; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Young JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000884; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	64	94	97	3	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 24	2011	69	6					1099	1113		10.1016/j.neuron.2011.02.023	http://dx.doi.org/10.1016/j.neuron.2011.02.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435556	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000288886900008
J	Li, HL; de Faria, JP; Andrew, P; Nitarska, J; Richardson, WD				Li, Huiliang; de Faria, Joana Paes; Andrew, Paul; Nitarska, Justyna; Richardson, William D.			Phosphorylation Regulates OLIG2 Cofactor Choice and the Motor Neuron-Oligodendrocyte Fate Switch	NEURON			English	Article							PROTEIN-KINASE-A; EMBRYONAL CARCINOMA-CELLS; SPINAL-CORD; TRANSCRIPTION FACTORS; BHLH PROTEINS; HEDGEHOG; SPECIFICATION; DIFFERENTIATION; EXPRESSION; LINEAGE	A fundamental feature of central nervous system development is that neurons are generated before glia. In the embryonic spinal cord, for example, a group of neuroepithelial stem cells (NSCs) generates motor neurons (MNs), before switching abruptly to oligodendrocyte precursors (OLPs). We asked how transcription factor OLIG2 participates in this MN-OLP fate switch. We found that Serine 147 in the helix-loop-helix domain of OLIG2 was phosphorylated during MN production and dephosphorylated at the onset of OLP genesis. Mutating Serine 147 to Alanine (S147A) abolished MN production without preventing OLP production in transgenic mice, chicks, or cultured P19 cells. We conclude that S147 phosphorylation, possibly by protein kinase A, is required for MN but not OLP genesis and propose that dephosphorylation triggers the MN-OLP switch. Wild-type OLIG2 forms stable homodimers, whereas mutant (unphosphorylated) OLIG2(S147A) prefers to form heterodimers with Neurogenin 2 or other bHLH partners, suggesting a molecular basis for the switch.	[Li, Huiliang; de Faria, Joana Paes; Andrew, Paul; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Li, Huiliang; de Faria, Joana Paes; Andrew, Paul; Richardson, William D.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England; [Nitarska, Justyna] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	w.richardson@ucl.ac.uk	de Faria, Joana Paes/M-8815-2014; Richardson FMedSci FRS, William D/C-1762-2008	de Faria, Joana Paes/0000-0001-7046-6197; Nitarska, Justyna/0000-0001-6992-6686; Richardson FMedSci FRS, William D/0000-0001-7261-2485	UK Medical Research Council; Wellcome Trust; MRC [G0800575] Funding Source: UKRI; Medical Research Council [G0800575] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank our colleagues in the Wolfson Institute for Biomedical Research, particularly Marta del Barrio and Raquel Taveira-Marques, for helpful advice and discussions. We gratefully acknowledge Nicoletta Kessaris for help with triple-label immunofluorescence (Figure 4A) and Richa Tripathi for confocal micrography (Figure 5). We thank Ulla Dennehy, Matthew Grist, Helin Zhuang, and Sabrina Pacheco for technical assistance, Michael Wegner and Charles Stiles for providing antibodies, Judy Varner for PKA and dnPKA expression vectors, Samuel Pfaff for the HB9-luciferase reporter, and David Rowitch and David Anderson for Olig null mice. The work was funded by grants from the UK Medical Research Council and The Wellcome Trust.	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; BERG RW, 1990, DEV BIOL, V138, P123, DOI 10.1016/0012-1606(90)90182-I; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Du ZW, 2006, MOL CELL NEUROSCI, V33, P371, DOI 10.1016/j.mcn.2006.08.007; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; FOGARTY MH, 2006, THESIS U LONDON; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Huillard E, 2010, MOL CELL BIOL, V30, P2737, DOI 10.1128/MCB.01566-09; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kuspert M, 2011, NUCLEIC ACIDS RES, V39, P1280, DOI 10.1093/nar/gkq951; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; Qi YC, 2001, DEVELOPMENT, V128, P2723; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shin SJ, 2007, STEM CELLS DEV, V16, P131, DOI 10.1089/scd.2006.0023; Staines WA, 1996, NEUROSCIENCE, V71, P845, DOI 10.1016/0306-4522(95)00494-7; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sun T, 2001, CURR BIOL, V11, P1413, DOI 10.1016/S0960-9822(01)00441-9; Sun T, 2003, J NEUROSCI, V23, P9547; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tiecke E, 2007, DEV BIOL, V305, P312, DOI 10.1016/j.ydbio.2007.02.017; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yeo SY, 2007, P NATL ACAD SCI USA, V104, P5913, DOI 10.1073/pnas.0607062104; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	70	96	105	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					918	929		10.1016/j.neuron.2011.01.030	http://dx.doi.org/10.1016/j.neuron.2011.01.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382552	hybrid, Green Published			2022-12-24	WOS:000288736500010
J	Fields, HL				Fields, Howard L.			The Doctor's Dilemma: Opiate Analgesics and Chronic Pain	NEURON			English	Editorial Material							TOLERANCE; DEPENDENCE; MORPHINE; MECHANISMS; OPIOIDS	Opiates are utilized routinely and effectively as a short-term analgesic treatment for a variety of acute pain conditions such as occur following trauma, and for patients with painful terminal diseases such as cancer. Because opiate analgesics are highly addictive substances, their use in the treatment of chronic nonmalignant pain remains controversial.	[Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA; [Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Fields, HL (corresponding author), Univ Calif San Francisco, Dept Neurol, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	hlf@gallo.ucsf.edu	Fields, Howard/ABG-9073-2020		NIDA NIH HHS [DA-016782-06, R01 DA016782-06, R01 DA016782] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016782] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anonymous, 2006, P121; Ballantyne JC, 2007, PAIN, V129, P235, DOI 10.1016/j.pain.2007.03.028; Betourne A, 2008, NEUROSCIENCE, V157, P12, DOI 10.1016/j.neuroscience.2008.08.045; Chang G, 2007, MED CLIN N AM, V91, P199, DOI 10.1016/j.mcna.2006.10.003; Cohen SP, 2008, REGION ANESTH PAIN M, V33, P199, DOI 10.1016/j.rapm.2007.10.009; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Gardell LR, 2006, NEUROSCI LETT, V396, P44, DOI 10.1016/j.neulet.2005.11.009; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Lenard NR, 2007, EUR J PHARMACOL, V566, P75, DOI 10.1016/j.ejphar.2007.02.040; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Pasternak GW, 2011, RECEPT SER, P1, DOI 10.1007/978-1-60761-993-2; Pletcher MJ, 2006, DRUG ALCOHOL DEPEN, V85, P171, DOI 10.1016/j.drugalcdep.2006.04.011; von Zastrow M, 2010, DRUG ALCOHOL DEPEN, V108, P166, DOI 10.1016/j.drugalcdep.2010.02.014	16	92	95	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					591	594		10.1016/j.neuron.2011.02.001	http://dx.doi.org/10.1016/j.neuron.2011.02.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338871	Bronze, Green Accepted			2022-12-24	WOS:000288413200003
J	Kochubey, O; Schneggenburger, R				Kochubey, Olexiy; Schneggenburger, Ralf			Synaptotagmin Increases the Dynamic Range of Synapses by Driving Ca2+-Evoked Release and by Clamping a Near-Linear Remaining Ca2+ Sensor	NEURON			English	Article							NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; VESICLE FUSION; SYNAPTIC-TRANSMISSION; MEMBRANE-FUSION; C2B DOMAIN; ASYNCHRONOUS RELEASE; CALCIUM-DEPENDENCE; GLUTAMATE RELEASE; GENETIC-ANALYSIS	Ca2+-evoked transmitter release shows a high dynamic range over spontaneous release. We investigated the role of the Ca2+ sensor protein, Synaptotagmin2 (Syt2), in both spontaneous and Ca2+-evoked release under direct control of presynaptic [Ca2+](i), using an in vivo rescue approach at the calyx of Held. Re-expression of Syt2 rescued the highly Ca2+ cooperative release and suppressed the elevated spontaneous release seen in Syt2 KO synapses. This latter release clamping function was partially mediated by the poly-lysine motif of the C2B domain. Using an aspartate mutation in the C2B domain (D364N) in which Ca2+ triggering was abolished but release clamping remained intact, we show that Syt2 strongly suppresses the action of another, near-linear Ca2+ sensor that mediates release over a wide range of [Ca2+](i). Thus, Syt2 increases the dynamic range of synapses by driving release with a high Ca2+ cooperativity, as well as by suppressing a remaining, near-linear Ca2+ sensor.	[Kochubey, Olexiy; Schneggenburger, Ralf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schneggenburger, R (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Synapt Mech, CH-1015 Lausanne, Switzerland.	ralf.schneggenburger@epfl.ch		Kochubey, Olexiy/0000-0002-8115-7733	Swiss National Science Foundation [3100A0_122496/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Sam Young for advice on virus vectors and for providing the modified adenovirus genomic and shuttle DNA plasmids, Robert Adachi and Thomas Sudhof for providing the Syt2 KO mice, H. Zhou and A. Beaudet for allowing us to use the E2T packaging cell line, Heather Murray for excellent technical assistance and Dr. David Perkel for critical reading of the manuscript. This study was supported by the Swiss National Science Foundation (Grant # 3100A0_122496/1).	ADLER EM, 1991, J NEUROSCI, V11, P1496; Basu J, 2007, J NEUROSCI, V27, P1200, DOI 10.1523/JNEUROSCI.4908-06.2007; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Catherine CR, 2005, MOL CELL NEUROSCI, V29, P462, DOI 10.1016/j.mcn.2005.03.015; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Kochubey O, 2009, J PHYSIOL-LONDON, V587, P3009, DOI 10.1113/jphysiol.2009.172387; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mackler JM, 2001, J COMP NEUROL, V436, P4, DOI 10.1002/cne.1049; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Scheuss V, 2007, J PHYSIOL-LONDON, V585, P361, DOI 10.1113/jphysiol.2007.140988; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Wang LY, 2008, J NEUROSCI, V28, P14450, DOI 10.1523/JNEUROSCI.4245-08.2008; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Wimmer VC, 2004, PFLUG ARCH EUR J PHY, V449, P319, DOI 10.1007/s00424-004-1327-9; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Xiao L, 2010, MOL CELL NEUROSCI, V44, P374, DOI 10.1016/j.mcn.2010.05.002; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zhou HS, 2000, VIROLOGY, V275, P348, DOI 10.1006/viro.2000.0515	56	79	79	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					736	748		10.1016/j.neuron.2011.01.013	http://dx.doi.org/10.1016/j.neuron.2011.01.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338883	Bronze, Green Submitted			2022-12-24	WOS:000288413200015
J	Cheng, PL; Lu, H; Shelly, M; Geo, HF; Poo, MM				Cheng, Pei-lin; Lu, Hui; Shelly, Maya; Geo, Hongfeng; Poo, Mu-ming			Phosphorylation of E3 Ligase Smurf1 Switches Its Substrate Preference in Support of Axon Development	NEURON			English	Article							POLARITY PROTEIN PAR6; NEURONAL POLARITY; CELL-POLARITY; TUMOR-SUPPRESSOR; ESTABLISHMENT; POLARIZATION; PATHWAY; CDC42; DEGRADATION; INITIATION	Ubiquitin E3 ligases serve for ubiquitination of specific substrates, and its ligase efficacy is regulated by interacting proteins or substrate modifications. Whether and how the ligases themselves are modified by cellular signaling is. unclear. Here we report that protein kinase A (PKA)-dependent phosphorylation of Smad Ubiquitin Regulatory Factor 1 (Smurf1) can switch its substrate preference between two proteins of opposing actions on axon development. Extracellular factors that promote axon formation elevated Smurf1 phosphorylation at a PKA site Thr(306), and preventing this phosphorylation reduced axon formation in cultured hippocampal neurons and impaired polarization of cortical neurons in vivo. Thr(306)-phosphorylation changed the relative affinities of Smurf1 for its substrates, leading to reduced degradation of polarity protein Par6 and increased degradation of growth-inhibiting RhoA. Thus, PKA-dependent phosphorylation of the E3 ligase could switch its substrate preference, contributing to selective protein degradation required for localized cellular function.	[Cheng, Pei-lin; Lu, Hui; Shelly, Maya; Geo, Hongfeng; Poo, Mu-ming] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; [Cheng, Pei-lin; Lu, Hui; Shelly, Maya; Geo, Hongfeng; Poo, Mu-ming] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Cheng, Pei-Lin/ABB-2255-2021; Lu, Hui/K-2322-2013	Cheng, Pei-Lin/0000-0002-0090-8153; shelly, maya/0000-0002-2211-1751	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Thakar, S. Li, M. Nasir, and D. Liepmann (University of California, Berkeley, CA) for help with PDMS microfluidic molds for making patterned substrates. We thank E. Burstein (University of Michigan Medical School) for providing Myc-tagged ubiquitin constructs, X.B. Yuan (Institute of Neuroscience, Shanghai) for constitutive active RhoA construct, X. Zhang (Institute of Neuroscience, Shanghai) for pCAG-IRES-EGFP, and R. Tsien (University of California, San Diego, CA) for tdTomato construct. This work was supported in part by a grant from the National Institutes of Health.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Blumer KJ, 2003, NAT CELL BIOL, V5, P1048, DOI 10.1038/ncb1203-1048; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gallo G, 2002, J NEUROSCI, V22, P5016, DOI 10.1523/JNEUROSCI.22-12-05016.2002; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsu S, 2005, BIOCHEM BIOPH RES CO, V337, P401, DOI 10.1016/j.bbrc.2005.08.272; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kato M, 2010, PROTEOMICS, V10, P115, DOI 10.1002/pmic.200900497; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nelson WJ, 1997, CURR BIOL, V7, pR562, DOI 10.1016/S0960-9822(06)00282-X; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; Renshaw MW, 1996, J BIOL CHEM, V271, P21691, DOI 10.1074/jbc.271.36.21691; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Sordella R, 2008, DEV CELL, V14, P150, DOI 10.1016/j.devcel.2008.01.015; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	52	116	116	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					231	243		10.1016/j.neuron.2010.12.021	http://dx.doi.org/10.1016/j.neuron.2010.12.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262463	Bronze			2022-12-24	WOS:000286792900008
J	Hipp, JF; Engel, AK; Siegel, M				Hipp, Joerg F.; Engel, Andreas K.; Siegel, Markus			Oscillatory Synchronization in Large-Scale Cortical Networks Predicts Perception	NEURON			English	Article							VISUAL-ATTENTION; TOP-DOWN; NEURONAL OSCILLATIONS; CORTEX; INTEGRATION; MODULATION; RESPONSES; COHERENCE; REFLECTS; DISCRIMINATION	Normal brain function requires the dynamic interaction of functionally specialized but widely distributed cortical regions. Long-range synchronization of oscillatory signals has been suggested to mediate these interactions within large-scale cortical networks, but direct evidence is sparse. Here we show that oscillatory synchronization is organized in such large-scale networks. We implemented an analysis approach that allows for imaging synchronized cortical networks and applied this technique to EEG recordings in humans. We identified two networks: beta-band synchronization (similar to 20 Hz) in a fronto-parieto-occipital network and gamma-band synchronization (similar to 80 Hz) in a centro-temporal network. Strong perceptual correlates support their functional relevance: the strength of synchronization within these networks predicted the subjects' percept of an ambiguous audiovisual stimulus as well as the integration of auditory and visual information. Our results provide evidence that oscillatory neuronal synchronization mediates neuronal communication within frequency-specific, large-scale cortical networks.	[Hipp, Joerg F.; Engel, Andreas K.; Siegel, Markus] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Siegel, Markus] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Siegel, Markus] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Massachusetts Institute of Technology (MIT); Northwell Health; Eberhard Karls University of Tubingen	Hipp, JF (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany.	j.hipp@uke.de	Hipp, Joerg F/D-8936-2014; Engel, Andreas K/C-7781-2012; Siegel, Markus/H-5225-2012; Engel, Andreas K./AAH-6384-2019	Hipp, Joerg F/0000-0002-7875-2988; Engel, Andreas K/0000-0003-4899-8466; Siegel, Markus/0000-0001-5115-936X; Engel, Andreas K./0000-0003-4899-8466	European Union [IST-2005-027268, NEST-PATH-043457, HEALTH-F2-2008-200728]; German Research Foundation [GRK 1247/1, 1247/2]; German Federal Ministry of Education and Research [01GW0561]	European Union(European Commission); German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We thank T.H. Donner, C. Hipp, T.J. Buschman, J. Roy, G.G. Supp, and E.K. Miller for helpful discussions and comments on the manuscript. This work was supported by grants from the European Union (IST-2005-027268, NEST-PATH-043457, and HEALTH-F2-2008-200728), the German Research Foundation (GRK 1247/1 and 1247/2), and the German Federal Ministry of Education and Research (01GW0561, Neuroimage Nord).	Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; Donner TH, 2007, J NEUROPHYSIOL, V98, P345, DOI 10.1152/jn.01141.2006; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Green DM, 1966, SIGNAL DETECTION THE; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; HOLM S, 1979, SCAND J STAT, V6, P65; Hummel F, 2005, CEREB CORTEX, V15, P670, DOI 10.1093/cercor/bhh170; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kujala J, 2008, NEUROIMAGE, V39, P1706, DOI 10.1016/j.neuroimage.2007.10.042; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Meredith MA, 2009, HEARING RES, V258, P64, DOI 10.1016/j.heares.2009.03.005; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nunez P.L., 2006, ELECT FIELDS BRAIN; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rose M, 2005, J NEUROSCI, V25, P10101, DOI 10.1523/JNEUROSCI.2998-05.2005; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Siegel M, 2003, J NEUROSCI, V23, P4251; Siegel M, 2007, CEREB CORTEX, V17, P732, DOI 10.1093/cercor/bhk025; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Stein BE., 1993, MERGING SENSES; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	82	398	404	3	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					387	396		10.1016/j.neuron.2010.12.027	http://dx.doi.org/10.1016/j.neuron.2010.12.027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262474	Bronze, Green Published			2022-12-24	WOS:000286792900019
J	Li, JL; Erisir, A; Cline, H				Li, Jianli; Erisir, Alev; Cline, Hollis			In Vivo Time-Lapse Imaging and Serial Section Electron Microscopy Reveal Developmental Synaptic Rearrangements	NEURON			English	Article							DENDRITIC ARBOR DEVELOPMENT; NMDA RECEPTOR; VISUAL ACTIVITY; RETINOGENICULATE SYNAPSE; RETINOTECTAL PROJECTION; DEPENDENT REGULATION; PRENATAL DEVELOPMENT; CEREBRAL-CORTEX; NERVOUS-SYSTEM; AXONAL ARBORS	Dendrites, axons, and synapses are dynamic during circuit development; however, changes in microcircuit connections as branches stabilize have not been directly demonstrated. By combining in vivo time-lapse imaging of Xenopus tectal neurons with electron microscope reconstructions of imaged neurons, we report the distribution and ultrastructure of synapses on individual vertebrate neurons and relate these synaptic properties to dynamics in dendritic and axonal arbor structure over hours or days of imaging. Dynamic dendrites have a high density of immature synapses, whereas stable dendrites, have sparser, mature synapses. Axons initiate contacts from multisynapse boutons on stable branches. Connections are refined by decreasing convergence from multiple inputs to postsynaptic dendrites and by decreasing divergence from multisynapse boutons to postsynaptic sites. Visual deprivation or NMDAR antagonists decreased synapse maturation and elimination, suggesting that coactive input activity promotes microcircuit development by concurrently regulating synapse elimination and maturation of remaining contacts.	[Li, Jianli; Cline, Hollis] Scripps Res Inst, La Jolla, CA 92037 USA; [Erisir, Alev] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Scripps Research Institute; University of Virginia	Cline, H (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	cline@scripps.edu	Erisir, Alev/A-5952-2014	Erisir, Alev/0000-0002-7538-7911	NIH [RO1 EY-011261, EY-011261-14S1, DP10D000458, RO1-EY12138]; NATIONAL EYE INSTITUTE [R01EY011261, R01EY012138] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH (RO1 EY-011261, EY-011261-14S1, DP10D000458 [H.C.] and RO1-EY12138 [A.E.]). We thank Dr. Mitya Chklovski for help aligning image stacks, Stephen Hearn of the Cold Spring Harbor Laboratory Electron Microscopy Facility, Dr. Martha Bickford for her helpful insight, and members of the Cline lab for discussions.	Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Bestman JE, 2006, NAT PROTOC, V1, P1267, DOI 10.1038/nprot.2006.186; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bosman LWJ, 2008, J NEUROSCI, V28, P798, DOI 10.1523/JNEUROSCI.4074-07.2008; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; CRAGG BG, 1975, J COMP NEUROL, V160, P147, DOI 10.1002/cne.901600202; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Guic E, 2008, BIOL RES, V41, P425, DOI /S0716-97602008000400008; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirov SA, 1999, J NEUROSCI, V19, P2876; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Lee LJ, 2005, J NEUROSCI, V25, P2304, DOI 10.1523/JNEUROSCI.4902-04.2005; Li JL, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.006.2010; Li JL, 2010, J COMP NEUROL, V518, P2365, DOI 10.1002/cne.22338; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nikolakopoulou AM, 2010, J COMP NEUROL, V518, P972, DOI 10.1002/cne.22258; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Richards BA, 2010, NAT NEUROSCI, V13, P1098, DOI 10.1038/nn.2612; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Ruthazer ES, 2010, TRENDS NEUROSCI, V33, P183, DOI 10.1016/j.tins.2010.01.003; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; RUTHAZER ES, 2004, IMAGING NEUROSCIENCE; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schomberg D., 1993, ENZYME HDB; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Sorensen SA, 2006, J NEUROSCI, V26, P1539, DOI 10.1523/JNEUROSCI.3807-05.2006; SRETAVAN D, 1984, NATURE, V308, P845, DOI 10.1038/308845a0; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang H, 2008, J NEUROSCI, V28, P13621, DOI 10.1523/JNEUROSCI.4785-08.2008; WARTON SS, 1989, SYNAPSE, V3, P136, DOI 10.1002/syn.890030205; WILLIAMS CV, 1991, J NEUROSCI, V11, P445; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; ZECEVIC N, 1989, DEV BRAIN RES, V50, P11, DOI 10.1016/0165-3806(89)90124-7	66	45	45	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					273	286		10.1016/j.neuron.2010.12.022	http://dx.doi.org/10.1016/j.neuron.2010.12.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262466	Bronze, Green Accepted			2022-12-24	WOS:000286792900011
J	Govindarajan, A; Israely, I; Huang, SY; Tonegawa, S				Govindarajan, Arvind; Israely, Inbal; Huang, Shu-Ying; Tonegawa, Susumu			The Dendritic Branch Is the Preferred Integrative Unit for Protein Synthesis-Dependent LTP	NEURON			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL NEURONS; RAT CA1; SYNAPTIC-TRANSMISSION; STRUCTURAL PLASTICITY; REPEATED TETANIZATION; ACTIVE DENDRITES; LATE-PHASE; MEMORY; SPINES	The late-phase of long-term potentiation (L-LTP), the cellular correlate of long-term memory, induced at some synapses facilitates L-LTP expression at other synapses receiving stimulation too weak to induce L-LTP by itself. Using glutamate uncaging and two-photon imaging, we demonstrate that the efficacy of this facilitation decreases with increasing time between stimulations, increasing distance between stimulated spines and with the spines being on different dendritic branches. Paradoxically, stimulated spines compete for L-LTP expression if stimulated too closely together in time. Furthermore, the facilitation is temporally bidirectional but asymmetric. Additionally, L-LTP formation is itself biased toward occurring on spines within a branch. These data support the Clustered Plasticity Hypothesis, which states that such spatial and temporal limits lead to stable engram formation, preferentially at synapses clustered within dendritic branches rather than dispersed throughout the dendritic arbor. Thus, dendritic branches rather than individual synapses are the primary functional units for long-term memory storage.	[Govindarajan, Arvind; Israely, Inbal; Huang, Shu-Ying; Tonegawa, Susumu] MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Biol, Cambridge, MA 02139 USA; [Govindarajan, Arvind; Israely, Inbal; Huang, Shu-Ying; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN MIT Ctr Neural Circuit Genet, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu		Israely, Inbal/0000-0001-7234-6359	RIKEN; HHMI; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER	RIKEN; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Daniel Johnston, Yasunori Hayashi, and members of the S.T. laboratory for comments on earlier versions of the manuscript. This work was supported by RIKEN, HHMI, and the NIH.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Ballarini F, 2009, P NATL ACAD SCI USA, V106, P14599, DOI 10.1073/pnas.0907078106; Barrett AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000259; CHUTKOW JG, 1974, NEUROLOGY, V24, P780, DOI 10.1212/WNL.24.8.780; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey J U, 2001, Results Probl Cell Differ, V34, P27; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Gelinas JN, 2005, J NEUROSCI, V25, P3294, DOI 10.1523/JNEUROSCI.4175-04.2005; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Huang Y Y, 1994, Learn Mem, V1, P74; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; O'Carroll CM, 2004, NEUROPHARMACOLOGY, V47, P324, DOI 10.1016/j.neuropharm.2004.04.005; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sajikumar S, 2008, LEARN MEMORY, V15, P46, DOI 10.1101/lm.816908; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Swanson-Park JL, 1999, NEUROSCIENCE, V92, P485, DOI 10.1016/S0306-4522(99)00010-X; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Williams SR, 2007, NEURON, V56, P947, DOI 10.1016/j.neuron.2007.12.004; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635	53	209	212	2	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 13	2011	69	1					132	146		10.1016/j.neuron.2010.12.008	http://dx.doi.org/10.1016/j.neuron.2010.12.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220104	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000286446300013
J	Browne, LE; Cao, LS; Broomhead, HE; Bragg, L; Wilkinson, WJ; North, RA				Browne, Liam E.; Cao, Lishuang; Broomhead, Helen E.; Bragg, Laricia; Wilkinson, William J.; North, R. Alan			P2X receptor channels show threefold symmetry in ionic charge selectivity and unitary conductance	NATURE NEUROSCIENCE			English	Article							2ND TRANSMEMBRANE DOMAIN; POLAR RESIDUES; PORE; RECTIFICATION	In the closed structure of the P2X cation channel, three alpha-helical transmembrane domains cross the membrane obliquely. In rat P2X2 receptors, these intersect at Thr(339). Replacing Thr(339) by lysine in one, two or three subunits progressively increased chloride permeability and reduced unitary conductance. This implies that the closed-open transition involves a symmetrical separation of the three subunits and that Thr(339) from each subunit contributes symmetrically to the open channel permeation pathway.	[Browne, Liam E.; Cao, Lishuang; Broomhead, Helen E.; Bragg, Laricia; Wilkinson, William J.; North, R. Alan] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Browne, Liam E.; Cao, Lishuang; Broomhead, Helen E.; Bragg, Laricia; Wilkinson, William J.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	North, RA (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	r.a.north@manchester.ac.uk	North, Richard/GQA-6156-2022	Browne, Liam/0000-0002-5693-7703	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Egan TM, 1998, J NEUROSCI, V18, P2350; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Qu W, 2006, J GEN PHYSIOL, V127, P375, DOI 10.1085/jgp.200509378; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P353, DOI 10.1111/j.1469-7793.1998.353bt.x	15	33	34	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					17	18		10.1038/nn.2705	http://dx.doi.org/10.1038/nn.2705			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21170052	Green Accepted			2022-12-24	WOS:000285684900006
J	Robbins, EM; Krupp, AJ; de Arce, KP; Ghosh, AK; Fogel, AI; Boucard, A; Sudhof, TC; Stein, V; Biederer, T				Robbins, Elissa M.; Krupp, Alexander J.; de Arce, Karen Perez; Ghosh, Ananda K.; Fogel, Adam I.; Boucard, Antony; Suedhof, Thomas C.; Stein, Valentin; Biederer, Thomas			SynCAM 1 Adhesion Dynamically Regulates Synapse Number and Impacts Plasticity and Learning	NEURON			English	Article							LONG-TERM DEPRESSION; SPATIAL MEMORY; DENDRITIC SPINES; GENE-EXPRESSION; MICE; NEUROLIGINS; MOLECULES; DISORDERS; BRAIN; NEUROTRANSMITTER	Synaptogenesis is required for wiring neuronal circuits in the developing brain and continues to remodel adult networks. However, the molecules organizing synapse development and maintenance in vivo remain incompletely understood. We now demonstrate that the immunoglobulin adhesion molecule SynCAM 1 dynamically alters synapse number and plasticity. Overexpression of SynCAM 1 in transgenic mice promotes excitatory synapse number, while loss of SynCAM 1 results in fewer excitatory synapses. By turning off SynCAM 1 overexpression in transgenic brains, we show that it maintains the newly induced synapses. SynCAM 1 also functions at mature synapses to alter their plasticity by regulating long-term depression. Consistent with these effects on neuronal connectivity, SynCAM 1 expression affects spatial learning, with knock-out mice learning better. The reciprocal effects of increased SynCAM 1 expression and loss reveal that this adhesion molecule contributes to the regulation of synapse number and plasticity, and impacts how neuronal networks undergo activity-dependent changes.	[Robbins, Elissa M.; de Arce, Karen Perez; Ghosh, Ananda K.; Fogel, Adam I.; Biederer, Thomas] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Krupp, Alexander J.; Stein, Valentin] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Boucard, Antony; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA	Yale University; Max Planck Society; Stanford University	Biederer, T (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.biederer@yale.edu	Boucard, Antony/ABA-9769-2020; Stein, Valentin/A-8025-2008; Boucard, Antony/CAJ-3093-2022; Biederer, Thomas/AAZ-6133-2021	Stein, Valentin/0000-0003-1222-4928; Biederer, Thomas/0000-0003-0912-1514; BOUCARD, Antony Jr/0000-0002-5538-0464; Robbins, Elissa/0000-0003-1737-3228	National Institute of Health [R01 DA018928]; March of Dimes Basil O'Connor Award; Scottish Rite Schizophrenia fellowship; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018928] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Connor Award(March of Dimes); Scottish Rite Schizophrenia fellowship; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Ms Y. Lei, N. Meyer, and A. Gruschka for technical assistance and Drs. S. Chandra, L. Chen, R. Klein, and T. Mrsic-Flogel for discussions and comments on the manuscript. We are grateful to Dr. T. Momoi for generously providing the SynCAM 1/RA175 KO mouse line, Dr. R. Hammer for generating the transgenic line, and Dr. M. Picciotto for support of behavioral studies. We thank M. Graham and Dr. C. Rahner for expert support of our EM studies. E.M.R. performed histochemical and ultrastructural studies, protein expression and interaction analyses, and behavioral experiments, A.J.K. performed electrophysiological analyses, K.P. performed and analyzed ultrastructural studies, A.K.G. performed behavioral studies, A.I.F. quantified protein expression, A.B. initially bred transgenic mice and confirmed expression, T.B. and T.C.S. conceived in collaboration the transgenic approach and T.C.S. supervised A.B., V.S. conceived and supervised the physiological approaches and performed electrophysiological analyses, and T.B. conceived and supervised nonphysiological approaches, performed protein expression and interaction analyses and histochemical studies, and wrote the manuscript. This work was supported by the National Institute of Health Grant R01 DA018928 (to T.B.), a March of Dimes Basil O'Connor Award (to T.B.), and a Scottish Rite Schizophrenia fellowship (to E.M.R).	Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fujita E, 2006, MOL CELL BIOL, V26, P718, DOI 10.1128/MCB.26.2.718-726.2006; GAGE FH, 1989, NEUROBIOL AGING, V10, P347, DOI 10.1016/0197-4580(89)90047-X; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gresack JE, 2004, NEUROSCIENCE, V128, P459, DOI 10.1016/j.neuroscience.2004.06.011; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lyckman AW, 2008, P NATL ACAD SCI USA, V105, P9409, DOI 10.1073/pnas.0710172105; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Stagi M, 2010, P NATL ACAD SCI USA, V107, P7568, DOI 10.1073/pnas.0911798107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Zelano J, 2009, J COMP NEUROL, V517, P670, DOI 10.1002/cne.22186; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	55	108	110	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					894	906		10.1016/j.neuron.2010.11.003	http://dx.doi.org/10.1016/j.neuron.2010.11.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145003	Green Accepted, Bronze			2022-12-24	WOS:000285664900011
J	Yang, XF; Kaeser-Woo, YJ; Pang, ZPP; Xu, W; Sudhof, TC				Yang, Xiaofei; Kaeser-Woo, Yea Jin; Pang, Zhiping P.; Xu, Wei; Suedhof, Thomas C.			Complexin Clamps Asynchronous Release by Blocking a Secondary Ca2+ Sensor via Its Accessory alpha Helix	NEURON			English	Article							SYNAPTIC VESICLE EXOCYTOSIS; SPONTANEOUS NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; SNARE COMPLEXES; DISTINCT DOMAINS; SYNAPTOTAGMIN-I; BINDING; PROTEINS; PHOSPHOLIPIDS; TRANSMISSION	Complexin activates and clamps neurotransmitter release; impairing complexin function decreases synchronous, but increases spontaneous and asynchronous synaptic vesicle exocytosis. Here, we show that complexin-different from the Ca2+ sensor synaptotagmin-1-activates synchronous exocytosis by promoting synaptic vesicle priming, but clamps spontaneous and asynchronous exocytosis similar to synaptotagmin-1-by blocking a secondary Ca2+ sensor. Activation and clamping functions of complexin depend on distinct, autonomously acting sequences, namely its N-terminal region and accessory alpha helix, respectively. Mutations designed to test whether the accessory alpha helix of connplexin clamps exocytosis by inserting into SNARE-complexes support this hypothesis, suggesting that the accessory alpha helix blocks completion of trans-SNARE-complex assembly until Ca2+ binding to synaptotagmin relieves this block. Moreover, a juxtamembranous mutation in the SNARE-protein synaptobrevin-2, which presumably impairs force transfer from nascent trans-SNARE complexes onto fusing membranes, also unclamps spontaneous fusion by disinhibiting a secondary Ca2+ sensor. Thus, complexin performs mechanistically distinct activation and clamping functions that operate in conjunction with synaptotagmin-1 by controlling trans-SNARE-complex assembly.	[Yang, Xiaofei; Kaeser-Woo, Yea Jin; Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	tcs1@stanford.edu	Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chicka MC, 2009, BIOCHEMISTRY-US, V48, P657, DOI 10.1021/bi801962d; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2008, J BIOL CHEM, V283, P21211, DOI 10.1074/jbc.M803478200; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Lu B, 2010, J MOL BIOL, V396, P602, DOI 10.1016/j.jmb.2009.12.020; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pan B, 2009, NEURON, V62, P539, DOI 10.1016/j.neuron.2009.03.025; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; PERIN MS, 1991, J BIOL CHEM, V266, P623; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Seiler F, 2009, FEBS LETT, V583, P2343, DOI 10.1016/j.febslet.2009.06.025; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Strenzke N, 2009, J NEUROSCI, V29, P7991, DOI 10.1523/JNEUROSCI.0632-09.2009; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tokumaru H, 2008, BRAIN CELL BIOL, V36, P173, DOI 10.1007/s11068-008-9032-9; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Xue MS, 2010, NAT STRUCT MOL BIOL, V17, P568, DOI 10.1038/nsmb.1791; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446	49	109	111	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 9	2010	68	5					907	920		10.1016/j.neuron.2010.11.001	http://dx.doi.org/10.1016/j.neuron.2010.11.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145004	Green Accepted, Bronze			2022-12-24	WOS:000285664900012
J	Charrier, C; Machado, P; Tweedie-Cullen, RY; Rutishauser, D; Mansuy, IM; Triller, A				Charrier, Cecile; Machado, Patricia; Tweedie-Cullen, Ry Y.; Rutishauser, Dorothea; Mansuy, Isabelle M.; Triller, Antoine			A crosstalk between beta 1 and beta 3 integrins controls glycine receptor and gephyrin trafficking at synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SINGLE-PARTICLE TRACKING; FACIAL MOTOR NUCLEUS; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; INHIBITORY SYNAPSES; NEURITE OUTGROWTH; LATERAL DIFFUSION; PLASMA-MEMBRANE; PHOSPHORYLATION	The regulation of glycine receptor (GlyR) number at synapses is necessary for the efficacy of inhibition and the control of neuronal excitability in the spinal cord. GlyR accumulation at synapses depends on the scaffolding molecule gephyrin and is linked to GlyR synaptic dwell time. However, the mechanisms that tune GlyR synaptic exchanges in response to different neuronal environments are unknown. Integrins are cell adhesion molecules and signaling receptors. Using single quantum dot imaging and fluorescence recovery after photobleaching, we found in rats that beta 1 and beta 3 integrins adjust synaptic strength by regulating the synaptic dwell time of both GlyRs and gephyrin. beta 1 and beta 3 integrins crosstalked via calcium/calmodulin-dependent protein kinase II and adapted GlyR lateral diffusion and gephyrin-dependent trapping at synapses. This provides a mechanism for maintaining or adjusting the steady state of postsynaptic molecule exchanges and the level of glycinergic inhibition in response to neuron-and glia-derived signals or extracellular matrix remodeling.	[Charrier, Cecile; Machado, Patricia; Triller, Antoine] Ecole Normale Super, CNRS, UMR8197, Inserm U1024,IBENS, Paris, France; [Tweedie-Cullen, Ry Y.; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Swiss Fed Inst Technol, Zurich, Switzerland; [Rutishauser, Dorothea] Univ Zurich, Swiss Fed Inst Technol, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Triller, A (corresponding author), Ecole Normale Super, CNRS, UMR8197, Inserm U1024,IBENS, Paris, France.	triller@biologie.ens.fr	Mansuy, Isabelle M/N-3042-2015	Mansuy, Isabelle M/0000-0001-7785-5371; TRILLER, Antoine/0000-0002-7530-1233; Charrier, Cecile/0000-0002-9053-1715; Rutishauser, Dorothea/0000-0003-2303-103X	INSERM; Agence Nationale de la Recherche [ANR08BLAN0282]; Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle epiniere et l'Encephale; Ministere de la Recherche et de la Technologie; Association Francaise contre les Myopathies	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Pierre-Gilles de Gennes; Institut pour la Recherche sur la Moelle epiniere et l'Encephale; Ministere de la Recherche et de la Technologie; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	We thank members of the Triller laboratory, S. Supplisson, K. Aubrey, L. Wang and O. Pascual for kindly providing access to their patch-clamp rig and for helpful discussions, Y. Goda and L. Cingolani for integrin constructs and C. Specht, B. Barbour and R. Miles for critical reading of the manuscript. This work was supported by INSERM (A. T.), Agence Nationale de la Recherche (ANR08BLAN0282; A. T.), Fondation Pierre-Gilles de Gennes (A. T.), Institut pour la Recherche sur la Moelle epiniere et l'Encephale (A. T.), Ministere de la Recherche et de la Technologie (C. C. and P. M.) and Association Francaise contre les Myopathies (C.C.).	Bedet C, 2006, J BIOL CHEM, V281, P30046, DOI 10.1074/jbc.M602155200; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; Chan CS, 2006, J NEUROSCI, V26, P223, DOI 10.1523/JNEUROSCI.4110-05.2006; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Hanus C, 2004, J NEUROSCI, V24, P1119, DOI 10.1523/JNEUROSCI.4380-03.2004; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; Kramar EA, 2006, P NATL ACAD SCI USA, V103, P5579, DOI 10.1073/pnas.0601354103; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Levi S, 1998, J CELL SCI, V111, P335; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; Meier J, 2000, J CELL SCI, V113, P2783; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Moller JC, 1996, GLIA, V17, P121; Paarmann I, 2006, J BIOL CHEM, V281, P34918, DOI 10.1074/jbc.M607764200; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; STAUBLI U, 1990, BEHAV NEURAL BIOL, V53, P1, DOI 10.1016/0163-1047(90)90712-F; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	50	72	73	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1388	U182		10.1038/nn.2645	http://dx.doi.org/10.1038/nn.2645			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935643	Green Submitted			2022-12-24	WOS:000283658200020
J	Elliott, E; Ezra-Nevo, G; Regev, L; Neufeld-Cohen, A; Chen, A				Elliott, Evan; Ezra-Nevo, Gili; Regev, Limor; Neufeld-Cohen, Adi; Chen, Alon			Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice	NATURE NEUROSCIENCE			English	Article							BRAIN; CORTICOTROPIN; ADAPTATION	DNA methylation regulates gene transcription and has been suggested to encode psychopathologies derived from early life stress. We found that methylation regulated the expression of the Crf (also known as Crh) gene and that chronic social stress in adult mice induced long-term demethylation of this genomic region. Demethylation was observed only in the subset of defeated mice that displayed social avoidance and site-specific knockdown of Crf attenuated the stress-induced social avoidance.	[Elliott, Evan; Ezra-Nevo, Gili; Regev, Limor; Neufeld-Cohen, Adi; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Chen, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	alon.chen@weizmann.ac.il		Chen, Alon/0000-0003-3625-8233; Ezra-Nevo, Gili/0000-0002-7617-6139; Elliott, Evan/0000-0002-1630-969X	Pratt Foundation; Israel Science Foundation; Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer's Research Fund; Gerhard and Hannah Bacharach	Pratt Foundation; Israel Science Foundation(Israel Science Foundation); Nella and Leon Benoziyo Center for Neurosciences; Nella and Leon Benoziyo Center for Neurological Diseases; Carl and Micaela Einhorn-Dominic Brain Research Institute; Irwin Green Alzheimer's Research Fund; Gerhard and Hannah Bacharach	This work was supported by Roberto and Renata Ruhman, Mark Besen and the Pratt Foundation, the Israel Science Foundation, the Legacy Heritage Biomedical Science program of the Israel Science Foundation, the Nella and Leon Benoziyo Center for Neurosciences, the Nella and Leon Benoziyo Center for Neurological Diseases, the Carl and Micaela Einhorn-Dominic Brain Research Institute, the Irwin Green Alzheimer's Research Fund, and Gerhard and Hannah Bacharach. A. C. is incumbent of the Philip Harris and Gerald Ronson Career Development Chair.	Aguilera G, 2007, STRESS, V10, P153, DOI 10.1080/10253890701391192; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; PAXINOS F, 2001, MOUSE BRAIN STEREOTA; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	15	315	322	2	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1351	1353		10.1038/nn.2642	http://dx.doi.org/10.1038/nn.2642			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890295				2022-12-24	WOS:000283658200014
J	Weber, AM; Wong, FK; Tufford, AR; Schlichter, LC; Matveev, V; Stanley, EF				Weber, Alexander M.; Wong, Fiona K.; Tufford, Adele R.; Schlichter, Lyanne C.; Matveev, Victor; Stanley, Elise F.			N-type Ca2+ channels carry the largest current: implications for nanodomains and transmitter release	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; ACTIVE ZONE; NEURONS; SYNAPSE; VESICLE	Presynaptic terminals favor intermediate-conductance Ca(V)2.2 (N type) over high-conductance Ca(V)1 (L type) channels for single-channel, Ca2+ nanodomain-triggered synaptic vesicle fusion. However, the standard Ca(V)1>Ca(V)2>Ca(V)3 conductance hierarchy is based on recordings using nonphysiological divalent ion concentrations. We found that, with physiological Ca2+ gradients, the hierarchy was Ca(V)2.2>Ca(V)1>Ca(V)3. Mathematical modeling predicts that the Ca(V)2.2 Ca2+ nanodomain, which is similar to 25% more extensive than that generated by Ca(V)1, can activate a calcium-fusion sensor located on the proximal face of the synaptic vesicle.	[Weber, Alexander M.; Wong, Fiona K.; Tufford, Adele R.; Stanley, Elise F.] Toronto Western Res Inst, Lab Synapt Transmiss, Toronto, ON, Canada; [Weber, Alexander M.; Wong, Fiona K.; Tufford, Adele R.; Schlichter, Lyanne C.; Stanley, Elise F.] Toronto Western Res Inst, Genes & Dev Div, Toronto, ON, Canada; [Matveev, Victor] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; New Jersey Institute of Technology	Stanley, EF (corresponding author), Toronto Western Res Inst, Lab Synapt Transmiss, Toronto, ON, Canada.	estanley@uhnres.utoronto.ca		Weber, Alexander/0000-0001-7295-0775; Matveev, Victor/0000-0002-9867-5190; Tufford, Adele/0000-0002-3631-2562	Canadian Institutes for Health Research [MOP-86643, MT-13657]; Canada Research Chair; Ontario Graduate Scholarship; National Science Foundation [DMS-0817703]; Division Of Mathematical Sciences [0817703] Funding Source: National Science Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank G. Zamponi, P. Backx, S. Ikeda and A. Chan for critique of the manuscript, and Q. Li and X. P. Zhu for technical assistance. This work was supported primarily by Canadian Institutes for Health Research (MOP-86643) and a Canada Research Chair (E. F. S.). We also received funding from the Canadian Institutes for Health Research (MT-13657, L. C. S.), Ontario Graduate Scholarship (F. K. W.) and National Science Foundation (DMS-0817703, V.M.).	Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; Gentile L, 2005, EUR J NEUROSCI, V21, P278, DOI 10.1111/j.1460-9568.2004.03841.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; Shahrezaei V, 2005, J NEUROPHYSIOL, V94, P1912, DOI 10.1152/jn.00256.2005; Shahrezaei V, 2006, J NEUROSCI, V26, P13240, DOI 10.1523/JNEUROSCI.1418-06.2006; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; Wachman ES, 2004, J NEUROSCI, V24, P2877, DOI 10.1523/JNEUROSCI.1660-03.2004	15	72	73	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1348	1350		10.1038/nn.2657	http://dx.doi.org/10.1038/nn.2657			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953196				2022-12-24	WOS:000283658200013
J	Ray, S; Maunsell, JHR				Ray, Supratim; Maunsell, John H. R.			Differences in Gamma Frequencies across Visual Cortex Restrict Their Possible Use in Computation	NEURON			English	Article							STRIATE CORTICAL ACTIVITY; NEURONAL SYNCHRONY; OSCILLATION FREQUENCY; TEMPORAL STRUCTURE; FIELD POTENTIALS; ALERT MACAQUE; EXCITATION; DYNAMICS; INHIBITION; MODULATION	Neuronal oscillations in the gamma band (30-80 Hz) have been suggested to play a central role in feature binding or establishing channels for neural communication. For these functions, the gamma rhythm frequency must be consistent across neural assemblies encoding the features of a stimulus. Here we test the dependence of gamma frequency on stimulus contrast in V1 cortex of awake behaving macaques and show that gamma frequency increases monotonically with contrast. Changes in stimulus contrast over time leads to a reliable gamma frequency modulation on a fast timescale. Further, large stimuli whose contrast varies across space generate gamma rhythms at significantly different frequencies in simultaneously recorded neuronal assemblies separated by as little as 400 mu m, making the gamma rhythm a poor candidate for binding or communication, at least in V1. Instead, our results suggest that the gamma rhythm arises from local interactions between excitation and inhibition.	[Ray, Supratim; Maunsell, John H. R.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Ray, Supratim; Maunsell, John H. R.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Ray, S (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	supratim_ray@hms.harvard.edu	Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439; Ray, Supratim/0000-0002-1968-1382	HHMI; NIH [R01EY005911]; NATIONAL EYE INSTITUTE [R01EY005911] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Drs. Marlene Cohen, Nathan Crone, Kaushik Ghose, Mark Histed, and Ernst Niebur for helpful comments on an earlier version of the manuscript and Vivian Imamura for technical support. This work was supported by HHMI and NIH grant R01EY005911.	Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berens P., 2009, 184 MPI; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Burns SP, 2010, J NEUROSCI, V30, P4033, DOI 10.1523/JNEUROSCI.5319-09.2010; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Dong Y, 2008, J VISION, V8, DOI 10.1167/8.7.30; Friedberg F, 2009, J BEHAV MED, V32, P209, DOI 10.1007/s10865-008-9189-9; Friedman-Hill S, 2000, CEREB CORTEX, V10, P1105, DOI 10.1093/cercor/10.11.1105; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gieselmann MA, 2008, EUR J NEUROSCI, V28, P447, DOI 10.1111/j.1460-9568.2008.06358.x; Gray CM, 1997, J NEUROSCI, V17, P3239; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Ito I, 2009, NEURON, V64, P692, DOI 10.1016/j.neuron.2009.10.004; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kang K, 2010, J COMPUT NEUROSCI, V29, P495, DOI 10.1007/s10827-009-0190-2; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; Maldonado PE, 2000, CEREB CORTEX, V10, P1117, DOI 10.1093/cercor/10.11.1117; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Palanca BJA, 2005, NEURON, V46, P333, DOI 10.1016/j.neuron.2005.03.002; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Shu YS, 2003, J NEUROSCI, V23, P10388; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; UHLHAAS PJ, 2009, NEUROSCIENCE, V3, P17; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009	49	292	294	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					885	896		10.1016/j.neuron.2010.08.004	http://dx.doi.org/10.1016/j.neuron.2010.08.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826318	Green Accepted, Bronze			2022-12-24	WOS:000281938900021
J	Richards, BA; Voss, OP; Akerman, CJ				Richards, Blake A.; Voss, Oliver P.; Akerman, Colin J.			GABAergic circuits control stimulus-instructed receptive field development in the optic tectum	NATURE NEUROSCIENCE			English	Article							DEVELOPING RETINOTECTAL SYNAPSES; EXPERIENCE-DEPENDENT PLASTICITY; CORRELATED NEURONAL-ACTIVITY; VISUAL-CORTEX; FEEDFORWARD INHIBITION; GLUTAMATERGIC SYNAPSES; HYPOTHALAMIC NEURONS; SYNAPTIC PLASTICITY; EXCITATORY ACTIONS; ORIENTATION MAPS	During the development of sensory systems, receptive fields are modified by stimuli in the environment. This is thought to rely on learning algorithms that are sensitive to correlations in spike timing between cells, but the manner in which developing circuits selectively exploit correlations that are related to sensory inputs is unknown. We recorded from neurons in the developing optic tectum of Xenopus laevis and found that repeated presentation of moving visual stimuli induced receptive field changes that reflected the properties of the stimuli and that this form of learning was disrupted when GABAergic transmission was blocked. Consistent with a role for spike timing-dependent mechanisms, GABA blockade altered spike-timing patterns in the tectum and increased correlations between cells that would affect plasticity at intratectal synapses. This is a previously unknown role for GABAergic signals in development and highlights the importance of regulating the statistics of spiking activity for learning.	[Richards, Blake A.; Voss, Oliver P.; Akerman, Colin J.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Akerman, CJ (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	colin.akerman@pharm.ox.ac.uk		Richards, Blake/0000-0001-9662-2151	Biotechnology and Biological Sciences Research Council [BB/E0154761]; Medical Research Council [G0601503]; European Research Council under the European Community [243273]; Research Councils UK; British Pharmacological Society; Wellcome Trust; Natural Sciences and Engineering Research Council of Canada; Biotechnology and Biological Sciences Research Council [BB/E015476/1] Funding Source: researchfish; BBSRC [BB/E015476/1] Funding Source: UKRI; MRC [G0601503] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council under the European Community(European Research Council (ERC)); Research Councils UK(UK Research & Innovation (UKRI)); British Pharmacological Society; Wellcome Trust(Wellcome Trust); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank H. Cline, K. Lamsa and O. Paulsen for helpful discussions and for comments on the manuscript. This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/E0154761) and the Medical Research Council (G0601503). The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement number 243273. In addition, C.J.A. was supported by a Fellowship from the Research Councils UK and British Pharmacological Society, and B.A.R. was supported by a Wellcome Trust Doctoral Fellowship and a Post Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.	Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; DAYAN P, 2003, THEORETICAL NEUROSCI, P3; Dunning DD, 1999, J NEUROPHYSIOL, V82, P3286, DOI 10.1152/jn.1999.82.6.3286; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gao XB, 2001, J NEUROPHYSIOL, V85, P425, DOI 10.1152/jn.2001.85.1.425; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hollrigel GS, 1997, J NEUROSCI, V17, P5119; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Liu Y, 2007, J NEUROSCI, V27, P5301, DOI 10.1523/JNEUROSCI.0376-07.2007; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; MUELLER AL, 1984, J NEUROSCI, V4, P860; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Pavlov I, 2004, EUR J NEUROSCI, V20, P3019, DOI 10.1111/j.1460-9568.2004.03806.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pratt KG, 2008, NAT NEUROSCI, V11, P467, DOI 10.1038/nn2076; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Shon AP, 2004, NETWORK-COMP NEURAL, V15, P179, DOI 10.1088/0954-898X/15/3/002; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; STRYKER MP, 1989, PROBLEMS CONCEPTS DE, P110; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Tyzio R, 1999, J NEUROSCI, V19, P10372; Ulrich D, 2003, EUR J NEUROSCI, V18, P2159, DOI 10.1046/j.1460-9568.2003.02942.x; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; Wenisch OG, 2005, BIOL CYBERN, V93, P239, DOI 10.1007/s00422-005-0006-z; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	50	20	20	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1098	U95		10.1038/nn.2612	http://dx.doi.org/10.1038/nn.2612			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694002	Green Submitted, Green Accepted			2022-12-24	WOS:000281332600015
J	Israelson, A; Arbel, N; Da Cruz, S; Ilieva, H; Yamanaka, K; Shoshan-Barmatz, V; Cleveland, DW				Israelson, Adrian; Arbel, Nir; Da Cruz, Sandrine; Ilieva, Hristelina; Yamanaka, Koji; Shoshan-Barmatz, Varda; Cleveland, Don W.			Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; INNER MITOCHONDRIAL-MEMBRANE; RESPIRATORY-CHAIN FUNCTION; MOTOR-NEURON DISEASE; SUPEROXIDE-DISMUTASE; CYTOCHROME-C; REGULATORY MECHANISM; SKELETAL-MUSCLE	Mutations in superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by loss of motor neurons. With conformation-specific antibodies, we now demonstrate that misfolded mutant SOD1 binds directly to the voltage-dependent anion channel (VDAC1), an integral membrane protein imbedded in the outer mitochondrial membrane. This interaction is found on isolated spinal cord mitochondria and can be reconstituted with purified components in vitro. ADP passage through the outer membrane is diminished in spinal mitochondria from mutant SOD1-expressing ALS rats. Direct binding of mutant SOD1 to VDAC1 inhibits conductance of individual channels when reconstituted in a lipid bilayer. Reduction of VDAC1 activity with targeted gene disruption is shown to diminish survival by accelerating onset of fatal paralysis in mice expressing the ALS-causing mutation SOD1(G37R). Taken together, our results establish a direct link between misfolded mutant SOD1 and mitochondrial dysfunction in this form of inherited ALS.	[Israelson, Adrian; Da Cruz, Sandrine; Ilieva, Hristelina; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Israelson, Adrian; Da Cruz, Sandrine; Ilieva, Hristelina; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Israelson, Adrian; Da Cruz, Sandrine; Ilieva, Hristelina; Cleveland, Don W.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Arbel, Nir; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Arbel, Nir; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Ben Gurion University; Ben Gurion University; RIKEN	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Yamanaka, Koji/ABD-1034-2020; Israelson, Adrian/AAL-2339-2021; Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Cleveland, Don/0000-0002-1934-3682; Israelson, Adrian/0000-0002-8289-7653	NIH [R37 NS27036]; EMBO; IsrALS; Institute for Cancer Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); IsrALS; Institute for Cancer Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Neil Cashman (University of British Columbia) and Amor-fix Life Sciences (Vancouver) for generously providing us with DSE2 antibodies, William Craigen (Baylor College of Medicine) for VDAC1 knockout mice, and Larry Hayward (UMass Medical School) for wild type and mutant SOD1 baculovirus stock. This work has been supported by a grant from the NIH (R37 NS27036). A.I. has been supported by EMBO Long-Term Fellowship and by a postdoctoral fellowship from IsrALS. D.W.C. receives salary support from the Ludwig Institute for Cancer Research.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bailey AO, 2007, ANAL CHEM, V79, P6410, DOI 10.1021/ac070585g; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Bergemalm D, 2006, J NEUROSCI, V26, P4147, DOI 10.1523/JNEUROSCI.5461-05.2006; Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cashman NR, 2004, NAT REV DRUG DISCOV, V3, P874, DOI 10.1038/nrd1525; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Echaniz-Laguna A, 2002, ANN NEUROL, V52, P623, DOI 10.1002/ana.10357; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Higgins CMJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-16; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Israelson A, 2005, CHEM BIOL, V12, P1169, DOI 10.1016/j.chembiol.2005.08.006; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Jung CW, 2002, J NEUROCHEM, V83, P535, DOI 10.1046/j.1471-4159.2002.01112.x; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Kong JM, 1998, J NEUROSCI, V18, P3241; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nguyen KT, 2009, P NATL ACAD SCI USA, V106, P2007, DOI 10.1073/pnas.0810934106; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Pedrini S, 2010, HUM MOL GENET, V19, P2974, DOI 10.1093/hmg/ddq202; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Roy SS, 2009, MOL CELL, V33, P377, DOI 10.1016/j.molcel.2009.01.018; Sasaki S, 1996, ACTA NEUROPATHOL, V91, P278, DOI 10.1007/s004010050426; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Velde CV, 2008, P NATL ACAD SCI USA, V105, P4022, DOI 10.1073/pnas.0712209105; Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yamamoto T, 2006, J PROTEOME RES, V5, P3336, DOI 10.1021/pr060291w; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zamzami N, 2003, CURR BIOL, V13, pR71, DOI 10.1016/S0960-9822(02)01433-1; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	86	222	233	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					575	587		10.1016/j.neuron.2010.07.019	http://dx.doi.org/10.1016/j.neuron.2010.07.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797535	Bronze, Green Accepted			2022-12-24	WOS:000281534600008
J	Nelson, BS; Takahashi, TT				Nelson, Brian S.; Takahashi, Terry T.			Spatial Hearing in Echoic Environments: The Role of the Envelope in Owls	NEURON			English	Article							MULTIPLE SOUND SOURCES; BARN OWLS; INFERIOR COLLICULUS; SIMULATED ECHOES; LOCALIZATION; NEURONS; RESPONSES; TIME; LATERALIZATION; REPRESENTATION	In the precedence effect, sounds emanating directly from the source are localized preferentially over their reflections. Although most studies have focused on the delay between the onset of a sound and its echo, humans still experience the precedence effect when this onset delay is removed. We tested in barn owls the hypothesis that an ongoing delay, equivalent to the onset delay, is discernible from the envelope features of amplitude-modulated stimuli and may be sufficient to evoke this effect. With sound pairs having only envelope cues, owls localized direct sounds preferentially, and neurons in their auditory space-maps discharged more vigorously to them, but only if the sounds were amplitude modulated. Under conditions that yielded the precedence effect, acoustical features known to evoke neuronal discharges were more abundant in the envelopes of the direct sounds than of the echoes, suggesting that specialized neural mechanisms for echo suppression were unnecessary.	[Nelson, Brian S.; Takahashi, Terry T.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Nelson, BS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	bsnelson@uoregon.edu			National Institutes of Deafness and Communication Disorders [(F32) DC008267, (RO1) DC003925]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003925, F32DC008267] Funding Source: NIH RePORTER	National Institutes of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Drs. C.H. Keller and E.A. Whitchurch for technical support and helpful discussions. This study was supported by grants from the National Institutes of Deafness and Communication Disorders: (F32) DC008267 to B.S.N and (RO1) DC003925.	ALBECK Y, 1995, J NEUROPHYSIOL, V74, P1689, DOI 10.1152/jn.1995.74.4.1689; Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bala ADS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000675; Blauert J., 1997, SPATIAL HEARING PSYC; Burger RM, 2001, J NEUROSCI, V21, P4830, DOI 10.1523/JNEUROSCI.21-13-04830.2001; Dent ML, 2002, J COMP PHYSIOL A, V187, P937, DOI 10.1007/s00359-001-0259-5; Devore S, 2009, NEURON, V62, P123, DOI 10.1016/j.neuron.2009.02.018; Dizon RM, 2006, J ACOUST SOC AM, V119, P2947, DOI 10.1121/1.2189451; Euston DR, 2002, J NEUROSCI, V22, P284, DOI 10.1523/JNEUROSCI.22-01-00284.2002; Fitzpatrick DC, 1995, J NEUROPHYSIOL, V74, P2469, DOI 10.1152/jn.1995.74.6.2469; HAAS H, 1951, ACUSTICA, V1, P49; Hartung K, 2001, J ACOUST SOC AM, V110, P1505, DOI 10.1121/1.1390339; Joris PX, 2006, HEARING RES, V216, P19, DOI 10.1016/j.heares.2006.03.010; Keller CH, 1996, J NEUROSCI, V16, P4300; Keller CH, 1996, J COMP PHYSIOL A, V178, P499; Keller CH, 2000, J NEUROPHYSIOL, V84, P2638, DOI 10.1152/jn.2000.84.5.2638; Keller CH, 2005, J NEUROSCI, V25, P10446, DOI 10.1523/JNEUROSCI.2093-05.2005; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; KNUDSEN EI, 1978, SCIENCE, V202, P778, DOI 10.1126/science.715444; LINDEMANN W, 1986, J ACOUST SOC AM, V80, P1608, DOI 10.1121/1.394325; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; Litovsky RY, 1998, J NEUROPHYSIOL, V80, P1302, DOI 10.1152/jn.1998.80.3.1302; MEDDIS R, 1990, J ACOUST SOC AM, V87, P1813, DOI 10.1121/1.399379; MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; Nelson BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003598; Pecka M, 2007, J NEUROSCI, V27, P1782, DOI 10.1523/JNEUROSCI.5335-06.2007; RAKERD B, 1985, J ACOUST SOC AM, V78, P524, DOI 10.1121/1.392474; Siveke I, 2008, J NEUROSCI, V28, P2043, DOI 10.1523/JNEUROSCI.4488-07.2008; SNOW WB, 1954, J ACOUST SOC AM, V26, P1071, DOI 10.1121/1.1907451; Spezio ML, 2003, J NEUROSCI, V23, P4677; Spitzer MW, 2006, J NEUROPHYSIOL, V95, P3571, DOI 10.1152/jn.00982.2005; Spitzer MW, 2004, J NEUROPHYSIOL, V92, P2051, DOI 10.1152/jn.01235.2003; Spitzer MW, 2003, J ACOUST SOC AM, V113, P1631, DOI 10.1121/1.1548152; TAKAHASHI TT, 1994, J NEUROSCI, V14, P4780; Tollin DJ., 1998, P NATO ADV STUD I CO, P77; Trahiotis C, 2002, HEARING RES, V168, P55, DOI 10.1016/S0378-5955(02)00357-X; WAGNER H, 1992, J COMP PHYSIOL A, V170, P3; WAGNER H, 1991, J COMP PHYSIOL A, V169, P281; WAGNER H, 1993, J NEUROSCI, V13, P371; WALLACH H, 1949, AM J PSYCHOL, V62, P315, DOI 10.2307/1418275; Whitchurch EA, 2006, J NEUROPHYSIOL, V96, P730, DOI 10.1152/jn.00072.2006; YIN TCT, 1987, J NEUROPHYSIOL, V58, P562, DOI 10.1152/jn.1987.58.3.562; YIN TCT, 1994, J NEUROSCI, V14, P5170; ZUREK PM, 1980, J ACOUST SOC AM, V67, P952, DOI 10.1121/1.383974	44	29	29	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					643	655		10.1016/j.neuron.2010.07.014	http://dx.doi.org/10.1016/j.neuron.2010.07.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797540	Bronze, Green Accepted			2022-12-24	WOS:000281534600013
J	Dahmen, JC; Keating, P; Nodal, FR; Schulz, AL; King, AJ				Dahmen, Johannes C.; Keating, Peter; Nodal, Fernando R.; Schulz, Andreas L.; King, Andrew J.			Adaptation to Stimulus Statistics in the Perception and Neural Representation of Auditory Space	NEURON			English	Article							INTERAURAL TIME DIFFERENCES; CATS SUPERIOR COLLICULUS; SOUND LEVEL STATISTICS; WHITE-NOISE ANALYSIS; INFERIOR COLLICULUS; INFORMATION-TRANSMISSION; SOMATOSENSORY CORTEX; CONTRAST ADAPTATION; TEMPORAL CONTRAST; RECEPTIVE-FIELDS	Sensory systems are known to adapt their coding strategies to the statistics of their environment, but little is still known about the perceptual implications of such adjustments. We investigated how auditory spatial processing adapts to stimulus statistics by presenting human listeners and anesthetized ferrets with noise sequences in which interaural level differences (ILD) rapidly fluctuated according to a Gaussian distribution. The mean of the distribution biased the perceived laterality of a subsequent stimulus, whereas the distribution's variance changed the listeners' spatial sensitivity. The responses of neurons in the inferior colliculus changed in line with these perceptual phenomena. Their ILD preference adjusted to match the stimulus distribution mean, resulting in large shifts in rate-ILD functions, while their gain adapted to the stimulus variance, producing pronounced changes in neural sensitivity. Our findings suggest that processing of auditory space is geared toward emphasizing relative spatial differences rather than the accurate representation of absolute position.	[Dahmen, Johannes C.; Keating, Peter; Nodal, Fernando R.; Schulz, Andreas L.; King, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Dahmen, JC (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	johannes.dahmen@dpag.ox.ac.uk; andrew.king@dpag.ox.ac.uk	Nodal, Fernando/U-5700-2019; King, Andrew J/M-6708-2013	Nodal, Fernando/0000-0002-1039-6032; King, Andrew J/0000-0001-5180-7179; Dahmen, Johannes/0000-0001-9889-8303	Wellcome Trust [WT076508AIA]; 4 year studentship; Newton-Abraham Studentship	Wellcome Trust(Wellcome TrustEuropean Commission); 4 year studentship; Newton-Abraham Studentship	This work was supported by the Wellcome Trust through a Principal Research Fellowship to A.J.K. (WT076508AIA) and a 4 year studentship to J.C.D., and by a Newton-Abraham Studentship to P.K. We are grateful to Ben Willmore for comments on the manuscript.	Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BINNS KE, 1992, BRAIN RES, V589, P231, DOI 10.1016/0006-8993(92)91282-J; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Bonin V, 2006, J NEUROSCI, V26, P6346, DOI 10.1523/JNEUROSCI.0284-06.2006; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Carlile S, 2001, J ACOUST SOC AM, V110, P416, DOI 10.1121/1.1375843; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Dahmen Johannes C, 2008, J Neurosci, V28, P13629, DOI 10.1523/JNEUROSCI.4429-08.2008; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dean I, 2008, J NEUROSCI, V28, P6430, DOI 10.1523/JNEUROSCI.0470-08.2008; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Dunn FA, 2006, CURR OPIN NEUROBIOL, V16, P363, DOI 10.1016/j.conb.2006.06.013; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Furukawa S, 2005, J NEUROPHYSIOL, V93, P3313, DOI 10.1152/jn.01219.2004; Garcia-Lazaro JA, 2007, EUR J NEUROSCI, V26, P2359, DOI 10.1111/j.1460-9568.2007.05847.x; Getzmann S, 2004, HEARING RES, V191, P14, DOI 10.1016/j.heares.2003.12.020; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; Kashino M, 1998, J ACOUST SOC AM, V103, P3597, DOI 10.1121/1.423064; KASHINO M, 1998, PSYCHOL PHYSL ADV HE, P322; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; KNUDSEN EI, 1983, SCIENCE, V222, P939, DOI 10.1126/science.6635667; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Magnusson AK, 2008, NEURON, V59, P125, DOI 10.1016/j.neuron.2008.05.011; MAIER JK, 2009, JARO-J ASSOC RES OTO, V11, P319, DOI DOI 10.1007/S10162-009-0200-200; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Nakamoto KT, 2008, J NEUROPHYSIOL, V99, P2347, DOI 10.1152/jn.01326.2007; Park TJ, 2008, HEARING RES, V238, P58, DOI 10.1016/j.heares.2007.10.009; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; PETTIGREW JD, 1973, SCIENCE, V182, P599, DOI 10.1126/science.182.4112.597; Phillips DP, 2005, HEARING RES, V202, P188, DOI 10.1016/j.heares.2004.11.001; Sach AJ, 2000, J EXP PSYCHOL HUMAN, V26, P717, DOI 10.1037/0096-1523.26.2.717; SAKITT B, 1973, NATURE, V241, P133, DOI 10.1038/241133a0; Schnupp JWH, 1997, J NEUROPHYSIOL, V78, P2717, DOI 10.1152/jn.1997.78.5.2717; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Tollin DJ, 2008, J NEUROSCI, V28, P4848, DOI 10.1523/JNEUROSCI.5421-07.2008; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Watkins PV, 2008, NAT NEUROSCI, V11, P1259, DOI 10.1038/nn.2201; Wen B, 2009, J NEUROSCI, V29, P13797, DOI 10.1523/JNEUROSCI.5610-08.2009; YIN TCT, 1985, J NEUROPHYSIOL, V53, P746, DOI 10.1152/jn.1985.53.3.746; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	61	116	116	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 24	2010	66	6					937	948		10.1016/j.neuron.2010.05.018	http://dx.doi.org/10.1016/j.neuron.2010.05.018			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620878	Green Published, hybrid			2022-12-24	WOS:000279420800015
J	Lee, MC; Yasuda, R; Ehlers, MD				Lee, Ming-Chia; Yasuda, Ryohei; Ehlers, Michael D.			Metaplasticity at Single Glutamatergic Synapses	NEURON			English	Article							LONG-TERM POTENTIATION; RECEPTOR SUBUNIT COMPOSITION; NR2B-CONTAINING NMDA RECEPTORS; BIDIRECTIONAL SYNAPTIC PLASTICITY; VISUAL-CORTEX; DENDRITIC SPINES; DEVELOPMENTAL REGULATION; POSTNATAL-DEVELOPMENT; HIPPOCAMPAL-NEURONS; DIFFERENTIAL ROLES	Optimal function of neuronal networks requires interplay between rapid forms of Hebbian plasticity and homeostatic mechanisms that adjust the threshold for plasticity, termed metaplasticity. Numerous forms of rapid synapse plasticity have been examined in detail. However, the rules that govern synaptic metaplasticity are much less clear. Here, we demonstrate a local subunit-specific switch in NMDA receptors that alternately primes or prevents potentiation at single synapses. Prolonged suppression of neurotransmitter release enhances NMDA receptor currents, increases the number of functional NMDA receptors containing NR2B, and augments calcium transients at single dendritic spines. This local switch in NMDA receptors requires spontaneous glutamate release but is independent of action potentials. Moreover, single inactivated synapses exhibit a lower induction threshold for both long-term synaptic potentiation and plasticity-induced spine growth. Thus, spontaneous glutamate release adjusts plasticity threshold at single synapses by local regulation of NMDA receptors, providing a novel spatially delimited form of synaptic metaplasticity.	[Lee, Ming-Chia; Yasuda, Ryohei; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yasuda, Ryohei; Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	NINDS/NIH; NIMH/NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748, R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410, R01NS047574] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Benjamin Arenkiel, Ian Davison, David Fitzpatrick, Juliet Hernandez, Matt Kennedy, Shih-Chieh Lin, Tom Newpher, Sri Raghavachari, and Richard Weinberg for critical review of the manuscript. We thank Irina Lebedeva and Marguerita Klein for excellent technical assistance. This work was supported by grants from the NINDS/NIH and NIMH/NIH to M.D.E. and NIMH/NIH to R.Y. M.D.E. is an Investigator of the Howard Hughes Medical Institute. R.Y. is an Early Career Scientist of the Howard Hughes Medical Institute.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Arrigoni E, 2004, BRIT J PHARMACOL, V142, P317, DOI 10.1038/sj.bjp.0705744; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Capogna M, 1997, J NEUROSCI, V17, P7190; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen L, 2000, MOL BRAIN RES, V78, P196, DOI 10.1016/S0169-328X(00)00076-0; Colonnese MT, 2003, J NEUROPHYSIOL, V89, P57, DOI 10.1152/jn.00049.2002; Cormier RJ, 2001, J NEUROPHYSIOL, V85, P399, DOI 10.1152/jn.2001.85.1.399; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Fusi S, 2007, NAT NEUROSCI, V10, P485, DOI 10.1038/nn1859; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Ito I, 2000, NEUROPHARMACOLOGY, V39, P943, DOI 10.1016/S0028-3908(99)00217-8; Ito I, 1997, J PHYSIOL-LONDON, V500, P401, DOI 10.1113/jphysiol.1997.sp022030; Jung SC, 2008, NEURON, V60, P657, DOI 10.1016/j.neuron.2008.08.029; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Kumar SS, 2003, J NEUROSCI, V23, P10074; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; YASUDA R, 2004, SCI STKE, P15; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	78	143	144	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					859	870		10.1016/j.neuron.2010.05.015	http://dx.doi.org/10.1016/j.neuron.2010.05.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620872	Bronze, Green Accepted			2022-12-24	WOS:000279420800009
J	Pang, R; Law, WL; Chu, ACY; Poon, JT; Lam, CSC; Chow, AKM; Ng, L; Cheung, LWH; Lan, XR; Lan, HY; Tan, VPY; Yau, TC; Poon, RT; Wong, BCY				Pang, Roberta; Law, Wai Lun; Chu, Andrew C. Y.; Poon, Jensen T.; Lam, Cohn S. C.; Chow, Ariel K. M.; Ng, Lui; Cheung, Leonard W. H.; Lan, Xiao R.; Lan, Hui Y.; Tan, Victoria P. Y.; Yau, Thomas C.; Poon, Ronnie T.; Wong, Benjamin C. Y.			A Subpopulation of CD26(+) Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer	CELL STEM CELL			English	Article							DIPEPTIDYL-PEPTIDASE-IV; HUMAN PANCREATIC-CANCER; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; EXTRACELLULAR-MATRIX; INITIATING CELLS; CARCINOMA CELLS; TUMOR-GROWTH; E-CADHERIN; IDENTIFICATION	Recent evidence suggests that a subpopulation of cancer cells, cancer stem cells (CSCs), is responsible for tumor growth in colorectal cancer. However, the role of CSCs in colorectal cancer metastasis is unclear. Here, we identified a subpopulation of CD26(+) cells uniformly present in both the primary and metastatic tumors in colorectal cancer patients with liver metastasis. Furthermore, in patients without distant metastasis at the time of presentation, the presence of CD26(+) cells in their primary tumors predicted distant metastasis on follow-up. Isolated CD26(+) cells, but not CD26(-) cells, led to development of distant metastasis when injected into the mouse cecal wall. CD26(+) cells were also associated with enhanced invasiveness and chemoresistance. Our findings have uncovered a critical role of CSCs in metastatic progression of cancer. Furthermore, the ability to predict metastasis based on analysis of CSC subsets in the primary tumor may have important clinical implication as a selection criterion for adjuvant therapy.	[Pang, Roberta; Lam, Cohn S. C.; Ng, Lui; Cheung, Leonard W. H.; Lan, Xiao R.; Lan, Hui Y.; Tan, Victoria P. Y.; Yau, Thomas C.; Wong, Benjamin C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Pang, Roberta; Chu, Andrew C. Y.; Chow, Ariel K. M.; Poon, Ronnie T.; Wong, Benjamin C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Pokfulam, Hong Kong, Peoples R China; [Law, Wai Lun; Poon, Jensen T.; Poon, Ronnie T.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Wong, BCY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	bcywong@hku.hk	Lan, Hui Yao/C-9734-2015; Wong, Benjamin Chun Yu/ABB-1962-2020; Chow, Ariel/HGF-2363-2022; Poon, Jensen/E-1252-2012; Ng, Lui/AAG-4397-2019; Cheung, Leonard Wing Hong/E-8033-2010; Yau, Thomas Chung Cheung/B-3429-2011	Lan, Hui Yao/0000-0003-4283-9755; Ng, Lui/0000-0002-9010-2654; Cheung, Leonard Wing Hong/0000-0002-9293-8287; Yau, Thomas Chung Cheung/0000-0002-7114-0305; Chow, Ariel/0000-0002-5729-5415	Strategic Research Theme of Cancer; Seed Funding Research Grant; University of Hong Kong	Strategic Research Theme of Cancer; Seed Funding Research Grant; University of Hong Kong(University of Hong Kong)	We thank A.M. Cheung for technical assistance in flow cytometry analysis, R. De Maria and X.W. Wang for critical discussion of the manuscript, A. Chan and S.Y. Fan for specimen collection, and G.S.W. Tsao for support. This study is supported by Strategic Research Theme of Cancer, Seed Funding Research Grant, and Donation of the Li Ka Shing Foundation of Matching Grants of The University of Hong Kong.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Benoist S, 2006, J CLIN ONCOL, V24, P3939, DOI 10.1200/JCO.2006.05.8727; Bischoff SC, 1997, J IMMUNOL, V159, P5560; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Chung DC, 1998, GASTROENTEROLOGY, V114, P1330, DOI 10.1016/S0016-5085(98)70441-X; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; De La Haba-Rodriguez J, 2002, NEOPLASMA, V49, P307; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Ferrand A, 2009, BBA-MOL CELL RES, V1793, P477, DOI 10.1016/j.bbamcr.2009.01.004; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirai K, 1999, PATHOL INT, V49, P264, DOI 10.1046/j.1440-1827.1999.00859.x; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kajiyama H, 2003, CANCER RES, V63, P2278; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; LaBarge MA, 2008, J CLIN INVEST, V118, P2021, DOI 10.1172/JCI36046; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Moll R, 1998, Subcell Biochem, V31, P205; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Mulrooney JP, 2001, J CELL SCI, V114, P2525; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Pro B, 2004, HISTOL HISTOPATHOL, V19, P1345, DOI 10.14670/HH-19.1345; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato T, 2005, CANCER RES, V65, P6950, DOI 10.1158/0008-5472.CAN-05-0647; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STANLEY R, 2000, PATHOLOGY GENETICS T; Sun YX, 2008, CLIN EXP METASTAS, V25, P765, DOI 10.1007/s10585-008-9188-9; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Thompson MA, 2007, MINI-REV MED CHEM, V7, P253, DOI 10.2174/138955707780059853; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331	47	408	435	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					603	615		10.1016/j.stem.2010.04.001	http://dx.doi.org/10.1016/j.stem.2010.04.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569697	Bronze			2022-12-24	WOS:000278840700020
J	Matta, JA; Ashby, MC; Sanz-Clemente, A; Roche, KW; Isaac, JTR				Matta, Jose A.; Ashby, Michael C.; Sanz-Clemente, Antonio; Roche, Katherine W.; Isaac, John T. R.			mGluR5 and NMDA Receptors Drive the Experience- and Activity-Dependent NMDA Receptor NR2B to NR2A Subunit Switch	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC-TRANSMISSION; MICE LACKING; FUNCTIONAL-PROPERTIES; HIPPOCAMPAL LTP; EXPRESSION; TRAFFICKING; PLASTICITY; ENHANCEMENT; INDUCTION	In cerebral cortex there is a developmental switch from NR2B- to NR2A-containing NMDA receptors (NMDARs) driven by activity and sensory experience. This subunit switch alters NMDAR function, influences synaptic plasticity, and its dysregulation is associated with neurological disorders. However, the mechanisms driving the subunit switch are not known. Here, we show in hippocampal CA1 pyramidal neurons that the NR2B to NR2A switch driven acutely by activity requires activation of NMDARs and mGluR5, involves PLC, Ca2+ release from IP3R-dependent stores, and PKC activity. In mGluR5 knockout mice the developmental NR2B-NR2A switch in CA1 is deficient. Moreover, in visual cortex of mGluR5 knockout mice, the NR2B-NR2A switch evoked in vivo by visual experience is absent. Thus, we establish that mGluR5 and NMDARs are required for the activity-dependent NR2B-NR2A switch and play a critical role in experience-dependent regulation of NMDAR subunit composition in vivo.	[Matta, Jose A.; Ashby, Michael C.; Isaac, John T. R.] Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA; [Sanz-Clemente, Antonio; Roche, Katherine W.] Natl Inst Neurol Disorders & Stroke, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Matta, JA (corresponding author), Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA.	mattaja@mail.nih.gov; isaacjo@lilly.com	Roche, Katherine/W-9893-2019; Sanz-Clemente, Antonio/AAF-7124-2019	Sanz-Clemente, Antonio/0000-0002-1256-4722; Ashby, Michael/0000-0002-8593-8473; Roche, Katherine/0000-0001-7282-6539	National Institute of Neurological Disorders and Stroke; NIGMS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003036, ZIANS002994] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Program. J.A.M. is supported on a Pharmacology Research Associate fellowship from NIGMS. We are grateful to Chris McBain and members cif the McBain and Isaac labs for discussions on this study. We thank Hey Kyoung Lee and Emily Petrus for advice on the visual cortex experiments.	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Cosford NDP, 2003, J MED CHEM, V46, P204, DOI 10.1021/jm025570j; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Fan MMY, 2007, J NEUROSCI, V27, P3768, DOI 10.1523/JNEUROSCI.4356-06.2007; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Flint AC, 1997, J NEUROSCI, V17, P2469; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Itoh S, 2001, BRAIN RES, V901, P237, DOI 10.1016/S0006-8993(01)02373-3; Jia ZP, 1998, LEARN MEMORY, V5, P331; Kingston AE, 1999, ANN NY ACAD SCI, V890, P438, DOI 10.1111/j.1749-6632.1999.tb08022.x; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; Peng Y, 2010, HIPPOCAMPUS, V20, P646, DOI 10.1002/hipo.20654; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Ross WN, 2005, CELL MOL NEUROBIOL, V25, P283, DOI 10.1007/s10571-005-3060-0; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans NA, 2000, DEV BRAIN RES, V123, P41, DOI 10.1016/S0165-3806(00)00082-1; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Taufiq AM, 2005, LEARN MEMORY, V12, P594, DOI 10.1101/lm.17405; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xu Z, 2009, J NEUROSCI, V29, P8764, DOI 10.1523/JNEUROSCI.1014-09.2009; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	68	131	137	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 28	2011	70	2					339	351		10.1016/j.neuron.2011.02.045	http://dx.doi.org/10.1016/j.neuron.2011.02.045			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521618	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000291073700014
J	Zhang, LA; Stokes, N; Polak, L; Fuchs, E				Zhang, Liang; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine			Specific MicroRNAs Are Preferentially Expressed by Skin Stem Cells To Balance Self-Renewal and Early Lineage Commitment	CELL STEM CELL			English	Article							VITAMIN-D-RECEPTOR; HAIR FOLLICLE; C-ELEGANS; ANIMAL MICRORNAS; GENE-EXPRESSION; B-LYMPHOCYTES; MOUSE SKIN; DIFFERENTIATION; MORPHOGENESIS; PROLIFERATION	Increasing evidence suggests that microRNAs may play important roles in regulating self-renewal and differentiation in mammalian stem cells (SCs). Here, we explore this issue in skin. We first characterize microRNA expression profiles of skin SCs versus their committed proliferative progenies and identify a microRNA subset associating with "stemness." Of these, miR-125b is dramatically downregulated in early SC progeny. We engineer an inducible mice system and show that when miR-125b is sustained in SC progenies, tissue balance is reversibly skewed toward stemness at the expense of epidermal, oil-gland, and HF differentiation. Using gain- and loss-of-function in vitro, we further implicate miR-125b as a repressor of SC differentiation. In vivo, transcripts repressed upon miR-125b induction are enriched >700% for predicted miR-125b targets normally downregulated upon SC-lineage commitment. We verify some of these miR-125b targets, and show that Blimp1 and VDR in particular can account for many tissue imbalances we see when miR-125b is deregulated.	[Zhang, Liang; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Zhang, Liang; Stokes, Nicole; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Xie, Huangming/B-2260-2012; zhang, liang/F-4145-2011	Zhang, Liang/0000-0003-4396-9199	HHMI; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We especially thank (1) Fuchs laboratory members J. Nowak, J. Ross, L. Fish, and S. Williams for developing initial strategies for FACS-purifications and for generating initial P4 HF-SC vs ORS microarray data and T. Chen, Y.-C. Hsu, and H. Zhang for discussions; (2) A. North (RU Bioimaging Resource Center) for assistance with image acquisition; (3) RU Comparative Biology Center, an ALAAC-accredited animal facility, for health care of our mice; and (4) Exiqon for providing LNA-modified antagomirs and other LNA reagents. E.F. is a Howard Hughes Medical Institute Investigator, and L.Z. is an HHMI postdoctoral associate. The work was supported by HHMI and a grant from the NIH.	Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Crist CG, 2009, CELL CYCLE, V8, P3627, DOI 10.4161/cc.8.22.9960; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; *GENSTAT, 2008, N01NSO2331 ROCK U NI; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QT, 2008, CELL STEM CELL, V2, P195, DOI 10.1016/j.stem.2008.02.008; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Palmer HG, 2008, J INVEST DERMATOL, V128, P2113, DOI 10.1038/jid.2008.43; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	64	132	138	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					294	308		10.1016/j.stem.2011.01.014	http://dx.doi.org/10.1016/j.stem.2011.01.014			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362569	Green Accepted, Bronze			2022-12-24	WOS:000288404400011
J	Altier, C; Garcia-Caballero, A; Simms, B; You, HT; Chen, LN; Walcher, J; Tedford, HW; Hermosilla, T; Zamponi, GW				Altier, Christophe; Garcia-Caballero, Agustin; Simms, Brett; You, Haitao; Chen, Lina; Walcher, Jan; Tedford, H. William; Hermosilla, Tamara; Zamponi, Gerald W.			The Cav beta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; ALPHA(1) SUBUNIT; GENE RFP2; COMPLEX; TRAFFICKING; CONTRACTION; EXPRESSION; PROTEINS	It is well established that the auxiliary Cav beta subunit regulates calcium channel density in the plasma membrane, but the cellular mechanism by which this occurs has remained unclear. We found that the Cav beta subunit increased membrane expression of Cav1.2 channels by preventing the entry of the channels into the endoplasmic reticulum-associated protein degradation (ERAD) complex. Without Cav beta, Cav1.2 channels underwent robust ubiquitination by the RFP2 ubiquitin ligase and interacted with the ERAD complex proteins derlin-1 and p97, culminating in targeting of the channels to the proteasome for degradation. On treatment with the proteasomal inhibitor MG132, Cav beta-free channels were rescued from degradation and trafficked to the plasma membrane. The coexpression of Cav beta interfered with ubiquitination and targeting of the channel to the ERAD complex, thereby facilitating export from the endoplasmic reticulum and promoting expression on the cell surface. Thus, Cav beta regulates the ubiquitination and stability of the calcium channel complex.	[Altier, Christophe; Garcia-Caballero, Agustin; Simms, Brett; You, Haitao; Chen, Lina; Walcher, Jan; Tedford, H. William; Hermosilla, Tamara; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	zamponi@ucalgary.ca		Zamponi, Gerald W./0000-0002-0644-9066	Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Canadian Institutes for Health Research; AFHMR; AHFMR	Heart and Stroke Foundation of Alberta; Northwest Territories and Nunavut; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); AFHMR; AHFMR(Alberta Heritage Foundation for Medical Research)	We thank J. Striessnig, S. Ferguson, J. Stutts, B. Schwappach, E. Bourinet and T. Snutch for cDNA constructs, and E. Stanley for help with the ICQ colocalization analysis. This work was supported by operating grants to G. W. Z. from the Heart and Stroke Foundation of Alberta, the Northwest Territories and Nunavut, and the Canadian Institutes for Health Research. G. W. Z. is a Scientist of the Alberta Heritage Foundation for Medical Research (AHFMR) and a Canada Research Chair in Molecular Neurobiology. H.Y. is supported by an AFHMR fellowship and B. S. is supported by an AHFMR studentship.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Baranova A, 2003, GENE, V321, P103, DOI 10.1016/j.gene.2003.08.007; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Corcoran MM, 2004, GENE CHROMOSOME CANC, V40, P285, DOI 10.1002/gcc.20046; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lie AA, 1999, NEUROSCIENCE, V93, P449, DOI 10.1016/S0306-4522(99)00162-1; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	40	175	177	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					173	U252		10.1038/nn.2712	http://dx.doi.org/10.1038/nn.2712			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21186355	Green Published			2022-12-24	WOS:000286595400014
J	Li, XA; Zhu, LL; Yang, AC; Lin, JW; Tang, F; Jin, SB; Wei, Z; Li, JS; Jin, Y				Li, Xiang; Zhu, Lili; Yang, Acong; Lin, Jiangwei; Tang, Fan; Jin, Shibo; Wei, Zhe; Li, Jinsong; Jin, Ying			Calcineurin-NFAT Signaling Critically Regulates Early Lineage Specification in Mouse Embryonic Stem Cells and Embryos	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; DEPENDENT TRANSCRIPTIONAL PATHWAY; SELF-RENEWAL; LYMPHOCYTE-ACTIVATION; PRIMITIVE ENDODERM; GENE-EXPRESSION; KINASE-ACTIVITY; SRC FAMILY; C-SRC; DIFFERENTIATION	Self-renewal and pluripotency are hallmarks of embryonic stem cells (ESCs). However, the signaling pathways that trigger their transition from self-renewal to differentiation remain elusive. Here, we report that calcineurin-NFAT signaling is both necessary and sufficient to switch ESCs from an undifferentiated state to lineage-specific cells and that the inhibition of this pathway can maintain long-term ESC self-renewal independent of leukemia inhibitory factor. Mechanistically, this pathway converges with the Erk1/2 pathway to regulate Src expression and promote the epithelial-mesenchymal transition (EMT), a process required for lineage specification in response to differentiation stimuli. Furthermore, calcineurin-NFAT signaling is activated when the earliest differentiation event occurs in mouse embryos, and its inhibition disrupts extraembryonic lineage development. Collectively, our results demonstrate that the NFAT and Erk1/2 cascades form a signaling switch for early lineage segregation in mouse ESCs and provide significant insights into the regulation of the balance between ESC self-renewal and early lineage specification,	[Li, Xiang; Zhu, Lili; Yang, Acong; Tang, Fan; Jin, Shibo; Wei, Zhe; Jin, Ying] Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200025, Peoples R China; [Li, Xiang; Zhu, Lili; Wei, Zhe] Chinese Acad Sci, Grad Sch, Beijing 100000, Peoples R China; [Yang, Acong; Tang, Fan; Jin, Ying] Shanghai Jiao Tong Univ, Shanghai Stem Cell Inst, Sch Med, Shanghai 200025, Peoples R China; [Lin, Jiangwei; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Mol Cell Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Yang, Acong/B-2929-2012; Wei, Zhe/N-8462-2015	Wei, Zhe/0000-0001-8558-4639; , jin ying/0000-0003-0070-2048; Yang, Acong/0000-0002-1279-566X; li, jin song/0000-0003-3456-662X; Zhu, Lili/0000-0003-2632-4786	National Natural Science Foundation [91019929, 30911130361, 31000625]; National High Technology Research and Development Program of China [2009CB941100, 2007CB947904, 2007CB948004, 2101CB945200, 2007CB947101]; Shanghai Science & Technology Developmental Foundations [08dj1400502, 07DZ22919]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Science & Technology Developmental Foundations; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The authors wish to thank Drs. H. Niwa, A. Rao, S. Miyatake, X. Cao, S. Hanks, T. Xu, and T. Takeya for generously providing plasmids; Drs. A. Smith and G. Daley for their mouse ESC lines, and Drs. A. Smith, R.D. McKinnon, D. Li, and A. Chong for critical reading of the manuscript. This study was supported by grants from the National Natural Science Foundation (91019929, 30911130361, and 31000625) and National High Technology Research and Development Program of China (2009CB941100, 2007CB947904, 2007CB948004, 2101CB945200, and 2007CB947101) and from Shanghai Science & Technology Developmental Foundations (08dj1400502 and 07DZ22919). The study was also supported by the Shanghai Leading Academic Discipline Project (S30201).	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiao XM, 2008, MOL BIOL CELL, V19, P1378, DOI 10.1091/mbc.E07-08-0753; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Kumagai N, 2004, BIOCHEM BIOPH RES CO, V325, P758, DOI 10.1016/j.bbrc.2004.10.094; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Stankunas K, 1999, COLD SPRING HARB SYM, V64, P505, DOI 10.1101/sqb.1999.64.505; Tan TK, 2010, AM J PATHOL, V176, P1256, DOI 10.2353/ajpath.2010.090188; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Ullmann U, 2008, MOL HUM REPROD, V14, P169, DOI 10.1093/molehr/gan001; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x	54	78	85	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					46	58		10.1016/j.stem.2010.11.027	http://dx.doi.org/10.1016/j.stem.2010.11.027			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211781	Bronze			2022-12-24	WOS:000286786200010
J	Wilson, NK; Foster, SD; Wang, XN; Knezevic, K; Schutte, J; Kainnakis, P; Chilarska, PM; Kinston, S; Ouwehand, WH; Dzierzak, E; Pimanda, JE; de Bruijn, MFTR; Gottgens, B				Wilson, Nicola K.; Foster, Samuel D.; Wang, Xiaonan; Knezevic, Kathy; Schuette, Judith; Kainnakis, Polynikis; Chilarska, Paulina M.; Kinston, Sarah; Ouwehand, Willem H.; Dzierzak, Elaine; Pimanda, John E.; de Bruijn, Marella F. T. R.; Goettgens, Berthold			Combinatorial Transcriptional Control In Blood Stem/Progenitor Cells: Genome-wide Analysis of Ten Major Transcriptional Regulators	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; CHROMATIN OCCUPANCY; LINEAGE COMMITMENT; GENE-EXPRESSION; MOUSE EMBRYO; FETAL LIVER; CHIP-SEQ; GATA-2; LEUKEMIA; RUNX1	Combinatorial transcription factor (TF) interactions control cellular phenotypes and, therefore, underpin stem cell formation, maintenance, and differentiation. Here, we report the genome-wide binding patterns and combinatorial interactions for ten key regulators of blood stem/progenitor cells (SCL/TAL1, LYL1, LMO2, GATA2, RUNX1, MEIS1, PU.1, ERG, FLI-1, and GFI1B), thus providing the most comprehensive IF data set for any adult stem/progenitor cell type to date. Genome-wide computational analysis of complex binding patterns, followed by functional validation, revealed the following: first, a previously unrecognized combinatorial interaction between a heptad of TFs (SCL, LYL1, LMO2, GATA2, RUNX1, ERG, and FLI-1). Second, we implicate direct protein-protein interactions between four key regulators (RUNX1, GATA2, SCL, and ERG) in stabilizing complex binding to DNA. Third, Runx1(+/-)::Gata2(+/-) compound heterozygous mice are not viable with severe hematopoietic defects at midgestation. Taken together, this study demonstrates the power of genome-wide analysis in generating novel functional insights into the transcriptional control of stem and progenitor cells.	[Wilson, Nicola K.; Foster, Samuel D.; Wang, Xiaonan; Schuette, Judith; Chilarska, Paulina M.; Kinston, Sarah; Ouwehand, Willem H.; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Knezevic, Kathy; Pimanda, John E.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Knezevic, Kathy; Pimanda, John E.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Kainnakis, Polynikis; Dzierzak, Elaine] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Kainnakis, Polynikis; Dzierzak, Elaine] Erasmus Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands; [de Bruijn, Marella F. T. R.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England	University of Cambridge; University of New South Wales Sydney; University of New South Wales Sydney; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford	Gottgens, B (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	bg200@cam.ac.uk	cheng, yong/I-4270-2012	Gottgens, Berthold/0000-0001-6302-5705; Foster, Samuel/0000-0001-5375-7080; Ouwehand, Willem/0000-0002-7744-1790; Kaimakis, Polynikis/0000-0002-2928-1729; Wang, Xiaonan/0000-0003-3759-778X	Leukaemia and Lymphoma Research; Leukaemia and Lymphoma Foundation; UK Medical Research Council; National Institute for Health Research Cambridge Biomedical Research Centre; National Health and Medical Research Council of Australia; Australian Research Council; Medical Research Council [G0800784, MC_U137970202, G1000847, G0900951, G0800784B, G1000801h] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; MRC [G0900951, G0800784, MC_U137970202, G1000847] Funding Source: UKRI	Leukaemia and Lymphoma Research; Leukaemia and Lymphoma Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Rendon and O. Burren for help with mapping ChIP-Seq reads, S. Anand for advice on immunoprecipitation assays, D. Hebenstreit for help with generating density profiles, and S. Teichmann and L. Wernisch for helpful discussions. Work in the authors' laboratories is supported by Leukaemia and Lymphoma Research, the Leukaemia and Lymphoma Foundation, the UK Medical Research Council, the National Institute for Health Research Cambridge Biomedical Research Centre, and the National Health and Medical Research Council of Australia and the Australian Research Council (K.K. and J.P.).	Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; BAILEY TL, 1994, ISMB, V2, P28; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gao JW, 2009, NANO LETT, V9, P4128, DOI 10.1021/nl902358m; GERING M, 2002, EMBO J, V21, P3039; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun W, 2004, BLOOD, V104, P3565, DOI 10.1182/blood-2003-12-4349; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xu G, 2006, LEUKEMIA, V20, P1002, DOI 10.1038/sj.leu.2404223; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	60	492	500	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					532	544		10.1016/j.stem.2010.07.016	http://dx.doi.org/10.1016/j.stem.2010.07.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887958	Bronze			2022-12-24	WOS:000283270600014
J	Liu, J; Wu, DC; Wang, YT				Liu, Jun; Wu, Dong Chuan; Wang, Yu Tian			Allosteric potentiation of glycine receptor chloride currents by glutamate	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SYNAPSES; CHANNELS; NEURONS; GABA; CLEARANCE	Neuronal excitability in the CNS is primarily controlled by a balance between synaptic excitation and inhibition. In the brainstem and spinal cord, synaptic excitation and inhibition are mediated by the excitatory transmitter glutamate acting on ionotropic glutamate receptor-gated cationic channels and the inhibitory transmitter glycine acting on glycine receptor (GlyR)-gated chloride channels. We found that glutamate and its analog ligands potentiated GlyR-mediated currents in both cultured spinal neurons and spinal cord slices of rats. This potentiation was not dependent on activation of any known glutamate receptor and manifested as an increase in single-channel open probability. Moreover, this glutamate potentiation was seen in HEK293 cells that transiently expressed GlyRs. Our data strongly suggest that glutamate allosterically potentiates GlyR-gated chloride channels, thereby blurring the traditional distinction between excitatory and inhibitory transmitters. Such a rapid homeostatic regulatory mechanism may be important for tuning functional balance between synaptic excitation and inhibition in the CNS.	[Liu, Jun; Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Liu, Jun; Wu, Dong Chuan; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Wu, Dong Chuan; Wang, Yu Tian] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Wu, Dong Chuan; Wang, Yu Tian] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Wu, Dong Chuan; Wang, Yu Tian] China Med Univ Hosp, Grad Inst Immunol, Taichung, Taiwan	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wang, YT (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada.	ytwang@interchange.ubc.ca	Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008; Wu, Dong Chuan/O-3909-2015	WU, DONG CHUAN/0000-0002-9539-5935	Canadian Institutes for Health Research; Heart and Stroke Foundation of British Columbia and Yukon; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; National Sciences and Engineering Research Council; Michael Smith Foundation for Health Research; British Columbia Epilepsy Society	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon; Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia Epilepsy Society	We thank Y.P. Li for preparation and maintenance of spinal cord neuronal cultures and L. Oschipok for his excellent editorial assistance. This work was supported by the Canadian Institutes for Health Research, the Heart and Stroke Foundation of British Columbia and Yukon, and the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH99-TD-B-111-004). J.L. was supported by postdoctoral fellowships from National Sciences and Engineering Research Council, the Michael Smith Foundation for Health Research and the British Columbia Epilepsy Society. Y.T.W. is a Howard Hughes Medical Institute International Scholar and the holder of the Heart and Stroke Foundation of British Columbia and Yukon chair in stroke research.	Baker DA, 2002, J NEUROSCI, V22, P9134; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dingledine R, 1990, Adv Exp Med Biol, V268, P17; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hartmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002979; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Nyitrai G, 2006, CURR TOP MED CHEM, V6, P935, DOI 10.2174/156802606777323674; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Stafford MM, 2010, HIPPOCAMPUS, V20, P134, DOI 10.1002/hipo.20600; STELZER A, 1989, NATURE, V337, P170, DOI 10.1038/337170a0; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; TWYMAN RE, 1991, J PHYSIOL-LONDON, V435, P303, DOI 10.1113/jphysiol.1991.sp018512; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; Windhorst U, 1996, PROG NEUROBIOL, V49, P517, DOI 10.1016/0301-0082(96)00023-8; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xu TL, 2000, EUR J NEUROSCI, V12, P1647; Zhu L, 2002, J PHARMACOL EXP THER, V302, P1193, DOI 10.1124/jpet.102.033894	31	28	28	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1225	1232		10.1038/nn.2633	http://dx.doi.org/10.1038/nn.2633			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20835251				2022-12-24	WOS:000282171300014
J	Smith, KN; Singh, AM; Dalton, S				Smith, Keriayn N.; Singh, Amar M.; Dalton, Stephen			Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells	CELL STEM CELL			English	Article							EMBRYONIC STEM; C-MYC; N-MYC; TRANSCRIPTIONAL NETWORK; MIR-17-92 CLUSTER; MOUSE; NANOG; CYCLE; MICRORNA; PATHWAY	The generation of induced pluripotent stem cells (iPSCs) provides a novel method to facilitate investigations into the mechanisms that control stem cell pluripotency and self-renewal. Myc has previously been shown to be critical for murine embryonic stem cell (mESC) maintenance, while also enhancing directed reprogramming of fibroblasts by effecting widespread changes in gene expression. Despite several studies identifying in vivo target genes, the precise mechanism by which Myc regulates pluripotency remains unknown. Here we report that codeletion of c- and N-MYC in iPSCs and ESCs results in their spontaneous differentiation to primitive endoderm. We show that Myc sustains pluripotency through repression of the primitive endoderm master regulator GATA6, while also contributing to cell cycle control by regulation of the mir-17-92 miRNA cluster. Our findings demonstrate the indispensable requirement for c- or N-myc in pluripotency beyond proliferative and metabolic control.	[Smith, Keriayn N.; Singh, Amar M.; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Dalton, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, 500 DW Brooks Dr, Athens, GA 30602 USA.	sdalton@uga.edu	Smith, Keri/B-6560-2012	Smith, Keriayn/0000-0002-4351-2765; Dalton, Stephen/0000-0002-3450-1263	National Institute of Child Health and Human Development [HD049647]; National Institute for General Medical Sciences [GM75334]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to S.D. from the National Institute of Child Health and Human Development (HD049647) and the National Institute for General Medical Sciences (GM75334). We thank Paul Knoepfler for kindly providing c-myc<SUP>fl/fl</SUP>;N-myc<SUP>fl/fl</SUP> mice and c-myc<SUP>fl/fl</SUP>;N-myc<SUP>fl/fl</SUP> mESCs, John Cleveland for AB2.1 mESCs, Malgorzata Borowiak and Douglas Melton for the Sox17-GFP mESCs, Naohiro Terada for AFP-GFP mESCs, Shin-lchi Nishikawa for Gata6 shRNA constructs, and Xinmin Li for the Rb2-Luciferase Reporter. Thanks to Juan Cui and Ying Xu for assistance with bioinformatics analysis, Julie Nelson for assistance with FAGS sorting, David Reynolds and Tamas Nagy for assistance with teratoma analysis, and David Martin and Helen Zhang for assistance with blastocyst injections.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; APARICIO O, 2004, CURR PROTOC CELL BIO, V17, P1; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; CHARRON J, 1990, MOL CELL BIOL, V10, P1799, DOI 10.1128/MCB.10.4.1799; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Malynn BA, 2000, GENE DEV, V14, P1390; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Savatier P, 1996, ONCOGENE, V12, P309; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102	40	145	146	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					343	354		10.1016/j.stem.2010.06.023	http://dx.doi.org/10.1016/j.stem.2010.06.023			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804970	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000282037800011
J	Kokovay, E; Goderie, S; Wang, Y; Lotz, S; Lin, G; Sun, Y; Roysam, B; Shen, Q; Temple, S				Kokovay, Erzsebet; Goderie, Susan; Wang, Yue; Lotz, Steve; Lin, Gang; Sun, Yu; Roysam, Badrinath; Shen, Qin; Temple, Sally			Adult SVZ Lineage Cells Home to and Leave the Vascular Niche via Differential Responses to SDF1/CXCR4 Signaling	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; POSTNATAL SUBVENTRICULAR ZONE; CHEMOKINE RECEPTOR CXCR4; PROGENITOR CELLS; NEUROBLAST MIGRATION; NEURONAL MIGRATION; MAMMALIAN BRAIN; NEUROGENESIS; STROKE; PRECURSORS	Neural progenitor cells (NPCs) in the adult subventricular zone (SVZ) are associated with ependymal and vasculature niches, which regulate stem cell self-renewal and differentiation. Activated Type B stem cells and their progeny, the transit-amplifying type C cells, which express EGFR, are most highly associated with vascular cells, indicating that this niche supports lineage progression. Here, we show that proliferative SVZ progenitor cells home to endothelial cells in a stromal-derived factor 1 (SDF1)- and CXC chemokine receptor 4 (CXCR4)-dependent manner. We show that SDF1 strongly upregulates EGFR and alpha 6 integrin in activated type B and type C cells, enhancing their activated state and their ability to bind laminin in the vascular niche. SDF1 increases the motility of type A neuroblasts, which migrate from the SVZ toward the olfactory bulb. Thus, differential responses to SDF1 can regulate progenitor cell occupancy of and exit from the adult SVZ vascular niche.	[Kokovay, Erzsebet; Goderie, Susan; Wang, Yue; Lotz, Steve; Shen, Qin; Temple, Sally] New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Kokovay, Erzsebet; Shen, Qin; Temple, Sally] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Lin, Gang; Roysam, Badrinath] Rensselaer Polytech Inst, Rensselaer, NY 12180 USA; [Sun, Yu] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Albany Medical College; Rensselaer Polytechnic Institute; Harvard University; Dana-Farber Cancer Institute	Temple, S (corresponding author), New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org			NIH [R01NS051531]; Regenerative Research Foundation; NIDA [5T32DA007307]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regenerative Research Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Chris Fasano and Tim Phoenix for assistance in generating lentiviral shRNA contructs and Patty Lederman for invaluable technical support. This project was supported by NIH grant R01NS051531 and the Regenerative Research Foundation, and E.K. was supported in part by NIDA grant 5T32DA007307.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bagri A, 2002, DEVELOPMENT, V129, P4249; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d; De Clercq E, 2000, MOL PHARMACOL, V57, P833; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Guo ZG, 2007, COLLOID SURFACE B, V60, P1, DOI 10.1016/j.colsurfb.2007.05.013; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jackson EL, 2008, CELLS TISSUES ORGANS, V188, P212, DOI 10.1159/000114541; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu XS, 2008, BRAIN RES, V1226, P18, DOI 10.1016/j.brainres.2008.06.013; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Voermans C, 2001, EXP HEMATOL, V29, P1456, DOI 10.1016/S0301-472X(01)00740-8; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	273	282	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					163	173		10.1016/j.stem.2010.05.019	http://dx.doi.org/10.1016/j.stem.2010.05.019			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682445	Green Accepted, Bronze			2022-12-24	WOS:000281107400009
J	Mosca, TJ; Schwarz, TL				Mosca, Timothy J.; Schwarz, Thomas L.			The nuclear import of Frizzled2-C by Importins-beta 11 and alpha 2 promotes postsynaptic development	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; REGULATES SYNAPTIC GROWTH; RECEPTOR SUBUNIT COMPOSITION; TUMOR-SUPPRESSOR GENE; NEUROTRANSMITTER RELEASE; II RECEPTOR; WNT; WINGLESS; PROTEIN; TRANSPORT	Synapse-to-nucleus signaling is critical for synaptic development and plasticity. In Drosophila, the ligand Wingless causes the C terminus of its Frizzled2 receptor (Fz2-C) to be cleaved and translocated from the postsynaptic density to nuclei. The mechanism of nuclear import is unknown and the developmental consequences of this translocation are uncertain. We found that Fz2-C localization to muscle nuclei required the nuclear import factors Importin-beta 11 and Importin-alpha 2 and that this pathway promoted the postsynaptic development of the subsynaptic reticulum (SSR), an elaboration of the postsynaptic plasma membrane. importin-beta 11 (imp-beta 11) and dfz2 mutants had less SSR, and some boutons lacked the postsynaptic marker Discs Large. These developmental defects in imp-beta 11 mutants could be overcome by expression of Fz2-C fused to a nuclear localization sequence that can bypass Importin-beta 11. Thus, Wnt-activated growth of the postsynaptic membrane is mediated by the synapse-to-nucleus translocation and active nuclear import of Fz2-C via a selective Importin-beta 11/alpha 2 pathway.	[Mosca, Timothy J.; Schwarz, Thomas L.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Mosca, Timothy J.; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Schwarz, TL (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	thomas.schwarz@childrens.harvard.edu		Mosca, Timothy/0000-0003-3485-0719	US National Institutes of Health [RO1 NS041062, MH075058]; National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge V. Budnik and colleagues for generously providing antibodies and fly stocks and helpful discussions. We thank S. Cotterrill, R. Fleming, I. Kiss, P. Macdonald, B. Mechler, H. Bellen, M. Noll, M. Ramaswami, H. Saumweber, D. Schmucker, G. Struhl, J. Szabad, J. P. Vincent, S. Wasserman, Y. Jan, L. Zipursky, the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. We also thank M. Kovtun and members of the Schwarz laboratory for helpful discussions and critical readings of the manuscript, as well as M. Liana and L. Bu of the Intellectual and Developmental Disability Research Center Histology (grant number P30HD18655) and Imaging Cores for technical assistance. This work was supported by US National Institutes of Health grants RO1 NS041062 and MH075058 (T. L. S.) and a predoctoral fellowship from the National Defense Science and Engineering Graduate Foundation (T. J. M.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Cantera R, 1999, MOL CELL NEUROSCI, V13, P131, DOI 10.1006/mcne.1999.0739; Chen CM, 1999, DEVELOPMENT, V126, P5441; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; FAEDER IR, 1970, J CELL BIOL, V46, P300, DOI 10.1083/jcb.46.2.300; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Giagtzoglou N, 2009, J NEUROSCI, V29, P5628, DOI 10.1523/JNEUROSCI.0794-09.2009; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Higashi-Kovtun ME, 2010, J NEUROSCI, V30, P5253, DOI 10.1523/JNEUROSCI.3739-09.2010; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Menon KP, 2009, J NEUROSCI, V29, P5558, DOI 10.1523/JNEUROSCI.0520-09.2009; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Perry RBT, 2009, SEMIN CELL DEV BIOL, V20, P600, DOI 10.1016/j.semcdb.2009.04.014; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Rheuben MB, 1999, INT REV NEUROBIOL, V43, P69, DOI 10.1016/S0074-7742(08)60541-3; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong K, 1999, J NEUROPHYSIOL, V82, P1497, DOI 10.1152/jn.1999.82.3.1497; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016	50	67	68	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					935	U50		10.1038/nn.2593	http://dx.doi.org/10.1038/nn.2593			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20601947	Green Accepted			2022-12-24	WOS:000280400600011
J	Curtis, SJ; Sinkevicius, KW; Li, DA; Lau, AN; Roach, RR; Zamponi, R; Woolfenden, AE; Kirsch, DG; Wong, KK; Kim, CF				Curtis, Stephen J.; Sinkevicius, Kerstin W.; Li, Danan; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Woolfenden, Amber E.; Kirsch, David G.; Wong, Kwok-Kin; Kim, Carla F.			Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells	CELL STEM CELL			English	Article							ADULT-MOUSE LUNG; STEM-CELLS; INITIATING CELLS; MARKER; MEDULLOBLASTOMA; HETEROGENEITY; EXPRESSION; MUTATIONS; HIERARCHY; MODEL	Successful cancer therapy requires the elimination or incapacitation of all tumor cells capable of regenerating a tumor. Therapeutic advances therefore necessitate the characterization of the cells that are able to propagate a tumor in vivo. We show an important link between tumor genotype and isolation of tumor-propagating cells (TPCs). Three mouse models of the most common form of human lung cancer each had TPCs with a unique cell-surface phenotype. The cell-surface marker Sca1 did not enrich for TPCs in tumors initiated with oncogenic Kras, and only Sca1-negative cells propagated EGFR mutant tumors. In contrast, Sca1-positive cells were enriched for tumor-propagating activity in Kras tumors with p53 deficiency. Primary tumors that differ in genotype at just one locus can therefore have tumor-propagating cell populations with distinct markers. Our studies show that the genotype of tumor samples must be considered in studies to identify, characterize, and target tumor-propagating cells.	[Curtis, Stephen J.; Sinkevicius, Kerstin W.; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Kim, Carla F.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Curtis, Stephen J.; Sinkevicius, Kerstin W.; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Kim, Carla F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Curtis, Stephen J.; Sinkevicius, Kerstin W.; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Danan; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA; [Woolfenden, Amber E.] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Novartis; Duke University; Duke University	Kim, CF (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	carla.kim@childrens.harvard.edu	Zamponi, Raffaella/V-5683-2018	Zamponi, Raffaella/0000-0002-3313-1387; Lau, Allison/0000-0003-4250-7355; wong, kwok kin/0000-0001-6323-235X	DoD, Air Force Office of Scientific Research [32 CFR 168a]; American Cancer Society [PF-09-121-01-DDC]; Dana Farber Harvard Cancer Center Lung Cancer [P50 CA090578, R01 AG2400401, R01 CA122794, R01 CA140594]; V Foundation, American Cancer Society [RSG-08-082-01-MGO]; Harvard Stem Cell Institute; NIH/NCI [2P50CA090578]; Lung Cancer Alliance; NATIONAL CANCER INSTITUTE [P50CA090578, R01CA122794, R01CA140594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG024004] Funding Source: NIH RePORTER	DoD, Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); American Cancer Society(American Cancer Society); Dana Farber Harvard Cancer Center Lung Cancer; V Foundation, American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Lawrence, K. Mercer, E. Jackson, A. Dooley, S. Perera, the DFCI, CHB HemOnc, MIT FACS facilities, and members of the Kim Lab for technical assistance and discussions; E. Passegue for cell cycle protocol; R. Bronson for histopathology; T. Jacks for mouse strains and helpful discussions; and G. Evan, S. Ryeom, L. Zon, C. Cepko, S. Elledge, S. Armstrong, H. Hock, and K. Cichowski for critical reading. This work was supported by a DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a (to S.J.C.), PF-09-121-01-DDC from the American Cancer Society (to K.W.S.), Dana Farber Harvard Cancer Center Lung Cancer SPORE grant P50 CA090578, R01 AG2400401, R01 CA122794, and R01 CA140594 (to K-K.W.), the V Foundation, American Cancer Society Research Scholar Grant #RSG-08-082-01-MGO, the Harvard Stem Cell Institute, NIH/NCI 2P50CA090578, and The Lung Cancer Alliance (to C.F.K.). We apologize for not citing primary references because of space constraints.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; MCLEMORE TL, 1987, CANCER RES, V47, P5132; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342	27	107	112	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					127	133		10.1016/j.stem.2010.05.021	http://dx.doi.org/10.1016/j.stem.2010.05.021			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621056	Green Accepted, Bronze			2022-12-24	WOS:000280222300019
J	Campanucci, V; Krishnaswamy, A; Cooper, E				Campanucci, Veronica; Krishnaswamy, Arjun; Cooper, Ellis			Diabetes Depresses Synaptic Transmission in Sympathetic Ganglia by Inactivating nAChRs through a Conserved Intracellular Cysteine Residue	NEURON			English	Article							ACETYLCHOLINE-RECEPTORS; AUTONOMIC GANGLIA; GENE; NEUROPATHOLOGY; AMINOGUANIDINE; STREPTOZOTOCIN; EXPRESSION; MUTATION; CELLS; OBESE	Most people with diabetes develop severe complications of the autonomic nervous system; yet, the underlying causes of many diabetic-induced dysautonomias are poorly understood. Here we explore the idea that these dysautonomias results, in part, from a defect in synaptic transmission. To test this idea, we investigated cultured sympathetic neurons and show that hyperglycemia inactivates nAChRs through a mechanism involving an elevation in reactive oxygen species and an interaction with highly conserved cysteine residues located near the intracellular mouth of the nAChR channel. Consistent with this, we show that diabetic mice have depressed ganglionic transmission and reduced sympathetic reflexes, whereas diabetic mice expressing mutant postsynaptic nAChRs that lack the conserved cysteine residues on the alpha 3 subunit have normal synaptic transmission in sympathetic ganglia and normal sympathetic reflexes. Our work suggests a new model for diabetic-induced dysautonomias and identifies ganglionic nAChRs as targets of hyperglycemia-induced downstream signals.	[Campanucci, Veronica; Krishnaswamy, Arjun; Cooper, Ellis] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Cooper, E (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	ellis.cooper@mcgill.ca			Canadian Institutes for Health Research; Juvenile Diabetes Research Foundation; Heart and Stroke Foundation of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	We thank Ms B. Pie and Ms N. Grenier for excellent technical assistance and Prof L. Cooper for comments on drafts of our manuscript. This work was supported by the Canadian Institutes for Health Research, Juvenile Diabetes Research Foundation, and Heart and Stroke Foundation of Canada.	AXELSSON J, 1971, ANNU REV PHYSIOL, V33, P1, DOI 10.1146/annurev.ph.33.030171.000245; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Campanucci VA, 2008, J NEUROSCI, V28, P1733, DOI 10.1523/JNEUROSCI.5130-07.2008; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; de Arriba SG, 2007, NEUROBIOL AGING, V28, P1044, DOI 10.1016/j.neurobiolaging.2006.05.007; Duby JJ, 2004, AM J HEALTH-SYST PH, V61, P160, DOI 10.1093/ajhp/61.2.160; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; Klein CM, 2003, ANN NEUROL, V53, P752, DOI 10.1002/ana.10556; Krishnaswamy A, 2009, NEURON, V61, P272, DOI 10.1016/j.neuron.2008.11.025; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Low PA, 2002, CURR OPIN NEUROL, V15, P605, DOI 10.1097/00019052-200210000-00011; MCFARLANE S, 1992, J NEUROPHYSIOL, V67, P1291, DOI 10.1152/jn.1992.67.5.1291; Poth K, 1997, J NEUROSCI, V17, P586; Rassadi S, 2005, J NEUROSCI, V25, P8555, DOI 10.1523/JNEUROSCI.1983-05.2005; Schmidt RE, 1996, MICROSC RES TECHNIQ, V35, P107; Schmidt RE, 2002, AUTON NEUROSCI-BASIC, V96, P63, DOI 10.1016/S1566-0702(01)00372-1; Schmidt RE, 2008, J NEUROPATH EXP NEUR, V67, P1166, DOI 10.1097/NEN.0b013e318190d6db; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; Vernino S, 2008, NEUROLOGY, V70, P1926, DOI 10.1212/01.wnl.0000312280.44805.5d; Vernino S, 2009, AUTON NEUROSCI-BASIC, V146, P3, DOI 10.1016/j.autneu.2008.09.005; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2003, SEMIN NEUROL, V23, P365; Webster J, 2005, NEUROTOX RES, V7, P95, DOI 10.1007/BF03033780; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	31	51	52	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					827	834		10.1016/j.neuron.2010.06.010	http://dx.doi.org/10.1016/j.neuron.2010.06.010			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620869	Bronze			2022-12-24	WOS:000279420800006
J	Chakrabarti, L; Zahra, R; Jackson, SM; Kazemi-Esfarjani, P; Sopher, BL; Mason, AG; Toneff, T; Ryu, S; Shaffer, S; Kansy, JW; Eng, J; Merrihew, G; MacCoss, MJ; Murphy, A; Goodlett, DR; Hook, V; Bennett, CL; Pallanck, LJ; La Spada, AR				Chakrabarti, Lisa; Zahra, Rabaab; Jackson, Stephen M.; Kazemi-Esfarjani, Parsa; Sopher, Bryce L.; Mason, Amanda G.; Toneff, Thomas; Ryu, Soyoung; Shaffer, Scott; Kansy, Janice W.; Eng, Jeremiah; Merrihew, Gennifer; MacCoss, Michael J.; Murphy, Anne; Goodlett, David R.; Hook, Vivian; Bennett, Craig L.; Pallanck, Leo J.; La Spada, Albert R.			Mitochondrial Dysfunction in NnaD Mutant Flies and Purkinje Cell Degeneration Mice Reveals a Role for Nna Proteins in Neuronal Bioenergetics	NEURON			English	Article							SHOTGUN PROTEOMICS; COMPLEX-I; DROSOPHILA; FISSION; DISEASE; MOUSE; CARBOXYPEPTIDASES; NEURODEGENERATION; EXPRESSION; MITOPHAGY	The Purkinje cell degeneration (pcd) mouse is a recessive model of neurodegeneration, involving cerebellum and retina. Purkinje cell death in pcd is dramatic, as >99% of Purkinje neurons are lost in 3 weeks. Loss of function of Nna1 causes pcd, and Nna1 is a highly conserved zinc carboxypeptidase. To determine the basis of pcd, we implemented a two-pronged approach, combining characterization of loss-of-function phenotypes of the Drosophila Nna1 ortholog (NnaD) with proteomics analysis of pcd mice. Reduced NnaD function yielded larval lethality, with survivors displaying phenotypes that mirror disease in pcd. Quantitative proteomics revealed expression alterations for glycolytic and oxidative phosphorylation enzymes. Nna proteins localize to mitochondria, loss of NnaD/Nna1 produces mitochondrial abnormalities, and pcd mice display altered proteolytic processing of Nna1 interacting proteins. Our studies indicate that Nna1 loss of function results in altered bioenergetics and mitochondrial dysfunction.	[Zahra, Rabaab; Kazemi-Esfarjani, Parsa; Mason, Amanda G.; Kansy, Janice W.; Bennett, Craig L.; La Spada, Albert R.] Univ Calif San Diego, Dept Pediat, Div Genet, Rady Childrens Hosp, La Jolla, CA 92093 USA; [Chakrabarti, Lisa] Univ Nottingham, Sch Med, Sch Biomed Sci, Nottingham NG7 2UH, England; [Jackson, Stephen M.; Sopher, Bryce L.; Eng, Jeremiah] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; [Toneff, Thomas; Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Ryu, Soyoung; Shaffer, Scott; Goodlett, David R.] Univ Washington, Med Ctr, Dept Med Chem, Seattle, WA 98195 USA; [Merrihew, Gennifer; MacCoss, Michael J.; Pallanck, Leo J.] Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA; [Murphy, Anne] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [La Spada, Albert R.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [La Spada, Albert R.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of Nottingham; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	La Spada, AR (corresponding author), Univ Calif San Diego, Dept Pediat, Div Genet, Rady Childrens Hosp, La Jolla, CA 92093 USA.	alaspada@ucsd.edu	La Spada, Albert/AAG-8809-2020; Zahra, Rabaab/ABD-1397-2020; Shaffer, Scott A/F-8650-2010; Chakrabarti, Lisa/G-4236-2011; Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902; Bennett, CRAIG/0000-0002-5847-1687; Chakrabarti, Lisa/0000-0001-7213-6837; Zahra, Rabaab/0000-0001-8784-0114	NIH [EY14997, EY18106, P41 RR011823, EY01730]; MRDDRC Center [P30 HD02274]; NIEHS Center [P30 ES07033]; UC Davis NTRI [UL1-DE19583]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018106, R01EY014997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRDDRC Center; NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UC Davis NTRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Possin and E. Parker for invaluable assistance and S. Kreher for the pG4PN plasmid. This work was supported by funding from the NIH (EY14997 to A.R.L., EY18106 to L.C., P41 RR011823 to M.J.M., EY01730 [Vision Research Core] to UWMC, P30 HD02274 [MRDDRC Center Grant] to UW, P30 ES07033 [NIEHS Center Grant] to UW, and UL1-DE19583 [UC Davis NTRI]).	Abeliovich A, 2010, NATURE, V463, P744, DOI 10.1038/463744a; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Chakrabarti L, 2006, MAMM GENOME, V17, P103, DOI 10.1007/s00335-005-0096-x; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gassner B, 1997, J PHARMACOL EXP THER, V281, P855; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jellinger Kurt A., 2006, Current Alzheimer Research, V3, P377, DOI 10.2174/156720506778249434; Joshi L, 1999, J BIOL CHEM, V274, P9803, DOI 10.1074/jbc.274.14.9803; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kaplan J, 2002, NEUROCHEM INT, V40, P553, DOI 10.1016/S0197-0186(01)00127-9; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; SVIRKLYS LG, 1980, CLIN CHIM ACTA, V108, P309, DOI 10.1016/0009-8981(80)90018-2; Tolan DR, 2007, CEREBELLUM, V6, P130, DOI 10.1080/14734220601064759; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wiley SE, 2009, METHOD ENZYMOL, V456, P233, DOI 10.1016/S0076-6879(08)04413-3; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	39	34	36	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					835	847		10.1016/j.neuron.2010.05.024	http://dx.doi.org/10.1016/j.neuron.2010.05.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620870	Bronze, Green Accepted			2022-12-24	WOS:000279420800007
J	Nili, U; Goldberg, H; Weizman, A; Dudai, Y				Nili, Uri; Goldberg, Hagar; Weizman, Abraham; Dudai, Yadin			Fear Thou Not: Activity of Frontal and Temporal Circuits in Moments of Real-Life Courage	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; CONDITIONED FEAR; EMOTION REGULATION; EXTINCTION MEMORY; AMYGDALA; NEURONS; HUMANS; PHOBIA; STIMULATION	How does the brain encode courage in a real-life fearful situation that demands an immediate response? In this study, volunteers who fear snakes had to bring a live snake into close proximity with their heads while their brains were scanned using functional magnetic resonance imaging (fMRI). Bringing the snake closer was associated with a dissociation between subjective fear and somatic arousal. Activity in the subgenual anterior cingulate cortex (sgACC) and the right temporal pole was positively correlated with such action. Further, activity in the sgACC was positively correlated with the level of fear upon choosing to overcome fear but not upon succumbing to it. Conversely, activity in a set of interrelated temporal lobe structures, including the amygdala, was attenuated as the level of fear increased when choosing to overcome fear. We propose how the internally reinforced fast representational shift, in which the courageous-response representation gains control over behavior, takes place.	[Nili, Uri; Goldberg, Hagar; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Weizman, Abraham] Tel Aviv Univ, Felsenstein Med Res Ctr, Sackler Fac Med, IL-49100 Petah Tiqwa, Israel; [Weizman, Abraham] Geha Mental Hlth Ctr, Res Unit, IL-49100 Petah Tiqwa, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il	Weizman, Abraham/AAK-6450-2020	Weizman, Abraham/0000-0002-9765-8938	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	We thank Nir Shvalb for help with the design and construction of the experimental setup, and Yossi Chalamish for interviewing potential candidates for the experiment. We are also grateful to Aya Ben Yakov, Ilan Dinstein, Micah Edelson, Orit Furman, Efrat Furst, Rachel Ludmer, Avi Mendelsohn, Ronly Paz, and Tali Sharot for valuable discussions. The support of the Israeli Science Foundation is gratefully acknowledged.	AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; AGRAS S, 1969, COMPR PSYCHIAT, V10, P151, DOI 10.1016/0010-440X(69)90022-4; Ahs F, 2009, PSYCHIAT RES-NEUROIM, V172, P103, DOI 10.1016/j.pscychresns.2008.11.004; Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gallagher M, 2000, AMYGDALA FUNCTIONAL, P311; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goossens L, 2007, BIOL PSYCHIAT, V62, P1119, DOI 10.1016/j.biopsych.2007.04.024; Hermann A, 2009, SOC COGN AFFECT NEUR, V4, P257, DOI 10.1093/scan/nsp013; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; KAADA BR, 1949, J NEUROPHYSIOL, V12, P347, DOI 10.1152/jn.1949.12.5.347; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; KLORMAN R, 1974, BEHAV THER, V5, P401, DOI 10.1016/S0005-7894(74)80008-0; Kondo H, 2003, J COMP NEUROL, V465, P499, DOI 10.1002/cne.10842; Kross E, 2009, BIOL PSYCHIAT, V65, P361, DOI 10.1016/j.biopsych.2008.10.019; LANG PJ, 1983, J ABNORM PSYCHOL, V92, P276, DOI 10.1037/0021-843X.92.3.276; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LEITENBERG H, 1971, J ABNORM PSYCHOL, V78, P59, DOI 10.1037/h0031478; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Matthews SC, 2004, NEUROIMAGE, V22, P1151, DOI 10.1016/j.neuroimage.2004.03.005; Meyer G., 1973, SURG APPROACHES PSYC, V1973, P39; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Paus T, 2004, J PSYCHIATR NEUROSCI, V29, P268; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; RACHMAN S, 1984, BEHAV THER, V15, P109, DOI 10.1016/S0005-7894(84)80045-3; Rachman S., 2004, ANXIETY; Rachman SJ, 2004, SOC RES, V71, P149; Rachman Stanley, 1990, FEAR AND COURAGE; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; SENECA, 1969, COMMUNICATION, P95; Spielberger C. D., 1983, MIND GARDEN; Straube T, 2006, NEUROIMAGE, V29, P125, DOI 10.1016/j.neuroimage.2005.07.007; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357	56	62	64	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					949	962		10.1016/j.neuron.2010.06.009	http://dx.doi.org/10.1016/j.neuron.2010.06.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	619HP	20620879	Bronze			2022-12-24	WOS:000279420800016
J	Aponte, Y; Atasoy, D; Sternson, SM				Aponte, Yexica; Atasoy, Deniz; Sternson, Scott M.			AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training	NATURE NEUROSCIENCE			English	Article							AGOUTI-RELATED-PROTEIN; NEUROPEPTIDE-Y; ARCUATE NUCLEUS; IN-VIVO; HYPOTHALAMIC CART; MICE; LEPTIN; MELANOCORTIN; RATS; STIMULATION	Two intermingled hypothalamic neuron populations specified by expression of agouti-related peptide (AGRP) or proopiomelanocortin (POMC) positively and negatively influence feeding behavior, respectively, possibly by reciprocally regulating downstream melanocortin receptors. However, the sufficiency of these neurons to control behavior and the relationship of their activity to the magnitude and dynamics of feeding are unknown. To measure this, we used channelrhodopsin-2 for cell type-specific photostimulation. Activation of only 800 AGRP neurons in mice evoked voracious feeding within minutes. The behavioral response increased with photoexcitable neuron number, photostimulation frequency and stimulus duration. Conversely, POMC neuron stimulation reduced food intake and body weight, which required melanocortin receptor signaling. However, AGRP neuron-mediated feeding was not dependent on suppressing this melanocortin pathway, indicating that AGRP neurons directly engage feeding circuits. Furthermore, feeding was evoked selectively over drinking without training or prior photostimulus exposure, which suggests that AGRP neurons serve a dedicated role coordinating this complex behavior.	[Aponte, Yexica; Atasoy, Deniz; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	sternsons@janelia.hhmi.org	Aponte, Yeka/AAL-4643-2020; Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018	Aponte, Yeka/0000-0002-5967-2579; Atasoy, Deniz/0000-0002-3325-8820; Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank G. Shtengel for assistance with photostimulation equipment and software, R. Shusterman for assistance with data analysis, H. Peng for image analysis tools, J. Osborne and T. Tabachnik for equipment design and fabrication, A. Arnold for imaging support, B. Shields and A. Hu for histology support, and J. Cox for mouse breeding and genotyping support. K. Svoboda, G. Murphy, J. Dudman, A. Lee, and S.E.R. Egnor commented on the manuscript. This research was funded by the Howard Hughes Medical Institute.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cowley MA, 2003, ANN NY ACAD SCI, V994, P175, DOI 10.1111/j.1749-6632.2003.tb03178.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; LEVINE AS, 1984, PEPTIDES, V5, P1025, DOI 10.1016/0196-9781(84)90165-7; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tolkamp BJ, 1999, ANIM BEHAV, V57, P807, DOI 10.1006/anbe.1998.1022; Tolkamp BJ, 1998, J THEOR BIOL, V194, P235, DOI 10.1006/jtbi.1998.0759; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; TSUJII S, 1989, BRAIN RES BULL, V23, P165, DOI 10.1016/0361-9230(89)90142-1; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	34	694	708	9	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					351	355		10.1038/nn.2739	http://dx.doi.org/10.1038/nn.2739			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21209617	Green Accepted			2022-12-24	WOS:000287650100016
J	Bernacchia, A; Seo, H; Lee, D; Wang, XJ				Bernacchia, Alberto; Seo, Hyojung; Lee, Daeyeol; Wang, Xiao-Jing			A reservoir of time constants for memory traces in cortical neurons	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MIXED-STRATEGY GAME; PRIMATE PREFRONTAL CORTEX; DECISION-MAKING; WORKING-MEMORY; COMPETITIVE GAME; DOPAMINE NEURONS; NEURAL-NETWORKS; RHESUS-MONKEYS; REWARD SIGNALS	According to reinforcement learning theory of decision making, reward expectation is computed by integrating past rewards with a fixed timescale. In contrast, we found that a wide range of time constants is available across cortical neurons recorded from monkeys performing a competitive game task. By recognizing that reward modulates neural activity multiplicatively, we found that one or two time constants of reward memory can be extracted for each neuron in prefrontal, cingulate and parietal cortex. These timescales ranged from hundreds of milliseconds to tens of seconds, according to a power law distribution, which is consistent across areas and reproduced by a 'reservoir' neural network model. These neuronal memory timescales were weakly, but significantly, correlated with those of monkey's decisions. Our findings suggest a flexible memory system in which neural subpopulations with distinct sets of long or short memory timescales may be selectively deployed according to the task demands.	[Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA	Yale University; Yale University	Wang, XJ (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	xjwang@yale.edu	Seo, Hyojung/A-6860-2008; Lee, Daeyeol/A-6794-2008; Wang, Xiao-Jing/D-2722-2009	Lee, Daeyeol/0000-0003-3474-019X; 	US National Institutes of Health [R01 MH062349, R01 MH073246, DA029330]; Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073246, R01MH062349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029330] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Mazer and M. W. Jung for comments on an earlier version of the manuscript, and R. Chaudhuri, M. Harre and J. Murray for discussions. This work was supported by the US National Institutes of Health grant R01 MH062349 and the Swartz Foundation (A. B. and X.-J.W.), and by US National Institutes of Health grants R01 MH073246 (X.-J.W. and D. L.) and DA029330 (D.L.).	Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Bromberg-Martin ES, 2010, NEURON, V67, P499, DOI 10.1016/j.neuron.2010.06.031; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Ganguli S, 2008, NEURON, V58, P15, DOI 10.1016/j.neuron.2008.01.038; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jaegera H, 2007, NEURAL NETWORKS, V20, P335, DOI 10.1016/j.neunet.2007.04.016; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kim S, 2009, NEURAL NETWORKS, V22, P294, DOI 10.1016/j.neunet.2009.03.010; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Lapish CC, 2008, P NATL ACAD SCI USA, V105, P11963, DOI 10.1073/pnas.0804045105; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Passingham D, 2004, CURR OPIN NEUROBIOL, V14, P163, DOI 10.1016/j.conb.2004.03.003; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Soltani A, 2006, NEURAL NETWORKS, V19, P1075, DOI 10.1016/j.neunet.2006.05.044; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Trefethen L. N., 2020, SPECTRA PSEUDOSPECTR, P133; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034	50	183	183	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					366	372		10.1038/nn.2752	http://dx.doi.org/10.1038/nn.2752			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21317906	Green Accepted			2022-12-24	WOS:000287650100018
J	Diekelmann, S; Buchel, C; Born, J; Rasch, B				Diekelmann, Susanne; Buechel, Christian; Born, Jan; Rasch, Bjoern			Labile or stable: opposing consequences for memory when reactivated during waking and sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; SLOW-WAVE SLEEP; PROTEIN-SYNTHESIS; DECLARATIVE MEMORY; PREFRONTAL CORTEX; FEAR MEMORIES; RECONSOLIDATION; CONSOLIDATION; HIPPOCAMPUS; RETRIEVAL	Memory consolidation is a dynamic process. Reconsolidation theory assumes that reactivation during wakefulness transiently destabilizes memories, requiring them to reconsolidate in order to persist. Memory reactivation also occurs during slow-wave sleep (SWS) and is assumed to underlie the consolidating effect of sleep. Here, we tested whether the same principle of transient destabilization applies to memory reactivation during SWS. We reactivated memories in humans by presenting associated odor cues either during SWS or wakefulness. Reactivation was followed by an interference task to probe memory stability. As we expected, reactivation during waking destabilized memories. In contrast, reactivation during SWS immediately stabilized memories, thereby directly increasing their resistance to interference. Functional magnetic resonance imaging revealed that reactivation during SWS mainly activated hippocampal and posterior cortical regions, whereas reactivation during wakefulness primarily activated prefrontal cortical areas. Our results show that reactivation of memory serves distinct functions depending on the brain state of wakefulness or sleep.	[Diekelmann, Susanne; Born, Jan; Rasch, Bjoern] Univ Tubingen, Dept Med Psychol & Neurobiol, Tubingen, Germany; [Diekelmann, Susanne; Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Rasch, Bjoern] Univ Basel, Div Cognit Neurosci, Basel, Switzerland	Eberhard Karls University of Tubingen; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel	Rasch, B (corresponding author), Univ Tubingen, Dept Med Psychol & Neurobiol, Tubingen, Germany.	born@kfg.mu-luebeck.de; bjoern.rasch@unibas.ch	Born, Jan/K-2596-2016; Rasch, Bjorn/A-3119-2015	Born, Jan/0000-0002-1847-6248; Rasch, Bjorn/0000-0001-7607-3415	Deutsche Forschungsgemeinschaft [SFB 654, SFB TR 58]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank I. Wilhelm for helpful discussions and J. Martens, F. Hobrack, M. Palm and K. Muller for assistance with data collection. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 654 and SFB TR 58).	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Payne JD, 2009, NEUROBIOL LEARN MEM, V92, P327, DOI 10.1016/j.nlm.2009.03.007; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Polyn SM, 2008, TRENDS COGN SCI, V12, P24, DOI 10.1016/j.tics.2007.10.010; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rodriguez WA, 1999, PROG NEURO-PSYCHOPH, V23, P1285, DOI 10.1016/S0278-5846(99)00063-9; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schwabe L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007519; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Stickgold R, 2007, NAT NEUROSCI, V10, P540, DOI 10.1038/nn0507-540; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	46	232	239	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					381	386		10.1038/nn.2744	http://dx.doi.org/10.1038/nn.2744			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	725MW	21258327				2022-12-24	WOS:000287650100020
J	Hochmuth, CE; Biteau, B; Bohmann, D; Jasper, H				Hochmuth, Christine E.; Biteau, Benoit; Bohmann, Dirk; Jasper, Heinrich			Redox Regulation by Keap1 and Nrf2 Controls Intestinal Stem Cell Proliferation in Drosophila	CELL STEM CELL			English	Article							OXIDATIVE STRESS; REACTIVE OXYGEN; SELF-RENEWAL; DUAL OXIDASE; LIFE-SPAN; HOMEOSTASIS; PATHWAY; MIDGUT; DIFFERENTIATION; ACTIVATION	In Drosophila, intestinal stem cells (ISCs) respond to oxidative challenges and inflammation by increasing proliferation rates. This phenotype is part of a regenerative response, but can lead to hyperproliferation and epithelial degeneration in the aging animal. Here we show that Nrf2, a master regulator of the cellular redox state, specifically controls the proliferative activity of ISCs, promoting intestinal homeostasis. We find that Nrf2 is constitutively active in ISCs and that repression of Nrf2 by its negative regulator Keap1 is required for ISC proliferation. We further show that Nrf2 and Keap1 exert this function in ISCs by regulating the intracellular redox balance. Accordingly, loss of Nrf2 in ISCs causes accumulation of reactive oxygen species and accelerates age-related degeneration of the intestinal epithelium. Our findings establish Keap1 and Nrf2 as a critical redox management system that regulates stem cell function in high-turnover tissues.	[Hochmuth, Christine E.; Biteau, Benoit; Jasper, Heinrich] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Bohmann, Dirk] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14620 USA	University of Rochester; University of Rochester	Jasper, H (corresponding author), Univ Rochester, Dept Biol, River Campus Box 270211, Rochester, NY 14627 USA.	henri_jasper@urmc.rochester.edu			National Institute on Aging [NIH RO1 AG028127]; NYSTEM [N08G-048]; Ellison Medical Foundation [AG-SS-2224-08]; AFAR/Ellison postdoctoral fellowship; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NYSTEM; Ellison Medical Foundation(Lawrence Ellison Foundation); AFAR/Ellison postdoctoral fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIH RO1 AG028127 to H.J.), NYSTEM (grant # N08G-048), and the Ellison Medical Foundation (AG-SS-2224-08), as well as an AFAR/Ellison postdoctoral fellowship to B.B. We would like to thank Mark Noble for comments and Olga Dunaevsky for technical assistance.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McMahon M, 2001, CANCER RES, V61, P3299; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Radyuk SN, 2003, BIOCHEM J, V371, P743, DOI 10.1042/BJ20021522; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Toledano MB, 2010, CELL, V140, P454, DOI 10.1016/j.cell.2010.02.003; Toledano MB, 2009, MOL CELL, V34, P637, DOI 10.1016/j.molcel.2009.06.005; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Veraksa A, 2000, DEVELOPMENT, V127, P4023; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	49	249	257	4	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					188	199		10.1016/j.stem.2010.12.006	http://dx.doi.org/10.1016/j.stem.2010.12.006			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295275	Green Accepted, Bronze			2022-12-24	WOS:000287633400012
J	Bickart, KC; Wright, CI; Dautoff, RJ; Dickerson, BC; Barrett, LF				Bickart, Kevin C.; Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman			Amygdala volume and social network size in humans	NATURE NEUROSCIENCE			English	Article							BRAIN; PRIMATES	We found that amygdala volume correlates with the size and complexity of social networks in adult humans. An exploratory analysis of subcortical structures did not find strong evidence for similar relationships with any other structure, but there were associations between social network variables and cortical thickness in three cortical areas, two of them with amygdala connectivity. These findings indicate that the amygdala is important in social behavior.	[Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Massachusetts Gen Hosp, Psychiat Neuroimaging Res Program, Charlestown, MA 02129 USA; [Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Harvard Univ, Sch Med, Charlestown, MA USA; [Bickart, Kevin C.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Wright, Christopher I.; Dautoff, Rebecca J.; Dickerson, Bradford C.; Barrett, Lisa Feldman] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Dickerson, Bradford C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dickerson, Bradford C.] Harvard Univ, Sch Med, Boston, MA USA; [Barrett, Lisa Feldman] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Northeastern University	Barrett, LF (corresponding author), Massachusetts Gen Hosp, Psychiat Neuroimaging Res Program, Charlestown, MA 02129 USA.	l.barrett@neu.edu	Barrett, Lisa Feldman/ABC-8157-2020		US National Institutes of Health [DP1OD003312]; US National Institute on Aging [R01-AG030311, R01-AG029411, R21-AG29840]; NATIONAL INSTITUTE ON AGING [R01AG029411, R21AG029840, R01AG030311] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003312] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Michael Brickhouse for assistance with morphometric analyses. This study was supported by grants from the US National Institutes of Health Director's Pioneer Award (DP1OD003312) and the US National Institute on Aging (R01-AG030311, R01-AG029411 and R21-AG29840).	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Barger N, 2007, AM J PHYS ANTHROPOL, V134, P392, DOI 10.1002/ajpa.20684; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Barton RA., 2000, AMYGDALA FUNCTIONAL, P480; Buchanan T., 2009, HUMAN AMYGDALA, P289; Cohen Sheldon, 1997, JAMA (Journal of the American Medical Association), V277, P1940, DOI 10.1001/jama.277.24.1940; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Freese J. L., 2009, HUMAN AMYGDALA, P3; Gurung RAR, 2003, PSYCHOL AGING, V18, P487, DOI 10.1037/0882-7974.18.3.487; Lewis KP, 2006, J COMP PSYCHOL, V120, P31, DOI 10.1037/0735-7036.120.1.31; O'Brien LM, 2006, HARVARD REV PSYCHIAT, V14, P141, DOI 10.1080/10673220600784119; RUSSELL D, 1984, J PERS SOC PSYCHOL, V46, P1313, DOI 10.1037/0022-3514.46.6.1313; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	15	322	323	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					163	164		10.1038/nn.2724	http://dx.doi.org/10.1038/nn.2724			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21186358	Green Published, Green Accepted			2022-12-24	WOS:000286595400012
J	Wang, X; Vaingankar, V; Soto-Sanchez, C; Sommer, FT; Hirsch, JA				Wang, Xin; Vaingankar, Vishal; Soto-Sanchez, Cristina; Sommer, Friedrich T.; Hirsch, Judith A.			Thalamic interneurons and relay cells use complementary synaptic mechanisms for visual processing	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; METABOTROPIC GLUTAMATE RECEPTORS; A-LAMINAE; PERIGENICULATE NUCLEUS; AXON COLLATERALS; CAT; NEURONS; INHIBITION; ORGANIZATION	Synapses made by local interneurons dominate the thalamic circuits that process signals traveling from the eye downstream. The anatomical and physiological differences between interneurons and the (relay) cells that project to cortex are vast. To explore how these differences might influence visual processing, we made intracellular recordings from both classes of cells in vivo in cats. Macroscopically, all receptive fields were similar, consisting of two concentrically arranged subregions in which dark and bright stimuli elicited responses of the reverse sign. Microscopically, however, the responses of the two types of cells had opposite profiles. Excitatory stimuli drove trains of single excitatory postsynaptic potentials in relay cells, but graded depolarizations in interneurons. Conversely, suppressive stimuli evoked smooth hyperpolarizations in relay cells and unitary inhibitory postsynaptic potentials in interneurons. Computational analyses suggested that these complementary patterns of response help to preserve information encoded in the fine timing of retinal spikes and to increase the amount of information transmitted to cortex.	[Wang, Xin; Vaingankar, Vishal; Soto-Sanchez, Cristina; Hirsch, Judith A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Wang, Xin; Vaingankar, Vishal; Soto-Sanchez, Cristina; Hirsch, Judith A.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Sommer, Friedrich T.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA	University of Southern California; University of Southern California; University of California System; University of California Berkeley	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013; Sánchez, Cristina Soto/Y-8008-2018	Soto-Sanchez, Cristina/0000-0003-4447-5967	US National Institutes of Health [EY09593]; Redwood Center for Theoretical Neuroscience; National Science Foundation [IIS-0713657]; NATIONAL EYE INSTITUTE [R01EY009593, R29EY009593] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Redwood Center for Theoretical Neuroscience; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to L. M. Martinez for discussions throughout the project and thank Q. Wang for custom software. J. Provost, S. X. X. Xing, B. Gary, M. Bathen and M. Gerstmar reconstructed labeled cells, and M. Gerstmar also assisted with event sorting. This work was supported by the US National Institutes of Health (EY09593, J. A. H.), the Redwood Center for Theoretical Neuroscience (F. T. S.) and the National Science Foundation (IIS-0713657, F. T. S.).	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Blitz DM, 2003, J NEUROPHYSIOL, V90, P2438, DOI 10.1152/jn.00562.2003; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; BULLIER J, 1979, J NEUROPHYSIOL, V42, P274, DOI 10.1152/jn.1979.42.1.274; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; Coomes DL, 2002, J COMP NEUROL, V453, P45, DOI 10.1002/cne.10387; Cox CL, 2003, J NEUROSCI, V23, P7642; CUCCHIARO JB, 1991, J COMP NEUROL, V310, P316, DOI 10.1002/cne.903100304; Dan Y, 1996, J NEUROSCI, V16, P3351; Datskovskaia A, 2001, J COMP NEUROL, V430, P85, DOI 10.1002/1096-9861(20010129)430:1<85::AID-CNE1016>3.0.CO;2-K; Denning KS, 2005, J NEUROSCI, V25, P3531, DOI 10.1523/JNEUROSCI.4417-04.2005; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; DUBIN MW, 1977, J NEUROPHYSIOL, V40, P410, DOI 10.1152/jn.1977.40.2.410; FITZPATRICK D, 1984, J NEUROSCI, V4, P1809; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; FRISHMAN LJ, 1983, J PHYSIOL-LONDON, V339, P475, DOI 10.1113/jphysiol.1983.sp014728; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Godwin DW, 1996, J NEUROSCI, V16, P8181; Govindaiah G, 2006, J NEUROSCI, V26, P13443, DOI 10.1523/JNEUROSCI.3578-06.2006; Granseth B, 2003, J NEUROPHYSIOL, V89, P2952, DOI 10.1152/jn.01160.2002; GUILLERY RW, 1966, J COMP NEUROL, V128, P21, DOI 10.1002/cne.901280104; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P39, DOI 10.1007/BF00321475; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HIRSCH JC, 1987, NEUROSCIENCE, V23, P457, DOI 10.1016/0306-4522(87)90069-8; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; HUMPHREY AL, 1988, J COMP NEUROL, V268, P448, DOI 10.1002/cne.902680312; Koepsell K, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.004.2009; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MASTRONARDE DN, 1992, VISUAL NEUROSCI, V8, P407, DOI 10.1017/S0952523800004934; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; PAPE HC, 1995, NEUROSCIENCE, V68, P1105, DOI 10.1016/0306-4522(95)00205-W; PASIK P, 1976, EXP BRAIN RES, V25, P1; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; SHERMAN SM, 1988, EXP BRAIN RES, V73, P384; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; WILSON JR, 1989, J NEUROSCI, V9, P2931; Wilson JR, 1996, VISUAL NEUROSCI, V13, P1129, DOI 10.1017/S095252380000777X	50	42	42	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					224	+		10.1038/nn.2707	http://dx.doi.org/10.1038/nn.2707			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21170053	Green Accepted			2022-12-24	WOS:000286595400020
J	Jiang, HQ; Grenley, MO; Bravo, MJ; Blumhagen, RZ; Edgar, BA				Jiang, Huaqi; Grenley, Marc O.; Bravo, Maria-Jose; Blumhagen, Rachel Z.; Edgar, Bruce A.			EGFR/Ras/MAPK Signaling Mediates Adult Midgut Epithelial Homeostasis and Regeneration in Drosophila	CELL STEM CELL			English	Article							STEM-CELL PROLIFERATION; METASTATIC COLORECTAL-CANCER; GROWTH-FACTOR RECEPTOR; ONCOGENIC K-RAS; EGF RECEPTOR; BACTERIAL-INFECTION; TGF-ALPHA; TISSUE HOMEOSTASIS; SELF-RENEWAL; COLON	Many tissues in higher animals undergo dynamic homeostatic growth, wherein damaged or aged cells are replaced by the progeny of resident stem cells. TO maintain homeostasis, stem cells must respond to tissue needs. Here we show that in response to damage or stress in the intestinal (midgut) epithelium of adult Drosophila, multiple EGFR ligands and rhomboids (intramembrane proteases that activate some EGFR ligands) are induced, leading to the activation of EGFR signaling in intestinal stem cells (ISCs). Activation of EGFR signaling promotes ISC division and midgut epithelium regeneration, thereby maintaining tissue homeostasis. ISCs defective in EGFR signaling cannot grow or divide, are poorly maintained, and cannot support midgut epithelium regeneration after enteric infection by the bacterium Pseudomonas entomophila. Furthermore, ISC proliferation induced by Jak/Stat signaling is dependent upon EGFR signaling. Thus the EGFR/Ras/MAPK signaling pathway plays central, essential roles in ISC maintenance and the feedback system that mediates intestinal homeostasis.	[Jiang, Huaqi; Grenley, Marc O.; Bravo, Maria-Jose; Blumhagen, Rachel Z.; Edgar, Bruce A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Edgar, Bruce A.] German Canc Res Ctr, Ctr Mol Biol Heidelberg ZMBH Alliance, D-69120 Heidelberg, Germany	Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ)	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	b.edgar@dkfz.de			NIH [R01 GM51186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051186] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Celeste Berg, Denise Montell, Gyeong-Hun Baeg, Erika Bach, Jocelyn McDonald, Matthew Freeman, and the VDRC (Austria), NIG (Japan), Bloomington (USA) Drosophila Stock Centers for fly stocks; the Moen's lab for confocal imaging; Xiaohang Yang for Pdm-1 antibody; David D. O'Keefe for advice on anti-dpERK staining; and members of the B.A.E. lab for comments. This work was supported by NIH grant R01 GM51186 to B.A.E.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Bilger A, 2008, CARCINOGENESIS, V29, P1825, DOI 10.1093/carcin/bgn038; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; CLIFFORD RJ, 1989, GENETICS, V123, P771; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gabay L, 1997, DEVELOPMENT, V124, P3535; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Karim FD, 1998, DEVELOPMENT, V125, P1; Lee D, 2004, MOL CELL BIOL, V24, P8907, DOI 10.1128/MCB.24.20.8907-8916.2004; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nishimura T, 2008, ONCOL REP, V19, P105; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reich A, 2002, EMBO J, V21, P4287, DOI 10.1093/emboj/cdf439; Rintelen F, 2003, DEVELOPMENT, V130, P3479, DOI 10.1242/dev.00568; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schnepp B, 1998, GENE DEV, V12, P908, DOI 10.1101/gad.12.7.908; Schnorr JD, 1996, GENETICS, V144, P1545; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Troyer KL, 2001, GASTROENTEROLOGY, V121, P68, DOI 10.1053/gast.2001.25478; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645	56	316	325	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					84	95		10.1016/j.stem.2010.11.026	http://dx.doi.org/10.1016/j.stem.2010.11.026			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21167805	Green Accepted, Bronze			2022-12-24	WOS:000286786200013
J	Harris, JA; Devidze, N; Verret, L; Ho, K; Halabisky, B; Thwin, MT; Kim, D; Hamto, P; Lo, I; Yu, GQ; Palop, JJ; Masliah, E; Mucke, L				Harris, Julie A.; Devidze, Nino; Verret, Laure; Ho, Kaitlyn; Halabisky, Brian; Thwin, Myo T.; Kim, Daniel; Hamto, Patricia; Lo, Iris; Yu, Gui-Qiu; Palop, Jorge J.; Masliah, Eliezer; Mucke, Lennart			Transsynaptic Progression of Amyloid-beta-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network	NEURON			English	Article							IMPAIR SYNAPTIC PLASTICITY; TRANSGENIC MOUSE MODELS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SPATIAL MEMORY; RETROSPLENIAL CORTEX; INTERSTITIAL FLUID; GENE-EXPRESSION; ANIMAL-MODEL; MICE	The entorhinal cortex (EC) is one of the earliest affected, most vulnerable brain regions in Alzheimer's disease (AD), which is associated with amyloid-beta (A beta) accumulation in many brain areas. Selective overexpression of mutant amyloid precursor protein (APP) predominantly in layer II/III neurons of the EC caused cognitive and behavioral abnormalities characteristic of mouse models with widespread neuronal APP overexpression, including hyperactivity, disinhibition, and spatial learning and memory deficits. APP/A beta overexpression in the EC elicited abnormalities in synaptic functions and activity-related molecules in the dentate gyrus and CA1 and epileptiform activity in parietal cortex. Soluble A beta was observed in the dentate gyrus, and A beta deposits in the hippocampus were localized to perforant pathway terminal fields. Thus, APP/A beta expression in EC neurons causes transsynaptic deficits that could initiate the cortical-hippocampal network dysfunction in mouse models and human patients with AD.	[Harris, Julie A.; Devidze, Nino; Verret, Laure; Ho, Kaitlyn; Halabisky, Brian; Thwin, Myo T.; Kim, Daniel; Hamto, Patricia; Lo, Iris; Yu, Gui-Qiu; Palop, Jorge J.; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Harris, Julie A.; Verret, Laure; Halabisky, Brian; Palop, Jorge J.; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lmucke@gladstone.ucsf.edu	Verret, Laure/D-2219-2011; Palop, Jorge/AAH-9014-2020; Verret, Laure/D-9224-2017; Palop, Jorge J./D-8128-2011	Verret, Laure/0000-0001-5272-6063; Verret, Laure/0000-0001-5272-6063; Palop, Jorge/0000-0001-6086-1070	NIH [AG011385, AG022074]; McBean Foundation; NATIONAL INSTITUTE ON AGING [R01AG011385, P01AG022074, R37AG011385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McBean Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants AG011385 and AG022074 to L.M. and a fellowship from the McBean Foundation to J.A.H. We thank Mark Mayford for providing neuropsin-tTA mice, David Borchelt for donating the tet-APP mice to Jackson Laboratory, M. Howard for help with electrophysiological recordings, X. Wang and H. Solanoy for technical support, S. Ordway for editorial review, and M. De la Cruz for administrative assistance.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Albasser MM, 2007, EUR J NEUROSCI, V26, P1254, DOI 10.1111/j.1460-9568.2007.05753.x; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, J ALZHEIMERS DIS, V9, P35; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Garcia-Alloza M, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-19; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; He J, 2002, NEUROPSYCHOPHARMACOL, V26, P259, DOI 10.1016/S0893-133X(01)00332-3; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Jones BF, 2007, HIPPOCAMPUS, V17, P957, DOI 10.1002/hipo.20330; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lazarov O, 2002, J NEUROSCI, V22, P9785; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Masdeu JC, 2005, J NEUROL SCI, V236, P55, DOI 10.1016/j.jns.2005.05.001; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Molinari S, 1996, P NATL ACAD SCI USA, V93, P8028, DOI 10.1073/pnas.93.15.8028; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ognibene E, 2005, BEHAV BRAIN RES, V156, P225, DOI 10.1016/j.bbr.2004.05.028; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Ramirez JJ, 2007, NEUROBIOL LEARN MEM, V87, P264, DOI 10.1016/j.nlm.2006.09.002; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROBERTS GW, 1993, NEUROREPORT, V4, P7, DOI 10.1097/00001756-199301000-00001; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheng JG, 2002, J NEUROSCI, V22, P9794; Spencer B, 2007, EXPERT OPIN BIOL TH, V7, P1853, DOI 10.1517/14712598.7.12.1853; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Wu William, 2006, Current Alzheimer Research, V3, P529, DOI 10.2174/156720506779025161; WYSS JM, 1992, HIPPOCAMPUS, V2, P1; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035	92	231	246	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					428	441		10.1016/j.neuron.2010.10.020	http://dx.doi.org/10.1016/j.neuron.2010.10.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040845	Green Accepted, Bronze			2022-12-24	WOS:000284255800012
J	Korotkova, T; Fuchs, EC; Ponomarenko, A; von Engelhardt, J; Monyer, H				Korotkova, Tatiana; Fuchs, Elke C.; Ponomarenko, Alexey; von Engelhardt, Jakob; Monyer, Hannah			NMDA Receptor Ablation on Parvalbumin-Positive Interneurons Impairs Hippocampal Synchrony, Spatial Representations, and Working Memory	NEURON			English	Article							SOURCE DENSITY ANALYSIS; THETA-RHYTHM; GAMMA OSCILLATIONS; RAT HIPPOCAMPUS; BEHAVING RAT; POTENTIAL OSCILLATIONS; TARGETED DISRUPTION; INHIBITORY NEURONS; ENTORHINAL CORTEX; PHASE-PRECESSION	Activity of parvalbumin-positive hippocampal interneurons is critical for network synchronization but the receptors involved therein have remained largely unknown. Here we report network and behavioral deficits in mice with selective ablation of NMDA receptors in parvalbumin-positive interneurons (NR1(PVCre-/-)). Recordings of local field potentials and unitary neuronal activity in the hippocampal CA1 area revealed altered theta oscillations (5-10 Hz) in freely behaving NR1(PVCre-/-) mice. Moreover, in contrast to controls, in NR1(PVCre-/-) mice the remaining theta rhythm was abolished by the administration of atropine. Gamma oscillations (35-85 Hz) were increased and less modulated by the concurrent theta rhythm in the mutant. Positional firing of pyramidal cells in NR1(PVCre-/-) mice was less spatially and temporally precise. Finally, NR1(PVCre-/-) mice exhibited impaired spatial working as well as spatial short- and long-term recognition memory but showed no deficits in open field exploratory activity and spatial reference learning.	[Korotkova, Tatiana; Fuchs, Elke C.; Ponomarenko, Alexey; von Engelhardt, Jakob; Monyer, Hannah] IZN, Dept Clin Neurobiol, D-69120 Heidelberg, Germany		Monyer, H (corresponding author), German Canc Res Ctr, INF 280, D-69120 Heidelberg, Germany.	monyer@urz.uni-hd.de	von Engelhardt, Jakob/AAD-4920-2021; Ponomarenko, Alexey/F-7783-2017; von Engelhardt, Jakob/G-7397-2015	von Engelhardt, Jakob/0000-0003-3861-3294; Ponomarenko, Alexey/0000-0002-5185-0107; von Engelhardt, Jakob/0000-0003-3861-3294; Monyer, Hannah/0000-0002-9332-5749	Schilling Foundation; DFG; Leibniz Society	Schilling Foundation; DFG(German Research Foundation (DFG)); Leibniz Society	We wish to thank Drs. P.H. Seeburg and F. Single for providing the "floxed" NR1 mouse line; and Drs. K. Allen, A. Caputi and E. Reznik for inspiring discussions; and U. Amtmann, I. Preugschat-Gumprecht, R. Hinz and A. Sergiyenko for expert technical assistance. This work was supported by the Schilling Foundation, by the DFG (Leibniz Award to H.M.), and in part by the Leibniz Society (to T.K. and A.P.).	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1983, BRAIN RES, V266, P334, DOI 10.1016/0006-8993(83)90665-0; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gulyas AI, 1999, J NEUROSCI, V19, P10082; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hentschke H, 2007, EUR J NEUROSCI, V26, P1642, DOI 10.1111/j.1460-9568.2007.05779.x; Horvath Z, 1988, SYNAPTIC PLASTICITY, P45; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; JEFFERY KJ, 1995, NEUROREPORT, V6, P2166, DOI 10.1097/00001756-199511000-00017; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kawabe K, 1998, BRAIN RES, V781, P300, DOI 10.1016/S0006-8993(97)01256-0; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; LI XG, 1992, EXP BRAIN RES, V90, P519; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; Ma JY, 2000, BEHAV BRAIN RES, V111, P1, DOI 10.1016/S0166-4328(00)00138-8; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MITCHELL SJ, 1982, J NEUROSCI, V2, P292; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Racz A, 2009, J NEUROSCI, V29, P2563, DOI 10.1523/JNEUROSCI.5036-08.2009; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Shin J, 2005, P NATL ACAD SCI USA, V102, P18165, DOI 10.1073/pnas.0505498102; SIK A, 1995, J NEUROSCI, V15, P6651; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Vanderwolf C.H., 1983, NEUROBIOLOGY HIPPOCA, P275; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106	87	337	340	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					557	569		10.1016/j.neuron.2010.09.017	http://dx.doi.org/10.1016/j.neuron.2010.09.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040854	Bronze			2022-12-24	WOS:000284255800021
J	Henriksen, EJ; Colgin, LL; Barnes, CA; Witter, MP; Moser, MB; Moser, EI				Henriksen, Espen J.; Colgin, Laura L.; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.			Spatial Representation along the Proximodistal Axis of CA1	NEURON			English	Article							FREELY-MOVING RAT; HIPPOCAMPAL PLACE CELLS; ENTORHINAL CORTEX; GRID CELLS; PHASE PRECESSION; EPISODIC MEMORY; INFORMATION; INPUT; SUBICULUM; LOCATION	CA1 cells receive direct input from space-responsive cells in medial entorhinal cortex (MEC), such as grid cells, as well as more nonspatial cells in lateral entorhinal cortex (LEC). Because MEC projects preferentially to the proximal part of the CA1, bordering CA2, whereas LEC innervates only the distal part, bordering subiculum, we asked if spatial tuning is graded along the transverse axis of CA1. Tetrodes were implanted along the entire proximodistal axis of dorsal CA1 in rats. Data were recorded in cylinders large enough to elicit firing at more than one location in many neurons. Distal CA1 cells showed more dispersed firing and had a larger number of firing fields than proximal cells. Phase-locking of spikes to MEC theta oscillations was weaker in distal CA1 than in proximal CA1. The findings suggest that spatial firing in CA1 is organized transversally, with the strongest spatial modulation occurring in the MEC-associated proximal part.	[Henriksen, Espen J.; Colgin, Laura L.; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway; [Henriksen, Espen J.; Colgin, Laura L.; Barnes, Carol A.; Witter, Menno P.; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway; [Barnes, Carol A.] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ 85724 USA; [Barnes, Carol A.] Univ Arizona, ARL Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Arizona; University of Arizona	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Colgin, Laura/0000-0002-4853-8913	Kavli Foundation, a Centre of Excellence; Norwegian Research Council [AG012609]; McKnight Brain Research Foundation; NATIONAL INSTITUTE ON AGING [R01AG012609, R37AG012609] Funding Source: NIH RePORTER	Kavli Foundation, a Centre of Excellence; Norwegian Research Council(Research Council of NorwayEuropean Commission); McKnight Brain Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T Kirkesola, S Leutgeb, L Lu. and H Stensland for advice and help with data acquisition. and A M Amundgard, K Haugen, K Jenssen, E Krakvik, R Skjerpeng, and H Waade for technical assistance The work was supported by the Kavli Foundation, a Centre of Excellence grant from the Norwegian Research Council, AG012609, and the McKnight Brain Research Foundation.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Knierim JJ, 2006, HIPPOCAMPUS, V16, P755, DOI 10.1002/hipo.20203; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser EI, 2008, HIPPOCAMPUS, V18, P1142, DOI 10.1002/hipo.20483; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1989, J NEUROSCI, V9, P4101; Naber PA, 1999, EUR J NEUROSCI, V11, P4119, DOI 10.1046/j.1460-9568.1999.00835.x; Naber PA, 2001, HIPPOCAMPUS, V11, P99, DOI 10.1002/hipo.1028; O'Keefe J, 1999, HIPPOCAMPUS, V9, P352, DOI 10.1002/(SICI)1098-1063(1999)9:4<352::AID-HIPO3>3.0.CO;2-1; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; SHARP PE, 1994, J NEUROSCI, V14, P2339; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stephan H., 1975, ALLOCORTEX HDB MIKRO; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; TAMAMAKI N, 1995, J COMP NEUROL, V353, P379, DOI 10.1002/cne.903530306; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Young BJ, 1997, J NEUROSCI, V17, P5183; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; ZHU XO, 1995, EUR J NEUROSCI, V7, P753, DOI 10.1111/j.1460-9568.1995.tb00679.x	50	173	175	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					127	137		10.1016/j.neuron.2010.08.042	http://dx.doi.org/10.1016/j.neuron.2010.08.042			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920796	Green Accepted, Bronze			2022-12-24	WOS:000283704200013
J	Milyavsky, M; Gan, OI; Trottier, M; Komosa, M; Tabach, O; Notta, F; Lechman, E; Hermans, KG; Eppert, K; Konovalova, Z; Ornatsky, O; Domany, E; Meyn, MS; Dick, JE				Milyavsky, Michael; Gan, Olga I.; Trottier, Magan; Komosa, Martin; Tabach, Ofer; Notta, Faiyaz; Lechman, Eric; Hermans, Karin G.; Eppert, Kolja; Konovalova, Zhanna; Ornatsky, Olga; Domany, Eytan; Meyn, M. Stephen; Dick, John E.			A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-Renewal	CELL STEM CELL			English	Article							DOUBLE-STRAND BREAKS; RADIATION SENSITIVITY; MAMMALIAN-CELLS; REPAIR; VIVO; PHENOTYPE; EXPANSION; CULTURE; BLOOD; MICE	Highly regenerative tissues such as blood must possess effective DNA damage responses (DDR) that balance long-term regeneration with protection from leukemogenesis. Hematopoietic stem cells (HSCs) sustain life-long blood production, yet their response to DNA damage remains largely unexplored. We report that human HSCs exhibit delayed DNA double-strand break rejoining, persistent gamma H2AX foci, and enhanced p53- and ASPP1-dependent apoptosis after gamma-radiation compared to progenitors. p53 inactivation or Bcl-2 overexpression reduced radiation-induced apoptosis and preserved in vivo repopulating HSC function. Despite similar protection from irradiation-induced apoptosis, only Bcl-2-overexpressing HSCs showed higher self-renewal capacity, establishing that intact p53 positively regulates self-renewal independently from apoptosis. The reduced self-renewal of HSCs with inactivated p53 was associated with increased spontaneous gamma H2AX foci in secondary transplants of HSCs. Our data reveal distinct physiological roles of p53 that together ensure optimal HSC function: apoptosis regulation and prevention of gamma H2AX foci accumulation upon HSC self-renewal.	[Milyavsky, Michael; Gan, Olga I.; Notta, Faiyaz; Lechman, Eric; Hermans, Karin G.; Eppert, Kolja; Konovalova, Zhanna; Dick, John E.] Univ Toronto, Dept Stem Cell & Dev Biol, Campbell Family Canc Res Inst,Univ Hlth Network, Ontario Canc Inst,Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada; [Milyavsky, Michael; Gan, Olga I.; Trottier, Magan; Notta, Faiyaz; Lechman, Eric; Hermans, Karin G.; Eppert, Kolja; Konovalova, Zhanna; Meyn, M. Stephen; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Ornatsky, Olga] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5G 1L7, Canada; [Meyn, M. Stephen] Univ Toronto, Dept Pediat, Toronto, ON M5G 1L7, Canada; [Trottier, Magan; Komosa, Martin; Meyn, M. Stephen] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Tabach, Ofer; Domany, Eytan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Weizmann Institute of Science	Dick, JE (corresponding author), Univ Toronto, Dept Stem Cell & Dev Biol, Campbell Family Canc Res Inst,Univ Hlth Network, Ontario Canc Inst,Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	DOMANY, EYTAN/K-1560-2012	Eppert, Kolja/0000-0001-9061-8856; Lechman, Eric/0000-0001-8874-2874; Dick, John/0000-0002-9527-8317	European Molecular Biology Organization (EMBO); European Hematology Association; The Netherland Society for Scientific Research (NOW); The Stem Cell Network of National Centers of Excellence; Canadian Cancer Society Research Institute; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; Premier's Summit Award funded from the province of Ontario; Leukemia and Lymphoma Society; Canadian Institutes for Health Research (CHIR); Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC)	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Hematology Association; The Netherland Society for Scientific Research (NOW); The Stem Cell Network of National Centers of Excellence; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; Premier's Summit Award funded from the province of Ontario; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes for Health Research (CHIR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank S. Harding and Dr. R.G. Bristow (Princess Margaret Hospital, Toronto, Ontario) for helping with immunofluorescent imaging; P. Scheufler, P. Savage, and the obstetrics unit of Trillium Hospital (Mississauga, Ontario) for providing cord blood samples and co-op students for processing cord blood samples; S. Zhao, L. Jamieson, and P.A. Penttila (Hospital for Sick Children, Toronto, Ontario) for sorting; and the J.E.D. lab members for critical review of the manuscript. This work was supported by postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and European Hematology Association and Canadian Institutes for Health Research (CIHR) (MM.) and The Netherland Society for Scientific Research (NOW) (K.G.H.) and grants from The Stem Cell Network of National Centers of Excellence, Canadian Cancer Society Research Institute, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research, Premier's Summit Award funded from the province of Ontario, Leukemia and Lymphoma Society, and Canadian Institutes for Health Research, and a Canada Research Chair. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Bertrand P, 2004, TRENDS GENET, V20, P235, DOI 10.1016/j.tig.2004.04.003; Chen JC, 2008, EXP HEMATOL, V36, P1236, DOI 10.1016/j.exphem.2008.04.012; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Danet GH, 2001, EXP HEMATOL, V29, P1465, DOI 10.1016/S0301-472X(01)00750-0; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Domen J, 2003, EXP HEMATOL, V31, P631, DOI 10.1016/S0301-472X(03)00084-5; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Dorrell C, 2000, BLOOD, V95, P102; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Gulston M, 2004, NUCLEIC ACIDS RES, V32, P1602, DOI 10.1093/nar/gkh306; JI WZ, 1995, CANCER RES, V55, P2876; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Meng AM, 2003, CANCER RES, V63, P5414; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Palacios R, 1996, P NATL ACAD SCI USA, V93, P5247, DOI 10.1073/pnas.93.11.5247; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; PROKOCIMER M, 1994, BLOOD, V84, P2391; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Raphael BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r59; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; VANBEKKUM DW, 1991, RADIAT RES, V128, pS4, DOI 10.2307/3577994; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WAGEMAKER G, 1995, STEM CELLS, V13, P257, DOI 10.1002/stem.5530130731; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wilson PF, 2010, MUTAT RES-FUND MOL M, V683, P91, DOI 10.1016/j.mrfmmm.2009.10.013; Wouters A, 2007, ONCOLOGIST, V12, P690, DOI 10.1634/theoncologist.12-6-690; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoshida K, 2002, LEUKEMIA RES, V26, P1085, DOI 10.1016/S0145-2126(02)00032-2	50	201	209	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					186	197		10.1016/j.stem.2010.05.016	http://dx.doi.org/10.1016/j.stem.2010.05.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20619763	Bronze			2022-12-24	WOS:000281107400011
J	Chakrabarti, L; Best, TK; Cramer, NP; Carney, RSE; Isaac, JTR; Galdzicki, Z; Haydar, TF				Chakrabarti, Lina; Best, Tyler K.; Cramer, Nathan P.; Carney, Rosalind S. E.; Isaac, John T. R.; Galdzicki, Zygmunt; Haydar, Tarik F.			Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome	NATURE NEUROSCIENCE			English	Article							TS65DN MOUSE MODEL; LONG-TERM POTENTIATION; CORTICAL INTERNEURONS; FRONTAL-CORTEX; SPECIFICATION; EXPRESSION; HIPPOCAMPUS; FOREBRAIN; PHENOTYPE; DEFICITS	Over-inhibition is thought to be one of the underlying causes of the cognitive deficits in Ts65Dn mice, the most widely used model of Down syndrome. We found a direct link between gene triplication and defects in neuron production during embryonic development. These neurogenesis defects led to an imbalance between excitatory and inhibitory neurons and to increased inhibitory drive in the Ts65Dn forebrain. We discovered that Olig1 and Olig2, two genes that are triplicated in Down syndrome and in Ts65Dn mice, were overexpressed in the Ts65Dn forebrain. To test the hypothesis that Olig triplication causes the neurological phenotype, we used a genetic approach to normalize the dosage of these two genes and thereby rescued the inhibitory neuron phenotype in the Ts65Dn brain. These data identify seminal alterations during brain development and suggest a mechanistic relationship between triplicated genes and these brain abnormalities in the Ts65Dn mouse.	[Chakrabarti, Lina; Carney, Rosalind S. E.; Haydar, Tarik F.] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Best, Tyler K.; Cramer, Nathan P.; Galdzicki, Zygmunt] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Isaac, John T. R.] NINDS, Dev Synapt Plast Sect, Bethesda, MD 20892 USA	Children's National Health System; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Haydar, TF (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	thaydar@bu.edu		Cramer, Nathan/0000-0001-6146-3664; Haydar, Tarik/0000-0001-6772-3076	Dana Foundation; National Down Syndrome Society; Jerome Lejeune Foundation; Uniformed Services University of the Health Sciences; Intellectual and Developmental Disabilities Research Center [P30 HD40677];  [RO1 HD05780]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, R01NS076503] Funding Source: NIH RePORTER	Dana Foundation; National Down Syndrome Society; Jerome Lejeune Foundation; Uniformed Services University of the Health Sciences; Intellectual and Developmental Disabilities Research Center; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank V. Gallo, J. Corbin, and members of Corbin and Haydar laboratories for discussions and critical reading of the manuscript. This work was supported by a Dana Foundation Neuro-Immuno Imaging grant (T. F. H.), RO1 HD05780 (T. F. H. and Z.G.), the National Down Syndrome Society (L. C.), the Jerome Lejeune Foundation (Z.G.), Uniformed Services University of the Health Sciences (Z.G.) and a gift from Robin and Rob Wilder. Imaging was supported by the Intellectual and Developmental Disabilities Research Center (P30 HD40677).	Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Clark S, 2006, EXP NEUROL, V200, P256, DOI 10.1016/j.expneurol.2006.02.005; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Cortez MA, 2009, PEDIATR RES, V65, P499, DOI 10.1203/PDR.0b013e31819d9076; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; EPSTEIN CJ, 1986, EXPERIENTIA, V42, P1117, DOI 10.1007/BF01941286; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Harashima C, 2006, J COMP NEUROL, V494, P815, DOI 10.1002/cne.20844; Haydar TF, 2005, MENT RETARD DEV D R, V11, P303, DOI 10.1002/mrdd.20088; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KORENBERG JR, 1990, AM J MED GENET, P91; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Perez-Cremades D, 2010, J NEURAL TRANSM, V117, P445, DOI 10.1007/s00702-010-0376-9; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; PORTEUS MH, 1991, NEURON, V7, P221, DOI 10.1016/0896-6273(91)90260-7; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; SEGAL DJ, 1974, J CELL PHYSL, V90, P83; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Valcanis H, 2003, J NEUROSCI, V23, P5113; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	152	152	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					927	U39		10.1038/nn.2600	http://dx.doi.org/10.1038/nn.2600			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20639873	Green Accepted			2022-12-24	WOS:000280400600010
J	Kantak, SS; Sullivan, KJ; Fisher, BE; Knowlton, BJ; Winstein, CJ				Kantak, Shailesh S.; Sullivan, Katherine J.; Fisher, Beth E.; Knowlton, Barbara J.; Winstein, Carolee J.			Neural substrates of motor memory consolidation depend on practice structure	NATURE NEUROSCIENCE			English	Article							CORTEX	Motor-skill practice drives subsequent offline activity in functionally related resting human brain networks. We investigated the manner in which offline neural networks are modulated by practice structures that affect motor-skill retention. Interference to dorsolateral-prefrontal cortex (DLPFC), but not to primary motor cortex (M1), after variable practice attenuated motor-skill retention, whereas interference to M1, but not to DLPFC, after constant practice attenuated motor-skill retention. We conclude that neural substrates of motor-memory consolidation are modulated by practice structure.	[Kantak, Shailesh S.; Sullivan, Katherine J.; Fisher, Beth E.; Winstein, Carolee J.] Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Motor Behav & Neurorehabil Lab, Los Angeles, CA 90089 USA; [Kantak, Shailesh S.; Fisher, Beth E.] Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Neuroplast & Imaging Lab, Los Angeles, CA USA; [Knowlton, Barbara J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Winstein, Carolee J.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of Southern California	Winstein, CJ (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Biokinesiol & Phys Therapy, Motor Behav & Neurorehabil Lab, Los Angeles, CA 90089 USA.	winstein@usc.edu	Fisher, Beth E/G-5430-2012	Winstein, Carolee/0000-0001-9789-4626	North American Society for the Psychology of Sport and Physical Activity; Graduate School of the University of Southern California	North American Society for the Psychology of Sport and Physical Activity; Graduate School of the University of Southern California	We thank E. M. Robertson for his thoughtful and constructive comments on an earlier version of the manuscript. The research was supported by a grant from the North American Society for the Psychology of Sport and Physical Activity and an Oakley Fellowship from the Graduate School of the University of Southern California.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Cahill L, 2001, TRENDS NEUROSCI, V24, P578, DOI 10.1016/S0166-2236(00)01885-3; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Lee T.D., 2004, SKILL ACQUISITION SP, P29; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Robertson EM, 2006, NEUROSCIENTIST, V12, P261, DOI 10.1177/1073858406287935; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2005, J NEUROSCI, V25, P6372, DOI 10.1523/JNEUROSCI.1851-05.2005; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SHEA CH, 1991, RES Q EXERCISE SPORT, V62, P187, DOI 10.1080/02701367.1991.10608709; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0	15	128	131	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					923	925		10.1038/nn.2596	http://dx.doi.org/10.1038/nn.2596			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	632DK	20622872				2022-12-24	WOS:000280400600009
J	Encinas, JM; Michurina, TV; Peunova, N; Park, JH; Tordo, J; Peterson, DA; Fishell, G; Koulakov, A; Enikolopov, G				Encinas, Juan M.; Michurina, Tatyana V.; Peunova, Natalia; Park, June-Hee; Tordo, Julie; Peterson, Daniel A.; Fishell, Gord; Koulakov, Alex; Enikolopov, Grigori			Division-Coupled Astrocytic Differentiation and Age-Related Depletion of Neural Stem Cells in the Adult Hippocampus	CELL STEM CELL			English	Article							DENTATE GYRUS; IMMUNOCYTOCHEMICAL ANALYSIS; PROGENITOR CELLS; SELF-RENEWAL; OLD-AGE; NEUROGENESIS; PROLIFERATION; QUIESCENT; NEURONS; BRAIN	Production of new neurons in the adult hippocampus decreases with age; this decline may underlie age-related cognitive impairment. Here we show that continuous depletion of the neural stem cell pool, as a consequence of their division, may contribute to the age-related decrease in hippocampal neurogenesis. Our results indicate that adult hippocampal stem cells, upon exiting their quiescent state, rapidly undergo a series of asymmetric divisions to produce dividing progeny destined to become neurons and subsequently convert into mature astrocytes. Thus, the decrease in the number of neural stem cells is a division-coupled process and is directly related to their production of new neurons. We present a scheme of the neurogenesis cascade in the adult hippocampus that includes a proposed "disposable stem cell" model and accounts for the disappearance of hippocampal neural stem cells, the appearance of new astrocytes, and the age-related decline in the production of new neurons.	[Encinas, Juan M.; Michurina, Tatyana V.; Peunova, Natalia; Park, June-Hee; Tordo, Julie; Koulakov, Alex; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, N Chicago, IL 60064 USA; [Peterson, Daniel A.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL 60064 USA; [Fishell, Gord] NYU, Sch Med, Smilow Neurosci Program, New York, NY 10016 USA	Cold Spring Harbor Laboratory; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; New York University	Enikolopov, G (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	enik@cshl.edu	Enikolopov, Grigori/P-5731-2019; Encinas, Juan Manuel/N-5906-2014; Encinas, Juan Manuel/ABB-5304-2020	Enikolopov, Grigori/0000-0001-8178-8917; Encinas, Juan Manuel/0000-0002-0402-972X; Encinas, Juan Manuel/0000-0002-0402-972X; Fishell, Gordon/0000-0002-9640-9278	National Institutes of Health; NIA; NICHD; NINDS; NIMH; NARSAD, NYSTEM; Ira Hazan Fund; Ellison Medical Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH081258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD, NYSTEM(NARSAD); Ira Hazan Fund; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Krimmer for help with experiments, A. Joyner (MSKCC) for the Gli1-CreER line, J. Samanta (NYU) for the animals, Y. Lazebnik and B. Earnshaw for advice, and A. Sierra (BCM) and J. Banerji (MGH) for insightful discussions and comments. J.M.E. is a recipient of a Young Investigator Award from NARSAD. This work was supported by grants from the National Institutes of Health: from NIA to D.A.P., from NICHD to G.F., from NINDS and NIMH to G.E., and from NARSAD, NYSTEM, the Ira Hazan Fund, and The Ellison Medical Foundation to G.E.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, J COMP NEUROL, V519, P6, DOI 10.1002/cne.22503; Enikolopov G, 2008, ADULT NEUROGENESIS; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Olariu A, 2007, J COMP NEUROL, V501, P659, DOI 10.1002/cne.21268; Park JH, 2010, EXP NEUROL, V222, P267, DOI 10.1016/j.expneurol.2010.01.004; Pilegaard K, 1996, ANAL QUANT CYTOL, V18, P279; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	591	608	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					566	579		10.1016/j.stem.2011.03.010	http://dx.doi.org/10.1016/j.stem.2011.03.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	768IN	21549330	Green Accepted, Bronze			2022-12-24	WOS:000290927600016
J	Wu, CWH; Vasalatiy, O; Liu, N; Wu, HT; Cheal, S; Chen, DY; Koretsky, AP; Griffiths, GL; Tootell, RBH; Ungerleider, LG				Wu, Carolyn W-H; Vasalatiy, Olga; Liu, Ning; Wu, Haitao; Cheal, Sarah; Chen, Der-Yow; Koretsky, Alan P.; Griffiths, Gary L.; Tootell, Roger B. H.; Ungerleider, Leslie G.			Development of a MR-Visible Compound for Tracing Neuroanatomical Connections In Vivo	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; TOXIN SUBUNIT-B; MANGANESE-ENHANCED MRI; WHITE-MATTER MICROSTRUCTURE; CENTRAL-NERVOUS-SYSTEM; SLOW AXONAL-TRANSPORT; STANDING LIMB LOSS; RAT MOTOR CORTEX; CHOLERA-TOXIN; DIFFUSION TENSOR	Traditional studies of neuroanatomical connections require injection of tracer compounds into living brains, then histology of the postmortem tissue. Here, we describe and validate a compound that reveals neuronal connections in vivo, using MRI. The classic anatomical tracer CTB (cholera-toxin subunit-B) was conjugated with a gadolinium-chelate to form GdDOTA-CTB. GdDOTA-CTB was injected into the primary somatosensory cortex (Si) or the olfactory pathway of rats. High-resolution MR images were collected at a range of time points at 11.71 and 7T. The transported GdDOTA-CTB was visible for at least 1 month post-injection, clearing within 2 months. Control injections of non-conjugated GdDOTA into Si were not transported and cleared within 1-2 days. Control injections of Gd-Albumin were not transported either, clearing within 7 days. These MR results were verified by classic immunohistochemical staining for CTB, in the same animals. The GdDOTA-CTB neuronal transport was target specific, monosynaptic, stable for several weeks, and reproducible.	[Wu, Carolyn W-H; Chen, Der-Yow; Koretsky, Alan P.] NINDS, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20814 USA; [Vasalatiy, Olga; Wu, Haitao; Cheal, Sarah; Griffiths, Gary L.] NHLBI, Imaging Probe Dev Ctr, NIH, Bethesda, MD 20814 USA; [Liu, Ning; Tootell, Roger B. H.; Ungerleider, Leslie G.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20814 USA; [Wu, Carolyn W-H] CEA Saclay, Lab Integrated Biol, Unit Brain Plast, NeuroSpin I2BM, F-91191 Gif Sur Yvette, Ile de France, France; [Tootell, Roger B. H.] Massachusetts Gen Hosp Charlestown, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); CEA; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts General Hospital	Wu, CWH (corresponding author), NINDS, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20814 USA.	carolyn.wu@cea.fr	Koretsky, Alan P/C-7940-2015	Koretsky, Alan P/0000-0002-8085-4756	NIMH; NINDS IRP; NeuroSpin/CEA; Martinos Center for Biomedical Imaging; NCRR; MIND Institute; NIH [R01 EY017081]; French L'Agence Nationale de la Recherche [ANR-09-BLAN-0061-CSD8]; NATIONAL EYE INSTITUTE [R01EY022096, R01EY017081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002989, ZIANS003047] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS IRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NeuroSpin/CEA(French Atomic Energy Commission); Martinos Center for Biomedical Imaging; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MIND Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French L'Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Steve Dodd for pulse sequence optimization, David Yu for brain slicing, and Kathy Sharer for animal ordering and care. This work was supported in part by the NIMH and NINDS IRP, NeuroSpin/CEA, the Martinos Center for Biomedical Imaging, the NCRR, the MIND Institute, NIH grant R01 EY017081 to R.B.H.T., and the French L'Agence Nationale de la Recherche grant ANR-09-BLAN-0061-CSD8 to C.W.-H.W.	Akers RM, 1978, J COMP NEUROL, V181, P513, DOI 10.1002/cne.901810305; Alitto HJ, 2003, CURR OPIN NEUROBIOL, V13, P440, DOI 10.1016/S0959-4388(03)00096-5; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Aoki I, 2002, MAGNET RESON MED, V48, P927, DOI 10.1002/mrm.10320; Astary GW, 2010, J NEUROSCI METH, V187, P129, DOI 10.1016/j.jneumeth.2010.01.002; Bava S, 2009, PSYCHIAT RES-NEUROIM, V173, P228, DOI 10.1016/j.pscychresns.2009.04.005; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BROWN LL, 1992, P NATL ACAD SCI USA, V89, P7403, DOI 10.1073/pnas.89.16.7403; BROWN LL, 1995, BRAIN RES, V686, P207, DOI 10.1016/0006-8993(95)00457-2; Brubaker CJ, 2009, NEUROTOXICOLOGY, V30, P867, DOI 10.1016/j.neuro.2009.07.007; BRUCE K, 1992, J NEUROSCI METH, V45, P23, DOI 10.1016/0165-0270(92)90040-K; Camchong J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.035.2009; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Chuang KH, 2009, MAGN RESON IMAGING, V27, P594, DOI 10.1016/j.mri.2008.10.006; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Clark CA, 2001, MAGNET RESON MED, V45, P1126, DOI 10.1002/mrm.1149; Colechio EM, 2009, BRAIN STRUCT FUNCT, V213, P423, DOI 10.1007/s00429-009-0215-7; Conte WL, 2009, BRAIN STRUCT FUNCT, V213, P367, DOI 10.1007/s00429-009-0212-x; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Desbois C, 2001, NEUROSCIENCE, V102, P885, DOI 10.1016/S0306-4522(00)00537-6; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ekstrom LB, 2009, J NEUROSCI, V29, P10683, DOI 10.1523/JNEUROSCI.0673-09.2009; ENOCHS WS, 1993, EXP NEUROL, V123, P235, DOI 10.1006/exnr.1993.1156; ERICSON H, 1988, J NEUROSCI METH, V24, P225, DOI 10.1016/0165-0270(88)90167-7; Eschenko O, 2010, NEUROIMAGE, V49, P2544, DOI 10.1016/j.neuroimage.2009.10.079; Eschenko O, 2010, MAGN RESON IMAGING, V28, P1165, DOI 10.1016/j.mri.2009.12.022; FABRI M, 1991, BRAIN RES, V538, P351, DOI 10.1016/0006-8993(91)90455-5; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Field CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003928; Fonteijn HMJ, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/423192; FUJIMOTO K, 1993, BRAIN RES, V609, P185, DOI 10.1016/0006-8993(93)90872-K; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; GRAIF M, 1986, BRIT J RADIOL, V59, P865, DOI 10.1259/0007-1285-59-705-865; GRAYBIEL AM, 1989, P NATL ACAD SCI USA, V86, P9020, DOI 10.1073/pnas.86.22.9020; Hayama T, 1997, BRAIN RES BULL, V43, P341, DOI 10.1016/S0361-9230(97)00018-X; Hoover JE, 2003, J NEUROPHYSIOL, V89, P1576, DOI 10.1152/jn.01009.2002; Imai T, 2008, NEURON, V58, P465, DOI 10.1016/j.neuron.2008.05.004; Ishitsuka R., 2008, PROBES TAGS STUDY BI, P53; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; Jones E.G., 2012, THALAMUS; Kaas J, 1998, NAT NEUROSCI, V1, P341, DOI 10.1038/1546; Kikuta S, 2008, J NEUROSCI, V28, P11989, DOI 10.1523/JNEUROSCI.3106-08.2008; KILLACKEY HP, 1985, DEV BRAIN RES, V22, P141, DOI 10.1016/0165-3806(85)90077-X; Kincaid AE, 1996, J COMP NEUROL, V374, P578; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; LAMANTIA AS, 1990, J NEUROSCI, V10, P2156; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Liu CH, 2004, MAGN RESON MED, V51, P978, DOI 10.1002/mrm.20047; Liu XB, 1999, J COMP NEUROL, V414, P67; LUPPI PH, 1986, J COMP NEUROL, V244, P204, DOI 10.1002/cne.902440207; MACLEOD NK, 1984, EXP BRAIN RES, V55, P535; MANZONI T, 1989, EXP BRAIN RES, V76, P251; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Nagaraja TN, 2006, J NEUROSCI METH, V157, P238, DOI 10.1016/j.jneumeth.2006.05.013; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Owen SLF, 2007, BRIT J NEUROSURG, V21, P485, DOI 10.1080/02688690701558358; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Peled S, 2006, MAGN RESON IMAGING, V24, P1263, DOI 10.1016/j.mri.2006.07.009; Port M, 2008, BIOMETALS, V21, P469, DOI 10.1007/s10534-008-9135-x; Prince MR, 2009, J MAGN RESON IMAGING, V30, P1298, DOI 10.1002/jmri.21973; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Sakai ST, 1998, J COMP NEUROL, V391, P506, DOI 10.1002/(SICI)1096-9861(19980222)391:4<506::AID-CNE7>3.0.CO;2-4; Sakai ST, 2000, J COMP NEUROL, V417, P164; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; SCHOEN SW, 1993, J COMP NEUROL, V333, P578, DOI 10.1002/cne.903330410; SHERMAN SM, 1990, SYNAPTIC ORG BRAIN, P246; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Silva AC, 2008, J NEUROSCI METH, V167, P246, DOI 10.1016/j.jneumeth.2007.08.020; Simmons JM, 2008, J NEUROSCI, V28, P7637, DOI 10.1523/JNEUROSCI.1488-08.2008; SMITHSON KG, 1989, NEUROSCIENCE, V31, P277, DOI 10.1016/0306-4522(89)90373-4; Sosnovik David E, 2008, Top Magn Reson Imaging, V19, P59, DOI 10.1097/RMR.0b013e318176c57b; Teipel SJ, 2010, NEUROIMAGE, V49, P2021, DOI 10.1016/j.neuroimage.2009.10.067; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Tucciarone J, 2009, NEUROIMAGE, V44, P923, DOI 10.1016/j.neuroimage.2008.07.036; Tuch DS, 2005, PHILOS T R SOC B, V360, P869, DOI 10.1098/rstb.2005.1651; Van der Linden A, 2002, NEUROSCIENCE, V112, P467, DOI 10.1016/S0306-4522(02)00070-2; VANEVERDINGEN KJ, 1994, RADIOLOGY, V193, P485, DOI 10.1148/radiology.193.2.7526413; Wang TJ, 2009, NEUROSCIENCE, V158, P776, DOI 10.1016/j.neuroscience.2008.10.025; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; WEST MO, 1990, J NEUROPHYSIOL, V64, P1233, DOI 10.1152/jn.1990.64.4.1233; Wu CWH, 2002, SOMATOSENS MOT RES, V19, P153, DOI 10.1080/08990220220133261; Wu CWH, 2000, NEURON, V28, P967, DOI 10.1016/S0896-6273(00)00167-7; WU CWH, 2006, SOC NEUR M ATL GA US; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477	97	19	18	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 28	2011	70	2					229	243		10.1016/j.neuron.2011.03.010	http://dx.doi.org/10.1016/j.neuron.2011.03.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521610	Bronze, Green Accepted			2022-12-24	WOS:000291073700006
J	Wang, Y; Liu, Y; Malek, SN; Zheng, P; Liu, Y				Wang, Yin; Liu, Yan; Malek, Sami N.; Zheng, Pan; Liu, Yang			Targeting HIF1 alpha Eliminates Cancer Stem Cells in Hematological Malignancies	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; HYPOXIA-INDUCIBLE FACTORS; PROGENITOR CELLS; INITIATING CELLS; SELF-RENEWAL; TUMOR-GROWTH; NOTCH; IDENTIFICATION; ECHINOMYCIN; INHIBITOR	Molecular targeting of cancer stem cells (CSCs) has therapeutic potential for efficient treatment of cancer, although relatively few specific targets have been identified so far. Hypoxia-inducible factor (HIF) was recently shown to regulate the tumorigenic capacity of glioma stem cells under hypoxic conditions. Surprisingly, we found that, under normoxia, HIF1 alpha signaling was selectively activated in the stem cells of mouse lymphoma and human acute myeloid leukemia (AML). HIF1 alpha shRNA and HIF inhibitors abrogated the colony-forming unit (cfu) activity of mouse lymphoma and human AML CSCs. Importantly, the HIF-inhibitor echinomycin efficiently eradicated mouse lymphoma and serially transplantable human AML in xenogeneic models by preferential elimination of CSCs. Hif1 alpha maintains mouse lymphoma CSCs by repressing a negative feedback loop in the Notch pathway. Taken together, our results demonstrate an essential function of Hif1 alpha-Notch interaction in maintaining CSCs and provide an effective approach to target CSCs for therapy of hematological malignancies.	[Wang, Yin; Liu, Yan; Zheng, Pan; Liu, Yang] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Wang, Yin; Liu, Yan; Liu, Yang] Univ Michigan, Div Immunotherapy, Sect Gen Surg, Ann Arbor, MI 48109 USA; [Zheng, Pan] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Malek, Sami N.; Liu, Yang] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zheng, P (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [R01CA058033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036690] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Z. Xu for advice on the structure of Notch signaling complex, Dr. X. Chang, Dr. W. Zou, and Ms. L. Vatan for helping with flow cytometry, Drs. E. Fearon and Y. Zhu for helpful discussions, and Dr. J. Connett and Ms. D. Kroft for editorial assistance. This study is supported by grants from the National Institutes of Health, USA. All authors are coinventors of a pending patent application that was licensed to Oncolmmune, Inc. Y.L. and P.Z. are among the cofounders with equity interest in Oncolmmune, Inc.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Camenisch G, 2001, PFLUG ARCH EUR J PHY, V443, P240, DOI 10.1007/s004240100679; Costello RT, 2000, CANCER RES, V60, P4403; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Guzman ML, 2007, BLOOD, V110, P4427, DOI 10.1182/blood-2007-05-090621; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MUSS HB, 1990, AM J CLIN ONCOL-CANC, V13, P191, DOI 10.1097/00000421-199006000-00002; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pereira T, 2003, J BIOL CHEM, V278, P6816, DOI 10.1074/jbc.M209297200; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vlaminck B, 2007, FEBS J, V274, P5533, DOI 10.1111/j.1742-4658.2007.06072.x; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	51	301	318	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					399	411		10.1016/j.stem.2011.02.006	http://dx.doi.org/10.1016/j.stem.2011.02.006			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474104	Green Accepted, Bronze			2022-12-24	WOS:000289707100012
J	Constantinople, CM; Bruno, RM				Constantinople, Christine M.; Bruno, Randy M.			Effects and Mechanisms of Wakefulness on Local Cortical Networks	NEURON			English	Article							LOCUS-COERULEUS NEURONS; BARREL CORTEX; NEOCORTICAL ACTIVATION; SOMATOSENSORY CORTEX; THALAMIC CONTROL; NUCLEUS BASALIS; BEHAVING MICE; VISUAL-CORTEX; STATES; SLEEP	Mammalian brains generate internal activity independent of environmental stimuli. Internally generated states may bring about distinct cortical processing modes. To investigate how brain state impacts cortical circuitry, we recorded intracellularly from the same neurons, under anesthesia and subsequent wakefulness, in rat barrel cortex. In every cell examined throughout layers 2-6, wakefulness produced a temporal pattern of synaptic inputs differing markedly from those under anesthesia. Recurring periods of synaptic quiescence, prominent under anesthesia, were abolished by wakefulness, which produced instead a persistently depolarized state. This switch in dynamics was unaffected by elimination of afferent synaptic input from thalamus, suggesting that arousal alters cortical dynamics by neuromodulators acting directly on cortex. Indeed, blockade of noradrenergic, but not cholinergic, pathways induced synaptic quiescence during wakefulness. We conclude that global brain states can switch local recurrent networks into different regimes via direct neuromodulation.	[Constantinople, Christine M.; Bruno, Randy M.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Constantinople, Christine M.; Bruno, Randy M.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA	Columbia University; Columbia University	Bruno, RM (corresponding author), Columbia Univ, Dept Neurosci, 701 W 168th St, New York, NY 10032 USA.	rb2604@columbia.edu	Bruno, Randy M./ABC-2117-2021	Bruno, Randy M./0000-0002-5122-4632	NIH [R01 NS069679-01]; Rita Allen Foundation; NSF; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069679] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Anita Disney, Attila Losonczy, Charles Zuker, Nate Sawtell, Elaine Zhang, and Alejandro Ramirez for comments on the manuscript and Drew Baughman for histology. This work was supported by NIH R01 NS069679-01 and Rita Allen Foundation grants (R.M.B.) and an NSF Student Fellowship (C.M.C.).	ASTONJONES G, 1981, J NEUROSCI, V1, P876; BERRIDGE CW, 1993, NEUROSCIENCE, V55, P381, DOI 10.1016/0306-4522(93)90507-C; Blanco-Centurion C, 2004, EUR J NEUROSCI, V19, P2741, DOI 10.1111/j.0953-816X.2004.03366.x; Briand LA, 2007, PROG NEUROBIOL, V83, P69, DOI 10.1016/j.pneurobio.2007.06.007; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Eggermann E, 2009, P NATL ACAD SCI USA, V106, P11753, DOI 10.1073/pnas.0810062106; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Gompf HS, 2010, J NEUROSCI, V30, P14543, DOI 10.1523/JNEUROSCI.3037-10.2010; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hirata A, 2010, J NEUROPHYSIOL, V103, P1147, DOI 10.1152/jn.00955.2009; JONES BE, 1977, BRAIN RES, V124, P473, DOI 10.1016/0006-8993(77)90948-9; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; METHERATE R, 1992, J NEUROSCI, V12, P4701; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Rigas P, 2009, J NEUROPHYSIOL, V102, P119, DOI 10.1152/jn.00126.2009; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schubert D, 2003, J NEUROSCI, V23, P2961; Seamari Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000888; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; VANDERWOLF CH, 1988, BRAIN RES BULL, V20, P529, DOI 10.1016/0361-9230(88)90143-8; Watson BO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003971; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068	43	279	280	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 24	2011	69	6					1061	1068		10.1016/j.neuron.2011.02.040	http://dx.doi.org/10.1016/j.neuron.2011.02.040			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435553	Green Accepted, Bronze			2022-12-24	WOS:000288886900005
J	Wang, WC; Lazzara, MM; Ranganath, C; Knight, RT; Yonelinas, AP				Wang, Wei-Chun; Lazzara, Michele M.; Ranganath, Charan; Knight, Robert T.; Yonelinas, Andrew P.			The Medial Temporal Lobe Supports Conceptual Implicit Memory	NEURON			English	Article							CATEGORY EXEMPLAR PRODUCTION; HUMAN PERIRHINAL CORTEX; AMNESIC PATIENTS; HIPPOCAMPAL-FORMATION; RECOGNITION MEMORY; PERCEPTUAL MEMORY; EXPLICIT MEMORY; SEMANTIC MEMORY; OBJECT FEATURES; FAMILIARITY	The medial temporal lobe (MTL) is generally thought to be critical for explicit, but not implicit, memory. Here, we demonstrate that the perirhinal cortex (PRc), within the MTL, plays a role in conceptually-driven implicit memory. Amnesic patients with MTL lesions that converged on the left PRc exhibited deficits on two conceptual implicit tasks (i.e., exemplar generation and semantic decision). A separate functional magnetic resonance imaging (fMRI) study in healthy subjects indicated that PRc activation during encoding of words was predictive of subsequent exemplar generation. Moreover, across subjects, the magnitude of the fMRI and behavioral conceptual priming effects were directly related. Additionally, the PRc region implicated in the fMRI study was the same region of maximal lesion overlap in the patients with impaired conceptual priming. These patient and imaging results converge to suggest that the PRc plays a critical role in conceptual implicit memory, and possibly conceptual processing in general.	[Wang, Wei-Chun; Ranganath, Charan; Yonelinas, Andrew P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Ranganath, Charan] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Lazzara, Michele M.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60601 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wang, WC (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	wwa@ucdavis.edu		Wang, Wei-Chun/0000-0003-1788-2727	National Institutes of Health [MH68721, MH59352, MH83734, NS21135]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083734, R01MH068721, R01MH059352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Award Numbers MH68721 (to C.R.), MH59352 (to A.P.Y.), MH83734 (to C.R. and A.P.Y.), and NS21135 (R.T.K.) from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Many thanks to Clay Clayworth for his assistance on the patient lesion reconstructions.	BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; BLAXTON TA, 1992, MEM COGNITION, V20, P549, DOI 10.3758/BF03199587; Blum D, 2001, PSYCHON B REV, V8, P147, DOI 10.3758/BF03196151; BOWERS JS, 1990, J EXP PSYCHOL LEARN, V16, P404, DOI 10.1037/0278-7393.16.3.404; Buchel C, 1999, J NEUROSCI, V19, P10869; Bussey TJ, 2007, HIPPOCAMPUS, V17, P898, DOI 10.1002/hipo.20320; Cermak LS, 1998, J INT NEUROPSYCH SOC, V4, P576, DOI 10.1017/S1355617798466062; CERMAK LS, 1988, BRAIN COGNITION, V7, P145, DOI 10.1016/0278-2626(88)90026-7; Cermak LS, 1998, NEUROPSYCHOLOGY, V12, P65, DOI 10.1037/0894-4105.12.1.65; Cheng DT, 2008, P NATL ACAD SCI USA, V105, P8108, DOI 10.1073/pnas.0800374105; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; CUMMINGS JL, 1984, NEUROLOGY, V34, P679, DOI 10.1212/WNL.34.5.679; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davies RR, 2005, BRAIN, V128, P1984, DOI 10.1093/brain/awh582; Davies RR, 2004, EUR J NEUROSCI, V20, P2441, DOI 10.1111/j.1460-9568.2004.03710.x; Devlin JT, 2007, CURR BIOL, V17, P1484, DOI 10.1016/j.cub.2007.07.066; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Fleischman DA, 2005, BRAIN, V128, P2006, DOI 10.1093/brain/awh559; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P386, DOI 10.1037/0278-7393.11.2.386; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; Greene AJ, 2006, J COGNITIVE NEUROSCI, V18, P1156, DOI 10.1162/jocn.2006.18.7.1156; Hamann SB, 1997, BEHAV NEUROSCI, V111, P850, DOI 10.1037/0735-7044.111.4.850; Haskins AL, 2008, NEURON, V59, P554, DOI 10.1016/j.neuron.2008.07.035; Holdstock JS, 2009, CEREB CORTEX, V19, P2993, DOI 10.1093/cercor/bhp073; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Insausti R, 1998, AM J NEURORADIOL, V19, P659; KARTSOUNIS LD, 1995, J NEUROL NEUROSUR PS, V59, P95, DOI 10.1136/jnnp.59.1.95; Keane MM, 1997, NEUROPSYCHOLOGY, V11, P59, DOI 10.1037/0894-4105.11.1.59; Kirwan CB, 2008, J NEUROSCI, V28, P10541, DOI 10.1523/JNEUROSCI.3456-08.2008; Levy DA, 2004, PSYCHOL SCI, V15, P680, DOI 10.1111/j.0956-7976.2004.00740.x; Manns JR, 2001, HIPPOCAMPUS, V11, P776, DOI 10.1002/hipo.1093; McGlincheyBerroth R, 1997, BEHAV NEUROSCI, V111, P873, DOI 10.1037/0735-7044.111.5.873; Moss HE, 2005, CEREB CORTEX, V15, P616, DOI 10.1093/cercor/bhh163; O'Kane G, 2005, HIPPOCAMPUS, V15, P326, DOI 10.1002/hipo.20053; Ostergaard AL, 1999, J INT NEUROPSYCH SOC, V5, P175, DOI 10.1017/S1355617799533018; PRESS GA, 1989, NATURE, V341, P54, DOI 10.1038/341054a0; Preston AR, 2008, CEREB CORTEX, V18, P2192, DOI 10.1093/cercor/bhm245; Rajaram S, 2000, J EXP PSYCHOL LEARN, V26, P1070, DOI 10.1037//0278-7393.26.4.1070; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Roediger H. L., 1993, HANDB NEUR, P63; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; Schacter DL, 2000, OXFORD HDB MEMORY, P627; Schott BH, 2006, J NEUROSCI, V26, P792, DOI 10.1523/JNEUROSCI.2402-05.2006; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Taylor KI, 2006, P NATL ACAD SCI USA, V103, P8239, DOI 10.1073/pnas.0509704103; Taylor KI, 2009, BRAIN, V132, P671, DOI 10.1093/brain/awn361; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; Vaidya CJ, 1996, NEUROPSYCHOLOGY, V10, P529, DOI 10.1037/h0092735; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie, 2002, NEUROPSYCHOLOGY MEMO, P35; Voss JL, 2009, HIPPOCAMPUS, V19, P773, DOI 10.1002/hipo.20608; Wagner AD, 1998, ACTA PSYCHOL, V98, P211, DOI 10.1016/S0001-6918(97)00043-7; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; Wechsler D, 1987, WMS R WECHSLER MEMOR; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	65	71	72	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 9	2010	68	5					835	842		10.1016/j.neuron.2010.11.009	http://dx.doi.org/10.1016/j.neuron.2010.11.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	699LM	21144998	Bronze, Green Accepted			2022-12-24	WOS:000285664900006
J	Lajonchere, CM				Lajonchere, Clara M.		AGRE Consortium	Changing the Landscape of Autism Research: The Autism Genetic Resource Exchange	NEURON			English	Editorial Material							CHILDREN	Autism Speaks' Autism Genetic Resource Exchange (AGRE) represents the largest private collection of genetic and phenotype data for families with ASD that is made available to qualified researchers worldwide. The availability of large and comprehensive registries that include detailed phenotype and genetic information for individuals affected with an ASD and family members is crucial for the discovery of autism susceptibility genes and the development and application of biologically based approaches to diagnosis and treatment. The model that AGRE has developed can be applied broadly to other disorders with complex etiologies.	[Lajonchere, Clara M.] Autism Speaks, Los Angeles, CA 90036 USA; [AGRE Consortium] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Lajonchere, Clara M.] Univ So Calif, Viterbi Sch Engn, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Lajonchere, CM (corresponding author), Autism Speaks, Los Angeles, CA 90036 USA.	clajonchere@autismspeaks.org			NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER; NIMH NIH HHS [U24 MH081810, 1U24MH081810] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; Ganz ML, 2007, ARCH PEDIAT ADOL MED, V161, P343, DOI 10.1001/archpedi.161.4.343; Lee H, 2010, AM J MED GENET B, V153B, P1119, DOI 10.1002/ajmg.b.31103; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	8	45	46	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 21	2010	68	2					187	191		10.1016/j.neuron.2010.10.009	http://dx.doi.org/10.1016/j.neuron.2010.10.009			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	681IJ	20955925	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000284304300006
J	Kieslinger, M; Hiechinger, S; Dobreva, G; Consalez, GG; Grosschedl, R				Kieslinger, Matthias; Hiechinger, Silvia; Dobreva, Gergana; Consalez, G. Giacomo; Grosschedl, Rudolf			Early B Cell Factor 2 Regulates Hematopoietic Stem Cell Homeostasis in a Cell-Nonautonomous Manner	CELL STEM CELL			English	Article							FRIZZLED-RELATED PROTEIN-1; BONE-MARROW; BETA-CATENIN; SELF-RENEWAL; LONG-TERM; LYMPHOID PROGENITORS; WNT; MAINTENANCE; NICHE; DIFFERENTIATION	Hematopoiesis requires the interaction of hematopoietic stem cells (HSCs) with various stromal microenvironments. Here, we examine the role of early B cell factor 2 (Ebf2), a transcription factor expressed in a subset of immature osteoblastic cells. Ebf2(-/-) mice show decreased frequencies of HSCs and lineage-committed progenitors. This defect is cell nonautonomous, as shown by the fact that transplantation of Ebf2-deficient bone marrow into wild-type hosts results in normal hematopoiesis. In coculture experiments, Ebf2(-/-) osteoblastic cells have reduced potential to support short-term proliferation of HSCs. Expression profiling of sorted Ebf2(-/-) osteoblastic cells indicated that several genes implicated in the maintenance of HSCs are downregulated relative to Ebf2(+/-) cells, whereas genes encoding secreted frizzled-related proteins are upregulated. Moreover, wild-type HSCs cocultured with Ebf2(-/-) osteoblastic cells show a reduced Wnt response relative to coculture with Ebf2(+/-) cells. Thus, Ebf2 acts as a transcriptional determinant of an osteoblastic niche that regulates the maintenance of hematopoietic progenitors, in part by modulating Wnt signaling.	[Kieslinger, Matthias; Dobreva, Gergana; Grosschedl, Rudolf] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; [Kieslinger, Matthias; Hiechinger, Silvia] Natl Res Ctr Environm Hlth, Helmholtz Ctr Munich, D-81377 Munich, Germany; [Consalez, G. Giacomo] Ist Sci San Raffaele, I-20132 Milan, Italy	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Kieslinger, M (corresponding author), Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany.	matthias.kieslinger@helmholtz-muenchen.de; grosschedl@immunbio.mpg.de	Consalez, Giacomo/AAA-2146-2019	Consalez, Giacomo/0000-0003-4594-6273; Dobreva, Gergana/0000-0002-4814-9416	Max Planck Society; Bavarian research foundation [T1]; German Research Foundation [TRR54, SFB620]	Max Planck Society(Max Planck Society); Bavarian research foundation; German Research Foundation(German Research Foundation (DFG))	We thank Dr. T. Reya for providing lentiviral vectors. We are grateful to I. Falk, R. Istvanffy, and R. Oostendorp for help with FACS analysis and B. Ksienzyk, C. Buske, M. Feuring-Buske, J. Ellwart, and K. Nispel for FAGS sorting. We thank V. Erben and C. Petritsch for help with confocal microscopy. This work was supported by funds of the Max Planck Society and grants of the Bavarian research foundation (Forimmun, T1) and German Research Foundation (TRR54 and SFB620). Author contributions: M.K. performed most of the experiments; S.H. performed the experiments in Figure 4 and G.D. performed the microarray analysis shown in Table Si; G.G.C. provided the Ebf2<SUP>+/-</SUP> mice and performed the immunohistochemistry shown in Figure S3; and R.G. supervised the study and wrote the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Choong ML, 2003, FEBS LETT, V550, P155, DOI 10.1016/S0014-5793(03)00844-5; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hattori K, 2003, LEUKEMIA LYMPHOMA, V44, P575, DOI 10.1080/1042819021000037985; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Kincade PW, 1998, CELL ADHES COMMUN, V6, P211, DOI 10.3109/15419069809004476; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malgaretti N, 1997, J BIOL CHEM, V272, P17632, DOI 10.1074/jbc.272.28.17632; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nemeth MJ, 2009, STEM CELLS, V27, P1109, DOI 10.1002/stem.32; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	67	42	42	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					496	507		10.1016/j.stem.2010.07.015	http://dx.doi.org/10.1016/j.stem.2010.07.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887955	Bronze			2022-12-24	WOS:000283270600011
J	Yu, Y; Chen, Z; Li, WG; Cao, H; Feng, EG; Yu, F; Liu, H; Jiang, HL; Xu, TL				Yu, Ye; Chen, Zhi; Li, Wei-Guang; Cao, Hui; Feng, En-Guang; Yu, Fang; Liu, Hong; Jiang, Hualiang; Xu, Tian-Le			A Nonproton Ligand Sensor in the Acid-Sensing Ion Channel	NEURON			English	Article							TARANTULA TOXIN PSALMOTOXIN-1; DORSAL-HORN NEURONS; TRP CHANNELS; MECHANOSENSORY FUNCTION; EXTRACELLULAR DOMAIN; INFLAMMATORY PAIN; ASIC 1A; MODULATION; ISCHEMIA; CA2+	Acid-sensing ion channels (ASICs) have long been considered as extracellular proton (H+)-gated cation channels, and peripheral ASIC3 channels seem to be a natural sensor of acidic pain. Here, we report the identification of a nonproton sensor on ASIC3. We show first that 2-guanidine-4-methylquinazoline (GMQ) causes persistent ASIC3 channel activation at the normal pH. Using GMQ as a probe and combining mutagenesis and covalent modification analysis, we then uncovered a ligand sensor lined by residues around E423 and E79 of the extracellular "palm" domain of the ASIC3 channel that-is crucial for activation by nonproton activators. Furthermore, we show that GMQ activates sensory neurons and causes pain-related behaviors in an ASIC3,dependent manner, indicating the functional significance of ASIC activation by nonproton ligands. Thus, natural ligands beyond protons may activate ASICs under physiological and pathological conditions through the nonproton ligand sensor, serving for channel activation independent of abrupt and marked acidosis.	[Chen, Zhi; Feng, En-Guang; Liu, Hong; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Yu, Fang; Xu, Tian-Le] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Yu, Ye; Li, Wei-Guang; Cao, Hui; Yu, Fang; Xu, Tian-Le] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; tlxu@ion.ac.cn		Yu, Ye/0000-0002-4054-8543	National Natural Science Foundation of China [30830035, 30700145, 9091300]; National Basic Research Program of China [2006CB500803, 2011CB809005, 2009CB918502]; Shanghai Municipal Government [09XD1404900]; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Government; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank all groups that provided us with ASIC cDNAs and thank Drs. J.A. Wemmie, M.P Price, and M J Welsh for their kind gills of asic3 and asic1 knockout mice. We also thank Drs. M -m Poo and M.X Zhu for helpful comments on the manuscript This study was supported by grants from the National Natural Science Foundation of China (Nos. 30830035, 30700145, and 9091300), the National Basic Research Program of China (2006CB500803, 2011CB809005, and 2009CB918502), and the Shanghai Municipal Government (09XD1404900). Y.Y is a postdoctoral fellow supported by the K.C. Wong Education Foundation (Hong Kong) and China Postdoctoral Science Foundation	Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; Canessa CM, 2007, NATURE, V449, P293, DOI 10.1038/449293a; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coric T, 2008, FASEB J, V22, P1914, DOI 10.1096/fj.07-100313; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Li YF, 2003, J PHYSIOL-LONDON, V552, P73, DOI 10.1113/jphysiol.2003.047324; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Otake K, 1998, BRAIN RES, V787, P1, DOI 10.1016/S0006-8993(97)01200-6; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Reis DJ, 1998, NEUROSCI LETT, V250, P185, DOI 10.1016/S0304-3940(98)00466-2; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang W, 2006, J BIOL CHEM, V281, P2497, DOI 10.1074/jbc.M507123200; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Welsh MJ, 2002, J BIOL CHEM, V277, P2369, DOI 10.1074/jbc.R100060200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu TL, 2009, PROG NEUROBIOL, V87, P171, DOI 10.1016/j.pneurobio.2009.01.004; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Zhang MH, 2000, CRIT CARE MED, V28, pN60, DOI 10.1097/00003246-200004001-00007; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	62	143	150	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 7	2010	68	1					61	72		10.1016/j.neuron.2010.09.001	http://dx.doi.org/10.1016/j.neuron.2010.09.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674AA	20920791	Bronze			2022-12-24	WOS:000283704200008
J	Jurado, S; Biou, V; Malenka, RC				Jurado, Sandra; Biou, Virginie; Malenka, Robert C.			A calcineurin/AKAP complex is required for NMDA receptor-dependent long-term depression	NATURE NEUROSCIENCE			English	Article							AKAP SIGNALING COMPLEXES; AKAP150-ANCHORED PKA; AMPA RECEPTORS; DISTINCT; DYNAMICS; BINDING; SITE; LTD	AKAP79/150 is a protein scaffold that is thought to position specific kinases (protein kinase A and C) and phosphastases (calcineurin) in appropriate synaptic domains so that their activities can regulate excitatory synaptic strength. Using a viral-mediated molecular replacement strategy in rat hippocampal slices, we found that AKAP is required for NMDA receptor-dependent long-term depression solely because of its interaction with calcineurin.	[Jurado, Sandra; Biou, Virginie; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; [Biou, Virginie] Crucell Switzerland AG, Bern, Switzerland	Stanford University; Johnson & Johnson	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu	Jurado, Sandra/S-9936-2017	Jurado, Sandra/0000-0001-9864-9307	US National Institutes of Health [MH63394]; Ramon Areces Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063394, R01MH063394, P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramon Areces Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka laboratory for constructive comments on the manuscript and during the course of the experiments. We especially thank D. Goswami for performing the experiments shown in Supplementary Figure 4. This work was supported by a gift from the Morby Charitable Fund for Alzheimer's Research and a grant from the US National Institutes of Health (MH63394). S.J. was supported by a Postdoctoral Fellowship from the Ramon Areces Foundation.	Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	15	86	89	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1053	1055		10.1038/nn.2613	http://dx.doi.org/10.1038/nn.2613			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694001	Green Accepted			2022-12-24	WOS:000281332600008
J	O'Connor, DH; Peron, SP; Huber, D; Svoboda, K				O'Connor, Daniel H.; Peron, Simon P.; Huber, Daniel; Svoboda, Karel			Neural Activity in Barrel Cortex Underlying Vibrissa-Based Object Localization in Mice	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; DENDRITIC CALCIUM DYNAMICS; IN-VIVO; PYRAMIDAL NEURONS; AUDITORY-CORTEX; SENSORIMOTOR SYSTEM; RECEPTIVE-FIELDS; VISUAL-CORTEX; SINGLE NEURON; BEHAVING MICE	Classical studies have related the spiking of selected neocortical neurons to behavior, but little is known about activity sampled from the entire neural population. We recorded from neurons selected independent of spiking, using cell-attached recordings and two-photon calcium imaging, in the barrel cortex of mice performing an object localization task. Spike rates varied across neurons, from silence to >60 Hz. Responses were diverse, with some neurons showing large increases in spike rate when whiskers contacted the object. Nearly half the neurons discriminated object location; a small fraction of neurons discriminated perfectly. More active neurons were more discriminative. Layer (L) 4 and L5 contained the highest fractions of discriminating neurons (similar to 63% and 79%, respectively), but a few L2/3 neurons were also highly discriminating. Approximately 13,000 spikes per activated barrel column were available to mice for decision making. Coding of object location in the barrel cortex is therefore highly redundant.	[O'Connor, Daniel H.; Peron, Simon P.; Huber, Daniel; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Peron, Simon/0000-0001-8265-6940	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the Howard Hughes Medical Institute. We thank Nathan Clack and Gene Myers for whisker tracking software; Jinyang Liu and Tim O'Connor for programming; Lin Tian and Loren Looger for GCaMP3 virus; Dan Flickinger for mechanical design; Nick Betley, Amy Hu, Brenda Shields, Boris Zemelman, Tomas Hromadka and Tony Zador for advice; Andrew Hires, Tomas Hromadka and Miguel Maravall for comments on the manuscript.	ADRIAN ED, 1932, MECH NERVOUS ACTION; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P58, DOI 10.1113/jphysiol.1953.sp004828; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Green DM, 1966, SIGNAL DETECTION THE; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1959, SCIENCE, V129, P1279, DOI 10.1126/science.129.3358.1279; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; IYER V, 2009, 2009 NEUR M PLANN CH; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; METHERATE R, 1991, BRAIN RES, V559, P163, DOI 10.1016/0006-8993(91)90301-B; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOUNTCASTLE VB, 1995, CEREB CORTEX, V5, P377, DOI 10.1093/cercor/5.5.377; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; Pantoja J, 2007, J NEUROSCI, V27, P10608, DOI 10.1523/JNEUROSCI.5279-06.2007; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Uka T, 2003, J NEUROSCI, V23, P3515; Vijayan S, 2010, J NEUROPHYSIOL, V103, P2074, DOI 10.1152/jn.00474.2009; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; WURTZ RH, 1968, SCIENCE, V162, P1148, DOI 10.1126/science.162.3858.1148	81	314	314	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					1048	1061		10.1016/j.neuron.2010.08.026	http://dx.doi.org/10.1016/j.neuron.2010.08.026			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869600	Bronze			2022-12-24	WOS:000282801100015
J	Smith, SL; Hausser, M				Smith, Spencer L.; Haeusser, Michael			Parallel processing of visual space by neighboring neurons in mouse visual cortex	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; SPATIAL-INTERVAL DISCRIMINATION; RECEPTIVE-FIELD PROPERTIES; IN-VIVO; STRIATE CORTEX; ORIENTATION COLUMNS; INHIBITORY NEURONS; OPTIC TRACT; CAT; ORGANIZATION	Visual cortex shows smooth retinotopic organization on the macroscopic scale, but it is unknown how receptive fields are organized at the level of neighboring neurons. This information is crucial for discriminating among models of visual cortex. We used in vivo two-photon calcium imaging to independently map ON and OFF receptive field subregions of local populations of layer 2/3 neurons in mouse visual cortex. Receptive field subregions were often precisely shared among neighboring neurons. Furthermore, large subregions seem to be assembled from multiple smaller, non-overlapping subregions of other neurons in the same local population. These experiments provide, to our knowledge, the first characterization of the diversity of receptive fields in a dense local network of visual cortex and reveal elementary units of receptive field organization. Our results suggest that a limited pool of afferent receptive fields is available to a local population of neurons and reveal new organizational principles for the neural circuitry of the mouse visual cortex.	[Smith, Spencer L.] UCL, Wolfson Inst Biomed Res, London, England; UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London; University of London; University College London	Smith, SL (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	spencer.smith@wibr.ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Wellcome Trust; Gatsby Charitable Foundation; Human Frontier Science Program; MRC [G0500244] Funding Source: UKRI; Medical Research Council [G0500244] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to B. Clark, M. Carandini, J. Cottam, M. Havenith, J. Jack, B. Judkewitz, P. Latham, M. London, A. Mathy, I. Smith and C. Wilms for discussions and for comments on the manuscript. This work was supported by a Human Frontier Science Program Long-Term Fellowship to S.L.S., and grants by the Wellcome Trust and the Gatsby Charitable Foundation to M.H.	BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968, DOI 10.1152/jn.1982.48.4.968; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gao EQ, 2010, J NEUROSCI, V30, P5912, DOI 10.1523/JNEUROSCI.6456-09.2010; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Gordon JA, 1997, LEARN MEMORY, V4, P245, DOI 10.1101/lm.4.3.245; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; HAMMOND P, 1974, J PHYSIOL-LONDON, V242, P99, DOI 10.1113/jphysiol.1974.sp010696; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; LEVI DM, 1987, J OPT SOC AM A, V4, P1304, DOI 10.1364/JOSAA.4.001304; LEVI DM, 1990, VISION RES, V30, P1735, DOI 10.1016/0042-6989(90)90156-F; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; METIN C, 1988, EXP BRAIN RES, V69, P594; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; SOODAK RE, 1987, P NATL ACAD SCI USA, V84, P3936, DOI 10.1073/pnas.84.11.3936; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TORREALBA F, 1982, J COMP NEUROL, V211, P377, DOI 10.1002/cne.902110405; TORREALBA F, 1981, BRAIN RES, V219, P428, DOI 10.1016/0006-8993(81)90305-X; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P177, DOI 10.1098/rspb.1981.0033; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009; Yen SC, 2007, J NEUROPHYSIOL, V97, P1326, DOI 10.1152/jn.00747.2006	50	136	136	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1144	U149		10.1038/nn.2620	http://dx.doi.org/10.1038/nn.2620			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20711183	Green Accepted			2022-12-24	WOS:000281332600021
J	Klein, AM; Nakagawa, T; Ichikawa, R; Yoshida, S; Simons, BD				Klein, Allon M.; Nakagawa, Toshinori; Ichikawa, Rie; Yoshida, Shosei; Simons, Benjamin D.			Mouse Germ Line Stem Cells Undergo Rapid and Stochastic Turnover	CELL STEM CELL			English	Article							DROSOPHILA OVARY; SPERMATOGONIA; NICHE; SPERMATOGENESIS; PROGENITOR; RECOMBINATION; EPIDERMIS; PROTEIN; TESTIS	In cycling tissues, adult stem cells may be lost and subsequently replaced to ensure homeostasis. To examine the frequency of stem cell replacement, we analyzed the population dynamics of labeled stem cells in steady-state mouse spermatogenesis. Our results show that spermatogenic stem cells are continuously replaced, on average within 2 weeks. The analysis exposes a simple and robust scaling behavior of clone size distributions that shows stem cell replacement to be stochastic, meaning that stem cells are equipotent and equally likely to be lost or to multiply to replace their neighbors, irrespective of their clonal history. The surprisingly fast rate of stem cell replacement is supported experimentally by 3D clone morphology and by live-imaging of spermatogonial migration. These results suggest that short-lived stem cells may be a common feature of mammalian stem cell systems and reveal a natural mechanism for matching the rates of cell proliferation and loss in tissue.	[Nakagawa, Toshinori; Yoshida, Shosei] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Ichikawa, Rie; Yoshida, Shosei] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan; [Yoshida, Shosei] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Simons, Benjamin D.] Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England	Kyoto University; Harvard University; Harvard Medical School; University of Cambridge; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Yoshida, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	shosei@nibb.ac.jp; bds10@cam.ac.uk	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Yoshida, Shosei/0000-0001-8861-1866; Nakagawa, Toshinori/0000-0001-7620-1720	MEXT, Japan [20116004]; EPSRC LSI [EP/F043325/1]; EPSRC [EP/F043325/1, EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1, EP/F043325/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [20116004] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EPSRC LSI(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to A. Philpott and T. Ogawa for their insightful comments and discussions. We thank Y. Nabeshima for his continuous support and encouragement, R Sugimoto for discussions and technical instruction, and M. Sukeno and T. Obata for their technical assistance. We also thank T. Sasaoka and the staff of the Division of Model Animal Research, NIBB Bio-Resource Center, and Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, for support on animal experiments. The experimental work was partly supported by Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas, 'Regulatory Mechanism of Gamete Stem Cells' from MEXT, Japan to S.Y. (no. 20116004). A.M.K. is supported by an EPSRC LSI fellowship ref. EP/F043325/1.	ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Bachelier L., 1900, THEORIE SPECULATION; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; De Rooij DG, 2000, J ANDROL, V21, P776; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kimura MA, 1985, NEUTRAL THEORY MOL E; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Spence AJ, 2009, CURR BIOL, V19, pR57, DOI 10.1016/j.cub.2008.10.042; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	22	174	180	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					214	224		10.1016/j.stem.2010.05.017	http://dx.doi.org/10.1016/j.stem.2010.05.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682447	Bronze			2022-12-24	WOS:000281107400013
J	Suh, BC; Leal, K; Hille, B				Suh, Byung-Chang; Leal, Karina; Hille, Bertil			Modulation of High-Voltage Activated Ca2+ Channels by Membrane Phosphatidylinositol 4,5-Bisphosphate	NEURON			English	Article							RECEPTOR-MEDIATED INHIBITION; RAT SYMPATHETIC NEURONS; GATED CALCIUM-CHANNELS; SLOW MUSCARINIC INHIBITION; BETA-GAMMA-SUBUNITS; N-TYPE; PHOSPHOLIPASE-C; K+ CHANNELS; LIVING CELLS; PIP2	Modulation of voltage-gated Ca2+ channels controls activities of excitable cells. We show that high-voltage activated Ca2+ channels are regulated by membrane phosphatidylinositol 4,5-bisphosphate (PIP2) with different sensitivities. Plasma membrane PIP2 depletion by rapamycin-induced translocation of an inositol lipid 5-phosphatase or by a voltage-sensitive 5-phosphatase (VSP) suppresses Ca(V)1.2 and Ca(V)1.3 channel currents by similar to 35% and Ca(V)2.1 and Ca(V)2.2 currents by 29% and 55%, respectively. Other Ca-V channels are less sensitive. Inhibition is not relieved by strong depolarizing prepulses. It changes the voltage dependence of channel gating little. Recovery of currents from inhibition needs intracellular hydrolysable ATP, presumably for PIP2 resynthesis. When PIP2 is increased by overexpressing PIP 5-kinase, activation and inactivation of Ca(V)2.2 current slow and voltage-dependent gating shifts to slightly higher voltages. Thus, endogenous membrane PIP2 supports high-voltage activated L-, N-, and P/Q-type Ca2+ channels, and stimuli that activate phospholipase C deplete PIP2 and reduce those Ca2+ channel currents.	[Suh, Byung-Chang; Hille, Bertil] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Leal, Karina] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Leal, Karina] Univ Washington, Sch Med, Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Suh, BC (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	bcs@uw.edu			National Institutes of Health [NS08174, NS0222625, T32 GM07108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174, R37NS008174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Drs. Sharona E. Gordon, Todd Scheuer, Jill B. Jensen, and Bjoern H. Falkenburger for help with FRET approaches, valuable discussions, and comments on our manuscript, Lindsey A. Burnett and Mark W. Moody for plasmid amplification, and Lea M. Miller for technical assistance. We thank many labs who supplied plasmids (see Supplemental Experimental Procedures). This work was supported by National Institutes of Health Grant NS08174 (B.H.), NS0222625 (W.A. Catterall), and T32 GM07108 (K.L.).	Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Bannister RA, 2002, BIOPHYS J, V83, P3256, DOI 10.1016/S0006-3495(02)75327-7; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Lechner SG, 2005, MOL PHARMACOL, V68, P1387, DOI 10.1124/mol.105.014886; Lin ZX, 1996, J MOL NEUROSCI, V7, P257, DOI 10.1007/BF02737063; LIPSCOMBE D, 1989, NATURE, V340, P639, DOI 10.1038/340639a0; Liu LW, 2006, J NEUROSCI, V26, P11588, DOI 10.1523/JNEUROSCI.2102-06.2006; Liu LW, 2003, P NATL ACAD SCI USA, V100, P295, DOI 10.1073/pnas.0136826100; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; Melliti K, 2001, J PHYSIOL-LONDON, V532, P337, DOI 10.1111/j.1469-7793.2001.0337f.x; Michailidis IE, 2007, PFLUG ARCH EUR J PHY, V455, P147, DOI 10.1007/s00424-007-0272-9; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	44	111	116	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 29	2010	67	2					224	238		10.1016/j.neuron.2010.07.001	http://dx.doi.org/10.1016/j.neuron.2010.07.001			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670831	Bronze, Green Accepted			2022-12-24	WOS:000280461500008
J	Seki, T; Yuasa, S; Oda, M; Egashira, T; Yae, K; Kusumoto, D; Nakata, H; Tohyama, S; Hashimoto, H; Kodaira, M; Okada, Y; Seimiya, H; Fusaki, N; Hasegawa, M; Fukuda, K				Seki, Tomohisa; Yuasa, Shinsuke; Oda, Mayumi; Egashira, Toru; Yae, Kojiro; Kusumoto, Dai; Nakata, Hikari; Tohyama, Shugo; Hashimoto, Hisayuki; Kodaira, Masaki; Okada, Yohei; Seimiya, Hiroyuki; Fusaki, Noemi; Hasegawa, Mamoru; Fukuda, Keiichi			Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells	CELL STEM CELL			English	Article							SENDAI-VIRUS; EFFICIENT		[Seki, Tomohisa; Yuasa, Shinsuke; Egashira, Toru; Yae, Kojiro; Kusumoto, Dai; Nakata, Hikari; Tohyama, Shugo; Hashimoto, Hisayuki; Kodaira, Masaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Yuasa, Shinsuke; Oda, Mayumi; Okada, Yohei] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan; [Okada, Yohei] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Seimiya, Hiroyuki] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Tokyo 1358550, Japan; [Fusaki, Noemi; Hasegawa, Mamoru] DNAVEC Corp, Ibaraki 12511, Japan; [Fusaki, Noemi] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Keio University; Keio University; Keio University; Japanese Foundation for Cancer Research; DNAVEC Corporation; Japan Science & Technology Agency (JST)	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan.	kfukuda@sc.itc.keio.ac.jp	Oda, Mayumi/Z-2010-2019; Okada, Yohei/L-1662-2013; Yuasa, Shinsuke/L-8310-2013; Seki, Tomohisa/L-3524-2013; Hashimoto, Hisayuki/AAS-1938-2020; Fusaki, Noemi/U-1628-2019; Oda, Mayumi/AAU-4837-2020; Fukuda, Keiichi/L-3777-2013	Oda, Mayumi/0000-0001-5102-7076; Hashimoto, Hisayuki/0000-0001-7367-4805; Seimiya, Hiroyuki/0000-0003-3314-9736; Yae, Kojiro/0000-0002-3766-2812; Yuasa, Shinsuke/0000-0001-5593-7552; Kodaira, Masaki/0000-0002-7293-617X; Seki, Tomohisa/0000-0002-4281-135X	project for realization of regenerative medicine; Ministry of Education, Science, and Culture, Japan; New Energy and Industrial Technology Development Organization (NEDO)	project for realization of regenerative medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by research grants from the project for realization of regenerative medicine, the Ministry of Education, Science, and Culture, Japan, and by a grant from the New Energy and Industrial Technology Development Organization (NEDO). We thank Dr. Kyotaro Hirashima for technical assistance with TRAP assay. N.F. is an employee of DNAVEC Corporation and M.H. is a founder and shareholder of DNAVEC Corporation	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Okano S, 2003, GENE THER, V10, P1381, DOI 10.1038/sj.gt.3301998; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	13	382	432	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					11	14		10.1016/j.stem.2010.06.003	http://dx.doi.org/10.1016/j.stem.2010.06.003			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621043	Bronze			2022-12-24	WOS:000280222300006
J	Luong, MX; Auerbach, J; Crook, JM; Daheron, L; Hei, D; Lomax, G; Loring, JF; Ludwig, T; Schlaeger, TM; Smith, KP; Stacey, G; Xu, RH; Zeng, FY				Luong, Mai X.; Auerbach, Jonathan; Crook, Jeremy M.; Daheron, Laurence; Hei, Derek; Lomax, Geoffrey; Loring, Jeanne F.; Ludwig, Tenneille; Schlaeger, Thorsten M.; Smith, Kelly P.; Stacey, Glyn; Xu, Ren-He; Zeng, Fanyi			A Call for Standardized Naming and Reporting of Human ESC and iPSC Lines	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; FIBROBLASTS	Human embryonic and induced pluripotent stem cell lines are being generated at a rapid pace and now number in the thousands. We propose a standard nomenclature and suggest the use of a centralized database for all cell line names and a minimum set of information for reporting new derivations.	[Luong, Mai X.; Smith, Kelly P.] Univ Massachusetts, Sch Med, Dept Cell Biol, Int Stem Cell Registry, Shrewsbury, MA 01545 USA; [Auerbach, Jonathan] GlobalStem, Rockville, MD 20850 USA; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Obrien Inst, Fitzroy, Vic 3065, Australia; [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [Daheron, Laurence] Harvard IPSC Core Facil, Cambridge, MA 02138 USA; [Hei, Derek] Waisman Clin Biomfg Facil, Madison, WI 53705 USA; [Lomax, Geoffrey] CIRM, San Francisco, CA 94107 USA; [Loring, Jeanne F.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Ludwig, Tenneille] WiCell Res Inst, WISC Bank, Madison, WI 53705 USA; [Schlaeger, Thorsten M.] Childrens Hosp Boston, Human Embryon Stem Cell Core Facil, Boston, MA 02115 USA; [Stacey, Glyn] Natl Inst Biol Stand & Controls HPA, UK Stem Cell Bank, Potters Bar EN6 3QG, Herts, England; [Xu, Ren-He] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA; [Zeng, Fanyi] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China	University of Massachusetts System; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Scripps Research Institute; WiCell Research Institute; Harvard University; Boston Children's Hospital; National Institute for Biological Standards & Control; University of Connecticut; Shanghai Jiao Tong University	Luong, MX (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Int Stem Cell Registry, Shrewsbury, MA 01545 USA.	mai.luong@umassmed.edu	Xu, Ren-He/M-3125-2016; Xu, Ren-He/AAK-7392-2021; Crook, Jeremy Micah/AAH-8441-2020; Loring, Jeanne F/A-1620-2011	Crook, Jeremy Micah/0000-0002-6415-1639; Loring, Jeanne F/0000-0001-6226-9767; Schlaeger, Thorsten/0000-0002-1599-9908	MRC [MC_qA137914, G1001045] Funding Source: UKRI; Medical Research Council [G1001045] Funding Source: Medline; Medical Research Council [MC_qA137914] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Coecke S, 2005, ATLA-ALTERN LAB ANIM, V33, P261, DOI 10.1177/026119290503300313; Galende E, 2010, CELL REPROGRAM, V12, P117, DOI 10.1089/cell.2009.0077; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	9	41	41	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					357	359		10.1016/j.stem.2011.03.002	http://dx.doi.org/10.1016/j.stem.2011.03.002			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474098	Bronze			2022-12-24	WOS:000289707100006
J	Parsons, RG; Davis, M				Parsons, Ryan G.; Davis, Michael			Temporary disruption of fear-potentiated startle following PKM zeta inhibition in the amygdala	NATURE NEUROSCIENCE			English	Article							MEMORY; MAINTENANCE; STORAGE; RATS; LTP	We examined whether protein kinase M zeta (PKM zeta) inhibition in the amygdala permanently disrupts fear memory by testing retention at various intervals after PKM zeta blockade. Although the expression of fear memory was disrupted when the inhibitor was applied shortly before testing, it had no effect when rats were tested with longer retention intervals. These results suggest that PKM zeta inhibition does not erase memory, but temporarily disrupts expression of memory.	[Parsons, Ryan G.; Davis, Michael] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Parsons, RG (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	rparso3@emory.edu		Parsons, Ryan/0000-0001-8136-9413	US National Institutes of Health [R37 MH047840, F32 MH090700]; Center for Behavioral Neuroscience (National Science Foundation) [IBN-987675]; US National Institutes of Health/National Center for Research Resources [P51RR000165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047840, R37MH047840, F32MH090700] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Behavioral Neuroscience (National Science Foundation)(National Science Foundation (NSF)); US National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank G. Gafford for comments on the manuscript. This research was supported by grants R37 MH047840 (to M. D.) and F32 MH090700 (to R. G. P.) from the US National Institutes of Health. Support was also provided by the Center for Behavioral Neuroscience (National Science Foundation agreement IBN-987675) and by an US National Institutes of Health/National Center for Research Resources base grant (P51RR000165) to Yerkes National Primate Research Center.	Estes WK, 1997, PSYCHOL REV, V104, P148, DOI 10.1037/0033-295X.104.1.148; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Jones SV, 2005, BEHAV NEUROSCI, V119, P329, DOI 10.1037/0735-7044.119.1.329; Kwapis JL, 2009, BEHAV NEUROSCI, V123, P844, DOI 10.1037/a0016343; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Paschall GY, 2002, BEHAV NEUROSCI, V116, P4, DOI 10.1037//0735-7044.116.1.4; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Sossin WS, 2008, TRENDS NEUROSCI, V31, P170, DOI 10.1016/j.tins.2008.01.001; Stafford JM, 2009, LEARN MEMORY, V16, P494, DOI 10.1101/lm.1452209	14	48	49	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					295	296		10.1038/nn.2745	http://dx.doi.org/10.1038/nn.2745			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	725MW	21258326	Green Accepted			2022-12-24	WOS:000287650100007
J	Zhang, J; Li, B; Yu, L; He, YC; Li, HZ; Zhu, JN; Wang, JJ				Zhang, Jun; Li, Bin; Yu, Lei; He, Ye-Cheng; Li, Hong-Zhao; Zhu, Jing-Ning; Wang, Jian-Jun			A Role for Orexin in Central Vestibular Motor Control	NEURON			English	Article							BRAIN-STEM SLICES; HYPOCRETIN OREXIN; BEHAVIORAL STATE; KNOCKOUT MICE; SPINAL-CORD; GUINEA-PIG; NEURONS; RAT; NUCLEUS; OREXIN/HYPOCRETIN	The absence of orexin results in narcolepsy-cataplexy. While the function of the central orexinergic system in sleep regulation has been well studied, the role of orexin in motor control is largely unknown. Here, we show that orexin-A acts via OX1 and OX2 receptors to directly depolarize neurons in the rat lateral vestibular nucleus (LVN), a subcortical motor center, and enhance their sensitivity. A dual ionic mechanism involving both Na+-Ca2+ exchangers and inward rectifier K+ channels underlies these effects. Furthermore, orexin-A regulates central vestibular-mediated posture, motor balance and negative geotaxis. Orexin is critical when an animal is facing a major motor challenge as opposed to during rest and general movements. Therefore, orexin participates not only in sleep and emotion (nonsomatic) but also in motor (somatic) regulation, suggesting that the central orexinergic system plays an important role in somatic-nonsomatic integration. These findings may account for why the absence of orexin results in narcolepsy-cataplexy.	[Zhang, Jun; Li, Bin; Yu, Lei; He, Ye-Cheng; Li, Hong-Zhao; Zhu, Jing-Ning; Wang, Jian-Jun] Nanjing Univ, Dept Biol Sci & Technol, Nanjing 210093, Peoples R China; [Zhang, Jun; Li, Bin; Yu, Lei; He, Ye-Cheng; Li, Hong-Zhao; Zhu, Jing-Ning; Wang, Jian-Jun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China	Nanjing University; Nanjing University	Zhu, JN (corresponding author), Nanjing Univ, Dept Biol Sci & Technol, Mailbox 426,22 Hankou Rd, Nanjing 210093, Peoples R China.	jnzhu@nju.edu.cn; jjwang@nju.edu.cn	Zhu, Jing-Ning/C-7482-2014	Zhu, Jing-Ning/0000-0002-3695-9200; , Jun/0000-0003-4889-179X; Li, Bin/0000-0003-3880-9799	National Natural Science Foundation of China [30931160433]; State Educational Ministry of China [20070284057, 20100091110016]; Natural Science Foundation of Jiangsu Province, China [BK2006713]; China Postdoctoral Science Foundation [20100471305]; Jiangsu Planned Projects for Postdoctoral Research Funds [0902067C]; Jiangsu Planned Projects for Postgraduate Research and Innovatio [CX09B_0082];  [30670671];  [30700201];  [31070959];  [31071021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Educational Ministry of China; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; Jiangsu Planned Projects for Postgraduate Research and Innovatio; ; ; ; 	We wish to thank Dr. Tian-Le Xu (Institute of Neuroscience, Chinese Academy of Sciences, China) for his help in immunostaining experiments. We thank Dr. Timothy J. Ebner (Department of Neuroscience, University of Minnesota, USA) for reading the manuscript. This work was supported by grants 30670671, 30700201, 31070959, 31071021, and NSFC/RGC Joint Research Scheme 30931160433 from the National Natural Science Foundation of China; RFDP grants 20070284057 and 20100091110016 from the State Educational Ministry of China; grant BK2006713 from the Natural Science Foundation of Jiangsu Province, China; grant 20100471305 from China Postdoctoral Science Foundation; grant 0902067C from the Jiangsu Planned Projects for Postdoctoral Research Funds; and grant CX09B_0082 from the Jiangsu Planned Projects for Postgraduate Research and Innovation.	ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Bagnall MW, 2008, NEURON, V60, P343, DOI 10.1016/j.neuron.2008.10.002; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Broberger C, 1998, J COMP NEUROL, V402, P460; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cutler DJ, 1999, PEPTIDES, V20, P1455, DOI 10.1016/S0196-9781(99)00157-6; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; Espana RA, 2007, SLEEP, V30, P1417, DOI 10.1093/sleep/30.11.1417; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HERMANS RHM, 1992, NEUROTOXICOL TERATOL, V14, P119, DOI 10.1016/0892-0362(92)90060-N; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Korotkova TM, 2002, REGUL PEPTIDES, V104, P83, DOI 10.1016/S0167-0115(01)00323-8; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Liu RJ, 2002, J NEUROSCI, V22, P9453; Martins PJF, 2004, REGUL PEPTIDES, V117, P155, DOI 10.1016/j.regpep.2003.10.003; Matsuki Taizo, 2008, V46, P27, DOI 10.1007/400_2007_047; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; MOLINANEGRO P, 1980, ACTA OTO-LARYNGOL, V89, P524, DOI 10.3109/00016488009127170; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peyron C, 1998, J NEUROSCI, V18, P9996; Ris L, 2001, EUR J NEUROSCI, V13, P2234, DOI 10.1046/j.0953-816x.2001.01603.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; SHAMBOUL KM, 1979, J ANAT, V129, P107; Shiraishi T, 2000, PHYSIOL BEHAV, V71, P251, DOI 10.1016/S0031-9384(00)00341-3; Song YN, 2006, NEUROSCIENCE, V140, P33, DOI 10.1016/j.neuroscience.2006.01.045; SUAREZ C, 1993, LARYNGOSCOPE, V103, P762; Takakusaki K, 2005, J PHYSIOL-LONDON, V568, P1003, DOI 10.1113/jphysiol.2005.085829; Torterolo P, 2003, SLEEP, V26, P25; Uno A, 2003, J NEUROPHYSIOL, V90, P1689, DOI 10.1152/jn.00201.2003; WILSON VJ, 1978, PHYSIOL REV, V58, P80, DOI 10.1152/physrev.1978.58.1.80; Wu M, 2004, J NEUROSCI, V24, P3527, DOI 10.1523/JNEUROSCI.5364-03.2004; Wu M, 2002, J NEUROSCI, V22, P7754; Yamuy J, 2004, J NEUROSCI, V24, P5336, DOI 10.1523/JNEUROSCI.4812-03.2004; Yu L, 2010, CEREBELLUM, V9, P88, DOI 10.1007/s12311-009-0146-0; Zhang J, 2008, NEUROSCI LETT, V448, P15, DOI 10.1016/j.neulet.2008.10.027; Zhu JN, 2006, J NEUROSCI RES, V84, P1597, DOI 10.1002/jnr.21059; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	47	79	86	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 24	2011	69	4					793	804		10.1016/j.neuron.2011.01.026	http://dx.doi.org/10.1016/j.neuron.2011.01.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338887	Bronze			2022-12-24	WOS:000288413200019
J	Golebiewska, A; Brons, NHC; Bjerkvig, R; Niclou, SP				Golebiewska, Anna; Brons, Nicolaas H. C.; Bjerkvig, Rolf; Niclou, Simone P.			Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research	CELL STEM CELL			English	Review							DRUG EFFLUX TRANSPORTERS; BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; BONE-MARROW; NEURAL STEM; IN-VIVO; RESISTANCE PROTEIN; ABCG2 EXPRESSION; MOUSE MODEL; DYE EFFLUX	The "Side Population" (SP) discrimination assay is a flow cytometry method used to detect stem cells based on the dye efflux properties of ABC transporters. We discuss the SP assay and its applications in stem cell biology, with an emphasis on the technical challenges related to sample preparation, data acquisition, analysis, and interpretation. We highlight the value of multicolor phenotyping, the impact of DNA ploidy, and the importance of distinguishing graft versus host cells for an appropriate SP discrimination. To improve the consistency and reliability of data between laboratories, we propose a set of recommendations for SP assay data reporting.	[Golebiewska, Anna; Bjerkvig, Rolf; Niclou, Simone P.] Ctr Rech Publ Sante, Dept Oncol, NorLux Neurooncol Lab, L-1526 Luxembourg, Luxembourg; [Brons, Nicolaas H. C.] Ctr Rech Publ Sante, Core Facil Flow Cytometry, L-1526 Luxembourg, Luxembourg; [Bjerkvig, Rolf] Univ Bergen, Dept Biomed, N-5009 N Bergen, Norway	Luxembourg Institute of Health; Luxembourg Institute of Health; University of Bergen	Niclou, SP (corresponding author), Ctr Rech Publ Sante, Dept Oncol, NorLux Neurooncol Lab, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg.	simone.niclou@crp-sante.lu	Niclou, Simone/P-2304-2018; Golebiewska, Anna/E-1332-2015	Niclou, Simone/0000-0002-3417-9534; Golebiewska, Anna/0000-0002-4160-2521				Adamski D, 2007, FEBS LETT, V581, P3076, DOI 10.1016/j.febslet.2007.05.073; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; ARNDTJOVIN DJ, 1977, J HISTOCHEM CYTOCHEM, V25, P585, DOI 10.1177/25.7.70450; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bjerkvig R, 2009, SEMIN CANCER BIOL, V19, P279, DOI 10.1016/j.semcancer.2009.09.001; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Chua C, 2008, J NEUROSURG, V109, P856, DOI 10.3171/JNS/2008/109/11/0856; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Cooray HC, 2002, NEUROREPORT, V13, P2059, DOI 10.1097/00001756-200211150-00014; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Fromm MF, 2000, INT J CLIN PHARM TH, V38, P69; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Goodell Margaret A, 2005, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0918s34; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hori S, 2004, J NEUROCHEM, V90, P526, DOI 10.1111/j.1471-4159.2004.02537.x; Iwatani H, 2004, KIDNEY INT, V65, P1604, DOI 10.1111/j.1523-1755.2004.00561.x; Kim M, 2003, J NEUROSCI, V23, P10703; LALANDE ME, 1979, J HISTOCHEM CYTOCHEM, V27, P394, DOI 10.1177/27.1.86569; Lankas GR, 1998, REPROD TOXICOL, V12, P457, DOI 10.1016/S0890-6238(98)00027-6; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; LI CL, 1992, J EXP MED, V175, P1443, DOI 10.1084/jem.175.6.1443; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Ling V, 1995, AM J MED, V99, pS31, DOI 10.1016/S0002-9343(99)80283-6; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Mayer U, 1996, BRIT J PHARMACOL, V119, P1038, DOI 10.1111/j.1476-5381.1996.tb15775.x; MCALISTER I, 1990, BLOOD, V75, P1240; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Orford M, 2009, BIOCHEM BIOPH RES CO, V384, P199, DOI 10.1016/j.bbrc.2009.04.089; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Petriz J., 2007, CURR PROTOC CYTOM, V23; Potschka H, 2001, EPILEPSIA, V42, P1231, DOI 10.1046/j.1528-1157.2001.01901.x; Rabindran SK, 2000, CANCER RES, V60, P47; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Segal MB, 2000, CELL MOL NEUROBIOL, V20, P183, DOI 10.1023/A:1007045605751; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; Smit JW, 1998, BRIT J PHARMACOL, V124, P416, DOI 10.1038/sj.bjp.0701845; Storms RW, 2000, BLOOD, V96, P2125; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Summer R, 2004, AM J PHYSIOL-LUNG C, V287, pL477, DOI 10.1152/ajplung.00020.2004; Sun HY, 2003, ADV DRUG DELIVER REV, V55, P83, DOI 10.1016/S0169-409X(02)00172-2; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Telford WG, 2004, CYTOM PART A, V57A, P45, DOI 10.1002/cyto.a.10109; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Terunuma A, 2003, J INVEST DERMATOL, V121, P1095, DOI 10.1046/j.1523-1747.2003.12531.x; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; WOLF NS, 1993, EXP HEMATOL, V21, P614; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Wulf GG, 2003, HAEMATOLOGICA, V88, P368; Yin LQ, 2008, CANCER RES, V68, P800, DOI 10.1158/0008-5472.CAN-07-2545; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje; Zheng XS, 2007, CANCER RES, V67, P3691, DOI 10.1158/0008-5472.CAN-06-3912; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Ziu M, 2006, J NEURO-ONCOL, V79, P125, DOI 10.1007/s11060-006-9121-5	81	236	246	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					136	147		10.1016/j.stem.2011.01.007	http://dx.doi.org/10.1016/j.stem.2011.01.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295271	Bronze			2022-12-24	WOS:000287633400008
J	Sasaki, T; Takemori, H; Yagita, Y; Terasaki, Y; Uebi, T; Horike, N; Takagi, H; Susumu, T; Teraoka, H; Kusano, K; Hatano, O; Oyama, N; Sugiyama, Y; Sakoda, S; Kitagawa, K				Sasaki, Tsutomu; Takemori, Hiroshi; Yagita, Yoshiki; Terasaki, Yasukazu; Uebi, Tatsuya; Horike, Nanao; Takagi, Hiroaki; Susumu, Teruo; Teraoka, Hiroshi; Kusano, Ken-ichi; Hatano, Osamu; Oyama, Naoki; Sugiyama, Yukio; Sakoda, Saburo; Kitagawa, Kazuo			SIK2 Is a Key Regulator for Neuronal Survival after Ischemia via TORC1-CREB	NEURON			English	Article							MEDIATED GENE-EXPRESSION; SENSITIVE COINCIDENCE DETECTOR; ELEMENT-BINDING PROTEIN; CREB COACTIVATOR TORC2; SALT-INDUCIBLE KINASE; TRANSCRIPTION FACTOR; NMDA RECEPTORS; BRAIN-INJURY; IN-VITRO; PHOSPHORYLATION	The cAMP responsive element-binding protein (CREB) functions in a broad array of biological and pathophysiological processes. We found that salt-inducible kinase 2 (SIK2) was abundantly expressed in neurons and suppressed CREB-mediated gene expression after oxygen-glucose deprivation (OGD). OGD induced the degradation of SIK2 protein concomitantly with the dephosphorylation of the CREB-specific coactivator transducer of regulated CREB activity 1 (TORC1), resulting in the activation of CREB and its downstream gene targets. Ca2+/calmodulin-dependent protein kinase I/IV are capable of phosphorylating SIK2 at Thr484, resulting in SIK2 degradation in cortical neurons. Neuronal survival after OGD was significantly increased in neurons isolated from sik2(-/-) mice, and ischemic neuronal injury was significantly reduced in the brains of sik2(-/-) mice subjected to transient focal ischemia. These findings suggest that SIK2 plays critical roles in neuronal survival, is modulated by CaMK I/IV, and regulates CREB via TORC1.	[Takemori, Hiroshi; Uebi, Tatsuya; Horike, Nanao] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, Osaka 5670085, Japan; [Sasaki, Tsutomu; Yagita, Yoshiki; Terasaki, Yasukazu; Oyama, Naoki; Sugiyama, Yukio; Sakoda, Saburo; Kitagawa, Kazuo] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; [Takagi, Hiroaki; Susumu, Teruo; Teraoka, Hiroshi; Kusano, Ken-ichi] ProteinExpress Co Ltd, Chuo Ku, Chiba 2600856, Japan; [Hatano, Osamu] Nara Med Univ, Dept Anat, Nara 6348521, Japan	National Institute of Health Sciences - Japan; Osaka University; Nara Medical University	Takemori, H (corresponding author), Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, 7-6-8 Asagi, Osaka 5670085, Japan.	takemori@nibio.go.jp; kitagawa@medone.med.osaka-u.ac.jp	Yagita, Yoshiki/S-6954-2016	Sugiyama, Yukio/0000-0002-5712-9599; sasaki, tsutomu/0000-0001-8726-978X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Mishima Kaiun Memorial Foundation; Suzuken Memorial Foundation; Strategic Project to Support the Formation of Research Bases at Private Universities	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Suzuken Memorial Foundation; Strategic Project to Support the Formation of Research Bases at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Ms. K. Nishiyama, Mrs. J. Morita-Kajimura, and Mr. R. Nakai for laboratory assistance, and Ms. C. Kurano for secretarial assistance. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Takeda Science Foundation, Mishima Kaiun Memorial Foundation, Suzuken Memorial Foundation, and Strategic Project to Support the Formation of Research Bases at Private Universities.	Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Feldman JD, 2000, J NEUROCHEM, V74, P2227, DOI 10.1046/j.1471-4159.2000.0742227.x; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goodman RH, 2000, GENE DEV, V14, P1553; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P1336, DOI 10.1097/00004647-199812000-00008; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Takemori H, 2008, J STEROID BIOCHEM, V108, P287, DOI 10.1016/j.jsbmb.2007.09.006; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	45	94	114	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 13	2011	69	1					106	119		10.1016/j.neuron.2010.12.004	http://dx.doi.org/10.1016/j.neuron.2010.12.004			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220102	Bronze			2022-12-24	WOS:000286446300011
J	Le Belle, JE; Orozco, NM; Paucar, AA; Saxe, JP; Mottahedeh, J; Pyle, AD; Wu, H; Kornblum, HI				Le Belle, Janel E.; Orozco, Nicolas M.; Paucar, Andres A.; Saxe, Jonathan P.; Mottahedeh, Jack; Pyle, April D.; Wu, Hong; Kornblum, Harley I.			Proliferative Neural Stem Cells Have High Endogenous ROS Levels that Regulate Self-Renewal and Neurogenesis in a PI3K/Akt-Dependant Manner	CELL STEM CELL			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; REACTIVE OXYGEN; REDOX REGULATION; DEPENDENT REGULATION; SUBVENTRICULAR ZONE; NADPH OXIDASES; PTEN; RECEPTOR; DIFFERENTIATION; BRAIN	The majority of research on reactive oxygen species (ROS) has focused on their cellular toxicities. Stem cells generally have been thought to maintain low levels of ROS as a protection against these processes. However, recent studies suggest that ROS can also play roles as second messengers, activating normal cellular processes. Here, we investigated ROS function in primary brain-derived neural progenitors. Somewhat surprisingly, we found that proliferative, self-renewing multipotent neural progenitors with the phenotypic characteristics of neural stem cells (NSC) maintained a high ROS status and were highly responsive to ROS stimulation. ROS-mediated enhancements in self-renewal and neurogenesis were dependent on PI3K/Akt signaling. Pharmacological or genetic manipulations that diminished cellular ROS levels also interfered with normal NSC and/or multipotent progenitor function both in vitro and in vivo. This study has identified a redox-mediated regulatory mechanism of NSC function that may have significant implications for brain injury, disease, and repair.	[Le Belle, Janel E.; Orozco, Nicolas M.; Paucar, Andres A.; Mottahedeh, Jack; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Le Belle, Janel E.; Orozco, Nicolas M.; Paucar, Andres A.; Mottahedeh, Jack; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Saxe, Jonathan P.; Wu, Hong; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Pyle, April D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Pyle, April D.; Wu, Hong; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Pyle, April D.; Wu, Hong; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Wu, Hong] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kornblum, HI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.	harley@ucla.edu		Saxe, Jonathan/0000-0001-7301-6423	Cure Autism Now Fellowship; Autism Speaks Basic and Clinical grant; Autism Speaks Environmental Sciences; Center for Autism Research and Treatment (CART) [06LEB2008]; NIH/NICHD [11 P50-HD-055784]; NIH [MH65756]; Henry Singleton Brain Cancer Research Program; James S. McDonnell Foundation; Miriam and Sheldon Adelson Program in Neural Repair and Rehabilitation; University of California, Cancer Research Coordinating Committee; National Institutes of Health [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; UCLA Chancellor's Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052563] Funding Source: NIH RePORTER	Cure Autism Now Fellowship; Autism Speaks Basic and Clinical grant; Autism Speaks Environmental Sciences; Center for Autism Research and Treatment (CART); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry Singleton Brain Cancer Research Program; James S. McDonnell Foundation; Miriam and Sheldon Adelson Program in Neural Repair and Rehabilitation; University of California, Cancer Research Coordinating Committee(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); UCLA Chancellor's Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the following grants and awards: Cure Autism Now Fellowship (to J.E.L.), Autism Speaks Basic and Clinical grant (to H.I.K.), Autism Speaks Environmental Sciences grant (to J.E.L.), Center for Autism Research and Treatment (CART) Pilot Grant Award #06LEB2008, which is supported by NIH/NICHD grant 11 P50-HD-055784 (to J.E.L.), NIH MH65756 (to H.I.K. and H.W.), Henry Singleton Brain Cancer Research Program and James S. McDonnell Foundation Award (to H.W.), Miriam and Sheldon Adelson Program in Neural Repair and Rehabilitation (to H.W. and H.I.K.), University of California, Cancer Research Coordinating Committee grant (to A.D.P.), and the Jonsson Comprehensive Cancer Center grant (to A.D.P.). Flow cytometry and cell sorting was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility, which is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, the David Geffen School of Medicine at UCLA, and the UCLA Chancellor's Office.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chiarugi P, 2007, CELL SIGNAL, V19, P672, DOI 10.1016/j.cellsig.2006.11.009; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Doetsch F, 1997, J NEUROSCI, V17, P5046; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guo SH, 2008, J NEUROCHEM, V105, P1849, DOI 10.1111/j.1471-4159.2008.05287.x; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kunz A, 2007, J CEREBR BLOOD F MET, V27, P545, DOI 10.1038/sj.jcbfm.9600369; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Leslie NR, 2006, ANTIOXID REDOX SIGN, V8, P1765, DOI 10.1089/ars.2006.8.1765; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Madhavan L, 2006, STEM CELLS, V24, P2110, DOI 10.1634/stemcells.2006-0018; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Studer L, 2000, J NEUROSCI, V20, P7377; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wang Y, 2009, INVEST OPHTH VIS SCI, V50, P2291, DOI 10.1167/iovs.08-2568; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoneyama M, 2010, NEUROCHEM INT, V56, P740, DOI 10.1016/j.neuint.2009.11.018; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	52	550	555	6	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					59	71		10.1016/j.stem.2010.11.028	http://dx.doi.org/10.1016/j.stem.2010.11.028			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211782	Green Accepted, Bronze			2022-12-24	WOS:000286786200011
J	Huang, XY; Xu, WF; Liang, JM; Takagaki, K; Gao, X; Wu, JY				Huang, Xiaoying; Xu, Weifeng; Liang, Jianmin; Takagaki, Kentaroh; Gao, Xin; Wu, Jian-young			Spiral Wave Dynamics in Neocortex	NEURON			English	Article							TURTLE OLFACTORY-BULB; VISUAL-CORTEX; PROPAGATING WAVES; CORTICAL RESPONSE; ELECTRICAL WAVES; TRAVELING-WAVES; CARDIAC-MUSCLE; OSCILLATIONS; PHASE; NETWORKS	Although spiral waves are ubiquitous features of nature and have been observed in many biological systems, their existence and potential function in mammalian cerebral cortex remain uncertain. Using voltage-sensitive dye imaging, we found that spiral waves occur frequently in the neocortex in vivo, both during pharmacologically induced oscillations and during sleep-like states. While their life span is limited, spiral waves can modify ongoing cortical activity by influencing oscillation frequencies and spatial coherence and by reducing amplitude in the area surrounding the spiral phase singularity. During sleep-like states, the rate of occurrence of spiral waves varies greatly depending on brain states. These results support the hypothesis that spiral waves, as an emergent activity pattern, can organize and modulate cortical population activity on the mesoscopic scale and may contribute to both normal cortical processing and to pathological patterns of activity such as those found in epilepsy.	[Huang, Xiaoying; Xu, Weifeng; Liang, Jianmin; Takagaki, Kentaroh; Gao, Xin; Wu, Jian-young] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20057 USA; [Takagaki, Kentaroh] Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; [Liang, Jianmin] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130021, Peoples R China	Georgetown University; Leibniz Institut fur Neurobiologie (LIN); Jilin University	Wu, JY (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20057 USA.	wuj@georgetown.edu	Takagaki, Kentaroh/A-9829-2009; Huang, Xiao-Ying/E-5994-2011	Takagaki, Kentaroh/0000-0002-1852-529X; Huang, Xiao-Ying/0000-0002-3514-216X	NIH [NS036447, NS059034]; American Epilepsy Society; Lennox Trust; Humboldt Foundation/Stiftung; Georgetown-China Scholarship council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036447, R01NS059034] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Epilepsy Society; Lennox Trust; Humboldt Foundation/Stiftung(Alexander von Humboldt Foundation); Georgetown-China Scholarship council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. S.J. Schiff, L.B. Cohen, G. Bard Ermentrout, S.D. Van Hooser, D. Fitzpatrick, and S.H. Strogatz for helpful discussion and comments on the manuscript. Supported by NIH grant NS036447, NS059034 (J.-y.W.), fellowships from the American Epilepsy Society and the Lennox Trust Fund (to X.H.), the Humboldt Foundation/Stiftung (to K.T.) and Georgetown-China Scholarship council (to J.L.).	Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Bub G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028105; Bub G, 2003, J CARDIOVASC ELECTR, V14, pS229, DOI 10.1046/j.1540.8167.90315.x; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; DAVIDENKO JM, 1992, J ELECTROCARDIOL, V24, P113; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Dorries KM, 2000, J NEUROPHYSIOL, V83, P754, DOI 10.1152/jn.2000.83.2.754; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Gottwald G, 2001, CHAOS, V11, P487, DOI 10.1063/1.1395624; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Harris-White ME, 1998, J NEUROPHYSIOL, V79, P1045, DOI 10.1152/jn.1998.79.2.1045; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jalife J, 2003, J CARDIOVASC ELECTR, V14, P776, DOI 10.1046/j.1540-8167.2003.03136.x; Jalife J, 1996, ACTA PHYSIOL SCAND, V157, P123, DOI 10.1046/j.1365-201X.1996.505249000.x; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; KEENER JP, 1986, PHYSICA D, V21, P307, DOI 10.1016/0167-2789(86)90007-2; Kheowan OU, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046221; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lam YW, 2003, EUR J NEUROSCI, V17, P436, DOI 10.1046/j.1460-9568.2003.02457.x; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; LONDON JA, 1989, J NEUROSCI, V9, P2182; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Palsson E, 1996, P NATL ACAD SCI USA, V93, P1151, DOI 10.1073/pnas.93.3.1151; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Prechtl JC, 2000, P NATL ACAD SCI USA, V97, P877, DOI 10.1073/pnas.97.2.877; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Senseman D M, 1999, J Neurosci, V19, pRC3; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; Sharon D, 2007, CEREB CORTEX, V17, P2866, DOI 10.1093/cercor/bhm019; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; Steinbock O., 1993, PHYS PLASMAS, V47, P1506; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun JF, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046213; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WINFREE AT, 1989, J THEOR BIOL, V138, P353, DOI 10.1016/S0022-5193(89)80200-0; Winfree AT., 1980, GEOMETRY BIOL TIME; Wu J.-Y., 1993, FLUORESCENT LUMINESC, P389; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016	57	196	202	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					978	990		10.1016/j.neuron.2010.11.007	http://dx.doi.org/10.1016/j.neuron.2010.11.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145009	Green Accepted, Bronze			2022-12-24	WOS:000285664900017
J	Lu, HDD; Chen, G; Tanigawa, H; Roe, AW				Lu, Haidong D.; Chen, Gang; Tanigawa, Hisashi; Roe, Anna W.			A Motion Direction Map in Macaque V2	NEURON			English	Article							RECEPTIVE-FIELD PROPERTIES; PRIMARY VISUAL-CORTEX; FUNCTIONAL-ORGANIZATION; AREA V2; SELECTIVE CELLS; INTRINSIC SIGNALS; STRIATE CORTEX; MONKEY; PRIMATE; COLOR	In mammals, the perception of motion starts with direction-selective neurons in the visual cortex. Despite numerous studies in monkey primary and second visual cortex (V1 and V2), there has been no evidence of direction maps in these areas. In the present study, we used optical imaging methods to study the organization of motion response in macaque V1 and V2. In contrast to the findings in other mammals (e.g., cats and ferrets), we found no direction maps in macaque Vi. Robust direction maps, however, were found in V2 thick/pale stripes and avoided thin stripes. In many cases direction maps were located within thick stripes and exhibited pinwheel or linear organizations. The presence of motion maps in V2 points to a newfound prominence of V2 in motion processing, for contributing to motion perception in the dorsal pathway and/or for motion cue-dependent form perception in the ventral pathway.	[Lu, Haidong D.; Chen, Gang; Tanigawa, Hisashi; Roe, Anna W.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Vanderbilt University	Lu, HDD (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	haidong@ion.ac.cn	Tanigawa, Hisashi/H-4792-2014; chen, gang/H-3169-2012	Tanigawa, Hisashi/0000-0002-7736-0683; Roe, Anna Wang/0000-0003-4146-9705	NIH [EY11744]; Vanderbilt Vision Research Center; Vanderbilt University Center for Integrative & Cognitive Neuroscience; NATIONAL EYE INSTITUTE [R01EY011744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Vision Research Center; Vanderbilt University Center for Integrative & Cognitive Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Robert Friedman for technical assistance and Lisa Chu for surgical assistance. This work was supported by NIH grant EY11744 to A.W.R., Vanderbilt Vision Research Center, and Vanderbilt University Center for Integrative & Cognitive Neuroscience.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Bosking WH, 1997, J NEUROSCI, V17, P2112; Chen G, 2008, NEURON, V58, P442, DOI 10.1016/j.neuron.2008.02.032; Chen LM, 2002, J NEUROSCI METH, V113, P41, DOI 10.1016/S0165-0270(01)00475-7; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Diogo ACM, 2003, J NEUROSCI, V23, P3881; DOW BM, 1974, J NEUROPHYSIOL, V37, P927, DOI 10.1152/jn.1974.37.5.927; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Gur M, 2005, CEREB CORTEX, V15, P1207, DOI 10.1093/cercor/bhi003; Handa T, 2010, NEUROREPORT, V21, P532, DOI 10.1097/WNR.0b013e3283393a5f; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Kaskan PM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00023; Kisvarday ZF, 2001, CEREB CORTEX, V11, P636, DOI 10.1093/cercor/11.7.636; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Lim HJ, 2009, J NEUROPHYSIOL, V102, P2603, DOI 10.1152/jn.91255.2008; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3371; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2009, NEUROIMAGE, V44, P636, DOI 10.1016/j.neuroimage.2008.10.007; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; Lu HD, 2007, CEREB CORTEX, V17, P2675, DOI 10.1093/cercor/bhl177; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; Marcar VL, 2000, J NEUROPHYSIOL, V84, P2786, DOI 10.1152/jn.2000.84.6.2786; Moutoussis K, 2002, J NEUROPHYSIOL, V87, P2104, DOI 10.1152/jn.00248.2001; Movshon JA, 1996, J NEUROSCI, V16, P7733; MUNK MHJ, 1995, P NATL ACAD SCI USA, V92, P988, DOI 10.1073/pnas.92.4.988; Nassi JJ, 2007, NEURON, V55, P799, DOI 10.1016/j.neuron.2007.07.037; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; Ponce CR, 2008, NAT NEUROSCI, V11, P216, DOI 10.1038/nn2039; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; Roe A. W., 2009, VISUAL SYSTEM FUNCTI, V10, P331; Roe AW, 2007, APPL OPTICS, V46, P1872, DOI 10.1364/AO.46.001872; Roe AW, 2007, J NEUROSCI, V27, P11820, DOI 10.1523/JNEUROSCI.4164-07.2007; Roe AW, 2005, P NATL ACAD SCI USA, V102, P3869, DOI 10.1073/pnas.0500097102; ROE AW, 1995, J NEUROSCI, V15, P3689; Roe AW, 1999, J NEUROPHYSIOL, V82, P2719, DOI 10.1152/jn.1999.82.5.2719; Roe AW, 2004, METH NE FRO NEUROSCI, P109; Roe AW, 1997, CEREBR CORT, V12, P295; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Shipp S, 2002, VISUAL NEUROSCI, V19, P187, DOI 10.1017/S0952523802191164; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Shmuel A, 1996, J NEUROSCI, V16, P6945; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; Tanaka K, 1996, NEURAL NETWORKS, V9, P1459, DOI 10.1016/S0893-6080(96)00045-7; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TOOTELL RBH, 1989, J NEUROSCI, V9, P2620; Ts'o DY, 2001, VISION RES, V41, P1333, DOI 10.1016/S0042-6989(01)00076-1; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Xiao YP, 2003, NATURE, V421, P535, DOI 10.1038/nature01372; Xu XM, 2004, P NATL ACAD SCI USA, V101, P2566, DOI 10.1073/pnas.0308745101	72	81	82	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					1002	1013		10.1016/j.neuron.2010.11.020	http://dx.doi.org/10.1016/j.neuron.2010.11.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145011	Bronze, Green Accepted			2022-12-24	WOS:000285664900019
J	Agetsuma, M; Aizawa, H; Aoki, T; Nakayama, R; Takahoko, M; Goto, M; Sassa, T; Amo, R; Shiraki, T; Kawakami, K; Hosoya, T; Higashijima, S; Okamoto, H				Agetsuma, Masakazu; Aizawa, Hidenori; Aoki, Tazu; Nakayama, Ryoko; Takahoko, Mikako; Goto, Midori; Sassa, Takayuki; Amo, Ryunosuke; Shiraki, Toshiyuki; Kawakami, Koichi; Hosoya, Toshihiko; Higashijima, Shin-ichi; Okamoto, Hitoshi			The habenula is crucial for experience-dependent modification of fear responses in zebrafish	NATURE NEUROSCIENCE			English	Article							NUCLEUS; CONNECTIONS; EXPRESSION	The zebrafish dorsal habenula (dHb) shows conspicuous asymmetry in its connection with the interpeduncular nucleus (IPN) and is equivalent to the mammalian medial habenula. Genetic inactivation of the lateral subnucleus of dHb (dHbL) biased fish towards freezing rather than the normal flight response to a conditioned fear stimulus, suggesting that the dHbL-IPN pathway is important for controlling experience-dependent modification of fear responses.	[Nakayama, Ryoko; Takahoko, Mikako; Shiraki, Toshiyuki] RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan; [Amo, Ryunosuke] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Shizuoka, Japan; [Kawakami, Koichi] Grad Univ Adv Studies, Dept Genet, Shizuoka, Japan; [Higashijima, Shin-ichi] Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Natl Inst Nat Sci, Aichi, Japan; [Okamoto, Hitoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	RIKEN; Waseda University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST)	Okamoto, H (corresponding author), RIKEN Brain Sci Inst, Res Resource Ctr, Wako, Saitama, Japan.	hitoshi@brain.riken.jp	Aoki, Tazu/F-5051-2011; Agetsuma, Masakazu/AAD-1654-2019; Hosoya, Toshihiko/Q-2514-2018; Kawakami, Koichi/AAF-1380-2019; Okamoto, Hitoshi/P-9767-2015; SASSA, Takayuki/B-2519-2012	Agetsuma, Masakazu/0000-0002-8606-4886; Hosoya, Toshihiko/0000-0001-8559-8344; Okamoto, Hitoshi/0000-0002-7512-8549; SASSA, Takayuki/0000-0003-3145-9829; Higashijima, Shin-ichi/0000-0001-6350-4992; Aizawa, Hidenori/0000-0002-2896-1298; Amo, Ryunosuke/0000-0001-8644-2296	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Okamoto laboratory	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Okamoto laboratory	We thank Y. Yoshihara, T. Koide and other members of the Yoshihara laboratory for transgenic fish and advice on the behavioral experiments, S. Watanabe for help in setting up the behavioral experiments, N. Copeland for the BAC homologous recombination system, S. Fraser for GAL4VP16 and UAS plasmids, M. Parsons for the UAS:nfsB-mCherry plasmid, A. Thomson for correction of the manuscript and S. Jesuthasan for communication of unpublished data. We are grateful to all of the members of the Okamoto laboratory for support and advice, the Research Resource Center of RIKEN BSI for animal care and the National BioResource Project of Japan for fish strains. This work was supported by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan to H.O. and H. A. and by the Core Research for Evolutional Science and Technology of Japan Science and Technology Agency to H.O.	Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Goto M, 2001, J COMP NEUROL, V438, P86, DOI 10.1002/cne.1303; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Mongeau R, 2003, J NEUROSCI, V23, P3855; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Reti IM, 2002, J NEUROCHEM, V82, P935, DOI 10.1046/j.1471-4159.2002.01051.x; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6	15	249	253	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1354	1356		10.1038/nn.2654	http://dx.doi.org/10.1038/nn.2654			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20935642				2022-12-24	WOS:000283658200015
J	Chang, EF; Rieger, JW; Johnson, K; Berger, MS; Barbaro, NM; Knight, RT				Chang, Edward F.; Rieger, Jochem W.; Johnson, Keith; Berger, Mitchel S.; Barbaro, Nicholas M.; Knight, Robert T.			Categorical speech representation in human superior temporal gyrus	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL MAGNET; AUDITORY-CORTEX; LOBE; ACTIVATION; NONSPEECH; LANGUAGE; SOUNDS; CONSONANTS	Speech perception requires the rapid and effortless extraction of meaningful phonetic information from a highly variable acoustic signal. A powerful example of this phenomenon is categorical speech perception, in which a continuum of acoustically varying sounds is transformed into perceptually distinct phoneme categories. We found that the neural representation of speech sounds is categorically organized in the human posterior superior temporal gyrus. Using intracranial high-density cortical surface arrays, we found that listening to synthesized speech stimuli varying in small and acoustically equal steps evoked distinct and invariant cortical population response patterns that were organized by their sensitivities to critical acoustic features. Phonetic category boundaries were similar between neurometric and psychometric functions. Although speech-sound responses were distributed, spatially discrete cortical loci were found to underlie specific phonetic discrimination. Our results provide direct evidence for acoustic-to-higher order phonetic level encoding of speech sounds in human language receptive cortex.	[Chang, Edward F.; Berger, Mitchel S.; Barbaro, Nicholas M.; Knight, Robert T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Chang, Edward F.; Rieger, Jochem W.; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Rieger, Jochem W.] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Johnson, Keith] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Otto von Guericke University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	changed@neurosurg.ucsf.edu; jochem.rieger@med.ovgu.de	Johnson, Keith/AAM-6322-2020	Johnson, Keith/0000-0002-2569-8121; Rieger, Jochem/0000-0003-0955-2306	US National Institutes of Health [NS21135, PO4813, F32NS061552, K99NS065120, FKZ-MK48-2009/003, RI1511/1-3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065120, F32NS061552, K99NS065120, R01NS021135] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the four individuals who participated in this experiment and to A. Flinker for help with data acquisition. This research was supported by US National Institutes of Health grants NS21135 (R. T. K.), PO4813 (R. T. K.), F32NS061552 (E. F. C.), K99NS065120 (E. F. C.), FKZ-MK48-2009/003 (J.W.R.) and RI1511/1-3 (J.W.R.).	Benson RR, 2006, NEUROIMAGE, V31, P342, DOI 10.1016/j.neuroimage.2005.11.029; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; BLUMSTEIN SE, 1980, J ACOUST SOC AM, V67, P648, DOI 10.1121/1.383890; Blumstein SE, 2005, J COGNITIVE NEUROSCI, V17, P1353, DOI 10.1162/0898929054985473; BOATMAN D, 1995, BRAIN LANG, V51, P269, DOI 10.1006/brln.1995.1061; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Desai R, 2008, J COGNITIVE NEUROSCI, V20, P1174, DOI 10.1162/jocn.2008.20081; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; HAGLUND MM, 1994, NEUROSURGERY, V34, P567, DOI 10.1227/00006123-199404000-00001; Harnad Stevan, 1987, CATEGORICAL PERCEPTI; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; IVERSON P, 1995, J ACOUST SOC AM, V97, P553, DOI 10.1121/1.412280; Iverson P, 2000, PERCEPT PSYCHOPHYS, V62, P874, DOI 10.3758/BF03206929; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Koh KM, 2007, J MACH LEARN RES, V8, P1519; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Penfield W, 1954, EPILEPSY FUNCTIONAL; Perkell J.S., 1986, INVARIANCE VARIABILI; Raizada RDS, 2007, NEURON, V56, P726, DOI 10.1016/j.neuron.2007.11.001; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Uppenkamp S, 2006, NEUROIMAGE, V31, P1284, DOI 10.1016/j.neuroimage.2006.01.004; Vihman M. M., 1996, PHONOLOGICAL DEV ORI; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Whalen DH, 2006, J ACOUST SOC AM, V119, P575, DOI 10.1121/1.2139627	35	346	353	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1428	U169		10.1038/nn.2641	http://dx.doi.org/10.1038/nn.2641			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890293	Green Submitted, Green Accepted			2022-12-24	WOS:000283658200025
J	Oviedo, HV; Bureau, I; Svoboda, K; Zador, AM				Oviedo, Hysell V.; Bureau, Ingrid; Svoboda, Karel; Zador, Anthony M.			The functional asymmetry of auditory cortex is reflected in the organization of local cortical circuits	NATURE NEUROSCIENCE			English	Article							IN-VIVO; SPECTRAL INTEGRATION; RECEPTIVE-FIELDS; VISUAL-CORTEX; NEURONS; MOUSE; LAMINAR; ARCHITECTURE; CONNECTIONS; PROJECTIONS	The primary auditory cortex (A1) is organized tonotopically, with neurons sensitive to high and low frequencies arranged in a rostro-caudal gradient. We used laser scanning photostimulation in acute slices to study the organization of local excitatory connections onto layers 2 and 3 (L2/3) of the mouse A1. Consistent with the organization of other cortical regions, synaptic inputs along the isofrequency axis (orthogonal to the tonotopic axis) arose predominantly within a column. By contrast, we found that local connections along the tonotopic axis differed from those along the isofrequency axis: some input pathways to L3 (but not L2) arose predominantly out-of-column. In vivo cell-attached recordings revealed differences between the sound-responsiveness of neurons in L2 and L3. Our results are consistent with the hypothesis that auditory cortical microcircuitry is specialized to the one-dimensional representation of frequency in the auditory cortex.	[Oviedo, Hysell V.; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Bureau, Ingrid] Inst Neurobiol Mediterranee, INSERM, U901, Marseille, France; [Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA	Cold Spring Harbor Laboratory; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Howard Hughes Medical Institute	Zador, AM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu	; Bureau, Ingrid/O-3941-2016	Zador, Anthony/0000-0002-8431-9136; Bureau, Ingrid/0000-0001-9166-2250	US National Institutes of Health; Patterson Foundation; Swartz Foundation; Autism Speaks; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005415] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patterson Foundation; Swartz Foundation; Autism Speaks; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Burbach for invaluable technical help, S. Joshi for invaluable input on juxtacellular labeling, N. Gray, G. Otazu and T. Hackett for discussions, and W. Bair (Department of Physiology, Anatomy and Genetics, University of Oxford) for spike detection software. This work was supported by grants from the US National Institutes of Health, the Patterson Foundation (H.V.O.) the Swartz Foundation and Autism Speaks.	Anderson LA, 2009, BRAIN RES, V1252, P130, DOI 10.1016/j.brainres.2008.11.037; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Barbour DL, 2008, J NEUROSCI, V28, P11174, DOI 10.1523/JNEUROSCI.2093-08.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IMIG TJ, 1978, J COMP NEUROL, V182, P637, DOI 10.1002/cne.901820406; Joshi S, 2006, J NEUROSCI METH, V156, P37, DOI 10.1016/j.jneumeth.2006.02.004; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; KOWALSKI N, 1995, J NEUROPHYSIOL, V73, P1513, DOI 10.1152/jn.1995.73.4.1513; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; MATSUBARA JA, 1988, J COMP NEUROL, V268, P38, DOI 10.1002/cne.902680105; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; Nelken I, 2008, CURR OPIN NEUROBIOL, V18, P413, DOI 10.1016/j.conb.2008.08.014; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; TSO DY, 1986, J NEUROSCI, V6, P1160; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Van Hooser SD, 2006, J NEUROSCI, V26, P7680, DOI 10.1523/JNEUROSCI.0108-06.2006; Velenovsky DS, 2003, J NEUROSCI, V23, P308; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	43	77	77	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1413	U154		10.1038/nn.2659	http://dx.doi.org/10.1038/nn.2659			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953193	Green Accepted			2022-12-24	WOS:000283658200023
J	Bavelier, D; Green, CS; Dye, MWG				Bavelier, Daphne; Green, C. Shawn; Dye, Matthew W. G.			Children, Wired: For Better and for Worse	NEURON			English	Article							MULTIPLE-OBJECT TRACKING; VIOLENT VIDEO GAMES; INTERNET ADDICTION; COMPUTER GAME; GENDER-DIFFERENCES; TELEVISION; ATTENTION; EXPOSURE; BRAIN; ADOLESCENTS	Children encounter technology constantly at home and in school. Television, DVDs, video games, the Internet, and smart phones all play a formative role in children's development. The term "technology" subsumes a large variety of somewhat independent items, and it is no surprise that current research indicates causes for both optimism and concern depending upon the content of the technology, the context in which the technology immerses the user, and the user's developmental stage. Furthermore, because the field is still in its infancy, results can be surprising: video games designed to be reasonably mindless result in widespread enhancements of various abilities, acting, we will argue, as exemplary learning tools. Counterintuitive outcomes like these, besides being practically relevant, challenge and eventually lead to refinement of theories concerning fundamental principles of brain plasticity and learning.	[Bavelier, Daphne] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Green, C. Shawn] Univ Minnesota, Dept Psychol, Ctr Cognit Sci, Minneapolis, MN 55455 USA; [Dye, Matthew W. G.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Rochester; University of Minnesota System; University of Minnesota Twin Cities; University of Illinois System; University of Illinois Urbana-Champaign	Bavelier, D (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	daphne@bcs.rochester.edu	Dye, Matthew William Geoffrey/AAW-1407-2020	Dye, Matthew/0000-0001-6260-641X; Bavelier, Daphne/0000-0002-5904-1240	James S. McDonnell Foundation [EY016880]; Office of Naval Research; NATIONAL EYE INSTITUTE [R01EY016880] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Office of Naval Research(Office of Naval Research); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are thankful to T. Jacques as well as L. Takeuchi and G. Cayton-Hodges from the Joan Ganz Cooney Center at Sesame Workshop for their help in literature searches. We also thank T. Jacques for invaluable help with manuscript preparation. This work was funded by EY016880, the James S. McDonnell Foundation, and the Office of Naval Research (MURI Program) to D.B.	Anderson DR, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00121; Angrist J, 2002, ECON J, V112, P735, DOI 10.1111/1468-0297.00068; [Anonymous], 2010, CNN NEWS; [Anonymous], 2009, DAILY MAIL; Attewell P, 2001, SOCIOL EDUC, V74, P252, DOI 10.2307/2673277; Banerjee AV, 2007, Q J ECON, V122, P1235, DOI 10.1162/qjec.122.3.1235; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Barr R, 2008, INFANCY, V13, P30, DOI 10.1080/15250000701779378; Barrow L, 2009, AM ECON J-ECON POLIC, V1, P52, DOI 10.1257/pol.1.1.52; BELTRAN DO, 2008, 576 AUSTR NAT U CTR; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Brem S, 2010, P NATL ACAD SCI USA, V107, P7939, DOI 10.1073/pnas.0904402107; British Broadcasting Corporation (BBC), 2005, BBC NEWS; Bushman BJ, 2010, PSYCHOL BULL, V136, P182, DOI 10.1037/a0018718; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Cao F, 2007, CHILD CARE HLTH DEV, V33, P275, DOI 10.1111/j.1365-2214.2006.00715.x; Caprara GV, 2000, PSYCHOL SCI, V11, P302, DOI 10.1111/1467-9280.00260; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; DeLoache JS, 2009, AM BEHAV SCI, V52, P1115, DOI 10.1177/0002764209331537; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Dye MWG, 2009, CURR DIR PSYCHOL SCI, V18, P321, DOI 10.1111/j.1467-8721.2009.01660.x; Dynarski M., 2007, EFFECTIVENESS READIN; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Fahle M, 2002, PERCEPTUAL LEARNING; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Ferguson CJ, 2008, CRIM JUSTICE BEHAV, V35, P311, DOI 10.1177/0093854807311719; Ferguson CJ, 2007, AGGRESS VIOLENT BEH, V12, P470, DOI 10.1016/j.avb.2007.01.001; Ferguson CJ, 2010, PSYCHOL BULL, V136, P174, DOI 10.1037/a0018566; Ferguson CJ, 2009, J PEDIATR-US, V154, P759, DOI 10.1016/j.jpeds.2008.11.033; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Fiorini M, 2010, ECON EDUC REV, V29, P55, DOI 10.1016/j.econedurev.2009.06.006; Fisch S., 2001, G IS GROWING 30 YEAR; GEE JP, 2003, ACM COMPUTERS ENTERT, V1, P1, DOI DOI 10.1145/950566.950595; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; Gentile DA, 2008, J YOUTH ADOLESCENCE, V37, P127, DOI 10.1007/s10964-007-9206-2; Gentile DA, 2009, PERS SOC PSYCHOL B, V35, P752, DOI 10.1177/0146167209333045; Gentzkow M, 2008, Q J ECON, V123, P279, DOI 10.1162/qjec.2008.123.1.279; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; GREEN CS, 2010, CURR BIOL IN PRESS; Greenfield PM, 2009, SCIENCE, V323, P69, DOI 10.1126/science.1167190; Griffiths MD, 1998, PSYCHOL REP, V82, P475, DOI 10.2466/PR0.82.2.475-480; Han DH, 2007, J ADDICT MED, V1, P133, DOI 10.1097/ADM.0b013e31811f465f; Haninger K, 2004, JAMA-J AM MED ASSOC, V291, P856, DOI 10.1001/jama.291.7.856; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hewig J, 2010, BIOL PSYCHIAT, V67, P781, DOI 10.1016/j.biopsych.2009.11.009; Hoeft F, 2008, J PSYCHIATR RES, V42, P253, DOI 10.1016/j.jpsychires.2007.11.010; HUBERTWALLANDER BP, 2010, COGNITIVE S IN PRESS; HUESMANN LR, 2009, J ADOLESCENT HEALTH, V41, pS6; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Johansson A, 2004, SCAND J PSYCHOL, V45, P223, DOI 10.1111/j.1467-9450.2004.00398.x; Johnson S., 2005, EVERYTHING BAD IS GO; KALYUGA S, 2009, EVALUATING MANAGING; Karle JW, 2010, ACTA PSYCHOL, V134, P70, DOI 10.1016/j.actpsy.2009.12.007; Kebritchi M, 2010, COMPUT EDUC, V55, P427, DOI 10.1016/j.compedu.2010.02.007; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kornell N, 2008, PSYCHOL SCI, V19, P585, DOI 10.1111/j.1467-9280.2008.02127.x; Krcmar M, 2010, J CHILD MEDIA, V4, P119, DOI 10.1080/17482791003629586; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Kumari S, 2010, SOC SCI COMPUT REV, V28, P170, DOI 10.1177/0894439309334815; Kutner Lawrence, 2008, GRAND THEFT CHILDHOO; LAM LT, 2010, ARCH PEDIAT IN PRESS, DOI DOI 10.1001/ARCHPEDIATRICS.2010.159; LI R, 2010, PLOS IN PRESS; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Li XM, 2004, PEDIATRICS, V113, P1715, DOI 10.1542/peds.113.6.1715; Linebarger DL, 2005, AM BEHAV SCI, V48, P624, DOI 10.1177/0002764204271505; Lynch J, 2010, J SURG EDUC, V67, P184, DOI 10.1016/j.jsurg.2010.02.010; MACKEY AP, 2010, DEV SCI IN PRESS; Mahrer NE, 2009, CURR PAIN HEADACHE R, V13, P100, DOI 10.1007/s11916-009-0019-8; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Mayo MJ, 2009, SCIENCE, V323, P79, DOI 10.1126/science.1166900; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Miedl SF, 2010, PSYCHIAT RES-NEUROIM, V181, P165, DOI 10.1016/j.pscychresns.2009.11.008; MUTZ DC, 1993, COMMUN RES, V20, P51, DOI 10.1177/009365093020001003; *NASA, 2003, REAL ATT GETT SPIN; Neville H., 2009, CHANGING BRAINS EFFE; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; PAIK H, 1994, COMMUN RES, V21, P516, DOI 10.1177/009365094021004004; Penuel W. R., 2009, SUMMATIVE EVALUATION; Pies Ronald, 2009, Psychiatry (Edgmont), V6, P31; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Richert RA, 2010, ARCH PEDIAT ADOL MED, V164, P432, DOI 10.1001/archpediatrics.2010.24; Rideout V., 2006, MEDIA FAMILY ELECT M; Robb MB, 2009, BRIT J DEV PSYCHOL, V27, P27, DOI 10.1348/026151008X320156; Roberts D. F., 2005, GENERATION M MEDIA L; Rosser JC, 2007, ARCH SURG-CHICAGO, V142, P181, DOI 10.1001/archsurg.142.2.181; Rouse CE, 2004, ECON EDUC REV, V23, P323, DOI 10.1016/j.econedurev.2003.10.005; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; Salguero RAT, 2002, ADDICTION, V97, P1601; Schmidt ME, 2007, LEA COMMUN SER, P65; Schmidt ME, 2009, PEDIATRICS, V123, pe370, DOI 10.1542/peds.2008-3221; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Shapiro MG, 2010, NAT BIOTECHNOL, V28, P264, DOI 10.1038/nbt.1609; Siegler RS, 2008, DEVELOPMENTAL SCI, V11, P655, DOI 10.1111/j.1467-7687.2008.00714.x; Small G., 2008, IBRAIN SURVIVING TEC; Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002; Subrahmanyam K, 2001, J APPL DEV PSYCHOL, V22, P7, DOI 10.1016/S0193-3973(00)00063-0; Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; Trick LM, 2005, COGNITIVE DEV, V20, P373, DOI 10.1016/j.cogdev.2005.05.009; Vandewater EA, 2006, PEDIATRICS, V117, pE181, DOI 10.1542/peds.2005-0812; Vogel R, 2006, Z GER LINGUISTIK, V34, P229, DOI 10.1515/ZGL.2006.014; Weis R, 2010, PSYCHOL SCI, V21, P463, DOI 10.1177/0956797610362670; Wellings J., 2009, DIGITAL PROMISE TRAN; Wenglinsky H., 1998, DOES IT COMPUTE RELA; WILSON BJ, 1997, NATL TELEVISION VIOL; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; ZILL N, 1994, VIEWING SESAME STREE; Zimmerman FJ, 2005, ARCH PEDIAT ADOL MED, V159, P619, DOI 10.1001/archpedi.159.7.619; Zimmerman FJ, 2007, J PEDIATR-US, V151, P364, DOI 10.1016/j.jpeds.2007.04.071; 2010, QUEST LEARN; 2010, SCH ONE	122	86	87	5	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					692	701		10.1016/j.neuron.2010.08.035	http://dx.doi.org/10.1016/j.neuron.2010.08.035			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	651PF	20826302	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000281938900005
J	Nedelsky, NB; Pennuto, M; Smith, RB; Palazzolo, I; Moore, J; Nie, ZP; Neale, G; Taylor, JP				Nedelsky, Natalia B.; Pennuto, Maria; Smith, Rebecca B.; Palazzolo, Isabella; Moore, Jennifer; Nie, Zhiping; Neale, Geoffrey; Taylor, J. Paul			Native Functions of the Androgen Receptor Are Essential to Pathogenesis in a Drosophila Model of Spinobulbar Muscular Atrophy	NEURON			English	Article							POLYGLUTAMINE-INDUCED DISEASE; TRANSGENIC MOUSE MODEL; TUMOR-SUPPRESSOR; MEDIATED TRANSACTIVATION; MUTANT HUNTINGTIN; STRUCTURAL BASIS; GENE-EXPRESSION; LIGAND-BINDING; PROTEIN; DOMAIN	Spinobulbar muscular atrophy (SBMA) is a neurodegenerative disease caused by expansion of a polyglutamine tract in the androgen receptor (AR). This mutation confers toxic function to AR through unknown mechanisms. Mutant AR toxicity requires binding of its hormone ligand, suggesting that pathogenesis involves ligand-induced changes in AR. However, whether toxicity is mediated by native AR function or a novel AR function is unknown. We systematically investigated events downstream of ligand-dependent AR activation in a Drosophila model of SBMA. We show that nuclear translocation of AR is necessary, but not sufficient, for toxicity and that DNA binding by AR is necessary for toxicity. Mutagenesis studies demonstrated that a functional AF-2 domain is essential for toxicity, a finding corroborated by a genetic screen that identified AF-2 interactors as dominant modifiers of degeneration. These findings indicate that SBMA pathogenesis is mediated by misappropriation of native protein function, a mechanism that may apply broadly to polyglutamine diseases.	[Nedelsky, Natalia B.; Smith, Rebecca B.; Moore, Jennifer; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Nedelsky, Natalia B.] Univ Penn, Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Nie, Zhiping] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Pennuto, Maria] Italian Inst Technol, Dept Neurosci, I-16163 Genoa, Italy; [Palazzolo, Isabella] Natl Inst Neurol Disorders & Stroke, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Pennsylvania; University of Pennsylvania; Istituto Italiano di Tecnologia - IIT; University of Genoa; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jpaul.taylor@stjude.org	Taylor, J. Paul/N-2482-2018; Pennuto, Maria/E-3270-2019	Taylor, J. Paul/0000-0002-5794-0349; Pennuto, Maria/0000-0001-8634-0767	Muscular Dystrophy Association; Kennedy's Disease Association; NIH [NS053825]; ALSAC (American Lebanese Syrian Associated Charities); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053825] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Kennedy's Disease Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC (American Lebanese Syrian Associated Charities)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Eric Baehrecke, Christina McPhee, Yakup Batlevi, and Kevin Cook for technical advice and reagents. Drosophila anti-lamin antibody (mAb-ADL 84) was a gift from Paul Fisher (SUNY Stonybrook). FLAG-FHL2 DNA was a gift from Christopher Mack (University of North Carolina). NLS-AR24Q was a gift from Bryce Paschal (University of Virginia). We thank Andrew Lieberman for KK/AA DNA. We also thank Rita Balice-Gordon, Thomas Jongens, Robert Kalb, and Taylor lab members for helpful comments. Financial support was provided by the Muscular Dystrophy Association, the Kennedy's Disease Association, NIH grant NS053825, and ALSAC (American Lebanese Syrian Associated Charities).	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Andrew DJ, 2000, MECH DEVELOP, V92, P5, DOI 10.1016/S0925-4773(99)00321-4; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruggenwirth HT, 1998, ENDOCRINOLOGY, V139, P103, DOI 10.1210/en.139.1.103; Burd CJ, 2005, MOL ENDOCRINOL, V19, P607, DOI 10.1210/me.2004-0266; Callewaert L, 2003, J BIOL CHEM, V278, P8212, DOI 10.1074/jbc.M210744200; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chen GC, 2005, J BIOL CHEM, V280, P36355, DOI 10.1074/jbc.M506147200; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Hayes SA, 2001, CANCER RES, V61, P2112; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lee YF, 1999, P NATL ACAD SCI USA, V96, P14724, DOI 10.1073/pnas.96.26.14724; Liao GQ, 2003, J BIOL CHEM, V278, P5052, DOI 10.1074/jbc.M206374200; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lin HK, 2004, MOL ENDOCRINOL, V18, P2409, DOI 10.1210/me.2004-0117; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Ohtsu H, 2002, J MED CHEM, V45, P5037, DOI 10.1021/jm020200g; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Powzaniuk M, 2004, MOL ENDOCRINOL, V18, P2011, DOI 10.1210/me.2004-0065; QUIGLEY CA, 1992, J CLIN ENDOCR METAB, V74, P927, DOI 10.1210/jc.74.4.927; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schapira M, 2002, CURR CANCER DRUG TAR, V2, P243, DOI 10.2174/1568009023333845; Schneikert J, 1996, J BIOL CHEM, V271, P23907, DOI 10.1074/jbc.271.39.23907; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Suzuki E, 2009, P NATL ACAD SCI USA, V106, P3818, DOI 10.1073/pnas.0809819106; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Takeyama K, 2004, BIOSCI BIOTECH BIOCH, V68, P1209, DOI 10.1271/bbb.68.1209; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor J, 2006, J BIOL CHEM, V281, P2730, DOI 10.1074/jbc.M506751200; TEARLE RG, 1989, GENETICS, V122, P595; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; Wang L, 2004, MOL CELL BIOL, V24, P2202, DOI 10.1128/MCB.24.5.2202-2213.2004; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Yeh SY, 1998, BIOCHEM BIOPH RES CO, V248, P361, DOI 10.1006/bbrc.1998.8974; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhang YQ, 2004, MOL CELL BIOL, V24, P1044, DOI 10.1128/MCB.24.3.1044-1057.2004; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	74	124	124	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					936	952		10.1016/j.neuron.2010.08.034	http://dx.doi.org/10.1016/j.neuron.2010.08.034			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869592	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000282801100007
J	Guenther, MG; Frampton, GM; Soldner, F; Hockemeyer, D; Mitalipova, M; Jaenisch, R; Young, RA				Guenther, Matthew G.; Frampton, Garrett M.; Soldner, Frank; Hockemeyer, Dirk; Mitalipova, Maya; Jaenisch, Rudolf; Young, Richard A.			Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							DEVELOPMENTAL REGULATORS; HISTONE-H3 LYSINE-4; POLYCOMB COMPLEXES; GENERATION; METHYLATION; MEMORY; MOUSE; SIGNATURE; SYSTEM; TISSUE	Knowledge of both the global chromatin structure and the gene expression programs of human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) should provide a robust means to assess whether the genomes of these cells have similar pluripotent states. Recent studies have suggested that ESCs and iPSCs represent different pluripotent states with substantially different gene expression profiles. We describe here a comparison of global chromatin structure and gene expression data for a panel of human ESCs and iPSCs. Genome-wide maps of nucleosomes with histone H3K4me3 and H3K27me3 modifications indicate that there is little difference between ESCs and iPSCs with respect to these marks. Gene expression profiles confirm that the transcriptional programs of ESCs and iPSCs show very few consistent differences. Although some variation in chromatin structure and gene expression was observed in these cell lines, these variations did not serve to distinguish ESCs from iPSCs.	[Guenther, Matthew G.; Frampton, Garrett M.; Soldner, Frank; Hockemeyer, Dirk; Mitalipova, Maya; Jaenisch, Rudolf; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Frampton, Garrett M.; Jaenisch, Rudolf; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Frampton, Garrett/0000-0002-2361-2750; Hockemeyer, Dirk/0000-0002-5598-5092	NCI NIH HHS [R01 CA084198, R01 CA146445-02, R01 CA146445] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668, R01 HG002668-07] Funding Source: Medline; NICHD NIH HHS [R37 HD045022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA146445, R01CA084198] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ebert BL, 2004, BLOOD, V104, P923, DOI 10.1182/blood-2004-01-0274; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; KIM K, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	52	332	340	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					249	257		10.1016/j.stem.2010.06.015	http://dx.doi.org/10.1016/j.stem.2010.06.015			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682450	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000281107400016
J	Bejjanki, VR; Beck, JM; Lu, ZL; Pouget, A				Bejjanki, Vikranth R.; Beck, Jeffrey M.; Lu, Zhong-Lin; Pouget, Alexandre			Perceptual learning as improved probabilistic inference in early sensory areas	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; V1; DISCRIMINATION; MECHANISMS; MODEL; REPRESENTATION; SPECIFICITY; PLASTICITY; EFFICIENCY; NETWORK	Extensive training on simple tasks such as fine orientation discrimination results in large improvements in performance, a form of learning known as perceptual learning. Previous models have argued that perceptual learning is due to either sharpening and amplification of tuning curves in early visual areas or to improved probabilistic inference in later visual areas (at the decision stage). However, early theories are inconsistent with the conclusions of psychophysical experiments manipulating external noise, whereas late theories cannot explain the changes in neural responses that have been reported in cortical areas V1 and V4. Here we show that we can capture both the neurophysiological and behavioral aspects of perceptual learning by altering only the feedforward connectivity in a recurrent network of spiking neurons so as to improve probabilistic inference in early visual areas. The resulting network shows modest changes in tuning curves, in line with neurophysiological reports, along with a marked reduction in the amplitude of pairwise noise correlations.	[Bejjanki, Vikranth R.; Beck, Jeffrey M.; Pouget, Alexandre] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; [Beck, Jeffrey M.] Gatsby Computat Neurosci Unit, London, England; [Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	University of Rochester; University of London; University College London; University of Southern California	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365; Lu, Zhong-Lin/0000-0002-7295-727X	Gatsby Charitable Foundation; US National Eye Institute [9 R01 EY017491-05, P30 EY001319]; Multidisciplinary University Research Initiative [N00014-07-1-0937]; US National Institute on Drug Abuse [BCS0346785]; James S. McDonnell Foundation; NATIONAL EYE INSTITUTE [R01EY017491, P30EY001319] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Multidisciplinary University Research Initiative(MURI); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); James S. McDonnell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	J.M.B. was supported by the Gatsby Charitable Foundation. Z.-L.L. is supported by US National Eye Institute grant 9 R01 EY017491-05 and A. P. by Multidisciplinary University Research Initiative grant N00014-07-1-0937, US National Institute on Drug Abuse grant BCS0346785 and a research grant from the James S. McDonnell Foundation. This work was also partially supported by award P30 EY001319 from the US National Eye Institute.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; BECK JM, NEURAL COMP IN PRESS; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 1999, VISION RES, V39, P3197, DOI 10.1016/S0042-6989(99)00059-0; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gerstner W., 2002, SPIKING NEURON MODEL; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Jacobs RA, 2009, J VISION, V9, DOI 10.1167/9.4.22; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Levi DM, 2003, J NEUROSCI, V23, P2522; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Lu ZL, 2010, VISION RES, V50, P375, DOI 10.1016/j.visres.2009.08.027; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Montani F, 2007, J NEUROSCI, V27, P2338, DOI 10.1523/JNEUROSCI.3417-06.2007; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Pouget A, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P265; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwabe L, 2005, J NEUROSCI, V25, P3323, DOI 10.1523/JNEUROSCI.4493-04.2005; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SIMONCELLI EP, 1991, IEEE C COMP VIS PATT, P310, DOI 10.1109/CVPR.1991.139707; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Spiridon M, 2001, NETWORK-COMP NEURAL, V12, P409, DOI 10.1088/0954-898X/12/4/301; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	50	88	89	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					642	U139		10.1038/nn.2796	http://dx.doi.org/10.1038/nn.2796			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	754VU	21460833	Green Accepted			2022-12-24	WOS:000289886600021
J	Kohli, MA; Lucae, S; Saemann, PG; Schmidt, MV; Demirkan, A; Hek, K; Czamara, D; Alexander, M; Salyakina, D; Ripke, S; Hoehn, D; Specht, M; Menke, A; Hennings, J; Heck, A; Wolf, C; Ising, M; Schreiber, S; Czisch, M; Muller, MB; Uhr, M; Bettecken, T; Becker, A; Schramm, J; Rietschel, M; Maier, W; Bradley, B; Ressler, KJ; Nothen, MM; Cichon, S; Craig, IW; Breen, G; Lewis, CM; Hofman, A; Tiemeier, H; van Duijn, CM; Holsboer, F; Muller-Myhsok, B; Binder, EB				Kohli, Martin A.; Lucae, Susanne; Saemann, Philipp G.; Schmidt, Mathias V.; Demirkan, Ayse; Hek, Karin; Czamara, Darina; Alexander, Michael; Salyakina, Daria; Ripke, Stephan; Hoehn, David; Specht, Michael; Menke, Andreas; Hennings, Johannes; Heck, Angela; Wolf, Christiane; Ising, Marcus; Schreiber, Stefan; Czisch, Michael; Mueller, Marianne B.; Uhr, Manfred; Bettecken, Thomas; Becker, Albert; Schramm, Johannes; Rietschel, Marcella; Maier, Wolfgang; Bradley, Bekh; Ressler, Kerry J.; Noethen, Markus M.; Cichon, Sven; Craig, Ian W.; Breen, Gerome; Lewis, Cathryn M.; Hofman, Albert; Tiemeier, Henning; van Duijn, Cornelia M.; Holsboer, Florian; Mueller-Myhsok, Bertram; Binder, Elisabeth B.			The Neuronal Transporter Gene SLC6A15 Confers Risk to Major Depression	NEURON			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC SOCIAL STRESS; HIPPOCAMPAL VOLUME; HOSPITAL ANXIETY; V7-3 SLC6A15; DISORDER; SYMPTOMS; NEUROENDOCRINE; POLYMORPHISMS; MECHANISMS	Major depression (MD) is one of the most prevalent psychiatric disorders and a leading cause of loss in work productivity. A combination of genetic and environmental risk factors probably contributes to MD. We present data from a genome-wide association study revealing a neuron-specific neutral amino acid transporter (SLC6A15) as a susceptibility gene for MD. Risk allele carrier status in humans and chronic stress in mice were associated with a down-regulation of the expression of this gene in the hippocampus, a brain region implicated in the pathophysiology of MD. The same polymorphisms also showed associations with alterations in hippocampal volume and neuronal integrity. Thus, decreased SLC6A15 expression, due to genetic or environmental factors, might alter neuronal circuits related to the susceptibility for MD. Our convergent data from human genetics, expression studies, brain imaging, and animal models suggest a pathophysiological mechanism for MD that may be accessible to drug targeting.	[Kohli, Martin A.; Lucae, Susanne; Saemann, Philipp G.; Schmidt, Mathias V.; Czamara, Darina; Salyakina, Daria; Ripke, Stephan; Hoehn, David; Specht, Michael; Menke, Andreas; Hennings, Johannes; Heck, Angela; Wolf, Christiane; Ising, Marcus; Czisch, Michael; Mueller, Marianne B.; Uhr, Manfred; Bettecken, Thomas; Becker, Albert; Holsboer, Florian; Mueller-Myhsok, Bertram; Binder, Elisabeth B.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Demirkan, Ayse; Hek, Karin; Hofman, Albert; Tiemeier, Henning; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-300 CA Rotterdam, Netherlands; [Alexander, Michael; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Inst Human Genet, D-53127 Bonn, Germany; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, D-24105 Kiel, Germany; [Becker, Albert] Univ Clin Bonn, Inst Neuropathol, D-53127 Bonn, Germany; [Schramm, Johannes] Univ Clin Bonn, Dept Neurosurg, D-53127 Bonn, Germany; [Rietschel, Marcella] Heidelberg Univ, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; [Bradley, Bekh; Ressler, Kerry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Bradley, Bekh] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ressler, Kerry J.] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53115 Bonn, Germany; [Ressler, Kerry J.] Atlanta VA Med Ctr, Atlanta, GA 30033 USA; [Cichon, Sven] Forschungszentrum Julich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany; [Craig, Ian W.; Breen, Gerome; Lewis, Cathryn M.] Kings Coll London, Inst Psychiat, London SE5 8AF, England	Max Planck Society; Erasmus University Rotterdam; Erasmus MC; University of Bonn; University of Kiel; University of Bonn; University of Bonn; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; Emory University; Howard Hughes Medical Institute; University of Bonn; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Helmholtz Association; Research Center Julich; University of London; King's College London	Kohli, MA (corresponding author), Max Planck Inst Psychiat, D-80804 Munich, Germany.	mkohli@med.miami.edu; binder@mpipsykl.mpg.de	Müller, Marianne B./AAL-8911-2021; Tiemeier, Henning/H-6534-2019; Craig, Ian/AAF-9167-2019; Ripke, Stephan/AAK-5486-2021; Menke, Andreas/D-5939-2014; Ressler, Kerry/N-8741-2018; Breen, Gerome/A-5540-2010; Cichon, Sven/B-9618-2014; Lewis, Cathryn/A-5225-2010	Müller, Marianne B./0000-0002-0269-6131; Tiemeier, Henning/0000-0002-4395-1397; Menke, Andreas/0000-0002-1498-1992; Hek, Karin/0000-0001-9551-1564; Van Duijn, Cornelia/0000-0002-2374-9204; Nothen, Markus/0000-0002-8770-2464; ripke, stephan/0000-0003-3622-835X; Ressler, Kerry/0000-0002-5158-1103; Hennings, Johannes/0000-0003-3259-7991; Breen, Gerome/0000-0003-2053-1792; Cichon, Sven/0000-0002-9475-086X; Salyakina, Daria/0000-0003-3283-3691; Heck, Angela/0000-0002-1543-3197; Schmidt, Mathias/0000-0002-3788-2268; Lewis, Cathryn/0000-0002-8249-8476; Demirkan, Ayse/0000-0002-7546-0867	Excellence Foundation for the Advancement of the Max Planck Society; Bavarian Ministry of Commerce; Federal Ministry of Education and Research (BMBF) [FKZ 01GS0481, 01GS08145]; Netherlands Organization of Scientific Research (NWO) [175.010.2005.011, 911- 03-012]; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) [050-060-810]; Hersenstichting; Centre for Medical Systems Biology (CMSB); UK MRC [G0701420]; Wellcome Trust [085475]; NeuroNova; NIMH; Behrens-Weise Foundation; PharmaNeuroBoost; NIDA; Lundbeck; Burroughs Wellcome Foundation; NARSAD;  [RO1 MH071537-01A1]; MRC [G0701420, G0701003] Funding Source: UKRI; Medical Research Council [G0701003, G0701420, G9817803B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071537] Funding Source: NIH RePORTER	Excellence Foundation for the Advancement of the Max Planck Society; Bavarian Ministry of Commerce; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Hersenstichting; Centre for Medical Systems Biology (CMSB); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NeuroNova; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Behrens-Weise Foundation; PharmaNeuroBoost; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Lundbeck(Lundbeck Corporation); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NARSAD(NARSAD); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work has been funded by the Excellence Foundation for the Advancement of the Max Planck Society, the Bavarian Ministry of Commerce, and the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN2 and NGFN-Plus, FKZ 01GS0481 and 01GS08145 (Moods)). The Dutch studies are supported by the Netherlands Organization of Scientific Research (NWO Investments #175.010.2005.011, 911- 03-012), the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO project #050-060-810), the Hersenstichting, and the Centre for Medical Systems Biology (CMSB). The Atlanta cohort was sponsored by RO1 MH071537-01A1. The RADIANT study was supported by the UK MRC (G0701420). This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2 (for author contributions see http://www.wtccc.org.uk). Funding for the project was provided by the Wellcome Trust under award 085475. This study was also supported by NeuroNova (a nonprofit Company for advancement of Genomics). The authors would like to thank G. Ernst-Jansen, G. Gajewsky, J. Huber, E. Kappelmann, S. Sauer, S. Damast, M. Koedel, M. Asmus, A. Sangl, and H. Pfister for their excellent technical support. We further are grateful to R. Hemauer, R. Borschke, and E. Schreiter for excellent MRI data aquisition. We acknowledge the work of Yurii S. Aulchenko, A. Cecile, J.W. Janssens, Maksim Struchalin, and Ben A. Oostra for the ERF study. E.B.B. currently receives grant support from NIMH, the Behrens-Weise Foundation, and PharmaNeuroBoost. F.H. is founder and shareholder of Affectis Pharmaceuticals and HolsboerMaschmeyer NeuroChemie GmbH. Over the past two years, B.M.-M. has been a consultant for Affectis. C.M.v.D. discloses her affiliation to the Centre for Medical Systems Biology (CMSB). Within the last 3 years, K.J.R. has received research funding support from NIMH, NIDA, Lundbeck, Burroughs Wellcome Foundation, and NARSAD, and he has an unrelated agreement with Extinction Pharmaceuticals for NMDA-based therapeutics. Patent applications: A.M., EBB., and F.H. are inventors of means and methods for diagnosing predisposition for treatment emergent suicidal ideation (TESI), international application number PCT/EP2009/061575. EBB., F.H., B.M.-M., and M.U. are inventors of (1) FKBP5, a novel target for antidepressant therapy, international publication number WO 2005/054500; and (2) polymorphisms in ABCB1 associated with a lack of clinical response to medicaments, international application number PCT/EP2005/005194.	Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; *ALL I BRAIN SCI, 2008, ALL BRAIN ATL; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Broer S, 2006, NEUROCHEM INT, V48, P559, DOI 10.1016/j.neuint.2005.11.021; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Choy WC, 2009, PSYCHIAT GENET, V19, P32, DOI 10.1097/YPG.0b013e328320804e; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Drgonova J, 2007, BRAIN RES, V1183, P10, DOI 10.1016/j.brainres.2007.09.001; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Fava M, 2006, PSYCHOTHER PSYCHOSOM, V75, P139, DOI 10.1159/000091771; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frodl T, 2002, AM J PSYCHIAT, V159, P1112, DOI 10.1176/appi.ajp.159.7.1112; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glahn DC, 2007, HUM BRAIN MAPP, V28, P488, DOI 10.1002/hbm.20401; Heck A, 2009, AM J MED GENET B, V150B, P104, DOI 10.1002/ajmg.b.30784; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hennings JM, 2008, J PSYCHIATR RES, V43, P215, DOI 10.1016/j.jpsychires.2008.05.002; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Li CX, 2008, NEUROCHEM RES, V33, P2342, DOI 10.1007/s11064-008-9739-0; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394; Masson J, 1996, RECEPTOR CHANNEL, V4, P227; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rietschel M, 2010, BIOL PSYCHIAT, V68, P578, DOI 10.1016/j.biopsych.2010.05.038; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Schmidt MV, 2010, PSYCHONEUROENDOCRINO, V35, P635, DOI 10.1016/j.psyneuen.2009.10.002; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sterlemann V, 2008, HORM BEHAV, V53, P386, DOI 10.1016/j.yhbeh.2007.11.001; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sullivan EV, 2001, HIPPOCAMPUS, V11, P754, DOI 10.1002/hipo.1091; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Viinamaki H, 2004, NORD J PSYCHIAT, V58, P49, DOI 10.1080/08039480310000798; Wang JL, 2005, PSYCHOL MED, V35, P865, DOI 10.1017/S0033291704003241; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; WESTFALL PH, 2001, MULTIPLE TESTS GENET; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	69	154	156	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 28	2011	70	2					252	265		10.1016/j.neuron.2011.04.005	http://dx.doi.org/10.1016/j.neuron.2011.04.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	770FZ	21521612	Bronze, Green Accepted			2022-12-24	WOS:000291073700008
J	Tollervey, JR; Curk, T; Rogelj, B; Briese, M; Cereda, M; Kayikci, M; Konig, J; Hortobagyi, T; Nishimura, AL; Zupunski, V; Patani, R; Chandran, S; Rot, G; Zupan, B; Shaw, CE; Ule, J				Tollervey, James R.; Curk, Tomaz; Rogelj, Boris; Briese, Michael; Cereda, Matteo; Kayikci, Melis; Koenig, Julian; Hortobagyi, Tibor; Nishimura, Agnes L.; Zupunski, Vera; Patani, Rickie; Chandran, Siddharthan; Rot, Gregor; Zupan, Blaz; Shaw, Christopher E.; Ule, Jernej			Characterizing the RNA targets and position-dependent splicing regulation by TDP-43	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; BINDING PROTEIN; BCL-2 FAMILY; ROLES; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; EVOLUTION; APOPTOSIS	TDP-43 is a predominantly nuclear RNA-binding protein that forms inclusion bodies in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The mRNA targets of TDP-43 in the human brain and its role in RNA processing are largely unknown. Using individual nucleotide-resolution ultraviolet cross-linking and immunoprecipitation (ICLIP), we found that TDP-43 preferentially bound long clusters of UG-rich sequences in vivo. Analysis of RNA binding by TDP-43 in brains from subjects with FTLD revealed that the greatest increases in binding were to the MALAT1 and NEAT1 noncoding RNAs. We also found that binding of TDP-43 to pre-mRNAs influenced alternative splicing in a similar position-dependent manner to Nova proteins. In addition, we identified unusually long clusters of TDP-43 binding at deep intronic positions downstream of silenced exons. A substantial proportion of alternative mRNA isoforms regulated by TDP-43 encode proteins that regulate neuronal development or have been implicated in neurological diseases, highlighting the importance of TDP-43 for the regulation of splicing in the brain.	[Tollervey, James R.; Briese, Michael; Cereda, Matteo; Kayikci, Melis; Koenig, Julian; Ule, Jernej] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Curk, Tomaz; Rot, Gregor; Zupan, Blaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Rogelj, Boris; Hortobagyi, Tibor; Nishimura, Agnes L.; Zupunski, Vera; Shaw, Christopher E.] Kings Coll London, MRC, Ctr Neurodegenerat Res, London WC2R 2LS, England; [Cereda, Matteo] Sci Inst IRCCS E Medea, Bosisio Parini, LC, Italy; [Zupunski, Vera] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Patani, Rickie; Chandran, Siddharthan] MRC, Lab Regenerat Med, Dept Clin Neurosci, Cambridge, England; [Chandran, Siddharthan] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH8 9YL, Midlothian, Scotland	MRC Laboratory Molecular Biology; University of Ljubljana; University of London; King's College London; IRCCS Eugenio Medea; University of Ljubljana; University of Edinburgh	Ule, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jule@mrc-lmb.cam.ac.uk	Cereda, Matteo/V-5988-2019; Curk, Tomaž/D-9836-2015; Zupan, Blaz/L-1595-2019; Rogelj, Boris/G-9252-2011; Ule, Jernej/C-6315-2013; Patani, R/J-3107-2018; Nishimura, Agnes L/B-2905-2011	Cereda, Matteo/0000-0003-1799-5537; Curk, Tomaž/0000-0003-4888-7256; Rogelj, Boris/0000-0003-3898-1943; Ule, Jernej/0000-0002-2452-4277; Patani, R/0000-0002-3825-7675; Zupan, Blaz/0000-0002-5864-7056; Briese, Michael/0000-0001-7137-8260; Nishimura, Agnes/0000-0001-5295-797X; Konig, Julian/0000-0002-9398-5421; Shaw, Christopher/0000-0003-0251-0146	European Research Council [206726-CLIP]; Slovenian Research Agency [P2-0209, J2-2197, L2-1112, Z7-3665]; Wellcome Trust; MRC [089701/Z/09/Z]; Motor Neuron Disease Association; Heaton-Ellis Trust; Psychiatry Research Trust; MRC [MC_U105185858] Funding Source: UKRI; Medical Research Council [G0500289B, G0700711B, MC_U105185858] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neuron Disease Association; Heaton-Ellis Trust; Psychiatry Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. Zarnack for advice and comments on the manuscript, F. Baralle, Y. Ayalla and A. D. Ambrogio for HeLa knockdown RNA, and J. Hadfield and the genomic team at CRI for Illumina sequencing. This work was supported by the European Research Council (206726-CLIP), the MRC, Slovenian Research Agency (P2-0209, J2-2197, L2-1112, Z7-3665), Wellcome Trust and MRC Strategic Grant Award (089701/Z/09/Z), Motor Neuron Disease Association, Heaton-Ellis Trust and Psychiatry Research Trust.	Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Becker EBE, 2007, CELL CYCLE, V6, P1332, DOI 10.4161/cc.6.11.4316; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Ness JM, 2006, BRAIN RES, V1099, P150, DOI 10.1016/j.brainres.2006.04.132; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088	38	708	718	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					452	U180		10.1038/nn.2778	http://dx.doi.org/10.1038/nn.2778			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358640	Green Accepted			2022-12-24	WOS:000288849400016
J	Cai, XY; Kim, S; Lee, D				Cai, Xinying; Kim, Soyoun; Lee, Daeyeol			Heterogeneous Coding of Temporally Discounted Values in the Dorsal and Ventral Striatum during Intertemporal Choice	NEURON			English	Article							MACAQUE PREFRONTAL CORTEX; FAST-SPIKING INTERNEURONS; NEURONAL-ACTIVITY; DECISION-MAKING; BASAL GANGLIA; ORBITOFRONTAL CORTEX; PRIMATE STRIATUM; MONETARY REWARDS; DOPAMINE NEURONS; DELAYED REWARDS	In choosing between different rewards expected after unequal delays, humans and animals often prefer the smaller but more immediate reward, indicating that the subjective value or utility of reward is depreciated according to its delay. Here, we show that neurons in the primate caudate nucleus and ventral striatum modulate their activity according to temporally discounted values of rewards with a similar time course. However, neurons in the caudate nucleus encoded the difference in the temporally discounted values of the two alternative targets more reliably than neurons in the ventral striatum. In contrast, neurons in the ventral striatum largely encoded the sum of the temporally discounted values, and therefore, the overall goodness of available options. These results suggest a more pivotal role for the dorsal striatum in action selection during intertemporal choice.	[Cai, Xinying; Kim, Soyoun; Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Lee, D (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	daeyeol.lee@yale.edu	Lee, Daeyeol/A-6794-2008; Cai, Xinying/G-2440-2012	Lee, Daeyeol/0000-0003-3474-019X; Kim, Soyoun/0000-0003-1348-6401	National Institute of Health [RL1 DA024855, P01 NS048328, P30 EY000785]; NATIONAL EYE INSTITUTE [R01EY015788, P30EY000785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RL1DA024855] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Mark Hammond and Patrice Kurnath for technical assistance. This study was supported by the National Institute of Health (RL1 DA024855, P01 NS048328, and P30 EY000785).	APICELLA P, 1991, EXP BRAIN RES, V85, P491; Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Berke JD, 2008, J NEUROSCI, V28, P10075, DOI 10.1523/JNEUROSCI.2192-08.2008; Bickel WK, 2009, J NEUROSCI, V29, P8839, DOI 10.1523/JNEUROSCI.5319-08.2009; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Gregorios-Pippas L, 2009, J NEUROPHYSIOL, V101, P1507, DOI 10.1152/jn.90730.2008; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Hwang J, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.009.2009; Izawa EI, 2005, EUR J NEUROSCI, V22, P1502, DOI 10.1111/j.1460-9568.2005.04311.x; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Kim S, 2009, NEURAL NETWORKS, V22, P294, DOI 10.1016/j.neunet.2009.03.010; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Kobayashi S, 2007, EXP BRAIN RES, V176, P341, DOI 10.1007/s00221-006-0622-4; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Parent A, 1996, NEUROSCI RES, V25, P309; Pine A, 2009, J NEUROSCI, V29, P9575, DOI 10.1523/JNEUROSCI.1126-09.2009; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2009, J NEUROSCI, V29, P13365, DOI 10.1523/JNEUROSCI.2572-09.2009; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Sharott A, 2009, J NEUROSCI, V29, P4571, DOI 10.1523/JNEUROSCI.5097-08.2009; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292; WALDVOGEL HJ, 1993, BRAIN RES, V610, P311, DOI 10.1016/0006-8993(93)91415-O; Weber BJ, 2008, BRAIN RES, V1234, P104, DOI 10.1016/j.brainres.2008.07.105; WILLIAMS GV, 1993, BEHAV BRAIN RES, V55, P243, DOI 10.1016/0166-4328(93)90120-F; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y; Xu LJ, 2009, BRAIN RES, V1261, P65, DOI 10.1016/j.brainres.2008.12.061	61	120	121	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 13	2011	69	1					170	182		10.1016/j.neuron.2010.11.041	http://dx.doi.org/10.1016/j.neuron.2010.11.041			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220107	Green Accepted, Bronze			2022-12-24	WOS:000286446300016
J	Chang, MC; Park, JM; Pelkey, KA; Grabenstatter, HL; Xu, DS; Linden, DJ; Sutula, TP; McBain, CJ; Worley, PF				Chang, Michael C.; Park, Joo Min; Pelkey, Kenneth A.; Grabenstatter, Heidi L.; Xu, Desheng; Linden, David J.; Sutula, Thomas P.; McBain, Chris J.; Worley, Paul F.			Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons	NATURE NEUROSCIENCE			English	Article							FAST-SPIKING CELLS; AMPA RECEPTORS; MESSENGER-RNAS; PLASTICITY; NEURONS; PENTRAXIN; SUBUNIT; AGGREGATION; INHIBITION; INTERACTS	Homeostatic synaptic scaling alters the strength of synapses to compensate for prolonged changes in network activity and involves both excitatory and inhibitory neurons. The immediate-early gene Narp (neuronal activity-regulated pentraxin) encodes a secreted synaptic protein that can bind to and induce clustering of AMPA receptors (AMPARs). We found that Narp prominently accumulated at excitatory synapses on parvalbumin-expressing interneurons (PV-INs). Increasing network activity resulted in a homeostatic increase of excitatory synaptic strength onto PV-INs that increased inhibitory drive and this response was absent in neurons cultured from Narp(-/-) mice. Activity-dependent changes in the strength of excitatory inputs on PV-INs in acute hippocampal slices were also dependent on Narp and Narp(-/-) mice had increased sensitivity to kindling-induced seizures. We propose that Narp recruits AMPARs at excitatory synapses onto PV-INs to rebalance network excitation/inhibition dynamics following episodes of increased circuit activity.	[Chang, Michael C.; Park, Joo Min; Xu, Desheng; Linden, David J.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Pelkey, Kenneth A.; McBain, Chris J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD USA; [Grabenstatter, Heidi L.; Sutula, Thomas P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	pworley@jhmi.edu			US National Institutes of Health [PAR-02-059, NS 39156]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039156] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.S. Perin for the Narp<SUP>-/-</SUP> mouse, R.L. Huganir (Johns Hopkins University) for antibodies to GluR1, M. Dehoff and P. Chuang for animal care, M. Papapavlou for administrative assistance and X. Yuan and B. Jeffries for technical assistance. Work in the laboratory of C.J.M. is supported by a US National Institutes of Health intramural award. Work in the laboratory of P.F.W. is supported by US National Institutes of Health grants PAR-02-059 and NS 39156.	Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; KOSAKA T, 1989, BRAIN RES, V483, P158, DOI 10.1016/0006-8993(89)90048-6; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mi RF, 2002, J NEUROSCI, V22, P7606; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Nissen W, 2010, J NEUROSCI, V30, P1337, DOI 10.1523/JNEUROSCI.3481-09.2010; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Sayin U, 2003, J NEUROSCI, V23, P2759; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Tsui CC, 1996, J NEUROSCI, V16, P2463; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	46	187	192	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1090	U83		10.1038/nn.2621	http://dx.doi.org/10.1038/nn.2621			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729843	Green Accepted			2022-12-24	WOS:000281332600014
J	Huang, J; Zhang, W; Qiao, WH; Hu, AQ; Wang, ZR				Huang, Ju; Zhang, Wei; Qiao, Wenhui; Hu, Aiqun; Wang, Zuoren			Functional Connectivity and Selective Odor Responses of Excitatory Local Interneurons in Drosophila Antennal Lobe	NEURON			English	Article							OLFACTORY INFORMATION; MOLECULAR-BASIS; NEURONS; TRANSMISSION; INHIBITION; MECHANISMS; MAP	Local interneurons in the Drosophila antennal lobe are thought to play important roles in shaping odor responses. However, the physiological properties of excitatory local interneurons (eLNs) and their connectivity in the antennal lobe remain unclear. We first characterized the firing patterns of krasavietz-Gal4-labeled eLNs (krasavietz eLNs) in response to depolarizing currents. Paired recordings of krasavietz eLNs and PNs showed reciprocal excitatory connections mediated by dendrodendritic cholinergic synapses and gap junctions. Reciprocal connections were also found between two krasavietz eLNs but were rare between krasavietz eLNs and inhibitory LNs. Analysis of response onset latencies showed that krasavietz eLNs received monosynaptic inputs from ORNs. Furthermore, each eLN responded with distinct patterns to different odors, and each odor elicited distinct responses in different eLNs, with specific temporal patterns of spiking, indicating that eLNs serve specific coding functions in addition to global excitation in Drosophila olfactory processing.	[Huang, Ju; Zhang, Wei; Qiao, Wenhui; Hu, Aiqun; Wang, Zuoren] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China; [Huang, Ju; Zhang, Wei; Qiao, Wenhui] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, ZR (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China.	zuorenwang@ion.ac.cn	Huang, Ju/I-4327-2015; zhang, wei/H-7371-2014	zhang, wei/0000-0002-1648-3364; Qiao, Wenhui/0000-0002-3325-2058; Huang, Ju/0000-0003-4280-0690	 [973-2006CB806604];  [NSF30625020]	; 	We thank Dr. G. Miesenbock (University of Oxford, UK) for providing Krasavietz-Gal4, KL107-Gal4, and UAS-P2X<INF>2</INF> flies, Dr. R.F. Stocker (University of Fribourg, Switzerland) for GH146-Gal4 and GH298-Gal4 flies, Dr. Kei Ito (University of Tokyo, Japan) for Np1227-Gal4 and Np2426-Gal4 flies, Dr. Tzumin Lee (Janelia Farm Research Campus) for GH146-LexA::GAD, LexAOP-mCD2::GFP, UAS-DsRed flies, and Dr. E. Buchner (University of Wurzburg, Germany) for providing nc82 antibody. We thank Dr. R.I. Wilson and Dr. O.R. Shawn (Harvard University) for technical guidance. We thank Dr. M.M. Poo for critical reading of and comments on the manuscript. This work was supported by the 973-2006CB806604, NSF30625020 to Z.W.	Antonsen BL, 2003, J COMP NEUROL, V466, P1, DOI 10.1002/cne.10802; ASAHINA K, 2009, NAT NEUROSCI, V10, P1474; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dykes IM, 2004, J NEUROSCI, V24, P886, DOI 10.1523/JNEUROSCI.3676-03.2004; Fan RJ, 2005, J COMP PHYSIOL A, V191, P1157, DOI 10.1007/s00359-005-0047-8; GIAUME C, 1984, J PHYSIOL-LONDON, V356, P151, DOI 10.1113/jphysiol.1984.sp015458; Gu HY, 2006, J NEUROSCI, V26, P265, DOI 10.1523/JNEUROSCI.4109-05.2006; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wilson RI, 2008, CURR OPIN NEUROBIOL, V18, P408, DOI 10.1016/j.conb.2008.08.015; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	27	93	96	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					1021	1033		10.1016/j.neuron.2010.08.025	http://dx.doi.org/10.1016/j.neuron.2010.08.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869598	Bronze			2022-12-24	WOS:000282801100013
J	Boccara, CN; Sargolini, F; Thoresen, VH; Solstad, T; Witter, MP; Moser, EI; Moser, MB				Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Grid cells in pre- and parasubiculum	NATURE NEUROSCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; MEMBRANE-POTENTIAL OSCILLATIONS; SPATIAL REPRESENTATION SYSTEM; FREELY MOVING RATS; LAYER-II; RETROHIPPOCAMPAL REGION; HIPPOCAMPAL-FORMATION; PATH-INTEGRATION; DIRECTION CELLS; COGNITIVE MAP	Allocentric space is mapped by a widespread brain circuit of functionally specialized cell types located in interconnected subregions of the hippocampal-parahippocampal cortices. Little is known about the neural architectures required to express this variety of firing patterns. In rats, we found that one of the cell types, the grid cell, was abundant not only in medial entorhinal cortex (MEC), where it was first reported, but also in pre- and parasubiculum. The proportion of grid cells in pre- and parasubiculum was comparable to deep layers of MEC. The symmetry of the grid pattern and its relationship to the theta rhythm were weaker, especially in presubiculum. Pre- and parasubicular grid cells intermingled with head-direction cells and border cells, as in deep MEC layers. The characterization of a common pool of space-responsive cells in architecturally diverse subdivisions of parahippocampal cortex constrains the range of mechanisms that might give rise to their unique functional discharge phenotypes.	[Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway; [Boccara, Charlotte N.; Sargolini, Francesca; Thoresen, Veslemoy Hult; Solstad, Trygve; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Ctr Biol Memory, N-7034 Trondheim, Norway; [Sargolini, Francesca] Univ Aix Marseille 1, CNRS, UMR Pole 3C 6155, Lab Neurobiol Cognit, Marseille, France	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway.	edvard.moser@ntnu.no	Boccara, Charlotte/AAP-8625-2020	Sargolini, Francesca/0000-0002-5038-3746	Kavli Foundation; Norwegian Research Council	Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank R. Skjerpeng for programming, D. Derdikman for help with code, J. Ainge for donating an implanted rat, and A. M. Amundgard, I. Hammer, K. Haugen, K. Jenssen and H. Waade for technical assistance. This work was supported by the Kavli Foundation and a Centre of Excellence grant from the Norwegian Research Council.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fricker D, 2009, J PHYSIOL-LONDON, V587, P4249, DOI 10.1113/jphysiol.2009.175349; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Funahashi M, 1997, J PHYSIOL-LONDON, V501, P387, DOI 10.1111/j.1469-7793.1997.387bn.x; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Glasgow SD, 2008, J NEUROPHYSIOL, V100, P2746, DOI 10.1152/jn.90351.2008; Glasgow SD, 2007, J NEUROPHYSIOL, V97, P3868, DOI 10.1152/jn.01306.2006; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hargreaves EL, 2007, HIPPOCAMPUS, V17, P826, DOI 10.1002/hipo.20316; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Klink R, 1997, HIPPOCAMPUS, V7, P571; KOHLER C, 1986, J COMP NEUROL, V246, P149, DOI 10.1002/cne.902460202; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1996, CEREB CORTEX, V6, P238, DOI 10.1093/cercor/6.2.238; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1990, J NEUROSCI, V10, P420; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WOUTERLOOD FG, 1995, J NEUROCYTOL, V24, P135, DOI 10.1007/BF01181556; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009	50	335	340	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					987	U112		10.1038/nn.2602	http://dx.doi.org/10.1038/nn.2602			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20657591				2022-12-24	WOS:000280400600018
J	Wiechert, MT; Judkewitz, B; Riecke, H; Friedrich, RW				Wiechert, Martin T.; Judkewitz, Benjamin; Riecke, Hermann; Friedrich, Rainer W.			Mechanisms of pattern decorrelation by recurrent neuronal circuits	NATURE NEUROSCIENCE			English	Article							ZEBRAFISH OLFACTORY-BULB; ODOR REPRESENTATIONS; LATERAL INHIBITION; MITRAL CELLS; FIRING RATE; SPIKE; SEPARATION; SYNCHRONY; NETWORKS; DYNAMICS	Decorrelation is a fundamental computation that optimizes the format of neuronal activity patterns. Channel decorrelation by adaptive mechanisms results in efficient coding, whereas pattern decorrelation facilitates the readout and storage of information. Mechanisms achieving pattern decorrelation, however, remain unclear. We developed a theoretical framework that relates high-dimensional pattern decorrelation to neuronal and circuit properties in a mathematically stringent fashion. For a generic class of random neuronal networks, we proved that pattern decorrelation emerges from neuronal nonlinearities and is amplified by recurrent connectivity. This mechanism does not require adaptation of the network, is enhanced by sparse connectivity, depends on the baseline membrane potential and is robust. Connectivity measurements and computational modeling suggest that this mechanism is involved in pattern decorrelation in the zebrafish olfactory bulb. These results reveal a generic relationship between the structure and function of neuronal circuits that is probably relevant for pattern processing in various brain areas.	[Wiechert, Martin T.; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Judkewitz, Benjamin] UCL, Wolfson Inst Biomed Res, London, England; [Riecke, Hermann] Northwestern Univ, Evanston, IL USA	Friedrich Miescher Institute for Biomedical Research; University of London; University College London; Northwestern University	Friedrich, RW (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	rainer.friedrich@fmi.ch	Judkewitz, Benjamin/C-3645-2014; Riecke, Hermann/AAB-7558-2021; Riecke, Hermann/E-6118-2012; Riecke, Hermann E/B-7388-2009	Judkewitz, Benjamin/0000-0002-8570-3869; Riecke, Hermann/0000-0002-6070-4742; Friedrich, Rainer/0000-0001-9107-0482	Novartis Research Foundation; Max-Planck-Society; Alexander-von-Humboldt Foundation; National Science Foundation [DMS-0719944]; European Union [IST-507610]; Deutsche Forschungsgemeinschaft [SFB 488, FOR 643]	Novartis Research Foundation; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Y.-P. Zhang and O. Fajardo for help with histological procedures, T. Oertner, B. Roska and J.M. Stix for comments on the manuscript, and members of the Friedrich laboratory for discussions. This work was supported by the Novartis Research Foundation, the Max-Planck-Society, the Alexander-von-Humboldt Foundation, the National Science Foundation (DMS-0719944 to H. R.), the European Union (IST-507610 to R. W. F.) and the Deutsche Forschungsgemeinschaft (SFB 488; FOR 643 to R. W. F.).	Amari S.-i., 1995, INT S NONL THEOR ITS, P37; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; ATICK JJ, 1993, NEURAL COMPUT, V5, P45, DOI 10.1162/neco.1993.5.1.45; Bapat R.B., 1997, NONNEGATIVE MATRICES, DOI DOI 10.1017/CBO9780511529979; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BAUM RF, 1969, IEEE T INFORM THEORY, V15, P448, DOI 10.1109/TIT.1969.1054328; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galassi M., 2009, GNU SCI LIB REFERENC, DOI [10.5555/1538674, DOI 10.5555/1538674]; Hahnloser RHR, 2003, NEURAL COMPUT, V15, P621, DOI 10.1162/089976603321192103; HARTLINE HK, 1957, J GEN PHYSIOL, V40, P357, DOI 10.1085/jgp.40.3.357; HASSELMO ME, 1990, COLD SPRING HARB SYM, V55, P599; Hummel R. A., 1975, COMPUT GRAPH IMAGE P, V4, P209; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Itskov V, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.018101; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Meister M, 2001, J NEUROSCI, V21, P1351; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Parra LC, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P135; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Srivastava V, 2008, J THEOR BIOL, V253, P514, DOI 10.1016/j.jtbi.2008.03.031; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Weinstein E, 1993, IEEE T SPEECH AUDI P, V1, P405, DOI 10.1109/89.242486; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	50	71	73	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					1003	U132		10.1038/nn.2591	http://dx.doi.org/10.1038/nn.2591			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20581841				2022-12-24	WOS:000280400600020
J	Rauschecker, JP; Leaver, AM; Muhlau, M				Rauschecker, Josef P.; Leaver, Amber M.; Muehlau, Mark			Tuning Out the Noise: Limbic-Auditory Interactions in Tinnitus	NEURON			English	Article							DEEP BRAIN-STIMULATION; PARTIAL COCHLEAR LESIONS; NUCLEUS-ACCUMBENS; CORTICAL REORGANIZATION; FREQUENCY ORGANIZATION; SLEEP DISTURBANCE; MUSIC CORRELATE; ANIMAL-MODELS; HEARING-LOSS; ADULT CATS	Tinnitus, the most common auditory disorder, affects about 40 million people in the United States alone, and its incidence is rising due to an aging population and increasing noise exposure. Although several approaches for the alleviation of tinnitus exist, there is as of yet no cure. The present article proposes a testable model for tinnitus that is grounded in recent findings from human imaging and focuses on brain areas in cortex, thalamus, and ventral striatum. Limbic and auditory brain areas are thought to interact at the thalamic level. While a tinnitus signal originates from lesion-induced plasticity of the auditory pathways, it can be tuned out by feedback connections from limbic regions, which block the tinnitus signal from reaching auditory cortex. If the limbic regions are compromised, this "noise-cancellation" mechanism breaks down, and chronic tinnitus results. Hopefully, this model will ultimately enable the development of effective treatment.	[Rauschecker, Josef P.; Leaver, Amber M.] Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20057 USA; [Muehlau, Mark] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany	Georgetown University; Technical University of Munich	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20057 USA.	rauschej@georgetown.edu	Rauschecker, Josef P/A-4120-2013	Rauschecker, Josef P./0000-0003-4353-9084	National Institutes of Health [R01 NS052494, RC1 DC010720]; Tinnitus Research Consortium (TRC); Tinnitus Research Initiative (TRI); Skirball Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [RC1DC010720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tinnitus Research Consortium (TRC); Tinnitus Research Initiative (TRI); Skirball Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Grant support was provided by the National Institutes of Health (grants R01 NS052494, RC1 DC010720), the Tinnitus Research Consortium (TRC), the Tinnitus Research Initiative (TRI), and the Skirball Foundation. We thank P. Chablani and A. Seydell for critical comments on the manuscript, and D. Klemm, P. Kusmierek and X. Zhan for help with the graphics.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; ALSTER J, 1993, BIOL PSYCHIAT, V34, P84, DOI 10.1016/0006-3223(93)90260-K; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Baldo P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003853.pub2; Bauer CA, 2003, OTOLARYNG CLIN N AM, V36, P267, DOI 10.1016/S0030-6665(02)00171-8; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Birbaumer N, 1997, J NEUROSCI, V17, P5503; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Brown P, 2000, J NEUROSCI, V20, P1952; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Calford MB, 2005, NATURE, V438, pE3, DOI 10.1038/nature04359; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; DREVETS WC, 1997, NATURE, V386, P827; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eichhammer P, 2007, PROG BRAIN RES, V166, P83, DOI 10.1016/S0079-6123(07)66008-7; Elbert T, 1998, NEUROREPORT, V9, P3571, DOI 10.1097/00001756-199811160-00006; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; FIELDS RD, 2007, SCI AM MIND, V18, P12; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Flor H, 2009, NEUROREHABILITATION, V25, P19, DOI 10.3233/NRE-2009-0496; Florence SL, 1995, J NEUROSCI, V15, P8083; Folmer RL, 2000, AM J OTOLARYNG, V21, P287, DOI 10.1053/ajot.2000.9871; Folmer RL, 2001, OTOLARYNG HEAD NECK, V124, P394, DOI 10.1067/mhn.2001.114673; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Gruber AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005062; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hallam RS, 1996, SCAND AUDIOL, V25, P263, DOI 10.3109/01050399609074965; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Hirata Y, 2004, NEUROREPORT, V15, P815, DOI 10.1097/00001756-200404090-00015; Hoffman HJ, 2004, TINNITUS THEORY MANA; HOKE M, 1989, HEARING RES, V37, P281, DOI 10.1016/0378-5955(89)90028-2; Insel TR, 2007, SCIENCE, V317, P757, DOI 10.1126/science.1147565; Irvine DRF, 2001, AUDIOL NEURO-OTOL, V6, P192, DOI 10.1159/000046831; Jastreboff P. J., 2000, HDB TINNITUS, P357; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Johansen-Berg H, 2008, CEREB CORTEX, V18, P1374, DOI 10.1093/cercor/bhm167; Jones E.G., 2012, THALAMUS; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; LEAVER AM, 2006, SOC NEUROSCI, V32; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Lobarinas Edward, 2008, Seminars in Hearing, V29, P333, DOI 10.1055/s-0028-1095893; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; MARRIAGE J, 1995, J LARYNGOL OTOL, V109, P915, DOI 10.1017/S0022215100131676; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; MCCORMICK DA, 1991, J PHYSIOL-LONDON, V442, P235, DOI 10.1113/jphysiol.1991.sp018791; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; MCCULLOUGH LD, 1993, NEUROSCIENCE, V52, P919, DOI 10.1016/0306-4522(93)90538-Q; MCKENNA L, 2006, TINNITUS TREATMENT; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; ODonnell P, 1997, J NEUROSCI, V17, P2143; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Rajan R, 1998, J COMP NEUROL, V399, P35; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Rauschecker JP, 1999, SCIENCE, V285, P1686, DOI 10.1126/science.285.5434.1686; Roberts LE, 2007, PROG BRAIN RES, V166, P487, DOI 10.1016/S0079-6123(07)66047-6; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Robinson S, 2007, PROG BRAIN RES, V166, P263, DOI 10.1016/S0079-6123(07)66024-5; Salvi R, 2009, DRUG FUTURE, V34, P381, DOI 10.1358/dof.2009.034.05.1362442; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schneider P, 2009, NEUROIMAGE, V45, P927, DOI 10.1016/j.neuroimage.2008.12.045; SCHWABER MK, 1993, AM J OTOL, V14, P252; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Sherman, 2006, EXPLORING THALAMUS I, P357; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shulman Abraham, 2009, Int Tinnitus J, V15, P5; Simpson JJ, 2000, HEARING RES, V145, P1, DOI 10.1016/S0378-5955(00)00093-9; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Tyler R, 2008, AM J AUDIOL, V17, pS176, DOI 10.1044/1059-0889(2008/07-0044); Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yu XJ, 2009, J NEUROPHYSIOL, V101, P980, DOI 10.1152/jn.91130.2008	103	430	456	1	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 24	2010	66	6					819	826		10.1016/j.neuron.2010.04.032	http://dx.doi.org/10.1016/j.neuron.2010.04.032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620868	Green Accepted, Bronze			2022-12-24	WOS:000279420800005
J	Yang, JQ; Krishnamoorthy, G; Saxena, A; Zhang, GH; Shi, JY; Yang, HH; Delaloye, K; Sept, D; Cui, JM				Yang, Junqiu; Krishnamoorthy, Gayathri; Saxena, Akansha; Zhang, Guohui; Shi, Jingyi; Yang, Huanghe; Delaloye, Kelli; Sept, David; Cui, Jianmin			An Epilepsy/Dyskinesia-Associated Mutation Enhances BK Channel Activation by Potentiating Ca2+ Sensing	NEURON			English	Article							POTASSIUM CHANNELS; K+ CHANNEL; SOLVENT VISCOSITY; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; VOLTAGE SENSOR; SINGLE-CELL; MECHANISM; MEMBRANE; DOMAIN	Ca2+-activated BK channels modulate neuronal activities, including spike frequency adaptation and synaptic transmission. Previous studies found that Ca2+-binding sites and the activation gate are spatially separated in the channel protein, but the mechanism by which Ca2+ binding opens the gate over this distance remains unknown. By studying an Asp-to-Gly mutation (D434G) associated with human syndrome of generalized epilepsy and paroxysmal dyskinesia (GEPD), we show that a cytosolic motif immediately following the activation gate S6 helix, known as the AC region, mediates the allosteric coupling between Ca2+ binding and channel opening. The GEPD mutation inside the AC region increases BK channel activity by enhancing this allosteric coupling. We found that Ca2+ sensitivity is enhanced by increases in solution viscosity that reduce protein dynamics. The GEPD mutation alters such a response, suggesting that a less flexible AC region may be more effective in coupling Ca2+ binding to channel opening.	[Yang, Junqiu; Krishnamoorthy, Gayathri; Zhang, Guohui; Shi, Jingyi; Yang, Huanghe; Delaloye, Kelli; Cui, Jianmin] Washington Univ, Cardiac Bioelect & Arrhythmia Ctr, St Louis, MO 63130 USA; [Yang, Junqiu] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA; [Krishnamoorthy, Gayathri] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Saxena, Akansha; Sept, David] Washington Univ, Ctr Computat Biol, St Louis, MO 63130 USA; [Saxena, Akansha; Zhang, Guohui; Shi, Jingyi; Yang, Huanghe; Delaloye, Kelli; Sept, David; Cui, Jianmin] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Case Western Reserve University; Washington University (WUSTL); Washington University (WUSTL)	Sept, D (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	dsept@umich.edu; jcui@biomed.wustl.edu	Sept, David/F-6497-2011; Yang, Junqiu/C-5579-2014	Natarajan, Gayathri/0000-0001-7654-5013; Krishnamoorthy, Gayathri/0000-0002-2208-3244; Sept, David/0000-0003-3719-2483; Yang, Huanghe/0000-0001-9521-9328	National Institutes of Health [R01-HL70393]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Frank Horrigan, Toshi Hoshi, Urvi Lee, Lawrence Salkoff, and Chris Lingle for helpful suggestions. We thank Dr. Jin-Yu Shao for allowing us to use the Rheometer. The mSIo1 clone was kindly provided by Lawrence Salkoff (Washington University, St. Louis, MO). This work was supported by National Institutes of Health (grant R01-HL70393 to J.C.). J.C. is an Associate Professor of Biomedical Engineering on the Spencer T. Olin Endowment.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Ashcroft F. M., 2000, ION CHANNELS DIS CHA; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Diez-Sampedro A, 2006, J NEUROPHYSIOL, V96, P1507, DOI 10.1152/jn.00461.2006; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Krishnamoorthy G, 2005, J GEN PHYSIOL, V126, P227, DOI 10.1085/jgp.200509321; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Kukita F, 2000, J PHYSIOL-LONDON, V522, P357, DOI 10.1111/j.1469-7793.2000.00357.x; Kukita F, 1997, J PHYSIOL-LONDON, V498, P109, DOI 10.1113/jphysiol.1997.sp021845; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; PICO A, 2003, THESIS ROCKEFELLER U; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; Wandelt B, 2005, BIOSENS BIOELECTRON, V20, P1728, DOI 10.1016/j.bios.2004.06.045; Wang B, 2009, J GEN PHYSIOL, V133, P283, DOI 10.1085/jgp.200810141; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yellen G, 1998, NAT STRUCT BIOL, V5, P421, DOI 10.1038/nsb0698-421; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	50	73	76	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 24	2010	66	6					871	883		10.1016/j.neuron.2010.05.009	http://dx.doi.org/10.1016/j.neuron.2010.05.009			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	619HP	20620873	Green Accepted, Bronze			2022-12-24	WOS:000279420800010
J	Bretzner, F; Gilbert, F; Baylis, F; Brownstone, RM				Bretzner, Frederic; Gilbert, Frederic; Baylis, Francoise; Brownstone, Robert M.			Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury	CELL STEM CELL			English	Article							COMMITTED PROGENITOR CELLS; MULTIPLE-SCLEROSIS; CLINICAL-TRIALS; INFLAMMATORY RESPONSE; DOUBLE-BLIND; THERAPEUTIC MISCONCEPTION; TRANSPLANTATION; MACROPHAGES; DIFFERENTIATION; RECOVERY	Geron recently announced that it had begun enrolling patients in the world's first-in-human clinical trial involving cells derived from human embryonic stem cells (hESCs). This trial raises important questions regarding the future of hESC-based therapies, especially in spinal cord injury (SCI) patients. We address some safety and efficacy concerns with this research, as well as the ethics of fair subject selection. We consider other populations that might be better for this research: chronic complete SCI patients for a safety trial, subacute incomplete SCI patients for an efficacy trial, and perhaps primary progressive multiple sclerosis (MS) patients for a combined safety and efficacy trial.	[Bretzner, Frederic; Brownstone, Robert M.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 3J5, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Philosophy, Halifax, NS B3H 3J5, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS B3H 3J5, Canada; [Brownstone, Robert M.] Dalhousie Univ, Dept Surg Neurosurg, Halifax, NS B3H 3J5, Canada; [Gilbert, Frederic] Univ Tasmania, ACES, Hobart, Tas 7005, Australia	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; University of Tasmania	Bretzner, F (corresponding author), Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS B3H 3J5, Canada.	frederic.bretzner@dal.ca	Baylis, Francoise/AAP-4565-2021; Gilbert, Frederic/D-5452-2012	Gilbert, Frederic/0000-0003-0524-8649; Baylis, Francoise/0000-0003-2961-5802; Bretzner, Frederic/0000-0002-7387-3414; Brownstone, Robert/0000-0001-5135-2725	Canadian Institutes of Health Research (CIHR) [NNF 80045]; Canada Research Chair in Bioethics and Philosophy	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Bioethics and Philosophy	We thank members of the NovelTechEthics research team at Dalhousie University, Renee Hartlieb, and anonymous reviewers for helpful comments on an earlier version of this paper. We also thank Philippe Magown for discussion and comments on the design of clinical trials and Virender Bhan for discussion about MS patients. This work was funded in part by the Canadian Institutes of Health Research (CIHR) NNF 80045, States of Mind: Emerging Issues in Neuroethics awarded to Francoise Baylis, Canada Research Chair in Bioethics and Philosophy. The spinal cord research of Robert Brownstone is supported by grants from the CIHR. At the time of writing, Frederic Gilbert was a research postdoctoral fellow on the States of Mind grant. Frederic Bretzner is a CIHR and Paralysis Project of America (PPA) postdoctoral fellow researcher.	Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Anderson JA, 2010, KENNEDY INST ETHIC J, V20, P75, DOI 10.1353/ken.0.0307; [Anonymous], 2008, WMA DECL HELS ETH PR; [Anonymous], 2000, J SPINAL CORD MED, V23, P289; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Bottai D, 2010, EXP NEUROL, V223, P452, DOI 10.1016/j.expneurol.2010.01.010; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Chang HT, 2007, SPINAL CORD, V45, P174, DOI 10.1038/sj.sc.3101910; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Corbetta M, 2002, P NATL ACAD SCI USA, V99, P17066, DOI 10.1073/pnas.262669099; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; D Cardenas D, 2007, SPINAL CORD, V45, P158, DOI 10.1038/sj.sc.3101947; DeForge D, 2004, SPINAL CORD, V42, P674, DOI 10.1038/sj.sc.3101653; Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; ERGO F, 2003, J CEREB BLOOD FLOW M, V23, P780; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; *GER, 2010, PRECL SAF STUD; *GER, 2010, PHAS 1 SAF STUD GRNO; *GER, 2009, GER COMM FDA HOLD SP; *GER, 2009, GER REC FDA CLEAR BE; Geron, 2010, GER PROC 1 HUM CLIN; GILBERT F, 2009, GERONS HESC TRIAL SP; Goodman AD, 2007, MULT SCLER, V13, P357, DOI 10.1177/1352458506069538; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hall VJ, 2008, ANN ACAD MED SINGAP, V37, P163; Hardison JL, 2006, EXP NEUROL, V197, P420, DOI 10.1016/j.expneurol.2005.10.016; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Illes J, 2011, STEM CELL REV REP, V7, P997, DOI 10.1007/s12015-011-9259-1; Kakulas BA, 1999, SPINAL CORD, V37, P79, DOI 10.1038/sj.sc.3100807; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kimmelman J, 2006, HASTINGS CENT REP, V36, P23, DOI 10.1353/hcr.2006.0012; Kimmelman J, 2007, HASTINGS CENT REP, V37, P36, DOI 10.1353/hcr.2007.0092; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Kovacsovics-Bankowski M, 2009, CELL IMMUNOL, V255, P55, DOI 10.1016/j.cellimm.2008.10.004; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Levine RJ, 1988, ETHICS REGULATIONS C; Lo B, 2005, STEM CELLS, V23, P1454, DOI 10.1634/stemcells.2005-0324; MAYNARD FM, 1979, J NEUROSURG, V50, P611, DOI 10.3171/jns.1979.50.5.0611; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Miller FG, 2003, NEW ENGL J MED, V348, P1383, DOI 10.1056/NEJMsb030228; Moon Lawrence, 2005, J Neurol Phys Ther, V29, P55; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Ruof MC, 2004, KENNEDY INST ETHIC J, V14, P411, DOI 10.1353/ken.2004.0044; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; Scott CT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E23; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; *STEAM CELL INC, 2011, IN WORLDS 1 NEUR STE; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Totoiu MO, 2004, EXP NEUROL, V187, P254, DOI 10.1016/j.expneurol.2004.01.028; van der Bruggen MAM, 2001, J NEUROL, V248, P665, DOI 10.1007/s004150170111; Wade N., 2005, NY TIMES; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; 2004, NAT NEUROSCI, V7, P1013; 2004, NATURE, V428, P587	78	85	86	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 6	2011	8	5					468	475		10.1016/j.stem.2011.04.012	http://dx.doi.org/10.1016/j.stem.2011.04.012			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	768IN	21549321	Bronze			2022-12-24	WOS:000290927600006
J	Branco, T; Hausser, M				Branco, Tiago; Haeusser, Michael			Synaptic Integration Gradients in Single Cortical Pyramidal Cell Dendrites	NEURON			English	Article							LOCATION-DEPENDENT VARIABILITY; BASAL DENDRITES; ACTION-POTENTIALS; ACTIVE DENDRITES; VISUAL-CORTEX; NEURONS; DISTAL; RAT; PLASTICITY; EPSP	Cortical pyramidal neurons receive thousands of synaptic inputs arriving at different dendritic locations with varying degrees of temporal synchrony. It is not known if different locations along single cortical dendrites integrate excitatory inputs in different ways. Here we have used two-photon glutamate uncaging and compartmental modeling to reveal a gradient of nonlinear synaptic integration in basal and apical oblique dendrites of cortical pyramidal neurons. Excitatory inputs to the proximal dendrite sum linearly and require precise temporal coincidence for effective summation, whereas distal inputs are amplified with high gain and integrated over broader time windows. This allows distal inputs to overcome their electrotonic disadvantage, and become surprisingly more effective than proximal inputs at influencing action potential output. Thus, single dendritic branches can already exhibit non-uniform synaptic integration, with the computational strategy shifting from temporal coding to rate coding along the dendrite.	[Branco, Tiago; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Branco, Tiago; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Branco, T (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	t.branco@ucl.ac.uk; m.hausser@ucl.ac.uk	Branco, Tiago/C-1503-2008; Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Wellcome Trust; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	We thank Mickey London, Arnd Roth, and Beverley Clark for helpful discussions and comments on the manuscript. This work was supported by grants from the Wellcome Trust and the Gatsby Charitable Foundation.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Andersen P., 2006, HIPPOCAMPUS BOOK; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Cais O, 2008, NEUROSCIENCE, V151, P428, DOI 10.1016/j.neuroscience.2007.11.002; Cook EP, 1997, J NEUROPHYSIOL, V78, P2116, DOI 10.1152/jn.1997.78.4.2116; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; Jack J.J.B., 1975, ELECT CURRENT FLOW E; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Katz Y, 2009, NEURON, V63, P171, DOI 10.1016/j.neuron.2009.06.023; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, pU9; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Mathews PJ, 2010, NAT NEUROSCI, V13, P601, DOI 10.1038/nn.2530; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rall W, 1964, NEURAL THEORY MODELI, P73; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; Stuart G, 1998, J NEUROSCI, V18, P3501; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Thomson AM, 1998, NEUROSCIENCE, V84, P669, DOI 10.1016/S0306-4522(97)00557-5; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	64	202	206	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 10	2011	69	5					885	892		10.1016/j.neuron.2011.02.006	http://dx.doi.org/10.1016/j.neuron.2011.02.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739RU	21382549	Green Accepted, Bronze			2022-12-24	WOS:000288736500007
J	Smukler, SR; Arntfield, ME; Razavi, R; Bikopoulos, G; Karpowicz, P; Seaberg, R; Dai, FH; Lee, S; Ahrens, R; Fraser, PE; Wheeler, MB; van der Kooy, D				Smukler, Simon R.; Arntfield, Margot E.; Razavi, Rozita; Bikopoulos, George; Karpowicz, Phillip; Seaberg, Raewyn; Dai, Feihan; Lee, Simon; Ahrens, Rosemary; Fraser, Paul E.; Wheeler, Michael B.; van der Kooy, Derek			The Adult Mouse and Human Pancreas Contain Rare Multipotent Stem Cells that Express Insulin	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GREEN FLUORESCENT PROTEIN; BETA-CELLS; PROGENITOR CELLS; PRECURSOR CELLS; POSITIVE CELLS; NEURAL CREST; ISLET CELLS; IN-VITRO; PROLIFERATION	The search for putative precursor cells within the pancreas has been the focus of extensive research. Previously, we identified rare pancreas-derived multipotent precursor (PMP) cells in the mouse with the intriguing capacity to generate progeny in the pancreatic and neural lineages. Here, we establish the embryonic pancreas as the developmental source of PMPs through lineage-labeling experiments. We also show that PMPs express insulin and can contribute to multiple pancreatic and neural cell types in vivo. In addition, we have isolated PMPs from adult human islet tissue that are also capable of extensive proliferation, self-renewal, and generation of multiple differentiated pancreatic and neural cell types. Finally, both mouse and human PMP-derived cells ameliorated diabetes in transplanted mice. These findings demonstrate that the adult Mammalian pancreas contains a population of insulin(+) multipotent stem cells and suggest that these cells may provide a promising line of investigation toward potential therapeutic benefit.	[Smukler, Simon R.; Arntfield, Margot E.; Razavi, Rozita; Karpowicz, Phillip; Seaberg, Raewyn; van der Kooy, Derek] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Bikopoulos, George; Dai, Feihan; Lee, Simon; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Ahrens, Rosemary; Fraser, Paul E.; van der Kooy, Derek] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Smukler, SR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	simon.smukler@utoronto.ca	Karpowicz, Phillip/C-3334-2016	Wheeler, Michael B./0000-0002-7480-7267; Karpowicz, Phillip/0000-0002-3116-4804	Juvenile Diabetes Research Foundation; Canadian Stem Cell Network; Banting & Best Diabetes Centre; Canadian Institutes of Health Research; MRC [MC_G1000734] Funding Source: UKRI; Medical Research Council [MC_G1000734] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Stem Cell Network; Banting & Best Diabetes Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors wish to thank members of the D.v.d.K. lab for thoughtful discussion and critical reading of the manuscript, D. Dixon for excellent tissue isolation and purification, M. Brown for assistance with the transplantation techniques, C. Smith, D. White, and P.A. Pentilla for expert assistance with FACS analysis, S. Doyle for electron microscopy sample preparation and imaging, J. Aubin for providing MSC samples, J. Shapiro for providing human islet tissue, and C. Lobe, D. Melton, M. Hara, and A. McMahon for generously providing transgenic mice. This work was supported by the Juvenile Diabetes Research Foundation, the Canadian Stem Cell Network, the Banting & Best Diabetes Centre, and the Canadian Institutes of Health Research.	Atouf F, 2007, DIABETES, V56, P699, DOI 10.2337/db06-1446; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Chase LG, 2007, DIABETES, V56, P3, DOI 10.2337/db06-1165; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Itoh S, 2009, J CELL BIOCHEM, V108, P368, DOI 10.1002/jcb.22262; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Manesso E, 2009, AM J PHYSIOL-ENDOC M, V297, pE323, DOI 10.1152/ajpendo.00284.2009; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Pierret C, 2006, STEM CELLS DEV, V15, P286, DOI 10.1089/scd.2006.15.286; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Szot GL, 2007, JOVE-J VIS EXP, V9, P404, DOI DOI 10.3791/404; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2003, DIABETES-METAB RES, V19, P363, DOI 10.1002/dmrr.406	35	161	170	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					281	293		10.1016/j.stem.2011.01.015	http://dx.doi.org/10.1016/j.stem.2011.01.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362568	Bronze			2022-12-24	WOS:000288404400010
J	Imamura, F; Ayoub, AE; Rakic, P; Greer, CA				Imamura, Fumiaki; Ayoub, Albert E.; Rakic, Pasko; Greer, Charles A.			Timing of neurogenesis is a determinant of olfactory circuitry	NATURE NEUROSCIENCE			English	Article							MITRAL CELL AXONS; PIRIFORM CORTEX; MAP TOPOGRAPHY; TUFTED CELLS; BULB; MOUSE; ORGANIZATION; ODOR; RAT; REPRESENTATIONS	An odorant receptor map in mammals that is constructed by the glomerular coalescence of sensory neuron axons in the olfactory bulb is essential for proper odor information processing. How this map is linked with olfactory cortex is unknown. Using a battery of methods, including various markers of cell division in combination with tracers of neuronal connections and time-lapse live imaging, we found that early-and late-generated mouse mitral cells became differentially distributed in the dorsal and ventral subdivisions of the odorant receptor map. In addition, the late-generated mitral cells extended substantially stronger projections to the olfactory tubercle than did the early-generated cells. Together, these data indicate that the odorant receptor map is developmentally linked to the olfactory cortices in part by the birthdate of mitral cells. Thus, different olfactory cortical regions become involved in processing information from distinct regions of the odorant receptor map.	[Imamura, Fumiaki; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Ayoub, Albert E.; Rakic, Pasko; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Ayoub, Albert E.; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT USA	Yale University; Yale University; Yale University	Greer, CA (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	charles.greer@yale.edu	Imamura, Fumiaki/F-5041-2012; Ayoub, Albert/G-1783-2011	Ayoub, Albert/0000-0002-5493-1172; Imamura, Fumiaki/0000-0003-1410-3126	US National Institute of Child Health and Human Development; US National Institute of Health; Kavli Institute for Neuroscience at Yale; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000210, R03DC011134] Funding Source: NIH RePORTER	US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Neuroscience at Yale; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Mori for the antibody to OCAM, Y. Yoshihara for the antibody to Tbx21, A. Bordey for the DCX-GFP mice and all of the members of the Greer, Rakic and Treloar laboratories for technical assistance and discussion. The antibody to RC2 developed by M. Yamamoto was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the US National Institute of Child Health and Human Development and maintained by the Department of Biology, University of Iowa. This work was supported by the US National Institute of Health and the Kavli Institute for Neuroscience at Yale.	Bailey MS, 1999, J COMP NEUROL, V415, P423; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; Blanchart A, 2008, EUR J NEUROSCI, V27, P2838, DOI 10.1111/j.1460-9568.2008.06283.x; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Fouquet C, 2007, J NEUROSCI, V27, P3037, DOI 10.1523/JNEUROSCI.0172-07.2007; GRAFE MR, 1982, DEV BRAIN RES, V3, P387, DOI 10.1016/0165-3806(82)90006-2; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; HINDS JW, 1972, J COMP NEUROL, V146, P253, DOI 10.1002/cne.901460208; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hirata T, 1999, J NEUROBIOL, V38, P93; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Imamura F, 2006, J COMP NEUROL, V495, P754, DOI 10.1002/cne.20896; Inaki K, 2004, J COMP NEUROL, V479, P243, DOI 10.1002/cne.20270; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Johnson BA, 2009, J COMP NEUROL, V514, P658, DOI 10.1002/cne.22046; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Matsumoto H, 2010, J NEUROPHYSIOL, V103, P3490, DOI 10.1152/jn.00035.2010; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2000, PHILOS T R SOC B, V355, P1801, DOI 10.1098/rstb.2000.0736; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Puche AC, 2001, J COMP NEUROL, V434, P1, DOI 10.1002/cne.1160; Rakic P, 2009, TRENDS NEUROSCI, V32, P291, DOI 10.1016/j.tins.2009.01.007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1981, J NEUROPHYSIOL, V46, P918, DOI 10.1152/jn.1981.46.5.918; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Treloar HB, 2003, J COMP NEUROL, V458, P389, DOI 10.1002/cne.10590; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103	47	71	71	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					331	337		10.1038/nn.2754	http://dx.doi.org/10.1038/nn.2754			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21297629	Green Accepted			2022-12-24	WOS:000287650100013
J	Stevenson, IH; Kording, KP				Stevenson, Ian H.; Kording, Konrad P.			How advances in neural recording affect data analysis	NATURE NEUROSCIENCE			English	Article							FIELD POTENTIALS; ENSEMBLE; PATTERNS; ARRAYS; MODEL; STATE; MOTOR	Over the last five decades, progress in neural recording techniques has allowed the number of simultaneously recorded neurons to double approximately every 7 years, mimicking Moore's law. Such exponential growth motivates us to ask how data analysis techniques are affected by progressively larger numbers of recorded neurons. Traditionally, neurons are analyzed independently on the basis of their tuning to stimuli or movement. Although tuning curve approaches are unaffected by growing numbers of simultaneously recorded neurons, newly developed techniques that analyze interactions between neurons become more accurate and more complex as the number of recorded neurons increases. Emerging data analysis techniques should consider both the computational costs and the potential for more accurate models associated with this exponential growth of the number of recorded neurons.	[Stevenson, Ian H.; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Stevenson, Ian H.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Appl Math, Chicago, IL 60611 USA	Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Northwestern University	Stevenson, IH (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	i-stevenson@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	Chicago Community Trust; US National Institutes of Health [1R01NS063399, 2P01NS044393]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044393, R01NS063399] Funding Source: NIH RePORTER	Chicago Community Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to A. Kohn and members of the Kohn laboratory for providing data from visual cortex (US National Institutes of Health EY016774) and N. Hatsopoulos and J. Reimer for providing data from motor cortex. All animal use procedures were approved by the institutional animal care and use committees at Albert Einstein College of Medicine and the University of Chicago, respectively. Thanks to B. Yu and J. Cunningham for providing the GPFA code and B. Yu for insightful discussions. This work was supported by the Chicago Community Trust and US National Institutes of Health grants 1R01NS063399 and 2P01NS044393.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Babadi B, 2010, J VISION, V10, DOI 10.1167/10.10.22; BARNA JS, 1981, ELECTROEN CLIN NEURO, V52, P494, DOI 10.1016/0013-4694(81)90035-3; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Kelly RC, 2010, J COMPUT NEUROSCI, V29, P567, DOI 10.1007/s10827-009-0208-9; KRUGER J, 1981, EXP BRAIN RES, V41, P191; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Maynard EM, 1999, J NEUROSCI, V19, P8083; MOORE G, 2006, UNDERSTANDING MOORES, pCH7; Moore GE, 1965, ELECTRONICS, V38, P114; Nicolelis M, 2007, METHODS NEURAL ENSEM, DOI DOI 10.1201/9781420006414; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; PANINSKI L, 2009, J COMPUT NEUROSCI, V29, P1; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Papadimitriou C.H, 2003, COMPUT COMPLEX; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rebesco JM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00039; ROUSCHE P, 2002, IEEE T REHABIL ENG, V7, P56; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stevenson IH, 2009, IEEE T NEUR SYS REH, V17, P203, DOI 10.1109/TNSRE.2008.2010471; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	43	305	309	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					139	142		10.1038/nn.2731	http://dx.doi.org/10.1038/nn.2731			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270781	Green Accepted			2022-12-24	WOS:000286595400008
J	Uchida, S; Hara, K; Kobayashi, A; Otsuki, K; Yamagata, H; Hobara, T; Suzuki, T; Miyata, N; Watanabe, Y				Uchida, Shusaku; Hara, Kumiko; Kobayashi, Ayumi; Otsuki, Koji; Yamagata, Hirotaka; Hobara, Teruyuki; Suzuki, Takayoshi; Miyata, Naoki; Watanabe, Yoshifumi			Epigenetic Status of Gdnf in the Ventral Striatum Determines Susceptibility and Adaptation to Daily Stressful Events	NEURON			English	Article							HISTONE DEACETYLASE; BEHAVIORAL VULNERABILITY; NEUROTROPHIC FACTOR; GENE-EXPRESSION; SOCIAL DEFEAT; MECP2; MODEL; REQUIREMENT; INVOLVEMENT; MECHANISMS	Stressful events during adulthood are potent adverse environmental factors that can predispose individuals to psychiatric disorders, including depression; however, many individuals exposed to stressful events can adapt and function normally. While stress vulnerability may influence depression, the molecular mechanisms underlying the susceptibility and adaptation to chronic stress within the brain are poorly understood. In this study, two genetically distinct mouse strains that exhibit different behavioral responses to chronic stress were used to demonstrate how the differential epigenetic status of the glial cell-derived neurotrophic factor (Gdnf) gene in the ventral striatum modulates susceptibility and adaptation to chronic stress. Our results suggest that the histone modifications and DNA methylation of the Gdnf promoter have crucial roles in the control of behavioral responses to chronic stress. Our data provide insights into these mechanisms, suggesting that epigenetic modifications of Gdnf, along with genetic and environmental factors, contribute to behavioral responses to stress.	[Uchida, Shusaku; Hara, Kumiko; Kobayashi, Ayumi; Otsuki, Koji; Yamagata, Hirotaka; Hobara, Teruyuki; Watanabe, Yoshifumi] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Yamaguchi 7558505, Japan; [Suzuki, Takayoshi; Miyata, Naoki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Aichi 4678603, Japan	Yamaguchi University; Nagoya City University	Uchida, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, 1-1-1 Minamikogushi, Yamaguchi 7558505, Japan.	s-uchida@yamaguchi-u.ac.jp; yoshiwat@yamaguchi-u.ac.jp		Hara, Kumiko/0000-0003-3418-2255; Uchida, Shusaku/0000-0002-1451-6222	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	The authors thank Drs. Koh Shinoda, Akinori Ishikawa, Yoichi Mizukami, Koh-ichi Udoh, and Tomoaki Murata for technical advice. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (S.U. and Y.W.) and a grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Ministry of Health, Labor and Welfare (S.U. and Y.W.).	Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bhansali P, 2007, J NEUROSCI, V27, P1467, DOI 10.1523/JNEUROSCI.4632-06.2007; Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726; Cen XB, 2006, J NEUROSCI, V26, P3335, DOI 10.1523/JNEUROSCI.5010-05.2006; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Humphrey GW, 2008, DIFFERENTIATION, V76, P348, DOI 10.1111/j.1432-0436.2007.00232.x; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lanfumey L, 1999, NEUROREPORT, V10, P3369, DOI 10.1097/00001756-199911080-00021; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Palumbo ML, 2009, STRESS, V12, P350, DOI 10.1080/10253890802506383; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rangon CM, 2007, J NEUROSCI, V27, P7532, DOI 10.1523/JNEUROSCI.5330-06.2007; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Suzuki N, 2009, J MED CHEM, V52, P2909, DOI 10.1021/jm900125m; Takai Daiya, 2003, In Silico Biology, V3, P235; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2008, EUR J NEUROSCI, V27, P2250, DOI 10.1111/j.1460-9568.2008.06218.x; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566	46	275	291	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 27	2011	69	2					359	372		10.1016/j.neuron.2010.12.023	http://dx.doi.org/10.1016/j.neuron.2010.12.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714FM	21262472	Bronze			2022-12-24	WOS:000286792900017
J	Abuin, L; Bargeton, B; Ulbrich, MH; Isacoff, EY; Kellenberger, S; Benton, R				Abuin, Liliane; Bargeton, Benoite; Ulbrich, Maximilian H.; Isacoff, Ehud Y.; Kellenberger, Stephan; Benton, Richard			Functional Architecture of Olfactory Ionotropic Glutamate Receptors	NEURON			English	Article							DROSOPHILA ODORANT RECEPTORS; PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING CORE; GATED ION CHANNELS; FINE-STRUCTURE; MOLECULAR DETERMINANTS; CHEMOSENSORY RECEPTORS; EXPRESSION; KAINATE; AMPA	Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that mediate chemical communication between neurons at synapses. A variant iGluR subfamily, the Ionotropic Receptors (IRs), was recently proposed to detect environmental volatile chemicals in olfactory cilia. Here, we elucidate how these peripheral chemosensors have evolved mechanistically from their iGluR ancestors. Using a Drosophila model, we demonstrate that IRs act in combinations of up to three subunits, comprising individual odor-specific receptors and one or two broadly expressed coreceptors. Heteromeric IR complex formation is necessary and sufficient for trafficking to cilia and mediating odor-evoked electrophysiological responses in vivo and in vitro. IRs display heterogeneous ion conduction specificities related to their variable pore sequences, and divergent ligand-binding domains function in odor recognition and cilia localization. Our results provide insights into the conserved and distinct architecture of these olfactory and synaptic ion channels and offer perspectives into the use of IRs as genetically encoded chemical sensors.	[Abuin, Liliane; Benton, Richard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Bargeton, Benoite; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Ulbrich, Maximilian H.; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ulbrich, Maximilian H.; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA	University of Lausanne; University of Lausanne; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Benton, R (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	richard.benton@unil.ch	isacoff, ehud/AAP-1459-2020; Ulbrich, Maximilian H/C-6929-2008	Kellenberger, Stephan/0000-0003-1755-6198; Benton, Richard/0000-0003-4305-8301; Ulbrich, Maximilian/0000-0001-8123-1668; Isacoff, Ehud Y./0000-0003-4775-9359	Swiss National Science Foundation [31003A-117717]; NIH [R01NS035549]; NSF [FIBR 0623527]; European Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yael Grosjean for sharing the IR84a mutant prior to publication, Raphael Rytz for generating the tree in Figure 1A, and Michael Saina for analyzing IR8a expression in axon termini. We acknowledge Kazushige Touhara for use of pXpress, Roger Tsien for use of mCherry, the Bloomington Stock Center for Drosophila strains, and the Developmental Studies Hybridoma Bank for monoclonal antibodies. We are grateful to Sophie Martin, Chun Tang, and members of the Benton group for discussions and comments on the manuscript. Research in S.K.'s laboratory is supported by the Swiss National Science Foundation (31003A-117717). Research in E.Y.I.'s laboratory is supported by the NIH (R01NS035549) and NSF (FIBR 0623527). This work was funded by a European Research Council Starting Independent Researcher Grant to R.B.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Coussen F, 2009, NEUROSCIENCE, V158, P25, DOI 10.1016/j.neuroscience.2007.12.052; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; Gereau R.W., 2008, GLUTAMATE RECEPTORS; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; JONES MG, 1990, BRIT J PHARMACOL, V101, P968, DOI 10.1111/j.1476-5381.1990.tb14189.x; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; McClintock TS, 2003, NEUROREPORT, V14, P1547, DOI 10.1097/00001756-200308260-00001; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Parsons CG, 2008, EUR J PHARMACOL, V587, P99, DOI 10.1016/j.ejphar.2008.03.053; RAGSDALE D, 1989, J PHARMACOL EXP THER, V251, P156; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Shaham S, 2010, NAT REV NEUROSCI, V11, P212, DOI 10.1038/nrn2740; SHANBHAG SR, 1995, CELL TISSUE RES, V282, P237, DOI 10.1007/BF00319115; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sonnleitner A, 2002, P NATL ACAD SCI USA, V99, P12759, DOI 10.1073/pnas.192261499; Spehr M, 2009, J NEUROCHEM, V109, P1570, DOI 10.1111/j.1471-4159.2009.06085.x; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Tomita S, 2010, PHYSIOLOGY, V25, P41, DOI 10.1152/physiol.00033.2009; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Ulbrich MH, 2008, P NATL ACAD SCI USA, V105, P14163, DOI 10.1073/pnas.0802075105; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Walker CS, 2006, P NATL ACAD SCI USA, V103, P10781, DOI 10.1073/pnas.0604482103; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	67	355	367	14	123	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 13	2011	69	1					44	60		10.1016/j.neuron.2010.11.042	http://dx.doi.org/10.1016/j.neuron.2010.11.042			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220098	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000286446300007
J	Christie, JM; Chiu, DN; Jahr, CE				Christie, Jason M.; Chiu, Delia N.; Jahr, Craig E.			Ca2+-dependent enhancement of release by subthreshold somatic depolarization	NATURE NEUROSCIENCE			English	Article							NEURONAL CALCIUM SENSOR-1; MOSSY FIBER BOUTONS; CEREBELLAR GRANULE CELLS; RAT BRAIN-STEM; TRANSMITTER RELEASE; CENTRAL SYNAPSE; PRESYNAPTIC TERMINALS; PURKINJE-CELLS; CA2+ CHANNELS; CNS SYNAPSE	In many neurons, subthreshold somatic depolarization can spread electrotonically into the axon and modulate subsequent spike-evoked transmission. Although release probability is regulated by intracellular Ca2+, the Ca2+ dependence of this modulatory mechanism has been debated. Using paired recordings from synaptically connected molecular layer interneurons (MLIs) of the rat cerebellum, we observed Ca2+-mediated strengthening of release following brief subthreshold depolarization of the soma. Two-photon microscopy revealed that, at the axon, somatic depolarization evoked Ca2+ influx through voltage-sensitive Ca2+ channels and facilitated spike-evoked Ca2+ entry. Exogenous Ca2+ buffering diminished these Ca2+ transients and eliminated the strengthening of release. Axonal Ca2+ entry elicited by subthreshold somatic depolarization also triggered asynchronous transmission that may deplete vesicle availability and thereby temper release strengthening. In this cerebellar circuit, activity-dependent presynaptic plasticity depends on Ca2+ elevations resulting from both sub-and suprathreshold electrical activity initiated at the soma.	[Christie, Jason M.; Chiu, Delia N.; Jahr, Craig E.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Chiu, Delia N.] Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Christie, JM (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	jason.christie@maxplanckflorida.org		Christie, Jason/0000-0003-0276-2554	US National Institutes of Health [NS066037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066037] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Herman, M. McGinley, B. Nahir and J. Pugh for their helpful discussions and comments on the manuscript. This work was supported by US National Institutes of Health grant NS066037 (C.E.J.).	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brenowitz SD, 2007, J NEUROSCI, V27, P7888, DOI 10.1523/JNEUROSCI.1064-07.2007; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Diana MA, 2003, J NEUROSCI, V23, P5906; Dittman JS, 2000, J NEUROSCI, V20, P1374; DODT HU, 2002, SCI STKE, V120, P12; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glitsch M, 1999, J NEUROSCI, V19, P511; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hori T, 2009, J PHYSIOL-LONDON, V587, P2987, DOI 10.1113/jphysiol.2009.168765; Jinno S, 2004, CEREBELLUM, V3, P83, DOI 10.1080/14734220310025187; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Mejia-Gervacio S, 2007, NEURON, V53, P843, DOI 10.1016/j.neuron.2007.02.023; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Muller M, 2010, J NEUROSCI, V30, P2007, DOI 10.1523/JNEUROSCI.4378-09.2010; Muller M, 2008, J PHYSIOL-LONDON, V586, P5503, DOI 10.1113/jphysiol.2008.155838; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Palay S. L., 1974, CEREBELLAR CORTEX CY; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Sabatini BL, 1997, J NEUROSCI, V17, P3425; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Scott R, 2008, J NEUROSCI, V28, P7765, DOI 10.1523/JNEUROSCI.1296-08.2008; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Tottene A, 1996, J NEUROSCI, V16, P6353; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	80	81	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					62	U86		10.1038/nn.2718	http://dx.doi.org/10.1038/nn.2718			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21170054	Green Accepted			2022-12-24	WOS:000285684900015
J	Vaegter, CB; Jansen, P; Fjorback, AW; Glerup, S; Skeldal, S; Kjolby, M; Richner, M; Erdmann, B; Nyengaard, JR; Tessarollo, L; Lewin, GR; Willnow, TE; Chao, MV; Nykjaer, A				Vaegter, Christian B.; Jansen, Pernille; Fjorback, Anja W.; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Erdmann, Bettina; Nyengaard, Jens R.; Tessarollo, Lino; Lewin, Gary R.; Willnow, Thomas E.; Chao, Moses V.; Nykjaer, Anders			Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT GANGLION; SENSORY NEURONS; NERVOUS-SYSTEM; BIOCHEMICAL-CHARACTERIZATION; TARGETED DISRUPTION; AXONAL-TRANSPORT; MICE LACKING; GENE; PROTEIN; BRAIN	Binding of target-derived neurotrophins to Trk receptors at nerve terminals is required to stimulate neuronal survival, differentiation, innervation and synaptic plasticity. The distance between the soma and nerve terminal is great, making efficient anterograde Trk transport critical for Trk synaptic translocation and signaling. The mechanism responsible for this trafficking remains poorly understood. Here we show that the sorting receptor sortilin interacts with TrkA, TrkB and TrkC and enables their anterograde axonal transport, thereby enhancing neurotrophin signaling. Cultured DRG neurons lacking sortilin showed blunted MAP kinase signaling and reduced neurite outgrowth upon stimulation with NGF. Moreover, deficiency for sortilin markedly aggravated TrkA, TrkB and TrkC phenotypes present in p75(NTR) knockouts, and resulted in increased embryonic lethality and sympathetic neuropathy in mice heterozygous for TrkA. Our findings demonstrate a role for sortilin as an anterograde trafficking receptor for Trk and a positive modulator of neurotrophin-induced neuronal survival.	[Vaegter, Christian B.; Jansen, Pernille; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Nykjaer, Anders] Aarhus Univ, Dept Med Biochem, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark; [Fjorback, Anja W.; Nyengaard, Jens R.] Aarhus Univ, Stereol & Electron Microscopy Lab, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark; [Erdmann, Bettina; Lewin, Gary R.; Willnow, Thomas E.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Tessarollo, Lino] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Chao, Moses V.] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr, New York, NY USA	Aarhus University; Lundbeckfonden; Aarhus University; Lundbeckfonden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University	Nykjaer, A (corresponding author), Aarhus Univ, Dept Med Biochem, Lundbeck Fdn, Res Ctr MIND, Aarhus, Denmark.	cv@biokemi.au.dk; an@biokemi.au.dk	Kjolby, Mads/ABB-4210-2020; Kjolby, Mads/F-3672-2011; Vægter, Christian Bjerggaard/A-7909-2008; Vægter, Christian Bjerggaard/AFW-0912-2022; Lewin, Gary R/B-8028-2011	Vægter, Christian Bjerggaard/0000-0001-6573-146X; Vægter, Christian Bjerggaard/0000-0001-6573-146X; Chao, Moses/0000-0002-6969-3744; Nykjaer, Anders/0000-0001-6422-6736; Kjolby, Mads/0000-0002-1043-6137; Willnow, Thomas/0000-0001-9515-7921; Lewin, Gary/0000-0002-2890-6352	Lundbeck Foundation; Danish Medical Research Council; Elvira and Rasmus Rissforts Foundation; MEMORIES (European Union); US National Institutes of Health [NS21072, AG025970, HD23315]; Deutsche Forschungsgemeinschaft; Danish Council for Strategic Research; Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010390] Funding Source: NIH RePORTER; Villum Fonden [00008721] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Elvira and Rasmus Rissforts Foundation; MEMORIES (European Union)(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Villum Fonden(Villum Fonden)	We thank L. Reichardt (University of California, San Francisco) for the TrkA antibody. The ImageJ KymoToolBox plug-in was kindly provided by F. Cordelieres (Universite Paris-Sud Orsay), and the NeuriteTracer plug-in by M. Pool (Rue University). This work was supported by the Lundbeck Foundation, The Danish Medical Research Council, Elvira and Rasmus Rissforts Foundation, MEMORIES (European Union, Framework Programme 6), US National Institutes of Health (NS21072, AG025970 and HD23315), the Deutsche Forschungsgemeinschaft, Danish Council for Strategic Research, and Center for Stochastic Geometry and Advanced Bioimaging (Villum Foundation).	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Arnett MG, 2007, BRAIN RES, V1183, P32, DOI 10.1016/j.brainres.2007.09.051; Ascano M, 2009, J NEUROSCI, V29, P11674, DOI 10.1523/JNEUROSCI.1542-09.2009; Bergmann I, 1997, EUR J NEUROSCI, V9, P18, DOI 10.1111/j.1460-9568.1997.tb01349.x; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jenkins PM, 2009, J NEUROSCI, V29, P10541, DOI 10.1523/JNEUROSCI.1590-09.2009; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Minichiello L, 1995, DEVELOPMENT, V121, P4067; MU XJ, 1993, J NEUROSCI, V13, P4029; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Perez-Pinera P, 2008, NEUROSCI LETT, V433, P43, DOI 10.1016/j.neulet.2007.12.035; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Russell FD, 2000, NEUROSCIENCE, V97, P575, DOI 10.1016/S0306-4522(00)00079-8; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Sokoloff AJ, 2007, MUSCLE NERVE, V36, P183, DOI 10.1002/mus.20797; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thang SH, 2000, J NEUROSCI, V20, P2917; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	50	129	136	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					54	U78		10.1038/nn.2689	http://dx.doi.org/10.1038/nn.2689			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21102451	Green Accepted			2022-12-24	WOS:000285684900014
J	Dahdal, D; Reeves, DC; Ruben, M; Akabas, MH; Blau, J				Dahdal, David; Reeves, David C.; Ruben, Marc; Akabas, Myles H.; Blau, Justin			Drosophila Pacemaker Neurons Require G Protein Signaling and GABAergic Inputs to Generate Twenty-Four Hour Behavioral Rhythms	NEURON			English	Article							PIGMENT-DISPERSING FACTOR; CIRCADIAN CLOCK; INTRACELLULAR CA2+; GABA(B) RECEPTORS; PDF NEURONS; EXPRESSION; PERIOD; SLEEP; MELANOGASTER; CELLS	Intercellular signaling is important for accurate circadian rhythms. In Drosophila, the small ventral lateral neurons (s-LN(v)s) are the dominant pacemaker neurons and set the pace of most other clock neurons in constant darkness. Here we show that two distinct G protein signaling pathways are required in LN(v)s for 24 hr rhythms. Reducing signaling in LN(v)s via the G alpha subunit Gs, which signals via cAMP, or via the G alpha subunit Go, which we show signals via Phospholipase 21c, lengthens the period of behavioral rhythms. In contrast, constitutive Gs or Go signaling makes most flies arrhythmic. Using dissociated LN(v)s in culture, we found that Go and the metabotropic GABA(B)-R3 receptor are required for the inhibitory effects of GABA on LN(v)s and that reduced GABAB-R3 expression in vivo lengthens period. Although no clock neurons produce GABA, hyperexciting GABAergic neurons disrupts behavioral rhythms and s-LNv molecular clocks. Therefore, s-LN(v)s require GABAergic inputs for 24 hr rhythms.	[Dahdal, David; Ruben, Marc; Blau, Justin] NYU, Dept Biol, New York, NY 10003 USA; [Reeves, David C.; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Reeves, David C.; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	New York University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Blau, J (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	justin.blau@nyu.edu	Ruben, Marc/GQI-4245-2022	Akabas, Myles/0000-0001-8781-7846	National Center for Research Resources, National Institutes of Health (NIH) [C06 RR-15518-01]; NIH [NS030808, GM063911]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Harold Atwood, Mike Forte, Leslie Griffith, Paul Hardin, Dierk Reiff, Gregg Roman, Julie Simpson, Andrew Tomlinson, Bloomington Stock Center, DSHB, and VDRC for flies and antibodies. We thank Chris Wegener for sharing unpublished data and Gregg Roman and Mike Nitabach for their advice and suggestions. We thank Karim Baroudy, Taniya Kaur, and Alyson Knowles for help in the initial stages of this project and Ben Collins for help with dissections. We also thank Matthieu Cavey, Ben Collins, Alex Keene, Dogukan Mizrak, Afroditi Petsakou, and Daniel Vasiliauskas for comments on the manuscript. Confocal images were obtained in the NYU Center for Genomics & Systems Biology. The investigation was largely conducted in a facility constructed with support from Research Facilities Improvement Grant Number C06 RR-15518-01 from National Center for Research Resources, National Institutes of Health (NIH). The work was supported by NIH grants NS030808 (M.A.) and GM063911 (J.B.).	Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; ALBERT JL, 1993, J PHYSIOL-LONDON, V463, P605, DOI 10.1113/jphysiol.1993.sp019613; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Blanchard FJ, 2010, J NEUROSCI, V30, P5855, DOI 10.1523/JNEUROSCI.2688-09.2010; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Cheung US, 1999, J NEUROBIOL, V40, P1, DOI 10.1002/(SICI)1097-4695(199907)40:1<1::AID-NEU1>3.0.CO;2-1; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Day JP, 2005, BIOCHEM J, V388, P333, DOI 10.1042/BJ20050057; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Fei H, 2010, J EXP BIOL, V213, P1717, DOI 10.1242/jeb.036053; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Hamasaka Y, 2007, J COMP NEUROL, V505, P32, DOI 10.1002/cne.21471; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kaneko M, 1997, J NEUROSCI, V17, P6745; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; Kilman VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005235; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; LAKINTHOMAS PL, 1985, GENETICS, V109, P49; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; McCormack TJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r58; Mehren JE, 2006, LEARN MEMORY, V13, P686, DOI 10.1101/lm.317806; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; POLLACK I, 1991, CELL TISSUE RES, V266, P391, DOI 10.1007/BF00318195; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Schneider NL, 2005, J NEUROSCI, V25, P5138, DOI 10.1523/JNEUROSCI.5138-A-04.2005; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; SHORTRIDGE RD, 1991, J BIOL CHEM, V266, P12474; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Wegener C, 2004, J NEUROPHYSIOL, V91, P912, DOI 10.1152/jn.00678.2003; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wolfgang WJ, 1996, P NATL ACAD SCI USA, V93, P14542, DOI 10.1073/pnas.93.25.14542; Yasuyama K, 1999, J COMP NEUROL, V412, P193, DOI 10.1002/(SICI)1096-9861(19990920)412:2<193::AID-CNE1>3.0.CO;2-0; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027	69	34	34	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 9	2010	68	5					964	977		10.1016/j.neuron.2010.11.017	http://dx.doi.org/10.1016/j.neuron.2010.11.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LM	21145008	Bronze, Green Accepted			2022-12-24	WOS:000285664900016
J	Vodyanik, MA; Yu, JY; Zhang, X; Tian, SL; Stewart, R; Thomson, JA; Slukvin, II				Vodyanik, Maxim A.; Yu, Junying; Zhang, Xin; Tian, Shulan; Stewart, Ron; Thomson, James A.; Slukvin, Igor I.			A Mesoderm-Derived Precursor for Mesenchymal Stem and Endothelial Cells	CELL STEM CELL			English	Article							STROMAL CELLS; NEURAL CREST; IN-VITRO; HEMATOPOIETIC PROGENITORS; AORTIC ENDOTHELIUM; COMMON PRECURSOR; RECEPTOR APJ; DORSAL AORTA; DIFFERENTIATION; LINEAGE	Among the three embryonic germ layers, the mesoderm is a major source of the mesenchymal precursors giving rise to skeletal and connective tissues, but these precursors have not previously been identified and characterized. Using human embryonic stem cells directed toward mesendodermal differentiation, we show that mesenchymal stem/stromal cells (MSCs) originate from a population of mesodermal cells identified by expression of apelin receptor. In semisolid medium, these precursors form FGF2-dependent compact spheroid colonies containing mesenchymal cells with a transcriptional profile representative of mesoderm-derived embryonic mesenchyme. When transferred to adherent cultures, individual colonies give rise to MSC lines with chondro-, osteo-, and adipogenic differentiation potentials. Although the MSC lines lacked endothelial potential, endothelial cells could be derived from the mesenchymal colonies, suggesting that, similar to hematopoietic cells, MSCs arise from precursors with angiogenic potential. Together, these studies identified a common precursor of mesenchymal and endothelial cells, mesenchy-moangioblast, as the source of mesoderm-derived MSCs.	[Vodyanik, Maxim A.; Yu, Junying; Thomson, James A.; Slukvin, Igor I.] Univ Wisconsin, Grad Sch, Natl Primate Res Ctr, Madison, WI 53715 USA; [Zhang, Xin] WiCell Res Inst, Madison, WI 53726 USA; [Tian, Shulan; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53706 USA; [Slukvin, Igor I.] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Slukvin, II (corresponding author), Univ Wisconsin, Grad Sch, Natl Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.	islukvin@wisc.edu			National Institutes of Health [R01 HL081962, P01 GM081629, P51 RR000167]; Charlotte Geyer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Geyer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Toru Nakano for providing OP9 cells, Dietmar Vestweber for providing endomucin antibodies, Gordon Keller for providing HES2.R26tdRFP hESC line, Mitchell Probasco for cell sorting, Clay Glennon for time-lapse photography, and Joan Larson and Krista Eastman for editorial assistance. This work was supported by funds from the National Institutes of Health (R01 HL081962, P01 GM081629, and P51 RR000167) and the Charlotte Geyer Foundation. J.A.T. owns stock, serves on the Board of Directors, and serves as Chief Scientific Officer of Cellular Dynamics International. J.A.T. also serves as Scientific Director of the WiCell Research Institute. I.I.S. owns stock and is the scientific founder of Cellular Dynamics International.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Blazsek I, 2000, BLOOD, V96, P3763, DOI 10.1182/blood.V96.12.3763.h8003763_3763_3771; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; Choi K, 1998, DEVELOPMENT, V125, P725; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; D'Aniello C, 2009, CIRC RES, V105, P231, DOI 10.1161/CIRCRESAHA.109.201186; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; Delorme B, 2006, REGEN MED, V1, P497, DOI 10.2217/17460751.1.4.497; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Devic E, 1996, MECH DEVELOP, V59, P129, DOI 10.1016/0925-4773(96)00585-0; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Inui M, 2006, DEV BIOL, V298, P188, DOI 10.1016/j.ydbio.2006.06.028; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Karlsson C, 2009, STEM CELL RES; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; NODEN DM, 1990, ANN NY ACAD SCI, V588, P236, DOI 10.1111/j.1749-6632.1990.tb13214.x; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trentin A, 2004, P NATL ACAD SCI USA, V101, P4495, DOI 10.1073/pnas.0400629101; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; VODYANIK MA, 2007, CURR PROTOC CELL BIO, V27, P559; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	63	213	231	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					718	729		10.1016/j.stem.2010.11.011	http://dx.doi.org/10.1016/j.stem.2010.11.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112566	Bronze, Green Accepted			2022-12-24	WOS:000285537700013
J	Krajbich, I; Armel, C; Rangel, A				Krajbich, Ian; Armel, Carrie; Rangel, Antonio			Visual fixations and the computation and comparison of value in simple choice	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL DECISION-MAKING; 2-CHOICE REACTION-TIME; ORBITOFRONTAL CORTEX; SENSORY STIMULI; FIELD-THEORY; NEURAL BASIS; AREA LIP; MODELS; BEHAVIOR; MICROSTIMULATION	Most organisms facing a choice between multiple stimuli will look repeatedly at them, presumably implementing a comparison process between the items' values. Little is known about the nature of the comparison process in value-based decision-making or about the role of visual fixations in this process. We created a computational model of value-based binary choice in which fixations guide the comparison process and tested it on humans using eye-tracking. We found that the model can quantitatively explain complex relationships between fixation patterns and choices, as well as several fixation-driven decision biases.	[Krajbich, Ian; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Armel, Carrie] Stanford Univ, Precourt Inst Energy Efficiency, Palo Alto, CA 94304 USA	California Institute of Technology; Stanford University	Rangel, A (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	rangel@hss.caltech.edu			Moore Foundation	Moore Foundation(Gordon and Betty Moore Foundation)	We thank E. Johnson, P. Bossaerts and C. Koch for comments and J. Pulst-Korenberg for help with data collection. This work received financial support from the Moore Foundation.	Arana FS, 2003, J NEUROSCI, V23, P9632; Armel KC, 2008, JUDGM DECIS MAK, V3, P396; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Busemeyer J. R., 2004, BLACKWELL HDB JUDGME, P133, DOI DOI 10.1002/9780470752937.CH7; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LAMING D, 1979, ACTA PSYCHOL, V43, P431, DOI 10.1016/0001-6918(79)90001-5; Link SW, 1992, WAVE THEORY DIFFEREN; Luce RD, 1986, RESPONSE TIMES THEIR; Mas-Colell A., 1995, MICROECONOMIC THEORY; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Roe RM, 2001, PSYCHOL REV, V108, P370, DOI 10.1037//0033-295X.108.2.370; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Smith PL, 2000, J MATH PSYCHOL, V44, P408, DOI 10.1006/jmps.1999.1260; SMITH PL, 1995, PSYCHOL REV, V102, P567, DOI 10.1037/0033-295X.102.3.567; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; STONE M, 1960, PSYCHOMETRIKA, V25, P251, DOI 10.1007/BF02289729; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334	46	722	733	10	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1292	1298		10.1038/nn.2635	http://dx.doi.org/10.1038/nn.2635			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	654MB	20835253				2022-12-24	WOS:000282171300023
J	Kounnas, MZ; Danks, AM; Cheng, SA; Tyree, C; Ackerman, E; Zhang, XL; Ahn, K; Nguyen, P; Comer, D; Mao, L; Yu, CZ; Pleynet, D; Digregorio, PJ; Velicelebi, G; Stauderman, KA; Comer, WT; Mobley, WC; Li, YM; Sisodia, SS; Tanzi, RE; Wagner, SL				Kounnas, Maria Z.; Danks, Anne M.; Cheng, Soan; Tyree, Curtis; Ackerman, Elizabeth; Zhang, Xulun; Ahn, Kwangwook; Nguyen, Phuong; Comer, Dan; Mao, Long; Yu, Chengzhi; Pleynet, David; Digregorio, Paul J.; Velicelebi, Gonul; Stauderman, Kenneth A.; Comer, William T.; Mobley, William C.; Li, Yue-Ming; Sisodia, Sangram S.; Tanzi, Rudolph E.; Wagner, Steven L.			Modulation of gamma-Secretase Reduces beta-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease	NEURON			English	Article							IN-VIVO; INTRACELLULAR DOMAIN; A-BETA; NOTCH; INHIBITORS; COMPLEX; BRAIN; DIFFERENTIATION; PRESENILIN-1; PATHOLOGY	Alzheimer's disease (AD) is characterized pathologically by the abundance of senile plaques and neurofibrillary tangles in the brain. We synthesized over 1200 novel gamma-secretase modulator (GSM) compounds that reduced A beta(42) levels without inhibiting epsilon-site cleavage of APP and Notch, the generation of the APP and Notch intracellular domains, respectively. These compounds also reduced A beta(40) levels while concomitantly elevating levels of A beta(38) and A beta(37). Immobilization of a potent GSM onto an agarose matrix quantitatively recovered Pen-2 and to a lesser degree PS-1 NTFs from cellular extracts. Moreover, oral administration (once daily) of another potent GSM to Tg 2576 transgenic AD mice displayed dose-responsive lowering of plasma and brain A beta(42); chronic daily administration led to significant reductions in both diffuse and neuritic plaques. These effects were observed in the absence of Notch-related changes (e.g., intestinal proliferation of goblet cells), which are commonly associated with repeated exposure to functional gamma-secretase inhibitors (GSIs).	[Zhang, Xulun; Sisodia, Sangram S.] Univ Chicago, Ctr Mol Neurobiol, Chicago, IL 60637 USA; [Ahn, Kwangwook; Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Kounnas, Maria Z.; Danks, Anne M.; Cheng, Soan; Tyree, Curtis; Ackerman, Elizabeth; Nguyen, Phuong; Comer, Dan; Mao, Long; Yu, Chengzhi; Pleynet, David; Digregorio, Paul J.; Velicelebi, Gonul; Stauderman, Kenneth A.; Comer, William T.; Wagner, Steven L.] TorreyPines Therapeut Inc, La Jolla, CA 92037 USA; [Mobley, William C.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	University of Chicago; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego	Wagner, SL (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA.	slwagner@ucsd.edu	LI, Yue/GRS-8071-2022; Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Comer, Daniel/0000-0003-4311-9602	Eisai, Co. Ltd.; NIH [RO1 AG026660]; John Adler Foundation; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	Eisai, Co. Ltd.(Eisai Co Ltd); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Adler Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors wish to thank Nicolas Patch for technical support, Pat Baskin for critical review of the manuscript, and Eisai, Co. Ltd. and the NIH grant RO1 AG026660 (to Y.-M.L.) and the John Adler Foundation (to S.S.S.) for financial support. M.Z.K. and W.T.C. are employees of Neurogenetic Pharmaceuticals, Inc. (NGP), and W.T.C., R.E.T., and S.L.W. are shareholders and cofounders of NGP.	Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; CAMPBELL SK, 1987, SOC NEUR ABSTR, V13; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cirrito JR, 2003, J NEUROSCI, V23, P8844; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyde LA, 2006, J PHARMACOL EXP THER, V319, P1133, DOI 10.1124/jpet.106.111716; Imbimbo BP, 2007, J PHARMACOL EXP THER, V323, P822, DOI 10.1124/jpet.107.129007; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Kreft AF, 2009, J MED CHEM, V52, P6169, DOI 10.1021/jm900188z; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Lewis HD, 2003, BIOCHEMISTRY-US, V42, P7580, DOI 10.1021/bi034310g; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Pissarnitski D, 2007, CURR OPIN DRUG DISC, V10, P392; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Starrett J.E., 2009, U.S. Patent Application, Patent No. [2009/0111858 Al, 20090111858]; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wagner SL, 1999, J CLIN INVEST, V104, P1329, DOI 10.1172/JCI8729; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	40	198	214	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					769	780		10.1016/j.neuron.2010.08.018	http://dx.doi.org/10.1016/j.neuron.2010.08.018			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826309	Green Accepted, Bronze			2022-12-24	WOS:000281938900012
J	Simsek, T; Kocabas, F; Zheng, JK; DeBerardinis, RJ; Mahmoud, AI; Olson, EN; Schneider, JW; Zhang, CC; Sadek, HA				Simsek, Tugba; Kocabas, Fatih; Zheng, Junke; DeBerardinis, Ralph J.; Mahmoud, Ahmed I.; Olson, Eric N.; Schneider, Jay W.; Zhang, Cheng Cheng; Sadek, Hesham A.			The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche	CELL STEM CELL			English	Article							MODELING PO(2) DISTRIBUTIONS; ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; PROGENITOR CELLS; OXYGEN-TENSION; HIF-ALPHA; KAPPA-B; EXPRESSION; GENES; MEIS1	Bone marrow transplantation is the primary therapy for numerous hematopoietic disorders. The efficiency of bone marrow transplantation depends on the function of long-term hematopoietic stem cells (LT-HSCs), which is markedly influenced by their hypoxic niche. Survival in this low-oxygen microenvironment requires significant metabolic adaptation. Here, we show that LT-HSCs utilize glycolysis instead of mitochondrial oxidative phosphorylation to meet their energy demands. We used flow cytometry to identify a unique low mitochondrial activity/glycolysis-dependent subpopulation that houses the majority of hematopoietic progenitors and LT-HSCs. Finally, we demonstrate that Meis1 and Hif-1 alpha are markedly enriched in LT-HSCs and that Meis1 regulates HSC metabolism through transcriptional activation of Hif-1 alpha. These findings reveal an important transcriptional network that regulates HSC metabolism.	[Zheng, Junke; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zheng, Junke; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Simsek, Tugba; Kocabas, Fatih; Mahmoud, Ahmed I.; Schneider, Jay W.; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Genet, Dallas, TX 75390 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, CC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	alec.zhang@utsouthwestern.edu; hesham.sadek@utsouthwestestern.edu	Kocabas, Fatih/B-2975-2012; Kocabas, Fatih/AAM-6391-2021; Zhang, Cheng/GRS-8698-2022	Kocabas, Fatih/0000-0001-8096-6056; Kocabas, Fatih/0000-0001-8096-6056; Mahmoud, Ahmed/0000-0003-1528-7393; Kocabas, Fatih/0000-0002-2854-9180	American Heart Association; Donald W. Reynolds Center for Clinical Cardiovascular Research; Welch Foundation [I-1701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115275] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Donald W. Reynolds Center for Clinical Cardiovascular Research; Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Joseph Garcia for his valuable input and Sean Goetsch for technical assistance. Work in the laboratory of H.A.S. was supported by grants from the American Heart Association and the Donald W. Reynolds Center for Clinical Cardiovascular Research. Support for C.C.Z. was provided by the Welch Foundation (I-1701).	Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; BRADLEY TR, 1978, J CELL PHYSIOL, V97, P517, DOI 10.1002/jcp.1040970327; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; CHANCE B, 1959, J BIOL CHEM, V234, P3044; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hagg M, 2005, EXP CELL RES, V306, P180, DOI 10.1016/j.yexcr.2005.01.017; Hirota K, 2004, J BIOL CHEM, V279, P41521, DOI 10.1074/jbc.M405164200; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, CANCER RES, V57, P5328; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; KATAHIRA J, 1987, INT J CELL CLONING, V5, P412, DOI 10.1002/stem.5530050506; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kim CG, 2006, MOL CELLS, V21, P343; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KOLLER MR, 1992, EXP HEMATOL, V20, P264; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; LaIuppa JA, 1998, EXP HEMATOL, V26, P835; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MURRAY L, 1995, BLOOD, V85, P368; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; PEAULT B, 1993, LEUKEMIA, V7, pS98; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	60	718	742	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					380	390		10.1016/j.stem.2010.07.011	http://dx.doi.org/10.1016/j.stem.2010.07.011			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804973	Bronze, Green Accepted			2022-12-24	WOS:000282037800014
J	Manookin, MB; Weick, M; Stafford, BK; Demb, JB				Manookin, Michael B.; Weick, Michael; Stafford, Benjamin K.; Demb, Jonathan B.			NMDA Receptor Contributions to Visual Contrast Coding	NEURON			English	Article							RETINAL GANGLION-CELLS; AMINO-ACID RECEPTORS; IONOTROPIC GLUTAMATE RECEPTORS; EXCITATORY SYNAPTIC CURRENTS; D-ASPARTATE RECEPTORS; MOUSE BARREL CORTEX; CONE BIPOLAR CELLS; RABBIT RETINA; RAT RETINA; FUNCTIONAL-ORGANIZATION	In the retina, it is not well understood how visual processing depends on AMPA- and NMDA-type glutamate receptors. Here we investigated how these receptors contribute to contrast coding in identified guinea pig ganglion cell types in vitro. NMDA-mediated responses were negligible in ON alpha cells but substantial in OFF alpha and delta cells. OFF delta cell NMDA receptors were composed of GluN2B subunits. Using a novel deconvolution method, we determined the individual contributions of AMPA, NMDA, and inhibitory currents to light responses of each cell type. OFF alpha and delta cells used NMDA receptors for encoding either the full contrast range (alpha), including near-threshold responses, or only a high range (delta). However, contrast sensitivity depended substantially on NMDA receptors only in OFF alpha cells. NMDA receptors contribute to visual contrast coding in a cell-type-specific manner. Certain cell types generate excitatory responses using primarily AMPA receptors or disinhibition.	[Manookin, Michael B.; Demb, Jonathan B.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48105 USA; [Manookin, Michael B.; Weick, Michael; Stafford, Benjamin K.; Demb, Jonathan B.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Demb, Jonathan B.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Demb, JB (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48105 USA.	jdemb@umich.edu		Manookin, Michael/0000-0001-8116-7619; Demb, Jonathan/0000-0003-2227-9041	Research to Prevent Blindness; Alfred P. Sloan Foundation; NIH [EY14454, T32EY13934, EY07003]; Rackham Predoctoral Fellowship; NATIONAL EYE INSTITUTE [P30EY007003, R01EY014454, T32EY013934, F31EY007003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham Predoctoral Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Daniel Green for comments on the manuscript and Mania Kupershtok for technical assistance. This work was supported by a Research to Prevent Blindness Career Development Award, an Alfred P. Sloan Foundation Fellowship, the NIH (EY14454; T32EY13934; Core Grant EY07003), and a Rackham Predoctoral Fellowship.	AIZENMAN E, 1988, J PHYSIOL-LONDON, V396, P75, DOI 10.1113/jphysiol.1988.sp016951; Beaudoin DL, 2008, J PHYSIOL-LONDON, V586, P5487, DOI 10.1113/jphysiol.2008.156224; Berntson A, 2000, J PHYSIOL-LONDON, V524, P879, DOI 10.1111/j.1469-7793.2000.00879.x; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Binshtok AM, 2006, J NEUROSCI, V26, P708, DOI 10.1523/JNEUROSCI.4409-05.2006; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; BOOS R, 1990, J NEUROPHYSIOL, V64, P1368, DOI 10.1152/jn.1990.64.5.1368; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; COHEN ED, 1994, J NEUROPHYSIOL, V72, P1260, DOI 10.1152/jn.1994.72.3.1260; COHEN ED, 1994, VISUAL NEUROSCI, V11, P317, DOI 10.1017/S0952523800001668; Cohen ED, 2000, J NEUROPHYSIOL, V83, P3217, DOI 10.1152/jn.2000.83.6.3217; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Demb JB, 2004, J NEUROPHYSIOL, V92, P2510, DOI 10.1152/jn.00108.2004; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DeVries SH, 2006, NEURON, V50, P735, DOI 10.1016/j.neuron.2006.04.034; Dhingra NK, 2003, J NEUROPHYSIOL, V89, P2360, DOI 10.1152/jn.01042.2002; DIAMOND JS, 1993, NEURON, V11, P725, DOI 10.1016/0896-6273(93)90082-3; DIAMOND JS, 1995, J PHYSIOL-LONDON, V487, P711, DOI 10.1113/jphysiol.1995.sp020912; Dingledine R, 1999, PHARMACOL REV, V51, P7; Du JL, 2009, P NATL ACAD SCI USA, V106, P18890, DOI 10.1073/pnas.0910659106; Dumitrescu ON, 2006, VISUAL NEUROSCI, V23, P79, DOI 10.1017/S0952523806231079; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Espinosa F, 2009, J NEUROPHYSIOL, V101, P2290, DOI 10.1152/jn.90754.2008; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Fletcher EL, 2000, J COMP NEUROL, V420, P98; FOX K, 1990, J NEUROPHYSIOL, V64, P1413, DOI 10.1152/jn.1990.64.5.1413; Gerstner W., 2002, SPIKING NEURON MODEL; Gottesman J, 2003, VISUAL NEUROSCI, V20, P329, DOI 10.1017/S0952523803203114; Grunert U, 2002, J COMP NEUROL, V447, P138, DOI 10.1002/cne.10220; Gustafson EC, 2007, J NEUROPHYSIOL, V98, P122, DOI 10.1152/jn.00057.2006; Hartveit E, 1997, J NEUROPHYSIOL, V77, P1716, DOI 10.1152/jn.1997.77.4.1716; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Jacoby RA, 2001, VISUAL NEUROSCI, V18, P703, DOI 10.1017/S0952523801185044; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Kalbaugh TL, 2009, J NEUROSCI, V29, P1469, DOI 10.1523/JNEUROSCI.4240-08.2009; KARSCHIN A, 1988, J NEUROSCI, V8, P2895; Lukasiewicz PD, 1997, J NEUROPHYSIOL, V77, P57, DOI 10.1152/jn.1997.77.1.57; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; MASSEY SC, 1990, J NEUROPHYSIOL, V63, P16, DOI 10.1152/jn.1990.63.1.16; MASSEY SC, 1988, J PHYSIOL-LONDON, V405, P635, DOI 10.1113/jphysiol.1988.sp017353; Matsui K, 1998, J NEUROSCI, V18, P4500; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Miller RF, 2008, INVEST OPHTH VIS SCI, V49, P5184, DOI 10.1167/iovs.08-2456; MITTMAN S, 1990, J PHYSIOL-LONDON, V428, P175, DOI 10.1113/jphysiol.1990.sp018206; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Pang JJ, 2008, J PHYSIOL-LONDON, V586, P2889, DOI 10.1113/jphysiol.2008.151050; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2007, J PHYSIOL-LONDON, V580, P23, DOI 10.1113/jphysiol.2006.125302; Sivyer B, 2010, P NATL ACAD SCI USA, V107, P5628, DOI 10.1073/pnas.0909621107; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; Taylor WR, 2002, J NEUROSCI, V22, P7712; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; van Wyk M, 2006, J NEUROSCI, V26, P13250, DOI 10.1523/JNEUROSCI.1991-06.2006; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xu Y, 2008, J COMP NEUROL, V507, P1871, DOI 10.1002/cne.21644; Yin L, 2006, J NEUROSCI, V26, P12351, DOI 10.1523/JNEUROSCI.1071-06.2006; Zaghloul KA, 2003, J NEUROSCI, V23, P2645; Zhang AJ, 2009, J NEUROSCI, V29, P789, DOI 10.1523/JNEUROSCI.4984-08.2009; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009	78	44	44	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 29	2010	67	2					280	293		10.1016/j.neuron.2010.06.020	http://dx.doi.org/10.1016/j.neuron.2010.06.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632WZ	20670835	Green Accepted, Bronze			2022-12-24	WOS:000280461500012
J	Bromberg-Martin, ES; Matsumoto, M; Hikosaka, O				Bromberg-Martin, Ethan S.; Matsumoto, Masayuki; Hikosaka, Okihide			Distinct Tonic and Phasic Anticipatory Activity in Lateral Habenula and Dopamine Neurons	NEURON			English	Article							MIDBRAIN DOPAMINE; REWARD PREDICTION; MONKEY MIDBRAIN; RESPONSES; NUCLEUS; SIGNAL; REPRESENTATION; CONTINGENCIES; STIMULATION; UNCERTAINTY	Dopamine has a crucial role in anticipation of motivational events. To investigate the underlying mechanisms of this process, we analyzed the activity of dopamine neurons and one of their major sources of input, neurons in the lateral habenula, while animals anticipated upcoming behavioral tasks. We found that lateral habenula and dopamine neurons anticipated tasks in two distinct manners. First, neurons encoded the timing distribution of upcoming tasks through gradual changes in their tonic activity. This tonic signal encoded rewarding tasks in preference to punishing tasks and was correlated with classic phasic coding of motivational value. Second, neurons transmitted a phasic signal marking the time when a task began. This phasic signal encoded rewarding and punishing tasks in similar manners, as though reflecting motivational salience. Our data suggest that the habenula-dopamine pathway motivates anticipation through a combination of tonic reward-related and phasic salience-related signals.	[Bromberg-Martin, Ethan S.; Matsumoto, Masayuki; Hikosaka, Okihide] NIH, Sensorimotor Res Lab, Natl Eye Inst, Bethesda, MD 20892 USA; [Matsumoto, Masayuki] Kyoto Univ, Primate Res Inst, Aichi 4848506, Japan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Kyoto University	Bromberg-Martin, ES (corresponding author), NIH, Sensorimotor Res Lab, Natl Eye Inst, Bldg 10, Bethesda, MD 20892 USA.	bromberge@mail.nih.gov			National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank H. Nakahara, S. Kaveri, T. Yang, L. Paninski, S. Hong, M. Yasuda, S. Yamamoto, Y. Tachibana, and H. Kim for valuable discussions. This work was supported by the intramural research program at the National Eye Institute.	Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Balci F, 2009, P NATL ACAD SCI USA, V106, P2459, DOI 10.1073/pnas.0812709106; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Han JS, 1997, J NEUROSCI, V17, P3913; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; MACDOUGA.JM, 1969, J COMP PHYSIOL PSYCH, V68, P568, DOI 10.1037/h0027638; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; MILLER SM, 1987, J PERS SOC PSYCHOL, V52, P345, DOI 10.1037/0022-3514.52.2.345; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; THORNTON EW, 1984, BEHAV BRAIN RES, V12, P327, DOI 10.1016/0166-4328(84)90158-X; THORNTON EW, 1990, BEHAV NEURAL BIOL, V53, P291, DOI 10.1016/0163-1047(90)90560-S; Van Damme S, 2006, BEHAV RES THER, V44, P1555, DOI 10.1016/j.brat.2005.11.008; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	52	99	100	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 15	2010	67	1					144	155		10.1016/j.neuron.2010.06.016	http://dx.doi.org/10.1016/j.neuron.2010.06.016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	629SW	20624598	Bronze, Green Accepted			2022-12-24	WOS:000280221000015
J	Samavarchi-Tehrani, P; Golipour, A; David, L; Sung, HK; Beyer, TA; Datti, A; Woltjen, K; Nagy, A; Wrana, JL				Samavarchi-Tehrani, Payman; Golipour, Azadeh; David, Laurent; Sung, Hoon-Ki; Beyer, Tobias A.; Datti, Alessandro; Woltjen, Knut; Nagy, Andras; Wrana, Jeffrey L.			Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; MIR-200 FAMILY; NANOG; FIBROBLASTS; EXPRESSION; DIFFERENTIATION; GENERATION; SALL4; INDUCTION; SYSTEM	Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) by expression of defined embryonic factors. However, little is known of the molecular mechanisms underlying the reprogramming process. Here we explore somatic cell reprogramming by exploiting a secondary mouse embryonic fibroblast model that forms iPSCs with high efficiency upon inducible expression of Oct4, Klf4, c-Myc, and Sox2. Temporal analysis of gene expression revealed that reprogramming is a multistep process that is characterized by initiation, maturation, and stabilization phases. Functional analysis by systematic RNAi screening further uncovered a key role for BMP signaling and the induction of mesenchymal-to-epithelial transition (MET) during the initiation phase. We show that this is linked to BMP-dependent induction of miR-205 and the miR-200 family of microRNAs that are key regulators of MET. These studies thus define a multistep mechanism that incorporates a BMP-miRNA-MET axis during somatic cell reprogramming.	[Samavarchi-Tehrani, Payman; Golipour, Azadeh; David, Laurent; Beyer, Tobias A.; Datti, Alessandro; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Sung, Hoon-Ki; Woltjen, Knut; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Stem Cells & Tissue Engn, Toronto, ON M5G 1X5, Canada; [Samavarchi-Tehrani, Payman; Golipour, Azadeh; Nagy, Andras; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Woltjen, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	woltjen@cira.kyoto-u.ac.jp; nagy@lunenfeld.ca; wrana@lunenfeld.ca	Sung, Hoon-Ki/A-1922-2016; Wrana, Jeffrey/F-8857-2013; Datti, Alessandro/ABA-1108-2021; Nagy, Andras/G-6465-2013; Sung, Hoon-Ki/G-3049-2013	Sung, Hoon-Ki/0000-0001-6677-9385; Datti, Alessandro/0000-0001-6824-7382; Nagy, Andras/0000-0003-4311-0413; Woltjen, Knut/0000-0003-2293-1183; David, Laurent/0000-0003-3594-0353	CIHR [MOP12860, MOP-210751]; Canadian Stem Cell Network; Ontario Ministry of Resource and Innovation; Swish National Science Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Stem Cell Network; Ontario Ministry of Resource and Innovation; Swish National Science Foundation	The authors thank T. Sun and F. Vizeacoumar for assistance with robotics, J. Audet for the FACS machine, M. Gertsenstein and M. Pereira for the chimera production, M. Narimatsu for helping with chimera processing, M. Mileikovkaia for advice, J. Ellis for discussions, and L. Attisano for critical review of the manuscript. This work was supported by funds from CIHR (to J.L.W. grant #MOP12860 and A.N. grant #MOP-210751), the Canadian Stem Cell Network (J.L.W. and A.N.), and the Ontario Ministry of Resource and Innovation (J.L.W.). L.D. and P.S.-T. are CIHR Fellowship recipients and T.A.B. is a Swish National Science Foundation Fellowship recipient. A.N. is a CRC Chair in Stem Cell and Regeneration. J.L.W. is an HHMI International Scholar and CRC Chair in Systems Biology.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Furusawa T, 2006, BIOL REPROD, V75, P555, DOI 10.1095/biolreprod.105.049502; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; GURDON J. B., 1964, ADVANCE MORPHO GENESIS, V4, P1; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004	38	757	790	3	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					64	77		10.1016/j.stem.2010.04.015	http://dx.doi.org/10.1016/j.stem.2010.04.015			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621051	Bronze			2022-12-24	WOS:000280222300014
J	Chen, FJ; Liu, Y; Sugiura, Y; Allen, PD; Gregg, RG; Lin, WC				Chen, Fujun; Liu, Yun; Sugiura, Yoshie; Allen, Paul D.; Gregg, Ronald G.; Lin, Weichun			Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors	NATURE NEUROSCIENCE			English	Article							MUTATION MUSCULAR DYSGENESIS; RYANODINE-RECEPTOR; GENE-EXPRESSION; BETA-SUBUNIT; CA2+ CURRENT; DEVELOPMENTAL GENETICS; NEURONAL-ACTIVITY; CHARGE MOVEMENTS; ACH SENSITIVITY; CELL-CULTURE	Developing skeletal myofibers in vertebrates are intrinsically 'pre-patterned' for motor nerve innervation. However, the intrinsic factors that regulate muscle pre-patterning remain unknown. We found that a functional skeletal muscle dihydropyridine receptor (DHPR, the L-type Ca(2+) channel in muscle) was required for muscle pre-patterning during the development of the neuromuscular junction (NMJ). Targeted deletion of the beta 1 subunit of DHPR (Cacnb1) in mice led to muscle pre-patterning defects, aberrant innervation and precocious maturation of the NMJ. Reintroducing Cacnb1 into Cacnb1(-/-) muscles reversed the pre-patterning defects and restored normal development of the NMJ. The mechanism by which DHPRs govern muscle pre-patterning is independent of their role in excitation-contraction coupling, but requires Ca(2+) influx through the L-type Ca(2+) channel. Our findings indicate that the skeletal muscle DHPR retrogradely regulates the patterning and formation of the NMJ.	[Chen, Fujun; Liu, Yun; Sugiura, Yoshie; Lin, Weichun] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA; [Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; University of Louisville	Lin, WC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	weichun.lin@utsouthwestern.edu	Tuluc, Petronel/C-2527-2011	Liu, Yun/0000-0003-2063-7132; Gregg, Ronald/0000-0001-5805-224X	US National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS 055028]; Edward Mallinckrodt, Jr. Scholar Program; Cain Foundation in Medical Research at University of Texas Southwestern Medical Center; US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [P01AR044750]; NATIONAL EYE INSTITUTE [R01EY012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR044750, P01AR052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055028] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Edward Mallinckrodt, Jr. Scholar Program; Cain Foundation in Medical Research at University of Texas Southwestern Medical Center; US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Takahashi, E. Olson, B. Szaro, J. Johnson, C. Green, K. Walton, J. Terman, J. McArdle and R. Bassel-Duby for critical reading and commenting on the manuscript, S. Cannon, D. Francis, E. Kavalali and I. Bezprozvanny for valuable suggestions on muscle physiology and S. Burden for AChR alpha and MuSK in situ probes. This study was supported by grants (to W. L.) from the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NS 055028), the Edward Mallinckrodt, Jr. Scholar Program, and the Cain Foundation in Medical Research at University of Texas Southwestern Medical Center, and by a grant (to P. D. A.) from the US National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (P01AR044750).	Ahern CA, 2003, BIOPHYS J, V84, P942, DOI 10.1016/S0006-3495(03)74911-X; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barone V, 1998, FEBS LETT, V422, P160, DOI 10.1016/S0014-5793(98)00003-9; Bertocchini F, 1997, EMBO J, V16, P6956, DOI 10.1093/emboj/16.23.6956; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; COHEN SA, 1973, SCIENCE, V181, P76, DOI 10.1126/science.181.4094.76; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FISCHBACH GD, 1971, J CELL PHYSIOL, V78, P289, DOI 10.1002/jcp.1040780218; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; KOENIG J, 1982, DEV BIOL, V92, P188, DOI 10.1016/0012-1606(82)90162-2; LEE KS, 1983, NATURE, V302, P790, DOI 10.1038/302790a0; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Liu Y, 2008, DEVELOPMENT, V135, P1957, DOI 10.1242/dev.018119; LOMO T, 1972, J PHYSIOL-LONDON, V221, P493, DOI 10.1113/jphysiol.1972.sp009764; LOMO T, 1975, J PHYSIOL-LONDON, V252, P603, DOI 10.1113/jphysiol.1975.sp011161; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; PAI AC, 1965, DEV BIOL, V11, P82, DOI 10.1016/0012-1606(65)90038-2; PAI AC, 1965, DEV BIOL, V11, P93, DOI 10.1016/0012-1606(65)90039-4; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; POWELL JA, 1984, DEV BIOL, V101, P168, DOI 10.1016/0012-1606(84)90127-1; RIEGER F, 1987, NATURE, V330, P563, DOI 10.1038/330563a0; ROTZLER S, 1991, NATURE, V349, P337, DOI 10.1038/349337a0; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SPECTOR I, 1977, P NATL ACAD SCI USA, V74, P5166, DOI 10.1073/pnas.74.11.5166; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236	50	48	48	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					570	U52		10.1038/nn.2792	http://dx.doi.org/10.1038/nn.2792			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	754VU	21441923	Green Accepted			2022-12-24	WOS:000289886600012
J	Loffredo, FS; Steinhauser, ML; Gannon, J; Lee, RT				Loffredo, Francesco S.; Steinhauser, Matthew L.; Gannon, Joseph; Lee, Richard T.			Bone Marrow-Derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair	CELL STEM CELL			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM-CELLS; HEART; REGENERATION; MULTIPOTENT; DISEASE; INJURY; ADOPT; GATA4	Cell therapy can improve cardiac function in animals and humans after injury, but the mechanism is unclear,. We performed cell therapy experiments in genetically engineered mice that permanently express green fluorescent protein (GFP) only in cardiomyocytas after a pulse of 4-OH-tamoxifen. Myocardial infarction diluted the GFP(+) cardiomyocyte pool, indicating refreshment by non-GFP(+) progenitors. Cell therapy with bone marrow-derived c-kit(+) cells, but not mesenchymal stem cells, further diluted the GFP(+) pool, consistent with c-kit(+) cell-mediated augmentation of cardiomyocyte progenitor activity. This effect could not be explained by transdifferentiation to cardiomyocytes by exogenously delivered c-kit(+) cells or by cell fusion. Therapy with c-kit(+) cells but riot mesenchymal stem cells improved cardiac function. These findings suggest that stimulation of endogenous cardiogenic progenitor activity is a critical mechanism of cardiac cell therapy.	[Loffredo, Francesco S.; Steinhauser, Matthew L.; Gannon, Joseph; Lee, Richard T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Harvard Stem Cell Inst, Cambridge, MA 02139 USA; [Loffredo, Francesco S.; Steinhauser, Matthew L.; Gannon, Joseph; Lee, Richard T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Lee, RT (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Harvard Stem Cell Inst, Cambridge, MA 02139 USA.	rlee@partners.org	Loffredo, Francesco S/F-6638-2014; Kalina, Roman Maciej RM Kalina/D-7937-2017; Loffredo, Francesco/P-1389-2019; Steinhauser, Matthew L./GVT-6393-2022	Loffredo, Francesco S/0000-0001-5911-780X; Kalina, Roman Maciej RM Kalina/0000-0003-2064-2724; Loffredo, Francesco/0000-0001-5911-780X; Steinhauser, Matthew L./0000-0001-5287-9246; Lee, Richard/0000-0003-4687-1381	NIH [R01 AG032977]; NATIONAL INSTITUTE ON AGING [R01AG032977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R.T.L. is a founder of Provasculon, Inc. This work was supported by a grant from the NIH (R01 AG032977).	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	30	317	332	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 8	2011	8	4					389	398		10.1016/j.stem.2011.02.002	http://dx.doi.org/10.1016/j.stem.2011.02.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	752QI	21474103	Bronze, Green Accepted			2022-12-24	WOS:000289707100011
J	Pielage, J; Bulat, V; Zuchero, JB; Fetter, RD; Davis, GW				Pielage, Jan; Bulat, Victoria; Zuchero, J. Bradley; Fetter, Richard D.; Davis, Graeme W.			Hts/Adducin Controls Synaptic Elaboration and Elimination	NEURON			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; FILAMENT NUCLEATION; ACTIN-FILAMENTS; ALPHA-ADDUCIN; CELL MOTILITY; BETA-ADDUCIN; IN-VIVO; F-ACTIN; PROTEIN; PLASTICITY	Neural development requires both synapse elaboration and elimination, yet relatively little is known about how these opposing activities are coordinated. Here, we provide evidence Hts/Adducin can serve this function. We show that Drosophila Hts/Adducin is enriched both pre- and postsynaptically at the NMJ. We then demonstrate that presynaptic Hts/Adducin is necessary and sufficient to control two opposing processes associated with synapse remodeling: (1) synapse stabilization as determined by light level and ultrastructural and electrophysiological assays and (2) the elaboration of actin-based, filopodia-like protrusions that drive synaptogenesis and growth. Synapse remodeling is sensitive to Hts/Adducin levels, and we provide evidence that the synaptic localization of Hts/Adducin is controlled via phosphorylation. Mechanistically, Drosophila Hts/Adducin protein has actin-capping activity. We propose that phosphorylation-dependent regulation of Hts/Adducin controls the level, localization, and activity of Hts/Adducin, influencing actin-based synapse elaboration and spectrin-based synapse stabilization. Hts/Adducin may define a mechanism to switch between synapse stability and dynamics.	[Pielage, Jan; Fetter, Richard D.; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zuchero, J. Bradley] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Pielage, Jan; Bulat, Victoria] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Friedrich Miescher Institute for Biomedical Research	Pielage, J (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	jan.pielage@fmi.ch; graeme.davis@ucsf.edu		Pielage, Jan/0000-0002-5115-5884; Zuchero, J. Bradley/0000-0002-4706-2538	Novartis research foundation; NIH [NS047342]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047342] Funding Source: NIH RePORTER	Novartis research foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank V. Budnik, M. Hortsch, and L. Cooley for generous gifts of antibodies and fly stocks. This work was supported by the Novartis research foundation (J.P.) and NIH grant (NS047342) (G.W.D.).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Barkalow KL, 2003, J CELL BIOL, V161, P557, DOI 10.1083/jcb.200211122; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1988, J BIOL CHEM, V263, P5860; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Chen CL, 2007, J CELL SCI, V120, P1157, DOI 10.1242/jcs.03408; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; GORDON DJ, 1976, J BIOL CHEM, V251, P4778; Gruenbaum LM, 2003, J NEUROSCI, V23, P2675; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koch I, 2008, NEURON, V58, P210, DOI 10.1016/j.neuron.2008.03.019; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Massaro CM, 2009, J CELL BIOL, V187, P101, DOI 10.1083/jcb.200903166; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nunes P, 2006, MOL BIOL CELL, V17, P4709, DOI 10.1091/mbc.E06-03-0253; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; SEIDEL B, 1995, BRAIN RES, V700, P13, DOI 10.1016/0006-8993(95)00962-P; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; YUE L, 1992, GENE DEV, V6, P2443, DOI 10.1101/gad.6.12b.2443; Zaccai M, 1996, ZYGOTE, V4, P159, DOI 10.1017/S096719940000304X; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	58	71	71	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 24	2011	69	6					1114	1131		10.1016/j.neuron.2011.02.007	http://dx.doi.org/10.1016/j.neuron.2011.02.007			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741TF	21435557	Bronze, Green Accepted			2022-12-24	WOS:000288886900009
J	Najm, FJ; Chenoweth, JG; Anderson, PD; Nadeau, JH; Redline, RW; McKay, RDG; Tesar, PJ				Najm, Fadi J.; Chenoweth, Josh G.; Anderson, Philip D.; Nadeau, Joseph H.; Redline, Raymond W.; McKay, Ronald D. G.; Tesar, Paul J.			Isolation of Epiblast Stem Cells from Preimplantation Mouse Embryos	CELL STEM CELL			English	Article							SELF-RENEWAL; BLASTOCYST INJECTION; GROUND-STATE; ES CELLS; PLURIPOTENCY; DERIVATION; LINES; FATE	Pluripotent stem cells provide a platform to interrogate control elements that function to generate all cell types of the body. Despite their utility for modeling development and disease, the relationship of mouse and human pluripotent stem cell states to one another remains largely undefined. We have shown that mouse embryonic stem (ES) cells and epiblast stem cells (EpiSCs) are distinct, pluripotent states isolated from pre- and post-implantation embryos respectively. Human ES cells are different than mouse ES cells and share defining features with EpiSCs, yet are derived from pre-implantation human embryos. Here we show that EpiSCs can be routinely derived from pre-implantation mouse embryos. The preimplantation-derived EpiSCs exhibit molecular features and functional properties consistent with bona fide EpiSCs. These results provide a simple method for isolating EpiSCs and offer direct insight into the intrinsic and extrinsic mechanisms that regulate the acquisition of distinct pluripotent states.	[Najm, Fadi J.; Anderson, Philip D.; Nadeau, Joseph H.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Najm, Fadi J.; Anderson, Philip D.; Nadeau, Joseph H.; Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Ctr Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Redline, Raymond W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chenoweth, Josh G.; McKay, Ronald D. G.] NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tesar, PJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	paul.tesar@case.edu	Tesar, Paul J/C-9848-2014; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155	Case Western Reserve University School of Medicine; Center for Stem Cell and Regenerative Medicine; Athymic Animal and Radiation Resources Core facilities of the Case Comprehensive Cancer Center [P30 CA43703]; NIH/NINDS; NATIONAL CANCER INSTITUTE [R01CA075056, P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981] Funding Source: NIH RePORTER	Case Western Reserve University School of Medicine; Center for Stem Cell and Regenerative Medicine; Athymic Animal and Radiation Resources Core facilities of the Case Comprehensive Cancer Center; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by funding from the Case Western Reserve University School of Medicine, the Center for Stem Cell and Regenerative Medicine, the Athymic Animal and Radiation Resources Core facilities of the Case Comprehensive Cancer Center (P30 CA43703), and the NIH/NINDS intramural research program. P.J.T. is a Robertson Investigator of the New York Stem Cell Foundation and a Mt. Sinai Health Care Foundation Scholar. We are grateful to Leslie Cooperman as well as members of the P. Scacheri laboratory for technical assistance and provision of reagents and Irene Tsung for graphical abstract artwork.	Anderson PD, 2009, CANCER RES, V69, P9112, DOI 10.1158/0008-5472.CAN-09-3342; Aoki H, 2009, DEV DYNAM, V238, P2266, DOI 10.1002/dvdy.22008; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 2003, DIABETES, V52, P205, DOI 10.2337/diabetes.52.1.205; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gardner RL, 1997, INT J DEV BIOL, V41, P235; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; LAWSON KA, 1991, DEVELOPMENT, V113, P891; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; ROSSANT J, 1978, J EMBRYOL EXP MORPH, V48, P239; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tesar PJ, 2005, P NATL ACAD SCI USA, V102, P8239, DOI 10.1073/pnas.0503231102; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	34	115	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					318	325		10.1016/j.stem.2011.01.016	http://dx.doi.org/10.1016/j.stem.2011.01.016			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362571	Green Accepted, Bronze			2022-12-24	WOS:000288404400013
J	Greenberg, KP; Pham, A; Werblin, FS				Greenberg, Kenneth P.; Pham, Aaron; Werblin, Frank S.			Differential Targeting of Optical Neuromodulators to Ganglion Cell Soma and Dendrites Allows Dynamic Control of Center-Surround Antagonism	NEURON			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; PHOTORECEPTOR DEGENERATION; RETINAL DEGENERATION; RECEPTIVE-FIELDS; ANKYRIN; PALMITOYLATION; ORGANIZATION; CHANNELS; RANVIER	Retinal degenerative diseases cause photoreceptor loss and often result in remodeling and deafferentation of the inner retina. Fortunately, ganglion cell morphology appears to remain intact long after photoreceptors and distal retinal circuitry have degenerated. We have introduced the optical neuromodulators channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR) differentially into the soma and dendrites of ganglion cells to recreate antagonistic center-surround receptive field interactions. We then reestablished the physiological receptive field dimensions of primate parafoveal ganglion cells by convolving Gaussian-blurred versions of the visual scene at the appropriate wavelength for each neuromodulator with the Gaussians inherent in the soma and dendrites. These Gaussian-modified ganglion cells responded with physiologically relevant antagonistic receptive field components and encoded edges with parafoveal resolution. This approach bypasses the degenerated areas of the distal retina and could provide a first step in restoring sight to individuals suffering from retinal disease.	[Greenberg, Kenneth P.; Pham, Aaron; Werblin, Frank S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Greenberg, KP (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	kgreenb@berkeley.edu			National Institutes of Health [5R01EY015512]; Ruth L. Kirschstein Postdoctoral Fellowship [F32EY018790]; NATIONAL EYE INSTITUTE [F32EY018790, R01EY015512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Boyden, K. Deisseroth, and D. Arnold for kindly providing plasmid constructs. We thank G. Spor and B. Massie for assistance with custom software and optical hardware, T. Russell for electrophysiology advice, and A. Ishida for critical comments of this manuscript. This study was supported by a National Institutes of Health grant (5R01EY015512) to F.S.W and a Ruth L. Kirschstein Postdoctoral Fellowship (F32EY018790) to K.P.G.	BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Gautama T, 2001, VISION RES, V41, P3917, DOI 10.1016/S0042-6989(01)00246-2; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; Hartline HK, 1940, J OPT SOC AM, V30, P239, DOI 10.1364/JOSA.30.000239; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lee BB, 1998, VISUAL NEUROSCI, V15, P161, DOI 10.1017/S095252389815112X; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	26	77	90	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 24	2011	69	4					713	720		10.1016/j.neuron.2011.01.024	http://dx.doi.org/10.1016/j.neuron.2011.01.024			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735KO	21338881	Bronze			2022-12-24	WOS:000288413200013
J	Kattman, SJ; Witty, AD; Gagliardi, M; Dubois, NC; Niapour, M; Hotta, A; Ellis, J; Keller, G				Kattman, Steven J.; Witty, Alec D.; Gagliardi, Mark; Dubois, Nicole C.; Niapour, Maryam; Hotta, Akitsu; Ellis, James; Keller, Gordon			Stage-Specific Optimization of Activin/Nodal and BMP Signaling Promotes Cardiac Differentiation of Mouse and Human Pluripotent Stem Cell Lines	CELL STEM CELL			English	Article							CARDIOVASCULAR PROGENITOR CELLS; BONE MORPHOGENETIC PROTEIN-4; PRIMITIVE STREAK; SMOOTH-MUSCLE; DEFINITIVE HEMATOPOIESIS; WNT/BETA-CATENIN; RECEPTOR-ALPHA; EXPRESSION; MESODERM; INDUCTION	Efficient differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to a variety of lineages requires step-wise approaches replicating the key commitment stages found during embryonic development. Here we show that expression of PdgfR-alpha segregates mouse ESC-derived Flk-1 mesoderm into Flk-1(+)PdgfR-alpha(+) cardiac and Flk-1(+)PdgfR-alpha(-) hematopoietic subpopulations. By monitoring Flk-1 and PdgfR-alpha expression, we found that specification of cardiac mesoderm and cardiomyocytes is determined by remarkably small changes in levels of Activin/Nodal and BMP signaling. Translation to human ESCs and iPSCs revealed that the emergence of cardiac mesoderm could also be monitored by coexpression of KDR and PDGFR-alpha and that this process was similarly dependent on optimal levels of Activin/Nodal and BMP signaling. Importantly, we found that individual mouse and human pluripotent stem cell lines require optimization of these signaling pathways for efficient cardiac differentiation, illustrating a principle that may well apply in other contexts.	[Kattman, Steven J.; Witty, Alec D.; Gagliardi, Mark; Dubois, Nicole C.; Niapour, Maryam; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Witty, Alec D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Hotta, Akitsu; Ellis, James] SickKids Toronto, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Ellis, James] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Keller, G (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada.	gkeller@uhnresearch.ca	Ellis, James/F-4789-2011	Ellis, James/0000-0002-4400-0091; Hotta, Akitsu/0000-0002-2619-7441; Keller, Gordon/0000-0001-9309-9297	National Institutes of Health [R01 HL080627, CIHR 84524, F32 HL078112]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080627, F32HL078112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank members of the G.K. laboratory and Dr. Ian Scott for discussions and critical reading of the manuscript, Konrad Hochedlinger (Massachusetts General Hospital, Boston) for providing the Oct4-GFP and Sox2-GFP m-iPSC lines, George Daley (Harvard Medical School, Boston) for providing the MSC-iPS1 and 38-2 cell line, and Pier-Andree Penttila and the Sick Kids/UHN Flow Cytometry Facility for their assistance with cell sorting. This work was supported by National Institutes of Health grants R01 HL080627, CIHR 84524 to G.K. and F32 HL078112 to S.J.K. S.J.K. is currently an employee at Cellular Dynamics International.	Agius E, 2000, DEVELOPMENT, V127, P1173; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Davis S, 2004, DEV BIOL, V270, P47, DOI 10.1016/j.ydbio.2004.01.048; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fujiwara T, 2002, DEVELOPMENT, V129, P4685; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gritsman K, 2000, DEVELOPMENT, V127, P921; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hirata H, 2007, J BIOSCI BIOENG, V103, P412, DOI 10.1263/jbb.103.412; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lu CC, 2004, DEV BIOL, V273, P149, DOI 10.1016/j.ydbio.2004.06.004; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; NOSTRO MC, 2011, DEVELOPMENT IN PRESS; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; RUZICKA DL, 1988, J CELL BIOL, V107, P2575, DOI 10.1083/jcb.107.6.2575; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; SUGI Y, 1992, DEV DYNAM, V193, P116, DOI 10.1002/aja.1001930203; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	57	801	850	4	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					228	240		10.1016/j.stem.2010.12.008	http://dx.doi.org/10.1016/j.stem.2010.12.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295278	Bronze			2022-12-24	WOS:000287633400015
J	Jin, JZ; Wang, YS; Swadlow, HA; Alonso, JM				Jin, Jianzhong; Wang, Yushi; Swadlow, Harvey A.; Alonso, Jose M.			Population receptive fields of ON and OFF thalamic inputs to an orientation column in visual cortex	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; CORTICAL SIMPLE CELLS; CAT STRIATE CORTEX; OFF-CENTER INPUTS; ON-CENTER; SELECTIVITY; NEURONS; AFFERENTS; MODEL; ARCHITECTURE	The primary visual cortex of primates and carnivores is organized into columns of neurons with similar preferences for stimulus orientation, but the developmental origin and function of this organization are still matters of debate. We found that the orientation preference of a cortical column is closely related to the population receptive field of its ON and OFF thalamic inputs. The receptive field scatter from the thalamic inputs was more limited than previously thought and matched the average receptive field size of neurons at the input layers of cortex. Moreover, the thalamic population receptive field (calculated as ON - OFF average) had separate ON and OFF subregions, similar to cortical neurons in layer 4, and provided an accurate prediction of the preferred orientation of the column. These results support developmental models of orientation maps that are based on the receptive field arrangement of ON and OFF visual inputs to cortex.	[Jin, Jianzhong; Wang, Yushi; Swadlow, Harvey A.; Alonso, Jose M.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10010 USA; [Swadlow, Harvey A.; Alonso, Jose M.] Univ Connecticut, Dept Psychol, Storrs, CT USA	State University of New York (SUNY) System; SUNY Optometry; University of Connecticut	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, New York, NY 10010 USA.	jalonso@sunyopt.edu			US National Institutes of Health [EY05253, MH085357]; NATIONAL EYE INSTITUTE [R37EY005253, R01EY005253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085357] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Weng for helping with some experiments. This work was supported by the US National Institutes of Health (grants EY05253 to J.M.A. and MH085357 to H. A. S.).	Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BULLIER J, 1982, J NEUROPHYSIOL, V47, P417, DOI 10.1152/jn.1982.47.3.417; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chapman B, 2000, J NEUROSCI, V20, P1922; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; FERSTER D, 1990, VISUAL NEUROSCI, V4, P135, DOI 10.1017/S0952523800002297; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MCCONNELL SK, 1984, P NATL ACAD SCI-BIOL, V81, P1590, DOI 10.1073/pnas.81.5.1590; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; Miller KD, 2003, CEREB CORTEX, V13, P73, DOI 10.1093/cercor/13.1.73; MILLER KD, 1994, J NEUROSCI, V14, P409; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Nakagama H, 2000, BIOL CYBERN, V83, P85, DOI 10.1007/s004220000148; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Stoelzel CR, 2008, J NEUROSCI, V28, P5018, DOI 10.1523/JNEUROSCI.4726-07.2008; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; Yeh CI, 2009, J NEUROPHYSIOL, V101, P2166, DOI 10.1152/jn.91088.2008; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	44	120	121	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					232	U323		10.1038/nn.2729	http://dx.doi.org/10.1038/nn.2729			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217765				2022-12-24	WOS:000286595400021
J	Fotowat, H; Harrison, RR; Gabbiani, F				Fotowat, Haleh; Harrison, Reid R.; Gabbiani, Fabrizio			Multiplexing of Motor Information in the Discharge of a Collision Detecting Neuron during Escape Behaviors	NEURON			English	Article							LOOMING-SENSITIVE NEURON; CONTRALATERAL MOVEMENT DETECTOR; OBJECT APPROACH; WIDE-FIELD; DROSOPHILA-MELANOGASTER; VISUAL INTERNEURONS; RANA-CATESBEIANA; NUCLEUS ROTUNDUS; DECISION-MAKING; SINGLE NEURONS	Locusts possess an identified neuron, the descending contralateral movement detector (DCMD), conveying visual information about impending collision from the brain to thoracic motor centers. We built a telemetry system to simultaneously record, in freely behaving animals, the activity of the DCMD and of motoneurons involved in jump execution. Cocontraction of antagonistic leg muscles, a required preparatory phase, was triggered after the DCMD firing rate crossed a threshold. Thereafter, the number of DCMD spikes predicted precisely motoneuron activity and jump occurrence. Additionally, the time of DCMD peak firing rate predicted that of jump. Ablation experiments suggest that the DCMD, together with a nearly identical ipsilateral descending neuron, is responsible for the timely execution of the escape. Thus, three distinct features that are multiplexed in a single neuron's sensory response to impending collision-firing rate threshold, peak firing time, and spike count-probably control three distinct motor aspects of escape behaviors.	[Harrison, Reid R.] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA; [Harrison, Reid R.] Univ Utah, Dept Biomed Engn, Salt Lake City, UT 84112 USA; [Gabbiani, Fabrizio] Rice Univ, Houston, TX 77005 USA; [Fotowat, Haleh; Gabbiani, Fabrizio] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Rice University; Baylor College of Medicine	Fotowat, H (corresponding author), McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada.	haleh.fotowat@mail.mcgill.ca; gabbiani@bcm.edu			Air Force Research Laboratory, National Institute of Mental Health; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065339] Funding Source: NIH RePORTER; Direct For Biological Sciences [0904065] Funding Source: National Science Foundation	Air Force Research Laboratory, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)United States Department of DefenseUS Air Force Research Laboratory); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Air Force Research Laboratory, Human Fronteir Science Program, National Institute of Mental Health, and National Science Foundation. We would like to thank Drs. H. Krapp and J. Maunsell and Mr. P. Jones for comments.	BURROWS M, 1988, J COMP PHYSIOL A, V163, P425, DOI 10.1007/BF00604897; BURROWS M, 1973, J COMP PHYSIOL, V85, P221, DOI 10.1007/BF00694231; Burrows M., 1996, NEUROBIOLOGY INSECT; CAMHI JM, 1989, J COMP PHYSIOL A, V165, P83, DOI 10.1007/BF00613802; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Farrow K, 2003, J NEUROSCI, V23, P9805; Fotowat H, 2007, J NEUROSCI, V27, P10047, DOI 10.1523/JNEUROSCI.1515-07.2007; Fotowat H, 2009, J NEUROPHYSIOL, V102, P875, DOI 10.1152/jn.00073.2009; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Gabbiani F, 2005, J NEUROPHYSIOL, V94, P2150, DOI 10.1152/jn.00411.2005; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Gabbiani F, 2001, J NEUROSCI, V21, P314, DOI 10.1523/JNEUROSCI.21-01-00314.2001; Gray JR, 2010, J COMP PHYSIOL A, V196, P927, DOI 10.1007/s00359-010-0576-7; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; GYNTHER IC, 1989, J NEUROPHYSIOL, V61, P45, DOI 10.1152/jn.1989.61.1.45; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; HEITLER WJ, 1995, EUR J NEUROSCI, V7, P981, DOI 10.1111/j.1460-9568.1995.tb01086.x; HOYLE G, 1978, J EXP BIOL, V73, P205; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; JACOBS GA, 1985, SCIENCE, V228, P344, DOI 10.1126/science.3983633; Jellema T, 1999, J COMP NEUROL, V404, P212; Judge SJ, 1997, J EXP BIOL, V200, P2209; KILLMANN F, 1985, J NEUROCYTOL, V14, P637, DOI 10.1007/BF01200802; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Kristan WB, 1997, CURR OPIN NEUROBIOL, V7, P826, DOI 10.1016/S0959-4388(97)80142-0; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Marsat G, 2006, J NEUROSCI, V26, P10542, DOI 10.1523/JNEUROSCI.2221-06.2006; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Nakagawa H, 2010, J NEUROPHYSIOL, V104, P2487, DOI 10.1152/jn.01055.2009; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Oliva D, 2007, J EXP BIOL, V210, P865, DOI 10.1242/jeb.02707; OSHEA M, 1974, J EXP BIOL, V60, P1; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; PEARSON KG, 1981, J COMP PHYSIOL, V144, P391, DOI 10.1007/BF00612571; PEARSON KG, 1980, J NEUROPHYSIOL, V43, P257, DOI 10.1152/jn.1980.43.2.257; Peron S, 2009, NAT NEUROSCI, V12, P318, DOI 10.1038/nn.2259; Preuss T, 2006, J NEUROSCI, V26, P3454, DOI 10.1523/JNEUROSCI.5259-05.2006; RIND FC, 1984, J EXP BIOL, V110, P143; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; Rogers SM, 2007, J NEUROSCI, V27, P4621, DOI 10.1523/JNEUROSCI.4615-06.2007; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rowell C. H. F., 1971, J COMP PHYSIOL A, V73, P167; ROWELL CHF, 1971, J EXP BIOL, V55, P727; Santer RD, 2006, J NEUROPHYSIOL, V95, P3391, DOI 10.1152/jn.00024.2006; Santer RD, 2005, J COMP PHYSIOL A, V191, P965, DOI 10.1007/s00359-005-0023-3; Santer RD, 2008, J COMP PHYSIOL A, V194, P69, DOI 10.1007/s00359-007-0289-8; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; SIMMONS P, 1980, J EXP BIOL, V86, P87; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; TRIMARCHI JR, 1993, J EXP BIOL, V177, P149; van Hateren JH, 2005, J NEUROSCI, V25, P4343, DOI 10.1523/JNEUROSCI.0616-05.2005; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329; Wicklein M, 2000, J COMP NEUROL, V424, P356; Yamamoto K, 2003, BRAIN BEHAV EVOLUT, V62, P201, DOI 10.1159/000073272	65	78	78	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 13	2011	69	1					147	158		10.1016/j.neuron.2010.12.007	http://dx.doi.org/10.1016/j.neuron.2010.12.007			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220105	Green Accepted, Bronze			2022-12-24	WOS:000286446300014
J	He, SQ; Zhang, ZN; Guan, JS; Liu, HR; Zhao, B; Wang, HB; Li, QA; Yang, H; Luo, J; Li, ZY; Wang, QO; Lu, YJ; Bao, L; Zhang, X				He, Shao-Qiu; Zhang, Zhen-Ning; Guan, Ji-Song; Liu, Hong-Rui; Zhao, Bo; Wang, Hai-Bo; Li, Qian; Yang, Hong; Luo, Jie; Li, Zi-Yan; Wang, Qiong; Lu, Ying-Jin; Bao, Lan; Zhang, Xu			Facilitation of mu-Opioid Receptor Activity by Preventing delta-Opioid Receptor-Mediated Codegradation	NEURON			English	Article							DORSAL-ROOT GANGLIA; PROTEIN-COUPLED RECEPTORS; NOXIOUS THERMAL STIMULI; RAT SPINAL-CORD; KNOCK-OUT MICE; DOWN-REGULATION; PHYSICAL-DEPENDENCE; MORPHINE ANALGESIA; SUBSTANCE-P; TOLERANCE	delta-opioid receptors (DORs) form heteromers with mu-opioid receptors (MORs) and negatively regulate MOR-mediated spinal analgesia. However, the underlying mechanism remains largely unclear. The present study shows that the activity of MORs can be enhanced by preventing MORs from DOR-mediated codegradation. Treatment with DOR-specific agonists led to endocytosis of both DORs and MORs. These receptors were further processed for ubiquitination and lysosomal degradation, resulting in a reduction of surface MORs. Such effects were attenuated by treatment with an interfering peptide containing the first transmembrane domain of MOR (MORTm1), which interacted with DORs and disrupted the MOR/DOR interaction. Furthermore, the systemically applied fusion protein consisting of MORTM1 and TAT at the C terminus could disrupt the MOR/DOR interaction in the mouse spinal cord, enhance the morphine analgesia, and reduce the antinociceptive tolerance to morphine. Thus, dissociation of MORs from DORs in the cell membrane is a potential strategy to improve opioid analgesic therapies.	[Zhang, Zhen-Ning; Liu, Hong-Rui; Wang, Hai-Bo; Li, Qian; Luo, Jie; Li, Zi-Yan; Wang, Qiong; Bao, Lan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [He, Shao-Qiu; Guan, Ji-Song; Zhao, Bo; Wang, Hai-Bo; Yang, Hong; Lu, Ying-Jin; Zhang, Xu] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [He, Shao-Qiu; Guan, Ji-Song; Zhao, Bo; Wang, Hai-Bo; Yang, Hong; Lu, Ying-Jin; Zhang, Xu] Chinese Acad Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences	Bao, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China.	baolan@sibs.ac.cn; xu.zhang@ion.ac.cn	Zhao, Bo/S-6404-2019; Li, Qian/P-4417-2015; Li, Qian/AAE-8688-2022	Li, Qian/0000-0003-1300-3377; Li, Qian/0000-0003-1300-3377; Zhang, Zhen-Ning/0000-0003-3798-7104; Zhao, Bo/0000-0003-2881-5714	National Natural Science Foundation of China [30630029, 30621062]; National Basic Research Program of China [2009CB522005, 2010CB912000, 2011CBA00400, 2007CB914501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	We thank Dr. L. Ma for providing the DOR (M) plasmid and Dr. R. Elde for the DOR antibodies. This work was supported by National Natural Science Foundation of China (30630029 and 30621062) and National Basic Research Program of China (2009CB522005, 2010CB912000, 2011CBA00400, 2007CB914501).	ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; BESSE D, 1992, NEUROSCIENCE, V50, P921, DOI 10.1016/0306-4522(92)90215-N; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; CESSELIN F, 1989, BRAIN RES, V484, P71, DOI 10.1016/0006-8993(89)90349-1; Chefer VI, 2009, NEUROPSYCHOPHARMACOL, V34, P887, DOI 10.1038/npp.2008.128; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Fan T, 2005, J BIOL CHEM, V280, P38478, DOI 10.1074/jbc.M505644200; Filizola M, 2002, PROTEIN ENG, V15, P881, DOI 10.1093/protein/15.11.881; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Gallantine EL, 2005, BASIC CLIN PHARMACOL, V97, P39, DOI 10.1111/j.1742-7843.2005.pto_97107.x; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Holler D, 2004, BIOCHEM PHARMACOL, V67, P1013, DOI 10.1016/j.bcp.2004.01.003; Ji RR, 1995, J NEUROSCI, V15, P8156; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Law PY, 2000, MOL PHARMACOL, V58, P388, DOI 10.1124/mol.58.2.388; LEE NM, 1980, EUR J PHARMACOL, V68, P181, DOI 10.1016/0014-2999(80)90319-2; Ma JY, 2006, MOL PHARMACOL, V69, P1137, DOI 10.1124/mol.105.019109; Mennicken F, 2003, J COMP NEUROL, V465, P349, DOI 10.1002/cne.10839; MINAMI M, 1995, MOL BRAIN RES, V30, P203, DOI 10.1016/0169-328X(94)00290-U; Morinville A, 2003, J NEUROSCI, V23, P4888; Nitsche JF, 2002, J NEUROSCI, V22, P10906; Overland AC, 2009, J NEUROSCI, V29, P13264, DOI 10.1523/JNEUROSCI.1907-09.2009; Pak Y, 1999, J BIOL CHEM, V274, P27610, DOI 10.1074/jbc.274.39.27610; Patwardhan AM, 2005, J NEUROSCI, V25, P8825, DOI 10.1523/JNEUROSCI.0160-05.2005; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Rau KK, 2005, J CHEM NEUROANAT, V29, P255, DOI 10.1016/j.jchemneu.2005.02.002; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Schiller PW, 1999, J MED CHEM, V42, P3520, DOI 10.1021/jm980724+; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Spike RC, 2002, EUR J NEUROSCI, V15, P1306, DOI 10.1046/j.1460-9568.2002.01969.x; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Trapaidze N, 2000, DNA CELL BIOL, V19, P93, DOI 10.1089/104454900314609; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Walwyn W, 2005, MOL PHARMACOL, V68, P1688, DOI 10.1124/mol.105.014829; Wang HB, 2010, P NATL ACAD SCI USA, V107, P13117, DOI 10.1073/pnas.1008382107; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; Xie WY, 2009, J NEUROSCI, V29, P3551, DOI 10.1523/JNEUROSCI.0415-09.2009; Zhang X, 1998, NEUROSCIENCE, V82, P223; Zhang X, 1998, NEUROSCIENCE, V82, P1225; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	55	163	176	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 13	2011	69	1					120	131		10.1016/j.neuron.2010.12.001	http://dx.doi.org/10.1016/j.neuron.2010.12.001			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220103	Bronze			2022-12-24	WOS:000286446300012
J	Leaver, AM; Renier, L; Chevillet, MA; Morgan, S; Kim, HJ; Rauschecker, JP				Leaver, Amber M.; Renier, Laurent; Chevillet, Mark A.; Morgan, Susan; Kim, Hung J.; Rauschecker, Josef P.			Dysregulation of Limbic and Auditory Networks in Tinnitus	NEURON			English	Article							FUNCTIONAL NEUROANATOMY; FREQUENCY ORGANIZATION; CORTICAL PROJECTIONS; INFERIOR COLLICULUS; VOLUME MEASUREMENT; PREFRONTAL CORTEX; COCHLEAR LESIONS; GRAY-MATTER; ADULT CATS; BRAIN	Tinnitus is a common disorder characterized by ringing in the ear in the absence of sound. Converging evidence suggests that tinnitus pathophysiology involves damage to peripheral and/or central auditory pathways. However, whether auditory system dysfunction is sufficient to explain chronic tinnitus is unclear, especially in light of evidence implicating other networks, including the limbic system. Using functional magnetic resonance imaging and voxel-based morphometry, we assessed tinnitus-related functional and anatomical anomalies in auditory and limbic networks. Moderate hyperactivity was present in the primary and posterior auditory cortices of tinnitus patients. However, the nucleus accumbens exhibited the greatest degree of hyperactivity, specifically to sounds frequency-matched to patients' tinnitus. Complementary structural differences were identified in ventromedial prefrontal cortex, another limbic structure heavily connected to the nucleus accumbens. Furthermore, tinnitus-related anomalies were intercorrelated in the two limbic regions and between limbic and primary auditory areas, indicating the importance of auditory-limbic interactions in tinnitus.	[Leaver, Amber M.; Renier, Laurent; Chevillet, Mark A.; Rauschecker, Josef P.] Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20057 USA; [Morgan, Susan] Georgetown Univ, Med Ctr, Div Audiol, Washington, DC 20057 USA; [Kim, Hung J.] Georgetown Univ, Med Ctr, Dept Otolaryngol, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20057 USA.	rauschej@georgetown.edu	Rauschecker, Josef P/A-4120-2013	Rauschecker, Josef P./0000-0003-4353-9084	National Institutes of Health [RC1-DC010720, F31-DC008921]; Skirball Foundation; Tinnitus Research Initiative; Tinnitus Research Consortium; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [RC1DC010720, F31DC008921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skirball Foundation; Tinnitus Research Initiative; Tinnitus Research Consortium; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We wish to thank Jeremy Purcell, Kenta Takagaki, and Anne Fieger for their technical assistance. This work was funded by the National Institutes of Health (Grants RC1-DC010720 to J.P.R. and F31-DC008921 to A.M.L.), Skirball Foundation, Tinnitus Research Initiative, and Tinnitus Research Consortium.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Alain C, 2005, NEUROIMAGE, V26, P592, DOI 10.1016/j.neuroimage.2005.02.006; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bar M, 2009, TRENDS COGN SCI, V13, P456, DOI 10.1016/j.tics.2009.08.009; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cheung SW, 2010, NEUROSCIENCE, V169, P1768, DOI 10.1016/j.neuroscience.2010.06.007; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; *DEP VET AFF, 2008, ANN BEN REP FISC YEA; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; DIVAC I, 1987, NEUROSCIENCE, V21, P197, DOI 10.1016/0306-4522(87)90333-2; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Hoffman HJ, 2004, TINNITUS THEORY MANA; Irvine DRF, 2003, J COMP NEUROL, V467, P354, DOI 10.1002/cne.10921; Jastreboff PJ, 2007, PROG BRAIN RES, V166, P415, DOI 10.1016/S0079-6123(07)66040-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; JAYARAMAN A, 1980, BRAIN RES, V195, P29, DOI 10.1016/0006-8993(80)90863-X; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Lowry LD, 2004, OTOL NEUROTOL, V25, P474, DOI 10.1097/00129492-200407000-00013; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Plewnia C, 2007, HUM BRAIN MAPP, V28, P238, DOI 10.1002/hbm.20270; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Robinson Shannon K, 2008, Int Tinnitus J, V14, P119; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Shulman, 1995, Int Tinnitus J, V1, P13; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; SULLIVAN MD, 1988, GEN HOSP PSYCHIAT, V10, P285, DOI 10.1016/0163-8343(88)90037-0; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Talairach J., 1988, COPLANAR STEREOTAXIS; Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030; Tyler R, 2008, AM J AUDIOL, V17, pS176, DOI 10.1044/1059-0889(2008/07-0044); Weisz N, 2005, BRAIN, V128, P2722, DOI 10.1093/brain/awh588; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; Wilson EC, 2007, J NEUROPHYSIOL, V97, P2230, DOI 10.1152/jn.00788.2006; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	68	281	293	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 13	2011	69	1					33	43		10.1016/j.neuron.2010.12.002	http://dx.doi.org/10.1016/j.neuron.2010.12.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220097	Bronze, Green Accepted			2022-12-24	WOS:000286446300006
J	Katzel, D; Zemelman, BV; Buetfering, C; Wolfel, M; Miesenbock, G				Kaetzel, Dennis; Zemelman, Boris V.; Buetfering, Christina; Woelfel, Markus; Miesenboeck, Gero			The columnar and laminar organization of inhibitory connections to neocortical excitatory cells	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; SOMATOSENSORY CORTEX; PYRAMIDAL CELLS; BARREL CORTEX; GABAERGIC INTERNEURONS; DISYNAPTIC INHIBITION; CORTICAL-NEURONS; MARTINOTTI CELLS; RAT NEOCORTEX; PHOTOSTIMULATION	The cytoarchitectonic similarities of different neocortical regions have given rise to the idea of 'canonical' connectivity between excitatory neurons of different layers within a column. It is unclear whether similarly general organizational principles also exist for inhibitory neocortical circuits. Here we delineate and compare local inhibitory-to-excitatory wiring patterns in all principal layers of primary motor (M1), somatosensory (S1) and visual (V1) cortex, using genetically targeted photostimulation in a mouse knock-in line that conditionally expresses channelrhodopsin-2 in GABAergic neurons. Inhibitory inputs to excitatory neurons derived largely from the same cortical layer within a three-column diameter. However, subsets of pyramidal cells in layers 2/3 and 5B received extensive translaminar inhibition. These neurons were prominent in V1, where they might correspond to complex cells, less numerous in barrel cortex and absent in M1. Although inhibitory connection patterns were stereotypical, the abundance of individual motifs varied between regions and cells, potentially reflecting functional specializations.	[Kaetzel, Dennis; Buetfering, Christina; Miesenboeck, Gero] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Zemelman, Boris V.; Woelfel, Markus; Miesenboeck, Gero] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	University of Oxford; Yale University	Miesenbock, G (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	gero.miesenboeck@dpag.ox.ac.uk	Buetfering, Christina/CAG-0104-2022; Buetfering, Christina/I-2879-2014	Miesenboeck, Gero/0000-0003-2940-3228; Zemelman, Boris/0000-0003-2463-4887; Katzel, Dennis/0000-0002-7334-9823	UK Medical Research Council; US National Institutes of Health; Dana Foundation; US Office of Naval Research; Boehringer Ingelheim Fonds; Christopher Welch Scholarship Fund; MRC [G0700888, G0701225] Funding Source: UKRI; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017297] Funding Source: NIH RePORTER; Medical Research Council [G0701225, G0700888] Funding Source: researchfish; Wellcome Trust [090309/Z/09/Z] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; US Office of Naval Research(Office of Naval Research); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Christopher Welch Scholarship Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank P. Chambon (Universite de Strasbourg), F. Costantini (Columbia University), S. Dymecki (Harvard Medical School), G. Nagel (Universitat Wurzburg) and P. Soriano (Mount Sinai School of Medicine) for plasmids and T. Ellender, M. Kohl, K. Lamsa, W. Nissen, T. Nottoli, R. Roorda, Y. Tan and L. Upton for assistance and/or discussions. This work was supported by the UK Medical Research Council (G. M.), the US National Institutes of Health (G.M.), the Dana Foundation (G.M.), the US Office of Naval Research (G.M.), the Boehringer Ingelheim Fonds (D.K.) and the Christopher Welch Scholarship Fund (D.K.).	Barbour DL, 2008, J NEUROSCI, V28, P11174, DOI 10.1523/JNEUROSCI.2093-08.2008; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Blatow M, 2005, J PHYSIOL-LONDON, V562, P99, DOI 10.1113/jphysiol.2004.078584; Brill J, 2009, J NEUROSCI, V29, P7413, DOI 10.1523/JNEUROSCI.6098-08.2009; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chance FS, 2000, NETWORK-COMP NEURAL, V11, P119, DOI 10.1088/0954-898X/11/2/301; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, PROG BRAIN RES, V58, P209, DOI 10.1016/S0079-6123(08)60022-9; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hegemann P, 2001, J PHYCOL, V37, P668, DOI 10.1046/j.1529-8817.2001.01095.x; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Mountcastle V.B., 1978, MINDFUL BRAIN CORTIC, P7; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Otsuka T, 2009, J NEUROSCI, V29, P10533, DOI 10.1523/JNEUROSCI.2219-09.2009; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	49	163	164	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					100	U135		10.1038/nn.2687	http://dx.doi.org/10.1038/nn.2687			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21076426	Green Accepted			2022-12-24	WOS:000285684900020
J	Nomura, T; Goritz, C; Catchpole, T; Henkemeyer, M; Frisen, J				Nomura, Tadashi; Goritz, Christian; Catchpole, Timothy; Henkemeyer, Mark; Frisen, Jonas			EphB Signaling Controls Lineage Plasticity of Adult Neural Stem Cell Niche Cells	CELL STEM CELL			English	Article							EPENDYMAL CELLS; RECOMBINANT ADENOVIRUS; GENE-TRANSFER; GLIAL-CELLS; PROLIFERATION; PROGENITOR; ZONE; NEUROGENESIS; SURFACE; MANIPULATION	Stem cells remain in specialized niches over the life-span of the organism in many organs to ensure tissue homeostasis and enable regeneration. How the niche is maintained is not understood, but is probably as important as intrinsic stem cell self-renewal capacity for tissue integrity. We here demonstrate a high degree of phenotypic plasticity of the two main niche cell types, ependymal cells and astrocytes, in the neurogenic lateral ventricle walls in the adult mouse brain. In response to a lesion, astrocytes give rise to ependymal cells and ependymal cells give rise to niche astrocytes. We identify EphB2 forward signaling as a key pathway regulating niche cell plasticity. EphB2 acts downstream of Notch and is required for the maintenance of ependymal cell characteristics, thereby inhibiting the transition from ependymal cell to astrocyte. Our results show that niche cell identity is actively maintained and that niche cells retain a high level of plasticity.	[Nomura, Tadashi; Goritz, Christian; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Catchpole, Timothy; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Karolinska Institutet; University of Texas System; University of Texas Southwestern Medical Center Dallas	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021	Göritz, Christian/0000-0003-0799-766X; Henkemeyer, Mark/0000-0002-7525-1061	Swedish Research Council; Swedish Cancer Society; Swedish Agency for Innovation Systems; Karolinska Institute; Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse; NIH [RO1 MH066332]; Uehara Memorial Foundation; Scandinavia-Japan Sasakawa Foundation; Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Agency for Innovation Systems(Vinnova); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Scandinavia-Japan Sasakawa Foundation; Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Drs. U. Lendahl for NICD, dnRbpj, and 12xRbpj-dsGFP expression vectors, T. Pawson for EphB2 and EphB2<SUP>Y604F,Y61F</SUP> vectors, M. Genander for ephrin-Bl vector, F. Farnebo for ephrin-B2 expression vector, K. Tanigaki and T. Honjo for Rbe<SUP>loxP/loxP</SUP> mice, F. Pfrieger for Cx30-CreER mice, T. Li for the Rootletin antibody, and A. Simon and members of the J.F. laboratory for valuable discussions. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Swedish Agency for Innovation Systems, the Karolinska Institute, Tobias Stiftelsen, Knut och Alice Wallenbergs Stiftelse, and NIH grant RO1 MH066332. T.N. is supported by fellowships from the Uehara Memorial Foundation and Scandinavia-Japan Sasakawa Foundation and C.G. by a postdoctoral fellowship from the Wenner-Gren Foundation.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Davidson BL, 1997, EXP NEUROL, V144, P125, DOI 10.1006/exnr.1996.6398; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Genander M, 2010, STEM CELLS, V28, P1196, DOI 10.1002/stem.442; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gomez-Roldan MDC, 2008, J COMP NEUROL, V507, P1571, DOI 10.1002/cne.21618; Grondona JM, 1996, J NEUROPATH EXP NEUR, V55, P999, DOI 10.1097/00005072-199609000-00007; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	76	77	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					730	743		10.1016/j.stem.2010.11.009	http://dx.doi.org/10.1016/j.stem.2010.11.009			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112567	Green Accepted, Bronze			2022-12-24	WOS:000285537700014
J	Day, JJ; Sweatt, JD				Day, Jeremy J.; Sweatt, J. David			DNA methylation and memory formation	NATURE NEUROSCIENCE			English	Article							BDNF GENE; SYNAPTIC PLASTICITY; CHROMATIN-STRUCTURE; ADULT NEUROGENESIS; MOLECULAR TURNOVER; DEMETHYLATION; TRANSCRIPTION; EPIGENETICS; REPAIR; 5-HYDROXYMETHYLCYTOSINE	Memory formation and storage require long-lasting changes in memory-related neuronal circuits. Recent evidence indicates that DNA methylation may serve as a contributing mechanism in memory formation and storage. These emerging findings suggest a role for an epigenetic mechanism in learning and long-term memory maintenance and raise apparent conundrums and questions. For example, it is unclear how DNA methylation might be reversed during the formation of a memory, how changes in DNA methylation alter neuronal function to promote memory formation, and how DNA methylation patterns differ between neuronal structures to enable both consolidation and storage of memories. Here we evaluate the existing evidence supporting a role for DNA methylation in memory, discuss how DNA methylation may affect genetic and neuronal function to contribute to behavior, propose several future directions for the emerging subfield of neuroepigenetics, and begin to address some of the broader implications of this work.	[Sweatt, J. David] Univ Alabama, Dept Neurobiol, Birmingham, AL USA; Univ Alabama, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama, Dept Neurobiol, Birmingham, AL USA.	dsweatt@uab.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399; Sweatt, J. David/0000-0003-3567-485X	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA029419] Funding Source: NIH RePORTER; NIDA NIH HHS [F32 DA029419, F32 DA029419-01A1] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brown SE, 2008, NEUROSCI LETT, V440, P49, DOI 10.1016/j.neulet.2008.05.028; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mammen AL, 1997, J NEUROSCI, V17, P7351; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Razin A, 1981, Prog Nucleic Acid Res Mol Biol, V25, P33, DOI 10.1016/S0079-6603(08)60482-1; Roberson ED, 2001, REV NEUROSCIENCE, V12, P41; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sananbenesi F, 2009, BIOL CHEM, V390, P1145, DOI 10.1515/BC.2009.131; Santos KF, 2005, BRAZ J MED BIOL RES, V38, P1531, DOI 10.1590/S0100-879X2005001000010; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Wood MA, 2006, LEARN MEMORY, V13, P241, DOI 10.1101/lm.278206; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	50	325	338	3	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1319	1323		10.1038/nn.2666	http://dx.doi.org/10.1038/nn.2666			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20975755	Green Accepted			2022-12-24	WOS:000283658200008
J	Clapper, JR; Moreno-Sanz, G; Russo, R; Guijarro, A; Vacondio, F; Duranti, A; Tontini, A; Sanchini, S; Sciolino, NR; Spradley, JM; Hohmann, AG; Calignano, A; Mor, M; Tarzia, G; Piomelli, D				Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele			Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTORS; CB2 RECEPTORS; RAT MODEL; ANALGESIA; SYSTEM; FAAH; LOCALIZATION; ACTIVATION; INHIBITORS	Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown. To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degradation of the endocannabinoid anandamide. URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS. Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing. CB1 cannabinoid receptor blockade prevented these effects. These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS. Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.	[Clapper, Jason R.; Moreno-Sanz, Guillermo; Guijarro, Ana; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Moreno-Sanz, Guillermo] Univ Complutense, Dept Biochem & Mol Biol 3, E-28040 Madrid, Spain; [Russo, Roberto; Calignano, Antonio] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Vacondio, Federica; Mor, Marco] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy; [Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Tarzia, Giorgio] Univ Urbino Carlo Bo, Dept Hlth & Drug Sci, Urbino, Italy; [Sciolino, Natale R.; Hohmann, Andrea G.] Univ Georgia, Dept Psychol, Neurosci & Behav Program, Athens, GA 30602 USA; [Spradley, Jessica M.; Hohmann, Andrea G.] Univ Georgia, Program Neurosci, Biomed Hlth Sci Inst, Athens, GA 30602 USA; [Piomelli, Daniele] Italian Inst Technol, Genoa, Italy	University of California System; University of California Irvine; Complutense University of Madrid; University of Naples Federico II; University of Parma; University of Urbino; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Istituto Italiano di Tecnologia - IIT	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	daniele.piomelli@iit.it	Calignano, Antonio/K-2542-2018; russo, roberto/A-3193-2012; Vacondio, Federica/C-1295-2009; Mor, Marco/D-2394-2009	russo, roberto/0000-0001-5950-1617; Mor, Marco/0000-0003-0199-1849; GUIJARRO ANTON, Ana Isabel/0000-0002-1595-2173; Vacondio, Federica/0000-0002-0729-4385; CALIGNANO, Antonio/0000-0002-1742-3179; Sciolino, Natale/0000-0003-2794-1989	National Institutes on Drug Abuse; University of Parma; Italian Ministry for Public Education, University and Research; Fulbright Commission; University of California; Agilent Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	National Institutes on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of Parma; Italian Ministry for Public Education, University and Research; Fulbright Commission; University of California(University of California System); Agilent Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Dotsey for help with experiments. This research was supported by grants from the National Institutes on Drug Abuse (D.P. and A.G.H.), the University of Parma (M.M.) and the Italian Ministry for Public Education, University and Research (G.T., A.D and A.T.). G.M.-S. was partially supported by the Fulbright Commission and the Exchange Abroad Program, University of California. The support of the Agilent Foundation is gratefully acknowledged.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ahluwalia J, 2003, J NEUROCHEM, V84, P585, DOI 10.1046/j.1471-4159.2003.01550.x; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Clapper JR, 2009, CHEMMEDCHEM, V4, P1505, DOI 10.1002/cmdc.200900210; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Dziadulewicz EK, 2007, J MED CHEM, V50, P3851, DOI 10.1021/jm070317a; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Hohmann AG, 1999, NEUROSCIENCE, V92, P1171, DOI 10.1016/S0306-4522(99)00220-1; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Imai Y, 2003, MOL PHARMACOL, V64, P610, DOI 10.1124/mol.64.3.610; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kaufmann I, 2009, EUR SURG RES, V43, P325, DOI 10.1159/000235870; Kunos G, 2009, TRENDS PHARMACOL SCI, V30, P1, DOI 10.1016/j.tips.2008.10.001; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Nackley AG, 2003, NEUROSCIENCE, V117, P659, DOI 10.1016/S0306-4522(02)00870-9; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Russo R, 2007, EUR J PHARMACOL, V566, P117, DOI 10.1016/j.ejphar.2007.03.007; Sagar DR, 2008, BRIT J PHARMACOL, V155, P1297, DOI 10.1038/bjp.2008.335; Schlosburg JE, 2009, AAPS J, V11, P39, DOI 10.1208/s12248-008-9075-y; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Stein Christoph, 2009, Handb Exp Pharmacol, P495, DOI 10.1007/978-3-540-79090-7_14; Tegeder I, 2003, BRAIN, V126, P1092, DOI 10.1093/brain/awg115	37	243	249	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1265	1270		10.1038/nn.2632	http://dx.doi.org/10.1038/nn.2632			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20852626	Green Accepted, Green Submitted			2022-12-24	WOS:000282171300019
J	Nishijima, T; Piriz, J; Duflot, S; Fernandez, AM; Gaitan, G; Gomez-Pinedo, U; Verdugo, JMG; Leroy, F; Soya, H; Nunez, A; Torres-Aleman, I				Nishijima, Takeshi; Piriz, Joaquin; Duflot, Sylvie; Fernandez, Ana M.; Gaitan, Gema; Gomez-Pinedo, Ulises; Garcia Verdugo, Jose M.; Leroy, Felix; Soya, Hideaki; Nunez, Angel; Torres-Aleman, Ignacio			Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNS	NEURON			English	Article							RAT-BRAIN; RECEPTORS; MATRIX-METALLOPROTEINASE-9; NEUROPROTECTION; NEUROGENESIS; HYPOTHESIS; EXERCISE; MEGALIN; BINDING	Upon entry into the central nervous system (CNS), serum insulin-like growth factor-1 (IGF-I) modulates neuronal growth, survival, and excitability. Yet mechanisms that trigger IGF-I entry across the blood-brain barrier remain unclear. We show that neuronal activity elicited by electrical, sensory, or behavioral stimulation increases IGF-I input in activated regions. Entrance of serum IGF-I is triggered by diffusible messengers (i.e., ATP, arachidonic acid derivatives) released during neurovascular coupling. These messengers stimulate matrix metalloproteinase-9, leading to cleavage of the IGF binding protein-3 (IGFBP-3). Cleavage of IGFBP-3 allows the passage of serum IGF-I into the CNS through an interaction with the endothelial transporter lipoprotein related receptor 1. Activity-dependent entrance of serum IGF-I into the CNS may help to explain disparate observations such as proneurogenic effects of epilepsy, rehabilitatory effects of neural stimulation, and modulatory effects of blood flow on brain activity.	[Nishijima, Takeshi; Piriz, Joaquin; Duflot, Sylvie; Fernandez, Ana M.; Gaitan, Gema; Leroy, Felix; Torres-Aleman, Ignacio] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Nishijima, Takeshi; Piriz, Joaquin; Duflot, Sylvie; Fernandez, Ana M.; Gaitan, Gema; Leroy, Felix; Torres-Aleman, Ignacio] CIBERNED, Madrid 28002, Spain; [Gomez-Pinedo, Ulises; Garcia Verdugo, Jose M.] Univ Valencia, CIPF, Valencia 46110, Spain; [Gomez-Pinedo, Ulises; Garcia Verdugo, Jose M.] CIBERNED, Valencia 46110, Spain; [Soya, Hideaki] Univ Tsukuba, Tsukuba, Ibaraki 3058574, Japan; [Nunez, Angel] Univ Autonoma Madrid, Madrid 28029, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Prince Felipe Research Center; University of Valencia; CIBERNED; University of Tsukuba; Autonomous University of Madrid	Torres-Aleman, I (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	torres@cajal.csic.es	Nuñez, Angel/Y-9137-2019; leroy, felix/X-2748-2019; Torres-Aleman, Ignacio/A-1613-2008; , ulises.gomez-pinedo/C-3414-2016; García-Verdugo, José Manuel/L-8421-2017	Nuñez, Angel/0000-0002-8013-4812; Torres-Aleman, Ignacio/0000-0001-8107-7947; , ulises.gomez-pinedo/0000-0003-3097-5557; García-Verdugo, José Manuel/0000-0001-9872-6499; Piriz, Joaquin/0000-0002-4588-6568; Fernandez, Ana M./0000-0001-5160-3854; leroy, felix/0000-0003-1715-3233	Spanish Ministry of Science [SAF2007-60051]; CIBERNED; Japan-Spain collaborative program [JSPS-CSIC-2006JP0010]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERNED(Instituto de Salud Carlos III); Japan-Spain collaborative program	We are thankful to I. Alvarez, M. Garcia, M. Oliva, and L. Guinea for technical support and L. Genis and A. Trueba for help with the cell cultures. This work was funded by Spanish Ministry of Science (SAF2007-60051), by CIBERNED, and by a joint Japan-Spain collaborative program (JSPS-CSIC-2006JP0010). IT-A. is founder of a company (9% ownership) devoted to the use of IGF-I for neurodegenerative diseases.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Arwert LI, 2005, NEUROENDOCRINOLOGY, V81, P31, DOI 10.1159/000084872; AULETTA M, 1992, J NEUROSCI RES, V31, P14, DOI 10.1002/jnr.490310103; Banks WA, 2006, ENDOCRINOLOGY, V147, P2609, DOI 10.1210/en.2006-0335; Banks WA, 2010, BBA-MOL BASIS DIS, V1802, P881, DOI 10.1016/j.bbadis.2009.10.011; Bilodeau N, 2010, J PROTEOME RES, V9, P708, DOI 10.1021/pr900481b; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Carro E, 2003, MOL NEUROBIOL, V27, P153, DOI 10.1385/MN:27:2:153; Carro E, 2000, J NEUROSCI, V20, P2926; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Ciucci F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000475; Dietrich MO, 2008, NEUROBIOL AGING, V29, P902, DOI 10.1016/j.neurobiolaging.2007.01.008; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; GARCIASEGURA LM, 1991, BRAIN RES, V560, P167, DOI 10.1016/0006-8993(91)91228-S; GEARY ES, 1989, HORM METAB RES, V21, P1, DOI 10.1055/s-2007-1009135; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Kaelin-Lang A, 2008, NEUROREHABILITATION, V23, P89; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Lee WH, 1999, ENDOCRINE, V11, P181, DOI 10.1385/ENDO:11:2:181; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101; Manes S, 1999, J BIOL CHEM, V274, P6935, DOI 10.1074/jbc.274.11.6935; MARKS JL, 1991, MOL ENDOCRINOL, V5, P1158, DOI 10.1210/mend-5-8-1158; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Moore CI, 2008, J NEUROPHYSIOL, V99, P2035, DOI 10.1152/jn.01366.2006; Nunez A, 2003, J NEUROPHYSIOL, V89, P3008, DOI 10.1152/jn.00089.2003; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; PARDRIDGE WM, 1993, ANN NY ACAD SCI, V692, P126; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091; Pulford BE, 2001, ENDOCRINOLOGY, V142, P213, DOI 10.1210/en.142.1.213; REINHARDT RR, 1994, ENDOCRINOLOGY, V135, P1753, DOI 10.1210/en.135.5.1753; Roy C S, 1890, J Physiol, V11, P85; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Shi YR, 2008, J CEREBR BLOOD F MET, V28, P111, DOI 10.1038/sj.jcbfm.9600511; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	47	204	215	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 9	2010	67	5					834	846		10.1016/j.neuron.2010.08.007	http://dx.doi.org/10.1016/j.neuron.2010.08.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	651PF	20826314	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000281938900017
J	Duvick, L; Barnes, J; Ebner, B; Agrawa, S; Andresen, M; Lim, J; Giesler, GJ; Zoghbi, HY; Orr, HT				Duvick, Lisa; Barnes, Justin; Ebner, Blake; Agrawa, Smita; Andresen, Michael; Lim, Janghoo; Giesler, Glenn J.; Zoghbi, Huda Y.; Orr, Harry T.			SCA1-like Disease in Mice Expressing Wild-Type Ataxin-1 with a Serine to Aspartic Acid Replacement at Residue 776	NEURON			English	Article							SCA1 TRANSGENIC MICE; POLYGLUTAMINE-INDUCED DISEASE; HUMAN MUTANT HUNTINGTIN; TRINUCLEOTIDE REPEAT; MOUSE MODEL; NEURODEGENERATION; AGGREGATION; DEGENERATION; DYSFUNCTION; DISORDERS	Glutamine tract expansion triggers nine neurodegenerative diseases by conferring toxic properties to the mutant protein. In SCA1, phosphorylation of ATXN1 at Ser776 is thought to be key for pathogenesis. Here, we show that replacing Ser776 with a phosphomimicking Asp converted ATXN1 with a wild-type glutamine tract into a pathogenic protein. ATXN1[30Q]-D776-induced disease in Purkinje cells shared most features with disease caused by ATXN1[82Q] having an expanded polyglutamine tract. However, in contrast to disease induced by ATXN1[82Q] that progresses to cell death, ATXN1[30Q]-D776 failed to induce cell death. These results support a model where pathogenesis involves changes in regions of the protein in addition to the polyglutamine tract. Moreover, disease initiation and progression to neuronal dysfunction are distinct from induction of cell death. Ser776 is critical for the pathway to neuronal dysfunction, while an expanded polyglutamine tract is essential for neuronal death.	[Duvick, Lisa; Barnes, Justin; Ebner, Blake; Agrawa, Smita; Andresen, Michael; Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Duvick, Lisa; Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Barnes, Justin; Giesler, Glenn J.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Lim, Janghoo; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Dept Mol Genet, Houston, TX 77030 USA; [Lim, Janghoo; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Dept Human Genet, Houston, TX 77030 USA; [Lim, Janghoo; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Dept Pediat, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute	Orr, HT (corresponding author), Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA.	orrxx002@umn.edu		Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	NIH/NINDS [NS062561, NS048944, NS022920, NS045667]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045667, R01NS048944, R01NS027699, F31NS062561, R37NS022920, R01NS022920] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Orion Rainwater and Robert Ehlenfeldt for propagation of transgenic mouse lines and DigiGait analysis. This study was supported by NIH/NINDS grants NS062561, NS048944 (J.B.), NS (H.Y.Z.), and NS022920 and NS045667 (H.T.O.).	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Clark HB, 1997, J NEUROSCI, V17, P7385; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Ito M, 1984, CEREBELLUM NEURAL CO; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	29	110	115	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					929	935		10.1016/j.neuron.2010.08.022	http://dx.doi.org/10.1016/j.neuron.2010.08.022			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869591	Bronze, Green Accepted			2022-12-24	WOS:000282801100006
J	Li, N; DiCarlo, JJ				Li, Nuo; DiCarlo, James J.			Unsupervised Natural Visual Experience Rapidly Reshapes Size-Invariant Object Representation in Inferior Temporal Cortex	NEURON			English	Article							LONG-TERM-MEMORY; INFEROTEMPORAL CORTEX; NEURONS; RECOGNITION; SELECTIVITY; RESPONSES; FACE; ASSOCIATION; POSITION; MONKEYS	We easily recognize objects and faces across a myriad of retinal images produced by each object. One hypothesis is that this tolerance (a.k.a. "invariance") is learned by relying on the fact that object identities are temporally stable. While we previously found neuronal evidence supporting this idea at the top of the nonhuman primate ventral visual stream (inferior temporal cortex, or IT), we here test if this is a general tolerance learning mechanism. First, we found that the same type of unsupervised experience that reshaped IT position tolerance also predictably reshaped IT size tolerance, and the magnitude of reshaping was quantitatively similar. Second, this tolerance reshaping can be induced under naturally occurring dynamic visual experience, even without eye movements. Third, unsupervised temporal contiguous experience can build new neuronal tolerance. These results suggest that the ventral visual stream uses a general unsupervised tolerance learning algorithm to build its invariant object representation.	[Li, Nuo; DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	DiCarlo, JJ (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	dicarlo@mit.edu			NIH [R01-EY014970]; NRSA [1F31EY020057]; McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE [R01EY014970, F31EY020057] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Professors T. Poggio, N. Kanwisher, and E. Miller and the members of our laboratory for valuable discussion and comment on this work. We also thank J. Deutsch, B. Andken, and Dr. R. Marini for technical support. This work was supported by the NIH (grant R01-EY014970 and its ARRA supplement to J.J.D., NRSA 1F31EY020057 to N.L.) and The McKnight Endowment Fund for Neuroscience.	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Brady TF, 2008, PSYCHOL SCI, V19, P678, DOI 10.1111/j.1467-9280.2008.02142.x; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Cox DD, 2005, NAT NEUROSCI, V8, P1145, DOI 10.1038/nn1519; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li N, 2009, J NEUROPHYSIOL, V102, P360, DOI 10.1152/jn.90745.2008; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masquelier T., 2007, LEARNING COMPLEX CEL; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Sigala N, 2002, J COGNITIVE NEUROSCI, V14, P187, DOI 10.1162/089892902317236830; SPREKELER H, 2009, ROBUST LEARNING POSI; Sprekeler H, 2007, PLOS COMPUT BIOL, V3, P1136, DOI 10.1371/journal.pcbi.0030112; STRYKER MP, 1991, NATURE, V354, P108, DOI 10.1038/354108d0; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Vogels R, 1996, PROG BRAIN RES, V112, P195; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wallis G, 1998, NETWORK-COMP NEURAL, V9, P265, DOI 10.1088/0954-898X/9/2/007; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; Wallis G, 2009, J VISION, V9, DOI 10.1167/9.7.6; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wyss R, 2006, PLOS BIOL, V4, P836, DOI 10.1371/journal.pbio.0040120	47	77	78	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP	2010	67	6					1062	1075		10.1016/j.neuron.2010.08.029	http://dx.doi.org/10.1016/j.neuron.2010.08.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	662IN	20869601	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000282801100016
J	Staerk, J; Dawlaty, MM; Gao, Q; Maetzel, D; Hanna, J; Sommer, CA; Mostoslavsky, G; Jaenisch, R				Staerk, Judith; Dawlaty, Meelad M.; Gao, Qing; Maetzel, Dorothea; Hanna, Jacob; Sommer, Cesar A.; Mostoslavsky, Gustavo; Jaenisch, Rudolf			Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							COLONY-STIMULATING FACTOR; HUMAN SOMATIC-CELLS; MATURE B; RECEPTOR; GENERATION; DIFFERENTIATION; PURIFICATION; SELECTION; LEUKEMIA; HYPAQUE		[Staerk, Judith; Dawlaty, Meelad M.; Gao, Qing; Maetzel, Dorothea; Hanna, Jacob; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, Boston, MA 02118 USA; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Boston University; Boston University; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Sommer, Cesar A/H-7062-2012; Sommer, Cesar A/H-9187-2013; Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Mostoslavsky, Gustavo/0000-0002-0784-2169; Staerk, Judith/0000-0001-8698-6998	NIH [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869]; Harvard Clinical and Translational Science Center, from the National Center for Research Resources [UL1 RR025758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R01CA087869, R37CA084198] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center, from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Raaji Alaggapan and Ping Xu for support with tissue culture and Jessie Dausman, Ruth Flannery, and Dongdong Fu for help with animal husbandry and teratoma processing. We thank all volunteers for donating blood, Catherine Ricciardi at CRC for taking blood, Dirk Hockemeyer for providing the 800 bp TTAGGG telomere probe and advice with telomere Southern blots, and members of the Jaenisch lab for critical reading of the manuscript. R.J. is supported by NIH grants 5-RO1-HDO45022, 5-R37-CA084198, and 5-RO1-CA087869. J.S. is a long-term HFSP postdoctoral fellow; M.M.D. is a Damon Runyon postdoctoral fellow. R.J. is an advisor to Stemgent and Fate Therapeutics. Blood donations were conducted at the Clinical Research Center (CRC) at the Massachusetts Institute of Technology, supported by Grant Number UL1 RR025758-Harvard Clinical and Translational Science Center, from the National Center for Research Resources. Experiments with human subjects have been approved by the MIT Committee on the Use of Humans as Experimental Subjects.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Miller CP, 2009, STEM CELLS, V27, P2353, DOI 10.1002/stem.156; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Touw IP, 1997, BAILLIERE CLIN HAEM, V10, P577, DOI 10.1016/S0950-3536(97)80027-3; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	30	285	313	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					20	24		10.1016/j.stem.2010.06.002	http://dx.doi.org/10.1016/j.stem.2010.06.002			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621045	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000280222300008
J	Cremona, ML; Matthies, HJG; Pau, K; Bowton, E; Speed, N; Lute, BJ; Anderson, M; Sen, N; Robertson, SD; Vaughan, RA; Rothman, JE; Galli, A; Javitch, JA; Yamamoto, A				Cremona, M. Laura; Matthies, Heinrich J. G.; Pau, Kelvin; Bowton, Erica; Speed, Nicole; Lute, Brandon J.; Anderson, Monique; Sen, Namita; Robertson, Sabrina D.; Vaughan, Roxanne A.; Rothman, James E.; Galli, Aurelio; Javitch, Jonathan A.; Yamamoto, Ai			Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CLATHRIN-DEPENDENT MECHANISM; CELL-SURFACE EXPRESSION; DOPAMINE TRANSPORTER; GLUTAMATE TRANSPORTER; LIPID MICRODOMAINS; RAFT MICRODOMAINS; COCAINE BINDING; RECEPTOR; CHOLESTEROL	Plasmalemmal neurotransmitter transporters (NTTs) regulate the level of neurotransmitters, such as dopamine (DA) and glutamate, after their release at brain synapses. Stimuli including protein kinase C (PKC) activation can lead to the internalization of some NTTs and a reduction in neurotransmitter clearance capacity. We found that the protein Flotillin-1 (Flot1), also known as Reggie-2, was required for PKC-regulated internalization of members of two different NTT families, the DA transporter (DAT) and the glial glutamate transporter EAAT2, and we identified a conserved serine residue in Flot1 that is essential for transporter internalization. Further analysis revealed that Flot1 was also required to localize DAT within plasma membrane microdomains in stable cell lines, and was essential for amphetamine-induced reverse transport of DA in neurons but not for DA uptake. In sum, our findings provide evidence for a critical role of Flot1-enriched membrane microdomains in PKC-triggered DAT endocytosis and the actions of amphetamine.	[Cremona, M. Laura; Pau, Kelvin; Anderson, Monique; Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA; [Cremona, M. Laura; Pau, Kelvin; Anderson, Monique; Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA; [Matthies, Heinrich J. G.; Bowton, Erica; Speed, Nicole; Lute, Brandon J.; Robertson, Sabrina D.; Galli, Aurelio] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Mol Neurosci, Kennedy Ctr, Nashville, TN 37232 USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY USA; [Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58201 USA; [Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Columbia University; Columbia University; Vanderbilt University; Columbia University; Columbia University; Columbia University; University of North Dakota Grand Forks; Yale University	Yamamoto, A (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA.	ay46@columbia.edu	Yamamoto, Ai/D-1100-2011; Matthies, Heinrich/AAD-2375-2019; Matthies, Heinrich/B-7284-2017	Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Javitch, Jonathan/0000-0001-7395-2967; Robertson, Sabrina/0000-0003-4598-6929	US National Institute of Neurological Disorders and Stroke [RO1 NS050199]; Parkinson's Disease Foundation; US National Institute on Drug Abuse [PO1 DA12408, DA13975, K05 DA022413, DA13147]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R01DA013975, P01DA012408, R01DA013147, R56DA013975] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson's Disease Foundation; US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Karam, T. Melia, A. Pizzo, H. Stenmark and H. Yano for critical reading of this manuscript, and J. Rothstein (Johns Hopkins) for the Eaat2 cDNA. This work was supported by US National Institute of Neurological Disorders and Stroke research grant RO1 NS050199 and the Parkinson's Disease Foundation (A.Y.) and US National Institute on Drug Abuse research grants PO1 DA12408 (A. G. and J. A. J.), DA13975 (A. G.), K05 DA022413 (J. A. J.) and DA13147 (R. A. V.).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Becart S, 2003, J CELL SCI, V116, P2565, DOI 10.1242/jcs.00449; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Buckley KM, 2000, J PHYSIOL-LONDON, V525, P11, DOI 10.1111/j.1469-7793.2000.t01-2-00011.x; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Galbiati F, 1998, GENE, V210, P229, DOI 10.1016/S0378-1119(98)00064-X; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jacobowitz DM, 2004, NEUROTOX RES, V6, P245, DOI 10.1007/BF03033435; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Wang LB, 2003, J LIPID RES, V44, P807, DOI 10.1194/jlr.M200449-JLR200; Wharton J, 2005, J BIOL CHEM, V280, P13483, DOI 10.1074/jbc.M413891200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	50	139	142	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					469	U103		10.1038/nn.2781	http://dx.doi.org/10.1038/nn.2781			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21399631	Green Accepted			2022-12-24	WOS:000288849400018
J	Kleinlogel, S; Feldbauer, K; Dempski, RE; Fotis, H; Wood, PG; Bamann, C; Bamberg, E				Kleinlogel, Sonja; Feldbauer, Katrin; Dempski, Robert E.; Fotis, Heike; Wood, Phillip G.; Bamann, Christian; Bamberg, Ernst			Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh	NATURE NEUROSCIENCE			English	Article							RESTORES VISUAL RESPONSES; SURFACE-CHARGE; PHOTOCYCLE; CHANNELS; CALCIUM; BACTERIORHODOPSIN; EXPRESSION; MEMBRANE; CELLS; MICE	The light-gated cation channel channelrhodopsin-2 (ChR2) has rapidly become an important tool in neuroscience, and its use is being considered in therapeutic interventions. Although wild-type and known variant ChR2s are able to drive light-activated spike trains, their use in potential clinical applications is limited by either low light sensitivity or slow channel kinetics. We present a new variant, calcium translocating channelrhodopsin (CatCh), which mediates an accelerated response time and a voltage response that is similar to 70-fold more light sensitive than that of wild-type ChR2. CatCh's superior properties stem from its enhanced Ca2+ permeability. An increase in [Ca2+](i) elevates the internal surface potential, facilitating activation of voltage-gated Na+ channels and indirectly increasing light sensitivity. Repolarization following light-stimulation is markedly accelerated by Ca2+-dependent BK channel activation. Our results demonstrate a previously unknown principle: shifting permeability from monovalent to divalent cations to increase sensitivity without compromising fast kinetics of neuronal activation. This paves the way for clinical use of light-gated channels.	[Kleinlogel, Sonja; Feldbauer, Katrin; Dempski, Robert E.; Fotis, Heike; Wood, Phillip G.; Bamann, Christian; Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Chem & Pharmaceut Sci Dept, Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Bamberg, E (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	ernst.bamberg@biophys.mpg.de		Bamann, Christian/0000-0001-7473-438X	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 807]; Centre of Excellence Frankfurt Macromolecular Complexes; Federal Ministry of Education and Research of Germany [01GQ0815]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre of Excellence Frankfurt Macromolecular Complexes; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We would like to thank I. Bartnik for the preparation of the hippocampal neuron cultures, S. O'Shea for the help with the calcium imaging experiments, V. Busskamp for the support in recombinant adeno-associated virus construction, H. Biehl for excellent technical assistance, and K. Hartung, H. Spors, U. Terpitz and M. van Wyk for helpful discussions. The work was supported by grants from the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 807, Centre of Excellence Frankfurt Macromolecular Complexes and the Federal Ministry of Education and Research of Germany (01GQ0815) to E.B., and by the Max Planck Society.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cady C, 2001, BRAIN RES, V921, P1, DOI 10.1016/S0006-8993(01)03063-3; Caldwell JH, 2008, J BIOL CHEM, V283, P24300, DOI 10.1074/jbc.M802593200; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HILLE B, 2001, ION CHANNELS EXCITAB, P649; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joh NH, 2009, J AM CHEM SOC, V131, P10846, DOI 10.1021/ja904711k; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MULLER RU, 1972, J GEN PHYSIOL, V60, P285, DOI 10.1085/jgp.60.3.285; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; Subramaniam S, 1997, P NATL ACAD SCI USA, V94, P1767, DOI 10.1073/pnas.94.5.1767; Thyagarajan S, 2010, J NEUROSCI, V30, P8745, DOI 10.1523/JNEUROSCI.4417-09.2010; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	280	303	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					513	U152		10.1038/nn.2776	http://dx.doi.org/10.1038/nn.2776			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21399632				2022-12-24	WOS:000288849400023
J	Caretti, G; Palacios, D; Sartorelli, V; Puri, PL				Caretti, Giuseppina; Palacios, Daniela; Sartorelli, Vittorio; Puri, Pier Lorenzo			Phosphoryl-EZH-ion	CELL STEM CELL			English	Review							SUPPRESSES METHYLATION; SKELETAL-MUSCLE; GENE-EXPRESSION; PROTEIN EZH2; POLYCOMB; CHROMATIN; DIFFERENTIATION; KINASES; ATLAS; CELLS	Polycomb group (PcG) proteins regulate gene expression in embryonic and adult stem cells, but the mechanisms responsible for PcG gene targeting and regulation remain largely unknown. Recent evidence shows that EZH2, the enzymatic subunit of Polycomb Repressive Complex 2 (PRC2), is a nuclear phosphoprotein linking cell-cycle-intrinsic or extracellular signals to specific epigenetic signatures.	[Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Caretti, Giuseppina] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Palacios, Daniela; Puri, Pier Lorenzo] IRCCS Fdn Santa Lucia, DTI, I-00143 Rome, Italy; [Palacios, Daniela; Puri, Pier Lorenzo] European Brain Res Inst, I-00143 Rome, Italy; [Puri, Pier Lorenzo] Sanford Burnham Inst Med Res, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Milan; IRCCS Santa Lucia; Sanford Burnham Prebys Medical Discovery Institute	Sartorelli, V (corresponding author), NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA.	sartorev@mail.nih.gov; plpuri@dti.telethon.it	Palacios, Daniela/AAA-7608-2019; Palacios, Daniela/K-4698-2016	Palacios, Daniela/0000-0002-2207-2369; Palacios, Daniela/0000-0002-2207-2369; Puri, Pier Lorenzo/0000-0003-4964-0095; Sartorelli, Vittorio/0000-0002-9284-3675	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR053779]; AIRC [MFAG 5386]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041126, R01AR052779] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fondazione Telethon(Fondazione Telethon)	P.L.P. is an Associate Telethon Scientist of the Dulbecco Telethon Institute (DTI) and Associate Investigator of Sanford Children's Health Research Center. This work has been supported by R01 AR053779 from the National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (PLP) and by the Intramural Program of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health (V.S.). G.C. is supported by AIRC MFAG 5386. We thank Dr. D. Pasini and Dr. J.G. Ryall for critical reading of the manuscript.	Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chow CW, 2006, CELL, V127, P887, DOI 10.1016/j.cell.2006.11.015; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mozzetta C, 2011, CELL CYCLE, V10, P191, DOI 10.4161/cc.10.2.14441; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	24	24	24	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					262	265		10.1016/j.stem.2011.02.012	http://dx.doi.org/10.1016/j.stem.2011.02.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362566	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000288404400008
J	Kelly, KF; Ng, DY; Jayakumaran, G; Wood, GA; Koide, H; Doble, BW				Kelly, Kevin F.; Ng, Deborah Y.; Jayakumaran, Gowtham; Wood, Geoffrey A.; Koide, Hiroshi; Doble, Bradley W.			beta-Catenin Enhances Oct-4 Activity and Reinforces Pluripotency through a TCF-Independent Mechanism	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; NANOG EXPRESSION; WNT; ACTIVATION; DIFFERENTIATION; BLASTOCYST; TRANSCRIPTION; COMPETENCE; GENERATION	Understanding the mechanisms regulating pluripotency in embryonic and induced pluripotent stem cells is required to ensure their safe use in clinical applications. Glycogen synthase kinase-3 (GSK-3) has emerged as an important regulator of pluripotency, based primarily on studies with small-molecule GSK-3 inhibitors. Here, we use mouse embryonic stem cells (ESCs) lacking GSK-3 to demonstrate that a single GSK-3 substrate, beta-catenin, controls the ability of ESCs to exit the pluripotent state and to differentiate into neurectoderm. Unexpectedly, the effects of beta-catenin on pluripotency do not appear to be dependent on TCF-mediated signaling, based on experiments utilizing a beta-catenin C-terminal truncation mutant or highly efficient dominant-negative TCF strategies. Alternatively, we find that stabilized beta-catenin forms a complex with and enhances the activity of Oct-4, a core component of the transcriptional network regulating pluripotency. Collectively, our data suggest previously underappreciated, divergent TCF-dependent and TCF-independent roles for beta-catenin in ESCs.	[Kelly, Kevin F.; Ng, Deborah Y.; Doble, Bradley W.] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Ng, Deborah Y.; Jayakumaran, Gowtham; Doble, Bradley W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Wood, Geoffrey A.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Koide, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan	McMaster University; McMaster University; University of Guelph; Kanazawa University	Doble, BW (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	dobleb@mcmaster.ca	Doble, Bradley/V-7848-2019; Koide, Hiroshi/E-9000-2011; Doble, Brad/L-7551-2016; Wood, Geoffrey/ABB-2052-2021	Doble, Bradley/0000-0002-0260-2983; Doble, Brad/0000-0002-0260-2983; Wood, Geoffrey/0000-0003-1756-8607; Koide, Hiroshi/0000-0001-5916-3179	Canadian Institutes of Health Research [MOP85057, MOP89359, MOP102490]; Canada Research Chairs Program; Ontario Ministry of Research and Innovation; Ontario Ministry of Training, Colleges, and Universities; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Ministry of Training, Colleges, and Universities; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank Melissa Coubrough, Shravanti Rampalli, and Mary Jo Smith for their technical assistance and advice. We thank the following investigators who generously provided plasmid reagents: Dr. Randall Moon (TCF reporter), Dr. Bert Vogelstein (TCF4DN), Drs. Marian Waterman and Hans Clevers (TCF1DN), Dr. Hans Scholer (Oct reporter), and Dr. Jun-ichi Miyazaki (pCAGG). Funding was provided by the Canadian Institutes of Health Research to SW. D. (MOP85057, MOP89359, MOP102490) and K.F.K. (postdoctoral fellowship), the Canada Research Chairs Program (B.W.D.), the Ontario Ministry of Research and Innovation (B.W.D. and K.F.K.), the Ontario Ministry of Training, Colleges, and Universities (D.Y.N.), and the Canada Foundation for Innovation (B.W.D.).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Haegele L, 2003, MOL CELL NEUROSCI, V24, P696, DOI 10.1016/S1044-7431(03)00232-X; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	46	179	188	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					214	227		10.1016/j.stem.2010.12.010	http://dx.doi.org/10.1016/j.stem.2010.12.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295277	Green Accepted, Bronze			2022-12-24	WOS:000287633400014
J	Wang, YL; Li, GN; Stanco, A; Long, JE; Crawford, D; Potter, GB; Pleasure, SJ; Behrens, T; Rubenstein, JLR				Wang, Yanling; Li, Guangnan; Stanco, Amelia; Long, Jason E.; Crawford, Dianna; Potter, Gregory B.; Pleasure, Samuel J.; Behrens, Timothy; Rubenstein, John L. R.			CXCR4 and CXCR7 Have Distinct Functions in Regulating Interneuron Migration	NEURON			English	Article							CHEMOKINE RECEPTOR CXCR4; CELL-DERIVED FACTOR-1; CAJAL-RETZIUS CELLS; CORTICAL INTERNEURONS; BETA-ARRESTIN; GABAERGIC INTERNEURONS; VENTRAL TELENCEPHALON; TANGENTIAL MIGRATION; GANGLIONIC EMINENCES; MICE	CXCL12/CXCR4 signaling is critical for cortical interneuron migration and their final laminar distribution. No information is yet available on CXCR7, a newly defined CXCL12 receptor. Here we demonstrated that CXCR7 regulated interneuron migration autonomously, as well as nonautonomously through its expression in immature projection neurons. Migrating cortical interneurons coexpressed Cxcr4 and Cxcr7, and Cxcr7(-/-) and Cxcr4(-/-) mutants had similar defects in interneuron positioning. Ectopic CXCL12 expression and pharmacological blockade of CXCR4 in Cxcr7(-/-) mutants showed that both receptors were essential for responding to CXCL12 during interneuron migration. Furthermore, live imaging revealed that Cxcr4(-/-) and Cxcr7(-/-) mutants had opposite defects in interneuron motility and leading process morphology. In vivo inhibition of G alpha (i/o) signaling in migrating interneurons phenocopied the interneuron lamination defects of Cxcr4(-/-) mutants. On the other hand, CXCL12 stimulation of CXCR7, but not CXCR4, promoted MAP kinase signaling. Thus, we suggest that CXCR4 and CXCR7 have distinct roles and signal transduction in regulating interneuron movement and laminar positioning.	[Wang, Yanling; Stanco, Amelia; Potter, Gregory B.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Li, Guangnan; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Li, Guangnan; Pleasure, Samuel J.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Li, Guangnan; Pleasure, Samuel J.] Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94158 USA; [Long, Jason E.; Behrens, Timothy] Genentech Corp, San Francisco, CA 94080 USA; [Crawford, Dianna] Amgen Inc, Thousand Oaks, CA 91320 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; Amgen	Wang, YL (corresponding author), Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, 1550 4th St, San Francisco, CA 94158 USA.	yanling.wang@ucsf.edu; john.rubenstein@ucsf.edu		Potter, Gregory/0000-0002-0585-6575; /0000-0002-8589-4239	Citizens United for Research in Epilepsy (CURE.), Nina Ireland; Larry L. Hillblom Foundation; Weston Havens Foundation; NIMH [R37 MH049428]; Epilepsy Foundation;  [K02 MH074985];  [R01 MH077694]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074985, R37MH049428, T32MH089920, R01MH077694] Funding Source: NIH RePORTER	Citizens United for Research in Epilepsy (CURE.), Nina Ireland; Larry L. Hillblom Foundation; Weston Havens Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Epilepsy Foundation; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Marc von Zastrow and Mark Penfold for helpful discussions and reagents. This work was supported by the research grants to J.L.R.R. from Citizens United for Research in Epilepsy (CURE.), Nina Ireland, Larry L. Hillblom Foundation, Weston Havens Foundation, and NIMH R37 MH049428; to Y.W. from C.U.R.E Rhode Island Award from the Epilepsy Foundation; and to S.J.P. from K02 MH074985 and R01 MH077694. Timothy W. Behrens and Jason E. Long are full-time employees of Genentech, Inc. Dianna Crawford is a full-time employee of Amgen, Inc.	Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Bagri A, 2002, DEVELOPMENT, V129, P4249; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Baudoin JP, 2008, DEV NEUROSCI-BASEL, V30, P132, DOI 10.1159/000109858; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Lazarini F, 2000, EUR J NEUROSCI, V12, P117, DOI 10.1046/j.1460-9568.2000.00894.x; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; LIBERT F, 1991, GENOMICS, V11, P225, DOI 10.1016/0888-7543(91)90125-X; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; Loug JE, 2009, CEREB CORTEX, V19, pI96, DOI 10.1093/cercor/bhp045; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2000, J NEUROSCI, V20, P6063; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Reiner O, 2009, MOL NEUROBIOL, V40, P1, DOI 10.1007/s12035-009-8065-0; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stumm RK, 2003, J NEUROSCI, V23, P5123; Sussel L, 1999, DEVELOPMENT, V126, P3359; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	63	208	213	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 13	2011	69	1					61	76		10.1016/j.neuron.2010.12.005	http://dx.doi.org/10.1016/j.neuron.2010.12.005			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709NB	21220099	Green Accepted, Bronze			2022-12-24	WOS:000286446300008
J	Di Marzo, V				Di Marzo, Vincenzo			Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight	NATURE NEUROSCIENCE			English	Article							DIACYLGLYCEROL LIPASE-ALPHA; VANILLOID TYPE-1 RECEPTORS; MOUSE-BRAIN; IMMUNOHISTOCHEMICAL LOCALIZATION; INHIBITORY SYNAPSES; MULTIPLE MECHANISMS; CEREBELLAR CORTEX; DOPAMINE NEURONS; 2-ARACHIDONOYLGLYCEROL; SYSTEM	Studies of the endocannabinoid system in the CNS have been mostly focused on endocannabinoid receptors and inactivating mechanisms. Until recently, very little was known about the role of biosynthetic enzymes in endocannabinoid signaling. New data from the recent development of pharmacological and genetic tools for the study of these enzymes point to their fundamental role in determining where and when endocannabinoids function, and raise the possibility of new intriguing and previously unsuspected concepts in the general strategy of endocannabinoid signaling. However, even with these new tools, the cross-talk between anandamide and 2-arachidonoylglycerol biosynthesis makes it difficult to dissect one from the other, and data will need to be interpreted with this in mind.	CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy	Consiglio Nazionale delle Ricerche (CNR)	Di Marzo, V (corresponding author), CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy.	vdimarzo@icmib.na.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070	US National Institutes of Health [DA-009789]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The author thanks T. Bisogno and S. Petrosino for their help. Support from the US National Institutes of Health (grant DA-009789) is also acknowledged.	Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 2009, CHEMMEDCHEM, V4, P946, DOI 10.1002/cmdc.200800442; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; D'Asti E, 2010, ENDOCRINOLOGY, V151, P1685, DOI 10.1210/en.2009-1092; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; Fukaya M, 2008, EUR J NEUROSCI, V28, P1744, DOI 10.1111/j.1460-9568.2008.06495.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gomez O, 2010, GLIA, V58, P1913, DOI 10.1002/glia.21061; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hashimotodani Y, 2008, NEUROPHARMACOLOGY, V54, P58, DOI 10.1016/j.neuropharm.2007.06.002; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Marinelli S, 2009, NAT NEUROSCI, V12, P1488, DOI 10.1038/nn.2430; Marinelli S, 2008, J NEUROSCI, V28, P13532, DOI 10.1523/JNEUROSCI.0847-08.2008; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Min R, 2010, J NEUROSCI, V30, P2710, DOI 10.1523/JNEUROSCI.BC-3622-09.2010; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Nomura S, 2007, EUR J NEUROSCI, V25, P659, DOI 10.1111/j.1460-9568.2007.05334.x; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Roloff AM, 2010, J NEUROSCI, V30, P3072, DOI 10.1523/JNEUROSCI.4603-09.2010; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; van der Stelt M, 2005, EMBO J, V24, P3026, DOI 10.1038/sj.emboj.7600784; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	50	125	126	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2011	14	1					9	15		10.1038/nn.2720	http://dx.doi.org/10.1038/nn.2720			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699TE	21187849				2022-12-24	WOS:000285684900005
J	Ables, ET; Drummond-Barbosa, D				Ables, Elizabeth T.; Drummond-Barbosa, Daniela			The Steroid Hormone Ecdysone Functions with Intrinsic Chromatin Remodeling Factors to Control Female Germline Stem Cells in Drosophila	CELL STEM CELL			English	Article							BREAST-CANCER; NUCLEAR RECEPTORS; BROAD-COMPLEX; INSULIN; GENE; METAMORPHOSIS; TRANSCRIPTION; MELANOGASTER; MAINTENANCE; OOGENESIS	Steroid hormones are known systemic regulators of multiple normal and cancerous tissues; however, whether or how they impact the fate and function of adult stem cells is unclear. In the Drosophila ovary, insulin signals modulate the proliferation and self-renewal of germline stem cells (GSCs), yet despite evidence that additional systemic factors control GSC activity, these have remained largely unknown. Here, we report that ecdysone, a steroid hormone structurally related to mammalian sex steroids, directly regulates adult GSC proliferation and self-renewal independently of insulin signaling. Ecdysone controls GSCs through a functional interaction with the chromatin remodeling factors ISWI, an intrinsic epigenetic factor required for GSC fate and activity, and Nurf301, the largest subunit of the ISWI-containing NURF chromatin remodeling complex. Our findings support a link between systemic steroid hormones and the intrinsic chromatin remodeling machinery as a potential mechanism to promote broad transcriptional programs required for adult stem cell self-renewal.	[Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Reprod Biol, Baltimore, MD 21205 USA; [Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Drummond-Barbosa, D (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	dbarbosa@jhsph.edu		Ables, Elizabeth/0000-0002-6934-9302	National Institutes of Health [R01 GM069875, T32 DK007563, F32 GM086031]; American Cancer Society [RSG-DDC-112316]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069875, F32GM086031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank M. Bender, E. Hafen, T. Lee, E. Matunis, C. Cherry, D. Montell, J. Truman, J. Tamkun, J. Maines, W.-M. Deng, T. Nystul, A. Spradling, the Bloomington Stock Center, and the Developmental Studies Hybridoma Bank for reagents; the Vanderbilt and Johns Hopkins Microscopy Facilities; and V. Culotta, B. Zirkin, H.-J. Hsu, and L. LaFever for critical reading of this manuscript. E.T.A. and D.D.-B. designed experiments, interpreted results, and wrote the manuscript. E.T.A. performed all experiments. This work was supported by National Institutes of Health R01 GM069875 and American Cancer Society RSG-DDC-112316. E.T.A. was supported by training grant T32 DK007563 and National Research Service Award F32 GM086031 from the National Institutes of Health.	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carney GE, 2000, GENETICS, V154, P1203; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; D'Errico I, 2008, CELL MOL LIFE SCI, V65, P1523, DOI 10.1007/s00018-008-7552-1; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng WM, 1997, DEVELOPMENT, V124, P4639; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Fair Alecia Malin, 2009, V472, P57, DOI 10.1007/978-1-60327-492-0_3; Flajollet S, 2007, MOL CELL ENDOCRINOL, V270, P23, DOI 10.1016/j.mce.2007.02.004; FLETCHER JC, 1995, GENETICS, V141, P1025; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Ghbeish N, 2001, P NATL ACAD SCI USA, V98, P3867, DOI 10.1073/pnas.061437798; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Jeong Y, 2009, EXP MOL MED, V41, P525, DOI 10.3858/emm.2009.41.8.091; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lanzino M, 2008, CURR CANCER DRUG TAR, V8, P597, DOI 10.2174/156800908786241104; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Ninov N, 2009, PLOS BIOL, V7, P892, DOI 10.1371/journal.pbio.1000079; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Schubiger M, 2005, DEVELOPMENT, V132, P5239, DOI 10.1242/dev.02093; SCHWARTZ MB, 1985, J INSECT PHYSIOL, V31, P947, DOI 10.1016/0022-1910(85)90029-0; Spradling Allan C., 1993, P1; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Xu W, 2005, BIOCHEM CELL BIOL, V83, P418, DOI 10.1139/O05-057	58	108	110	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					581	592		10.1016/j.stem.2010.10.001	http://dx.doi.org/10.1016/j.stem.2010.10.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040900	Green Accepted, Bronze			2022-12-24	WOS:000284390500010
J	Bell, RD; Winkler, EA; Sagare, AP; Singh, I; LaRue, B; Deane, R; Zlokovic, BV				Bell, Robert D.; Winkler, Ethan A.; Sagare, Abhay P.; Singh, Itender; LaRue, Barb; Deane, Rashid; Zlokovic, Berislav V.			Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging	NEURON			English	Article							AMYLOID-BETA PEPTIDE; PDGF-B; PROGENITOR CELLS; MOTOR-NEURONS; MOUSE MODELS; MUTANT MICE; BARRIER; DEFICIENT; RECEPTOR; EXPRESSION	Pericytes play a key role in the development of cerebral microcirculation. The exact role of pericytes in the neurovascular unit in the adult brain and during brain aging remains, however, elusive. Using adult viable pericyte-deficient mice, we show that pericyte loss leads to brain vascular damage by two parallel pathways: (1) reduction in brain microcirculation causing diminished brain capillary perfusion, cerebral blood flow, and cerebral blood flow responses to brain activation that ultimately mediates chronic perfusion stress and hypoxia, and (2) blood-brain barrier breakdown associated with brain accumulation of serum proteins and several vasculotoxic and/or neurotoxic macromolecules ultimately leading to secondary neuronal degenerative changes. We show that age-dependent vascular damage in pericyte-deficient mice precedes neuronal degenerative changes, learning and memory impairment, and the neuroinflammatory response. Thus, pericytes control key neurovascular functions that are necessary for proper neuronal structure and function, and pericyte loss results in a progressive age-dependent vascular-mediated neurodegeneration.	[Bell, Robert D.; Winkler, Ethan A.; Sagare, Abhay P.; Singh, Itender; LaRue, Barb; Deane, Rashid; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Bell, Robert D.; Winkler, Ethan A.; Sagare, Abhay P.; Singh, Itender; LaRue, Barb; Deane, Rashid; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurol, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu	Sagare, Abhay/Y-3273-2019	Sagare, Abhay/0000-0002-8178-3785	National Institutes of Health [R37AG023084, R37NS34467]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health Grants R37AG023084 and R37NS34467 to B.V.Z. We thank Dr. Philippe Soriano for providing the breeding pairs for Pdgfr beta<SUP>+/</SUP> mice and the F7 mutants, Rachal Love for assisting with experiments in Meox2<SUP>+/-</SUP> mice, Theresa Barrett for assisting with Golgi-Cox imaging, Dr. Maiken Nedergaard for letting us use her electophysiologic equipment for LFP measurements, Dr. Karl Kasischke for assistance in measurements of blood flow responses to electrical hind limb stimulation, and Dr. Harris Gelbard and Daniel Marker for reviewing electro-physiological data.	Alikhani M, 2010, MOL VIS, V16, P408; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen B, 2010, STROKE, V41, pE351; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Diffley JM, 2009, MOL VIS, V15, P135; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Kroll S, 2009, ANN NY ACAD SCI, V1165, P228, DOI 10.1111/j.1749-6632.2009.04040.x; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu XS, 2007, NEUROSCIENCE, V146, P1053, DOI 10.1016/j.neuroscience.2007.02.056; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; Mackic JB, 1998, J NEUROCHEM, V70, P210; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Rule RR, 2010, NEUROLOGY, V74, P821, DOI 10.1212/WNL.0b013e3181d3e2dd; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; Shimizu F, 2011, J CELL PHYSIOL, V226, P255, DOI 10.1002/jcp.22337; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Ten VS, 2004, STROKE, V35, P2183, DOI 10.1161/01.STR.0000137768.25203.df; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; VATES GE, 2010, AM J PATHOL, V171, P1989; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Winters BD, 2005, J NEUROSCI, V25, P52, DOI 10.1523/JNEUROSCI.3827-04.2005; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	61	944	970	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					409	427		10.1016/j.neuron.2010.09.043	http://dx.doi.org/10.1016/j.neuron.2010.09.043			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040844	Bronze, Green Accepted			2022-12-24	WOS:000284255800011
J	Bender, KJ; Ford, CP; Trussell, LO				Bender, Kevin J.; Ford, Christopher P.; Trussell, Laurence O.			Dopaminergic Modulation of Axon Initial Segment Calcium Channels Regulates Action Potential Initiation	NEURON			English	Article							DORSAL COCHLEAR NUCLEUS; CEREBELLAR PURKINJE NEURONS; PROTEIN-KINASE-C; NEOCORTICAL PYRAMIDAL NEURONS; VENTRAL TEGMENTAL AREA; SODIUM-CHANNELS; COINCIDENCE DETECTION; CARTWHEEL NEURONS; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA	Action potentials initiate in the axon initial segment (AIS), a specialized compartment enriched with Na(+) and K(+) channels. Recently, we found that T- and R-type Ca(2+) channels are concentrated in the AIS, where they contribute to local subthreshold membrane depolarization and thereby influence action potential initiation. While periods of high-frequency activity can alter availability of AIS voltage-gated channels, mechanisms for long-term modulation of AIS channel function remain unknown. Here, we examined the regulatory pathways that control AIS Ca(2+) channel activity in brainstem interneurons. T-type Ca(2+) channels were downregulated by dopamine receptor activation acting via protein kinase C, which in turn reduced neuronal output. These effects occurred without altering AIS Na(+) or somatodendritic T-type channel activity and could be mediated by endogenous dopamine sources present in the auditory brainstem. This pathway represents a new mechanism to inhibit neurons by specifically regulating Ca(2+) channels directly involved in action potential initiation.	[Bender, Kevin J.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; [Bender, Kevin J.; Ford, Christopher P.; Trussell, Laurence O.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Bender, KJ (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	benderke@ohsu.edu			NIH [K99DC011080, K99DA026417, NS028901]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028901, R37NS028901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC011080, R01DC004450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA026417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to J. Trapani, J. Deignan, and members of the Trussed and Williams labs for comments, and to J. Williams for reading the manuscript. We thank D. Grandy and J. Williams for knockout and transgenic mice, and to A. Truitt, M. Grandy, K. Suchland, A. Matsui, and N. Quillinan for genotyping expertise. This research was supported by NIH grants K99DC011080 (K.J.B.), K99DA026417 (C.P.F.), and NS028901 (LOT.).	Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; BERREBI AS, 1990, J NEUROCYTOL, V19, P643, DOI 10.1007/BF01188033; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Callewaert G, 1996, J PHYSIOL-LONDON, V495, P641, DOI 10.1113/jphysiol.1996.sp021622; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cardell M, 1998, NEUROSCIENCE, V82, P709; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Chen BT, 2001, J NEUROSCI, V21, P7841, DOI 10.1523/JNEUROSCI.21-19-07841.2001; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; Dai Y, 2009, J NEUROPHYSIOL, V101, P112, DOI 10.1152/jn.01373.2007; Darrow KN, 2006, J COMP NEUROL, V498, P403, DOI 10.1002/cne.21050; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Ford CP, 2009, J NEUROSCI, V29, P13344, DOI 10.1523/JNEUROSCI.3546-09.2009; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; Glaser S, 2003, AM J PHYSIOL-GASTR L, V284, pG683, DOI 10.1152/ajpgi.00302.2002; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; Kim Y, 2007, J NEUROPHYSIOL, V97, P1705, DOI 10.1152/jn.00536.2006; KLEPPER A, 1991, BRAIN RES, V557, P190, DOI 10.1016/0006-8993(91)90134-H; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kothmann WW, 2009, J NEUROSCI, V29, P14903, DOI 10.1523/JNEUROSCI.3436-09.2009; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; Kress GJ, 2008, J NEUROPHYSIOL, V100, P281, DOI 10.1152/jn.90295.2008; Kress GJ, 2010, HIPPOCAMPUS, V20, P558, DOI 10.1002/hipo.20667; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Lambert RC, 2006, CNS NEUROL DISORD-DR, V5, P611, DOI 10.2174/187152706779025544; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LLEDO PM, 1992, NEURON, V8, P455, DOI 10.1016/0896-6273(92)90273-G; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Luscher C, 1996, J PHYSIOL-LONDON, V490, P319; MARCHETTI C, 1986, PFLUG ARCH EUR J PHY, V406, P104, DOI 10.1007/BF00586670; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; Molitor SC, 2003, J NEUROPHYSIOL, V89, P2225, DOI 10.1152/jn.00709.2002; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; O'Flaherty JT, 2001, J BIOL CHEM, V276, P24743, DOI 10.1074/jbc.M101093200; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Osorio N, 2005, J PHYSIOL-LONDON, V569, P801, DOI 10.1113/jphysiol.2005.097022; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Petzold GC, 2009, NAT NEUROSCI, V12, P784, DOI 10.1038/nn.2335; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; Roberts MT, 2008, J NEUROSCI, V28, P9440, DOI 10.1523/JNEUROSCI.2226-08.2008; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; Rosker C, 2007, AM J PHYSIOL-CELL PH, V293, pC783, DOI 10.1152/ajpcell.00070.2007; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; Shore SE, 2006, HEARING RES, V216, P90, DOI 10.1016/j.heares.2006.01.006; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; STAMFORD JA, 1990, J NEUROSCI METH, V34, P67, DOI 10.1016/0165-0270(90)90043-F; STANZIONE P, 1984, NEUROSCIENCE, V13, P1105, DOI 10.1016/0306-4522(84)90291-4; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Uebachs M, 2006, J PHYSIOL-LONDON, V571, P519, DOI 10.1113/jphysiol.2005.103614; WOUTERLOOD FG, 1984, J COMP NEUROL, V227, P136, DOI 10.1002/cne.902270114; YASUDA R, 2004, SCI STKE, P15; YOUNG ED, 2001, INTEGRATIVE FUNCTION, P160; Zhao YL, 2006, J NEUROSCI, V26, P8847, DOI 10.1523/JNEUROSCI.1919-06.2006; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	83	78	78	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 4	2010	68	3					500	511		10.1016/j.neuron.2010.09.026	http://dx.doi.org/10.1016/j.neuron.2010.09.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040850	Green Accepted, Bronze			2022-12-24	WOS:000284255800017
J	Cury, KM; Uchida, N				Cury, Kevin M.; Uchida, Naoshige			Robust Odor Coding via Inhalation-Coupled Transient Activity in the Mammalian Olfactory Bulb	NEURON			English	Article							MITRAL CELL-ACTIVITY; SINGLE NEURONS; PATTERNED RESPONSE; SNIFFING BEHAVIOR; SPIKE LATENCIES; DISCRIMINATION; RATS; DYNAMICS; STIMULUS; REPRESENTATIONS	It has been proposed that a single sniff generates a "snapshot" of the olfactory world. However, odor coding on this timescale is poorly understood, and it is not known whether coding is invariant to changes in respiration frequency. We investigated this by recording spike trains from the olfactory bulb in awake, behaving rats. During rapid sniffing, odor inhalation triggered rapid and reliable cell- and odor-specific temporal spike patterns. These fine temporal responses conveyed substantial odor information within the first similar to 100 ms, and correlated with behavioral discrimination time on a trial-by-trial basis. Surprisingly, the initial transient portions of responses were highly conserved between rapid sniffing and slow breathing. Firing rates over the entire respiration cycle carried less odor information, did not correlate with behavior, and were poorly conserved across respiration frequency. These results suggest that inhalation-coupled transient activity forms a robust neural code that is invariant to changes in respiration behavior.	[Cury, Kevin M.; Uchida, Naoshige] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University	Uchida, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, 16 Divin Ave, Cambridge, MA 02138 USA.	uchida@mcb.harvard.edu		Cury, Kevin Michael/0000-0002-3740-4151; Uchida, Naoshige/0000-0002-5755-9409	Smith Family Young Investigator Award; Milton Fund; Alfred Sloan Foundation; Harvard University	Smith Family Young Investigator Award; Milton Fund; Alfred Sloan Foundation(Alfred P. Sloan Foundation); Harvard University	We thank John Assad, Kenny Blum, Katherine Gaudry, Rafi Haddad, Gabriel Kreiman, Zachary Mainen, Ofer Mazor, Markus Meister, Keiji Miura, Venkatesh Murthy, Tomokazu Sato, Gary Sing, Rachel Wilson, Alice Wang, and other members of the Uchida lab for valuable comments and discussions. We are grateful to Ed Soucy for technical support. This work was supported by the Smith Family Young Investigator Award, Milton Fund, and Alfred Sloan Foundation, and startup funding from Harvard University.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Cang JH, 2003, J NEUROSCI, V23, P4108; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Green DM, 1966, SIGNAL DETECTION THE; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Luce RD, 1986, RESPONSE TIMES THEIR; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Mainen ZF, 2006, CURR OPIN NEUROBIOL, V16, P429, DOI 10.1016/j.conb.2006.06.003; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MEREDITH M, 1978, J GEN PHYSIOL, V71, P615, DOI 10.1085/jgp.71.6.615; Moazzezi R, 2008, NETWORK-COMP NEURAL, V19, P236, DOI 10.1080/09548980802314917; Oka Y, 2009, J NEUROSCI, V29, P12070, DOI 10.1523/JNEUROSCI.1415-09.2009; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Rinberg D, 2006, SEMIN CELL DEV BIOL, V17, P454, DOI 10.1016/j.semcdb.2006.04.009; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Schoenfeld TA, 2006, CHEM SENSES, V31, P131, DOI 10.1093/chemse/bjj015; Scott JW, 2006, CHEM SENSES, V31, P119, DOI 10.1093/chemse/bjj013; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wesson DW, 2008, CHEM SENSES, V33, P581, DOI 10.1093/chemse/bjn029; Wesson DW, 2009, J NEUROPHYSIOL, V101, P1089, DOI 10.1152/jn.90981.2008; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2008, CURR OPIN NEUROBIOL, V18, P408, DOI 10.1016/j.conb.2008.08.015; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; [No title captured]	64	195	198	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 4	2010	68	3					570	585		10.1016/j.neuron.2010.09.040	http://dx.doi.org/10.1016/j.neuron.2010.09.040			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680SX	21040855	Bronze			2022-12-24	WOS:000284255800022
J	Dhawale, AK; Hagiwara, A; Bhalla, US; Murthy, VN; Albeanu, DF				Dhawale, Ashesh K.; Hagiwara, Akari; Bhalla, Upinder S.; Murthy, Venkatesh N.; Albeanu, Dinu F.			Non-redundant odor coding by sister mitral cells revealed by light addressable glomeruli in the mouse	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; MITRAL/TUFTED CELLS; IN-VIVO; FUNCTIONAL-ORGANIZATION; OPTICAL INTERROGATION; NEURAL CIRCUITRY; TRANSGENIC MICE; CORTEX; INHIBITION; REPRESENTATIONS	Sensory inputs frequently converge on the brain in a spatially organized manner, often with overlapping inputs to multiple target neurons. Whether the responses of target neurons with common inputs become decorrelated depends on the contribution of local circuit interactions. We addressed this issue in the olfactory system using newly generated transgenic mice that express channelrhodopsin-2 in all of the olfactory sensory neurons. By selectively stimulating individual glomeruli with light, we identified mitral/tufted cells that receive common input (sister cells). Sister cells had highly correlated responses to odors, as measured by average spike rates, but their spike timing in relation to respiration was differentially altered. In contrast, non-sister cells correlated poorly on both of these measures. We suggest that sister mitral/tufted cells carry two different channels of information: average activity representing shared glomerular input and phase-specific information that refines odor representations and is substantially independent for sister cells.	[Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hagiwara, Akari; Murthy, Venkatesh N.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Dhawale, Ashesh K.; Albeanu, Dinu F.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Dhawale, Ashesh K.; Bhalla, Upinder S.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Harvard University; Harvard University; Cold Spring Harbor Laboratory; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu; albeanu@cshl.edu		Murthy, Venkatesh/0000-0003-2443-4252; Dhawale, Ashesh/0000-0001-7438-1115; Albeanu, Dinu/0000-0001-7825-7744	Cold Spring Harbor Laboratory; International Society for Neurochemistry (Tata Institute of Fundamental Research); Merck; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011291] Funding Source: NIH RePORTER	Cold Spring Harbor Laboratory; International Society for Neurochemistry (Tata Institute of Fundamental Research); Merck(Merck & Company); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the Genome Manipulation Facility at Harvard University for help with generating the ORC mice. We are grateful to M. Meister, A. Kepecs, G. Turner, A. Khan, S. Kumari and P. Gupta for comments on the manuscript. B. Burbach, H. Cho, R. Eifert and M. Davis provided excellent technical support. We thank G. Otazu and S. Ranade for advice on building tetrodes and H. Oviedo and A. Zador for access to the laser-scanning photostimulation rig. Our special thanks go to Megabus for swift transportation and to the House of Marks. A. K. D. and D. F. A. were supported by the Cold Spring Harbor Laboratory Fellows Program. Additional support for A. K. D. was provided by the International Society for Neurochemistry, Sarojini Damodaran fellowship (Tata Institute of Fundamental Research) and Merck.	Adams Douglas, 1979, HITCHHIKERS GUIDE GA; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Gire DH, 2009, J NEUROSCI, V29, P13454, DOI 10.1523/JNEUROSCI.2368-09.2009; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Kosaka T, 2004, NEUROSCI RES, V49, P373, DOI 10.1016/j.neures.2004.04.003; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; MONOD B, 1989, BEHAV BRAIN RES, V33, P51, DOI 10.1016/S0166-4328(89)80018-X; MOULY AM, 1986, BEHAV BRAIN RES, V21, P1, DOI 10.1016/0166-4328(86)90054-9; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Quirk MC, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.013.2009; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	150	151	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1404	U183		10.1038/nn.2673	http://dx.doi.org/10.1038/nn.2673			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953197	Green Accepted			2022-12-24	WOS:000283658200022
J	Scott, CE; Wynn, SL; Sesay, A; Cruz, C; Cheung, M; Gaviro, MVG; Booth, S; Gao, B; Cheah, KSE; Lovell-Badge, R; Briscoe, J				Scott, Charlotte E.; Wynn, Sarah L.; Sesay, Abdul; Cruz, Catarina; Cheung, Martin; Gaviro, Maria-Victoria Gomez; Booth, Sarah; Gao, Bo; Cheah, Kathryn S. E.; Lovell-Badge, Robin; Briscoe, James			SOX9 induces and maintains neural stem cells	NATURE NEUROSCIENCE			English	Article							SONIC HEDGEHOG; SELF-RENEWAL; GENE-EXPRESSION; EPENDYMAL CELLS; CNS PRECURSOR; GLIAL-CELLS; IN-VITRO; MOUSE; DIFFERENTIATION; PROLIFERATION	Neural stem cells (NSCs) are uncommitted cells of the CNS defined by their multipotentiality and ability to self renew. We found these cells to not be present in substantial numbers in the CNS until after embryonic day (E) 10.5 in mouse and E5 in chick. This coincides with the induction of SOX9 in neural cells. Gain- and loss-of-function studies indicated that SOX9 was essential for multipotent NSC formation. Moreover, Sonic Hedgehog was able to stimulate precocious generation of NSCs by inducing Sox9 expression. SOX9 was also necessary for the maintenance of multipotent NSCs, as shown by in vivo fate mapping experiments in the adult subependymal zone and olfactory bulbs. In addition, loss of SOX9 led ependymal cells to adopt a neuroblast identity. These data identify a functional link between extrinsic and intrinsic mechanisms of NSCs specification and maintenance, and establish a central role for SOX9 in the process.	[Scott, Charlotte E.; Wynn, Sarah L.; Sesay, Abdul; Gaviro, Maria-Victoria Gomez; Booth, Sarah; Lovell-Badge, Robin] Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, London NW7 1AA, England; [Scott, Charlotte E.; Cruz, Catarina; Cheung, Martin; Briscoe, James] Natl Inst Med Res, Div Dev Neurobiol, MRC, London NW7 1AA, England; [Wynn, Sarah L.; Cheung, Martin; Gao, Bo; Cheah, Kathryn S. E.] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Hong Kong	Lovell-Badge, R (corresponding author), Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, Mill Hill, London NW7 1AA, England.	rlovell@nimr.mrc.ac.uk; jbrisco@nimr.mrc.ac.uk	cruz, catarina/I-1387-2013; Cheung, Martin Chi Hang/C-4235-2009	cruz, catarina/0000-0001-9139-8453; Lovell-Badge, Robin/0000-0001-9364-4179; Gomez-Gaviro, Maria Victoria/0000-0002-8683-5150; Gao, Bo/0000-0002-8684-5199; Cheung, Martin Chi Hang/0000-0002-3471-8534; Briscoe, James/0000-0002-1020-5240	UK Medical Research Council; US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) [U117512772]; Hong Kong Research Grants Council; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Schedl (INSERM U636, Nice) for the conditional Sox9 mutant mice, A. Nagy (Samuel Lunenfeld Research Institute) for the pCall2 vector, W.C.W. Chan for blastocyst injections and production of Z/Sox9 mice and T. Caspary (Emory University) for the Arl13b antibody. The CMV:cre construct was a gift from S.O'Gorman (Salk Institute). Thank you to S. Guioli, F. Guillemot and L. Reynard for critical reading of the manuscript, to C. Andoniadou for advice and training in the ways of neurosphere cultures, to W. Han Yau in the photographics department at NIMR for help with illustrations, to T. Matabanadzo and other biological services staff at NIMR for help with the mouse colonies and other members of our laboratories for discussion and encouragement. This work was supported by the UK Medical Research Council (U117512772), a US National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering) Quantum Grant (R.L.-B. and C.E.S.), and grants from the Hong Kong Research Grants Council and the Hong Kong University Grants Council Area of Excellence Scheme (S.L.W. and K.S.E.C.).	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bien-Willner GA, 2007, HUM MOL GENET, V16, P1143, DOI 10.1093/hmg/ddm061; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kordes U, 2006, J NEURO-ONCOL, V80, P151, DOI 10.1007/s11060-006-9180-7; Kordes U, 2005, DEV BRAIN RES, V157, P209, DOI 10.1016/j.devbrainres.2005.03.009; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Takaki M, 2006, STEM CELLS, V24, P1414, DOI 10.1634/stemcells.2005-0394; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1	45	223	230	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1181	1189		10.1038/nn.2646	http://dx.doi.org/10.1038/nn.2646			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20871603	Green Submitted			2022-12-24	WOS:000282171300009
J	Tchieu, J; Kuoy, E; Chin, MH; Trinh, H; Patterson, M; Sherman, SP; Aimiuwu, O; Lindgren, A; Hakimian, S; Zack, JA; Clark, AT; Pyle, AD; Lowry, WE; Plath, K				Tchieu, Jason; Kuoy, Edward; Chin, Mark H.; Trinh, Hung; Patterson, Michaela; Sherman, Sean P.; Aimiuwu, Otaren; Lindgren, Anne; Hakimian, Shahrad; Zack, Jerome A.; Clark, Amander T.; Pyle, April D.; Lowry, William E.; Plath, Kathrin			Female Human iPSCs Retain an Inactive X Chromosome	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; DOSAGE COMPENSATION; FIBROBLASTS; MICE; METHYLATION; GENERATION	Generating induced pluripotent stem cells (iPSCs) requires massive epigenome reorganization. It is unclear whether reprogramming of female human cells reactivates the inactive X chromosome (Xi), as in mouse. Here we establish that human (h)iPSCs derived from several female fibroblasts under standard culture conditions carry an Xi. Despite the lack of reactivation, the Xi undergoes defined chromatin changes, and expansion of hiPSCs can lead to partial loss of XIST RNA. These results indicate that hiPSCs are epigenetically dynamic and do not display a pristine state of X inactivation with two active Xs as found in some female human embryonic stem cell lines. Furthermore, whereas fibroblasts are mosaic for the Xi, hiPSCs are clonal. This nonrandom pattern of X chromosome inactivation in female hiPSCs, which is maintained upon differentiation, has critical implications for clinical applications and disease modeling, and could be exploited for a unique form of gene therapy for X-linked diseases.	[Tchieu, Jason; Kuoy, Edward; Chin, Mark H.; Trinh, Hung; Patterson, Michaela; Sherman, Sean P.; Aimiuwu, Otaren; Lindgren, Anne; Hakimian, Shahrad; Zack, Jerome A.; Clark, Amander T.; Pyle, April D.; Lowry, William E.; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Jonsson Comprehens Canc Ctr,Mol Biol Inst, Los Angeles, CA 90024 USA; [Tchieu, Jason; Kuoy, Edward; Chin, Mark H.; Trinh, Hung; Patterson, Michaela; Sherman, Sean P.; Aimiuwu, Otaren; Lindgren, Anne; Hakimian, Shahrad; Zack, Jerome A.; Clark, Amander T.; Pyle, April D.; Lowry, William E.; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90024 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Jonsson Comprehens Canc Ctr,Mol Biol Inst, Los Angeles, CA 90024 USA.	kplath@mednet.ucla.edu	Tchieu, Jason/AAG-1551-2020	Tchieu, Jason/0000-0002-9793-9836; Sherman, Sean/0000-0002-6295-0680; Kuoy, Edward/0000-0003-4721-1254; Plath, Kathrin/0000-0001-7796-3372	Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NRSA [T32CA009056]; CIRM [TG2-01169]; NIH [DP20D001686]; CIRM Young Investigator Award [RN1-00564]; NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Alissa Minkovsky for critical reading of the manuscript; Dr. Gustavo Mostoslavsky (Boston University) for providing the STEMCCA reprogramming vector; Dr. Donald Kohn (UCLA) for generating concentrated lentiviral STEMCCA preparations; Dr. Michael Grunstein (UCLA) for providing antibodies; Dr. Nissim Benvenisty (Hebrew University) for expression profiling and karyotyping of various hiPSC lines; Dr. Silvia Diaz-Perez (UCLA). for consultation on X chromosome painting; and Genevieve Kendall, Rebecca Anderson, and Drs. Stan Nelson and Carrie Miceli (ULCA) for providing assistance with DMD-hiPSC RNA isolation and PCR experiments. J.T. is supported by a training grant of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, M.H.C. by a Ruth L. Kirschstein Institutional Training Grant (NRSA # T32CA009056), S.P.S. by CIRM TG2-01169, K.P. by the NIH Director's Young Innovator Award (DP20D001686) and a CIRM Young Investigator Award (RN1-00564), and A.D.P. by the NIH P30 Supplement-# 3P30AR057230-01S1 and Department of Defense (DOD) funds #08109003. W.E.L. holds the Maria Rowena Ross Term Chair in Cell Biology and Biochemistry and is supported by CIRM #RS1-00259-1 and the Basil O'Connor Starter Scholar Award of The March of Dimes. This work was also supported by the CIRM New Cell Line grant to J.A.Z., W.E.L., and K.P.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	41	196	203	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					329	342		10.1016/j.stem.2010.06.024	http://dx.doi.org/10.1016/j.stem.2010.06.024			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20727844	Green Accepted, Bronze			2022-12-24	WOS:000282037800010
J	Lee, Y; Kim, SH; Montell, C				Lee, Youngseok; Kim, Sang Hoon; Montell, Craig			Avoiding DEET through Insect Gustatory Receptors	NEURON			English	Article							CAFFEINE RESPONSE; REPELLENT DEET; DROSOPHILA; TASTE; NEURONS; GENES; SMELL	DEET is the most widely used insect repellent worldwide. In Drosophila olfactory receptor neurons (ORNs), DEET is detected through a mechanism employing the olfactory receptor, OR83b. However, it is controversial as to whether ORNs respond directly to DEET or whether DEET blocks the response to attractive odors. Here, we showed that DEET suppressed feeding behavior in Drosophila, and this effect was mediated by gustatory receptor neurons (GRNs). DEET was potent in suppressing feeding as <0.1% DEET elicited aversive behavior. Inhibition of feeding required multiple gustatory receptors (GRs) expressed in inhibitory GRNs. DEET stimulated action potentials in GRNs that respond to aversive compounds, and this response was lost in the Gr32a, Gr33a, and Gr66a mutants. Since 0.02% DEET elicited action potentials, we conclude that DEET directly activates of GRNs. We suggest that the effectiveness of DEET in pest control owes to its dual action in inducing avoidance simultaneously via GRNs and ORNs.	[Lee, Youngseok; Kim, Sang Hoon; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Lee, Youngseok; Kim, Sang Hoon; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Sensory Biol, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Lee, Youngseok/0000-0003-0459-1138	Samsung; NIDCD [DC007864]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	Samsung(Samsung); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Drs. H. Amrein and T. Tanimura for fly stocks, S.J. Moon for the unpublished Gr33a-GAL4 line, and M. Jin for the drawing in Figure 1E. S.H.K. was supported in part by a Samsung Fellowship. This work was supported by a grant to C.M. from the NIDCD (DC007864).	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Pimentel David, 2009, P83, DOI 10.1007/978-1-4020-8992-3_3; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	24	147	157	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 26	2010	67	4					555	561		10.1016/j.neuron.2010.07.006	http://dx.doi.org/10.1016/j.neuron.2010.07.006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646JA	20797533	Bronze, Green Accepted			2022-12-24	WOS:000281534600006
J	Reiff, DF; Plett, J; Mank, M; Griesbeck, O; Borst, A				Reiff, Dierk F.; Plett, Johannes; Mank, Marco; Griesbeck, Oliver; Borst, Alexander			Visualizing retinotopic half-wave rectified input to the motion detection circuitry of Drosophila	NATURE NEUROSCIENCE			English	Article							LARGE MONOPOLAR CELLS; FRUIT-FLY; CHLORIDE CHANNELS; COMPOUND EYE; LOBULA PLATE; OPTIC LOBE; WILD-TYPE; MELANOGASTER; RETINA; SYSTEM	In the visual system of Drosophila, photoreceptors R1-R6 relay achromatic brightness information to five parallel pathways. Two of them, the lamina monopolar cells L1 and L2, represent the major input lines to the motion detection circuitry. We devised a new method for optical recording of visually evoked changes in intracellular Ca(2+) in neurons using targeted expression of a genetically encoded Ca(2+) indicator. Ca(2+) in single terminals of L2 neurons in the medulla carried no information about the direction of motion. However, we found that brightness decrements (light-OFF) induced a strong increase in intracellular Ca(2+) but brightness increments (light-ON) induced only small changes, suggesting that half-wave rectification of the input signal occurs. Thus, L2 predominantly transmits brightness decrements to downstream circuits that then compute the direction of image motion.	[Reiff, Dierk F.; Plett, Johannes; Mank, Marco; Griesbeck, Oliver; Borst, Alexander] Max Planck Inst Neurobiol, Martinsried, Germany	Max Planck Society	Reiff, DF (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	reiff@neuro.mpg.de		Griesbeck, Oliver/0000-0001-5883-5594				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Buschbeck EK, 1996, J NEUROSCI, V16, P4563; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Clifford CWG, 2002, PROG NEUROBIOL, V68, P409, DOI 10.1016/S0301-0082(02)00154-5; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; COOMBE PE, 1986, J COMP PHYSIOL A, V159, P655, DOI 10.1007/BF00612038; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DOUGLASS JK, 1995, J NEUROSCI, V15, P5596; Douglass JK, 1996, J NEUROSCI, V16, P4551; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franceschini N., 1989, P360; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HASSENSTEIN B, 1952, VERH DTSCH ZOOL GES, V7, P95; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; JARVILEHTO M, 1973, Z ZELLFORSCH MIK ANA, V136, P291, DOI 10.1007/BF00307446; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Molnar A, 2009, J COMPUT NEUROSCI, V27, P569, DOI 10.1007/s10827-009-0170-6; Mronz M, 2008, J EXP BIOL, V211, P2026, DOI 10.1242/jeb.008268; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; SKINGSLEY DR, 1995, J COMP PHYSIOL A, V176, P611, DOI 10.1007/BF01021581; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Tammero LF, 2002, J EXP BIOL, V205, P2785; Tammero LF, 2002, J EXP BIOL, V205, P327; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; VANDOORN AJ, 1982, EXP BRAIN RES, V45, P179, DOI 10.1007/BF00235777; VANSANTEN JPH, 1984, J OPT SOC AM A, V1, P451, DOI 10.1364/JOSAA.1.000451; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; ZETTLER F, 1973, J COMP PHYSIOL, V85, P89, DOI 10.1007/BF00694142; ZETTLER F, 1972, Z VERGL PHYSIOL, V76, P233, DOI 10.1007/BF00303230; ZETTLER F, 1987, J EXP BIOL, V131, P435; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	50	70	70	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2010	13	8					973	U92		10.1038/nn.2595	http://dx.doi.org/10.1038/nn.2595			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	632DK	20622873				2022-12-24	WOS:000280400600016
